Psyllid ID: psy9535

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590---
Protein Sequence
MYLSSDHTTMIGLSFDNIESSKELWMYIEKLTSCPENICLSMPKSKHKSASNLVNQHNQKIKFKLPDKKWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVSISNHSTNNSHL
Secondary Structure (PSIPRED)
ccccccccEEccccccccccccEEEEEEHHHHHccHHHEEEccccccccccHHHHHHccccccccccHHHHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccccccccccEEEEEccccEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHccccccccEEccccccccEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccccccccccccccccccEEccccEEEEEcccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccEEEcccccccccccccccccccccccHHHHHHHHHHcccccccccccccHHcccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cEEEccHHHHHcccHccccccccHHHHHHcccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccEcHHHHHHHHcccccccccHHHHHccccccccEEEcEcccccEEEEEEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHEEEEEcccccEEEEEEEccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHccccEEEccHHHHHHEEccccccHHHHHcHHHEcccccccccEEEEEEEccccccHHHcccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHccccccccccccccccEEccccccccccccccccccccEEEEEEEccccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHHccccEEEEccHHHHHEccccccccHcHccHHEEEcccccccccccEEEEEcccccHHHcccccccccHHHHHHHEEEHHHHcccccccccccHHHHHHHHHHHccccHHccccccccccc
Coil and Loop (DISEMBL)
mylssdhttmiglsfdniESSKELWMYIEKLtscpeniclsmpkskhksaSNLVNQHNQKIKFKLPDKKWLQEVIQQEEANNKTEYIGELIAFTfcdleratdgfnrkpyprrgnklgegqfgtVYYGKLKNGMEIAVKTLennanysssnsdnteaaMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRlarvnntppldsnkrYSIALGVAEALHYLHslskpiihrdvksanvlldenfvpklgdfgivkmsetsnmktmytenltgtrpymppeamhcqistktdvFSYGVILLELLtgmkpiddnnTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCNSLANLyvgkvssrtqennninwelhytGIPVIILDTGETKQCQLFKlarvnntppldsnkrYSIALGVAEALHYLHslskpiihrdvksanvlldenfvpklgdfgivkmsetsnvktmytenltgtrpymppeamhcqistktdvfsygaqiktqhitnvdiadrERYYSLqtmlpghhegdhvsisnhstnnshl
Flexible Loop (DISEMBL)
mylssdhttmigLSFDNIESSKELWMYIEKLTSCPENICLSMPKSKHKSASNLVNQHNQKIKFKLPDKKWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDgfnrkpyprrgnklgegqfGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDenfvpklgdfgivkmsetsnmkTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVIILDTGETKQCQLFKLarvnntppldsNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEnfvpklgdfgivkmsetsnvktmYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKtqhitnvdiaDRERYYSLQTMLPGhhegdhvsisnhstnnshl
Low Complexity Region (SEG)
MYLSSDHTTMIGLSFDNIESSKELWMYIEKLTSCPENICLSMPKSKHKSASNLVNQHNQKIKFKLPDKKWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEnnanysssnsdnTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVSISNHSTNNSHL
Disordered region (IsUnstruct)
*********MIGLSFDNIESSKELWMYIEKLTSCPENICLS*******************IKFKLPDKKWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTL***************AAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET*NMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTML*********************
Disordered Region (DISOPRED)
*****D*TTMIGLS*****SSKELWMYIEKLTSCPENICLSMPKS*********************************************IAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVK*****************AAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVIILDTGETKQCQLFKLARVN**PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVSISNHSTNNS*L
Disordered Region (DISEMBL)
********TMIGLSFDNIESSKELWMYIEKLTSCPENICLSMP*********LVNQHNQKIKFKLPDKKWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVSIS*********
Disordered Region (DISPRO)
MYLSSDHTTMIGLSFDNIESSKELWMYIEKLTSCPENICLSMP********************************************GELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENN*******SD*TEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVSISNHSTN****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MYLSSDHTTMIGLSFDNIESSKELWMYIEKLTSCPENICLSMPKSKHKSASNLVNQHNQKIKFKLPDKKWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVSISNHSTNNSHL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	593	2.2.26 [Sep-21-2011]
Q1RMT8	461	Interleukin-1 receptor-as	yes	N/A	0.480	0.618	0.358	4e-48
Q9NWZ3	460	Interleukin-1 receptor-as	no	N/A	0.470	0.606	0.354	8e-47
Q8R4K2	459	Interleukin-1 receptor-as	yes	N/A	0.376	0.485	0.396	8e-45
Q0WVM4	634	Probable LRR receptor-lik	yes	N/A	0.468	0.438	0.378	1e-43
Q8VYT3	648	Probable LRR receptor-lik	no	N/A	0.482	0.441	0.368	8e-42
Q93ZS4	632	Protein NSP-INTERACTING K	no	N/A	0.473	0.444	0.357	4e-41
C0LGU5	614	Probable LRR receptor-lik	no	N/A	0.505	0.488	0.353	5e-41
Q94F62	615	BRASSINOSTEROID INSENSITI	no	N/A	0.475	0.458	0.368	2e-40
C0LGT1	613	Probable LRR receptor-lik	no	N/A	0.473	0.458	0.366	3e-40
Q9SKG5	620	Somatic embryogenesis rec	no	N/A	0.475	0.454	0.380	3e-40

>sp|Q1RMT8|IRAK4_BOVIN Interleukin-1 receptor-associated kinase 4 OS=Bos taurus GN=IRAK4 PE=2 SV=1

 Score =  193 bits (490), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 109/304 (35%), Positives = 180/304 (59%), Gaps = 19/304 (6%)

Query: 92  AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSN 151
           +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L    + S+  
Sbjct: 168 SFSFFELKDVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-RTVAVKKLAAMVDISTEE 226

Query: 152 SDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR 210
                        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL DRL+ 
Sbjct: 227 LKQQ---------FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 277

Query: 211 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
           ++ TPPL  N R  IA G A  L YLH      IHRD+KSAN+LLDE+F  K+ DFG+ +
Sbjct: 278 LDGTPPLSWNMRCKIAQGAANGLSYLHENHH--IHRDIKSANILLDEDFTAKISDFGLAR 335

Query: 271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 329
            SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++   
Sbjct: 336 ASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 394

Query: 330 ---ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD 386
              +     + ++E  + + +D++  + + T +ET+  +   +C   +K+KR  ++ +  
Sbjct: 395 QLLLDIKEEIEDEEKTIEDYVDRKMNDIDSTSIETMYSVA-SQCLHEKKNKRPDIKKVQQ 453

Query: 387 LLSK 390
           LL +
Sbjct: 454 LLEE 457

Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections.
Bos taurus (taxid: 9913)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9NWZ3|IRAK4_HUMAN Interleukin-1 receptor-associated kinase 4 OS=Homo sapiens GN=IRAK4 PE=1 SV=1

 Score =  188 bits (478), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 110/310 (35%), Positives = 181/310 (58%), Gaps = 31/310 (10%)

Query: 92  AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSN 151
           +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct: 167 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL---------- 215

Query: 152 SDNTEAAMIPILL------FENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSL 204
                AAM+ I        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL
Sbjct: 216 -----AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 270

Query: 205 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 264
            DRL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 271 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 328

Query: 265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
           DFG+ + SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +
Sbjct: 329 DFGLARASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 387

Query: 325 DDNNT----ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS 380
           D++      +     + ++E  + + +DK+  + + T VE +  +   +C   +K+KR  
Sbjct: 388 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA-SQCLHEKKNKRPD 446

Query: 381 MRDIVDLLSK 390
           ++ +  LL +
Sbjct: 447 IKKVQQLLQE 456

Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8R4K2|IRAK4_MOUSE Interleukin-1 receptor-associated kinase 4 OS=Mus musculus GN=Irak4 PE=1 SV=1

 Score =  182 bits (461), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 94/237 (39%), Positives = 146/237 (61%), Gaps = 14/237 (5%)

Query: 92  AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSN 151
           +F+F +L+  T+ F+ +P    GN++GEG FG VY G + N + +AVK L      S+  
Sbjct: 167 SFSFHELKSITNNFDEQPASAGGNRMGEGGFGVVYKGCVNNTI-VAVKKLGAMVEISTEE 225

Query: 152 SDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR 210
                        F+ E++ ++ C+H NL+ LLG  ++  N C+VY YM NGSL DRL+ 
Sbjct: 226 LKQQ---------FDQEIKVMATCQHENLVELLGFSSDSDNLCLVYAYMPNGSLLDRLSC 276

Query: 211 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
           ++ TPPL  + R  +A G A  + +LH      IHRD+KSAN+LLD++F  K+ DFG+ +
Sbjct: 277 LDGTPPLSWHTRCKVAQGTANGIRFLHENHH--IHRDIKSANILLDKDFTAKISDFGLAR 334

Query: 271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDN 327
            S     +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLEL+TG+  +D+N
Sbjct: 335 AS-ARLAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLELITGLAAVDEN 390

Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1

 Score =  178 bits (451), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 118/312 (37%), Positives = 169/312 (54%), Gaps = 34/312 (10%)

Query: 87  IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNAN 146
           +G L +FTF +L  ATDGF+ K        LG G FG VY GK  +G  +AVK L++  N
Sbjct: 281 LGNLRSFTFRELHVATDGFSSKSI------LGAGGFGNVYRGKFGDGTVVAVKRLKD-VN 333

Query: 147 YSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLY 205
            +S NS            F  E++ +S   H NLLRL+G C ++    +VY YM NGS+ 
Sbjct: 334 GTSGNSQ-----------FRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVA 382

Query: 206 DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPKLG 264
            RL      P LD N R  IA+G A  L YLH    P IIHRDVK+AN+LLDE F   +G
Sbjct: 383 SRL---KAKPALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVG 439

Query: 265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM-- 321
           DFG+ K+   ++  +  T  + GT  ++ PE +   Q S KTDVF +G++LLEL+TGM  
Sbjct: 440 DFGLAKL--LNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRA 497

Query: 322 ----KPIDDNNTILYYYLVVEQEVPVREVLDKEAG-EWNETHVETLIGIVFEKCCVFEKD 376
               K +     +L +   + +E+ V E++D+E G  ++   V  ++ +    C  F   
Sbjct: 498 LEFGKSVSQKGAMLEWVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVAL-LCTQFLPA 556

Query: 377 KRASMRDIVDLL 388
            R  M ++V +L
Sbjct: 557 HRPKMSEVVQML 568

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1

 Score =  172 bits (435), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 119/323 (36%), Positives = 178/323 (55%), Gaps = 37/323 (11%)

Query: 76  QQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGME 135
           +QEE     + +G L +FTF +L   TDGF+ K      N LG G FG VY GKL +G  
Sbjct: 277 KQEEG---LQGLGNLRSFTFRELHVYTDGFSSK------NILGAGGFGNVYRGKLGDGTM 327

Query: 136 IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCI 194
           +AVK L++  N +S +S            F  E++ +S   H NLLRL+G C  +    +
Sbjct: 328 VAVKRLKD-INGTSGDSQ-----------FRMELEMISLAVHKNLLRLIGYCATSGERLL 375

Query: 195 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANV 253
           VY YM NGS+  +L    + P LD N R  IA+G A  L YLH    P IIHRDVK+AN+
Sbjct: 376 VYPYMPNGSVASKL---KSKPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANI 432

Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGV 312
           LLDE F   +GDFG+ K+   ++  +  T  + GT  ++ PE +   Q S KTDVF +G+
Sbjct: 433 LLDECFEAVVGDFGLAKL--LNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGI 490

Query: 313 ILLELLTGMKPIDDNNTI------LYYYLVVEQEVPVREVLDKEAG-EWNETHVETLIGI 365
           +LLEL+TG++ ++   T+      L +   + +E+ V E+LD+E G  +++  V  ++ +
Sbjct: 491 LLLELITGLRALEFGKTVSQKGAMLEWVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQV 550

Query: 366 VFEKCCVFEKDKRASMRDIVDLL 388
               C  +    R  M ++V +L
Sbjct: 551 AL-LCTQYLPAHRPKMSEVVLML 572

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1

 Score =  170 bits (430), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 112/313 (35%), Positives = 171/313 (54%), Gaps = 32/313 (10%)

Query: 87  IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNAN 146
           +G L  +TF +L  AT+ FN K      N LG G +G VY G L +G  +AVK L++  N
Sbjct: 283 LGHLKRYTFKELRSATNHFNSK------NILGRGGYGIVYKGHLNDGTLVAVKRLKD-CN 335

Query: 147 YSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLY 205
            +              + F+ EV+T+S   H NLLRL G C+ N    +VY YM NGS+ 
Sbjct: 336 IAGGE-----------VQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVA 384

Query: 206 DRLA-RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPKL 263
            RL   +   P LD ++R  IA+G A  L YLH    P IIHRDVK+AN+LLDE+F   +
Sbjct: 385 SRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVV 444

Query: 264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMK 322
           GDFG+ K+ +  +  +  T  + GT  ++ PE +   Q S KTDVF +G++LLEL+TG K
Sbjct: 445 GDFGLAKLLD--HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQK 502

Query: 323 PID------DNNTILYYYLVVEQEVPVREVLDKEAGE-WNETHVETLIGIVFEKCCVFEK 375
            +D          +L +   + QE  +++++DK+  + ++   +E ++ +    C  F  
Sbjct: 503 ALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVAL-LCTQFNP 561

Query: 376 DKRASMRDIVDLL 388
             R  M +++ +L
Sbjct: 562 SHRPKMSEVMKML 574

Involved in defense response to geminivirus infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1

 Score =  169 bits (428), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 121/342 (35%), Positives = 177/342 (51%), Gaps = 42/342 (12%)

Query: 70  WLQEVIQQEEANNKTEY-IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYG 128
           W +  + +       E+ IG L  F+F +++ AT  F+ K      N LG+G FG VY G
Sbjct: 264 WHRSRLSRSHVQQDYEFEIGHLKRFSFREIQTATSNFSPK------NILGQGGFGMVYKG 317

Query: 129 KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI----LLFENEVQTLSQCKHVNLLRLL 184
            L NG  +AVK L++                 PI    + F+ EV+ +    H NLLRL 
Sbjct: 318 YLPNGTVVAVKRLKD-----------------PIYTGEVQFQTEVEMIGLAVHRNLLRLF 360

Query: 185 GLCNNIM-NCIVYEYMCNGSLYDRLA-RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP 242
           G C       +VY YM NGS+ DRL       P LD N+R SIALG A  L YLH    P
Sbjct: 361 GFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRRISIALGAARGLVYLHEQCNP 420

Query: 243 -IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-Q 300
            IIHRDVK+AN+LLDE+F   +GDFG+ K+ +  +  +  T  + GT  ++ PE +   Q
Sbjct: 421 KIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRD--SHVTTAVRGTIGHIAPEYLSTGQ 478

Query: 301 ISTKTDVFSYGVILLELLTGMKPIDDNN------TILYYYLVVEQEVPVREVLDKE-AGE 353
            S KTDVF +GV++LEL+TG K ID  N       IL +   ++ E    E++D++  GE
Sbjct: 479 SSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWVRTLKAEKRFAEMVDRDLKGE 538

Query: 354 WNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVC 395
           +++  +E ++ +    C     + R  M  ++ +L   +  C
Sbjct: 539 FDDLVLEEVVELAL-LCTQPHPNLRPRMSQVLKVLEGLVEQC 579

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2

 Score =  167 bits (423), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 116/315 (36%), Positives = 165/315 (52%), Gaps = 33/315 (10%)

Query: 86  YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNA 145
           ++G+L  F+  +L+ A+D F+ K      N LG G FG VY G+L +G  +AVK L+   
Sbjct: 270 HLGQLKRFSLRELQVASDNFSNK------NILGRGGFGKVYKGRLADGTLVAVKRLKEER 323

Query: 146 NYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL 204
                            L F+ EV+ +S   H NLLRL G C       +VY YM NGS+
Sbjct: 324 TQGGE------------LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 371

Query: 205 YDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPK 262
              L  R  + PPLD  KR  IALG A  L YLH    P IIHRDVK+AN+LLDE F   
Sbjct: 372 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 431

Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM 321
           +GDFG+ K+ +  +  T  T  + GT  ++ PE +   + S KTDVF YGV+LLEL+TG 
Sbjct: 432 VGDFGLAKLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 489

Query: 322 KPI-------DDNNTILYYYLVVEQEVPVREVLDKE-AGEWNETHVETLIGIVFEKCCVF 373
           +         DD+  +L +   + +E  +  ++D +  G + +  VE LI +    C   
Sbjct: 490 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL-LCTQS 548

Query: 374 EKDKRASMRDIVDLL 388
              +R  M ++V +L
Sbjct: 549 SPMERPKMSEVVRML 563

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1

 Score =  167 bits (422), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 115/314 (36%), Positives = 166/314 (52%), Gaps = 33/314 (10%)

Query: 87  IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNAN 146
            G+L  F + +L+ ATD F+ K      N LG+G FG VY G L +  ++AVK L    +
Sbjct: 272 FGQLKRFAWRELQLATDNFSEK------NVLGQGGFGKVYKGVLPDNTKVAVKRL---TD 322

Query: 147 YSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLY 205
           + S   D           F+ EV+ +S   H NLLRL+G C       +VY +M N SL 
Sbjct: 323 FESPGGDAA---------FQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLA 373

Query: 206 DRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPKL 263
            RL  +    P LD   R  IALG A    YLH    P IIHRDVK+ANVLLDE+F   +
Sbjct: 374 HRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 433

Query: 264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMK 322
           GDFG+ K+ +    +T  T  + GT  ++ PE +   + S +TDVF YG++LLEL+TG +
Sbjct: 434 GDFGLAKLVDVR--RTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 491

Query: 323 PID-------DNNTILYYYLVVEQEVPVREVLDKEA-GEWNETHVETLIGIVFEKCCVFE 374
            ID       D+  +L +   +E+E  +  ++DK   GE+ +  VE +I +    C    
Sbjct: 492 AIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVAL-LCTQGS 550

Query: 375 KDKRASMRDIVDLL 388
            + R  M ++V +L
Sbjct: 551 PEDRPVMSEVVRML 564

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2

 Score =  166 bits (421), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 120/315 (38%), Positives = 164/315 (52%), Gaps = 33/315 (10%)

Query: 86  YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNA 145
           ++G+L  FT  +L  ATD F+ K      N LG G FG VY G+L +G  +AVK L+   
Sbjct: 275 HLGQLKRFTLRELLVATDNFSNK------NVLGRGGFGKVYKGRLADGNLVAVKRLKEER 328

Query: 146 NYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL 204
                            L F+ EV+ +S   H NLLRL G C       +VY YM NGS+
Sbjct: 329 TKGGE------------LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 376

Query: 205 YDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHS-LSKPIIHRDVKSANVLLDENFVPK 262
              L  R    P LD  KR  IALG A  L YLH    + IIHRDVK+AN+LLDE F   
Sbjct: 377 ASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAV 436

Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM 321
           +GDFG+ K+   ++  +  T  + GT  ++ PE +   + S KTDVF YGV+LLEL+TG 
Sbjct: 437 VGDFGLAKLMNYND--SHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 494

Query: 322 KPI-------DDNNTILYYYLVVEQEVPVREVLDKE-AGEWNETHVETLIGIVFEKCCVF 373
           K         DD+  +L +   V +E  +  ++D E  G++ ET VE LI +    C   
Sbjct: 495 KAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMAL-LCTQS 553

Query: 374 EKDKRASMRDIVDLL 388
              +R  M ++V +L
Sbjct: 554 SAMERPKMSEVVRML 568

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	593
291239163	598	PREDICTED: hypothetical protein [Saccogl	0.470	0.466	0.406	1e-52
326911443	419	PREDICTED: interleukin-1 receptor-associ	0.465	0.658	0.379	6e-52
242009174	485	serine-threonine protein kinase, plant-t	0.480	0.587	0.371	3e-51
224093672	464	PREDICTED: interleukin-1 receptor-associ	0.465	0.594	0.372	1e-49
213514070	372	interleukin-1 receptor-associated kinase	0.495	0.790	0.374	2e-49
348512857	461	PREDICTED: interleukin-1 receptor-associ	0.559	0.720	0.350	2e-49
384402280	467	interleukin-1 receptor-associated kinase	0.504	0.640	0.376	3e-49
269993241	474	interleukin-1 receptor-associated kinase	0.477	0.597	0.382	4e-49
318103835	459	interleukin-1 receptor-associated kinase	0.483	0.625	0.380	6e-48
269993243	525	interleukin-1 receptor-associated kinase	0.495	0.56	0.368	3e-47

>gi|291239163|ref|XP_002739502.1| PREDICTED: hypothetical protein [Saccoglossus kowalevskii]

 Score =  214 bits (545), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 126/310 (40%), Positives = 171/310 (55%), Gaps = 31/310 (10%)

Query: 93  FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS 152
            ++ DL   TDGFN       GN +GEG FG V+ G   NG ++A+K L+          
Sbjct: 307 LSYTDLSHMTDGFNISKQEDGGNFIGEGAFGIVFLGNASNGNKLAIKKLK---------- 356

Query: 153 DNTEAAMIPIL-----LFENEVQTLSQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSL 204
                   P+L      F+NE++TL +CKHVNL+ LLG    CN++  C+VYEYMCNGSL
Sbjct: 357 ----VGDTPLLSRITEQFKNEIKTLFRCKHVNLVPLLGYSCDCNHL--CLVYEYMCNGSL 410

Query: 205 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 264
            DRL    NTPPL    R SI+  VA+ + YLHS  + +IHRD+KSANVLLDENFV K+G
Sbjct: 411 QDRLMCNGNTPPLSWTTRVSISKDVAKGITYLHS--ENLIHRDIKSANVLLDENFVAKVG 468

Query: 265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
           DFG+++           T  + GT PYMP EA    I+ K D +SYGV+LLE++TG+   
Sbjct: 469 DFGLIRPGPEIGHSITRTSTVFGTSPYMPKEAFSGTITPKQDTYSYGVVLLEIMTGLPVF 528

Query: 325 DDNNTILYYYLVVEQEVPVRE----VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS 380
           D++         VE E    E    ++D    +WNE  +  L  I   KC    + KR  
Sbjct: 529 DESRKSCDLCSHVEDECDADEDFISIVDSNMNDWNEESITELYLIAL-KCLEHTRKKRPF 587

Query: 381 MRDIVDLLSK 390
           M +I+  + +
Sbjct: 588 MAEILPRIER 597

Source: Saccoglossus kowalevskii

Species: Saccoglossus kowalevskii

Genus: Saccoglossus

Family: Harrimaniidae

Class: Enteropneusta

Phylum: Hemichordata

Superkingdom: Eukaryota

>gi|326911443|ref|XP_003202068.1| PREDICTED: interleukin-1 receptor-associated kinase 4-like [Meleagris gallopavo]

 Score =  211 bits (538), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 112/295 (37%), Positives = 180/295 (61%), Gaps = 19/295 (6%)

Query: 93  FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS 152
           F F DLE  T+ F+ +P    GNKLGEG FG V+ G + NG  +AVK L    + S+ + 
Sbjct: 128 FCFRDLENVTNNFDERPESAGGNKLGEGGFGIVFKGYI-NGRNVAVKKLAAVVDVSAQDL 186

Query: 153 DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARV 211
                       F+ E++ +++CKH NL+ LLG  ++    C+VYEYM NGSL DRLA +
Sbjct: 187 KQQ---------FDQEIEIMAKCKHENLVELLGFSSDGAQPCLVYEYMPNGSLLDRLACL 237

Query: 212 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 271
           + TPP+  N R  IA G A  +++LH  +   IHRD+KSAN+LL + +VPK+ DFG+ + 
Sbjct: 238 DGTPPISWNTRCEIAQGTASGINFLHDNNH--IHRDIKSANILLTDKYVPKISDFGLARA 295

Query: 272 SETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT-- 329
           S T   +T+ T+ + GT  YM PEA+  +I+ K+D+FS+GV+LLE++TG+ P+D+N    
Sbjct: 296 SVTFT-RTIMTDRVVGTAAYMAPEALRGEITPKSDIFSFGVVLLEVITGLPPVDENREPQ 354

Query: 330 --ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMR 382
             +     + ++E  V + +D +  +W+ T V  +  +  ++C   +K++R +++
Sbjct: 355 LLLSIKDEIEDEEATVEDYVDVKMSDWDATSVHKMYSLA-DRCLNEKKNRRPNIQ 408

Source: Meleagris gallopavo

Species: Meleagris gallopavo

Genus: Meleagris

Family: Phasianidae

Order: Galliformes

Class: Aves

Phylum: Chordata

Superkingdom: Eukaryota

>gi|242009174|ref|XP_002425367.1| serine-threonine protein kinase, plant-type, putative [Pediculus humanus corporis] gi|212509152|gb|EEB12629.1| serine-threonine protein kinase, plant-type, putative [Pediculus humanus corporis]

 Score =  209 bits (532), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 128/345 (37%), Positives = 180/345 (52%), Gaps = 60/345 (17%)

Query: 88  GELIAFTFCDLERATDGFNRKPYPR----------RGNKLGEGQFGTVYYGKLKNGMEIA 137
           G++I   +  LE+ T+ FN  P  +           G+KLG G FGTVY+G+L+NG ++A
Sbjct: 141 GDVIHIPYSTLEQVTNNFNETPLKKCIHGDGVVHFTGHKLGSGAFGTVYFGELENGKQVA 200

Query: 138 VKTLE-NNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL-CNNIMNCIV 195
           VK L   N N  +               FENE++ LS+ +HVNL+ L+G  C+   NC++
Sbjct: 201 VKKLHMTNINLKNQ--------------FENEIKVLSEYRHVNLVPLIGFSCDTDDNCLI 246

Query: 196 YEYMCNGSLYDRLARVNNTP-----------------------------PLDSNKRYSIA 226
           YE+M NGSL D+L     +P                             PL   KR  IA
Sbjct: 247 YEFMSNGSLLDKLQIKIGSPSVCNSLDANKVLNGMVSNCGSPSAILTDKPLGWMKRIEIA 306

Query: 227 LGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           L V E +++LH+  K P+IHRD+KSAN+LLD     KLGDFG+VK+        M T  +
Sbjct: 307 LDVCEGINFLHNSKKFPLIHRDIKSANILLDHRLTGKLGDFGLVKIKPNLTESKMLTSTV 366

Query: 286 TGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV--PV 343
            GT  YM PEA    +S K DVFSYGV+LLELLTG+ P D+N         VE  V   +
Sbjct: 367 FGTSAYMAPEAFRGDVSVKMDVFSYGVVLLELLTGLPPYDENREGCDLVTYVEDAVDDSI 426

Query: 344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL 388
             +LDK+AG WN    + +      + C+ EK  R  ++++++ L
Sbjct: 427 EFLLDKKAGFWNSEIAQKI--FTLSQSCLEEKKTRPLIKNVLETL 469

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|224093672|ref|XP_002194205.1| PREDICTED: interleukin-1 receptor-associated kinase 4 [Taeniopygia guttata]

 Score =  204 bits (519), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 110/295 (37%), Positives = 174/295 (58%), Gaps = 19/295 (6%)

Query: 93  FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS 152
           F F DLE  T+ F+ +P    GNKLGEG FG V+ G + NG  +AVK L    + S  + 
Sbjct: 173 FLFHDLESITNNFDARPESAGGNKLGEGGFGIVFKGYI-NGKNVAVKKLIAMVDVSVQDL 231

Query: 153 DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARV 211
                       FE E+  +++C+H NL+ LLG  ++    C+VYEYM NGSL DRLA +
Sbjct: 232 KQQ---------FEQEINIMAKCQHENLVELLGFSSDGAQPCLVYEYMPNGSLLDRLACL 282

Query: 212 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 271
           + TPP+  N R  I  G A  +++LH  +   IHRD+KSAN+LL + +VPK+ DFG+ + 
Sbjct: 283 DETPPIPWNMRCKIVQGTANGINFLHENNH--IHRDIKSANILLTDTYVPKISDFGLARA 340

Query: 272 SETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTIL 331
           S T   +T+ TE + GT  YM PEA+  +I+ K+D+FS+GV+LLE++TG+ P+D+N    
Sbjct: 341 SVTFT-QTIMTERIVGTAAYMAPEALRGEITPKSDIFSFGVVLLEIITGLPPVDENREPQ 399

Query: 332 YYYLVV----EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMR 382
               +     ++E  + + +D +  +W+   +  +  I  ++C   +K++R  ++
Sbjct: 400 LLLTIKDEIEDEEATIEDYVDVKMSDWDVPSIHKMYSIA-DRCLNDKKNRRPDIK 453

Source: Taeniopygia guttata

Species: Taeniopygia guttata

Genus: Taeniopygia

Family: Estrildidae

Order: Passeriformes

Class: Aves

Phylum: Chordata

Superkingdom: Eukaryota

>gi|213514070|ref|NP_001135238.1| interleukin-1 receptor-associated kinase 4 [Salmo salar] gi|209155030|gb|ACI33747.1| Interleukin-1 receptor-associated kinase 4 [Salmo salar]

 Score =  203 bits (516), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 118/315 (37%), Positives = 183/315 (58%), Gaps = 21/315 (6%)

Query: 76  QQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGME 135
           Q+++  N T      +  +F +L++ T  F+ +P    G++LGEG FGTVY G L NG  
Sbjct: 53  QEDQEPNGT---AGFLRLSFHELKKITGHFDERPVSDGGSRLGEGGFGTVYKG-LINGKP 108

Query: 136 IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CI 194
           +AVK L +  + S              + F  EVQTL   KH NL+ ++G   +  + C+
Sbjct: 109 VAVKKLHSMEDISLEELS---------VQFIQEVQTLMVLKHENLVDMVGFSRDGHHPCL 159

Query: 195 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 254
           VY YM NGSL DRLA ++ +PPL  ++R  IA+G A  L YLHS     +HRDVKS N+L
Sbjct: 160 VYAYMSNGSLLDRLACLDGSPPLSWHRRCLIAVGTARGLDYLHSNHH--VHRDVKSGNIL 217

Query: 255 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVIL 314
           LDE  VPK+ DFG+ + S T +  T+ TE + GT  YM  EA+  +I+ K+D++S+GV+L
Sbjct: 218 LDELLVPKISDFGLTRASATRSSATVMTERIVGTTAYMANEALRGEITPKSDIYSFGVVL 277

Query: 315 LELLTGMKPIDDNNTILYYY----LVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKC 370
           LE+L+G+ P+D+N    +       + E+E+ + + +DK+  +W+   VE     +   C
Sbjct: 278 LEILSGLPPVDENRDPKFLMEMKDEIDEEEMALEDFVDKKMTDWDLPLVERTY-FLASDC 336

Query: 371 CVFEKDKRASMRDIV 385
              +K+KR  M +++
Sbjct: 337 LSDKKNKRPPMEEVL 351

Source: Salmo salar

Species: Salmo salar

Genus: Salmo

Family: Salmonidae

Order: Salmoniformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

>gi|348512857|ref|XP_003443959.1| PREDICTED: interleukin-1 receptor-associated kinase 4-like [Oreochromis niloticus]

 Score =  203 bits (516), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 126/359 (35%), Positives = 195/359 (54%), Gaps = 27/359 (7%)

Query: 33  SCPENICLSMPKSKHKSASNLVNQHNQKIKFKLPDKKWLQEVIQQEEANNKTEYIGELIA 92
           S P    L+  K++  +++ L+ + +     + P    LQ  ++  E N +  + G   +
Sbjct: 104 SSPLETQLTPLKTRSTASTRLLEERD----VQQPVTTVLQ--LRTPEENTEPIHTG-FSS 156

Query: 93  FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS 152
           F + DL R T  F+ +     G+++GEG FGTVY G L +   +AVK L    +      
Sbjct: 157 FLYSDLMRITGNFDDRSTSAGGSRIGEGGFGTVYKGLLDDK-PVAVKKLNPVDDMPLDKL 215

Query: 153 DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL-CNNIMNCIVYEYMCNGSLYDRLARV 211
            +          F  E+QTL   KH NL+ ++G  C+    C+VY +M NGSL DRLA  
Sbjct: 216 QDQ---------FNQEIQTLKVLKHENLVDMVGFSCDEQHLCLVYAFMANGSLLDRLACF 266

Query: 212 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 271
             +PPL  + R  IA G A+ L YLHS     +HRDVKSAN+LLDE FV K+ DFG+ + 
Sbjct: 267 EGSPPLSWHHRCLIAEGTAKGLEYLHSNHH--VHRDVKSANILLDEQFVAKISDFGLTRA 324

Query: 272 SETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN--- 328
           S      TM TE + GTR YM PEA+  +I+ K+DVFS+GV+LLE+L+G+ P+D+N    
Sbjct: 325 SAKRTSTTMMTERIVGTRAYMAPEALRGEITPKSDVFSFGVVLLEILSGLPPVDENREPQ 384

Query: 329 ---TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
               + Y     ++E+ + + +DK+  +W  + VE++  +    C    K++R  +R +
Sbjct: 385 FLMEMRYDIDDEDEELTLEDFVDKKMKDWELSQVESIYSLAC-NCLHDRKNRRPVIRQV 442

Source: Oreochromis niloticus

Species: Oreochromis niloticus

Genus: Oreochromis

Family: Cichlidae

Order: Perciformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

>gi|384402280|gb|AFH88675.1| interleukin-1 receptor-associated kinase 4 [Trachidermus fasciatus]

 Score =  202 bits (515), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 121/321 (37%), Positives = 179/321 (55%), Gaps = 22/321 (6%)

Query: 74  VIQQEEANNKTE--YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK 131
           V+Q +     +E  Y   + +F + +L   T  F+ +P    G +LGEG FGTVY G L 
Sbjct: 142 VLQPQIPTESSEPGYTDSISSFFYNELMEITGNFDDRPVSDGGRRLGEGGFGTVYKGLL- 200

Query: 132 NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL-CNNI 190
           N   +AVK L N  +  S +    +        F  EVQTL   KH NL+ ++G  C+  
Sbjct: 201 NDKPVAVKKL-NPMDDISLDELRVQ--------FNQEVQTLKVLKHENLVDMVGFSCDGQ 251

Query: 191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKS 250
             C+VY  M NGSL DRLA +  +PPL   +R  IA G A  L YLHS     +HRDVKS
Sbjct: 252 HPCLVYALMVNGSLLDRLACLEGSPPLSWRQRSLIAEGTARGLEYLHSNHH--VHRDVKS 309

Query: 251 ANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSY 310
           AN+LLDE FV K+ DFG+ + S      TM TE + GTR YM PEA+  +I+ ++DVFS+
Sbjct: 310 ANILLDETFVAKISDFGLTRASAKRTSTTMMTERIVGTRAYMAPEALRGEITPRSDVFSF 369

Query: 311 GVILLELLTGMKPIDDNNTILYYYLVV------EQEVPVREVLDKEAGEWNETHVETLIG 364
           GV+LLE+L+G+ P  +N    +   +       ++E+ + + LDK  G+W+ + VE++  
Sbjct: 370 GVVLLEILSGLPPAAENREPQFLMEMRHDIDDEDEELTLEDFLDKTMGDWDLSQVESVYS 429

Query: 365 IVFEKCCVFEKDKRASMRDIV 385
           +    C    K++R  ++ ++
Sbjct: 430 LAC-NCLHDRKNRRPVIKQVL 449

Source: Trachidermus fasciatus

Species: Trachidermus fasciatus

Genus: Trachidermus

Family: Cottidae

Order: Scorpaeniformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

>gi|269993241|emb|CBI63173.1| interleukin-1 receptor-associated kinase 4 [Oncorhynchus mykiss] gi|269993247|emb|CBI63176.1| interleukin-1 receptor-associated kinase 4 [Oncorhynchus mykiss]

 Score =  202 bits (514), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 115/301 (38%), Positives = 177/301 (58%), Gaps = 18/301 (5%)

Query: 90  LIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSS 149
            +  +F +L++ T  F+ +P    G++LGEG FGTVY G L NG  +AVK L +  + S 
Sbjct: 166 FLRLSFHELKKITGHFDERPVSEGGSRLGEGGFGTVYKG-LINGKPVAVKKLHSMEDISL 224

Query: 150 SNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRL 208
                        + F  EVQTL   KH NL+ ++G   +  + C+VY YM NGSL DRL
Sbjct: 225 EELS---------VQFIQEVQTLMVLKHENLVDMVGFSRDGHHPCLVYAYMSNGSLLDRL 275

Query: 209 ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI 268
           A ++ +PPL  ++R  IA+G A  L YLHS     +HRDVKS N+LLDE  VPK+ DFG+
Sbjct: 276 ACLDGSPPLSWHRRCLIAVGTARGLDYLHSNHH--VHRDVKSGNILLDELLVPKISDFGL 333

Query: 269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
            + S T +  T+ TE + GT  YM  EA+  +I+ K+D++S+GV+LLE+L+G+ P+D+N 
Sbjct: 334 TRASATRSSATVMTERIVGTTAYMANEALRGEITPKSDIYSFGVVLLEILSGLPPVDENR 393

Query: 329 TILYYY----LVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
              +       + E+E+ + + +DK+  +W+   VE     +   C   +K+KR  M ++
Sbjct: 394 DPKFLMEMKDEIDEEEMALEDFVDKKMTDWDLPLVERTY-FLASDCLSDKKNKRPLMEEV 452

Query: 385 V 385
           +
Sbjct: 453 L 453

Source: Oncorhynchus mykiss

Species: Oncorhynchus mykiss

Genus: Oncorhynchus

Family: Salmonidae

Order: Salmoniformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

>gi|318103835|ref|NP_001188114.1| interleukin-1 receptor-associated kinase 4 [Ictalurus punctatus] gi|308322829|gb|ADO28552.1| interleukin-1 receptor-associated kinase 4 [Ictalurus punctatus]

 Score =  198 bits (504), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 116/305 (38%), Positives = 179/305 (58%), Gaps = 18/305 (5%)

Query: 92  AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSN 151
           +FT+ +L R T  ++ +P    G++LGEG FG V+ G L N   +AVK L    + S   
Sbjct: 168 SFTYRELTRITGNWDERPASLGGSRLGEGGFGIVFKG-LHNIKPVAVKKLNLVDDLSPEE 226

Query: 152 SDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL-CNNIMNCIVYEYMCNGSLYDRLAR 210
             +          F  E+QTL   KHVNL+ ++G  C+    C+VY YM NGSL DRLA 
Sbjct: 227 LRSQ---------FNQEIQTLKMLKHVNLVNMVGYSCDGQYPCLVYAYMSNGSLLDRLAC 277

Query: 211 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
           ++ + PL    R +I LG A  L YLH+ +   IHRDVKS N+LLDE+FVPK+ DFG+ +
Sbjct: 278 LDGSSPLSWQVRCAITLGTARGLEYLHNNNH--IHRDVKSGNILLDESFVPKISDFGLTR 335

Query: 271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDN-NT 329
            S   +  T+ TE + GT  YM PEA+  +I+ K+DVFS+GV+LLE+L+G+ P+D+N + 
Sbjct: 336 ASAKLSCTTVITERIVGTTAYMAPEALRGEITPKSDVFSFGVVLLEILSGLPPVDENRDP 395

Query: 330 ILYYYL---VVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD 386
            L   +   + ++E+ + E +DK+  + +   VE +  +  ++     K++R  M +++ 
Sbjct: 396 KLLMEMKDEIEDEEITLEEFIDKKILDLDMESVERMYNVASQRLNE-RKNRRPLMNEVIA 454

Query: 387 LLSKS 391
            L  S
Sbjct: 455 ELEGS 459

Source: Ictalurus punctatus

Species: Ictalurus punctatus

Genus: Ictalurus

Family: Ictaluridae

Order: Siluriformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

>gi|269993243|emb|CBI63174.1| interleukin-1 receptor-associated kinase 4 [Coregonus maraena] gi|302353978|emb|CBI63179.2| interleukin-1 receptor-associated kinase 4 [Coregonus maraena]

 Score =  196 bits (498), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 116/315 (36%), Positives = 180/315 (57%), Gaps = 21/315 (6%)

Query: 76  QQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGME 135
           Q+++  N T      +  +F +L++ T  F+ +P    G++LGEG FGTVY G L N   
Sbjct: 155 QEDQDPNDT---AGFLRLSFHELKKITGNFDERPVGDGGSRLGEGGFGTVYKG-LINDKP 210

Query: 136 IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CI 194
           +AVK L +  + S              + F  EVQTL   KH NL+ ++G   +  + C+
Sbjct: 211 VAVKKLHSMEDISLKELS---------VQFIQEVQTLMVLKHENLVDMVGFSRDGHHPCL 261

Query: 195 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 254
           VY YM NGSL DRLA ++ +PPL  ++R  IA+G A  L YLHS     +HRDVKS N+L
Sbjct: 262 VYAYMSNGSLLDRLACLDGSPPLSWHRRCLIAVGTARGLDYLHSNHH--VHRDVKSGNIL 319

Query: 255 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVIL 314
           L+E  VPK+ DFG+ + S T +  T+ TE + GT  YM  EA+  +I+ K+D++S+GV+L
Sbjct: 320 LNELLVPKISDFGLTRASATRSSSTVMTERIVGTTAYMANEALRGEITPKSDIYSFGVVL 379

Query: 315 LELLTGMKPIDDNNTILYYY----LVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKC 370
           LE+L+G+ P+D+N    +       + E+E+ + + +DK    W+   VE     +   C
Sbjct: 380 LEILSGLPPVDENRDPKFLMEMKDEIDEEEMALEDFVDKRMTYWDLPLVEKTY-FLPSDC 438

Query: 371 CVFEKDKRASMRDIV 385
              +K+KR  M +++
Sbjct: 439 LTDKKNKRPRMEEVL 453

Source: Coregonus maraena

Species: Coregonus maraena

Genus: Coregonus

Family: Salmonidae

Order: Salmoniformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	593
UNIPROTKB|E1C1A7	464	IRAK4 "Uncharacterized protein	0.478	0.612	0.372	1.5e-51
UNIPROTKB|A9QT42	460	IRAK4 "Uncharacterized protein	0.480	0.619	0.371	5.2e-49
UNIPROTKB|Q1RMT8	461	IRAK4 "Interleukin-1 receptor-	0.480	0.618	0.368	3.7e-48
UNIPROTKB|Q9NWZ3	460	IRAK4 "Interleukin-1 receptor-	0.480	0.619	0.361	4.2e-47
UNIPROTKB|E2RDL0	460	IRAK4 "Uncharacterized protein	0.477	0.615	0.360	1.1e-46
RGD|1305303	461	Irak4 "interleukin-1 receptor-	0.482	0.620	0.350	3.4e-45
MGI|MGI:2182474	459	Irak4 "interleukin-1 receptor-	0.480	0.620	0.348	2.4e-44
ZFIN|ZDB-GENE-040426-738	483	irak4 "interleukin-1 receptor-	0.477	0.585	0.338	1.2e-42
TAIR|locus:2036636	632	NIK3 "NSP-interacting kinase 3	0.473	0.444	0.354	1.1e-40
TAIR|locus:2205260	1047	AT1G56120 [Arabidopsis thalian	0.433	0.245	0.383	9.1e-40

UNIPROTKB|E1C1A7 IRAK4 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 535 (193.4 bits), Expect = 1.5e-51, P = 1.5e-51
 Identities = 113/303 (37%), Positives = 180/303 (59%)

Query:    93 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXX 152
             F F DLE  T+ F+ +P    GNKLGEG FG V+ G + NG  +AVK L           
Sbjct:   173 FWFHDLESVTNNFDERPESAGGNKLGEGGFGIVFKGYI-NGRNVAVKKLAAVVDVSAQDL 231

Query:   153 XXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARV 211
                         F+ E++ +++CKH NL+ LLG  ++    C+VYEYM NGSL DRLA +
Sbjct:   232 KQQ---------FDQEIEIMAKCKHENLVELLGFSSDGAQPCLVYEYMPNGSLLDRLACL 282

Query:   212 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 271
             + TPP+  N R  IA G A  +++LH  +   IHRD+KSAN+LL + +VPK+ DFG+ + 
Sbjct:   283 DGTPPISWNTRCEIAQGTANGINFLHDNNH--IHRDIKSANILLTDTYVPKISDFGLARA 340

Query:   272 SETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT-- 329
             S T   +T+ T+ + GT  YM PEA+  +I+ K+D+FS+GV+LLE++TG+ P+D+N    
Sbjct:   341 SVTFT-RTIMTDRVVGTAAYMAPEALRGEITPKSDIFSFGVVLLEVITGLPPVDENREPQ 399

Query:   330 ILYYYL--VVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDL 387
             +L      + ++E  + + +D +  +W+ T V  +  +  ++C   +K++R +M+ +   
Sbjct:   400 LLLSIKDEIEDEEATIEDYVDVKMSDWDATSVHKMYSLA-DQCLNEKKNRRPNMKMVQQY 458

Query:   388 LSK 390
             L +
Sbjct:   459 LQE 461

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

UNIPROTKB|A9QT42 IRAK4 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 511 (184.9 bits), Expect = 5.2e-49, P = 5.2e-49
 Identities = 113/304 (37%), Positives = 180/304 (59%)

Query:    92 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 151
             +F FC+L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct:   167 SFAFCELKDVTNNFDERPVSIGGNKMGEGGFGVVYKGYVNN-RAVAVKKL------AAVV 219

Query:   152 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR 210
                TE        F+ E++ L++C+H NL+ LLG  ++  + C+VY YM NGSL DRL+ 
Sbjct:   220 DISTEELKQQ---FDQEIKVLAKCQHENLVELLGFSSDGDDLCLVYVYMSNGSLLDRLSC 276

Query:   211 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
             +++TPPL    R  IA G A  L +LH      IHRD+KSAN+LLDE+F  K+ DFG+ +
Sbjct:   277 LDDTPPLSWYMRCKIAQGAANGLSFLHENHH--IHRDIKSANILLDEDFTAKISDFGLAR 334

Query:   271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 329
              SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++   
Sbjct:   335 ASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 393

Query:   330 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD 386
               +L     +E +E  + + +DK+  + + T +ET+  +   +C   +K+KR  ++ +  
Sbjct:   394 QLLLDIKEEIEDEEKTIEDYIDKKMNDTDSTSIETMYSVA-SQCLHEKKNKRPDIKKVQQ 452

Query:   387 LLSK 390
             LL +
Sbjct:   453 LLQE 456

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

UNIPROTKB|Q1RMT8 IRAK4 "Interleukin-1 receptor-associated kinase 4" [Bos taurus (taxid:9913)]

 Score = 503 (182.1 bits), Expect = 3.7e-48, P = 3.7e-48
 Identities = 112/304 (36%), Positives = 180/304 (59%)

Query:    92 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 151
             +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct:   168 SFSFFELKDVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-RTVAVKKL------AAMV 220

Query:   152 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR 210
                TE        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL DRL+ 
Sbjct:   221 DISTEELKQQ---FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 277

Query:   211 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
             ++ TPPL  N R  IA G A  L YLH      IHRD+KSAN+LLDE+F  K+ DFG+ +
Sbjct:   278 LDGTPPLSWNMRCKIAQGAANGLSYLHENHH--IHRDIKSANILLDEDFTAKISDFGLAR 335

Query:   271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 329
              SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++   
Sbjct:   336 ASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 394

Query:   330 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD 386
               +L     +E +E  + + +D++  + + T +ET+  +   +C   +K+KR  ++ +  
Sbjct:   395 QLLLDIKEEIEDEEKTIEDYVDRKMNDIDSTSIETMYSVA-SQCLHEKKNKRPDIKKVQQ 453

Query:   387 LLSK 390
             LL +
Sbjct:   454 LLEE 457

GO:0005737 "cytoplasm" evidence=IEA

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0045087 "innate immune response" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

UNIPROTKB|Q9NWZ3 IRAK4 "Interleukin-1 receptor-associated kinase 4" [Homo sapiens (taxid:9606)]

 Score = 493 (178.6 bits), Expect = 4.2e-47, P = 4.2e-47
 Identities = 110/304 (36%), Positives = 179/304 (58%)

Query:    92 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 151
             +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct:   167 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKL------AAMV 219

Query:   152 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR 210
                TE        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL DRL+ 
Sbjct:   220 DITTEELKQQ---FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 276

Query:   211 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
             ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ DFG+ +
Sbjct:   277 LDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLAR 334

Query:   271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 329
              SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++   
Sbjct:   335 ASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 393

Query:   330 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD 386
               +L     +E +E  + + +DK+  + + T VE +  +   +C   +K+KR  ++ +  
Sbjct:   394 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA-SQCLHEKKNKRPDIKKVQQ 452

Query:   387 LLSK 390
             LL +
Sbjct:   453 LLQE 456

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0007254 "JNK cascade" evidence=IEA

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=IEA

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002224 "toll-like receptor signaling pathway" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0004672 "protein kinase activity" evidence=EXP

GO:0004674 "protein serine/threonine kinase activity" evidence=EXP;TAS

GO:0005829 "cytosol" evidence=TAS

GO:0005886 "plasma membrane" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0010008 "endosome membrane" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

UNIPROTKB|E2RDL0 IRAK4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 489 (177.2 bits), Expect = 1.1e-46, P = 1.1e-46
 Identities = 109/302 (36%), Positives = 177/302 (58%)

Query:    92 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 151
             +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct:   167 SFSFYELKNVTNNFDERPISLGGNKMGEGGFGVVYKGYVNN-KTVAVKKL------AAMV 219

Query:   152 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR 210
                TE        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL DRL+ 
Sbjct:   220 DISTEELKQQ---FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 276

Query:   211 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
             ++ TPPL  + R  IA G A  + +LH      IHRD+KSAN+LLDE+F  K+ DFG+ +
Sbjct:   277 LDGTPPLSWHMRCKIAQGAANGISFLHENHH--IHRDIKSANILLDEDFTAKVSDFGLAR 334

Query:   271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 329
              SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++   
Sbjct:   335 ASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 393

Query:   330 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD 386
               +L     +E +E  + + +D +  + + T +ET+  +   +C   +K+KR  +  +  
Sbjct:   394 QLLLDIKEEIEDEEKTIEDYIDPKMNDTDPTSIETMYSVA-SQCLHEKKNKRPDIEKVQQ 452

Query:   387 LL 388
             LL
Sbjct:   453 LL 454

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

RGD|1305303 Irak4 "interleukin-1 receptor-associated kinase 4" [Rattus norvegicus (taxid:10116)]

 Score = 475 (172.3 bits), Expect = 3.4e-45, P = 3.4e-45
 Identities = 107/305 (35%), Positives = 176/305 (57%)

Query:    92 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 151
             +F+F +L+  T+ F+ +P    GN++GEG FG VY G + N   +AVK L          
Sbjct:   169 SFSFYELKSITNDFDERPVSIGGNRMGEGGFGVVYKGCVNN-TTVAVKKL------GAMV 221

Query:   152 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR 210
                TE        F+ E++ +++C+H NL+ LLG  ++  N C+VY YM NGSL DRL+ 
Sbjct:   222 EISTEELKQQ---FDQEIKVMAKCQHENLVELLGFSSDSDNLCLVYAYMPNGSLLDRLSC 278

Query:   211 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
             ++ TPPL  + R  IA G A  + +LH      IHRD+KSAN+LLD++F  K+ DFG+ +
Sbjct:   279 LDGTPPLSWHMRCKIARGAANGIRFLHENHH--IHRDIKSANILLDQDFTAKISDFGLAR 336

Query:   271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 329
              S     +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLEL+TG+  +D+N   
Sbjct:   337 AS-AKLAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLELITGLAAVDENREP 395

Query:   330 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD 386
               +L     +E +E  + +  D++  + +   VE +  +   +C   +K++R  +  +  
Sbjct:   396 QLLLDIKEEIEDKEKTIEDCTDEKMSDADPASVEAMYSVA-SQCLHEKKNRRPDIAKVQQ 454

Query:   387 LLSKS 391
             LL ++
Sbjct:   455 LLQET 459

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA;ISO

GO:0003674 "molecular_function" evidence=ND

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO

GO:0005149 "interleukin-1 receptor binding" evidence=IEA;ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0007254 "JNK cascade" evidence=IMP

GO:0019221 "cytokine-mediated signaling pathway" evidence=ISO;IMP

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IMP

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=IMP

MGI|MGI:2182474 Irak4 "interleukin-1 receptor-associated kinase 4" [Mus musculus (taxid:10090)]

 Score = 467 (169.5 bits), Expect = 2.4e-44, P = 2.4e-44
 Identities = 106/304 (34%), Positives = 174/304 (57%)

Query:    92 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 151
             +F+F +L+  T+ F+ +P    GN++GEG FG VY G + N + +AVK L          
Sbjct:   167 SFSFHELKSITNNFDEQPASAGGNRMGEGGFGVVYKGCVNNTI-VAVKKL------GAMV 219

Query:   152 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR 210
                TE        F+ E++ ++ C+H NL+ LLG  ++  N C+VY YM NGSL DRL+ 
Sbjct:   220 EISTEELKQQ---FDQEIKVMATCQHENLVELLGFSSDSDNLCLVYAYMPNGSLLDRLSC 276

Query:   211 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
             ++ TPPL  + R  +A G A  + +LH      IHRD+KSAN+LLD++F  K+ DFG+ +
Sbjct:   277 LDGTPPLSWHTRCKVAQGTANGIRFLHENHH--IHRDIKSANILLDKDFTAKISDFGLAR 334

Query:   271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 329
              S     +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLEL+TG+  +D+N   
Sbjct:   335 ASARL-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLELITGLAAVDENREP 393

Query:   330 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD 386
               +L     +E +E  + +  D++  + +   VE +      +C   +K++R  +  +  
Sbjct:   394 QLLLDIKEEIEDEEKTIEDYTDEKMSDADPASVEAMYSAA-SQCLHEKKNRRPDIAKVQQ 452

Query:   387 LLSK 390
             LL +
Sbjct:   453 LLQE 456

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0007254 "JNK cascade" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019221 "cytokine-mediated signaling pathway" evidence=ISO;IDA

GO:0045087 "innate immune response" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=ISO

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=ISO

ZFIN|ZDB-GENE-040426-738 irak4 "interleukin-1 receptor-associated kinase 4" [Danio rerio (taxid:7955)]

 Score = 451 (163.8 bits), Expect = 1.2e-42, P = 1.2e-42
 Identities = 102/301 (33%), Positives = 167/301 (55%)

Query:    93 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXX 152
             F+  +L   T  ++ +P    G +LG G FG V+ G++ +   +AVK L           
Sbjct:   186 FSLHELTAMTQHWDERPLSDGGCRLGSGGFGVVFRGRMGD-KHVAVKKLNPLDGSSYEDL 244

Query:   153 XXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL-CNNIMNCIVYEYMCNGSLYDRLARV 211
                         F  E+QTL    H N+LR+LG  C+    C+V+E M NGSL +RLA  
Sbjct:   245 RKQ---------FNQEIQTLRSLSHENVLRVLGCSCSGPPLCVVFELMVNGSLLERLACA 295

Query:   212 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 271
              +TP L    R  I +G A  L YLH+ +   IHRDVKSAN+LLDE FV K+ DFG+ + 
Sbjct:   296 EHTPALTWRNRCWITVGAARGLSYLHTHAH--IHRDVKSANILLDEGFVAKISDFGLTRS 353

Query:   272 SETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDN-NTI 330
             +   ++ T+ TE + GT  YM PEA+  +I+ K+DVFS+GV+LLE+L+G+ P+D++ +  
Sbjct:   354 AAAGSLMTLQTERIVGTTAYMAPEALRGEITAKSDVFSFGVVLLEVLSGLPPVDESRDPA 413

Query:   331 LYYYL---VVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDL 387
             L   +   + ++++ + +  D+   +W    ++ +      +C   +K+KR ++  ++ +
Sbjct:   414 LLLEMKDDLDDEDLSLLDFTDRRMQDWRTEELQIMYEAA-SQCLCQKKNKRPAIAQVLSV 472

Query:   388 L 388
             L
Sbjct:   473 L 473

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0009617 "response to bacterium" evidence=IDA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IDA

TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 424 (154.3 bits), Expect = 1.1e-40, Sum P(2) = 1.1e-40
 Identities = 111/313 (35%), Positives = 168/313 (53%)

Query:    87 IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXX 146
             +G L  +TF +L  AT+ FN K      N LG G +G VY G L +G  +AVK L+    
Sbjct:   283 LGHLKRYTFKELRSATNHFNSK------NILGRGGYGIVYKGHLNDGTLVAVKRLKDCNI 336

Query:   147 XXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLY 205
                             + F+ EV+T+S   H NLLRL G C+ N    +VY YM NGS+ 
Sbjct:   337 AGGE------------VQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVA 384

Query:   206 DRLA-RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPKL 263
              RL   +   P LD ++R  IA+G A  L YLH    P IIHRDVK+AN+LLDE+F   +
Sbjct:   385 SRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVV 444

Query:   264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMK 322
             GDFG+ K+ +  +  +  T  + GT  ++ PE +   Q S KTDVF +G++LLEL+TG K
Sbjct:   445 GDFGLAKLLD--HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQK 502

Query:   323 PID------DNNTILYYYLVVEQEVPVREVLDKEAGE-WNETHVETLIGIVFEKCCVFEK 375
              +D          +L +   + QE  +++++DK+  + ++   +E ++ +    C  F  
Sbjct:   503 ALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVAL-LCTQFNP 561

Query:   376 DKRASMRDIVDLL 388
               R  M +++ +L
Sbjct:   562 SHRPKMSEVMKML 574

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)]

 Score = 390 (142.3 bits), Expect = 9.1e-40, Sum P(2) = 9.1e-40
 Identities = 109/284 (38%), Positives = 150/284 (52%)

Query:   115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
             NKLGEG FG VY G L +G E+AVK L                       F  E+  +S 
Sbjct:   714 NKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQ-------------FVAEIIAISS 760

Query:   175 CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
               H NL++L G C       +VYEY+ NGSL D+    + +  LD + RY I LGVA  L
Sbjct:   761 VLHRNLVKLYGCCFEGDHRLLVYEYLPNGSL-DQALFGDKSLHLDWSTRYEICLGVARGL 819

Query:   234 HYLHS-LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
              YLH   S  IIHRDVK++N+LLD   VPK+ DFG+ K+ +  + KT  +  + GT  Y+
Sbjct:   820 VYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYD--DKKTHISTRVAGTIGYL 877

Query:   293 PPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV------EQEVPVRE 345
              PE AM   ++ KTDV+++GV+ LEL++G K  D+N      YL+       E+   V E
Sbjct:   878 APEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEKNRDV-E 936

Query:   346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS 389
             ++D E  E+N   V+ +IGI    C       R  M  +V +LS
Sbjct:   937 LIDDELSEYNMEEVKRMIGIAL-LCTQSSYALRPPMSRVVAMLS 979

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	593
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-49
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-48
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-48
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-46
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-45
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-44
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-36
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-35
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-28
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-23
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-22
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-20
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-19
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-19
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-18
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-18
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-18
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-17
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-17
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-17
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-17
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-16
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-16
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-15
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-14
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-14
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-13
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-12
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-12
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-12
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-11
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-11
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-11
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-11
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-10
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-10
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-10
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-10
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-10
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-10
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-10
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-10
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-10
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-09
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-09
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-09
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-09
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-09
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-09
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-09
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-09
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-08
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-08
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-08
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-08
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-08
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-08
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-08
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-08
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-08
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-08
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-07
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-07
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-07
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-07
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-07
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-07
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-07
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-06
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-06
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-06
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-06
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-06
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-06
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-06
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-06
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-05
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-05
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-05
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-05
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-05
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-05
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-05
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-05
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-05
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-05
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-05
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-05
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-05
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-05
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-05
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-05
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-05
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-04
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-04
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-04
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-04
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-04
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-04
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-04
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-04
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-04
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-04
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-04
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-04
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-04
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-04
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-04
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-04
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-04
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-04
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-04
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-04
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-04
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-04
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-04
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	0.001
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.001
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	0.001
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.001
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	0.001
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	0.001
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	0.001
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.001
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	0.001
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	0.001
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.001
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.001
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	0.001
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	0.001
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	0.002
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	0.002
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	0.002
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.002
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	0.003
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	0.003
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	0.003
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	0.003
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	0.003
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	0.004
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	0.004
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	0.004
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.004
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.004
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.004

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  170 bits (433), Expect = 7e-49
 Identities = 88/296 (29%), Positives = 134/296 (45%), Gaps = 58/296 (19%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 166
             G KLGEG FG VY G LK        ++AVKTL+  A+      +  E        F 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS-----EEEREE-------FL 49

Query: 167 NEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            E   + +  H N++RLLG+C       IV EYM  G L D L    +   L       +
Sbjct: 50  EEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQM 107

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           AL +A+ + YL S  K  +HRD+ + N L+ EN V K+ DFG   +S        Y +  
Sbjct: 108 ALQIAKGMEYLES--KNFVHRDLAARNCLVTENLVVKISDFG---LSRDIYEDDYYRKRG 162

Query: 286 TGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 341
            G  P  +M PE+    + ++K+DV+S+GV+L E+ T G +P        Y        +
Sbjct: 163 GGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP--------Y------PGM 208

Query: 342 PVREVLDK-EAGE--------WNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL 388
              EVL+  E G          +E  +  L+     +C  ++ + R +  ++V+ L
Sbjct: 209 SNEEVLELLEDGYRLPRPENCPDE--LYELM----LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  167 bits (426), Expect = 6e-48
 Identities = 88/287 (30%), Positives = 135/287 (47%), Gaps = 44/287 (15%)

Query: 114 GNKLGEGQFGTVYYGKLKNG-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 168
           G KLGEG FG VY G LK       +E+AVKTL+ +A+               I  F  E
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDAS------------EQQIEEFLRE 51

Query: 169 VQTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            + + +  H N+++LLG+C     +M  IV EYM  G L D L R N    L  +   S 
Sbjct: 52  ARIMRKLDHPNIVKLLGVCTEEEPLM--IVMEYMPGGDLLDYL-RKNRPKELSLSDLLSF 108

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           AL +A  + YL S  K  IHRD+ + N L+ EN V K+ DFG+ +     +   +    L
Sbjct: 109 ALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL 166

Query: 286 TGTRPY--MPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 341
               P   M PE+    + ++K+DV+S+GV+L E+ T G +P        Y  +   +  
Sbjct: 167 ----PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP--------YPGMSNAE-- 212

Query: 342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL 388
            V E L K        +    +  +  +C   + + R +  ++V++L
Sbjct: 213 -VLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  167 bits (426), Expect = 7e-48
 Identities = 88/287 (30%), Positives = 134/287 (46%), Gaps = 45/287 (15%)

Query: 114 GNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 168
           G KLGEG FG VY GKLK       +E+AVKTL+ +A         +E     I  F  E
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA---------SEQQ---IEEFLRE 51

Query: 169 VQTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            + + +  H N+++LLG+C     +   IV EYM  G L   L    N P L  +   S 
Sbjct: 52  ARIMRKLDHPNVVKLLGVCTEEEPLY--IVMEYMEGGDLLSYL--RKNRPKLSLSDLLSF 107

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           AL +A  + YL S  K  IHRD+ + N L+ EN V K+ DFG+ +     +        L
Sbjct: 108 ALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL 165

Query: 286 TGTRPY--MPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 341
               P   M PE+    + ++K+DV+S+GV+L E+ T G +P        Y  +  E+  
Sbjct: 166 ----PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP--------YPGMSNEE-- 211

Query: 342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL 388
            V E L          +    +  +  +C   + + R +  ++V++L
Sbjct: 212 -VLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  162 bits (413), Expect = 5e-46
 Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 49/292 (16%)

Query: 115 NKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
            KLGEG FG VY GKLK       E+AVKTL+ +A    S  +  +        F  E +
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA----SEEERKD--------FLKEAR 48

Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRL------ARVNNTPPLDSNKRY 223
            + +  H N++RLLG+C       +V EYM  G L D L              L      
Sbjct: 49  VMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLL 108

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
           S A+ +A+ + YL S  K  +HRD+ + N L+ E+ V K+ DFG   +S        Y +
Sbjct: 109 SFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFG---LSRDVYDDDYYRK 163

Query: 284 NLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ 339
              G  P  +M PE++   I ++K+DV+S+GV+L E+ T G  P        Y       
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--------Y------P 209

Query: 340 EVPVREVLDK-EAGEWNE--THVETLIGIVFEKCCVFEKDKRASMRDIVDLL 388
            +   EVL+    G       +    +  +   C   + + R +  ++V+ L
Sbjct: 210 GLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  157 bits (400), Expect = 8e-45
 Identities = 71/206 (34%), Positives = 101/206 (49%), Gaps = 24/206 (11%)

Query: 117 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LGEG FGTVY  + K  G ++A+K ++   + S                   E++ L + 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE------------LLREIEILKKL 48

Query: 176 KHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L G+  +     +V EY   GSL D L    N   L  ++   I L + E L 
Sbjct: 49  NHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLE 106

Query: 235 YLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
           YLHS    IIHRD+K  N+LLD  N   KL DFG+ K+  +          + GT  YM 
Sbjct: 107 YLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK---TIVGTPAYMA 161

Query: 294 PEAMHCQ--ISTKTDVFSYGVILLEL 317
           PE +  +   S K+D++S GVIL EL
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  157 bits (399), Expect = 4e-44
 Identities = 93/283 (32%), Positives = 131/283 (46%), Gaps = 38/283 (13%)

Query: 112 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
               KLG G FGTVY  K K  G  +AVK L       S  S   + A         E++
Sbjct: 2   ELLRKLGSGSFGTVYKAKHKGTGKIVAVKIL----KKRSEKSKKDQTAR-------REIR 50

Query: 171 TLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
            L +  H N++RL+      +++   +V EY   G L+D L+R     PL  ++   IAL
Sbjct: 51  ILRRLSHPNIVRLIDAFEDKDHL--YLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIAL 105

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
            +   L YLHS    IIHRD+K  N+LLDEN V K+ DFG+ K    S+  ++ T    G
Sbjct: 106 QILRGLEYLHSNG--IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTT--FVG 160

Query: 288 TRPYMPPE--AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 345
           T  YM PE          K DV+S GVIL ELLTG  P    N +       +Q   +R 
Sbjct: 161 TPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENIL-------DQLQLIRR 213

Query: 346 VLDKEA-GEWNETH--VETLIGIVFEKCCVFEKDKRASMRDIV 385
           +L      +  +     E    ++ +KC   +  KR +  +I+
Sbjct: 214 ILGPPLEFDEPKWSSGSEEAKDLI-KKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  149 bits (379), Expect = 3e-41
 Identities = 73/279 (26%), Positives = 115/279 (41%), Gaps = 38/279 (13%)

Query: 112 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
               KLGEG FG VY  + K  G  +A+K ++                         E++
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER------------ILREIK 49

Query: 171 TLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
            L + KH N++RL  +    + +   +V EY   G L+D L        L  ++      
Sbjct: 50  ILKKLKHPNIVRLYDVFEDEDKL--YLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLR 104

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLT 286
            +  AL YLHS    I+HRD+K  N+LLDE+   KL DFG+ + +     + T       
Sbjct: 105 QILSALEYLHSKG--IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF-----V 157

Query: 287 GTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 345
           GT  YM PE +  +      D++S GVIL ELLTG  P   ++ +L  +  + +      
Sbjct: 158 GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKP----- 212

Query: 346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
                              ++  K  V + +KR +  + 
Sbjct: 213 --KPPFPPPEWDISPEAKDLI-RKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  135 bits (342), Expect = 5e-36
 Identities = 81/280 (28%), Positives = 122/280 (43%), Gaps = 43/280 (15%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
            RG  LG G FG+VY    K  G  +AVK++E     S  + +  EA        E E++
Sbjct: 3   TRGELLGRGSFGSVYLALDKDTGELMAVKSVE----LSGDSEEELEA-------LEREIR 51

Query: 171 TLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSN--KRYSI 225
            LS  +H N++R  G   +       I  EY+  GSL   L +      L     ++Y+ 
Sbjct: 52  ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF---GKLPEPVIRKYTR 108

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
              + E L YLHS    I+HRD+K AN+L+D + V KL DFG  K           T ++
Sbjct: 109 Q--ILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG-DIETGEGTGSV 163

Query: 286 TGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKP---IDDNNTILYYYLVVEQEV 341
            GT  +M PE +  +      D++S G  ++E+ TG  P   + +    LY      +  
Sbjct: 164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPP 223

Query: 342 PVREVLDKEAGEWNETHVETLIGIVF-EKCCVFEKDKRAS 380
            + E L +EA +             F  KC   +  KR +
Sbjct: 224 EIPEHLSEEAKD-------------FLRKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  132 bits (334), Expect = 6e-35
 Identities = 69/236 (29%), Positives = 108/236 (45%), Gaps = 28/236 (11%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
               K+G+G FG VY  +  + G E+A+K +       S            I+   NE+Q
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVI----KLESKEKKE------KII---NEIQ 49

Query: 171 TLSQCKHVNLLRLLG--LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
            L +CKH N+++  G  L  + +   IV E+   GSL D L +  N    +S   Y +  
Sbjct: 50  ILKKCKHPNIVKYYGSYLKKDELW--IVMEFCSGGSLKD-LLKSTNQTLTESQIAY-VCK 105

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
            + + L YLHS    IIHRD+K+AN+LL  +   KL DFG+          T     + G
Sbjct: 106 ELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLS----AQLSDTKARNTMVG 159

Query: 288 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
           T  +M PE ++ +    K D++S G+  +EL  G  P  +   +   + +     P
Sbjct: 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPP 215

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  122 bits (308), Expect = 2e-31
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 34/225 (15%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
            ++G+G FG VY  +   +G    +K +    + S+ +    E A+       NEV+ L 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEI----DLSNMSEKEREDAL-------NEVKILK 54

Query: 174 QCKHVNLLRLLGLCNNIMN----CIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALG 228
           +  H N+++      +       CIV EY   G L  ++  +     P    +     + 
Sbjct: 55  KLNHPNIIKY---YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNM-KTMYTENLT 286
           +  AL YLHS  + I+HRD+K  N+ L  N + KLGDFGI K +S T ++ KT+      
Sbjct: 112 LCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-----V 164

Query: 287 GTRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNN 328
           GT  Y+ PE   CQ    + K+D++S G +L EL T   P +  N
Sbjct: 165 GTPYYLSPEL--CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  112 bits (282), Expect = 8e-28
 Identities = 74/276 (26%), Positives = 114/276 (41%), Gaps = 37/276 (13%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
            R   LG+G  G VY  + K  G   A+K +     +   + +  +  +        E++
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-----HVDGDEEFRKQLL-------RELK 51

Query: 171 TLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
           TL  C+   +++  G         IV EYM  GSL D L +V   P         IA  +
Sbjct: 52  TLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY---IARQI 108

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
            + L YLH+    IIHRD+K +N+L++     K+ DFGI K+ E +  +        GT 
Sbjct: 109 LKGLDYLHTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN---TFVGTV 164

Query: 290 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 348
            YM PE +  +  S   D++S G+ LLE   G  P        ++ L       ++ + D
Sbjct: 165 TYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL-------MQAICD 217

Query: 349 KEAGEWNETHV--ETLIGIVFEKCCVFEKD--KRAS 380
                        E      F   C+ +KD  KR S
Sbjct: 218 GPPPSLPAEEFSPEF---RDFISACL-QKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  112 bits (282), Expect = 9e-28
 Identities = 74/249 (29%), Positives = 125/249 (50%), Gaps = 50/249 (20%)

Query: 117 LGEGQFGTVYYGKL--KNGME----IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           LGEG FG VY G+L   N       +A+KTL+ NA                   F  E +
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE------------FRQEAE 60

Query: 171 TLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTP-------------- 215
            +S  +H N++ LLG+C      C+++EY+ +G L++ L  V N+P              
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFL--VRNSPHSDVGAESGDETVK 118

Query: 216 -PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 274
             LD +    IA+ +A  + YL S     +HRD+ + N L+ E    K+ DFG+ +   +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176

Query: 275 SNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILY 332
           ++   + +++L   R +MPPEA ++ + +T++D++S+GV+L E+ + G++P         
Sbjct: 177 ADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP--------- 226

Query: 333 YYLVVEQEV 341
           YY    QEV
Sbjct: 227 YYGFSNQEV 235

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 2e-27
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 41/216 (18%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           KLG GQFG V+ G      ++AVKTL+                M P    + E Q + + 
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLK-------------PGTMSPEAFLQ-EAQIMKKL 58

Query: 176 KHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPP---LDSNKRYSIALGV 229
           +H  L++L  +C+    I   IV EYM  GSL D L     +     L   +   +A  +
Sbjct: 59  RHDKLVQLYAVCSEEEPIY--IVTEYMSKGSLLDFL----KSGEGKKLRLPQLVDMAAQI 112

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           AE + YL S  +  IHRD+ + N+L+ EN V K+ DFG+ ++ E       YT    G +
Sbjct: 113 AEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE----YTAR-EGAK 165

Query: 290 PYMP-----PEAMHC-QISTKTDVFSYGVILLELLT 319
              P     PEA +  + + K+DV+S+G++L E++T
Sbjct: 166 --FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 5e-27
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 36/211 (17%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           G  +G+G+FG V  G  + G ++AVK L++++  + +              F  E   ++
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA--------------FLAEASVMT 55

Query: 174 QCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
             +H NL++LLG+    N +   IV EYM  GSL D L R      +   ++   AL V 
Sbjct: 56  TLRHPNLVQLLGVVLQGNPLY--IVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVC 112

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           E + YL    K  +HRD+ + NVL+ E+ V K+ DFG+ K +          +     + 
Sbjct: 113 EGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS---------QGQDSGKL 161

Query: 290 --PYMPPEAM-HCQISTKTDVFSYGVILLEL 317
              +  PEA+   + STK+DV+S+G++L E+
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 6e-27
 Identities = 74/235 (31%), Positives = 117/235 (49%), Gaps = 28/235 (11%)

Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G+ +G G FG VY G  L+ G  +A+K +              E A+  I+    E+  L
Sbjct: 5   GDLIGRGAFGVVYKGLNLETGDFVAIKQISLE--------KIKEEALKSIM---QEIDLL 53

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIALGVA 230
              KH N+++ +G      +  I+ EY  NGSL   + +    P  L +   Y +  G  
Sbjct: 54  KNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQG-- 111

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTR 289
             L YLH   + +IHRD+K+AN+L  ++ V KL DFG+  K+++ S        ++ GT 
Sbjct: 112 --LAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD----DASVVGT- 162

Query: 290 PY-MPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
           PY M PE +     ST +D++S G  ++ELLTG  P  D N +   + +V+ + P
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP 217

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 7e-27
 Identities = 69/289 (23%), Positives = 133/289 (46%), Gaps = 41/289 (14%)

Query: 112 RRGNKLGEGQFGTVYYG-----KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 166
            +   LG G FGTVY G       K  + +A+K L    +  ++     EA ++      
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVM------ 63

Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
                 +   H +++RLLG+C +    ++ + M  G L D +   N+   + S    +  
Sbjct: 64  ------ASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVR--NHKDNIGSQYLLNWC 115

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
           + +A+ + YL    K ++HRD+ + NVL+      K+ DFG+ K+ +    +        
Sbjct: 116 VQIAKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173

Query: 287 GTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR 344
             + +M  E++  +I T K+DV+SYGV + EL+T G KP +               +P  
Sbjct: 174 PIK-WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG--------------IPAV 218

Query: 345 EVLD--KEAGEWNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
           E+ D  ++     +  + T+ + +V  KC + + + R + +++++  SK
Sbjct: 219 EIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  112 bits (279), Expect = 9e-27
 Identities = 92/385 (23%), Positives = 150/385 (38%), Gaps = 34/385 (8%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             KLGEG FG VY  + +    +A+K L       S            +  F  E+Q L+
Sbjct: 5   LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKE----------VERFLREIQILA 52

Query: 174 QCKH-VNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
              H  N+++L     +     +V EY+  GSL D L ++    PL  ++   I   +  
Sbjct: 53  SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYTENLT---G 287
           AL YLH  SK IIHRD+K  N+LLD +  V KL DFG+ K+       +      +   G
Sbjct: 113 ALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170

Query: 288 TRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ--EV 341
           T  YM PE +        S+ +D++S G+ L ELLTG+ P +           ++   E+
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230

Query: 342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD-------LLSKSMFV 394
           P   +    +    E   +    ++ +K    +   R S    +         L +S   
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLL-KKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289

Query: 395 CNSLANLYVGKVSSRTQENNNINWELHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDS 454
                +       S       +   L+   I    L   ++   +      V+++P   S
Sbjct: 290 DLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSS 349

Query: 455 NKRYSIALGVAEALHYLHSLSKPII 479
           +   S A     +L  + + S P  
Sbjct: 350 SLLLSTASSKRSSLPKISARSSPSS 374

Length = 384

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  108 bits (273), Expect = 1e-26
 Identities = 76/235 (32%), Positives = 109/235 (46%), Gaps = 36/235 (15%)

Query: 113 RGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
           RGNK+G G FG VY    L  G  +AVK +           DN       I    +E++ 
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQ--------DNDPKT---IKEIADEMKV 52

Query: 172 LSQCKHVNLLRLLGL-CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L   KH NL++  G+  +     I  EY C+G   + L            + Y++ L   
Sbjct: 53  LELLKHPNLVKYYGVEVHREKVYIFMEY-CSGGTLEELLEHGRILDEHVIRVYTLQL--L 109

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTR 289
           E L YLHS    I+HRD+K AN+ LD N V KLGDFG  VK+   +       ++L GT 
Sbjct: 110 EGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167

Query: 290 PYMPPEAMHCQISTKT---------DVFSYGVILLELLTGMKP---IDDNNTILY 332
            YM PE     + T           D++S G ++LE+ TG +P   +D+   I++
Sbjct: 168 AYMAPE-----VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  107 bits (269), Expect = 6e-26
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 29/216 (13%)

Query: 115 NKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
            +LGEG FG V   +        G ++AVK+L ++      +             FE E+
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD------------FEREI 57

Query: 170 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L    H N+++  G+C         ++ EY+ +GSL D L R  +   ++  +    +
Sbjct: 58  EILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR--HRDQINLKRLLLFS 115

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL S  +  IHRD+ + N+L++   + K+ DFG+ K+      K  Y     
Sbjct: 116 SQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPED--KDYYYVKEP 171

Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S+ +DV+S+GV L EL T
Sbjct: 172 GESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  106 bits (266), Expect = 9e-26
 Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 39/217 (17%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             KLG G FG V+ G  KN + +A+K L+++              ++    F+ EVQ L 
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-------------LLKQQDFQKEVQALK 57

Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLA----RVNNTPPLDSNKRYSIALG 228
           + +H +L+ L  +C+      I+ E M  GSL   L     +V     L       +A  
Sbjct: 58  RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQ 112

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE-----TSNMKTMYTE 283
           VAE + YL    +  IHRD+ + N+L+ E+ V K+ DFG+ ++ +     +S+ K  Y  
Sbjct: 113 VAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK- 169

Query: 284 NLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 319
                  +  PEA  H   STK+DV+S+G++L E+ T
Sbjct: 170 -------WTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 2e-25
 Identities = 69/216 (31%), Positives = 101/216 (46%), Gaps = 18/216 (8%)

Query: 112 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLE-NNANYSSSNSDNTEAAMIPILLFENEV 169
           RRG  LG+G FG VY    +  G E+AVK +  +  +  +    N           E E+
Sbjct: 5   RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNA---------LECEI 55

Query: 170 QTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
           Q L   +H  +++  G L ++    I  EYM  GS+ D+L        L           
Sbjct: 56  QLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQ 112

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           + E + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T        +++TGT
Sbjct: 113 ILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170

Query: 289 RPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 323
             +M PE +  +    K DV+S G  ++E+LT   P
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  103 bits (258), Expect = 1e-24
 Identities = 69/226 (30%), Positives = 113/226 (50%), Gaps = 20/226 (8%)

Query: 113 RGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
           +G  +G+G +G VY    +  G  +AVK +E  A   +   D+ +  M+  L   +E++T
Sbjct: 5   KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPA-TIAGRHDSRQKDMVKAL--RSEIET 61

Query: 172 LSQCKHVNLLRLLGL--CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
           L    H+N+++ LG       ++ I  EY+  GS+     R       +          V
Sbjct: 62  LKDLDHLNIVQYLGFETTEEYLS-IFLEYVPGGSI-GSCLR--TYGRFEEQLVRFFTEQV 117

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET--SNMKTMYTENLTG 287
            E L YLHS  K I+HRD+K+ N+L+D + + K+ DFGI K S+    N + M   ++ G
Sbjct: 118 LEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM---SMQG 172

Query: 288 TRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNNTI 330
           +  +M PE +H      S K D++S G ++LE+  G +P  D   I
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  102 bits (257), Expect = 1e-24
 Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 29/213 (13%)

Query: 116 KLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           KLGEG +G+VY     + G  +A+K +           D  E           E+  L Q
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------EDLQE--------IIKEISILKQ 54

Query: 175 CKHVNLLRLLG---LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           C    +++  G      ++   IV EY   GS+ D +   N T  L   +  +I     +
Sbjct: 55  CDSPYIVKYYGSYFKNTDLW--IVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLK 110

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            L YLHS     IHRD+K+ N+LL+E    KL DFG+      +  K      + GT  +
Sbjct: 111 GLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK---RNTVIGTPFW 165

Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKP 323
           M PE       + K D++S G+  +E+  G  P
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  102 bits (256), Expect = 2e-24
 Identities = 70/215 (32%), Positives = 111/215 (51%), Gaps = 27/215 (12%)

Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+             E  M  +  F  E   + 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-------------EDTM-EVEEFLKEAAVMK 57

Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 58  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 116

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 117 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIK 170

Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 205

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 4e-24
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 28/214 (13%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             +LG GQFG V+ GK +  +++A+K +              E AM      E E + + 
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDVAIKMIR-------------EGAMSEDDFIE-EAKVMM 54

Query: 174 QCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           +  H NL++L G+C       IV EYM NG L + L        L +     +   V EA
Sbjct: 55  KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE--RKGKLGTEWLLDMCSDVCEA 112

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR--- 289
           + YL   S   IHRD+ + N L+ E+ V K+ DFG+ +      +   YT +  GT+   
Sbjct: 113 MEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV----LDDQYTSS-QGTKFPV 165

Query: 290 PYMPPEA-MHCQISTKTDVFSYGVILLELLTGMK 322
            + PPE   + + S+K+DV+S+GV++ E+ +  K
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 73/218 (33%), Positives = 105/218 (48%), Gaps = 25/218 (11%)

Query: 112 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           R+G  LG G FG+VY G  L +G   AVK +    + +       EA    +   E E+ 
Sbjct: 3   RKGELLGSGSFGSVYEGLNLDDGDFFAVKEV----SLADDGQTGQEA----VKQLEQEIA 54

Query: 171 TLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIALG 228
            LS+ +H N+++ LG      N  I  E +  GSL   L +  + P P+       I LG
Sbjct: 55  LLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG 114

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTG 287
               L YLH   +  +HRD+K AN+L+D N V KL DFG+ K + E S  K+       G
Sbjct: 115 ----LEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF-----KG 163

Query: 288 TRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKP 323
           +  +M PE +  Q       D++S G  +LE+ TG  P
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 30/216 (13%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           KLG+G +G+VY  K L +    A+K      +  S +    E A+       NE++ L+ 
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALK----EVDLGSMSQKEREDAV-------NEIRILAS 55

Query: 175 CKHVNLLR-----LLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIALG 228
             H N++      L G   N + CIV EY   G L   +++       +   + + I + 
Sbjct: 56  VNHPNIISYKEAFLDG---NKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           +   L  LH     I+HRD+KSAN+LL  N + K+GD GI K+     +K    +   GT
Sbjct: 112 LLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKV-----LKKNMAKTQIGT 164

Query: 289 RPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 323
             YM PE    +  S K+D++S G +L E+ T   P
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 98.3 bits (245), Expect = 4e-23
 Identities = 66/219 (30%), Positives = 106/219 (48%), Gaps = 24/219 (10%)

Query: 115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           NK+G+G FG V+    K +    A+K +    + S  N    E A+       +E + L+
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQI----DLSKMNRREREEAI-------DEARVLA 54

Query: 174 QCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           +     ++R      +     IV EY  NG L+  L ++    PL  ++ +   + +   
Sbjct: 55  KLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLG 113

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L +LHS  K I+HRD+KS N+ LD     K+GD G+ K+   +   T +   + GT  Y+
Sbjct: 114 LAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN---TNFANTIVGTPYYL 168

Query: 293 PPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNN 328
            PE   C+    + K+DV++ GV+L E  TG  P D NN
Sbjct: 169 SPEL--CEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 98.7 bits (246), Expect = 6e-23
 Identities = 73/237 (30%), Positives = 119/237 (50%), Gaps = 55/237 (23%)

Query: 117 LGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           LGEG FG V+ G+  +         +AVKTL+     ++SN    +        FE E +
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKE----TASNDARKD--------FEREAE 60

Query: 171 TLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSL------YDRLARVNNTP----- 215
            L+  +H N+++  G+C      IM   V+EYM +G L      +   A    +P     
Sbjct: 61  LLTNFQHENIVKFYGVCTEGDPPIM---VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117

Query: 216 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 275
            L  ++   IA+ +A  + YL S     +HRD+ + N L+  + V K+GDFG   MS   
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFG---MS--- 169

Query: 276 NMKTMYTEN---LTGTR--P--YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 323
             + +YT +   + G    P  +MPPE+ M+ + +T++DV+S+GV+L E+ T G +P
Sbjct: 170 --RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 42/109 (38%), Positives = 51/109 (46%), Gaps = 9/109 (8%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           LF         PL  ++   IAL +   L YLHS    IIHRD+K  N+LLDEN V K+ 
Sbjct: 85  LFDYLSRGG--PLSEDEAKKIALQILRGLEYLHSNG--IIHRDLKPENILLDENGVVKIA 140

Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPE--AMHCQISTKTDVFSYG 546
           DFG+ K    S+          GT  YM PE          K DV+S G
Sbjct: 141 DFGLAKKLLKSSSSLT---TFVGTPWYMAPEVLLGGNGYGPKVDVWSLG 186

Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 68/214 (31%), Positives = 90/214 (42%), Gaps = 24/214 (11%)

Query: 116 KLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
            +G+G FG VY     +    +A+K +            + E A   I   + E+Q LSQ
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVI------------DLEEAEDEIEDIQQEIQFLSQ 55

Query: 175 CKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           C+   + +  G         I+ EY   GS  D L        LD      I   V   L
Sbjct: 56  CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGL 111

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLH   K  IHRD+K+AN+LL E    KL DFG V    TS M    T    GT  +M 
Sbjct: 112 EYLHEEGK--IHRDIKAANILLSEEGDVKLADFG-VSGQLTSTMSKRNT--FVGTPFWMA 166

Query: 294 PEA-MHCQISTKTDVFSYGVILLELLTGMKPIDD 326
           PE         K D++S G+  +EL  G  P+ D
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 97.2 bits (242), Expect = 1e-22
 Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 24/207 (11%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           KLG GQFG V+ G      ++A+K+L+             + +M P   F  E   + Q 
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLK-------------QGSMSP-EAFLAEANLMKQL 58

Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+RL  +       I+ EYM NGSL D L +      L  NK   +A  +AE + +
Sbjct: 59  QHPRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAF 117

Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +    K  IHRD+++AN+L+ E    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 118 IER--KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 171

Query: 294 PEAM-HCQISTKTDVFSYGVILLELLT 319
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 76/272 (27%), Positives = 119/272 (43%), Gaps = 41/272 (15%)

Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           K+GEG  G VY    +  G E+A+K +            N E  +       NE+  +  
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKM-------RLRKQNKELII-------NEILIMKD 71

Query: 175 CKHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           CKH N++        + + +  V EYM  GSL D +   N     +    Y +   V + 
Sbjct: 72  CKHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAY-VCREVLQG 128

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMKTMYTENLTGTRP 290
           L YLHS  + +IHRD+KS N+LL ++   KL DFG       E S   ++      GT P
Sbjct: 129 LEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-----VGT-P 180

Query: 291 Y-MPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 348
           Y M PE +  +    K D++S G++ +E+  G  P      +   +L+  + +P      
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL---- 236

Query: 349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRAS 380
           K   +W+    + L      KC V + +KR S
Sbjct: 237 KNPEKWSPEFKDFL-----NKCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 37/216 (17%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL--FENEVQTLS 173
           K+G+G FG VY G LK   E+AVKT  +               + P L   F  E + L 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRST--------------LPPDLKRKFLQEAEILK 47

Query: 174 QCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           Q  H N+++L+G+C     I   IV E +  GSL   L +  N   L   K   ++L  A
Sbjct: 48  QYDHPNIVKLIGVCVQKQPIY--IVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAA 103

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
             + YL   SK  IHRD+ + N L+ EN V K+ DFG+ +  E      +YT  ++    
Sbjct: 104 AGMEYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG----IYT--VSDGLK 155

Query: 291 YMP-----PEAM-HCQISTKTDVFSYGVILLELLTG 320
            +P     PEA+ + + ++++DV+SYG++L E  + 
Sbjct: 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 68/224 (30%), Positives = 103/224 (45%), Gaps = 42/224 (18%)

Query: 117 LGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           LG+G FG VY G  K          +A+KT+  NA    S  +  E        F NE  
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----SMRERIE--------FLNEAS 61

Query: 171 TLSQ--CKHVNLLRLLGLC---NNIMNCIVYEYMCNGSL--YDRLAR-----VNNTPPLD 218
            + +  C HV  +RLLG+       +  +V E M  G L  Y R  R          P  
Sbjct: 62  VMKEFNCHHV--VRLLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPT 117

Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 278
             K   +A  +A+ + YL +  K  +HRD+ + N ++ E+   K+GDFG   M+      
Sbjct: 118 LQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLTVKIGDFG---MTRDIYET 172

Query: 279 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
             Y +   G  P  +M PE++   + +TK+DV+S+GV+L E+ T
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 95.4 bits (237), Expect = 6e-22
 Identities = 69/206 (33%), Positives = 108/206 (52%), Gaps = 32/206 (15%)

Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK 176
           +G+G+FG V  G  + G ++AVK ++N+A   +               F  E   ++Q +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASVMTQLR 57

Query: 177 HVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           H NL++LLG+         IV EYM  GSL D L R      L  +     +L V EA+ 
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 116

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 292
           YL + +   +HRD+ + NVL+ E+ V K+ DFG+ K  E S+ +       TG  P  + 
Sbjct: 117 YLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD------TGKLPVKWT 166

Query: 293 PPEAM-HCQISTKTDVFSYGVILLEL 317
            PEA+   + STK+DV+S+G++L E+
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 93.5 bits (233), Expect = 9e-22
 Identities = 40/110 (36%), Positives = 55/110 (50%), Gaps = 9/110 (8%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKL 498
           L  L +  N   L  ++   I L + E L YLHS    IIHRD+K  N+LLD  N   KL
Sbjct: 78  LKDLLK-ENEGKLSEDEILRILLQILEGLEYLHS--NGIIHRDLKPENILLDSDNGKVKL 134

Query: 499 GDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYG 546
            DFG   +S+         + + GT  YM PE +  +   S K+D++S G
Sbjct: 135 ADFG---LSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLG 181

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 93.8 bits (233), Expect = 2e-21
 Identities = 70/219 (31%), Positives = 107/219 (48%), Gaps = 21/219 (9%)

Query: 113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           +G  LG+G +GTVY G    G  IAVK +E      +SN    E     +   + EV  L
Sbjct: 4   KGEVLGKGAYGTVYCGLTNQGQLIAVKQVE----LDTSNVLAAEKEYEKL---QEEVDLL 56

Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIALGV 229
              KHVN+++ LG C  +N ++ I  E++  GS+   L R    P P+       I  GV
Sbjct: 57  KSLKHVNIVQYLGTCLDDNTIS-IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGV 115

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK---MSETSNMKTMYTENLT 286
           A    YLH  +  ++HRD+K  NV+L  N + KL DFG  +           +   +++ 
Sbjct: 116 A----YLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169

Query: 287 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 324
           GT  +M PE ++      K+D++S G  + E+ TG  P+
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 29/221 (13%)

Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             +G+G FGTV   + K+ G  +  K +    +Y   N    E   +      +EV  L 
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEI----DYG--NMTEKEKQQLV-----SEVNILR 54

Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYM--CNGSLYDRLARV-----NNTPPLDSNKRYSIA 226
           + KH N++R      +  N  +Y  M  C G   D LA++          ++    + I 
Sbjct: 55  ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGG--D-LAQLIQKCKKERKYIEEEFIWRIL 111

Query: 227 LGVAEALHYLHSLSKP---IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
             +  AL+  H+ S P   ++HRD+K AN+ LD N   KLGDFG+ K+       + + +
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD---SSFAK 168

Query: 284 NLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKP 323
              GT  YM PE + H     K+D++S G ++ EL     P
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 68/222 (30%), Positives = 97/222 (43%), Gaps = 37/222 (16%)

Query: 115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           ++LGEG  G+V   +LK  GM  A+KT+          +D        IL    E++   
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTI---------TTDPNPDLQKQIL---RELEINK 54

Query: 174 QCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSL---YDRL----ARVNNTPPLDSNKRY 223
            CK   +++  G   +  +    I  EY   GSL   Y ++     R+            
Sbjct: 55  SCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG------ 108

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
            IA  V + L YLHS  + IIHRD+K +N+LL      KL DFG+      S   T    
Sbjct: 109 KIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT---- 162

Query: 284 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
             TGT  YM PE +  +  S  +DV+S G+ LLE+     P 
Sbjct: 163 -FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 21/215 (9%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             +G G    VY    L N  ++A+K +    +     +   E           EVQ +S
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRI----DLEKCQTSVDELR--------KEVQAMS 54

Query: 174 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           QC H N+++     +  + +  +V  Y+  GSL D +        LD     ++   V +
Sbjct: 55  QCNHPNVVKYYTSFVVGDEL-WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLK 113

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN-LTGTRP 290
            L YLHS  +  IHRD+K+ N+LL E+   K+ DFG+         +T        GT  
Sbjct: 114 GLEYLHSNGQ--IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171

Query: 291 YMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKP 323
           +M PE M        K D++S+G+  +EL TG  P
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 92.3 bits (229), Expect = 6e-21
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 35/216 (16%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           G  +GEG+FG V  G+   G ++AVK ++          D T  A      F  E   ++
Sbjct: 11  GEIIGEGEFGAVLQGEYT-GQKVAVKNIK---------CDVTAQA------FLEETAVMT 54

Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           +  H NL+RLLG+  +    IV E M  G+L + L R      +   +    +L VAE +
Sbjct: 55  KLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGM 113

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS----ETSNMKTMYTENLTGTR 289
            YL S  K ++HRD+ + N+L+ E+ V K+ DFG+ ++     + S +   +T       
Sbjct: 114 EYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT------- 164

Query: 290 PYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
               PEA+ H + S+K+DV+SYGV+L E+ + G  P
Sbjct: 165 ---APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 92.6 bits (230), Expect = 6e-21
 Identities = 71/223 (31%), Positives = 118/223 (52%), Gaps = 17/223 (7%)

Query: 113 RGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
           +G  +G G FG+VY G    +G  +AVK +E  +   S++S + + +M+  L    E+  
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPS--VSASSKDRKRSMLDAL--AREIAL 59

Query: 172 LSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
           L + +H N+++ LG  L  + +N I  EY+  GS+    A +NN    +     +    +
Sbjct: 60  LKELQHENIVQYLGSSLDADHLN-IFLEYVPGGSV---AALLNNYGAFEETLVRNFVRQI 115

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN---LT 286
            + L+YLH+  + IIHRD+K AN+L+D     K+ DFGI K  E +++ T        L 
Sbjct: 116 LKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173

Query: 287 GTRPYMPPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNN 328
           G+  +M PE +     T K D++S G +++E+LTG  P  D  
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.9 bits (228), Expect = 7e-21
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 27/215 (12%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V YGK +   ++A+K ++     S S  +           F  E + + + 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDE-----------FIEEAKVMMKL 56

Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H  L++L G+C       IV EYM NG L + L           ++   +   V E + 
Sbjct: 57  SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRF--QPSQLLEMCKDVCEGMA 114

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 292
           YL S  K  IHRD+ + N L+D+    K+ DFG+ +      +   YT ++    P  + 
Sbjct: 115 YLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWS 168

Query: 293 PPEAMH-CQISTKTDVFSYGVILLELLT-GMKPID 325
           PPE +   + S+K+DV+++GV++ E+ + G  P +
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 22/209 (10%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           ++GEG  G V+  K  + G  +A+K +              E  +    L   E++ L  
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALR---------RLEGGIPNQAL--REIKALQA 55

Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           C+H  +++LL +  +     +V EYM    L + L       P    K Y   L   + +
Sbjct: 56  CQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRML--LKGV 112

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+H+    I+HRD+K AN+L+  + V K+ DFG+ ++      +    +    TR Y  
Sbjct: 113 AYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ--VATRWYRA 168

Query: 294 PEAMHCQ--ISTKTDVFSYGVILLELLTG 320
           PE ++         D+++ G I  ELL G
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 88/307 (28%), Positives = 141/307 (45%), Gaps = 64/307 (20%)

Query: 110 YPRR----GNKLGEGQFGTVY----YGKLKNG--MEIAVKTLENNANYSSSNSDNTEAAM 159
           +PR     G  LG G FG V     YG  K+   M++AVK L+      +++S   EA M
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK-----PTAHSSEREALM 86

Query: 160 IPILLFENEVQTLSQC-KHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTP 215
                  +E++ +S    H N++ LLG C     I+  ++ EY C G L + L R     
Sbjct: 87  -------SELKIMSHLGNHENIVNLLGACTIGGPIL--VITEYCCYGDLLNFLRR-KRES 136

Query: 216 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSE 273
            L      S +  VA+ + +L S  K  IHRD+ + NVLL    + K+ DFG+ +  M++
Sbjct: 137 FLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194

Query: 274 TSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELLT-------GMKP 323
            SN    Y        P  +M PE++ +C  + ++DV+SYG++L E+ +       GM P
Sbjct: 195 -SN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM-P 248

Query: 324 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRD 383
           +D      +Y L+ E        + +        H    I  + + C   +  KR + + 
Sbjct: 249 VDSK----FYKLIKEGYR-----MAQPE------HAPAEIYDIMKTCWDADPLKRPTFKQ 293

Query: 384 IVDLLSK 390
           IV L+ K
Sbjct: 294 IVQLIGK 300

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 68/218 (31%), Positives = 99/218 (45%), Gaps = 29/218 (13%)

Query: 116 KLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
           KLG+G FG V  G+        + +AVK L+         SD     M     F  E   
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK---------SDKLSDIMDD---FLKEAAI 49

Query: 172 LSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
           +    H NL+RL G  L + +M  +V E    GSL DRL R +       +     A+ +
Sbjct: 50  MHSLDHENLIRLYGVVLTHPLM--MVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQI 106

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT--ENLTG 287
           A  + YL S  K  IHRD+ + N+LL  +   K+GDFG+  M      +  Y   E+L  
Sbjct: 107 ANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGL--MRALPQNEDHYVMEEHLKV 162

Query: 288 TRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
              +  PE++     S  +DV+ +GV L E+ T G +P
Sbjct: 163 PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 31/219 (14%)

Query: 115 NKLGEGQFGTVYYG--KLKNGMEI--AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
            +LG G FG+V  G   +K+G E+  AVKTL+             +   +       E  
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI------AAGKKEFL------REAS 48

Query: 171 TLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
            ++Q  H  ++RL+G+C      +V E    G L   L +    P  D  +   +A  VA
Sbjct: 49  VMAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVA 105

Query: 231 EALHYLHSLSKPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
             + YL   SK  +HRD+ + NVLL + +   K+ DFG   MS      + Y    T  R
Sbjct: 106 MGMAYLE--SKHFVHRDLAARNVLLVNRHQA-KISDFG---MSRALGAGSDYYRATTAGR 159

Query: 290 -P---YMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 323
            P   Y P    + + S+K+DV+SYGV L E  + G KP
Sbjct: 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 33/220 (15%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
            ++GEG +G VY  +  K G  +A+K +           +N E    PI     E++ L 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI---------RMEN-EKEGFPITAIR-EIKLLQ 53

Query: 174 QCKHVNLLRLLGLC-----NNIMNCIVYEYMCNGSLYD--RLARVNNTPPLDSNKRYSIA 226
           + +H N++RL  +       +I   +V+EYM     +D   L         +S  +    
Sbjct: 54  KLRHPNIVRLKEIVTSKGKGSIY--MVFEYMD----HDLTGLLDSPEVKFTESQIK-CYM 106

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + E L YLHS    I+HRD+K +N+L++ + V KL DFG+ +   T      YT N  
Sbjct: 107 KQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADYT-NRV 162

Query: 287 GTRPYMPPEA-MHC-QISTKTDVFSYGVILLELLTGMKPI 324
            T  Y PPE  +   +   + D++S G IL EL  G KPI
Sbjct: 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG-KPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 91.4 bits (227), Expect = 3e-20
 Identities = 74/276 (26%), Positives = 120/276 (43%), Gaps = 38/276 (13%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           ++G G FG VY+ + ++    +A+K +    +YS   S+     +I       EV+ L Q
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKM----SYSGKQSNEKWQDII------KEVRFLQQ 71

Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
            +H N +   G         +V EY C GS  D L    +  PL   +  +I  G  + L
Sbjct: 72  LRHPNTIEYKGCYLREHTAWLVMEY-CLGSASDILEV--HKKPLQEVEIAAICHGALQGL 128

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLHS  +  IHRD+K+ N+LL E    KL DFG   +   +N       +  GT  +M 
Sbjct: 129 AYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-------SFVGTPYWMA 179

Query: 294 PE---AM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 349
           PE   AM   Q   K DV+S G+  +EL     P+ + N +   Y + + + P       
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL----- 234

Query: 350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
            + +W++     +     + C       R S  +++
Sbjct: 235 SSNDWSDYFRNFV-----DSCLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 68/216 (31%), Positives = 93/216 (43%), Gaps = 27/216 (12%)

Query: 115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
            +LG G  G V     +  G  +AVKT+           +      I       E+  L 
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIR-------LEINEAIQKQIL-----RELDILH 54

Query: 174 QCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           +C    ++   G      +I  C+  EYM  GSL   L  V    P     +  IA+ V 
Sbjct: 55  KCNSPYIVGFYGAFYNNGDISICM--EYMDGGSLDKILKEVQGRIPERILGK--IAVAVL 110

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           + L YLH   K IIHRDVK +N+L++     KL DFG+      S  KT       GT  
Sbjct: 111 KGLTYLHEKHK-IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-----FVGTSS 164

Query: 291 YMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPID 325
           YM PE +     S K+D++S G+ L+EL TG  P  
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 68/211 (32%), Positives = 105/211 (49%), Gaps = 32/211 (15%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           KLG GQFG V+ G      ++AVKTL+                M P    E E Q + + 
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLK-------------PGTMSPESFLE-EAQIMKKL 58

Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRL----ARVNNTPPLDSNKRYSIALGVAE 231
           +H  L++L  + +     IV EYM  GSL D L     R    P L       +A  VA 
Sbjct: 59  RHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL-----VDMAAQVAA 113

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 290
            + Y+  ++   IHRD++SAN+L+ +  V K+ DFG+ ++ E +     YT       P 
Sbjct: 114 GMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE----YTARQGAKFPI 167

Query: 291 -YMPPE-AMHCQISTKTDVFSYGVILLELLT 319
            +  PE A++ + + K+DV+S+G++L EL+T
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 32/218 (14%)

Query: 117 LGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+L    K  +++A+KTL+  A  S     +          F  E   +
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLK--AGSSDKQRLD----------FLTEASIM 59

Query: 173 SQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            Q  H N++RL G+      +M  I+ EYM NGSL   L    N       +   +  G+
Sbjct: 60  GQFDHPNIIRLEGVVTKSRPVM--IITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGI 115

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           A  + YL  ++   +HRD+ + N+L++ N V K+ DFG+ +  E S     YT    G  
Sbjct: 116 ASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE--ATYTTK-GGKI 170

Query: 290 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           P  +  PEA+ + + ++ +DV+S+G+++ E+++ G +P
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 89.6 bits (222), Expect = 5e-20
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 28/223 (12%)

Query: 112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
               ++G GQFG V+ G      ++A+KT+   A    S  D           F  E Q 
Sbjct: 7   TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA---MSEED-----------FIEEAQV 52

Query: 172 LSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           + +  H  L++L G+C      C+V+E+M +G L D L                + L V 
Sbjct: 53  MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVC 110

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           E + YL S +  +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+ 
Sbjct: 111 EGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFV----LDDQYTSS-TGTKF 163

Query: 290 --PYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 329
              +  PE     + S+K+DV+S+GV++ E+ +  K   +N +
Sbjct: 164 PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 89.4 bits (222), Expect = 7e-20
 Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 31/211 (14%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           KLG GQFG V+ G   N   +AVKTL+          D  +        F  E Q + + 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLK------PGTMDPKD--------FLAEAQIMKKL 58

Query: 176 KHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           +H  L++L  +C     I   IV E M  GSL + L        L   +   +A  VA  
Sbjct: 59  RHPKLIQLYAVCTLEEPIY--IVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASG 115

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR--- 289
           + YL + +   IHRD+ + NVL+ EN + K+ DFG+ ++      + +Y E   G +   
Sbjct: 116 MAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVI----KEDIY-EAREGAKFPI 168

Query: 290 PYMPPEA-MHCQISTKTDVFSYGVILLELLT 319
            +  PEA ++ + S K+DV+S+G++L E++T
Sbjct: 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 88.7 bits (221), Expect = 8e-20
 Identities = 70/249 (28%), Positives = 104/249 (41%), Gaps = 43/249 (17%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   + K+  ++ A+K L+             E           E   LS+ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK-----KKKIIKRKEVEHT-----LTERNILSRI 50

Query: 176 KHVNLLRL---------LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
            H  +++L         L         +V EY   G L+  L++       +  + Y   
Sbjct: 51  NHPFIVKLHYAFQTEEKL--------YLVLEYAPGGELFSHLSKEGRFSE-ERARFY--- 98

Query: 227 LGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
              AE   AL YLHSL   II+RD+K  N+LLD +   KL DFG+ K   +   +T  T 
Sbjct: 99  --AAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT-NT- 152

Query: 284 NLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
              GT  Y+ PE  +        D +S GV+L E+LTG  P    +    Y  +++  + 
Sbjct: 153 -FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR 211

Query: 343 VREVLDKEA 351
             E L  EA
Sbjct: 212 FPEFLSPEA 220

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 89.2 bits (222), Expect = 8e-20
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 23/217 (10%)

Query: 120 GQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV 178
           G +G V+  K K+  +I A+K +   A+    N  +        +L E ++  LSQ +  
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVI-KKADMIRKNQVDQ-------VLTERDI--LSQAQSP 53

Query: 179 NLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH 237
            +++L           +V EY+  G L   L  V +    +   R  IA  +  AL YLH
Sbjct: 54  YVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLD--EDVARIYIA-EIVLALEYLH 110

Query: 238 SLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN-----LTGTRPYM 292
           S    IIHRD+K  N+L+D N   KL DFG+ K+        +  +      + GT  Y+
Sbjct: 111 SNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 293 PPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNN 328
            PE +  Q  +KT D +S G IL E L G+ P     
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 41/230 (17%)

Query: 114 GNKLGEGQFGTVYYG------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
           G  LGEG FG V                +AVK L+++A      SD         L+ E 
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSD---------LVSEM 66

Query: 168 EVQTLSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY--- 223
           E+  +   KH N++ LLG+C       +V EY  +G+L D L R    P   ++      
Sbjct: 67  EMMKMIG-KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRP 124

Query: 224 -----------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
                      S A  VA  + +L S  K  IHRD+ + NVL+ E+ V K+ DFG   ++
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADFG---LA 179

Query: 273 ETSNMKTMYTENLTGTRPY--MPPEAMHCQIST-KTDVFSYGVILLELLT 319
              +    Y +   G  P   M PEA+  ++ T ++DV+S+GV+L E+ T
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 88.0 bits (218), Expect = 3e-19
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 29/218 (13%)

Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+  + Y+     +          F +E   +
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLK--SGYTEKQRRD----------FLSEASIM 59

Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNT--PPLDSNKRYSIALGV 229
            Q  H N++ L G+        I+ E+M NG+L D   R N+     +   +   +  G+
Sbjct: 60  GQFDHPNIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVI---QLVGMLRGI 115

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           A  + YL  ++   +HRD+ + N+L++ N V K+ DFG+ +  E       YT +L G  
Sbjct: 116 AAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173

Query: 290 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           P  +  PEA+ + + ++ +DV+SYG+++ E+++ G +P
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 88.0 bits (219), Expect = 3e-19
 Identities = 75/308 (24%), Positives = 116/308 (37%), Gaps = 62/308 (20%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTL-------ENNANYSSSNSDNTEAAMIPILLF 165
           G  +GEG F TV   K K    E A+K L       E    Y            I     
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY----------VKI----- 50

Query: 166 ENEVQTLSQCK-HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
             E + L++   H  +++L     +  N   V EY  NG L   + +  +     +  R+
Sbjct: 51  --EKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT--RF 106

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------------ 271
             A  +  AL YLHS    IIHRD+K  N+LLD++   K+ DFG  K+            
Sbjct: 107 YAAE-ILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163

Query: 272 -----SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPID 325
                            +  GT  Y+ PE +        +D+++ G I+ ++LTG  P  
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223

Query: 326 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
            +N  L +  +++ E         +A        + LI    EK  V +   R  + +  
Sbjct: 224 GSNEYLTFQKILKLEYSFPPNFPPDA--------KDLI----EKLLVLDPQDRLGVNEGY 271

Query: 386 DLLSKSMF 393
           D L    F
Sbjct: 272 DELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 88.0 bits (218), Expect = 3e-19
 Identities = 75/267 (28%), Positives = 123/267 (46%), Gaps = 62/267 (23%)

Query: 110 YPRRG----NKLGEGQFGTVYYGK---LKNGME---IAVKTLENNANYSSSNSDNTEAAM 159
           YPR        +G+G FG V+  +   L        +AVK L+  A      S + +A  
Sbjct: 2   YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA------SADMQAD- 54

Query: 160 IPILLFENEVQTLSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVN----- 212
                F+ E   +++  H N+++LLG+C     M C+++EYM  G L + L   +     
Sbjct: 55  -----FQREAALMAEFDHPNIVKLLGVCAVGKPM-CLLFEYMAYGDLNEFLRHRSPRAQC 108

Query: 213 --------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 258
                         N  PL   ++  IA  VA  + YL    +  +HRD+ + N L+ EN
Sbjct: 109 SLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLATRNCLVGEN 166

Query: 259 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILL 315
            V K+ DFG   +S        Y  +     P  +MPPE++ + + +T++DV++YGV+L 
Sbjct: 167 MVVKIADFG---LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 223

Query: 316 ELLT-GMKPIDDNNTILYYYLVVEQEV 341
           E+ + GM+P         YY +  +EV
Sbjct: 224 EIFSYGMQP---------YYGMAHEEV 241

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 69/217 (31%), Positives = 100/217 (46%), Gaps = 18/217 (8%)

Query: 112 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           R G  LG+G FG VY       G E+AVK ++ +   S   S    A        E E+Q
Sbjct: 5   RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPE-SPETSKEVNA-------LECEIQ 56

Query: 171 TLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
            L    H  +++  G   + M     I  E+M  GS+ D+L        L  N       
Sbjct: 57  LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTR 113

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
            + E + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T  +     +++TG
Sbjct: 114 QILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171

Query: 288 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 323
           T  +M PE +  +    K D++S G  ++E+LT   P
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 87.6 bits (217), Expect = 3e-19
 Identities = 74/226 (32%), Positives = 110/226 (48%), Gaps = 34/226 (15%)

Query: 117 LGEGQFGTVYYGKLKN-------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           LG G FG VY G   +        + +AVKTL   A    ++ +  E        F  E 
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----TDQEKKE--------FLKEA 50

Query: 170 QTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL--YDRLARVNNTPP--LDSNKRYS 224
             +S   H N+++LLG+C  N    I+ E M  G L  Y R ARV    P  L   +   
Sbjct: 51  HLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLD 110

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGDFGIVKMSETSNMKT 279
           I L VA+   YL  +    IHRD+ + N L+ E     + V K+GDFG+ +    S+   
Sbjct: 111 ICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168

Query: 280 MYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 323
              E L   R +M PE+ +  + +T++DV+S+GV++ E+LT G +P
Sbjct: 169 KEGEGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 87.4 bits (216), Expect = 4e-19
 Identities = 70/217 (32%), Positives = 103/217 (47%), Gaps = 18/217 (8%)

Query: 112 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           RRG  LG+G FG VY    +  G E+A K ++ +   S   S    A        E E+Q
Sbjct: 5   RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPE-SPETSKEVSA-------LECEIQ 56

Query: 171 TLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
            L   +H  +++  G   +       I  EYM  GS+ D+L +          ++Y+   
Sbjct: 57  LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQ- 114

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
            + E + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T  M      ++TG
Sbjct: 115 -ILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171

Query: 288 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 323
           T  +M PE +  +    K DV+S G  ++E+LT   P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 87.0 bits (215), Expect = 4e-19
 Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 24/207 (11%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G      ++A+KTL+                M+P    + E Q + + 
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLK-------------PGTMMPEAFLQ-EAQIMKKL 58

Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+ L  + +     IV E+M  GSL D L +  +   L   +   +A  +A+ + Y
Sbjct: 59  RHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAY 117

Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY---M 292
           +  ++   IHRD+++AN+L+ +N V K+ DFG+ ++ E +     YT       P     
Sbjct: 118 IERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE----YTARQGAKFPIKWTA 171

Query: 293 PPEAMHCQISTKTDVFSYGVILLELLT 319
           P  A++ + + K+DV+S+G++L EL+T
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 87.0 bits (215), Expect = 6e-19
 Identities = 65/233 (27%), Positives = 117/233 (50%), Gaps = 45/233 (19%)

Query: 116 KLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           +LGEG FG V+  +  N       M +AVK L+          + +E+A      F+ E 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK----------EASESAR---QDFQREA 58

Query: 170 QTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP---------- 215
           + L+  +H +++R  G+C      +M   V+EYM +G L +R  R +             
Sbjct: 59  ELLTVLQHQHIVRFYGVCTEGRPLLM---VFEYMRHGDL-NRFLRSHGPDAKILAGGEDV 114

Query: 216 ---PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
               L   +  +IA  +A  + YL SL    +HRD+ + N L+ +  V K+GDFG+ +  
Sbjct: 115 APGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDI 172

Query: 273 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 323
            +++   +    +   R +MPPE+ ++ + +T++D++S+GV+L E+ T G +P
Sbjct: 173 YSTDYYRVGGRTMLPIR-WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 87.3 bits (216), Expect = 6e-19
 Identities = 63/240 (26%), Positives = 113/240 (47%), Gaps = 45/240 (18%)

Query: 110 YPRR----GNKLGEGQFGTVYYGKLKNGME---------------IAVKTLENNANYSSS 150
           +PR+      KLGEGQFG V+  + +   E               +AVK L  +   ++ 
Sbjct: 2   FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR 61

Query: 151 NSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL----- 204
           N             F  E++ +S+ K+ N++RLLG+C ++   C++ EYM NG L     
Sbjct: 62  ND------------FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLS 109

Query: 205 ----YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV 260
                      NN P +       +A+ +A  + YL SL+   +HRD+ + N L+  ++ 
Sbjct: 110 QREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYT 167

Query: 261 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT 319
            K+ DFG+ +   + +   +    +   R +M  E++   + +T +DV+++GV L E+ T
Sbjct: 168 IKIADFGMSRNLYSGDYYRIQGRAVLPIR-WMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 71/250 (28%), Positives = 115/250 (46%), Gaps = 59/250 (23%)

Query: 105 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEI-----------------AVKTLENNANY 147
           F R+P      KLGEGQFG V+  +     +                  AVK L  +A+ 
Sbjct: 2   FPRQPL-NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 148 SSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--IMNCIVYEYMCNGSLY 205
           ++               F  EV+ LS+    N+ RLLG+C     + C++ EYM NG L 
Sbjct: 61  NARED------------FLKEVKILSRLSDPNIARLLGVCTVDPPL-CMIMEYMENGDLN 107

Query: 206 DRLAR--------VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE 257
             L +          N+  L  +    +A  +A  + YL SL+   +HRD+ + N L+ +
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGK 165

Query: 258 NFVPKLGDFGIVKMSETSNMKTMYTEN---LTGTRP----YMPPEAMH-CQISTKTDVFS 309
           N+  K+ DFG   MS     + +Y+ +   + G  P    +M  E++   + +TK+DV++
Sbjct: 166 NYTIKIADFG---MS-----RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA 217

Query: 310 YGVILLELLT 319
           +GV L E+LT
Sbjct: 218 FGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 87.4 bits (216), Expect = 6e-19
 Identities = 74/226 (32%), Positives = 107/226 (47%), Gaps = 45/226 (19%)

Query: 117 LGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           +GEG FG V    +K     M  A+K L+    ++S N             F  E++ L 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKE---FASENDHRD---------FAGELEVL- 56

Query: 174 QCK---HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 216
            CK   H N++ LLG C N     I  EY   G+L D  R +RV  T P           
Sbjct: 57  -CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115

Query: 217 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 276
           L S +    A  VA  + YL    K  IHRD+ + NVL+ EN   K+ DFG+ +  E   
Sbjct: 116 LTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV 173

Query: 277 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
            KTM      G  P  +M  E+++  + +TK+DV+S+GV+L E+++
Sbjct: 174 KKTM------GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 68/225 (30%), Positives = 98/225 (43%), Gaps = 34/225 (15%)

Query: 112 RRGNKLGEGQFGTVYYGKL--KNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLF 165
                LG G FG VY G    ++G    +++AVKTL        S S+  E+       F
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL------PESCSEQDESD------F 56

Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRL----ARVNNTPPLDSN 220
             E   +S+  H N++RL+G+    +   I+ E M  G L   L     R      L   
Sbjct: 57  LMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK 116

Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNM 277
                A  VA+   YL       IHRD+ + N LL       V K+ DFG   M+     
Sbjct: 117 DLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFG---MARDIYR 171

Query: 278 KTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
            + Y +      P  +MPPEA    I ++KTDV+S+GV+L E+ +
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 86.4 bits (215), Expect = 7e-19
 Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 8/108 (7%)

Query: 442 KLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 501
            +        L      S A+ +A+ + YL S  K  +HRD+ + N L+ E+ V K+ DF
Sbjct: 92  PVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDF 149

Query: 502 GIVKMSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           G   +S        Y +   G  P  +M PE++   I ++K+DV+S+G
Sbjct: 150 G---LSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFG 194

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 85.9 bits (212), Expect = 1e-18
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 24/207 (11%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+         + + EA       F  E Q + + 
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------PGTMSPEA-------FLQEAQVMKKL 58

Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 59  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 117

Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY---M 292
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P     
Sbjct: 118 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 171

Query: 293 PPEAMHCQISTKTDVFSYGVILLELLT 319
           P  A++ + + K+DV+S+G++L EL T
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 34/216 (15%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG G FG V   K+K+     A+K ++          +  +   I      +E + L +C
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-----VETGQQEHI-----FSEKEILEEC 50

Query: 176 KHVNLLRLLGLCNNIMNCIVY---EYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            H  +++L     +     +Y   EY   G L+  L         +   R+ IA  V  A
Sbjct: 51  NHPFIVKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFD--EYTARFYIA-CVVLA 105

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
             YLH+    II+RD+K  N+LLD N   KL DFG  K  ++   KT +T    GT  Y+
Sbjct: 106 FEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KT-WT--FCGTPEYV 159

Query: 293 PPEAMHCQISTK-----TDVFSYGVILLELLTGMKP 323
            PE     I  K      D +S G++L ELLTG  P
Sbjct: 160 APE----IILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 72/225 (32%), Positives = 113/225 (50%), Gaps = 31/225 (13%)

Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           +G+G FG VY+G L   +G +I  AVK+L       +  +D  E        F  E   +
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSL-------NRITDLEEVEQ-----FLKEGIIM 50

Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 51  KDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVA 108

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTR 289
           + + YL   SK  +HRD+ + N +LDE+F  K+ DFG   ++     K  Y+  N TG +
Sbjct: 109 KGMEYL--ASKKFVHRDLAARNCMLDESFTVKVADFG---LARDIYDKEYYSVHNHTGAK 163

Query: 290 ---PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNT 329
               +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D ++
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 25/208 (12%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           KLG GQFG V+ G   N  ++AVKTL+                 + +  F  E   +   
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLK--------------PGTMSVQAFLEEANLMKTL 58

Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H  L+RL  +        I+ EYM  GSL D L + +    +   K    +  +AE + 
Sbjct: 59  QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 292
           Y+    K  IHRD+++ANVL+ E+ + K+ DFG+ ++ E +     YT       P  + 
Sbjct: 118 YIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE----YTAREGAKFPIKWT 171

Query: 293 PPEAMHC-QISTKTDVFSYGVILLELLT 319
            PEA++    + K+DV+S+G++L E++T
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 85.2 bits (212), Expect = 2e-18
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 8/103 (7%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            +   L       +AL +A+ + YL S  K  +HRD+ + N L+ EN V K+ DFG   +
Sbjct: 94  KHGEKLTLKDLLQMALQIAKGMEYLES--KNFVHRDLAARNCLVTENLVVKISDFG---L 148

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYG 546
           S        Y +   G  P  +M PE+    + ++K+DV+S+G
Sbjct: 149 SRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFG 191

Length = 258

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 88.4 bits (219), Expect = 2e-18
 Identities = 72/229 (31%), Positives = 106/229 (46%), Gaps = 36/229 (15%)

Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG G  GTV   K + +G   AVK ++     S ++ +  +A          EV  L  C
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEG-MSEADKNRAQA----------EVCCLLNC 88

Query: 176 KHVNLLRLLGLC-------------NNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNK 221
              ++++    C             N +M  +V +Y   G L   + +R         ++
Sbjct: 89  DFFSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHE 144

Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTM 280
              + + V  A+H++HS  K +IHRD+KSAN+LL  N + KLGDFG  KM + T +    
Sbjct: 145 AGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG 202

Query: 281 YTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
            T    GT  Y+ PE       S K D+FS GV+L ELLT  +P D  N
Sbjct: 203 RT--FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 84.9 bits (211), Expect = 3e-18
 Identities = 72/238 (30%), Positives = 108/238 (45%), Gaps = 24/238 (10%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG G FG V   + K   +  A+K L           ++            NE + L   
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVL----------NEKRILQSI 58

Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H  L+ L G   +  N  +V EY+  G L+  L R +   P    + Y  A  V  AL 
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFY--AAQVVLALE 115

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLHSL   I++RD+K  N+LLD +   K+ DFG  K  +    +T YT  L GT  Y+ P
Sbjct: 116 YLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RT-YT--LCGTPEYLAP 167

Query: 295 EAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           E +  +   K  D ++ G+++ E+L G  P  D+N I  Y  ++E +V        +A
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDA 225

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 84.5 bits (210), Expect = 4e-18
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 28/219 (12%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDN--TEAAMIPILLFENE 168
            +  KLGEG +G VY  +  K G  +A+K +  +      N +      A+        E
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD------NEEEGIPSTAL-------RE 48

Query: 169 VQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           +  L + KH N+++LL + +      +V+EY C+  L   L       PL  N   SI  
Sbjct: 49  ISLLKELKHPNIVKLLDVIHTERKLYLVFEY-CDMDLKKYLD--KRPGPLSPNLIKSIMY 105

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
            +   L Y H  S  I+HRD+K  N+L++ + V KL DFG+ + +    ++T YT  +  
Sbjct: 106 QLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLAR-AFGIPLRT-YTHEVV- 160

Query: 288 TRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 324
           T  Y  PE  +  +  ST  D++S G I  E++TG KP+
Sbjct: 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG-KPL 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 85.0 bits (210), Expect = 4e-18
 Identities = 72/226 (31%), Positives = 112/226 (49%), Gaps = 45/226 (19%)

Query: 117 LGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           +GEG FG V   ++K     M+ A+K ++  A    S  D+ +        F  E++ L 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRD--------FAGELEVL- 61

Query: 174 QCK---HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 216
            CK   H N++ LLG C +     +  EY  +G+L D  R +RV  T P           
Sbjct: 62  -CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 217 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 276
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 178

Query: 277 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
            KTM      G  P  +M  E+++  + +T +DV+SYGV+L E+++
Sbjct: 179 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 66/233 (28%), Positives = 118/233 (50%), Gaps = 44/233 (18%)

Query: 116 KLGEGQFGTVYYGK------LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           +LGEG FG V+  +       K+ M +AVK L++    ++               F+ E 
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKD------------FQREA 58

Query: 170 QTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLY--------DRLARVNNTP-- 215
           + L+  +H ++++  G+C +    IM   V+EYM +G L         D +  V+  P  
Sbjct: 59  ELLTNLQHEHIVKFYGVCGDGDPLIM---VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115

Query: 216 ---PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
               L  ++   IA  +A  + YL   S+  +HRD+ + N L+  N + K+GDFG+ +  
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 173

Query: 273 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 323
            +++   +    +   R +MPPE+ M+ + +T++DV+S+GVIL E+ T G +P
Sbjct: 174 YSTDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.2 bits (209), Expect = 7e-18
 Identities = 70/237 (29%), Positives = 102/237 (43%), Gaps = 54/237 (22%)

Query: 113 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
           +G KLGEG +  VY  + K  G  +A+K ++      + +  N  A          E++ 
Sbjct: 4   KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL--------REIKL 55

Query: 172 LSQCKHVNLLRLL---GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
           L + KH N++ LL   G  +NI   +V+E+M      D    + +          SI L 
Sbjct: 56  LQELKHPNIIGLLDVFGHKSNI--NLVFEFM----ETDLEKVIKDK---------SIVLT 100

Query: 229 VAE----------ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 278
            A+           L YLHS    I+HRD+K  N+L+  + V KL DFG+ +   + N K
Sbjct: 101 PADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158

Query: 279 TMYTENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLEL------LTGMKPID 325
              T  +  TR Y  PE    A H       D++S G I  EL      L G   ID
Sbjct: 159 --MTHQVV-TRWYRAPELLFGARH--YGVGVDMWSVGCIFAELLLRVPFLPGDSDID 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 83.8 bits (207), Expect = 7e-18
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 33/225 (14%)

Query: 108 KPYPRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTL--ENNANYSSSNSDNTEAAMI 160
           K + +R   LGEG FG V   +        G ++AVK+L  E+  N+ +           
Sbjct: 3   KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD---------- 52

Query: 161 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPL 217
                + E++ L    H N+++  G+C         ++ E++ +GSL + L R  N   L
Sbjct: 53  ----LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL 108

Query: 218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 277
               +Y++   + + + YL S  +  +HRD+ + NVL++     K+GDFG+ K  ET   
Sbjct: 109 KQQLKYAVQ--ICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD-- 162

Query: 278 KTMYTENLTGTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           K  YT       P   Y P   +  +    +DV+S+GV L ELLT
Sbjct: 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 84.3 bits (208), Expect = 7e-18
 Identities = 83/303 (27%), Positives = 133/303 (43%), Gaps = 42/303 (13%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           ++G G FG VY+ + ++N   +A+K +    +YS   S+     +I       EV+ L +
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKM----SYSGKQSNEKWQDII------KEVRFLQK 71

Query: 175 CKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
            +H N ++  G         +V EY C GS  D L    +  PL   +  ++  G  + L
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGL 128

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLHS +  +IHRDVK+ N+LL E  + KLGDFG   +   +N          GT  +M 
Sbjct: 129 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-------XFVGTPYWMA 179

Query: 294 PEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 349
           PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + E P       
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL----- 234

Query: 350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCNSLANLYVGKVSSR 409
           ++G W+E          F   C+    K    R   ++L K  FV        +  +  R
Sbjct: 235 QSGHWSEYFRN------FVDSCL---QKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQR 285

Query: 410 TQE 412
           T++
Sbjct: 286 TKD 288

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 36/103 (34%), Positives = 52/103 (50%), Gaps = 9/103 (8%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            N P L  +   S AL +A  + YL S  K  IHRD+ + N L+ EN V K+ DFG   +
Sbjct: 94  KNRPKLSLSDLLSFALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFG---L 148

Query: 507 SETSNVKTMYTENLTGTRPY--MPPEA-MHCQISTKTDVFSYG 546
           S        Y +   G  P   M PE+    + ++K+DV+S+G
Sbjct: 149 SRDLYDDDYYRKRG-GKLPIRWMAPESLKEGKFTSKSDVWSFG 190

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 67/227 (29%), Positives = 114/227 (50%), Gaps = 35/227 (15%)

Query: 116 KLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           +LGEG FG V+  +  N       + +AVKTL++        SDN          F  E 
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-------SDNARKD------FHREA 58

Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLY--------DRLARVNNTPP--LD 218
           + L+  +H ++++  G+C      I V+EYM +G L         D +       P  L 
Sbjct: 59  ELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELT 118

Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 278
            ++   IA  +A  + YL   S+  +HRD+ + N L+ EN + K+GDFG+ +   +++  
Sbjct: 119 QSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176

Query: 279 TMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 323
            +    +   R +MPPE+ M+ + +T++DV+S GV+L E+ T G +P
Sbjct: 177 RVGGHTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 81.8 bits (203), Expect = 2e-17
 Identities = 34/103 (33%), Positives = 47/103 (45%), Gaps = 15/103 (14%)

Query: 452 LDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 505
           L    R S          +  AL YLHS    I+HRD+K  N+LLDE+   KL DFG+ +
Sbjct: 88  LKKRGRLSEDEARFYLRQILSALEYLHSKG--IVHRDLKPENILLDEDGHVKLADFGLAR 145

Query: 506 -MSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
            +     + T       GT  YM PE +  +      D++S G
Sbjct: 146 QLDPGEKLTTF-----VGTPEYMAPEVLLGKGYGKAVDIWSLG 183

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 74/285 (25%), Positives = 136/285 (47%), Gaps = 42/285 (14%)

Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           +G G+FG V+ G LK      + +A+KTL+    Y+     +          F +E   +
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLK--PGYTEKQRQD----------FLSEASIM 60

Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++RL G+        I+ EYM NG+L D+  R ++     S +   +  G+A 
Sbjct: 61  GQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLR-DHDGEFSSYQLVGMLRGIAA 118

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 290
            + YL  ++   +HRD+ + N+L++ N   K+ DFG+ ++ E     T  T    G  P 
Sbjct: 119 GMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG--GKIPI 174

Query: 291 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV--PVRE 345
            +  PEA+ + + ++ +DV+S+G+++ E+++ G +P         Y+ +   EV   + +
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP---------YWDMSNHEVMKAIND 225

Query: 346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
                A     + V  L+     +C   ++ +R    DIV+LL K
Sbjct: 226 GFRLPAPMDCPSAVYQLM----LQCWQQDRARRPRFVDIVNLLDK 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 69/217 (31%), Positives = 102/217 (47%), Gaps = 18/217 (8%)

Query: 112 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           R G  LG G FG VY       G E+AVK +  + + S   S    A        E E+Q
Sbjct: 5   RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPD-SQETSKEVNA-------LECEIQ 56

Query: 171 TLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
            L   +H  +++  G   +       I  EYM  GS+ D+L +       +  +RY+   
Sbjct: 57  LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQ- 114

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
            + + + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T  M     +++TG
Sbjct: 115 -ILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171

Query: 288 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 323
           T  +M PE +  +    K DV+S    ++E+LT   P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 70/244 (28%), Positives = 113/244 (46%), Gaps = 52/244 (21%)

Query: 110 YPRR----GNKLGEGQFGTVYYGKLKNGME------------------IAVKTLENNANY 147
           +PR+      KLGEGQFG V+  + + GME                  +AVK L  +AN 
Sbjct: 2   FPRKRLTFKEKLGEGQFGEVHLCEAE-GMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60

Query: 148 SSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD 206
           ++ N             F  E++ +S+ K  N++RLL +C  +   C++ EYM NG L  
Sbjct: 61  NARND------------FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 207 RLARVN-NTPPLDSNKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 258
            L+R         ++           +A  +A  + YL SL+   +HRD+ + N L+ +N
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKN 166

Query: 259 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHC-QISTKTDVFSYGVILL 315
           +  K+ DFG   MS        Y        P  +M  E++   + +T +DV+++GV L 
Sbjct: 167 YTIKIADFG---MSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223

Query: 316 ELLT 319
           E+LT
Sbjct: 224 EILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 67/250 (26%), Positives = 120/250 (48%), Gaps = 50/250 (20%)

Query: 116 KLGEGQFGTVYYGKLK-NGME----IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           +LGE  FG +Y G L   GM+    +A+KTL++  N                  F+ E  
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE------------FQQEAS 59

Query: 171 TLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTP-------------- 215
            +++  H N++ LLG+       C+++EY+  G L++ L  +  +P              
Sbjct: 60  LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFL--IMRSPHSDVGCSSDEDGTV 117

Query: 216 --PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 273
              LD      IA+ +A  + YL S     +H+D+ + N+L+ E    K+ D G+ +   
Sbjct: 118 KSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 274 TSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTIL 331
           +++   +  ++L   R +MPPEA M+ + S+ +D++S+GV+L E+ + G++P        
Sbjct: 176 SADYYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP-------- 226

Query: 332 YYYLVVEQEV 341
            YY    QEV
Sbjct: 227 -YYGFSNQEV 235

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 81.8 bits (203), Expect = 3e-17
 Identities = 36/105 (34%), Positives = 51/105 (48%), Gaps = 9/105 (8%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
           R N    L  +   S AL +A  + YL S  K  IHRD+ + N L+ EN V K+ DFG  
Sbjct: 93  RKNRPKELSLSDLLSFALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFG-- 148

Query: 505 KMSETSNVKTMYTENLTGTRPY--MPPEA-MHCQISTKTDVFSYG 546
            +S        Y     G  P   M PE+    + ++K+DV+S+G
Sbjct: 149 -LSRDLYDDDYYKVKG-GKLPIRWMAPESLKEGKFTSKSDVWSFG 191

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 70/234 (29%), Positives = 102/234 (43%), Gaps = 24/234 (10%)

Query: 115 NKLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
            ++G+G FG VY G      E+ A+K ++             E A   I   + E+  LS
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIID------------LEEAEDEIEDIQQEITVLS 57

Query: 174 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           QC    + R  G         I+ EY+  GS  D L       PL+     +I   + + 
Sbjct: 58  QCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKG 113

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLHS  K  IHRD+K+ANVLL E    KL DFG+      + +K        GT  +M
Sbjct: 114 LDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFWM 168

Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 345
            PE +       K D++S G+  +EL  G  P  D + +   +L+ +   P  E
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLE 222

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 28/218 (12%)

Query: 114 GNKLGEGQFGTVYYG--KLKNGMEI--AVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           G  +GEGQFG VY G        +I  AVKT +N  +         E        F  E 
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-----PSVRE-------KFLQEA 58

Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
             + Q  H ++++L+G+       IV E    G L   L     +  L S   YS  L  
Sbjct: 59  YIMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQL-- 116

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           + AL YL S  K  +HRD+ + NVL+      KLGDFG+ +  E  +    Y +   G  
Sbjct: 117 STALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES----YYKASKGKL 170

Query: 290 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKP 323
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 81.9 bits (202), Expect = 3e-17
 Identities = 73/281 (25%), Positives = 123/281 (43%), Gaps = 42/281 (14%)

Query: 112 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
            R  K+G+G  GTVY    +  G E+A+K +    N                 L  NE+ 
Sbjct: 22  TRFEKIGQGASGTVYTAIDVATGQEVAIKQM----NLQQQPKKE---------LIINEIL 68

Query: 171 TLSQCKHVNLLRLLG---LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
            + + KH N++  L    + + +   +V EY+  GSL D    V     +D  +  ++  
Sbjct: 69  VMRENKHPNIVNYLDSYLVGDELW--VVMEYLAGGSLTD----VVTETCMDEGQIAAVCR 122

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMKTMYTENL 285
              +AL +LHS    +IHRD+KS N+LL  +   KL DFG       E S   TM     
Sbjct: 123 ECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM----- 175

Query: 286 TGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 344
            GT  +M PE +       K D++S G++ +E++ G  P  + N +   YL+     P  
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235

Query: 345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
           +  +K +  + +            +C   + +KR S ++++
Sbjct: 236 QNPEKLSAIFRD---------FLNRCLEMDVEKRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 36/226 (15%)

Query: 117 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG VY  + K  G+  A K ++  +       +  E  M+       E+  LS+C
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIES------EEELEDFMV-------EIDILSEC 59

Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNG----SLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           KH N++ L           +    C+G    S+   L R      L   +   +   + E
Sbjct: 60  KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLE 114

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRP 290
           AL++LHS    +IHRD+K+ N+LL  +   KL DFG+       N  T+   +   GT  
Sbjct: 115 ALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGV----SAKNKSTLQKRDTFIGTPY 168

Query: 291 YMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNTI 330
           +M PE + C+         K D++S G+ L+EL     P  + N +
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM 214

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 81.1 bits (200), Expect = 5e-17
 Identities = 64/218 (29%), Positives = 113/218 (51%), Gaps = 31/218 (14%)

Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+  A Y+     +          F +E   +
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLK--AGYTEKQRRD----------FLSEASIM 59

Query: 173 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            Q  H N++ L G+      +M  IV EYM NGSL D   R ++       +   +  G+
Sbjct: 60  GQFDHPNIIHLEGVVTKSKPVM--IVTEYMENGSL-DAFLRKHDGQ-FTVIQLVGMLRGI 115

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G  
Sbjct: 116 ASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GGKI 171

Query: 290 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           P  +  PEA+ + + ++ +DV+SYG+++ E+++ G +P
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 40/225 (17%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
            ++G G +G VY  + +  G  +A+K   LE   ++                  + E+  
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI---------------IQQEISM 53

Query: 172 LSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
           L +C+H N++   G  L  + +  IV EY   GSL D + +V   P         IA   
Sbjct: 54  LKECRHPNIVAYFGSYLRRDKL-WIVMEYCGGGSLQD-IYQVTRGPL----SELQIAYVC 107

Query: 230 AEAL---HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENL 285
            E L    YLH   K  IHRD+K AN+LL E+   KL DFG+  +++ T   +     + 
Sbjct: 108 RETLKGLAYLHETGK--IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK----SF 161

Query: 286 TGTRPYMPPEA----MHCQISTKTDVFSYGVILLELLTGMKPIDD 326
            GT  +M PE            K D+++ G+  +EL     P+ D
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 80.9 bits (199), Expect = 7e-17
 Identities = 71/226 (31%), Positives = 111/226 (49%), Gaps = 45/226 (19%)

Query: 117 LGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           +GEG FG V   ++K     M+ A+K ++    Y+S +             F  E++ L 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRD---------FAGELEVL- 49

Query: 174 QCK---HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 216
            CK   H N++ LLG C +     +  EY  +G+L D  R +RV  T P           
Sbjct: 50  -CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 108

Query: 217 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 276
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 166

Query: 277 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
            KTM      G  P  +M  E+++  + +T +DV+SYGV+L E+++
Sbjct: 167 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 80.9 bits (199), Expect = 7e-17
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 26/232 (11%)

Query: 115 NKLGEGQFGTVYYGKLKNGME--IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
            ++G+G FG V+ G + N  +  +A+K ++             E A   I   + E+  L
Sbjct: 10  ERIGKGSFGEVFKG-IDNRTQQVVAIKIID------------LEEAEDEIEDIQQEITVL 56

Query: 173 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           SQC    + +  G         I+ EY+  GS  D L       P D  +  ++   + +
Sbjct: 57  SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILK 112

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            L YLHS  K  IHRD+K+ANVLL E    KL DFG+      + +K        GT  +
Sbjct: 113 GLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFW 167

Query: 292 MPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
           M PE +      +K D++S G+  +EL  G  P  D + +   +L+ +   P
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP 219

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 80.9 bits (199), Expect = 7e-17
 Identities = 69/234 (29%), Positives = 108/234 (46%), Gaps = 26/234 (11%)

Query: 116 KLGEGQFGTVYYGKLKNGME--IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           K+G+G FG V+ G + N  +  +A+K ++             E A   I   + E+  LS
Sbjct: 11  KIGKGSFGEVFKG-IDNRTQKVVAIKIID------------LEEAEDEIEDIQQEITVLS 57

Query: 174 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           QC    + +  G    +    I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 58  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 113

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      + +K        GT  +M
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWM 168

Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 345
            PE +      +K D++S G+  +EL  G  P  + + +   +L+ +   P  E
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE 222

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 26/211 (12%)

Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
            +GEG +G V   + K  G  +A+K  +         S++ E      L    EV+ L Q
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKE--------SEDDEDVKKTAL---REVKVLRQ 56

Query: 175 CKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            +H N++ L         +   +V+EY    +L + L       P D+ + Y   L   +
Sbjct: 57  LRHENIVNLKEAFRRKGRLY--LVFEY-VERTLLELLEASPGGLPPDAVRSYIWQL--LQ 111

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           A+ Y HS    IIHRD+K  N+L+ E+ V KL DFG  + +  +   +  T+ +  TR Y
Sbjct: 112 AIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVA-TRWY 167

Query: 292 MPPEAMHCQIS--TKTDVFSYGVILLELLTG 320
             PE +    +     DV++ G I+ ELL G
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 44/106 (41%), Positives = 63/106 (59%), Gaps = 10/106 (9%)

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
           IA+ + +AL YLHS    +IHRDVK +NVL++ N   KL DFGI      S  KT+    
Sbjct: 108 IAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID--- 163

Query: 285 LTGTRPYMPPEAMHCQIST-----KTDVFSYGVILLELLTGMKPID 325
             G +PYM PE ++ +++      K+DV+S G+ ++EL TG  P D
Sbjct: 164 -AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 17/229 (7%)

Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
           +G +LG G F + Y  + +K G  +AVK +    N SS   +  EA          E++ 
Sbjct: 4   KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALR-------KEIRL 56

Query: 172 LSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           +++  H +++R+LG  C +    +  E+M  GS+   L   +           +    + 
Sbjct: 57  MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLL 113

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFG-IVKMSETSNMKTMYTENLTGT 288
             L YLH     IIHRDVK AN+L+D      ++ DFG   +++        +   L GT
Sbjct: 114 RGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171

Query: 289 RPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLV 336
             +M PE +  +   ++ DV+S G +++E+ T   P +      +  L+
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 43/232 (18%)

Query: 116 KLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           KLGEG FG VY   ++K G  +A+K +  +           E    PI     E++ L +
Sbjct: 15  KLGEGTFGEVYKARQIKTGRVVALKKILMH----------NEKDGFPITALR-EIKILKK 63

Query: 175 CKHVNLLRLLGL-------CNNIMNCI--VYEYMC---NGSLYDRLARVNNTPPLDSNKR 222
            KH N++ L+ +              +  V  YM    +G L +    V  T        
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN--PSVKLTESQIKC-- 119

Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY- 281
               L + E ++YLH     I+HRD+K+AN+L+D   + K+ DFG+ +  +         
Sbjct: 120 --YMLQLLEGINYLHE--NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 282 ----TENLTG---TRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 324
               T   T    TR Y PPE +    + +T  D++  G +  E+ T  +PI
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPI 226

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 79/296 (26%), Positives = 124/296 (41%), Gaps = 35/296 (11%)

Query: 108 KPYPRRGNKLGEGQFGTV--YYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPI 162
           K Y ++   LGEG FG V  Y     N   G  +AVKTL+           NT       
Sbjct: 3   KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-----RECGQQNTSG----- 52

Query: 163 LLFENEVQTLSQCKHVNLLRLLGLCNNIMNCI---VYEYMCNGSLYDRLARVNNTPPLDS 219
             ++ E+  L    H N+++  G C+         + EY+  GSL D L +      L+ 
Sbjct: 53  --WKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNL 106

Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
            +    A  + E + YLHS  +  IHRD+ + NVLLD + + K+GDFG+ K     +   
Sbjct: 107 AQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 164

Query: 280 MYTENLTGTRP---YMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV 336
              E+  G  P   Y        + S  +DV+S+GV L ELLT               + 
Sbjct: 165 RVRED--GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG 222

Query: 337 VEQ----EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL 388
            +Q     V + E+L++        +    + I+ + C   E   R + R ++ +L
Sbjct: 223 PKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 14/105 (13%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +   + + L YLHS    IIHRD+K+AN+LL  +   KL DFG+          T     
Sbjct: 103 VCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLS----AQLSDTKARNT 156

Query: 520 LTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRE 563
           + GT  +M PE ++ +    K D++S G       IT +++A+ +
Sbjct: 157 MVGTPYWMAPEVINGKPYDYKADIWSLG-------ITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 72/253 (28%), Positives = 111/253 (43%), Gaps = 36/253 (14%)

Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           +LG+G FG VY  K K  G   A K +E      + + +  E  M+       E++ L+ 
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIE------TKSEEELEDYMV-------EIEILAT 65

Query: 175 CKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYD----RLARVNNTPPLDSNKRYSIALGVA 230
           C H  +++LLG         +    C G   D     L R    P +       I   + 
Sbjct: 66  CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-----ICRQML 120

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTR 289
           EAL YLHS    IIHRD+K+ NVLL  +   KL DFG+       N+KT+   ++  GT 
Sbjct: 121 EALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGV----SAKNVKTLQRRDSFIGTP 174

Query: 290 PYMPPEAMHCQI------STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 343
            +M PE + C+         K D++S G+ L+E+     P  + N +     + + E P 
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 234

Query: 344 REVLDKEAGEWNE 356
                K + E+ +
Sbjct: 235 LSQPSKWSMEFRD 247

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 73/249 (29%), Positives = 112/249 (44%), Gaps = 33/249 (13%)

Query: 115 NKLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           +++G G FG VY+    +  E+ AVK +    +YS   ++     +I       EV+ L 
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKM----SYSGKQTNEKWQDII------KEVKFLQ 76

Query: 174 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           Q KH N +   G         +V EY C GS  D L    +  PL   +  +I  G  + 
Sbjct: 77  QLKHPNTIEYKGCYLKEHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAITHGALQG 133

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLHS +   IHRD+K+ N+LL E    KL DFG    S  +N       +  GT  +M
Sbjct: 134 LAYLHSHNM--IHRDIKAGNILLTEPGQVKLADFGSASKSSPAN-------SFVGTPYWM 184

Query: 293 PPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 348
            PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + + P      
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL---- 240

Query: 349 KEAGEWNET 357
            ++ EW ++
Sbjct: 241 -QSNEWTDS 248

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 72/233 (30%), Positives = 100/233 (42%), Gaps = 45/233 (19%)

Query: 117 LGEGQFGTVYYGKL---KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           +G G FGTV   K+    +G  +AVK +        S  D  E     +L+  + V   S
Sbjct: 12  IGRGAFGTVN--KMLHKPSGTIMAVKRI-------RSTVDEKE--QKRLLMDLDVVMRSS 60

Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYM------CNGSLYDRLARVNNTPPLDSNKRYSIA 226
            C    +++  G      +C I  E M          +Y+ L  V     +       IA
Sbjct: 61  DC--PYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSV-----IPEEILGKIA 113

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
           +   +AL+YL    K IIHRDVK +N+LLD N   KL DFGI      S  KT       
Sbjct: 114 VATVKALNYLKEELK-IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD----A 168

Query: 287 GTRPYMPPEAMHCQIST--------KTDVFSYGVILLELLTGMKPIDDNNTIL 331
           G RPYM PE    +I          ++DV+S G+ L E+ TG  P    N++ 
Sbjct: 169 GCRPYMAPE----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF 217

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 73/243 (30%), Positives = 110/243 (45%), Gaps = 60/243 (24%)

Query: 116 KLGEGQFGTVYYGKLKNGME-----------------IAVKTLENNANYSSSNSDNTEAA 158
           KLGEGQFG V+  ++ N  +                 +AVK L  +AN ++ N       
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND------ 65

Query: 159 MIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL---------YDRL 208
                 F  EV+ LS+ K  N++RLLG+C +    C++ EYM NG L          D+ 
Sbjct: 66  ------FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKE 119

Query: 209 ARVNNTPPLDS-------NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP 261
              N+  P          +    +AL +A  + YL SL+   +HRD+ + N L+ EN   
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTI 177

Query: 262 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HC----QISTKTDVFSYGVILL 315
           K+ DFG   MS        Y   + G R  +P   M   C    + +T +DV+++GV L 
Sbjct: 178 KIADFG---MSRNLYAGDYY--RIQG-RAVLPIRWMAWECILMGKFTTASDVWAFGVTLW 231

Query: 316 ELL 318
           E+L
Sbjct: 232 EIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 69/218 (31%), Positives = 101/218 (46%), Gaps = 23/218 (10%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           K+GEG FG +Y  K K+  E  V       + +       EA+       + EV  L++ 
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVI---KEIDLTKMPVKEKEAS-------KKEVILLAKM 56

Query: 176 KHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           KH N++        N    IV EY C+G   D + R+N    +  ++   ++  V  +L 
Sbjct: 57  KHPNIVTFFASFQENGRLFIVMEY-CDGG--DLMKRINRQRGVLFSEDQILSWFVQISLG 113

Query: 235 YLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
             H   + I+HRD+KS N+ L +N  V KLGDFGI +     N          GT  Y+ 
Sbjct: 114 LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR---QLNDSMELAYTCVGTPYYLS 170

Query: 294 PEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNN 328
           PE   CQ    + KTD++S G +L EL T   P + NN
Sbjct: 171 PEI--CQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 78.3 bits (193), Expect = 4e-16
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 26/218 (11%)

Query: 117 LGEGQFG-TVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG    Y + ++   +  K + N    S     +   A+       NE+  LS  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEV-NLTRLSEKERRD---AL-------NEIVILSLL 56

Query: 176 KHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           +H N++      + +N +  I  EY   G+LYD++ R       +          +  A+
Sbjct: 57  QHPNIIAYYNHFMDDNTL-LIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAV 114

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+H     I+HRD+K+ N+ L +  + KLGDFGI K+      +    E + GT  YM 
Sbjct: 115 SYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI---LGSEYSMAETVVGTPYYMS 169

Query: 294 PEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNN 328
           PE   CQ    + K+D+++ G +L ELLT  +  D  N
Sbjct: 170 PEL--CQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 79.4 bits (195), Expect = 4e-16
 Identities = 71/247 (28%), Positives = 114/247 (46%), Gaps = 33/247 (13%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           ++G G FG VY+ + ++    +A+K +    +YS   S+     +I       EV+ L +
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKM----SYSGKQSNEKWQDII------KEVKFLQR 81

Query: 175 CKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
            KH N +   G         +V EY C GS  D L    +  PL   +  +I  G  + L
Sbjct: 82  IKHPNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAITHGALQGL 138

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLHS +  +IHRD+K+ N+LL E    KL DFG   ++  +N       +  GT  +M 
Sbjct: 139 AYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-------SFVGTPYWMA 189

Query: 294 PEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 349
           PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + E P       
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL----- 244

Query: 350 EAGEWNE 356
           ++ EW++
Sbjct: 245 QSNEWSD 251

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 77.6 bits (191), Expect = 6e-16
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 26/208 (12%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V+ GK +  +++A+K +   A                   F  E + + + 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED--------------FIEEAKVMMKL 56

Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H  L++L G+C       IV E+M NG L + L +      L  +   S+   V E + 
Sbjct: 57  SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGME 114

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 292
           YL   S   IHRD+ + N L+    V K+ DFG+ +      +   YT +     P  + 
Sbjct: 115 YLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYV----LDDEYTSSSGAKFPVKWS 168

Query: 293 PPEAMH-CQISTKTDVFSYGVILLELLT 319
           PPE  +  + S+K+DV+S+GV++ E+ T
Sbjct: 169 PPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 77.9 bits (192), Expect = 6e-16
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 42/223 (18%)

Query: 117 LGEGQFGTVYYGKLKNGME------IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           LG G+FG V+  K K   E      + VK L+       +  +N ++       F  E+ 
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ------KTKDENLQSE------FRRELD 60

Query: 171 TLSQCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRL------ARVNNTPPLDSNKRY 223
              +  H N++RLLGLC     + ++ EY   G L   L            PPL + ++ 
Sbjct: 61  MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
           ++   +A  + +L +     +HRD+ + N L+             VK+S  S  K +Y  
Sbjct: 121 ALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQR--------EVKVSLLSLSKDVYNS 170

Query: 284 ------NLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 319
                 N      ++ PEA+     STK+DV+S+GV++ E+ T
Sbjct: 171 EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 8e-16
 Identities = 60/231 (25%), Positives = 90/231 (38%), Gaps = 45/231 (19%)

Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ- 174
           +GEG +G VY  +  K G  +A+K ++          D  E         + E   L + 
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIE-------DEEEEI-------KEEYNILRKY 59

Query: 175 CKHVNLLRLLG--LCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--- 224
             H N+    G  +  N         +V E    GS+ D    V         KR     
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL---VKGL--RKKGKRLKEEW 114

Query: 225 ---IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 281
              I       L YLH     +IHRD+K  N+LL +N   KL DFG+    +++  +   
Sbjct: 115 IAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR--- 169

Query: 282 TENLTGTRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDD 326
                GT  +M PE + C          ++DV+S G+  +EL  G  P+ D
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 76.8 bits (190), Expect = 1e-15
 Identities = 31/82 (37%), Positives = 43/82 (52%), Gaps = 4/82 (4%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           E L YLHS    I+HRD+K AN+L+D + V KL DFG  K           T ++ GT  
Sbjct: 112 EGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG-DIETGEGTGSVRGTPY 168

Query: 526 YMPPEAMHCQI-STKTDVFSYG 546
           +M PE +  +      D++S G
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLG 190

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 76.4 bits (189), Expect = 1e-15
 Identities = 37/85 (43%), Positives = 51/85 (60%), Gaps = 14/85 (16%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNV-KTMYTENLTGTR 524
           AL YLHS  + I+HRD+K  N+ L  N + KLGDFGI K +S T ++ KT+      GT 
Sbjct: 115 ALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-----VGTP 167

Query: 525 PYMPPEAMHCQ---ISTKTDVFSYG 546
            Y+ PE   CQ    + K+D++S G
Sbjct: 168 YYLSPEL--CQNKPYNYKSDIWSLG 190

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 31/215 (14%)

Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL---FENEVQTLS 173
           LG+G FG V+ G LK+   +AVKT + +               +P  L   F +E + L 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKED---------------LPQELKIKFLSEARILK 47

Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           Q  H N+++L+G+C       IV E +  G     L +  +   L + +    AL  A  
Sbjct: 48  QYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAG 105

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL S  K  IHRD+ + N L+ EN V K+ DFG+ +  +      +Y+ +     P  
Sbjct: 106 MAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG----IYSSSGLKQIPIK 159

Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PEA+ + + S+++DV+SYG++L E  + G+ P
Sbjct: 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCP 194

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 26/208 (12%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           KLG GQFG V+        ++AVKT++                 + +  F  E   +   
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMK--------------PGSMSVEAFLAEANVMKTL 58

Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEALH 234
           +H  L++L  +       I+ E+M  GSL D L +   +  PL   K    +  +AE + 
Sbjct: 59  QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMA 116

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 292
           ++    +  IHRD+++AN+L+  + V K+ DFG+ ++ E +     YT       P  + 
Sbjct: 117 FIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKWT 170

Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLT 319
            PEA+     + K+DV+S+G++L+E++T
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 34/216 (15%)

Query: 117 LGEGQFGTV---YYGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
           LG+G FG+V    Y  L++  G  +AVK L+++   +    D           FE E++ 
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRD-----------FEREIEI 58

Query: 172 LSQCKHVNLLRLLGLC-----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           L   +H N+++  G+C      N+   +V EY+  GSL D L    +   LD  K    A
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRNLR--LVMEYLPYGSLRDYL--QKHRERLDHRKLLLYA 114

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL S  K  +HRD+ + N+L++     K+GDFG+ K+      K  Y     
Sbjct: 115 SQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD--KEYYKVREP 170

Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 171 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 75/239 (31%), Positives = 114/239 (47%), Gaps = 45/239 (18%)

Query: 110 YPRR----GNKLGEGQFGTVY----YGKLKNGME----IAVKTLENNANYSSSNSDNTEA 157
           +PR     G  LGEG FG V     YG  K+  +    +AVK L++NA      +D   A
Sbjct: 9   FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA------TDKDLA 62

Query: 158 AMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-ARVNNTP 215
            +I     E E+  L   KH N++ LLG+C       ++ EY   G+L + L AR    P
Sbjct: 63  DLIS----EMELMKLIG-KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGP 117

Query: 216 ------------PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL 263
                        L      S A  VA  + YL S  +  IHRD+ + NVL+ E+ V K+
Sbjct: 118 DYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLAARNVLVTEDNVMKI 175

Query: 264 GDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
            DFG+ +     +    Y +   G  P  +M PEA+  ++ T ++DV+S+G+++ E+ T
Sbjct: 176 ADFGLARGVHDID---YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 64/241 (26%), Positives = 111/241 (46%), Gaps = 34/241 (14%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           +R   +G G +G VY GK +  G  +A+K +       + ++ + + + I     + EV 
Sbjct: 4   QRLELIGRGAYGAVYRGKHVPTGRVVALKII-------NLDTPDDDVSDI-----QREVA 51

Query: 171 TLSQCKHV---NLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
            LSQ +     N+ +  G         I+ EY   GS+   L +     P+   ++Y I+
Sbjct: 52  LLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAG---PIA--EKY-IS 104

Query: 227 LGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
           + + E   AL Y+H     +IHRD+K+AN+L+      KL DFG+  +   ++ K     
Sbjct: 105 VIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK---RS 159

Query: 284 NLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
              GT  +M PE +       TK D++S G+ + E+ TG  P  D +      L+ + + 
Sbjct: 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP 219

Query: 342 P 342
           P
Sbjct: 220 P 220

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 37/96 (38%), Positives = 47/96 (48%), Gaps = 7/96 (7%)

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           +  AL YLHS  K IIHRD+K  N+LLDE     + DF I        + T      +GT
Sbjct: 109 IVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST----SGT 162

Query: 289 RPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKP 323
             YM PE +  Q  +   D +S GV   E L G +P
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 27/211 (12%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  +    G  +A+K +                          E++ L +
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKI------KLRFESEGIPKTA-----LREIKLLKE 54

Query: 175 CKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
             H N+++LL +     ++   +V+E+M +  LY  +        L  +   S    + +
Sbjct: 55  LNHPNIIKLLDVFRHKGDLY--LVFEFM-DTDLYKLIKD--RQRGLPESLIKSYLYQLLQ 109

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            L + HS    I+HRD+K  N+L++   V KL DFG+ +   +      YT  +  TR Y
Sbjct: 110 GLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVV-TRWY 164

Query: 292 MPPEAM--HCQISTKTDVFSYGVILLELLTG 320
             PE +      ST  D++S G I  ELL+ 
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.9 bits (186), Expect = 5e-15
 Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 41/288 (14%)

Query: 104 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI 162
           G  +K Y R   K+G+G  GTVY    +  G E+A+K +                     
Sbjct: 15  GDPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE------------ 61

Query: 163 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D    V     +D  
Sbjct: 62  -LIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTD----VVTETCMDEG 115

Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMK 278
           +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG       E S   
Sbjct: 116 QIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173

Query: 279 TMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 337
           TM      GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+ 
Sbjct: 174 TM-----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228

Query: 338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
               P  +         N   +  +      +C   + D+R S ++++
Sbjct: 229 TNGTPELQ---------NPERLSAVFRDFLNRCLEMDVDRRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 75.6 bits (186), Expect = 5e-15
 Identities = 47/142 (33%), Positives = 78/142 (54%), Gaps = 12/142 (8%)

Query: 188 NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD 247
           NNI  C+  E+M  GSL DR+ +     P++   +  IA+ V E L YL+++ + I+HRD
Sbjct: 76  NNI--CMCMEFMDCGSL-DRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR-IMHRD 129

Query: 248 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTD 306
           +K +N+L++     KL DFG+     +  +     +   GT  YM PE +   + + K+D
Sbjct: 130 IKPSNILVNSRGQIKLCDFGV-----SGELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184

Query: 307 VFSYGVILLELLTGMKPIDDNN 328
           V+S G+ ++EL  G  P   +N
Sbjct: 185 VWSLGISIIELALGKFPFAFSN 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 66/290 (22%), Positives = 142/290 (48%), Gaps = 43/290 (14%)

Query: 112 RRGNKLGEGQFGTVYYG-------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL 164
           R+   LG G FGTV+ G        +K  + +A+KT+++ +   +               
Sbjct: 10  RKLKLLGSGVFGTVHKGIWIPEGDSIK--IPVAIKTIQDRSGRQTFQE------------ 55

Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
             + +  +    H  ++RLLG+C      +V +    GSL D + +  +   LD  +  +
Sbjct: 56  ITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQ--HRDSLDPQRLLN 113

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
             + +A+ ++YL      ++HR++ + N+LL  + + ++ DFG+  +    + K  Y+E+
Sbjct: 114 WCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171

Query: 285 LTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP 342
            T  + +M  E++     T ++DV+SYGV + E+++ G +P         Y  +   EVP
Sbjct: 172 KTPIK-WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP---------YAGMRPHEVP 221

Query: 343 VREVLDKEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
             ++L+K  GE   +  + T+ + +V  KC + +++ R + +++ +  ++
Sbjct: 222 --DLLEK--GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 45/219 (20%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE-------- 166
           K+G+GQF  VY    L +G  +A+K ++                     +FE        
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQ---------------------IFEMMDAKARQ 47

Query: 167 ---NEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLAR--VNNTPPLDS 219
               E+  L Q  H N+++ L   + NN +N IV E    G L  R+ +        +  
Sbjct: 48  DCLKEIDLLKQLDHPNVIKYLASFIENNELN-IVLELADAGDL-SRMIKHFKKQKRLIPE 105

Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
              +   + +  AL ++HS  K I+HRD+K ANV +    V KLGD G+ +   +   KT
Sbjct: 106 RTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KT 160

Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLEL 317
               +L GT  YM PE +H    + K+D++S G +L E+
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 74.9 bits (184), Expect = 6e-15
 Identities = 68/217 (31%), Positives = 97/217 (44%), Gaps = 32/217 (14%)

Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTL-ENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           LG+G +G VY  + L   + IA+K + E ++ Y                L E E+   S 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-------------LHE-EIALHSY 61

Query: 175 CKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG--VA 230
            KH N+++ LG    N     I  E +  GSL   L   +   PL  N++  I     + 
Sbjct: 62  LKHRNIVQYLGSDSENGFFK-IFMEQVPGGSLSALLR--SKWGPLKDNEQTIIFYTKQIL 118

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           E L YLH     I+HRD+K  NVL++  + V K+ DFG  K     N     TE  TGT 
Sbjct: 119 EGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN---PCTETFTGTL 173

Query: 290 PYMPPEAMHCQI---STKTDVFSYGVILLELLTGMKP 323
            YM PE +           D++S G  ++E+ TG  P
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 34/224 (15%)

Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G G  G VY  +  K G  +AVK +       + N +        IL+  + V     C
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM-----RRTGNKEE----NKRILMDLDVVLKSHDC 73

Query: 176 KHVNLLRLLGLCNNIMNCIVYEYM-CNGSLYDRLA-RVNNTPPLDSNKRYSIALGVAEAL 233
            ++  ++  G    I +  V+  M    +  D+L  R+    P+  +    + + + +AL
Sbjct: 74  PYI--VKCYGYF--ITDSDVFICMELMSTCLDKLLKRIQG--PIPEDILGKMTVAIVKAL 127

Query: 234 HYL---HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           HYL   H     +IHRDVK +N+LLD +   KL DFGI      S  KT       G   
Sbjct: 128 HYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT----RSAGCAA 179

Query: 291 YMPPEAMHCQIST-----KTDVFSYGVILLELLTGMKPIDDNNT 329
           YM PE +           + DV+S G+ L+EL TG  P  +  T
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 75.1 bits (184), Expect = 8e-15
 Identities = 68/231 (29%), Positives = 108/231 (46%), Gaps = 41/231 (17%)

Query: 114 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 165
           G  LGEG FG V           K K  + +AVK L+++A     +   +E  M+ ++  
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 77

Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSL--YDRLAR---------VNN 213
                     KH N++ LLG C       ++ EY   G+L  Y R  R         +  
Sbjct: 78  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128

Query: 214 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 271
            P   +      S    VA  + YL   S+  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLAR- 185

Query: 272 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 186 -DVNNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 74.5 bits (184), Expect = 9e-15
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 30/216 (13%)

Query: 116 KLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           +LG+G FG+VY  + K   E+ A+K +     + S      E  M        EV++L +
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKM--KKKFYS-----WEECMN-----LREVKSLRK 53

Query: 175 CK-HVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
              H N+++L  +     N     V+EYM  G+LY  L +     P   +   SI   + 
Sbjct: 54  LNEHPNIVKLKEVF--RENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQIL 109

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           + L ++H       HRD+K  N+L+    V K+ DFG+ +  E  +    YT+ +  TR 
Sbjct: 110 QGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPP-YTDYV-STRW 163

Query: 291 YMPPEA-MHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
           Y  PE  +     S+  D+++ G I+ EL T ++P+
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYT-LRPL 198

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 72/244 (29%), Positives = 107/244 (43%), Gaps = 44/244 (18%)

Query: 116 KLGEGQFGTVYYGK---------LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 166
           +LG+G FGTVY  K         LK   EI V  L  N    +    N EA         
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEA--------- 53

Query: 167 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-- 223
              Q LS+  H  +++           CI+ EY     L  +L  + +T    S  +   
Sbjct: 54  ---QLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCE 110

Query: 224 ---SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS-NMKT 279
               + LGV    HY+H   + I+HRD+K+ N+ L  N + K+GDFG+ ++   S ++ T
Sbjct: 111 WFIQLLLGV----HYMHQ--RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLAT 163

Query: 280 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
                 TGT  YM PEA+ H    +K+D++S G IL E+       +  N +     +VE
Sbjct: 164 ----TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219

Query: 339 QEVP 342
              P
Sbjct: 220 GPTP 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 66/240 (27%), Positives = 116/240 (48%), Gaps = 34/240 (14%)

Query: 114 GNKLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           G  LGEG+FG+V  G+L      +++AVKT++      S   D           F +E  
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED-----------FLSEAV 52

Query: 171 TLSQCKHVNLLRLLGLC-NNIMN------CIVYEYMCNGSLYDRL--ARVNNTPP-LDSN 220
            + +  H N++RL+G+C   + +       ++  +M +G L+  L  +R+ + P  L + 
Sbjct: 53  CMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQ 112

Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
                   +A  + YL S  K  IHRD+ + N +L+EN    + DFG+ K     +    
Sbjct: 113 MLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD---Y 167

Query: 281 YTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDD-NNTILYYYL 335
           Y +      P  ++  E++  ++ +TK+DV+S+GV + E+ T G  P     N+ +Y YL
Sbjct: 168 YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 36/221 (16%)

Query: 115 NKLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           N++GEG +G VY  +     EI A+K +  +           E   IPI     E+  L 
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMD----------NERDGIPISSLR-EITLLL 61

Query: 174 QCKHVNLLRLLGLC-----NNIMNCIVYEYMCN---GSLYDRLARVNNTPPLDSNKRYSI 225
             +H N++ L  +      ++I   +V EY C     SL D     N   P   ++   +
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIF--LVMEY-CEQDLASLLD-----NMPTPFSESQVKCL 113

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
            L +   L YLH     IIHRD+K +N+LL +    K+ DFG+ +           T  +
Sbjct: 114 MLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLART--YGLPAKPMTPKV 169

Query: 286 TGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
             T  Y  PE +  C   T   D+++ G IL ELL   KP+
Sbjct: 170 V-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 80/286 (27%), Positives = 137/286 (47%), Gaps = 45/286 (15%)

Query: 117 LGEGQFGTVYYGK-LKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
           LG G FGTVY G  + +G    + +A+K L  N    +S   N E     IL   +E   
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN----TSPKANKE-----IL---DEAYV 62

Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++      + RLLG+C      +V + M  G L D +    N   + S    +  + +A+
Sbjct: 63  MAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAK 120

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 290
            + YL  +   ++HRD+ + NVL+      K+ DFG+ ++ +    +T Y  +  G  P 
Sbjct: 121 GMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDID--ETEYHAD-GGKVPI 175

Query: 291 -YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL 347
            +M  E+ +H + + ++DV+SYGV + EL+T G KP D               +P RE+ 
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG--------------IPAREIP 221

Query: 348 D-KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
           D  E GE   +  + T+ + ++  KC + + + R   R++VD  S+
Sbjct: 222 DLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 43/232 (18%)

Query: 114 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 165
           G  LGEG FG V           K    + +AVK L+++A     +   +E  M+ ++  
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMI-- 74

Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSN---- 220
                     KH N++ LLG C       ++ EY   G+L + L R    P +D +    
Sbjct: 75  ---------GKHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTC 124

Query: 221 ----------KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
                        S A  VA  + YL   S+  IHRD+ + NVL+ E+ V K+ DFG+ +
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 271 MSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
             +  N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV+L E+ T
Sbjct: 183 --DVHNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 22/239 (9%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   + K   E+ A+K L+ +        D+ E  M+       E + L+  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDV---VIQDDDVECTMV-------EKRVLALQ 57

Query: 176 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
                L  L  C   ++ +  V EY+  G L   + +V         +    A  ++  L
Sbjct: 58  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGL 114

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            +LH   + II+RD+K  NV+LD     K+ DFG   M +   +  + T    GT  Y+ 
Sbjct: 115 FFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFG---MCKEHMVDGVTTRTFCGTPDYIA 169

Query: 294 PEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           PE +  Q   K+ D ++YGV+L E+L G  P D  +    +  ++E  V   + L KEA
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 228

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.8 bits (179), Expect = 4e-14
 Identities = 41/106 (38%), Positives = 60/106 (56%), Gaps = 17/106 (16%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           IA+ + +AL YLHS    +IHRDVK +NVL++ N   KL DFGI      S  KT+    
Sbjct: 108 IAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID--- 163

Query: 520 LTGTRPYMPPEAMHCQIST-----KTDVFSYGAQIKTQHITNVDIA 560
             G +PYM PE ++ +++      K+DV+S G       IT +++A
Sbjct: 164 -AGCKPYMAPERINPELNQKGYDVKSDVWSLG-------ITMIELA 201

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 72.8 bits (178), Expect = 4e-14
 Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 40/224 (17%)

Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           +LG+G FG VY G  K  ++      +A+KT+            N  A+M   + F NE 
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV------------NEAASMRERIEFLNEA 60

Query: 170 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRL----ARVNNTP---PLDS 219
             + +  C HV  +RLLG+ +      ++ E M  G L   L      + N P   P   
Sbjct: 61  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118

Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 278
            K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 119 KKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 173

Query: 279 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 174 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 71/239 (29%), Positives = 105/239 (43%), Gaps = 22/239 (9%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   + K   E+ A+K L+ +        D+ E  M+     E  V  L   
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVII---QDDDVECTMV-----EKRVLALPGK 59

Query: 176 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
                L  L  C   M+ +  V EY+  G L   + +V              A  +A  L
Sbjct: 60  PP--FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGL 114

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            +LHS  K II+RD+K  NV+LD     K+ DFG   M + +      T    GT  Y+ 
Sbjct: 115 FFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFG---MCKENIFGGKTTRTFCGTPDYIA 169

Query: 294 PEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           PE +  Q   K+ D +++GV+L E+L G  P D  +    +  ++E  V   + L KEA
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 228

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 43/232 (18%)

Query: 114 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 165
           G  LGEG FG V           K     ++AVK L+++A     +   +E  M+ ++  
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 80

Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLD------ 218
                     KH N++ LLG C       ++ EY   G+L + L R    P ++      
Sbjct: 81  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYCYNPT 130

Query: 219 --------SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
                        S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ +
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188

Query: 271 MSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
                +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 189 ---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 35/217 (16%)

Query: 115 NKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
            K+GEG  G V        G ++AVK ++                    LLF NEV  + 
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRE------------LLF-NEVVIMR 71

Query: 174 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
             +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +
Sbjct: 72  DYQHPNIVEMYSSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIATVCLAVLK 126

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL +LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    ++L GT  +
Sbjct: 127 ALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSK-EVPRRKSLVGTPYW 181

Query: 292 MPPEAMHCQIS-----TKTDVFSYGVILLELLTGMKP 323
           M PE     IS     T+ D++S G++++E++ G  P
Sbjct: 182 MAPEV----ISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 32/84 (38%), Positives = 47/84 (55%), Gaps = 7/84 (8%)

Query: 467 ALHYLHSLSKP---IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           AL+  H+ S P   ++HRD+K AN+ LD N   KLGDFG+ K+       + + +   GT
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD---SSFAKTYVGT 173

Query: 524 RPYMPPEAM-HCQISTKTDVFSYG 546
             YM PE + H     K+D++S G
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLG 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 66/249 (26%), Positives = 111/249 (44%), Gaps = 28/249 (11%)

Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           +LG+G FG VY  + K  G+  A K ++      + + +  E  M+       E+  L+ 
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVID------TKSEEELEDYMV-------EIDILAS 58

Query: 175 CKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           C H N+++LL       N  +    C G   D +  +    PL   +   +     EAL+
Sbjct: 59  CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM-LELERPLTEPQIRVVCKQTLEALN 117

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY-TENLTGTRPYMP 293
           YLH     IIHRD+K+ N+L   +   KL DFG+       N +T+   ++  GT  +M 
Sbjct: 118 YLHE--NKIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPYWMA 171

Query: 294 PEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL 347
           PE + C+ S       K DV+S G+ L+E+     P  + N +     + + E P     
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP 231

Query: 348 DKEAGEWNE 356
            + + E+ +
Sbjct: 232 SRWSSEFKD 240

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 29/212 (13%)

Query: 116 KLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           K+GEG +G V+  K +N   G  +A+K       +  S  D     +  I L   E++ L
Sbjct: 8   KIGEGSYGVVF--KCRNRETGQIVAIK------KFVESEDD---PVIKKIAL--REIRML 54

Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
            Q KH NL+ L+ +      ++ +V+EY C+ ++ + L +  N   +  +    I     
Sbjct: 55  KQLKHPNLVNLIEVFRRKRKLH-LVFEY-CDHTVLNELEK--NPRGVPEHLIKKIIWQTL 110

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           +A+++ H  +   IHRDVK  N+L+ +    KL DFG  ++   +     YT+    TR 
Sbjct: 111 QAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTD-YVATRW 165

Query: 291 YMPPEAM--HCQISTKTDVFSYGVILLELLTG 320
           Y  PE +    Q     DV++ G +  ELLTG
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 72.8 bits (178), Expect = 5e-14
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 37/286 (12%)

Query: 104 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI 162
           G  +K Y R   K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 16  GDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 62

Query: 163 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D    V     +D  
Sbjct: 63  -LIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTD----VVTETCMDEG 116

Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
           +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG          K  
Sbjct: 117 QIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172

Query: 281 YTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
               + GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+   
Sbjct: 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231

Query: 340 EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
             P  +         N   +  +      +C   + +KR S ++++
Sbjct: 232 GTPELQ---------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 72.9 bits (179), Expect = 6e-14
 Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 35/239 (14%)

Query: 108 KPYPRRGNKLGEGQFGTVY-YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI-LLF 165
           + Y ++G  LGEG +G V        G  +A+K ++     +    D     M  I    
Sbjct: 8   ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67

Query: 166 ENEVQTLSQCKHVNLLRLLGL-CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
             E++ +++ KH N++ L+ +        +V + M      D L +V     +D   R +
Sbjct: 68  LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA----SD-LKKV-----VDRKIRLT 117

Query: 225 ------IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-------VKM 271
                 I L +   L+ LH      +HRD+  AN+ ++   + K+ DFG+          
Sbjct: 118 ESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175

Query: 272 SETSNMKTMY-TENLTG---TRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 324
              S  +TM   E +T    T  Y  PE +    +     D++S G I  ELLTG KP+
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233

Length = 335

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 76/287 (26%), Positives = 134/287 (46%), Gaps = 37/287 (12%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           +R   LG G FGTVY G  +  G  + +       N ++    N E        F +E  
Sbjct: 10  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--------FMDEAL 61

Query: 171 TLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
            ++   H +L+RLLG+C +    +V + M +G L D +    +   + S    +  + +A
Sbjct: 62  IMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIA 119

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           + + YL    + ++HRD+ + NVL+      K+ DFG+ ++ E    +  Y  +  G  P
Sbjct: 120 KGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE--YNAD-GGKMP 174

Query: 291 --YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV 346
             +M  E +H  + + ++DV+SYGV + EL+T G KP D               +P RE+
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG--------------IPTREI 220

Query: 347 LD-KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            D  E GE   +  + T+ + +V  KC + + D R   +++    S+
Sbjct: 221 PDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 72.3 bits (177), Expect = 7e-14
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 36/222 (16%)

Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           +LG+G FG VY G  ++ ++      +AVKT+    N S+S  +  E       L E  V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTV----NESASLRERIE------FLNEASV 62

Query: 170 QTLSQCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLARV---NNT--PPLDSNK 221
                C HV  +RLLG+ +      +V E M +G L  Y R  R    NN   PP    +
Sbjct: 63  MKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120

Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTM 280
              +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ + + ET      
Sbjct: 121 MIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD----Y 174

Query: 281 YTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
           Y +   G  P  +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 71.9 bits (176), Expect = 9e-14
 Identities = 66/237 (27%), Positives = 110/237 (46%), Gaps = 48/237 (20%)

Query: 114 GNKLGEGQFGTVYYG-----KLKNGME-IAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
           G  LGEG+FG V        K + G   +AVK L+ NA+ S              LL  +
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD----------LL--S 52

Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSL--YDRLAR-----------VNN 213
           E   L Q  H ++++L G C+      ++ EY   GSL  + R +R             N
Sbjct: 53  EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112

Query: 214 TPPLDSNKRYSIALG--------VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 265
           +  LD+    ++ +G        ++  + YL  +   ++HRD+ + NVL+ E    K+ D
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISD 170

Query: 266 FGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
           FG   +S     +  Y +   G  P  +M  E++   I +T++DV+S+GV+L E++T
Sbjct: 171 FG---LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 34/76 (44%), Positives = 44/76 (57%), Gaps = 5/76 (6%)

Query: 456 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKT 514
           + Y++ L   E L YLHS    I+HRD+K AN+ LD N V KLGDFG  VK+   +    
Sbjct: 102 RVYTLQL--LEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157

Query: 515 MYTENLTGTRPYMPPE 530
              ++L GT  YM PE
Sbjct: 158 EEVQSLAGTPAYMAPE 173

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 61/248 (24%), Positives = 114/248 (45%), Gaps = 49/248 (19%)

Query: 114 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           G  LGEG+FG+V  G+L       +++AVKT++    ++ S  +           F +E 
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL-DIHTYSEIEE----------FLSEA 52

Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC-------IVYEYMCNGSL-----YDRLARVNNTPPL 217
             +    H N+++L+G+C    +        ++  +M +G L     Y RL  +    PL
Sbjct: 53  ACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL 112

Query: 218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 277
            +  ++   + +A  + YL +  +  IHRD+ + N +L E+    + DFG+         
Sbjct: 113 QTLLKF--MVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFGL--------S 160

Query: 278 KTMYTENL--TGTRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLT-GMKPIDD-N 327
           K +Y+ +    G    MP + +  +       ++K+DV+++GV + E+ T G  P     
Sbjct: 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220

Query: 328 NTILYYYL 335
           N  +Y YL
Sbjct: 221 NHEIYDYL 228

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 71.7 bits (175), Expect = 1e-13
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 41/288 (14%)

Query: 104 GFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI 162
           G  +K Y R   K+G+G  GTV+    +  G E+A+K +                     
Sbjct: 15  GDPKKKYTRY-EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKE------------ 61

Query: 163 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D    V     +D  
Sbjct: 62  -LIINEILVMKELKNPNIVNFLDSFLVGDEL-FVVMEYLAGGSLTD----VVTETCMDEA 115

Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMK 278
           +  ++     +AL +LH+    +IHRD+KS NVLL  +   KL DFG       E S   
Sbjct: 116 QIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173

Query: 279 TMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 337
           TM      GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+ 
Sbjct: 174 TM-----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228

Query: 338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
               P  +         N   +  +      +C   + +KR S ++++
Sbjct: 229 TNGTPELQ---------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 33/218 (15%)

Query: 117 LGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           LG G+FG +  G L    K  + +A+ TL    +                  F  E  TL
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG------------FLAEALTL 60

Query: 173 SQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            Q  H N++RL G+    N +M  IV EYM NG+L   L +  +   L + +   +  G+
Sbjct: 61  GQFDHSNIVRLEGVITRGNTMM--IVTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGL 116

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           A  + YL  +    +H+ + +  VL++ + V K+  F  +   +    + +YT  ++G  
Sbjct: 117 ASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRL---QEDKSEAIYT-TMSGKS 170

Query: 290 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           P  +  PEA+ +   S+ +DV+S+G+++ E+++ G +P
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 50/132 (37%), Positives = 75/132 (56%), Gaps = 11/132 (8%)

Query: 194 IVYEYMCNGSLYDRLAR-VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           ++ +++  G L+ RL++ V  T   +  K Y   L  A AL +LHSL   II+RD+K  N
Sbjct: 75  LILDFLRGGDLFTRLSKEVMFTE--EDVKFYLAEL--ALALDHLHSLG--IIYRDLKPEN 128

Query: 253 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYG 311
           +LLDE    KL DFG+ K S     K     +  GT  YM PE ++ +  T++ D +S+G
Sbjct: 129 ILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNRRGHTQSADWWSFG 185

Query: 312 VILLELLTGMKP 323
           V++ E+LTG  P
Sbjct: 186 VLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 44/133 (33%), Positives = 64/133 (48%), Gaps = 10/133 (7%)

Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
            I  E+M  GSL   L +    P     K   I++ V   L YL    K I+HRDVK +N
Sbjct: 75  SICMEHMDGGSLDQVLKKAGRIPENILGK---ISIAVLRGLTYLREKHK-IMHRDVKPSN 130

Query: 253 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYG 311
           +L++     KL DFG+      S   +       GTR YM PE +     + ++D++S G
Sbjct: 131 ILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHYTVQSDIWSLG 185

Query: 312 VILLELLTGMKPI 324
           + L+E+  G  PI
Sbjct: 186 LSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 70/240 (29%), Positives = 104/240 (43%), Gaps = 24/240 (10%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   +LK   E+ AVK L+ +        D+ E  M        E + L+  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDV---ILQDDDVECTM-------TEKRVLALA 52

Query: 176 KHVNLLRLLGLCNNIMN--CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
                L  L  C    +    V EY  NG   D +  +  +   D  +    A  +   L
Sbjct: 53  GKHPFLTQLHSCFQTKDRLFFVMEY-VNGG--DLMFHIQRSGRFDEPRARFYAAEIVLGL 109

Query: 234 HYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
            +LH   + II+RD+K  NVLLD E  + K+ DFG+ K      +    T    GT  Y+
Sbjct: 110 QFLHE--RGIIYRDLKLDNVLLDSEGHI-KIADFGMCKEGILGGVT---TSTFCGTPDYI 163

Query: 293 PPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
            PE +  Q      D ++ GV+L E+L G  P + ++    +  ++E EV     L KEA
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEA 223

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 21/131 (16%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL   +  +I  G  + L YLHS  +  IHRD+K+ N+LL E    KL DFG   +   +
Sbjct: 111 PLQEVEIAAICHGALQGLAYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168

Query: 511 NVKTMYTENLTGTRPYMPPE---AM-HCQISTKTDVFSYGAQIKTQHITNVDIADRE-RY 565
           N       +  GT  +M PE   AM   Q   K DV+S G       IT +++A+R+   
Sbjct: 169 N-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-------ITCIELAERKPPL 214

Query: 566 YSLQTMLPGHH 576
           +++  M   +H
Sbjct: 215 FNMNAMSALYH 225

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 72/241 (29%), Positives = 112/241 (46%), Gaps = 26/241 (10%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   + K   E+ A+K L+ +        D+ E  M+       E + L+  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDV---VIQDDDVECTMV-------EKRVLALS 57

Query: 176 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEA 232
                L  L  C   M+ +  V EY+  G L  ++ +V     P        IA+G    
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG---- 113

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM-KTMYTENLTGTRPY 291
           L +LHS  K II+RD+K  NV+LD     K+ DFG+ K     NM   + T+   GT  Y
Sbjct: 114 LFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDY 167

Query: 292 MPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 350
           + PE +  Q   K+ D +++GV+L E+L G  P +  +    +  ++E  V   + + KE
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 227

Query: 351 A 351
           A
Sbjct: 228 A 228

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 69.5 bits (170), Expect = 6e-13
 Identities = 71/239 (29%), Positives = 106/239 (44%), Gaps = 22/239 (9%)

Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   +LK +G   AVK L+ +        D+ E  M      E  + +L+  
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVIL---QDDDVECTMT-----EKRILSLA-R 53

Query: 176 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
            H  L +L   C    + +  V E++  G L   +  +  +   D  +    A  +  AL
Sbjct: 54  NHPFLTQLY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSAL 109

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            +LH   K II+RD+K  NVLLD     KL DFG+ K     N KT  T    GT  Y+ 
Sbjct: 110 MFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKT--TSTFCGTPDYIA 164

Query: 294 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           PE +         D ++ GV+L E+L G  P +  N    +  ++  EV     L ++A
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDA 223

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 21/230 (9%)

Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G+G +G V   + + +G +  +K L    N  +++    +AA       E E Q LSQ 
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKL----NLRNASRRERKAA-------EQEAQLLSQL 56

Query: 176 KHVNLL--RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++  R      + +  IV  +   G LY +L +      L  N+     + +A AL
Sbjct: 57  KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMAL 115

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLH   K I+HRD+K+ NV L    + K+GD GI ++ E           L GT  YM 
Sbjct: 116 QYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC---DMASTLIGTPYYMS 170

Query: 294 PEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
           PE    +  + K+DV++ G  + E+ T     +  +     Y ++E ++P
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 68.1 bits (167), Expect = 9e-13
 Identities = 35/109 (32%), Positives = 52/109 (47%), Gaps = 13/109 (11%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           I     + L YLHS     IHRD+K+ N+LL+E    KL DFG+      +  K      
Sbjct: 104 ILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK---RNT 158

Query: 520 LTGTRPYMPPEA-MHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYS 567
           + GT  +M PE       + K D++S G       IT +++A+ +  YS
Sbjct: 159 VIGTPFWMAPEVIQEIGYNNKADIWSLG-------ITAIEMAEGKPPYS 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 64/225 (28%), Positives = 88/225 (39%), Gaps = 28/225 (12%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G  LG G FG V   K K  G   A+K L+           +             E   L
Sbjct: 23  GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQ----------EKSIL 72

Query: 173 SQCKH---VNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            +  H   VN++      +      + E++  G L+  L R     P D  K Y     +
Sbjct: 73  MELSHPFIVNMMC--SFQDENRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYHAE--L 127

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
             A  YLHS  K II+RD+K  N+LLD     K+ DFG  K           T  L GT 
Sbjct: 128 VLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV------PDRTFTLCGTP 179

Query: 290 PYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYY 333
            Y+ PE +  +   K  D ++ GV+L E + G  P  D+     Y
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY 224

Length = 329

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 35/215 (16%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
            K+GEG F  V   +  K G   A+K ++ +  + S    N             E+Q L 
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKH--FKSLEQVNNL----------REIQALR 52

Query: 174 QCK-HVNLLRLLG-LCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
           +   H N+LRL+  L +     +  V+E M + +LY+ L +     PL   +  S    +
Sbjct: 53  RLSPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYE-LIK-GRKRPLPEKRVKSYMYQL 109

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
            ++L ++H     I HRD+K  N+L+ ++ + KL DFG  +       K  YTE ++ TR
Sbjct: 110 LKSLDHMHR--NGIFHRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYIS-TR 162

Query: 290 PYMPPEAMHCQIST-----KTDVFSYGVILLELLT 319
            Y  PE   C ++      K D+++ G +  E+L+
Sbjct: 163 WYRAPE---CLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 20/210 (9%)

Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V+  +LK      A+K L+ +        D+ E  M+     E  V +L+  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD---DDVECTMV-----EKRVLSLAW- 53

Query: 176 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H  L  L        N   V EY+  G L   +  + +    D  +    A  +   L 
Sbjct: 54  EHPFLTHLYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQ 110

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           +LHS  K I++RD+K  N+LLD +   K+ DFG+ K +   + K   T    GT  Y+ P
Sbjct: 111 FLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDYIAP 165

Query: 295 EAMHCQ-ISTKTDVFSYGVILLELLTGMKP 323
           E +  Q  +T  D +S+GV+L E+L G  P
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 69.9 bits (171), Expect = 2e-12
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 39/217 (17%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           N +  G+ G  Y GK +KNGM+  VK + +       NS       IP     +E+  + 
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEIND------VNS-------IP----SSEIADMG 738

Query: 174 QCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + +H N+++L+GLC +     +++EY+   +L + L        L   +R  IA+G+A+A
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKA 792

Query: 233 LHYLHSLSKP-IIHRDVKSANVLLDENFVPKL--GDFGIVKMSETSNMKTMYTENLTGTR 289
           L +LH    P ++  ++    +++D    P L     G++       + +          
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS---------- 842

Query: 290 PYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPID 325
            Y+ PE      I+ K+D++ +G+IL+ELLTG  P D
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879

Length = 968

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 67.9 bits (167), Expect = 2e-12
 Identities = 60/235 (25%), Positives = 95/235 (40%), Gaps = 63/235 (26%)

Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G G +G V      + G ++A+K + N                    +F++ +      
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN--------------------VFDDLID----A 43

Query: 176 KHV----NLLRLLGLCNNIMNC----------------IVYEYMCNGSLYDRLARVNNTP 215
           K +     LLR L    NI+                  IV E M      D L +V  +P
Sbjct: 44  KRILREIKLLRHLR-HENIIGLLDILRPPSPEDFNDVYIVTELM----ETD-LHKVIKSP 97

Query: 216 -PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 274
            PL  +        +   L YLHS +  +IHRD+K +N+L++ N   K+ DFG+ +  + 
Sbjct: 98  QPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155

Query: 275 SNMKTMYTENLTG---TRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 324
              +      LT    TR Y  PE +    + +   D++S G I  ELLT  KP+
Sbjct: 156 DEDE---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 44/113 (38%), Positives = 60/113 (53%), Gaps = 17/113 (15%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT-ENLTGTR 524
           EAL YLHS    IIHRD+K+ NVLL  +   KL DFG+       NVKT+   ++  GT 
Sbjct: 121 EALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGV----SAKNVKTLQRRDSFIGTP 174

Query: 525 PYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHE 577
            +M PE + C+ + K   + Y A I +  IT +++A  E         P HHE
Sbjct: 175 YWMAPEVVMCE-TMKDTPYDYKADIWSLGITLIEMAQIE---------PPHHE 217

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 27/212 (12%)

Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           K+GEG  G V   + K +G ++AVK ++                    LLF NEV  +  
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRE------------LLF-NEVVIMRD 74

Query: 175 CKHVNLLRLL--GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            +H N++ +    L    +  ++ E++  G+L D +++      L+  +  ++   V +A
Sbjct: 75  YQHQNVVEMYKSYLVGEEL-WVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQA 129

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLHS  + +IHRD+KS ++LL  +   KL DFG          K    ++L GT  +M
Sbjct: 130 LCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWM 184

Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 323
            PE +      T+ D++S G++++E++ G  P
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 5/88 (5%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           IA  + + L YLH+    IIHRD+K +N+L++     K+ DFGI K+ E +  +      
Sbjct: 104 IARQILKGLDYLHTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN---T 159

Query: 520 LTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
             GT  YM PE +  +  S   D++S G
Sbjct: 160 FVGTVTYMSPERIQGESYSYAADIWSLG 187

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 66.4 bits (162), Expect = 5e-12
 Identities = 35/88 (39%), Positives = 52/88 (59%), Gaps = 10/88 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET--SNVKTMYTENLT 521
           V E L YLHS  K I+HRD+K+ N+L+D + + K+ DFGI K S+    N + M   ++ 
Sbjct: 117 VLEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM---SMQ 171

Query: 522 GTRPYMPPEAMHCQ---ISTKTDVFSYG 546
           G+  +M PE +H      S K D++S G
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLG 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 28/219 (12%)

Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK 176
           +G G FG V+  + K   ++ +              D   AA       +NE Q L    
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQ---IPVEQMTKDERLAA-------QNECQVLKLLS 57

Query: 177 HVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           H N++      N + +    IV EY   G+L + + +  N+  LD +      + +  AL
Sbjct: 58  HPNIIEYYE--NFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLAL 114

Query: 234 HYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           H++H+  K I+HRD+K+ N+LLD++  V K+GDFGI K    S+    YT  + GT  Y+
Sbjct: 115 HHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYT--VVGTPCYI 168

Query: 293 PPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNN 328
            PE   C+    + K+D+++ G +L EL +  +  +  N
Sbjct: 169 SPEL--CEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 35/221 (15%)

Query: 116 KLGEGQFGTVYYG-KLKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           ++G G +G VY    L  G   AVK   LE   ++S               L + E+  +
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS---------------LIQQEIFMV 60

Query: 173 SQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
            +CKH N++   G  L    +  I  EY   GSL D     + T PL   +   +     
Sbjct: 61  KECKHCNIVAYFGSYLSREKL-WICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETL 116

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTR 289
           + L YLHS  K  +HRD+K AN+LL +N   KL DFG+  K++ T   +    ++  GT 
Sbjct: 117 QGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR----KSFIGTP 170

Query: 290 PYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDD 326
            +M PE    +     +   D+++ G+  +EL     P+ D
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 33/89 (37%), Positives = 52/89 (58%), Gaps = 10/89 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTG 522
           V + L YLH   + +IHRD+K+AN+L  ++ V KL DFG+  K+++ S        ++ G
Sbjct: 108 VLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD----DASVVG 161

Query: 523 TRPY-MPPEAMHCQ-ISTKTDVFSYGAQI 549
           T PY M PE +     ST +D++S G  +
Sbjct: 162 T-PYWMAPEVIEMSGASTASDIWSLGCTV 189

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 27/216 (12%)

Query: 116 KLGEGQFGTV---YYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           +LG G FGTV    Y   K+   +AVK L+N+ N         + A+   LL E  V  +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN---------DPALKDELLREANV--M 50

Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            Q  +  ++R++G+C      +V E    G L   L +  +   +       +   V+  
Sbjct: 51  QQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMG 107

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRP- 290
           + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N    Y     G  P 
Sbjct: 108 MKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN---YYKAKTHGKWPV 162

Query: 291 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
            +  PE M + + S+K+DV+S+GV++ E  + G KP
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 36/212 (16%)

Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILL---FENEVQT 171
           ++G G FG V+ G+L+ +   +AVK+                   +P  L   F  E + 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRET---------------LPPDLKAKFLQEARI 46

Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           L Q  H N++RL+G+C       +   +  G  +    R    P L   +   +    A 
Sbjct: 47  LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAA 105

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE------TSNMKTMYTENL 285
            + YL S  K  IHRD+ + N L+ E  V K+ DFG+ +  E      T  MK +  +  
Sbjct: 106 GMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK-- 161

Query: 286 TGTRPYMPPEAM-HCQISTKTDVFSYGVILLE 316
                +  PEA+ + + S+++DV+S+G++L E
Sbjct: 162 -----WTAPEALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 74/298 (24%), Positives = 119/298 (39%), Gaps = 53/298 (17%)

Query: 115 NKLGEGQFGTVYYGKLKNGMEIA---VKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
           +++G G FG V  G+   GM  A   VK L  +A                 LLF  EVQ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ------------LLFLQEVQP 48

Query: 172 LSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL--YDRLARVNNTPPLDSNKRYSIALG 228
             +  H N+L+ LG C  +I   +V E+   G L  Y R  R         +    +A  
Sbjct: 49  YRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACE 108

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           VA  L +LH      IH D+   N  L  +   K+GD+G+            Y    T  
Sbjct: 109 VASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLA----LEQYPEDYYI--TKD 160

Query: 289 RPYMP-----PEAMH--------CQISTKTDVFSYGVILLELLT-GMKPIDD-NNTILYY 333
              +P     PE +            + K++++S GV + EL T   +P  D ++  +  
Sbjct: 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK 220

Query: 334 YLVVEQEV--PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS 389
            +V EQ++  P  ++  K +  W E        + F   C  + + R +  ++ +LL+
Sbjct: 221 QVVREQDIKLPKPQLDLKYSDRWYEV-------MQF---CWLDPETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 70/227 (30%), Positives = 101/227 (44%), Gaps = 34/227 (14%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ- 174
           +G+G FG V   + K   +  AVK L+  A                IL  + E   +S+ 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKA----------------ILKKKEEKHIMSER 46

Query: 175 ---CKHVNLLRLLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
               K+V    L+GL  +         V +Y+  G L+  L R      L+   R+  A 
Sbjct: 47  NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCF--LEPRARF-YAA 103

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
            +A AL YLHSL+  I++RD+K  N+LLD      L DFG+ K +   N     T    G
Sbjct: 104 EIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT---TSTFCG 158

Query: 288 TRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYY 333
           T  Y+ PE +H Q   +T D +  G +L E+L G+ P    NT   Y
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 205

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 8/91 (8%)

Query: 458 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT 517
           + I + +   L  LH     I+HRD+KSAN+LL  N + K+GD GI K+     +K    
Sbjct: 106 WRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKV-----LKKNMA 158

Query: 518 ENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGA 547
           +   GT  YM PE    +  S K+D++S G 
Sbjct: 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGC 189

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 36/81 (44%), Positives = 46/81 (56%), Gaps = 4/81 (4%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           A+H++HS  K +IHRD+KSAN+LL  N + KLGDFG  KM   + V         GT  Y
Sbjct: 155 AVHHVHS--KHMIHRDIKSANILLCSNGLVKLGDFGFSKMY-AATVSDDVGRTFCGTPYY 211

Query: 527 MPPEA-MHCQISTKTDVFSYG 546
           + PE       S K D+FS G
Sbjct: 212 VAPEIWRRKPYSKKADMFSLG 232

Length = 496

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 66.8 bits (163), Expect = 2e-11
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 15/166 (9%)

Query: 165 FENEVQTLSQCKHVNLLRLL--GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 222
           F  E    ++  H N++ LL  G     +   V+EY+   +L + LA     P  ++ + 
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGR- 83

Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKM----SETS 275
             + L V +AL   H+  + I+HRD+K  N+++         K+ DFGI  +     +  
Sbjct: 84  --LMLQVLDALACAHN--QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDAD 139

Query: 276 NMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLTG 320
                 T  + GT  Y  PE +  +  T  +D++++G+I LE LTG
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 20/215 (9%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   +LK   E+ A+K L+ +        D+ +  M      E  +  L+  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL---QDDDVDCTMT-----EKRILALAA- 53

Query: 176 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           KH  L  L            V EY+  G L  ++ R       D  +    A  V  AL 
Sbjct: 54  KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK---FDEPRSRFYAAEVTLALM 110

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           +LH     +I+RD+K  N+LLD     KL DFG   M +   +  + T    GT  Y+ P
Sbjct: 111 FLHR--HGVIYRDLKLDNILLDAEGHCKLADFG---MCKEGILNGVTTTTFCGTPDYIAP 165

Query: 295 EAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 328
           E +         D ++ GV++ E++ G  P + +N
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 27/212 (12%)

Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           K+GEG  G V     K+ G ++AVK ++                    LLF NEV  +  
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 75

Query: 175 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
             H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V  A
Sbjct: 76  YHHENVVDMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRA 130

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLH+  + +IHRD+KS ++LL  +   KL DFG          K    ++L GT  +M
Sbjct: 131 LSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKSLVGTPYWM 185

Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 323
            PE +      T+ D++S G++++E++ G  P
Sbjct: 186 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 34/233 (14%)

Query: 112 RRGNKLGEGQFGTVYYGKLKNGMEIAV--KTLENNANYSSSNSDNTEAAMIPILLFENEV 169
            +  K+G+G FG V+  + K   +I    K L  N           E   I  L    E+
Sbjct: 15  EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE---------KEGFPITAL---REI 62

Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC---------IVYEYMCNGSLYDRLARVNNTPPLDSN 220
           + L   KH N++ L+ +C               +V+E+ C   L   L+  N    L   
Sbjct: 63  KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF-CEHDLAGLLSNKNVKFTLSEI 121

Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK- 278
           K+  +   +   L+Y+H  +K I+HRD+K+AN+L+ ++ + KL DFG+ +  S + N K 
Sbjct: 122 KK--VMKMLLNGLYYIHR-NK-ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177

Query: 279 TMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 329
             YT N   T  Y PPE +          D++  G I+ E+ T   PI   NT
Sbjct: 178 NRYT-NRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNT 228

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 40/136 (29%), Positives = 60/136 (44%), Gaps = 13/136 (9%)

Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
            +V EY+ NG     L +     P D  K+Y     V   +  LH   + IIHRD+K  N
Sbjct: 73  YLVMEYL-NGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQ--RGIIHRDIKPEN 127

Query: 253 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYG 311
           +L+D+    KL DFG+ +    +       +   GT  Y+ PE +      K +D +S G
Sbjct: 128 LLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDYLAPETILGVGDDKMSDWWSLG 180

Query: 312 VILLELLTGMKPIDDN 327
            ++ E L G  P    
Sbjct: 181 CVIFEFLFGYPPFHAE 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 68/212 (32%), Positives = 94/212 (44%), Gaps = 33/212 (15%)

Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG G  GTVY    L     +AVK +           D T      I+   +E++ L +C
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIP---------LDITVELQKQIM---SELEILYKC 56

Query: 176 KHVNLLRLLG---LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
               ++   G   + N I  C   E+M  GSL D   ++    P     R  IA+ V + 
Sbjct: 57  DSPYIIGFYGAFFVENRISICT--EFMDGGSL-DVYRKI----PEHVLGR--IAVAVVKG 107

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YL SL   I+HRDVK +N+L++     KL DFG+      S  KT       GT  YM
Sbjct: 108 LTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY-----VGTNAYM 160

Query: 293 PPEAMHC-QISTKTDVFSYGVILLELLTGMKP 323
            PE +   Q    +DV+S G+  +EL  G  P
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 62/218 (28%), Positives = 108/218 (49%), Gaps = 28/218 (12%)

Query: 117 LGEGQFGTVYYG-------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           LG G FGTVY G       K+K  + +A+K L      ++S   N E     IL   +E 
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVK--IPVAIKELRE----ATSPKANKE-----IL---DEA 60

Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
             ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +
Sbjct: 61  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQI 118

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           A+ ++YL    + ++HRD+ + NVL+      K+ DFG+ K+   ++ K  + E      
Sbjct: 119 AKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-GADEKEYHAEGGKVPI 175

Query: 290 PYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPID 325
            +M  E+ +H   + ++DV+SYGV + EL+T G KP D
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 58/230 (25%), Positives = 109/230 (47%), Gaps = 37/230 (16%)

Query: 116 KLGEGQFGTVYYGKL------KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           +LGE +FG VY G L      +    +A+KTL++ A                   F++E 
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE------------FKHEA 59

Query: 170 QTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTP-----PLDSNKRY 223
              S+ +H N++ LLG+        +++ Y  +  L++ L  V  +P       D +K  
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFL--VMRSPHSDVGSTDDDKTV 117

Query: 224 SIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 275
              L  A+ +H +  +        S  ++H+D+ + NVL+ +    K+ D G+ +    +
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177

Query: 276 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 323
           +   +   +L   R +M PEA M+ + S  +D++SYGV+L E+ + G++P
Sbjct: 178 DYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 31/242 (12%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIA---VKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           ++G G +G VY  +  N  E+A   V  LE   +++               + + E+  +
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA---------------VVQQEIIMM 60

Query: 173 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
             CKH N++   G         I  E+   GSL D     + T PL  ++   ++    +
Sbjct: 61  KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY---HVTGPLSESQIAYVSRETLQ 117

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            L+YLHS  K  +HRD+K AN+LL +N   KL DFG+      +  K    ++  GT  +
Sbjct: 118 GLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK---RKSFIGTPYW 172

Query: 292 MPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL 347
           M PE    +     +   D+++ G+  +EL     P+ D + +   +L+ +      ++ 
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK 232

Query: 348 DK 349
           DK
Sbjct: 233 DK 234

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 36/88 (40%), Positives = 46/88 (52%), Gaps = 8/88 (9%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           IA  V + L YLHS  + IIHRD+K +N+LL      KL DFG+      S   T     
Sbjct: 110 IAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT----- 162

Query: 520 LTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
            TGT  YM PE +  +  S  +DV+S G
Sbjct: 163 FTGTSFYMAPERIQGKPYSITSDVWSLG 190

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 43/109 (39%), Positives = 54/109 (49%), Gaps = 24/109 (22%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           IA+   +AL+YL    K IIHRDVK +N+LLD N   KL DFGI      S  KT     
Sbjct: 112 IAVATVKALNYLKEELK-IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD--- 167

Query: 520 LTGTRPYMPPEAMHCQIST--------KTDVFSYGAQIKTQHITNVDIA 560
             G RPYM PE    +I          ++DV+S G       IT  ++A
Sbjct: 168 -AGCRPYMAPE----RIDPSARDGYDVRSDVWSLG-------ITLYEVA 204

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 24/212 (11%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   +LK   E  A+K L+ +        D+ E  M+     E  V  L+  
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED---DDVECTMV-----ERRVLALAW- 53

Query: 176 KHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           +H  L  L   C          V EY+  G L   +  + ++   D  +    A  +   
Sbjct: 54  EHPFLTHLF--CTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICG 108

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L +LH   K II+RD+K  NVLLD++   K+ DFG+ K +     K        GT  Y+
Sbjct: 109 LQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK---ASTFCGTPDYI 163

Query: 293 PPEAMHCQISTKT-DVFSYGVILLELLTGMKP 323
            PE +  Q   ++ D +S+GV+L E+L G  P
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 63.1 bits (154), Expect = 6e-11
 Identities = 36/88 (40%), Positives = 47/88 (53%), Gaps = 7/88 (7%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           IA+ V + L YLH   K IIHRDVK +N+L++     KL DFG+      S  KT     
Sbjct: 105 IAVAVLKGLTYLHEKHK-IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT----- 158

Query: 520 LTGTRPYMPPEAMH-CQISTKTDVFSYG 546
             GT  YM PE +     S K+D++S G
Sbjct: 159 FVGTSSYMAPERIQGNDYSVKSDIWSLG 186

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (155), Expect = 6e-11
 Identities = 67/247 (27%), Positives = 103/247 (41%), Gaps = 39/247 (15%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G+G FG V   + ++   I A+KT+      S S   +T        L E  V     C
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHT--------LAERTVLAQVNC 52

Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR------YSIALGV 229
             +  L+             + +     LY  LA +N        +R             
Sbjct: 53  PFIVPLK-------------FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYT 99

Query: 230 AE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK-TMYTENL 285
           AE   AL  LH  +  +I+RD+K  N+LLD      L DFG+ K+    NMK    T   
Sbjct: 100 AELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKL----NMKDDDKTNTF 153

Query: 286 TGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 344
            GT  Y+ PE +     TK  D ++ GV+L E+LTG+ P  D N    Y  ++++ +   
Sbjct: 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP 213

Query: 345 EVLDKEA 351
           +  D++A
Sbjct: 214 DGFDRDA 220

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 63.8 bits (155), Expect = 6e-11
 Identities = 64/236 (27%), Positives = 101/236 (42%), Gaps = 25/236 (10%)

Query: 117 LGEGQFGTVYYGKLKNG--MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           LG G FG V     KN     +A+K  E +        D+  +          E + L+ 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS----------ERKILNY 87

Query: 175 CKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H   + L G   +     +V E++  G  +  L R N   P D    Y  A  +    
Sbjct: 88  INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFY--AAQIVLIF 144

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YL SL+  I++RD+K  N+LLD++   K+ DFG  K+ +T       T  L GT  Y+ 
Sbjct: 145 EYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR------TYTLCGTPEYIA 196

Query: 294 PEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 348
           PE  ++       D ++ G+ + E+L G  P   N  +L Y  ++E  +   + LD
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLD 252

Length = 340

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 41/223 (18%)

Query: 116 KLGEGQFGTVYYG--KL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           +LG G FG V  G  K+ K  +++A+K L+N       N  +    M+       E + +
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE------NEKSVRDEMM------REAEIM 49

Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL-GVAE 231
            Q  +  ++R++G+C      +V E    G L   L          S K+  I +  V E
Sbjct: 50  HQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFL----------SGKKDEITVSNVVE 99

Query: 232 ALH-------YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
            +H       YL    K  +HRD+ + NVLL      K+ DFG+ K     +  + Y   
Sbjct: 100 LMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD--SYYKAR 155

Query: 285 LTGTRP--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKP 323
             G  P  +  PE ++  + S+++DV+SYG+ + E  + G KP
Sbjct: 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 45/225 (20%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE--------- 166
           K+G GQF  VY                     ++   D    A+  + +FE         
Sbjct: 9   KIGRGQFSEVYR--------------------ATCLLDRKPVALKKVQIFEMMDAKARQD 48

Query: 167 --NEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK- 221
              E+  L Q  H N+++ L   + +N +N IV E    G L   +        L   + 
Sbjct: 49  CVKEIDLLKQLNHPNVIKYLDSFIEDNELN-IVLELADAGDLSQMIKYFKKQKRLIPERT 107

Query: 222 --RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
             +Y + L    A+ ++HS  + ++HRD+K ANV +    V KLGD G+ +   +   KT
Sbjct: 108 VWKYFVQL--CSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KT 160

Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 323
               +L GT  YM PE +H    + K+D++S G +L E+     P
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 63.5 bits (154), Expect = 7e-11
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 11/159 (6%)

Query: 168 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 109

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 110 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 163

Query: 287 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 324
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 63.5 bits (154), Expect = 7e-11
 Identities = 68/240 (28%), Positives = 106/240 (44%), Gaps = 24/240 (10%)

Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   K K  G   A+K L+     +     +T        L EN V  L   
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRV--LQNS 52

Query: 176 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H  L  L      +   C V EY   G L+  L+R       D  + Y     +  AL 
Sbjct: 53  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALD 109

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 292
           YLHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MKT       GT  Y+
Sbjct: 110 YLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FCGTPEYL 163

Query: 293 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEA 223

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 27/225 (12%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLE-NNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           K+G GQF  VY    L +G+ +A+K ++  +   + + +D  +           E+  L 
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-----------EIDLLK 57

Query: 174 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK---RYSIALG 228
           Q  H N+++     + +N +N IV E    G L   +        L   K   +Y + L 
Sbjct: 58  QLNHPNVIKYYASFIEDNELN-IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL- 115

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
              AL ++HS  + ++HRD+K ANV +    V KLGD G+ +   +   KT    +L GT
Sbjct: 116 -CSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGT 169

Query: 289 RPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILY 332
             YM PE +H    + K+D++S G +L E+     P   +   LY
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 25/210 (11%)

Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKT-LENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
            +GEG +G V   K K  G  +A+K  LE     S  +    + AM        E++ L 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLE-----SEDDKMVKKIAM-------REIRMLK 55

Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           Q +H NL+ L+ +        +V+E++ + ++ D L +  N   LD ++       +   
Sbjct: 56  QLRHENLVNLIEVFRRKKRLYLVFEFV-DHTVLDDLEKYPNG--LDESRVRKYLFQILRG 112

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + + HS    IIHRD+K  N+L+ ++ V KL DFG  +         +YT+    TR Y 
Sbjct: 113 IEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTD-YVATRWYR 167

Query: 293 PPEAMHCQIS--TKTDVFSYGVILLELLTG 320
            PE +          D+++ G ++ E+LTG
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 8e-11
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 42/230 (18%)

Query: 116 KLGEGQFGTVYYGKLKNGM---EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
            +G G +G VY  K KNG    E A+K  +            T  +         E+  L
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFK------GDKEQYTGISQSAC----REIALL 56

Query: 173 SQCKHVNLLRLLGLC-NNIMNCI--VYEYMCNGSLYDRLA-----RVNNTPPLDSNKRYS 224
            + KH N++ L+ +   +    +  +++Y    + +D        R      +  +   S
Sbjct: 57  RELKHENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKS 112

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVKMSETSNMKTM 280
           +   +   +HYLHS    ++HRD+K AN+L+     E  V K+GD G+ ++   + +K +
Sbjct: 113 LLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN-APLKPL 169

Query: 281 YTEN-LTGTRPYMPPE----AMHCQISTKT-DVFSYGVILLELLTGMKPI 324
              + +  T  Y  PE    A H    TK  D+++ G I  ELLT ++PI
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT-LEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 62.3 bits (152), Expect = 9e-11
 Identities = 32/85 (37%), Positives = 41/85 (48%), Gaps = 7/85 (8%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLHS  K IIHRD+K  N+LLDE     + DF I             T + +GT
Sbjct: 109 IVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT----LTTSTSGT 162

Query: 524 RPYMPPEAMHCQISTK-TDVFSYGA 547
             YM PE +  Q  +   D +S G 
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGV 187

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 63.7 bits (155), Expect = 9e-11
 Identities = 82/333 (24%), Positives = 128/333 (38%), Gaps = 103/333 (30%)

Query: 69  KWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFG 123
           +W  ++I+  E NN          +TF D  +    +N K  +PR     G  LG G FG
Sbjct: 7   RW--KIIEAAEGNN----------YTFIDPTQLP--YNEKWEFPRDNLQFGKTLGAGAFG 52

Query: 124 TVY------YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF------ENEVQT 171
            V        GK  N + +AVK L+     +S+++D  EA M  + +       +N V  
Sbjct: 53  KVVEATAFGLGKEDNVLRVAVKMLK-----ASAHTDEREALMSELKILSHLGQHKNIVNL 107

Query: 172 LSQCKH----------------VNLLR-----LLGLCNNIM----NCIVYEYMCNGSLYD 206
           L  C H                +N LR      L     +         Y+ +     Y 
Sbjct: 108 LGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYI 167

Query: 207 R-------------------------------LARVNNTPPLDSNKRYSIALGVAEALHY 235
           R                                    ++ PLD +     +  VA+ + +
Sbjct: 168 RSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDF 227

Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRP--YM 292
           L S  K  IHRDV + NVLL +  V K+ DFG+ + +   SN    Y        P  +M
Sbjct: 228 LAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----YVVKGNARLPVKWM 281

Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
            PE++  C  + ++DV+SYG++L E+ + G  P
Sbjct: 282 APESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 63.2 bits (152), Expect = 1e-10
 Identities = 37/105 (35%), Positives = 52/105 (49%), Gaps = 10/105 (9%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSET 509
           PL  ++   I   +  AL YLHS  K IIHRD+K  N+LLD +  V KL DFG+ K+   
Sbjct: 97  PLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154

Query: 510 SNVKTMYTENLT---GTRPYMPPEAMH----CQISTKTDVFSYGA 547
               +      +   GT  YM PE +        S+ +D++S G 
Sbjct: 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGI 199

Length = 384

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 28/98 (28%), Positives = 41/98 (41%), Gaps = 20/98 (20%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM-----------------SET 509
           AL YLHS    IIHRD+K  N+LLD++   K+ DFG  K+                    
Sbjct: 114 ALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 510 SNVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYG 546
                    +  GT  Y+ PE +        +D+++ G
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALG 209

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 30/74 (40%), Positives = 40/74 (54%), Gaps = 7/74 (9%)

Query: 457 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMY 516
           R+ IA  V  A  YLH+    II+RD+K  N+LLD N   KL DFG  K  +  + +  +
Sbjct: 96  RFYIA-CVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAK--KLKSGQKTW 150

Query: 517 TENLTGTRPYMPPE 530
           T    GT  Y+ PE
Sbjct: 151 T--FCGTPEYVAPE 162

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 26/213 (12%)

Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSS-SNSDNTEAAMIPILLFENEVQ 170
           +  K+GEG FG     K K +G +  +K +    N S  S  +  E+          EV 
Sbjct: 4   KVKKIGEGSFGKAILVKSKEDGKQYVIKEI----NISKMSPKEREES--------RKEVA 51

Query: 171 TLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            LS  KH N+++         N  IV +Y   G LY    ++N    +   +   +   V
Sbjct: 52  VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLY---KKINAQRGVLFPEDQILDWFV 108

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
              L   H   + I+HRD+KS N+ L ++   KLGDFGI ++   S ++   T    GT 
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELART--CIGTP 165

Query: 290 PYMPPEAMHCQ---ISTKTDVFSYGVILLELLT 319
            Y+ PE   C+    + K+D+++ G +L E+ T
Sbjct: 166 YYLSPEI--CENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 34/217 (15%)

Query: 119 EGQFGTVYYGKLKNGM-----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           EG FG ++YG L +       E+ VKT++++A            + I + L   E   L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA------------SEIQVTLLLQESCLLY 63

Query: 174 QCKHVNLLRLLGLCNNIMNC--IVYEYMCNGSLYD-----RLARVNNTPPLDSNKRYSIA 226
              H N+L +L +C        ++Y YM  G+L       RL   NN   L + +   +A
Sbjct: 64  GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY-TENL 285
           + +A  + YLH     +IH+D+ + N ++DE    K+ D  + +     +   +   EN 
Sbjct: 124 IQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN- 180

Query: 286 TGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELLT 319
              RP  +M  E++ + + S+ +DV+S+GV+L EL+T
Sbjct: 181 ---RPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 36/227 (15%)

Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLENNANYSSSNSDNTEAAMIP----ILLFENEVQT 171
           LG+G FG V   +LK   E  AVK L+ +        D+ E  M+      L +EN   T
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID---DDVECTMVEKRVLALAWENPFLT 59

Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
              C       L           V E++  G L   +  + +    D  +    A  +  
Sbjct: 60  HLYCTFQTKEHLF---------FVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVC 107

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN----LTG 287
            L +LHS  K II+RD+K  NV+LD +   K+ DFG+ K       + ++ +N      G
Sbjct: 108 GLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCK-------ENVFGDNRASTFCG 158

Query: 288 TRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI--DDNNTIL 331
           T  Y+ PE +   + +   D +S+GV+L E+L G  P   DD + + 
Sbjct: 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 71/240 (29%), Positives = 111/240 (46%), Gaps = 38/240 (15%)

Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G+G FG V   K K +G   AVK L+  A                 +L + E + +   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKA-----------------ILKKKEQKHIMAE 45

Query: 176 KHVNLLR------LLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
           ++V LL+      L+GL  +         V +Y+  G L+  L R  + P  +   R+  
Sbjct: 46  RNV-LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP--EPRARF-Y 101

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           A  +A AL YLHSL+  II+RD+K  N+LLD      L DFG+ K     + KT  T   
Sbjct: 102 AAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT--TSTF 156

Query: 286 TGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 344
            GT  Y+ PE +  Q   +T D +  G +L E+L G+ P    +T   Y  ++ + + ++
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK 216

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 65/244 (26%), Positives = 118/244 (48%), Gaps = 39/244 (15%)

Query: 114 GNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           G  LG+G+FG+V   +LK    +  ++AVK L+ +   SS            I  F  E 
Sbjct: 4   GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-----------IEEFLREA 52

Query: 170 QTLSQCKHVNLLRLLGLCNNI-------MNCIVYEYMCNGSLYDRL--ARVNNTP---PL 217
             + +  H N+++L+G+           +  ++  +M +G L+  L  +R+   P   PL
Sbjct: 53  ACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPL 112

Query: 218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 277
            +  R+ I   +A  + YL S  K  IHRD+ + N +L+EN    + DFG+ K   + + 
Sbjct: 113 QTLVRFMI--DIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD- 167

Query: 278 KTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDD-NNTILY 332
              Y +      P  ++  E++   + +T +DV+++GV + E++T G  P     N+ +Y
Sbjct: 168 --YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225

Query: 333 YYLV 336
            YL+
Sbjct: 226 NYLI 229

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 11/159 (6%)

Query: 168 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           E+Q L +C    ++   G   ++    I  E+M  GSL   L      P     K   ++
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VS 109

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
           + V   L YL    + I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 110 IAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 163

Query: 287 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 324
           GTR YM PE +     S ++D++S G+ L+EL  G  PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 33/82 (40%), Positives = 45/82 (54%), Gaps = 3/82 (3%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           E + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T        +++TGT  
Sbjct: 115 EGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172

Query: 526 YMPPEAMHCQ-ISTKTDVFSYG 546
           +M PE +  +    K DV+S G
Sbjct: 173 WMSPEVISGEGYGRKADVWSVG 194

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 34/110 (30%), Positives = 57/110 (51%), Gaps = 10/110 (9%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L KL ++    PL  ++ +   + +   L +LHS  K I+HRD+KS N+ LD     K+G
Sbjct: 86  LHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIG 143

Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYG 546
           D G+ K+   +     +   + GT  Y+ PE   C+    + K+DV++ G
Sbjct: 144 DLGVAKLLSDNTN---FANTIVGTPYYLSPEL--CEDKPYNEKSDVWALG 188

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 61.0 bits (149), Expect = 2e-10
 Identities = 29/67 (43%), Positives = 38/67 (56%), Gaps = 5/67 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLHSL   II+RD+K  N+LLD +   KL DFG+ K   +   +T  T    GT
Sbjct: 102 IVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT-NT--FCGT 156

Query: 524 RPYMPPE 530
             Y+ PE
Sbjct: 157 PEYLAPE 163

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 46/222 (20%)

Query: 117 LGEGQFGTVYYGKLKN---------GMEIAV--KTLENNANYSSSNSDNTEAAMIPILLF 165
           LG+G F  +Y G L+          G E++V  K L ++   S +              F
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA--------------F 48

Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
                 +SQ  H +L++L G+C    N +V EY+  G L   L R  N   L   K   +
Sbjct: 49  FETASLMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSL-HWKLD-V 106

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL-----DENFVP--KLGDFGIVKMSETSNMK 278
           A  +A ALHYL    K ++H +V   N+L+     +E +VP  KL D GI        + 
Sbjct: 107 AKQLASALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI-------PIT 157

Query: 279 TMYTENLTGTRPYMPPEAM---HCQISTKTDVFSYGVILLEL 317
            +  E      P++ PE +      ++   D +S+G  LLE+
Sbjct: 158 VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 42/224 (18%)

Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
           R N++G G  GTVY    +  G   A+K +  N         + +     I     E++ 
Sbjct: 78  RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN---------HEDTVRRQIC---REIEI 125

Query: 172 LSQCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           L    H N+++    C+++ +      ++ E+M  GSL      + +   L       +A
Sbjct: 126 LRDVNHPNVVK----CHDMFDHNGEIQVLLEFMDGGSLEGT--HIADEQFLAD-----VA 174

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             +   + YLH   + I+HRD+K +N+L++     K+ DFG+ ++      +TM   N +
Sbjct: 175 RQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA----QTMDPCNSS 228

Query: 287 -GTRPYMPPEAMHCQISTKT------DVFSYGVILLELLTGMKP 323
            GT  YM PE ++  ++         D++S GV +LE   G  P
Sbjct: 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 76/289 (26%), Positives = 127/289 (43%), Gaps = 57/289 (19%)

Query: 117 LGEGQFGTVYYGKLKN--------GMEIAVKTLEN-NANYSSSNSDNTEAAMIPILLFEN 167
           LG+G F  ++ G  +           E+ +K L+  + NYS S     EAA +       
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESF---FEAASM------- 52

Query: 168 EVQTLSQCKHVNLLRLLGLC----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
               +SQ  H +L+   G+C     +IM   V EY+  GSL   L +  N   +  + + 
Sbjct: 53  ----MSQLSHKHLVLNYGVCVCGDESIM---VQEYVKFGSLDTYLKKNKNLINI--SWKL 103

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS-NMKTMYT 282
            +A  +A ALH+L    K + H +V + NVLL      K G+   +K+S+   ++  +  
Sbjct: 104 EVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK 161

Query: 283 ENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGM-KPI---DDNNTILYYYLV 336
           E L    P++PPE +     +S   D +S+G  L E+ +G  KP+   D    + +Y   
Sbjct: 162 EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE-- 219

Query: 337 VEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
              ++P        A +W E      +  +  +C  +E D R S R I+
Sbjct: 220 DRHQLP--------APKWTE------LANLINQCMDYEPDFRPSFRAII 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 25/240 (10%)

Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   + K  G   A+K L      +     +T            E + L   
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT----------ESRVLQNT 52

Query: 176 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H  L  L      +   C V EY   G L+  L+R       +  + Y     +  AL 
Sbjct: 53  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAE--IVSALE 109

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 292
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MKT       GT  Y+
Sbjct: 110 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-----FCGTPEYL 162

Query: 293 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 222

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 19/172 (11%)

Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL---ARVNNTPPLDSNKR 222
           NE + L +  H  ++RL    ++     ++ EY+  G L+  L    R +N+  L     
Sbjct: 50  NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL----- 104

Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
              A  +  AL YLHS    I++RD+K  N+LLD+    KL DFG  K  +  +     T
Sbjct: 105 -FYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDR----T 155

Query: 283 ENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYY 333
             L GT  Y+ PE +  +   K  D ++ G+++ E+L G  P  D+N    Y
Sbjct: 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY 207

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 30/95 (31%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPY 291
           L Y+HS +  +IHRD+K +N+L++E+   ++GDFG+ + +S +      +      TR Y
Sbjct: 120 LKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177

Query: 292 MPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 324
             PE +    + +T  D++S G I  E+L G + +
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 13/89 (14%)

Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           AL V E + YL    K  +HRD+ + NVL+ E+ V K+ DFG+ K   +           
Sbjct: 108 ALDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAK-EASQGQD------- 157

Query: 521 TGTRP--YMPPEAM-HCQISTKTDVFSYG 546
           +G  P  +  PEA+   + STK+DV+S+G
Sbjct: 158 SGKLPVKWTAPEALREKKFSTKSDVWSFG 186

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 40/218 (18%)

Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           KLGEG + TVY G+ +  G  +A+K +  +A       + T +  I       E+  + +
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAE------EGTPSTAI------REISLMKE 54

Query: 175 CKHVNLLRL---LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            KH N++RL   +   N +M  +V+EYM +  L   +        LD N   S    + +
Sbjct: 55  LKHENIVRLHDVIHTENKLM--LVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLK 111

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-----VKMSETSN-MKTMY---T 282
            + + H     ++HRD+K  N+L+++    KL DFG+     + ++  SN + T++    
Sbjct: 112 GIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAP 169

Query: 283 ENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTG 320
           + L G+R Y          ST  D++S G I+ E++TG
Sbjct: 170 DVLLGSRTY----------STSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 46/136 (33%), Positives = 64/136 (47%), Gaps = 16/136 (11%)

Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           ++ +Y+  G L+  L +  +    +S  R  IA  V  AL +LH L   II+RD+K  N+
Sbjct: 82  LILDYVNGGELFTHLYQREHFT--ESEVRVYIAEIVL-ALDHLHQLG--IIYRDIKLENI 136

Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM------HCQISTKTDV 307
           LLD      L DFG+ K       +  Y+    GT  YM PE +      H       D 
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTIEYMAPEVIRGGSGGH---DKAVDW 191

Query: 308 FSYGVILLELLTGMKP 323
           +S GV+  ELLTG  P
Sbjct: 192 WSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 66/238 (27%), Positives = 104/238 (43%), Gaps = 34/238 (14%)

Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G+G FG V   K K +G   AVK L+     +     +  A    +L            
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLL------------ 50

Query: 176 KHVNLLRLLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           K+V    L+GL  +         V +++  G L+  L R  + P  +   R+  A  +A 
Sbjct: 51  KNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP--EPRARFYAA-EIAS 107

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK----MSETSNMKTMYTENLTG 287
           AL YLHS++  I++RD+K  N+LLD      L DFG+ K     S+T       T    G
Sbjct: 108 ALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT-------TTTFCG 158

Query: 288 TRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 344
           T  Y+ PE +  Q    T D +  G +L E+L G+ P    +    Y  ++ + + +R
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR 216

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 30/87 (34%), Positives = 43/87 (49%), Gaps = 5/87 (5%)

Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN-LT 521
            V + L YLHS  +  IHRD+K+ N+LL E+   K+ DFG+         +T        
Sbjct: 110 EVLKGLEYLHSNGQ--IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV 167

Query: 522 GTRPYMPPEAMHCQ--ISTKTDVFSYG 546
           GT  +M PE M        K D++S+G
Sbjct: 168 GTPCWMAPEVMEQVHGYDFKADIWSFG 194

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 27/214 (12%)

Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V EYM  G L + ++  N   P    K Y+    V  AL  +HS+   +IHRDVK  N+
Sbjct: 120 MVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAE--VVLALDAIHSMG--LIHRDVKPDNM 173

Query: 254 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 307
           LLD++   KL DFG  +KM ET     +  +   GT  Y+ PE +  Q        + D 
Sbjct: 174 LLDKHGHLKLADFGTCMKMDETG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 308 FSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVF 367
           +S GV L E+L G  P   ++ +  Y  +++ +  +    D E  +    H + LI    
Sbjct: 231 WSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK----HAKNLI---- 282

Query: 368 EKCCVFEKDKRASM-RDIVDLLSKSMFVCNSLAN 400
              C F  D+   + R+ V+ + +  F  N   N
Sbjct: 283 ---CAFLTDREVRLGRNGVEEIKQHPFFKNDQWN 313

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 27/212 (12%)

Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           K+GEG  G V    +K+ G  +AVK ++                    LLF NEV  +  
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 73

Query: 175 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +A
Sbjct: 74  YQHENVVEMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKA 128

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L  LH+  + +IHRD+KS ++LL  +   KL DFG        + +    ++L GT  +M
Sbjct: 129 LSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ---VSKEVPRRKSLVGTPYWM 183

Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 323
            PE +       + D++S G++++E++ G  P
Sbjct: 184 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 60.3 bits (147), Expect = 5e-10
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 40/220 (18%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QT 171
             ++GEG +GTVY  + L  G  +A+K +             +E  +    L E  + + 
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKV---------RVPLSEEGIPLSTLREIALLKQ 54

Query: 172 LSQCKHVNLLRLLGLCNNIMNC------IVYEYMCNGSLYDRLARVNNTPP--LDSNKRY 223
           L   +H N++RLL +C+           +V+E+  +  L   L++    P   L      
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKC---PKPGLPPETIK 110

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMK 278
            +   +   + +LHS    I+HRD+K  N+L+  +   K+ DFG+ +     M+ TS + 
Sbjct: 111 DLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV 168

Query: 279 TMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLEL 317
           T++         Y  PE  +    +T  D++S G I  EL
Sbjct: 169 TLW---------YRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 59.9 bits (146), Expect = 6e-10
 Identities = 42/118 (35%), Positives = 52/118 (44%), Gaps = 13/118 (11%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
            LD      I   V   L YLH   K  IHRD+K+AN+LL E    KL DFG V    TS
Sbjct: 94  KLDETYIAFILREVLLGLEYLHEEGK--IHRDIKAANILLSEEGDVKLADFG-VSGQLTS 150

Query: 511 NVKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYS 567
            +    T    GT  +M PE         K D++S G       IT +++A  E   S
Sbjct: 151 TMSKRNT--FVGTPFWMAPEVIKQSGYDEKADIWSLG-------ITAIELAKGEPPLS 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 61.6 bits (149), Expect = 6e-10
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 14/170 (8%)

Query: 165 FENEVQTLSQCKHVNLLR----LLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
            ENE+  L +  H N+L+    L    N  M    Y++     +YD      + P L   
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQT 269

Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
           +   I   +  A+ Y+H   K +IHRD+K  N+ L+ +    LGDFG     E       
Sbjct: 270 RA--IMKQLLCAVEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325

Query: 281 Y--TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKPIDDN 327
           Y     +    P +     +C+I   TD++S G+ILL++L+    PI D 
Sbjct: 326 YGWVGTVATNSPEILAGDGYCEI---TDIWSCGLILLDMLSHDFCPIGDG 372

Length = 501

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 41/119 (34%), Positives = 59/119 (49%), Gaps = 12/119 (10%)

Query: 205 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 264
            D    V+ + PL   +  +I   + EAL YLH   + IIHRDVK+ N+ LDE     LG
Sbjct: 170 CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLG 227

Query: 265 DFGIV-KMSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELL 318
           DFG   K+    +    Y    +GT     PE +    +C    KTD++S G++L E+ 
Sbjct: 228 DFGAACKLDAHPDTPQCY--GWSGTLETNSPELLALDPYC---AKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 60.6 bits (147), Expect = 6e-10
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 14/159 (8%)

Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           E++ L   +H N++    L +  ++ +   Y     L   L R+  + PL+         
Sbjct: 59  ELKLLKHLRHENII---SLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLY 115

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
            +   L Y+HS    ++HRD+K +N+L++EN   K+ DFG+ ++ +   M T Y      
Sbjct: 116 QILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQD-PQM-TGYVS---- 167

Query: 288 TRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 324
           TR Y  PE M    +   + D++S G I  E+L G KP+
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 60.5 bits (146), Expect = 6e-10
 Identities = 45/162 (27%), Positives = 79/162 (48%), Gaps = 13/162 (8%)

Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           C V EY+  G L+  L+R       D  + Y     +  AL YLHS    I++RD+K  N
Sbjct: 71  CFVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAE--IVSALDYLHS--GKIVYRDLKLEN 125

Query: 253 VLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFS 309
           ++LD++   K+ DFG+ K  +++ + MKT       GT  Y+ PE +         D + 
Sbjct: 126 LMLDKDGHIKITDFGLCKEGITDAATMKT-----FCGTPEYLAPEVLEDNDYGRAVDWWG 180

Query: 310 YGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
            GV++ E++ G  P  + +    + L++ +++     L  +A
Sbjct: 181 LGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADA 222

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 23/230 (10%)

Query: 104 GFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPIL 163
           GF +     + +KLGEG + TVY G+         K  +N         ++ E A    +
Sbjct: 1   GFGKLETYIKLDKLGEGTYATVYKGR--------SKLTDNLVALKEIRLEHEEGAPCTAI 52

Query: 164 LFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKR 222
               EV  L   KH N++ L  + +   +  +V+EY+ +  L   L    N+  + + K 
Sbjct: 53  ---REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL 108

Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
           +   L     L+Y H   + ++HRD+K  N+L++E    KL DFG+ +     ++ T   
Sbjct: 109 FLFQL--LRGLNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTY 161

Query: 283 ENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 330
            N   T  Y PP+ +      ST+ D++  G I  E+ TG +P+   +T+
Sbjct: 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG-RPLFPGSTV 210

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 59.9 bits (146), Expect = 7e-10
 Identities = 28/65 (43%), Positives = 37/65 (56%), Gaps = 4/65 (6%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           E L YLHS    I+HRD+K +N+L++ + V KL DFG+ +   T      YT N   T  
Sbjct: 111 EGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADYT-NRVITLW 166

Query: 526 YMPPE 530
           Y PPE
Sbjct: 167 YRPPE 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 59.5 bits (145), Expect = 9e-10
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 12/91 (13%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNVKTMYT 517
           +   V + L YLHS  + +IHRD+KS N+LL ++   KL DFG       E S   ++  
Sbjct: 121 VCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-- 176

Query: 518 ENLTGTRPY-MPPEAMHCQ-ISTKTDVFSYG 546
               GT PY M PE +  +    K D++S G
Sbjct: 177 ---VGT-PYWMAPEVIKRKDYGPKVDIWSLG 203

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 59.8 bits (145), Expect = 9e-10
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 39/221 (17%)

Query: 116 KLGEGQFGTVYYGKLKNGMEI-AVK--TLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           K+GEG +GTV+  K +   EI A+K   L+++     S++               E+  L
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-------------LREICLL 53

Query: 173 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            + KH N++RL   L ++    +V+EY C+  L       N     D     S    + +
Sbjct: 54  KELKHKNIVRLYDVLHSDKKLTLVFEY-CDQDLKKYFDSCNGDI--DPEIVKSFMFQLLK 110

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK------MSETSNMKTMYTENL 285
            L + HS    ++HRD+K  N+L+++N   KL DFG+ +         ++ + T++    
Sbjct: 111 GLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLW---- 164

Query: 286 TGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPI 324
                Y PP+ +      ST  D++S G I  EL    +P+
Sbjct: 165 -----YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 33/84 (39%), Positives = 48/84 (57%), Gaps = 6/84 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL ++HS  K I+HRD+K ANV +    V KLGD G+ +   +   KT    +L GT
Sbjct: 115 LCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGT 169

Query: 524 RPYMPPEAMHCQ-ISTKTDVFSYG 546
             YM PE +H    + K+D++S G
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLG 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 21/238 (8%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   + K   +  A+K L+     +     +T        L E+ V  L   
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT--------LTESRV--LQNT 52

Query: 176 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H  L  L      +   C V EY   G L+  L+R       D  + Y     +  AL 
Sbjct: 53  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALG 109

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLHS    +++RD+K  N++LD++   K+ DFG+ K    S+  TM T    GT  Y+ P
Sbjct: 110 YLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKT--FCGTPEYLAP 164

Query: 295 EAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           E +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEA 222

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 52/241 (21%), Positives = 106/241 (43%), Gaps = 26/241 (10%)

Query: 162 ILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPP 216
           I + ENE++ L +    N+L++ G   +I++      ++ EY   G L + L   +    
Sbjct: 62  IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL---DKEKD 118

Query: 217 LDSNKRYSIALGVAEALHYLH-SLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 275
           L    +  +A+   + L+ L+   +KP  ++++ S + L+ EN+  K+   G+ K+  + 
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSP 176

Query: 276 NMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL 335
             K +   N      Y     +  + + K D++S GV+L E+ TG  P ++  T   Y L
Sbjct: 177 PFKNV---NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233

Query: 336 VVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVC 395
           ++          +K             I  + E C   +  KR ++++I+  L  S++  
Sbjct: 234 II----------NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL--SLYKF 281

Query: 396 N 396
            
Sbjct: 282 Y 282

Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 16/94 (17%)

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---T 288
            L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++         + +TG   T
Sbjct: 130 GLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTD---------DEMTGYVAT 178

Query: 289 RPYMPPEAMHCQIS-TKT-DVFSYGVILLELLTG 320
           R Y  PE M   +   +T D++S G I+ ELLTG
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 30/220 (13%)

Query: 116 KLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           ++G+G +G V+  K K+  EI A+K +            +    +  +     E   L+ 
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRM----------KKSLLFKLNEVRHVLTERDILTT 57

Query: 175 CKHVNLLRLLGLCNNIMNCIVY---EYMCNGSLYDRLARVNNTPPLDSNK-RYSIALGVA 230
            K   L++LL    +     +Y   EY+  G   D    +NN   L  +  R+ +A    
Sbjct: 58  TKSEWLVKLLYAFQDDEY--LYLAMEYVPGG---DFRTLLNNLGVLSEDHARFYMAEMF- 111

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           EA+  LH L    IHRD+K  N L+D +   KL DFG+ K   T      Y  ++ G+  
Sbjct: 112 EAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------YANSVVGSPD 163

Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNT 329
           YM PE +  +    T D +S G +L E L G  P   +  
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 47/160 (29%), Positives = 79/160 (49%), Gaps = 6/160 (3%)

Query: 167 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLA-RVNNTPPLDSNKRYS 224
           +E+  L+ C H  +++      ++    ++ EY   G L  ++  R+    P    +   
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
           +   +  AL  +HS  + ++HRD+KSAN+ L    + KLGDFG  K   + ++      +
Sbjct: 174 LFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY-SDSVSLDVASS 230

Query: 285 LTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKP 323
             GT  Y+ PE     + S K D++S GVIL ELLT  +P
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 8/92 (8%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN---- 519
           +  AL YLHS    IIHRD+K  N+L+D N   KL DFG+ K+        +  +     
Sbjct: 102 IVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159

Query: 520 -LTGTRPYMPPEAMHCQISTKT-DVFSYGAQI 549
            + GT  Y+ PE +  Q  +KT D +S G  +
Sbjct: 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCIL 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 39/115 (33%), Positives = 60/115 (52%), Gaps = 17/115 (14%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT-ENLTG 522
           + EAL++LHS    +IHRD+K+ N+LL  +   KL DFG+       N  T+   +   G
Sbjct: 112 MLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGV----SAKNKSTLQKRDTFIG 165

Query: 523 TRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHE 577
           T  +M PE + C+ + K + + Y A I +  IT +++A  E         P HHE
Sbjct: 166 TPYWMAPEVVACE-TFKDNPYDYKADIWSLGITLIELAQME---------PPHHE 210

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 36/130 (27%), Positives = 54/130 (41%), Gaps = 26/130 (20%)

Query: 446 VNNTPPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           V         KR        I       L YLH     +IHRD+K  N+LL +N   KL 
Sbjct: 100 VKGL--RKKGKRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLV 155

Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ------ISTKTDVFSYGAQIKTQH 553
           DFG+    +++  +        GT  +M PE + C          ++DV+S G       
Sbjct: 156 DFGVSAQLDSTLGR---RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG------- 205

Query: 554 ITNVDIADRE 563
           IT +++AD +
Sbjct: 206 ITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 50/147 (34%), Positives = 69/147 (46%), Gaps = 24/147 (16%)

Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE---ALHYLHSLSKPIIHRDVK 249
           C+V EY+  G     L  +    P+D  + Y      AE   AL YLH+    I+HRD+K
Sbjct: 77  CMVMEYVEGGDCATLLKNIG-ALPVDMARMY-----FAETVLALEYLHNYG--IVHRDLK 128

Query: 250 SANVLLDENFVPKLGDFGIVK---MSETSNMKTMYTENLT---------GTRPYMPPEAM 297
             N+L+      KL DFG+ K   MS T+N+   + E  T         GT  Y+ PE +
Sbjct: 129 PDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188

Query: 298 HCQISTK-TDVFSYGVILLELLTGMKP 323
             Q   K  D ++ G+IL E L G  P
Sbjct: 189 LRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 65/212 (30%), Positives = 92/212 (43%), Gaps = 24/212 (11%)

Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G+G FG V   K K +G   AVK L+          ++  A        E  V  L   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMA--------ERNV-LLKNL 53

Query: 176 KHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           KH  L+ L            V +Y+  G L+  L R      L+   R+  A  VA A+ 
Sbjct: 54  KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCF--LEPRARF-YAAEVASAIG 110

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 292
           YLHSL+  II+RD+K  N+LLD      L DFG+ K  +          T    GT  Y+
Sbjct: 111 YLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-----TSTFCGTPEYL 163

Query: 293 PPEAMHCQISTKT-DVFSYGVILLELLTGMKP 323
            PE +  +   +T D +  G +L E+L G+ P
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 59.5 bits (145), Expect = 2e-09
 Identities = 40/116 (34%), Positives = 60/116 (51%), Gaps = 18/116 (15%)

Query: 218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------ 271
           D +KRY I   + +AL Y+HS    +IHRD+K +N+LL+ +   KL DFG+ +       
Sbjct: 106 DVHKRY-IMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162

Query: 272 SETSNMKTMYTENLTGTRPYMPPE---AMHCQISTKTDVFSYGVILLELLTGMKPI 324
           +  + + T Y      TR Y  PE         +   D++S G IL E+L G KP+
Sbjct: 163 NPENPVLTDYVA----TRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLLG-KPL 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 23/219 (10%)

Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           +KLGEG + TV+ G+         K  EN         ++ E A    +    EV  L  
Sbjct: 11  DKLGEGTYATVFKGR--------SKLTENLVALKEIRLEHEEGAPCTAI---REVSLLKN 59

Query: 175 CKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
            KH N++ L  + +      +V+EY+ +  L   L    N   + + K +   L     L
Sbjct: 60  LKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQL--LRGL 116

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y H   + I+HRD+K  N+L++E    KL DFG+ +     ++ T    N   T  Y P
Sbjct: 117 SYCHK--RKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRP 171

Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 330
           P+ +    + ST  D++  G IL E+ TG +P+   +T+
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATG-RPMFPGSTV 209

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 45/136 (33%), Positives = 64/136 (47%), Gaps = 15/136 (11%)

Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V EYM  G L + ++  N   P    + Y+    V  AL  +HS+    IHRDVK  N+
Sbjct: 120 MVMEYMPGGDLVNLMS--NYDIPEKWARFYTAE--VVLALDAIHSMG--FIHRDVKPDNM 173

Query: 254 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAM-----HCQISTKTDV 307
           LLD++   KL DFG  +KM        +  +   GT  Y+ PE +           + D 
Sbjct: 174 LLDKSGHLKLADFGTCMKMDANG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 308 FSYGVILLELLTGMKP 323
           +S GV L E+L G  P
Sbjct: 231 WSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 42/218 (19%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  +    G  +A+K +  +          TE   +P      E+  L +
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAIR-EISLLKE 55

Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSL--YDRLARVNNTP-PLDSNKRYSIALGVA 230
             H N+++LL + +      +V+E++ +  L  +   + ++  P PL  +  + +  G+A
Sbjct: 56  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------SETSNMKTMY--- 281
               + HS    ++HRD+K  N+L++     KL DFG+ +       + T  + T++   
Sbjct: 115 ----FCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 168

Query: 282 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT 319
            E L G + Y          ST  D++S G I  E++T
Sbjct: 169 PEILLGCKYY----------STAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 33/87 (37%), Positives = 53/87 (60%), Gaps = 9/87 (10%)

Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           +L VAE + YL S  K ++HRD+ + N+L+ E+ V K+ DFG+ +      V +M  +N 
Sbjct: 106 SLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLAR------VGSMGVDNS 157

Query: 521 TGTRPYMPPEAM-HCQISTKTDVFSYG 546
                +  PEA+ H + S+K+DV+SYG
Sbjct: 158 KLPVKWTAPEALKHKKFSSKSDVWSYG 184

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 32/219 (14%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE-NEVQTLS 173
           K+GEG +G VY  +    G  +A+K          +  +  E  + P  L E + +Q LS
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALK---------KTRLEMDEEGIPPTALREISLLQMLS 58

Query: 174 QCKH-VNLLRLLGLCNN---IMNCIVYEYMCNG--SLYDRLARVNNTP-PLDSNKR--YS 224
           +  + V LL +  +          +V+EY+ +      D   R    P P  + K   Y 
Sbjct: 59  ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTE 283
           +  GVA    + H     ++HRD+K  N+L+D +  + K+ D G+ + + +  +K+ YT 
Sbjct: 119 LLKGVA----HCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKS-YTH 170

Query: 284 NLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTG 320
            +  T  Y  PE +      ST  D++S G I  E+   
Sbjct: 171 EIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)

Query: 115 NKLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           N++ EG +G VY  + K   EI A+K L+             E    PI     E+  L 
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKME----------KEKEGFPITSLR-EINILL 59

Query: 174 QCKHVNLLRL----LGL-CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
           + +H N++ +    +G   + I   +V EY+ +  L   +       P   ++   + L 
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDKIY--MVMEYVEH-DLKSLME--TMKQPFLQSEVKCLMLQ 114

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           +   + +LH     I+HRD+K++N+LL+   + K+ DFG+ +    S +K  YT+ +  T
Sbjct: 115 LLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKP-YTQLVV-T 169

Query: 289 RPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 324
             Y  PE +    + ST  D++S G I  ELLT  KP+
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 12/132 (9%)

Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
            IV EYM        LA V    PL           +   L Y+HS +  ++HRD+K AN
Sbjct: 92  YIVQEYMETD-----LANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPAN 144

Query: 253 VLLD-ENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKT-DVF 308
           V ++ E+ V K+GDFG+ + +    + K   +E L  T+ Y  P   +     TK  D++
Sbjct: 145 VFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMW 203

Query: 309 SYGVILLELLTG 320
           + G I  E+LTG
Sbjct: 204 AAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 74/247 (29%), Positives = 104/247 (42%), Gaps = 37/247 (14%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENN---ANYSSSNSDNTEAAMIPILLFENEVQTL 172
           LG G FG V   + K   E+ A+K L+     A       D  E+ M    +FE    T 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR------DEVESLMCEKRIFE----TA 56

Query: 173 SQCKHVNLLRLLGLCNNIMN--CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           +  +H  L+ L   C    +  C V EY   G L   +     + P      Y  A  V 
Sbjct: 57  NSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP--RAVFY--AACVV 111

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVK--MSETSNMKTMYTENLTG 287
             L YLH     I++RD+K  N+LLD E FV K+ DFG+ K  M          T    G
Sbjct: 112 LGLQYLHE--NKIVYRDLKLDNLLLDTEGFV-KIADFGLCKEGMGFGDR-----TSTFCG 163

Query: 288 TRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPI--DDNNTILYYYLVVEQEVPVR 344
           T  ++ PE +     T+  D +  GV++ E+L G  P   DD   +  +  +V  EV   
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV--FDSIVNDEVRYP 221

Query: 345 EVLDKEA 351
             L +EA
Sbjct: 222 RFLSREA 228

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 16/158 (10%)

Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V EY+  G L   + R    P  + + R+  A  +  AL++LH   + II+RD+K  NV
Sbjct: 73  LVIEYVNGGDLMFHMQRQRKLP--EEHARF-YAAEICIALNFLHE--RGIIYRDLKLDNV 127

Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGV 312
           LLD +   KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV
Sbjct: 128 LLDADGHIKLTDYGMCKEGLGPGDT---TSTFCGTPNYIAPEILRGEEYGFSVDWWALGV 184

Query: 313 ILLELLTGMKPID------DNNTILYYYLVVEQEVPVR 344
           ++ E++ G  P D      D NT  Y + V+  E P+R
Sbjct: 185 LMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 35/241 (14%)

Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G G +G VY G+ +K G   A+K +           D TE     I L  N ++  S  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVM-----------DVTEDEEEEIKLEINMLKKYSH- 71

Query: 176 KHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
            H N+    G         ++    +V E+   GS+ D L +      L  +    I   
Sbjct: 72  -HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICRE 129

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTG 287
           +   L +LH+    +IHRD+K  NVLL EN   KL DFG+  ++  T   +  +     G
Sbjct: 130 ILRGLAHLHA--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----IG 183

Query: 288 TRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           T  +M PE + C          ++D++S G+  +E+  G  P+ D + +   +L+     
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 243

Query: 342 P 342
           P
Sbjct: 244 P 244

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 6/88 (6%)

Query: 443 LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 502
           L       P    K Y   L   + + Y+H+    I+HRD+K AN+L+  + V K+ DFG
Sbjct: 89  LRDEERPLPEAQVKSYMRML--LKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFG 144

Query: 503 IVKMSETSNVKTMYTENLTGTRPYMPPE 530
           + ++      +    +    TR Y  PE
Sbjct: 145 LARLFSEEEPRLYSHQ--VATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 57.4 bits (138), Expect = 5e-09
 Identities = 41/118 (34%), Positives = 60/118 (50%), Gaps = 13/118 (11%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PLD  +  +I   + + L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      +
Sbjct: 97  PLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154

Query: 511 NVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGAQIKTQHITNVDIADRERYYS 567
            +K        GT  +M PE +      +K D++S G       IT +++A  E  +S
Sbjct: 155 QIK---RNTFVGTPFWMAPEVIKQSAYDSKADIWSLG-------ITAIELAKGEPPHS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 36/98 (36%), Positives = 46/98 (46%), Gaps = 6/98 (6%)

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL +LH     II+RD+K  N+LLD     KL DFG+ K S         T    GT  Y
Sbjct: 112 ALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV---THTFCGTIEY 166

Query: 292 MPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
           M PE  M        D +S G ++ ++LTG  P    N
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 10/132 (7%)

Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V +YM  G L+  L +       +   ++ IA  V  AL +LH     I++RD+K  N+
Sbjct: 73  LVTDYMSGGELFWHLQKEGRFS--EDRAKFYIAELVL-ALEHLHKYD--IVYRDLKPENI 127

Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYG 311
           LLD      L DFG+ K + T N KT  T    GT  Y+ PE +      +   D +S G
Sbjct: 128 LLDATGHIALCDFGLSKANLTDN-KT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLG 184

Query: 312 VILLELLTGMKP 323
           V++ E+  G  P
Sbjct: 185 VLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 16/93 (17%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE-----TSNVKT 514
           +A  VAE + YL    +  IHRD+ + N+L+ E+ V K+ DFG+ ++ +     +S+ K 
Sbjct: 109 MACQVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI 166

Query: 515 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYG 546
            Y         +  PEA  H   STK+DV+S+G
Sbjct: 167 PYK--------WTAPEAASHGTFSTKSDVWSFG 191

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 37/95 (38%), Positives = 54/95 (56%), Gaps = 10/95 (10%)

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMYTENLTGTRPY 291
           L Y+HS +  ++HRD+K +N+LL+ N   K+ DFG+ +  SE  +  T Y      TR Y
Sbjct: 121 LKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV----TRWY 174

Query: 292 MPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 324
             PE +    + +T  DV+S G I  ELL G KP+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 25/102 (24%), Positives = 48/102 (47%), Gaps = 7/102 (6%)

Query: 448 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 507
           +   ++  +    +  + + + YL S  +  IHRD+ + N+L++   + K+ DFG+ K+ 
Sbjct: 102 HRDQINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVL 159

Query: 508 ETSNVKTMYTENLTGTRP---YMPPEAMHCQISTKTDVFSYG 546
                K  Y     G  P   Y P      + S+ +DV+S+G
Sbjct: 160 PED--KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFG 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 57.0 bits (137), Expect = 7e-09
 Identities = 39/117 (33%), Positives = 56/117 (47%), Gaps = 11/117 (9%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL+     +I   + + L YLHS  K  IHRD+K+ANVLL E    KL DFG+      +
Sbjct: 97  PLEETYIATILREILKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154

Query: 511 NVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYS 567
            +K        GT  +M PE +      K   + + A I +  IT +++A  E   S
Sbjct: 155 QIK---RNTFVGTPFWMAPEVI------KQSAYDFKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 57.6 bits (139), Expect = 7e-09
 Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 11/162 (6%)

Query: 168 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           E   L    H +++R+   L +  + C+V  +  +  LY  L     + PL  ++   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLT--KRSRPLPIDQALIIE 163

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + E L YLH+    IIHRDVK+ N+ +++     +GD G  +    +         L 
Sbjct: 164 KQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----GLA 217

Query: 287 GTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDN 327
           GT     PE +   + ++K D++S G++L E+L     I ++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259

Length = 357

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 61/232 (26%), Positives = 105/232 (45%), Gaps = 27/232 (11%)

Query: 104 GFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPIL 163
           GF +     +  KLGEG + TV+ G+         K  EN         ++ E A    +
Sbjct: 1   GFGKMETYIKLEKLGEGTYATVFKGR--------SKLTENLVALKEIRLEHEEGAPCTAI 52

Query: 164 LFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNK- 221
               EV  L   KH N++ L  + +   +  +V+EY+ +  L   +    N   + + K 
Sbjct: 53  ---REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKI 108

Query: 222 -RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
             Y I  G+A    Y H   + ++HRD+K  N+L++E    KL DFG+ +     ++ T 
Sbjct: 109 FLYQILRGLA----YCHR--RKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTK 159

Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 330
              N   T  Y PP+ +    + ST+ D++  G I  E+ +G +P+   +T+
Sbjct: 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG-RPLFPGSTV 210

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 57.0 bits (138), Expect = 8e-09
 Identities = 26/82 (31%), Positives = 47/82 (57%), Gaps = 5/82 (6%)

Query: 468 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRPY 526
           L Y+HS +  +IHRD+K +N+L++E+   ++GDFG+ + +S +      +      TR Y
Sbjct: 120 LKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177

Query: 527 MPPEAMHC--QISTKTDVFSYG 546
             PE +    + +T  D++S G
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVG 199

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 33/108 (30%), Positives = 51/108 (47%), Gaps = 8/108 (7%)

Query: 442 KLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 501
                     L      S A  VA  + +L S  K  IHRD+ + NVL+ E+ V K+ DF
Sbjct: 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADF 176

Query: 502 GIVKMSETSNVKTMYTENLTGTRPY--MPPEAMHCQIST-KTDVFSYG 546
           G   ++   +    Y +   G  P   M PEA+  ++ T ++DV+S+G
Sbjct: 177 G---LARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 221

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 38/114 (33%), Positives = 56/114 (49%), Gaps = 13/114 (11%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           P D  +  ++   + + L YLHS  K  IHRD+K+ANVLL E    KL DFG+      +
Sbjct: 97  PFDEFQIATMLKEILKGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154

Query: 511 NVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGAQIKTQHITNVDIADRE 563
            +K        GT  +M PE +      +K D++S G       IT +++A  E
Sbjct: 155 QIK---RNTFVGTPFWMAPEVIQQSAYDSKADIWSLG-------ITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.5 bits (136), Expect = 9e-09
 Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 34/225 (15%)

Query: 117 LGEGQFGTVY-YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G+G +G VY     K+G   AVK L+       S+ D    A   IL      Q+L   
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEIEAEYNIL------QSLPN- 77

Query: 176 KHVNLLRLLGLCNNIMNCI------VYEYMCNGSLYDRLAR--VNNTPPLDSNKRYSIAL 227
            H N+++  G+       +      V E +CNG     L +  +     LD      I  
Sbjct: 78  -HPNVVKFYGMFYKADKLVGGQLWLVLE-LCNGGSVTELVKGLLICGQRLDEAMISYILY 135

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
           G    L +LH+    IIHRDVK  N+LL      KL DFG+     ++ ++   +    G
Sbjct: 136 GALLGLQHLHN--NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VG 190

Query: 288 TRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDD 326
           T  +M PE + C+         + DV+S G+  +EL  G  P+ D
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 27/64 (42%), Positives = 37/64 (57%), Gaps = 8/64 (12%)

Query: 468 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRPY 526
           L YLH   +  +HRD+K AN+L+D N V KL DFG+ K + E S  K+       G+  +
Sbjct: 115 LEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF-----KGSPYW 167

Query: 527 MPPE 530
           M PE
Sbjct: 168 MAPE 171

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 7/92 (7%)

Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT--E 518
           A+ +A  + YL S  K  IHRD+ + N+LL  +   K+GDFG+  M      +  Y   E
Sbjct: 103 AVQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGL--MRALPQNEDHYVMEE 158

Query: 519 NLTGTRPYMPPEAM-HCQISTKTDVFSYGAQI 549
           +L     +  PE++     S  +DV+ +G  +
Sbjct: 159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTL 190

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 3/87 (3%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           + E + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T  +     +++TGT
Sbjct: 115 ILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172

Query: 524 RPYMPPEAMHCQ-ISTKTDVFSYGAQI 549
             +M PE +  +    K D++S G  +
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTV 199

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 56.4 bits (137), Expect = 1e-08
 Identities = 36/96 (37%), Positives = 49/96 (51%), Gaps = 10/96 (10%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           LF   R +   P    + Y  A  V  AL YLHSL   I++RD+K  N+LLD +   K+ 
Sbjct: 88  LFSHLRKSGRFPEPVARFY--AAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKIT 143

Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ 535
           DFG  K  +    +T YT  L GT  Y+ PE +  +
Sbjct: 144 DFGFAKRVKG---RT-YT--LCGTPEYLAPEIILSK 173

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 20/117 (17%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL   +  ++  G  + L YLHS +  +IHRDVK+ N+LL E  + KLGDFG   +   +
Sbjct: 111 PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168

Query: 511 NVKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGAQIKTQHITNVDIADRE 563
           N          GT  +M PE +      Q   K DV+S G       IT +++A+R+
Sbjct: 169 N-------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-------ITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 10/86 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  A+ Y+H     I+HRD+K+ N+ L +  + KLGDFGI K+      +    E + GT
Sbjct: 110 IVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI---LGSEYSMAETVVGT 164

Query: 524 RPYMPPEAMHCQ---ISTKTDVFSYG 546
             YM PE   CQ    + K+D+++ G
Sbjct: 165 PYYMSPEL--CQGVKYNFKSDIWALG 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 34/95 (35%), Positives = 45/95 (47%), Gaps = 16/95 (16%)

Query: 460 IALGVAEALHYL---HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMY 516
           + + + +ALHYL   H     +IHRDVK +N+LLD +   KL DFGI      S  KT  
Sbjct: 119 MTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT-- 172

Query: 517 TENLTGTRPYMPPEAMHCQIST-----KTDVFSYG 546
                G   YM PE +           + DV+S G
Sbjct: 173 --RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLG 205

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 39/113 (34%), Positives = 58/113 (51%), Gaps = 17/113 (15%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMY-TENLTGTR 524
           EAL+YLH     IIHRD+K+ N+L   +   KL DFG+       N +T+   ++  GT 
Sbjct: 114 EALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTP 167

Query: 525 PYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHE 577
            +M PE + C+ S K   + Y A + +  IT +++A  E         P HHE
Sbjct: 168 YWMAPEVVMCETS-KDRPYDYKADVWSLGITLIEMAQIE---------PPHHE 210

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 35/84 (41%), Positives = 49/84 (58%), Gaps = 6/84 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A AL +LHSL   II+RD+K  N+LLDE    KL DFG+ K S     K     +  GT
Sbjct: 107 LALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGT 161

Query: 524 RPYMPPEAMHCQISTKT-DVFSYG 546
             YM PE ++ +  T++ D +S+G
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFG 185

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 69/229 (30%), Positives = 101/229 (44%), Gaps = 43/229 (18%)

Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKT--LENNANYSSSNSDNTEAAMIPILLFENEVQT 171
            ++GEG +G VY  + K+ G  +A+K   L+N            E    PI     E++ 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDN------------EKEGFPITAIR-EIKI 59

Query: 172 LSQCKHVNLLRLLGLCNNIMNC-----------IVYEYMCN---GSLYDRLARVNNTPPL 217
           L Q  H N++ L  +  +  +            +V+EYM +   G L   L   +     
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE---- 115

Query: 218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 277
           D  K  S    + E L+Y H   K  +HRD+K +N+LL+     KL DFG+ ++   S  
Sbjct: 116 DHIK--SFMKQLLEGLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYN-SEE 170

Query: 278 KTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 324
              YT N   T  Y PPE +    +     DV+S G IL EL T  KPI
Sbjct: 171 SRPYT-NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 34/223 (15%)

Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           KLGEG + TVY GK K NG  +A+K +       +  +   EA+++  L           
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL----------- 60

Query: 175 CKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIALGVAE 231
            KH N++ L  + +      +V+EY     ++  L +  +  P  L           +  
Sbjct: 61  -KHANIVLLHDIIHTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            L Y+H   + I+HRD+K  N+L+ +    KL DFG+ +     ++ +    N   T  Y
Sbjct: 115 GLSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWY 169

Query: 292 MPPEAM--HCQISTKTDVFSYGVILLELLT------GMKPIDD 326
            PP+ +    + ST  D++  G I +E++       GMK I D
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 15/148 (10%)

Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSN-KRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           +V EY   G L   L R  +    D +  ++ +A  +  A+H +H +    +HRD+K  N
Sbjct: 78  LVMEYQPGGDLLSLLNRYED--QFDEDMAQFYLA-ELVLAIHSVHQMG--YVHRDIKPEN 132

Query: 253 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-------HCQISTKT 305
           VL+D     KL DFG    +  +  K + ++   GT  Y+ PE +             + 
Sbjct: 133 VLIDRTGHIKLADFG--SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVEC 190

Query: 306 DVFSYGVILLELLTGMKPIDDNNTILYY 333
           D +S GVI  E++ G  P  +  +   Y
Sbjct: 191 DWWSLGVIAYEMIYGRSPFHEGTSAKTY 218

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 18/159 (11%)

Query: 195 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 254
           V E++  G L   + R    P  + + R+  A  ++ AL++LH   + II+RD+K  NVL
Sbjct: 74  VIEFVSGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNFLHE--RGIIYRDLKLDNVL 128

Query: 255 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVI 313
           LD     KL D+G   M +        T    GT  Y+ PE +  +      D ++ GV+
Sbjct: 129 LDAEGHIKLTDYG---MCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVL 185

Query: 314 LLELLTGMKPID--------DNNTILYYYLVVEQEVPVR 344
           + E++ G  P D        D NT  Y + V+  E  +R
Sbjct: 186 MFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-LEKQIR 223

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 55.9 bits (134), Expect = 1e-08
 Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 37/242 (15%)

Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ- 174
           +G G +G VY G+ +K G   A+K ++          D  E         + E+  L + 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMD-------VTGDEEEE-------IKQEINMLKKY 59

Query: 175 CKHVNLLRLLG--LCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
             H N+    G  +  N         +V E+   GS+ D +         +    Y I  
Sbjct: 60  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICR 118

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLT 286
            +   L +LH     +IHRD+K  NVLL EN   KL DFG+  ++  T   +  +     
Sbjct: 119 EILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----I 172

Query: 287 GTRPYMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           GT  +M PE + C  +       K+D++S G+  +E+  G  P+ D + +   +L+    
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 232

Query: 341 VP 342
            P
Sbjct: 233 AP 234

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 55.5 bits (133), Expect = 2e-08
 Identities = 33/87 (37%), Positives = 47/87 (54%), Gaps = 3/87 (3%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           + E + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T  +      ++TGT
Sbjct: 115 ILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 524 RPYMPPEAMHCQ-ISTKTDVFSYGAQI 549
             +M PE +  +    K DV+S G  +
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTV 199

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 11/98 (11%)

Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L S +    A  VA  + YL    K  IHRD+ + NVL+ EN   K+ DFG+ +  E   
Sbjct: 116 LTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV 173

Query: 512 VKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
            KTM      G  P  +M  E+++  + +TK+DV+S+G
Sbjct: 174 KKTM------GRLPVRWMAIESLNYSVYTTKSDVWSFG 205

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 11/98 (11%)

Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 178

Query: 512 VKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
            KTM      G  P  +M  E+++  + +T +DV+SYG
Sbjct: 179 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYG 210

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 56.4 bits (137), Expect = 2e-08
 Identities = 24/69 (34%), Positives = 36/69 (52%), Gaps = 8/69 (11%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG---T 523
            L YLHS +  +IHRD+K +N+L++ N   K+ DFG   ++   +        LT    T
Sbjct: 115 GLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFG---LARGVDPDEDEKGFLTEYVVT 169

Query: 524 RPYMPPEAM 532
           R Y  PE +
Sbjct: 170 RWYRAPELL 178

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 6/94 (6%)

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL +LH L   I++RD+K  N+LLD      L DFG+ K   +   +  Y+    GT  Y
Sbjct: 117 ALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIEY 172

Query: 292 MPPEAMHCQI--STKTDVFSYGVILLELLTGMKP 323
           M PE +  +       D +S G+++ ELLTG  P
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 4/93 (4%)

Query: 237 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 296
           H   K ++HRD+KS N+ L +N   KLGDFG  ++  +      Y     GT  Y+PPE 
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GAYACTYVGTPYYVPPEI 171

Query: 297 M-HCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
             +   + K+D++S G IL EL T   P   N+
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 30/235 (12%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G G FG V   K+K+   I A+K L        +  +  + A       E  V     C
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKIL--------NKWEMLKRAETACFREERNVLVNGDC 60

Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE---A 232
           + +  L       N +  +V +Y   G L   L++  +  P D  + Y     +AE   A
Sbjct: 61  QWITTLHYAFQDENYLY-LVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVLA 114

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPY 291
           +H +H L    +HRD+K  NVLLD N   +L DFG  +KM++     T+ +    GT  Y
Sbjct: 115 IHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG---TVQSSVAVGTPDY 169

Query: 292 MPPEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +        +   + D +S GV + E+L G  P    + +  Y  ++  E
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 224

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 18/168 (10%)

Query: 195 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 254
           V EY+  G L   + R    P  + + R+  A  ++ AL+YLH   + II+RD+K  NVL
Sbjct: 74  VIEYVNGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNYLHE--RGIIYRDLKLDNVL 128

Query: 255 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVI 313
           LD     KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV+
Sbjct: 129 LDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVL 185

Query: 314 LLELLTGMKPID--------DNNTILYYYLVV-EQEVPVREVLDKEAG 352
           + E++ G  P D        D NT  Y + V+ E+++ +   L  +A 
Sbjct: 186 MFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 233

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 32/85 (37%), Positives = 48/85 (56%), Gaps = 6/85 (7%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN---LTG 522
           + L+YLH+  + IIHRD+K AN+L+D     K+ DFGI K  E +++ T        L G
Sbjct: 117 KGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174

Query: 523 TRPYMPPEAMHCQIST-KTDVFSYG 546
           +  +M PE +     T K D++S G
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLG 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 29/87 (33%), Positives = 51/87 (58%), Gaps = 5/87 (5%)

Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  ++   +HRD+ + N+L++ N V K+ DFG+ +  E       YT +L G
Sbjct: 114 GIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171

Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 172 KIPIRWTAPEAIAYRKFTSASDVWSYG 198

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 55.2 bits (134), Expect = 3e-08
 Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 17/90 (18%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI--- 503
               PL  N   SI   +   L Y HS    I+HRD+K  N+L++ + V KL DFG+   
Sbjct: 90  KRPGPLSPNLIKSIMYQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLARA 147

Query: 504 --VKMSE-TSNVKTMYTENLTGTRPYMPPE 530
             + +   T  V T++         Y  PE
Sbjct: 148 FGIPLRTYTHEVVTLW---------YRAPE 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 55.5 bits (133), Expect = 3e-08
 Identities = 39/117 (33%), Positives = 59/117 (50%), Gaps = 20/117 (17%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL   +  +I  G  + L YLHS +  +IHRD+K+ N+LL E    KL DFG   ++  +
Sbjct: 121 PLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178

Query: 511 NVKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGAQIKTQHITNVDIADRE 563
           N       +  GT  +M PE +      Q   K DV+S G       IT +++A+R+
Sbjct: 179 N-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-------ITCIELAERK 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 34/87 (39%), Positives = 52/87 (59%), Gaps = 13/87 (14%)

Query: 462 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS-NVKTMYTENL 520
           LGV    HY+H   + I+HRD+K+ N+ L  N + K+GDFG+ ++   S ++ T      
Sbjct: 117 LGV----HYMHQ--RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLAT----TF 165

Query: 521 TGTRPYMPPEAM-HCQISTKTDVFSYG 546
           TGT  YM PEA+ H    +K+D++S G
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLG 192

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 3e-08
 Identities = 32/96 (33%), Positives = 53/96 (55%), Gaps = 7/96 (7%)

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS-ETSNMKTMYTENLTGTRP 290
            L Y+HS +  ++HRD+K +N+LL+ N   K+ DFG+ +++    +     TE    TR 
Sbjct: 118 GLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE-YVATRW 174

Query: 291 YMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 324
           Y  PE M      +   D++S G IL E+L+  +P+
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 45/134 (33%), Positives = 62/134 (46%), Gaps = 13/134 (9%)

Query: 197 EYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD 256
           EYM  GSL    A    T  +  +    I   V + L +L      IIHRDVK  NVL++
Sbjct: 79  EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVN 137

Query: 257 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFS 309
            N   KL DFG+      S  KT    N+ G + YM PE +           + ++DV+S
Sbjct: 138 GNGQVKLCDFGVSGNLVASLAKT----NI-GCQSYMAPERIKSGGPNQNPTYTVQSDVWS 192

Query: 310 YGVILLELLTGMKP 323
            G+ +LE+  G  P
Sbjct: 193 LGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 12/134 (8%)

Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG-VAEALHYLHSLSKPIIHRDVKSAN 252
           ++ +Y+  G L+  L++          +   I  G +  AL +LH L   II+RD+K  N
Sbjct: 82  LILDYINGGELFTHLSQRERF----KEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLEN 135

Query: 253 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS---TKTDVFS 309
           +LLD N    L DFG+ K      ++  Y  +  GT  YM P+ +           D +S
Sbjct: 136 ILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMAPDIVRGGDGGHDKAVDWWS 193

Query: 310 YGVILLELLTGMKP 323
            GV++ ELLTG  P
Sbjct: 194 MGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 23/208 (11%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENN-ANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           +GEG +G V   + K   EI A+K  +++  N     +   E  M+  L  EN V+    
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 175 CKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            +    L L           V+EY+   ++ + L  + N  P +  + Y   L   +A+H
Sbjct: 69  FRRRGKLYL-----------VFEYV-EKNMLELLEEMPNGVPPEKVRSYIYQL--IKAIH 114

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMP 293
           + H     I+HRD+K  N+L+  N V KL DFG  + +SE SN    YTE    TR Y  
Sbjct: 115 WCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTE-YVATRWYRS 169

Query: 294 PE-AMHCQISTKTDVFSYGVILLELLTG 320
           PE  +        D++S G IL EL  G
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 35/98 (35%), Positives = 55/98 (56%), Gaps = 13/98 (13%)

Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  +     +L V EA+ YL + +   +HRD+ + NVL+ E+ V K+ DFG+ K  E S+
Sbjct: 99  LGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASS 154

Query: 512 VKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
            +       TG  P  +  PEA+   + STK+DV+S+G
Sbjct: 155 TQD------TGKLPVKWTAPEALREKKFSTKSDVWSFG 186

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 54.9 bits (133), Expect = 4e-08
 Identities = 26/64 (40%), Positives = 35/64 (54%), Gaps = 5/64 (7%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
            L YLHS    I+HRD+K  N+L+  + V KL DFG+ +   + N K   T  +  TR Y
Sbjct: 114 GLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVV-TRWY 168

Query: 527 MPPE 530
             PE
Sbjct: 169 RAPE 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 40/117 (34%), Positives = 57/117 (48%), Gaps = 20/117 (17%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL   +  +I  G  + L YLHS +   IHRD+K+ N+LL E    KL DFG    S  +
Sbjct: 117 PLQEVEIAAITHGALQGLAYLHSHNM--IHRDIKAGNILLTEPGQVKLADFGSASKSSPA 174

Query: 511 NVKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGAQIKTQHITNVDIADRE 563
           N       +  GT  +M PE +      Q   K DV+S G       IT +++A+R+
Sbjct: 175 N-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-------ITCIELAERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 11/122 (9%)

Query: 427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 486
            ++ +  +T   +L K  +      L  +  Y +  G+A    + HS    I+HRD+K  
Sbjct: 74  YLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA----FCHSHG--ILHRDLKPE 127

Query: 487 NVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFS 544
           N+L++   V KL DFG+ +   +      YT  +  TR Y  PE +      ST  D++S
Sbjct: 128 NLLINTEGVLKLADFGLARSFGSPV--RPYTHYVV-TRWYRAPELLLGDKGYSTPVDIWS 184

Query: 545 YG 546
            G
Sbjct: 185 VG 186

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 36/215 (16%)

Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           KLGEG + TVY G  + NG  +A+K +          S  TE   +P      E   L  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVI----------SMKTEEG-VPFTAIR-EASLLKG 59

Query: 175 CKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIAL 227
            KH N++    L ++I++       V+EYM     +  LA+     P  L          
Sbjct: 60  LKHANIV----LLHDIIHTKETLTFVFEYM-----HTDLAQYMIQHPGGLHPYNVRLFMF 110

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
            +   L Y+H   + I+HRD+K  N+L+      KL DFG+ + +++   +T  +E +  
Sbjct: 111 QLLRGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV-- 165

Query: 288 TRPYMPPEAM--HCQISTKTDVFSYGVILLELLTG 320
           T  Y PP+ +      S+  D++  G I +E+L G
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 54.7 bits (132), Expect = 5e-08
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 30/214 (14%)

Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLENN-ANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           +G G FG V+     ++G  +A+K + N   N  S      E  M            L  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKM------------LCF 55

Query: 175 CKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTP-PLDSNK----RYSIALG 228
            KH N+L  L  L    ++     Y+    +   L ++  +P PL S+      Y I  G
Sbjct: 56  FKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG 115

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
               L YLHS    I+HRD+K  N+L++ N V K+ DFG+ ++ E    K M  E +  T
Sbjct: 116 ----LKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--T 167

Query: 289 RPYMPPEA-MHCQ-ISTKTDVFSYGVILLELLTG 320
           + Y  PE  M  +  ++  D++S G I  ELL  
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 52/234 (22%)

Query: 116 KLGEGQFGTVYYGKLKNGM---EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           ++G G FG V  G++ +G    ++ VK L  +A+                + F  E Q  
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQ------------MKFLEEAQPY 49

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSL--YDRLARV--NNTPPLDSNKR--YSI 225
              +H NLL+ LG C  +    +V E+   G L  Y R  R     TP   + +R    I
Sbjct: 50  RSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI 109

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN- 284
           ALG+      LH      IH D+   N LL  +   K+GD+G+      S+ K  Y E+ 
Sbjct: 110 ALGL------LHLHKNNFIHSDLALRNCLLTADLTVKIGDYGL------SHNK--YKEDY 155

Query: 285 -LTGTRPYMP-----PE---AMHCQI-----STKTDVFSYGVILLELLT-GMKP 323
            +T  + ++P     PE    +H  +     + +++V+S GV + EL   G +P
Sbjct: 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 6e-08
 Identities = 48/158 (30%), Positives = 67/158 (42%), Gaps = 34/158 (21%)

Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V EYM  G L + L R +  P  +   R+ IA  V  AL  +H L    IHRD+K  N+
Sbjct: 78  LVMEYMPGGDLMNLLIRKDVFP--EETARFYIAELVL-ALDSVHKLG--FIHRDIKPDNI 132

Query: 254 LLDENFVPKLGDFGI-------------------------VKMSETSNMKTMYTENLT-G 287
           L+D +   KL DFG+                         V +    + +     N T G
Sbjct: 133 LIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVG 192

Query: 288 TRPYMPPEAMHCQIS--TKTDVFSYGVILLELLTGMKP 323
           T  Y+ PE +        + D +S GVIL E+L G  P
Sbjct: 193 TPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 37/139 (26%), Positives = 59/139 (42%), Gaps = 10/139 (7%)

Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           C+V   M  G L   +  V   P     +    A  +   L +LH     I++RD+K  N
Sbjct: 69  CLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPEN 125

Query: 253 VLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSY 310
           VLLD++   ++ D G+ V++     +K        GT  YM PE +  ++     D F+ 
Sbjct: 126 VLLDDHGNVRISDLGLAVELKGGKKIKGR-----AGTPGYMAPEVLQGEVYDFSVDWFAL 180

Query: 311 GVILLELLTGMKPIDDNNT 329
           G  L E++ G  P      
Sbjct: 181 GCTLYEMIAGRSPFRQRKE 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 46/136 (33%), Positives = 68/136 (50%), Gaps = 15/136 (11%)

Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V EYM  G L + ++  N   P    + Y+    V  AL  +HS+    IHRDVK  N+
Sbjct: 120 MVMEYMPGGDLVNLMS--NYDVPEKWARFYTAE--VVLALDAIHSMG--FIHRDVKPDNM 173

Query: 254 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 307
           LLD++   KL DFG  +KM++   ++    +   GT  Y+ PE +  Q        + D 
Sbjct: 174 LLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 308 FSYGVILLELLTGMKP 323
           +S GV L E+L G  P
Sbjct: 231 WSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 53.6 bits (129), Expect = 8e-08
 Identities = 29/97 (29%), Positives = 57/97 (58%), Gaps = 4/97 (4%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
            LD +    IA+ +A  + YL S     +HRD+ + N L+ E    K+ DFG+ +   ++
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177

Query: 511 NVKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYG 546
           +   + +++L   R +MPPEA ++ + +T++D++S+G
Sbjct: 178 DYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFG 213

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 53.6 bits (129), Expect = 8e-08
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 38/221 (17%)

Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKT--LENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           K+GEG +G VY G+ K  G  +A+K   LE+            E   +P      E+  L
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLES------------EEEGVPSTAIR-EISLL 53

Query: 173 SQCKHVNLLRLLGLCNNIMN----CIVYEYMCNGSLYDRLARVNNTPP---LDSNKRYSI 225
            + +H N++ L  +   +M      +++E++      D    +++ P    +D+    S 
Sbjct: 54  KELQHPNIVCLQDV---LMQESRLYLIFEFLS----MDLKKYLDSLPKGQYMDAELVKSY 106

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
              + + + + HS  + ++HRD+K  N+L+D   V KL DFG+ +         +YT  +
Sbjct: 107 LYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEV 162

Query: 286 TGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 324
             T  Y  PE +    + ST  D++S G I  E+ T  KP+
Sbjct: 163 V-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 29/81 (35%), Positives = 41/81 (50%), Gaps = 8/81 (9%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSET 509
           P D+ + Y   L   +A+ Y HS    IIHRD+K  N+L+ E+ V KL DFG  + +   
Sbjct: 98  PPDAVRSYIWQL--LQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153

Query: 510 SNVKTMYTENLTGTRPYMPPE 530
                  T+ +  TR Y  PE
Sbjct: 154 PASP--LTDYVA-TRWYRAPE 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 12/91 (13%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMY-----TENL 520
           E ++YLH     I+HRD+K+AN+L+D   + K+ DFG+ +  +             T   
Sbjct: 126 EGINYLHE--NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183

Query: 521 TG---TRPYMPPEAM--HCQISTKTDVFSYG 546
           T    TR Y PPE +    + +T  D++  G
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIG 214

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 7/91 (7%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           IA+ V E L YL+++ + I+HRD+K +N+L++     KL DFG+     +  +     + 
Sbjct: 108 IAVAVVEGLTYLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGV-----SGELINSIADT 161

Query: 520 LTGTRPYMPPEAMHC-QISTKTDVFSYGAQI 549
             GT  YM PE +   + + K+DV+S G  I
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISI 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 41/115 (35%), Positives = 57/115 (49%), Gaps = 14/115 (12%)

Query: 437 QCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP 496
           +C LF    V+ + PL   +  +I   + EAL YLH   + IIHRDVK+ N+ LDE    
Sbjct: 169 KCDLFTY--VDRSGPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENA 224

Query: 497 KLGDFGIV-KMSETSNVKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYG 546
            LGDFG   K+    +    Y    +GT     PE +    +C    KTD++S G
Sbjct: 225 VLGDFGAACKLDAHPDTPQCY--GWSGTLETNSPELLALDPYC---AKTDIWSAG 274

Length = 392

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 53/228 (23%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKT--LENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           K+GEG +G VY  +    G  +A+K   LE       +  +   +  I       E+  L
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLE-------TEDEGVPSTAI------REISLL 52

Query: 173 SQCKHVNLLRLLGLCNNIMNC-----IVYEY--MCNGSLYDRLARVNNTPPLDSNKRYSI 225
            +  H N++RLL    ++++      +V+E+  +      D        PPL  +  Y +
Sbjct: 53  KELNHPNIVRLL----DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQL 108

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------SETSNMKT 279
             G+A    Y HS    ++HRD+K  N+L+D     KL DFG+ +       + T  + T
Sbjct: 109 LQGIA----YCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVT 162

Query: 280 MY---TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
           ++    E L G+R Y          ST  D++S G I  E++   +P+
Sbjct: 163 LWYRAPEILLGSRQY----------STPVDIWSIGCIFAEMVNR-RPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 36/108 (33%), Positives = 58/108 (53%), Gaps = 17/108 (15%)

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG----IVKMSETSNMKT 279
           S +  VA  + +L S  +  IHRD+ + N+LL EN V K+ DFG    I K  +      
Sbjct: 177 SYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------ 228

Query: 280 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
            Y        P  +M PE++  ++ +T++DV+S+GV+L E+ + G  P
Sbjct: 229 -YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 26/216 (12%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G G FG V   KLKN  ++ A+K L        +  +  + A       E +V      
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKIL--------NKWEMLKRAETACFREERDVLVNGDN 60

Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA-EALH 234
           + +  L       N +  +V +Y   G L   L++  +  P D  + Y   + +A +++H
Sbjct: 61  QWITTLHYAFQDENNLY-LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMP 293
            LH      +HRD+K  N+L+D N   +L DFG  +K+ E     T+ +    GT  Y+ 
Sbjct: 120 QLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---TVQSSVAVGTPDYIS 171

Query: 294 PEAMHCQISTK------TDVFSYGVILLELLTGMKP 323
           PE +      K       D +S GV + E+L G  P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 28/86 (32%), Positives = 47/86 (54%), Gaps = 9/86 (10%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           V E + YL S  K  IHRD+ + N L+D+    K+ DFG+ +      +   YT ++   
Sbjct: 109 VCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV----LDDEYTSSVGSK 162

Query: 524 RP--YMPPEAMH-CQISTKTDVFSYG 546
            P  + PPE +   + S+K+DV+++G
Sbjct: 163 FPVRWSPPEVLLYSKFSSKSDVWAFG 188

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 8/102 (7%)

Query: 448 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 507
           N  PL   ++  IA  VA  + YL    +  +HRD+ + N L+ EN V K+ DFG   +S
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIADFG---LS 177

Query: 508 ETSNVKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                   Y  +     P  +MPPE++ + + +T++DV++YG
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYG 219

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 31/82 (37%), Positives = 46/82 (56%), Gaps = 3/82 (3%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           + + + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T  +     +++TGT
Sbjct: 115 ILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172

Query: 524 RPYMPPEAMHCQ-ISTKTDVFS 544
             +M PE +  +    K DV+S
Sbjct: 173 PYWMSPEVISGEGYGRKADVWS 194

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 35/91 (38%), Positives = 48/91 (52%), Gaps = 15/91 (16%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNVKTMYTE 518
           I+LG    L ++H   + I+HRD+KS N+ L +N  V KLGDFGI +     N       
Sbjct: 110 ISLG----LKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR---QLNDSMELAY 160

Query: 519 NLTGTRPYMPPEAMHCQ---ISTKTDVFSYG 546
              GT  Y+ PE   CQ    + KTD++S G
Sbjct: 161 TCVGTPYYLSPEI--CQNRPYNNKTDIWSLG 189

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 31/84 (36%), Positives = 48/84 (57%), Gaps = 6/84 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL ++HS  + ++HRD+K ANV +    V KLGD G+ +   +   KT    +L GT
Sbjct: 115 LCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGT 169

Query: 524 RPYMPPEAMHCQ-ISTKTDVFSYG 546
             YM PE +H    + K+D++S G
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLG 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 48/230 (20%)

Query: 116 KLGEGQFGTV---YYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           +LG+G +G V      +      +A+K + N                    +F  ++   
Sbjct: 7   ELGQGAYGIVCSARNAETSEEETVAIKKITN--------------------VFSKKILAK 46

Query: 173 SQCKHVNLLRLLGLCNNIMNC----IVYEYMCNGS-LYDRLARVNNTPPLDSNKR----- 222
              + + LLR      NI       IV+    N   LY+ L   +    + S +      
Sbjct: 47  RALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAH 106

Query: 223 -----YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSN 276
                Y I  G    L Y+HS +  ++HRD+K  N+L++ +   K+ DFG+ +  SE   
Sbjct: 107 FQSFIYQILCG----LKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160

Query: 277 MKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 324
               +      TR Y  PE M      +   DV+S G IL ELL G KP+
Sbjct: 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 35/172 (20%)

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---TR 289
           L Y+HS    IIHRD+K +NV ++E+   ++ DFG+ + ++         + +TG   TR
Sbjct: 131 LKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQAD---------DEMTGYVATR 179

Query: 290 PYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVREV 346
            Y  PE M      +   D++S G I+ ELL G      N+ I     ++E    P  EV
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239

Query: 347 LDKEAGEWNETHVETL-------IGIVF-----------EKCCVFEKDKRAS 380
           L K + E    ++++L       +  +F           EK  V + DKR S
Sbjct: 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS 291

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 6/96 (6%)

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y+H+ +  + HRD+K  N+L + +   K+ DFG+ +++       ++  +   TR Y
Sbjct: 115 ALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 292 MPPEAMHCQISTKT---DVFSYGVILLELLTGMKPI 324
             PE      S  T   D++S G I  E+LTG KP+
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 33/95 (34%), Positives = 55/95 (57%), Gaps = 18/95 (18%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           IA+ +A  + YL S     +HRD+ + N L+  + V K+GDFG   MS     + +YT +
Sbjct: 127 IAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFG---MS-----RDVYTTD 176

Query: 520 ---LTGTR--P--YMPPEA-MHCQISTKTDVFSYG 546
              + G    P  +MPPE+ M+ + +T++DV+S+G
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 211

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 30/104 (28%), Positives = 52/104 (50%), Gaps = 8/104 (7%)

Query: 446 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 505
                P    K   +A  +A+ + YL +  K  +HRD+ + N ++ E+   K+GDFG   
Sbjct: 110 NPGLGPPTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLTVKIGDFG--- 164

Query: 506 MSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           M+        Y +   G  P  +M PE++   + +TK+DV+S+G
Sbjct: 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFG 208

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 32/84 (38%), Positives = 45/84 (53%), Gaps = 6/84 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A AL YLH   K I+HRD+K+ NV L    + K+GD GI ++ E           L GT
Sbjct: 111 IAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC---DMASTLIGT 165

Query: 524 RPYMPPEAMHCQ-ISTKTDVFSYG 546
             YM PE    +  + K+DV++ G
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALG 189

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 35/88 (39%), Positives = 46/88 (52%), Gaps = 8/88 (9%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           IA+ V + L YL SL   I+HRDVK +N+L++     KL DFG+      S  KT     
Sbjct: 100 IAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY---- 153

Query: 520 LTGTRPYMPPEAMHC-QISTKTDVFSYG 546
             GT  YM PE +   Q    +DV+S G
Sbjct: 154 -VGTNAYMAPERISGEQYGIHSDVWSLG 180

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 41/140 (29%), Positives = 66/140 (47%), Gaps = 20/140 (14%)

Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE---ALHYLHSLSKPIIHRDVKS 250
           +V +Y   G L   L++  +  P D  + Y     +AE   A+  +H L    +HRD+K 
Sbjct: 78  LVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVLAIDSVHQLG--YVHRDIKP 130

Query: 251 ANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------QIST 303
            NVLLD+N   +L DFG  +++       T+ +    GT  Y+ PE +        +   
Sbjct: 131 DNVLLDKNGHIRLADFGSCLRLLADG---TVQSNVAVGTPDYISPEILQAMEDGKGRYGP 187

Query: 304 KTDVFSYGVILLELLTGMKP 323
           + D +S GV + E+L G  P
Sbjct: 188 ECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 37/136 (27%), Positives = 61/136 (44%), Gaps = 10/136 (7%)

Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           C+V   M  G L   +  V     L+  +    +  +   + +LHS+   I++RD+K  N
Sbjct: 69  CLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPEN 125

Query: 253 VLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSY 310
           VLLD+    +L D G+ V++ +             GT  YM PE +  +  S   D F+ 
Sbjct: 126 VLLDDQGNCRLSDLGLAVELKDGKT-----ITQRAGTNGYMAPEILKEEPYSYPVDWFAM 180

Query: 311 GVILLELLTGMKPIDD 326
           G  + E++ G  P  D
Sbjct: 181 GCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 60/232 (25%)

Query: 116 KLGEGQFGTVYYGKLKNGME-IAVKT--LENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           K+GEG +G VY  + +   E IA+K   LE             E   +P      E+  L
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQ------------EDEGVPSTAIR-EISLL 55

Query: 173 SQCKHVNLLRLLGLCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKR----- 222
            + +H N++RL     ++++      +V+EY+      D    ++++P    N R     
Sbjct: 56  KEMQHGNIVRL----QDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTY 107

Query: 223 -YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKM------SET 274
            Y I  G+A    Y HS    ++HRD+K  N+L+D      KL DFG+ +       + T
Sbjct: 108 LYQILRGIA----YCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161

Query: 275 SNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 324
             + T++         Y  PE +      ST  D++S G I  E++   KP+
Sbjct: 162 HEVVTLW---------YRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203

Length = 294

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 11/92 (11%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
            +   V EA+ YL S     IHRD+ + N L+ E+ V K+ DFG+ +      +   YT 
Sbjct: 104 DMCSDVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLARYV----LDDQYTS 157

Query: 519 NLTGTR---PYMPPEA-MHCQISTKTDVFSYG 546
           +  GT+    + PPE   + + S+K+DV+S+G
Sbjct: 158 S-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFG 188

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 27/90 (30%), Positives = 52/90 (57%), Gaps = 9/90 (10%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A+ + Y+  ++   IHRD+++AN+L+ +N V K+ DFG+ ++ E +     YT  
Sbjct: 107 MAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE----YTAR 160

Query: 520 LTGTRPY---MPPEAMHCQISTKTDVFSYG 546
                P     P  A++ + + K+DV+S+G
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 28/97 (28%), Positives = 56/97 (57%), Gaps = 4/97 (4%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
            L   +  +IA  +A  + YL SL    +HRD+ + N L+ +  V K+GDFG+ +   ++
Sbjct: 118 QLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 175

Query: 511 NVKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYG 546
           +   +    +   R +MPPE+ ++ + +T++D++S+G
Sbjct: 176 DYYRVGGRTMLPIR-WMPPESILYRKFTTESDIWSFG 211

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 11/84 (13%)

Query: 468 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTGTRPY 526
           L YLH   K  IHRD+K AN+LL E+   KL DFG+  +++ T   +     +  GT  +
Sbjct: 114 LAYLHETGK--IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK----SFIGTPYW 167

Query: 527 MPPEA----MHCQISTKTDVFSYG 546
           M PE            K D+++ G
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALG 191

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 30/81 (37%), Positives = 47/81 (58%), Gaps = 6/81 (7%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           A+ ++HS  + ++HRD+K ANV +    V KLGD G+ +   +   KT    +L GT  Y
Sbjct: 118 AVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGTPYY 172

Query: 527 MPPEAMHCQ-ISTKTDVFSYG 546
           M PE +H    + K+D++S G
Sbjct: 173 MSPERIHENGYNFKSDIWSLG 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 34/107 (31%), Positives = 59/107 (55%), Gaps = 10/107 (9%)

Query: 217 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETS 275
           LD+    S +  VA+ + +L   SK  IHRD+ + N+LL    + K+ DFG+ + +   S
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268

Query: 276 NMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELLT 319
           N    Y        P  +M PE++ +C  + ++DV+SYG++L E+ +
Sbjct: 269 N----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 15/93 (16%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +AE + YL S  +  IHRD+ + N+L+ EN V K+ DFG+ ++ E       YT  
Sbjct: 108 MAAQIAEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE----YTAR 161

Query: 520 LTGTRPYMP-----PEAMHC-QISTKTDVFSYG 546
             G +   P     PEA +  + + K+DV+S+G
Sbjct: 162 -EGAK--FPIKWTAPEAANYGRFTIKSDVWSFG 191

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 51.4 bits (124), Expect = 5e-07
 Identities = 31/84 (36%), Positives = 45/84 (53%), Gaps = 13/84 (15%)

Query: 453 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------ 506
           D +KRY I   + +AL Y+HS    +IHRD+K +N+LL+ +   KL DFG+ +       
Sbjct: 106 DVHKRY-IMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162

Query: 507 SETSNVKTMYTENLTGTRPYMPPE 530
           +  + V T Y      TR Y  PE
Sbjct: 163 NPENPVLTDYVA----TRWYRAPE 182

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.0 bits (124), Expect = 5e-07
 Identities = 79/295 (26%), Positives = 116/295 (39%), Gaps = 60/295 (20%)

Query: 44  KSKHKSASNLVNQHNQKIKFKLPDKKWLQEVIQQEEANNKTEYIGELIAFTFCDLERATD 103
           +  HK+            KF++ DKK  +E  ++   NN  E   E         E+  D
Sbjct: 15  EKNHKANKGGSG------KFEMNDKKLDEE--ERSHNNNAGEDEDE---------EKMID 57

Query: 104 G-FNRKPYP--RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAM 159
              NR P    + GN +G G FG VY    +    ++A+K +  +  Y +          
Sbjct: 58  NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN---------- 107

Query: 160 IPILLFENEVQTLSQCKHVNLLRLLGLC---------NNIMNCIVYEYMCNG--SLYDRL 208
                   E+  +    H+N++ L              NI   +V E++           
Sbjct: 108 -------RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHY 160

Query: 209 ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFG 267
           AR N+  PL   K YS  L    AL Y+HS  K I HRD+K  N+L+D N    KL DFG
Sbjct: 161 ARNNHALPLFLVKLYSYQL--CRALAYIHS--KFICHRDLKPQNLLIDPNTHTLKLCDFG 216

Query: 268 IVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTG 320
             K          Y      +R Y  PE M      +T  D++S G I+ E++ G
Sbjct: 217 SAKNLLAGQRSVSY----ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 51.1 bits (122), Expect = 6e-07
 Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 7/86 (8%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           + E + YLHS  +  IHRD+ + NVLLD + + K+GDFG+ K     +      E+  G 
Sbjct: 116 ICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED--GD 171

Query: 524 RP---YMPPEAMHCQISTKTDVFSYG 546
            P   Y        + S  +DV+S+G
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFG 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 32/105 (30%), Positives = 59/105 (56%), Gaps = 4/105 (3%)

Query: 443 LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 502
           +A  N    L  ++   IA  +A  + YL   S+  +HRD+ + N L+ EN + K+GDFG
Sbjct: 108 MAEGNRPAELTQSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFG 165

Query: 503 IVKMSETSNVKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYG 546
           + +   +++   +    +   R +MPPE+ M+ + +T++DV+S G
Sbjct: 166 MSRDVYSTDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSLG 209

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 51.3 bits (123), Expect = 7e-07
 Identities = 29/73 (39%), Positives = 39/73 (53%), Gaps = 6/73 (8%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTG 522
           V  AL  +HS+    IHRDVK  N+LLD++   KL DFG  +KM     V+    +   G
Sbjct: 151 VVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR---CDTAVG 205

Query: 523 TRPYMPPEAMHCQ 535
           T  Y+ PE +  Q
Sbjct: 206 TPDYISPEVLKSQ 218

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 12/100 (12%)

Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSET 509
           L      S +  VA+ + +L S  K  IHRD+ + NVLL    + K+ DFG+ +  M++ 
Sbjct: 138 LTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND- 194

Query: 510 SNVKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
           SN    Y        P  +M PE++ +C  + ++DV+SYG
Sbjct: 195 SN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 230

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 50.8 bits (121), Expect = 8e-07
 Identities = 33/91 (36%), Positives = 53/91 (58%), Gaps = 8/91 (8%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
           S A  VA  + YL   S+  IHRD+ + NVL+ E+ V K+ DFG+ +  +  N+   Y +
Sbjct: 138 SCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR--DVHNID-YYKK 192

Query: 519 NLTGTRP--YMPPEAMHCQIST-KTDVFSYG 546
              G  P  +M PEA+  ++ T ++DV+S+G
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 8/99 (8%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSE 508
           PLD +     +  VA+ + +L S  K  IHRDV + NVLL +  V K+ DFG+ +  M++
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Query: 509 TSNVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYG 546
           ++ V      N      +M PE++  C  + ++DV+SYG
Sbjct: 266 SNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 301

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 50/171 (29%), Positives = 77/171 (45%), Gaps = 29/171 (16%)

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           +   L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      T
Sbjct: 129 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VAT 180

Query: 289 RPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE 345
           R Y  PE M      +   D++S G I+ ELLTG       + I    L++     P  E
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240

Query: 346 VLDKEAGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           +L K + E    ++++L            IG       + EK  V + DKR
Sbjct: 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 291

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 28/88 (31%), Positives = 53/88 (60%), Gaps = 4/88 (4%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           IA  +A  + YL   S+  +HRD+ + N L+  N + K+GDFG+ +   +++   +    
Sbjct: 128 IASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 520 LTGTRPYMPPEA-MHCQISTKTDVFSYG 546
           +   R +MPPE+ M+ + +T++DV+S+G
Sbjct: 186 MLPIR-WMPPESIMYRKFTTESDVWSFG 212

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 50.5 bits (121), Expect = 9e-07
 Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 7/88 (7%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           I++ V   L YL    K I+HRDVK +N+L++     KL DFG+      S   +     
Sbjct: 104 ISIAVLRGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----- 157

Query: 520 LTGTRPYMPPEAMH-CQISTKTDVFSYG 546
             GTR YM PE +     + ++D++S G
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLG 185

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 32/226 (14%)

Query: 116 KLGEGQFGTVYYGK-LKNGME-IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           ++GEG +G V+  + LKNG   +A+K +             T    +P+     EV  L 
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ----------TGEEGMPLSTIR-EVAVLR 56

Query: 174 QCK---HVNLLRLLGLCN------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
             +   H N++RL  +C            +V+E++ +  L   L +V   P + +     
Sbjct: 57  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-PGVPTETIKD 114

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
           +   +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ ++        M   +
Sbjct: 115 MMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----MALTS 168

Query: 285 LTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 329
           +  T  Y  PE  +    +T  D++S G I  E+    KP+   ++
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSS 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 50.1 bits (119), Expect = 1e-06
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 11/98 (11%)

Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 166

Query: 512 VKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
            KTM      G  P  +M  E+++  + +T +DV+SYG
Sbjct: 167 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYG 198

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 7/82 (8%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           AL Y+H     +IHRD+K+AN+L+      KL DFG+  +   ++ K        GT  +
Sbjct: 113 ALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK---RSTFVGTPYW 167

Query: 527 MPPEAMH--CQISTKTDVFSYG 546
           M PE +       TK D++S G
Sbjct: 168 MAPEVITEGKYYDTKADIWSLG 189

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 36/109 (33%), Positives = 60/109 (55%), Gaps = 9/109 (8%)

Query: 441 FKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 500
           + +ARV +   +      S    VA  + YL   S+  IHRD+ + NVL+ EN V K+ D
Sbjct: 124 YDIARVPDEQ-MTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIAD 180

Query: 501 FGIVKMSETSNVKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYG 546
           FG+ +  + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+G
Sbjct: 181 FGLAR--DVNNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 35/88 (39%), Positives = 47/88 (53%), Gaps = 6/88 (6%)

Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  +A AL YLHSL+  I++RD+K  N+LLD      L DFG+ K +   N     T   
Sbjct: 102 AAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT---TSTF 156

Query: 521 TGTRPYMPPEAMHCQISTKT-DVFSYGA 547
            GT  Y+ PE +H Q   +T D +  GA
Sbjct: 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGA 184

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 44/164 (26%), Positives = 63/164 (38%), Gaps = 28/164 (17%)

Query: 168 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVY-EYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
           E   L    H ++++L G    N   C++   Y  +  LY  LA   N    D     +I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICDI---LAI 187

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY---- 281
              V  A+ YLH     IIHRD+K+ N+ ++      LGDFG        N    Y    
Sbjct: 188 ERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245

Query: 282 -----TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTG 320
                   L    PY P            D++S G++L E+ T 
Sbjct: 246 TIATNAPELLARDPYGP----------AVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 27/90 (30%), Positives = 51/90 (56%), Gaps = 9/90 (10%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 107 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTAR 160

Query: 520 LTGTRPY---MPPEAMHCQISTKTDVFSYG 546
                P     P  A++ + + K+DV+S+G
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 10/90 (11%)

Query: 462 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT-ENL 520
           L VA+ + YL   SK  +HRD+ + N +LDE+F  K+ DFG   ++     K  Y+  N 
Sbjct: 105 LQVAKGMEYL--ASKKFVHRDLAARNCMLDESFTVKVADFG---LARDIYDKEYYSVHNH 159

Query: 521 TGTR---PYMPPEAMHCQ-ISTKTDVFSYG 546
           TG +    +M  E++  Q  +TK+DV+S+G
Sbjct: 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFG 189

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 26/68 (38%), Positives = 35/68 (51%), Gaps = 7/68 (10%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           +   L +LH   + II+RD+K  NVLLD E  + K+ DFG+ K      V    T    G
Sbjct: 105 IVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHI-KIADFGMCKEGILGGVT---TSTFCG 158

Query: 523 TRPYMPPE 530
           T  Y+ PE
Sbjct: 159 TPDYIAPE 166

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 34/84 (40%), Positives = 53/84 (63%), Gaps = 12/84 (14%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           ALH++H+  K I+HRD+K+ N+LLD++  V K+GDFGI K    S+    YT  + GT  
Sbjct: 113 ALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYT--VVGTPC 166

Query: 526 YMPPEAMHCQ---ISTKTDVFSYG 546
           Y+ PE   C+    + K+D+++ G
Sbjct: 167 YISPEL--CEGKPYNQKSDIWALG 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 33/80 (41%), Positives = 43/80 (53%), Gaps = 5/80 (6%)

Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  +A AL YLHSL+  II+RD+K  N+LLD      L DFG+ K     + KT  T   
Sbjct: 102 AAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT--TSTF 156

Query: 521 TGTRPYMPPEAMHCQISTKT 540
            GT  Y+ PE +  Q   +T
Sbjct: 157 CGTPEYLAPEVLRKQPYDRT 176

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 32/82 (39%), Positives = 38/82 (46%), Gaps = 6/82 (7%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           AL +LH     II+RD+K  N+LLD     KL DFG+ K S         T    GT  Y
Sbjct: 112 ALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV---THTFCGTIEY 166

Query: 527 MPPE-AMHCQISTKTDVFSYGA 547
           M PE  M        D +S GA
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGA 188

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 36/134 (26%), Positives = 60/134 (44%), Gaps = 9/134 (6%)

Query: 193 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 251
           C+V   M  G L   +  V+   P     +       +   L +LH   + II+RD+K  
Sbjct: 69  CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPE 126

Query: 252 NVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFS 309
           NVLLD +   ++ D G+ V++ +  +     T+   GT  +M PE +   +     D F+
Sbjct: 127 NVLLDNDGNVRISDLGLAVELKDGQSK----TKGYAGTPGFMAPELLQGEEYDFSVDYFA 182

Query: 310 YGVILLELLTGMKP 323
            GV L E++    P
Sbjct: 183 LGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 32/214 (14%)

Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           KLGEG + TVY G+ K  G  +A+K +              E A    +    E   L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHE---------EGAPFTAI---REASLLKD 59

Query: 175 CKHVNLLRLLGLCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            KH N++ L    ++I++      +V+EY+ +  L   +        + + + +   L  
Sbjct: 60  LKHANIVTL----HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQL-- 112

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
              L Y H   + ++HRD+K  N+L+ E    KL DFG+ + +++   KT   E +  T 
Sbjct: 113 LRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV--TL 167

Query: 290 PYMPPEAM--HCQISTKTDVFSYGVILLELLTGM 321
            Y PP+ +    + ST  D++  G I  E+ TG 
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 25/241 (10%)

Query: 117 LGEGQFGTVYYGKLKNGME--IAVKTLE-NNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           LG G FG VY  + KN  +  +A+K +  +N  +     +  ++         + V  ++
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKS-------IGDIVSEVT 60

Query: 174 ----QCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR-YSIAL 227
               Q +H N++R       N    IV + +    L +    +       + +R ++I +
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMYTENLT 286
            +  AL YLH   K I+HRD+   N++L E+    + DFG+ K     S + ++      
Sbjct: 121 QMVLALRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV-----V 174

Query: 287 GTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-PVR 344
           GT  Y  PE +  +    K DV+++G IL ++ T   P    N +     +VE    P+ 
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP 234

Query: 345 E 345
           E
Sbjct: 235 E 235

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 29/90 (32%), Positives = 52/90 (57%), Gaps = 9/90 (10%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  VA  + Y+  ++   IHRD++SAN+L+ +  V K+ DFG+ ++ E +     YT  
Sbjct: 107 MAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE----YTAR 160

Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 28/96 (29%), Positives = 54/96 (56%), Gaps = 4/96 (4%)

Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           LD      IA+ +A  + YL S     +H+D+ + N+L+ E    K+ D G+ +   +++
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178

Query: 512 VKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYG 546
              +  ++L   R +MPPEA M+ + S+ +D++S+G
Sbjct: 179 YYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFG 213

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 34/91 (37%), Positives = 53/91 (58%), Gaps = 8/91 (8%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
           S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ +  +  ++   Y +
Sbjct: 144 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHID-YYKK 198

Query: 519 NLTGTRP--YMPPEAMHCQIST-KTDVFSYG 546
              G  P  +M PEA+  +I T ++DV+S+G
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 14/93 (15%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
           ++ L V +AL +LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    +
Sbjct: 119 TVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVS-KEVPRRK 173

Query: 519 NLTGTRPYMPPEAMHCQIS-----TKTDVFSYG 546
           +L GT  +M PE     IS     T+ D++S G
Sbjct: 174 SLVGTPYWMAPEV----ISRLPYGTEVDIWSLG 202

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 7/88 (7%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +
Sbjct: 108 VSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANS 161

Query: 520 LTGTRPYMPPEAMH-CQISTKTDVFSYG 546
             GTR YM PE +     S ++D++S G
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMG 189

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 71/290 (24%), Positives = 117/290 (40%), Gaps = 55/290 (18%)

Query: 117 LGEGQFGTVY-YGKLKNGMEIAVKTL----------ENNANYSSSNSDNTEAAMIPILLF 165
           +G+G +G V+     KNG + AVK L          E   N   + SD+        + +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85

Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 224
           + +V+   Q     L  +L LCN             GS+ D +        L   +R   
Sbjct: 86  KKDVKNGDQ-----LWLVLELCNG------------GSVTDLVKGF-----LKRGERMEE 123

Query: 225 --IALGVAEALHYLHSL-SKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 281
             IA  + EAL  L  L     IHRDVK  N+LL      KL DFG+     ++ ++   
Sbjct: 124 PIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 183

Query: 282 TENLTGTRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL 335
           +    GT  +M PE + C+         + DV+S G+  +EL  G  P+ D + +   + 
Sbjct: 184 S---VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK 240

Query: 336 VVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
           +     P     +  + E+N+            KC   + +KR ++ D++
Sbjct: 241 IPRNPPPTLHQPELWSNEFND---------FIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 35/118 (29%), Positives = 61/118 (51%), Gaps = 10/118 (8%)

Query: 206 DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 265
            R   +N +P L        +  VA  + +L   SK  +HRD+ + NVL+ E  + K+ D
Sbjct: 225 RRDTLINESPALSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICD 282

Query: 266 FGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELLT 319
           FG+ + +   SN    Y    +   P  +M PE++ +   +T +DV+S+G++L E+ T
Sbjct: 283 FGLARDIMRDSN----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 9/99 (9%)

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           VA  + +L   S+  IHRD+ + N+LL EN V K+ DFG+ +          Y    +  
Sbjct: 183 VARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVRKGSAR 237

Query: 289 RP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
            P  +M PE++  ++ +T++DV+S+GV+L E+ + G  P
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 12/113 (10%)

Query: 237 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 296
           H  ++ +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  YM PE 
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEV 166

Query: 297 MHCQIS--TKTDVFSYGVILLELLTGMKPI-----DDNNTILYYYLVVEQEVP 342
           +   ++  +  D FS G +L +LL G  P       D + I    L +  E+P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 8/91 (8%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
           S A  VA  + YL S  +  IHRD+ + NVL+ E+ V K+ DFG+ +     +    Y +
Sbjct: 138 SCAYQVARGMEYLES--RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID---YYKK 192

Query: 519 NLTGTRP--YMPPEAMHCQIST-KTDVFSYG 546
              G  P  +M PEA+  ++ T ++DV+S+G
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 48.3 bits (116), Expect = 4e-06
 Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 18/139 (12%)

Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           ++ +Y+ +G L+D L        L   +   I   + EAL+ LH     IIH D+K  NV
Sbjct: 86  LIMDYIKDGDLFDLL---KKEGKLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENV 140

Query: 254 LLDENFVP-KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM---HCQISTKTDVFS 309
           L D       L D+G+ K+  T    + Y     GT  Y  PE +   +  +S   D ++
Sbjct: 141 LYDRAKDRIYLCDYGLCKIIGT---PSCY----DGTLDYFSPEKIKGHNYDVS--FDWWA 191

Query: 310 YGVILLELLTGMKPIDDNN 328
            GV+  ELLTG  P  ++ 
Sbjct: 192 VGVLTYELLTGKHPFKEDE 210

Length = 267

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 27/218 (12%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSS-SNSDNTEAAMIPILLFENEVQTLS 173
           ++G G +GTVY  +   +G  +A+K++    N      S   E A++         + L 
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALL---------KRLE 57

Query: 174 QCKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
              H N++RL+ +C            +V+E++ +  L   L +V   P L +     +  
Sbjct: 58  AFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVP-PPGLPAETIKDLMR 115

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
                L +LH+    I+HRD+K  N+L+      KL DFG+ ++        M    +  
Sbjct: 116 QFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ----MALTPVVV 169

Query: 288 TRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPI 324
           T  Y  PE  +    +T  D++S G I  E+    KP+
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 9/98 (9%)

Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  NK   +A  +AE + ++    K  IHRD+++AN+L+ E    K+ DFG+ ++ E + 
Sbjct: 99  LTINKLIDMAAQIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156

Query: 512 VKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
               YT       P  +  PEA+ +   + K+DV+S+G
Sbjct: 157 ----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 190

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 28/68 (41%), Positives = 37/68 (54%), Gaps = 6/68 (8%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           + E L YLH     I+HRD+K  NVL++  + V K+ DFG  K    + +    TE  TG
Sbjct: 117 ILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPC-TETFTG 171

Query: 523 TRPYMPPE 530
           T  YM PE
Sbjct: 172 TLQYMAPE 179

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 48.5 bits (116), Expect = 5e-06
 Identities = 28/67 (41%), Positives = 42/67 (62%), Gaps = 5/67 (7%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVK-TMYTENLTGT 523
             L+Y+H  +K I+HRD+K+AN+L+ ++ + KL DFG+ +  S + N K   YT N   T
Sbjct: 130 NGLYYIHR-NK-ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT-NRVVT 186

Query: 524 RPYMPPE 530
             Y PPE
Sbjct: 187 LWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 29/82 (35%), Positives = 44/82 (53%), Gaps = 5/82 (6%)

Query: 449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 508
           T PL  ++   ++    + L+YLHS  K  +HRD+K AN+LL +N   KL DFG+     
Sbjct: 100 TGPLSESQIAYVSRETLQGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQIT 157

Query: 509 TSNVKTMYTENLTGTRPYMPPE 530
            +  K    ++  GT  +M PE
Sbjct: 158 ATIAK---RKSFIGTPYWMAPE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 48.6 bits (116), Expect = 5e-06
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 22/89 (24%)

Query: 468 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE-------TSNVKTMY---T 517
           L YLHS    I+HRD+K  N+L++ N V K+ DFG+ ++ E       T  V T Y    
Sbjct: 116 LKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173

Query: 518 ENLTGTRPYMPPEAMHCQISTKTDVFSYG 546
           E L G+R Y          ++  D++S G
Sbjct: 174 EILMGSRHY----------TSAVDIWSVG 192

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 35/113 (30%), Positives = 54/113 (47%), Gaps = 12/113 (10%)

Query: 237 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 296
           H  ++ +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  YM PE 
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEV 166

Query: 297 MH--CQISTKTDVFSYGVILLELLTGMKPI-----DDNNTILYYYLVVEQEVP 342
           +       +  D FS G +L +LL G  P       D + I    L V  E+P
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 48.4 bits (115), Expect = 5e-06
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 43/222 (19%)

Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN----EVQT 171
           +G G +GTV      + G ++A+K L     Y    S+          LF      E++ 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKL-----YRPFQSE----------LFAKRAYRELRL 67

Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
           L   KH N++ LL +    ++   +   Y+    +   L ++     L  ++   +   +
Sbjct: 68  LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM 127

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG-- 287
            + L Y+H+    IIHRD+K  N+ ++E+   K+ DFG+ + +++          +TG  
Sbjct: 128 LKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE---------MTGYV 176

Query: 288 -TRPYMPPEA----MHCQISTKTDVFSYGVILLELLTGMKPI 324
            TR Y  PE     MH   +   D++S G I+ E+LTG KP+
Sbjct: 177 VTRWYRAPEVILNWMH--YTQTVDIWSVGCIMAEMLTG-KPL 215

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 47.8 bits (114), Expect = 6e-06
 Identities = 34/108 (31%), Positives = 46/108 (42%), Gaps = 11/108 (10%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDF 501
           R      L        A  VA+   YL       IHRD+ + N LL       V K+ DF
Sbjct: 106 RPERPSSLTMKDLLFCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGPGRVAKIADF 163

Query: 502 GIVKMSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           G   M+      + Y +      P  +MPPEA    I ++KTDV+S+G
Sbjct: 164 G---MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFG 208

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 38/128 (29%), Positives = 61/128 (47%), Gaps = 15/128 (11%)

Query: 424 GIPVII--LDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHR 481
           GI +I+  L +G  K+     L R  N   L    +Y++   + + + YL S  +  +HR
Sbjct: 82  GIKLIMEFLPSGSLKE----YLPRNKNKINLKQQLKYAVQ--ICKGMDYLGS--RQYVHR 133

Query: 482 DVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP---YMPPEAMHCQIST 538
           D+ + NVL++     K+GDFG+ K  ET   K  YT       P   Y P   +  +   
Sbjct: 134 DLAARNVLVESEHQVKIGDFGLTKAIETD--KEYYTVKDDLDSPVFWYAPECLIQSKFYI 191

Query: 539 KTDVFSYG 546
            +DV+S+G
Sbjct: 192 ASDVWSFG 199

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 47.9 bits (114), Expect = 6e-06
 Identities = 26/64 (40%), Positives = 33/64 (51%), Gaps = 4/64 (6%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           AL +LH L   II+RD+K  N+LLD      L DFG+ K       +  Y+    GT  Y
Sbjct: 117 ALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTIEY 172

Query: 527 MPPE 530
           M PE
Sbjct: 173 MAPE 176

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
           ++ L V  AL YLH+  + +IHRD+KS ++LL  +   KL DFG          K    +
Sbjct: 122 TVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RK 176

Query: 519 NLTGTRPYMPPEAM-HCQISTKTDVFSYGAQI 549
           +L GT  +M PE +      T+ D++S G  +
Sbjct: 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.1 bits (114), Expect = 7e-06
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 9/99 (9%)

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           VA+ + +L   S+  IHRD+ + N+LL EN V K+ DFG+ +          Y       
Sbjct: 188 VAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVRKGDAR 242

Query: 289 RP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
            P  +M PE +  ++ + ++DV+S+GV+L E+ + G  P
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 47.3 bits (113), Expect = 8e-06
 Identities = 33/91 (36%), Positives = 46/91 (50%), Gaps = 11/91 (12%)

Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           A  VA  + YL S  K  +HRD+ + NVLL + +   K+ DFG   MS      + Y   
Sbjct: 101 AHQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQA-KISDFG---MSRALGAGSDYYRA 154

Query: 520 LTGTR-P---YMPPEAMHCQISTKTDVFSYG 546
            T  R P   Y P    + + S+K+DV+SYG
Sbjct: 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.1 bits (114), Expect = 8e-06
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + T+ M T Y      TR Y
Sbjct: 135 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV----TRYY 188

Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
             PE  +        D++S G I+ EL+ G       + I  +  V+EQ
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 47.6 bits (113), Expect = 9e-06
 Identities = 32/86 (37%), Positives = 42/86 (48%), Gaps = 10/86 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNVKTMYTENLT 521
             +AL +LHS    +IHRD+KS N+LL  +   KL DFG       E S   TM      
Sbjct: 124 CLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-----V 176

Query: 522 GTRPYMPPEAM-HCQISTKTDVFSYG 546
           GT  +M PE +       K D++S G
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLG 202

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 47.7 bits (113), Expect = 9e-06
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +++ V   L YL    + I+HRDVK +N+L++     KL DFG+     +  +      +
Sbjct: 108 VSIAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANS 161

Query: 520 LTGTRPYMPPEAMH-CQISTKTDVFSYG 546
             GTR YM PE +     S ++D++S G
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMG 189

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 47.5 bits (113), Expect = 9e-06
 Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 16/109 (14%)

Query: 443 LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 502
           L R+  + PL+          +   L Y+HS    ++HRD+K +N+L++EN   K+ DFG
Sbjct: 96  LHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFG 153

Query: 503 IVKMSETSNVKTMYTENLTG---TRPYMPPEAMHC--QISTKTDVFSYG 546
           + ++ +           +TG   TR Y  PE M    +   + D++S G
Sbjct: 154 LARIQDP---------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAG 193

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 27/104 (25%), Positives = 52/104 (50%), Gaps = 4/104 (3%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
           N+   + S    +  + +A+ + YL    K ++HRD+ + NVL+      K+ DFG+ K+
Sbjct: 101 NHKDNIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158

Query: 507 SETSNVKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGAQI 549
            +    +          + +M  E++  +I T K+DV+SYG  +
Sbjct: 159 LDVDEKEYHAEGGKVPIK-WMALESILHRIYTHKSDVWSYGVTV 201

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 11/91 (12%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           + L V E + YL S +  +IHRD+ + N L+ EN V K+ DFG+ +      +   YT +
Sbjct: 105 MCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFV----LDDQYTSS 158

Query: 520 LTGTR---PYMPPEAM-HCQISTKTDVFSYG 546
            TGT+    +  PE     + S+K+DV+S+G
Sbjct: 159 -TGTKFPVKWSSPEVFSFSKYSSKSDVWSFG 188

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 11/91 (12%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  VA  + YL + +   IHRD+ + NVL+ EN + K+ DFG+ ++     +K    E 
Sbjct: 108 MAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARV-----IKEDIYEA 160

Query: 520 LTGTR---PYMPPEA-MHCQISTKTDVFSYG 546
             G +    +  PEA ++ + S K+DV+S+G
Sbjct: 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFG 191

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 29/86 (33%), Positives = 50/86 (58%), Gaps = 9/86 (10%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +AE + Y+    K  IHRD+++ANVL+ E+ + K+ DFG+ ++ E +     YT      
Sbjct: 112 IAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE----YTAREGAK 165

Query: 524 RP--YMPPEAMHC-QISTKTDVFSYG 546
            P  +  PEA++    + K+DV+S+G
Sbjct: 166 FPIKWTAPEAINFGSFTIKSDVWSFG 191

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)

Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 114 GIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GG 169

Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 170 KIPIRWTAPEAIAYRKFTSASDVWSYG 196

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 27/90 (30%), Positives = 40/90 (44%), Gaps = 7/90 (7%)

Query: 443 LARV--NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 500
           LA +  N   P   ++   + L +   L YLH     IIHRD+K +N+LL +    K+ D
Sbjct: 94  LASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIAD 151

Query: 501 FGIVKMSETSNVKTMYTENLTGTRPYMPPE 530
           FG+ +           T  +  T  Y  PE
Sbjct: 152 FGLART--YGLPAKPMTPKVV-TLWYRAPE 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 27/85 (31%), Positives = 44/85 (51%), Gaps = 15/85 (17%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           +L ++H     I HRD+K  N+L+ ++ + KL DFG  +       K  YTE ++ TR Y
Sbjct: 112 SLDHMHR--NGIFHRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYIS-TRWY 164

Query: 527 MPPEAMHCQIST-----KTDVFSYG 546
             PE   C ++      K D+++ G
Sbjct: 165 RAPE---CLLTDGYYGPKMDIWAVG 186

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 26/82 (31%), Positives = 39/82 (47%), Gaps = 11/82 (13%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           P D  K+Y     V   +  LH   + IIHRD+K  N+L+D+    KL DFG+ +    +
Sbjct: 95  PEDWAKQY--IAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN 150

Query: 511 NVKTMYTENLTGTRPYMPPEAM 532
                  +   GT  Y+ PE +
Sbjct: 151 -------KKFVGTPDYLAPETI 165

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 6/81 (7%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
            L +LH   K II+RD+K  NVLLD++   K+ DFG+ K +     K        GT  Y
Sbjct: 108 GLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK---ASTFCGTPDY 162

Query: 527 MPPEAMHCQISTKT-DVFSYG 546
           + PE +  Q   ++ D +S+G
Sbjct: 163 IAPEILKGQKYNESVDWWSFG 183

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 31/73 (42%), Positives = 42/73 (57%), Gaps = 6/73 (8%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTG 522
           V  AL  +HS+   +IHRDVK  N+LLD++   KL DFG  +KM ET  V+    +   G
Sbjct: 151 VVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR---CDTAVG 205

Query: 523 TRPYMPPEAMHCQ 535
           T  Y+ PE +  Q
Sbjct: 206 TPDYISPEVLKSQ 218

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 28/85 (32%), Positives = 46/85 (54%), Gaps = 16/85 (18%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG---T 523
            L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++         + +TG   T
Sbjct: 130 GLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTD---------DEMTGYVAT 178

Query: 524 RPYMPPEAMHCQIS-TKT-DVFSYG 546
           R Y  PE M   +   +T D++S G
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVG 203

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 28/81 (34%), Positives = 46/81 (56%), Gaps = 7/81 (8%)

Query: 468 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYM 527
           L Y+HS +  ++HRD+K +N+LL+ N   K+ DFG+ +   T++ K  +      TR Y 
Sbjct: 121 LKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLAR---TTSEKGDFMTEYVVTRWYR 175

Query: 528 PPEAMHC--QISTKTDVFSYG 546
            PE +    + +T  DV+S G
Sbjct: 176 APELLLNCSEYTTAIDVWSVG 196

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 41/227 (18%)

Query: 117 LGEGQFGTVYYGKL--KNGMEIAVKTLENNANYSSSNSDNTEAAM-----------IPIL 163
           LG+G    +Y G+L  + G E     +E+       N++  E  +           I + 
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 164 LFENEVQTLSQCKHVNLLRLLGLC----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDS 219
            FE     +SQ  H++L  + G+C     NIM   V E++ +G L   L +     P+  
Sbjct: 63  FFET-ASLMSQVSHIHLAFVHGVCVRGSENIM---VEEFVEHGPLDVCLRKEKGRVPVAW 118

Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-----DENFVP--KLGDFGIVKMS 272
             + ++A  +A AL YL    K ++H +V + N+LL      E   P  KL D G+    
Sbjct: 119 --KITVAQQLASALSYLED--KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV---- 170

Query: 273 ETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLEL 317
              +   +  E      P++ PE +     +ST  D +S+G  LLE+
Sbjct: 171 ---SFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 29/118 (24%), Positives = 55/118 (46%), Gaps = 25/118 (21%)

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM--- 280
           +I  G    L+YLH      IHR++K++++L+  +        G+V +S  S++ ++   
Sbjct: 105 NILFGALRGLNYLHQ--NGYIHRNIKASHILISGD--------GLVSLSGLSHLYSLVRN 154

Query: 281 ---------YTENLTGTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKPIDD 326
                    + +  T   P++ PE +   +     K+D++S G+   EL TG  P  D
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 55/231 (23%), Positives = 103/231 (44%), Gaps = 33/231 (14%)

Query: 110 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           +   G K+G G +G VY  K K+G        +++ +Y+    + T  +M        E+
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDG--------KDDRDYALKQIEGTGISMSAC----REI 49

Query: 170 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEY----MCNGSLYDRLARVNNTP-PLDSNK 221
             L + KH N++ L  +  +  +    ++++Y    + +   + R ++ N  P  L    
Sbjct: 50  ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 109

Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVKMSETSNM 277
             S+   + + +HYLH  +  ++HRD+K AN+L+     E    K+ D G  ++  +   
Sbjct: 110 VKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167

Query: 278 KTMYTENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPI 324
                + +  T  Y  PE    A H   +   D+++ G I  ELLT  +PI
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTS-EPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 46.8 bits (112), Expect = 2e-05
 Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 6/94 (6%)

Query: 437 QCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP 496
           +  L++L +     P   +   SI   + + L ++H       HRD+K  N+L+    V 
Sbjct: 81  EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVV 138

Query: 497 KLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPE 530
           K+ DFG+ +   +    T Y      TR Y  PE
Sbjct: 139 KIADFGLAREIRSRPPYTDY----VSTRWYRAPE 168

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 10/89 (11%)

Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNVKTMYTE 518
           A  +A  L +LHS  K II+RD+K  NV+LD     K+ DFG+ K  +      +T    
Sbjct: 107 AAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---- 160

Query: 519 NLTGTRPYMPPEAMHCQISTKT-DVFSYG 546
              GT  Y+ PE +  Q   K+ D +++G
Sbjct: 161 -FCGTPDYIAPEIIAYQPYGKSVDWWAFG 188

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 27/97 (27%), Positives = 44/97 (45%), Gaps = 7/97 (7%)

Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           +  +    I     +A+++ H  +   IHRDVK  N+L+ +    KL DFG  ++   + 
Sbjct: 97  VPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARI--LTG 152

Query: 512 VKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYG 546
               YT+    TR Y  PE +    Q     DV++ G
Sbjct: 153 PGDDYTD-YVATRWYRAPELLVGDTQYGPPVDVWAIG 188

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 30/70 (42%), Positives = 37/70 (52%), Gaps = 5/70 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL +LH   K II+RD+K  NVLLD     KL DFG+ K     N KT  T    GT
Sbjct: 105 ITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKT--TSTFCGT 159

Query: 524 RPYMPPEAMH 533
             Y+ PE + 
Sbjct: 160 PDYIAPEILQ 169

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 26/69 (37%), Positives = 40/69 (57%), Gaps = 5/69 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLHS    +++RD+K  N++LD++   K+ DFG+ K    S+  TM T    GT
Sbjct: 104 IVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKT--FCGT 158

Query: 524 RPYMPPEAM 532
             Y+ PE +
Sbjct: 159 PEYLAPEVL 167

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 8/99 (8%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTG 522
           +   L +LH+    +IHRD+K  NVLL EN   KL DFG+  ++  T   +  +     G
Sbjct: 130 ILRGLAHLHA--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----IG 183

Query: 523 TRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIAD 561
           T  +M PE + C        + Y + I +  IT +++A+
Sbjct: 184 TPYWMAPEVIACD-ENPDATYDYRSDIWSLGITAIEMAE 221

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 27/76 (35%), Positives = 41/76 (53%), Gaps = 4/76 (5%)

Query: 472 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEA 531
           H   K ++HRD+KS N+ L +N   KLGDFG  ++  +      Y     GT  Y+PPE 
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GAYACTYVGTPYYVPPEI 171

Query: 532 M-HCQISTKTDVFSYG 546
             +   + K+D++S G
Sbjct: 172 WENMPYNNKSDIWSLG 187

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 7/90 (7%)

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 183

Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTG 320
             PE  +        D++S G I+ E++ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 8/87 (9%)

Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  ++   +HRD+ + N+L++ N V K+ DFG+ +  E S     YT    G
Sbjct: 114 GIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE--ATYTTK-GG 168

Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+S+G
Sbjct: 169 KIPIRWTAPEAIAYRKFTSASDVWSFG 195

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 31/101 (30%), Positives = 56/101 (55%), Gaps = 12/101 (11%)

Query: 450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSE 508
           P L   K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + E
Sbjct: 116 PSL--KKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171

Query: 509 TSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           T      Y +   G  P  +M PE++   + +T +DV+S+G
Sbjct: 172 TD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 208

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 34/92 (36%), Positives = 41/92 (44%), Gaps = 10/92 (10%)

Query: 439 QLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL 498
           +LF   R     P D  K Y     +  A  YLHS  K II+RD+K  N+LLD     K+
Sbjct: 104 ELFTHLRKAGRFPNDVAKFYHAE--LVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKV 159

Query: 499 GDFGIVKMSETSNVKTMYTENLTGTRPYMPPE 530
            DFG  K           T  L GT  Y+ PE
Sbjct: 160 TDFGFAKKV------PDRTFTLCGTPEYLAPE 185

Length = 329

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 30/80 (37%), Positives = 45/80 (56%), Gaps = 6/80 (7%)

Query: 468 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYM 527
           L +LHS  K I++RD+K  N+LLD +   K+ DFG+ K +   + K   T    GT  Y+
Sbjct: 109 LQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDYI 163

Query: 528 PPEAMHCQ-ISTKTDVFSYG 546
            PE +  Q  +T  D +S+G
Sbjct: 164 APEILLGQKYNTSVDWWSFG 183

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 6/87 (6%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           V +AL YLHS  + +IHRD+KS ++LL  +   KL DFG          K    ++L GT
Sbjct: 126 VLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGT 180

Query: 524 RPYMPPEAM-HCQISTKTDVFSYGAQI 549
             +M PE +      T+ D++S G  +
Sbjct: 181 PYWMAPEVISRTPYGTEVDIWSLGIMV 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 10/90 (11%)

Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNVKTMYTE 518
           A  VA A+ YLHSL+  II+RD+K  N+LLD      L DFG+ K  +          T 
Sbjct: 102 AAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-----TS 154

Query: 519 NLTGTRPYMPPEAMHCQISTKT-DVFSYGA 547
              GT  Y+ PE +  +   +T D +  GA
Sbjct: 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGA 184

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 16/95 (16%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG----IVKMSETSNVKT 514
           S +  VA  + +L S  +  IHRD+ + N+LL EN V K+ DFG    I K  +      
Sbjct: 177 SYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------ 228

Query: 515 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
            Y        P  +M PE++  ++ +T++DV+S+G
Sbjct: 229 -YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFG 262

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 31/112 (27%), Positives = 52/112 (46%), Gaps = 18/112 (16%)

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS-------- 275
           SI   +   + Y+HS  K ++HRD+K  N+LL       + D+G     +          
Sbjct: 117 SIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 276 -NMKTMYTENLT------GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLT 319
            + + +   ++T      GT  YM PE  +    S  TD+++ GVIL ++LT
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 22/96 (22%)

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---TR 289
           L Y+HS    IIHRD+K  N+ ++E+   K+ DFG+ + ++           +TG   TR
Sbjct: 130 LKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAE---------MTGYVVTR 178

Query: 290 PYMPPEA----MHCQISTKT-DVFSYGVILLELLTG 320
            Y  PE     MH     +T D++S G I+ E+LTG
Sbjct: 179 WYRAPEVILNWMH---YNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 191

Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 349
             PE  +        D++S G I+ E++ G       + I  +  V+EQ   P  E + K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 10/99 (10%)

Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETS 510
           LD+    S +  VA+ + +L   SK  IHRD+ + N+LL    + K+ DFG+ + +   S
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268

Query: 511 NVKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
           N    Y        P  +M PE++ +C  + ++DV+SYG
Sbjct: 269 N----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 303

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 16/156 (10%)

Query: 167 NEVQTLSQCKHVNLLRLLGL-CNNIMNCIVY-EYMCNGSLYDRL-ARVNNTPPLDSNKRY 223
           +E + L +  H  +L LL +     + C+V  +Y  +  LY  L AR+    PL   +  
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD--LYTYLGARLR---PLGLAQVT 263

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGDFGIVKMSETSNMKTMY 281
           ++A  +  A+ Y+H   + IIHRD+K+ NVL++  E+    LGDFG    +  S     +
Sbjct: 264 AVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWSTPFH 319

Query: 282 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLE 316
              + GT     PE +     T + D++S G+++ E
Sbjct: 320 Y-GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 30/110 (27%), Positives = 55/110 (50%), Gaps = 9/110 (8%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L    R  N   +++     +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ 
Sbjct: 89  LLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVA 146

Query: 500 DFGIVKMSETSNVKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
           DFG+ ++         YT +     P  +  PE++ + + S K+DV+++G
Sbjct: 147 DFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 192

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 26/65 (40%), Positives = 36/65 (55%), Gaps = 5/65 (7%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           + L YLHS  K  +HRD+K AN+LL +N   KL DFG+      +  K    ++  GT  
Sbjct: 117 QGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK---RKSFIGTPY 171

Query: 526 YMPPE 530
           +M PE
Sbjct: 172 WMAPE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 32/94 (34%), Positives = 46/94 (48%), Gaps = 10/94 (10%)

Query: 439 QLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL 498
           + F   R N   P D    Y  A  +     YL SL+  I++RD+K  N+LLD++   K+
Sbjct: 117 EFFTFLRRNKRFPNDVGCFY--AAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKM 172

Query: 499 GDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAM 532
            DFG  K+ +T       T  L GT  Y+ PE +
Sbjct: 173 TDFGFAKVVDTR------TYTLCGTPEYIAPEIL 200

Length = 340

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 26/69 (37%), Positives = 41/69 (59%), Gaps = 5/69 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLHS  + +++RD+K  N++LD++   K+ DFG+ K    S+  TM T    GT
Sbjct: 104 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKT--FCGT 158

Query: 524 RPYMPPEAM 532
             Y+ PE +
Sbjct: 159 PEYLAPEVL 167

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 7/91 (7%)

Query: 443 LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDF 501
           LA V    PL           +   L Y+HS +  ++HRD+K ANV ++ E+ V K+GDF
Sbjct: 102 LANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDF 159

Query: 502 GIVKM--SETSNVKTMYTENLTGTRPYMPPE 530
           G+ ++     S+ K   +E L  T+ Y  P 
Sbjct: 160 GLARIVDPHYSH-KGYLSEGLV-TKWYRSPR 188

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 27/64 (42%), Positives = 35/64 (54%), Gaps = 4/64 (6%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           AL +LH L   II+RD+K  N+LLD N    L DFG+ K      V+  Y  +  GT  Y
Sbjct: 117 ALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEY 172

Query: 527 MPPE 530
           M P+
Sbjct: 173 MAPD 176

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 34/87 (39%), Positives = 45/87 (51%), Gaps = 9/87 (10%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK- 505
           N  PP    K  S    + +A+H+ H     I+HRD+K  N+L+  N V KL DFG  + 
Sbjct: 95  NGVPP---EKVRSYIYQLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFARN 149

Query: 506 MSETSNVKTMYTENLTGTRPYMPPEAM 532
           +SE SN    YTE    TR Y  PE +
Sbjct: 150 LSEGSNAN--YTE-YVATRWYRSPELL 173

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 55/231 (23%), Positives = 102/231 (44%), Gaps = 33/231 (14%)

Query: 110 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           +   G K+G G +G VY  K K+G        ++   Y+    + T  +M        E+
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDG--------KDEKEYALKQIEGTGISMSAC----REI 49

Query: 170 QTLSQCKHVNLLRLLGLC---NNIMNCIVYEY----MCNGSLYDRLARVNNTP-PLDSNK 221
             L + KH N++ L  +    ++    ++++Y    + +   + R ++ N  P  L  + 
Sbjct: 50  ALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSM 109

Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVKMSETSNM 277
             S+   + + +HYLH  +  ++HRD+K AN+L+     E    K+ D G  ++  +   
Sbjct: 110 VKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167

Query: 278 KTMYTENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPI 324
                + +  T  Y  PE    A H   +   D+++ G I  ELLT  +PI
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTS-EPI 215

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.4 bits (108), Expect = 5e-05
 Identities = 51/240 (21%), Positives = 86/240 (35%), Gaps = 61/240 (25%)

Query: 116 KLGEG--QFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
            +G+       V+  K K     +AVK        +  +    +     + L + E+ T 
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVK------KINLDSCSKED-----LKLLQQEIITS 53

Query: 173 SQCKHVNLLRLLGLCNNIMNC--------IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
            Q +H N+          +          +V   M  GS  D L         +     +
Sbjct: 54  RQLQHPNI-------LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP----EGLPELA 102

Query: 225 IAL---GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM- 280
           IA     V  AL Y+HS  K  IHR VK++++LL  +        G V +S      +M 
Sbjct: 103 IAFILKDVLNALDYIHS--KGFIHRSVKASHILLSGD--------GKVVLSGLRYSVSMI 152

Query: 281 -----------YTENLTGTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKPIDD 326
                      + ++     P++ PE +   +     K+D++S G+   EL  G  P  D
Sbjct: 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 49/214 (22%)

Query: 202 GSLYDRLARVNNTPP--------------LDSNKRYSIALGVAEALHYLHSLSKPIIHRD 247
            S YDR A    +                L +    S    VA  + +L   SK  +HRD
Sbjct: 205 RSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRD 262

Query: 248 VKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-ST 303
           + + NVLL +  + K+ DFG+ + +   SN    Y    +   P  +M PE++   + +T
Sbjct: 263 LAARNVLLAQGKIVKICDFGLARDIMHDSN----YVSKGSTFLPVKWMAPESIFDNLYTT 318

Query: 304 KTDVFSYGVILLELLT-GMKP-----IDDN--NTILYYYLVVEQEVPVREVLDKEAGEWN 355
            +DV+SYG++L E+ + G  P     +D    N I   Y + + +   +EV D     WN
Sbjct: 319 LSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWN 378

Query: 356 ETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS 389
                             E +KR S   + D++ 
Sbjct: 379 S-----------------EPEKRPSFLHLSDIVE 395

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 13/97 (13%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +   + YLH   + I+HRD+K +N+L++     K+ DFG+ ++      +TM   N
Sbjct: 173 VARQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA----QTMDPCN 226

Query: 520 LT-GTRPYMPPEAMHCQISTKT------DVFSYGAQI 549
            + GT  YM PE ++  ++         D++S G  I
Sbjct: 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSI 263

Length = 353

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 26/87 (29%), Positives = 49/87 (56%), Gaps = 7/87 (8%)

Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  ++   +HRD+ + N+L++ N   K+ DFG+ ++ E     T  T    G
Sbjct: 115 GIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG--G 170

Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+S+G
Sbjct: 171 KIPIRWTAPEAIAYRKFTSASDVWSFG 197

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 26/86 (30%), Positives = 48/86 (55%), Gaps = 9/86 (10%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +AE + ++    +  IHRD+++AN+L+  + V K+ DFG+ ++ E +     YT      
Sbjct: 111 IAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAK 164

Query: 524 RP--YMPPEAM-HCQISTKTDVFSYG 546
            P  +  PEA+     + K+DV+S+G
Sbjct: 165 FPIKWTAPEAINFGSFTIKSDVWSFG 190

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 36/105 (34%), Positives = 50/105 (47%), Gaps = 16/105 (15%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
            F L R  + P  +   R+  A  +A AL YLHS++  I++RD+K  N+LLD      L 
Sbjct: 84  FFHLQRERSFP--EPRARFYAA-EIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLT 138

Query: 500 DFGIVK----MSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKT 540
           DFG+ K     S+T       T    GT  Y+ PE +  Q    T
Sbjct: 139 DFGLCKEGIAQSDT-------TTTFCGTPEYLAPEVIRKQPYDNT 176

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 45.4 bits (107), Expect = 7e-05
 Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 8/90 (8%)

Query: 458 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT 517
           Y I L    AL  +HS  + ++HRD+KSAN+ L    + KLGDFG  K   + +V     
Sbjct: 176 YQIVL----ALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY-SDSVSLDVA 228

Query: 518 ENLTGTRPYMPPEAMH-CQISTKTDVFSYG 546
            +  GT  Y+ PE     + S K D++S G
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLG 258

Length = 478

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 44.5 bits (106), Expect = 7e-05
 Identities = 26/83 (31%), Positives = 45/83 (54%), Gaps = 7/83 (8%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
             + +LH     I+HRD+K++N+LL+   + K+ DFG+ +  E  +    YT+ +  T  
Sbjct: 117 SGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVV-TLW 171

Query: 526 YMPPEAMHC--QISTKTDVFSYG 546
           Y  PE +    + ST  D++S G
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVG 194

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 44.9 bits (106), Expect = 7e-05
 Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 7/101 (6%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
             + PL  ++   I   + E L YLH+    IIHRDVK+ N+ +++     +GD G  + 
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQF 206

Query: 507 SETSNVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYG 546
                V       L GT     PE +   + ++K D++S G
Sbjct: 207 ----PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAG 243

Length = 357

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 36/133 (27%), Positives = 62/133 (46%), Gaps = 10/133 (7%)

Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           C+V   M  G L   +  + N P  +  +    A  +   L  LH   +  ++RD+K  N
Sbjct: 76  CLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPEN 132

Query: 253 VLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSY 310
           +LLD+    ++ D G+ VK+ E  +++        GT  YM PE ++ Q  T   D +  
Sbjct: 133 ILLDDYGHIRISDLGLAVKIPEGESIR-----GRVGTVGYMAPEVLNNQRYTLSPDYWGL 187

Query: 311 GVILLELLTGMKP 323
           G ++ E++ G  P
Sbjct: 188 GCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 44.5 bits (105), Expect = 8e-05
 Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 6/90 (6%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK---MSETSNVKTMYTENL 520
           + + + YLH+    ++HRD+K  NV+L  N + KL DFG  +           +   +++
Sbjct: 111 ILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168

Query: 521 TGTRPYMPPEAMH-CQISTKTDVFSYGAQI 549
            GT  +M PE ++      K+D++S G  +
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTV 198

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 44.4 bits (105), Expect = 8e-05
 Identities = 30/83 (36%), Positives = 48/83 (57%), Gaps = 10/83 (12%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           AL ++H   + I+HRD+KS N+ L ++   KLGDFGI ++   S V+   T    GT  Y
Sbjct: 113 ALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELART--CIGTPYY 167

Query: 527 MPPEAMHCQ---ISTKTDVFSYG 546
           + PE   C+    + K+D+++ G
Sbjct: 168 LSPEI--CENRPYNNKSDIWALG 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 44.4 bits (105), Expect = 9e-05
 Identities = 31/125 (24%), Positives = 55/125 (44%), Gaps = 19/125 (15%)

Query: 431 DTGETKQCQLFKLARVNNT--PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 488
           D G+ KQ      ++      PPL + ++ ++   +A  + +L +     +HRD+ + N 
Sbjct: 91  DLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNC 148

Query: 489 LLDENFVPKLGDFGIVKMSETSNVKTMYTE------NLTGTRPYMPPEAMHCQI-STKTD 541
           L+             VK+S  S  K +Y        N      ++ PEA+     STK+D
Sbjct: 149 LVSSQR--------EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSD 200

Query: 542 VFSYG 546
           V+S+G
Sbjct: 201 VWSFG 205

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 44.6 bits (105), Expect = 9e-05
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 6/87 (6%)

Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  ++  L +LH   + II+RD+K  NV+LD     K+ DFG   M +   V  + T   
Sbjct: 107 AAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFG---MCKEHMVDGVTTRTF 161

Query: 521 TGTRPYMPPEAMHCQISTKT-DVFSYG 546
            GT  Y+ PE +  Q   K+ D ++YG
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYG 188

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.4 bits (105), Expect = 9e-05
 Identities = 34/95 (35%), Positives = 46/95 (48%), Gaps = 22/95 (23%)

Query: 451 PLDSNKRYSIALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-- 505
           P+D  + Y      AE   AL YLH+    I+HRD+K  N+L+      KL DFG+ K  
Sbjct: 99  PVDMARMY-----FAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151

Query: 506 -MSETSNVKTMYTENLT---------GTRPYMPPE 530
            MS T+N+   + E  T         GT  Y+ PE
Sbjct: 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 14/101 (13%)

Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L   K   ++L  A  + YL S  K  IHRD+ + N L+ EN V K+ DFG+ +  E   
Sbjct: 90  LTVKKLLQMSLDAAAGMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG- 146

Query: 512 VKTMYTENLTGTRPYMP-----PEAM-HCQISTKTDVFSYG 546
              +YT  ++     +P     PEA+ + + ++++DV+SYG
Sbjct: 147 ---IYT--VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYG 182

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 29/89 (32%), Positives = 44/89 (49%), Gaps = 5/89 (5%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFG-IVKMSETSNVKTMYTENLT 521
           +   L YLH     IIHRDVK AN+L+D      ++ DFG   +++        +   L 
Sbjct: 112 LLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169

Query: 522 GTRPYMPPEAMHCQISTKT-DVFSYGAQI 549
           GT  +M PE +  +   ++ DV+S G  I
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVI 198

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 9/91 (9%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
           S+   V E + YL   S   IHRD+ + N L+    V K+ DFG+ +      +   YT 
Sbjct: 104 SMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYV----LDDEYTS 157

Query: 519 NLTGTRP--YMPPEAMH-CQISTKTDVFSYG 546
           +     P  + PPE  +  + S+K+DV+S+G
Sbjct: 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFG 188

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 27/64 (42%), Positives = 35/64 (54%), Gaps = 8/64 (12%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           AL YLHS    I++RD+K  N+LLD+    KL DFG  K  +  +     T  L GT  Y
Sbjct: 113 ALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRD----RTWTLCGTPEY 164

Query: 527 MPPE 530
           + PE
Sbjct: 165 LAPE 168

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 20/105 (19%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTG 522
           +   L +LH     +IHRD+K  NVLL EN   KL DFG+  ++  T   +  +     G
Sbjct: 120 ILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----IG 173

Query: 523 TRPYMPPEAMHCQIST------KTDVFSYGAQIKTQHITNVDIAD 561
           T  +M PE + C  +       K+D++S G       IT +++A+
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLG-------ITAIEMAE 211

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 26/82 (31%), Positives = 45/82 (54%), Gaps = 4/82 (4%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
            L Y+HS +  ++HRD+K +N+LL+ N   K+ DFG+ ++++  +  T +      TR Y
Sbjct: 118 GLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175

Query: 527 MPPEAM--HCQISTKTDVFSYG 546
             PE M      +   D++S G
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVG 197

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 27/71 (38%), Positives = 35/71 (49%), Gaps = 7/71 (9%)

Query: 478 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQIS 537
           IIHRDVK  NVL++ N   KL DFG+      S  KT    N+ G + YM PE +  +  
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT----NI-GCQSYMAPERI--KSG 176

Query: 538 TKTDVFSYGAQ 548
                 +Y  Q
Sbjct: 177 GPNQNPTYTVQ 187

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 8/120 (6%)

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 184

Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 349
             PE  +        D++S G I+ E++         + I  +  V+EQ   P  E + K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 9/98 (9%)

Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L + +    AL  A  + YL S  K  IHRD+ + N L+ EN V K+ DFG+ +  +   
Sbjct: 90  LKTKQLVKFALDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG- 146

Query: 512 VKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
              +Y+ +     P  +  PEA+ + + S+++DV+SYG
Sbjct: 147 ---IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYG 181

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 23/87 (26%), Positives = 50/87 (57%), Gaps = 4/87 (4%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A+ ++YL      ++HR++ + N+LL  + + ++ DFG+  +    + K  Y+E+ T  
Sbjct: 118 IAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175

Query: 524 RPYMPPEAMHCQIST-KTDVFSYGAQI 549
           + +M  E++     T ++DV+SYG  +
Sbjct: 176 K-WMALESILFGRYTHQSDVWSYGVTV 201

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 32/87 (36%), Positives = 47/87 (54%), Gaps = 6/87 (6%)

Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  +A  L +LHS  K II+RD+K  NV+LD     K+ DFG+ K +    V    T+  
Sbjct: 107 AAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT---TKTF 161

Query: 521 TGTRPYMPPEAMHCQISTKT-DVFSYG 546
            GT  Y+ PE +  Q   K+ D +++G
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFG 188

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 47/196 (23%), Positives = 82/196 (41%), Gaps = 46/196 (23%)

Query: 420 LHYTGIPVIILDTGETKQCQLFKL----------ARVNNTPPLDSNKRYSIALGVAEALH 469
           L++  I V +LD+GE     LF +            +     L + +   + L V +AL 
Sbjct: 35  LYHPNI-VALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALA 93

Query: 470 YLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKM---SETSNVKTM-YTENLTG 522
             H+  + I+HRD+K  N+++         K+ DFGI  +      ++V T+  T  + G
Sbjct: 94  CAHN--QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLG 151

Query: 523 TRPYMPPEAMHCQIST-KTDVFSYG------------------AQIKTQHITNVDIADRE 563
           T  Y  PE +  +  T  +D++++G                  A+I  Q ++ VD+    
Sbjct: 152 TPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDV---- 207

Query: 564 RYYSLQTMLPGHHEGD 579
              SL   + GH  G 
Sbjct: 208 ---SLPPWIAGHPLGQ 220

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 27/78 (34%), Positives = 37/78 (47%), Gaps = 5/78 (6%)

Query: 453 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNV 512
           D  +    A  V  AL +LH     +I+RD+K  N+LLD     KL DFG+ K    +  
Sbjct: 94  DEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG- 150

Query: 513 KTMYTENLTGTRPYMPPE 530
             + T    GT  Y+ PE
Sbjct: 151 --VTTTTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
           ++ L V +AL  LH+  + +IHRD+KS ++LL  +   KL DFG        + +    +
Sbjct: 120 AVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ---VSKEVPRRK 174

Query: 519 NLTGTRPYMPPEAM-HCQISTKTDVFSYGAQI 549
           +L GT  +M PE +       + D++S G  +
Sbjct: 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 206

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 26/86 (30%), Positives = 43/86 (50%), Gaps = 17/86 (19%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNVKTMYTENLT 521
            + +LHS    I+HRD+K  N+L+  +   K+ DFG+ +     M+ TS V T++     
Sbjct: 119 GVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLW----- 171

Query: 522 GTRPYMPPEA-MHCQISTKTDVFSYG 546
               Y  PE  +    +T  D++S G
Sbjct: 172 ----YRAPEVLLQSSYATPVDMWSVG 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 43.4 bits (103), Expect = 2e-04
 Identities = 20/45 (44%), Positives = 27/45 (60%), Gaps = 5/45 (11%)

Query: 464 VAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 505
           +AE   AL  +H L    IHRD+K  N+L+D +   KL DFG+ K
Sbjct: 107 IAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCK 149

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 29/73 (39%), Positives = 41/73 (56%), Gaps = 6/73 (8%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTG 522
           V  AL  +HS+    IHRDVK  N+LLD++   KL DFG  +KM++   V+    +   G
Sbjct: 151 VVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVG 205

Query: 523 TRPYMPPEAMHCQ 535
           T  Y+ PE +  Q
Sbjct: 206 TPDYISPEVLKSQ 218

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 9/88 (10%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTG 522
           +   + +LHS+   I++RD+K  NVLLD+    +L D G+ V++ +             G
Sbjct: 104 ITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-----ITQRAG 156

Query: 523 TRPYMPPEAMHCQI-STKTDVFSYGAQI 549
           T  YM PE +  +  S   D F+ G  I
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSI 184

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 44.0 bits (103), Expect = 2e-04
 Identities = 58/248 (23%), Positives = 99/248 (39%), Gaps = 55/248 (22%)

Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           K+G G+FG V+  K K   E      I+ + L+             E + + I     EV
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER-----------EKSQLVI-----EV 63

Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVY---EYMCNGSLYDRLARVNNT-PPLDSNKRYSI 225
             + + KH N++R +    N  N  +Y   E+   G L   + +       ++ +    I
Sbjct: 64  NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123

Query: 226 ALGVAEALHYLHSLS-----KPIIHRDVKSANVLLDENF-----------------VPKL 263
              +  AL Y H+L      + ++HRD+K  N+ L                     + K+
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183

Query: 264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST---KTDVFSYGVILLELLTG 320
           GDFG+ K     +M      +  GT  Y  PE +  +  +   K+D+++ G I+ EL +G
Sbjct: 184 GDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239

Query: 321 MKPIDDNN 328
             P    N
Sbjct: 240 KTPFHKAN 247

Length = 1021

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 18/64 (28%), Positives = 33/64 (51%), Gaps = 2/64 (3%)

Query: 442 KLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 501
                NN P +       +A+ +A  + YL SL+   +HRD+ + N L+  ++  K+ DF
Sbjct: 116 TFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADF 173

Query: 502 GIVK 505
           G+ +
Sbjct: 174 GMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 10/98 (10%)

Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SET 509
           +D  +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG       E 
Sbjct: 112 MDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169

Query: 510 SNVKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
           S   TM      GT  +M PE +  +    K D++S G
Sbjct: 170 SKRSTM-----VGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 31/106 (29%), Positives = 58/106 (54%), Gaps = 12/106 (11%)

Query: 447 NNT--PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
           NN   PP    +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ 
Sbjct: 109 NNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMT 166

Query: 505 K-MSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           + + ET      Y +   G  P  +M PE++   + +T +D++S+G
Sbjct: 167 RDIYETD----YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG 208

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 25/71 (35%), Positives = 42/71 (59%), Gaps = 8/71 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNVKTMYTENLT 521
           +  AL YLHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + +KT       
Sbjct: 104 IVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FC 157

Query: 522 GTRPYMPPEAM 532
           GT  Y+ PE +
Sbjct: 158 GTPEYLAPEVL 168

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 27/69 (39%), Positives = 40/69 (57%), Gaps = 5/69 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLHS    I++RD+K  N++LD++   K+ DFG+ K   T +  TM T    GT
Sbjct: 104 IVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-DAATMKT--FCGT 158

Query: 524 RPYMPPEAM 532
             Y+ PE +
Sbjct: 159 PEYLAPEVL 167

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 27/66 (40%), Positives = 36/66 (54%), Gaps = 5/66 (7%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           AL +LH     I++RD+K  N+LLD      L DFG+ K + T N KT  T    GT  Y
Sbjct: 108 ALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT--TNTFCGTTEY 162

Query: 527 MPPEAM 532
           + PE +
Sbjct: 163 LAPEVL 168

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 34/110 (30%), Positives = 51/110 (46%), Gaps = 22/110 (20%)

Query: 458 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT 517
           Y   LG    L +LH+    IIHRDVK  N+LL      KL DFG+     ++ ++   +
Sbjct: 135 YGALLG----LQHLHN--NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188

Query: 518 ENLTGTRPYMPPEAMHCQ------ISTKTDVFSYGAQIKTQHITNVDIAD 561
               GT  +M PE + C+         + DV+S G       IT +++ D
Sbjct: 189 ---VGTPFWMAPEVIACEQQYDYSYDARCDVWSLG-------ITAIELGD 228

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 25/65 (38%), Positives = 35/65 (53%), Gaps = 7/65 (10%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM-YTENLTGTRP 525
           AL++LH   + II+RD+K  NVLLD     KL D+G+ K      ++    T    GT  
Sbjct: 108 ALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTTSTFCGTPN 161

Query: 526 YMPPE 530
           Y+ PE
Sbjct: 162 YIAPE 166

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 14/95 (14%)

Query: 443 LARVNNTPPLDSNKRYSIALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L++  +  P D  + Y     +AE   A+H +H L    +HRD+K  NVLLD N   +L 
Sbjct: 92  LSKFEDRLPEDMARFY-----IAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLA 144

Query: 500 DFG-IVKMSETSNVKTMYTENLTGTRPYMPPEAMH 533
           DFG  +KM++   V++       GT  Y+ PE + 
Sbjct: 145 DFGSCLKMNQDGTVQSSVA---VGTPDYISPEILQ 176

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 25/79 (31%), Positives = 38/79 (48%), Gaps = 6/79 (7%)

Query: 464 VAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           +AE   A+  +H L    IHRD+K  N+LLD     KL DFG+    + S+    Y   L
Sbjct: 107 IAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY-RIL 163

Query: 521 TGTRPYMPPEAMHCQISTK 539
           +   P    + +   +S+K
Sbjct: 164 SHALPSNFLDFISKPMSSK 182

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 12/101 (11%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSE 508
            L      S A  ++  + YL  +   ++HRD+ + NVL+ E    K+ DFG+ +    E
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 509 TSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
            S VK        G  P  +M  E++   I +T++DV+S+G
Sbjct: 181 DSYVKRS-----KGRIPVKWMAIESLFDHIYTTQSDVWSFG 216

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 25/79 (31%), Positives = 38/79 (48%), Gaps = 5/79 (6%)

Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           LD ++       +   + + HS    IIHRD+K  N+L+ ++ V KL DFG  +      
Sbjct: 97  LDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154

Query: 512 VKTMYTENLTGTRPYMPPE 530
              +YT+    TR Y  PE
Sbjct: 155 --EVYTD-YVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 28/84 (33%), Positives = 45/84 (53%), Gaps = 14/84 (16%)

Query: 468 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN----LTGT 523
           L +LHS  K II+RD+K  NV+LD +   K+ DFG+ K       + ++ +N      GT
Sbjct: 109 LQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCK-------ENVFGDNRASTFCGT 159

Query: 524 RPYMPPEAMH-CQISTKTDVFSYG 546
             Y+ PE +   + +   D +S+G
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFG 183

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 42.5 bits (100), Expect = 4e-04
 Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 6/66 (9%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNVKTMYTENLTGTR 524
            A+H +H +    +HRD+K  NVL+D     KL DFG   +++     K + ++   GT 
Sbjct: 113 LAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN---KMVNSKLPVGTP 167

Query: 525 PYMPPE 530
            Y+ PE
Sbjct: 168 DYIAPE 173

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 25/69 (36%), Positives = 36/69 (52%), Gaps = 4/69 (5%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           AL +LH L   I++RD+K  N+LLD      L DFG+ K   +   +  Y+    GT  Y
Sbjct: 117 ALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIEY 172

Query: 527 MPPEAMHCQ 535
           M PE +  +
Sbjct: 173 MAPEIIRGK 181

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 41/165 (24%), Positives = 59/165 (35%), Gaps = 51/165 (30%)

Query: 229 VAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           +AE   A+  +H L    IHRD+K  N+LLD     KL DFG+    + S+    Y   L
Sbjct: 107 IAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY-RIL 163

Query: 286 TGTRP------------------------------------YMPPEA-MHCQISTKTDVF 308
           +   P                                    Y+ PE  +    + + D +
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223

Query: 309 SYGVILLELLTGMKPIDDNNTILYY--------YLVVEQEVPVRE 345
           S GVI+ E+L G  P   +N    Y         L    EVP+  
Sbjct: 224 SLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSP 268

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 43/177 (24%), Positives = 68/177 (38%), Gaps = 52/177 (29%)

Query: 195 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 254
           V +Y+  G +   L R+      +   R+ IA  +  A+  +H +    IHRD+K  N+L
Sbjct: 79  VMDYIPGGDMMSLLIRLGIFE--EDLARFYIA-ELTCAIESVHKMG--FIHRDIKPDNIL 133

Query: 255 LDENFVPKLGDFGIV---------------------------KMSETSN--MKTMYTEN- 284
           +D +   KL DFG+                            + SE     +K +     
Sbjct: 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRK 193

Query: 285 ----------LTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDN 327
                     L GT  Y+ PE +    + Q+    D +S GVIL E+L G  P   +
Sbjct: 194 RQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL---CDWWSVGVILYEMLVGQPPFLAD 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 42.0 bits (98), Expect = 5e-04
 Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 6/96 (6%)

Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           +D  +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG         
Sbjct: 113 MDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
            K      + GT  +M PE +  +    K D++S G
Sbjct: 171 SK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.6 bits (100), Expect = 5e-04
 Identities = 52/167 (31%), Positives = 75/167 (44%), Gaps = 19/167 (11%)

Query: 120 GQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH- 177
           G FG VY G+ KN  ++ AVK ++         +D     M+  +  E +   LS+    
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKK--------ADMINKNMVHQVQAERDALALSKSPFI 66

Query: 178 VNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH 237
           V+L   L   NN+   +V EY+  G +   L          + K  S    VA AL YLH
Sbjct: 67  VHLYYSLQSANNVY--LVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS---EVALALDYLH 121

Query: 238 SLSKPIIHRDVKSANVLLDENFVPKLGDFGI--VKMSETSNMKTMYT 282
                IIHRD+K  N+L+      KL DFG+  V ++   NM  + T
Sbjct: 122 RHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILT 166

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 41.6 bits (98), Expect = 6e-04
 Identities = 28/89 (31%), Positives = 49/89 (55%), Gaps = 9/89 (10%)

Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           +  ++ AL YL S  K  +HRD+ + NVL+      KLGDFG+ +  E  +    Y +  
Sbjct: 113 SYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES----YYKAS 166

Query: 521 TGTRP--YMPPEAMHC-QISTKTDVFSYG 546
            G  P  +M PE+++  + ++ +DV+ +G
Sbjct: 167 KGKLPIKWMAPESINFRRFTSASDVWMFG 195

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 41.9 bits (99), Expect = 6e-04
 Identities = 18/39 (46%), Positives = 25/39 (64%), Gaps = 6/39 (15%)

Query: 468 LHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFG 502
           +HYLHS    ++HRD+K AN+L+     E  V K+GD G
Sbjct: 121 VHYLHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 10/87 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTG 522
           VA  + +L   S+  IHRD+ + N+LL EN V K+ DFG+ + + +  +    Y    + 
Sbjct: 183 VARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKGSA 236

Query: 523 TRP--YMPPEAMHCQI-STKTDVFSYG 546
             P  +M PE++  ++ +T++DV+S+G
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFG 263

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 41.2 bits (96), Expect = 8e-04
 Identities = 32/84 (38%), Positives = 43/84 (51%), Gaps = 10/84 (11%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNVKTMYTENLTGT 523
           +AL +LH+    +IHRD+KS NVLL  +   KL DFG       E S   TM      GT
Sbjct: 126 QALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-----VGT 178

Query: 524 RPYMPPEAMHCQI-STKTDVFSYG 546
             +M PE +  +    K D++S G
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLG 202

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 41.1 bits (97), Expect = 8e-04
 Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 21/90 (23%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------SETSNVKTMY--- 516
           + + Y HS    ++HRD+K  N+L+D     KL DFG+ +       + T  V T++   
Sbjct: 110 QGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167

Query: 517 TENLTGTRPYMPPEAMHCQISTKTDVFSYG 546
            E L G+R Y          ST  D++S G
Sbjct: 168 PEILLGSRQY----------STPVDIWSIG 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 41.4 bits (97), Expect = 9e-04
 Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 10/133 (7%)

Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           C+V   M  G L   +  + N P  D  +    A  +   L  LH   + I++RD+K  N
Sbjct: 76  CLVLTLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPEN 132

Query: 253 VLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSY 310
           +LLD+    ++ D G+ V++ E   ++        GT  YM PE +  +  T   D +  
Sbjct: 133 ILLDDYGHIRISDLGLAVEIPEGETIR-----GRVGTVGYMAPEVVKNERYTFSPDWWGL 187

Query: 311 GVILLELLTGMKP 323
           G ++ E++ G  P
Sbjct: 188 GCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 30/103 (29%), Positives = 47/103 (45%), Gaps = 7/103 (6%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            +   LD  K    A  + + + YL S  K  +HRD+ + N+L++     K+GDFG+ K+
Sbjct: 100 KHRERLDHRKLLLYASQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTKV 157

Query: 507 SETSNVKTMYTENLTGTRP---YMPPEAMHCQISTKTDVFSYG 546
                 K  Y     G  P   Y P      + S  +DV+S+G
Sbjct: 158 LPQD--KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFG 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 23/64 (35%), Positives = 32/64 (50%), Gaps = 5/64 (7%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           AL  LH  +  +I+RD+K  N+LLD      L DFG+ K++         T    GT  Y
Sbjct: 105 ALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMK---DDDKTNTFCGTPEY 159

Query: 527 MPPE 530
           + PE
Sbjct: 160 LAPE 163

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 27/86 (31%), Positives = 44/86 (51%), Gaps = 7/86 (8%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           V+  + YL    K  +HRD+ + NVLL      K+ DFG+ K     +  + Y     G 
Sbjct: 104 VSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD--SYYKARSAGK 159

Query: 524 RP--YMPPEAMHC-QISTKTDVFSYG 546
            P  +  PE ++  + S+++DV+SYG
Sbjct: 160 WPLKWYAPECINFRKFSSRSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 25/82 (30%), Positives = 38/82 (46%), Gaps = 7/82 (8%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMY--TENLTGTR 524
           A+ Y+H   K +IHRD+K  N+ L+ +    LGDFG     E       Y     +    
Sbjct: 279 AVEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNS 336

Query: 525 PYMPPEAMHCQISTKTDVFSYG 546
           P +     +C+I   TD++S G
Sbjct: 337 PEILAGDGYCEI---TDIWSCG 355

Length = 501

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 41.2 bits (97), Expect = 0.001
 Identities = 27/70 (38%), Positives = 35/70 (50%), Gaps = 11/70 (15%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVK--MSETSNVKTMYTENL 520
           V   L YLH     I++RD+K  N+LLD E FV K+ DFG+ K  M          T   
Sbjct: 110 VVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFV-KIADFGLCKEGMGFGDR-----TSTF 161

Query: 521 TGTRPYMPPE 530
            GT  ++ PE
Sbjct: 162 CGTPEFLAPE 171

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 26/65 (40%), Positives = 35/65 (53%), Gaps = 4/65 (6%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           E L+Y H   K  +HRD+K +N+LL+     KL DFG+ ++   S     YT N   T  
Sbjct: 127 EGLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYN-SEESRPYT-NKVITLW 182

Query: 526 YMPPE 530
           Y PPE
Sbjct: 183 YRPPE 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 13/92 (14%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTE 518
           I  G    L +LH     I++RD+K  NVLLD++   ++ D G+ V++     +K     
Sbjct: 104 IICG----LEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR--- 154

Query: 519 NLTGTRPYMPPEAMHCQI-STKTDVFSYGAQI 549
              GT  YM PE +  ++     D F+ G  +
Sbjct: 155 --AGTPGYMAPEVLQGEVYDFSVDWFALGCTL 184

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 10/93 (10%)

Query: 443 LARVNNTPPLDSNKRYSIALGVA-EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 501
           L++  +  P D  + Y   + +A +++H LH      +HRD+K  N+L+D N   +L DF
Sbjct: 92  LSKFEDRLPEDMARFYLAEMVIAIDSVHQLH-----YVHRDIKPDNILMDMNGHIRLADF 146

Query: 502 G-IVKMSETSNVKTMYTENLTGTRPYMPPEAMH 533
           G  +K+ E   V++       GT  Y+ PE + 
Sbjct: 147 GSCLKLMEDGTVQSSVA---VGTPDYISPEILQ 176

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 5/83 (6%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP 525
            L Y+HS +  ++HRD+K  N+L++ +   K+ DFG+ +  SE       +      TR 
Sbjct: 117 GLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174

Query: 526 YMPPEAM--HCQISTKTDVFSYG 546
           Y  PE M      +   DV+S G
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVG 197

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 24/83 (28%), Positives = 42/83 (50%), Gaps = 5/83 (6%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           AL Y+H+ +  + HRD+K  N+L + +   K+ DFG+ +++       ++  +   TR Y
Sbjct: 115 ALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 527 MPPEAMHCQISTKT---DVFSYG 546
             PE      S  T   D++S G
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIG 195

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 23/65 (35%), Positives = 35/65 (53%), Gaps = 6/65 (9%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNVKTMYTENLTGTRP 525
           A+  +H L    +HRD+K  NVLLD+N   +L DFG  +++     V++       GT  
Sbjct: 114 AIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA---VGTPD 168

Query: 526 YMPPE 530
           Y+ PE
Sbjct: 169 YISPE 173

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 37/113 (32%), Positives = 52/113 (46%), Gaps = 24/113 (21%)

Query: 110 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAM 159
           +PR     G  LG G FG V     YG  K+   M +AVK L+      S++    EA M
Sbjct: 32  FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLK-----PSAHLTEREALM 86

Query: 160 IPILLFENEVQTLSQC-KHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLAR 210
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R
Sbjct: 87  -------SELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRR 132

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 40.6 bits (96), Expect = 0.001
 Identities = 29/92 (31%), Positives = 38/92 (41%), Gaps = 12/92 (13%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-KL 498
           LF L  +     L   +   I   + EAL+ LH     IIH D+K  NVL D       L
Sbjct: 96  LFDL--LKKEGKLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKDRIYL 151

Query: 499 GDFGIVKMSETSNVKTMYTENLTGTRPYMPPE 530
            D+G+ K+       + Y     GT  Y  PE
Sbjct: 152 CDYGLCKI---IGTPSCY----DGTLDYFSPE 176

Length = 267

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 27/86 (31%), Positives = 46/86 (53%), Gaps = 8/86 (9%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           VA+ + +L   S+  IHRD+ + N+LL EN V K+ DFG+ +          Y       
Sbjct: 188 VAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD---PDYVRKGDAR 242

Query: 524 RP--YMPPEAMHCQI-STKTDVFSYG 546
            P  +M PE +  ++ + ++DV+S+G
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFG 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 9/94 (9%)

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRP 290
            L  LH   + I++RD+K  N+LLD++   ++ D G+ V + E   +K        GT  
Sbjct: 114 GLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-----GRVGTVG 166

Query: 291 YMPPEAMHCQIST-KTDVFSYGVILLELLTGMKP 323
           YM PE +  +  T   D ++ G +L E++ G  P
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 35/133 (26%), Positives = 61/133 (45%), Gaps = 10/133 (7%)

Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           C+V   M  G L   +  + N P  D  +    A  +   L  L    + I++RD+K  N
Sbjct: 76  CLVLTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPEN 132

Query: 253 VLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSY 310
           +LLD+    ++ D G+ V++ E   ++        GT  YM PE ++ +  T   D +  
Sbjct: 133 ILLDDRGHIRISDLGLAVQIPEGETVR-----GRVGTVGYMAPEVINNEKYTFSPDWWGL 187

Query: 311 GVILLELLTGMKP 323
           G ++ E++ G  P
Sbjct: 188 GCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 18/45 (40%), Positives = 28/45 (62%), Gaps = 2/45 (4%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI 503
            +AL +A  + YL SL+   +HRD+ + N L+ EN   K+ DFG+
Sbjct: 142 HVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIADFGM 184

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 22/154 (14%)

Query: 426 PVIILDTGETKQCQLFKL-ARVNNTPP-LDSNKRYSIALGVAEALHYLHSLSKPIIHRDV 483
           PV+IL   +      F L +R+ + P  L +         +A  + YL S  K  IHRD+
Sbjct: 81  PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDL 138

Query: 484 KSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKT 540
            + N +L+EN    + DFG+ K     +    Y +      P  ++  E++  ++ +TK+
Sbjct: 139 AARNCMLNENMNVCVADFGLSKKIYNGD---YYRQGRIAKMPVKWIAIESLADRVYTTKS 195

Query: 541 DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPG 574
           DV+S+G       +T  +IA R      QT  PG
Sbjct: 196 DVWSFG-------VTMWEIATRG-----QTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y H   + ++HRD+K  N+L++E    KL DFG+ +     +V T    N   T
Sbjct: 113 ILRGLAYCHR--RKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVT 167

Query: 524 RPYMPPEAM--HCQISTKTDVFSYG 546
             Y PP+ +    + ST+ D++  G
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVG 192

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 10/105 (9%)

Query: 446 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 505
           +N +P L        +  VA  + +L   SK  +HRD+ + NVL+ E  + K+ DFG+ +
Sbjct: 230 INESPALSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287

Query: 506 -MSETSNVKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
            +   SN    Y    +   P  +M PE++ +   +T +DV+S+G
Sbjct: 288 DIMRDSN----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFG 328

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 43/156 (27%), Positives = 59/156 (37%), Gaps = 45/156 (28%)

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT----- 286
           A+  +H L    IHRD+K  N+LLD     KL DFG+    + ++ +T +  NLT     
Sbjct: 113 AIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH-RTEFYRNLTHNPPS 169

Query: 287 ----------------------------GTRPYMPPEA-MHCQISTKTDVFSYGVILLEL 317
                                       GT  Y+ PE  M    +   D +S GVI+ E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 318 LTGMKPIDDNNTILYY--------YLVVEQEVPVRE 345
           L G  P         Y         LV   EVP+ E
Sbjct: 230 LIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISE 265

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 40.3 bits (95), Expect = 0.002
 Identities = 63/249 (25%), Positives = 92/249 (36%), Gaps = 66/249 (26%)

Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPI-----LLFENEV 169
            LG+G  G V+  +LK  G   A+K L+                MI       +L E E+
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKE-------------MIKRNKVKRVLTEQEI 54

Query: 170 QTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIAL 227
             L+   H  L  L          C+V +Y   G L+  L R        +  + Y    
Sbjct: 55  --LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY---- 108

Query: 228 GVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE----------- 273
             AE   AL YLH L   I++RD+K  N+LL E+    L DF + K S+           
Sbjct: 109 -AAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165

Query: 274 --TSNMKTMYTENLT-------------GTRPYMPPE----AMHCQISTKTDVFSYGVIL 314
             +         + T             GT  Y+ PE      H    +  D ++ G++L
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH---GSAVDWWTLGILL 222

Query: 315 LELLTGMKP 323
            E+L G  P
Sbjct: 223 YEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 25/72 (34%), Positives = 38/72 (52%), Gaps = 7/72 (9%)

Query: 479 IHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP--YMPPEAM-HC 534
           +HRD+ + NVLL      K+ DFG+ K +    N    Y     G  P  +  PE M + 
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADEN---YYKAKTHGKWPVKWYAPECMNYY 173

Query: 535 QISTKTDVFSYG 546
           + S+K+DV+S+G
Sbjct: 174 KFSSKSDVWSFG 185

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 29/85 (34%), Positives = 43/85 (50%), Gaps = 8/85 (9%)

Query: 425 IPVIILDTGETKQCQLFKLA-RVNNTP---PLDSNKRYSIALGVAEALHYLHSLSKPIIH 480
           IP++IL   +      F L  R+   P   PL +  R+ I   +A  + YL S  K  IH
Sbjct: 81  IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI--DIASGMEYLSS--KNFIH 136

Query: 481 RDVKSANVLLDENFVPKLGDFGIVK 505
           RD+ + N +L+EN    + DFG+ K
Sbjct: 137 RDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 39.7 bits (93), Expect = 0.003
 Identities = 30/85 (35%), Positives = 43/85 (50%), Gaps = 10/85 (11%)

Query: 447 NNTPPLDSNK-RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 505
           NN   L  +  R+ +A    EA+  LH L    IHRD+K  N L+D +   KL DFG+  
Sbjct: 93  NNLGVLSEDHARFYMAEMF-EAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGL-- 147

Query: 506 MSETSNVKTMYTENLTGTRPYMPPE 530
              +  + T Y  ++ G+  YM PE
Sbjct: 148 ---SKGIVT-YANSVVGSPDYMAPE 168

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 27/81 (33%), Positives = 41/81 (50%), Gaps = 7/81 (8%)

Query: 468 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYM 527
           L Y H   + I+HRD+K  N+L++E    KL DFG+ +     +V T    N   T  Y 
Sbjct: 116 LSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYR 170

Query: 528 PPEAM--HCQISTKTDVFSYG 546
           PP+ +    + ST  D++  G
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVG 191

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 27/92 (29%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 456 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM 515
           + ++I + +  AL YLH   K I+HRD+   N++L E+    + DFG+ K  +  +    
Sbjct: 114 RIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---- 168

Query: 516 YTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
              ++ GT  Y  PE +  +    K DV+++G
Sbjct: 169 KLTSVVGTILYSCPEIVKNEPYGEKADVWAFG 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 39.4 bits (92), Expect = 0.004
 Identities = 24/89 (26%), Positives = 38/89 (42%), Gaps = 14/89 (15%)

Query: 453 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-------VK 505
           +S  +  I L +   L+ LH      +HRD+  AN+ ++   + K+ DFG+         
Sbjct: 118 ESQVK-CILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPY 174

Query: 506 MSETSNVKTMY-TENLTG---TRPYMPPE 530
               S  +TM   E +T    T  Y  PE
Sbjct: 175 SDTLSKDETMQRREEMTSKVVTLWYRAPE 203

Length = 335

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 39.4 bits (92), Expect = 0.004
 Identities = 27/94 (28%), Positives = 41/94 (43%), Gaps = 27/94 (28%)

Query: 470 YLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------SETSNVKTM 515
           YL  L        S  ++HRD+K  N+L++     KL DFG+ +       + T  V T+
Sbjct: 105 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 164

Query: 516 Y---TENLTGTRPYMPPEAMHCQISTKTDVFSYG 546
           +    E L G + Y          ST  D++S G
Sbjct: 165 WYRAPEILLGCKYY----------STAVDIWSLG 188

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 39.0 bits (91), Expect = 0.004
 Identities = 33/116 (28%), Positives = 51/116 (43%), Gaps = 30/116 (25%)

Query: 446 VNNTPPLDSNKR------YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKL 498
           ++++P    N R      Y I  G+A    Y HS    ++HRD+K  N+L+D      KL
Sbjct: 91  MDSSPDFAKNPRLIKTYLYQILRGIA----YCHS--HRVLHRDLKPQNLLIDRRTNALKL 144

Query: 499 GDFGIVKM------SETSNVKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYG 546
            DFG+ +       + T  V T++         Y  PE +      ST  D++S G
Sbjct: 145 ADFGLARAFGIPVRTFTHEVVTLW---------YRAPEILLGSRHYSTPVDIWSVG 191

Length = 294

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 41/109 (37%), Positives = 50/109 (45%), Gaps = 11/109 (10%)

Query: 444 ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFG 502
           AR N+  PL   K YS  L    AL Y+HS  K I HRD+K  N+L+D N    KL DFG
Sbjct: 161 ARNNHALPLFLVKLYSYQL--CRALAYIHS--KFICHRDLKPQNLLIDPNTHTLKLCDFG 216

Query: 503 IVKMSETSNVKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGAQI 549
             K          Y      +R Y  PE M      +T  D++S G  I
Sbjct: 217 SAKNLLAGQRSVSY----ICSRFYRAPELMLGATNYTTHIDLWSLGCII 261

Length = 440

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 39.9 bits (93), Expect = 0.004
 Identities = 39/143 (27%), Positives = 64/143 (44%), Gaps = 18/143 (12%)

Query: 437 QCQLFKL--ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--E 492
           +  L+    AR+    PL   +  ++A  +  A+ Y+H   + IIHRD+K+ NVL++  E
Sbjct: 243 RSDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPE 297

Query: 493 NFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYG----- 546
           +    LGDFG    +  S     +   + GT     PE +     T + D++S G     
Sbjct: 298 DIC--LGDFGAACFARGSWSTPFHY-GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Query: 547 AQIKTQHITNVDIADRERYYSLQ 569
           A + T  + +    D  R Y  Q
Sbjct: 355 AAVHTASLFSASRGDERRPYDAQ 377

Length = 461

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 39.3 bits (91), Expect = 0.004
 Identities = 27/105 (25%), Positives = 52/105 (49%), Gaps = 13/105 (12%)

Query: 428 IILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 487
           ++++  +   CQ+ ++        LD  +   +   +   + +LHS    IIHRD+K +N
Sbjct: 99  LVMELMDANLCQVIQME-------LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSN 149

Query: 488 VLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAM 532
           +++  +   K+ DFG+ + + TS + T Y      TR Y  PE +
Sbjct: 150 IVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYYRAPEVI 190

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	593
KOG1187|consensus	361		100.0
KOG0192|consensus	362		100.0
KOG0575|consensus	592		100.0
KOG0615|consensus	475		100.0
KOG0581|consensus	364		100.0
KOG0595|consensus	429		100.0
KOG0197|consensus	468		100.0
KOG0591|consensus	375		100.0
KOG0598|consensus	357		100.0
KOG0198|consensus	313		100.0
KOG0193|consensus	678		100.0
KOG0578|consensus	550		100.0
KOG0593|consensus	396		100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0583|consensus	370		100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0592|consensus	604		100.0
KOG0616|consensus	355		100.0
KOG4721|consensus	904		100.0
KOG0582|consensus	516		100.0
KOG1026|consensus	774		100.0
KOG0194|consensus	474		100.0
KOG0605|consensus	550		100.0
KOG0588|consensus	786		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0597|consensus	808		100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0580|consensus	281		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0661|consensus	538		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0585|consensus	576		100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0600|consensus	560		100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0196|consensus	996		100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG1095|consensus	1025		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0201|consensus	467		100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0659|consensus	318		100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0611|consensus	668		100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0694|consensus	694		100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG1094|consensus	807		100.0
KOG0663|consensus	419		100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0603|consensus	612		100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG4278|consensus	1157		100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0658|consensus	364		100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0599|consensus	411		100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0589|consensus	426		100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG4257|consensus	974		100.0
KOG0032|consensus	382		100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0584|consensus	632		100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0199|consensus	1039		100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG4279|consensus	1226		100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0577|consensus	948		100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0660|consensus	359		100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG1989|consensus	738		100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0594|consensus	323		100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0579|consensus	1187		100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG2345|consensus	302		100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0574|consensus	502		100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG4250|consensus	732		100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG2052|consensus	513		100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0610|consensus	459		100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0033|consensus	355		100.0
KOG4645|consensus	1509		100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG3653|consensus	534		100.0
KOG0586|consensus	596		100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0596|consensus	677		100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG4717|consensus	864		100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0983|consensus	391		100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0200|consensus	609		100.0
KOG0690|consensus	516		100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG1151|consensus	775		100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG1006|consensus	361		100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0986|consensus	591		100.0
KOG0612|consensus	1317		100.0
KOG0667|consensus	586		100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG1025|consensus	1177		100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0696|consensus	683		100.0
KOG0576|consensus	829		100.0
KOG0607|consensus	463		100.0
KOG1035|consensus	1351		100.0
KOG0604|consensus	400		100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0587|consensus	953		100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG4236|consensus	888		99.98
KOG0608|consensus	1034		99.97
KOG0603|consensus	612		99.97
KOG0666|consensus	438		99.97
KOG0984|consensus	282		99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0614|consensus	732		99.97
KOG0662|consensus	292		99.97
KOG0669|consensus	376		99.96
KOG0695|consensus	593		99.96
KOG1024|consensus	563		99.96
KOG1027|consensus	903		99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0671|consensus	415		99.96
KOG0664|consensus	449		99.95
KOG0590|consensus	601		99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1152|consensus	772		99.94
KOG0665|consensus	369		99.94
KOG0668|consensus	338		99.94
KOG0670|consensus	752		99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG1167|consensus	418		99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG0195|consensus	448		99.91
KOG0661|consensus	538		99.91
KOG1345|consensus	378		99.91
KOG1290|consensus	590		99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG0591|consensus	375		99.89
KOG0598|consensus	357		99.88
KOG0595|consensus	429		99.88
KOG0616|consensus	355		99.87
KOG0581|consensus	364		99.87
KOG0599|consensus	411		99.87
KOG0594|consensus	323		99.86
KOG1187|consensus	361		99.86
KOG0592|consensus	604		99.86
KOG0192|consensus	362		99.86
KOG1164|consensus	322		99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
KOG0575|consensus	592		99.85
KOG0583|consensus	370		99.85
KOG0593|consensus	396		99.85
KOG0600|consensus	560		99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
KOG0615|consensus	475		99.84
KOG0590|consensus	601		99.84
KOG0198|consensus	313		99.83
KOG0663|consensus	419		99.83
KOG1035|consensus	1351		99.83
KOG1023|consensus	484		99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
KOG0659|consensus	318		99.82
KOG0033|consensus	355		99.82
KOG0694|consensus	694		99.82
KOG0667|consensus	586		99.82
KOG0588|consensus	786		99.81
KOG0582|consensus	516		99.81
KOG0193|consensus	678		99.81
KOG0585|consensus	576		99.81
KOG0983|consensus	391		99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
KOG0666|consensus	438		99.81
KOG0984|consensus	282		99.81
KOG0660|consensus	359		99.8
KOG0986|consensus	591		99.8
KOG0578|consensus	550		99.8
KOG0197|consensus	468		99.8
KOG4721|consensus	904		99.79
KOG0032|consensus	382		99.79
KOG0658|consensus	364		99.79
KOG1165|consensus	449		99.78
KOG0597|consensus	808		99.78
KOG0611|consensus	668		99.78
KOG1163|consensus	341		99.78
PRK10345	210	hypothetical protein; Provisional	99.78
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.77
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.77
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.77
KOG2345|consensus	302		99.77
KOG0589|consensus	426		99.77
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.77
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.76
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.76
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.76
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.76
KOG0604|consensus	400		99.76
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.76
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.75
KOG1006|consensus	361		99.75
KOG0577|consensus	948		99.75
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.75
smart00090	237	RIO RIO-like kinase.	99.75
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.75
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.75
KOG4236|consensus	888		99.75
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.75
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.75
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.75
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.75
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.75
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.75
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.75
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.75
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.75
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.75
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.75
PTZ00267	478	NIMA-related protein kinase; Provisional	99.74
KOG0605|consensus	550		99.74
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.74
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.74
KOG0580|consensus	281		99.74
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.74

>KOG1187|consensus

Probab=100.00  E-value=1e-56  Score=473.40  Aligned_cols=279  Identities=40%  Similarity=0.653  Sum_probs=234.2

Q ss_pred             cceeecHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHH
Q psy9535          89 ELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE  168 (593)
Q Consensus        89 ~~~~~~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~E  168 (593)
                      ....|++.+|+.||+||+.      .++||+||||.||+|.+.+|+.||||++.......             ..+|.+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~------~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-------------~~eF~~E  121 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSE------SNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-------------EREFLNE  121 (361)
T ss_pred             CcceeeHHHHHHHHhCCch------hcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-------------hhHHHHH
Confidence            5778999999999999998      68999999999999999999999999886432110             0149999


Q ss_pred             HHHHhcCCCCceeeEEEEEeccc--ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeEe
Q psy9535         169 VQTLSQCKHVNLLRLLGLCNNIM--NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIH  245 (593)
Q Consensus       169 v~il~~l~HpNIv~l~g~~~~~~--~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~IiH  245 (593)
                      +.+|++++|||+|+|+|||.+..  .+||||||+||||.++|+..... +++|..|++||.++|+||+|||+... +|||
T Consensus       122 i~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiH  200 (361)
T KOG1187|consen  122 VEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIH  200 (361)
T ss_pred             HHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEec
Confidence            99999999999999999998743  79999999999999999875543 89999999999999999999998654 6999


Q ss_pred             cccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCC
Q psy9535         246 RDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPI  324 (593)
Q Consensus       246 rDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~  324 (593)
                      |||||+|||||+++++||+|||+|+..... .....+. ..||.+|+|||+. .+..+.|+|||||||+|+||+||++|.
T Consensus       201 rDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~~~~~-~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~  278 (361)
T KOG1187|consen  201 RDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTSVSTT-VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAV  278 (361)
T ss_pred             CCCCHHHeeECCCCCEEccCccCcccCCcc-ccceeee-cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCccc
Confidence            999999999999999999999999765431 1111111 1799999999976 567899999999999999999999998


Q ss_pred             CCC-----chHHHHHHHHhhcCccccccccccC--CCCH-HHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         325 DDN-----NTILYYYLVVEQEVPVREVLDKEAG--EWNE-THVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       325 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      +..     ..+..|.........+.+++|+...  .+.. ..+..++..+ .+|++.+|.+||+|.||+++|..
T Consensus       279 d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a-~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  279 DQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELA-LRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             CCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHH-HHHcCcCCCcCcCHHHHHHHHHh
Confidence            742     2367777777777788999998853  4443 4666666555 49999999999999999999954

>KOG0192|consensus

Probab=100.00  E-value=1e-49  Score=418.01  Aligned_cols=252  Identities=33%  Similarity=0.515  Sum_probs=200.3

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEeccc--
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM--  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~--  191 (593)
                      ++.||+|+||+||+|.|+....||||++........      .     ...|.+|+.+|++++|||||+|+|+|.+..  
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~------~-----~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~  114 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDE------S-----RKAFRREASLLSRLRHPNIVQFYGACTSPPGS  114 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChH------H-----HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            356999999999999998434499999965421110      0     336999999999999999999999998864  


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC-ccEEeecccce
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFGIVK  270 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~-~~Kl~DFGla~  270 (593)
                      .+||||||++|+|.++|+.. ....+++..+++++.|||+||.|||+..+ ||||||||+|||++.++ ++||+|||+++
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccce
Confidence            78999999999999999874 34679999999999999999999998433 99999999999999997 99999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC---CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ......   ...+...||+.|||||++..   .++.|+|||||||+||||+||+.||.+.........+...... +.+ 
T Consensus       193 ~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R-p~~-  267 (362)
T KOG0192|consen  193 EKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR-PPI-  267 (362)
T ss_pred             eecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC-CCC-
Confidence            765432   11223689999999999874   4899999999999999999999999986654333333322211 111 


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                          ..    .+...+..++++||..||++||++.+|+..|+..
T Consensus       268 ----p~----~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  268 ----PK----ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             ----Cc----cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence                00    0223345566789999999999999999999864

>KOG0575|consensus

Probab=100.00  E-value=1.4e-46  Score=398.07  Aligned_cols=247  Identities=28%  Similarity=0.414  Sum_probs=206.0

Q ss_pred             CCCCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         110 YPRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       110 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      .+.+++.||+|||+.||.++. .+|..||+|++.+........          .....+||+|.++|+|||||+++++++
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~----------reKv~~EIeIHr~L~HpnIV~f~~~FE   88 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQ----------REKVLNEIEIHRSLKHPNIVQFYHFFE   88 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcch----------HHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence            345689999999999999997 789999999997654333222          124678999999999999999999998


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      + ...|||.|+|++|+|..++++.   .++++.++..++.||+.||.|||+  .+|||||||..|+||++++++||+|||
T Consensus        89 Ds~nVYivLELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~--~~IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   89 DSNNVYIVLELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHS--LGIIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             cCCceEEEEEecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHh--cCceecccchhheeecCcCcEEecccc
Confidence            8 5568999999999999988742   579999999999999999999999  559999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ||.........   ..+.+|||.|+|||++. ...+..+||||+||+||.||+|++||....-...+..+...+..++..
T Consensus       164 LAt~le~~~Er---k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~  240 (592)
T KOG0575|consen  164 LATQLEYDGER---KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSH  240 (592)
T ss_pred             eeeeecCcccc---cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccc
Confidence            99887654322   23579999999999875 457889999999999999999999999876666666666665554443


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +.            ...+.++.+.+..+|.+|||+.+|+.
T Consensus       241 ls------------~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  241 LS------------AEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             cC------------HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            22            23445667889999999999999975

>KOG0615|consensus

Probab=100.00  E-value=4.7e-47  Score=384.17  Aligned_cols=254  Identities=25%  Similarity=0.416  Sum_probs=197.8

Q ss_pred             CCCCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         110 YPRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       110 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      ++...+.||+|+||.|-+|.. ++|+.||||++++..........   .   .....++|+++|++|+|||||++++++.
T Consensus       173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~---~---~~~~v~~EieILkkL~HP~IV~~~d~f~  246 (475)
T KOG0615|consen  173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAI---A---KTRDVQNEIEILKKLSHPNIVRIKDFFE  246 (475)
T ss_pred             eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccc---c---chhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence            345678999999999999975 57999999999876433221100   0   0112479999999999999999999998


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC---CccEEe
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLG  264 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~---~~~Kl~  264 (593)
                      . +..|+||||+.||+|.+++...+   .+.+..-.-+++|++.|+.|||+  .+|+||||||+||||..+   ..+||+
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~--~GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHS--QGIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             cCCceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHH--cCcccccCCcceEEeccCCcceEEEec
Confidence            7 45599999999999999997643   46667777899999999999999  569999999999999755   789999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCcccccCC----CCCcchhhHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhh
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQ  339 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~-~~~~~~~~  339 (593)
                      |||+|+......    ...+.||||.|.|||++..+    +..|+|+||+||+||-+++|.+||.+..... ...++..+
T Consensus       322 DFGlAK~~g~~s----fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G  397 (475)
T KOG0615|consen  322 DFGLAKVSGEGS----FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG  397 (475)
T ss_pred             ccchhhccccce----ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC
Confidence            999999876432    34568999999999988543    3448999999999999999999998754433 33444444


Q ss_pred             cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         340 EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...+-..        ....+.+....++.+.+..||++|||+.|+++
T Consensus       398 ~y~f~p~--------~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  398 RYAFGPL--------QWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cccccCh--------hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            3332211        12334455666788999999999999999864

>KOG0581|consensus

Probab=100.00  E-value=2.8e-46  Score=376.25  Aligned_cols=242  Identities=29%  Similarity=0.397  Sum_probs=192.9

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c-
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I-  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~-  190 (593)
                      .+.||+|..|+|||++++ +++.+|+|++..+.     +..       ..++..+|++++++++||+||+++|+|.. . 
T Consensus        84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~-----~~~-------~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~  151 (364)
T KOG0581|consen   84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI-----DPA-------LQKQILRELEILRSCQSPYIVGFYGAFYSNGE  151 (364)
T ss_pred             hhhcccCCCcEEEEEEEcCCCeEEEEEeecccC-----CHH-------HHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence            368999999999999986 68889999994331     101       12357899999999999999999998865 4 


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ...|+||||.+|||.+.++..   ..+++...-+|+.++++||.|||+. +.||||||||+|||++..|.+||||||.++
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~  227 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSG  227 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccH
Confidence            378999999999999999865   3588999999999999999999963 569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCC-----chHHHHHHHHhhcCccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDN-----NTILYYYLVVEQEVPVR  344 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~-----~~~~~~~~~~~~~~~~~  344 (593)
                      ....+     ...+++||..|||||.+.+ .|+.++||||||++++|+++|+.||...     .....+..++.+..|  
T Consensus       228 ~lvnS-----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP--  300 (364)
T KOG0581|consen  228 ILVNS-----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP--  300 (364)
T ss_pred             Hhhhh-----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC--
Confidence            76544     2345799999999998765 6899999999999999999999999763     222222333332221  


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                              ..+.......++..+..|++.||.+||+..|+++
T Consensus       301 --------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  301 --------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             --------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                    1111123334566778999999999999999864

>KOG0595|consensus

Probab=100.00  E-value=5.6e-46  Score=376.97  Aligned_cols=199  Identities=34%  Similarity=0.554  Sum_probs=169.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||+||+|+++ ++..||||.+.+...    ....       ......|+.+|+.++|||||+|++++.. +.
T Consensus        15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l----~~k~-------~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~   83 (429)
T KOG0595|consen   15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL----NKKL-------VELLLSEIKILKELKHPNIVRLLDCIEDDDF   83 (429)
T ss_pred             hhhccCcceEEEEEeEeccCCceEEeeeehhhcc----CHHH-------HHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence            567999999999999985 689999999965421    1111       1236789999999999999999999977 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC------CccEEee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN------FVPKLGD  265 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~------~~~Kl~D  265 (593)
                      .+||||||.||+|.++|++++   .+++.....++.|+|.||++||+  ++||||||||.||||+..      -.+||+|
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~--~~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHE--NNIIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCcceEEeccCCCCCCCceEEecc
Confidence            689999999999999998754   58999999999999999999998  669999999999999764      5689999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHH
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILY  332 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~  332 (593)
                      ||+||......    ...+.+|||.|||||++ .++|+.|+|+||.|++||||++|+.||+.......
T Consensus       159 FGfAR~L~~~~----~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL  222 (429)
T KOG0595|consen  159 FGFARFLQPGS----MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL  222 (429)
T ss_pred             cchhhhCCchh----HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence            99999887543    24568999999999987 67899999999999999999999999997654433

>KOG0197|consensus

Probab=100.00  E-value=6.6e-46  Score=389.29  Aligned_cols=247  Identities=30%  Similarity=0.464  Sum_probs=197.3

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI-MN  192 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~-~~  192 (593)
                      .+.||+|-||.||.|.|+....||||.++.....              ...|.+|+++|++|+|+|||+|+|+|..+ ..
T Consensus       211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~--------------~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi  276 (468)
T KOG0197|consen  211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS--------------PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI  276 (468)
T ss_pred             HHHhcCCccceEEEEEEcCCCcccceEEeccccC--------------hhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence            4789999999999999987779999999754211              12589999999999999999999999884 57


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      +||||||+.|||.++|.. .....+...+.+.++.|||+|++||++  +++|||||...|||++++..+||+||||||..
T Consensus       277 yIVtE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes--~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  277 YIVTEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLES--KNYIHRDLAARNILVDEDLVVKISDFGLARLI  353 (468)
T ss_pred             EEEEEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHh--CCccchhhhhhheeeccCceEEEccccccccc
Confidence            999999999999999987 334578999999999999999999998  56999999999999999999999999999955


Q ss_pred             ccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .++...  ......-..-|.|||++ .++++.|||||||||+||||+| |+.||...........+..+ ..++      
T Consensus       354 ~d~~Y~--~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-yRlp------  424 (468)
T KOG0197|consen  354 GDDEYT--ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-YRLP------  424 (468)
T ss_pred             CCCcee--ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc-CcCC------
Confidence            443321  11111223569999976 5789999999999999999998 89998876544433333222 1111      


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                          .+..+...+-.++..||+.+|++|||+..+...|+.
T Consensus       425 ----~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~  460 (468)
T KOG0197|consen  425 ----RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLED  460 (468)
T ss_pred             ----CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence                112233445667889999999999999988888776

>KOG0591|consensus

Probab=100.00  E-value=8.4e-45  Score=351.59  Aligned_cols=253  Identities=25%  Similarity=0.374  Sum_probs=196.7

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE-Ee-cc
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL-CN-NI  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~-~~-~~  190 (593)
                      .++||+|+||.|||+.. .+|..||.|.++-..    -+.  .+     ......|+.+|++|+|||||+.++. +. +.
T Consensus        24 l~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~----md~--k~-----rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   24 LKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM----MDA--KA-----RQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             HHHHcCCcchheEEeeeccCcchhhhhhcchhh----ccH--HH-----HHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            46899999999999974 589999999986321    111  11     2346789999999999999999983 32 33


Q ss_pred             c-ceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--eEecccCCCCeeecCCCccEEeec
Q psy9535         191 M-NCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       191 ~-~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~--IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      . .+||||||..|+|.+.++... ....+++...+++..|+++||..+|+.-+.  |+||||||.||+|+.+|.+||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            3 679999999999999987643 245689999999999999999999984344  999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      ||+++....   +..+.+.+|||.||+||.+. ..|+.||||||+||++|||+.-+.||.+.+-......+..++.+   
T Consensus       173 GL~r~l~s~---~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~---  246 (375)
T KOG0591|consen  173 GLGRFLSSK---TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP---  246 (375)
T ss_pred             hhHhHhcch---hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC---
Confidence            999987654   33456789999999999764 57999999999999999999999999987544443333332211   


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                             +.+...-.+-+..++..|+..||+.||+...+++.+..
T Consensus       247 -------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  247 -------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             -------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                   11223334445667789999999999996555554443

>KOG0598|consensus

Probab=100.00  E-value=5.5e-44  Score=359.60  Aligned_cols=237  Identities=28%  Similarity=0.392  Sum_probs=191.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||+||.++.+ +++.+|+|++++.......     +     ......|..||.+++||.||+|.-.+++ ..
T Consensus        30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~-----e-----~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k   99 (357)
T KOG0598|consen   30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKK-----E-----VRHTKAERNILSKIKHPFIVKLIYSFQTEEK   99 (357)
T ss_pred             eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhh-----h-----HHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence            579999999999999865 6899999999875433221     1     1235689999999999999999987766 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .|+|+||+.||.|..+|.+.   ..+++..+.-++.+|+.||.|||+  ++||||||||+|||||.+|+++|+||||++.
T Consensus       100 LylVld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDFGLCKE  174 (357)
T ss_pred             EEEEEeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence            79999999999999999864   358889888899999999999999  6699999999999999999999999999996


Q ss_pred             cccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc-cccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV-REVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~  349 (593)
                      ....+.   .+.+++||+.|||||++ ...++..+|+||+||++|||++|.+||...+....+..+..+..+. +..++ 
T Consensus       175 ~~~~~~---~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls-  250 (357)
T KOG0598|consen  175 DLKDGD---ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLS-  250 (357)
T ss_pred             cccCCC---ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCC-
Confidence            544432   24458999999999976 5568999999999999999999999999888776666666555221 11122 


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCC
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRAS  380 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs  380 (593)
                                 ...+.++.+-+..||++|-.
T Consensus       251 -----------~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  251 -----------EEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             -----------HHHHHHHHHHhccCHHHhcC
Confidence                       12334556778899999964

>KOG0198|consensus

Probab=100.00  E-value=8.6e-44  Score=363.26  Aligned_cols=247  Identities=30%  Similarity=0.464  Sum_probs=191.1

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      .++.||+|+||.||++... +|...|||.+.....  .      .     ...+++|+.+|++++|||||+.+|.... .
T Consensus        21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~------~-----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~   87 (313)
T KOG0198|consen   21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--P------T-----SESLEREIRILSRLNHPNIVQYYGSSSSRE   87 (313)
T ss_pred             hhccccCccceEEEEEEecCCCcceeeeeeecccc--h------h-----HHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence            4789999999999999875 489999999864310  0      0     2247899999999999999999997433 2


Q ss_pred             --cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC-CCccEEeecc
Q psy9535         191 --MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFG  267 (593)
Q Consensus       191 --~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~-~~~~Kl~DFG  267 (593)
                        ..++.|||+++|||.+++.+.+.  .+++..+..++.||++||.|||+  ++||||||||+|||++. ++.+||+|||
T Consensus        88 ~~~~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaDFG  163 (313)
T KOG0198|consen   88 NDEYNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLADFG  163 (313)
T ss_pred             CeeeEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEeccCc
Confidence              46799999999999999987553  69999999999999999999998  67999999999999999 7999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccCCC--CCcchhhHHHHHHHHHHhCCCCCCCC-chHHHHHHHHhhcCccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDN-NTILYYYLVVEQEVPVR  344 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~~ksDVwSfGvvl~ElltG~~P~~~~-~~~~~~~~~~~~~~~~~  344 (593)
                      +++................||+.|||||++....  ..++|||||||++.||+||+.||... ........+.... ..+
T Consensus       164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P  242 (313)
T KOG0198|consen  164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLP  242 (313)
T ss_pred             cccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCC
Confidence            9987653111112233578999999999876332  34899999999999999999999863 2222222222111 111


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .+         +..+....+.++.+|++.+|++|||+.++++
T Consensus       243 ~i---------p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~  275 (313)
T KOG0198|consen  243 EI---------PDSLSDEAKDFLRKCFKRDPEKRPTAEELLE  275 (313)
T ss_pred             CC---------CcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            11         1123445666778999999999999999875

>KOG0193|consensus

Probab=100.00  E-value=5e-44  Score=376.94  Aligned_cols=257  Identities=29%  Similarity=0.509  Sum_probs=199.9

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEeccc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  191 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~  191 (593)
                      .++.+||+|+||+||+|+|.  ..||||.++...-.   .    +    ..+.|.+||..+++-+|.||+-++|||.++.
T Consensus       395 ~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt---~----~----qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  395 LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPT---P----E----QLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             hccceeccccccceeecccc--cceEEEEEecCCCC---H----H----HHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            45789999999999999996  36999999754211   1    1    2447999999999999999999999999988


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      ..||+.+|+|-||+.+||...  ..++..+.+.||.|||+|+.|||.  ++|||||||+.||+|.+++.+||+||||+..
T Consensus       462 ~AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  462 LAIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             eeeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCcEEEecccceee
Confidence            899999999999999998654  468999999999999999999998  7799999999999999999999999999865


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC----CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~----~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      -..-.. ........|...|||||++..    .|+..|||||||||+|||+||..||.........+.+-.+ .-.++..
T Consensus       538 k~~w~g-~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG-~l~pd~s  615 (678)
T KOG0193|consen  538 KTRWSG-EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG-YLMPDLS  615 (678)
T ss_pred             eeeecc-ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc-ccCccch
Confidence            322111 111233468899999997743    4789999999999999999999999854433222222111 1111111


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhccc
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMF  393 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~  393 (593)
                      .      ....+.+.++.++..||.+++++||.+.+|+..|+....
T Consensus       616 ~------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  616 K------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             h------hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            1      112234456667789999999999999999997776443

>KOG0578|consensus

Probab=100.00  E-value=3.6e-43  Score=369.45  Aligned_cols=258  Identities=26%  Similarity=0.442  Sum_probs=210.5

Q ss_pred             HHHHhcCCCCCCCCCCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC
Q psy9535          98 LERATDGFNRKPYPRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK  176 (593)
Q Consensus        98 l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~  176 (593)
                      |+.....=+...++..-.+||+|+.|.||.++. .+++.||||++........      +       ...+|+.+|+..+
T Consensus       262 l~~v~~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k------e-------LilnEi~Vm~~~~  328 (550)
T KOG0578|consen  262 LKRVVSQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK------E-------LLLNEILVMRDLH  328 (550)
T ss_pred             hheeccCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch------h-------hhHHHHHHHHhcc
Confidence            333444444444555568999999999999975 4689999999975421111      1       3579999999999


Q ss_pred             CCceeeEEEEE-ecccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee
Q psy9535         177 HVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  255 (593)
Q Consensus       177 HpNIv~l~g~~-~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl  255 (593)
                      |+|||+++..+ ..+..|.|||||.+|+|.|.+..    ..+++.+...|++++++||+|||.  ++|||||||.+||||
T Consensus       329 H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~--~gIiHrDIKSDnILL  402 (550)
T KOG0578|consen  329 HPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHA--RGIIHRDIKSDNILL  402 (550)
T ss_pred             chHHHHHHHHhcccceeEEEEeecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHh--cceeeeccccceeEe
Confidence            99999999855 45778999999999999998865    348999999999999999999998  669999999999999


Q ss_pred             cCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHH
Q psy9535         256 DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  334 (593)
Q Consensus       256 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~  334 (593)
                      +.+|.+||+|||++........   ...+.+|||+|||||+.. ..|++|+||||||++++||+-|.+||-.++.+...+
T Consensus       403 ~~~g~vKltDFGFcaqi~~~~~---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly  479 (550)
T KOG0578|consen  403 TMDGSVKLTDFGFCAQISEEQS---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY  479 (550)
T ss_pred             ccCCcEEEeeeeeeeccccccC---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH
Confidence            9999999999999987655432   234579999999999774 579999999999999999999999999888888777


Q ss_pred             HHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         335 LVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ++.....+...         .++.+...++.++.+|++.|+++||++.|+++
T Consensus       480 LIa~ng~P~lk---------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  480 LIATNGTPKLK---------NPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HHhhcCCCCcC---------CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            77665544222         23445567888889999999999999999875

>KOG0593|consensus

Probab=100.00  E-value=2.6e-43  Score=344.30  Aligned_cols=252  Identities=26%  Similarity=0.398  Sum_probs=193.4

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      .++|+|+||+||||+.+ +|+.||||++....+    +.   ...    +--.+|+..|++++|||+|.|+.+|.. ...
T Consensus         8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed----d~---~Vk----KIAlREIrmLKqLkH~NLVnLiEVFrrkrkl   76 (396)
T KOG0593|consen    8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED----DP---VVK----KIALREIRMLKQLKHENLVNLIEVFRRKRKL   76 (396)
T ss_pred             hccccCcceEEEEeccCCcccEEEEEeeccCCc----cH---HHH----HHHHHHHHHHHhcccchHHHHHHHHHhccee
Confidence            47899999999999986 699999999865321    11   111    124689999999999999999998876 556


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      .||+|||.. ++.+.|.+..  ..++.....++++|++.|+.|+|+  +++|||||||+|||++.++.+||||||+||..
T Consensus        77 hLVFE~~dh-TvL~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILit~~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   77 HLVFEYCDH-TVLHELERYP--NGVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILITQNGVVKLCDFGFARTL  151 (396)
T ss_pred             EEEeeecch-HHHHHHHhcc--CCCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEEecCCcEEeccchhhHhh
Confidence            899999975 4545555443  358889999999999999999998  56999999999999999999999999999987


Q ss_pred             ccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCc--------
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP--------  342 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~--------  342 (593)
                      ...+  ..+ +..+.|.+|.|||.+-+  +|+..+||||+||++.||++|.+-|.+.++....+.+...-++        
T Consensus       152 ~~pg--d~Y-TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i  228 (396)
T KOG0593|consen  152 SAPG--DNY-TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI  228 (396)
T ss_pred             cCCc--chh-hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence            6432  222 34678999999997744  6899999999999999999999999887776665555432222        


Q ss_pred             -----------cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHH
Q psy9535         343 -----------VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV  385 (593)
Q Consensus       343 -----------~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~  385 (593)
                                 +++.-+++.-+..-..+..++..++..|++.||++|++..|++
T Consensus       229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll  282 (396)
T KOG0593|consen  229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL  282 (396)
T ss_pred             hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence                       1111111111111122344666778899999999999999875

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7.5e-42  Score=350.67  Aligned_cols=264  Identities=21%  Similarity=0.339  Sum_probs=203.2

Q ss_pred             cCcceeecHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHH
Q psy9535          87 IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE  166 (593)
Q Consensus        87 ~~~~~~~~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~  166 (593)
                      ..+++.++..+++..+           ...||+|++|.||+|.+ +|+.||||.++....    ...  .    ....|.
T Consensus         9 ~~~~~~i~~~~i~~~~-----------~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~----~~~--~----~~~~~~   66 (283)
T PHA02988          9 INDIKCIESDDIDKYT-----------SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK----GHK--V----LIDITE   66 (283)
T ss_pred             cCcceecCHHHcCCCC-----------CeEEeeCCceEEEEEEE-CCEEEEEEecccccc----ccH--H----HHHHHH
Confidence            3456666777773321           35799999999999998 588999999864311    100  0    023588


Q ss_pred             HHHHHHhcCCCCceeeEEEEEec-----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q psy9535         167 NEVQTLSQCKHVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK  241 (593)
Q Consensus       167 ~Ev~il~~l~HpNIv~l~g~~~~-----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  241 (593)
                      +|+.+|++++|||||+++|++.+     ...++||||+++|+|.+++...   ..+++.....++.|++.||.|||+. .
T Consensus        67 ~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~-~  142 (283)
T PHA02988         67 NEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKY-T  142 (283)
T ss_pred             HHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhc-C
Confidence            99999999999999999998865     2457999999999999999753   3588999999999999999999973 2


Q ss_pred             CeEecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc---CCCCCcchhhHHHHHHHHHH
Q psy9535         242 PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---CQISTKTDVFSYGVILLELL  318 (593)
Q Consensus       242 ~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~~ksDVwSfGvvl~Ell  318 (593)
                      +++||||||+|||+++++.+||+|||+++......      ....||+.|+|||++.   ..++.++|||||||++|||+
T Consensus       143 ~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~  216 (283)
T PHA02988        143 NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF  216 (283)
T ss_pred             CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH
Confidence            47899999999999999999999999988653321      1246899999999874   46889999999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         319 TGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       319 tG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      +|+.||....................  .+        ..+...+..++.+||+.||++|||+.||++.|+...
T Consensus       217 ~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~--------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        217 TGKIPFENLTTKEIYDLIINKNNSLK--LP--------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HCCCCCCCCCHHHHHHHHHhcCCCCC--CC--------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            99999987654443333322221111  00        012234666788999999999999999999998643

>KOG0583|consensus

Probab=100.00  E-value=5.4e-42  Score=362.41  Aligned_cols=246  Identities=30%  Similarity=0.465  Sum_probs=197.7

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~  189 (593)
                      .+++.||+|+||+|+.|+.. +|..||||.+......... ...       .....+|+.++++++ ||||++++.++..
T Consensus        20 ~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~-~~~-------~~~i~rEi~~~~~~~~HpnI~~l~ev~~t   91 (370)
T KOG0583|consen   20 ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS-QKL-------DELIKREISILRRLRSHPNIIRLLEVFAT   91 (370)
T ss_pred             eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc-ccc-------chhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence            45789999999999999764 7899999977543111111 000       113558999999999 9999999998876


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC-CccEEeecc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFG  267 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~-~~~Kl~DFG  267 (593)
                       ...++||||+.+|+|++++...   ..+.+.....++.|++.|++|||+  ++|+||||||+|||||.+ +++||+|||
T Consensus        92 ~~~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   92 PTKIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             CCeEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence             4578999999999999999873   457889999999999999999998  569999999999999999 999999999


Q ss_pred             cceecc-cCCCcceeeccccCCCCcCCcccccCC--C-CCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc
Q psy9535         268 IVKMSE-TSNMKTMYTENLTGTRPYMPPEAMHCQ--I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  343 (593)
Q Consensus       268 la~~~~-~~~~~~~~~~~~~GT~~Y~APE~~~~~--~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~  343 (593)
                      ++.... ...    ...+.+||+.|+|||++.++  | +.++||||+||+||.|++|+.||++.+....+..+..+...+
T Consensus       167 ~s~~~~~~~~----~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~  242 (370)
T KOG0583|consen  167 LSAISPGEDG----LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKI  242 (370)
T ss_pred             cccccCCCCC----cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccC
Confidence            998773 221    23457999999999988653  4 468999999999999999999999977666666655555555


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHH
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV  385 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~  385 (593)
                      +..+.           ...+..++.+|+..+|.+|+++.+|+
T Consensus       243 p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  243 PSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             CCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            55442           12234466899999999999999997

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.4e-42  Score=360.02  Aligned_cols=255  Identities=25%  Similarity=0.401  Sum_probs=190.5

Q ss_pred             CCCCcccccCceEEEEEEE------cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKL------KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLL  184 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~------~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~  184 (593)
                      ++.++||+|+||.||+|.+      .++..||||++....     ...  .     ...|.+|+.++.++ +|||||+++
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~--~-----~~~~~~E~~~l~~l~~h~niv~~~   77 (338)
T cd05102          10 RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-----TAS--E-----HKALMSELKILIHIGNHLNVVNLL   77 (338)
T ss_pred             eeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-----chH--H-----HHHHHHHHHHHHHhccCcceeeEE
Confidence            3468899999999999974      235679999986321     001  1     12578999999999 899999999


Q ss_pred             EEEec--ccceEEEEeccCCCHHHHHhhcCC-------------------------------------------------
Q psy9535         185 GLCNN--IMNCIVYEYMCNGSLYDRLARVNN-------------------------------------------------  213 (593)
Q Consensus       185 g~~~~--~~~~lV~Ey~~~GsL~~~L~~~~~-------------------------------------------------  213 (593)
                      |+|..  ...++||||+++|+|.+++.....                                                 
T Consensus        78 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (338)
T cd05102          78 GACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST  157 (338)
T ss_pred             eEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccc
Confidence            98865  346889999999999999975321                                                 


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecccCCCcceeec
Q psy9535         214 ----------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE  283 (593)
Q Consensus       214 ----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~  283 (593)
                                ..++++.....++.|+++||.|||+  ++|+||||||+|||++.++.+||+|||+++....... .....
T Consensus       158 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~  234 (338)
T cd05102         158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKG  234 (338)
T ss_pred             ccchhccccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhccc
Confidence                      1347888999999999999999998  5699999999999999999999999999986533221 11122


Q ss_pred             cccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHH
Q psy9535         284 NLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVET  361 (593)
Q Consensus       284 ~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (593)
                      ...||+.|+|||++ ...++.++|||||||+||||++ |..||.................... .     .    .....
T Consensus       235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-~-----~----~~~~~  304 (338)
T cd05102         235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR-A-----P----ENATP  304 (338)
T ss_pred             CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC-C-----C----CCCCH
Confidence            34567899999976 4558899999999999999997 9999976432221111111111100 0     0    11122


Q ss_pred             HHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         362 LIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       362 ~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .+..++.+||+.||++||++.||++.|++.
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            345567899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0592|consensus

Probab=100.00  E-value=3.2e-42  Score=359.39  Aligned_cols=246  Identities=28%  Similarity=0.412  Sum_probs=202.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      |+.||+|+|++||+|+.+ +++++|||++.+.-......          ......|-.+|.+| .||-||+|+--+.+ .
T Consensus        78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~K----------vkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~  147 (604)
T KOG0592|consen   78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKK----------VKYVTREKEALTQLSGHPGIVKLYFTFQDEE  147 (604)
T ss_pred             hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcc----------cchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence            789999999999999864 78999999997653322211          12356788889999 89999999987766 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..|+|+||++||+|.++|++.+   .+++.....++.+|+.||+|||+  .+||||||||+|||||+|+++||+|||.|+
T Consensus       148 sLYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEEeeccccc
Confidence            6789999999999999999864   58999999999999999999998  569999999999999999999999999999


Q ss_pred             ecccCCCc----------ceeeccccCCCCcCCcccccCC-CCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh
Q psy9535         271 MSETSNMK----------TMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  339 (593)
Q Consensus       271 ~~~~~~~~----------~~~~~~~~GT~~Y~APE~~~~~-~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~  339 (593)
                      .+......          .....+++||..|.+||++... .+..+|+|+||||||+|+.|.+||.+.+....+..++.-
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l  302 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL  302 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence            86543221          1111458999999999988654 678899999999999999999999999888888888777


Q ss_pred             cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         340 EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...+++.+.            ..+..++++-+..||.+|+|..+|-+
T Consensus       303 ~y~fp~~fp------------~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  303 DYEFPEGFP------------EDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             cccCCCCCC------------HHHHHHHHHHHccCccccccHHHHhh
Confidence            766655443            23445667888999999999988754

>KOG0616|consensus

Probab=100.00  E-value=6.8e-42  Score=333.88  Aligned_cols=232  Identities=30%  Similarity=0.423  Sum_probs=193.7

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ...||.|+||+|.+.+.+ +|..+|+|++++...          ..+.......+|..+|+.+.||.+++|.+.|.+ ..
T Consensus        49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v----------VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~  118 (355)
T KOG0616|consen   49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV----------VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN  118 (355)
T ss_pred             eeeeccCccceEEEEEEccCCceeehhhcCHHHH----------HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence            368999999999999876 688999999975421          112223346789999999999999999998876 66


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||++||.|..+|++.   ..+++..+..+|.||+.||+|||+  ..|++|||||+|||||.+|.+||+|||+|+.
T Consensus       119 lymvmeyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             EEEEEeccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeeeccCCcEEEEeccceEE
Confidence            78999999999999999875   358999999999999999999998  4599999999999999999999999999997


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ....      +-+.||||.|+|||++.. .+..++|+|||||++|||+.|.+||.+.+....+..++.+...++..+.+.
T Consensus       194 v~~r------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~  267 (355)
T KOG0616|consen  194 VSGR------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSD  267 (355)
T ss_pred             ecCc------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHH
Confidence            6542      345799999999997754 577788999999999999999999999999999999998888777665543


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCC
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKR  378 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~R  378 (593)
                                  ++.++.+-++.|-.+|
T Consensus       268 ------------~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  268 ------------AKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ------------HHHHHHHHHhhhhHhh
Confidence                        2334445556666666

>KOG4721|consensus

Probab=100.00  E-value=1.4e-42  Score=361.50  Aligned_cols=236  Identities=30%  Similarity=0.513  Sum_probs=189.9

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccce
Q psy9535         115 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNC  193 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~  193 (593)
                      +-||.|+.|.||+|+++ ++.||||+++..                    -+.+|.-|++|+||||+.+.|+|.. .-.|
T Consensus       130 eWlGSGaQGAVF~Grl~-netVAVKKV~el--------------------kETdIKHLRkLkH~NII~FkGVCtqsPcyC  188 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH-NETVAVKKVREL--------------------KETDIKHLRKLKHPNIITFKGVCTQSPCYC  188 (904)
T ss_pred             hhhccCcccceeeeecc-CceehhHHHhhh--------------------hhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence            46999999999999997 689999987521                    2457889999999999999999987 5668


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecc
Q psy9535         194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  273 (593)
Q Consensus       194 lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~  273 (593)
                      ||||||+.|-|+..|+..   .++.....+.+..+||.|+.|||.  +.|||||||+-||||..+..+||+|||-++...
T Consensus       189 IiMEfCa~GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~--hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~  263 (904)
T KOG4721|consen  189 IIMEFCAQGQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHL--HKIIHRDLKSPNILISYDDVVKISDFGTSKELS  263 (904)
T ss_pred             EeeeccccccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHH--hhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence            999999999999999863   457778888999999999999998  559999999999999999999999999988665


Q ss_pred             cCCCcceeeccccCCCCcCCcccccCC-CCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccC
Q psy9535         274 TSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG  352 (593)
Q Consensus       274 ~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (593)
                      ...  +  ...++||..|||||++..+ .+.|+|||||||||||||||..||.+-......+-+  +. ....+      
T Consensus       264 ~~S--T--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV--Gs-NsL~L------  330 (904)
T KOG4721|consen  264 DKS--T--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV--GS-NSLHL------  330 (904)
T ss_pred             hhh--h--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec--cC-Ccccc------
Confidence            432  1  2358999999999998765 688999999999999999999999874432211110  00 00011      


Q ss_pred             CCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         353 EWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       353 ~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                       ..+..+.+-+.+++++||...|..||++++|+..|+-
T Consensus       331 -pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  331 -PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             -cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence             1122334456678899999999999999999987753

>KOG0582|consensus

Probab=100.00  E-value=3.8e-41  Score=344.17  Aligned_cols=255  Identities=25%  Similarity=0.371  Sum_probs=199.4

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe-cc
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-NI  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~-~~  190 (593)
                      +...||.|.-++||+|+.. .+..||||++.-.....            .+...++|++.|+.++||||++.+..+. +.
T Consensus        30 L~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~------------~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   30 LQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN------------DLDALRKEVQTMSLIDHPNIVTYHCSFVVDS   97 (516)
T ss_pred             EEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh------------hHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence            3578999999999999864 67899999996532111            1224789999999999999999998664 56


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..|+||.||.+||+.+.++..-. ..+++..+..|.++++.||.|||.  ++.||||||+.||||+.+|.+||+|||.+.
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~--~G~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQ--NGHIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHh--cCceecccccccEEEcCCCcEEEcCceeee
Confidence            78999999999999999987543 358999999999999999999998  569999999999999999999999999876


Q ss_pred             ecccCCCcceee-ccccCCCCcCCccccc---CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         271 MSETSNMKTMYT-ENLTGTRPYMPPEAMH---CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       271 ~~~~~~~~~~~~-~~~~GT~~Y~APE~~~---~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ............ ..++||++|||||++.   ..|+.|+|||||||+..||++|..||.....+......+.+..|....
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t  254 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT  254 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence            655444322222 5679999999999852   368999999999999999999999999876655554444444443321


Q ss_pred             --cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 --LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 --~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        ++.+.    .......+..++..|++.||.+|||+.++++
T Consensus       255 ~~~~~d~----~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  255 SGLDKDE----DKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ccCChHH----hhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence              11110    1112234555667999999999999999864

>KOG1026|consensus

Probab=100.00  E-value=4.1e-42  Score=376.80  Aligned_cols=253  Identities=29%  Similarity=0.476  Sum_probs=195.8

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .+.||+|+||+||+|+..      +.+.||||.+++....            ...+.|++|+++|+.++|||||+|+|+|
T Consensus       491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~------------~~~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN------------QARQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH------------HHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            368999999999999853      2467999999754211            0123799999999999999999999999


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNN-----------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  255 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl  255 (593)
                      .+ +..++|+|||..|+|.++|.....           ..+|+..+.+.||.|||.|++||-+  +.+|||||-..|+|+
T Consensus       559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~--~~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS--HHFVHRDLATRNCLV  636 (774)
T ss_pred             ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--Ccccccchhhhhcee
Confidence            77 566899999999999999975321           2348999999999999999999987  449999999999999


Q ss_pred             cCCCccEEeecccceecccCCCcceeeccccCCCCcCCcc-cccCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHH
Q psy9535         256 DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYY  333 (593)
Q Consensus       256 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE-~~~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~  333 (593)
                      .++..+||+||||+|..-..+.-... ....=...||||| ++.++++++||||||||||||++| |+.||.+.......
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~-~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI  715 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVR-GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI  715 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhccc-CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence            99999999999999854332211110 0111246799999 568999999999999999999997 99999886554444


Q ss_pred             HHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         334 YLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      ..+..+..  .+         .++.+...+..++..||+.+|.+||+++||-..|+...
T Consensus       716 e~i~~g~l--L~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  716 ECIRAGQL--LS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             HHHHcCCc--cc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            43333321  11         11122334555677999999999999999999998743

>KOG0194|consensus

Probab=100.00  E-value=1.4e-41  Score=361.86  Aligned_cols=254  Identities=30%  Similarity=0.422  Sum_probs=197.8

Q ss_pred             CCCcccccCceEEEEEEEcC--C--CE-EEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLKN--G--ME-IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~--g--~~-vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      ++++||+|+||.||+|+++.  +  .. ||||..+...          ......+..|.+|+++|++++|||||+++|++
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~----------~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS----------ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccc----------cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            35899999999999998753  2  23 8999986421          01112245799999999999999999999998


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      .. ...+||||+|.||+|.++|.+...  .++..+++.++.++|+||+|||+  +++|||||-.+|+|++.++.+||+||
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~--k~~IHRDIAARNcL~~~~~~vKISDF  306 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHS--KNCIHRDIAARNCLYSKKGVVKISDF  306 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHH--CCCcchhHhHHHheecCCCeEEeCcc
Confidence            76 566899999999999999987543  58999999999999999999998  66999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      ||++........   .....-...|+|||.+. +.++.++|||||||++||+++ |..||.+.........+.....+..
T Consensus       307 GLs~~~~~~~~~---~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~  383 (474)
T KOG0194|consen  307 GLSRAGSQYVMK---KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP  383 (474)
T ss_pred             ccccCCcceeec---cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC
Confidence            998764311110   00112246799999874 568899999999999999998 8999998776655555533332211


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhccc
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMF  393 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~  393 (593)
                      .          +......+..++.+||..+|++||+|.+|.+.|+...-
T Consensus       384 ~----------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  384 I----------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             C----------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence            1          01223445566789999999999999999999987543

>KOG0605|consensus

Probab=100.00  E-value=4.8e-41  Score=351.01  Aligned_cols=243  Identities=21%  Similarity=0.288  Sum_probs=188.5

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      -..||+|+||.||+|+-+ +|..+|+|+|++.......+          +.-...|-.+|....+|+||+|+-.+.+ ..
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Q----------v~hV~aERdiL~~~ds~~vVKLyYsFQD~~~  215 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQ----------VEHVRAERDILAEVDSPWVVKLYYSFQDKEY  215 (550)
T ss_pred             heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhh----------HHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence            578999999999999865 69999999998764433222          1235679999999999999999988877 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .||||||++||++..+|.+.   ..|++..+..++.+++.|++-||.  .++|||||||+|+|||..|++||+||||+.-
T Consensus       216 LYLiMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~--~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQ--LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             eEEEEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHH--cCcccccCChhheeecCCCCEeeccccccch
Confidence            79999999999999999864   468999999999999999999998  5599999999999999999999999999853


Q ss_pred             cccC----------------------CCc------ce----------------eeccccCCCCcCCccccc-CCCCCcch
Q psy9535         272 SETS----------------------NMK------TM----------------YTENLTGTRPYMPPEAMH-CQISTKTD  306 (593)
Q Consensus       272 ~~~~----------------------~~~------~~----------------~~~~~~GT~~Y~APE~~~-~~~~~ksD  306 (593)
                      ....                      ...      ..                .....+|||.|||||++. ..|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            2110                      000      00                011357999999999875 45888999


Q ss_pred             hhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCC
Q psy9535         307 VFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS  380 (593)
Q Consensus       307 VwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs  380 (593)
                      +||+|||+||||.|.+||..+.....|..+......+...-+.    .    +.....++|.+|+. ||++|-.
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~----~----~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV----D----LSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC----c----ccHHHHHHHHHHhc-CHHHhcC
Confidence            9999999999999999999988887777776554222111110    1    11223445556666 9999976

>KOG0588|consensus

Probab=100.00  E-value=9.8e-41  Score=354.64  Aligned_cols=245  Identities=28%  Similarity=0.435  Sum_probs=203.2

Q ss_pred             CCCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         111 PRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       111 ~~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      +++|+-||+|+-|.|-.|++ .+|+.+|||.+.+.........          ...++|+-+|+-+.||||++|++++.+
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~----------~~IerEIviMkLi~HpnVl~LydVwe~   83 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQP----------AGIEREIVIMKLIEHPNVLRLYDVWEN   83 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccc----------cchhhhhHHHHHhcCCCeeeeeeeecc
Confidence            36789999999999999986 5899999999976543332221          146889999999999999999998876


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...|+|.||+++|.|+++|-++   +++++.+..+++.||+.|+.|+|..  +|+||||||+|+|||..+++||+|||+
T Consensus        84 ~~~lylvlEyv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~--~icHRDLKpENlLLd~~~nIKIADFGM  158 (786)
T KOG0588|consen   84 KQHLYLVLEYVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAF--NICHRDLKPENLLLDVKNNIKIADFGM  158 (786)
T ss_pred             CceEEEEEEecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhh--cceeccCCchhhhhhcccCEeeeccce
Confidence             6778999999999999999874   4689999999999999999999984  499999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccCC-C-CCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      |.+......    ..+-||+|.|.|||++.+. | +.++||||.|||||.||||+.||++++-...+..+..+...++..
T Consensus       159 AsLe~~gkl----LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~  234 (786)
T KOG0588|consen  159 ASLEVPGKL----LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSN  234 (786)
T ss_pred             eecccCCcc----ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCc
Confidence            987654432    2346999999999987654 4 568999999999999999999999887766666666555444433


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +.            ...+.++.+++..||.+|.|+.||++
T Consensus       235 Is------------~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  235 IS------------SEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             CC------------HHHHHHHHHHhccCccccccHHHHhh
Confidence            32            23455677899999999999999976

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.1e-40  Score=348.32  Aligned_cols=240  Identities=23%  Similarity=0.357  Sum_probs=187.1

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccce
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNC  193 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~  193 (593)
                      .||+|+||.||+++.. +|+.||||+++.......          .....+.+|+.++++++||||+++++++.. ...+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAK----------DEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC   71 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------HHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence            6999999999999874 689999999864311100          012247789999999999999999998866 5568


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecc
Q psy9535         194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  273 (593)
Q Consensus       194 lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~  273 (593)
                      +||||+++|+|.+++...   ..+++.....++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++...
T Consensus        72 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~  146 (323)
T cd05571          72 FVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence            999999999999998753   368899999999999999999998  569999999999999999999999999987532


Q ss_pred             cCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccC
Q psy9535         274 TSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG  352 (593)
Q Consensus       274 ~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (593)
                      ....   ......||+.|+|||++. ..++.++|||||||++|||++|+.||...+..............++.       
T Consensus       147 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~-------  216 (323)
T cd05571         147 SDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR-------  216 (323)
T ss_pred             cCCC---cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Confidence            2211   123457999999999874 45789999999999999999999999876544333333322222111       


Q ss_pred             CCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHH
Q psy9535         353 EWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIV  385 (593)
Q Consensus       353 ~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~  385 (593)
                           .+...+..++.+||+.||++||     ++.+++
T Consensus       217 -----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  249 (323)
T cd05571         217 -----TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIM  249 (323)
T ss_pred             -----CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHH
Confidence                 1122345567899999999999     677764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0597|consensus

Probab=100.00  E-value=2.4e-41  Score=352.67  Aligned_cols=241  Identities=27%  Similarity=0.410  Sum_probs=192.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      -+.||+|+||.||||+.+ +.+.||+|.+.+....      .     ..+....+|++|++.++|||||.++.+++. ..
T Consensus         7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~------~-----k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~   75 (808)
T KOG0597|consen    7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN------E-----KELKNLRQEVRILRSLKHPNIVEMLESFETSAH   75 (808)
T ss_pred             HHHhcCCccceeeecccccceeEEEEEEehhcCCc------h-----HHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence            467999999999999865 6889999999754211      1     113347899999999999999999998876 57


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .|+|+||+.| +|..+|...   ..+++.....|+.+++.||.|||+  .+|+|||+||.||||+.++.+|+||||+||.
T Consensus        76 ~~vVte~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs--~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~  149 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHS--NRILHRDMKPQNILLEKGGTLKLCDFGLARA  149 (808)
T ss_pred             EEEEehhhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh--cCcccccCCcceeeecCCCceeechhhhhhh
Confidence            7899999986 999999763   458999999999999999999998  5599999999999999999999999999997


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ....   +...+.+.|||.|||||+..+ .|+..+|.||+||++|||.+|++||....-......+.....+.       
T Consensus       150 m~~~---t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~-------  219 (808)
T KOG0597|consen  150 MSTN---TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP-------  219 (808)
T ss_pred             cccC---ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC-------
Confidence            6543   344567899999999997754 57889999999999999999999998654333322332222211       


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                          +. .+......+++.-+..||.+|.+..+++.
T Consensus       220 ----p~-~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  220 ----PS-TASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ----cc-cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                11 23334445666778999999999999864

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.7e-40  Score=340.05  Aligned_cols=258  Identities=29%  Similarity=0.388  Sum_probs=187.8

Q ss_pred             CCCCcccccCceEEEEEEEcC-----------------CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKN-----------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ  174 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~-----------------g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~  174 (593)
                      +..++||+|+||.||+|++.+                 +..||||.+....     . ...      ...|.+|+.++.+
T Consensus         8 ~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~-~~~------~~~~~~E~~~l~~   75 (304)
T cd05096           8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-----N-KNA------RNDFLKEVKILSR   75 (304)
T ss_pred             eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-----C-HHH------HHHHHHHHHHHhh
Confidence            346789999999999997532                 3369999986421     1 111      2258899999999


Q ss_pred             CCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHh
Q psy9535         175 CKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN----------------TPPLDSNKRYSIALGVAEALHYLH  237 (593)
Q Consensus       175 l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH  237 (593)
                      ++||||++++|++.+ ...++||||+++|+|.+++.....                ...+++.....++.|++.||.|||
T Consensus        76 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH  155 (304)
T cd05096          76 LKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS  155 (304)
T ss_pred             cCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            999999999998876 566899999999999999865321                134788899999999999999999


Q ss_pred             cCCCCeEecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHH
Q psy9535         238 SLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLE  316 (593)
Q Consensus       238 ~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~E  316 (593)
                      +  .+|+||||||+|||++.++.+||+|||+++....... ........+++.|||||++ .+.++.++|||||||++||
T Consensus       156 ~--~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  232 (304)
T cd05096         156 S--LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE  232 (304)
T ss_pred             H--CCccccCcchhheEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence            8  5699999999999999999999999999986533221 1112234568899999976 4568899999999999999


Q ss_pred             HHh--CCCCCCCCchHHHHHHHHhh-cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         317 LLT--GMKPIDDNNTILYYYLVVEQ-EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       317 llt--G~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                      |++  |..||............... .............     .+...+..++.+||+.+|++|||+.+|.+.|+
T Consensus       233 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         233 ILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPP-----PCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             HHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCC-----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            987  56777654332221111100 0000000000000     11223455678999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.6e-40  Score=338.12  Aligned_cols=248  Identities=20%  Similarity=0.265  Sum_probs=186.4

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|.. .+|+.||||.+.........          ....+.+|+.++++++|+||+++++++.+ ..
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----------~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~   74 (285)
T cd05631           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK----------GEAMALNEKRILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhh----------hHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe
Confidence            57899999999999986 47899999998653211100          01247789999999999999999998865 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++.
T Consensus        75 ~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  151 (285)
T cd05631          75 LCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQ  151 (285)
T ss_pred             EEEEEEecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence            689999999999998886533 2468999999999999999999998  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......    .....||+.|+|||++. ..++.++|||||||++|||++|+.||.....................     
T Consensus       152 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  222 (285)
T cd05631         152 IPEGET----VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE-----  222 (285)
T ss_pred             cCCCCe----ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc-----
Confidence            533211    12357999999999774 46889999999999999999999999864322111111100000000     


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCC-----hHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRAS-----MRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs-----m~eV~~  386 (593)
                        .+ .......+..++.+||..||++||+     +.++++
T Consensus       223 --~~-~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         223 --EY-SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             --cC-CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence              00 0112233556778999999999997     666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=344.17  Aligned_cols=244  Identities=23%  Similarity=0.302  Sum_probs=188.5

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccceE
Q psy9535         117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  194 (593)
Q Consensus       117 LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~l  194 (593)
                      ||+|+||.||+|+.. +++.||+|.+........          .....+.+|+.++++++||||+++++++.+ ...++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   70 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSR----------SEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYL   70 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEE
Confidence            799999999999875 588999999864311110          012257789999999999999999998866 56689


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceeccc
Q psy9535         195 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  274 (593)
Q Consensus       195 V~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~  274 (593)
                      ||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus        71 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  145 (312)
T cd05585          71 VLAFINGGELFHHLQRE---GRFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK  145 (312)
T ss_pred             EEcCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence            99999999999999753   358899999999999999999998  5699999999999999999999999999875432


Q ss_pred             CCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCC
Q psy9535         275 SNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGE  353 (593)
Q Consensus       275 ~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (593)
                      ...   ......||+.|+|||++. ..++.++|||||||++|||++|+.||........+.........++.        
T Consensus       146 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--------  214 (312)
T cd05585         146 DDD---KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD--------  214 (312)
T ss_pred             CCC---ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC--------
Confidence            211   123467999999999774 45788999999999999999999999876544433333222211111        


Q ss_pred             CCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         354 WNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       354 ~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                          .....+..++.+||..||++||++..+.+.|..
T Consensus       215 ----~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         215 ----GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             ----cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence                112234556789999999999976555555544

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.2e-40  Score=352.24  Aligned_cols=254  Identities=28%  Similarity=0.472  Sum_probs=190.4

Q ss_pred             CCCcccccCceEEEEEEE------cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKL------KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  185 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~------~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g  185 (593)
                      .+++||+|+||.||+|++      .++..||||+++....     ...       ...+.+|+.+|+.+ +|||||+++|
T Consensus        39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-----~~~-------~~~~~~Ei~il~~l~~HpnIv~l~~  106 (375)
T cd05104          39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-----LTE-------REALMSELKVLSYLGNHINIVNLLG  106 (375)
T ss_pred             hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-----cHH-------HHHHHHHHHHHHHhcCCcceeeeee
Confidence            368999999999999964      2356899999864311     111       12478899999999 8999999999


Q ss_pred             EEec-ccceEEEEeccCCCHHHHHhhcCC---------------------------------------------------
Q psy9535         186 LCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------------------------------------------  213 (593)
Q Consensus       186 ~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~---------------------------------------------------  213 (593)
                      +|.. ...++||||+++|+|.+++.....                                                   
T Consensus       107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  186 (375)
T cd05104         107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR  186 (375)
T ss_pred             eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence            9876 566899999999999999965321                                                   


Q ss_pred             ---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         214 ---------------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       214 ---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                                           ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~  264 (375)
T cd05104         187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDI  264 (375)
T ss_pred             cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCchhhEEEECCCcEEEecCccceec
Confidence                                 1257889999999999999999998  56999999999999999999999999999865


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ...... .......++..|+|||++. ..++.++|||||||++|||++ |..||...................      .
T Consensus       265 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------~  337 (375)
T cd05104         265 RNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM------L  337 (375)
T ss_pred             cCcccc-cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC------C
Confidence            433211 1112234567899999764 467889999999999999998 899997643222222222211110      0


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .....+    ..+..++.+||+.||++||+|.||++.|++.
T Consensus       338 ~~~~~~----~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 SPECAP----SEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            011111    2345567899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0580|consensus

Probab=100.00  E-value=4.4e-41  Score=319.65  Aligned_cols=244  Identities=26%  Similarity=0.422  Sum_probs=199.0

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      .|+.||+|-||.||.|+.+ ++..||+|++.+.......          ...++.+|++|-+.|+||||++++|++.+ .
T Consensus        26 igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~----------v~~qlrREiEIqs~L~hpnilrlY~~fhd~~   95 (281)
T KOG0580|consen   26 IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQ----------VEHQLRREIEIQSHLRHPNILRLYGYFHDSK   95 (281)
T ss_pred             ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhc----------chhhhhheeEeecccCCccHHhhhhheeccc
Confidence            3899999999999999875 6889999999765322111          12358899999999999999999999877 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..||++||.++|+|+..|.... ...+++.....+..|+|.||.|+|.  +.||||||||+|+|++..+..||+|||-+.
T Consensus        96 riyLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence            5689999999999999998543 2458888888999999999999998  669999999999999999999999999876


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......     ..+.+||..|.|||...+ ..+.++|+|++||+.||++.|.+||........+..+......++..+  
T Consensus       173 ~~p~~k-----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~i--  245 (281)
T KOG0580|consen  173 HAPSNK-----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTI--  245 (281)
T ss_pred             ecCCCC-----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCccc--
Confidence            544221     235799999999997755 578889999999999999999999988766666666554443333222  


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                ..-.++++.+|+..+|.+|.+..||++
T Consensus       246 ----------s~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  246 ----------SGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ----------ChhHHHHHHHHhccCccccccHHHHhh
Confidence                      233456778999999999999999875

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.3e-40  Score=346.97  Aligned_cols=234  Identities=24%  Similarity=0.360  Sum_probs=186.1

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.+ +|+.||||.+........          .....+.+|+.++++++||||+++++++.+ ..
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   92 (329)
T PTZ00263         23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM----------KQVQHVAQEKSILMELSHPFIVNMMCSFQDENR   92 (329)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhh----------hhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence            578999999999999875 689999999864311100          012357899999999999999999998866 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++.....++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  167 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGFAKK  167 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence            68999999999999999763   357888888999999999999998  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .....      ....||+.|+|||++.+ .++.++|||||||++|||++|+.||.+......+..+.....+.+..    
T Consensus       168 ~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~----  237 (329)
T PTZ00263        168 VPDRT------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW----  237 (329)
T ss_pred             cCCCc------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCC----
Confidence            54321      23579999999998754 47889999999999999999999998766544444433332222211    


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCC
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRAS  380 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs  380 (593)
                          .    ...+..++.+||+.||.+||+
T Consensus       238 ----~----~~~~~~li~~~L~~dP~~R~~  259 (329)
T PTZ00263        238 ----F----DGRARDLVKGLLQTDHTKRLG  259 (329)
T ss_pred             ----C----CHHHHHHHHHHhhcCHHHcCC
Confidence                1    123455778999999999997

>KOG0661|consensus

Probab=100.00  E-value=3.1e-41  Score=347.18  Aligned_cols=251  Identities=23%  Similarity=0.349  Sum_probs=193.8

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-~  190 (593)
                      .++||.|.||.||+|+- .+|..||||++++.-..       .+..     .=.+|+..|++|+ |||||+|..++.+ +
T Consensus        15 i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-------~ee~-----~nLREvksL~kln~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen   15 IRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-------WEEC-----MNLREVKSLRKLNPHPNIIKLKEVIRDND   82 (538)
T ss_pred             HHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-------HHHH-----HHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence            36899999999999985 47899999999754211       1111     2368999999999 9999999998765 3


Q ss_pred             -cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         191 -MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       191 -~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                       ..++|||||. .+|+++++.+  ..++++..+..|++||++||+|+|.  +++.|||+||+|||+.....+||+|||||
T Consensus        83 ~~L~fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk--~GfFHRDlKPENiLi~~~~~iKiaDFGLA  157 (538)
T KOG0661|consen   83 RILYFVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK--HGFFHRDLKPENILISGNDVIKIADFGLA  157 (538)
T ss_pred             ceEeeeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh--cCcccccCChhheEecccceeEecccccc
Confidence             5689999995 6899999875  4689999999999999999999998  67999999999999998999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccc--cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc-cc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR-EV  346 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~--~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~-~~  346 (593)
                      |.......-    +..+.|.+|.|||++  .+.|+.+.|+||+|||++|+.+-++-|.+.++....+.+..--+... +.
T Consensus       158 Rev~SkpPY----TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~  233 (538)
T KOG0661|consen  158 REVRSKPPY----TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS  233 (538)
T ss_pred             cccccCCCc----chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence            987655432    245789999999976  34588899999999999999999999998777666665543221111 11


Q ss_pred             ccc-------------ccCC-----CCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDK-------------EAGE-----WNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~-------------~~~~-----~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...             ....     ..+. +......++.+|+.+||++|||+.|.++
T Consensus       234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  234 WPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             chhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            100             0000     0011 1122334567999999999999999875

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-40  Score=339.99  Aligned_cols=239  Identities=25%  Similarity=0.365  Sum_probs=188.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +|+.||||++........          .....+.+|+.++++++||||+++++++.+ ..
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   75 (291)
T cd05612           6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL----------KQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF   75 (291)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhh----------HHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe
Confidence            578999999999999875 689999999864311000          012257899999999999999999998765 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++.....++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            68999999999999999753   358899999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ....      .....||+.|+|||++.+ .++.++|||||||++|||++|+.||........+..+......++..    
T Consensus       151 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~----  220 (291)
T cd05612         151 LRDR------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH----  220 (291)
T ss_pred             ccCC------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCcc----
Confidence            5332      123579999999997754 47889999999999999999999998765544444333332222111    


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCC-----hHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRAS-----MRDIV  385 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs-----m~eV~  385 (593)
                              ....+..++.+|++.||.+||+     +.|++
T Consensus       221 --------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l  252 (291)
T cd05612         221 --------LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK  252 (291)
T ss_pred             --------CCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence                    1223556778999999999995     66654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.8e-40  Score=343.37  Aligned_cols=241  Identities=24%  Similarity=0.389  Sum_probs=186.6

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccce
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNC  193 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~  193 (593)
                      .||+|+||.||+++.. +|+.||||++........   .       ....+.+|+.+++.++||||+++++++.. ...+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~-------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   71 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAK---D-------EVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC   71 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---h-------HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence            6899999999999865 689999999975321110   0       12357889999999999999999998865 5668


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecc
Q psy9535         194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  273 (593)
Q Consensus       194 lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~  273 (593)
                      +||||+++|+|.+++...   ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        72 lv~Ey~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          72 FVMEYVNGGELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             EEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            999999999999988653   358899999999999999999998  569999999999999999999999999987532


Q ss_pred             cCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccC
Q psy9535         274 TSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG  352 (593)
Q Consensus       274 ~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (593)
                      ....   ......||+.|+|||++. ..++.++|||||||++|||++|+.||..................++..      
T Consensus       147 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~------  217 (328)
T cd05593         147 TDAA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT------  217 (328)
T ss_pred             Cccc---ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCC------
Confidence            2211   123357999999999874 457889999999999999999999997654433322222222221111      


Q ss_pred             CCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHHH
Q psy9535         353 EWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIVD  386 (593)
Q Consensus       353 ~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~~  386 (593)
                            +...+..++.+|++.+|++||     ++.|+++
T Consensus       218 ------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         218 ------LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             ------CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence                  122344567899999999997     7777753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9e-40  Score=342.41  Aligned_cols=257  Identities=20%  Similarity=0.345  Sum_probs=185.7

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI-  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~-  190 (593)
                      +.++||+|+||.||+|+.. +|..||||++......   . .  .     ...+.+|+.++++++||||+++++++... 
T Consensus         4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~-~--~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   72 (338)
T cd07859           4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH---V-S--D-----ATRILREIKLLRLLRHPDIVEIKHIMLPPS   72 (338)
T ss_pred             EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc---c-h--h-----HHHHHHHHHHHHhCCCCCEeeecceEeccC
Confidence            4578999999999999865 6899999998642110   0 0  0     12478999999999999999999987431 


Q ss_pred             -----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         191 -----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       191 -----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                           ..++||||+. ++|.+++...   ..+++..+..++.|+++||.|||+  .+|+||||||+|||++.++.+||+|
T Consensus        73 ~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kL~D  146 (338)
T cd07859          73 RREFKDIYVVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHT--ANVFHRDLKPKNILANADCKLKICD  146 (338)
T ss_pred             CCCCceEEEEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEcc
Confidence                 3589999995 7899888653   358999999999999999999998  5699999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCccccc---CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-cC
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EV  341 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-~~  341 (593)
                      ||+++................||+.|+|||++.   ..++.++|||||||++|||+||+.||............... ..
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~  226 (338)
T cd07859         147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT  226 (338)
T ss_pred             CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence            999986433221111123457999999999764   35788999999999999999999999765432211111100 00


Q ss_pred             ccccc---------------ccc-ccCCCCH--HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREV---------------LDK-EAGEWNE--THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~---------------~~~-~~~~~~~--~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +....               +.. .......  ......+..++.+||..+|++||++.|+++
T Consensus       227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000               000 0000000  001223456778999999999999999874

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0585|consensus

Probab=100.00  E-value=4.9e-40  Score=337.90  Aligned_cols=260  Identities=22%  Similarity=0.325  Sum_probs=199.2

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCC-chhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNS-DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~-~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      ++...||+|.||.|-+|+.. +++.||||++.+......... ........++....+||.+|++|+|||||+|+.+-++
T Consensus       100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD  179 (576)
T KOG0585|consen  100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD  179 (576)
T ss_pred             ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence            34788999999999999864 689999999976543322111 1112233345678899999999999999999998876


Q ss_pred             ---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         190 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       190 ---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                         +..|||+|||..|.+...   ......++..++.++++++..||+|||.  ++||||||||+|+||+++|++||+||
T Consensus       180 P~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRDIKPsNLLl~~~g~VKIsDF  254 (576)
T KOG0585|consen  180 PESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHY--QGIIHRDIKPSNLLLSSDGTVKISDF  254 (576)
T ss_pred             cccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEEcCCCcEEeecc
Confidence               456999999999987432   1122338999999999999999999998  55999999999999999999999999


Q ss_pred             ccceecccCCCc--ceeeccccCCCCcCCcccccC---C--CCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh
Q psy9535         267 GIVKMSETSNMK--TMYTENLTGTRPYMPPEAMHC---Q--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  339 (593)
Q Consensus       267 Gla~~~~~~~~~--~~~~~~~~GT~~Y~APE~~~~---~--~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~  339 (593)
                      |.+.........  .......+|||.|||||....   .  .+.+.||||+||+||-|+.|+.||.++..+..+..+...
T Consensus       255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~  334 (576)
T KOG0585|consen  255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND  334 (576)
T ss_pred             ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence            998765322111  111223689999999997644   2  245789999999999999999999988877777776655


Q ss_pred             cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         340 EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...+++.     +     +..+.+++++.+.+..||++|.+..+|..
T Consensus       335 pL~fP~~-----p-----e~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  335 PLEFPEN-----P-----EINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             cccCCCc-----c-----cccHHHHHHHHHHhhcChhheeehhhhee
Confidence            4433321     1     23345677788999999999999999854

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.2e-40  Score=331.71  Aligned_cols=249  Identities=26%  Similarity=0.402  Sum_probs=189.9

Q ss_pred             CCCcccccCceEEEEEEEc----CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~----~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      ..+.||+|+||.||+|.++    .+..||+|.++....      .. .     ...|.+|+.++++++||||++++|++.
T Consensus         9 ~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~------~~-~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~   76 (266)
T cd05064           9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS------DK-Q-----RRGFLAEALTLGQFDHSNIVRLEGVIT   76 (266)
T ss_pred             EeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC------HH-H-----HHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence            4678999999999999763    356899999864311      01 0     125889999999999999999999886


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      . ...++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+  .+++||||||+|||++.++.+|++|||
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~--~~iiH~dikp~nili~~~~~~~l~dfg  152 (266)
T cd05064          77 RGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSE--MGYVHKGLAAHKVLVNSDLVCKISGFR  152 (266)
T ss_pred             cCCCcEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeeccccHhhEEEcCCCcEEECCCc
Confidence            5 56789999999999999997632  368999999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      ++........  .......++..|+|||.+ ...++.++|||||||++||+++ |..||............... ...  
T Consensus       153 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~--  227 (266)
T cd05064         153 RLQEDKSEAI--YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRL--  227 (266)
T ss_pred             ccccccccch--hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CCC--
Confidence            8765322211  111123456789999976 4567889999999999999775 99999765443322222111 110  


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                         +.     +..+...+..++.+||+.+|++||++.+|.+.|.+
T Consensus       228 ---~~-----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         228 ---PA-----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             ---CC-----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence               00     11122345566779999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.5e-40  Score=342.21  Aligned_cols=241  Identities=23%  Similarity=0.369  Sum_probs=186.8

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccce
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNC  193 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~  193 (593)
                      .||+|+||.||+++.. +|..||+|++........          .....+.+|+.++++++||||+++++++.. ...+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   71 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------HHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence            6899999999999864 689999999875311100          012247789999999999999999998765 5668


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecc
Q psy9535         194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  273 (593)
Q Consensus       194 lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~  273 (593)
                      +||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        72 lv~E~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  146 (323)
T cd05595          72 FVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence            999999999999888753   358899999999999999999998  569999999999999999999999999987532


Q ss_pred             cCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccC
Q psy9535         274 TSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG  352 (593)
Q Consensus       274 ~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (593)
                      ....   ......||+.|+|||++. ..++.++|||||||++|||++|+.||..................++..      
T Consensus       147 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~------  217 (323)
T cd05595         147 SDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT------  217 (323)
T ss_pred             CCCC---ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCC------
Confidence            2211   122357999999999774 457889999999999999999999997755443333333222221111      


Q ss_pred             CCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHHH
Q psy9535         353 EWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIVD  386 (593)
Q Consensus       353 ~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~~  386 (593)
                            +...+..++.+||..||++||     ++.++++
T Consensus       218 ------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         218 ------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ------CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                  122345577899999999998     6777653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0600|consensus

Probab=100.00  E-value=7.4e-40  Score=339.31  Aligned_cols=254  Identities=24%  Similarity=0.363  Sum_probs=187.8

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec---
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~---  189 (593)
                      .++||+|.||.||+|+. .+|+.||+|++........ .    .      .-..+||.||++|.||||++|.+...+   
T Consensus       122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~----~------~t~~REI~ILr~l~HpNIikL~eivt~~~~  190 (560)
T KOG0600|consen  122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-F----P------ITAIREIKILRRLDHPNIIKLEEIVTSKLS  190 (560)
T ss_pred             HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-c----h------HHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence            36899999999999985 5799999999975421110 0    0      123689999999999999999997755   


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...|||+|||+. +|.-++..  ..-.++..++..++.|+++||+|+|+  ++|+|||||.+|||||.+|.+||+|||||
T Consensus       191 ~siYlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  191 GSIYLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHS--RGVLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             ceEEEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhh--cCeeeccccccceEEcCCCCEEeccccce
Confidence            367999999974 66666643  23468999999999999999999998  66999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc---
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR---  344 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~---  344 (593)
                      ++........ +| ..+-|.+|.|||.+.+  .|+.++|+||.||||.||++|++.|.+.........+..-.+...   
T Consensus       266 r~y~~~~~~~-~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  266 RFYTPSGSAP-YT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY  343 (560)
T ss_pred             eeccCCCCcc-cc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence            9876654322 23 3456999999997754  589999999999999999999999988766554444332211110   


Q ss_pred             ---------cccccccCCCCHH------HHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 ---------EVLDKEAGEWNET------HVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ---------~~~~~~~~~~~~~------~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                               ..+.+. ..+...      ......-.++...+..||++|.|+.++++
T Consensus       344 W~~~kLP~~~~~kp~-~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  344 WPVSKLPHATIFKPQ-QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccccCCcccccCCC-CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                     111110 000000      00111223456788899999999998764

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2e-39  Score=326.81  Aligned_cols=248  Identities=24%  Similarity=0.355  Sum_probs=190.7

Q ss_pred             cccccCceEEEEEEEc---CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         116 KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~---~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      +||+|+||.||+|.++   ++..+|+|.++....    ...       ....|.+|+.++++++||||++++|++.....
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~----~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   70 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN----DPA-------LKDELLREANVMQQLDNPYIVRMIGICEAESW   70 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC----cHH-------HHHHHHHHHHHHHhCCCCCcceEEEEEcCCCc
Confidence            5899999999999753   578899999853311    100       12258899999999999999999999988788


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus        71 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~  145 (257)
T cd05116          71 MLVMELAELGPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEE--TNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  145 (257)
T ss_pred             EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchhhEEEcCCCeEEECCCcccccc
Confidence            9999999999999999753   358899999999999999999998  56999999999999999999999999998865


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ..............+++.|+|||.+. ..++.++|||||||++|||++ |..||..............+..  ...    
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~--~~~----  219 (257)
T cd05116         146 GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER--MEC----  219 (257)
T ss_pred             CCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC--CCC----
Confidence            43321111112234567899999774 457789999999999999998 9999986544332222221111  010    


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ..     .+...+..++.+||+.+|++||++.+|++.|++
T Consensus       220 ~~-----~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 PQ-----RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CC-----CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            01     112235567789999999999999999999976

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.8e-40  Score=348.75  Aligned_cols=254  Identities=29%  Similarity=0.488  Sum_probs=190.1

Q ss_pred             CCCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  185 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g  185 (593)
                      .++.||+|+||.||+|++.      ++..||||++.....     .+.       ...+.+|+.+++.+ +|||||+++|
T Consensus        42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~-------~~~~~~E~~il~~l~~h~nIv~~~~  109 (374)
T cd05106          42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-----TDE-------REALMSELKILSHLGQHKNIVNLLG  109 (374)
T ss_pred             ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-----HHH-------HHHHHHHHHHHHhhccCCceeeEee
Confidence            3689999999999998742      245799999864311     111       12478899999999 8999999999


Q ss_pred             EEec-ccceEEEEeccCCCHHHHHhhcCC---------------------------------------------------
Q psy9535         186 LCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------------------------------------------  213 (593)
Q Consensus       186 ~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~---------------------------------------------------  213 (593)
                      +|.. ...++||||+++|+|.+++.....                                                   
T Consensus       110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (374)
T cd05106         110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS  189 (374)
T ss_pred             EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence            9876 566899999999999999864211                                                   


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecccCCC
Q psy9535         214 ----------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM  277 (593)
Q Consensus       214 ----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~  277 (593)
                                      ..++++....+++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++.......
T Consensus       190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                            1247888999999999999999998  5699999999999999999999999999876543221


Q ss_pred             cceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccccCCCC
Q psy9535         278 KTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWN  355 (593)
Q Consensus       278 ~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (593)
                       ........+++.|||||++ ...++.++|||||||++|||++ |+.||...................      ......
T Consensus       268 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~------~~~~~~  340 (374)
T cd05106         268 -YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM------SRPDFA  340 (374)
T ss_pred             -eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc------cCCCCC
Confidence             1112223466789999976 4568899999999999999997 999997643322222222111110      001111


Q ss_pred             HHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         356 ETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       356 ~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                          ...+..++.+||+.+|++||++.+|+++|++.
T Consensus       341 ----~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         341 ----PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                12345567799999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.1e-39  Score=324.95  Aligned_cols=245  Identities=26%  Similarity=0.439  Sum_probs=190.4

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      .+.||+|+||.||+++++++..+|+|.+.....    .    .      ..|.+|+.++++++||||+++++++.. ...
T Consensus         9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~----~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd05114           9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----S----E------EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL   74 (256)
T ss_pred             eeEecCCcCceEEEEEeccCceEEEEecccCCc----c----H------HHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence            468999999999999998888999998753210    0    1      147889999999999999999998876 556


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+++..
T Consensus        75 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~  150 (256)
T cd05114          75 YIVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLER--NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV  150 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcceEEEcCCCeEEECCCCCcccc
Confidence            89999999999999987532  358899999999999999999998  56999999999999999999999999998764


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .....  .......++..|+|||.+. ..++.++|||||||++|||++ |+.||....................    + 
T Consensus       151 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~----~-  223 (256)
T cd05114         151 LDDEY--TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR----P-  223 (256)
T ss_pred             CCCce--eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC----C-
Confidence            32221  1112234567899999774 457889999999999999999 9999987554333333322211110    1 


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                        ..    ....+..++.+||+.+|++||++.++++.|.
T Consensus       224 --~~----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         224 --KL----ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             --CC----CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              01    1123456677999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.1e-39  Score=337.38  Aligned_cols=250  Identities=25%  Similarity=0.389  Sum_probs=190.3

Q ss_pred             CCcccccCceEEEEEEEc-CCC----EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~----~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      .+.||+|+||.||+|++. +|.    .||||.++...     . ..      ....|.+|+.+++.++||||++++|+|.
T Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-----~-~~------~~~~~~~e~~~l~~l~h~niv~~~g~~~   79 (316)
T cd05108          12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-----S-PK------ANKEILDEAYVMASVDNPHVCRLLGICL   79 (316)
T ss_pred             eeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-----C-HH------HHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence            578999999999999864 343    38999985321     0 00      0125789999999999999999999998


Q ss_pred             cccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         189 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       189 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      ....++|+||+++|+|.+++....  ..+++...+.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        80 ~~~~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          80 TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             CCCceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEecCCCcEEEccccc
Confidence            887889999999999999997643  358899999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ++....... ........++..|+|||.+. ..++.++|||||||++|||++ |+.||.+......... ......... 
T Consensus       156 a~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~-  232 (316)
T cd05108         156 AKLLGADEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-LEKGERLPQ-  232 (316)
T ss_pred             cccccCCCc-ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HhCCCCCCC-
Confidence            987543321 11112234567899999764 567889999999999999998 9999986543322221 111111100 


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                          .... .    ..+..++.+||..+|++||++.+++..|...
T Consensus       233 ----~~~~-~----~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         233 ----PPIC-T----IDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             ----CCCC-C----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                0111 1    1234566799999999999999999988764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0196|consensus

Probab=100.00  E-value=2.8e-41  Score=363.37  Aligned_cols=283  Identities=27%  Similarity=0.427  Sum_probs=222.7

Q ss_pred             ceeecHHHHHHHhcCCCCCCC---CCCCCcccccCceEEEEEEEc-CC---CEEEEEEeecCCCCCCCCCchhHHhhhcH
Q psy9535          90 LIAFTFCDLERATDGFNRKPY---PRRGNKLGEGQFGTVYYGKLK-NG---MEIAVKTLENNANYSSSNSDNTEAAMIPI  162 (593)
Q Consensus        90 ~~~~~~~~l~~at~~f~~~~~---~~~~~~LG~G~fG~Vy~g~~~-~g---~~vAVK~l~~~~~~~~~~~~~~~~~~~~~  162 (593)
                      +..+||+|=-+|-..|..+--   .++.++||.|.||.||+|+++ .|   ..||||.|+...  ..+          ..
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tek----------qr  674 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEK----------QR  674 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHH----------HH
Confidence            556889988888888876533   367789999999999999986 23   469999997542  111          12


Q ss_pred             HHHHHHHHHHhcCCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q psy9535         163 LLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK  241 (593)
Q Consensus       163 ~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  241 (593)
                      ..|+.|+.||.++.||||++|-|+... ....||.|||+||+|..+|+.+.  ..+.+-+...++++||.|+.||-+.  
T Consensus       675 rdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm--  750 (996)
T KOG0196|consen  675 RDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM--  750 (996)
T ss_pred             hhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc--
Confidence            269999999999999999999999876 45578999999999999998765  4599999999999999999999884  


Q ss_pred             CeEecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCC--CCcCCcccc-cCCCCCcchhhHHHHHHHHHH
Q psy9535         242 PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT--RPYMPPEAM-HCQISTKTDVFSYGVILLELL  318 (593)
Q Consensus       242 ~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT--~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ell  318 (593)
                      ++|||||...|||++.+..+||+||||+|..+++.. .. .++..|.  ..|.|||++ .++++.+||||||||||||.+
T Consensus       751 ~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~-~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVm  828 (996)
T KOG0196|consen  751 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-AA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM  828 (996)
T ss_pred             CchhhhhhhhheeeccceEEEeccccceeecccCCC-cc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEec
Confidence            499999999999999999999999999998766542 22 2223443  579999976 678999999999999999977


Q ss_pred             h-CCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhccccccc
Q psy9535         319 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCNS  397 (593)
Q Consensus       319 t-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~~~~~  397 (593)
                      + |.+||-+..+......+ ++...++.-          ..+...+..++..||++|-.+||.+.+|+..|.+.+..-.+
T Consensus       829 SyGERPYWdmSNQdVIkaI-e~gyRLPpP----------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S  897 (996)
T KOG0196|consen  829 SYGERPYWDMSNQDVIKAI-EQGYRLPPP----------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS  897 (996)
T ss_pred             ccCCCcccccchHHHHHHH-HhccCCCCC----------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence            5 99999876554433332 233332222          22334455667799999999999999999999998776666


Q ss_pred             cccc
Q psy9535         398 LANL  401 (593)
Q Consensus       398 ~~~~  401 (593)
                      +...
T Consensus       898 Lk~~  901 (996)
T KOG0196|consen  898 LKTI  901 (996)
T ss_pred             hccc
Confidence            5543

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-39  Score=343.68  Aligned_cols=239  Identities=25%  Similarity=0.366  Sum_probs=188.0

Q ss_pred             CCcccccCceEEEEEEEcC--CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~--g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      .+.||+|+||.||+|+++.  +..||+|.+........          .....+.+|+.+++.++|||||++++++.+ .
T Consensus        35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQ----------KQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhh----------hhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            5789999999999998643  36899999864321110          012257889999999999999999998876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG~a~  179 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGFAK  179 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence            568999999999999999753   358899999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .....      .....||+.|||||++.+ .++.++|||||||++|||++|..||........+..+.......+..   
T Consensus       180 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~---  250 (340)
T PTZ00426        180 VVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKF---  250 (340)
T ss_pred             ecCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC---
Confidence            65332      123579999999998754 57889999999999999999999998766555444443332222111   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIV  385 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~  385 (593)
                               ....+..++.+|++.+|++|+     ++.+++
T Consensus       251 ---------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~  282 (340)
T PTZ00426        251 ---------LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK  282 (340)
T ss_pred             ---------CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH
Confidence                     112244567899999999995     677764

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-39  Score=339.59  Aligned_cols=242  Identities=24%  Similarity=0.318  Sum_probs=185.5

Q ss_pred             CcccccCceEEEEEEE----cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         115 NKLGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~----~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++||+|+||.||+++.    .+++.||||.++........         .....+.+|+.+|++++||||+++++++.. 
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~---------~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~   72 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQ---------KDTAHTKAERNILEAVKHPFIVDLIYAFQTG   72 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhh---------hhHHHHHHHHHHHHhCCCCchhceeeEEecC
Confidence            4799999999999975    35789999998643111100         011246789999999999999999998765 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++...   ..+.+..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  147 (323)
T cd05584          73 GKLYLILEYLSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLC  147 (323)
T ss_pred             CeEEEEEeCCCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence            5668999999999999998753   357888888899999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      +.......   ......||+.|+|||++. ..++.++|||||||++|||++|+.||..................++..  
T Consensus       148 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~--  222 (323)
T cd05584         148 KESIHEGT---VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPY--  222 (323)
T ss_pred             eecccCCC---cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--
Confidence            75432221   123457999999999774 457889999999999999999999998765443333333222221111  


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIV  385 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~  385 (593)
                                +...+..++.+||+.+|++||     ++.+++
T Consensus       223 ----------~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~  254 (323)
T cd05584         223 ----------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQ  254 (323)
T ss_pred             ----------CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHh
Confidence                      112345567899999999999     666654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-39  Score=330.28  Aligned_cols=248  Identities=33%  Similarity=0.519  Sum_probs=183.8

Q ss_pred             CCcccccCceEEEEEEEc-----CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         114 GNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-----~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      .+.||.|+||.||+|.+.     .+..|+||.++..     .....       ...|.+|++.+++++||||++++|+|.
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-----~~~~~-------~~~~~~e~~~l~~l~h~ni~~~~g~~~   71 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-----SSEEE-------EEEFLNEIQILRKLRHPNIVKLYGFCI   71 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-----SSHHH-------HHHHHHHHHHHHTHSBTTBE-EEEEEE
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-----ccccc-------ceeeeeccccccccccccccccccccc
Confidence            467999999999999886     2577999999532     11111       225889999999999999999999998


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      . ...++||||+++|+|.++|.... ...+++..+..|+.|+|+||.|||+  ++|+|+||+++|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~--~~iiH~~l~~~nill~~~~~~Kl~~f~  148 (259)
T PF07714_consen   72 ENEPLFLVMEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHS--NNIIHGNLSPSNILLDSNGQVKLSDFG  148 (259)
T ss_dssp             SSSSEEEEEE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHH--TTEEEST-SGGGEEEETTTEEEEESTT
T ss_pred             ccccccccccccccccccccccccc-ccccccccccccccccccccccccc--ccccccccccccccccccccccccccc
Confidence            5 45689999999999999998752 3568999999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      +++....... ........+...|+|||.+. ..++.++||||||+++|||++ |+.||.+.............. .. .
T Consensus       149 ~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~-~~-~  225 (259)
T PF07714_consen  149 LSRPISEKSK-YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ-RL-P  225 (259)
T ss_dssp             TGEETTTSSS-EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-ET-T
T ss_pred             cccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cc-e
Confidence            9987632221 11122345678899999874 457889999999999999999 789998765443333322211 11 0


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL  388 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L  388 (593)
                      .    ...     +...+..++.+||..+|++||+|.+|++.|
T Consensus       226 ~----~~~-----~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 I----PDN-----CPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             S----BTT-----SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             e----ccc-----hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            0    011     122344567899999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG1095|consensus

Probab=100.00  E-value=3.8e-40  Score=373.13  Aligned_cols=252  Identities=30%  Similarity=0.489  Sum_probs=195.4

Q ss_pred             CCCCcccccCceEEEEEEEcC--CC----EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKN--GM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  185 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~--g~----~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g  185 (593)
                      .+.+.||+|.||.||.|...+  |.    .||||.+.+...     ..  +     ...|.+|..+|++++|||||+++|
T Consensus       695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-----~~--~-----~~~Fl~Ea~~m~~f~HpNiv~liG  762 (1025)
T KOG1095|consen  695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-----EQ--E-----VSDFLKEALLMSKFDHPNIVSLIG  762 (1025)
T ss_pred             EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-----HH--H-----HHHHHHHHHHHhcCCCcceeeEEE
Confidence            346789999999999998753  43    489999865421     11  1     236999999999999999999999


Q ss_pred             EEec-ccceEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc
Q psy9535         186 LCNN-IMNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  260 (593)
Q Consensus       186 ~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~  260 (593)
                      +|.+ ...+|++|||++|+|..+|++.+.    ...+.....+.++.|||+|+.||++  +++|||||..+|+||+....
T Consensus       763 v~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~--~~fvHRDLAaRNCLL~~~r~  840 (1025)
T KOG1095|consen  763 VCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES--KHFVHRDLAARNCLLDERRV  840 (1025)
T ss_pred             eecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh--CCCcCcchhhhheeecccCc
Confidence            9977 566899999999999999987521    3468899999999999999999998  56999999999999999999


Q ss_pred             cEEeecccceecccCCCcceeeccccCC--CCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHH
Q psy9535         261 PKLGDFGIVKMSETSNMKTMYTENLTGT--RPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLV  336 (593)
Q Consensus       261 ~Kl~DFGla~~~~~~~~~~~~~~~~~GT--~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~  336 (593)
                      +||+|||+||..-....   +.....+.  ..|||||.+. +.++.|+|||||||+|||++| |..||.+.++.......
T Consensus       841 VKIaDFGlArDiy~~~y---yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~  917 (1025)
T KOG1095|consen  841 VKIADFGLARDIYDKDY---YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV  917 (1025)
T ss_pred             EEEcccchhHhhhhchh---eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH
Confidence            99999999994332221   11111222  4699999875 779999999999999999998 89999886655444433


Q ss_pred             HhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         337 VEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ..+. .+    ++  .    ..+...+..++..||+.+|++||++..|++.+...
T Consensus       918 ~~gg-RL----~~--P----~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  918 LEGG-RL----DP--P----SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             HhCC-cc----CC--C----CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            3332 11    11  1    12223344677799999999999999999977653

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.6e-39  Score=330.39  Aligned_cols=255  Identities=24%  Similarity=0.320  Sum_probs=186.6

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ...++||+|+||.||+|+.+ +++.||+|.++......  .          ...+.+|+.++++++||||+++++++.. 
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~   75 (288)
T cd07871           8 VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--A----------PCTAIREVSLLKNLKHANIVTLHDIIHTE   75 (288)
T ss_pred             eEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--c----------chhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            44678999999999999875 68899999986432110  0          0136789999999999999999998865 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+. |+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~DfG~~  150 (288)
T cd07871          76 RCLTLVFEYLD-SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLA  150 (288)
T ss_pred             CeEEEEEeCCC-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEECcCcce
Confidence            45689999997 59999886533  357889999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-cCcccc-
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVRE-  345 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-~~~~~~-  345 (593)
                      +.......   ......||+.|+|||.+.+  .++.++||||+||++|||+||+.||............... ..+..+ 
T Consensus       151 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (288)
T cd07871         151 RAKSVPTK---TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET  227 (288)
T ss_pred             eeccCCCc---cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence            76432211   1123468999999997643  4788999999999999999999999765433222222111 111000 


Q ss_pred             ---ccc---------cccCCCC----HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 ---VLD---------KEAGEWN----ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ---~~~---------~~~~~~~----~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         ..+         +......    ...+......++.+|++.||.+|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence               000         0000000    0011223456778999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=341.32  Aligned_cols=249  Identities=23%  Similarity=0.294  Sum_probs=190.5

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.++||+|+||.||+|+.. +|+.||||++.......          ......+.+|+.++.+++||||+++++++.+ .
T Consensus         5 ~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~   74 (333)
T cd05600           5 ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK----------LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE   74 (333)
T ss_pred             EEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh----------hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence            3578999999999999976 58999999986431100          0012357889999999999999999998876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~  149 (333)
T cd05600          75 YLYLAMEYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHE--LGYIHRDLKPENFLIDASGHIKLTDFGLSK  149 (333)
T ss_pred             EEEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence            568999999999999999753   358899999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ....      ......||+.|+|||++. ..++.++|||||||++|||++|..||........+............   +
T Consensus       150 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---~  220 (333)
T cd05600         150 GIVT------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR---P  220 (333)
T ss_pred             cccc------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC---C
Confidence            6433      123457999999999774 45788999999999999999999999875544333332221111100   0


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      . .......+...+..++.+|+..+|++||++.++++
T Consensus       221 ~-~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         221 V-YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             C-CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence            0 00000112233455667999999999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6e-39  Score=328.93  Aligned_cols=255  Identities=23%  Similarity=0.344  Sum_probs=185.6

Q ss_pred             CCCcccccCceEEEEEEEc--CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC---CCCceeeEEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLLGLC  187 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~--~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l---~HpNIv~l~g~~  187 (593)
                      ..+.||+|+||.||+|+..  +|+.||||.++........           ...+.+|+.+++++   +||||++++++|
T Consensus         5 ~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~hpniv~~~~~~   73 (290)
T cd07862           5 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-----------PLSTIREVAVLRHLETFEHPNVVRLFDVC   73 (290)
T ss_pred             eeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc-----------hHHHHHHHHHHHhhcccCCCCcceEEEEE
Confidence            4678999999999999863  4688999998653211110           01345677666655   799999999988


Q ss_pred             ec------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCcc
Q psy9535         188 NN------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  261 (593)
Q Consensus       188 ~~------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~  261 (593)
                      ..      ...++||||+. |+|.+++..... ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+
T Consensus        74 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~~~~  149 (290)
T cd07862          74 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQI  149 (290)
T ss_pred             ecccCCCCCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCCCCE
Confidence            42      34589999996 799999875432 458999999999999999999998  569999999999999999999


Q ss_pred             EEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q psy9535         262 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  340 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~  340 (593)
                      ||+|||+++......    ......||+.|+|||.+ ...++.++|||||||++|||++|+.||...........+....
T Consensus       150 kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~  225 (290)
T cd07862         150 KLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI  225 (290)
T ss_pred             EEccccceEeccCCc----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence            999999998654321    12345799999999976 4567889999999999999999999998765443333332211


Q ss_pred             C-ccccc-----------cccccCCCCH---HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         341 V-PVREV-----------LDKEAGEWNE---THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       341 ~-~~~~~-----------~~~~~~~~~~---~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      . +..+.           +.........   ..+...+..++.+|++.+|++|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            1 10000           0000000000   112344566788999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0201|consensus

Probab=100.00  E-value=9.2e-41  Score=341.32  Aligned_cols=242  Identities=29%  Similarity=0.410  Sum_probs=191.6

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|.. ++++.||+|++....     ..+       .+...++|+.+|++++++||.+.+|.+.. ..
T Consensus        18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-----~~d-------eIediqqei~~Ls~~~~~~it~yygsyl~g~~   85 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-----AED-------EIEDIQQEISVLSQCDSPNITEYYGSYLKGTK   85 (467)
T ss_pred             chhccccccceeeeeeeccccceEEEEEechhh-----cch-------hhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence            36899999999999986 468899999996431     111       12347889999999999999999997765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .+++||||.+|++.+.|..   +..+++....-|++++..||.|||+  ++.+|||||+.|||+..+|.+||+|||++..
T Consensus        86 LwiiMey~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~--~~kiHrDIKaanil~s~~g~vkl~DfgVa~q  160 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHS--EKKIHRDIKAANILLSESGDVKLADFGVAGQ  160 (467)
T ss_pred             HHHHHHHhcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhh--cceecccccccceeEeccCcEEEEecceeee
Confidence            6899999999999999975   2345778888899999999999998  5599999999999999999999999999877


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ...+++|||.|||||++.+ .|+.|+||||+|++.+||++|.+|+.+.......+.+.....|        
T Consensus       161 l~~~~~---rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP--------  229 (467)
T KOG0201|consen  161 LTNTVK---RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPP--------  229 (467)
T ss_pred             eechhh---ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCC--------
Confidence            654432   2246899999999998765 6999999999999999999999999875442221111111111        


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         .........++.+++.|+..+|+.||++.++++
T Consensus       230 ---~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  230 ---RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ---ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence               111133345667788999999999999999875

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.8e-39  Score=323.08  Aligned_cols=249  Identities=21%  Similarity=0.363  Sum_probs=188.9

Q ss_pred             cccccCceEEEEEEEc---CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         116 KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~---~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      .||+|+||.||+|.+.   .+..||||.+....     ....       ...|.+|+.++++++||||++++++|.....
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-----~~~~-------~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~   69 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-----EKSV-------RDEMMREAEIMHQLDNPYIVRMIGVCEAEAL   69 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-----ChHH-------HHHHHHHHHHHHhcCCCCeEEEEEEEcCCCe
Confidence            4899999999999764   35579999885431     1000       1258899999999999999999999987788


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++....  ..+++..+.+++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+++..
T Consensus        70 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  145 (257)
T cd05115          70 MLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKAL  145 (257)
T ss_pred             EEEEEeCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--cCeeecccchheEEEcCCCcEEeccCCccccc
Confidence            99999999999999987532  468999999999999999999998  56999999999999999999999999998754


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ..............+++.|+|||.+. ..++.++|||||||++|||++ |..||.................+  . .+  
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~-~~--  220 (257)
T cd05115         146 GADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL--D-CP--  220 (257)
T ss_pred             cCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC--C-CC--
Confidence            33321111111123467899999764 457889999999999999996 99999875443322222211110  0 00  


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                        ...    ...+..++.+||..+|++||++.+|.+.|+..
T Consensus       221 --~~~----~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 --AEC----PPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             --CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence              111    12344567899999999999999999998763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.6e-39  Score=326.69  Aligned_cols=250  Identities=22%  Similarity=0.405  Sum_probs=189.1

Q ss_pred             CCcccccCceEEEEEEEc-CCC----EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~----~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      .+.||+|+||.||+|.+. +|+    .||+|.+...     ....       ....+..|+.++++++||||++++|++.
T Consensus        12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-----~~~~-------~~~~~~~~~~~l~~l~h~~iv~~~~~~~   79 (279)
T cd05111          12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-----SGRQ-------TFQEITDHMLAMGSLDHAYIVRLLGICP   79 (279)
T ss_pred             ccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-----cchH-------HHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence            578999999999999874 454    3677776421     0000       0124778899999999999999999998


Q ss_pred             cccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         189 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       189 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      ....++|+||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+
T Consensus        80 ~~~~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Dfg~  155 (279)
T cd05111          80 GASLQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGV  155 (279)
T ss_pred             CCccEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCCcc
Confidence            777789999999999999997533  468999999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ++....... ........|+..|+|||.+. +.++.++|||||||++|||++ |..||.+................ .  
T Consensus       156 ~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--  231 (279)
T cd05111         156 ADLLYPDDK-KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL-A--  231 (279)
T ss_pred             ceeccCCCc-ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-C--
Confidence            986543321 11123356788999999764 568899999999999999998 99999765432221111111111 0  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                       .+   ....    ..+..++.+||..+|++||++.|+++.|...
T Consensus       232 -~~---~~~~----~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         232 -QP---QICT----IDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             -CC---CCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence             00   0111    1234456799999999999999999988763

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.8e-39  Score=329.86  Aligned_cols=256  Identities=20%  Similarity=0.237  Sum_probs=187.8

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|+.+ +++.||||++.......    ..       ...+.+|++++++++||||+++++++.. .
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~----~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (287)
T cd07848           5 VLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE----EV-------KETTLRELKMLRTLKQENIVELKEAFRRRG   73 (287)
T ss_pred             EEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc----cc-------hhhHHHHHHHHHhCCCccccchhhhEecCC
Confidence            3578999999999999986 58899999986532111    00       1247789999999999999999998865 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||++++.+..+...   ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        74 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  148 (287)
T cd07848          74 KLYLVFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFAR  148 (287)
T ss_pred             EEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence            66899999998877544332   2358899999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccc----
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE----  345 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~----  345 (593)
                      ........  ......||+.|+|||++. ..++.++|||||||++|||++|+.||.................+.+.    
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  226 (287)
T cd07848         149 NLSEGSNA--NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK  226 (287)
T ss_pred             cccccccc--cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence            65432211  122357999999999764 45788999999999999999999999875433222222111111000    


Q ss_pred             ----------ccccccCC-C-----CHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 ----------VLDKEAGE-W-----NETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ----------~~~~~~~~-~-----~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                ...+.... .     ....+...+..++.+|++.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                      00000000 0     00112344667888999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.9e-39  Score=339.32  Aligned_cols=242  Identities=24%  Similarity=0.360  Sum_probs=186.6

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccce
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNC  193 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~  193 (593)
                      .||+|+||.||+++.. +|..||+|.+........          .....+.+|++++..++||||+++++++.. ...+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~----------~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~   71 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC   71 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence            6899999999999864 689999999975321100          012246789999999999999999998765 5678


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecc
Q psy9535         194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  273 (593)
Q Consensus       194 lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~  273 (593)
                      +||||+++|+|.+++...   ..+++..+..++.|++.||.|||+. ++|+||||||+|||++.++.+||+|||+++...
T Consensus        72 lv~E~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~  147 (325)
T cd05594          72 FVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  147 (325)
T ss_pred             EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence            999999999999988653   3589999999999999999999962 469999999999999999999999999987543


Q ss_pred             cCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccC
Q psy9535         274 TSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG  352 (593)
Q Consensus       274 ~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (593)
                      ....   ......||+.|+|||++. ..++.++|||||||++|||++|+.||..................++..      
T Consensus       148 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~------  218 (325)
T cd05594         148 KDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT------  218 (325)
T ss_pred             CCCc---ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCC------
Confidence            2211   122357999999999774 457889999999999999999999997755433333332222222111      


Q ss_pred             CCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHHH
Q psy9535         353 EWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIVD  386 (593)
Q Consensus       353 ~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~~  386 (593)
                            ....+..++.+|++.||++|+     ++.++++
T Consensus       219 ------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         219 ------LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             ------CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence                  112345567899999999997     7888754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.3e-39  Score=327.88  Aligned_cols=251  Identities=27%  Similarity=0.502  Sum_probs=191.6

Q ss_pred             CCcccccCceEEEEEEEcC-C-----CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLKN-G-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~-g-----~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .+.||+|+||.||+|.... +     ..||+|.+....     . ...      ...|.+|+.++++++||||+++++++
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-----~-~~~------~~~~~~ei~~l~~l~h~~i~~~~~~~   77 (283)
T cd05048          10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-----E-PKV------QQEFRQEAELMSDLQHPNIVCLLGVC   77 (283)
T ss_pred             hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-----C-HHH------HHHHHHHHHHHHhcCCcccceEEEEE
Confidence            5789999999999998642 2     579999885321     0 110      12588999999999999999999988


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCe
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  253 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NI  253 (593)
                      .+ ...+++|||+++|+|.+++.....             ...+++.....++.|++.||.|||+  .+|+||||||+||
T Consensus        78 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Ni  155 (283)
T cd05048          78 TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNC  155 (283)
T ss_pred             cCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccccceE
Confidence            66 556899999999999999976321             1357889999999999999999998  5699999999999


Q ss_pred             eecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHH
Q psy9535         254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTIL  331 (593)
Q Consensus       254 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~  331 (593)
                      |+++++.+||+|||+++....... ........+|+.|+|||.+ ...++.++|||||||++|||++ |..||.......
T Consensus       156 l~~~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05048         156 LVGEGLTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE  234 (283)
T ss_pred             EEcCCCcEEECCCcceeecccccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999886533221 1112234578899999965 4568899999999999999998 999998654433


Q ss_pred             HHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         332 YYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ....+.....  ...         +..+...+..++.+||+.+|++||++.||++.|+.
T Consensus       235 ~~~~i~~~~~--~~~---------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 VIEMIRSRQL--LPC---------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcCCc--CCC---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            3222221111  110         11122345566789999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.9e-39  Score=331.81  Aligned_cols=255  Identities=23%  Similarity=0.319  Sum_probs=184.8

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      .+.++||+|+||.||+|+.. +|+.||||.+........            ...+.+|+.++++++||||+++++++.+ 
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~   75 (303)
T cd07869           8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT------------PFTAIREASLLKGLKHANIVLLHDIIHTK   75 (303)
T ss_pred             eEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc------------chhHHHHHHHHhhCCCCCcCeEEEEEecC
Confidence            34689999999999999875 689999999864321100            0136789999999999999999998866 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+. |+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  150 (303)
T cd07869          76 ETLTLVFEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGLA  150 (303)
T ss_pred             CeEEEEEECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECCCCcc
Confidence            45689999985 78888886532  458888999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhh-cCcccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYY-YLVVEQ-EVPVRE  345 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~-~~~~~~-~~~~~~  345 (593)
                      +.......   ......||+.|+|||++.+  .++.++|||||||++|||++|+.||.+....... ...... ..+...
T Consensus       151 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (303)
T cd07869         151 RAKSVPSH---TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED  227 (303)
T ss_pred             eeccCCCc---cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChh
Confidence            75432211   1123568999999997743  4688999999999999999999999864332111 111100 000000


Q ss_pred             ---------cccccc-CCCCHH---------HHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 ---------VLDKEA-GEWNET---------HVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ---------~~~~~~-~~~~~~---------~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                               ...+.. ....+.         .....+..++.+|++.||++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                     000000 000000         01123456778999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.2e-39  Score=336.08  Aligned_cols=236  Identities=26%  Similarity=0.360  Sum_probs=182.2

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-cc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~~  191 (593)
                      ++||+|+||.||+|+.. +|+.||||.+........   ..       ...+..|..++..+ +||||+++++++.. ..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~-------~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~   70 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD---DD-------VDCTMTEKRILALAAKHPFLTALHCCFQTKDR   70 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhh---hH-------HHHHHHHHHHHHhccCCCCccceeeEEEcCCe
Confidence            36999999999999875 578999999865321110   10       12466788888865 79999999998876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+.+...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~E~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~  145 (321)
T cd05591          71 LFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKE  145 (321)
T ss_pred             EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeeccccee
Confidence            68999999999999988753   358899999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...+.......+.......+..    
T Consensus       146 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~----  218 (321)
T cd05591         146 GILNGV---TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVW----  218 (321)
T ss_pred             cccCCc---cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC----
Confidence            432221   1234579999999997754 57889999999999999999999998766544444433322221111    


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCC
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRAS  380 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs  380 (593)
                              +...+..++.+|++.+|++||+
T Consensus       219 --------~~~~~~~ll~~~L~~dp~~R~~  240 (321)
T cd05591         219 --------LSKEAVSILKAFMTKNPNKRLG  240 (321)
T ss_pred             --------CCHHHHHHHHHHhccCHHHcCC
Confidence                    1122445667999999999993

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.6e-39  Score=345.80  Aligned_cols=255  Identities=27%  Similarity=0.403  Sum_probs=190.6

Q ss_pred             CCCCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLL  184 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~  184 (593)
                      .++++||+|+||.||+|+..      .+..||||++.....     ...       ...|.+|+++|+++. |||||+++
T Consensus        40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-----~~~-------~~~~~~Ei~~l~~l~~HpnIv~l~  107 (400)
T cd05105          40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-----SSE-------KQALMSELKIMTHLGPHLNIVNLL  107 (400)
T ss_pred             ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-----hHH-------HHHHHHHHHHHHhcCCCCCeeeEE
Confidence            34689999999999999753      134699999864311     000       125889999999996 99999999


Q ss_pred             EEEec-ccceEEEEeccCCCHHHHHhhcCC--------------------------------------------------
Q psy9535         185 GLCNN-IMNCIVYEYMCNGSLYDRLARVNN--------------------------------------------------  213 (593)
Q Consensus       185 g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~--------------------------------------------------  213 (593)
                      |+|.+ ...+||||||++|+|.++|.....                                                  
T Consensus       108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (400)
T cd05105         108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ  187 (400)
T ss_pred             EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence            99976 567899999999999999875321                                                  


Q ss_pred             -------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCC
Q psy9535         214 -------------------------------------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKS  250 (593)
Q Consensus       214 -------------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp  250 (593)
                                                                 ...+++..+..++.|++.||.|||+  .+|+||||||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dikp  265 (400)
T cd05105         188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAA  265 (400)
T ss_pred             cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCh
Confidence                                                       1247888899999999999999998  5699999999


Q ss_pred             CCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCc
Q psy9535         251 ANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNN  328 (593)
Q Consensus       251 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~  328 (593)
                      +|||++.++.+||+|||+++....... ........|++.|+|||.+. ..++.++|||||||++|||++ |..||....
T Consensus       266 ~Nill~~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~  344 (400)
T cd05105         266 RNVLLAQGKIVKICDFGLARDIMHDSN-YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI  344 (400)
T ss_pred             HhEEEeCCCEEEEEeCCcceecccccc-ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence            999999999999999999986533221 11122345778999999764 457889999999999999997 999997643


Q ss_pred             hHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         329 TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ................     .     +..+...+..++.+||+.+|++||++.+|++.|++.
T Consensus       345 ~~~~~~~~~~~~~~~~-----~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         345 VDSTFYNKIKSGYRMA-----K-----PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             hhHHHHHHHhcCCCCC-----C-----CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence            2211111111111110     0     011223355567799999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.9e-39  Score=336.39  Aligned_cols=238  Identities=28%  Similarity=0.375  Sum_probs=183.8

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-ccc
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~~~  192 (593)
                      .||+|+||.||+|+.+ +++.||||++.+......   .       ....+.+|+.++..+ +||||+++++++.. ...
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~-------~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   71 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD---D-------DVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL   71 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhc---c-------HHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence            6999999999999875 588999999865321110   0       112466788888776 69999999998876 556


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~iv~Ey~~~g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          72 FFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             EEEEcCCCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            8999999999999988753   358899999999999999999998  56999999999999999999999999998753


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  351 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (593)
                      .....   ......||+.|+|||++. ..++.++|||||||++|||++|+.||...+.......+.......+.      
T Consensus       147 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~------  217 (320)
T cd05590         147 IFNGK---TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT------  217 (320)
T ss_pred             CcCCC---cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC------
Confidence            22211   123457999999999775 45788999999999999999999999876554443333322221111      


Q ss_pred             CCCCHHHHHHHHHHHHHHhhccccCCCCChHH
Q psy9535         352 GEWNETHVETLIGIVFEKCCVFEKDKRASMRD  383 (593)
Q Consensus       352 ~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~e  383 (593)
                        +    +...+..++.+|++.||++||++.+
T Consensus       218 --~----~~~~~~~li~~~L~~dP~~R~~~~~  243 (320)
T cd05590         218 --W----LSQDAVDILKAFMTKNPTMRLGSLT  243 (320)
T ss_pred             --C----CCHHHHHHHHHHcccCHHHCCCCCC
Confidence              1    1223445678999999999999843

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-39  Score=338.77  Aligned_cols=238  Identities=24%  Similarity=0.329  Sum_probs=185.6

Q ss_pred             CcccccCceEEEEEEE----cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         115 NKLGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~----~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +.||+|+||.||+++.    .+|+.||+|++......   .        .....+.+|+++|++++||||+++++++.. 
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   70 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---V--------RDRVRTKMERDILAEVNHPFIVKLHYAFQTE   70 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh---h--------hhHHHHHHHHHHHHhCCCCCcccEEEEEEcC
Confidence            4799999999999875    35889999998643110   0        011246789999999999999999998866 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++.+.   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        71 ~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  145 (318)
T cd05582          71 GKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLS  145 (318)
T ss_pred             CEEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHeEECCCCcEEEeeccCC
Confidence            5668999999999999998653   358999999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      +.......   ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||...................+..  
T Consensus       146 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~--  220 (318)
T cd05582         146 KESIDHEK---KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF--  220 (318)
T ss_pred             cccCCCCC---ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCC--
Confidence            76433211   1234679999999998754 57889999999999999999999998765443333332222211111  


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRD  383 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~e  383 (593)
                                +...+..++.+||+.||++||++.+
T Consensus       221 ----------~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         221 ----------LSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ----------CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                      1223455678999999999999776

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.5e-39  Score=324.42  Aligned_cols=252  Identities=24%  Similarity=0.359  Sum_probs=184.0

Q ss_pred             cccccCceEEEEEEEcC---CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         116 KLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~~---g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .||+|+||.||+|.+.+   +..+|+|.++....      .. .     ...|.+|+.++++++||||++++|++.+ ..
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~------~~-~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   69 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS------VQ-E-----QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP   69 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCC------hH-H-----HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC
Confidence            58999999999998643   45799998754311      00 1     1257889999999999999999998876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      .++||||+++|+|.+++.....  ....++..+..++.|++.||+|||+  .+++||||||+||+++.++.+||+|||++
T Consensus        70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~  147 (269)
T cd05087          70 YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--NNFIHSDLALRNCLLTADLTVKIGDYGLS  147 (269)
T ss_pred             cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEECCcccc
Confidence            6899999999999999975332  2346777888899999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC--------CCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--------QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQE  340 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~  340 (593)
                      +....... ........|++.|+|||++..        .++.++|||||||++|||++ |+.||................
T Consensus       148 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  226 (269)
T cd05087         148 HNKYKEDY-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ  226 (269)
T ss_pred             ccccCcce-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcc
Confidence            75432221 111223467889999997642        24779999999999999996 999997644332222111111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         341 VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                      .  ....++....    .....+..++.+|| .+|++|||+.||++.|+
T Consensus       227 ~--~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 Q--LKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             c--CCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            0  1111111110    11223455778998 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.4e-39  Score=336.26  Aligned_cols=194  Identities=29%  Similarity=0.396  Sum_probs=162.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+++.. +|..||+|.+....     . .  .    ....|.+|+++|++++||||+++++++.. ..
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-----~-~--~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (331)
T cd06649          10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-----K-P--A----IRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   77 (331)
T ss_pred             EEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-----C-H--H----HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            578999999999999875 68889999986421     0 0  0    01258899999999999999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  153 (331)
T cd06649          78 ISICMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (331)
T ss_pred             EEEEeecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence            78999999999999998753   3588999999999999999999972 2599999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNN  328 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~  328 (593)
                      .....     .....||+.|+|||++. ..++.++|||||||++|||++|+.||....
T Consensus       154 ~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  206 (331)
T cd06649         154 LIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD  206 (331)
T ss_pred             ccccc-----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            53321     22357999999999775 457889999999999999999999997543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8e-39  Score=333.43  Aligned_cols=238  Identities=26%  Similarity=0.380  Sum_probs=180.7

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhc-CCCCceeeEEEEEec-ccc
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~-l~HpNIv~l~g~~~~-~~~  192 (593)
                      .||+|+||.||+|+.. +++.||||.++.......   ..       ...+..|..++.. .+||||+++++++.. ...
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~-------~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~   71 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED---DD-------VECTMVERRVLALAWEHPFLTHLFCTFQTKEHL   71 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hh-------HHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            6999999999999875 578899999975321110   00       1124556666664 489999999998765 566


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++...   ..+++.....++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~gg~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          72 FFVMEYLNGGDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            8999999999999988753   358899999999999999999998  56999999999999999999999999999764


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  351 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (593)
                      ....   .......||+.|+|||++. ..++.++|||||||++|||++|+.||...+.......+.......+.      
T Consensus       147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------  217 (316)
T cd05592         147 MNGE---GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR------  217 (316)
T ss_pred             CCCC---CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC------
Confidence            3222   1123457999999999775 45788999999999999999999999876544333332222111111      


Q ss_pred             CCCCHHHHHHHHHHHHHHhhccccCCCCChHH
Q psy9535         352 GEWNETHVETLIGIVFEKCCVFEKDKRASMRD  383 (593)
Q Consensus       352 ~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~e  383 (593)
                        .    ....+..++.+||+.+|++||++.+
T Consensus       218 --~----~~~~~~~ll~~~l~~~P~~R~~~~~  243 (316)
T cd05592         218 --W----ISKEAKDCLSKLFERDPTKRLGVDG  243 (316)
T ss_pred             --C----CCHHHHHHHHHHccCCHHHcCCChH
Confidence              1    1223445678999999999999853

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.7e-38  Score=320.21  Aligned_cols=245  Identities=25%  Similarity=0.425  Sum_probs=189.7

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      ...||+|+||.||+|++.++..||||.+.....    .          ...|.+|+.++++++||||++++++|.. ...
T Consensus         9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd05113           9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----S----------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI   74 (256)
T ss_pred             eeEecCcccceEEEEEecCCCcEEEEEcCCCcc----c----------HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence            468999999999999987777899999863210    0          1148899999999999999999999865 456


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+.+|+|.+++....  ..+++..++.++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+++..
T Consensus        75 ~lv~e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~  150 (256)
T cd05113          75 YIVTEYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV  150 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCCEEECCCccceec
Confidence            89999999999999987533  268999999999999999999998  56999999999999999999999999998865


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .....  .......|+..|+|||.+. ..++.++|||||||++|||++ |..||....................      
T Consensus       151 ~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------  222 (256)
T cd05113         151 LDDEY--TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR------  222 (256)
T ss_pred             CCCce--eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC------
Confidence            43221  1112234667899999775 467889999999999999999 9999976544332222222111100      


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                      ...     ....+..++.+||+.+|++||++.+|++.|+
T Consensus       223 ~~~-----~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         223 PHL-----ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCC-----CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            001     1223455677999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.7e-38  Score=320.25  Aligned_cols=248  Identities=27%  Similarity=0.417  Sum_probs=192.1

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      +.++||+|+||.||+|...++..||+|.+.....       .       ...|.+|+.++++++||||+++++++.. ..
T Consensus        10 ~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-------~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05072          10 LVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-------S-------VQAFLEEANLMKTLQHDKLVRLYAVVTKEEP   75 (261)
T ss_pred             EeeecCCcCCceEEEEEecCCceEEEEEccCCch-------h-------HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999988888999998753210       0       1258899999999999999999998765 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~  152 (261)
T cd05072          76 IYIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARV  152 (261)
T ss_pred             cEEEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCcccee
Confidence            689999999999999997643 3468899999999999999999998  5699999999999999999999999999987


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......  .......++..|+|||.+. ..++.++|||||||++|||+| |..||............... ....     
T Consensus       153 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~-----  224 (261)
T cd05072         153 IEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMP-----  224 (261)
T ss_pred             cCCCce--eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCC-----
Confidence            543221  1112334677899999764 457889999999999999998 99999764433222222111 1110     


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ....     ....+..++.+||..+|++||++.++.+.|++
T Consensus       225 ~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 RMEN-----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCC-----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            0011     11234456779999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0659|consensus

Probab=100.00  E-value=5.4e-39  Score=309.46  Aligned_cols=253  Identities=25%  Similarity=0.319  Sum_probs=191.2

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|.||.||+|+. .+|+.||||+++.....     +....      .-.+|+..|+.++|+||+.|++++.. ..
T Consensus         7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-----dGi~~------talREIK~Lqel~h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-----DGINR------TALREIKLLQELKHPNIIELIDVFPHKSN   75 (318)
T ss_pred             hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-----cCccH------HHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence            46899999999999986 57999999999765211     11111      24689999999999999999999876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      ..||+|||+ -+|...++..  ...++......++.++.+||+|||+  +.|+||||||.|+|++.+|.+||+|||+|+.
T Consensus        76 l~lVfEfm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~--~~IlHRDlKPnNLLis~~g~lKiADFGLAr~  150 (318)
T KOG0659|consen   76 LSLVFEFMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHS--KWILHRDLKPNNLLISSDGQLKIADFGLARF  150 (318)
T ss_pred             eEEEEEecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHh--hhhhcccCCccceEEcCCCcEEeecccchhc
Confidence            679999997 5788777653  3578999999999999999999998  5699999999999999999999999999998


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-ccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-PVREVLD  348 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~~~~~~~  348 (593)
                      ........  +. .+-|.+|.|||.+.+  .|+..+|+||.|||+.||+-|.+-|.+.+++.....+...-+ |..+...
T Consensus       151 f~~p~~~~--~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP  227 (318)
T KOG0659|consen  151 FGSPNRIQ--TH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP  227 (318)
T ss_pred             cCCCCccc--cc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence            76654322  22 267999999997643  589999999999999999999888887776655544433211 1111100


Q ss_pred             ---------------c-ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 ---------------K-EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ---------------~-~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                     . ......+...... -+++...+.+||.+|++++|.++
T Consensus       228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~-ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDA-LDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             cccccccHHHHhcCCCCccccccccccHHH-HHHHHhhhccCchhcccHHHHhc
Confidence                           0 0000111112233 34567899999999999999864

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.5e-39  Score=326.69  Aligned_cols=251  Identities=25%  Similarity=0.432  Sum_probs=188.7

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .+.||+|+||.||+|.+.      ++..||||++.....     ..  .     ...|.+|+.+++.++||||+++++++
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-----~~--~-----~~~~~~e~~~l~~l~~~~iv~~~~~~   78 (277)
T cd05062          11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-----MR--E-----RIEFLNEASVMKEFNCHHVVRLLGVV   78 (277)
T ss_pred             eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-----HH--H-----HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            688999999999998753      256799998753210     00  1     12588999999999999999999988


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNN-------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  259 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~  259 (593)
                      .. ...++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||+  .+++||||||+|||+++++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDF  156 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCcchheEEEcCCC
Confidence            76 566899999999999999875321       2346788899999999999999998  5699999999999999999


Q ss_pred             ccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHH
Q psy9535         260 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVV  337 (593)
Q Consensus       260 ~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~  337 (593)
                      .+||+|||+++......... ......+++.|||||.+. ..++.++|||||||++|||++ |..||.............
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM  235 (277)
T ss_pred             CEEECCCCCccccCCcceee-cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            99999999987543322111 111234678899999764 457889999999999999999 788987654433222222


Q ss_pred             hhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ....  ...    .     ..+...+..++.+||+.+|++||++.|+++.|++
T Consensus       236 ~~~~--~~~----~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         236 EGGL--LDK----P-----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             cCCc--CCC----C-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            2111  110    0     1112235567789999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.1e-38  Score=321.36  Aligned_cols=253  Identities=25%  Similarity=0.383  Sum_probs=189.3

Q ss_pred             CCCcccccCceEEEEEEEcC-CC--EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         113 RGNKLGEGQFGTVYYGKLKN-GM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~-g~--~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      ++++||+|+||.||+|++.. +.  .||||.++....    . .. .     ...|.+|++++++++||||++++++|..
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~----~-~~-~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC----T-RS-E-----MEDFLSEAVCMKEFDHPNVMRLIGVCLQ   71 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcC----C-HH-H-----HHHHHHHHHHHHhCCCCCcceEEEEEcc
Confidence            46789999999999998754 33  589998864211    0 10 1     2358889999999999999999998743


Q ss_pred             -------ccceEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC
Q psy9535         190 -------IMNCIVYEYMCNGSLYDRLARVN---NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  259 (593)
Q Consensus       190 -------~~~~lV~Ey~~~GsL~~~L~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~  259 (593)
                             ...++||||+++|+|.+++....   ....+++.....++.|++.||.|||+  ++|+||||||+|||+++++
T Consensus        72 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~  149 (272)
T cd05075          72 TVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENM  149 (272)
T ss_pred             CCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEEcCCC
Confidence                   13479999999999998875321   22358899999999999999999998  6699999999999999999


Q ss_pred             ccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHH
Q psy9535         260 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVV  337 (593)
Q Consensus       260 ~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~  337 (593)
                      .+||+|||+++........ .......+++.|+|||.+. ..++.++|||||||++|||++ |+.||........+....
T Consensus       150 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  228 (272)
T cd05075         150 NVCVADFGLSKKIYNGDYY-RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR  228 (272)
T ss_pred             CEEECCCCcccccCcccce-ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999865432211 1112234677899999764 457889999999999999999 899997654433333222


Q ss_pred             hhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      .... .. .    ..     .....+..++.+||+.+|++|||+.+|++.|++
T Consensus       229 ~~~~-~~-~----~~-----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         229 QGNR-LK-Q----PP-----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             cCCC-CC-C----CC-----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            2111 00 0    01     112235567789999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.2e-39  Score=343.96  Aligned_cols=247  Identities=23%  Similarity=0.295  Sum_probs=188.5

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+++.. ++..||||.+.........          ....|.+|+.+++.++||||+++++++.+ ..
T Consensus        48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~----------~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRS----------DSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhh----------hHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            578999999999999875 6889999998643111100          01247789999999999999999998876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++..    ..++......++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            6899999999999998864    247788888899999999999998  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-----CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ......  .......||+.|+|||++..     .++.++|||||||++|||++|+.||........+..+........  
T Consensus       192 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--  267 (370)
T cd05596         192 MDANGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT--  267 (370)
T ss_pred             ccCCCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC--
Confidence            543221  11234579999999997643     367899999999999999999999987665444444332211110  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCC--CCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDK--RASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~--RPsm~eV~~  386 (593)
                       -+...     .....+..++.+|+..+|++  ||++.|+++
T Consensus       268 -~~~~~-----~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         268 -FPDDI-----EISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             -CCCcC-----CCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence             01000     11233455677999999988  999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-38  Score=331.76  Aligned_cols=239  Identities=28%  Similarity=0.400  Sum_probs=182.1

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhc-CCCCceeeEEEEEec-ccc
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~-l~HpNIv~l~g~~~~-~~~  192 (593)
                      .||+|+||.||+|+.. +++.||||.++.......   ..       ...+..|..++.. ++||||+++++++.+ ...
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~-------~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD---DD-------VECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL   71 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc---ch-------HHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence            6999999999999875 578999999975321100   00       1135567778875 589999999998866 556


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++...   ..+++.....++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          72 FFVMEYLNGGDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            8999999999999998753   358899999999999999999998  56999999999999999999999999998753


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  351 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (593)
                      .....   ......||+.|+|||++. ..++.++|||||||++|||++|+.||...................+       
T Consensus       147 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~-------  216 (316)
T cd05619         147 MLGDA---KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP-------  216 (316)
T ss_pred             CCCCC---ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence            22211   123457999999999775 4578899999999999999999999987554333332222111111       


Q ss_pred             CCCCHHHHHHHHHHHHHHhhccccCCCCChH-HH
Q psy9535         352 GEWNETHVETLIGIVFEKCCVFEKDKRASMR-DI  384 (593)
Q Consensus       352 ~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~-eV  384 (593)
                       .+    ....+..++.+||+.+|++||++. ++
T Consensus       217 -~~----~~~~~~~li~~~l~~~P~~R~~~~~~l  245 (316)
T cd05619         217 -RW----LTREAKDILVKLFVREPERRLGVKGDI  245 (316)
T ss_pred             -cc----CCHHHHHHHHHHhccCHhhcCCChHHH
Confidence             11    122344567799999999999997 44

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.1e-38  Score=318.66  Aligned_cols=248  Identities=26%  Similarity=0.392  Sum_probs=193.8

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      +..+||+|+||.||+|.+..+..||+|.+.....    .    .      ..|.+|+.++++++|||++++++++.....
T Consensus        10 ~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~----~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   75 (260)
T cd05069          10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----M----P------EAFLQEAQIMKKLRHDKLVPLYAVVSEEPI   75 (260)
T ss_pred             eeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----c----H------HHHHHHHHHHHhCCCCCeeeEEEEEcCCCc
Confidence            4578999999999999987777899998754211    0    1      147899999999999999999999877778


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+||++++++.+||+|||+++..
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~  152 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLARLI  152 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence            99999999999999997643 2458899999999999999999998  56999999999999999999999999999765


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .....  .......++..|+|||... ..++.++|||||||++|||+| |+.||.+............. ....  .   
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~--~---  224 (260)
T cd05069         153 EDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMP--C---  224 (260)
T ss_pred             cCCcc--cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCC--C---
Confidence            43221  1112234678899999764 557889999999999999999 99999875443333222211 1100  0   


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                           +......+..++.+||..+|++||++.+|++.|++
T Consensus       225 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         225 -----PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -----CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                 01122345667789999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0611|consensus

Probab=100.00  E-value=2.3e-39  Score=326.27  Aligned_cols=242  Identities=25%  Similarity=0.442  Sum_probs=193.4

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|.||+|-++.. ..|+.||||.|+++....       ++.   +....+|++||+.|+||||++++.++++ +.
T Consensus        58 ~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkd-------eqD---lvhIRREIeIMSsLNHPhII~IyEVFENkdK  127 (668)
T KOG0611|consen   58 TETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKD-------EQD---LVHIRREIEIMSSLNHPHIIQIYEVFENKDK  127 (668)
T ss_pred             HHHhcCCcccceeehhhccCCcEeehhhhhhhhccc-------HHH---HHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence            35799999999999975 689999999997653221       121   2256899999999999999999999987 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      ..|||||..+|.|+|++.+.   ..|++.+...+++||..|+.|+|.  ++++|||||.+|||||.|+++||+||||+.+
T Consensus       128 IvivMEYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHk--nrVvHRDLKLENILLD~N~NiKIADFGLSNl  202 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHK--NRVVHRDLKLENILLDQNNNIKIADFGLSNL  202 (668)
T ss_pred             EEEEEEecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhh--ccceecccchhheeecCCCCeeeeccchhhh
Confidence            67999999999999999874   459999999999999999999998  5699999999999999999999999999887


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccCC-C-CCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......    .++++|+|.|.+||+..+. | ++.+|-||+||+||.|+.|..||++.+......++..+...  +   +
T Consensus       203 y~~~kf----LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr--E---P  273 (668)
T KOG0611|consen  203 YADKKF----LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR--E---P  273 (668)
T ss_pred             hccccH----HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc--C---C
Confidence            655432    3568999999999988765 3 67899999999999999999999985543332333222211  1   1


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDL  387 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~  387 (593)
                      .    .+..    ..-++.+++..+|++|.|+.+|...
T Consensus       274 ~----~PSd----A~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  274 E----TPSD----ASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             C----CCch----HHHHHHHHHhcCcccchhHHHHhhh
Confidence            1    1111    1224568889999999999999753

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.4e-38  Score=317.35  Aligned_cols=248  Identities=27%  Similarity=0.409  Sum_probs=193.3

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      +.++||+|+||.||+|...++..||+|.+.....    .    .      ..|.+|+.++++++|||++++++++.....
T Consensus        10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~----~----~------~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~   75 (260)
T cd05070          10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM----S----P------ESFLEEAQIMKKLRHDKLVQLYAVVSEEPI   75 (260)
T ss_pred             hhheeccccCceEEEEEecCCceeEEEEecCCCC----C----H------HHHHHHHHHHHhcCCCceEEEEeEECCCCc
Confidence            3578999999999999988888899999864311    0    1      148899999999999999999999877778


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+||++++++.+||+|||+++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~  152 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLARLI  152 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence            99999999999999997532 2458999999999999999999998  56999999999999999999999999999865


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .....  .......|+..|+|||.+. ..++.++|||||||++|||++ |..||.+............. ....     .
T Consensus       153 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~-----~  224 (260)
T cd05070         153 EDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMP-----C  224 (260)
T ss_pred             cCccc--ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCC-----C
Confidence            43221  1112234567899999764 457889999999999999999 89999765433322222111 1100     0


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      .     ......+..++.+||..+|++|||+.++.+.|+.
T Consensus       225 ~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         225 P-----QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             C-----CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0     1112235567789999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-38  Score=332.64  Aligned_cols=241  Identities=27%  Similarity=0.386  Sum_probs=185.6

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-cc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~~  191 (593)
                      +.||+|+||.||+|+.. +++.||||.+........   .       ....+.+|..++..+ +||||+++++++.. ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~-------~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~   70 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD---D-------DVECTMTEKRVLALAGKHPFLTQLHSCFQTKDR   70 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh---h-------HHHHHHHHHHHHHhccCCCCccceeeEEEcCCE
Confidence            36999999999999875 578999999975321110   0       012466788888877 69999999998866 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||+++++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  145 (318)
T cd05570          71 LFFVMEYVNGGDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKE  145 (318)
T ss_pred             EEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence            68999999999999988753   358999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......||+.|+|||++. ..++.++|||||||++|||++|+.||...................+.     
T Consensus       146 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~-----  217 (318)
T cd05570         146 GILGGV---TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR-----  217 (318)
T ss_pred             cCcCCC---cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-----
Confidence            322211   123357999999999775 45788999999999999999999999875544333332222211111     


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCCh-----HHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASM-----RDIV  385 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm-----~eV~  385 (593)
                             .+...+..++.+||+.||++||++     .+++
T Consensus       218 -------~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll  250 (318)
T cd05570         218 -------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIK  250 (318)
T ss_pred             -------cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHh
Confidence                   112234567789999999999999     6664

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-38  Score=319.00  Aligned_cols=249  Identities=26%  Similarity=0.390  Sum_probs=190.7

Q ss_pred             CcccccCceEEEEEEEc--C--CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         115 NKLGEGQFGTVYYGKLK--N--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~--~--g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      ++||+|+||.||+|++.  +  +..||+|.+......     ..       ...+.+|+++++++.|||||++++++...
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-----~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   68 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-----AG-------KKEFLREASVMAQLDHPCIVRLIGVCKGE   68 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-----HH-------HHHHHHHHHHHHhcCCCCeeeEEEEEcCC
Confidence            36999999999999763  2  268999998643211     01       12588999999999999999999998877


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++....   .+++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+|||+++
T Consensus        69 ~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~nili~~~~~~kl~df~~~~  143 (257)
T cd05060          69 PLMLVMELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSR  143 (257)
T ss_pred             ceEEEEEeCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhh--cCeeccCcccceEEEcCCCcEEeccccccc
Confidence            7899999999999999997632   58999999999999999999998  569999999999999999999999999988


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ................++..|+|||.+. ..++.++|||||||++|||++ |..||................ +..    
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~----  218 (257)
T cd05060         144 ALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-RLP----  218 (257)
T ss_pred             eeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cCC----
Confidence            6543321111111223457899999764 457889999999999999998 999997655433222222111 100    


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                       ...     .....+..++.+||..+|++||++.+|++.|++.
T Consensus       219 -~~~-----~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 -RPE-----ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             -CCC-----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence             001     1123455677899999999999999999999763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.3e-38  Score=331.81  Aligned_cols=238  Identities=26%  Similarity=0.359  Sum_probs=181.5

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhc-CCCCceeeEEEEEec-cc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~-l~HpNIv~l~g~~~~-~~  191 (593)
                      +.||+|+||.||+|+.+ +|..||||.++.......   ..       ...+..|..++.. ++||||+++++++.+ ..
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~-------~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   70 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID---DD-------VECTMVEKRVLALAWENPFLTHLYCTFQTKEH   70 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc---ch-------HHHHHHHHHHHHhccCCCCccCeeEEEEeCCE
Confidence            36999999999999875 688999999975321100   00       1135567777765 489999999998866 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+.+|+|.+++...   ..+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05620          71 LFFVMEFLNGGDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKE  145 (316)
T ss_pred             EEEEECCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence            68999999999999998753   358899999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .....   .......||+.|+|||++. ..++.++|||||||++|||++|+.||........+..........+      
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------  216 (316)
T cd05620         146 NVFGD---NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP------  216 (316)
T ss_pred             cccCC---CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence            32211   1123467999999999775 4578899999999999999999999987654333332222211111      


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMR  382 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~  382 (593)
                        .+.    ...+..++.+||+.||++||++.
T Consensus       217 --~~~----~~~~~~li~~~l~~dP~~R~~~~  242 (316)
T cd05620         217 --RWI----TKESKDILEKLFERDPTRRLGVV  242 (316)
T ss_pred             --CCC----CHHHHHHHHHHccCCHHHcCCCh
Confidence              111    12344567899999999999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0694|consensus

Probab=100.00  E-value=4.5e-39  Score=344.56  Aligned_cols=237  Identities=26%  Similarity=0.370  Sum_probs=188.5

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      ..+||+|+||+|+++..+ +++.+|||.+++......   ++.+.       ...|..|+... +||.+++|+.++.. .
T Consensus       373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~---d~Ve~-------~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR---DEVES-------LMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc---ccHHH-------HHHHHHHHHHhccCCeEeecccccccCC
Confidence            478999999999999986 578899999998755433   22232       34455555444 69999999998876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+.||++..+.+    ...+++..+..++..|+.||.|||+  ++||+||||.+|||||.+|.+||+|||+++
T Consensus       443 ~l~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~--~~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHE--NGIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             eEEEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHh--cCceeeecchhheEEcccCcEEeccccccc
Confidence            6689999999999543332    3569999999999999999999998  669999999999999999999999999999


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......   ..+.+++|||.|||||++.+ .|+..+|+|||||+|||||.|..||.+++....+..++..+...+..+..
T Consensus       517 e~m~~g---~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~  593 (694)
T KOG0694|consen  517 EGMGQG---DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSK  593 (694)
T ss_pred             ccCCCC---CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccH
Confidence            654332   23567999999999998865 58889999999999999999999999877777666666655444333222


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCCh
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASM  381 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm  381 (593)
                                  ....++.+-+..+|++|..+
T Consensus       594 ------------ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  594 ------------EAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ------------HHHHHHHHHhccCcccccCC
Confidence                        22235567889999999887

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.8e-38  Score=319.80  Aligned_cols=249  Identities=27%  Similarity=0.386  Sum_probs=194.0

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEeccc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  191 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~  191 (593)
                      ++.++||+|+||.||+|++.++..||+|.++....    .    .      ..|.+|++++++++||||+++++++.+..
T Consensus         9 ~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~----~------~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   74 (262)
T cd05071           9 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----S----P------EAFLQEAQVMKKLRHEKLVQLYAVVSEEP   74 (262)
T ss_pred             eEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----C----H------HHHHHHHHHHHhCCCCCcceEEEEECCCC
Confidence            44678999999999999887767899999864211    0    1      14889999999999999999999887777


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~  151 (262)
T cd05071          75 IYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL  151 (262)
T ss_pred             cEEEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcccEEEcCCCcEEeccCCceee
Confidence            899999999999999997532 2457899999999999999999998  5699999999999999999999999999976


Q ss_pred             cccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......  .......|+..|+|||.. ...++.++|||||||++|||+| |..||............... .+..     
T Consensus       152 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~-----  223 (262)
T cd05071         152 IEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP-----  223 (262)
T ss_pred             cccccc--ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-CCCC-----
Confidence            543321  111234567789999976 4568889999999999999999 88899765433322222111 1100     


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      .     ...+...+..++.+||+.+|++||++.++++.|+.
T Consensus       224 ~-----~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         224 C-----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             C-----ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            0     01122334567789999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.9e-39  Score=333.70  Aligned_cols=238  Identities=24%  Similarity=0.354  Sum_probs=180.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHH---HhcCCCCceeeEEEEEec
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT---LSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~i---l~~l~HpNIv~l~g~~~~  189 (593)
                      .+.||+|+||.||+|+.. +|+.||||.++.......   .  .     ...+.+|+.+   +++++||||+++++++..
T Consensus         4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~--~-----~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~   73 (324)
T cd05589           4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR---D--E-----VESLMCEKRIFETANSERHPFLVNLFACFQT   73 (324)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---h--H-----HHHHHHHHHHHHhccccCCCChhceeeEEEc
Confidence            468999999999999875 689999999975321110   0  0     1134555544   567889999999998876


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...++||||+++|+|...+..    ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus        74 ~~~~~lv~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrdlkp~Nill~~~~~~kL~Dfg~  147 (324)
T cd05589          74 EDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGL  147 (324)
T ss_pred             CCEEEEEEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCcEEeCcccC
Confidence             566899999999999888753    358999999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ++.......   ......||+.|||||.+. ..++.++|||||||++|||++|+.||...................+.  
T Consensus       148 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~--  222 (324)
T cd05589         148 CKEGMGFGD---RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--  222 (324)
T ss_pred             CccCCCCCC---cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--
Confidence            875322211   123467999999999774 45788999999999999999999999876544333333222211111  


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMR  382 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~  382 (593)
                           .     +...+..++.+||+.||.+||++.
T Consensus       223 -----~-----~~~~~~~li~~~L~~dP~~R~~~~  247 (324)
T cd05589         223 -----F-----LSREAISIMRRLLRRNPERRLGSG  247 (324)
T ss_pred             -----C-----CCHHHHHHHHHHhhcCHhHcCCCC
Confidence                 1     112344567899999999999644

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-38  Score=325.40  Aligned_cols=263  Identities=27%  Similarity=0.391  Sum_probs=189.3

Q ss_pred             CCCCCCcccccCceEEEEEEE-----cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEE
Q psy9535         110 YPRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  184 (593)
Q Consensus       110 ~~~~~~~LG~G~fG~Vy~g~~-----~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~  184 (593)
                      |.+..+.||+|+||+||++.+     .++..||+|.+.....     ...       ...|.+|++++++++||||++++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~-------~~~~~~E~~~l~~l~h~~i~~~~   72 (283)
T cd05080           5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-----QQN-------TSGWKKEINILKTLYHENIVKYK   72 (283)
T ss_pred             hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-----hHH-------HHHHHHHHHHHHhCCCCCEeeEE
Confidence            334567899999999988653     3578899999864311     000       12578999999999999999999


Q ss_pred             EEEec---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCcc
Q psy9535         185 GLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  261 (593)
Q Consensus       185 g~~~~---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~  261 (593)
                      +++..   ...++||||+++|+|.+++..    ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~  146 (283)
T cd05080          73 GCCSEQGGKGLQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLV  146 (283)
T ss_pred             EEEecCCCceEEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccChheEEEcCCCcE
Confidence            98864   235799999999999999875    248999999999999999999998  569999999999999999999


Q ss_pred             EEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhh
Q psy9535         262 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILY-YYLVVEQ  339 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~-~~~~~~~  339 (593)
                      ||+|||+++................++..|+|||.+. ..++.++|||||||++|||+||..|+........ .......
T Consensus       147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~  226 (283)
T cd05080         147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG  226 (283)
T ss_pred             EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc
Confidence            9999999886543221111112234567799999764 5678899999999999999999999865321110 0000000


Q ss_pred             c---CccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         340 E---VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       340 ~---~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      .   ....+..+.......+......+..++.+||+.+|++||++.+|++.|+.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~  280 (283)
T cd05080         227 QMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE  280 (283)
T ss_pred             ccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            0   00011111100000011122345567789999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.4e-39  Score=335.02  Aligned_cols=240  Identities=28%  Similarity=0.371  Sum_probs=181.7

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHH-HHhcCCCCceeeEEEEEec-ccc
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ-TLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~-il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      .||+|+||+||+|+.. +|+.||||++........   .  +     ...+.+|.. +++.++||||+++++++.+ ...
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~--~-----~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~   71 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK---K--E-----QKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL   71 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh---h--H-----HHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence            6999999999999875 689999999864311100   0  0     112444544 5688999999999998765 566


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          72 YFVLDYVNGGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             EEEEcCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            8999999999999988753   358899999999999999999998  56999999999999999999999999998753


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  351 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (593)
                      .....   ......||+.|+|||++. ..++.++|||||||++|||++|+.||...+....+............      
T Consensus       147 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~------  217 (323)
T cd05575         147 IEHSK---TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP------  217 (323)
T ss_pred             ccCCC---ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC------
Confidence            22211   123457999999999774 45788999999999999999999999876544333333322211111      


Q ss_pred             CCCCHHHHHHHHHHHHHHhhccccCCCCChHHHH
Q psy9535         352 GEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV  385 (593)
Q Consensus       352 ~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~  385 (593)
                       ..     ...+..++.+|++.+|.+||++.+.+
T Consensus       218 -~~-----~~~~~~li~~~l~~~p~~R~~~~~~~  245 (323)
T cd05575         218 -NI-----SVSARHLLEGLLQKDRTKRLGAKDDF  245 (323)
T ss_pred             -CC-----CHHHHHHHHHHhhcCHHhCCCCCCCH
Confidence             11     22345567799999999999986433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.1e-38  Score=347.38  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=181.7

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +.+++||+|+||.||+|... +++.||||++....     .            ...+|+.+|++++|||||++++++.. 
T Consensus        69 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~------------~~~~Ei~il~~l~h~niv~l~~~~~~~  131 (440)
T PTZ00036         69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----Q------------YKNRELLIMKNLNHINIIFLKDYYYTE  131 (440)
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----c------------hHHHHHHHHHhcCCCCCcceeeeEeec
Confidence            45789999999999999874 68899999885321     0            24579999999999999999987532 


Q ss_pred             --------ccceEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC-C
Q psy9535         190 --------IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-F  259 (593)
Q Consensus       190 --------~~~~lV~Ey~~~GsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~-~  259 (593)
                              ...++||||++ |+|.+++... .....+++.....++.|++.||.|||+  ++|+||||||+|||++.+ +
T Consensus       132 ~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~~~~~  208 (440)
T PTZ00036        132 CFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNTH  208 (440)
T ss_pred             ccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCcCHHHEEEcCCCC
Confidence                    12458999997 5787776542 223568999999999999999999998  569999999999999965 4


Q ss_pred             ccEEeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q psy9535         260 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  337 (593)
Q Consensus       260 ~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~  337 (593)
                      .+||+|||+|+.......    .....||+.|+|||++.+  .++.++|||||||++|||++|.+||.+...........
T Consensus       209 ~vkL~DFGla~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  284 (440)
T PTZ00036        209 TLKLCDFGSAKNLLAGQR----SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII  284 (440)
T ss_pred             ceeeeccccchhccCCCC----cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            799999999986543221    123578999999997643  57899999999999999999999998765433222222


Q ss_pred             hhc-Cccccc---cccc-----cCCCC--------HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         338 EQE-VPVREV---LDKE-----AGEWN--------ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       338 ~~~-~~~~~~---~~~~-----~~~~~--------~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ... .+..+.   ..+.     .....        +......+..++.+||..+|.+|||+.|+++
T Consensus       285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            110 010000   0000     00000        0011123455778999999999999999863

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.6e-39  Score=340.62  Aligned_cols=247  Identities=23%  Similarity=0.320  Sum_probs=185.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+++.. +++.||+|.+.+......   .       ....+.+|+.+++.++||||+++++++.+ ..
T Consensus        48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~-------~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR---S-------DSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---h-------hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            578999999999999875 588999999864311110   0       01247789999999999999999998876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++..    ..+++.....++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence            6899999999999999864    247888899999999999999998  5699999999999999999999999999987


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-----CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ......  .......||+.|||||++.+     .++.++|||||||++|||++|+.||........+..+........ .
T Consensus       192 ~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-~  268 (370)
T cd05621         192 MDETGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN-F  268 (370)
T ss_pred             cccCCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC-C
Confidence            543221  11234679999999998743     267899999999999999999999987654444333332211110 0


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCC--CCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDK--RASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~--RPsm~eV~~  386 (593)
                        +.     ...+...+..++.+|+..++.+  ||++.|+++
T Consensus       269 --p~-----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         269 --PE-----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             --CC-----cccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence              00     0112233445566777654443  888888764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-38  Score=349.00  Aligned_cols=248  Identities=21%  Similarity=0.296  Sum_probs=190.6

Q ss_pred             CCCCcccccCceEEEEEEEc-C-CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-N-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~-g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      .+.+.||+|+||.||+|... + +..||+|.+...      . .. .     ...+.+|+.+|+.++|||||++++++..
T Consensus        70 ~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~------~-~~-~-----~~~~~~E~~~l~~l~Hpniv~~~~~~~~  136 (478)
T PTZ00267         70 VLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN------D-ER-Q-----AAYARSELHCLAACDHFGIVKHFDDFKS  136 (478)
T ss_pred             EEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC------C-HH-H-----HHHHHHHHHHHHhCCCCCEeEEEEEEEE
Confidence            44678999999999999754 3 677899876422      1 00 1     1247789999999999999999998865


Q ss_pred             -ccceEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                       ...+|||||+++|+|.++|... ....++++.....++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus       137 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DFg  214 (478)
T PTZ00267        137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFG  214 (478)
T ss_pred             CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeCc
Confidence             5678999999999999988643 223568899999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      +++....... .......+||+.|+|||++. ..++.++|||||||++|||++|+.||.................+    
T Consensus       215 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----  289 (478)
T PTZ00267        215 FSKQYSDSVS-LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD----  289 (478)
T ss_pred             CceecCCccc-cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----
Confidence            9986543321 11233467999999999774 45788999999999999999999999875543333333222211    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        +...     .+...+..++.+||..+|++||++.+++.
T Consensus       290 --~~~~-----~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 --PFPC-----PVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --CCCc-----cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence              0000     11223455678999999999999999874

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-39  Score=339.78  Aligned_cols=248  Identities=22%  Similarity=0.336  Sum_probs=185.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|+.. +|+.||||++........      .    ....+.+|+.+|..++||||+++++++.+ ..
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~----~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~   75 (364)
T cd05599           6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEK------E----QVAHVRAERDILAEADNPWVVKLYYSFQDENY   75 (364)
T ss_pred             EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh------h----HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence            578999999999999875 689999999964311000      0    12247889999999999999999998876 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  150 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG  150 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEeeccccee
Confidence            68999999999999999753   358999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcc-----------------------------------eeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHH
Q psy9535         272 SETSNMKT-----------------------------------MYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILL  315 (593)
Q Consensus       272 ~~~~~~~~-----------------------------------~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~  315 (593)
                      ........                                   ......+||+.|+|||++. ..++.++|||||||++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  230 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY  230 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence            43211000                                   0011246999999999764 45789999999999999


Q ss_pred             HHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCC---hHHHH
Q psy9535         316 ELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS---MRDIV  385 (593)
Q Consensus       316 ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs---m~eV~  385 (593)
                      ||++|..||.................... .  +....     +...+..++.+|+. +|.+|++   +.|++
T Consensus       231 el~~G~~Pf~~~~~~~~~~~i~~~~~~~~-~--~~~~~-----~s~~~~~li~~ll~-~p~~R~~~~~~~~ll  294 (364)
T cd05599         231 EMLVGYPPFCSDNPQETYRKIINWKETLQ-F--PDEVP-----LSPEAKDLIKRLCC-EAERRLGNNGVNEIK  294 (364)
T ss_pred             HhhcCCCCCCCCCHHHHHHHHHcCCCccC-C--CCCCC-----CCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence            99999999987655443333322111110 0  00001     12233445667775 8999998   66664

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.7e-38  Score=332.88  Aligned_cols=236  Identities=23%  Similarity=0.342  Sum_probs=179.0

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-ccc
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~~~  192 (593)
                      .||+|+||.||+|+.. +++.||||.++.......      +    ....+.+|..++.++ +||||+++++++.+ ...
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~------~----~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~   71 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD------E----DIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh------h----HHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence            6999999999999875 688999999975321110      0    122477899999888 69999999998876 556


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          72 FFVIEFVSGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            8999999999999988653   358999999999999999999998  56999999999999999999999999998753


Q ss_pred             ccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCc--------hHH-HHHHHHhhcCc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN--------TIL-YYYLVVEQEVP  342 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~--------~~~-~~~~~~~~~~~  342 (593)
                      .....   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||+...        ... ...........
T Consensus       147 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (329)
T cd05588         147 IRPGD---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR  223 (329)
T ss_pred             ccCCC---ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC
Confidence            22111   1234679999999997754 57889999999999999999999996311        111 11111111111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCCh
Q psy9535         343 VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASM  381 (593)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm  381 (593)
                      .+.       .     +...+..++.+|++.||.+||++
T Consensus       224 ~p~-------~-----~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         224 IPR-------S-----LSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             CCC-------C-----CCHHHHHHHHHHhccCHHHcCCC
Confidence            111       1     11224456789999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.1e-39  Score=334.14  Aligned_cols=247  Identities=27%  Similarity=0.354  Sum_probs=185.3

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHH-HHHhcCCCCceeeEEEEEec-ccc
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev-~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      .||+|+||.||+|+.. +++.||+|++.........     .     ...+..|. .+++.++||||+++++++.. ...
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~-----~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~   71 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKK-----E-----EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL   71 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhh-----H-----HHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence            6999999999999875 5788999998643111000     0     11233444 45788999999999998765 566


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++...   ..++......++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~--~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          72 YFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             EEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            8999999999999998753   347788888899999999999998  56999999999999999999999999998753


Q ss_pred             ccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  351 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (593)
                      .....   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||........+............      
T Consensus       147 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~------  217 (325)
T cd05602         147 IEHNG---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP------  217 (325)
T ss_pred             ccCCC---CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCC------
Confidence            22211   1234679999999997754 5788999999999999999999999876554443333322211111      


Q ss_pred             CCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         352 GEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       352 ~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                            .+...+..++.+|++.+|.+||++.+.+..+.+..
T Consensus       218 ------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~  252 (325)
T cd05602         218 ------NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHI  252 (325)
T ss_pred             ------CCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCc
Confidence                  11223455678999999999999886655554443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.3e-38  Score=323.93  Aligned_cols=243  Identities=21%  Similarity=0.292  Sum_probs=180.8

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccceE
Q psy9535         117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  194 (593)
Q Consensus       117 LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~l  194 (593)
                      ||+|+||+||++... +|+.||||++........          .....+..|+.++++++||||+++.+++.. ...++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~l   70 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR----------KGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCL   70 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhh----------HHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEE
Confidence            699999999999865 688999999864311100          011246789999999999999999998765 55789


Q ss_pred             EEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecc
Q psy9535         195 VYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  273 (593)
Q Consensus       195 V~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~  273 (593)
                      ||||+++|+|.+.+.... ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        71 v~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  148 (280)
T cd05608          71 VMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELK  148 (280)
T ss_pred             EEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence            999999999998885432 23468999999999999999999998  569999999999999999999999999987654


Q ss_pred             cCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccC
Q psy9535         274 TSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG  352 (593)
Q Consensus       274 ~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (593)
                      ....   ......||+.|+|||++. ..++.++|||||||++|||++|+.||..................  ...     
T Consensus       149 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~-----  218 (280)
T cd05608         149 DGQS---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN--DSV-----  218 (280)
T ss_pred             CCCc---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc--cCC-----
Confidence            3321   123457999999999774 45788999999999999999999999754321111111100000  000     


Q ss_pred             CCCHHHHHHHHHHHHHHhhccccCCCCChH
Q psy9535         353 EWNETHVETLIGIVFEKCCVFEKDKRASMR  382 (593)
Q Consensus       353 ~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~  382 (593)
                      .. +......+..++.+||+.+|++||+++
T Consensus       219 ~~-~~~~~~~~~~li~~~l~~~P~~R~~~~  247 (280)
T cd05608         219 TY-PDKFSPASKSFCEALLAKDPEKRLGFR  247 (280)
T ss_pred             CC-cccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence            00 011223345567899999999999543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-38  Score=316.19  Aligned_cols=245  Identities=27%  Similarity=0.439  Sum_probs=188.7

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ..+.||+|+||.||+|+++++..+|+|.+.....    .    .      ..|.+|++++++++||||+++++++.. ..
T Consensus         8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~----~----~------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd05059           8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM----S----E------DDFIEEAKVMMKLSHPNLVQLYGVCTKQRP   73 (256)
T ss_pred             hhhhhccCCCceEEEeEecCCccEEEEEeccCCC----C----H------HHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3578999999999999987777899998853211    0    1      147889999999999999999998865 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++++|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++.
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~  149 (256)
T cd05059          74 IFIVTEYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLARY  149 (256)
T ss_pred             eEEEEecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHhhEEECCCCcEEECCccccee
Confidence            689999999999999997543  368999999999999999999998  5599999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .......  ......++..|+|||.+. ..++.++|||||||++|||++ |+.||................ ..      
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~------  220 (256)
T cd05059         150 VLDDQYT--SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-RL------  220 (256)
T ss_pred             ccccccc--ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-cC------
Confidence            5432111  111123456799999764 567889999999999999999 899997654433322222111 00      


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL  388 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L  388 (593)
                      ....    .....+..++.+||..+|++||++.|+++.|
T Consensus       221 ~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         221 YRPK----LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            0001    1122355677899999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.6e-38  Score=318.79  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=181.2

Q ss_pred             cccccCceEEEEEEEcC---CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         116 KLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~~---g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .||+|+||.||+|...+   ...+|+|.+....     ...  .     ...|.+|+.+++.++||||++++|+|.. ..
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-----~~~--~-----~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~   69 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-----TPD--E-----QLLFLQEVQPYRELNHPNVLQCLGQCIESIP   69 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC-----ChH--H-----HHHHHHHHHHHHhCCCCCcceEEEEECCCCc
Confidence            58999999999997543   3467888764321     100  1     1257899999999999999999998876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      .++||||+++|+|.+++.....  ....++.....++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~  147 (269)
T cd05042          70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--ADFIHSDLALRNCQLTADLSVKIGDYGLA  147 (269)
T ss_pred             eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh--cCEecccccHhheEecCCCcEEEeccccc
Confidence            6899999999999999976432  1234677888999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc--------CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH--------CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQE  340 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--------~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~  340 (593)
                      +........ .......+++.|+|||++.        ..++.++|||||||++|||++ |..||................
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  226 (269)
T cd05042         148 LEQYPEDYY-ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ  226 (269)
T ss_pred             cccccchhe-eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc
Confidence            653322110 1112235677899999763        235779999999999999999 788987654433222222211


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         341 VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                      .  .....+..    .......+..++..|| .||++||++.||++.|+
T Consensus       227 ~--~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 D--IKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             C--ccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1  01111111    1112233444566788 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.3e-38  Score=336.35  Aligned_cols=209  Identities=23%  Similarity=0.329  Sum_probs=167.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||+||+|+.. +++.||||++........          .....+.+|+.++.+++||||+++++.+.+ ..
T Consensus         6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~   75 (363)
T cd05628           6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK----------EQVGHIRAERDILVEADSLWVVKMFYSFQDKLN   75 (363)
T ss_pred             eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh----------hHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence            578999999999999865 689999999864311100          012247789999999999999999998876 46


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.+.   ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFGla~~  150 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG  150 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence            68999999999999999753   358999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCc--------------------------------ceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHH
Q psy9535         272 SETSNMK--------------------------------TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELL  318 (593)
Q Consensus       272 ~~~~~~~--------------------------------~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ell  318 (593)
                      .......                                .......+||+.|+|||++. ..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence            4321100                                00012357999999999764 45788999999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHH
Q psy9535         319 TGMKPIDDNNTILYYYLVV  337 (593)
Q Consensus       319 tG~~P~~~~~~~~~~~~~~  337 (593)
                      +|+.||........+..+.
T Consensus       231 ~G~~Pf~~~~~~~~~~~i~  249 (363)
T cd05628         231 IGYPPFCSETPQETYKKVM  249 (363)
T ss_pred             hCCCCCCCCCHHHHHHHHH
Confidence            9999998765544444433

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.9e-38  Score=332.62  Aligned_cols=237  Identities=24%  Similarity=0.355  Sum_probs=178.5

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-cc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~~  191 (593)
                      +.||+|+||.||+|+.. +++.||+|.++.......   .       ....+.+|+.++.++ +||||+++++++.. ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~-------~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   70 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD---E-------DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   70 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcch---h-------HHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCE
Confidence            36999999999999875 688999999975321110   0       012467888888776 79999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~E~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~  145 (329)
T cd05618          71 LFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  145 (329)
T ss_pred             EEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence            68999999999999888653   358999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCc--------hH-HHHHHHHhhcC
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNN--------TI-LYYYLVVEQEV  341 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~--------~~-~~~~~~~~~~~  341 (593)
                      ......   ......||+.|+|||++. ..++.++|||||||++|||++|+.||....        .. ..+........
T Consensus       146 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~  222 (329)
T cd05618         146 GLRPGD---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI  222 (329)
T ss_pred             ccCCCC---ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC
Confidence            322211   123467999999999775 457889999999999999999999995310        01 11111111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCCh
Q psy9535         342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASM  381 (593)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm  381 (593)
                      .++.            .....+..++.+||+.||++||+.
T Consensus       223 ~~p~------------~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 RIPR------------SLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCC------------CCCHHHHHHHHHHhcCCHHHcCCC
Confidence            1111            112234557789999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-38  Score=317.64  Aligned_cols=247  Identities=28%  Similarity=0.368  Sum_probs=191.4

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      .+.||+|+||.||+|...+++.||||.++....    .          ...|.+|+.++++++||||+++++++.. ...
T Consensus        11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05068          11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----D----------PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI   76 (261)
T ss_pred             EEEecccCCccEEEEEecCCeEEEEEeeCCCcc----c----------HHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence            578999999999999987788899999864311    0          1247899999999999999999998866 556


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  153 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA--QNYIHRDLAARNVLVGENNICKVADFGLARVI  153 (261)
T ss_pred             eeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence            89999999999999997543 3468999999999999999999998  56999999999999999999999999999876


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......  ......++..|+|||.+. ..++.++|||||||++|||+| |+.||............... ....     .
T Consensus       154 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~-----~  225 (261)
T cd05068         154 KEDIYE--AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMP-----C  225 (261)
T ss_pred             cCCccc--ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCC-----C
Confidence            432211  111122345799999764 457889999999999999999 99999775543333222211 1110     0


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ...     ....+..++.+||..+|++||++.++++.|+.
T Consensus       226 ~~~-----~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         226 PPG-----CPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCc-----CCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            011     11234556679999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.9e-38  Score=317.79  Aligned_cols=247  Identities=30%  Similarity=0.485  Sum_probs=190.7

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|.++ .+..||+|.+....       .  .     ...|.+|++++++++||||++++++|.. ..
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-------~--~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (263)
T cd05052          11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-------M--E-----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   76 (263)
T ss_pred             eeecCCcccceEEEEEEecCCceEEEEEecCCc-------h--H-----HHHHHHHHHHHHhCCCCChhheEEEEcCCCC
Confidence            478999999999999875 58899999985321       0  0     1247899999999999999999998865 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.... ...+++..+..++.|+++||.|||+  ++++||||||+|||+++++.+||+|||+++.
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~df~~~~~  153 (263)
T cd05052          77 FYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRL  153 (263)
T ss_pred             cEEEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence            689999999999999987543 3468999999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......  .......+++.|+|||.+. ..++.++|||||||++|||++ |..||........+..... ....      
T Consensus       154 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~------  224 (263)
T cd05052         154 MTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-GYRM------  224 (263)
T ss_pred             ccccee--eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCC------
Confidence            543221  1111233567899999764 457889999999999999998 9999976544333222211 1110      


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ....    .....+..++.+||..+|++||++.++++.|+.
T Consensus       225 ~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         225 ERPE----GCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCC----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            0001    112335556789999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.3e-38  Score=338.62  Aligned_cols=252  Identities=23%  Similarity=0.278  Sum_probs=183.5

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||+||+|+.. +++.||||++........      .    ....+.+|+.++++++|||||++++++.+ ..
T Consensus         6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~------~----~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~   75 (381)
T cd05626           6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR------N----QVAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (381)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh------H----HHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE
Confidence            578999999999999864 688999999964311100      0    12257899999999999999999998876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++.....++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHK--MGFIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             EEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            68999999999999999753   357888888999999999999998  5699999999999999999999999999763


Q ss_pred             cccCCCc--------------------------------------------ceeeccccCCCCcCCccccc-CCCCCcch
Q psy9535         272 SETSNMK--------------------------------------------TMYTENLTGTRPYMPPEAMH-CQISTKTD  306 (593)
Q Consensus       272 ~~~~~~~--------------------------------------------~~~~~~~~GT~~Y~APE~~~-~~~~~ksD  306 (593)
                      .......                                            ........||+.|+|||++. ..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD  230 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence            2110000                                            00012357999999999774 45788999


Q ss_pred             hhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         307 VFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       307 VwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ||||||++|||++|+.||....................  . +..... ...+..++..+  .|+..+|..||++.|++.
T Consensus       231 iwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~-~~~~~~-s~~~~dli~~l--l~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH--I-PPQVKL-SPEAVDLITKL--CCSAEERLGRNGADDIKA  304 (381)
T ss_pred             eeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC--C-CCCCCC-CHHHHHHHHHH--ccCcccccCCCCHHHHhc
Confidence            99999999999999999987554332222221111110  0 000111 12233333322  266677777999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.3e-38  Score=322.18  Aligned_cols=251  Identities=23%  Similarity=0.281  Sum_probs=186.3

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccceE
Q psy9535         117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  194 (593)
Q Consensus       117 LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~l  194 (593)
                      ||+|+||.||+++.+ +|+.||+|++.........    .+      ..+..|++++++++||||+++++++.. ...++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~----~~------~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~l   70 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKS----GE------KMALLEKEILEKVNSPFIVNLAYAFESKTHLCL   70 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcch----hh------HHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEE
Confidence            699999999999875 6899999998643211100    01      124569999999999999999998865 56689


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceeccc
Q psy9535         195 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  274 (593)
Q Consensus       195 V~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~  274 (593)
                      ||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.....
T Consensus        71 v~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~  147 (277)
T cd05607          71 VMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD  147 (277)
T ss_pred             EEecCCCCCHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence            999999999998886543 3458899999999999999999998  5699999999999999999999999999876543


Q ss_pred             CCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCC
Q psy9535         275 SNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGE  353 (593)
Q Consensus       275 ~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (593)
                      ...    .....||+.|+|||++. ..++.++|||||||++|||++|+.||................  .......... 
T Consensus       148 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~-  220 (277)
T cd05607         148 GKT----ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT--LEDEVKFEHQ-  220 (277)
T ss_pred             Cce----eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh--hccccccccc-
Confidence            221    12356999999999764 457889999999999999999999997533211111111110  0000000001 


Q ss_pred             CCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         354 WNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       354 ~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                          .....+..++.+||+.+|++||++.|+++.+.++
T Consensus       221 ----~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h  254 (277)
T cd05607         221 ----NFTEESKDICRLFLAKKPEDRLGSREKNDDPRKH  254 (277)
T ss_pred             ----cCCHHHHHHHHHHhccCHhhCCCCccchhhhhcC
Confidence                1222355677899999999999998877655443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.4e-38  Score=322.26  Aligned_cols=251  Identities=27%  Similarity=0.455  Sum_probs=190.3

Q ss_pred             CCcccccCceEEEEEEEcC------CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~------g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .+.||+|+||.||+|+..+      +..||||.++...     . ...      ...|.+|++++++++||||+++++++
T Consensus        10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-----~-~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~   77 (280)
T cd05049          10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-----S-NDA------RKDFEREAELLTNFQHENIVKFYGVC   77 (280)
T ss_pred             HhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-----C-HHH------HHHHHHHHHHHHhcCCCCchheeeEE
Confidence            4689999999999998632      4789999985321     1 101      12588999999999999999999988


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNN-----------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  255 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl  255 (593)
                      .. ...++||||+++|+|.+++...+.           ...+++.....++.|++.||.|||+  ++++||||||+|||+
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~h~dlkp~nili  155 (280)
T cd05049          78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS--QHFVHRDLATRNCLV  155 (280)
T ss_pred             ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeeccccccceEEE
Confidence            76 566899999999999999975421           2357889999999999999999998  569999999999999


Q ss_pred             cCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHH
Q psy9535         256 DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYY  333 (593)
Q Consensus       256 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~  333 (593)
                      +.++.+||+|||+++........ .......+++.|+|||++. ..++.++|||||||++|||++ |..||.........
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~  234 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI  234 (280)
T ss_pred             cCCCeEEECCcccceecccCcce-ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999998754322211 1112335678899999764 457889999999999999999 99999765433322


Q ss_pred             HHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         334 YLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ........  ...    .     ......+..++.+||+.+|++||++.||++.|.+
T Consensus       235 ~~~~~~~~--~~~----~-----~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         235 ECITQGRL--LQR----P-----RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHcCCc--CCC----C-----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            22221111  000    0     1112335567789999999999999999998853

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.3e-38  Score=330.83  Aligned_cols=238  Identities=26%  Similarity=0.337  Sum_probs=183.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      .+.||+|+||.||+|+.. +++.||||.+.+......   .       ....+..|..++..+ +|++|+++++++.. .
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~-------~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05616           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD---D-------DVECTMVEKRVLALSGKPPFLTQLHSCFQTMD   74 (323)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---h-------HHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence            578999999999999875 578999999875321110   0       012356688888777 58999999998866 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+.+...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG~~~  149 (323)
T cd05616          75 RLYFVMEYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCCCce
Confidence            568999999999999988753   358899999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .......   ......||+.|+|||++. ..++.++|||||||++|||+||+.||...........+.......+..   
T Consensus       150 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~---  223 (323)
T cd05616         150 ENMWDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS---  223 (323)
T ss_pred             ecCCCCC---ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc---
Confidence            5432211   123467999999999775 457899999999999999999999998765544443333322221111   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCCh
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASM  381 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm  381 (593)
                               ....+..++.+|++.+|++|++.
T Consensus       224 ---------~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         224 ---------MSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---------CCHHHHHHHHHHcccCHHhcCCC
Confidence                     11234456679999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-38  Score=350.19  Aligned_cols=250  Identities=27%  Similarity=0.354  Sum_probs=190.8

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI-  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~-  190 (593)
                      +.+.||+|+||.||+|+.. +|+.||||.+.....    ...  .     ...+.+|+.++..++|+||++++..+... 
T Consensus        36 i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~----~~~--~-----~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM----SEA--D-----KNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             EEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC----CHH--H-----HHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            4689999999999999864 789999999864311    101  1     22578999999999999999998765321 


Q ss_pred             --------cceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCcc
Q psy9535         191 --------MNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  261 (593)
Q Consensus       191 --------~~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~  261 (593)
                              ..++||||+++|+|.++|.... ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~--~~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEeCCCCE
Confidence                    2468999999999999997532 23468999999999999999999998  569999999999999999999


Q ss_pred             EEeecccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q psy9535         262 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  340 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~  340 (593)
                      ||+|||+++....... ........||+.|+|||++.+ .++.++|||||||++|||++|+.||................
T Consensus       183 kL~DFGls~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~  261 (496)
T PTZ00283        183 KLGDFGFSKMYAATVS-DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR  261 (496)
T ss_pred             EEEecccCeecccccc-ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence            9999999986543221 111234679999999998754 58899999999999999999999998765433333222211


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHH
Q psy9535         341 VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDL  387 (593)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~  387 (593)
                      ..      +....     +...+..++.+||+.+|++||++.++++.
T Consensus       262 ~~------~~~~~-----~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        262 YD------PLPPS-----ISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CC------CCCCC-----CCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11      00111     12235556789999999999999999753

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-39  Score=338.23  Aligned_cols=250  Identities=24%  Similarity=0.325  Sum_probs=190.7

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|+.. +|+.||||++........          .....|.+|+.++..++||||+++++++.+ .
T Consensus         5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (350)
T cd05573           5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKR----------NQIAHVRAERDILADADSPWIVKLYYSFQDEE   74 (350)
T ss_pred             EEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhc----------cHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence            3578999999999999875 689999999864321110          012357889999999999999999998866 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++.+.   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~  149 (350)
T cd05573          75 HLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFGLCK  149 (350)
T ss_pred             eEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCCCCc
Confidence            668999999999999999764   468899999999999999999998  669999999999999999999999999987


Q ss_pred             ecccCCC--------------------------cceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCC
Q psy9535         271 MSETSNM--------------------------KTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKP  323 (593)
Q Consensus       271 ~~~~~~~--------------------------~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P  323 (593)
                      .......                          .........||+.|+|||++.+ .++.++|||||||++|||++|+.|
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence            6543220                          0011223579999999997754 578899999999999999999999


Q ss_pred             CCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCC-hHHHHH
Q psy9535         324 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS-MRDIVD  386 (593)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs-m~eV~~  386 (593)
                      |........+..+........  + +....     +...+..++.+|+. +|.+||+ +.++++
T Consensus       230 f~~~~~~~~~~~i~~~~~~~~--~-p~~~~-----~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         230 FYSDTLQETYNKIINWKESLR--F-PPDPP-----VSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CCCCCHHHHHHHHhccCCccc--C-CCCCC-----CCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            987665444333332111100  0 00011     12234456678887 9999999 999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-38  Score=317.04  Aligned_cols=253  Identities=22%  Similarity=0.378  Sum_probs=189.4

Q ss_pred             CCCcccccCceEEEEEEEcC----CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~----g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      +++.||+|+||.||+|....    +..||||.++....    ...       ....|.+|+..++.++||||+++++++.
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~----~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~   71 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH----TYS-------EIEEFLSEAACMKDFDHPNVMKLIGVCF   71 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC----CHH-------HHHHHHHHHHHHHhCCCCCeeeEEeeec
Confidence            46889999999999998642    36799999864211    000       0225889999999999999999999875


Q ss_pred             ccc-------ceEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC
Q psy9535         189 NIM-------NCIVYEYMCNGSLYDRLARVN---NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  258 (593)
Q Consensus       189 ~~~-------~~lV~Ey~~~GsL~~~L~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~  258 (593)
                      ...       .++||||+++|+|.+++....   ....+++.....++.|++.||.|||+  .+|+||||||+|||++++
T Consensus        72 ~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~~  149 (273)
T cd05035          72 EASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLRED  149 (273)
T ss_pred             cCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEECCC
Confidence            422       479999999999999986532   22368999999999999999999998  569999999999999999


Q ss_pred             CccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHH
Q psy9535         259 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLV  336 (593)
Q Consensus       259 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~  336 (593)
                      +.+||+|||+++......... ......++..|+|||.+. ..++.++|||||||++|||++ |..||.+..........
T Consensus       150 ~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~  228 (273)
T cd05035         150 MTVCVADFGLSKKIYSGDYYR-QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL  228 (273)
T ss_pred             CeEEECCccceeecccccccc-ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999998654332111 111234567899999774 457889999999999999999 89999765443322222


Q ss_pred             HhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         337 VEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      .... .. ..    ...     ....+..++.+||+.+|++||++.||++.|++
T Consensus       229 ~~~~-~~-~~----~~~-----~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         229 RHGN-RL-KQ----PED-----CLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             HcCC-CC-CC----CcC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            2111 10 00    011     11234456679999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.6e-38  Score=315.63  Aligned_cols=248  Identities=27%  Similarity=0.403  Sum_probs=193.9

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      ..++||+|+||.||+|..++++.||+|.+.....    .          ...|.+|+.++++++||||+++++++.....
T Consensus        10 ~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~----~----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   75 (260)
T cd05067          10 LVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM----S----------PEAFLAEANLMKQLQHPRLVRLYAVVTQEPI   75 (260)
T ss_pred             eeeeeccCccceEEeeecCCCceEEEEEecCCCC----c----------HHHHHHHHHHHHhcCCcCeeeEEEEEccCCc
Confidence            3578999999999999988899999999864211    0          1248899999999999999999998877778


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+.+|+|.+++.... ...+++.++..++.|++.||+|||+  .+++||||||+||+++.++.++|+|||+++..
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence            99999999999999987543 3468999999999999999999998  56999999999999999999999999998765


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .....  .......++..|+|||.+. ..++.++|||||||++|||++ |+.||............... ... .     
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~-~-----  223 (260)
T cd05067         153 EDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRM-P-----  223 (260)
T ss_pred             CCCCc--ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-CCC-C-----
Confidence            43221  1112335678899999764 457889999999999999999 99999765433222222111 110 0     


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ....    ....+..++.+||..+|++||++.++...|+.
T Consensus       224 ~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 RPDN----CPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            0111    11235556779999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.9e-38  Score=320.53  Aligned_cols=250  Identities=26%  Similarity=0.403  Sum_probs=190.3

Q ss_pred             CCcccccCceEEEEEEEc-CCC----EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~----~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      .++||+|+||.||+|++. +|.    .||+|.++...     . ...      ...+.+|+.+++.++||||++++|+|.
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-----~-~~~------~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (279)
T cd05109          12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-----S-PKA------NKEILDEAYVMAGVGSPYVCRLLGICL   79 (279)
T ss_pred             eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-----C-HHH------HHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence            578999999999999864 454    48999885321     1 110      125788999999999999999999998


Q ss_pred             cccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         189 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       189 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      ....++++||+++|+|.+++....  ..+++..++.++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+
T Consensus        80 ~~~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~iiH~dlkp~Nil~~~~~~~kL~dfG~  155 (279)
T cd05109          80 TSTVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDFGL  155 (279)
T ss_pred             CCCcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCCCc
Confidence            877889999999999999987532  358999999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ++....... ........+++.|+|||.+ ...++.++|||||||++|||++ |..||.................+ .. 
T Consensus       156 ~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~-  232 (279)
T cd05109         156 ARLLDIDET-EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL-PQ-  232 (279)
T ss_pred             eeecccccc-eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-CC-
Confidence            987643221 1111223456789999976 4568889999999999999998 99999765433222222111111 00 


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                          ....     ...+..++.+||..||++||++.++++.|.+.
T Consensus       233 ----~~~~-----~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         233 ----PPIC-----TIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             ----CccC-----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                0111     12244566799999999999999999988764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-38  Score=333.34  Aligned_cols=241  Identities=23%  Similarity=0.286  Sum_probs=180.3

Q ss_pred             CCCcccccCceEEEEEEE----cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLC  187 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~----~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~  187 (593)
                      +.++||+|+||.||+++.    .+|+.||+|.+.+......         ......+.+|+.++.+++ ||||+++++++
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (332)
T cd05614           4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQK---------AKTVEHTRTERNVLEHVRQSPFLVTLHYAF   74 (332)
T ss_pred             EEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhh---------hhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence            357899999999999875    2578999999864311100         001224778999999994 99999999887


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      .. ...++||||+++|+|.+++...   ..+++.....++.|++.||.|||+  .+|+||||||+|||++.++.+||+||
T Consensus        75 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          75 QTEAKLHLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHK--LGIVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             ecCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHeEECCCCCEEEeeC
Confidence            65 5568999999999999998753   358899999999999999999998  56999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCc---hHHHH-HHHHhhc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNN---TILYY-YLVVEQE  340 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~---~~~~~-~~~~~~~  340 (593)
                      |+++.......  .......||+.|||||++.+  .++.++|||||||++|||+||+.||....   ..... .......
T Consensus       150 G~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  227 (332)
T cd05614         150 GLSKEFLSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD  227 (332)
T ss_pred             cCCccccccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC
Confidence            99876433221  11224579999999998754  36789999999999999999999996422   11111 1111111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCCh
Q psy9535         341 VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASM  381 (593)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm  381 (593)
                      .+.+.            .+...+..++.+||+.||++||++
T Consensus       228 ~~~~~------------~~~~~~~~li~~~l~~dp~~R~~~  256 (332)
T cd05614         228 PPFPS------------FIGPEAQDLLHKLLRKDPKKRLGA  256 (332)
T ss_pred             CCCCC------------CCCHHHHHHHHHHcCCCHHHcCCC
Confidence            11111            122334567789999999999943

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.3e-38  Score=337.00  Aligned_cols=241  Identities=24%  Similarity=0.327  Sum_probs=178.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|+.. +|+.||||.+....     . ...      ...|.+|++++++++|+||+++++++.. ..
T Consensus        79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~-~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  146 (353)
T PLN00034         79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-----E-DTV------RRQICREIEILRDVNHPNVVKCHDMFDHNGE  146 (353)
T ss_pred             hhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-----c-HHH------HHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence            468999999999999875 68999999985421     1 100      1257899999999999999999998866 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+.+|+|.+..       ...+.....++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus       147 ~~lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~  217 (353)
T PLN00034        147 IQVLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRI  217 (353)
T ss_pred             EEEEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccccccee
Confidence            68999999999986432       34567778899999999999998  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-----C-CCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-----Q-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~-~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      ......   ......||+.|+|||.+..     . .+.++|||||||++|||++|+.||.................... 
T Consensus       218 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-  293 (353)
T PLN00034        218 LAQTMD---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-  293 (353)
T ss_pred             cccccc---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC-
Confidence            543211   1123579999999997632     2 34589999999999999999999974321111010000000000 


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         ....    ......+..++.+||+.||++||++.||++
T Consensus       294 ---~~~~----~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        294 ---PEAP----ATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             ---CCCC----CccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0000    111223456678999999999999999875

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-38  Score=317.05  Aligned_cols=249  Identities=27%  Similarity=0.446  Sum_probs=190.8

Q ss_pred             CCcccccCceEEEEEEEcC----CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~----g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      .+.||+|+||.||+|++..    ...||||.+....     . .. .     ...|.+|+.++++++||||+++++++..
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-----~-~~-~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (266)
T cd05033           9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-----S-DK-Q-----RLDFLTEASIMGQFDHPNIIRLEGVVTK   76 (266)
T ss_pred             eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-----C-hH-H-----HHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence            6899999999999998742    3579999875321     1 10 1     1258899999999999999999998765


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus        77 ~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~di~p~nili~~~~~~~l~dfg~  152 (266)
T cd05033          77 SRPVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGL  152 (266)
T ss_pred             CCceEEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCCEEECccch
Confidence             56689999999999999997643  368999999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ++....... ...+....+++.|+|||.+. ..++.++||||||+++|||++ |..||................ ...  
T Consensus       153 ~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~--  228 (266)
T cd05033         153 SRRLEDSEA-TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-RLP--  228 (266)
T ss_pred             hhccccccc-ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCC--
Confidence            987642211 11122234567899999764 467889999999999999998 999997654333222222111 100  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                         ....     ....+..++.+||+.+|++||++.||++.|++
T Consensus       229 ---~~~~-----~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         229 ---PPMD-----CPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             ---CCCC-----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence               0111     12234567789999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.2e-38  Score=325.47  Aligned_cols=195  Identities=25%  Similarity=0.373  Sum_probs=155.4

Q ss_pred             CCcccccCceEEEEEEEc---CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         114 GNKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~---~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +.+||+|+||.||+|+..   +++.||+|.+....     .    .      ..+.+|+.+|++++||||+++++++.. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~----~------~~~~~E~~~l~~l~h~niv~~~~~~~~~   70 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----I----S------MSACREIALLRELKHPNVISLQKVFLSH   70 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----C----c------HHHHHHHHHHHhcCCCCCcceeeeEecC
Confidence            679999999999999864   46789999985321     0    0      135789999999999999999998753 


Q ss_pred             --ccceEEEEeccCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee----cC
Q psy9535         190 --IMNCIVYEYMCNGSLYDRLARVN------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DE  257 (593)
Q Consensus       190 --~~~~lV~Ey~~~GsL~~~L~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl----~~  257 (593)
                        ...++||||+. ++|.+++....      ....+++.....++.|++.||.|||+  .+|+||||||+|||+    +.
T Consensus        71 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~  147 (317)
T cd07868          71 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPE  147 (317)
T ss_pred             CCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCC
Confidence              34578999975 58888775321      12358899999999999999999998  569999999999999    45


Q ss_pred             CCccEEeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCC
Q psy9535         258 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDD  326 (593)
Q Consensus       258 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~  326 (593)
                      ++.+||+|||+++................||+.|+|||++.+  .++.++||||+||++|||++|++||..
T Consensus       148 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         148 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            679999999999875433211112234678999999997743  478899999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8e-38  Score=313.73  Aligned_cols=246  Identities=26%  Similarity=0.432  Sum_probs=185.3

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccce
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNC  193 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~  193 (593)
                      +||+|+||.||+|+.. +|+.||+|.+....     . ...      ...|.+|++++++++||||++++++|.. ...+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-----~-~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   69 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL-----P-PDL------KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY   69 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccC-----C-HHH------HHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeE
Confidence            6999999999999875 68999999875321     1 111      1258899999999999999999999866 4568


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecc
Q psy9535         194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  273 (593)
Q Consensus       194 lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~  273 (593)
                      +||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++...
T Consensus        70 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          70 IVMELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             EEEeeccCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEEcCCCcEEECccccCcccc
Confidence            9999999999999997532  458899999999999999999998  569999999999999999999999999987543


Q ss_pred             cCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccccc
Q psy9535         274 TSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  351 (593)
Q Consensus       274 ~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (593)
                      .... ........++..|+|||.+. +.++.++|||||||++|||++ |..||............... .+. .     .
T Consensus       146 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-~~~-~-----~  217 (252)
T cd05084         146 DGVY-ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VRL-P-----C  217 (252)
T ss_pred             cccc-cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCC-C-----C
Confidence            2211 10011112345799999764 457889999999999999998 89999764432221211111 110 0     0


Q ss_pred             CCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         352 GEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       352 ~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                          +......+..++.+||+.+|++||++.+|.+.|.
T Consensus       218 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 ----PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence                0111223455778999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.6e-38  Score=332.05  Aligned_cols=194  Identities=28%  Similarity=0.409  Sum_probs=161.6

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..++||+|+||.||+++.. +|..+|+|.+....     . ...      ...|.+|++++++++||||++++++|.+ .
T Consensus         9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-----~-~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (333)
T cd06650           9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-----K-PAI------RNQIIRELQVLHECNSPYIVGFYGAFYSDG   76 (333)
T ss_pred             eeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-----C-HHH------HHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence            3678999999999999876 68889999886421     1 000      1258899999999999999999998866 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++.....++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~  152 (333)
T cd06650          77 EISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSG  152 (333)
T ss_pred             EEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence            678999999999999999753   3578899999999999999999972 359999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCC
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDN  327 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~  327 (593)
                      ......     .....||+.|+|||.+.+ .++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         153 QLIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hhhhhc-----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            543221     123579999999997754 5788999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.9e-38  Score=321.95  Aligned_cols=251  Identities=25%  Similarity=0.439  Sum_probs=188.9

Q ss_pred             CCcccccCceEEEEEEE-----cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         114 GNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-----~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      .++||+|+||.||+|.+     .++..||+|.+....     ...  .     ...|.+|+.++++++||||+++++++.
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-----~~~--~-----~~~~~~E~~~l~~l~h~niv~~~~~~~   77 (283)
T cd05090          10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-----NPQ--Q-----WGEFQQEASLMAELHHPNIVCLLGVVT   77 (283)
T ss_pred             eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-----CHH--H-----HHHHHHHHHHHhhCCCCCeeeEEEEEe
Confidence            57899999999999975     246789999986321     100  0     125889999999999999999999876


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCe
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNN--------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  253 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NI  253 (593)
                      . ...++||||+++|+|.+++.....              ...+++.....++.|++.||.|||+  ++|+||||||+||
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~ni  155 (283)
T cd05090          78 QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNI  155 (283)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--cCeehhccccceE
Confidence            5 566899999999999999864321              1347889999999999999999998  5699999999999


Q ss_pred             eecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHH
Q psy9535         254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTIL  331 (593)
Q Consensus       254 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~  331 (593)
                      |++.++.+||+|||+++....... ........++..|+|||.+. ..++.++|||||||++|||++ |..||.......
T Consensus       156 li~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05090         156 LIGEQLHVKISDLGLSREIYSADY-YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE  234 (283)
T ss_pred             EEcCCCcEEeccccccccccCCcc-eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999976533221 11122345677899999764 567889999999999999998 999997654332


Q ss_pred             HHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         332 YYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ......... . ..    ....     +...+..++.+||+.+|.+||++.+|.+.|..
T Consensus       235 ~~~~~~~~~-~-~~----~~~~-----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 VIEMVRKRQ-L-LP----CSED-----CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcCC-c-CC----CCCC-----CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            222221111 1 10    0011     11234556679999999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.2e-38  Score=322.40  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=189.6

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .+.||+|+||.||+|+..      .+..||||+++...     . .  .    ....|.+|+.++++++||||+++++++
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-----~-~--~----~~~~~~~e~~~~~~l~h~~iv~~~~~~   77 (283)
T cd05091          10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-----E-G--P----LREEFKHEAMMRSRLQHPNIVCLLGVV   77 (283)
T ss_pred             HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-----C-H--H----HHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence            468999999999999863      24789999986321     0 0  0    012478999999999999999999998


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCe
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVN-------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  253 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NI  253 (593)
                      .. ...++++||+++++|.+++....             ....+++..+..++.|++.||.|||+  ++|+||||||+||
T Consensus        78 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~Ni  155 (283)
T cd05091          78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATRNV  155 (283)
T ss_pred             cCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchhhe
Confidence            76 55689999999999999985321             12357888899999999999999998  5699999999999


Q ss_pred             eecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHH
Q psy9535         254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTIL  331 (593)
Q Consensus       254 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~  331 (593)
                      |+++++.+||+|||+++....... ........+++.|+|||.+ .+.++.++|||||||++|||++ |..||.......
T Consensus       156 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  234 (283)
T cd05091         156 LVFDKLNVKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  234 (283)
T ss_pred             EecCCCceEecccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999886543321 1112234567899999976 4568889999999999999998 888987654433


Q ss_pred             HHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         332 YYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ...........  ..    ...     +...+..++.+||+.+|++||++++|++.|+.
T Consensus       235 ~~~~i~~~~~~--~~----~~~-----~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 VIEMIRNRQVL--PC----PDD-----CPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHcCCcC--CC----CCC-----CCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            33322222111  00    011     12234556779999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.1e-38  Score=333.49  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=188.7

Q ss_pred             CCCCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLL  184 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~  184 (593)
                      ++.+.||+|+||.||+|+..      +++.||+|+++...     ....       ...+.+|++++.++ +||||++++
T Consensus        10 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-----~~~~-------~~~~~~E~~~~~~l~~h~niv~~~   77 (337)
T cd05054          10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-----TASE-------YKALMTELKILIHIGHHLNVVNLL   77 (337)
T ss_pred             hhhcccccCcCceEEeccccccccccccceeeeeeccCCC-----CHHH-------HHHHHHHHHHHHhhccCcchhhee
Confidence            44689999999999999642      35789999985321     1111       12467899999999 899999999


Q ss_pred             EEEec--ccceEEEEeccCCCHHHHHhhcCC-------------------------------------------------
Q psy9535         185 GLCNN--IMNCIVYEYMCNGSLYDRLARVNN-------------------------------------------------  213 (593)
Q Consensus       185 g~~~~--~~~~lV~Ey~~~GsL~~~L~~~~~-------------------------------------------------  213 (593)
                      ++|..  ...+++|||+++|+|.+++.....                                                 
T Consensus        78 ~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (337)
T cd05054          78 GACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE  157 (337)
T ss_pred             eeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence            98865  345789999999999999864321                                                 


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecccCCCcceeecc
Q psy9535         214 ---------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN  284 (593)
Q Consensus       214 ---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  284 (593)
                               ..++++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++....... ......
T Consensus       158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~  234 (337)
T cd05054         158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGD  234 (337)
T ss_pred             cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccC
Confidence                     1268999999999999999999998  5699999999999999999999999999986533221 111223


Q ss_pred             ccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHH
Q psy9535         285 LTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETL  362 (593)
Q Consensus       285 ~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (593)
                      ..|+..|+|||++ ...++.++|||||||++|||++ |..||..................  ...    ..    .....
T Consensus       235 ~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~----~~----~~~~~  304 (337)
T cd05054         235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR--MRA----PE----YATPE  304 (337)
T ss_pred             CCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC--CCC----Cc----cCCHH
Confidence            4567889999966 4568899999999999999998 99999753221111111111110  000    00    11122


Q ss_pred             HHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         363 IGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       363 i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      +..++.+||+.+|++||++.||++.|++.
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            34456799999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.7e-38  Score=314.54  Aligned_cols=250  Identities=27%  Similarity=0.390  Sum_probs=191.0

Q ss_pred             CcccccCceEEEEEEEcC--C--CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         115 NKLGEGQFGTVYYGKLKN--G--MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~~--g--~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      ++||+|+||.||+|.+.+  +  ..||||.+......     .       ....|.+|+.++++++||||+++++.+...
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-----~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   68 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-----D-------IMDDFLKEAAIMHSLDHENLIRLYGVVLTH   68 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-----H-------HHHHHHHHHHHHhhcCCCCccceeEEEcCC
Confidence            368999999999998743  3  36999998643210     0       123588999999999999999999988776


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++..... ..+++.....++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus        69 ~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~di~p~nil~~~~~~~kl~dfg~~~  145 (257)
T cd05040          69 PLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMR  145 (257)
T ss_pred             eEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh--CCccccccCcccEEEecCCEEEeccccccc
Confidence            67899999999999999976432 468999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ................|+..|+|||.+. ..++.++|||||||++|||++ |..||.................. ..  .
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~--~  222 (257)
T cd05040         146 ALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-LE--R  222 (257)
T ss_pred             cccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-CC--C
Confidence            7644221111122346788999999775 457889999999999999999 99999765433322222111100 00  0


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                      +       ......+..++.+||..+|++||++.+|++.|.
T Consensus       223 ~-------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 P-------EACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             C-------ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            0       011223555677999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-38  Score=333.33  Aligned_cols=245  Identities=25%  Similarity=0.339  Sum_probs=184.4

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHH-HHhcCCCCceeeEEEEEec-ccc
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ-TLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~-il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      .||+|+||.||+|+.. +|+.||||++........   .  .     ...+..|.. +++.++||||+++++++.. ...
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~--~-----~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~   71 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR---K--E-----QKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL   71 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---h--H-----HHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence            6999999999999864 689999999864311100   0  0     113455554 5678999999999988765 567


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          72 YFVLDFVNGGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             EEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            8999999999999888653   468899999999999999999998  56999999999999999999999999998753


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  351 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (593)
                      .....   ......||+.|||||++. ..++.++|||||||++|||++|+.||........+...........    +  
T Consensus       147 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~--  217 (325)
T cd05604         147 IAQSD---TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----P--  217 (325)
T ss_pred             CCCCC---CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----C--
Confidence            22211   123457999999999875 4578899999999999999999999987654443333332221111    1  


Q ss_pred             CCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         352 GEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       352 ~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                       ..     ...+..++.+|++.+|.+||++++.++.+.+
T Consensus       218 -~~-----~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~  250 (325)
T cd05604         218 -GA-----SLTAWSILEELLEKDRQRRLGAKEDFLEIQE  250 (325)
T ss_pred             -CC-----CHHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence             11     1223446679999999999999765554444

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.2e-38  Score=329.00  Aligned_cols=238  Identities=26%  Similarity=0.325  Sum_probs=182.5

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCC-ceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV-NLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~Hp-NIv~l~g~~~~-~  190 (593)
                      .+.||+|+||.||+|+.. +++.||||++........   .       ....+..|+.++..++|+ +|+++++++.. .
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~-------~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (324)
T cd05587           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQD---D-------DVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   74 (324)
T ss_pred             EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhh---h-------HHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence            578999999999999875 578999999875321110   0       112467899999999775 58888887765 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05587          75 RLYFVMEYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCK  149 (324)
T ss_pred             EEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecCcce
Confidence            678999999999999998753   358899999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .......   ......||+.|+|||++.+ .++.++|||||||++|||+||+.||...........+.......+..   
T Consensus       150 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~---  223 (324)
T cd05587         150 ENIFGGK---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS---  223 (324)
T ss_pred             ecCCCCC---ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC---
Confidence            5322111   1224579999999997754 57889999999999999999999998765444333333222221111   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCCh
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASM  381 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm  381 (593)
                               +...+..++.+||..+|.+||+.
T Consensus       224 ---------~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         224 ---------LSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---------CCHHHHHHHHHHhhcCHHHcCCC
Confidence                     11223456679999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG1094|consensus

Probab=100.00  E-value=5.5e-39  Score=336.13  Aligned_cols=256  Identities=27%  Similarity=0.395  Sum_probs=192.2

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ..++||+|-||.|..|....+..||||+++......            ....|.+|+.+|.+|+|||||+|+|+|.. +.
T Consensus       542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~------------~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP  609 (807)
T KOG1094|consen  542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN------------ARNDFLKEIKILSRLKHPNIVELLGVCVQDDP  609 (807)
T ss_pred             hhhhhcCcccceeEEEEecCceEEEEeecCcccchh------------HHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence            468999999999999999878999999997642111            12369999999999999999999999976 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|+|||++|+|.++|.+... +.+.....++|+.|||.|++||.+..  +|||||.+.|+|+|.++++||+|||++|.
T Consensus       610 icmI~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  610 LCMITEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             hHHHHHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccc
Confidence            6899999999999999987532 22456677889999999999999855  99999999999999999999999999985


Q ss_pred             cccCCCcceeeccccCCCCcCCcc-cccCCCCCcchhhHHHHHHHHHH--hCCCCCCCCchHHHHHH--HHhhcCccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELL--TGMKPIDDNNTILYYYL--VVEQEVPVREV  346 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE-~~~~~~~~ksDVwSfGvvl~Ell--tG~~P~~~~~~~~~~~~--~~~~~~~~~~~  346 (593)
                      .-.... .......+-...||||| ++.++++++||||+|||+|||++  +...||.+..+......  ......+ +++
T Consensus       687 lysg~y-y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~-~~~  764 (807)
T KOG1094|consen  687 LYSGDY-YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG-RQV  764 (807)
T ss_pred             cccCCc-eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC-cce
Confidence            543321 11122234457899999 56789999999999999999986  57899976433211111  1111111 111


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      .-....-     +..-+..++.+||..|-++||++.++...|+.
T Consensus       765 ~l~~P~~-----cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  765 VLSRPPA-----CPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             eccCCCc-----CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            1111111     12223345569999999999999999988865

>KOG0663|consensus

Probab=100.00  E-value=3.3e-38  Score=312.24  Aligned_cols=254  Identities=24%  Similarity=0.298  Sum_probs=190.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec---
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~---  189 (593)
                      -++|++|+||.||+|+.+ ++..||+|+++....          ..-.++. -.+||.+|.+++|||||.+-.+...   
T Consensus        81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke----------k~GFPIt-sLREIniLl~~~H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE----------KEGFPIT-SLREINILLKARHPNIVEVKEVVVGSNM  149 (419)
T ss_pred             HhhcccCcceeEEEeccCCcceeEEeeecccccc----------cCCCcch-hHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence            478999999999999875 688899999975431          1112222 4689999999999999999886543   


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      +..|+|||||+ .+|...|....  .++...+...++.|+++|++|||.  ..|+||||||+|+|+...|.+||+|||||
T Consensus       150 d~iy~VMe~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~--~wilHRDLK~SNLLm~~~G~lKiaDFGLA  224 (419)
T KOG0663|consen  150 DKIYIVMEYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHD--NWILHRDLKTSNLLLSHKGILKIADFGLA  224 (419)
T ss_pred             ceeeeeHHHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhh--ceeEecccchhheeeccCCcEEecccchh
Confidence            56799999996 57888887643  578899999999999999999998  55999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      |.......  .+ +..+-|.+|.|||.+-+  .|++..|+||+|||+.||+++++-|.+...+.....+...-+...+.+
T Consensus       225 R~ygsp~k--~~-T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i  301 (419)
T KOG0663|consen  225 REYGSPLK--PY-TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI  301 (419)
T ss_pred             hhhcCCcc--cC-cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence            98765421  12 33567999999997643  589999999999999999999999988766555444433211111111


Q ss_pred             ccc--------------------cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKE--------------------AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~--------------------~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      -+.                    ...+....+.+.-..++..-+.+||.+|.|+.|.++
T Consensus       302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            100                    001111112233344666788999999999999754

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.7e-39  Score=334.39  Aligned_cols=247  Identities=23%  Similarity=0.314  Sum_probs=188.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+++.. +|+.||||.++.......          .....|.+|+.+++.++||||+++++++.+ ..
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~   75 (330)
T cd05601           6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQ----------ETVSFFEEERDILSISNSPWIPQLQYAFQDKDN   75 (330)
T ss_pred             EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence            578999999999999875 689999999975321000          012357889999999999999999998866 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.+..  ..+++.....++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~  151 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQ--MGYVHRDIKPENVLIDRTGHIKLADFGSAAR  151 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEcccCchHheEECCCCCEEeccCCCCeE
Confidence            689999999999999997642  368999999999999999999998  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-------CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      ......  .......||+.|+|||++.       ..++.++|||||||++|||++|+.||........+..+....... 
T Consensus       152 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-  228 (330)
T cd05601         152 LTANKM--VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL-  228 (330)
T ss_pred             CCCCCc--eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc-
Confidence            543321  1223357999999999764       346789999999999999999999998765544333332221110 


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV  385 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~  385 (593)
                      ..  +....     ....+..++.+|+. +|.+||++.+++
T Consensus       229 ~~--~~~~~-----~~~~~~~li~~ll~-~p~~R~t~~~l~  261 (330)
T cd05601         229 KF--PEDPK-----VSSDFLDLIQSLLC-GQKERLGYEGLC  261 (330)
T ss_pred             CC--CCCCC-----CCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence            00  00011     12234456678887 999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-38  Score=337.49  Aligned_cols=188  Identities=22%  Similarity=0.297  Sum_probs=156.4

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      .+.++||+|+||.||+++.. +++.||+|.....                   .+.+|++++++++|||||++++++.. 
T Consensus        95 ~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~-------------------~~~~E~~il~~l~HpnIv~~~~~~~~~  155 (391)
T PHA03212         95 SILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG-------------------GTATEAHILRAINHPSIIQLKGTFTYN  155 (391)
T ss_pred             EEEEEEcCCCCeEEEEEEECCCCCEEEEechhhh-------------------hhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence            44688999999999999864 6889999975311                   35789999999999999999998765 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++|+||+. ++|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       156 ~~~~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~--~~IvHrDiKP~NIll~~~~~vkL~DFG~a  229 (391)
T PHA03212        156 KFTCLILPRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFGAA  229 (391)
T ss_pred             CeeEEEEecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence            55689999985 7898888653   358899999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCC
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDD  326 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~  326 (593)
                      +.......  .......||+.|+|||++. ..++.++|||||||++|||++|..||..
T Consensus       230 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        230 CFPVDINA--NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             cccccccc--cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            75332211  1122457999999999774 4578899999999999999999988753

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.9e-38  Score=335.77  Aligned_cols=253  Identities=27%  Similarity=0.422  Sum_probs=190.3

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGL  186 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~  186 (593)
                      +++||+|+||.||+|+++      .+..||||+++...     ....       ...|.+|+.+|.++. |||||+++|+
T Consensus        42 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-----~~~~-------~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          42 GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-----RSSE-------KQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             hhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-----ChhH-------HHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            578999999999999864      24679999996431     1110       124789999999997 9999999999


Q ss_pred             Eec-ccceEEEEeccCCCHHHHHhhcCC----------------------------------------------------
Q psy9535         187 CNN-IMNCIVYEYMCNGSLYDRLARVNN----------------------------------------------------  213 (593)
Q Consensus       187 ~~~-~~~~lV~Ey~~~GsL~~~L~~~~~----------------------------------------------------  213 (593)
                      |.. ...++||||+++|+|.++|++...                                                    
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            876 566899999999999999975321                                                    


Q ss_pred             -------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCC
Q psy9535         214 -------------------------------------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKS  250 (593)
Q Consensus       214 -------------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp  250 (593)
                                                                 ...+++.....++.|++.||.|||+  ++|+||||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrdlkp  267 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLAA  267 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcCcccCCc
Confidence                                                       1246778889999999999999998  5699999999


Q ss_pred             CCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCc
Q psy9535         251 ANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNN  328 (593)
Q Consensus       251 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~  328 (593)
                      +|||+++++.+||+|||+++......... ......|++.|||||.+. ..++.++|||||||++|||++ |..||....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYI-SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccc-cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999999998643221111 112245788999999764 457889999999999999998 899997643


Q ss_pred             hHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         329 TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ................      ..    ..+...+..++.+||..+|.+||++.||++.|++.
T Consensus       347 ~~~~~~~~~~~~~~~~------~p----~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         347 MNEQFYNAIKRGYRMA------KP----AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             chHHHHHHHHcCCCCC------CC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            3222222222111110      00    01123455677899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-38  Score=322.60  Aligned_cols=247  Identities=21%  Similarity=0.279  Sum_probs=186.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||++... +++.||||.+........      .    ....+.+|+.++++++||||+++++++.. ..
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (285)
T cd05605           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR------K----GEAMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhh------h----hHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence            578999999999999864 689999999864321100      0    01246789999999999999999998865 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+|||+++++.++|+|||+++.
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLAVE  151 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence            789999999999998886532 2468999999999999999999998  5699999999999999999999999999886


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......    .....||+.|+|||++. ..++.++|||||||++|||++|+.||....................      
T Consensus       152 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------  221 (285)
T cd05605         152 IPEGET----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ------  221 (285)
T ss_pred             cCCCCc----cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc------
Confidence            543221    12357999999999764 4578899999999999999999999986443221111111000000      


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIV  385 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~  385 (593)
                       ..+ +......+..++.+||+.||++||     ++.+++
T Consensus       222 -~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~  259 (285)
T cd05605         222 -EEY-SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVK  259 (285)
T ss_pred             -ccc-CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHh
Confidence             000 111223455677899999999999     666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.4e-38  Score=337.35  Aligned_cols=247  Identities=23%  Similarity=0.297  Sum_probs=184.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+++.+ +++.||+|.+........   .       ....+.+|+.+++.++||||+++++++.+ ..
T Consensus        48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~---~-------~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR---S-------DSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhh---H-------HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            578999999999999876 688999999864211000   0       11247789999999999999999998866 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++..    ..++...+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            6899999999999999864    247888888999999999999998  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-----CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ......  .......||+.|||||++..     .++.++|||||||++|||++|+.||...+....+..+........ .
T Consensus       192 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-~  268 (371)
T cd05622         192 MNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT-F  268 (371)
T ss_pred             cCcCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc-C
Confidence            543321  11234679999999998743     267899999999999999999999987665444444332221111 0


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCC--CCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDK--RASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~--RPsm~eV~~  386 (593)
                        +..     ......+..++.+|+..++.+  ||++.|+++
T Consensus       269 --~~~-----~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~  303 (371)
T cd05622         269 --PDD-----NDISKEAKNLICAFLTDREVRLGRNGVEEIKR  303 (371)
T ss_pred             --CCc-----CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence              000     112233455666888743333  677777754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=9.2e-38  Score=316.22  Aligned_cols=251  Identities=26%  Similarity=0.439  Sum_probs=189.5

Q ss_pred             CCcccccCceEEEEEEEc-CCC---EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGM---EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~---~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      .+.||+|+||.||+|+.. ++.   .+|||.+.....      .. .     ...|.+|+.++++++||||+++++++..
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~------~~-~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (268)
T cd05063          10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT------EK-Q-----RQDFLSEASIMGQFSHHNIIRLEGVVTK   77 (268)
T ss_pred             eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC------HH-H-----HHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence            578999999999999875 333   699998854210      00 0     1257899999999999999999998866


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~  153 (268)
T cd05063          78 FKPAMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSD--MNYVHRDLAARNILVNSNLECKVSDFGL  153 (268)
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEEcCCCcEEECCCcc
Confidence             56689999999999999987533  468999999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ++................+++.|+|||.+. ..++.++|||||||++|||++ |+.||............... ...+. 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~-  231 (268)
T cd05063         154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPA-  231 (268)
T ss_pred             ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-CCCCC-
Confidence            876543321111111223456799999764 457889999999999999997 99999765433322222211 11110 


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                          ...     ....+..++.+||+.+|++||++.+|++.|.+.
T Consensus       232 ----~~~-----~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         232 ----PMD-----CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----CCC-----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                001     112345567799999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.3e-37  Score=319.71  Aligned_cols=251  Identities=26%  Similarity=0.426  Sum_probs=191.0

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .+.||+|+||.||+|+..      ++..+|+|.+....       .  .    ....|.+|++++++++||||+++++++
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-------~--~----~~~~~~~e~~~l~~l~h~~i~~~~~~~   76 (291)
T cd05094          10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-------L--A----ARKDFQREAELLTNLQHEHIVKFYGVC   76 (291)
T ss_pred             eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-------H--H----HHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence            478999999999999742      34568999875321       0  0    012588999999999999999999998


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCe
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  253 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NI  253 (593)
                      .. ...++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+  ++|+||||||+||
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Ni  154 (291)
T cd05094          77 GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS--QHFVHRDLATRNC  154 (291)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceE
Confidence            76 556899999999999999975321             2348899999999999999999998  5699999999999


Q ss_pred             eecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHH
Q psy9535         254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTIL  331 (593)
Q Consensus       254 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~  331 (593)
                      |++.++.+||+|||+++....... ........|++.|+|||.+. ..++.++|||||||++|||+| |+.||.......
T Consensus       155 l~~~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  233 (291)
T cd05094         155 LVGANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE  233 (291)
T ss_pred             EEccCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999876543221 11122345788999999764 457889999999999999999 999997654433


Q ss_pred             HHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         332 YYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ..........+  ..    ...     ....+..++.+||+.+|++||++.+|++.|...
T Consensus       234 ~~~~~~~~~~~--~~----~~~-----~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         234 VIECITQGRVL--ER----PRV-----CPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             HHHHHhCCCCC--CC----Ccc-----CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            22222111111  10    011     112355677899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.8e-38  Score=323.97  Aligned_cols=256  Identities=23%  Similarity=0.328  Sum_probs=186.5

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         111 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       111 ~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      +...++||+|+||.||+|+.+ ++..||+|.++.......            ...+.+|++++++++||||+++++++..
T Consensus         8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~E~~~l~~l~h~~iv~~~~~~~~   75 (309)
T cd07872           8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA------------PCTAIREVSLLKDLKHANIVTLHDIVHT   75 (309)
T ss_pred             eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc------------chhHHHHHHHHHhCCCCCcceEEEEEee
Confidence            345688999999999999875 678899999864321110            0136789999999999999999998865


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...++||||+. ++|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        76 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~  150 (309)
T cd07872          76 DKSLTLVFEYLD-KDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHR--RKVLHRDLKPQNLLINERGELKLADFGL  150 (309)
T ss_pred             CCeEEEEEeCCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECcccc
Confidence             56689999997 48888886543  357888999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-cCcccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVRE  345 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-~~~~~~  345 (593)
                      ++.......   ......||+.|+|||.+.+  .++.++|||||||++|||+||+.||............... ..+..+
T Consensus       151 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  227 (309)
T cd07872         151 ARAKSVPTK---TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE  227 (309)
T ss_pred             ceecCCCcc---ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            876433211   1123468999999997643  4788999999999999999999999765432222111110 000000


Q ss_pred             ----cc------ccccCCCC-------HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 ----VL------DKEAGEWN-------ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ----~~------~~~~~~~~-------~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                          ..      +.....+.       ...+...+..++.+|+..||.+|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                00      00000000       0012233456778999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4e-38  Score=319.34  Aligned_cols=243  Identities=25%  Similarity=0.393  Sum_probs=185.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec--
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN--  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~--  189 (593)
                      .+.||+|+||.||+|+.. +++.||+|.+....    ..    .      ..+.+|+.+++++ +||||+++++++..  
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~----~------~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (272)
T cd06637          11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DE----E------EEIKQEINMLKKYSHHRNIATYYGAFIKKN   76 (272)
T ss_pred             HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----cc----H------HHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence            578999999999999875 58889999986421    11    1      1367899999998 69999999998753  


Q ss_pred             -----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         190 -----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       190 -----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                           ...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+||++++++.+||+
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          77 PPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             CCCCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHEEECCCCCEEEc
Confidence                 23579999999999999987632 3468899999999999999999998  569999999999999999999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCccccc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  338 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~  338 (593)
                      |||+++.......   ......|++.|+|||++.      ..++.++|||||||++|||++|..||..............
T Consensus       154 Dfg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~  230 (272)
T cd06637         154 DFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR  230 (272)
T ss_pred             cCCCceecccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence            9999876533211   122357999999999763      2467799999999999999999999976543332222111


Q ss_pred             hcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         339 QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        .+.....+        ......+..++.+||..+|.+|||+.||++
T Consensus       231 --~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 --NPAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --CCCCCCCC--------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence              11111111        111223556778999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0603|consensus

Probab=100.00  E-value=2.6e-39  Score=344.75  Aligned_cols=407  Identities=23%  Similarity=0.295  Sum_probs=256.1

Q ss_pred             ccccCceEEEEEE----EcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-c
Q psy9535         117 LGEGQFGTVYYGK----LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-I  190 (593)
Q Consensus       117 LG~G~fG~Vy~g~----~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-~  190 (593)
                      +|+|+||.|+..+    .+.|..+|+|.+++.........           ....|..++..++ ||.+|++.-.+.. .
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-----------~t~~er~il~~~~~~~f~v~lhyafqt~~   70 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-----------HTKQERIILAFVHNTPFLVKLHYAFQTDG   70 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-----------ccccHHHHHhhccCCCceeeeeeeecccc
Confidence            7999999999753    34578899998876532221111           1335777888887 9999999877655 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..+++++|..+|.|...+...   ..++......+...+|-|++.+|+..  |+|||+|++||+++.+|.+|+.|||+++
T Consensus        71 kl~l~ld~~rgg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglsk  145 (612)
T KOG0603|consen   71 KLYLILDFLRGGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSK  145 (612)
T ss_pred             chhHhhhhcccchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhh
Confidence            678999999999999888653   23555556667788999999999854  9999999999999999999999999988


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ..-....       .+||.-|||||+.. .....+|.||||++++||+||..||..+    ....+...+...+.     
T Consensus       146 e~v~~~~-------~cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~~----~~~~Il~~~~~~p~-----  208 (612)
T KOG0603|consen  146 EAVKEKI-------ACGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGGD----TMKRILKAELEMPR-----  208 (612)
T ss_pred             HhHhhhh-------cccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCchH----HHHHHhhhccCCch-----
Confidence            7544321       28999999999887 5677899999999999999999999861    11122222222211     


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCCh--HHHHHHHhhcccc----------------------------------
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASM--RDIVDLLSKSMFV----------------------------------  394 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm--~eV~~~L~~~~~~----------------------------------  394 (593)
                             ++...++.++......+|..|-..  ..+.+.++...+.                                  
T Consensus       209 -------~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft  281 (612)
T KOG0603|consen  209 -------ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFT  281 (612)
T ss_pred             -------hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhc
Confidence                   122223333333334444444333  1111111110000                                  


Q ss_pred             ----------ccccc--ccccc------cc-cc----ccccccccccc--------------------------------
Q psy9535         395 ----------CNSLA--NLYVG------KV-SS----RTQENNNINWE--------------------------------  419 (593)
Q Consensus       395 ----------~~~~~--~~~~~------~~-~~----~~~~~~~~~~~--------------------------------  419 (593)
                                +.+-.  ..+.+      .+ ..    ......++..+                                
T Consensus       282 ~~~P~dsp~~~~~~s~~~if~g~sfva~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~  361 (612)
T KOG0603|consen  282 SQVPADSPLLSASGSDHTIFSGPSFVAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD  361 (612)
T ss_pred             cCCcccCCCCCCCccccchhcCCCccChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheeccccccc
Confidence                      00000  00000      00 00    00000000000                                


Q ss_pred             --------ccccCcceEee-----cCC-------chhhh-hHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc
Q psy9535         420 --------LHYTGIPVIIL-----DTG-------ETKQC-QLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPI  478 (593)
Q Consensus       420 --------~~~~~~~v~~~-----~~~-------~~~~~-~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~i  478 (593)
                              +.+...+.++-     ..+       |.... .+...   ....+....++..|+.+++.|+.|||+  +++
T Consensus       362 ~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~r---i~~~~~~~~e~~~w~~~lv~Av~~LH~--~gv  436 (612)
T KOG0603|consen  362 NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRR---IRSKPEFCSEASQWAAELVSAVDYLHE--QGV  436 (612)
T ss_pred             cccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHH---HHhcchhHHHHHHHHHHHHHHHHHHHh--cCe
Confidence                    00000010000     000       00000 11111   112234446777899999999999999  679


Q ss_pred             eecCCCCCcEee-cCCCceEEEecccceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccC
Q psy9535         479 IHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITN  556 (593)
Q Consensus       479 iHrdlKp~NILl-~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~  556 (593)
                      +||||||+|||+ +..+.++|+|||+++.....    +.+  .+=|..|.|||++.. .++.++|||||||+||+-+++.
T Consensus       437 vhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~t--p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~  510 (612)
T KOG0603|consen  437 VHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDT--PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGR  510 (612)
T ss_pred             eecCCChhheeecCCCCcEEEEEechhhhCchh----hcc--cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCC
Confidence            999999999999 58899999999998754332    111  233778999999865 4889999999999999977777


Q ss_pred             CCccchhhh-chhhhhcCC
Q psy9535         557 VDIADRERY-YSLQTMLPG  574 (593)
Q Consensus       557 ~~~~~~~~~-~~~~~~~~~  574 (593)
                      .|+...... ...+-+.+|
T Consensus       511 tp~~~~P~~~ei~~~i~~~  529 (612)
T KOG0603|consen  511 TLFAAHPAGIEIHTRIQMP  529 (612)
T ss_pred             CccccCCchHHHHHhhcCC
Confidence            776655555 333444444

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.4e-37  Score=314.46  Aligned_cols=255  Identities=22%  Similarity=0.331  Sum_probs=193.4

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|+.. +++.||||.+.......    .  +    ....|.+|++++++++||||+++++++.. .
T Consensus         6 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~--~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (267)
T cd08228           6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD----A--K----ARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN   75 (267)
T ss_pred             eeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC----H--H----HHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence            3678999999999999864 68999999886421111    0  1    11257899999999999999999998765 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ..++|+||+++|+|.+++.... ....++......++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence            6689999999999998886432 23457889999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCch-HHHHHHHHhhcCcccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNT-ILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~-~~~~~~~~~~~~~~~~~~  347 (593)
                      +.......   ......|++.|+|||.+. ...+.++||||||+++|||++|+.||..... ........... ..+.  
T Consensus       154 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--  227 (267)
T cd08228         154 RFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC-DYPP--  227 (267)
T ss_pred             eeccchhH---HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC-CCCC--
Confidence            86543221   112356899999999764 4578899999999999999999999965432 11111111111 1111  


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                            .........+..++.+||..+|++||++.+|++.|+..
T Consensus       228 ------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 ------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                  11112233456677899999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.3e-38  Score=330.33  Aligned_cols=237  Identities=26%  Similarity=0.334  Sum_probs=179.2

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHH-HHHhcCCCCceeeEEEEEec-ccc
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev-~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      +||+|+||.||+|+.. +|+.||+|.+........      .    ....+.+|. .+++.++||||+++++++.+ ...
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~------~----~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~   71 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK------K----EQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL   71 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh------h----HHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence            6999999999999875 688999999864311100      0    011344554 46788999999999998765 566


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+.+...   ..+++.....++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          72 YFVLDYVNGGELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             EEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            8999999999999888652   357888888999999999999998  56999999999999999999999999998753


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  351 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (593)
                      ....   .......||+.|+|||++. ..++.++|||||||++|||++|+.||...+.......+.......+       
T Consensus       147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~-------  216 (321)
T cd05603         147 VEPE---ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP-------  216 (321)
T ss_pred             CCCC---CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC-------
Confidence            2221   1123457999999999774 4578899999999999999999999987654433333322211111       


Q ss_pred             CCCCHHHHHHHHHHHHHHhhccccCCCCChH
Q psy9535         352 GEWNETHVETLIGIVFEKCCVFEKDKRASMR  382 (593)
Q Consensus       352 ~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~  382 (593)
                      ...     ...+..++.+|++.+|.+||+..
T Consensus       217 ~~~-----~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGK-----TVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCC-----CHHHHHHHHHHccCCHhhcCCCC
Confidence            011     12244566799999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=9.3e-38  Score=318.44  Aligned_cols=252  Identities=25%  Similarity=0.397  Sum_probs=192.8

Q ss_pred             CCcccccCceEEEEEEEcC-----CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         114 GNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~-----g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      .+.||+|+||.||+|.+..     +..||+|++....     . .  .    ....+.+|+.++++++||||+++++++.
T Consensus        11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-----~-~--~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~   78 (280)
T cd05043          11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-----S-E--I----QVTLLLQESCLLYGLSHQNILPILHVCI   78 (280)
T ss_pred             eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-----C-H--H----HHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            5789999999999998765     6789999875321     1 0  0    1225789999999999999999999886


Q ss_pred             c--ccceEEEEeccCCCHHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCcc
Q psy9535         189 N--IMNCIVYEYMCNGSLYDRLARVNNT-----PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  261 (593)
Q Consensus       189 ~--~~~~lV~Ey~~~GsL~~~L~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~  261 (593)
                      .  ...++++||+++|+|.+++......     ..+++..+..++.|++.||+|||+  .+++||||||+|||+++++.+
T Consensus        79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~i~H~di~p~nil~~~~~~~  156 (280)
T cd05043          79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK--RGVIHKDIAARNCVIDEELQV  156 (280)
T ss_pred             cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCHhhEEEcCCCcE
Confidence            5  5568999999999999999764322     468999999999999999999998  569999999999999999999


Q ss_pred             EEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhh
Q psy9535         262 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ  339 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~  339 (593)
                      ||+|||+++....... ........++..|+|||.+. ..++.++|||||||++||+++ |+.||............. .
T Consensus       157 kl~d~g~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~  234 (280)
T cd05043         157 KITDNALSRDLFPMDY-HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-D  234 (280)
T ss_pred             EECCCCCcccccCCce-EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-c
Confidence            9999999986533221 11112245677899999764 457889999999999999999 999998755433222222 1


Q ss_pred             cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         340 EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ......     ...     +...+..++.+||..+|++|||+.+|++.|+..
T Consensus       235 ~~~~~~-----~~~-----~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         235 GYRLAQ-----PIN-----CPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             CCCCCC-----CCc-----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111110     001     112345567899999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.3e-37  Score=309.86  Aligned_cols=245  Identities=27%  Similarity=0.441  Sum_probs=187.6

Q ss_pred             cccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccceE
Q psy9535         116 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  194 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~l  194 (593)
                      +||+|+||.||+|...++..||+|.+....     . ...      ...|.+|++++++++||||++++++|.. ...++
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-----~-~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   69 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-----P-QEL------KIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYI   69 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcC-----C-HHH------HHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEE
Confidence            689999999999998888999999875321     1 111      1248899999999999999999998876 56689


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceeccc
Q psy9535         195 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  274 (593)
Q Consensus       195 V~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~  274 (593)
                      ||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+++....
T Consensus        70 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  145 (250)
T cd05085          70 VMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDD  145 (250)
T ss_pred             EEECCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccChheEEEcCCCeEEECCCccceeccc
Confidence            999999999999986533  357899999999999999999998  5699999999999999999999999999875432


Q ss_pred             CCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccccC
Q psy9535         275 SNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG  352 (593)
Q Consensus       275 ~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (593)
                      ...  .......+++.|+|||++. ..++.++|||||||++|||++ |..||.............. .... .     ..
T Consensus       146 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~-~-----~~  216 (250)
T cd05085         146 GIY--SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-GYRM-S-----CP  216 (250)
T ss_pred             ccc--ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCCC-C-----CC
Confidence            211  1111224567899999764 457889999999999999998 9999976543322222111 1110 0     00


Q ss_pred             CCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         353 EWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       353 ~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                      .    .+...+..++.+||..+|++||++.|+++.|.
T Consensus       217 ~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 Q----KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             C----CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            0    11223555677999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.2e-37  Score=323.27  Aligned_cols=196  Identities=25%  Similarity=0.372  Sum_probs=155.6

Q ss_pred             CCCcccccCceEEEEEEEc---CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         113 RGNKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~---~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      .+.+||+|+||.||+|+..   ++..||+|.+.....         .      ..+.+|+.++++++||||+++++++..
T Consensus         5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---------~------~~~~~E~~~l~~l~h~niv~~~~~~~~   69 (317)
T cd07867           5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---------S------MSACREIALLRELKHPNVIALQKVFLS   69 (317)
T ss_pred             eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---------c------HHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence            3678999999999999865   357899999854210         0      136789999999999999999998743


Q ss_pred             ---ccceEEEEeccCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee----c
Q psy9535         190 ---IMNCIVYEYMCNGSLYDRLARVN------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----D  256 (593)
Q Consensus       190 ---~~~~lV~Ey~~~GsL~~~L~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl----~  256 (593)
                         ...++||||+. ++|.+.+....      ....+++..+..++.|++.||.|||+  .+|+||||||+|||+    +
T Consensus        70 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivH~Dlkp~Nil~~~~~~  146 (317)
T cd07867          70 HSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGP  146 (317)
T ss_pred             cCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEccCCC
Confidence               34579999976 57877775321      12358889999999999999999998  569999999999999    5


Q ss_pred             CCCccEEeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCC
Q psy9535         257 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDD  326 (593)
Q Consensus       257 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~  326 (593)
                      .++.+||+|||+++................||+.|+|||++.+  .++.++|||||||++|||+||+.||..
T Consensus       147 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         147 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             CCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            6689999999999865433211112234578999999997743  468899999999999999999999964

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG4278|consensus

Probab=100.00  E-value=4.6e-39  Score=337.46  Aligned_cols=244  Identities=30%  Similarity=0.518  Sum_probs=194.1

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||-|.||.||.|.|+ ....||||.++.+              .++..+|+.|..+|+.++|||+|+|+|+|.. ..
T Consensus       272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKED--------------tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             eeccCCCcccceeeeeeeccceeeehhhhhhc--------------chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            478999999999999996 4678999999643              1234579999999999999999999999976 67


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      +|||+|||++|+|.|+|++.++ ..++.-..+.+|.||+.|++||..  +++|||||...|+|+.++..+||+||||+|+
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEk--knFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHH--hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            7899999999999999998664 457777788899999999999987  6699999999999999999999999999999


Q ss_pred             cccCCCcceeeccccC---CCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         272 SETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~G---T~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      +..+..    + ...|   ..-|.|||.+ ...++.|+|||+|||+|||+.| |..||.+-+....+. .++....+.  
T Consensus       415 MtgDTY----T-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~-LLEkgyRM~--  486 (1157)
T KOG4278|consen  415 MTGDTY----T-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG-LLEKGYRMD--  486 (1157)
T ss_pred             hcCCce----e-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH-HHhcccccc--
Confidence            865432    1 1234   3569999966 5678999999999999999997 899998744322222 222222111  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                        .      ++.|..-+..++..||++.|.+||+++|+-+.++.
T Consensus       487 --~------PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  487 --G------PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             --C------CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence              1      11122234456679999999999999999988865

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.5e-37  Score=315.56  Aligned_cols=252  Identities=21%  Similarity=0.318  Sum_probs=180.3

Q ss_pred             cccccCceEEEEEEEcCCC---EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         116 KLGEGQFGTVYYGKLKNGM---EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~~g~---~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .||+|+||.||+|+..++.   .+++|.+.....     ...       ...|.+|+.+++.++||||++++++|.. ..
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-----~~~-------~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   69 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-----SKE-------QNEFLQQGDPYRILQHPNILQCLGQCVEAIP   69 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-----hHH-------HHHHHHHHHHHhccCCcchhheEEEecCCCc
Confidence            5999999999999764433   456666543210     001       1258899999999999999999999876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      .++||||+++|+|.+++.+... ...+++.....++.|+++||.|||+  .+|+||||||+|||++.++.+||+|||++.
T Consensus        70 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nil~~~~~~~~l~Dfg~~~  147 (268)
T cd05086          70 YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--HNFLHSDLALRNCFLTSDLTVKVGDYGIGP  147 (268)
T ss_pred             cEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCeeccCCccceEEEcCCccEEeccccccc
Confidence            6899999999999999976432 2346677788899999999999998  569999999999999999999999999976


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC--------CCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcC
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC--------QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  341 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~  341 (593)
                      ....... ........|++.|+|||++..        .++.++|||||||++|||++ |..||........+........
T Consensus       148 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  226 (268)
T cd05086         148 SRYKEDY-IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ  226 (268)
T ss_pred             ccCcchh-hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc
Confidence            4322111 111223568899999997632        24678999999999999997 5778876544333332222211


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                        ....++.....    ....+..++..|| .+|++||++.+|++.|.
T Consensus       227 --~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         227 --VKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             --cccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence              11122221111    1123344566899 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=311.77  Aligned_cols=251  Identities=29%  Similarity=0.415  Sum_probs=190.5

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      .++.||+|+||.||+|... +++.||+|.+.........        ......+.+|++++++++||||+++++++.+ .
T Consensus         6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   77 (263)
T cd06625           6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET--------KKEVNALECEIQLLKNLQHERIVQYYGCLRDDE   77 (263)
T ss_pred             ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhh--------HHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC
Confidence            3789999999999999864 6899999998643211100        0112358899999999999999999998866 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++|+||+++|+|.+++...   ..+++.....++.|++.||.|||+  .+|+||||||+||++++++.+||+|||+++
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv~~~~~~~l~dfg~~~  152 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASK  152 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence            668999999999999998753   357889999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ................|+..|+|||.+.+ .++.++|||||||++|||++|+.||.................. .. +  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~-~--  228 (263)
T cd06625         153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN-PQ-L--  228 (263)
T ss_pred             eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-CC-C--
Confidence            65332111111123568899999997754 4788999999999999999999999775443332222211111 00 0  


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                            +......+..++.+||..+|++||++.|+++
T Consensus       229 ------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         229 ------PSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             ------CccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence                  0112233556778999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0658|consensus

Probab=100.00  E-value=1.8e-38  Score=319.10  Aligned_cols=249  Identities=26%  Similarity=0.388  Sum_probs=182.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec---
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~---  189 (593)
                      .+++|.|+||.||+|... ++..||||+.-.+..+                 -.+|+++|++++|||||+|.-++..   
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----------------knrEl~im~~l~HpNIV~L~~~f~~~~~   91 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----------------KNRELQIMRKLDHPNIVRLLYFFSSSTE   91 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----------------CcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence            478999999999999875 5789999998543221                 1369999999999999999987643   


Q ss_pred             c-c--ceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC-CccEEe
Q psy9535         190 I-M--NCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLG  264 (593)
Q Consensus       190 ~-~--~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~-~~~Kl~  264 (593)
                      . .  ..+|||||| -+|++.++... ....++.-...-++.|+.+||.|||+  .+|+||||||.|+|+|.+ |.+|||
T Consensus        92 ~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKic  168 (364)
T KOG0658|consen   92 SDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKIC  168 (364)
T ss_pred             CchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEec
Confidence            2 2  248999998 58998887531 13456777777789999999999998  669999999999999965 999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-cC
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EV  341 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-~~  341 (593)
                      |||.|+.........    +...|..|.|||.+.+  .|+.+.||||.|||+.||+-|++-|.+++.......+..- +.
T Consensus       169 DFGSAK~L~~~epni----SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  169 DFGSAKVLVKGEPNI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT  244 (364)
T ss_pred             cCCcceeeccCCCce----eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence            999999876654322    2356899999997643  5899999999999999999999999886654433333221 11


Q ss_pred             ccccccc-----------cc--cCCC---CHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVLD-----------KE--AGEW---NETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~~-----------~~--~~~~---~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      |..+-+.           +.  ...+   ...........++.++++++|.+|.++.|++.
T Consensus       245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            1111100           00  0011   01111122334567999999999999988763

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-38  Score=335.54  Aligned_cols=250  Identities=21%  Similarity=0.294  Sum_probs=183.1

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..++||+|+||.||+++.. +|+.||||++.......       .   .....+.+|++++++++|||||++++++.+ .
T Consensus         5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-------~---~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~   74 (377)
T cd05629           5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFK-------K---DQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ   74 (377)
T ss_pred             EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHH-------h---HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            3578999999999999864 68999999986431110       0   012357889999999999999999998876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++.....++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~--~givHrDlkp~NIll~~~~~~kl~DfGla~  149 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHK--LGFIHRDIKPDNILIDRGGHIKLSDFGLST  149 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence            578999999999999998753   357888888999999999999998  569999999999999999999999999986


Q ss_pred             ecccCCC-------------c-------------------------------ceeeccccCCCCcCCccccc-CCCCCcc
Q psy9535         271 MSETSNM-------------K-------------------------------TMYTENLTGTRPYMPPEAMH-CQISTKT  305 (593)
Q Consensus       271 ~~~~~~~-------------~-------------------------------~~~~~~~~GT~~Y~APE~~~-~~~~~ks  305 (593)
                      .......             .                               .......+||+.|+|||++. ..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  229 (377)
T cd05629         150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC  229 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence            3211000             0                               00001246999999999764 4588999


Q ss_pred             hhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCC---CChH
Q psy9535         306 DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKR---ASMR  382 (593)
Q Consensus       306 DVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~R---Psm~  382 (593)
                      |||||||++|||++|..||........+........... .  +...     .+...+..++.+|+. +|.+|   |++.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~--p~~~-----~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLY-F--PDDI-----HLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC-C--CCCC-----CCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            999999999999999999987554433333222111100 0  0000     112234456677887 66655   5888


Q ss_pred             HHHH
Q psy9535         383 DIVD  386 (593)
Q Consensus       383 eV~~  386 (593)
                      |+++
T Consensus       301 ~~l~  304 (377)
T cd05629         301 EIKS  304 (377)
T ss_pred             HHhc
Confidence            7754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.8e-37  Score=316.87  Aligned_cols=253  Identities=27%  Similarity=0.428  Sum_probs=191.3

Q ss_pred             CCCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      ..+.||+|+||.||++...      ++..+|+|.+....       ..      ....|.+|++++++++||||++++++
T Consensus         9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-------~~------~~~~~~~e~~~l~~l~h~~i~~~~~~   75 (288)
T cd05093           9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-------DN------ARKDFHREAELLTNLQHEHIVKFYGV   75 (288)
T ss_pred             eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-------HH------HHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            3678999999999999742      24568999885321       00      01258899999999999999999999


Q ss_pred             Eec-ccceEEEEeccCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee
Q psy9535         187 CNN-IMNCIVYEYMCNGSLYDRLARVN----------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  255 (593)
Q Consensus       187 ~~~-~~~~lV~Ey~~~GsL~~~L~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl  255 (593)
                      +.. ...++||||+++|+|.+++....          ....+++..+..++.|++.||+|||+  ++++||||||+|||+
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~--~~i~H~dlkp~Nili  153 (288)
T cd05093          76 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLV  153 (288)
T ss_pred             EecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEE
Confidence            876 56689999999999999997532          12358999999999999999999998  569999999999999


Q ss_pred             cCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHH
Q psy9535         256 DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYY  333 (593)
Q Consensus       256 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~  333 (593)
                      ++++.+||+|||+++....... ........|++.|+|||.+. ..++.++|||||||++|||++ |..||.........
T Consensus       154 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~  232 (288)
T cd05093         154 GENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI  232 (288)
T ss_pred             ccCCcEEeccCCccccccCCce-eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999875533221 11112345678899999775 457889999999999999998 99999765443322


Q ss_pred             HHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         334 YLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      .........  ..    ....+     ..+..++.+||+.+|.+|||+.+|++.|++..
T Consensus       233 ~~i~~~~~~--~~----~~~~~-----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         233 ECITQGRVL--QR----PRTCP-----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHHHcCCcC--CC----CCCCC-----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            222222111  00    01111     22455677999999999999999999987743

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.6e-37  Score=310.03  Aligned_cols=245  Identities=27%  Similarity=0.390  Sum_probs=191.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|... +|..||+|.+.....    ....       ...+.+|++++++++||||+++++++.+ ..
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   73 (256)
T cd08529           5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM----NRRE-------REEAIDEARVLAKLDSSYIIRYYESFLDKGK   73 (256)
T ss_pred             eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC----CHHH-------HHHHHHHHHHHHhcCCCCeehheeeeccCCE
Confidence            468999999999999875 689999999864311    1111       2258899999999999999999998865 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++++|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++.
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~--~~i~h~dl~~~nili~~~~~~~l~df~~~~~  150 (256)
T cd08529          74 LNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKL  150 (256)
T ss_pred             EEEEEEeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEeCCCCEEEccccccee
Confidence            789999999999999997642 3468999999999999999999998  5699999999999999999999999999886


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......|++.|+|||++. ..++.++|||||||++|||++|+.||.................+  ..    
T Consensus       151 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~----  221 (256)
T cd08529         151 LSDNTN---FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP--PV----  221 (256)
T ss_pred             ccCccc---hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CC----
Confidence            543321   122356899999999764 45788999999999999999999999865543322222221111  00    


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..     .....+..++.+||+.+|++||++.++++
T Consensus       222 ~~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         222 SQ-----MYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             cc-----ccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            00     12233556778999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7.1e-38  Score=315.54  Aligned_cols=247  Identities=29%  Similarity=0.437  Sum_probs=192.5

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      .++||+|+||.||+|...++..+|+|.+.....      ..       ...+.+|+.+++.++||||+++++++.. ...
T Consensus        11 ~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~------~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   77 (261)
T cd05148          11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL------LK-------QQDFQKEVQALKRLRHKHLISLFAVCSVGEPV   77 (261)
T ss_pred             hhhhccCCCccEEEeEecCCCcEEEEeccccch------hh-------HHHHHHHHHHHhcCCCcchhheeeeEecCCCe
Confidence            578999999999999988889999999864311      00       1247889999999999999999998876 456


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++...
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~--~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             EEEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccCcceEEEcCCceEEEccccchhhc
Confidence            89999999999999997643 3468999999999999999999998  56999999999999999999999999998765


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .....   ......++..|+|||.+. ..++.++|||||||++|||++ |+.||................ ...     .
T Consensus       155 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~-----~  225 (261)
T cd05148         155 KEDVY---LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY-RMP-----C  225 (261)
T ss_pred             CCccc---cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC-cCC-----C
Confidence            43221   112334677899999764 457889999999999999998 899997654333322222111 100     0


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ..     .....+..++.+||..+|++|||+.++++.|+.
T Consensus       226 ~~-----~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         226 PA-----KCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CC-----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            01     111234456679999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1e-37  Score=326.63  Aligned_cols=238  Identities=24%  Similarity=0.346  Sum_probs=179.8

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-cc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~~  191 (593)
                      +.||+|+||.||+|+.. +++.||||+++.......          .....+.+|+.++.++ +||||+++++++.. ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   70 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD----------EDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR   70 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCE
Confidence            36999999999999875 578999999975321100          0122477899999888 69999999998865 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~  145 (327)
T cd05617          71 LFLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKE  145 (327)
T ss_pred             EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEeCCCCEEEecccccee
Confidence            68999999999999888653   358999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCC------chH-HHHHHHHhhcCcc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDN------NTI-LYYYLVVEQEVPV  343 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~------~~~-~~~~~~~~~~~~~  343 (593)
                      ......   ......||+.|+|||++. ..++.++|||||||++|||++|+.||...      ... ..+..........
T Consensus       146 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (327)
T cd05617         146 GLGPGD---TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI  222 (327)
T ss_pred             ccCCCC---ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC
Confidence            322211   123467999999999764 45788999999999999999999999531      111 1111111111111


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChH
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMR  382 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~  382 (593)
                      +..            +...+..++.+|+..||++||++.
T Consensus       223 p~~------------~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         223 PRF------------LSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCC------------CCHHHHHHHHHHhccCHHHcCCCC
Confidence            111            112244567799999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.3e-37  Score=319.47  Aligned_cols=253  Identities=27%  Similarity=0.380  Sum_probs=189.4

Q ss_pred             CCCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      +.+.||+|+||.||+|+..      ....+|+|.+....     ...  +     ...|.+|+.+++.++||||++++++
T Consensus         4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-----~~~--~-----~~~~~~E~~~l~~l~h~~iv~~~~~   71 (290)
T cd05045           4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-----SSS--E-----LRDLLSEFNLLKQVNHPHVIKLYGA   71 (290)
T ss_pred             ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-----CHH--H-----HHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            4678999999999999753      23568898875321     000  1     1258899999999999999999998


Q ss_pred             Eec-ccceEEEEeccCCCHHHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q psy9535         187 CNN-IMNCIVYEYMCNGSLYDRLARVN---------------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPII  244 (593)
Q Consensus       187 ~~~-~~~~lV~Ey~~~GsL~~~L~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~Ii  244 (593)
                      |.. ...++||||+.+|+|.+++....                     ...++++..++.++.|++.||.|||+  .+|+
T Consensus        72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~iv  149 (290)
T cd05045          72 CSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MKLV  149 (290)
T ss_pred             EecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH--CCee
Confidence            865 56689999999999999986421                     11358899999999999999999998  5699


Q ss_pred             ecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCC
Q psy9535         245 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMK  322 (593)
Q Consensus       245 HrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~  322 (593)
                      ||||||+|||+++++.+||+|||+++........ .......++..|+|||.+ ...++.++|||||||++|||++ |..
T Consensus       150 H~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~  228 (290)
T cd05045         150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  228 (290)
T ss_pred             hhhhhhheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999998764332211 111223567789999965 4457889999999999999999 999


Q ss_pred             CCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         323 PIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       323 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ||........+...... ....     ....     ....+..++.+||+.+|++||++.++++.|++.
T Consensus       229 p~~~~~~~~~~~~~~~~-~~~~-----~~~~-----~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         229 PYPGIAPERLFNLLKTG-YRME-----RPEN-----CSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             CCCCCCHHHHHHHHhCC-CCCC-----CCCC-----CCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence            99765443333222111 1000     0011     112344566799999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.1e-37  Score=313.06  Aligned_cols=254  Identities=26%  Similarity=0.415  Sum_probs=191.4

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.++.||+|+||.||+|...+|+.+|||.+........   .. .   .....+.+|++++++++|+||++++++|.+ .
T Consensus         3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~---~~-~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   75 (265)
T cd06631           3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVL---AA-E---KEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN   75 (265)
T ss_pred             cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchh---hH-H---HHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC
Confidence            34788999999999999887899999999864321110   00 0   112358899999999999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++.+.   .++++..+..++.|++.||+|||+  .+|+|+||||+||++++++.+||+|||+++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  150 (265)
T cd06631          76 TISIFMEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCAR  150 (265)
T ss_pred             eEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHhEEECCCCeEEeccchhhH
Confidence            568999999999999999753   357899999999999999999998  559999999999999999999999999987


Q ss_pred             ecccCCC---cceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         271 MSETSNM---KTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       271 ~~~~~~~---~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      .......   .........||..|+|||.+.+ .++.++|||||||++|||++|..||...................+.+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  230 (265)
T cd06631         151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL  230 (265)
T ss_pred             hhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCC
Confidence            5422111   0111223568999999998754 46889999999999999999999997654433222222211111111


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .    ..     ....+..++.+||+.+|++||++.++++
T Consensus       231 ~----~~-----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         231 P----DS-----FSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             C----CC-----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1    11     1223455678999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.8e-37  Score=312.74  Aligned_cols=250  Identities=26%  Similarity=0.416  Sum_probs=183.9

Q ss_pred             CcccccCceEEEEEEEc----CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         115 NKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~----~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +.||+|+||.||+|.+.    .+..||+|.+....     ..   .    ....|.+|+.+++.++||||++++++|.. 
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-----~~---~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   68 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-----DL---E----EVEQFLKEGIIMKDFSHPNVLSLLGICLPS   68 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC-----CH---H----HHHHHHHHHHHHccCCCCCcceEEEEeecC
Confidence            36899999999999863    23579999874321     00   0    12257889999999999999999998753 


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus        69 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlk~~nili~~~~~~kl~dfg~  144 (262)
T cd05058          69 EGSPLVVLPYMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLAS--KKFVHRDLAARNCMLDESFTVKVADFGL  144 (262)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCccc
Confidence             45689999999999999997533  346778888999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcc-eeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhC-CCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         269 VKMSETSNMKT-MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTG-MKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       269 a~~~~~~~~~~-~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG-~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      ++......... .......+++.|+|||.+ ...++.++|||||||++|||++| .+||...+............ ... 
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~~~-  222 (262)
T cd05058         145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RLL-  222 (262)
T ss_pred             cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CCC-
Confidence            87543321111 111234567889999976 45678899999999999999995 56666544332222211111 100 


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                           ....    ....+..++.+||+.+|++||++.||++.|++.
T Consensus       223 -----~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         223 -----QPEY----CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             -----CCCc----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                 0011    112344566799999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.7e-38  Score=318.98  Aligned_cols=259  Identities=25%  Similarity=0.385  Sum_probs=186.5

Q ss_pred             CCCcccccCceEEEEEEEc-----CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-----~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      ..+.||+|+||.||+|..+     ++..||||.+....      ..       ....|.+|++++++++||||+++++++
T Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~------~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~   74 (284)
T cd05081           8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST------AE-------HLRDFEREIEILKSLQHDNIVKYKGVC   74 (284)
T ss_pred             eeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC------HH-------HHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence            3578999999999999753     57889999985321      00       022588999999999999999999987


Q ss_pred             ec---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         188 NN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       188 ~~---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                      ..   ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~--~~i~H~dlkp~nili~~~~~~~l~  150 (284)
T cd05081          75 YSAGRRNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIG  150 (284)
T ss_pred             ccCCCCceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHhhEEECCCCeEEEC
Confidence            53   34689999999999999997532  358999999999999999999998  569999999999999999999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCc-
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP-  342 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~-  342 (593)
                      |||+++................++..|+|||.+. ..++.++|||||||++|||++|..|+.......  ......... 
T Consensus       151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--~~~~~~~~~~  228 (284)
T cd05081         151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF--MRMMGNDKQG  228 (284)
T ss_pred             CCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh--hhhccccccc
Confidence            9999986543321111111223445699999764 457889999999999999999987764322110  000000000 


Q ss_pred             ------cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         343 ------VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       343 ------~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                            +.+.+...........+...+..++.+||..+|++|||+.||++.|+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             ccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence                  000000000000011122335566789999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.5e-37  Score=317.57  Aligned_cols=257  Identities=28%  Similarity=0.381  Sum_probs=190.1

Q ss_pred             CCCCcccccCceEEEEEEEcC-----------------CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKN-----------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ  174 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~-----------------g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~  174 (593)
                      ++.+.||+|+||.||+|+...                 +..||+|.+.....      ..      ....|.+|++++++
T Consensus         8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~------~~------~~~~~~~e~~~l~~   75 (296)
T cd05051           8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS------DN------AREDFLKEVKILSR   75 (296)
T ss_pred             cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC------HH------HHHHHHHHHHHHHh
Confidence            446899999999999987542                 24589998864311      00      12258899999999


Q ss_pred             CCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q psy9535         175 CKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN--------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIH  245 (593)
Q Consensus       175 l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiH  245 (593)
                      ++||||+++++++.. ...++||||+++++|.+++.....        ...+++.....++.|++.||.|||+  .+|+|
T Consensus        76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~i~H  153 (296)
T cd05051          76 LSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES--LNFVH  153 (296)
T ss_pred             cCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH--cCccc
Confidence            999999999998876 567899999999999999976431        1258999999999999999999998  56999


Q ss_pred             cccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh--CCC
Q psy9535         246 RDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT--GMK  322 (593)
Q Consensus       246 rDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt--G~~  322 (593)
                      |||||+|||++.++.+||+|||+++....... ........+|+.|+|||.+. ..++.++|||||||++|||++  |..
T Consensus       154 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  232 (296)
T cd05051         154 RDLATRNCLVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ  232 (296)
T ss_pred             cccchhceeecCCCceEEccccceeecccCcc-eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCC
Confidence            99999999999999999999999876533221 11122345778999999764 468899999999999999998  778


Q ss_pred             CCCCCchHHHHHHHHhh--cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         323 PIDDNNTILYYYLVVEQ--EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       323 P~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                      ||........+......  ......... ...     .....+..++.+||+.+|++||++.||++.|.
T Consensus       233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         233 PYEHLTDQQVIENAGHFFRDDGRQIYLP-RPP-----NCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             CCCCcChHHHHHHHHhccccccccccCC-Ccc-----CCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            88764433222222111  000000000 001     11123455667999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0599|consensus

Probab=100.00  E-value=1.8e-38  Score=306.07  Aligned_cols=251  Identities=27%  Similarity=0.441  Sum_probs=200.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      .+.||+|..++|-++..+ +|.+.|+|++.......... ..    ......-.+|+.||+++ .||||++|.++++. .
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e-~~----~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGE-TP----YEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCc-cH----HHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            468999999999988654 78999999997654322211 11    11122346799999998 59999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++|+|.|+.|.|+|+|...   -.+++....+|++|+.+|++|||.  ++||||||||+|||+|++.++||+|||+|.
T Consensus        97 F~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa--~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHA--RNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHH--hhhhhcccChhheeeccccceEEeccceee
Confidence            568999999999999999753   458999999999999999999998  559999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-------CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  343 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-------~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~  343 (593)
                      .......    ....+|||+|+|||.+.+       .|+..+|+||.||+||.|+.|.+||.....+.....++.+...+
T Consensus       172 ~l~~Gek----LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF  247 (411)
T KOG0599|consen  172 QLEPGEK----LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF  247 (411)
T ss_pred             ccCCchh----HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc
Confidence            7765432    345799999999998754       36778999999999999999999998877777777776665443


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..      .+|.  ......++++.+|++.||.+|.|..|+++
T Consensus       248 ~s------peWa--dis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  248 RS------PEWA--DISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             CC------cchh--hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            31      1222  22334567788999999999999999864

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-37  Score=311.80  Aligned_cols=237  Identities=27%  Similarity=0.422  Sum_probs=181.5

Q ss_pred             CcccccCceEEEEEEEcCCC-----------EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeE
Q psy9535         115 NKLGEGQFGTVYYGKLKNGM-----------EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  183 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~~g~-----------~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l  183 (593)
                      +.||+|+||.||+|.+....           .||+|.+.....      .        ...|.+|+.++++++||||+++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~------~--------~~~~~~e~~~l~~l~h~~i~~~   66 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR------D--------SLAFFETASLMSQLSHKHLVKL   66 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh------h--------HHHHHHHHHHHHcCCCcchhhe
Confidence            36899999999999876422           477787643210      0        1258899999999999999999


Q ss_pred             EEEEecccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC----
Q psy9535         184 LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----  259 (593)
Q Consensus       184 ~g~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~----  259 (593)
                      +|+|.....++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++    
T Consensus        67 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dlkp~Nill~~~~~~~~  142 (259)
T cd05037          67 YGVCVRDENIMVEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLED--KKLVHGNVCGKNILVARYGLNEG  142 (259)
T ss_pred             eeEEecCCcEEEEEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh--CCeecccCccceEEEecCccccC
Confidence            99987777799999999999999997643  268899999999999999999998  5699999999999999887    


Q ss_pred             ---ccEEeecccceecccCCCcceeeccccCCCCcCCcccccC---CCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHH
Q psy9535         260 ---VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLT-GMKPIDDNNTILY  332 (593)
Q Consensus       260 ---~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~  332 (593)
                         .+||+|||+++.....       ....|+..|+|||.+..   .++.++|||||||++|||++ |..||........
T Consensus       143 ~~~~~kl~Dfg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~  215 (259)
T cd05037         143 YVPFIKLSDPGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK  215 (259)
T ss_pred             CceeEEeCCCCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH
Confidence               7999999998764331       12457788999998754   47889999999999999999 5778765432111


Q ss_pred             HHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         333 YYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                      ... ........       .. ..    ..+..++.+||..+|++||++.+|++.|.
T Consensus       216 ~~~-~~~~~~~~-------~~-~~----~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         216 ERF-YQDQHRLP-------MP-DC----AELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHH-HhcCCCCC-------CC-Cc----hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            111 11100000       00 00    23455678999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0589|consensus

Probab=100.00  E-value=1.9e-38  Score=331.99  Aligned_cols=246  Identities=21%  Similarity=0.305  Sum_probs=197.7

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+++|+|+||.++..+++ ++..+++|++..........    .       .-.+|+.++++++|||||...+.+.. +.
T Consensus         9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r----~-------~A~~E~~lis~~~hP~iv~y~ds~~~~~~   77 (426)
T KOG0589|consen    9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER----R-------SAIQEMDLLSKLLHPNIVEYKDSFEEDGQ   77 (426)
T ss_pred             hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh----H-------HHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence            578999999999988765 57889999997543222111    1       24689999999999999999997755 44


Q ss_pred             -ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         192 -NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       192 -~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                       .+|||+||.||+|.+.+.+.+ +..+++.....++.|++.|+.|||+  +.|+|||||++||+++.+..+||+|||+|+
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDfGlaK  154 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDFGLAK  154 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecchhhhh
Confidence             689999999999999998765 4568999999999999999999997  569999999999999999999999999999


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......   ....++.|||.||.||++.+ .|..|+||||+||++|||++-+++|...+.......+....      ..+
T Consensus       155 ~l~~~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~------~~P  225 (426)
T KOG0589|consen  155 ILNPED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL------YSP  225 (426)
T ss_pred             hcCCch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc------CCC
Confidence            876543   12456799999999998865 58999999999999999999999998876554444443332      122


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDL  387 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~  387 (593)
                      ....+.     ..++.++..|+..+|..||++.+++..
T Consensus       226 lp~~ys-----~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYS-----SELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCcccc-----HHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            222222     234456679999999999999999865

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=319.39  Aligned_cols=258  Identities=25%  Similarity=0.373  Sum_probs=186.4

Q ss_pred             CCCCcccccCceEEEEEEEcC---------------CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKN---------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK  176 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~---------------g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~  176 (593)
                      ++.++||+|+||.||+++...               ...||||.+....     ...  .     ...|.+|++++++++
T Consensus         8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~--~-----~~~~~~ei~~l~~l~   75 (295)
T cd05097           8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-----TKT--A-----RNDFLKEIKIMSRLK   75 (295)
T ss_pred             eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-----CHH--H-----HHHHHHHHHHHHhCC
Confidence            446889999999999987532               2348999985421     100  0     125889999999999


Q ss_pred             CCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q psy9535         177 HVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVN---------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHR  246 (593)
Q Consensus       177 HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHr  246 (593)
                      ||||+++++++.. ...++||||+++|+|.+++....         ....+++..+..++.|++.||.|||+  .+++||
T Consensus        76 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~  153 (295)
T cd05097          76 NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--LNFVHR  153 (295)
T ss_pred             CCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh--cCeecc
Confidence            9999999998865 56689999999999999986532         11247889999999999999999998  569999


Q ss_pred             ccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh--CCCC
Q psy9535         247 DVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT--GMKP  323 (593)
Q Consensus       247 DLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt--G~~P  323 (593)
                      ||||+|||++.++.+||+|||+++....... ........+++.|+|||.+ .+.++.++|||||||++|||++  |..|
T Consensus       154 dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p  232 (295)
T cd05097         154 DLATRNCLVGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP  232 (295)
T ss_pred             ccChhhEEEcCCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999999876433221 1112233567789999965 4568899999999999999998  6678


Q ss_pred             CCCCchHHHHHHHHhhcCc-cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         324 IDDNNTILYYYLVVEQEVP-VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                      |.................. ........ ...    ....+..++.+||+.+|++||+|.+|++.|.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         233 YSLLSDEQVIENTGEFFRNQGRQIYLSQ-TPL----CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             CcccChHHHHHHHHHhhhhccccccCCC-CCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            8654322211111100000 00000000 001    1123555677999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG4257|consensus

Probab=100.00  E-value=3.1e-38  Score=332.04  Aligned_cols=250  Identities=27%  Similarity=0.442  Sum_probs=194.6

Q ss_pred             CCCcccccCceEEEEEEEcC---C--CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLKN---G--MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~---g--~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .+++||+|.||.||+|.+.+   |  -.||||+.+.+.     ..++.+       .|..|..+|++++|||||+|+|+|
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-----t~d~te-------kflqEa~iMrnfdHphIikLIGv~  460 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-----TPDDTE-------KFLQEASIMRNFDHPHIIKLIGVC  460 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-----ChhhHH-------HHHHHHHHHHhCCCcchhheeeee
Confidence            46789999999999998642   3  348999987542     222223       499999999999999999999999


Q ss_pred             ecccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         188 NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       188 ~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      .+...|||||.++-|.|..+|....  ..|+......+++||+.||.|||+  +.+|||||...|||+....-+||+|||
T Consensus       461 ~e~P~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  461 VEQPMWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             eccceeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeecccc
Confidence            9999999999999999999998744  468888899999999999999998  669999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      |+|....+..-.  .+...-..-|||||.+ ..+++++||||-|||++||+++ |.+||.+-.+...           --
T Consensus       537 LSR~~ed~~yYk--aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----------I~  603 (974)
T KOG4257|consen  537 LSRYLEDDAYYK--ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----------IG  603 (974)
T ss_pred             hhhhccccchhh--ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------EE
Confidence            999887654211  1111223569999966 4679999999999999999886 9999986322110           00


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .+........++.+...+..++.+||++||.+||++.|+...|+..
T Consensus       604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence            0111001111223334455678899999999999999999888654

>KOG0032|consensus

Probab=100.00  E-value=2.1e-37  Score=327.58  Aligned_cols=248  Identities=27%  Similarity=0.427  Sum_probs=201.3

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEe
Q psy9535         111 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCN  188 (593)
Q Consensus       111 ~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~  188 (593)
                      +.+++.||+|.||.||+++.+ +|+.+|+|.+.+.......          ......+|+.+|+++. |||||++.+.++
T Consensus        37 Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~----------~~~~v~~Ev~il~~l~~hpniv~l~~~~e  106 (382)
T KOG0032|consen   37 YELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE----------DREDVRREVAILQQLSGHPNIVQLKDAFE  106 (382)
T ss_pred             EEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc----------cHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            445689999999999999876 4999999999765332211          1124789999999998 999999999887


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC----CCccEE
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE----NFVPKL  263 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~----~~~~Kl  263 (593)
                      + ...++|||++.||.|++.+...    .+++.....++.|++.|+.|||+  .+|+||||||+|+|+..    ++.+|+
T Consensus       107 ~~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~ik~  180 (382)
T KOG0032|consen  107 DPDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGRIKL  180 (382)
T ss_pred             cCCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCcEEE
Confidence            6 5668999999999999999875    28999999999999999999999  56999999999999963    357999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCc
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  342 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~  342 (593)
                      +|||++.......    .....+||+.|+|||++. ..++..+||||.||++|.|++|..||...........+......
T Consensus       181 ~DFGla~~~~~~~----~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~  256 (382)
T KOG0032|consen  181 IDFGLAKFIKPGE----RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFD  256 (382)
T ss_pred             eeCCCceEccCCc----eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCC
Confidence            9999999876522    234579999999999887 67999999999999999999999999987766555555544432


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +.      ...|.  .+...+..++.+++..||.+|+|+.++++
T Consensus       257 f~------~~~w~--~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  257 FT------SEPWD--DISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             CC------CCCcc--ccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            21      12222  12344566778999999999999999976

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.9e-38  Score=316.92  Aligned_cols=247  Identities=25%  Similarity=0.364  Sum_probs=186.3

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|+.. +|+.||+|++....     . ..       ...+.+|+.++++++||||+++++++.. .
T Consensus        13 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~-~~-------~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~   79 (267)
T cd06646          13 LIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-----G-DD-------FSLIQQEIFMVKECKHCNIVAYFGSYLSRE   79 (267)
T ss_pred             hhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-----c-ch-------HHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence            4678999999999999874 68899999986321     0 00       1146789999999999999999998865 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   .++++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++
T Consensus        80 ~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~  154 (267)
T cd06646          80 KLWICMEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGVAA  154 (267)
T ss_pred             EEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCccce
Confidence            668999999999999998753   358899999999999999999998  569999999999999999999999999988


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~----~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      .......   ......|++.|+|||.+.    ..++.++|||||||++|||++|+.||......................
T Consensus       155 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  231 (267)
T cd06646         155 KITATIA---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL  231 (267)
T ss_pred             eeccccc---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC
Confidence            6532211   112346899999999763    336779999999999999999999996543221111110000000000


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDL  387 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~  387 (593)
                           .  ........+..++.+||..+|++||++.+|++.
T Consensus       232 -----~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         232 -----K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             -----c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence                 0  001122345567789999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-37  Score=315.33  Aligned_cols=237  Identities=26%  Similarity=0.410  Sum_probs=177.2

Q ss_pred             cccccCceEEEEEEEcC-------------------------CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHH
Q psy9535         116 KLGEGQFGTVYYGKLKN-------------------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ  170 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~~-------------------------g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~  170 (593)
                      .||+|+||.||+|.+..                         ...||+|.+....      .   .    ....|.+|+.
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~---~----~~~~~~~~~~   68 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH------R---D----IALAFFETAS   68 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH------H---H----HHHHHHHHHH
Confidence            69999999999997521                         1348888875321      0   0    0125788999


Q ss_pred             HHhcCCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccC
Q psy9535         171 TLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  249 (593)
Q Consensus       171 il~~l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLK  249 (593)
                      ++++++||||++++|+|.+ ...++||||+++|+|.+++....  ..+++..++.++.|+++||+|||+  ++|+|||||
T Consensus        69 ~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlk  144 (274)
T cd05076          69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLED--KNLVHGNVC  144 (274)
T ss_pred             HHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHc--CCccCCCCC
Confidence            9999999999999999876 56689999999999998886532  458899999999999999999998  569999999


Q ss_pred             CCCeeecCCC-------ccEEeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHH-Hh
Q psy9535         250 SANVLLDENF-------VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLEL-LT  319 (593)
Q Consensus       250 p~NILl~~~~-------~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~El-lt  319 (593)
                      |+|||++..+       .+|++|||++......       ....|++.|+|||.+.+  .++.++|||||||++||| ++
T Consensus       145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~  217 (274)
T cd05076         145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD  217 (274)
T ss_pred             cccEEEeccCcccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            9999997643       3799999987643221       12357889999997743  478899999999999999 57


Q ss_pred             CCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         320 GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       320 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                      |+.||.......... ........+.       ...     ..+..++.+||+.+|++||+|.+|++.|+
T Consensus       218 g~~p~~~~~~~~~~~-~~~~~~~~~~-------~~~-----~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         218 GEVPLKERTPSEKER-FYEKKHRLPE-------PSC-----KELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             CCCCccccChHHHHH-HHHhccCCCC-------CCC-----hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            999997643222111 1111111110       011     12445667999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.1e-38  Score=335.85  Aligned_cols=203  Identities=24%  Similarity=0.319  Sum_probs=162.7

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.+.||+|+||.||+++.. +|+.||||.+........          .....+.+|+.+|++++||||+++++.+.+ .
T Consensus         5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (376)
T cd05598           5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMR----------NQAAHVKAERDILAEADNEWVVKLYYSFQDKD   74 (376)
T ss_pred             EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhh----------hhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            3578999999999999865 689999999864311000          012247889999999999999999998866 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++.+.   ..+++.....++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+|.
T Consensus        75 ~~~lv~E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ikL~DFG~a~  149 (376)
T cd05598          75 NLYFVMDYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (376)
T ss_pred             EEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence            668999999999999999753   357888888899999999999998  569999999999999999999999999975


Q ss_pred             ecccCCC----------------------------------------cceeeccccCCCCcCCcccccC-CCCCcchhhH
Q psy9535         271 MSETSNM----------------------------------------KTMYTENLTGTRPYMPPEAMHC-QISTKTDVFS  309 (593)
Q Consensus       271 ~~~~~~~----------------------------------------~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwS  309 (593)
                      .......                                        .........||+.|||||++.+ .++.++||||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  229 (376)
T cd05598         150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  229 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence            3210000                                        0000123579999999998744 5788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCchH
Q psy9535         310 YGVILLELLTGMKPIDDNNTI  330 (593)
Q Consensus       310 fGvvl~ElltG~~P~~~~~~~  330 (593)
                      |||++|||++|+.||......
T Consensus       230 lGvilyell~G~~Pf~~~~~~  250 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPA  250 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHH
Confidence            999999999999999876543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0584|consensus

Probab=100.00  E-value=1.7e-38  Score=337.20  Aligned_cols=247  Identities=25%  Similarity=0.395  Sum_probs=194.4

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         110 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       110 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      |.+...+||+|+|-+||||... +|.+||==.++....         -+....+.+|..|+.+|+.|+|||||+++.++.
T Consensus        41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~---------~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~  111 (632)
T KOG0584|consen   41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDV---------TQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV  111 (632)
T ss_pred             eeehhhhcccccceeeeeccccccchhhHHHHHhHHHh---------hcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence            4455679999999999999864 588887322221110         011112347999999999999999999999886


Q ss_pred             cc-c--ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC-CCccEEe
Q psy9535         189 NI-M--NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLG  264 (593)
Q Consensus       189 ~~-~--~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~-~~~~Kl~  264 (593)
                      +. .  ..+|+|.+..|+|..++++.+   .++......+++||+.||.|||+..+||||||||.+||+++. -|.+||+
T Consensus       112 d~~n~~in~iTEL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIG  188 (632)
T KOG0584|consen  112 DTDNKTINFITELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIG  188 (632)
T ss_pred             cCCCceeeeeeecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeec
Confidence            63 2  357999999999999998865   367888999999999999999998889999999999999985 5899999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCc--
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP--  342 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~--  342 (593)
                      |+|||.....+.     ...+.|||.|||||++...|+..+||||||++|+||+|+..||.........++.+.....  
T Consensus       189 DLGLAtl~r~s~-----aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~  263 (632)
T KOG0584|consen  189 DLGLATLLRKSH-----AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA  263 (632)
T ss_pred             chhHHHHhhccc-----cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH
Confidence            999999876543     2347899999999999989999999999999999999999999986655444444433322  


Q ss_pred             -cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 -VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 -~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       +..+-|+            .++.++++|+.. ..+|||+.|+++
T Consensus       264 sl~kV~dP------------evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  264 ALSKVKDP------------EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HhhccCCH------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence             1222222            245577899999 999999999864

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.2e-37  Score=325.56  Aligned_cols=239  Identities=25%  Similarity=0.330  Sum_probs=182.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-~  190 (593)
                      .+.||+|+||.||+|+.+ +|+.||||++........   .       ....+..|..++..+. |++|+++++++.. .
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~-------~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05615           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD---D-------DVECTMVEKRVLALQDKPPFLTQLHSCFQTVD   74 (323)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---h-------HHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence            478999999999999875 689999999874321110   0       1124677888888886 5678888887765 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg~~~  149 (323)
T cd05615          75 RLYFVMEYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             EEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEecccccc
Confidence            568999999999999998753   358999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .......   ......||+.|+|||++. ..++.++|||||||++|||++|+.||...........+.......+..   
T Consensus       150 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~---  223 (323)
T cd05615         150 EHMVDGV---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS---  223 (323)
T ss_pred             ccCCCCc---cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc---
Confidence            5432221   123457999999999775 457889999999999999999999998765544333333322221111   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMR  382 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~  382 (593)
                               +...+..++.+|++.+|.+|++..
T Consensus       224 ---------~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         224 ---------LSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             ---------CCHHHHHHHHHHcccCHhhCCCCC
Confidence                     112234566799999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=317.05  Aligned_cols=250  Identities=26%  Similarity=0.415  Sum_probs=189.9

Q ss_pred             CCcccccCceEEEEEEEcC------CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~------g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .+.||+|+||.||+|....      +..||+|.+....     . .. .     ...|.+|+.+++.++||||++++|++
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-----~-~~-~-----~~~~~~e~~~l~~~~~~~i~~~~~~~   78 (277)
T cd05032          11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-----S-MR-E-----RIEFLNEASVMKEFNCHHVVRLLGVV   78 (277)
T ss_pred             EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-----C-HH-H-----HHHHHHHHHHHHhCCCCceeEEEEEE
Confidence            5789999999999998642      3689999975321     1 00 1     12578999999999999999999988


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNN-------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  259 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~  259 (593)
                      .. ...++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++
T Consensus        79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~di~p~nill~~~~  156 (277)
T cd05032          79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccChheEEEcCCC
Confidence            66 566899999999999999975321       2347889999999999999999998  5699999999999999999


Q ss_pred             ccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHH
Q psy9535         260 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVV  337 (593)
Q Consensus       260 ~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~  337 (593)
                      .+||+|||+++........ .......||..|+|||.+. ..++.++|||||||++|||+| |..||.............
T Consensus       157 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  235 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI  235 (277)
T ss_pred             CEEECCcccchhhccCccc-ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence            9999999998765332211 1122345788999999764 567889999999999999998 999997654433322222


Q ss_pred             hhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                      ...  ....    ....     ...+..++.+||+.+|++|||+.++++.|+
T Consensus       236 ~~~--~~~~----~~~~-----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 DGG--HLDL----PENC-----PDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             cCC--CCCC----CCCC-----CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            111  1110    0111     233556778999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.6e-37  Score=314.53  Aligned_cols=236  Identities=24%  Similarity=0.394  Sum_probs=177.6

Q ss_pred             cccccCceEEEEEEEcC-------------CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceee
Q psy9535         116 KLGEGQFGTVYYGKLKN-------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR  182 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~~-------------g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~  182 (593)
                      .||+|+||.||+|++..             ...||+|.+....      ...       ...|.+|+.+++.++||||++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~-------~~~~~~~~~~l~~l~hp~iv~   68 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH------RDI-------SLAFFETASMMRQVSHKHIVL   68 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh------hhH-------HHHHHHHHHHHHhCCCCCEee
Confidence            68999999999998532             2258888864321      010       124788999999999999999


Q ss_pred             EEEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc-
Q psy9535         183 LLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-  260 (593)
Q Consensus       183 l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~-  260 (593)
                      ++|++.. ...++||||+++|+|..++....  ..+++..+..++.|+++||+|||+  ++|+||||||+|||++.++. 
T Consensus        69 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~  144 (262)
T cd05077          69 LYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLED--KDLVHGNVCTKNILLAREGID  144 (262)
T ss_pred             EEEEEecCCCCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhh--CCeECCCCCcccEEEecCCcc
Confidence            9999876 56689999999999988886532  458999999999999999999998  56999999999999987664 


Q ss_pred             ------cEEeecccceecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHH-hCCCCCCCCchHH
Q psy9535         261 ------PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELL-TGMKPIDDNNTIL  331 (593)
Q Consensus       261 ------~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~Ell-tG~~P~~~~~~~~  331 (593)
                            +|++|||++......       ....|+..|+|||.+.  ..++.++|||||||++|||+ +|..|+.......
T Consensus       145 ~~~~~~~~l~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~  217 (262)
T cd05077         145 GECGPFIKLSDPGIPITVLSR-------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE  217 (262)
T ss_pred             CCCCceeEeCCCCCCccccCc-------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence                  899999998654321       1246889999999774  35788999999999999998 5888886543211


Q ss_pred             HHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHH
Q psy9535         332 YYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL  388 (593)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L  388 (593)
                      . .........   ...    . .    ...+..++.+||+.||++||++.+|++.+
T Consensus       218 ~-~~~~~~~~~---~~~----~-~----~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         218 K-ERFYEGQCM---LVT----P-S----CKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             H-HHHHhcCcc---CCC----C-C----hHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            1 111111100   000    0 1    12345577899999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.2e-37  Score=313.67  Aligned_cols=251  Identities=25%  Similarity=0.422  Sum_probs=189.7

Q ss_pred             CCCcccccCceEEEEEEEc-C---CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-N---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~---g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      ..+.||+|+||.||+|+.. +   +..+|+|.++...     . .. .     ...|.+|+.++++++||||+++++++.
T Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-----~-~~-~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (267)
T cd05066           8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-----T-EK-Q-----RRDFLSEASIMGQFDHPNIIHLEGVVT   75 (267)
T ss_pred             eeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-----C-HH-H-----HHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            3679999999999999864 2   3369999885321     0 10 1     125889999999999999999999886


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      . ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+|||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd05066          76 KSKPVMIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILVNSNLVCKVSDFG  151 (267)
T ss_pred             cCCccEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeehhhchhcEEECCCCeEEeCCCC
Confidence            5 56689999999999999997643  358999999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      +++................++..|+|||.+. ..++.++|||||||++||+++ |..||............... ...+ 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~-  229 (267)
T cd05066         152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLP-  229 (267)
T ss_pred             cccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCC-
Confidence            9986544321111112223456899999775 467889999999999999886 99999765433222222111 1110 


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                          ....     ....+..++.+||+.+|.+||+|.++++.|.+
T Consensus       230 ----~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         230 ----APMD-----CPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             ----CCCC-----CCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence                0011     12234556779999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.8e-37  Score=318.29  Aligned_cols=252  Identities=25%  Similarity=0.433  Sum_probs=188.8

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .++||+|+||.||+|..+      .+..||+|.+.....      .  ..    ...|.+|+.++++++||||+++++++
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~--~~----~~~~~~e~~~l~~l~~~~i~~~~~~~   78 (288)
T cd05061          11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS------L--RE----RIEFLNEASVMKGFTCHHVVRLLGVV   78 (288)
T ss_pred             eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC------H--HH----HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            578999999999999753      245799998753210      0  00    12478899999999999999999987


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNN-------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  259 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~  259 (593)
                      .. ...++||||+++|+|.+++.....       ....++.....++.|++.||.|||+  ++|+||||||+|||++.++
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dikp~nili~~~~  156 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDF  156 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCCChheEEEcCCC
Confidence            65 567899999999999999975321       2345677888999999999999998  5699999999999999999


Q ss_pred             ccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHH
Q psy9535         260 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVV  337 (593)
Q Consensus       260 ~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~  337 (593)
                      .+||+|||+++.......... .....++..|+|||.+. +.++.++|||||||++|||++ |..||.............
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRK-GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM  235 (288)
T ss_pred             cEEECcCCccccccccccccc-cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            999999999886433221111 11234577899999764 467889999999999999999 788997644332222221


Q ss_pred             hhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .....  ..     .    ......+..++.+||+.+|++||++.++++.|.+.
T Consensus       236 ~~~~~--~~-----~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         236 DGGYL--DQ-----P----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             cCCCC--CC-----C----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            11110  00     0    01123456677899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.1e-38  Score=334.77  Aligned_cols=203  Identities=25%  Similarity=0.322  Sum_probs=163.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|+.. +++.||||++.......          ......+.+|+.++++++|||||++++++.+ ..
T Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~----------~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~   75 (382)
T cd05625           6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLL----------RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN   75 (382)
T ss_pred             EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhh----------HHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE
Confidence            578999999999999874 68899999986431100          0012357889999999999999999998876 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.+.   ..+++.....++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            68999999999999998753   357888888999999999999998  5699999999999999999999999999753


Q ss_pred             cccCCC--------------------------------------------cceeeccccCCCCcCCccccc-CCCCCcch
Q psy9535         272 SETSNM--------------------------------------------KTMYTENLTGTRPYMPPEAMH-CQISTKTD  306 (593)
Q Consensus       272 ~~~~~~--------------------------------------------~~~~~~~~~GT~~Y~APE~~~-~~~~~ksD  306 (593)
                      ......                                            ........+||+.|+|||++. ..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  230 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence            210000                                            000012357999999999764 46889999


Q ss_pred             hhHHHHHHHHHHhCCCCCCCCchHH
Q psy9535         307 VFSYGVILLELLTGMKPIDDNNTIL  331 (593)
Q Consensus       307 VwSfGvvl~ElltG~~P~~~~~~~~  331 (593)
                      ||||||++|||++|+.||.......
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~  255 (382)
T cd05625         231 WWSVGVILYEMLVGQPPFLAQTPLE  255 (382)
T ss_pred             EEechHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999998765443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0199|consensus

Probab=100.00  E-value=2.1e-38  Score=336.93  Aligned_cols=250  Identities=27%  Similarity=0.388  Sum_probs=197.9

Q ss_pred             CCCcccccCceEEEEEEEc--CCC--EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLK--NGM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~--~g~--~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      +.++||+|+||+|++|.|+  +|.  .||||+++......            ....|.+|+.+|.+|+|||+++|||+..
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~------------~mddflrEas~M~~L~H~hliRLyGvVl  181 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA------------IMDDFLREASHMLKLQHPHLIRLYGVVL  181 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch------------hHHHHHHHHHHHHhccCcceeEEeeeec
Confidence            3578999999999999986  354  48999997542111            1236999999999999999999999998


Q ss_pred             cccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         189 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       189 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      +....+|+|.++.|||.+.|++ .....|.......++.|||.|+.||.+  +..|||||...|+||...-.+|||||||
T Consensus       182 ~qp~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGL  258 (1039)
T KOG0199|consen  182 DQPAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGL  258 (1039)
T ss_pred             cchhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeecccc
Confidence            8778899999999999999998 445678888899999999999999998  6699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      .|.+..............-.+.|.|||.+ +..++.+||||+|||++|||+| |..||.+.........+-.+     +.
T Consensus       259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-----er  333 (1039)
T KOG0199|consen  259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-----ER  333 (1039)
T ss_pred             eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-----cc
Confidence            99876554322222223335679999977 5679999999999999999998 78999876554433322211     11


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL  388 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L  388 (593)
                      +      ..+..+.+.|..++..||..+|.+|||+..|.+.+
T Consensus       334 L------pRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  334 L------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             C------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            1      11233455677778899999999999999997443

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.8e-37  Score=328.85  Aligned_cols=251  Identities=25%  Similarity=0.334  Sum_probs=182.9

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI-  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~-  190 (593)
                      ..+.||+|+||.||+++.. +|..||||.+.....    ....       ...+.+|+.+++.++||||+++++++... 
T Consensus        25 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   93 (359)
T cd07876          25 QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ----NQTH-------AKRAYRELVLLKCVNHKNIISLLNVFTPQK   93 (359)
T ss_pred             EEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc----chhH-------HHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence            3678999999999999874 689999999864311    0000       12477899999999999999999987532 


Q ss_pred             ------cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         191 ------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       191 ------~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                            ..++||||+.+ +|.+.+..     .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~--~~ivHrDlkp~NIl~~~~~~~kl~  165 (359)
T cd07876          94 SLEEFQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKIL  165 (359)
T ss_pred             CccccceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEe
Confidence                  35899999964 57666642     47888889999999999999998  569999999999999999999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-c
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-P  342 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~  342 (593)
                      |||+++......    ......||+.|+|||++. ..++.++|||||||++|||++|+.||...+....+........ +
T Consensus       166 Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  241 (359)
T cd07876         166 DFGLARTACTNF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP  241 (359)
T ss_pred             cCCCccccccCc----cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999987543321    122357899999999775 4578899999999999999999999986544332222211110 0


Q ss_pred             cccc-----------cc--ccc---------CCC-------CHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREV-----------LD--KEA---------GEW-------NETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~-----------~~--~~~---------~~~-------~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..+.           ..  +..         ..+       ........+..++.+|++.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000           00  000         000       00011233556778999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.7e-37  Score=312.37  Aligned_cols=253  Identities=23%  Similarity=0.355  Sum_probs=192.5

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+. .+|..+|||.+......   ..   .    ....|.+|+.+++.++||||+++++++.. ..
T Consensus         7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~---~~---~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   76 (267)
T cd08229           7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM---DA---K----ARADCIKEIDLLKQLNHPNVIKYYASFIEDNE   76 (267)
T ss_pred             hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh---hH---H----HHHHHHHHHHHHHHccCCchhhhhheeEeCCe
Confidence            57899999999999986 47899999988643110   00   0    12258899999999999999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         192 NCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      .++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.+||+|||+++
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~  154 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEECcchhhh
Confidence            689999999999999887432 23468999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhhcCccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~~  348 (593)
                      .......   ......|++.|+|||.+. ..++.++||||||+++|||++|..||...... ......... ...     
T Consensus       155 ~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-----  225 (267)
T cd08229         155 FFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDY-----  225 (267)
T ss_pred             ccccCCc---ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-CCC-----
Confidence            6543221   112356899999999774 45788999999999999999999999653321 111111110 000     


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                         ...........+..++.+||..+|++||||.+|++.+++
T Consensus       226 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         226 ---PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             ---CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence               011111233346667789999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.3e-37  Score=322.53  Aligned_cols=201  Identities=20%  Similarity=0.295  Sum_probs=158.8

Q ss_pred             CCccccc--CceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         114 GNKLGEG--QFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       114 ~~~LG~G--~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      .++||+|  +||+||+++.+ +|+.||||++.....     ....      ...+.+|+.+++.++|||||++++++.. 
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~------~~~~~~e~~~l~~l~hpniv~~~~~~~~~   71 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-----TNEM------VTFLQGELHVSKLFNHPNIVPYRATFIAD   71 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhc-----cHHH------HHHHHHHHHHHHhcCCCCeeeEEEEEEEC
Confidence            4689999  78999999874 789999999864311     0110      1246789999999999999999998865 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++++|||.+
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~~~~~~~~l~~~~~~  148 (327)
T cd08227          72 NELWVVTSFMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSN  148 (327)
T ss_pred             CEEEEEEeccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCChhhEEEecCCcEEEcccchh
Confidence            56689999999999999986532 2358999999999999999999998  56999999999999999999999999865


Q ss_pred             eecccCCCc----ceeeccccCCCCcCCcccccC---CCCCcchhhHHHHHHHHHHhCCCCCCCCc
Q psy9535         270 KMSETSNMK----TMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNN  328 (593)
Q Consensus       270 ~~~~~~~~~----~~~~~~~~GT~~Y~APE~~~~---~~~~ksDVwSfGvvl~ElltG~~P~~~~~  328 (593)
                      .........    ........++..|+|||++.+   .++.++|||||||++|||++|+.||....
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  214 (327)
T cd08227         149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  214 (327)
T ss_pred             hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            432211100    001122357788999998753   47889999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.2e-37  Score=317.74  Aligned_cols=252  Identities=29%  Similarity=0.424  Sum_probs=189.9

Q ss_pred             CCcccccCceEEEEEEEcC------CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGL  186 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~------g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~  186 (593)
                      .+.||+|+||.||+|....      ...+|+|.+....     ..   +.    ...+.+|++++.++ +||||++++++
T Consensus        17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-----~~---~~----~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053          17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-----TE---KD----LSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-----CH---HH----HHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            5789999999999998642      3679999886421     00   10    12478899999999 89999999998


Q ss_pred             Eec-ccceEEEEeccCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCC
Q psy9535         187 CNN-IMNCIVYEYMCNGSLYDRLARV-------------NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN  252 (593)
Q Consensus       187 ~~~-~~~~lV~Ey~~~GsL~~~L~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~N  252 (593)
                      +.. ...++||||+++|+|.+++...             .....+++..++.++.|++.||.|||+  ++|+||||||+|
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~N  162 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARN  162 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCccccccceee
Confidence            866 4668999999999999999753             123468999999999999999999998  569999999999


Q ss_pred             eeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchH
Q psy9535         253 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTI  330 (593)
Q Consensus       253 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~  330 (593)
                      ||++.++.+||+|||+++......... ......++..|+|||.+. ..++.++|||||||++|||++ |..||......
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  241 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  241 (293)
T ss_pred             EEEcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence            999999999999999998654322111 112234567899999764 457889999999999999998 99999765443


Q ss_pred             HHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         331 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ............  .     ...    .....+..++.+||..+|++|||+.|+++.|+..
T Consensus       242 ~~~~~~~~~~~~--~-----~~~----~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         242 ELFKLLKEGYRM--E-----KPQ----NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHHHHHHcCCcC--C-----CCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            332222211110  0     000    1112344566799999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.8e-37  Score=318.59  Aligned_cols=251  Identities=29%  Similarity=0.455  Sum_probs=190.3

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGL  186 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~  186 (593)
                      ++.||+|+||.||+|...      ++..||||.++....     ...       ...|.+|+.+++++ +||||++++++
T Consensus        40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~-------~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-----SSE-------REALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-----hHH-------HHHHHHHHHHHHhccCCCCcceEEEE
Confidence            689999999999999741      345799998864311     010       12588999999999 79999999998


Q ss_pred             Eec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         187 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       187 ~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                      +.. ...++||||+++|+|.+++.... ...+++.++..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeehhhhccceEEEcCCCeEEECC
Confidence            865 56789999999999999997533 2348999999999999999999998  5699999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcc
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  343 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~  343 (593)
                      ||+++....... ........+++.|+|||.+. ..++.++|||||||++|||++ |..||...................
T Consensus       185 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  263 (302)
T cd05055         185 FGLARDIMNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM  263 (302)
T ss_pred             CcccccccCCCc-eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC
Confidence            999876533221 11122345678899999764 457889999999999999998 999997654332222222111110


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      .      ....    ....+..++.+||..+|++||++.||++.|.+
T Consensus       264 ~------~~~~----~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         264 A------QPEH----APAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             C------CCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            0      0011    12235567789999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.2e-37  Score=320.15  Aligned_cols=254  Identities=26%  Similarity=0.424  Sum_probs=190.5

Q ss_pred             CCCcccccCceEEEEEEEc--------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  183 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~--------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l  183 (593)
                      +++.||+|+||.||+|+..        ++..||+|.+....     ...  .     ...+.+|+.+++.+ +||||+++
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-----~~~--~-----~~~~~~E~~~l~~l~~h~~i~~~   86 (304)
T cd05101          19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-----TEK--D-----LSDLVSEMEMMKMIGKHKNIINL   86 (304)
T ss_pred             ecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-----chH--H-----HHHHHHHHHHHHhhccCCCchhe
Confidence            3678999999999999741        24579999875321     000  0     12478999999999 89999999


Q ss_pred             EEEEec-ccceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccC
Q psy9535         184 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  249 (593)
Q Consensus       184 ~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLK  249 (593)
                      ++++.. ...++||||+++|+|.+++.....             ...+++..+..++.|++.||.|||+  ++|+|||||
T Consensus        87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~givH~dlk  164 (304)
T cd05101          87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS--QKCIHRDLA  164 (304)
T ss_pred             eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH--CCeeecccc
Confidence            998876 556899999999999999976421             1357888999999999999999998  569999999


Q ss_pred             CCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCC
Q psy9535         250 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDN  327 (593)
Q Consensus       250 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~  327 (593)
                      |+|||++.++.+||+|||+++........ ..+....+++.|+|||++. ..++.++|||||||++|||++ |..||...
T Consensus       165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         165 ARNVLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             cceEEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999865432211 1122235678899999764 457889999999999999998 78888765


Q ss_pred             chHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         328 NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      ............. ... .         +..+...+..++.+||+.+|++||++.||++.|.+..
T Consensus       244 ~~~~~~~~~~~~~-~~~-~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         244 PVEELFKLLKEGH-RMD-K---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             CHHHHHHHHHcCC-cCC-C---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            4333222221111 100 0         0112233555678999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.6e-37  Score=314.72  Aligned_cols=255  Identities=27%  Similarity=0.352  Sum_probs=190.2

Q ss_pred             HHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC
Q psy9535          97 DLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC  175 (593)
Q Consensus        97 ~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l  175 (593)
                      |++.+|+++..      ...||+|+||.||+|+.. ++..||+|.+....      ...       ...|.+|+.+++++
T Consensus         2 ~~~~~~~~~~~------~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~------~~~-------~~~~~~e~~~l~~l   62 (268)
T cd06624           2 EYEYEYDENGE------RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD------SRY-------VQPLHEEIALHSYL   62 (268)
T ss_pred             CcccccccCCc------eEEEecCCceEEEEeEecCCCcEEEEEEecCCC------HHH-------HHHHHHHHHHHHhc
Confidence            45667778766      478999999999999865 57889999875321      011       12578999999999


Q ss_pred             CCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCee
Q psy9535         176 KHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  254 (593)
Q Consensus       176 ~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NIL  254 (593)
                      +|+||++++|++.. ...++|+||+++++|.+++.........++..+..++.|++.||.|||+  ++|+||||||+||+
T Consensus        63 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~h~dl~p~nil  140 (268)
T cd06624          63 KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD--NQIVHRDIKGDNVL  140 (268)
T ss_pred             CCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEE
Confidence            99999999998866 5568999999999999999753221122788888999999999999998  56999999999999


Q ss_pred             ecC-CCccEEeecccceecccCCCcceeeccccCCCCcCCcccccC---CCCCcchhhHHHHHHHHHHhCCCCCCCCchH
Q psy9535         255 LDE-NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTI  330 (593)
Q Consensus       255 l~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~  330 (593)
                      ++. ++.+||+|||++........   ......|++.|+|||.+..   .++.++|||||||++|||++|+.||......
T Consensus       141 ~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~  217 (268)
T cd06624         141 VNTYSGVVKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP  217 (268)
T ss_pred             EcCCCCeEEEecchhheecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            986 67999999999876533221   1123468999999997643   3678999999999999999999999753221


Q ss_pred             --HHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         331 --LYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       331 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        ..+........       +   .. +..+...+..++.+||+.+|++||++.|+++
T Consensus       218 ~~~~~~~~~~~~~-------~---~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         218 QAAMFKVGMFKIH-------P---EI-PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hhhHhhhhhhccC-------C---CC-CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence              11111000000       0   00 1112233455678999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.9e-37  Score=316.14  Aligned_cols=250  Identities=26%  Similarity=0.395  Sum_probs=186.3

Q ss_pred             CCcccccCceEEEEEEEcC------CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~------g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .+.||+|+||.||+|.+..      +..||+|.+....     . ...      ...|.+|+.++++++|+||+++++++
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-----~-~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~   78 (277)
T cd05036          11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-----S-EQD------ESDFLMEALIMSKFNHQNIVRLIGVS   78 (277)
T ss_pred             eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-----C-HHH------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            5789999999999998753      5678999875321     0 101      12488999999999999999999987


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC---
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---  259 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~---  259 (593)
                      .+ ...++||||+++|+|.+++.....    ...+++..++.++.|++.||.|||+  ++++||||||+|||++.++   
T Consensus        79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchheEEEeccCCCc
Confidence            65 566899999999999999976432    1358999999999999999999998  5699999999999998654   


Q ss_pred             ccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHH
Q psy9535         260 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVV  337 (593)
Q Consensus       260 ~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~  337 (593)
                      .+||+|||+++......... ......+++.|+|||++. ..++.++|||||||++|||++ |..||.............
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~  235 (277)
T cd05036         157 VAKIADFGMARDIYRASYYR-KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT  235 (277)
T ss_pred             ceEeccCccccccCCcccee-cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            69999999998653222111 111223456899999764 568999999999999999997 999998654332222221


Q ss_pred             hhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                      ... .. ..    ...     +...+..++.+||+.+|++||++.+|++.|.
T Consensus       236 ~~~-~~-~~----~~~-----~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 GGG-RL-DP----PKG-----CPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             cCC-cC-CC----CCC-----CCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111 10 00    011     1223455678999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-37  Score=327.84  Aligned_cols=255  Identities=24%  Similarity=0.381  Sum_probs=187.5

Q ss_pred             CCCCcccccCceEEEEEEE------cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKL------KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLL  184 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~------~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~  184 (593)
                      ++.+.||+|+||.||+|.+      .+++.||||.++...     ...  .     ...+.+|+.++.++ +||||++++
T Consensus        10 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~--~-----~~~~~~E~~~l~~l~~h~niv~~~   77 (343)
T cd05103          10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----THS--E-----HRALMSELKILIHIGHHLNVVNLL   77 (343)
T ss_pred             cccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-----ChH--H-----HHHHHHHHHHHHhccCCccHhhhc
Confidence            4578999999999999974      346889999986431     100  1     12477899999999 689999999


Q ss_pred             EEEec--ccceEEEEeccCCCHHHHHhhcCC-------------------------------------------------
Q psy9535         185 GLCNN--IMNCIVYEYMCNGSLYDRLARVNN-------------------------------------------------  213 (593)
Q Consensus       185 g~~~~--~~~~lV~Ey~~~GsL~~~L~~~~~-------------------------------------------------  213 (593)
                      ++|..  ...++||||+++|+|.+++.....                                                 
T Consensus        78 ~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (343)
T cd05103          78 GACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKS  157 (343)
T ss_pred             ceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCc
Confidence            98865  345789999999999999875321                                                 


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecccCCCc
Q psy9535         214 ---------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK  278 (593)
Q Consensus       214 ---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  278 (593)
                                     ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  234 (343)
T cd05103         158 LSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-  234 (343)
T ss_pred             cccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-
Confidence                           1236788889999999999999998  5699999999999999999999999999876432211 


Q ss_pred             ceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccccCCCCH
Q psy9535         279 TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNE  356 (593)
Q Consensus       279 ~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (593)
                      ........+++.|+|||.+ ...++.++|||||||++|||++ |..||...................      ....+..
T Consensus       235 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~  308 (343)
T cd05103         235 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------RAPDYTT  308 (343)
T ss_pred             hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC------CCCCCCC
Confidence            1111223467789999976 4457889999999999999997 999997643211111111111110      0011111


Q ss_pred             HHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         357 THVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       357 ~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                          ..+..++.+||+.+|++||++.||++.|+..
T Consensus       309 ----~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         309 ----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             ----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                1234455699999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.6e-37  Score=313.03  Aligned_cols=256  Identities=22%  Similarity=0.305  Sum_probs=187.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +|..||||.+.......    ..       ...+.+|+.++++++||||+++++++.+ ..
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   73 (285)
T cd07861           5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE----GV-------PSTAIREISLLKELQHPNIVCLQDVLMQESR   73 (285)
T ss_pred             eeEecccCceEEEEEEECCCCcEEEEEEeccccccC----Cc-------hHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe
Confidence            578999999999999875 68999999986431110    00       1146789999999999999999998865 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||++ |+|.+++........+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        74 ~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  150 (285)
T cd07861          74 LYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARA  150 (285)
T ss_pred             EEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEEcCCCcEEECcccceee
Confidence            689999997 7898888765444568999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-cc-----
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-PV-----  343 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~~-----  343 (593)
                      ......   ......|++.|+|||.+.+  .++.++|||||||++|||+||+.||................. +.     
T Consensus       151 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (285)
T cd07861         151 FGIPVR---VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWP  227 (285)
T ss_pred             cCCCcc---cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence            433211   1122367899999997743  368899999999999999999999986543322221111100 00     


Q ss_pred             --------ccccccccCCCC---HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 --------REVLDKEAGEWN---ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 --------~~~~~~~~~~~~---~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                              ....+.......   ...+...+..++.+||..||++|||+.+|+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         228 GVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             cchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                    000000000000   0011233446778999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG4279|consensus

Probab=100.00  E-value=1.5e-38  Score=337.25  Aligned_cols=242  Identities=28%  Similarity=0.381  Sum_probs=187.8

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      -+||+|.||+||-|+.. +...+|||.+........             +-...|+.+.++|+|.|||+.+|.|.+ +..
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~-------------QPLhEEIaLH~~LrHkNIVrYLGs~senGf~  647 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREV-------------QPLHEEIALHSTLRHKNIVRYLGSVSENGFF  647 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhh-------------ccHHHHHHHHHHHhhHhHHHHhhccCCCCeE
Confidence            46999999999999976 456799999864321110             125679999999999999999999876 445


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec-CCCccEEeecccc
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPL--DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIV  269 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~-~~~~~Kl~DFGla  269 (593)
                      -|.||-++||||.++|..+  .+|+  .+...-.+..||++||.|||+  ..|||||||-+|||++ -.|.+||+|||-+
T Consensus       648 kIFMEqVPGGSLSsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHe--n~IVHRDIKGDNVLvNTySGvlKISDFGTs  723 (1226)
T KOG4279|consen  648 KIFMEQVPGGSLSSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHE--NKIVHRDIKGDNVLVNTYSGVLKISDFGTS  723 (1226)
T ss_pred             EEEeecCCCCcHHHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhh--cceeeccccCCcEEEeeccceEEecccccc
Confidence            6889999999999999753  3455  677777889999999999998  4499999999999996 5799999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc---CCCCCcchhhHHHHHHHHHHhCCCCCCCCc-hHHHHHHHHhhcCcccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH---CQISTKTDVFSYGVILLELLTGMKPIDDNN-TILYYYLVVEQEVPVRE  345 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~~ksDVwSfGvvl~ElltG~~P~~~~~-~~~~~~~~~~~~~~~~~  345 (593)
                      +....-+.   .+.++.||..|||||++.   ..|+.++|||||||++.||.||++||.... .....+.+-  ...   
T Consensus       724 KRLAginP---~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG--myK---  795 (1226)
T KOG4279|consen  724 KRLAGINP---CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG--MYK---  795 (1226)
T ss_pred             hhhccCCc---cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc--cee---
Confidence            86654332   356789999999999884   358899999999999999999999997632 222222211  100   


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +     -+.-++++....+..+.+|+..+|.+||++.++++
T Consensus       796 v-----HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  796 V-----HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             c-----CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            0     01123455555666778999999999999999874

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.4e-37  Score=314.88  Aligned_cols=250  Identities=26%  Similarity=0.425  Sum_probs=188.7

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      ..+||+|+||.||++...      ++..+|+|.+....      ...       ...|.+|++++++++||||+++++++
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~------~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~   76 (280)
T cd05092          10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS------ESA-------RQDFQREAELLTVLQHQHIVRFYGVC   76 (280)
T ss_pred             ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC------HHH-------HHHHHHHHHHHhcCCCCCCceEEEEE
Confidence            578999999999999642      35679999875321      010       12588999999999999999999988


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCee
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNN------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  254 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NIL  254 (593)
                      .. ...++||||+++|+|.+++.....            ...+++..+..++.|++.||.|||+  .+|+||||||+|||
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~nil  154 (280)
T cd05092          77 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS--LHFVHRDLATRNCL  154 (280)
T ss_pred             ecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH--CCeecccccHhhEE
Confidence            76 556899999999999999975421            1348899999999999999999998  56999999999999


Q ss_pred             ecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHH
Q psy9535         255 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILY  332 (593)
Q Consensus       255 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~  332 (593)
                      +++++.+||+|||+++....... ........+++.|+|||.+. ..++.++|||||||++|||++ |..||........
T Consensus       155 ~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  233 (280)
T cd05092         155 VGQGLVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA  233 (280)
T ss_pred             EcCCCCEEECCCCceeEcCCCce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence            99999999999999875533221 11112234678899999764 567889999999999999998 9999976544332


Q ss_pred             HHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         333 YYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ..........  ..  +  ..     +...+..++.+||+.+|.+||++.||.+.|++
T Consensus       234 ~~~~~~~~~~--~~--~--~~-----~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         234 IECITQGREL--ER--P--RT-----CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHHcCccC--CC--C--CC-----CCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            2222211111  00  0  01     11234567789999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.9e-37  Score=316.73  Aligned_cols=248  Identities=21%  Similarity=0.286  Sum_probs=185.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||++... +++.||||.+........      ..    ...+.+|+.++++++|+||+++++.+.. ..
T Consensus         5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~------~~----~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~   74 (285)
T cd05630           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR------KG----ESMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch------HH----HHHHHHHHHHHHhCCCCCeeeeeEEEecCCE
Confidence            578999999999999875 688999999865321110      00    1136789999999999999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.++|+|||++..
T Consensus        75 ~~lv~e~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05630          75 LCLVLTLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVH  151 (285)
T ss_pred             EEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeccceee
Confidence            689999999999999886533 2458999999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......    .....||+.|+|||++. ..++.++|||||||++|||++|+.||.......................   
T Consensus       152 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---  224 (285)
T cd05630         152 VPEGQT----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY---  224 (285)
T ss_pred             cCCCcc----ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhc---
Confidence            433221    12347999999999774 4578899999999999999999999976432111100000000000000   


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCC-----hHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRAS-----MRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs-----m~eV~~  386 (593)
                      ...     ....+..++.+||+.||++|||     +.|+++
T Consensus       225 ~~~-----~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         225 SEK-----FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             Ccc-----CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            011     1223456678999999999999     677654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.6e-37  Score=315.85  Aligned_cols=244  Identities=20%  Similarity=0.283  Sum_probs=183.7

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||+||+|... +++.||+|.+........   .       ....+.+|++++++++|+||+++.+++.. +.
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~---~-------~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~   74 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKR---K-------GESMALNEKQILEKVNSQFVVNLAYAYETKDA   74 (285)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhh---h-------HHHHHHHHHHHHHHcCCcCceeEEEEEecCCE
Confidence            468999999999999874 688999999865321100   0       01246789999999999999999987765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++.
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~  151 (285)
T cd05632          75 LCLVLTIMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVK  151 (285)
T ss_pred             EEEEEEeccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCccee
Confidence            689999999999998887533 2468999999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......    .....||+.|+|||.+. ..++.++|||||||++|||++|..||.......................   
T Consensus       152 ~~~~~~----~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~---  224 (285)
T cd05632         152 IPEGES----IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY---  224 (285)
T ss_pred             cCCCCc----ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccccc---
Confidence            433211    12357999999999764 5578899999999999999999999986543222111111100000000   


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMR  382 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~  382 (593)
                      ...     ....+..++.+||+.+|++||++.
T Consensus       225 ~~~-----~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         225 SAK-----FSEEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             Ccc-----CCHHHHHHHHHHccCCHhHcCCCc
Confidence            011     122344567799999999999954

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-37  Score=313.15  Aligned_cols=247  Identities=28%  Similarity=0.457  Sum_probs=183.9

Q ss_pred             cccccCceEEEEEEEc-CCC--EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         116 KLGEGQFGTVYYGKLK-NGM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~--~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      .||+|+||.||+|+.. +|.  .+|+|.+....     ....       ...|.+|++++.++ +||||+++++++.. .
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-----~~~~-------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   69 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-----SKDD-------HRDFAGELEVLCKLGHHPNIINLLGACEHRG   69 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-----CHHH-------HHHHHHHHHHHHhhccCCCeeeEEEEEecCC
Confidence            6899999999999875 344  46888875321     0000       12478899999999 79999999998876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVN-------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  257 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~  257 (593)
                      ..++||||+++|+|.+++....             ....+++..+..++.|++.||+|||+  ++++||||||+|||+++
T Consensus        70 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nili~~  147 (270)
T cd05047          70 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGE  147 (270)
T ss_pred             CceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccccceEEEcC
Confidence            5689999999999999997532             12347899999999999999999998  56999999999999999


Q ss_pred             CCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHH
Q psy9535         258 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYL  335 (593)
Q Consensus       258 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~  335 (593)
                      ++.+||+|||+++......    ......+++.|+|||++. ..++.++|||||||++|||++ |..||...........
T Consensus       148 ~~~~kl~dfgl~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~  223 (270)
T cd05047         148 NYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  223 (270)
T ss_pred             CCeEEECCCCCccccchhh----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH
Confidence            9999999999986322111    011123466799999764 457889999999999999997 9999976443322222


Q ss_pred             HHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         336 VVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .... ...    +  ...    .+...+..++.+||..+|.+||++.++++.|.+.
T Consensus       224 ~~~~-~~~----~--~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         224 LPQG-YRL----E--KPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             HhCC-CCC----C--CCC----cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            1111 000    0  000    1122345667799999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-37  Score=324.27  Aligned_cols=206  Identities=25%  Similarity=0.319  Sum_probs=166.1

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+++.. +++.||||.+.+......          .....|.+|+.++..++||||+++++++.+ .
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (331)
T cd05597           5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKR----------AETACFREERDVLVNGDRRWITNLHYAFQDEN   74 (331)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhh----------hhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            3578999999999999875 689999999864211100          012247889999999999999999998876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++.+..  ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  150 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQ--LGYVHRDIKPDNVLLDKNGHIRLADFGSCL  150 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEECCCCHHHEEECCCCCEEEEECCcee
Confidence            6689999999999999997532  358889999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHH
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  334 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~  334 (593)
                      .......  .......||+.|||||++.      ..++.++|||||||++|||++|+.||........+.
T Consensus       151 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~  218 (331)
T cd05597         151 RLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  218 (331)
T ss_pred             ecCCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH
Confidence            6543221  1112246999999999874      236789999999999999999999998765444333

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=330.98  Aligned_cols=243  Identities=23%  Similarity=0.270  Sum_probs=182.0

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC---CCCceeeEEEEEec-cc
Q psy9535         117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       117 LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l---~HpNIv~l~g~~~~-~~  191 (593)
                      ||+|+||.||+|+.. +|+.||||++........          .....+..|..++.++   +||||+++++++.. ..
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~   70 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK----------KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSD   70 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh----------hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCe
Confidence            799999999999875 689999999864311100          0112345677777665   69999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++..+..++.|+++||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~  145 (330)
T cd05586          71 LYLVTDYMSGGELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHK--YDIVYRDLKPENILLDATGHIALCDFGLSKA  145 (330)
T ss_pred             EEEEEcCCCCChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence            78999999999999988753   358899999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......   ......||+.|+|||++.+  .++.++|||||||++|||++|+.||........+..+......++.    
T Consensus       146 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~----  218 (330)
T cd05586         146 NLTDNK---TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK----  218 (330)
T ss_pred             CCCCCC---CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC----
Confidence            332221   1234679999999997743  3788999999999999999999999876544433333222221110    


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL  388 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L  388 (593)
                             ..+...+..++.+||..+|++||++.+.++.+
T Consensus       219 -------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~l  250 (330)
T cd05586         219 -------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVEL  250 (330)
T ss_pred             -------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHH
Confidence                   01122345567899999999999755443333

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.8e-37  Score=314.28  Aligned_cols=254  Identities=23%  Similarity=0.317  Sum_probs=182.7

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC---CCCceeeEEEEEec
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLLGLCNN  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l---~HpNIv~l~g~~~~  189 (593)
                      .+.||+|+||.||+|+.+ +|+.||+|.++........     .      ..+.+|+++++++   +||||+++++++..
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~-----~------~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~   73 (288)
T cd07863           5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL-----P------LSTVREVALLKRLEAFDHPNIVRLMDVCAT   73 (288)
T ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC-----c------hHHHHHHHHHHHhhhcCCCCeeeeeeeecc
Confidence            578999999999999875 6899999998653211110     0      1245677666655   79999999998753


Q ss_pred             ------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         190 ------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       190 ------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                            ...++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||
T Consensus        74 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~kl  149 (288)
T cd07863          74 SRTDRETKVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVKL  149 (288)
T ss_pred             ccCCCCceEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEE
Confidence                  23579999997 58988887543 2458999999999999999999998  56999999999999999999999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-C
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-V  341 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~-~  341 (593)
                      +|||+++.......    .....||+.|+|||++ ...++.++|||||||++|||++|++||................ .
T Consensus       150 ~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~  225 (288)
T cd07863         150 ADFGLARIYSCQMA----LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL  225 (288)
T ss_pred             CccCccccccCccc----CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCC
Confidence            99999886543221    1235689999999976 4467889999999999999999999997654432222221100 0


Q ss_pred             c----ccc-------ccccccCCCC---HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 P----VRE-------VLDKEAGEWN---ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~----~~~-------~~~~~~~~~~---~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +    .+.       ...+......   ...+...+..++.+|++.||++|||+.|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0    000       0000000000   0112334556778999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.1e-37  Score=330.01  Aligned_cols=254  Identities=25%  Similarity=0.341  Sum_probs=184.9

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc--
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~--  190 (593)
                      .++||+|+||.||+|+.. +|+.||||++.....    ..   .    ....+.+|+.+++.++||||+++++++...  
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~---~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   73 (372)
T cd07853           5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ----NL---V----SCKRVFRELKMLCFFKHDNVLSALDILQPPHI   73 (372)
T ss_pred             cceeeeCCCEEEEEEEECCCCCEEEEEecccccc----ch---H----HHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence            688999999999999864 789999999853210    00   0    122477899999999999999999988653  


Q ss_pred             ----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         191 ----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       191 ----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                          ..++||||+. ++|.+.+..   ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+||
T Consensus        74 ~~~~~~~lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nili~~~~~~kL~Df  147 (372)
T cd07853          74 DPFEEIYVVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICDF  147 (372)
T ss_pred             cccceEEEEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHHEEECCCCCEEeccc
Confidence                4589999986 678887754   2468999999999999999999998  56999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--hcCc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVP  342 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~--~~~~  342 (593)
                      |+++........  ......||+.|+|||.+.+  .++.++|||||||++|||++|+.||...........+..  +..+
T Consensus       148 g~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~  225 (372)
T cd07853         148 GLARVEEPDESK--HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS  225 (372)
T ss_pred             cceeecccCccc--cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            999865432211  1223468999999997754  368899999999999999999999987544322222111  0000


Q ss_pred             cccc----------c-c-cccCCC------CHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREV----------L-D-KEAGEW------NETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~----------~-~-~~~~~~------~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ....          + . +.....      ........+..++.+|++.||++|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         226 LEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            0000          0 0 000000      00001223445677999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0577|consensus

Probab=100.00  E-value=9.8e-39  Score=334.02  Aligned_cols=240  Identities=28%  Similarity=0.453  Sum_probs=195.9

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         115 NKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      +.||.|+||.||.++. ++...||||++.-...    .....      -....+||..|.+++|||++..-||+.. ...
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGK----Qs~EK------WqDIlKEVrFL~~l~HPntieYkgCyLre~Ta  101 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK----QSNEK------WQDILKEVRFLRQLRHPNTIEYKGCYLREHTA  101 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeecccccc----ccHHH------HHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence            5699999999999986 4678899999864322    21111      1246789999999999999999999876 456


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      |||||||- ||-.|.|.-..  .++.+..+..|..|++.||.|||+  .+.||||||..||||++.|.+||+|||.|.+.
T Consensus       102 WLVMEYCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS--~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  102 WLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHS--HNRIHRDIKAGNILLSEPGLVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHH--hhHHhhhccccceEecCCCeeeeccccchhhc
Confidence            89999985 67777775432  478899999999999999999999  55999999999999999999999999998776


Q ss_pred             ccCCCcceeeccccCCCCcCCcccc----cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~----~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ...       .+++|||+|||||++    .++|+-|+||||+||+..||...++|+...+.....+.+...+.|...   
T Consensus       177 ~PA-------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq---  246 (948)
T KOG0577|consen  177 APA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ---  246 (948)
T ss_pred             Cch-------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC---
Confidence            543       247999999999965    467999999999999999999999999988888777777666555432   


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        .++     ....+..++..|++.-|.+|||..+++.
T Consensus       247 --s~e-----WS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  247 --SNE-----WSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             --Cch-----hHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence              223     3445566788999999999999988753

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-37  Score=312.85  Aligned_cols=237  Identities=27%  Similarity=0.380  Sum_probs=178.3

Q ss_pred             cccccCceEEEEEEEcC--------CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         116 KLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~~--------g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .||+|+||.||+|..+.        ...||+|.+....      ..       ....|.+|+.+++.++||||+++++++
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~------~~-------~~~~~~~e~~~l~~~~h~~iv~~~~~~   68 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH------RN-------YSESFFEAASMMSQLSHKHLVLNYGVC   68 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchh------HH-------HHHHHHHHHHHHHhCCCCChhheeeEE
Confidence            69999999999997642        2347888764321      00       012478899999999999999999988


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc------
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV------  260 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~------  260 (593)
                      .. ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.      
T Consensus        69 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~~  144 (258)
T cd05078          69 VCGDESIMVQEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNP  144 (258)
T ss_pred             EeCCCcEEEEecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEEecccccccCCC
Confidence            66 56789999999999999997543  358899999999999999999998  66999999999999987765      


Q ss_pred             --cEEeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCC-CCCCCCchHHHHHH
Q psy9535         261 --PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGM-KPIDDNNTILYYYL  335 (593)
Q Consensus       261 --~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~-~P~~~~~~~~~~~~  335 (593)
                        +|++|||++.....       .....|++.|+|||++..  .++.++|||||||++|||++|. .|+........ ..
T Consensus       145 ~~~~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~  216 (258)
T cd05078         145 PFIKLSDPGISITVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQ  216 (258)
T ss_pred             ceEEecccccccccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HH
Confidence              58999998764322       123568899999998754  4688999999999999999995 56554332221 11


Q ss_pred             HHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         336 VVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                      ........+.       .     ....+..++.+||+.+|++|||+.++++.|.
T Consensus       217 ~~~~~~~~~~-------~-----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         217 FYEDRHQLPA-------P-----KWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHccccCCC-------C-----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1111111110       0     0122456778999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.1e-37  Score=327.72  Aligned_cols=250  Identities=22%  Similarity=0.267  Sum_probs=182.9

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc--
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~--  190 (593)
                      .+.||+|+||.||++... .++.||||.+.....    ....       ...+.+|+.+++.++||||+++++++...  
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   90 (355)
T cd07874          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ----NQTH-------AKRAYRELVLMKCVNHKNIISLLNVFTPQKS   90 (355)
T ss_pred             EEEeeecCCEEEEEEEecCCCceEEEEEeCCccc----ChHH-------HHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence            578999999999999864 688999999864311    1000       12467899999999999999999987532  


Q ss_pred             -----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         191 -----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       191 -----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                           ..++||||+. ++|.+.+..     .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus        91 ~~~~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~--~givHrDikp~Nill~~~~~~kl~D  162 (355)
T cd07874          91 LEEFQDVYLVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_pred             ccccceeEEEhhhhc-ccHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEECCCCCEEEee
Confidence                 3489999996 467776643     47888899999999999999998  5699999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-cc
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-PV  343 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~~  343 (593)
                      ||+++......    ......||+.|+|||++.+ .++.++|||||||++|||++|+.||........+........ +.
T Consensus       163 fg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (355)
T cd07874         163 FGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  238 (355)
T ss_pred             CcccccCCCcc----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99998653322    1223578999999997754 578899999999999999999999987554333222211100 00


Q ss_pred             cc--------------------------ccccccC---CCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 RE--------------------------VLDKEAG---EWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~~--------------------------~~~~~~~---~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .+                          .......   ..........+..++.+|++.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence            00                          0000000   0000111234556778999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.3e-37  Score=320.51  Aligned_cols=255  Identities=27%  Similarity=0.416  Sum_probs=189.6

Q ss_pred             CCCcccccCceEEEEEEEc--------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  183 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~--------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l  183 (593)
                      +++.||+|+||.||+++..        ++..+|+|.+....     ...  .     ...+.+|+.+++++ +||||+++
T Consensus        22 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-----~~~--~-----~~~~~~e~~~l~~l~~h~~i~~~   89 (307)
T cd05098          22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-----TEK--D-----LSDLISEMEMMKMIGKHKNIINL   89 (307)
T ss_pred             EeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-----ChH--H-----HHHHHHHHHHHHHhcCCCCEeeE
Confidence            4689999999999999752        23569999986421     000  0     12477899999999 79999999


Q ss_pred             EEEEec-ccceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccC
Q psy9535         184 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  249 (593)
Q Consensus       184 ~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLK  249 (593)
                      +++|.. ...++||||+++|+|.+++.....             ...+++..+..++.|++.||+|||+  .+++|||||
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlk  167 (307)
T cd05098          90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS--KKCIHRDLA  167 (307)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCccccccc
Confidence            998876 566899999999999999976421             1358899999999999999999998  569999999


Q ss_pred             CCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCC
Q psy9535         250 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDN  327 (593)
Q Consensus       250 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~  327 (593)
                      |+|||++.++.+||+|||+++......... .+....+++.|+|||.+. ..++.++|||||||++|||++ |..||...
T Consensus       168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~  246 (307)
T cd05098         168 ARNVLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  246 (307)
T ss_pred             HHheEEcCCCcEEECCCcccccccccchhh-ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence            999999999999999999987553221111 111223557899999764 457889999999999999998 88898764


Q ss_pred             chHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhccc
Q psy9535         328 NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMF  393 (593)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~  393 (593)
                      ......... ..... .+.         +..+...+..++.+||..+|++||+|.+|++.|.+...
T Consensus       247 ~~~~~~~~~-~~~~~-~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         247 PVEELFKLL-KEGHR-MDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             CHHHHHHHH-HcCCC-CCC---------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            432222221 11111 000         01112344556779999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9.4e-37  Score=307.86  Aligned_cols=253  Identities=24%  Similarity=0.354  Sum_probs=193.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|... +|+.||+|.++........          ....+.+|++++++++|+||+++++++.. ..
T Consensus         7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----------~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~   76 (267)
T cd08224           7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK----------ARQDCLKEIDLLKQLDHPNVIKYLASFIENNE   76 (267)
T ss_pred             eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchh----------hHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            578999999999999876 7999999988643211110          01257899999999999999999998765 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         192 NCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      .++||||+++|+|.+++.... ....+++.++..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~~~~~~~~l~d~~~~~  154 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecCCcChhhEEECCCCcEEEeccceee
Confidence            689999999999999986532 23468999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCch-HHHHHHHHhhcCccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNT-ILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~-~~~~~~~~~~~~~~~~~~~  348 (593)
                      .......   ......|++.|+|||.+. ..++.++|||||||++|||++|+.||..... ......... .....    
T Consensus       155 ~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~----  226 (267)
T cd08224         155 FFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYP----  226 (267)
T ss_pred             eccCCCc---ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCCC----
Confidence            6543221   112346899999999764 4578899999999999999999999965331 111111100 00000    


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                          ..+.......+..++.+||..+|++||++.+|++.|+.
T Consensus       227 ----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~  264 (267)
T cd08224         227 ----PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE  264 (267)
T ss_pred             ----CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence                11111223345667789999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.8e-37  Score=318.43  Aligned_cols=250  Identities=28%  Similarity=0.419  Sum_probs=186.4

Q ss_pred             CCCcccccCceEEEEEEEc-CCC--EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~--~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~  188 (593)
                      ..+.||+|+||.||+|... +|.  .+|+|.++...     ....       ...|.+|++++.++ +||||+++++++.
T Consensus         6 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-----~~~~-------~~~~~~E~~~l~~l~~hp~iv~~~~~~~   73 (297)
T cd05089           6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-----SEND-------HRDFAGELEVLCKLGHHPNIINLLGACE   73 (297)
T ss_pred             eeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-----CHHH-------HHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence            3578999999999999875 343  47888875311     0000       12478899999999 7999999999886


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCee
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  254 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NIL  254 (593)
                      . ...++||||+++|+|.+++.....             ...+++..+..++.|++.||+|||+  ++|+||||||+|||
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil  151 (297)
T cd05089          74 NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVL  151 (297)
T ss_pred             cCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCcCCcceEE
Confidence            6 556899999999999999975321             1358899999999999999999998  56999999999999


Q ss_pred             ecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHH
Q psy9535         255 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILY  332 (593)
Q Consensus       255 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~  332 (593)
                      ++.++.+||+|||++.......    ......++..|+|||.+. ..++.++|||||||++|||++ |..||........
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~  227 (297)
T cd05089         152 VGENLASKIADFGLSRGEEVYV----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL  227 (297)
T ss_pred             ECCCCeEEECCcCCCcccccee----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            9999999999999986432111    011122356799999764 457889999999999999997 9999977544332


Q ss_pred             HHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         333 YYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ........ .      ....    ..+...+..++.+||..+|.+||++.+|++.|...
T Consensus       228 ~~~~~~~~-~------~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         228 YEKLPQGY-R------MEKP----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             HHHHhcCC-C------CCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            22221110 0      0000    11223355677899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0660|consensus

Probab=100.00  E-value=6.8e-38  Score=314.46  Aligned_cols=255  Identities=25%  Similarity=0.384  Sum_probs=187.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec---
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~---  189 (593)
                      .+.||+|+||.|+.+..+ +|..||||++...-    .       .....++-.+|+.+|+.++|+||+.+++....   
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F----~-------~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF----E-------NQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhh----h-------chHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            468999999999999864 78999999986321    1       11112346789999999999999999997643   


Q ss_pred             ---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         190 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       190 ---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                         ...|+|+|+| .-+|.+.++.   +..|+......+++|+++||.|+|+.  +|+||||||+|+|++.+..+||+||
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSA--nViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSA--NVIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhcc--cccccccchhheeeccCCCEEeccc
Confidence               3458999999 4677777764   23488899999999999999999994  5999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccc--cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc-
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV-  343 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~--~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~-  343 (593)
                      ||||..... .....-+..+-|.+|.|||++  ...|+.+.||||.|||+.||++|++-|.+.+.......+..--+.. 
T Consensus       170 GLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  170 GLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             cceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence            999987543 112222446779999999976  3468899999999999999999999998866544444333221111 


Q ss_pred             cccccc--------------c--cCCCCH--HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 REVLDK--------------E--AGEWNE--THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~~~~~~--------------~--~~~~~~--~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .+.+..              .  ...+..  ..+......++++.+..||.+|+|+.|.++
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            110000              0  000000  012233445678999999999999999753

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2e-37  Score=316.72  Aligned_cols=261  Identities=24%  Similarity=0.342  Sum_probs=194.6

Q ss_pred             ecHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHH
Q psy9535          93 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT  171 (593)
Q Consensus        93 ~~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~i  171 (593)
                      +.++.+..++++|..      .+.||+|+||.||+++.. +++.+|+|.+....     .  . .      ..+.+|+.+
T Consensus         8 ~~~~~~~~~~~~~~~------~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~--~-~------~~~~~e~~~   67 (286)
T cd06638           8 IIFDSFPDPSDTWEI------IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----D--I-D------EEIEAEYNI   67 (286)
T ss_pred             EEeecCCCcccceee------eeeeccCCCcEEEEEEECCCCceeEEEeecccc-----c--h-H------HHHHHHHHH
Confidence            344566777777764      578999999999999875 58899999875321     0  0 1      147789999


Q ss_pred             HhcC-CCCceeeEEEEEec------ccceEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q psy9535         172 LSQC-KHVNLLRLLGLCNN------IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPI  243 (593)
Q Consensus       172 l~~l-~HpNIv~l~g~~~~------~~~~lV~Ey~~~GsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~I  243 (593)
                      ++++ +||||+++++++..      ...++||||+++|+|.+++... .....+++..+..++.|+++||.|||+  .+|
T Consensus        68 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i  145 (286)
T cd06638          68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV--NKT  145 (286)
T ss_pred             HHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh--CCc
Confidence            9999 69999999998732      3468999999999999988642 223468899999999999999999998  569


Q ss_pred             EecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc------CCCCCcchhhHHHHHHHHH
Q psy9535         244 IHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLEL  317 (593)
Q Consensus       244 iHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~~ksDVwSfGvvl~El  317 (593)
                      +||||||+||+++.++.+||+|||+++.......   ......||+.|+|||++.      ..++.++|||||||++|||
T Consensus       146 ~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el  222 (286)
T cd06638         146 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL  222 (286)
T ss_pred             cccCCCHHhEEECCCCCEEEccCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHH
Confidence            9999999999999999999999999876543221   112346999999999763      2367899999999999999


Q ss_pred             HhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHH
Q psy9535         318 LTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDL  387 (593)
Q Consensus       318 ltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~  387 (593)
                      ++|+.||...............  .......+       ......+..++.+||+.+|++||++.||++.
T Consensus       223 ~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         223 GDGDPPLADLHPMRALFKIPRN--PPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hcCCCCCCCCchhHHHhhcccc--CCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            9999999765432222111111  00111111       0111234556789999999999999999763

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.3e-37  Score=312.10  Aligned_cols=249  Identities=29%  Similarity=0.450  Sum_probs=186.8

Q ss_pred             CcccccCceEEEEEEEcC-------CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         115 NKLGEGQFGTVYYGKLKN-------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~~-------g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      +.||+|+||.||+|+..+       +..||||.+.....     ...       ...|.+|++++++++||||++++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-----~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~   68 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-----DQE-------KKEFLKEAHLMSNFNHPNIVKLLGVC   68 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc-----hhh-------HHHHHHHHHHHHhcCCCCeeeEeeee
Confidence            368999999999998642       25799998753210     000       12588999999999999999999988


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC---
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVN----NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---  259 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~---  259 (593)
                      .. ...++||||+++|+|.+++....    ....+++..++.++.|++.||.|||+  .+++|+||||+|||++.++   
T Consensus        69 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~  146 (269)
T cd05044          69 LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDA  146 (269)
T ss_pred             cCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCC
Confidence            65 55689999999999999997532    12347899999999999999999998  5699999999999999877   


Q ss_pred             --ccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHH
Q psy9535         260 --VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYL  335 (593)
Q Consensus       260 --~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~  335 (593)
                        .+||+|||+++......... ......++..|+|||.+. +.++.++|||||||++|||+| |..||...........
T Consensus       147 ~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~  225 (269)
T cd05044         147 DRVVKIGDFGLARDIYKSDYYR-KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH  225 (269)
T ss_pred             CcceEECCcccccccccccccc-cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH
Confidence              89999999987543321111 112234678899999764 567889999999999999998 9999976544332222


Q ss_pred             HHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         336 VVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                      ..... ...      .    .......+..++.+||..+|.+||++.+|++.|.
T Consensus       226 ~~~~~-~~~------~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         226 VTAGG-RLQ------K----PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HhcCC-ccC------C----cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            21111 000      0    0112234556778999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-37  Score=318.09  Aligned_cols=263  Identities=25%  Similarity=0.448  Sum_probs=188.6

Q ss_pred             CCCCcccccCceEEEEEEE-----cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-----~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      +..+.||+|+||.||++++     .++..||+|.++...     ....       ...|.+|++++++++||||++++++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~   74 (284)
T cd05079           7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-----GGNH-------IADLKKEIEILRNLYHENIVKYKGI   74 (284)
T ss_pred             hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-----cHHH-------HHHHHHHHHHHHhCCCCCeeeeeeE
Confidence            4457899999999999974     247889999985321     0000       1258899999999999999999998


Q ss_pred             Eecc---cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         187 CNNI---MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       187 ~~~~---~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                      +...   ..++||||+++|+|.+++.+..  ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||
T Consensus        75 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~~l  150 (284)
T cd05079          75 CTEDGGNGIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKI  150 (284)
T ss_pred             EecCCCCceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccchheEEEcCCCCEEE
Confidence            8653   4579999999999999986532  358999999999999999999998  56999999999999999999999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHH-HHhhcC
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL-VVEQEV  341 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~-~~~~~~  341 (593)
                      +|||+++................|+..|+|||.+. ..++.++|||||||++|||+|+..|............ ......
T Consensus       151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd05079         151 GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM  230 (284)
T ss_pred             CCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccc
Confidence            99999886543322111223356778899999764 4578899999999999999998877543211000000 000000


Q ss_pred             cccc---ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         342 PVRE---VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       342 ~~~~---~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ....   .+........+......+..++.+||+.+|++||++.++++.|+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         231 TVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             cHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            0000   000000000001122345567789999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.8e-37  Score=309.02  Aligned_cols=241  Identities=29%  Similarity=0.462  Sum_probs=186.6

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec--cc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~--~~  191 (593)
                      .+.||+|+||.||+|... |..||+|.++...     .          ...|.+|+.++++++|+|+++++|++..  ..
T Consensus        11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-----~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05082          11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----T----------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   74 (256)
T ss_pred             eeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-----h----------HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence            578999999999999875 7889999875321     0          1247899999999999999999997643  45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+++.
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  151 (256)
T cd05082          75 LYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  151 (256)
T ss_pred             eEEEEECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccccchheEEEcCCCcEEecCCcccee
Confidence            689999999999999997643 2458899999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .....      ....++..|+|||++. ..++.++|||||||++|||++ |+.||............. .... ...   
T Consensus       152 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~-~~~---  220 (256)
T cd05082         152 ASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYK-MDA---  220 (256)
T ss_pred             ccccC------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCC-CCC---
Confidence            43321      1234567899999764 457889999999999999998 999997643322211111 1111 000   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                        .    ..+...+..++.+||..+|++|||+.++++.|+.
T Consensus       221 --~----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         221 --P----DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             --C----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence              0    1112334556779999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG1989|consensus

Probab=100.00  E-value=9.5e-38  Score=343.95  Aligned_cols=254  Identities=23%  Similarity=0.318  Sum_probs=191.9

Q ss_pred             CCCCcccccCceEEEEEEEcCC-CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEE-Ee
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKNG-MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGL-CN  188 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~g-~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~-~~  188 (593)
                      ++.+.|.+|||+.||.++...+ ..||+|++-..      +.   .    .+....+||++|++|+ |+|||.+++. ..
T Consensus        40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~------de---~----~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN------DE---E----ALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             EEEEEEccCCcEEEEEEEecCCCceeeeeeeecC------CH---H----HHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            4467899999999999998655 99999998532      10   1    1335689999999997 9999999993 21


Q ss_pred             c-------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCcc
Q psy9535         189 N-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  261 (593)
Q Consensus       189 ~-------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~  261 (593)
                      .       -+.+|+||||.||+|-|+|..+... .|++.++++|++|+++|+.+||.+..||||||||-+||||+.++..
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~  185 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNY  185 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCE
Confidence            1       1346899999999999999865443 4999999999999999999999988889999999999999999999


Q ss_pred             EEeecccceecccCCCcce----ee--ccccCCCCcCCccccc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHH
Q psy9535         262 KLGDFGIVKMSETSNMKTM----YT--ENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTIL  331 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~~~----~~--~~~~GT~~Y~APE~~~----~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~  331 (593)
                      ||||||.|.-.........    ..  -...-|+.|.|||++.    ..+++|+|||++||+||-|+....||++...+.
T Consensus       186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la  265 (738)
T KOG1989|consen  186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA  265 (738)
T ss_pred             EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee
Confidence            9999998753221110000    00  0123589999999652    358999999999999999999999998753221


Q ss_pred             HHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhccc
Q psy9535         332 YYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMF  393 (593)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~  393 (593)
                          ++.+...++..          ......+..+|..||+.+|++||++-+|+..+.+...
T Consensus       266 ----Ilng~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  266 ----ILNGNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ----EEeccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                11111111110          1233456667789999999999999999988766533

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5e-37  Score=316.64  Aligned_cols=242  Identities=27%  Similarity=0.454  Sum_probs=187.7

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +++.||+|.+.....      ..       ...+.+|+.+++.++||||+++++++.. ..
T Consensus        25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~------~~-------~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~   91 (296)
T cd06654          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ------PK-------KELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (296)
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc------ch-------HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence            568999999999999864 688999999864311      11       1147889999999999999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++..    ..+++.++..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~  165 (296)
T cd06654          92 LWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (296)
T ss_pred             EEEeecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEECccccchh
Confidence            7899999999999998864    347899999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......|++.|+|||.+.+ ..+.++|||||||++|||++|+.||.................+  ...   
T Consensus       166 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~---  237 (296)
T cd06654         166 ITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--ELQ---  237 (296)
T ss_pred             cccccc---ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC--CCC---
Confidence            433211   1123468999999997754 4788999999999999999999999775543322222111111  000   


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                          .+......+..++.+||..+|++||++.||++
T Consensus       238 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         238 ----NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ----CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                01122334556778999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.4e-37  Score=308.63  Aligned_cols=249  Identities=24%  Similarity=0.399  Sum_probs=192.4

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEeccc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  191 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~  191 (593)
                      +..++||+|+||.||+|...++..+|+|.+....       ..       ...|.+|++++++++|+||+++++++....
T Consensus         9 ~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-------~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   74 (260)
T cd05073           9 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-------MS-------VEAFLAEANVMKTLQHDKLVKLHAVVTKEP   74 (260)
T ss_pred             eEEeEecCccceEEEEEEecCCccEEEEecCCCh-------hH-------HHHHHHHHHHHHhcCCCCcceEEEEEcCCC
Confidence            4568999999999999998777889999875321       00       125889999999999999999999887777


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+++.
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  151 (260)
T cd05073          75 IYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARV  151 (260)
T ss_pred             eEEEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCCcceee
Confidence            789999999999999997643 3467899999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......  .......++..|+|||.+. ..++.++|||||||++||++| |+.||............... ... ..   
T Consensus       152 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~-~~---  224 (260)
T cd05073         152 IEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRM-PR---  224 (260)
T ss_pred             ccCCCc--ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCC-CC---
Confidence            543221  1112234667899999764 457889999999999999999 99999765433222222111 110 00   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                       ...     ....+..++.+||+.+|++||++.++.+.|+.
T Consensus       225 -~~~-----~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         225 -PEN-----CPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -ccc-----CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             011     11234456679999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.4e-37  Score=315.42  Aligned_cols=258  Identities=26%  Similarity=0.365  Sum_probs=187.1

Q ss_pred             CCCCcccccCceEEEEEEEc-----------------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-----------------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ  174 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-----------------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~  174 (593)
                      +..++||+|+||.||+++..                 ++..||+|.+....     ....       ...|.+|+.++++
T Consensus         8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-----~~~~-------~~~~~~E~~~l~~   75 (296)
T cd05095           8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-----NKNA-------RNDFLKEIKIMSR   75 (296)
T ss_pred             eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-----CHHH-------HHHHHHHHHHHHh
Confidence            34678999999999998542                 23468999885321     0000       1258899999999


Q ss_pred             CCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q psy9535         175 CKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN--------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIH  245 (593)
Q Consensus       175 l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiH  245 (593)
                      ++||||+++++++.. ...++||||+++|+|.+++.....        ...+++.....++.|++.||.|||+  .+|+|
T Consensus        76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H  153 (296)
T cd05095          76 LKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFVH  153 (296)
T ss_pred             CCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCeec
Confidence            999999999998865 567899999999999999976321        1247788899999999999999998  56999


Q ss_pred             cccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh--CCC
Q psy9535         246 RDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT--GMK  322 (593)
Q Consensus       246 rDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt--G~~  322 (593)
                      |||||+|||++.++.+||+|||+++........ .......+++.|+|||.. .+.++.++|||||||++|||++  |..
T Consensus       154 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~  232 (296)
T cd05095         154 RDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ  232 (296)
T ss_pred             ccCChheEEEcCCCCEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCC
Confidence            999999999999999999999998764332211 111223456789999964 5568899999999999999998  778


Q ss_pred             CCCCCchHHHHHHHHh--hcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         323 PIDDNNTILYYYLVVE--QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       323 P~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ||..............  ..... ....+....     +...+..++.+||+.+|++||++.||++.|++
T Consensus       233 p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         233 PYSQLSDEQVIENTGEFFRDQGR-QVYLPKPAL-----CPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             CccccChHHHHHHHHHHHhhccc-cccCCCCCC-----CCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            8865433222111100  00000 000011111     12345567789999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-37  Score=323.21  Aligned_cols=250  Identities=26%  Similarity=0.356  Sum_probs=182.7

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec--
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~--  189 (593)
                      ..+.||+|+||.||+|... ++..||||++.....    .       ......+.+|+.++++++||||+++++++..  
T Consensus        19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07878          19 NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ----S-------LIHARRTYRELRLLKHMKHENVIGLLDVFTPAT   87 (343)
T ss_pred             hheecccCCCeEEEEEEECCCCCEEEEEEeCchhh----h-------hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence            3578999999999999864 688999999854210    0       0011246789999999999999999987643  


Q ss_pred             -----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         190 -----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       190 -----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                           ...++++|++ +++|.+++..    ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+
T Consensus        88 ~~~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          88 SIENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             cccccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCChhhEEECCCCCEEEc
Confidence                 2247888876 7899887753    358999999999999999999998  569999999999999999999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-cC
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EV  341 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-~~  341 (593)
                      |||+++.....      .....||+.|+|||++.+  .++.++|||||||++|||++|+.||............... ..
T Consensus       161 Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  234 (343)
T cd07878         161 DFGLARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT  234 (343)
T ss_pred             CCccceecCCC------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999865332      123578999999998754  4788999999999999999999999765433222222111 01


Q ss_pred             ccccccccc-----------cCCCCHHH-------HHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVLDKE-----------AGEWNETH-------VETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~~~~-----------~~~~~~~~-------~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +..+.....           ....+...       ....+..++.+|+..||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            111110000           00000000       1123456778999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.2e-37  Score=316.47  Aligned_cols=260  Identities=25%  Similarity=0.366  Sum_probs=196.4

Q ss_pred             ecHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHH
Q psy9535          93 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT  171 (593)
Q Consensus        93 ~~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~i  171 (593)
                      ++..++..++++|..      .+.||+|+||.||++... +++.+|+|.+....       ..       ...+.+|+.+
T Consensus        12 ~~~~~~~~~~~~y~~------~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-------~~-------~~~~~~e~~~   71 (291)
T cd06639          12 LGLESLGDPTDTWEI------IETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-------DV-------DEEIEAEYNI   71 (291)
T ss_pred             hhcccCCCCCCCeEE------EEEeecCCCeEEEEEEECCCCCEEEEEEecccc-------cH-------HHHHHHHHHH
Confidence            455677777888865      578999999999999874 68899999985321       00       1146789999


Q ss_pred             HhcC-CCCceeeEEEEEecc------cceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q psy9535         172 LSQC-KHVNLLRLLGLCNNI------MNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPI  243 (593)
Q Consensus       172 l~~l-~HpNIv~l~g~~~~~------~~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~I  243 (593)
                      +.++ +|||++++++++...      ..++||||+++|+|.++++... ....+++..+..++.|++.||.|||+  .+|
T Consensus        72 l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i  149 (291)
T cd06639          72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN--NRI  149 (291)
T ss_pred             HHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCe
Confidence            9998 899999999988542      3689999999999999886422 23468999999999999999999998  569


Q ss_pred             EecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccccC------CCCCcchhhHHHHHHHHH
Q psy9535         244 IHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------QISTKTDVFSYGVILLEL  317 (593)
Q Consensus       244 iHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~~ksDVwSfGvvl~El  317 (593)
                      +||||||+||+++.++.+||+|||+++.......   ......|+..|+|||.+..      .++.++|||||||++|||
T Consensus       150 vH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el  226 (291)
T cd06639         150 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL  226 (291)
T ss_pred             eccCCCHHHEEEcCCCCEEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHH
Confidence            9999999999999999999999999876543221   1123468999999997643      257899999999999999


Q ss_pred             HhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         318 LTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       318 ltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ++|+.||................  .....++       ......+..++.+||+.+|++||++.|+++
T Consensus       227 ~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         227 GDGDPPLFDMHPVKTLFKIPRNP--PPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             hhCCCCCCCCcHHHHHHHHhcCC--CCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            99999997654332222211111  1111111       112223556778999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.4e-37  Score=309.75  Aligned_cols=248  Identities=27%  Similarity=0.400  Sum_probs=190.9

Q ss_pred             CCcccccCceEEEEEEEcC----CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~----g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      .++||+|+||.||+|.+.+    ...||||.......     ..       ....|.+|+.++++++||||+++++++.+
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-----~~-------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   78 (270)
T cd05056          11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-----PS-------VREKFLQEAYIMRQFDHPHIVKLIGVITE   78 (270)
T ss_pred             eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-----HH-------HHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence            5789999999999998643    24689998753210     01       11258899999999999999999999988


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          79 NPVWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccChheEEEecCCCeEEccCcee
Confidence            88899999999999999997532  358999999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      +.......  .......+++.|+|||.+. ..++.++|||||||++|||++ |..||.................. . . 
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~-~-  229 (270)
T cd05056         155 RYLEDESY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-P-M-  229 (270)
T ss_pred             eecccccc--eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-C-C-
Confidence            86543321  1112234567899999764 457889999999999999996 99999775543322222211111 0 0 


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                         ..     .+...+..++.+||..+|++||++.++++.|..
T Consensus       230 ---~~-----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~  264 (270)
T cd05056         230 ---PP-----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD  264 (270)
T ss_pred             ---CC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               01     112235556789999999999999999999876

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.1e-36  Score=308.51  Aligned_cols=249  Identities=29%  Similarity=0.435  Sum_probs=186.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec---
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~---  189 (593)
                      ++.||+|+||.||+|... +|..||+|.+........ .   .+    ....+.+|+.++++++||||+++++++..   
T Consensus         7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~-~---~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (266)
T cd06651           7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPE-T---SK----EVSALECEIQLLKNLQHERIVQYYGCLRDRAE   78 (266)
T ss_pred             cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCch-h---HH----HHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence            689999999999999874 689999999864321110 0   01    12357899999999999999999998754   


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++++||+++++|.+++...   ..+++.....++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~~~~~~~~l~dfg~~  153 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGAS  153 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence            3457899999999999999753   357899999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      +................|+..|+|||.+.+ .++.++|||||||++|||++|+.||................ .     .
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-~-----~  227 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-T-----N  227 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC-C-----C
Confidence            754321111111123468999999997754 47889999999999999999999997654332222111110 0     0


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +.    .+..+...+..++ +||..+|++||+|.||++
T Consensus       228 ~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         228 PQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            11    0122334455566 799999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.5e-37  Score=308.81  Aligned_cols=245  Identities=24%  Similarity=0.321  Sum_probs=189.7

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+++.. ++..+|+|.++....     ...       ...+.+|+.++++++||||+++++++.. ..
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-----~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   72 (255)
T cd08219           5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-----SSA-------VEDSRKEAVLLAKMKHPNIVAFKESFEADGH   72 (255)
T ss_pred             EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-----hHH-------HHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence            578999999999999875 688999999864311     000       1247789999999999999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.... ...+++.....++.|++.||.|||+  .+|+|+||||+|||+++++.++|+|||+++.
T Consensus        73 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~  149 (255)
T cd08219          73 LYIVMEYCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL  149 (255)
T ss_pred             EEEEEeeCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEECCCCcEEEcccCccee
Confidence            689999999999999887533 3458899999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......|++.|+|||++.+ ..+.++||||||+++|+|++|..||...+..............  ..    
T Consensus       150 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~----  220 (255)
T cd08219         150 LTSPGA---YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK--PL----  220 (255)
T ss_pred             eccccc---ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC--CC----
Confidence            543221   1223578999999998754 4788999999999999999999999875543322222211111  00    


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDL  387 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~  387 (593)
                      .     ......+..++.+||+.+|++||++.+|+..
T Consensus       221 ~-----~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 P-----SHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             C-----cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            0     1122235567789999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.9e-37  Score=323.88  Aligned_cols=207  Identities=24%  Similarity=0.307  Sum_probs=166.9

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+++.+ +++.||+|.+.+.....          ......|.+|+.++..++|+||+++++++.+ ..
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (332)
T cd05623           6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK----------RAETACFREERDVLVNGDNQWITTLHYAFQDENN   75 (332)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHH----------hhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE
Confidence            578999999999999876 57889999985421100          0012247889999999999999999998876 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.+..  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~--~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEeecchhee
Confidence            689999999999999997632  358899999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHH
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  336 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~  336 (593)
                      ......  .......||+.|+|||++.      ..++.++|||||||++|||++|+.||........+..+
T Consensus       152 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i  220 (332)
T cd05623         152 LMEDGT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  220 (332)
T ss_pred             cccCCc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            433221  1122357999999999764      34688999999999999999999999876554444443

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8e-37  Score=306.30  Aligned_cols=249  Identities=30%  Similarity=0.479  Sum_probs=192.5

Q ss_pred             CcccccCceEEEEEEEcC----CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         115 NKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~~----g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +.||+|+||.||+|....    +..||+|.+......     .       ....+.+|+..++.++|+||+++++++.. 
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-----~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   68 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE-----E-------ERKDFLKEARVMKKLGHPNVVRLLGVCTEE   68 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccch-----h-------HHHHHHHHHHHHhhcCCCChheeeeeecCC
Confidence            369999999999998753    788999998643111     0       12257899999999999999999998876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNN------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                      ...++||||+++|+|.+++.....      ...+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||
T Consensus        69 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili~~~~~~~l  146 (262)
T cd00192          69 EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKI  146 (262)
T ss_pred             CceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEECCCCcEEE
Confidence            556899999999999999986421      2568999999999999999999998  66999999999999999999999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcC
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  341 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~  341 (593)
                      +|||+++....... ........+++.|+|||.+. ..++.++||||+||++|||++ |..||................ 
T Consensus       147 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-  224 (262)
T cd00192         147 SDFGLSRDVYDDDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY-  224 (262)
T ss_pred             cccccccccccccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-
Confidence            99999987654321 11123356889999999764 467889999999999999999 699998764433333222211 


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                      ..      ..    +..+...+..++.+||..+|++||++.|+++.|+
T Consensus       225 ~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 RL------PK----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CC------CC----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            00      00    0111233455677999999999999999998763

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0594|consensus

Probab=100.00  E-value=1.2e-36  Score=306.22  Aligned_cols=255  Identities=24%  Similarity=0.311  Sum_probs=187.7

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCc-eeeEEEEEecc--
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN-LLRLLGLCNNI--  190 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpN-Iv~l~g~~~~~--  190 (593)
                      ++||+|+||+||+|+.+ +|+.||+|+++......  ..         ...-.+|+.+|++++|+| ||+|++++...  
T Consensus        17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E--G~---------P~taiREisllk~L~~~~~iv~L~dv~~~~~~   85 (323)
T KOG0594|consen   17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE--GV---------PSTAIREISLLKRLSHANHIVRLHDVIHTSNN   85 (323)
T ss_pred             HHhCCCCceEEEEEEEecCCCEEEEEEEecccccc--CC---------CchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence            57999999999999864 78999999997653210  00         012358999999999999 99999988653  


Q ss_pred             -----cceEEEEeccCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         191 -----MNCIVYEYMCNGSLYDRLARVNNT-PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       191 -----~~~lV~Ey~~~GsL~~~L~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                           ..++|+||+. -+|.+++...... ..++......++.|+++||+|||+  ++|+||||||.|||++++|.+||+
T Consensus        86 ~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~--~~IlHRDLKPQNlLi~~~G~lKla  162 (323)
T KOG0594|consen   86 HRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS--HGILHRDLKPQNLLISSSGVLKLA  162 (323)
T ss_pred             ccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCcceEEECCCCcEeee
Confidence                 3468999985 6899998865432 357778889999999999999998  669999999999999999999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-  341 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-  341 (593)
                      |||+|+.......  . .+..++|.+|.|||++-+  .|++..||||+|||+.||++++.-|.+.........+..--+ 
T Consensus       163 DFGlAra~~ip~~--~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt  239 (323)
T KOG0594|consen  163 DFGLARAFSIPMR--T-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT  239 (323)
T ss_pred             ccchHHHhcCCcc--c-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence            9999996543321  1 234578999999997643  488999999999999999999999988766444433322111 


Q ss_pred             c----ccccc-----ccccCCCC-HHHHH-------HHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 P----VREVL-----DKEAGEWN-ETHVE-------TLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~----~~~~~-----~~~~~~~~-~~~~~-------~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      |    .+.+.     +.....+. +..+.       .-...++.+|++++|.+|.|+...++
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~  301 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT  301 (323)
T ss_pred             CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence            1    01110     00001111 11111       12445667999999999999998865

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.4e-37  Score=314.99  Aligned_cols=251  Identities=28%  Similarity=0.488  Sum_probs=187.9

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .+.||+|+||.||+|+..      ++..||+|.+.....      ...      ...|.+|+.++++++||||++++++|
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~------~~~------~~~~~~ei~~l~~l~h~~iv~~~~~~   77 (288)
T cd05050          10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS------ADM------QADFQREAALMAEFDHPNIVKLLGVC   77 (288)
T ss_pred             cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC------HHH------HHHHHHHHHHHHhcCCCchheEEEEE
Confidence            578999999999999863      467899999853210      000      12588999999999999999999988


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVN-------------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  247 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrD  247 (593)
                      .. ...++||||+++|+|.+++....                   ....+++..++.++.|++.||.|||+  ++++|||
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--~~i~H~d  155 (288)
T cd05050          78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRD  155 (288)
T ss_pred             cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCeeccc
Confidence            76 45689999999999999997421                   12357889999999999999999998  5699999


Q ss_pred             cCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCC
Q psy9535         248 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPID  325 (593)
Q Consensus       248 LKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~  325 (593)
                      |||+|||++.++.+||+|||+++......... ......+++.|+|||.+. ..++.++|||||||++|||++ |..||.
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999987543221101 111234567899999764 567889999999999999998 888987


Q ss_pred             CCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         326 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ................  ..    . ..    .....+..++.+||+.+|++||++.|+++.|++
T Consensus       235 ~~~~~~~~~~~~~~~~--~~----~-~~----~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         235 GMAHEEVIYYVRDGNV--LS----C-PD----NCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCCHHHHHHHHhcCCC--CC----C-CC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            5443322222211111  00    0 00    111234456679999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.5e-37  Score=317.25  Aligned_cols=250  Identities=27%  Similarity=0.439  Sum_probs=188.2

Q ss_pred             CCcccccCceEEEEEEEc-CCC----EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~----~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      .+.||+|+||.||+|.+. +|.    .||+|.+....     ..   ..    ...|.+|+.++++++||||++++|+|.
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-----~~---~~----~~~~~~e~~~~~~l~h~niv~~~~~~~   79 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-----GP---KA----NVEFMDEALIMASMDHPHLVRLLGVCL   79 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-----CH---HH----HHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            578999999999999864 444    47888875321     10   00    124789999999999999999999998


Q ss_pred             cccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         189 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       189 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      ....++++||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        80 ~~~~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dikp~Nill~~~~~~kL~Dfg~  155 (303)
T cd05110          80 SPTIQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGL  155 (303)
T ss_pred             CCCceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhh--cCeeccccccceeeecCCCceEEccccc
Confidence            777789999999999999987532  358899999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ++....... ........++..|+|||.+. ..++.++|||||||++|||++ |..||............ .......  
T Consensus       156 ~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~--  231 (303)
T cd05110         156 ARLLEGDEK-EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLP--  231 (303)
T ss_pred             cccccCccc-ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCC--
Confidence            986543221 11122334678899999764 457889999999999999997 99999764332221111 1111110  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                         ......     ..+..++.+||..+|++||++.++++.|...
T Consensus       232 ---~~~~~~-----~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         232 ---QPPICT-----IDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             ---CCCCCC-----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               001111     1234456799999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.7e-37  Score=326.26  Aligned_cols=251  Identities=23%  Similarity=0.295  Sum_probs=184.0

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec--
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~--  189 (593)
                      ..+.||+|+||.||+|... .++.||||++.....    ...  .     ...+.+|+.+++.++||||+++++++..  
T Consensus        28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~--~-----~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~   96 (364)
T cd07875          28 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ----NQT--H-----AKRAYRELVLMKCVNHKNIIGLLNVFTPQK   96 (364)
T ss_pred             EEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc----Cch--h-----HHHHHHHHHHHHhcCCCCccccceeecccc
Confidence            3678999999999999864 688999999864311    000  0     1246789999999999999999997643  


Q ss_pred             -----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         190 -----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       190 -----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                           ...++||||+. ++|.+.+..     .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875          97 SLEEFQDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             cccccCeEEEEEeCCC-CCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEECCCCcEEEE
Confidence                 23589999996 567777643     47888899999999999999998  569999999999999999999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-c
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-P  342 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~  342 (593)
                      |||+++......    ......||+.|+|||++. ..++.++|||||||++|||++|+.||...+....+........ +
T Consensus       169 DfG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  244 (364)
T cd07875         169 DFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP  244 (364)
T ss_pred             eCCCccccCCCC----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999998654322    122357899999999774 4578899999999999999999999987654443333322111 0


Q ss_pred             cccccc-------------cccCCCC----------------HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREVLD-------------KEAGEWN----------------ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~~~-------------~~~~~~~----------------~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .++...             +....+.                .......+..++.+|++.||.+|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000000             0000000                0001123456778999999999999999865

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4e-37  Score=352.13  Aligned_cols=248  Identities=23%  Similarity=0.344  Sum_probs=187.4

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec--
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~--  189 (593)
                      +.++||+|+||.||+|+.. ++..||+|.+.....    ...  .     ...|..|+.+|++++|||||++++++..  
T Consensus        17 Il~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l----~e~--~-----~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266         17 VIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL----KER--E-----KSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             EEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc----CHH--H-----HHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            3578999999999999875 577899999864311    100  1     1257899999999999999999998743  


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCeEecccCCCCeeecC-----
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLS-----KPIIHRDVKSANVLLDE-----  257 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~IiHrDLKp~NILl~~-----  257 (593)
                       ...+|||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+..     ++||||||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence             34689999999999999997532 2346899999999999999999999843     45999999999999964     


Q ss_pred             ------------CCccEEeecccceecccCCCcceeeccccCCCCcCCccccc---CCCCCcchhhHHHHHHHHHHhCCC
Q psy9535         258 ------------NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---CQISTKTDVFSYGVILLELLTGMK  322 (593)
Q Consensus       258 ------------~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~~ksDVwSfGvvl~ElltG~~  322 (593)
                                  ...+||+|||+++.......    .....||+.|+|||++.   ..++.++|||||||+||||+||+.
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~  241 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT  241 (1021)
T ss_pred             ccccccccccCCCCceEEccCCcccccccccc----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence                        23589999999986543221    23457999999999773   247889999999999999999999


Q ss_pred             CCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         323 PIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       323 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ||..................++      ....     ...+..++..||..+|.+||++.|+++
T Consensus       242 PF~~~~~~~qli~~lk~~p~lp------i~~~-----S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        242 PFHKANNFSQLISELKRGPDLP------IKGK-----SKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCcCCcHHHHHHHHhcCCCCC------cCCC-----CHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            9986554333322222211110      0111     123455678999999999999999973

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.2e-37  Score=333.35  Aligned_cols=189  Identities=25%  Similarity=0.318  Sum_probs=156.4

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      .+.+.||+|+||.||+|+.. .++.||||.....                   .+.+|+++|++++|||||++++++.. 
T Consensus       172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~-------------------~~~~E~~iL~~L~HpnIv~l~~~~~~~  232 (461)
T PHA03211        172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA-------------------SSVHEARLLRRLSHPAVLALLDVRVVG  232 (461)
T ss_pred             EEEEEEccCCCeEEEEEEECCCCCEEEEeccccc-------------------CHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence            34578999999999999875 5788999963210                   25689999999999999999998765 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+ .|+|.+++....  ..+++..+..|+.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       233 ~~~~lv~e~~-~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl~~~~~vkL~DFGla  307 (461)
T PHA03211        233 GLTCLVLPKY-RSDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAA  307 (461)
T ss_pred             CEEEEEEEcc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEECCCCCEEEcccCCc
Confidence            5668999998 479998886532  368999999999999999999998  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCC
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPID  325 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~  325 (593)
                      +....... ........||+.|+|||++. ..++.++|||||||+||||++|..|+.
T Consensus       308 ~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        308 CFARGSWS-TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             eecccccc-cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            86543221 11122457999999999774 457889999999999999999887653

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.5e-37  Score=311.53  Aligned_cols=252  Identities=27%  Similarity=0.462  Sum_probs=189.1

Q ss_pred             CCCCcccccCceEEEEEEEc-CC---CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g---~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      ++.+.||+|+||.||+|++. +|   ..||||.+....     . .  .    ....|.+|+.++++++||||+++++++
T Consensus         7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-----~-~--~----~~~~~~~e~~~l~~l~h~ni~~~~~~~   74 (269)
T cd05065           7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-----T-E--K----QRRDFLSEASIMGQFDHPNIIHLEGVV   74 (269)
T ss_pred             EEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-----C-H--H----HHHHHHHHHHHHHhCCCcCcceEEEEE
Confidence            34678999999999999875 33   369999985321     1 1  1    123588999999999999999999988


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      .+ ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+||
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~--~g~~H~dl~p~nili~~~~~~kl~df  150 (269)
T cd05065          75 TKSRPVMIITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDF  150 (269)
T ss_pred             CCCCceEEEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccChheEEEcCCCcEEECCC
Confidence            66 45689999999999999987543  358999999999999999999998  56999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccC--CCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCc
Q psy9535         267 GIVKMSETSNMKTMYTENLTG--TRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP  342 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~G--T~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~  342 (593)
                      |+++................|  +..|+|||.+. ..++.++|||||||++|||++ |..||............. ...+
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~  229 (269)
T cd05065         151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYR  229 (269)
T ss_pred             ccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCc
Confidence            998765432211111111222  45799999764 467889999999999999886 999997654432222221 1111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         343 VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      .+.     ...     +...+..++.+||+.+|++||++.+|+..|++
T Consensus       230 ~~~-----~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         230 LPP-----PMD-----CPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             CCC-----ccc-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            110     011     12234556779999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.6e-37  Score=338.16  Aligned_cols=248  Identities=23%  Similarity=0.306  Sum_probs=176.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC------CCceeeEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK------HVNLLRLLGL  186 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~------HpNIv~l~g~  186 (593)
                      .++||+|+||+||+|... .++.||||+++.....        .      ..+..|++++..++      |+++++++++
T Consensus       134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--------~------~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY--------T------RDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             EEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh--------H------HHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            678999999999999874 5788999998632110        0      12345666665554      4568999988


Q ss_pred             Eec--ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC-----
Q psy9535         187 CNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-----  259 (593)
Q Consensus       187 ~~~--~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~-----  259 (593)
                      +..  ...++|||++ +++|.+++.+.   ..+++..+..|+.||+.||.|||+. .+||||||||+|||++.++     
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCCccccc
Confidence            865  3457888887 78899988753   3589999999999999999999962 2599999999999998765     


Q ss_pred             -----------ccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCC
Q psy9535         260 -----------VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDN  327 (593)
Q Consensus       260 -----------~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~  327 (593)
                                 .+||+|||++......      .....||+.|||||++. ..++.++|||||||++|||++|+.||+..
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~~~------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDERHS------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCccc------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                       4999999987543211      23468999999999764 45889999999999999999999999875


Q ss_pred             chHHHHHHHHhhcCcccc-------------cc----------ccc-------cCCCCHHHHHHHHHHHHHHhhccccCC
Q psy9535         328 NTILYYYLVVEQEVPVRE-------------VL----------DKE-------AGEWNETHVETLIGIVFEKCCVFEKDK  377 (593)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~-------------~~----------~~~-------~~~~~~~~~~~~i~~~~~~C~~~dp~~  377 (593)
                      ........+......++.             ..          ++.       ............+..++.+|++.||++
T Consensus       349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            543322222111111100             00          000       000000001234556788999999999


Q ss_pred             CCChHHHHH
Q psy9535         378 RASMRDIVD  386 (593)
Q Consensus       378 RPsm~eV~~  386 (593)
                      |||+.|+++
T Consensus       429 R~ta~e~L~  437 (467)
T PTZ00284        429 RLNARQMTT  437 (467)
T ss_pred             CCCHHHHhc
Confidence            999999874

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=310.69  Aligned_cols=251  Identities=25%  Similarity=0.419  Sum_probs=191.1

Q ss_pred             CCCcccccCceEEEEEEEc-CCC----EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~----~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      ..+.||+|+||.||+|.++ +|.    .||+|.+.....     ..       ....|.+|+.++++++||||++++++|
T Consensus        11 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-----~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~   78 (279)
T cd05057          11 KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-----PK-------ANKEILDEAYVMASVDHPHVVRLLGIC   78 (279)
T ss_pred             EcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-----HH-------HHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            3578999999999999864 333    589998754311     00       112588999999999999999999999


Q ss_pred             ecccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         188 NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       188 ~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      .....++||||+++|+|.+++....  ..+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~dfg  154 (279)
T cd05057          79 LSSQVQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFG  154 (279)
T ss_pred             ecCceEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECCCc
Confidence            8888899999999999999997643  358999999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      +++....... ........++..|+|||.+. ..++.++|||||||++||+++ |+.||................ ... 
T Consensus       155 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~-  231 (279)
T cd05057         155 LAKLLDVDEK-EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RLP-  231 (279)
T ss_pred             ccccccCccc-ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CCC-
Confidence            9986543221 11111223467899999764 567889999999999999999 999998754332222221111 100 


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                          .....     ...+..++.+||..+|++||++.++++.|.+.
T Consensus       232 ----~~~~~-----~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         232 ----QPPIC-----TIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             ----CCCCC-----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                00011     11244566799999999999999999998874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.6e-37  Score=317.34  Aligned_cols=249  Identities=28%  Similarity=0.452  Sum_probs=185.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCE--EEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGME--IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~--vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~  189 (593)
                      .+.||+|+||.||+|+++ +|..  +|+|.+....     ....       ...|.+|+.++.++ +||||+++++++..
T Consensus        12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-----~~~~-------~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~   79 (303)
T cd05088          12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-----SKDD-------HRDFAGELEVLCKLGHHPNIINLLGACEH   79 (303)
T ss_pred             eeeecCCCCceEEEEEEccCCceeeEEEEEecccC-----CHHH-------HHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence            578999999999999875 4544  5777764321     0010       12578899999999 89999999999876


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  255 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl  255 (593)
                       ...++||||+++|+|.+++.....             ...+++..+..++.|++.||+|||+  .+|+||||||+|||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dlkp~Nili  157 (303)
T cd05088          80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILV  157 (303)
T ss_pred             CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEe
Confidence             567899999999999999975421             2357899999999999999999998  569999999999999


Q ss_pred             cCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHH
Q psy9535         256 DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYY  333 (593)
Q Consensus       256 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~  333 (593)
                      +.++.+||+|||+++......    ......++..|+|||.+.. .++.++|||||||++|||+| |..||.........
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  233 (303)
T cd05088         158 GENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY  233 (303)
T ss_pred             cCCCcEEeCccccCcccchhh----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence            999999999999986432111    0111234678999997644 46889999999999999998 99999764433222


Q ss_pred             HHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         334 YLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .... ..... .    ....     ....+..++.+||+.+|++||++.++++.|...
T Consensus       234 ~~~~-~~~~~-~----~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         234 EKLP-QGYRL-E----KPLN-----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HHHh-cCCcC-C----CCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2111 11000 0    0001     112345567799999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.1e-37  Score=315.01  Aligned_cols=255  Identities=24%  Similarity=0.351  Sum_probs=186.7

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ...++||+|+||.||+|+.+ +++.||+|.+........            ...+.+|+.++++++||||+++++++.. 
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~E~~~l~~l~h~nI~~~~~~~~~~   76 (301)
T cd07873           9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA------------PCTAIREVSLLKDLKHANIVTLHDIIHTE   76 (301)
T ss_pred             EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc------------hhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence            44678999999999999875 688999999864321110            1136789999999999999999998865 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+. ++|.+++....  ..+++.....++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  151 (301)
T cd07873          77 KSLTLVFEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLA  151 (301)
T ss_pred             CeEEEEEeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHHHEEECCCCcEEECcCcch
Confidence            55689999997 69998887543  357889999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-cCcc---
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPV---  343 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-~~~~---  343 (593)
                      +.......   ......+++.|+|||.+.+  .++.++|||||||++|||++|+.||............... ..+.   
T Consensus       152 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  228 (301)
T cd07873         152 RAKSIPTK---TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET  228 (301)
T ss_pred             hccCCCCC---cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence            75432221   1122457899999997643  4678999999999999999999999865433222211111 0000   


Q ss_pred             -ccccccc------cCCCC-------HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 -REVLDKE------AGEWN-------ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 -~~~~~~~------~~~~~-------~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       +...+..      ...+.       ...+...+..++.+|++.||.+|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             0000000      00000       0112334566788999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.3e-37  Score=328.19  Aligned_cols=207  Identities=23%  Similarity=0.315  Sum_probs=166.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+++.. +|+.||||.+........          .....+.+|+.++.+++||||+++++.+.+ ..
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   75 (360)
T cd05627           6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK----------EQVAHIRAERDILVEADGAWVVKMFYSFQDKRN   75 (360)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhh----------hhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            578999999999999875 689999999864311110          012357889999999999999999998876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.+.   ..+++.....++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~--~givHrDLkp~NIli~~~~~vkL~DfG~~~~  150 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQ--LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG  150 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence            68999999999999999753   358899999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCc--------------------------------ceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHH
Q psy9535         272 SETSNMK--------------------------------TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELL  318 (593)
Q Consensus       272 ~~~~~~~--------------------------------~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ell  318 (593)
                      .......                                .......+||+.|+|||++. ..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence            4221100                                00012357999999999764 45788999999999999999


Q ss_pred             hCCCCCCCCchHHHHHH
Q psy9535         319 TGMKPIDDNNTILYYYL  335 (593)
Q Consensus       319 tG~~P~~~~~~~~~~~~  335 (593)
                      +|+.||........+..
T Consensus       231 tG~~Pf~~~~~~~~~~~  247 (360)
T cd05627         231 IGYPPFCSETPQETYRK  247 (360)
T ss_pred             cCCCCCCCCCHHHHHHH
Confidence            99999987655444333

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6e-37  Score=317.87  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=186.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+++.. +|..+|+|.+....     . ..      ....+.+|++++++++||||+++++++.. ..
T Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-----~-~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   73 (308)
T cd06615           6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-----K-PA------IRNQIIRELKVLHECNSPYIVGFYGAFYSDGE   73 (308)
T ss_pred             EeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-----C-HH------HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE
Confidence            578999999999999875 67889999875321     1 00      01247889999999999999999998865 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++.....++.|+++||.|||+. .+++||||||+|||++.++.+||+|||+++.
T Consensus        74 ~~lv~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  149 (308)
T cd06615          74 ISICMEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  149 (308)
T ss_pred             EEEEeeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh-CCEEECCCChHHEEEecCCcEEEccCCCccc
Confidence            78999999999999999753   4588999999999999999999972 3599999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccc-----
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE-----  345 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~-----  345 (593)
                      .....     .....|++.|+|||.+.+ .++.++|||||||++|||++|+.||.....................     
T Consensus       150 ~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (308)
T cd06615         150 LIDSM-----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR  224 (308)
T ss_pred             ccccc-----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence            43221     223578999999997744 5788999999999999999999999654322111111000000000     


Q ss_pred             ---------------------ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 ---------------------VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ---------------------~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                           .........+.......+..++.+||..+|++||++.+|++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  286 (308)
T cd06615         225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK  286 (308)
T ss_pred             cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                                 00000000000112233556778999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2e-36  Score=306.07  Aligned_cols=254  Identities=28%  Similarity=0.433  Sum_probs=190.3

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      .+..||+|+||.||+|... +++.||+|.+..........    .........|.+|+.++++++||||+++++++.+ .
T Consensus         4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (267)
T cd06628           4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSK----DRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD   79 (267)
T ss_pred             ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchh----HHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence            4678999999999999864 68899999886542211110    1111112358899999999999999999998865 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+|||+++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~--~~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHh--cCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            668999999999999999753   358889999999999999999998  569999999999999999999999999988


Q ss_pred             ecccCCCcc---eeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         271 MSETSNMKT---MYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       271 ~~~~~~~~~---~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      .........   .......|++.|+|||.+. ..++.++|||||||++|||++|+.||................  ... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~-  231 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA--SPE-  231 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC--CCc-
Confidence            654221100   0112346899999999764 457889999999999999999999998754433222211110  000 


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                          ..    ......+..++.+||+.+|++||++.||++
T Consensus       232 ----~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         232 ----IP----SNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ----CC----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                00    112233555678999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.6e-37  Score=323.04  Aligned_cols=207  Identities=25%  Similarity=0.309  Sum_probs=167.2

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.++||+|+||.||+++.. +++.||||.+.+.....          ......|.+|+.++..++|+||+++++++.+ .
T Consensus         5 i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~   74 (331)
T cd05624           5 IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLK----------RAETACFREERNVLVNGDCQWITTLHYAFQDEN   74 (331)
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHh----------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            3578999999999999875 67889999986421100          0012247889999999999999999998876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++.+..  ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG~a~  150 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLLDMNGHIRLADFGSCL  150 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCchHHEEEcCCCCEEEEecccee
Confidence            5689999999999999997632  358888999999999999999998  569999999999999999999999999997


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHH
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  335 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~  335 (593)
                      .......  .......||+.|+|||++.      +.++.++|||||||+||||++|+.||...+....+..
T Consensus       151 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~  219 (331)
T cd05624         151 KMNQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  219 (331)
T ss_pred             eccCCCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHH
Confidence            6543321  1122357999999999774      3467899999999999999999999987654443333

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.8e-36  Score=304.37  Aligned_cols=245  Identities=26%  Similarity=0.442  Sum_probs=188.1

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      .+.||+|+||.||+|.+.++..+|+|.+.....    .    .      ..|.+|++++++++||||+++++++.. ...
T Consensus         9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~----~----~------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05112           9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM----S----E------EDFIEEAQVMMKLSHPKLVQLYGVCTERSPI   74 (256)
T ss_pred             EeeecCcccceEEEEEEeCCCeEEEEECCCCCC----C----H------HHHHHHHHHHHhCCCCCeeeEEEEEccCCce
Confidence            468999999999999887788999998753211    0    1      147899999999999999999998865 556


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+++..
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  150 (256)
T cd05112          75 CLVFEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLES--SNVIHRDLAARNCLVGENQVVKVSDFGMTRFV  150 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccccceEEEcCCCeEEECCCcceeec
Confidence            89999999999999987533  357899999999999999999998  55999999999999999999999999998765


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......  ......++..|+|||.+. +.++.++|||||||++|||++ |+.||..................    ..+ 
T Consensus       151 ~~~~~~--~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~-  223 (256)
T cd05112         151 LDDQYT--SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL----YKP-  223 (256)
T ss_pred             ccCccc--ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC----CCC-
Confidence            332111  111234567899999764 567889999999999999998 99999765433222221111110    001 


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                        ...    ...+..++.+||+.+|++||++.||++.|.
T Consensus       224 --~~~----~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         224 --RLA----SQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             --CCC----CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence              111    123555678999999999999999998873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.9e-37  Score=311.41  Aligned_cols=244  Identities=25%  Similarity=0.412  Sum_probs=185.9

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. ++..+|+|.+....      ..       ....|.+|+++++.++||||+++++++.. ..
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~------~~-------~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~   76 (282)
T cd06643          10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS------EE-------ELEDYMVEIDILASCDHPNIVKLLDAFYYENN   76 (282)
T ss_pred             HhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC------HH-------HHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE
Confidence            467999999999999876 57788999885321      00       12257889999999999999999998765 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++....  .++++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  152 (282)
T cd06643          77 LWILIEFCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGVSAK  152 (282)
T ss_pred             EEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEccCCCEEEcccccccc
Confidence            689999999999998886532  468999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      ......   ......||+.|+|||++.      ..++.++|||||||++|||++|+.||.................+  .
T Consensus       153 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~  227 (282)
T cd06643         153 NTRTIQ---RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP--T  227 (282)
T ss_pred             cccccc---ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC--C
Confidence            432211   122356899999999763      23567999999999999999999999865443322222211111  1


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...+  .     .....+..++.+||+.+|++||++.++++
T Consensus       228 ~~~~--~-----~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         228 LAQP--S-----RWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             CCCc--c-----ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1000  1     11233556778999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0579|consensus

Probab=100.00  E-value=1.4e-38  Score=334.40  Aligned_cols=244  Identities=25%  Similarity=0.440  Sum_probs=192.6

Q ss_pred             CCcccccCceEEEEEEEcC-CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEE-EEeccc
Q psy9535         114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG-LCNNIM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~-g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g-~~~~~~  191 (593)
                      .-.||.|+||+||+|..++ +-..|.|.|....      ..       .+..|.-||+||+.|.||+||+|++ |+.+..
T Consensus        37 iGELGDGAFGKVyKA~nket~~lAAaKvIetks------eE-------ELEDylVEIeILa~CdHP~ivkLl~ayy~enk  103 (1187)
T KOG0579|consen   37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKS------EE-------ELEDYLVEIEILAECDHPVIVKLLSAYYFENK  103 (1187)
T ss_pred             HhhhcCccchhhhhhhcccchhhhhhhhhcccc------hh-------HHhhhhhhhhhhhcCCChHHHHHHHHHhccCc
Confidence            3468999999999998764 4456778775321      01       1235888999999999999999998 455677


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .+|+.|||.||-+...+-..+  .+|.+.++.-+++|++.||.|||+  +.|||||||..|||++-+|.++|+|||.+..
T Consensus       104 LwiliEFC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs--~~iIHRDLKAGNiL~TldGdirLADFGVSAK  179 (1187)
T KOG0579|consen  104 LWILIEFCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHS--QNIIHRDLKAGNILLTLDGDIRLADFGVSAK  179 (1187)
T ss_pred             eEEEEeecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhh--cchhhhhccccceEEEecCcEeeeccccccc
Confidence            899999999999988877654  479999999999999999999998  5699999999999999999999999998654


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC------CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      ....   .....++.|||+|||||++.+      .|+.++||||||++|.||.-+.+|..+.+.......+...++|.  
T Consensus       180 n~~t---~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPT--  254 (1187)
T KOG0579|consen  180 NKST---RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT--  254 (1187)
T ss_pred             chhH---HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCc--
Confidence            3221   112346899999999997643      47889999999999999999999998877665555544444332  


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ++.       +.....-+.+++.+|+..+|+.||++.++++
T Consensus       255 Llq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  255 LLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            221       2233445667788999999999999999864

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.8e-37  Score=307.17  Aligned_cols=242  Identities=29%  Similarity=0.468  Sum_probs=189.2

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      +.+.||+|+||.||+|.. +++.||+|.+....        .       ...|.+|+.++++++||||+++++++.....
T Consensus        10 ~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--------~-------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (254)
T cd05083          10 LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--------T-------AQAFLEETAVMTKLHHKNLVRLLGVILHNGL   73 (254)
T ss_pred             eeeeeccCCCCceEeccc-CCCceEEEeecCcc--------h-------HHHHHHHHHHHHhCCCCCcCeEEEEEcCCCc
Confidence            367899999999999975 57889999875321        0       1147899999999999999999999887778


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+|||+++..
T Consensus        74 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~  150 (254)
T cd05083          74 YIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVG  150 (254)
T ss_pred             EEEEECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCccceec
Confidence            99999999999999997643 2458899999999999999999998  56999999999999999999999999998764


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ....      ....++..|+|||.+. +.++.++|||||||++|||++ |+.||............. .....    +. 
T Consensus       151 ~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~----~~-  218 (254)
T cd05083         151 SMGV------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRM----EP-  218 (254)
T ss_pred             cccC------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCC----CC-
Confidence            3221      1223467899999764 567889999999999999998 999997654332222211 11110    00 


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ..     .....+..++.+||+.+|++||++.+|++.|++
T Consensus       219 ~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 PE-----GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CC-----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            01     112234556789999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.2e-37  Score=309.80  Aligned_cols=249  Identities=33%  Similarity=0.476  Sum_probs=186.9

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      .++.||+|+||.||+++.. +++.||+|.+.....      .. ..    .....+|+.++++++||||+++++++.. .
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~------~~-~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   71 (260)
T PF00069_consen    3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI------EE-EE----REENIREIKILRRLRHPNIVQILDVFQDDN   71 (260)
T ss_dssp             EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH------HH-HH----HHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred             EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc------cc-cc----cchhhhhhhccccccccccccccccccccc
Confidence            4578999999999999986 467899999975311      10 00    1123459999999999999999998865 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+.+++|.+++...   ..+++..+..++.|+++||.|||+  .+|+||||||+|||+++++.++|+|||++.
T Consensus        72 ~~~~v~~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~--~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~  146 (260)
T PF00069_consen   72 YLYIVMEYCPGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHS--KGIVHRDIKPENILLDENGEVKLIDFGSSV  146 (260)
T ss_dssp             EEEEEEEEETTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHH--TTEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred             ccccccccccccccccccccc---cccccccccccccccccccccccc--cccccccccccccccccccccccccccccc
Confidence            668999999999999999832   458999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-Ccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-VPVREVL  347 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~-~~~~~~~  347 (593)
                      ......   .......||+.|+|||++.  ...+.++||||+|+++|+|++|..||................ .......
T Consensus       147 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  223 (260)
T PF00069_consen  147 KLSENN---ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS  223 (260)
T ss_dssp             ESTSTT---SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT
T ss_pred             cccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc
Confidence            541111   1223467899999999875  567889999999999999999999998762111111111110 0000000


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                            .........+..++.+||+.+|++||++.++++
T Consensus       224 ------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 ------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ------cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  000000134556778999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.9e-36  Score=311.36  Aligned_cols=246  Identities=27%  Similarity=0.406  Sum_probs=188.3

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         109 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       109 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      ..+...+.||+|+||.||+|+.. +|+.||+|.+......   . .  +    ....+.+|+.+++.++||||++++++|
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~-~--~----~~~~~~~Ei~~l~~l~h~niv~~~~~~   84 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ---S-N--E----KWQDIIKEVRFLQQLRHPNTIEYKGCY   84 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC---c-H--H----HHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            33445688999999999999875 6899999998543111   1 0  1    012478899999999999999999998


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      .+ ...++||||+. |+|.+.+....  ..+++..+..++.|++.||.|||+  .+|+||||+|+||+++.++.+||+||
T Consensus        85 ~~~~~~~lv~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~~~~~~~kL~df  159 (307)
T cd06607          85 LREHTAWLVMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADF  159 (307)
T ss_pred             EeCCeEEEEHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEECCCCCEEEeec
Confidence            76 55689999986 67877775432  358999999999999999999998  56999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCccccc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  342 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~----~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~  342 (593)
                      |+++.....       ....|++.|+|||++.    ..++.++|||||||++|||+||+.||.................+
T Consensus       160 g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  232 (307)
T cd06607         160 GSASLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP  232 (307)
T ss_pred             CcceecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC
Confidence            998764322       1346889999999762    35788999999999999999999999775543332222211111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                ..........+..++.+||..+|++||++.+|+.
T Consensus       233 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         233 ----------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             ----------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                      0111112334566778999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG2345|consensus

Probab=100.00  E-value=7.7e-38  Score=298.79  Aligned_cols=258  Identities=24%  Similarity=0.326  Sum_probs=193.3

Q ss_pred             CCCCCcccccCceEEEEEE-EcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         111 PRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       111 ~~~~~~LG~G~fG~Vy~g~-~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      +++.+.||+|||+.||.++ ..++..+|+|++.-..     . ++       +..-++|++.-++++||||+++++++..
T Consensus        23 yri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-----~-~~-------~e~~~rEid~~rkf~s~~vl~l~dh~l~   89 (302)
T KOG2345|consen   23 YRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-----Q-ED-------IEEALREIDNHRKFNSPNVLRLVDHQLR   89 (302)
T ss_pred             EEEeeeecCCCceeeeeecccCcccchhhheeeccc-----h-HH-------HHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence            3556889999999999997 4578899999986431     1 11       1135789999999999999999987632


Q ss_pred             ------ccceEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccE
Q psy9535         190 ------IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  262 (593)
Q Consensus       190 ------~~~~lV~Ey~~~GsL~~~L~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~K  262 (593)
                            ...||++.|...|||.+.+..... +.-+++.+.+.|+.++++||++||+...++.||||||.|||+.+.+.++
T Consensus        90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v  169 (302)
T KOG2345|consen   90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV  169 (302)
T ss_pred             hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence                  235899999999999999876443 3468999999999999999999999777899999999999999999999


Q ss_pred             EeecccceecccCCCcce------eeccccCCCCcCCcccccC----CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHH
Q psy9535         263 LGDFGIVKMSETSNMKTM------YTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILY  332 (593)
Q Consensus       263 l~DFGla~~~~~~~~~~~------~~~~~~GT~~Y~APE~~~~----~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~  332 (593)
                      |.|||.+......-....      .-..-..|..|.|||.+..    .++.++|||||||+||+|+.|..||+...    
T Consensus       170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~----  245 (302)
T KOG2345|consen  170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY----  245 (302)
T ss_pred             EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh----
Confidence            999999875432110000      0011246899999998754    46889999999999999999999997411    


Q ss_pred             HHHHHhhcCcc-ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         333 YYLVVEQEVPV-REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       333 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                           .....+ ..+......-+......+.+..+++.|++.||.+||+..+++..++.
T Consensus       246 -----~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  246 -----QQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             -----hcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                 111111 12222221111111133445557789999999999999999988865

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.4e-36  Score=307.43  Aligned_cols=245  Identities=24%  Similarity=0.389  Sum_probs=185.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +++.||+|.++....      .  .     ...+.+|+.+++.++||||+++++++.. ..
T Consensus        14 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~--~-----~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~   80 (267)
T cd06645          14 IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG------E--D-----FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDK   80 (267)
T ss_pred             HHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch------h--H-----HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Confidence            467999999999999864 688999999864310      0  0     1247789999999999999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++.+...++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++..
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd06645          81 LWICMEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHS--KGKMHRDIKGANILLTDNGHVKLADFGVSAQ  155 (267)
T ss_pred             EEEEEeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECcceeeeE
Confidence            68999999999999998753   358899999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCcccc----cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~----~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ......   ......||+.|+|||.+    ...++.++|||||||++|||++|..||.......................
T Consensus       156 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd06645         156 ITATIA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK  232 (267)
T ss_pred             ccCccc---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc
Confidence            532211   12235799999999976    23478899999999999999999999865443222111111111111110


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +  ...+     ...+..++.+|++.+|++||++.+|++
T Consensus       233 ~--~~~~-----~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         233 D--KMKW-----SNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             c--cCCC-----CHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0  0111     123455778999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7e-37  Score=348.84  Aligned_cols=259  Identities=21%  Similarity=0.274  Sum_probs=188.9

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.++||+|+||.||+|+.. +|+.||||++......   . .  .    ....|.+|++++++++||||+++++++.+ 
T Consensus         5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~---~-e--~----~~~rflrEi~ILs~L~HPNIVkl~~v~~d~   74 (932)
T PRK13184          5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSE---N-P--L----LKKRFLREAKIAADLIHPGIVPVYSICSDG   74 (932)
T ss_pred             EEEEEEecCCCEEEEEEEECCCCcEEEEEEECccccc---C-H--H----HHHHHHHHHHHHHhCCCcCcCeEEEEEeeC
Confidence            34689999999999999875 5899999998643111   0 0  0    12258899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCcc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNN--------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  261 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~  261 (593)
                      +..++||||+++|+|.+++.....        ...+++..++.++.|+++||+|||+  ++|+||||||+|||++.++.+
T Consensus        75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs--~GIIHRDLKPeNILLd~dg~v  152 (932)
T PRK13184         75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEV  152 (932)
T ss_pred             CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH--CCccccCCchheEEEcCCCCE
Confidence            566899999999999999864211        1345677889999999999999998  569999999999999999999


Q ss_pred             EEeecccceecccCCCc---------------ceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCC
Q psy9535         262 KLGDFGIVKMSETSNMK---------------TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPID  325 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~---------------~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~  325 (593)
                      ||+|||+++........               ........||+.|||||.+. ..++.++|||||||++|||+||+.||.
T Consensus       153 KLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~  232 (932)
T PRK13184        153 VILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR  232 (932)
T ss_pred             EEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence            99999999865211000               00112357999999999764 457889999999999999999999997


Q ss_pred             CCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCC-hHHHHHHHhhc
Q psy9535         326 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS-MRDIVDLLSKS  391 (593)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs-m~eV~~~L~~~  391 (593)
                      .............  ...... .+      ...+...+..++.+|+..||++||+ +.++.+.|+..
T Consensus       233 ~~~~~ki~~~~~i--~~P~~~-~p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        233 RKKGRKISYRDVI--LSPIEV-AP------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             Ccchhhhhhhhhc--cChhhc-cc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            6432211111000  000000 00      0112233455677999999999964 66677766553

>KOG0574|consensus

Probab=100.00  E-value=5.9e-39  Score=312.80  Aligned_cols=241  Identities=25%  Similarity=0.431  Sum_probs=192.7

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE-Eecccc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL-CNNIMN  192 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~-~~~~~~  192 (593)
                      .+||+|+||.||++.++ +|+.||||++...       .+        +++..+|+.+|.+|+.|++|+.||. +.+...
T Consensus        39 ~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-------sD--------LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL  103 (502)
T KOG0574|consen   39 GKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-------TD--------LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL  103 (502)
T ss_pred             HHhcCCcchHHHHHHHhccCcEEEEEecCcc-------ch--------HHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence            58999999999999765 6999999997532       11        2346789999999999999999995 556788


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      |||||||..||+.|.++.++  .+|.+.+...++...+.||+|||...  =||||||..||||+.+|.+||+|||.|...
T Consensus       104 WIVMEYCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQL  179 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQL  179 (502)
T ss_pred             EeehhhcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchh
Confidence            99999999999999997644  57999999999999999999999854  699999999999999999999999998765


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  351 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (593)
                      .+.-.   ...++.|||.|||||++. -.|+.++||||+|++..||..|++||.+-......+.+-.  .|.+       
T Consensus       180 TDTMA---KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT--~PPP-------  247 (502)
T KOG0574|consen  180 TDTMA---KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT--KPPP-------  247 (502)
T ss_pred             hhhHH---hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC--CCCC-------
Confidence            44321   123578999999999885 4689999999999999999999999987543322211111  1111       


Q ss_pred             CCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         352 GEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       352 ~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .-..++.....+...+..|+...|++|.|+.++++
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            11123445555667788999999999999988765

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-36  Score=304.05  Aligned_cols=248  Identities=28%  Similarity=0.422  Sum_probs=192.1

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      +.++||+|+||.||+|...+++.||||.+.....    .          ...|.+|+.++++++||||+++++++.. ..
T Consensus        10 i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05034          10 LERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----S----------PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP   75 (261)
T ss_pred             eeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----C----------HHHHHHHHHHHhhCCCCCEeeeeeeeecCCc
Confidence            3678999999999999988788899999864311    0          1247899999999999999999998876 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++.
T Consensus        76 ~~~v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~  152 (261)
T cd05034          76 IYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLARL  152 (261)
T ss_pred             eEEEEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcchheEEEcCCCCEEECcccccee
Confidence            789999999999999997633 2468999999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......  .......++..|+|||.+. ..++.++|||||||++|||++ |+.||................ ..  ..  
T Consensus       153 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~--~~--  225 (261)
T cd05034         153 IEDDEY--TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-RM--PR--  225 (261)
T ss_pred             ccchhh--hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC--CC--
Confidence            543211  1111234567899999764 457889999999999999999 999997654333222222111 00  00  


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                       ....     ...+..++.+|+..+|++||++.++.+.|+.
T Consensus       226 -~~~~-----~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         226 -PPNC-----PEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -CCCC-----CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             0011     1234556789999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-36  Score=316.44  Aligned_cols=253  Identities=27%  Similarity=0.433  Sum_probs=188.4

Q ss_pred             CCCcccccCceEEEEEEEc--------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  183 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~--------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l  183 (593)
                      .+++||+|+||.||+|+..        .+..||+|.++...     ...  .     ...|.+|+.+++++ +||||+++
T Consensus        16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-----~~~--~-----~~~~~~E~~~l~~l~~h~~iv~~   83 (314)
T cd05099          16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-----TDK--D-----LADLISEMELMKLIGKHKNIINL   83 (314)
T ss_pred             eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-----ChH--H-----HHHHHHHHHHHHhccCCCCeeeE
Confidence            3689999999999999742        24569999875321     100  0     12478899999999 69999999


Q ss_pred             EEEEec-ccceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccC
Q psy9535         184 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  249 (593)
Q Consensus       184 ~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLK  249 (593)
                      +++|.. ...++||||+++|+|.+++.....             ...+++.....++.|++.||.|||+  ++|+|||||
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlk  161 (314)
T cd05099          84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLA  161 (314)
T ss_pred             EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeecccc
Confidence            998876 456899999999999999975321             2358899999999999999999998  669999999


Q ss_pred             CCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCC
Q psy9535         250 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDN  327 (593)
Q Consensus       250 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~  327 (593)
                      |+|||++.++.+||+|||+++......... ......+++.|||||.+. ..++.++|||||||++|||++ |..||...
T Consensus       162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         162 ARNVLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             ceeEEEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998654321111 111223556899999764 457889999999999999999 89999765


Q ss_pred             chHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         328 NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ............. . ...    ..     .+...+..++.+||..+|++||++.|+++.|.+.
T Consensus       241 ~~~~~~~~~~~~~-~-~~~----~~-----~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         241 PVEELFKLLREGH-R-MDK----PS-----NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             CHHHHHHHHHcCC-C-CCC----CC-----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            4333322222111 0 000    00     1112234566799999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.8e-36  Score=305.06  Aligned_cols=250  Identities=28%  Similarity=0.400  Sum_probs=185.8

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec--
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~--  189 (593)
                      .++.||+|+||.||+|+.. +|..||||.+........ . .  .    ....+.+|+.++++++||||+++++++.+  
T Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~-~-~--~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   77 (265)
T cd06652           6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPE-T-S--K----EVNALECEIQLLKNLLHERIVQYYGCLRDPM   77 (265)
T ss_pred             EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcc-c-H--H----HHHHHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence            3689999999999999875 589999998854321110 0 0  0    12357889999999999999999998765  


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...++||||+++|+|.+++...   ..+++.....++.|++.||.|||+  .+|+|+||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~Dfg~  152 (265)
T cd06652          78 ERTLSIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGA  152 (265)
T ss_pred             CceEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEecCCCCEEECcCcc
Confidence             2357899999999999998753   347888899999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ++................||..|+|||.+. ..++.++|||||||++|||++|+.||...............  +..   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~---  227 (265)
T cd06652         153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--PTN---  227 (265)
T ss_pred             ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC--CCC---
Confidence            875432211111122346899999999764 45788999999999999999999999765433322221111  100   


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       +   . .+......+..++.+|| .+|++||++.||++
T Consensus       228 -~---~-~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~  260 (265)
T cd06652         228 -P---V-LPPHVSDHCRDFLKRIF-VEAKLRPSADELLR  260 (265)
T ss_pred             -C---C-CchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence             0   0 11223334455667888 49999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.2e-36  Score=309.37  Aligned_cols=249  Identities=26%  Similarity=0.367  Sum_probs=187.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         109 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       109 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      ..++..++||+|+||.||+|+.. ++..||+|.+...      ....       ...|.+|+.++++++||||+++++++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~------~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~   78 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK------SEEE-------LEDYMVEIEILATCNHPYIVKLLGAF   78 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC------CHHH-------HHHHHHHHHHHHhCCCCcEeeeEEEE
Confidence            34455678999999999999875 5889999998532      1011       22578899999999999999999987


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      .. ...++||||+++|+|..++....  ..+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+||
T Consensus        79 ~~~~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~df  154 (292)
T cd06644          79 YWDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADF  154 (292)
T ss_pred             EeCCeEEEEEecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhc--CCeeecCCCcceEEEcCCCCEEEccC
Confidence            54 56789999999999988876533  358999999999999999999998  56999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCccccc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  340 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~  340 (593)
                      |++........   ......|++.|+|||.+.      ..++.++|||||||++|||++|..||................
T Consensus       155 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  231 (292)
T cd06644         155 GVSAKNVKTLQ---RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE  231 (292)
T ss_pred             ccceecccccc---ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC
Confidence            99875432211   112346899999999763      235778999999999999999999997654332222221111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         341 VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .+  ....  ..     .....+..++.+||..+|++||++.+|++
T Consensus       232 ~~--~~~~--~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         232 PP--TLSQ--PS-----KWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             Cc--cCCC--Cc-----ccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11  1000  01     11122445678999999999999999864

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-36  Score=318.88  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=190.5

Q ss_pred             CCCCcccccCceEEEEEEEc--------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceee
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLR  182 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~--------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~  182 (593)
                      .+++.||+|+||.||+++..        .+..||+|.+....     . .  .    ....|.+|+++++++ +||||++
T Consensus        15 ~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~-~--~----~~~~~~~E~~~l~~l~~h~~iv~   82 (334)
T cd05100          15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-----T-D--K----DLSDLVSEMEMMKMIGKHKNIIN   82 (334)
T ss_pred             eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-----C-H--H----HHHHHHHHHHHHHhhcCCCCeee
Confidence            34689999999999999752        12368999875321     0 0  0    022578999999999 7999999


Q ss_pred             EEEEEec-ccceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeccc
Q psy9535         183 LLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  248 (593)
Q Consensus       183 l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDL  248 (593)
                      ++++|.. ...++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+  ++|+||||
T Consensus        83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~givH~dl  160 (334)
T cd05100          83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRDL  160 (334)
T ss_pred             eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCeecccc
Confidence            9999876 456899999999999999975321             2357889999999999999999998  56999999


Q ss_pred             CCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCC
Q psy9535         249 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDD  326 (593)
Q Consensus       249 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~  326 (593)
                      ||+|||++.++.+||+|||+++........ .......++..|+|||++. ..++.++|||||||++|||++ |..||..
T Consensus       161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  239 (334)
T cd05100         161 AARNVLVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG  239 (334)
T ss_pred             ccceEEEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence            999999999999999999998865432211 1112234567899999764 457889999999999999998 8899976


Q ss_pred             CchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhccc
Q psy9535         327 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMF  393 (593)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~  393 (593)
                      ................  ..    ...     ....+..++.+||+.+|++||++.|+++.|.+...
T Consensus       240 ~~~~~~~~~~~~~~~~--~~----~~~-----~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         240 IPVEELFKLLKEGHRM--DK----PAN-----CTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             CCHHHHHHHHHcCCCC--CC----CCC-----CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            5443332222211110  00    011     11234456679999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.1e-37  Score=311.57  Aligned_cols=238  Identities=26%  Similarity=0.329  Sum_probs=179.8

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|+. .+++.||+|.+....     ....       ...|.+|+.++++++||||+++++++.. ..
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-----~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   73 (279)
T cd06619           6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-----TVEL-------QKQIMSELEILYKCDSPYIIGFYGAFFVENR   73 (279)
T ss_pred             eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-----ChHH-------HHHHHHHHHHHHhCCCCCeeeEEEEEEECCE
Confidence            56899999999999986 468899999986431     1010       1258899999999999999999998865 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|..+.       .+++.....++.|++.||.|||+  .+|+|+||||+|||++.++.+||+|||++..
T Consensus        74 ~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~  144 (279)
T cd06619          74 ISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQ  144 (279)
T ss_pred             EEEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence            68999999999996542       36788888999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchH------HHHHHHHhhcCccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTI------LYYYLVVEQEVPVR  344 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~------~~~~~~~~~~~~~~  344 (593)
                      .....     .....||..|+|||.+. ..++.++|||||||++|||++|+.||......      ...........+  
T Consensus       145 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  217 (279)
T cd06619         145 LVNSI-----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--  217 (279)
T ss_pred             ccccc-----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--
Confidence            53321     22357999999999774 45788999999999999999999999642110      000000000000  


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                             ...........+..++.+||+.+|++||++.|+++
T Consensus       218 -------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         218 -------PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             -------CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                   00000111123455667999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-36  Score=305.83  Aligned_cols=259  Identities=26%  Similarity=0.441  Sum_probs=190.3

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      .++.||+|+||.||+|... +|+.||+|.++..........   .........|.+|+.++++++||||+++++++.. .
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHD---SRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccc---hHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4678999999999999864 689999998854321111100   0000112357889999999999999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh--CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            568999999999999999764   468899999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC---CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ....... ........|+..|+|||.+..   .++.++||||||+++|||++|..||................  ....+
T Consensus       157 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~  233 (272)
T cd06629         157 KSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR--SAPPI  233 (272)
T ss_pred             ccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc--cCCcC
Confidence            6432211 111223568999999997643   26889999999999999999999997654433222211111  00011


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ....    ...+...+..++.+||..+|++||++.+|++
T Consensus       234 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         234 PPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             Cccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1110    0112234555677999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.3e-36  Score=301.62  Aligned_cols=246  Identities=27%  Similarity=0.385  Sum_probs=188.8

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec--
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~--  189 (593)
                      ..+.||+|+||.||++... +++.||+|.+......    ..  .     ...+.+|++++++++|||++++++.+..  
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~--~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (257)
T cd08223           4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS----RR--E-----RKAAEQEAQLLSQLKHPNIVAYRESWEGED   72 (257)
T ss_pred             EEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC----HH--H-----HHHHHHHHHHHHhCCCCCeeeeeeeecCCC
Confidence            3578999999999999865 5788999998643111    00  0     1247889999999999999999987753  


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++.... ...+++.++..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++
T Consensus        73 ~~~~lv~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~--~~i~H~di~p~nil~~~~~~~~l~df~~~  149 (257)
T cd08223          73 GLLYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIA  149 (257)
T ss_pred             CEEEEEecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCchhEEEecCCcEEEecccce
Confidence            34579999999999999997632 3468999999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      +.......   ......|++.|+|||.+. ..++.++|||||||++|||++|+.||.................  ...  
T Consensus       150 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--~~~--  222 (257)
T cd08223         150 RVLENQCD---MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--PPM--  222 (257)
T ss_pred             EEecccCC---ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CCC--
Confidence            86543221   122356899999999764 4578899999999999999999999976543222222221111  110  


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                             +......+..++.+||+.+|++||++.++++
T Consensus       223 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         223 -------PKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             -------ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                   0112234556778999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-36  Score=300.05  Aligned_cols=247  Identities=30%  Similarity=0.441  Sum_probs=188.1

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccce
Q psy9535         115 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNC  193 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~  193 (593)
                      ++||+|+||.||++...+++.||+|.+.....     ...       ...|.+|++++++++||||+++++++.+ ...+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~-----~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   68 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-----PDL-------KRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIY   68 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCC-----HHH-------HHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeE
Confidence            36999999999999987699999998864311     001       1258899999999999999999998876 5568


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecc
Q psy9535         194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  273 (593)
Q Consensus       194 lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~  273 (593)
                      +||||+.+++|.+++....  ..+++.....++.+++.||.|||+  ++++||||||+|||++.++.+||+|||+++...
T Consensus        69 ~v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          69 IVMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             EEEEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            9999999999999997533  357899999999999999999998  569999999999999999999999999987653


Q ss_pred             cCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccccc
Q psy9535         274 TSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  351 (593)
Q Consensus       274 ~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (593)
                      .... ........++..|+|||.+. +.++.++|||||||++|||+| |..||............... ....       
T Consensus       145 ~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-~~~~-------  215 (251)
T cd05041         145 GGIY-TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMP-------  215 (251)
T ss_pred             CCcc-eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-CCCC-------
Confidence            2111 11111223466799999764 457889999999999999999 88998765432222221111 0000       


Q ss_pred             CCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         352 GEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       352 ~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                         .+......+..++.+||..+|++||++.||++.|.
T Consensus       216 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         216 ---APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ---CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence               00112234556778999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.4e-36  Score=304.61  Aligned_cols=254  Identities=25%  Similarity=0.380  Sum_probs=192.3

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||.|+||.||+|... ++..+|+|++.......            ....+.+|+.+++.++|+||+++++.+.. .
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (267)
T cd06610           5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT------------SVDELRKEVQAMSQCNHPNVVKYYTSFVVGD   72 (267)
T ss_pred             eeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch------------HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC
Confidence            3688999999999999864 68899999985431100            12257899999999999999999997765 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++++|.+++........+++.....++.|++.||.|||+  .+|+||||||+||++++++.+||+|||++.
T Consensus        73 ~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~--~~i~h~~l~p~ni~~~~~~~~~l~df~~~~  150 (267)
T cd06610          73 ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGVSA  150 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccchHH
Confidence            668999999999999999764333468999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcc-eeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         271 MSETSNMKT-MYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       271 ~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ......... .......|+..|+|||.+..  ..+.++|||||||++|||++|+.||.................+   ..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~  227 (267)
T cd06610         151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP---SL  227 (267)
T ss_pred             HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC---Cc
Confidence            654432211 11233568999999997644  4788999999999999999999999865443322222221111   01


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...   .........+..++.+||..+|++||++.+|++
T Consensus       228 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         228 ETG---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCc---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            100   001122334556778999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.5e-36  Score=358.19  Aligned_cols=246  Identities=25%  Similarity=0.467  Sum_probs=187.8

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+. .+|..||||++.....                 ....|++++++++|||||+++|+|.+ ..
T Consensus       695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~  757 (968)
T PLN00113        695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----------------IPSSEIADMGKLQHPNIVKLIGLCRSEKG  757 (968)
T ss_pred             ccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----------------ccHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence            57899999999999987 4789999999853210                 12356889999999999999999976 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-SKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      .++||||+++|+|.++++.      ++|..+.+|+.|+|+||+|||.. .++|+||||||+|||++.++.+++. ||.+.
T Consensus       758 ~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~  830 (968)
T PLN00113        758 AYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG  830 (968)
T ss_pred             CEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence            6899999999999999953      78999999999999999999954 3569999999999999999988886 77654


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCC----chHHHHHHHHhhcCcccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDN----NTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~----~~~~~~~~~~~~~~~~~~  345 (593)
                      .....       ....||+.|||||++. ..++.|+|||||||++|||+||+.||+..    .....|............
T Consensus       831 ~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  903 (968)
T PLN00113        831 LLCTD-------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM  903 (968)
T ss_pred             ccccC-------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhh
Confidence            33211       1236899999999764 45889999999999999999999998642    223333332222222233


Q ss_pred             ccccccC---CCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         346 VLDKEAG---EWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       346 ~~~~~~~---~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .+++...   .........++ .++.+||+.+|++||+|.||++.|++.
T Consensus       904 ~~~~~~~~~~~~~~~~~~~~~-~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        904 WIDPSIRGDVSVNQNEIVEVM-NLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             eeCccccCCCCccHHHHHHHH-HHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            3333221   12233333333 455699999999999999999999874

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.6e-36  Score=309.76  Aligned_cols=257  Identities=25%  Similarity=0.368  Sum_probs=191.6

Q ss_pred             cHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHH
Q psy9535          94 TFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL  172 (593)
Q Consensus        94 ~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il  172 (593)
                      ++.++..+.+.|..      .+.||+|+||.||+|+.. +++.||+|.+....       .  .     ...+..|+.++
T Consensus         7 ~~~~~~~~~~~~~~------~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-------~--~-----~~~~~~e~~~l   66 (282)
T cd06636           7 DLSALRDPAGIFEL------VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-------D--E-----EEEIKLEINML   66 (282)
T ss_pred             hhhhhcChhhhhhh------heeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-------H--H-----HHHHHHHHHHH
Confidence            45556566666654      578999999999999874 68899999875321       0  0     11467899999


Q ss_pred             hcC-CCCceeeEEEEEec-------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q psy9535         173 SQC-KHVNLLRLLGLCNN-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPII  244 (593)
Q Consensus       173 ~~l-~HpNIv~l~g~~~~-------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~Ii  244 (593)
                      +++ +||||+++++++..       ...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+
T Consensus        67 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~--~~iv  143 (282)
T cd06636          67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA--HKVI  143 (282)
T ss_pred             HHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcc
Confidence            998 69999999998742       34589999999999999887533 2457888889999999999999998  5699


Q ss_pred             ecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc------CCCCCcchhhHHHHHHHHHH
Q psy9535         245 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELL  318 (593)
Q Consensus       245 HrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~~ksDVwSfGvvl~Ell  318 (593)
                      ||||||+||+++.++.+||+|||+++.......   ......|++.|+|||.+.      ..++.++|||||||++|||+
T Consensus       144 H~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~  220 (282)
T cd06636         144 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA  220 (282)
T ss_pred             cCCCCHHHEEECCCCCEEEeeCcchhhhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHH
Confidence            999999999999999999999999875432211   112356899999999763      24677999999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         319 TGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       319 tG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +|..||...............  .....        ........+..++.+||+.+|.+||++.|+++
T Consensus       221 ~g~~p~~~~~~~~~~~~~~~~--~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         221 EGAPPLCDMHPMRALFLIPRN--PPPKL--------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hCCCCccccCHHhhhhhHhhC--CCCCC--------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            999999764432221111111  00010        01112233556778999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-36  Score=301.80  Aligned_cols=243  Identities=30%  Similarity=0.484  Sum_probs=189.5

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ..+.||+|+||.||+|... |+.||||.+.....              ....+.+|+.++++++|+||+++++++.+ ..
T Consensus        10 ~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (256)
T cd05039          10 LGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--------------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP   74 (256)
T ss_pred             ceeeeecCCCceEEEEEec-CcEEEEEEeccchh--------------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC
Confidence            3578999999999999875 78999999864311              12258899999999999999999998875 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++..... ..+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+++.
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~Nili~~~~~~~l~d~g~~~~  151 (256)
T cd05039          75 LYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAKE  151 (256)
T ss_pred             eEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCccchhcccceEEEeCCCCEEEcccccccc
Confidence            7899999999999999976432 368999999999999999999998  5699999999999999999999999999886


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .....      ....++..|+|||.+. +.++.++||||||+++|||++ |..||............... .. ...   
T Consensus       152 ~~~~~------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~-~~~---  220 (256)
T cd05039         152 ASQGQ------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YR-MEA---  220 (256)
T ss_pred             ccccc------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-CC-CCC---
Confidence            53221      1234567899999764 567889999999999999997 99999765433222211111 01 000   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                        ..    .....+..++.+||..+|++||++.|+++.|+.
T Consensus       221 --~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         221 --PE----GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             --cc----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence              00    112234456679999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.4e-36  Score=306.32  Aligned_cols=254  Identities=22%  Similarity=0.325  Sum_probs=186.5

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ...||+|+||.||+|+.+ +|+.||+|++........ .          ...|.+|+.++++++||||+++++++.. ..
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-~----------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (286)
T cd07847           6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV-I----------KKIALREIRMLKQLKHPNLVNLIEVFRRKRK   74 (286)
T ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc-c----------cHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence            578999999999999876 589999999864321110 0          1147889999999999999999998876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++++|..++..   ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++..
T Consensus        75 ~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  149 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGFARI  149 (286)
T ss_pred             EEEEEeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECcccccee
Confidence            6899999999888777653   2358999999999999999999998  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc----cc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV----RE  345 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~----~~  345 (593)
                      ......   ......|+..|+|||.+.+  .++.++|||||||++|||++|+.||.+.................    ..
T Consensus       150 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (286)
T cd07847         150 LTGPGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ  226 (286)
T ss_pred             cCCCcc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            544321   1123468899999997643  46789999999999999999999998654322221111100000    00


Q ss_pred             cc----------ccccCC-CC----HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 VL----------DKEAGE-WN----ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ~~----------~~~~~~-~~----~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..          .+.... ..    ...+...+..++.+||+.+|++||++.|++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00          000000 00    0011234556778999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-36  Score=309.51  Aligned_cols=246  Identities=23%  Similarity=0.314  Sum_probs=186.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+++.. +|..||+|.+....     ...  .     ...|.+|++++++++||||+++++++.. ..
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-----~~~--~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (286)
T cd06622           6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-----DES--K-----FNQIIMELDILHKAVSPYIVDFYGAFFIEGA   73 (286)
T ss_pred             hhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-----CHH--H-----HHHHHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence            578999999999999876 78999999885321     100  0     1257899999999999999999997765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++++|.+++........+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  152 (286)
T cd06622          74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN  152 (286)
T ss_pred             EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence            689999999999998887543234689999999999999999999962 3699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-------CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-hcCcc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPV  343 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-------~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~-~~~~~  343 (593)
                      .....     .....|++.|+|||.+.+       .++.++|||||||++|||++|+.||.............. .....
T Consensus       153 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd06622         153 LVASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP  227 (286)
T ss_pred             ccCCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence            43221     223468899999997633       247799999999999999999999975432211111110 01111


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..        .+ ......+..++.+||+.+|++||++.++++
T Consensus       228 ~~--------~~-~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         228 PT--------LP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             CC--------CC-cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            11        01 112334556778999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.6e-36  Score=300.29  Aligned_cols=246  Identities=24%  Similarity=0.350  Sum_probs=190.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||.++.. ++..+|+|.+......    ..       ....|.+|++++++++|+||+++++++.+ ..
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~~-------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   73 (256)
T cd08221           5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS----EK-------ERRDALNEIVILSLLQHPNIIAYYNHFMDDNT   73 (256)
T ss_pred             eeEecccCCceEEEEEEcCCCcEEEEEEEeecccc----hh-------HHHHHHHHHHHHHhCCCCCeeEEEeEEecCCe
Confidence            578999999999998764 6889999998543110    00       01247899999999999999999998876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+++.
T Consensus        74 ~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~  150 (256)
T cd08221          74 LLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFLTKAGLIKLGDFGISKI  150 (256)
T ss_pred             EEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChHhEEEeCCCCEEECcCcceEE
Confidence            689999999999999997643 3468999999999999999999998  4599999999999999999999999999886


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......|++.|+|||.+.+ ..+.++||||||+++|||++|..||.................  ...    
T Consensus       151 ~~~~~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~--~~~----  221 (256)
T cd08221         151 LGSEYS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY--TPV----  221 (256)
T ss_pred             cccccc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--CCC----
Confidence            543321   1233578999999997643 578899999999999999999999987544333222222111  111    


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDL  387 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~  387 (593)
                      .     ......+..++.+||..+|++||++.++++.
T Consensus       222 ~-----~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         222 V-----SVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             c-----cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            0     1112234556779999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.1e-36  Score=312.30  Aligned_cols=242  Identities=26%  Similarity=0.408  Sum_probs=185.9

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ..+||+|+||.||+|... +++.||||.+.....    .  .       ...+.+|+.+++.++||||+++++++.. ..
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~--~-------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   92 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----Q--R-------RELLFNEVVIMRDYQHQNVVEMYKSYLVGEE   92 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----c--h-------HHHHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence            357999999999999864 689999999854211    0  0       1147789999999999999999997765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++..    ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~  166 (297)
T cd06659          93 LWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ  166 (297)
T ss_pred             EEEEEecCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHeEEccCCcEEEeechhHhh
Confidence            7899999999999987754    357899999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......|++.|+|||.+. ..++.++|||||||++|||++|+.||.................+..    ..
T Consensus       167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~  239 (297)
T cd06659         167 ISKDVP---KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL----KN  239 (297)
T ss_pred             cccccc---cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCc----cc
Confidence            433211   112356899999999774 4578899999999999999999999976544333222211111100    00


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...     ....+..++.+||+.+|++||++.++++
T Consensus       240 ~~~-----~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         240 AHK-----ISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             cCC-----CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            011     1223455678999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-36  Score=324.53  Aligned_cols=190  Identities=27%  Similarity=0.355  Sum_probs=157.4

Q ss_pred             CCCCcccccCceEEEEEEEc---CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~---~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      ...+.||+|+||.||++...   .+..||||.+....                  .+.+|+.+|++++|||||++++++.
T Consensus        95 ~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------------------~~~~E~~il~~l~h~~iv~~~~~~~  156 (392)
T PHA03207         95 NILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------------------TPGREIDILKTISHRAIINLIHAYR  156 (392)
T ss_pred             EEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------------------cHHHHHHHHHhcCCCCccceeeeEe
Confidence            34678999999999999753   35789999875320                  2467999999999999999999876


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      . ...++||||+. ++|.+++..   ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus       157 ~~~~~~lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~--~givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        157 WKSTVCMVMPKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             eCCEEEEEehhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccCc
Confidence            5 56689999985 789888843   2468999999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCC
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDD  326 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~  326 (593)
                      +++....... ........||+.|+|||++. ..++.++|||||||++|||++|+.||..
T Consensus       231 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  289 (392)
T PHA03207        231 AACKLDAHPD-TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG  289 (392)
T ss_pred             cccccCcccc-cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            9876543321 11123467999999999875 4578899999999999999999999965

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5e-36  Score=304.66  Aligned_cols=251  Identities=24%  Similarity=0.396  Sum_probs=189.1

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      ...||+|+||.||+|+.+      +...||+|.+....     . ..      ....|.+|++++++++||||+++++++
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-----~-~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~   77 (275)
T cd05046          10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-----D-EN------LQSEFRRELDMFRKLSHKNVVRLLGLC   77 (275)
T ss_pred             eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-----c-hH------HHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence            568999999999999864      24679999875321     1 00      012588999999999999999999998


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNNT------PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  260 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~  260 (593)
                      .+ ...++||||+++|+|.+++......      ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dlkp~Nili~~~~~  155 (275)
T cd05046          78 REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN--ARFVHRDLAARNCLVSSQRE  155 (275)
T ss_pred             CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh--cCcccCcCccceEEEeCCCc
Confidence            76 5678999999999999999764422      268999999999999999999998  55999999999999999999


Q ss_pred             cEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHh
Q psy9535         261 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVE  338 (593)
Q Consensus       261 ~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~  338 (593)
                      +|++|||+++.......  .......+++.|+|||.+. ...+.++|||||||++|||++ |..||..............
T Consensus       156 ~~l~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~  233 (275)
T cd05046         156 VKVSLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA  233 (275)
T ss_pred             EEEcccccccccCcccc--cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc
Confidence            99999999875432211  1112335678899999764 457789999999999999999 8889976443332222221


Q ss_pred             hcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         339 QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ......     ...     .....+..++.+||+.+|++||++.|+++.|.+
T Consensus       234 ~~~~~~-----~~~-----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         234 GKLELP-----VPE-----GCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CCcCCC-----CCC-----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            111110     001     122345567789999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-36  Score=320.01  Aligned_cols=184  Identities=25%  Similarity=0.387  Sum_probs=153.0

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.+.||+|+||.||+|+.. ++..||+|.....                   ....|+.++++++||||+++++++.. .
T Consensus        70 ~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------------------~~~~E~~~l~~l~h~~iv~~~~~~~~~~  130 (357)
T PHA03209         70 VIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------------------TTLIEAMLLQNVNHPSVIRMKDTLVSGA  130 (357)
T ss_pred             EEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------------------ccHHHHHHHHhCCCCCCcChhheEEeCC
Confidence            3688999999999999875 5778999974321                   13468999999999999999998866 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+ .|+|.+++....  ..+++..+..|+.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       131 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  205 (357)
T PHA03209        131 ITCMVLPHY-SSDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAAQ  205 (357)
T ss_pred             eeEEEEEcc-CCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEecCcccc
Confidence            568999998 578998887533  468999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCC
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI  324 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~  324 (593)
                      ......    ......||+.|+|||++. ..++.++|||||||++|||+++..|+
T Consensus       206 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        206 FPVVAP----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccCc----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            543221    122357999999999764 46889999999999999999866555

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.2e-36  Score=310.79  Aligned_cols=242  Identities=26%  Similarity=0.450  Sum_probs=187.6

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||.|+||.||+|.. .+|+.||+|.+....    ..  .       ...+.+|+.+++.++||||+++++++.. ..
T Consensus        24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~--~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (296)
T cd06655          24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QP--K-------KELIINEILVMKELKNPNIVNFLDSFLVGDE   90 (296)
T ss_pred             EEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----Cc--h-------HHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence            57899999999999986 468999999985421    11  1       1147889999999999999999998865 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|+||+++|+|.+++..    ..+++.++..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+++.
T Consensus        91 ~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~--~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~  164 (296)
T cd06655          91 LFVVMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ  164 (296)
T ss_pred             EEEEEEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccchh
Confidence            6899999999999998864    358999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......|++.|+|||.+. ..++.++|||||||++|||++|+.||.................+  ....  
T Consensus       165 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~--~~~~--  237 (296)
T cd06655         165 ITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP--ELQN--  237 (296)
T ss_pred             cccccc---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc--ccCC--
Confidence            433221   112346899999999774 45788999999999999999999999876543322222111111  1000  


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                           +..+...+..++.+||..+|++||++.+|++
T Consensus       238 -----~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         238 -----PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -----cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                 1112234556678999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.8e-36  Score=302.24  Aligned_cols=258  Identities=22%  Similarity=0.327  Sum_probs=190.6

Q ss_pred             CCcccccCceEEEEEEEcC--CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhc-CCCCceeeEEEEEec-
Q psy9535         114 GNKLGEGQFGTVYYGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGLCNN-  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~--g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~-l~HpNIv~l~g~~~~-  189 (593)
                      .+.||+|+||.||+|.+..  +..+|||.+.............   .......+.+|+.++.+ ++||||+++++++.. 
T Consensus         5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~---~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRE---RDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             hhhhcCCCCceEEEEEEcCCCCceeeeeEeecccccccccccc---chHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            5789999999999999764  6889999886432111100000   00112346788988865 799999999998765 


Q ss_pred             ccceEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      ...++||||+++++|.+++... .....+++..++.++.|++.||.|||+. .+++||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC-CceeecCCCHHHEEECCCCcEEEecccc
Confidence            5678999999999999988542 2234689999999999999999999952 4599999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      +.......    ......|+..|+|||.+. ..++.++||||||+++|||++|+.||..................  .. 
T Consensus       161 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~-  233 (269)
T cd08528         161 AKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE--PL-  233 (269)
T ss_pred             eeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC--cC-
Confidence            88654332    123457899999999764 45788999999999999999999999765433222222111110  00 


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                         ..    ......+..++.+||+.||++||++.||..+|+
T Consensus       234 ---~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         234 ---PE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ---Cc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence               00    011223555677999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.6e-36  Score=309.06  Aligned_cols=240  Identities=28%  Similarity=0.447  Sum_probs=184.8

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      +.||+|+||.||+|... ++..||+|.+.....      .  .    ....|.+|+.++++++||||+++++++.. ...
T Consensus        10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~------~--~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06642          10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA------E--D----EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL   77 (277)
T ss_pred             HHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc------h--H----HHHHHHHHHHHHHcCCCCccHhhhcccccCCce
Confidence            57999999999999864 578899998753210      0  0    01258899999999999999999998765 556


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++..    ..+++..+..++.|+++||.|||+  ++++|+||||+||++++++.+||+|||+++..
T Consensus        78 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06642          78 WIIMEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVAGQL  151 (277)
T ss_pred             EEEEEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc--CCeeccCCChheEEEeCCCCEEEccccccccc
Confidence            899999999999998853    358899999999999999999998  56999999999999999999999999998765


Q ss_pred             ccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  351 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (593)
                      .....   ......|+..|+|||.+.+ .++.++|||||||++|||++|+.|+.................       +..
T Consensus       152 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-------~~~  221 (277)
T cd06642         152 TDTQI---KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------PTL  221 (277)
T ss_pred             cCcch---hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCC-------CCC
Confidence            43221   1123468999999997754 578899999999999999999999975433221111111100       000


Q ss_pred             CCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         352 GEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       352 ~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                          .......+..++.+||+.+|++||+|.+|++
T Consensus       222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         222 ----EGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             ----CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                0111223455677999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-36  Score=309.64  Aligned_cols=247  Identities=25%  Similarity=0.356  Sum_probs=186.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||++... +|+.||+|.+.....     ..       ....|.+|+++++.++||||+++++++.. ..
T Consensus        10 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-----~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   77 (284)
T cd06620          10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-----SS-------VRKQILRELQIMHECRSPYIVSFYGAFLNENN   77 (284)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-----ch-------HHHHHHHHHHHHHHcCCCCcceEeeeEecCCE
Confidence            468999999999999875 688999998864311     00       01258899999999999999999998876 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.+.   .++++.....++.+++.||.|||+. .+++||||||+||+++.++.++|+|||+++.
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~  153 (284)
T cd06620          78 ICMCMEFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNV-HRIMHRDIKPSNILVNSRGQIKLCDFGVSGE  153 (284)
T ss_pred             EEEEEecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHh-cCeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence            68999999999999988753   3589999999999999999999962 3599999999999999999999999999865


Q ss_pred             cccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHH-------HHHHHHhhcCcc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTIL-------YYYLVVEQEVPV  343 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~-------~~~~~~~~~~~~  343 (593)
                      .....     .....||..|+|||++ ...++.++|||||||++|||++|+.||.......       .......     
T Consensus       154 ~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----  223 (284)
T cd06620         154 LINSI-----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ-----  223 (284)
T ss_pred             hhhhc-----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH-----
Confidence            42221     1235799999999976 4567889999999999999999999997543210       0000000     


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHH
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDL  387 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~  387 (593)
                       ..................+..++.+||+.+|++||++.||++.
T Consensus       224 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         224 -QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             -HHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             0000000111111122345567789999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.9e-36  Score=305.11  Aligned_cols=241  Identities=26%  Similarity=0.432  Sum_probs=187.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|... ++..||||.+.....      .  .    ....|.+|+.++++++||||+++++++.+ ..
T Consensus         9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~------~--~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (277)
T cd06640           9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA------E--D----EIEDIQQEITVLSQCDSPYVTKYYGSYLKGTK   76 (277)
T ss_pred             hhhcccCCCeEEEEEEEccCCEEEEEEEEecccc------H--H----HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence            467999999999999875 588999999864210      0  0    12358899999999999999999998866 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++..    .++++.....++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++..
T Consensus        77 ~~lv~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~  150 (277)
T cd06640          77 LWIIMEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGVAGQ  150 (277)
T ss_pred             EEEEEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCccCcCCChhhEEEcCCCCEEEccccccee
Confidence            7899999999999998864    357889999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......|+..|+|||.+. ...+.++|||||||++|||++|..||................          
T Consensus       151 ~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~----------  217 (277)
T cd06640         151 LTDTQI---KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN----------  217 (277)
T ss_pred             ccCCcc---ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC----------
Confidence            543221   122346889999999764 457889999999999999999999997654322211111000          


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       ...........+..++.+||..+|++||++.++++
T Consensus       218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06640         218 -PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK  252 (277)
T ss_pred             -CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence             00111123334556778999999999999999965

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1e-35  Score=298.55  Aligned_cols=247  Identities=26%  Similarity=0.400  Sum_probs=189.5

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      .++.||+|+||.||+|... ++..||+|.+..........    +    ....|.+|++++++++||||+++++++.+ .
T Consensus         4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~----~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQ----E----AVKQLEQEIALLSKLQHPNIVQYLGTEREED   75 (258)
T ss_pred             ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccch----H----HHHHHHHHHHHHHhcCCCCchheeeeEecCC
Confidence            3678999999999999876 78999999986532111100    1    12358899999999999999999998876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++++|.+++...   .++++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.+||+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~  150 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAK  150 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccce
Confidence            568999999999999998753   358899999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-C-CCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-Q-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~-~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ......    ......|++.|+|||.+.. . ++.++|+|||||++|||++|+.||.............. ......+  
T Consensus       151 ~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~--  223 (258)
T cd06632         151 QVVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR-SKELPPI--  223 (258)
T ss_pred             eccccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh-cccCCCc--
Confidence            654322    1233568999999997643 3 78899999999999999999999977543322222111 0111111  


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                             +..+...+..++.+||..+|++||++.+++.
T Consensus       224 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         224 -------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                   0112233455677999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=9.4e-36  Score=298.66  Aligned_cols=242  Identities=27%  Similarity=0.442  Sum_probs=188.1

Q ss_pred             CCcccccCceEEEEEEEcC-CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~-g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|+... ++.||+|.+.....               ...|.+|++++++++||||++++|++.. ..
T Consensus         8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~   72 (256)
T cd06612           8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---------------LQEIIKEISILKQCDSPYIVKYYGSYFKNTD   72 (256)
T ss_pred             hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---------------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCc
Confidence            5789999999999999864 78999999853210               2258899999999999999999998866 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++++||+++++|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||+|+||+++.++.+||+|||++..
T Consensus        73 ~~l~~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~  148 (256)
T cd06612          73 LWIVMEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQ  148 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEECCCCcEEEcccccchh
Confidence            689999999999999986533  468999999999999999999998  5599999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......|+..|+|||.+. ..++.++|||||||++|||++|+.||...............  .... .   
T Consensus       149 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~-~---  219 (256)
T cd06612         149 LTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK--PPPT-L---  219 (256)
T ss_pred             cccCcc---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC--CCCC-C---
Confidence            543321   112345899999999764 45788999999999999999999999764432221111100  0000 0   


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         ..+......+..++.+||+.+|++||++.||++
T Consensus       220 ---~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 ---SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             ---CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence               011122234556778999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.8e-36  Score=306.24  Aligned_cols=255  Identities=22%  Similarity=0.303  Sum_probs=185.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +|+.||||.+........    .       ...|.+|++++++++||||+++++++.+ ..
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   73 (284)
T cd07860           5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----V-------PSTAIREISLLKELNHPNIVKLLDVIHTENK   73 (284)
T ss_pred             eeeecCCCceEEEEEEECCCCCEEEEEEccccccccc----c-------chHHHHHHHHHHhcCCCCCcchhhhcccCCc
Confidence            578999999999999875 689999998864321110    0       1147889999999999999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+++.
T Consensus        74 ~~~v~e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~H~~l~p~nill~~~~~~~l~dfg~~~~  149 (284)
T cd07860          74 LYLVFEFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARA  149 (284)
T ss_pred             EEEEeeccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEeeccchhh
Confidence            689999995 68988887543 3468999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-C-CCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-Q-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~-~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ...... .  .....+++.|+|||.+.+ . ++.++|||||||++|||+||+.||........................+
T Consensus       150 ~~~~~~-~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd07860         150 FGVPVR-T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  226 (284)
T ss_pred             cccCcc-c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence            433211 1  122357889999997643 3 5788999999999999999999997654433222222111110000000


Q ss_pred             ----------ccCCCC-------HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 ----------EAGEWN-------ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ----------~~~~~~-------~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                ....+.       ...+...+..++.+||+.||++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                      000000       0011223455678999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-36  Score=304.21  Aligned_cols=245  Identities=24%  Similarity=0.397  Sum_probs=187.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEeccc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNNIM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~~~  191 (593)
                      .+.||+|+||.||+|+.+ +++.+|+|.+.....       .       ...|.+|+.+++++ .||||+++++++....
T Consensus        11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (275)
T cd06608          11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-------E-------EEEIKEEYNILRKYSNHPNIATFYGAFIKKN   76 (275)
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-------h-------HHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence            688999999999999875 578999999864311       0       12588999999999 6999999999886432


Q ss_pred             -------ceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         192 -------NCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       192 -------~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                             .++||||+++++|.+++.... ....+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.+||
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEEccCCeEEE
Confidence                   589999999999999887532 13468999999999999999999998  56999999999999999999999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCcccccC------CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  337 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~  337 (593)
                      +|||++........   ......|++.|+|||.+..      .++.++|||||||++|||++|+.||.............
T Consensus       155 ~d~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  231 (275)
T cd06608         155 VDFGVSAQLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP  231 (275)
T ss_pred             CCCccceecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh
Confidence            99999876433221   1123568999999997632      35778999999999999999999997644332222211


Q ss_pred             hhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..  ......       ........+..++.+||..||++|||+.++++
T Consensus       232 ~~--~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 RN--PPPTLK-------SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             cc--CCCCCC-------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11  111111       11112334566778999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3e-36  Score=311.04  Aligned_cols=242  Identities=27%  Similarity=0.458  Sum_probs=186.9

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|.. .+|+.||+|.+.....      .. .      ..+.+|+.+++.++||||+++++++.. ..
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~-~------~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (297)
T cd06656          24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ------PK-K------ELIINEILVMRENKNPNIVNYLDSYLVGDE   90 (297)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc------ch-H------HHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence            57899999999999986 4789999999864311      11 1      147889999999999999999998865 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.+    ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++..
T Consensus        91 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~  164 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  164 (297)
T ss_pred             EEEeecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEECcCccceE
Confidence            7899999999999999864    357889999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......|++.|+|||.+. ..++.++|||||||++|+|++|+.||.................+  ..    
T Consensus       165 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~--~~----  235 (297)
T cd06656         165 ITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP--EL----  235 (297)
T ss_pred             ccCCcc---CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC--CC----
Confidence            433221   112346899999999764 45788999999999999999999999764432211111111100  00    


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         ..+......+..++.+||..+|++||++.+|++
T Consensus       236 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         236 ---QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               011223344566778999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.4e-35  Score=300.81  Aligned_cols=253  Identities=24%  Similarity=0.372  Sum_probs=186.7

Q ss_pred             CCCcccccCceEEEEEEEc----CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~----~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      ..+.||+|+||.||+|.+.    ++..||||.+.....    ...       ....+.+|++++++++||||+++++++.
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~----~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~   71 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF----SSS-------DIEEFLREAACMKEFDHPNVIKLIGVSL   71 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC----ChH-------HHHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence            3578999999999999753    368899999864311    000       1224788999999999999999999875


Q ss_pred             cc-------cceEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC
Q psy9535         189 NI-------MNCIVYEYMCNGSLYDRLARVN---NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  258 (593)
Q Consensus       189 ~~-------~~~lV~Ey~~~GsL~~~L~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~  258 (593)
                      ..       ..++++||+.+|+|.+++....   ....+++.....++.|++.||+|||+  ++|+||||||+|||++.+
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~~  149 (273)
T cd05074          72 RSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNEN  149 (273)
T ss_pred             cCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEEcCC
Confidence            32       1267899999999998875321   12357889999999999999999998  569999999999999999


Q ss_pred             CccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHH
Q psy9535         259 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLV  336 (593)
Q Consensus       259 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~  336 (593)
                      +.+||+|||+++......... ......+++.|++||.+. ..++.++|||||||++|||++ |+.||............
T Consensus       150 ~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~  228 (273)
T cd05074         150 MTVCVADFGLSKKIYSGDYYR-QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL  228 (273)
T ss_pred             CCEEECcccccccccCCccee-cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence            999999999988653322111 112234567899999764 456889999999999999999 89998765433222222


Q ss_pred             HhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         337 VEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      .... ....     ...     ....+..++.+||+.+|++||++.++++.|++
T Consensus       229 ~~~~-~~~~-----~~~-----~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         229 IKGN-RLKQ-----PPD-----CLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             HcCC-cCCC-----CCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            1111 1100     001     11234556679999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-36  Score=307.65  Aligned_cols=244  Identities=26%  Similarity=0.419  Sum_probs=187.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|+.. ++..||+|.+....      ...       ...|.+|++++++++||||+++++.+.. ..
T Consensus        10 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~------~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (280)
T cd06611          10 IGELGDGAFGKVYKAQHKETGLFAAAKIIQIES------EEE-------LEDFMVEIDILSECKHPNIVGLYEAYFYENK   76 (280)
T ss_pred             HHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC------HHH-------HHHHHHHHHHHHhCCCCceeEEEEEEecCCe
Confidence            568999999999999875 68899999985321      000       1258899999999999999999998865 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++....  ..+++.....++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++..
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~nili~~~~~~~l~d~g~~~~  152 (280)
T cd06611          77 LWILIEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAK  152 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEECCCCCEEEccCccchh
Confidence            689999999999999887533  368999999999999999999998  5699999999999999999999999999765


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      ......   ......||+.|+|||.+.      ..++.++|||||||++|||++|+.||.................+  .
T Consensus       153 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~  227 (280)
T cd06611         153 NKSTLQ---KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPP--T  227 (280)
T ss_pred             hccccc---ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCC--C
Confidence            433221   122356899999999763      23567899999999999999999999765433322222111111  0


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...       +......+..++.+||+.+|++||++.+|++
T Consensus       228 ~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         228 LDQ-------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             cCC-------cccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            000       0111223455677999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.5e-36  Score=308.47  Aligned_cols=254  Identities=24%  Similarity=0.343  Sum_probs=187.5

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|.++ +++.||+|.+.......    ..       ...+.+|++++++++||||+++++++.. ..
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (286)
T cd07846           6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK----MV-------KKIAMREIRMLKQLRHENLVNLIEVFRRKKR   74 (286)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc----hh-------hHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence            578999999999999986 58999999876432111    00       1247789999999999999999998866 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+.+++|.++....   ..+++..+..++.|++.||.|||+  .+|+||||||+||++++++.+||+|||+++.
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~  149 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFART  149 (286)
T ss_pred             EEEEEecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence            68999999999888776542   348999999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc----c
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR----E  345 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~----~  345 (593)
                      ......   ......|+..|+|||.+.+  .++.++|||||||++|||++|++||........+.........+.    .
T Consensus       150 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (286)
T cd07846         150 LAAPGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE  226 (286)
T ss_pred             ccCCcc---ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence            543321   1123468899999997643  367899999999999999999999976544332222211110000    0


Q ss_pred             cc----------ccccCCCC-----HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 VL----------DKEAGEWN-----ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ~~----------~~~~~~~~-----~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..          .+......     ...+...+..++.+||..+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00          00000000     0112344666778999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.9e-36  Score=299.02  Aligned_cols=245  Identities=24%  Similarity=0.365  Sum_probs=189.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+++.. +|+.||+|.+......   . .  .     ...+.+|+.++++++||||+++++++.. ..
T Consensus         5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~---~-~--~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd08218           5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS---P-K--E-----REESRKEVAVLSNMKHPNIVQYQESFEENGN   73 (256)
T ss_pred             EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC---h-H--H-----HHHHHHHHHHHHhCCCCCeeeeEeeecCCCe
Confidence            578999999999999864 6899999998642110   0 0  0     1257899999999999999999998865 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+++|+||+|+|||++.++.++|+|||++..
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~  150 (256)
T cd08218          74 LYIVMDYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARV  150 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeeccceee
Confidence            689999999999999987532 2357899999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......|++.|+|||.+. ...+.++|||||||+++||++|+.||..............+..+  ..    
T Consensus       151 ~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~~----  221 (256)
T cd08218         151 LNSTVE---LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP--PV----  221 (256)
T ss_pred             cCcchh---hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC--CC----
Confidence            543221   112346899999999764 45678999999999999999999999765443322222222111  00    


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                           +......+..++.+||+.+|++||+|.+|++
T Consensus       222 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         222 -----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -----cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                 0112223556778999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-36  Score=303.41  Aligned_cols=242  Identities=27%  Similarity=0.402  Sum_probs=187.5

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||.|+||.||+|+.. +++.||+|.+.....     ...       ...|.+|++++++++||||+++++++.+ ..
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   73 (274)
T cd06609           6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-----EDE-------IEDIQQEIQFLSQCRSPYITKYYGSFLKGSK   73 (274)
T ss_pred             hhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-----chH-------HHHHHHHHHHHHHcCCCCeeeeeEEEEECCe
Confidence            578999999999999875 688999999853210     011       1247899999999999999999998765 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|+||+++|+|.+++...    ++++.....++.|++.||.|||+  .+++||||+|+||++++++.++|+|||+++.
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~  147 (274)
T cd06609          74 LWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGVSGQ  147 (274)
T ss_pred             EEEEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccccccee
Confidence            68999999999999998752    68999999999999999999998  5699999999999999999999999999987


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......|++.|+|||.+. ..++.++|||||||++|||+||+.||.................  ....+. 
T Consensus       148 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~-  221 (274)
T cd06609         148 LTSTMS---KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP--PSLEGN-  221 (274)
T ss_pred             eccccc---ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC--CCCccc-
Confidence            643321   122357899999999764 4578899999999999999999999976543322221111111  111000 


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        .     ....+..++.+||..+|++||++.++++
T Consensus       222 --~-----~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 --K-----FSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             --c-----cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              0     1223455677999999999999999965

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG4250|consensus

Probab=100.00  E-value=6.2e-37  Score=328.96  Aligned_cols=195  Identities=30%  Similarity=0.494  Sum_probs=165.1

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc--
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~--  190 (593)
                      .+.||+||||.||+|+. .+|+.||||.+++...     ...       .....+|+++|++++|||||++++.-+..  
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-----~r~-------~e~~~~EieilkKLnh~NIVk~f~iee~~~~   85 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-----LRP-------RERWCREIEILKKLNHPNIVKLFDIEETKFL   85 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcc-----cch-------HHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence            46899999999999996 4799999999875421     111       22467899999999999999999976543  


Q ss_pred             -----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec--CCC--cc
Q psy9535         191 -----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENF--VP  261 (593)
Q Consensus       191 -----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~--~~~--~~  261 (593)
                           ...+|||||.+|||...|.+-.+...|++.+.+.++.+++.||.|||+  ++|+||||||.||++-  .+|  .-
T Consensus        86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE--n~IvHRDlKP~NIvl~~Gedgq~Iy  163 (732)
T KOG4250|consen   86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE--NGIVHRDLKPGNIVLQIGEDGQSIY  163 (732)
T ss_pred             CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH--cCceeccCCCCcEEEeecCCCceEE
Confidence                 357999999999999999887777789999999999999999999998  6699999999999994  323  46


Q ss_pred             EEeecccceecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCC
Q psy9535         262 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDD  326 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~  326 (593)
                      ||+|||.||..+....    ..++.||+.|.+||.+.  +.++.-+|.|||||++||.+||..||-.
T Consensus       164 KLtDfG~Arel~d~s~----~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  164 KLTDFGAARELDDNSL----FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             eeecccccccCCCCCe----eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            9999999998766542    34689999999999886  4577789999999999999999999964

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.8e-36  Score=306.27  Aligned_cols=261  Identities=24%  Similarity=0.391  Sum_probs=188.1

Q ss_pred             CCcccccCceEEEEEEEc-----CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         114 GNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-----~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      .+.||+|+||.||+|++.     ++..||||.+......      .      ....|.+|++++++++||||+++++++.
T Consensus         9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~------~------~~~~~~~ei~~l~~l~~~~i~~~~~~~~   76 (284)
T cd05038           9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE------Q------HRSDFEREIEILRTLDHENIVKYKGVCE   76 (284)
T ss_pred             heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch------H------HHHHHHHHHHHHHhCCCCChheEEeeee
Confidence            468999999999999864     3678999998643110      0      1225899999999999999999999886


Q ss_pred             c---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         189 N---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       189 ~---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                      .   ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|
T Consensus        77 ~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~d  152 (284)
T cd05038          77 KPGGRSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISD  152 (284)
T ss_pred             cCCCCceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcc
Confidence            5   24689999999999999997643  358999999999999999999998  5699999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhhcC--
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYY-YLVVEQEV--  341 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~-~~~~~~~~--  341 (593)
                      ||++.................++..|+|||.+. ..++.++|||||||++|||+||..|+......... ........  
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd05038         153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV  232 (284)
T ss_pred             cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccH
Confidence            999987653221111111234566799999764 56788999999999999999999998653211100 00000000  


Q ss_pred             -ccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         342 -PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       342 -~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                       ...+.+........+..+...+..++.+||..+|++||+|.||+++|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence             0000000000000001112234556779999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-35  Score=303.42  Aligned_cols=256  Identities=23%  Similarity=0.318  Sum_probs=189.8

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.+.||+|+||.||+|+.. +|+.||||++.......     ..      ...|.+|+.++++++||||+++++++.. .
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-----~~------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   72 (286)
T cd07832           4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-----GI------PNQALREIKALQACQHPYVVKLLDVFPHGS   72 (286)
T ss_pred             EEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-----hh------hHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence            4578999999999999875 68999999986532110     00      1247899999999999999999998866 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+ +++|.+++....  .++++..+..++.|+++||.|||+  .+|+|+||||+||+++.++.++|+|||++.
T Consensus        73 ~~~~v~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~  147 (286)
T cd07832          73 GFVLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHA--NGIMHRDLKPANLLISADGVLKIADFGLAR  147 (286)
T ss_pred             eeEEEeccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence            568999999 999999987543  468999999999999999999998  569999999999999999999999999988


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc-----
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV-----  343 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~-----  343 (593)
                      ........  ......|+..|+|||.+.+  .++.++||||+||++|||++|.+||........+......-...     
T Consensus       148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (286)
T cd07832         148 LFSEEEPR--LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETW  225 (286)
T ss_pred             cccCCCCC--ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHH
Confidence            65433211  1123468999999997643  35789999999999999999988887654433333222211000     


Q ss_pred             c---c------ccccccCCCCH----HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 R---E------VLDKEAGEWNE----THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~---~------~~~~~~~~~~~----~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +   +      ...+.......    ......+..++.+|+..+|++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0   0      00000000000    011244566778999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG2052|consensus

Probab=100.00  E-value=1.8e-36  Score=309.73  Aligned_cols=254  Identities=26%  Similarity=0.438  Sum_probs=188.9

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHh--cCCCCceeeEEEEEec-
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS--QCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~--~l~HpNIv~l~g~~~~-  189 (593)
                      +.+.||+|.||.||+|+|+ |..||||++...+          |.      .+.+|.+|..  .|+|+||+.+++.-.. 
T Consensus       215 L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd----------E~------SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  215 LQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD----------ER------SWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             EEEEecCccccceeecccc-CCceEEEEecccc----------hh------hhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            3477999999999999998 8899999986321          11      3566666664  5699999999986432 


Q ss_pred             ----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCC-eEecccCCCCeeecCCC
Q psy9535         190 ----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHS-----LSKP-IIHRDVKSANVLLDENF  259 (593)
Q Consensus       190 ----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~-IiHrDLKp~NILl~~~~  259 (593)
                          ...|||.+|-++|||+|+|.+    ..++....++++..+|.||++||.     +++| |.|||||+.|||+.+++
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence                246899999999999999986    458999999999999999999994     4566 99999999999999999


Q ss_pred             ccEEeecccceecccC-CCcceeeccccCCCCcCCcccccCCC-------CCcchhhHHHHHHHHHHhC----------C
Q psy9535         260 VPKLGDFGIVKMSETS-NMKTMYTENLTGTRPYMPPEAMHCQI-------STKTDVFSYGVILLELLTG----------M  321 (593)
Q Consensus       260 ~~Kl~DFGla~~~~~~-~~~~~~~~~~~GT~~Y~APE~~~~~~-------~~ksDVwSfGvvl~ElltG----------~  321 (593)
                      .+.|+|+|||-..... +.........+||..|||||++....       ...+||||||.|+||++.+          +
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            9999999998764433 11112223458999999999985432       2358999999999999753          5


Q ss_pred             CCCCCC----chHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         322 KPIDDN----NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       322 ~P~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .||.+.    .+......++    -....-......|....+...+..+++.||..+|..|-|+--|-+.|.+.
T Consensus       434 ~Pyyd~Vp~DPs~eeMrkVV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  434 LPYYDVVPSDPSFEEMRKVV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             CCcccCCCCCCCHHHHhcce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            677652    1111111110    01111111133455566666777788999999999999998888877763

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-35  Score=307.49  Aligned_cols=258  Identities=21%  Similarity=0.292  Sum_probs=193.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+++.. +++.||+|.+........      .    ....+.+|+++++.++||||+++++.+.. ..
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~------~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (305)
T cd05609           6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILR------N----QIQQVFVERDILTFAENPFVVSMFCSFETKRH   75 (305)
T ss_pred             eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhH------H----HHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE
Confidence            478999999999999875 578999999864311000      0    11257789999999999999999998765 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++.....++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            68999999999999999653   358899999999999999999998  5699999999999999999999999999874


Q ss_pred             cccCCCc------------ceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Q psy9535         272 SETSNMK------------TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  338 (593)
Q Consensus       272 ~~~~~~~------------~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~  338 (593)
                      .......            ........|+..|+|||.+ ...++.++|||||||++|||++|..||.+............
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~  230 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS  230 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            2111000            0011234688999999976 44678899999999999999999999976544333332222


Q ss_pred             hcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhccccc
Q psy9535         339 QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVC  395 (593)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~~~  395 (593)
                      .....+.     ...    .....+..++.+||+.+|++||++.++.+.|+...+..
T Consensus       231 ~~~~~~~-----~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         231 DDIEWPE-----GDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             cccCCCC-----ccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            2111111     000    12223456778999999999999988888888755543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.1e-35  Score=305.19  Aligned_cols=239  Identities=28%  Similarity=0.378  Sum_probs=186.7

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+++.. +++.||+|.+........          .....+.+|++++++++||||+++++++.+ ..
T Consensus         6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (290)
T cd05580           6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKL----------KQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN   75 (290)
T ss_pred             EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence            578999999999999875 689999999864321100          012257899999999999999999998876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..++...+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg~~~~  150 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGFAKR  150 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence            68999999999999999764   458899999999999999999998  5699999999999999999999999999886


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ....      .....|++.|+|||.+. ...+.++||||||+++|||++|+.||.................+.+..    
T Consensus       151 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----  220 (290)
T cd05580         151 VKGR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF----  220 (290)
T ss_pred             cCCC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCcc----
Confidence            5432      22357899999999764 456788999999999999999999998765433333333222221111    


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIV  385 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~  385 (593)
                              ....+..++.+||..+|.+||     ++.|++
T Consensus       221 --------~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         221 --------FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             --------CCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence                    122345567899999999999     555553

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.2e-36  Score=305.99  Aligned_cols=254  Identities=22%  Similarity=0.282  Sum_probs=183.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +|..||+|.+.........           ...+.+|++++++++||||+++++++.+ ..
T Consensus         5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~-----------~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   73 (284)
T cd07839           5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-----------PSSALREICLLKELKHKNIVRLYDVLHSDKK   73 (284)
T ss_pred             EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccC-----------ccchhHHHHHHHhcCCCCeeeHHHHhccCCc
Confidence            468999999999999875 6899999998643211100           0136789999999999999999998765 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|+||+. |+|.+++....  ..+++.....++.|+++||.|||+  .+|+||||||+||+++.++.+||+|||+++.
T Consensus        74 ~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  148 (284)
T cd07839          74 LTLVFEYCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLARA  148 (284)
T ss_pred             eEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEcCCCcEEECccchhhc
Confidence            689999996 68888876532  458999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhhcCcc-----
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVPV-----  343 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~-~~~~~~~~~~~~~-----  343 (593)
                      ......   ......|++.|+|||.+.+  .++.++|||||||++|||+||..|+...... .............     
T Consensus       149 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07839         149 FGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW  225 (284)
T ss_pred             cCCCCC---CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHh
Confidence            433211   1123467899999997644  3688999999999999999999986543322 1111111100000     


Q ss_pred             ---ccccc-----cccC--CC--CHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 ---REVLD-----KEAG--EW--NETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ---~~~~~-----~~~~--~~--~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         ....+     ....  .+  ....+...+..++.+||+.||.+|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence               00000     0000  00  00112334556778999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0610|consensus

Probab=100.00  E-value=6.9e-36  Score=303.55  Aligned_cols=247  Identities=26%  Similarity=0.351  Sum_probs=195.2

Q ss_pred             CcccccCceEEEEEEEcC-CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~~-g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      ++||.|.-|+||++++++ +..+|+|++.+....+.          ..+.+.+.|-+||+.+.||.++.||+.++. ...
T Consensus        83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~r----------kKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASR----------KKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhh----------hHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            579999999999999874 58899999976532221          113356778999999999999999998876 566


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      |||||||+||+|..+++++.+ ..+++..+..++.+++-||+|||-.+  ||.|||||+||||.++|++.|+||-|+...
T Consensus       153 cl~meyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccccC
Confidence            899999999999998877554 56899999999999999999999854  999999999999999999999999986432


Q ss_pred             ccC--------------------------------C-C--------------------cceeeccccCCCCcCCcccccC
Q psy9535         273 ETS--------------------------------N-M--------------------KTMYTENLTGTRPYMPPEAMHC  299 (593)
Q Consensus       273 ~~~--------------------------------~-~--------------------~~~~~~~~~GT~~Y~APE~~~~  299 (593)
                      ...                                . .                    ....+..++||-.|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            100                                0 0                    0011234679999999998865


Q ss_pred             -CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCC
Q psy9535         300 -QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKR  378 (593)
Q Consensus       300 -~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~R  378 (593)
                       ..+.++|+|+|||++|||+.|..||.+.+....+..++.+...+++..          .+....+++|.+-+..||.+|
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~----------~vs~~akDLIr~LLvKdP~kR  379 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP----------EVSSAAKDLIRKLLVKDPSKR  379 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC----------cchhHHHHHHHHHhccChhhh
Confidence             478899999999999999999999999877777777776655544321          233445667778889999999


Q ss_pred             CC----hHHH
Q psy9535         379 AS----MRDI  384 (593)
Q Consensus       379 Ps----m~eV  384 (593)
                      -.    +.||
T Consensus       380 lg~~rGA~eI  389 (459)
T KOG0610|consen  380 LGSKRGAAEI  389 (459)
T ss_pred             hccccchHHh
Confidence            88    5555

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.2e-35  Score=305.76  Aligned_cols=257  Identities=25%  Similarity=0.339  Sum_probs=188.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|... +|+.||||.+..........  ..      ...+.+|++++++++|+||+++++++.+ ..
T Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~--~~------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   76 (298)
T cd07841           5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKD--GI------NFTALREIKLLQELKHPNIIGLLDVFGHKSN   76 (298)
T ss_pred             eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccc--hh------hHHHHHHHHHHhhcCCCCChhhhheeecCCE
Confidence            568999999999999875 68999999997542211001  00      1146789999999999999999998876 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+ +|+|.+++....  ..+++..+..++.|+++||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~~  151 (298)
T cd07841          77 INLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARS  151 (298)
T ss_pred             EEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCChhhEEEcCCCCEEEccceeeee
Confidence            68999999 999999987532  368999999999999999999998  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-Cccc----
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-VPVR----  344 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~-~~~~----  344 (593)
                      .......   .....+++.|+|||.+.+  .++.++|||||||++|||++|.+||................ .+..    
T Consensus       152 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (298)
T cd07841         152 FGSPNRK---MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP  228 (298)
T ss_pred             ccCCCcc---ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence            5443211   122357889999997643  46789999999999999999988887654433222221110 0000    


Q ss_pred             ------cccccc-cCCCC----HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 ------EVLDKE-AGEWN----ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ------~~~~~~-~~~~~----~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                            ...... .....    .......+..++.+||..+|++|||+.||++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                  000000 00000    0112234556778999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.9e-36  Score=304.23  Aligned_cols=245  Identities=27%  Similarity=0.353  Sum_probs=180.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHH-HhcCCCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT-LSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~i-l~~l~HpNIv~l~g~~~~-~  190 (593)
                      .+.||+|+||.||+|+.. +|..||||+++....     ... +      ..+..|+.+ ++.++||||+++++++.. .
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~-~------~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~   73 (283)
T cd06617           6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-----SQE-Q------KRLLMDLDISMRSVDCPYTVTFYGALFREG   73 (283)
T ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-----cHH-H------HHHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence            468999999999999875 689999999864311     011 1      124456554 666789999999998865 5


Q ss_pred             cceEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ..++||||++ |+|.+++... .....+++..+..++.|++.||.|||+. .+++||||||+|||++.++.+||+|||++
T Consensus        74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~i~h~dlkp~nil~~~~~~~kl~dfg~~  151 (283)
T cd06617          74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK-LSVIHRDVKPSNVLINRNGQVKLCDFGIS  151 (283)
T ss_pred             cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            6789999996 7888887653 2235689999999999999999999972 16999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC-----CCCCcchhhHHHHHHHHHHhCCCCCCCCch-HHHHHHHHhhcCcc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGVILLELLTGMKPIDDNNT-ILYYYLVVEQEVPV  343 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~~ksDVwSfGvvl~ElltG~~P~~~~~~-~~~~~~~~~~~~~~  343 (593)
                      +.......    .....|+..|+|||.+.+     .++.++|+|||||++|||++|+.||..... ........... . 
T Consensus       152 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-  225 (283)
T cd06617         152 GYLVDSVA----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-S-  225 (283)
T ss_pred             cccccccc----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC-C-
Confidence            76533211    122468999999997642     357899999999999999999999975322 12111111111 0 


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...        +.......+..++.+||..+|++||++.+|++
T Consensus       226 ~~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 PQL--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000        01112233455778999999999999999865

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=303.67  Aligned_cols=197  Identities=27%  Similarity=0.417  Sum_probs=159.9

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ...+.||+|+||.||+|+.+ +++.||||.+........            ...+.+|++++++++||||+++++++.+ 
T Consensus         8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~------------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (291)
T cd07844           8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA------------PFTAIREASLLKDLKHANIVTLHDIIHTK   75 (291)
T ss_pred             eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC------------chhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence            34678999999999999875 689999999864321110            0136689999999999999999998876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+. ++|.+++....  ..+++.....++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~  150 (291)
T cd07844          76 KTLTLVFEYLD-TDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLA  150 (291)
T ss_pred             CeEEEEEecCC-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCHHHEEEcCCCCEEECccccc
Confidence            56689999998 59999887543  368899999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNN  328 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~  328 (593)
                      +....... .  .....++..|+|||.+.+  .++.++|||||||++|||++|+.||....
T Consensus       151 ~~~~~~~~-~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         151 RAKSVPSK-T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             cccCCCCc-c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            75432211 1  112357889999997643  46889999999999999999999997643

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.5e-35  Score=304.29  Aligned_cols=256  Identities=20%  Similarity=0.277  Sum_probs=184.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEeccc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNNIM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~~~  191 (593)
                      .+.||+|+||.||+|+.. +|+.||||.+.......    ..       ...+.+|+.++++++ ||||+++++++....
T Consensus         6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~----~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   74 (295)
T cd07837           6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE----GI-------PPTALREISLLQMLSESIYIVRLLDVEHVEE   74 (295)
T ss_pred             eeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc----CC-------chHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence            578999999999999875 68999999875432110    00       114778999999995 699999999876532


Q ss_pred             ------ceEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC-CCccE
Q psy9535         192 ------NCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPK  262 (593)
Q Consensus       192 ------~~lV~Ey~~~GsL~~~L~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~-~~~~K  262 (593)
                            .++||||+++ +|.+++.....  ...+++..+..++.|++.||.|||+  ++|+||||||+||+++. ++.+|
T Consensus        75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~~~~~~k  151 (295)
T cd07837          75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLK  151 (295)
T ss_pred             CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEecCCCeEE
Confidence                  4899999985 89888865432  2468999999999999999999998  56999999999999998 89999


Q ss_pred             EeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q psy9535         263 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  340 (593)
Q Consensus       263 l~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~  340 (593)
                      |+|||+++.......  . .....+++.|+|||.+.+  .++.++|||||||++|||++|..||................
T Consensus       152 l~dfg~~~~~~~~~~--~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~  228 (295)
T cd07837         152 IADLGLGRAFSIPVK--S-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL  228 (295)
T ss_pred             EeecccceecCCCcc--c-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            999999875432211  0 112357889999997643  46889999999999999999999998755443332222110


Q ss_pred             -Ccccccccc-----c---cCCCCH-------HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         341 -VPVREVLDK-----E---AGEWNE-------THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       341 -~~~~~~~~~-----~---~~~~~~-------~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       .+.......     .   ...+.+       ......+..++.+||..+|.+||++.|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence             010000000     0   000000       112233556778999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=297.88  Aligned_cols=246  Identities=25%  Similarity=0.407  Sum_probs=188.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|... ++..+|+|.+......      .       ...+.+|++++++++||||++++|++.+ ..
T Consensus         8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~-------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (262)
T cd06613           8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD------D-------FEIIQQEISMLKECRHPNIVAYFGSYLRRDK   74 (262)
T ss_pred             EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh------h-------HHHHHHHHHHHHhCCCCChhceEEEEEeCCE
Confidence            578999999999999874 5788999998643110      0       1257899999999999999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .+++|||+++++|.+++....  ..++...+..++.|++.||.|||+  .+|+||||||+||++++++.+||+|||++..
T Consensus        75 ~~l~~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~  150 (262)
T cd06613          75 LWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVSAQ  150 (262)
T ss_pred             EEEEEeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCChhhEEECCCCCEEECccccchh
Confidence            689999999999999887532  458899999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC----CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~----~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ......   ......|+..|+|||.+..    .++.++|||||||++|||++|+.||...................... 
T Consensus       151 ~~~~~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-  226 (262)
T cd06613         151 LTATIA---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKL-  226 (262)
T ss_pred             hhhhhh---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccc-
Confidence            433211   1123568999999997643    57789999999999999999999997654332222221111110000 


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                            .........+..++.+||..+|.+||++.+|+.
T Consensus       227 ------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         227 ------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  011122234556778999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.7e-35  Score=305.65  Aligned_cols=243  Identities=27%  Similarity=0.424  Sum_probs=187.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +|..||+|.+......   . .  +.    ...+.+|++++++++|||++++++++.+ ..
T Consensus        30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~---~-~--~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (317)
T cd06635          30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ---S-N--EK----WQDIIKEVKFLQRIKHPNSIEYKGCYLREHT   99 (317)
T ss_pred             hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC---c-h--HH----HHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence            468999999999999864 6889999998643111   1 0  10    1247889999999999999999998876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+. |+|.+.+...  ..++++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++..
T Consensus       100 ~~lv~e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~  174 (317)
T cd06635         100 AWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASI  174 (317)
T ss_pred             EEEEEeCCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcccEEECCCCCEEEecCCCccc
Confidence            689999996 6888877643  2468999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~----~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ....       ....|++.|+|||.+.    +.++.++|||||||++|||++|+.||.................+.    
T Consensus       175 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~----  243 (317)
T cd06635         175 ASPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT----  243 (317)
T ss_pred             cCCc-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC----
Confidence            4321       2346899999999752    357889999999999999999999997654433333322221111    


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL  388 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L  388 (593)
                            .........+..++.+||+.+|.+||++.+|++.+
T Consensus       244 ------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         244 ------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             ------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                  01112223456677899999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.6e-35  Score=302.10  Aligned_cols=255  Identities=24%  Similarity=0.320  Sum_probs=187.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|+.. +|..||||.+.......     .       ...+.+|+.++++++||||+++++++.. ..
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   72 (284)
T cd07836           5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG-----T-------PSTAIREISLMKELKHENIVRLHDVIHTENK   72 (284)
T ss_pred             eeeeccCCceEEEEEEECCCCeEEEEEEeccccccc-----c-------hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc
Confidence            578999999999999975 68899999986432110     0       1136789999999999999999998876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||++ |+|.+++........+++..+..++.|++.||.|||+  .+++||||||+||++++++.+||+|||+++.
T Consensus        73 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~  149 (284)
T cd07836          73 LMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLARA  149 (284)
T ss_pred             EEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence            689999998 5898888765444568999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-Cccccc--
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-VPVREV--  346 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~-~~~~~~--  346 (593)
                      ......   ......||+.|+|||.+.+  .++.++|||||||++|||++|+.||................ .+....  
T Consensus       150 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd07836         150 FGIPVN---TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP  226 (284)
T ss_pred             hcCCcc---ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHH
Confidence            433211   1122457899999997643  35789999999999999999999997654322222111110 000000  


Q ss_pred             -------cccccCCCC-------HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 -------LDKEAGEWN-------ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 -------~~~~~~~~~-------~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                             .........       .......+..++.+|++.+|.+||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         227 GISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                   000000000       0112334556778999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.8e-35  Score=297.22  Aligned_cols=248  Identities=26%  Similarity=0.391  Sum_probs=189.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec---
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~---  189 (593)
                      .+.||.|+||.||++... +|..||+|.+.....    ...  .     ...+.+|++++++++||||+++++++..   
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~--~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (265)
T cd08217           5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM----TEK--E-----KQQLVSEVNILRELKHPNIVRYYDRIIDRSN   73 (265)
T ss_pred             eeeeccCCCeEEEEeeecCCCCEEEEEEEecccC----CHH--H-----HHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence            578999999999999864 688999999864311    100  1     1257889999999999999999997753   


Q ss_pred             ccceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CCCeEecccCCCCeeecCCCccEEee
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSL---SKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~---~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                      ...+++|||+++|+|.+++.... ...++++.....++.|++.||.|||..   ..+|+||||||+||+++.++.+||+|
T Consensus        74 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d  153 (265)
T cd08217          74 QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGD  153 (265)
T ss_pred             CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEec
Confidence            34589999999999999997532 235789999999999999999999933   26699999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      ||++........   ......|++.|+|||.+. ..++.++||||||+++|+|++|+.||...............  ...
T Consensus       154 ~g~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~  228 (265)
T cd08217         154 FGLAKILGHDSS---FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--KFR  228 (265)
T ss_pred             ccccccccCCcc---cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC--CCC
Confidence            999886543321   122356899999999764 45788999999999999999999999875432222221111  111


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .+         +......+..++.+|++.+|++||++.+|++
T Consensus       229 ~~---------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         229 RI---------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             CC---------ccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            10         1112234556778999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.1e-36  Score=306.77  Aligned_cols=241  Identities=25%  Similarity=0.398  Sum_probs=184.8

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      ..||+|+||.||++... ++..||||.+....      ...       ...+.+|+.++++++||||+++++.+.. ...
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~-------~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~   94 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK------QQR-------RELLFNEVVIMRDYHHENVVDMYNSYLVGDEL   94 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecch------HHH-------HHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence            46999999999999864 68899999985321      010       1247899999999999999999987765 566


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++++|.+++..    ..+++.....++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++...
T Consensus        95 ~lv~e~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (292)
T cd06658          95 WVVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV  168 (292)
T ss_pred             EEEEeCCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence            899999999999998853    347899999999999999999998  56999999999999999999999999998754


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  351 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (593)
                      .....   ......||+.|+|||.+. ..++.++|||||||++|||++|+.||................   ...+..  
T Consensus       169 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~--  240 (292)
T cd06658         169 SKEVP---KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL---PPRVKD--  240 (292)
T ss_pred             ccccc---cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---CCcccc--
Confidence            32211   112346899999999764 357889999999999999999999998654433222211110   010000  


Q ss_pred             CCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         352 GEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       352 ~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                          .......+..++.+||..+|.+|||+.|+++
T Consensus       241 ----~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         241 ----SHKVSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             ----ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                0012234556778999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.6e-35  Score=302.31  Aligned_cols=196  Identities=26%  Similarity=0.378  Sum_probs=158.0

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|... +|..||+|.+.......  .          ...+.+|+.++++++|+||+++++++.. .
T Consensus         9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~----------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   76 (291)
T cd07870           9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--V----------PFTAIREASLLKGLKHANIVLLHDIIHTKE   76 (291)
T ss_pred             EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--C----------cHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence            3578999999999999864 68899999986432111  0          1136789999999999999999998866 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+. ++|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        77 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  151 (291)
T cd07870          77 TLTFVFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFGLAR  151 (291)
T ss_pred             eEEEEEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEEcCCCcEEEecccccc
Confidence            5689999995 78887775432  357788888999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNN  328 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~  328 (593)
                      .......   ......+++.|+|||.+.+  .++.++|||||||++|||++|+.||....
T Consensus       152 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         152 AKSIPSQ---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             ccCCCCC---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            5432211   1123457899999998743  46789999999999999999999997644

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-36  Score=314.57  Aligned_cols=255  Identities=23%  Similarity=0.371  Sum_probs=183.6

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI-  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~-  190 (593)
                      +.++||+|+||.||+|+.. +|+.||||.+.....   .  ..       ...+.+|+.++++++||||+++++++... 
T Consensus         9 i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~---~--~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (336)
T cd07849           9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH---Q--TF-------CQRTLREIKILRRFKHENIIGILDIIRPPS   76 (336)
T ss_pred             EEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc---c--hh-------HHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence            4689999999999999864 689999999853210   0  00       12467899999999999999999977542 


Q ss_pred             -----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         191 -----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       191 -----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                           ..++|+||+. ++|.+.+..    ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|
T Consensus        77 ~~~~~~~~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~--~~ivH~dlkp~Nill~~~~~~kl~d  149 (336)
T cd07849          77 FESFNDVYIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKICD  149 (336)
T ss_pred             ccccceEEEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEECc
Confidence                 3589999986 588877753    358999999999999999999998  5699999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--hcC
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEV  341 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~--~~~  341 (593)
                      ||+++................||+.|+|||.+.  ..++.++|||||||++|||++|+.||........+.....  ...
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~  229 (336)
T cd07849         150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP  229 (336)
T ss_pred             ccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            999876543221111123357899999999753  3478899999999999999999999976543221111111  000


Q ss_pred             c---cccccccc------------cCCCC--HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 P---VREVLDKE------------AGEWN--ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~---~~~~~~~~------------~~~~~--~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +   .....+..            ...+.  .......+..++.+||+.+|++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~  291 (336)
T cd07849         230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA  291 (336)
T ss_pred             CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0   00000000            00000  0011233556778999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=306.48  Aligned_cols=254  Identities=25%  Similarity=0.345  Sum_probs=190.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|... ++..||+|.+.......    .  .    ....+.+|++++++++||||+++++.+.. ..
T Consensus         6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~----~--~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   75 (316)
T cd05574           6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK----R--N----KVKRVLTEQEILATLDHPFLPTLYASFQTETY   75 (316)
T ss_pred             eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch----H--H----HHHHHHHHHHHHHhCCCCCchhheeeeecCCE
Confidence            578999999999999875 58999999986532110    0  0    12257889999999999999999998866 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++..
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            689999999999999987532 3568999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCc--------------------------ceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCC
Q psy9535         272 SETSNMK--------------------------TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI  324 (593)
Q Consensus       272 ~~~~~~~--------------------------~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~  324 (593)
                      .......                          ........||..|+|||++. ..++.++|||||||++|||++|+.||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            4321100                          00112346899999999764 45788999999999999999999999


Q ss_pred             CCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         325 DDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ........+............          .......+..++.+||+.+|++||+....++.+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         233 KGSNRDETFSNILKKEVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCchHHHHHHHhcCCccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            765544333332222111110          00123445667789999999999994444444433

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.8e-35  Score=302.42  Aligned_cols=254  Identities=22%  Similarity=0.285  Sum_probs=186.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec---
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~---  189 (593)
                      .+.||+|+||.||+|... +++.||+|.++......    ..       ...+.+|+.++++++||||+++++++..   
T Consensus        10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~-------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   78 (293)
T cd07843          10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE----GF-------PITSLREINILLKLQHPNIVTVKEVVVGSNL   78 (293)
T ss_pred             hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc----cc-------hhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence            478999999999999976 58899999986442110    00       1136789999999999999999998754   


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+. ++|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~lv~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~~l~d~g~~  153 (293)
T cd07843          79 DKIYMVMEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLA  153 (293)
T ss_pred             CcEEEEehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCcEEEeecCce
Confidence            45689999997 59999887543  368999999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-Cccc--
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-VPVR--  344 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~-~~~~--  344 (593)
                      +....... .  .....|++.|+|||.+.+  ..+.++|+|||||++|||++|..||................ .+..  
T Consensus       154 ~~~~~~~~-~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
T cd07843         154 REYGSPLK-P--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI  230 (293)
T ss_pred             eeccCCcc-c--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence            86544321 1  122457899999997743  35789999999999999999999998654332222211100 0000  


Q ss_pred             ----------c------ccccc-cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 ----------E------VLDKE-AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ----------~------~~~~~-~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                .      ..... ...+....+...+..++.+||+.+|++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                      0      00000 000111112344566778999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.9e-35  Score=294.93  Aligned_cols=247  Identities=32%  Similarity=0.508  Sum_probs=188.2

Q ss_pred             CCcccccCceEEEEEEEcC-----CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         114 GNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~-----g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      .+.||+|+||.||+|+...     +..||+|.+......     .       ....+.+|+..+.+++||||+++++++.
T Consensus         4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~   71 (258)
T smart00219        4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-----Q-------QIEEFLREARIMRKLDHPNIVKLLGVCT   71 (258)
T ss_pred             cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-----H-------HHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence            5789999999999998753     378999998543110     0       1225889999999999999999999887


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      + ...+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||
T Consensus        72 ~~~~~~~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~--~~~~h~dl~~~nil~~~~~~~~l~dfg  148 (258)
T smart00219       72 EEEPLMIVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFG  148 (258)
T ss_pred             CCCeeEEEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhc--CCeeecccccceEEEccCCeEEEcccC
Confidence            6 566899999999999999975332 228999999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      +++.........  .....+++.|+|||.+. ..++.++||||+||++|||++ |..||..................  .
T Consensus       149 ~~~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~  224 (258)
T smart00219      149 LSRDLYDDDYYK--KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL--P  224 (258)
T ss_pred             Cceecccccccc--cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--C
Confidence            988665432111  11234788999999764 457889999999999999998 88888764433322222211110  0


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL  388 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L  388 (593)
                      .     ...    ....+..++.+|+..+|++|||+.|+++.|
T Consensus       225 ~-----~~~----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 K-----PEN----CPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             C-----CCc----CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0     001    222344567799999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=301.41  Aligned_cols=242  Identities=26%  Similarity=0.407  Sum_probs=185.1

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC---CCceeeEEEEEec
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLLRLLGLCNN  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~---HpNIv~l~g~~~~  189 (593)
                      .+.||+|+||.||+|.. .+|..||||.+.....     ...       ...+.+|+.++++++   |||++++++++.+
T Consensus         6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-----~~~-------~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~   73 (277)
T cd06917           6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-----DDD-------VSDIQREVALLSQLRQSQPPNITKYYGSYLK   73 (277)
T ss_pred             hhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-----chh-------HHHHHHHHHHHHHhccCCCCCeeeEeeeeee
Confidence            57899999999999987 4689999999854211     011       124788999999987   9999999998866


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...++||||+++++|.+++..    ..+++.....++.|++.||.|||+  .+|+||||+|+||+++.++.++|+|||+
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~  147 (277)
T cd06917          74 GPRLWIIMEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFGV  147 (277)
T ss_pred             CCEEEEEEecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHHEEEcCCCCEEEccCCc
Confidence             456899999999999998864    268899999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      +........   ......|+..|+|||.+..  .++.++|||||||++|||++|..||.............  .......
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--~~~~~~~  222 (277)
T cd06917         148 AALLNQNSS---KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP--KSKPPRL  222 (277)
T ss_pred             eeecCCCcc---ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc--cCCCCCC
Confidence            876544321   1123468999999997643  35789999999999999999999997654322111110  0000110


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                              ........+..++.+||..+|++||++.|++.
T Consensus       223 --------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         223 --------EDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             --------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                    01001223455677999999999999999965

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.2e-35  Score=295.32  Aligned_cols=249  Identities=30%  Similarity=0.456  Sum_probs=187.4

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|... +++.||+|.+......    ..       ....+.+|++++++++|+||+++++++.+ .
T Consensus         4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   72 (264)
T cd06626           4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND----PK-------TIKEIADEMKVLELLKHPNLVKYYGVEVHRE   72 (264)
T ss_pred             eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc----hH-------HHHHHHHHHHHHHhCCCCChhheeeeEecCC
Confidence            4578999999999999865 6899999998654211    00       12358899999999999999999998765 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++|+||+++++|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.
T Consensus        73 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~kl~d~g~~~  147 (264)
T cd06626          73 KVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAV  147 (264)
T ss_pred             EEEEEEecCCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccccccc
Confidence            668999999999999998753   347888999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCccee-eccccCCCCcCCcccccC-C---CCCcchhhHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhhcCccc
Q psy9535         271 MSETSNMKTMY-TENLTGTRPYMPPEAMHC-Q---ISTKTDVFSYGVILLELLTGMKPIDDNNTILY-YYLVVEQEVPVR  344 (593)
Q Consensus       271 ~~~~~~~~~~~-~~~~~GT~~Y~APE~~~~-~---~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~-~~~~~~~~~~~~  344 (593)
                      ........... .....|++.|+|||.+.. .   .+.++||||||+++|||++|+.||........ .........+  
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--  225 (264)
T cd06626         148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP--  225 (264)
T ss_pred             ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCC--
Confidence            65433221111 123568899999998753 2   67899999999999999999999975432211 1111111110  


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      . +    ....  .+...+..++.+||+.+|++||++.|++.
T Consensus       226 ~-~----~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         226 P-I----PDSL--QLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             C-C----Cccc--ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0 0    0110  11223445677999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-35  Score=297.48  Aligned_cols=255  Identities=25%  Similarity=0.398  Sum_probs=187.1

Q ss_pred             CCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      .++.||+|+||.||+|+. .+++.||+|.+..........    .   .....+.+|+.++++++||||+++++++.+ .
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~----~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   76 (268)
T cd06630           4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQ----E---EVVEALRKEIRLMARLNHPHIIRMLGATCEDS   76 (268)
T ss_pred             ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhH----H---HHHHHHHHHHHHHHHcCCCceehhhceeccCC
Confidence            368899999999999986 468999999986432111100    0   012358899999999999999999998876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC-ccEEeecccc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFGIV  269 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~-~~Kl~DFGla  269 (593)
                      ..++||||+++++|.+++...   .++++..+..++.|++.||.|||+  ++++||||||+||+++.++ .+||+|||++
T Consensus        77 ~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~--~~i~H~~i~~~nil~~~~~~~~~l~dfg~~  151 (268)
T cd06630          77 HFNLFVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAA  151 (268)
T ss_pred             eEEEEEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEcccccc
Confidence            568999999999999998753   368899999999999999999998  5699999999999998775 6999999998


Q ss_pred             eecccCCCc-ceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         270 KMSETSNMK-TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       270 ~~~~~~~~~-~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      +........ ........||..|+|||.+. ..++.++||||+||++|||++|..||................ .  ...
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~--~~~  228 (268)
T cd06630         152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA-S--ATT  228 (268)
T ss_pred             cccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh-c--cCC
Confidence            765432111 11122356899999999764 457889999999999999999999996532211111110000 0  000


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .+    ..+......+..++.+|+..+|++||++.++++
T Consensus       229 ~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 AP----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CC----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            00    011122334555677999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.4e-35  Score=294.64  Aligned_cols=244  Identities=25%  Similarity=0.371  Sum_probs=186.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||++... +++.+|||.+.....    ...  .     ...|.+|++++++++||||+++++.+.. ..
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~--~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (256)
T cd08220           5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM----TKD--E-----RLAAQNECQVLKLLSHPNIIEYYENFLEDKA   73 (256)
T ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEEecccc----ccH--H-----HHHHHHHHHHHhhCCCCchhheeeeEecCCE
Confidence            468999999999999864 688999999864311    000  1     1258899999999999999999987754 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC-CccEEeecccce
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVK  270 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~-~~~Kl~DFGla~  270 (593)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+||+++.+ +.+||+|||+++
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~  150 (256)
T cd08220          74 LMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISK  150 (256)
T ss_pred             EEEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence            689999999999999997643 3458999999999999999999998  569999999999999854 568999999988


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .......    .....|++.|+|||.+.. ..+.++|||||||++|+|++|..||...+.............  ....  
T Consensus       151 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--  222 (256)
T cd08220         151 ILSSKSK----AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF--APIS--  222 (256)
T ss_pred             ecCCCcc----ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC--CCCC--
Confidence            6543221    123568999999997754 468899999999999999999999976543322222211110  1110  


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        ..     ....+..++.+||..+|++|||+.|+++
T Consensus       223 --~~-----~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         223 --DR-----YSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             --CC-----cCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence              01     1223445667999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.1e-35  Score=299.81  Aligned_cols=241  Identities=29%  Similarity=0.489  Sum_probs=186.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|... ++..||||.+.....     ..  .     ...|.+|+.++++++||||+++++++.. ..
T Consensus         9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-----~~--~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   76 (277)
T cd06641           9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-----ED--E-----IEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   76 (277)
T ss_pred             heeEeecCCeEEEEEEECCCCcEEEEEEeccccc-----hH--H-----HHHHHHHHHHHHhcCCCCEeEEEEEEEeCCe
Confidence            578999999999999864 688999998753210     00  0     1258899999999999999999998866 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++..    ..+++.....++.|++.|+.|||+  .+++|+||||+||+++.++.++|+|||+++.
T Consensus        77 ~~lv~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06641          77 LWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQ  150 (277)
T ss_pred             EEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHcc--CCeecCCCCHHhEEECCCCCEEEeeccccee
Confidence            7899999999999998863    358899999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......|+..|+|||.+. ...+.++|||||||++|||++|..||.................+  . +.  
T Consensus       151 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~-~~--  222 (277)
T cd06641         151 LTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP--T-LE--  222 (277)
T ss_pred             cccchh---hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC--C-CC--
Confidence            543211   112346899999999764 45788999999999999999999999764433222221111110  0 10  


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       .     .....+..++.+||+.+|++||++.++++
T Consensus       223 -~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         223 -G-----NYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             -c-----ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence             1     11123445677999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0033|consensus

Probab=100.00  E-value=3.2e-37  Score=293.60  Aligned_cols=245  Identities=24%  Similarity=0.395  Sum_probs=192.5

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|.|+.||++.. .+|+.+|+|.+..+.-...    .       .+...+|+.|-+.|+|||||+|.....+ ..
T Consensus        16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~----~-------~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~   84 (355)
T KOG0033|consen   16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR----D-------FQKLEREARICRKLQHPNIVRLHDSIQEESF   84 (355)
T ss_pred             HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc----c-------HHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence            46799999999999865 4799999998865422111    1       1246789999999999999999987655 67


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec---CCCccEEeeccc
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGI  268 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~---~~~~~Kl~DFGl  268 (593)
                      .++|+|+|.||+|..-+-.+   ..+++..+-..+.||++||.|+|.  ++|||||+||+|+||.   ..--+||+|||+
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~~FGv  159 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLADFGL  159 (355)
T ss_pred             eEEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeecccce
Confidence            79999999999997766543   346777888899999999999998  6699999999999995   345689999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      |.......    .....+|||+|||||++.. .++..+||||.|||||-|+.|.+||.+++....+..+..+...++.  
T Consensus       160 Ai~l~~g~----~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~--  233 (355)
T KOG0033|consen  160 AIEVNDGE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS--  233 (355)
T ss_pred             EEEeCCcc----ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC--
Confidence            98776332    2345789999999998754 6888899999999999999999999997777777776666544332  


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                          ..|+  .+....+.++.+++..||.+|.|+.|.++
T Consensus       234 ----~~w~--~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  234 ----PEWD--TVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ----cccC--cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                1111  12223455677999999999999998753

>KOG4645|consensus

Probab=100.00  E-value=3.9e-37  Score=346.60  Aligned_cols=248  Identities=29%  Similarity=0.392  Sum_probs=190.8

Q ss_pred             CCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ..++.||.|.||.||-|.. .+|...|||.++-......           ......+|+.++..++|||+|+.+|+-.. 
T Consensus      1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k-----------~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHK-----------TFKLIAEEMKVLEGLNHPNLVRYYGVEVHR 1306 (1509)
T ss_pred             ccccccCCcceeeeEEeecCCccchhhhhhhhcCccccc-----------cCcchHHHHHHHHhccCccccccCceeecH
Confidence            5589999999999999874 5788899998764322110           01235689999999999999999998766 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      +..+|.||||.+|+|.+.+...   .-+++.....+..|++.|+.|||+  ++||||||||+||||+.+|.+|++|||.|
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~--~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHE--HGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHh--cCceecCCCccceeeecCCcEEeecccce
Confidence            5567899999999999998752   235666666788999999999998  56999999999999999999999999999


Q ss_pred             eecccCCC-cceeeccccCCCCcCCcccccCC----CCCcchhhHHHHHHHHHHhCCCCCCCC-chHHHHHHHHhhcCcc
Q psy9535         270 KMSETSNM-KTMYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDN-NTILYYYLVVEQEVPV  343 (593)
Q Consensus       270 ~~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~----~~~ksDVwSfGvvl~ElltG~~P~~~~-~~~~~~~~~~~~~~~~  343 (593)
                      ........ .........||+.|||||++.+.    ...++||||+|||++||+||+.||... +.....+.+..+..| 
T Consensus      1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P- 1460 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP- 1460 (1509)
T ss_pred             eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC-
Confidence            87654321 01112346899999999988543    355889999999999999999999763 334444444433322 


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                ..++.+...-...+++|++.||++|.++.|+++
T Consensus      1461 ----------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1461 ----------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             ----------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence                      112235556667889999999999988877654

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-35  Score=303.66  Aligned_cols=249  Identities=29%  Similarity=0.388  Sum_probs=186.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec---
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~---  189 (593)
                      .++||.|+||.||+|... +++.+|+|.+.....     ...       ...|.+|++++++++||||++++++|..   
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   73 (287)
T cd06621           6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-----PDL-------QKQILRELEINKSCKSPYIVKYYGAFLDESS   73 (287)
T ss_pred             EEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-----hHH-------HHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence            468999999999999875 588999999864311     011       1247899999999999999999998854   


Q ss_pred             ccceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      ...++||||+++|+|.+++.... ....++......++.|++.||.|||+  .+++|+||+|+||+++.++.+||+|||+
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~  151 (287)
T cd06621          74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGV  151 (287)
T ss_pred             CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecCCeEEEeeccc
Confidence            24589999999999998876422 23458889999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCch-----HHHHHHHHhhcCc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNT-----ILYYYLVVEQEVP  342 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~-----~~~~~~~~~~~~~  342 (593)
                      +.......     .....|+..|+|||.+. ..++.++|||||||++|||++|..||.....     ............ 
T Consensus       152 ~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  225 (287)
T cd06621         152 SGELVNSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-  225 (287)
T ss_pred             cccccccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-
Confidence            87543221     12346788999999764 4578899999999999999999999976421     111111111111 


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       ....+...   ........+..++.+||..+|++|||+.||++
T Consensus       226 -~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         226 -PELKDEPG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -hhhccCCC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             11100000   00112334566778999999999999999875

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.9e-35  Score=299.26  Aligned_cols=240  Identities=23%  Similarity=0.309  Sum_probs=175.9

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHH---HHhcCCCCceeeEEEEEec-c
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ---TLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~---il~~l~HpNIv~l~g~~~~-~  190 (593)
                      .||+|+||.||+++.. +|+.||||.+..........    ..      .+.+|..   ++...+||||+.+++++.. +
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~----~~------~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~   70 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG----ET------LALNERIMLSLVSTGDCPFIVCMTYAFHTPD   70 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH----HH------HHHHHHHHHHHHhhCCCCcEeEEEEEEecCC
Confidence            4899999999999874 68999999986542211100    11      2334433   3444589999999988765 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++.....++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.
T Consensus        71 ~~~lv~e~~~~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dikp~Nil~~~~~~~~l~dfg~~~  145 (279)
T cd05633          71 KLCFILDLMNGGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLAC  145 (279)
T ss_pred             eEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcCCCCCCHHHEEECCCCCEEEccCCcce
Confidence            678999999999999988753   358999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCch--HHHHHHHHhhcCccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNT--ILYYYLVVEQEVPVREV  346 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~--~~~~~~~~~~~~~~~~~  346 (593)
                      ......     .....||+.|+|||.+.  ..++.++|||||||++|||++|..||.....  ........ ..  .   
T Consensus       146 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~--~---  214 (279)
T cd05633         146 DFSKKK-----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LT--V---  214 (279)
T ss_pred             eccccC-----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hc--C---
Confidence            543221     12346999999999764  3478899999999999999999999965321  11111100 00  0   


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~~  386 (593)
                       +...    +......+..++.+||..+|++||     ++.|+++
T Consensus       215 -~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         215 -NVEL----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             -CcCC----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence             0000    111223355667899999999999     5877754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.3e-35  Score=298.42  Aligned_cols=251  Identities=22%  Similarity=0.307  Sum_probs=182.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec--
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN--  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~--  189 (593)
                      .++||+|+||.||+|+.. +++.||+|+++......    .  .      ....+|+.++.++. ||||+++++++.+  
T Consensus         4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~----~--~------~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   71 (282)
T cd07831           4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL----E--Q------VNNLREIQALRRLSPHPNILRLIEVLFDRK   71 (282)
T ss_pred             EeeccccccceEEEEEEcCCCcEEEEEEehhccCCc----h--h------hhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence            568999999999999864 68999999986432110    0  0      12447899999885 9999999998865  


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...++||||+. |+|.+.+....  ..+++..+..++.|++.||.|||+  .+|+||||||+||+++. +.+||+|||+
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~dfg~  145 (282)
T cd07831          72 TGRLALVFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLADFGS  145 (282)
T ss_pred             CCcEEEEEecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEeccc
Confidence             45689999996 68888886532  468999999999999999999998  56999999999999999 9999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccc-
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE-  345 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~-  345 (593)
                      ++.......    .....||+.|+|||.+.  ..++.++|||||||++|||++|..||...+................+ 
T Consensus       146 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  221 (282)
T cd07831         146 CRGIYSKPP----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAE  221 (282)
T ss_pred             ccccccCCC----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            886543321    12246889999999653  34678999999999999999999999765433222211111000000 


Q ss_pred             ---------ccc----cccCCCC---HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 ---------VLD----KEAGEWN---ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ---------~~~----~~~~~~~---~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                               ..+    .......   .......+..++.+||..+|++||++.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                     000    0000000   0112344566778999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=301.27  Aligned_cols=256  Identities=25%  Similarity=0.315  Sum_probs=186.4

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|... +++.||||.++......    .       ....+.+|++++++++|+||+++++++.. .
T Consensus         5 ~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~----~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   73 (288)
T cd07833           5 VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE----D-------VKKTALREVKVLRQLRHENIVNLKEAFRRKG   73 (288)
T ss_pred             EEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc----c-------chhHHHHHHHHHHhcCCCCeeehhheEEECC
Confidence            3578999999999999876 58899999886432110    0       01247899999999999999999998866 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||++++.+..++..   ...+++..+..++.|++.||.|||+  .+|+||||||+||++++++.+||+|||++.
T Consensus        74 ~~~iv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~  148 (288)
T cd07833          74 RLYLVFEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFAR  148 (288)
T ss_pred             EEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEEeeeccc
Confidence            57899999998766655543   2358999999999999999999998  569999999999999999999999999988


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-C-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc----
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR----  344 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~----  344 (593)
                      .......  .......|+..|+|||++. . .++.++||||||+++|||++|+.||....................    
T Consensus       149 ~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (288)
T cd07833         149 ALRARPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ  226 (288)
T ss_pred             ccCCCcc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence            7554331  1122356889999999764 3 467899999999999999999999976543222111111000000    


Q ss_pred             ---------------cccccc-cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 ---------------EVLDKE-AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ---------------~~~~~~-~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                     +..+.. .....+..+...+..++.+||..+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                           000000 000001112344566778999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.5e-35  Score=298.05  Aligned_cols=239  Identities=22%  Similarity=0.306  Sum_probs=176.7

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHH---HHHHhcCCCCceeeEEEEEec-c
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE---VQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~E---v~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      .||+|+||.||+++.. +|+.||+|.+..........    +.      .+..|   +..++...||||+++++++.. .
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~----~~------~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~   70 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG----ET------LALNERIMLSLVSTGDCPFIVCMSYAFHTPD   70 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchh----HH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence            4899999999999864 68899999986532111100    00      12333   345556789999999998765 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        71 ~~~~v~e~~~g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili~~~~~~kl~dfg~~~  145 (278)
T cd05606          71 KLSFILDLMNGGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLAC  145 (278)
T ss_pred             EEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence            668999999999999988642   468999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCch---HHHHHHHHhhcCcccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNT---ILYYYLVVEQEVPVRE  345 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~---~~~~~~~~~~~~~~~~  345 (593)
                      ......     .....||..|+|||.+..  .++.++|||||||++|||++|+.||.....   ..............  
T Consensus       146 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--  218 (278)
T cd05606         146 DFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL--  218 (278)
T ss_pred             ccCccC-----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCC--
Confidence            543221     123479999999998753  478899999999999999999999976421   11111110000000  


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHHH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIVD  386 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~~  386 (593)
                            ..    .....+..++.+|+..+|.+||     ++.++++
T Consensus       219 ------~~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 ------PD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ------CC----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                  00    1122345566799999999999     8888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-35  Score=298.27  Aligned_cols=255  Identities=24%  Similarity=0.310  Sum_probs=185.9

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|++|.||+|... +|..||||++........    .       ...|.+|++++++++|||++++++++.+ ..
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----~-------~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~   72 (283)
T cd07835           4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG----V-------PSTAIREISLLKELNHPNIVRLLDVVHSENK   72 (283)
T ss_pred             heEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc----c-------hhHHHHHHHHHHhcCCCCccCHhheeccCCe
Confidence            578999999999999875 799999999864321110    0       1137789999999999999999998876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+ +++|.+++..... ..+++..+..++.|+++||.|||+  ++++||||+|+||+++.++.+||+|||+++.
T Consensus        73 ~~iv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df~~~~~  148 (283)
T cd07835          73 LYLVFEFL-DLDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARA  148 (283)
T ss_pred             EEEEEecc-CcCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence            68999999 4799998875432 368999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-ccccc--
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-PVREV--  346 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~~~~~--  346 (593)
                      ......  . .....|++.|+|||++.+  .++.++|||||||++|||++|+.||................. +....  
T Consensus       149 ~~~~~~--~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (283)
T cd07835         149 FGVPVR--T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP  225 (283)
T ss_pred             cCCCcc--c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence            432211  1 122357889999997643  357899999999999999999999976554332222211100 00000  


Q ss_pred             -----------cccccCCCC---HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 -----------LDKEAGEWN---ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 -----------~~~~~~~~~---~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                 .........   .......+..++.+||+.+|++||++.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                       000000000   0011133455677999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.8e-35  Score=304.70  Aligned_cols=258  Identities=19%  Similarity=0.285  Sum_probs=183.5

Q ss_pred             Cccccc--CceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         115 NKLGEG--QFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       115 ~~LG~G--~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..||+|  +||+||+++.. +|+.||||.+.....    . .  +    ....|.+|+.+++.++||||+++++++.. .
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~----~-~--~----~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~   72 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC----T-E--E----HLKALQNEVVLSHFFRHPNIMTSWTVFTTGS   72 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC----C-H--H----HHHHHHHHHHHHHhCCCCCcceEeeeEecCC
Confidence            356666  99999999874 799999999864311    1 1  1    02357899999999999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++|+||+.+|+|.+++.... ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+|++|||.+.
T Consensus        73 ~~~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivHrDlkp~Nill~~~~~~~~~~~~~~~  149 (328)
T cd08226          73 WLWVISPFMAYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGLSHLY  149 (328)
T ss_pred             ceEEEEecccCCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEeCCCcEEEechHHHh
Confidence            5689999999999999987643 2358899999999999999999998  569999999999999999999999998654


Q ss_pred             ecccCCCcc----eeeccccCCCCcCCcccccC---CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc
Q psy9535         271 MSETSNMKT----MYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  343 (593)
Q Consensus       271 ~~~~~~~~~----~~~~~~~GT~~Y~APE~~~~---~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~  343 (593)
                      .........    .......++..|+|||++.+   .++.++|||||||++|||++|+.||...................
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (328)
T cd08226         150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS  229 (328)
T ss_pred             hhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCC
Confidence            322111000    00111235678999998754   36789999999999999999999997654322221111110000


Q ss_pred             c-----------------------------------cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 R-----------------------------------EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~-----------------------------------~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +                                   .+.+..............+..++.+||..||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             CccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            0                                   000000000011223344566788999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-35  Score=294.51  Aligned_cols=251  Identities=29%  Similarity=0.408  Sum_probs=187.2

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      ++++.||+|+||.||+|+.. +|..||+|.+....... ...   .    ....|.+|++++++++||||+++++++.+.
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~---~----~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   76 (264)
T cd06653           5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQ-ETS---K----EVNALECEIQLLKNLRHDRIVQYYGCLRDP   76 (264)
T ss_pred             eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccc-hhh---H----HHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence            34789999999999999864 68999999875321110 000   1    123588999999999999999999988652


Q ss_pred             ---cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         191 ---MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       191 ---~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                         ..++|+||+++++|.+++...   ..+++.....++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||
T Consensus        77 ~~~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          77 EEKKLSIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECccc
Confidence               357899999999999998753   347889999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      +++................|+..|+|||.+.+ ..+.++|||||||++|||++|+.||.+............  .+... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~-  228 (264)
T cd06653         152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTKP-  228 (264)
T ss_pred             cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--CCCCC-
Confidence            98764321111111123568999999997754 578899999999999999999999976543322221111  11111 


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                             ..+..+...+..++.+||+ +|.+||+..+++.
T Consensus       229 -------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         229 -------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                   1112233446667789999 5799999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.3e-35  Score=302.77  Aligned_cols=258  Identities=21%  Similarity=0.240  Sum_probs=182.8

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      ++.+|.|+++.||++.. +|+.||||++.....    ...       ....+.+|++++++++||||+++++++.+ ...
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~----~~~-------~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC----SKE-------DLKLLQQEIITSRQLQHPNILPYVTSFIVDSEL   74 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEecccc----chh-------HHHHHHHHHHHHHhcCCcchhhhhheeecCCeE
Confidence            44555666666666554 689999999864311    000       12358899999999999999999998765 566


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      +++|||+++|+|.+++.... ...+++.....++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||.+...
T Consensus        75 ~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~--~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~  151 (314)
T cd08216          75 YVVSPLMAYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM  151 (314)
T ss_pred             EEEEeccCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCcceEEEecCCceEEecCccceee
Confidence            89999999999999997643 2358889999999999999999998  56999999999999999999999999988754


Q ss_pred             ccCCCc----ceeeccccCCCCcCCcccccC---CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCc---
Q psy9535         273 ETSNMK----TMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP---  342 (593)
Q Consensus       273 ~~~~~~----~~~~~~~~GT~~Y~APE~~~~---~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~---  342 (593)
                      ......    ........++..|+|||++..   .++.++|||||||++|||++|+.||..............+..+   
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (314)
T cd08216         152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLL  231 (314)
T ss_pred             ccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccc
Confidence            322110    111223457889999998744   3778999999999999999999999865433222111111100   


Q ss_pred             -----------ccc----ccccc----cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 -----------VRE----VLDKE----AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 -----------~~~----~~~~~----~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                 ...    ..++.    ............+..++.+||..+|++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                       000    00000    000011122334556778999999999999999865

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.9e-35  Score=302.72  Aligned_cols=247  Identities=27%  Similarity=0.337  Sum_probs=180.0

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-cc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-IM  191 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-~~  191 (593)
                      .+||+|+||.||+++.. +|+.||||.+......     .  .     ...+.+|+.++.++. ||||++++|++.. ..
T Consensus        10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~--~-----~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~   77 (288)
T cd06616          10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-----K--E-----QKRLLMDLDVVMRSSDCPYIVKFYGALFREGD   77 (288)
T ss_pred             HHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-----H--H-----HHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc
Confidence            57999999999999875 6899999998643110     1  1     225789999999996 9999999998765 45


Q ss_pred             ceEEEEeccCCCHHHHH---hhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         192 NCIVYEYMCNGSLYDRL---ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      .+++|||+. +++.++.   ... ....+++.....++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~e~~~-~~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~  154 (288)
T cd06616          78 CWICMELMD-ISLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGI  154 (288)
T ss_pred             EEEEEeccc-CCHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeecch
Confidence            688999976 4554433   221 224689999999999999999999962 3699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccC----CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~----~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      ++.......    .....||+.|+|||.+..    .++.++|||||||++|||++|+.||................ ..+
T Consensus       155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~  229 (288)
T cd06616         155 SGQLVDSIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG-DPP  229 (288)
T ss_pred             hHHhccCCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCC-CCC
Confidence            875433221    123468999999998753    47889999999999999999999997644221111111111 101


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .. ...    ........+..++.+||+.+|++|||+.+|++
T Consensus       230 ~~-~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         230 IL-SNS----EEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             cC-CCc----CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11 000    00112234556778999999999999999865

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.4e-35  Score=300.81  Aligned_cols=257  Identities=23%  Similarity=0.303  Sum_probs=182.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc--
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~--  190 (593)
                      .++||+|+||.||+|+.. +++.||||.+........ .    .      ..+.+|+.++++++||||++++++|...  
T Consensus        17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~----~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   85 (310)
T cd07865          17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG-F----P------ITALREIKILQLLKHENVVNLIEICRTKAT   85 (310)
T ss_pred             EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC-c----h------hHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence            578999999999999875 689999999864321110 0    0      1356899999999999999999988542  


Q ss_pred             -------cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         191 -------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       191 -------~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                             ..++||||+. ++|.+.+....  ..+++.....++.|++.||.|||+  .+++||||||+|||++.++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl  160 (310)
T cd07865          86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHR--NKILHRDMKAANILITKDGILKL  160 (310)
T ss_pred             cccCCCceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEECCCCcEEE
Confidence                   2389999986 58888876532  358999999999999999999998  56999999999999999999999


Q ss_pred             eecccceecccCCCc-ceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q psy9535         264 GDFGIVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  340 (593)
Q Consensus       264 ~DFGla~~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~  340 (593)
                      +|||++......... ........|+..|+|||.+.+  .++.++||||||+++|||++|+.||................
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~  240 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC  240 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999998765432211 011123467889999997644  36789999999999999999999997654322211111100


Q ss_pred             Cccc-ccc---------ccc--cCCC---CHHH-----HHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         341 VPVR-EVL---------DKE--AGEW---NETH-----VETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       341 ~~~~-~~~---------~~~--~~~~---~~~~-----~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...+ +..         +..  ....   ....     ....+..++.+||..+|.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0000 000         000  0000   0000     0123446778999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.8e-35  Score=295.91  Aligned_cols=250  Identities=26%  Similarity=0.367  Sum_probs=189.7

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccceE
Q psy9535         117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  194 (593)
Q Consensus       117 LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~l  194 (593)
                      ||+|+||.||+++.. +|+.||+|.+.......   ..       ....+.+|++++++++||||+++++.+.. ...++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~---~~-------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   70 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR---KN-------QVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYL   70 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhh---hh-------HHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEE
Confidence            689999999999986 48999999986432110   00       12257889999999999999999987765 55689


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceeccc
Q psy9535         195 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  274 (593)
Q Consensus       195 V~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~  274 (593)
                      ||||+++|+|.+++.+..   .+++..+..++.|+++||.|||+  .+++||||+|+||+++.++.+||+|||++.....
T Consensus        71 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~  145 (265)
T cd05579          71 VMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV  145 (265)
T ss_pred             EEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--cCeecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence            999999999999997643   58999999999999999999998  5699999999999999999999999999875433


Q ss_pred             CCCc-----ceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         275 SNMK-----TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       275 ~~~~-----~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ....     ........|+..|+|||... ...+.++||||||+++|||++|..||....................... 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  224 (265)
T cd05579         146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV-  224 (265)
T ss_pred             CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccc-
Confidence            2110     01122356889999999764 4477899999999999999999999987554333322222111111100 


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                               .....+..++.+||+.+|++||++.+|.+.|...
T Consensus       225 ---------~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~  258 (265)
T cd05579         225 ---------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP  258 (265)
T ss_pred             ---------cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence                     0123445667899999999999997777777654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG3653|consensus

Probab=100.00  E-value=1.4e-36  Score=312.74  Aligned_cols=253  Identities=28%  Similarity=0.433  Sum_probs=186.8

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHh--cCCCCceeeEEEEEec--
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS--QCKHVNLLRLLGLCNN--  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~--~l~HpNIv~l~g~~~~--  189 (593)
                      ...||+|+||.||||.+. ++.||||++....                ...|++|-+|.+  .++|+||++++++-..  
T Consensus       215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~----------------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t  277 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE----------------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGT  277 (534)
T ss_pred             HHHhhcCccceeehhhcc-CceeEEEecCHHH----------------HHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence            467999999999999996 5899999985321                125777777665  5689999999997643  


Q ss_pred             ---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCeEecccCCCCeeecCCC
Q psy9535         190 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-------SKPIIHRDVKSANVLLDENF  259 (593)
Q Consensus       190 ---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~IiHrDLKp~NILl~~~~  259 (593)
                         ...+||+||.++|||.++|+.    ...+|....+|+..+++||+|||+.       .++|+|||||+.|||+.+|+
T Consensus       278 ~~~~eywLVt~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl  353 (534)
T KOG3653|consen  278 ADRMEYWLVTEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL  353 (534)
T ss_pred             ccccceeEEeeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence               256899999999999999986    3589999999999999999999962       23599999999999999999


Q ss_pred             ccEEeecccceecccCCCcceeeccccCCCCcCCcccccCCCC-------CcchhhHHHHHHHHHHhCCCCCCCC-----
Q psy9535         260 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS-------TKTDVFSYGVILLELLTGMKPIDDN-----  327 (593)
Q Consensus       260 ~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-------~ksDVwSfGvvl~ElltG~~P~~~~-----  327 (593)
                      ++.|+|||||.......... .+..-+||..|||||++.+...       .+.||||+|.|||||+++-.-++.+     
T Consensus       354 TccIaDFGLAl~~~p~~~~~-d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y  432 (534)
T KOG3653|consen  354 TCCIADFGLALRLEPGKPQG-DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY  432 (534)
T ss_pred             cEEeeccceeEEecCCCCCc-chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence            99999999998776443222 2334689999999999866432       2579999999999999864443210     


Q ss_pred             -----------chHH-HHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhccc
Q psy9535         328 -----------NTIL-YYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMF  393 (593)
Q Consensus       328 -----------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~  393 (593)
                                 .... .+..++... .-+.+.+    .|....-...+...++.||..||+.|-|+.-|-+++.....
T Consensus       433 qlpfe~evG~hPt~e~mq~~VV~kK-~RP~~p~----~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  433 QLPFEAEVGNHPTLEEMQELVVRKK-QRPKIPD----AWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             cCchhHHhcCCCCHHHHHHHHHhhc-cCCCChh----hhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence                       0111 111111111 0011111    12222234567778899999999999999999888876543

>KOG0586|consensus

Probab=100.00  E-value=1.1e-35  Score=315.70  Aligned_cols=246  Identities=26%  Similarity=0.429  Sum_probs=192.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         109 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       109 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .++.+...||+|.|++|.+|++. +|..||||.+.+......           .+..+.+|+++|+.++|||||+|+.+.
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-----------~~~k~~rev~imk~l~HPnIvkl~~v~  124 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-----------KRQKLGREVDIMKSLNHPNIVKLFSVI  124 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-----------HHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            34456789999999999999864 799999999976432111           122477999999999999999999988


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      .. ...++||||+.+|.++++|.+.+.   +.......+..|+.+|++|||+  +.|+|||||++||||+.+.++||+||
T Consensus       125 ~t~~~lylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~--k~ivHrdLk~eNilL~~~mnikIaDf  199 (596)
T KOG0586|consen  125 ETEATLYLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHS--KNIVHRDLKAENILLDENMNIKIADF  199 (596)
T ss_pred             eecceeEEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhh--cceeccccchhhcccccccceeeecc
Confidence            75 677999999999999999987653   4446777789999999999998  56999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccccCC--CCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      |++........    ..+.+|++.|.|||++.+.  .++++|+||+||+||-|+.|..||++.+-......++.+...+ 
T Consensus       200 gfS~~~~~~~~----lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rI-  274 (596)
T KOG0586|consen  200 GFSTFFDYGLM----LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRI-  274 (596)
T ss_pred             ccceeeccccc----ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecc-
Confidence            99988764432    3457999999999998654  4679999999999999999999999754322211122221111 


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                             ..+-..+++.    ++.+.+..+|.+|++++++.+
T Consensus       275 -------p~~ms~dce~----lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  275 -------PFYMSCDCED----LLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             -------cceeechhHH----HHHHhhccCccccCCHHHhhh
Confidence                   1122233444    445677899999999999864

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.5e-35  Score=294.68  Aligned_cols=245  Identities=27%  Similarity=0.387  Sum_probs=186.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|... +|..||+|.+..... ..   ..       ...+.+|++++++++|+||+++++.+.. ..
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~---~~-------~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~   73 (257)
T cd08225           5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PV---KE-------KEASKKEVILLAKMKHPNIVTFFASFQENGR   73 (257)
T ss_pred             EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cc---hh-------hHHHHHHHHHHHhCCCCChhhhhheeccCCe
Confidence            578999999999999875 588999999864311 00   01       1247789999999999999999998866 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC-ccEEeecccce
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFGIVK  270 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~-~~Kl~DFGla~  270 (593)
                      .++|+||+++++|.+++.... ...+++..+..++.|++.||.|||+  .+++|+||||+||++++++ .+||+|||++.
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~  150 (257)
T cd08225          74 LFIVMEYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR  150 (257)
T ss_pred             EEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEcCCCCeEEecccccch
Confidence            689999999999999997643 2458999999999999999999998  5599999999999999875 56999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .......   ......|++.|+|||.+. ..++.++|||||||++|||++|..||...+...........  ....    
T Consensus       151 ~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~----  221 (257)
T cd08225         151 QLNDSME---LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG--YFAP----  221 (257)
T ss_pred             hccCCcc---cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--cCCC----
Confidence            6543221   112346899999999764 45788999999999999999999999764432221111111  1111    


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .....     ...+..++.+||..+|++|||+.||++
T Consensus       222 ~~~~~-----~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         222 ISPNF-----SRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCC-----CHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            11111     123455667999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7e-35  Score=298.90  Aligned_cols=242  Identities=24%  Similarity=0.397  Sum_probs=186.5

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|... +++.||+|.+....    .  ..       ...+.+|+.++++++||||+++++++.. ..
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~--~~-------~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~   90 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----Q--QR-------RELLFNEVVIMRDYQHPNIVEMYSSYLVGDE   90 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----h--hH-------HHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence            368999999999999864 68899999875321    0  00       1147789999999999999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|+||+++++|.+++..    ..+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++..
T Consensus        91 ~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~  164 (285)
T cd06648          91 LWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             EEEEEeccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChhhEEEcCCCcEEEcccccchh
Confidence            7899999999999999875    358899999999999999999998  5699999999999999999999999998775


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......|++.|+|||.+.+ .++.++|||||||++|||++|+.||...+.............+  ..... 
T Consensus       165 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~-  238 (285)
T cd06648         165 VSKEVP---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPP--KLKNL-  238 (285)
T ss_pred             hccCCc---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCC--CCccc-
Confidence            433211   1123468999999997644 5788999999999999999999999775543333322222111  11000 


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                            ......+..++.+||..+|++||++.++++
T Consensus       239 ------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         239 ------HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ------ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence                  011233556778999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.1e-34  Score=292.55  Aligned_cols=235  Identities=26%  Similarity=0.365  Sum_probs=181.1

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccceE
Q psy9535         117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  194 (593)
Q Consensus       117 LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~l  194 (593)
                      ||+|+||.||+|+.. +++.||+|.+........   ..       ...+.+|+.++++++||||+++++++.+ ...++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   70 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET---GQ-------QEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYM   70 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhh---hH-------HHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEE
Confidence            699999999999875 588999999865321110   00       1258899999999999999999998765 55689


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceeccc
Q psy9535         195 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  274 (593)
Q Consensus       195 V~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~  274 (593)
                      ||||+++|+|.+++.+.   ..+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.+||+|||+++....
T Consensus        71 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~  145 (262)
T cd05572          71 LMEYCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS  145 (262)
T ss_pred             EEecCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence            99999999999999753   348899999999999999999998  5699999999999999999999999999886543


Q ss_pred             CCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCc--hHHHHHHHHhhcCcccccccccc
Q psy9535         275 SNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNN--TILYYYLVVEQEVPVREVLDKEA  351 (593)
Q Consensus       275 ~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  351 (593)
                      ..    ......|++.|+|||.+. ..++.++|+||||+++|||++|..||....  ....+.........         
T Consensus       146 ~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------  212 (262)
T cd05572         146 GQ----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK---------  212 (262)
T ss_pred             cc----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC---------
Confidence            32    112346899999999764 457889999999999999999999997654  22222222211100         


Q ss_pred             CCCCHHHHHHHHHHHHHHhhccccCCCCC
Q psy9535         352 GEWNETHVETLIGIVFEKCCVFEKDKRAS  380 (593)
Q Consensus       352 ~~~~~~~~~~~i~~~~~~C~~~dp~~RPs  380 (593)
                      ...+ ......+..++.+||..+|++||+
T Consensus       213 ~~~~-~~~~~~~~~~i~~~l~~~p~~R~~  240 (262)
T cd05572         213 LEFP-NYIDKAAKDLIKQLLRRNPEERLG  240 (262)
T ss_pred             CCCC-cccCHHHHHHHHHHccCChhhCcC
Confidence            0000 111233556778999999999999

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0596|consensus

Probab=100.00  E-value=1.8e-35  Score=308.81  Aligned_cols=246  Identities=24%  Similarity=0.264  Sum_probs=182.1

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-~~  191 (593)
                      .++||+||.++||++...+.+.+|+|++....           .....+..|.+|+..|.+|+ |.+||+|++|... +.
T Consensus       366 lk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-----------~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~  434 (677)
T KOG0596|consen  366 LKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-----------ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY  434 (677)
T ss_pred             HHhhcCCCcceeeeeecCCCcchhhhHHHHhh-----------cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence            46899999999999988777889988774321           11112347999999999996 8999999999764 66


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .|+|||| .+-+|..+|.+... ....| .+..+..|++.|+.++|.  ++|||.||||.|+|+-+ |.+||+|||+|..
T Consensus       435 lYmvmE~-Gd~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~--~gIVHSDLKPANFLlVk-G~LKLIDFGIA~a  508 (677)
T KOG0596|consen  435 LYMVMEC-GDIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQ--HGIVHSDLKPANFLLVK-GRLKLIDFGIANA  508 (677)
T ss_pred             EEEEeec-ccccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHH--hceeecCCCcccEEEEe-eeEEeeeechhcc
Confidence            7899997 46789999987543 33345 667799999999999998  66999999999999964 6999999999987


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC------------CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC------------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  339 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~------------~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~  339 (593)
                      ...+.. ......-+||+.||+||++..            +.+.+|||||+|||||+|+.|+.||..-.....  ..   
T Consensus       509 I~~DTT-sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a--Kl---  582 (677)
T KOG0596|consen  509 IQPDTT-SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA--KL---  582 (677)
T ss_pred             cCcccc-ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH--HH---
Confidence            655432 334456789999999997632            156799999999999999999999976432221  11   


Q ss_pred             cCcccccccccc-CCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         340 EVPVREVLDKEA-GEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       340 ~~~~~~~~~~~~-~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                          ..+.++.. -+++...-...+..++..|+++||++||+..|+++
T Consensus       583 ----~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  583 ----HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ----HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                11122210 01110000011445678999999999999999864

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=7.7e-35  Score=300.01  Aligned_cols=255  Identities=24%  Similarity=0.362  Sum_probs=184.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc--
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~--  190 (593)
                      .+.||+|+||.||+|... +|+.||||.++....... .    .      ..+.+|++++++++||||+++++++.+.  
T Consensus        12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-~----~------~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~   80 (302)
T cd07864          12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG-F----P------ITAIREIKILRQLNHRNIVNLKEIVTDKQD   80 (302)
T ss_pred             eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC-c----h------HHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence            578999999999999985 588999999865321110 0    1      1367899999999999999999987543  


Q ss_pred             ---------cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCcc
Q psy9535         191 ---------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  261 (593)
Q Consensus       191 ---------~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~  261 (593)
                               ..++|+||+++ ++.+.+...  ...+++..+..++.|++.||.|||+  .+|+||||||+||++++++.+
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK--KNFLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             hhhccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCcE
Confidence                     46899999975 777777643  2468999999999999999999998  569999999999999999999


Q ss_pred             EEeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh
Q psy9535         262 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  339 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~  339 (593)
                      ||+|||+++.........  .....++..|+|||.+.+  ..+.++|||||||++|||++|+.||...............
T Consensus       156 kl~dfg~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~  233 (302)
T cd07864         156 KLADFGLARLYNSEESRP--YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL  233 (302)
T ss_pred             EeCcccccccccCCcccc--cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            999999988654332111  112356888999997643  3678999999999999999999999865443322222111


Q ss_pred             -cCccc----cc--------cccccC--CC---CHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         340 -EVPVR----EV--------LDKEAG--EW---NETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       340 -~~~~~----~~--------~~~~~~--~~---~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       ..+..    .+        .+....  ..   ....+...+..++.+||+.+|.+||++.+|+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             00100    00        000000  00   00012234556778999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-35  Score=293.67  Aligned_cols=246  Identities=21%  Similarity=0.313  Sum_probs=183.9

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHH-HhcCCCCceeeEEEEEec-cc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT-LSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~i-l~~l~HpNIv~l~g~~~~-~~  191 (593)
                      +.||+|+||.||+|+.. +|+.||||.+........      ..    ...+..|..+ ....+|||++++++++.. ..
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~------~~----~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   71 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK------NQ----VTNVKAERAIMMIQGESPYVAKLYYSFQSKDY   71 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH------HH----HHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCe
Confidence            46899999999999874 689999999854311000      00    1123445444 455689999999998876 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|+||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+|||+++.
T Consensus        72 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  146 (260)
T cd05611          72 LYLVMEYLNGGDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRN  146 (260)
T ss_pred             EEEEEeccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEeeccccee
Confidence            68999999999999998753   358889999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ...       .....|++.|+|||.+.+ .++.++||||||+++|||++|..||........+..............   
T Consensus       147 ~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---  216 (260)
T cd05611         147 GLE-------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEV---  216 (260)
T ss_pred             ccc-------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcc---
Confidence            432       123468999999997644 468899999999999999999999987554433333222221111100   


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                       .    ..+...+..++.+||+.+|++||++.++.+.|..
T Consensus       217 -~----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         217 -K----EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             -c----ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence             0    1122335567789999999999998877776655

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.7e-35  Score=303.52  Aligned_cols=262  Identities=15%  Similarity=0.159  Sum_probs=173.3

Q ss_pred             CCCCcccccCceEEEEEEEcC----CCEEEEEEeecCCCCCCCCCchhHHhhh---cHHHHHHHHHHHhcCCCCceeeEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMI---PILLFENEVQTLSQCKHVNLLRLL  184 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~----g~~vAVK~l~~~~~~~~~~~~~~~~~~~---~~~~f~~Ev~il~~l~HpNIv~l~  184 (593)
                      ++.++||+|+||.||+|++.+    +..+|+|......   ..  ...+....   .......+...+..+.|+|+++++
T Consensus        15 ~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~---~~--~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         15 KIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN---ET--IVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             EEeeEEecCCCceEEEEEEcCCcccccceEEEeccccC---Cc--hhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            456899999999999998754    3456666532211   00  00011000   001123344566778999999999


Q ss_pred             EEEecc-----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC
Q psy9535         185 GLCNNI-----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  259 (593)
Q Consensus       185 g~~~~~-----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~  259 (593)
                      +++...     ..++++|++. .++.+.+...   ...++.....++.|++.||.|||+  ++|+||||||+|||++.++
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHE--HGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCC
Confidence            976542     2356777764 3566666542   235778889999999999999998  5699999999999999999


Q ss_pred             ccEEeecccceecccCCCc----ceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHH
Q psy9535         260 VPKLGDFGIVKMSETSNMK----TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  334 (593)
Q Consensus       260 ~~Kl~DFGla~~~~~~~~~----~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~  334 (593)
                      .+||+|||+|+........    ........||+.|+|||+.. ..++.++|||||||++|||++|+.||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999999865322110    01112357999999999765 457899999999999999999999997642111111


Q ss_pred             HHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHH
Q psy9535         335 LVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL  388 (593)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L  388 (593)
                      ...... -...+....   .....+...+..++..||..+|++||++.++.+.|
T Consensus       244 ~~~~~~-~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKCD-FIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHHH-HHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            000000 000000000   00011224456677899999999999999999876

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9.9e-35  Score=307.14  Aligned_cols=250  Identities=24%  Similarity=0.321  Sum_probs=183.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc--
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~--  190 (593)
                      .+.||+|+||.||+|+.. +|+.||||.+.....    ....       ...+.+|+.++++++||||+++++++...  
T Consensus        21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (353)
T cd07850          21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ----NVTH-------AKRAYRELVLMKLVNHKNIIGLLNVFTPQKS   89 (353)
T ss_pred             EEEeccCCCEEEEEEEECCCCCEEEEEecCcccc----ChhH-------HHHHHHHHHHHHhcCCCCCcceeeeeccCCC
Confidence            578999999999999865 689999999853211    1000       12466899999999999999999987532  


Q ss_pred             -----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         191 -----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       191 -----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                           ..++||||+. |+|.+.+..     .++......++.|++.||+|||+  .+|+||||||+|||++.++.+||+|
T Consensus        90 ~~~~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          90 LEEFQDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             ccccCcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEcc
Confidence                 3489999995 688888753     27888999999999999999998  5699999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-cc
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-PV  343 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~~  343 (593)
                      ||+++.......    .....||+.|+|||.+. ..++.++|||||||++|+|++|+.||...+....+........ +.
T Consensus       162 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  237 (353)
T cd07850         162 FGLARTAGTSFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS  237 (353)
T ss_pred             CccceeCCCCCC----CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999986543221    22346899999999764 4578899999999999999999999976544332222211100 00


Q ss_pred             --------------------------ccccccc----cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 --------------------------REVLDKE----AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 --------------------------~~~~~~~----~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                                .+.....    ............+..++.+|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                                      0000000    000001112334556778999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.3e-34  Score=299.94  Aligned_cols=254  Identities=23%  Similarity=0.328  Sum_probs=185.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec---
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~---  189 (593)
                      .+.||+|+||.||+|... +|..||+|.++........           ...+.+|+.++++++|+||+++++++..   
T Consensus        12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (309)
T cd07845          12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI-----------PISSLREITLLLNLRHPNIVELKEVVVGKHL   80 (309)
T ss_pred             eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC-----------cchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence            578999999999999875 6899999998643211100           0135679999999999999999998854   


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+. ++|.+++....  ..+++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~kL~dfg~~  155 (309)
T cd07845          81 DSIFLVMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLA  155 (309)
T ss_pred             CeEEEEEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECcccee
Confidence            34589999986 58888887533  468999999999999999999998  55999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-ccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-PVREV  346 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~~~~~  346 (593)
                      +....... .  .....+++.|+|||.+.+  .++.++|||||||++|||++|+.||...+............. +....
T Consensus       156 ~~~~~~~~-~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
T cd07845         156 RTYGLPAK-P--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI  232 (309)
T ss_pred             eecCCccC-C--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence            86543211 1  112346888999997743  468899999999999999999999987554433332222110 00000


Q ss_pred             ------------cccccCCCC--H---HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 ------------LDKEAGEWN--E---THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ------------~~~~~~~~~--~---~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                  .......+.  .   ......+..++.+|++.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                        000000000  0   001233455778999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.6e-35  Score=295.49  Aligned_cols=244  Identities=29%  Similarity=0.396  Sum_probs=186.1

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||++..+ +++.||+|.+.....     ...       ...+.+|++++++++||||+++++++.. ..
T Consensus         6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~-------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (265)
T cd06605           6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-----EAI-------QKQILRELDILHKCNSPYIVGFYGAFYNNGD   73 (265)
T ss_pred             HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-----hHH-------HHHHHHHHHHHHHCCCCchhhhheeeecCCE
Confidence            468999999999999876 689999999864311     011       1257899999999999999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|+||+++++|.+++....  ..++......++.|++.||.|||+ ..+++||||||+||+++.++.+||+|||++..
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~-~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~  150 (265)
T cd06605          74 ISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ  150 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcC-CCCeecCCCCHHHEEECCCCCEEEeecccchh
Confidence            689999999999999987643  468899999999999999999997 13499999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCc----hHHHHHHHHhhcCccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNN----TILYYYLVVEQEVPVREV  346 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~----~~~~~~~~~~~~~~~~~~  346 (593)
                      .....     .....|+..|+|||.+. ..++.++|||||||++|+|++|+.||....    .............. .. 
T Consensus       151 ~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~-  223 (265)
T cd06605         151 LVNSL-----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-PR-  223 (265)
T ss_pred             hHHHH-----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-CC-
Confidence            43221     11257899999999764 457889999999999999999999997542    11111111111110 00 


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                             .........+..++.+||..+|++||++.+++.
T Consensus       224 -------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         224 -------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             -------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                   011112333556778999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.6e-35  Score=301.57  Aligned_cols=242  Identities=28%  Similarity=0.452  Sum_probs=186.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|... ++..||+|.+....     . ..       ...|.+|+.++++++||||+++++++.. ..
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~-~~-------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   90 (293)
T cd06647          24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-----Q-PK-------KELIINEILVMRENKHPNIVNYLDSYLVGDE   90 (293)
T ss_pred             eeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-----c-hH-------HHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence            578999999999999864 68899999985321     0 00       1247889999999999999999998865 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|+||+++|+|.+++.+    ..+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++..
T Consensus        91 ~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~--~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~  164 (293)
T cd06647          91 LWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  164 (293)
T ss_pred             EEEEEecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh--CCEeeccCCHHHEEEcCCCCEEEccCcceec
Confidence            7899999999999999864    247889999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......|++.|+|||.+. ..++.++|||||||++|||++|+.||...+.............+  .     
T Consensus       165 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~-----  234 (293)
T cd06647         165 ITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP--E-----  234 (293)
T ss_pred             cccccc---ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCC--C-----
Confidence            433221   112346899999999764 45788999999999999999999999765432211111111100  0     


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        ......+...+..++.+||..+|++||++.+++.
T Consensus       235 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         235 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0011122334566778999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.7e-34  Score=292.98  Aligned_cols=243  Identities=27%  Similarity=0.432  Sum_probs=189.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|.+. ++..||+|.+.....       .       ...+.+|++++++++|+||+++++++.. ..
T Consensus        24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   89 (286)
T cd06614          24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-------N-------KELIINEILIMKDCKHPNIVDYYDSYLVGDE   89 (286)
T ss_pred             hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-------h-------HHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence            578999999999999886 688999999864311       0       1247889999999999999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|+||+++++|.+++....  ..+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.+||+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~  165 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQ  165 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCChhhEEEcCCCCEEECccchhhh
Confidence            789999999999999998643  368999999999999999999998  6699999999999999999999999998765


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......|++.|+|||.+. ..++.++|||||||++|||++|+.||.................  ....+  
T Consensus       166 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~--  238 (286)
T cd06614         166 LTKEKS---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI--PPLKN--  238 (286)
T ss_pred             hccchh---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CCCcc--
Confidence            433211   112345889999999764 4578899999999999999999999987554433222221111  11100  


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                           ...+...+..++.+||+.+|.+||++.+|++
T Consensus       239 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         239 -----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -----hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                 1112234556778999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.5e-34  Score=299.00  Aligned_cols=241  Identities=29%  Similarity=0.441  Sum_probs=184.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|+.. +|..||+|.+......   ...       ....+.+|++++++++|||++++++++.+ ..
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~---~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   95 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ---TNE-------KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT   95 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC---chH-------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence            357999999999999874 6889999998643211   100       01247789999999999999999998876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+. |+|.+.+....  .++++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++..
T Consensus        96 ~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dl~p~nili~~~~~~kL~dfg~~~~  170 (313)
T cd06633          96 AWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASK  170 (313)
T ss_pred             EEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence            689999995 68888876532  468999999999999999999998  5699999999999999999999999999764


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~----~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ...       .....|+..|+|||.+.    ..++.++|||||||++|||++|..||...+.............+  ...
T Consensus       171 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~  241 (313)
T cd06633         171 SSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLQ  241 (313)
T ss_pred             cCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCC
Confidence            321       12357899999999763    45788999999999999999999999875543333322221111  110


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         ...+     ...+..++.+||+.+|.+||++.+++.
T Consensus       242 ---~~~~-----~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         242 ---SNEW-----TDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ---cccc-----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0111     123556778999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-35  Score=302.79  Aligned_cols=200  Identities=24%  Similarity=0.358  Sum_probs=158.0

Q ss_pred             CCcccccCceEEEEEEEc---CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         114 GNKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~---~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      ..+||+|+||.||+|...   ++..||+|.+..........          ...+.+|+.++++++||||+++++++.+.
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (316)
T cd07842           5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGI----------SQSACREIALLRELKHENVVSLVEVFLEH   74 (316)
T ss_pred             EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCc----------cHHHHHHHHHHHhcCCCCccceEEEEeCC
Confidence            467999999999999874   47899999987532111110          11367899999999999999999988653


Q ss_pred             ---cceEEEEeccCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC----CCcc
Q psy9535         191 ---MNCIVYEYMCNGSLYDRLARVN--NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE----NFVP  261 (593)
Q Consensus       191 ---~~~lV~Ey~~~GsL~~~L~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~----~~~~  261 (593)
                         ..++||||+. ++|.+.+....  ....++......++.|++.||.|||+  .+|+||||||+|||++.    ++.+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~~~~~~~~~~~  151 (316)
T cd07842          75 ADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERGVV  151 (316)
T ss_pred             CCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEEcCCCCccceE
Confidence               4589999987 46777765322  12368899999999999999999998  56999999999999999    9999


Q ss_pred             EEeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCC
Q psy9535         262 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDD  326 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~  326 (593)
                      ||+|||+++................||+.|+|||.+.+  .++.++|||||||++|||++|+.||..
T Consensus       152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  218 (316)
T cd07842         152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG  218 (316)
T ss_pred             EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            99999998865433221111233578999999997643  468899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.3e-34  Score=295.06  Aligned_cols=248  Identities=23%  Similarity=0.296  Sum_probs=183.0

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccceE
Q psy9535         117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  194 (593)
Q Consensus       117 LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~l  194 (593)
                      ||+|+||+||++... +|+.||+|.+........   .       ....|.+|++++++++||||+++++++.. ...++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~---~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   70 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKR---K-------GEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCL   70 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhh---h-------hhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEE
Confidence            699999999999864 689999999864311100   0       01246789999999999999999998765 56789


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceeccc
Q psy9535         195 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  274 (593)
Q Consensus       195 V~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~  274 (593)
                      ||||+++|+|.+++..... ..+++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+|||+++....
T Consensus        71 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~  147 (277)
T cd05577          71 VMTLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG  147 (277)
T ss_pred             EEecCCCCcHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence            9999999999999976432 468999999999999999999998  5699999999999999999999999999876433


Q ss_pred             CCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCC
Q psy9535         275 SNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGE  353 (593)
Q Consensus       275 ~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (593)
                      ..    ......|+..|+|||.+. ..++.++|||||||++|+|++|+.||.....................       .
T Consensus       148 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~  216 (277)
T cd05577         148 GK----KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV-------E  216 (277)
T ss_pred             CC----ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccc-------c
Confidence            21    112346889999999764 45788999999999999999999999764321111111111000000       0


Q ss_pred             CCHHHHHHHHHHHHHHhhccccCCCCChHH-HHHHHh
Q psy9535         354 WNETHVETLIGIVFEKCCVFEKDKRASMRD-IVDLLS  389 (593)
Q Consensus       354 ~~~~~~~~~i~~~~~~C~~~dp~~RPsm~e-V~~~L~  389 (593)
                      . +......+..++.+||+.+|++||+..+ .++.|.
T Consensus       217 ~-~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll  252 (277)
T cd05577         217 Y-PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR  252 (277)
T ss_pred             C-CccCCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence            0 0011223456678999999999996655 444443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-34  Score=305.62  Aligned_cols=267  Identities=23%  Similarity=0.326  Sum_probs=188.6

Q ss_pred             ecHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHH
Q psy9535          93 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT  171 (593)
Q Consensus        93 ~~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~i  171 (593)
                      |+.+|+..++..+..  .+...+.||+|+||.||+|+.. +|..||||++......  .  ..       ...+.+|+.+
T Consensus         1 ~~~~~~~~~~~~~~~--~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~--~~-------~~~~~~e~~~   67 (342)
T cd07879           1 FYREEVNKTVWELPE--RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS--E--IF-------AKRAYRELTL   67 (342)
T ss_pred             Cchhhhhhhhhcccc--ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc--c--cc-------hhHHHHHHHH
Confidence            345566666533322  1233689999999999999864 6899999998643110  0  00       1146789999


Q ss_pred             HhcCCCCceeeEEEEEecc-------cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q psy9535         172 LSQCKHVNLLRLLGLCNNI-------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPII  244 (593)
Q Consensus       172 l~~l~HpNIv~l~g~~~~~-------~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~Ii  244 (593)
                      +++++||||+++++++...       ..++|+||+. ++|.+.+.     ..+++..+..++.|++.||.|||+  .+|+
T Consensus        68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~--~~i~  139 (342)
T cd07879          68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHS--AGII  139 (342)
T ss_pred             HHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCcc
Confidence            9999999999999987542       2479999986 46766542     358899999999999999999998  5699


Q ss_pred             ecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCC
Q psy9535         245 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMK  322 (593)
Q Consensus       245 HrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~  322 (593)
                      ||||||+|||++.++.+||+|||+++.....      .....||+.|+|||.+.+  .++.++|||||||++|||++|+.
T Consensus       140 H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~  213 (342)
T cd07879         140 HRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT  213 (342)
T ss_pred             cCCCCHHHEEECCCCCEEEeeCCCCcCCCCC------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999998754321      123467899999997643  47889999999999999999999


Q ss_pred             CCCCCchHHHHHHHHhhc-Cccccccccc-----------cCCCCHH-------HHHHHHHHHHHHhhccccCCCCChHH
Q psy9535         323 PIDDNNTILYYYLVVEQE-VPVREVLDKE-----------AGEWNET-------HVETLIGIVFEKCCVFEKDKRASMRD  383 (593)
Q Consensus       323 P~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----------~~~~~~~-------~~~~~i~~~~~~C~~~dp~~RPsm~e  383 (593)
                      ||................ .+.+...+..           .......       .....+..++.+||+.||++||++.+
T Consensus       214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e  293 (342)
T cd07879         214 LFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATE  293 (342)
T ss_pred             CCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            998754333222221111 0100000000           0000000       11223456778999999999999999


Q ss_pred             HHH
Q psy9535         384 IVD  386 (593)
Q Consensus       384 V~~  386 (593)
                      ++.
T Consensus       294 ~l~  296 (342)
T cd07879         294 ALE  296 (342)
T ss_pred             Hhc
Confidence            864

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.9e-34  Score=297.79  Aligned_cols=241  Identities=28%  Similarity=0.440  Sum_probs=183.9

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      +.||+|+||.||+|+.. ++..||+|.+......   . .. .     ...+.+|+++++.++|+|++++++++.. ...
T Consensus        21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~-~~-~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   90 (308)
T cd06634          21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ---S-NE-K-----WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (308)
T ss_pred             HheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc---C-hH-H-----HHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence            57999999999999875 5788999998642111   0 00 0     1247789999999999999999998866 456


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+. |+|.+.+....  .++++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+|||++...
T Consensus        91 ~lv~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             EEEEEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence            89999996 68888776432  458899999999999999999998  56999999999999999999999999998764


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~----~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ...       ....|++.|+|||.+.    ..++.++|||||||++|||++|..||.................+  .   
T Consensus       166 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~---  233 (308)
T cd06634         166 APA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--A---  233 (308)
T ss_pred             cCc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC--C---
Confidence            322       2346899999999763    35788999999999999999999999765433222222211111  0   


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDL  387 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~  387 (593)
                           .........+..++.+||..+|++||++.+|++.
T Consensus       234 -----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         234 -----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             -----cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence                 0011122345567789999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=293.48  Aligned_cols=255  Identities=25%  Similarity=0.350  Sum_probs=186.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc--
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~--  190 (593)
                      .++||+|+||.||+|+.. +|+.+|+|.+.....   .. ..       ...+.+|++++++++|||++++++++...  
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~---~~-~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   72 (287)
T cd07840           4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KE-GF-------PITAIREIKLLQKLRHPNIVRLKEIVTSKGK   72 (287)
T ss_pred             eEEeccCCCeEEEEEEECCCCeEEEEEEEecccc---cc-cc-------hHHHHHHHHHHHhccCCCeeeheeeEecCCC
Confidence            468999999999999876 588999999975420   00 00       12477899999999999999999988654  


Q ss_pred             -cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         191 -MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       191 -~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                       ..++||||++ ++|.+++....  ..+++..+..++.|++.||.|||+  .+++|+||||+|||+++++.+||+|||++
T Consensus        73 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g~~  147 (287)
T cd07840          73 GSIYMVFEYMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLA  147 (287)
T ss_pred             CcEEEEecccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEccccce
Confidence             5689999997 58988886532  468999999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc-c--
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV-R--  344 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~--  344 (593)
                      .........  ......++..|+|||.+.+  .++.++||||||+++|||++|+.||................... .  
T Consensus       148 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (287)
T cd07840         148 RPYTKRNSA--DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN  225 (287)
T ss_pred             eeccCCCcc--cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Confidence            865443211  1123457889999996643  46889999999999999999999998755432222221110000 0  


Q ss_pred             --cc--------cccccC------CCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 --EV--------LDKEAG------EWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 --~~--------~~~~~~------~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        ..        ......      ..........+..++.+||..+|.+||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence              00        000000      0000001233455678999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.2e-34  Score=297.86  Aligned_cols=255  Identities=22%  Similarity=0.301  Sum_probs=182.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +|+.||+|.+.......    ..       ...+.+|++++++++||||+++++++.+ ..
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE----GV-------PSTAIREISLLKEMQHGNIVRLQDVVHSEKR   75 (294)
T ss_pred             EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc----cc-------hHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence            578999999999999875 68899999885432110    00       1147789999999999999999998876 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC-CCccEEeecccce
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVK  270 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~-~~~~Kl~DFGla~  270 (593)
                      .++||||++ ++|.+++.... ...+++.....++.|++.||+|||+  ++|+||||||+||+++. ++.+||+|||+++
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg~~~  151 (294)
T PLN00009         76 LYLVFEYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLAR  151 (294)
T ss_pred             EEEEEeccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEccccccc
Confidence            689999995 68888876533 2346788888999999999999998  56999999999999985 5679999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-cCcccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVL  347 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-~~~~~~~~  347 (593)
                      .......   ......|++.|+|||.+.+  .++.++|||||||++|||+||+.||............... ..+.....
T Consensus       152 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (294)
T PLN00009        152 AFGIPVR---TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW  228 (294)
T ss_pred             ccCCCcc---ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            5433211   1122467899999997643  4678999999999999999999999765433222222110 11111100


Q ss_pred             cc---------ccCCCC-------HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DK---------EAGEWN-------ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~---------~~~~~~-------~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +.         ....+.       .......+..++.+|++.+|++||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00         000000       0011223445667999999999999999875

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1e-34  Score=304.76  Aligned_cols=255  Identities=24%  Similarity=0.345  Sum_probs=184.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEecc-
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNNI-  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~~-  190 (593)
                      .+.||+|+||.||+|... +|..||||++........      .     ...+.+|+.+++++ +||||++++++|... 
T Consensus        12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~------~-----~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~   80 (337)
T cd07852          12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT------D-----AQRTFREIMFLQELGDHPNIVKLLNVIKAEN   80 (337)
T ss_pred             hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch------h-----hhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence            578999999999999875 688999999854211000      0     11366899999999 999999999988542 


Q ss_pred             --cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         191 --MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       191 --~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                        ..++||||+. ++|.+++...    .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl~d~g~  153 (337)
T cd07852          81 DKDIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGL  153 (337)
T ss_pred             CceEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence              4589999997 6998888642    57899999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCc--ceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCc-c
Q psy9535         269 VKMSETSNMK--TMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP-V  343 (593)
Q Consensus       269 a~~~~~~~~~--~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~-~  343 (593)
                      ++........  ........||+.|+|||.+.  ...+.++|||||||++|||++|+.||.................. .
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07852         154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS  233 (337)
T ss_pred             hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            8865432211  01123356899999999763  34678999999999999999999999764433222211111100 0


Q ss_pred             ------------ccccc----cccCCCC--HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 ------------REVLD----KEAGEWN--ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ------------~~~~~----~~~~~~~--~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                  ...++    .......  .......+..++.+||+.+|++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence                        00000    0000000  0001233455677999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG4717|consensus

Probab=100.00  E-value=3.2e-35  Score=303.62  Aligned_cols=242  Identities=24%  Similarity=0.382  Sum_probs=192.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|.|.+|-++++- +|..||||++.+......      ..     ..+.+|+.-|+-++|||||+||.+... ..
T Consensus        23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~------st-----~hlfqEVRCMKLVQHpNiVRLYEViDTQTK   91 (864)
T KOG4717|consen   23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL------ST-----GHLFQEVRCMKLVQHPNIVRLYEVIDTQTK   91 (864)
T ss_pred             hhhhcCCceehhhhhhhhcccceeEEEEecccccchh------hh-----hHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence            467999999999999864 799999999976432111      11     134579999999999999999998876 46


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec-CCCccEEeecccce
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVK  270 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~-~~~~~Kl~DFGla~  270 (593)
                      .|||+|.-.+|+|+|++.+...  .+.+....+++.||+.|+.|+|...  +|||||||+||.+- +-|-+||.|||++.
T Consensus        92 lyLiLELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSN  167 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSN  167 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccc
Confidence            6899999999999999987653  5888999999999999999999865  99999999999874 66899999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CC-CCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      .......    .++.+|+..|.|||++.+ .| .+++||||+|||||-|++|+.||...+.....-.++.....++    
T Consensus       168 kf~PG~k----L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP----  239 (864)
T KOG4717|consen  168 KFQPGKK----LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP----  239 (864)
T ss_pred             cCCCcch----hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc----
Confidence            6554432    235799999999997754 45 4678999999999999999999987665444444444333333    


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                              ..+....+.++..+++.||.+|.+..||+.
T Consensus       240 --------shvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  240 --------SHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             --------hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                    234444556777899999999999999864

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-34  Score=304.70  Aligned_cols=263  Identities=25%  Similarity=0.346  Sum_probs=188.5

Q ss_pred             cHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHH
Q psy9535          94 TFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL  172 (593)
Q Consensus        94 ~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il  172 (593)
                      ...++..++++|..      .+.||+|+||.||+|.. .+|+.||||++.....    . .  .    ....+.+|+.++
T Consensus         8 ~~~~~~~~~~~y~~------~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~-~--~----~~~~~~~Ei~~l   70 (345)
T cd07877           8 LNKTIWEVPERYQN------LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ----S-I--I----HAKRTYRELRLL   70 (345)
T ss_pred             HHHHHhhccCceEE------EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch----h-h--H----HHHHHHHHHHHH
Confidence            34566677777764      57899999999999986 4689999999864210    0 0  0    012477899999


Q ss_pred             hcCCCCceeeEEEEEecc-------cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q psy9535         173 SQCKHVNLLRLLGLCNNI-------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIH  245 (593)
Q Consensus       173 ~~l~HpNIv~l~g~~~~~-------~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiH  245 (593)
                      ++++||||+++++++...       ..+++++++ +++|.+++..    ..+++..+..++.|+++||.|||+  .+|+|
T Consensus        71 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH  143 (345)
T cd07877          71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS--ADIIH  143 (345)
T ss_pred             HHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeee
Confidence            999999999999987532       235666665 8899887753    358899999999999999999998  56999


Q ss_pred             cccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCC
Q psy9535         246 RDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKP  323 (593)
Q Consensus       246 rDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P  323 (593)
                      |||||+||++++++.+||+|||+++.....      .....||+.|+|||.+.+  .++.++|||||||++|||++|+.|
T Consensus       144 ~dlkp~NIll~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  217 (345)
T cd07877         144 RDLKPSNLAVNEDCELKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL  217 (345)
T ss_pred             cCCChHHEEEcCCCCEEEeccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999998754321      123468999999997643  467899999999999999999999


Q ss_pred             CCCCchHHHHHHHHhhc-Cccccccccc--------------cCC--CCH--HHHHHHHHHHHHHhhccccCCCCChHHH
Q psy9535         324 IDDNNTILYYYLVVEQE-VPVREVLDKE--------------AGE--WNE--THVETLIGIVFEKCCVFEKDKRASMRDI  384 (593)
Q Consensus       324 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~--------------~~~--~~~--~~~~~~i~~~~~~C~~~dp~~RPsm~eV  384 (593)
                      |................ .+........              ...  +..  ......+..++.+|++.+|.+||++.++
T Consensus       218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~  297 (345)
T cd07877         218 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  297 (345)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHH
Confidence            97644322222111110 0000000000              000  000  0012234567789999999999999988


Q ss_pred             HH
Q psy9535         385 VD  386 (593)
Q Consensus       385 ~~  386 (593)
                      +.
T Consensus       298 l~  299 (345)
T cd07877         298 LA  299 (345)
T ss_pred             hc
Confidence            64

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-35  Score=296.14  Aligned_cols=252  Identities=23%  Similarity=0.368  Sum_probs=185.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-~  190 (593)
                      .+.||+|+||.||+|+.. +++.||||++......    ..  .      ..+.+|+..+++++ ||||+++++++.. .
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~--~------~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   71 (283)
T cd07830           4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WE--E------CMNLREVKSLRKLNEHPNIVKLKEVFREND   71 (283)
T ss_pred             heeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hh--H------HHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence            578999999999999985 5788999998643211    00  1      12457999999999 9999999998765 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+ +|+|.+.+.... ...+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.+||+|||+++
T Consensus        72 ~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~  147 (283)
T cd07830          72 ELYFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGLAR  147 (283)
T ss_pred             cEEEEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCCEEEeecccce
Confidence            668999999 899999987643 2468999999999999999999998  569999999999999999999999999988


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-cCcccc--
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVRE--  345 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-~~~~~~--  345 (593)
                      .......    .....|+..|+|||.+.  ..++.++||||||+++|||++|+.||............... ..+...  
T Consensus       148 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (283)
T cd07830         148 EIRSRPP----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW  223 (283)
T ss_pred             eccCCCC----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhh
Confidence            6543221    12346899999999763  34688999999999999999999999764432222111110 000000  


Q ss_pred             --------ccc--------cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 --------VLD--------KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 --------~~~--------~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                              ..+        .......+.. ...+..++.+||+.+|++||++.|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         224 PEGYKLASKLGFRFPQFAPTSLHQLIPNA-SPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhHhhhhccccccccccccccHHHHcccC-CHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                    000        0000000000 233556778999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1e-34  Score=304.53  Aligned_cols=256  Identities=21%  Similarity=0.337  Sum_probs=186.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec---
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~---  189 (593)
                      .+.||+|+||.||+|+.. +|..||+|++........    .       ...+.+|+.+|++++||||+++++++..   
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~----~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   78 (334)
T cd07855          10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT----L-------AKRTLRELKILRHFKHDNIIAIRDILRPPGA   78 (334)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEecccccccc----c-------hHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence            578999999999999865 689999999864321100    0       1246789999999999999999987643   


Q ss_pred             --ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         190 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       190 --~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                        ...++||||+. |+|.+++...   ..+++.....++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          79 DFKDVYVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             CCceEEEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEecccc
Confidence              34589999995 6898888642   358999999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCc-ceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-cCcc
Q psy9535         268 IVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPV  343 (593)
Q Consensus       268 la~~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-~~~~  343 (593)
                      +++........ ........|+..|+|||.+..  .++.++|||||||++|||++|+.||.+............. ..+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~  232 (334)
T cd07855         153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS  232 (334)
T ss_pred             cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence            98765432211 111234578999999997643  4788999999999999999999999775433222211111 1111


Q ss_pred             cccccc--------------ccCCCCH----HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 REVLDK--------------EAGEWNE----THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~~~~~~--------------~~~~~~~----~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .+..+.              .......    ......+..++.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            111100              0000000    112334566778999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.3e-34  Score=291.42  Aligned_cols=245  Identities=27%  Similarity=0.386  Sum_probs=188.1

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +|+.||||++......     ..       ...|.+|+..+.+++||||+++++++.. ..
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-----~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (264)
T cd06623           6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-----EF-------RKQLLRELKTLRSCESPYVVKCYGAFYKEGE   73 (264)
T ss_pred             eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-----HH-------HHHHHHHHHHHHhcCCCCeeeEEEEEccCCe
Confidence            578999999999999876 5899999998643110     00       1258899999999999999999998866 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++++|.+++...   ..+++..+..++.|+++||.|||+. .+++||||+|+||+++.++.++|+|||++..
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~-~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~  149 (264)
T cd06623          74 ISIVLEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTK-RHIIHRDIKPSNLLINSKGEVKIADFGISKV  149 (264)
T ss_pred             EEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhcc-CCCccCCCCHHHEEECCCCCEEEccCcccee
Confidence            68999999999999999753   4689999999999999999999971 3499999999999999999999999999886


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCc--hHHHHHHHHhhcCccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNN--TILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~--~~~~~~~~~~~~~~~~~~~~  348 (593)
                      .......   .....|+..|+|||.+. ..++.++||||||+++|||+||+.||....  ............ ....   
T Consensus       150 ~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~---  222 (264)
T cd06623         150 LENTLDQ---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-PPPS---  222 (264)
T ss_pred             cccCCCc---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-CCCC---
Confidence            5433211   12346889999999764 456789999999999999999999997653  211111111111 1000   


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                           .........+..++.+||..+|++||++.++++
T Consensus       223 -----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         223 -----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             -----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                 111102234555677999999999999999976

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-34  Score=290.89  Aligned_cols=255  Identities=22%  Similarity=0.298  Sum_probs=184.4

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC---CCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l---~HpNIv~l~g~~~  188 (593)
                      ..+.||+|+||.||+|+.+ +++.||+|.+.......     ...      ..+.+|+.+++++   +||||+++++++.
T Consensus         3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-----~~~------~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   71 (287)
T cd07838           3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-----GIP------LSTLREIALLKQLESFEHPNIVRLLDVCH   71 (287)
T ss_pred             EEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-----hhh------hhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence            3578999999999999986 48999999986432110     001      1355677766655   6999999999886


Q ss_pred             cc-c-----ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccE
Q psy9535         189 NI-M-----NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  262 (593)
Q Consensus       189 ~~-~-----~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~K  262 (593)
                      .. .     .+++|||+. ++|.+++..... ..+++..+..++.|++.||.|||+  .+++|+||||+|||++.++.+|
T Consensus        72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~--~~i~h~~l~~~nili~~~~~~~  147 (287)
T cd07838          72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHS--HRIVHRDLKPQNILVTSDGQVK  147 (287)
T ss_pred             eccCCCCceeEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhEEEccCCCEE
Confidence            53 3     679999997 589998876432 358999999999999999999998  5699999999999999999999


Q ss_pred             EeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC
Q psy9535         263 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  341 (593)
Q Consensus       263 l~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~  341 (593)
                      |+|||++........    .....|++.|+|||.+. ..++.++|||||||++|||++|..||.................
T Consensus       148 l~dfg~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  223 (287)
T cd07838         148 IADFGLARIYSFEMA----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG  223 (287)
T ss_pred             EeccCcceeccCCcc----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcC
Confidence            999999877543321    12245789999999764 4578899999999999999999999987554333222221100


Q ss_pred             c-------cc-----ccccccc-CCCC--HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 P-------VR-----EVLDKEA-GEWN--ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~-------~~-----~~~~~~~-~~~~--~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .       ..     ....... ....  ...+...+..++.+||+.||++||++.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0       00     0000000 0000  1122344556778999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.7e-34  Score=284.58  Aligned_cols=247  Identities=29%  Similarity=0.424  Sum_probs=190.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc--
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~--  190 (593)
                      .+.||+|+||.||+|... ++..|++|.+......    ..       ....+.+|+.++++++||||+++++.+...  
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (260)
T cd06606           5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS----EE-------ELEALEREIRILSSLQHPNIVRYYGSERDEEK   73 (260)
T ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeeccccc----hH-------HHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC
Confidence            578999999999999876 6899999998643211    00       123588999999999999999999988764  


Q ss_pred             -cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         191 -MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       191 -~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                       ..++|+||+++++|.+++....   .+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.+||+|||.+
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~~~~  148 (260)
T cd06606          74 NTLNIFLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCA  148 (260)
T ss_pred             CeEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEcccccE
Confidence             5679999999999999987643   68999999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ......... .......|+..|+|||.+.. ..+.++||||||+++|+|++|..||.....................   
T Consensus       149 ~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  224 (260)
T cd06606         149 KRLGDIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE---  224 (260)
T ss_pred             Eeccccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcC---
Confidence            876543210 01123568899999997754 4788999999999999999999999765422111111111001111   


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                            .+......+..++.+|++.+|++||++.|+++
T Consensus       225 ------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         225 ------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                  11112344566778999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=7.2e-35  Score=293.34  Aligned_cols=242  Identities=25%  Similarity=0.278  Sum_probs=185.9

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. ++..||+|.+........   .       ....+.+|++++++++||||+++++++.+ ..
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (258)
T cd05578           5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK---G-------SVRNVLNERRILQELNHPFLVNLWYSFQDEEN   74 (258)
T ss_pred             EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcch---h-------HHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence            578999999999999875 689999999864321110   0       12358899999999999999999988765 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|+||+.+++|.+++...   .++++.....++.|+++||.|||+  .+++|+||||+||++++++.+||+|||++..
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~  149 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATK  149 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEEcCCCCEEEeecccccc
Confidence            78999999999999999753   468899999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCch--HHHHHHHHhhcCccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT--ILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~--~~~~~~~~~~~~~~~~~~~  348 (593)
                      .....    ......|+..|+|||.+.. ..+.++|+||||+++|+|++|..||.....  ..........  . .... 
T Consensus       150 ~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~-~~~~-  221 (258)
T cd05578         150 VTPDT----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--A-DVLY-  221 (258)
T ss_pred             cCCCc----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--c-cccC-
Confidence            54322    1223568899999997644 468899999999999999999999986543  1111111110  0 0000 


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCCh--HHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASM--RDIV  385 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm--~eV~  385 (593)
                             +......+..++.+||..+|.+||++  .|++
T Consensus       222 -------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         222 -------PATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -------cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                   01112344556789999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.9e-34  Score=300.97  Aligned_cols=269  Identities=20%  Similarity=0.237  Sum_probs=187.5

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhh-hcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAM-IPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~-~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      .+.+.||+|+||.||+|+.. +|+.||||.+.................. .....+.+|++++++++||||+++++++..
T Consensus        12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   91 (335)
T PTZ00024         12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE   91 (335)
T ss_pred             hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence            45678999999999999865 6899999998654221110000000000 001136789999999999999999998765


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...++||||+. |+|.+++...   ..+++.....++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~--~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         92 GDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHK--WYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             CCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHeEECCCCCEEECCccc
Confidence             56689999996 7899988642   358899999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCC-----------cceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHH
Q psy9535         269 VKMSETSNM-----------KTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  335 (593)
Q Consensus       269 a~~~~~~~~-----------~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~  335 (593)
                      ++.......           .........+++.|+|||.+.+  .++.++|||||||++|||++|..||...........
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  245 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR  245 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            876541110           0001122357889999997743  368899999999999999999999987654433322


Q ss_pred             HHhhc-Ccccccc------------ccccCCCC---HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         336 VVEQE-VPVREVL------------DKEAGEWN---ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       336 ~~~~~-~~~~~~~------------~~~~~~~~---~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +.... .+.....            ........   .......+..++.+||+.+|++||++.|++.
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            22111 0100000            00000000   0011233456778999999999999999874

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.8e-34  Score=294.56  Aligned_cols=240  Identities=24%  Similarity=0.320  Sum_probs=179.3

Q ss_pred             CCCcccccCceEEEEEEE----cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLC  187 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~----~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~  187 (593)
                      ..+.||+|+||.||+++.    .+|..||+|++..........         ....+.+|+.++.++ +|+||+++++++
T Consensus         4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~---------~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (290)
T cd05613           4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAK---------TTEHTRTERQVLEHIRQSPFLVTLHYAF   74 (290)
T ss_pred             eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcch---------HHHHHHHHHHHHHhcccCCChhceeeEe
Confidence            357899999999999976    368899999986431111000         012477899999999 599999999887


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      .. ...++||||+++|+|.+++...   .++++.....++.|++.||.|||+  .+++||||||+|||++.++.+||+||
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          75 QTDTKLHLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             ecCCeEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEECCCCCEEEeeC
Confidence            65 4567999999999999999753   357888899999999999999998  56999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccccC---CCCCcchhhHHHHHHHHHHhCCCCCCCCch---HHHHHHHH-hh
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNT---ILYYYLVV-EQ  339 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~~ksDVwSfGvvl~ElltG~~P~~~~~~---~~~~~~~~-~~  339 (593)
                      |+++.........  .....|+..|+|||.+..   ..+.++|||||||++|||++|..||.....   ........ ..
T Consensus       150 g~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  227 (290)
T cd05613         150 GLSKEFHEDEVER--AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  227 (290)
T ss_pred             ccceecccccccc--cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc
Confidence            9987654322111  123568999999997643   357789999999999999999999964221   11111111 11


Q ss_pred             cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCC
Q psy9535         340 EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS  380 (593)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs  380 (593)
                      ..+.            +..+...+..++.+||+.+|++||+
T Consensus       228 ~~~~------------~~~~~~~~~~ll~~~l~~~p~~R~~  256 (290)
T cd05613         228 EPPY------------PQEMSALAKDIIQRLLMKDPKKRLG  256 (290)
T ss_pred             CCCC------------CccCCHHHHHHHHHHhcCCHHHhcC
Confidence            1111            1112334566778999999999983

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.3e-34  Score=296.41  Aligned_cols=241  Identities=24%  Similarity=0.396  Sum_probs=183.9

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      .+||+|+||.||++... +|..||||.+....    .  .  .     ...+.+|+.++++++|+||+++++++.. ...
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~--~--~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   92 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----Q--Q--R-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDEL   92 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc----h--h--H-----HHHHHHHHHHHHhcCCcchhheeeEEEeCCEE
Confidence            47999999999999874 68999999874321    0  0  0     1248899999999999999999998765 567


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++++|.+++..    ..+++.....++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++...
T Consensus        93 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~--~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~  166 (292)
T cd06657          93 WVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  166 (292)
T ss_pred             EEEEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence            899999999999988753    357899999999999999999998  56999999999999999999999999998754


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  351 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (593)
                      .....   ......||+.|+|||.+. ..++.++|||||||++|||++|..||................ +  ..+. ..
T Consensus       167 ~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~--~~~~-~~  239 (292)
T cd06657         167 SKEVP---RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-P--PKLK-NL  239 (292)
T ss_pred             ccccc---cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-C--cccC-Cc
Confidence            33211   112356899999999764 457889999999999999999999997654332222211111 1  0000 00


Q ss_pred             CCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         352 GEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       352 ~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..     ....+..++.+||..+|.+||++.++++
T Consensus       240 ~~-----~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         240 HK-----VSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cc-----CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            01     1122445678999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.8e-34  Score=295.60  Aligned_cols=251  Identities=22%  Similarity=0.267  Sum_probs=187.5

Q ss_pred             CCcccccCceEEEEEEE----cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEe
Q psy9535         114 GNKLGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN  188 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~----~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~  188 (593)
                      .+.||+|+||.||+++.    .++..||||.+........         ......+.+|++++.++ +||||+++++.+.
T Consensus         5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~---------~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~   75 (288)
T cd05583           5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQK---------AKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ   75 (288)
T ss_pred             EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhh---------hhHHHHHHHHHHHHHhccCCcchhhhheeee
Confidence            57899999999999874    2578899999864311100         00122578999999999 5999999998776


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      . ...++||||+++|+|.+++...   ..+++.....++.|+++||.|||+  .+++||||||+||+++.++.+||+|||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~dfg  150 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLTDFG  150 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEEECc
Confidence            5 4567999999999999998753   358889999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccCC---CCCcchhhHHHHHHHHHHhCCCCCCCCchH---HHHHH-HHhhc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNNTI---LYYYL-VVEQE  340 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~~ksDVwSfGvvl~ElltG~~P~~~~~~~---~~~~~-~~~~~  340 (593)
                      +++.......  .......|++.|+|||.+.+.   .+.++||||||+++|||++|..||......   ..... .....
T Consensus       151 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd05583         151 LSKEFLAEEE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK  228 (288)
T ss_pred             cccccccccc--cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC
Confidence            9876543321  112235689999999976443   578999999999999999999999643211   11111 11111


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         341 VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      .+.+            ......+..++.+||+.+|++|||+.++.+.|....
T Consensus       229 ~~~~------------~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~  268 (288)
T cd05583         229 PPFP------------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF  268 (288)
T ss_pred             CCCC------------cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence            1111            111223455678999999999999999988887643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.7e-34  Score=283.42  Aligned_cols=243  Identities=28%  Similarity=0.440  Sum_probs=188.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||++... ++..+|+|++.....      ..       ...+.+|++++++++||||+++++++.. ..
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   71 (253)
T cd05122           5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK------EK-------KEKIINEIQILKKCKHPNIVKYYGSYLKKDE   71 (253)
T ss_pred             eeeeccCCceEEEEEEECCCCcEEEEEEecccch------hH-------HHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            578999999999999875 688999999864321      00       1257899999999999999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++++||+++++|.+++....  ..+++..+..++.|+++||.|||+  .+++||||+|+||+++.++.+||+|||++..
T Consensus        72 ~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~  147 (253)
T cd05122          72 LWIVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQ  147 (253)
T ss_pred             EEEEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeecccccc
Confidence            689999999999999987642  468999999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......    .....|+..|+|||.+. ...+.++||||||+++|+|++|+.||..............  ......... 
T Consensus       148 ~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~-  220 (253)
T cd05122         148 LSDTKA----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPPGLRNP-  220 (253)
T ss_pred             cccccc----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCCCCcCcc-
Confidence            544321    22356899999999764 3467899999999999999999999987533222222111  111111111 


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       .     .....+..++.+||..+|++|||+.|+++
T Consensus       221 -~-----~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         221 -E-----KWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             -c-----ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             0     01223455678999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.7e-34  Score=296.74  Aligned_cols=258  Identities=24%  Similarity=0.301  Sum_probs=182.9

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec--
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~--  189 (593)
                      +.++||+|+||.||+|+.. +++.||||++.........           ...+.+|++++++++||||+++++++..  
T Consensus        12 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (311)
T cd07866          12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF-----------PITALREIKILKKLKHPNVVPLIDMAVERP   80 (311)
T ss_pred             EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc-----------chhHHHHHHHHHhcCCCCccchhhheeccc
Confidence            3578999999999999875 6899999998653211110           0135689999999999999999987643  


Q ss_pred             -------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccE
Q psy9535         190 -------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  262 (593)
Q Consensus       190 -------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~K  262 (593)
                             ...++||||+. ++|...+...  ...+++..+..++.|+++||.|||+  .+|+||||||+|||+++++.+|
T Consensus        81 ~~~~~~~~~~~lv~~~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~--~~i~H~dl~p~nil~~~~~~~~  155 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMD-HDLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILIDNQGILK  155 (311)
T ss_pred             ccccccCceEEEEEecCC-cCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEE
Confidence                   12478999986 4677776542  2468999999999999999999998  5699999999999999999999


Q ss_pred             EeecccceecccCCCcc--------eeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHH
Q psy9535         263 LGDFGIVKMSETSNMKT--------MYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILY  332 (593)
Q Consensus       263 l~DFGla~~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~  332 (593)
                      |+|||+++.........        .......|++.|+|||.+.+  .++.++|||||||++|||++|+.||.+......
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~  235 (311)
T cd07866         156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ  235 (311)
T ss_pred             ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999987643321100        11123467899999997643  478899999999999999999999986554332


Q ss_pred             HHHHHhhcCcc-----------cccc----ccccCCCCH---HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         333 YYLVVEQEVPV-----------REVL----DKEAGEWNE---THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       333 ~~~~~~~~~~~-----------~~~~----~~~~~~~~~---~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...........           ....    .........   ......+..++.+|++.+|++|||+.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            22211110000           0000    000000000   011133456778999999999999998864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0983|consensus

Probab=100.00  E-value=8.1e-35  Score=281.12  Aligned_cols=243  Identities=27%  Similarity=0.405  Sum_probs=180.3

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-cc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-IM  191 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-~~  191 (593)
                      ..||.|+-|.|++++.+ +|..+|||.+....+     .   +.    .++....+.++.+.. .|.||+.+||+.. ..
T Consensus        98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-----k---ee----~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-----K---EE----NKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             HhhcCCCccceEEEEEcccceEEEEEeecccCC-----H---HH----HHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            36899999999999876 588999999975421     1   11    224566777777665 8999999999865 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++.||.|. -.+..+|++.  ..++++...-++..-+..||.||-+ .++|||||+||+|||+|+.|++|+||||++..
T Consensus       166 V~IcMelMs-~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  166 VFICMELMS-TCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             HHHHHHHHH-HHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecccccce
Confidence            677888774 2334444443  2468888888889999999999976 35699999999999999999999999999877


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhhcCccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQEVPVREV  346 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~----~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~-~~~~~~~~~~~~~~~  346 (593)
                      ..++..    .+.-.|.+.|||||.+.    ..|+-++|||||||+|+||+||+.||...+... ..-.++..+ |  ..
T Consensus       242 lvdSkA----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e-P--P~  314 (391)
T KOG0983|consen  242 LVDSKA----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE-P--PL  314 (391)
T ss_pred             eecccc----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC-C--CC
Confidence            655432    23457999999999773    357889999999999999999999998854432 223333322 2  22


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ++...+ +.+     .+..++..|+..|+.+||.-.++++
T Consensus       315 L~~~~g-FSp-----~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  315 LPGHMG-FSP-----DFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCcccC-cCH-----HHHHHHHHHhhcCcccCcchHHHhc
Confidence            333222 333     3444667999999999999988754

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-34  Score=290.52  Aligned_cols=254  Identities=24%  Similarity=0.309  Sum_probs=188.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|++|.||+|... +|+.+|+|.+.......    ..       ...+.+|++++++++||||+++++++.. ..
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   72 (283)
T cd05118           4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE----GI-------PKTALREIKLLKELNHPNIIKLLDVFRHKGD   72 (283)
T ss_pred             ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc----hh-------HHHHHHHHHHHHHhcCCCcchHHHhhccCCC
Confidence            467999999999999875 68899999986432110    00       1247789999999999999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|+||++ ++|.+.+....  ..+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.+||+|||++..
T Consensus        73 ~~~v~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df~~~~~  147 (283)
T cd05118          73 LYLVFEFMD-TDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLARS  147 (283)
T ss_pred             EEEEEeccC-CCHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHH--CCeeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence            689999997 58888887633  468999999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-ccccc--
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-PVREV--  346 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~~~~~--  346 (593)
                      .....  .. .....++..|+|||.+.+  ..+.++|||||||++|+|+||+.||...+............. +....  
T Consensus       148 ~~~~~--~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (283)
T cd05118         148 FGSPV--RP-YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWP  224 (283)
T ss_pred             cCCCc--cc-ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcc
Confidence            54432  11 122458889999997643  468899999999999999999999977554333322221111 00000  


Q ss_pred             --cc---------cccCCC----CHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 --LD---------KEAGEW----NETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 --~~---------~~~~~~----~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        .+         +.....    ....+...+..++.+||+.+|.+||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence              00         000000    01123445667788999999999999999874

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3e-34  Score=295.51  Aligned_cols=244  Identities=26%  Similarity=0.388  Sum_probs=179.3

Q ss_pred             CCcccccCceEEEEEEEcC-CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~-g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-~  190 (593)
                      .+.||+|+||.||+|.+.. ++.||||.+.....     .. .      ...+..|+.++.+.. ||||++++|+|.+ .
T Consensus        20 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-----~~-~------~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   87 (296)
T cd06618          20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-----KE-E------NKRILMDLDVVLKSHDCPYIVKCYGYFITDS   87 (296)
T ss_pred             eeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-----hH-H------HHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence            5789999999999999864 89999999864311     00 0      113566777776665 9999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+. ++|.+.+....  .++++..+..++.|++.||.|||+. .+|+||||||+||++++++.+||+|||++.
T Consensus        88 ~~~~v~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg~~~  163 (296)
T cd06618          88 DVFICMELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGISG  163 (296)
T ss_pred             eEEEEeeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECccccch
Confidence            6689999974 57777665533  3689999999999999999999962 369999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccCC-----CCCcchhhHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhhcCccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVPVR  344 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~~~ksDVwSfGvvl~ElltG~~P~~~~~~~-~~~~~~~~~~~~~~  344 (593)
                      .......    .....|++.|+|||.+.+.     ++.++|||||||++|||++|+.||...... ...........+  
T Consensus       164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--  237 (296)
T cd06618         164 RLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP--  237 (296)
T ss_pred             hccCCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC--
Confidence            5433221    1223578899999977433     678999999999999999999999763322 111111111111  


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .. .. ...     ....+..++.+||..+|++||++.++++
T Consensus       238 ~~-~~-~~~-----~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         238 SL-PP-NEG-----FSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             CC-CC-CCC-----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00 00 001     1123455678999999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0200|consensus

Probab=100.00  E-value=2.2e-34  Score=324.02  Aligned_cols=252  Identities=29%  Similarity=0.471  Sum_probs=191.6

Q ss_pred             CCCcccccCceEEEEEEEc----C----CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK----N----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  183 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~----~----g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l  183 (593)
                      .++.||+|.||.|++|...    .    ...||||.++.....     .  +     ...+..|+++|+.+ +|||||.+
T Consensus       300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-----~--~-----~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-----S--E-----KKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             ccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-----H--H-----HHHHHHHHHHHHHhcCCcchhhh
Confidence            3568999999999999743    1    356999998754321     1  1     12588999999998 59999999


Q ss_pred             EEEEec-ccceEEEEeccCCCHHHHHhhcC-----CC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccC
Q psy9535         184 LGLCNN-IMNCIVYEYMCNGSLYDRLARVN-----NT--------PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  249 (593)
Q Consensus       184 ~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~-----~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLK  249 (593)
                      +|+|.. ...++|+||+..|+|.++|+..+     ..        ..+.....+.++.|||.|++||++  +++|||||-
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~--~~~vHRDLA  445 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS--VPCVHRDLA  445 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh--CCccchhhh
Confidence            999987 56689999999999999998765     00        238889999999999999999998  669999999


Q ss_pred             CCCeeecCCCccEEeecccceecccCCCcceeeccccCCCC--cCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCC
Q psy9535         250 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPID  325 (593)
Q Consensus       250 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~--Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~  325 (593)
                      ..|||+.++..+||+|||+||.........  ...-.||.+  |||||.+. ..++.|||||||||+|||++| |..||.
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~--~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp  523 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYR--TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP  523 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceE--ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence            999999999999999999999654433211  122234344  99999775 468999999999999999998 788998


Q ss_pred             CCc-hHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         326 DNN-TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       326 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      +.. ....+.. .......          ..+..+...+..++..||+.+|++||++.++++.+...
T Consensus       524 ~~~~~~~l~~~-l~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  524 GIPPTEELLEF-LKEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             CCCcHHHHHHH-HhcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            633 2222221 1111111          11122233455677899999999999999999999884

>KOG0690|consensus

Probab=100.00  E-value=2.2e-35  Score=290.54  Aligned_cols=262  Identities=26%  Similarity=0.383  Sum_probs=199.5

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE-eccc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~-~~~~  191 (593)
                      -++||+|.||+|-+++-+ +|+.+|||++++.......     +.+     .-..|-.+|..++||.+..|--.+ .++.
T Consensus       173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakd-----EVA-----HTlTE~RVL~~~~HPFLt~LKYsFQt~dr  242 (516)
T KOG0690|consen  173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKD-----EVA-----HTLTENRVLQNCRHPFLTSLKYSFQTQDR  242 (516)
T ss_pred             HHHhcCCccceEEEEeecccCceeehhhhhhhheeehH-----Hhh-----hhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence            367999999999999865 7999999999765332211     111     235688999999999998876544 4477


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .|+||||+.||.|+-+|.+.   ..+++.....+-..|+.||.|||+  ++||.||||.+|+|||++|++||+||||++.
T Consensus       243 lCFVMeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             EEEEEEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhheeccCCceEeeecccchh
Confidence            89999999999999888753   458888888889999999999998  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .-....   .+.+++|||.|+|||++. ..|+.++|+|.+|||+|||++|+.||...+....+..+...+..++..+.++
T Consensus       318 ~I~~g~---t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~e  394 (516)
T KOG0690|consen  318 EIKYGD---TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPE  394 (516)
T ss_pred             cccccc---eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHH
Confidence            433322   245689999999999985 4689999999999999999999999998777667777777776666555443


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCC--hHHHHHHHhhccccccccccccccc
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRAS--MRDIVDLLSKSMFVCNSLANLYVGK  405 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs--m~eV~~~L~~~~~~~~~~~~~~~~~  405 (593)
                                  .+.++..-+..||.+|..  -.++.+......+........+..+
T Consensus       395 ------------AktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kk  439 (516)
T KOG0690|consen  395 ------------AKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKK  439 (516)
T ss_pred             ------------HHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhc
Confidence                        223445667899999964  3444444444333333333333333

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-34  Score=299.16  Aligned_cols=257  Identities=25%  Similarity=0.324  Sum_probs=189.2

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI-  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~-  190 (593)
                      +.+.||+|+||.||+|+.. +|..||||++......    ...       ...+.+|+.+++.++||||+++++++... 
T Consensus         4 i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (330)
T cd07834           4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD----LID-------AKRILREIKLLRHLRHENIIGLLDILRPPS   72 (330)
T ss_pred             eeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc----chh-------hhhHHHHHHHHHhcCCcchhhhhhhhcccC
Confidence            4678999999999999875 5899999998643210    000       12478899999999999999999987653 


Q ss_pred             -----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         191 -----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       191 -----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                           ..++||||++ ++|.+++...   .++++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|
T Consensus        73 ~~~~~~~~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~--~gi~H~dlkp~nili~~~~~~~L~d  146 (330)
T cd07834          73 PEDFNDVYIVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICD  146 (330)
T ss_pred             cccccceEEEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEcc
Confidence                 4589999998 5898888643   378999999999999999999998  5699999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-c
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-P  342 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~  342 (593)
                      ||++.................||+.|+|||.+.+  .++.++|||||||++|+|++|+.||...........+..... +
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  226 (330)
T cd07834         147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP  226 (330)
T ss_pred             cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence            9999875443211111233568999999997743  478899999999999999999999987654433332222111 1


Q ss_pred             cccccc----cc----------cCCCC----HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREVLD----KE----------AGEWN----ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~~~----~~----------~~~~~----~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..+...    ..          .....    .......+..++.+||+.+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            100000    00          00000    0012233556778999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.2e-34  Score=301.31  Aligned_cols=254  Identities=24%  Similarity=0.345  Sum_probs=183.8

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI-  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~-  190 (593)
                      ..+.||+|+||.||+|+.. +|..||||.+.......    ..       ...+.+|+.+++.++||||+++++++... 
T Consensus         9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~----~~-------~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   77 (337)
T cd07858           9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR----ID-------AKRTLREIKLLRHLDHENVIAIKDIMPPPH   77 (337)
T ss_pred             EEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc----ch-------hHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence            3578999999999999864 68999999986431100    00       11366899999999999999999977532 


Q ss_pred             -----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         191 -----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       191 -----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                           ..++||||+. ++|.+++...   ..+++.....++.|++.||.|||+  ++++||||||+|||++.++.+||+|
T Consensus        78 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dlkp~Nil~~~~~~~kL~D  151 (337)
T cd07858          78 REAFNDVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLKICD  151 (337)
T ss_pred             ccccCcEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECc
Confidence                 3589999996 7898888642   458999999999999999999998  5699999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-cCc
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVP  342 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-~~~  342 (593)
                      ||+++......   .......||..|+|||.+.  ..++.++|||||||++|||++|+.||...+........... ..+
T Consensus       152 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  228 (337)
T cd07858         152 FGLARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP  228 (337)
T ss_pred             CccccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99988654321   1122346889999999764  35788999999999999999999999764322111111100 000


Q ss_pred             ccccc----ccc----------cCCC----CHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREVL----DKE----------AGEW----NETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~~----~~~----------~~~~----~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..+..    +..          ....    ....+...+..++.+||+.+|++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~  290 (337)
T cd07858         229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA  290 (337)
T ss_pred             ChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence            00000    000          0000    00112233556778999999999999999875

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.4e-34  Score=301.80  Aligned_cols=254  Identities=23%  Similarity=0.325  Sum_probs=181.5

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      ...+.||+|+||.||+|... +|..||+|.+.....      ..       ...+.+|++++++++||||+++++++...
T Consensus         8 ~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~------~~-------~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~   74 (342)
T cd07854           8 MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP------QS-------VKHALREIKIIRRLDHDNIVKVYEVLGPS   74 (342)
T ss_pred             EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC------ch-------HHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence            34678999999999999874 689999999864321      00       12477899999999999999999865432


Q ss_pred             ---------------cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee
Q psy9535         191 ---------------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  255 (593)
Q Consensus       191 ---------------~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl  255 (593)
                                     ..++||||+. ++|.+.+..    ..+++.....++.|++.||.|||+  .+|+||||||+|||+
T Consensus        75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~givH~dikp~Nili  147 (342)
T cd07854          75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFI  147 (342)
T ss_pred             ccccccccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEE
Confidence                           3579999997 688887753    358899999999999999999998  569999999999999


Q ss_pred             c-CCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHH
Q psy9535         256 D-ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILY  332 (593)
Q Consensus       256 ~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~  332 (593)
                      + .++.+||+|||+++................||..|+|||.+.  ..++.++|||||||++|||++|+.||........
T Consensus       148 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~  227 (342)
T cd07854         148 NTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ  227 (342)
T ss_pred             cCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            7 456789999999876533211111112346889999999653  3467899999999999999999999976554332


Q ss_pred             HHHHHhhcCccc-------------cccc--cccCCCCH----HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         333 YYLVVEQEVPVR-------------EVLD--KEAGEWNE----THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       333 ~~~~~~~~~~~~-------------~~~~--~~~~~~~~----~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ....... .+..             ....  ......+.    ..+...+..++.+|+..+|++|||+.|++.
T Consensus       228 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         228 MQLILES-VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHHHh-cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            2222111 0000             0000  00000000    012233455778999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.8e-33  Score=285.88  Aligned_cols=230  Identities=24%  Similarity=0.323  Sum_probs=171.2

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhc-CCCCceeeEEEEEec-ccce
Q psy9535         117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGLCNN-IMNC  193 (593)
Q Consensus       117 LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~-l~HpNIv~l~g~~~~-~~~~  193 (593)
                      ||+|+||.||+++.+ ++..+|+|.+.....    .              ..|+..... .+||||+++++++.. ...+
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~----~--------------~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF----N--------------AIEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhc----c--------------hhhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            699999999999864 688899999864310    0              012222211 279999999998765 5678


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC-ccEEeecccceec
Q psy9535         194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFGIVKMS  272 (593)
Q Consensus       194 lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~-~~Kl~DFGla~~~  272 (593)
                      +||||+++|+|.+++...   ..+++..+..++.|+++||.|||+  .+++||||||+||+++.++ .++|+|||+++..
T Consensus        86 iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             EEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            999999999999999753   268999999999999999999998  5599999999999999988 9999999998765


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILY-YYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~  350 (593)
                      ...       ....||..|+|||++. ..++.++|||||||++|||++|+.||........ ..............    
T Consensus       161 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----  229 (267)
T PHA03390        161 GTP-------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF----  229 (267)
T ss_pred             CCC-------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCc----
Confidence            322       1246899999999774 4578899999999999999999999975332111 11110000000000    


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCC-hHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRAS-MRDIV  385 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs-m~eV~  385 (593)
                           .......+..++.+||+.+|.+||+ +.|++
T Consensus       230 -----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l  260 (267)
T PHA03390        230 -----IKNVSKNANDFVQSMLKYNINYRLTNYNEII  260 (267)
T ss_pred             -----ccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence                 0122334556778999999999996 68875

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7e-34  Score=299.66  Aligned_cols=249  Identities=23%  Similarity=0.350  Sum_probs=182.5

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc--
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~--  190 (593)
                      .+.||+|+||.||+|... +|..||||.+.....    . ..      ....+.+|+.+|++++||||+++++++...  
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~-~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880          20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ----S-EL------FAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             EEEeeecCCeEEEEEEECCCCcEEEEEEeccccc----c-hH------HHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            578999999999999864 689999999853210    0 00      012467899999999999999999987542  


Q ss_pred             -----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         191 -----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       191 -----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                           ..++||||+ +++|.+++..    ..+++..+..++.|+++||.|||+  .+|+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~--~gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEee
Confidence                 237999998 7789887753    358999999999999999999998  5699999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  343 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~  343 (593)
                      ||+++.....      .....|++.|+|||.+.+  .++.++|||||||++|+|++|..||...................
T Consensus       162 fg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07880         162 FGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP  235 (343)
T ss_pred             cccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9998764322      123468999999997643  47889999999999999999999998654332222221111110


Q ss_pred             c-c---ccccc--------cCCCCH-------HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 R-E---VLDKE--------AGEWNE-------THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~-~---~~~~~--------~~~~~~-------~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      . +   .+...        ......       ..+...+..++.+|++.||++|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0 0   00000        000000       011223456778999999999999999864

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-34  Score=318.42  Aligned_cols=208  Identities=23%  Similarity=0.298  Sum_probs=148.4

Q ss_pred             CCCCcccccCceEEEEEEEcC--CCEEEEEEeecCCCCCCCCC----chhHHhhhcHHHHHHHHHHHhcCCCCceeeEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKN--GMEIAVKTLENNANYSSSNS----DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  185 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~--g~~vAVK~l~~~~~~~~~~~----~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g  185 (593)
                      ++.++||+|+||+||+|.++.  +..+++|.+...........    ............|++|+.+|++++|||||++++
T Consensus       151 ~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  230 (501)
T PHA03210        151 RVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEE  230 (501)
T ss_pred             EEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeE
Confidence            446899999999999987642  33333332211100000000    000000001235789999999999999999999


Q ss_pred             EEec-ccceEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccE
Q psy9535         186 LCNN-IMNCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  262 (593)
Q Consensus       186 ~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~K  262 (593)
                      ++.. ...++|+|++ +++|.+++.....  ...........|+.|++.||.|||+  ++||||||||+|||++.++.+|
T Consensus       231 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~--~gIiHrDLKP~NILl~~~~~vk  307 (501)
T PHA03210        231 ILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD--KKLIHRDIKLENIFLNCDGKIV  307 (501)
T ss_pred             EEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEE
Confidence            9876 4567899987 4678777754221  1123355667899999999999998  5699999999999999999999


Q ss_pred             EeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCC
Q psy9535         263 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI  324 (593)
Q Consensus       263 l~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~  324 (593)
                      |+|||+++.......  .......||+.|+|||++. ..++.++|||||||++|||++|..|+
T Consensus       308 L~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        308 LGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             EEeCCCceecCcccc--cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            999999986543321  1123467999999999774 45888999999999999999987543

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.8e-34  Score=297.52  Aligned_cols=258  Identities=22%  Similarity=0.348  Sum_probs=185.6

Q ss_pred             HHHhcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCC
Q psy9535          99 ERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH  177 (593)
Q Consensus        99 ~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~H  177 (593)
                      ...+++|..      .+.||+|+||.||+|... +|..||||++.......    ..       ...+.+|++++++++|
T Consensus         6 ~~~~~~y~~------~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~-------~~~~~~E~~~l~~l~h   68 (328)
T cd07856           6 FEITNRYVD------LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP----VL-------AKRTYRELKLLKHLRH   68 (328)
T ss_pred             eccccceEE------EEeecccCCeEEEEEEECCCCCEEEEEEeccccccc----ch-------hHHHHHHHHHHHhcCC
Confidence            345556654      688999999999999865 78999999886431110    00       1146789999999999


Q ss_pred             CceeeEEEEEec--ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee
Q psy9535         178 VNLLRLLGLCNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  255 (593)
Q Consensus       178 pNIv~l~g~~~~--~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl  255 (593)
                      |||+++++++..  ...++|+||+ +++|.+++..    .++++.....++.|+++||.|||+  .+|+||||||+|||+
T Consensus        69 pniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili  141 (328)
T cd07856          69 ENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHS--AGVVHRDLKPSNILI  141 (328)
T ss_pred             CCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEeE
Confidence            999999998754  4568999998 5789887753    357888888999999999999998  569999999999999


Q ss_pred             cCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHH
Q psy9535         256 DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYY  333 (593)
Q Consensus       256 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~  333 (593)
                      +.++.+||+|||+++.....      .....|++.|+|||.+.+  .++.++|||||||++|||++|+.||........+
T Consensus       142 ~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~  215 (328)
T cd07856         142 NENCDLKICDFGLARIQDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF  215 (328)
T ss_pred             CCCCCEEeCccccccccCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999998754321      123467889999997643  5788999999999999999999999765432211


Q ss_pred             HHHHhh-cCccccccc------------c-c-cCCCCHH----HHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         334 YLVVEQ-EVPVREVLD------------K-E-AGEWNET----HVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       334 ~~~~~~-~~~~~~~~~------------~-~-~~~~~~~----~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...... ..+..+..+            . . ....+..    .....+..++.+||+.+|++||++.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         216 SIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             HHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            111110 000000000            0 0 0000000    12234556778999999999999998853

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1151|consensus

Probab=100.00  E-value=6.9e-35  Score=296.55  Aligned_cols=281  Identities=26%  Similarity=0.362  Sum_probs=205.5

Q ss_pred             cCcceeecHHHHHHHhcC----CCCCCC----CCCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHH
Q psy9535          87 IGELIAFTFCDLERATDG----FNRKPY----PRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEA  157 (593)
Q Consensus        87 ~~~~~~~~~~~l~~at~~----f~~~~~----~~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~  157 (593)
                      ++..+..-..||+++.+.    |...+.    +-+.+.||+|||+.||++.. ...+.||||+-..+..+......+.  
T Consensus       433 LErvrnlHiRELKRi~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNY--  510 (775)
T KOG1151|consen  433 LERVRNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENY--  510 (775)
T ss_pred             HHHHHHHHHHHHHhhcccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhH--
Confidence            344555667788887654    333221    12346799999999999974 4578899998765544433222221  


Q ss_pred             hhhcHHHHHHHHHHHhcCCCCceeeEEEEEe--cccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q psy9535         158 AMIPILLFENEVQTLSQCKHVNLLRLLGLCN--NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY  235 (593)
Q Consensus       158 ~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~--~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~y  235 (593)
                          .+--.+|..|.+.|.||.||++|+|+.  .+.+|-|+|||+|.+|.-+|+..   ..+++.++..|+.||+.||.|
T Consensus       511 ----hKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~Y  583 (775)
T KOG1151|consen  511 ----HKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKY  583 (775)
T ss_pred             ----HHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHH
Confidence                123468999999999999999999874  46789999999999999999864   358899999999999999999


Q ss_pred             HhcCCCCeEecccCCCCeeec---CCCccEEeecccceecccCCCcc----eeeccccCCCCcCCccccc-C----CCCC
Q psy9535         236 LHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMH-C----QIST  303 (593)
Q Consensus       236 LH~~~~~IiHrDLKp~NILl~---~~~~~Kl~DFGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~~~-~----~~~~  303 (593)
                      |.+...||||-||||.||||.   ..|.+||+||||++++++.....    ..+....||.+|++||.+. +    +++.
T Consensus       584 LNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsn  663 (775)
T KOG1151|consen  584 LNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISN  663 (775)
T ss_pred             HhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCcccc
Confidence            999888899999999999995   45889999999999987654321    2356678999999999652 2    4788


Q ss_pred             cchhhHHHHHHHHHHhCCCCCCCCchHH---HHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCC
Q psy9535         304 KTDVFSYGVILLELLTGMKPIDDNNTIL---YYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS  380 (593)
Q Consensus       304 ksDVwSfGvvl~ElltG~~P~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs  380 (593)
                      |+||||.|||+|..+.|++||.......   ....++..    .++--     .+...+....+.++.+|+++..++|..
T Consensus       664 KVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA----tEVqF-----P~KPvVsseAkaFIRRCLaYRKeDR~D  734 (775)
T KOG1151|consen  664 KVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA----TEVQF-----PPKPVVSSEAKAFIRRCLAYRKEDRID  734 (775)
T ss_pred             ceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc----eeccC-----CCCCccCHHHHHHHHHHHHhhhhhhhh
Confidence            9999999999999999999998643321   11111111    11100     011122334555778999999999987


Q ss_pred             hHHHH
Q psy9535         381 MRDIV  385 (593)
Q Consensus       381 m~eV~  385 (593)
                      ..++.
T Consensus       735 V~qLA  739 (775)
T KOG1151|consen  735 VQQLA  739 (775)
T ss_pred             HHHHc
Confidence            66654

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=281.55  Aligned_cols=244  Identities=27%  Similarity=0.442  Sum_probs=189.3

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|+.. +++.||+|.+......    ...       ...+.+|++++++++|||++++++++.+ .
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (254)
T cd06627           4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK----EEA-------LKSIMQEIDLLKNLKHPNIVKYIGSIETSD   72 (254)
T ss_pred             eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC----HHH-------HHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Confidence            3578999999999999875 5789999998653210    011       2258899999999999999999998765 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~  147 (254)
T cd06627          73 SLYIILEYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVAT  147 (254)
T ss_pred             EEEEEEecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEECCCCCEEEeccccce
Confidence            568999999999999998753   468999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ........   .....|+..|+|||...+ ..+.++||||+|+++|+|++|..||.................  ...   
T Consensus       148 ~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~---  219 (254)
T cd06627         148 KLNDVSKD---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH--PPL---  219 (254)
T ss_pred             ecCCCccc---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC--CCC---
Confidence            76543221   123568999999997643 467899999999999999999999976554333222221111  100   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                            +..+...+..++.+||..+|++||++.+++.
T Consensus       220 ------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 ------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                  0111233455677999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.4e-33  Score=282.66  Aligned_cols=244  Identities=26%  Similarity=0.350  Sum_probs=188.1

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+++.. ++..+|+|.+......    ..  .     ...+.+|++++++++||||+++++++.. ..
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~--~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd08530           5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS----QK--E-----REDAVNEIRILASVNHPNIISYKEAFLDGNK   73 (256)
T ss_pred             eeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc----HH--H-----HHHHHHHHHHHHhCCCCCchhhhhhhccCCE
Confidence            578999999999999764 6889999998643211    00  0     1247789999999999999999987654 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      .++||||+++++|.+++.+... ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+++
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~  151 (256)
T cd08530          74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLGISK  151 (256)
T ss_pred             EEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEEecCCcEEEeeccchh
Confidence            7899999999999999865321 3468999999999999999999998  569999999999999999999999999988


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......     .....|++.|+|||.+.+ .++.++|+||||+++|||++|+.||................  ....   
T Consensus       152 ~~~~~~-----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~---  221 (256)
T cd08530         152 VLKKNM-----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--YPPI---  221 (256)
T ss_pred             hhccCC-----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCC---
Confidence            764431     122468899999997644 46789999999999999999999998754332222221111  1111   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                            .......+..++.+||..+|++||++.++++
T Consensus       222 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         222 ------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ------chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                  0122233556778999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG1006|consensus

Probab=100.00  E-value=5.6e-36  Score=288.26  Aligned_cols=262  Identities=29%  Similarity=0.351  Sum_probs=187.6

Q ss_pred             cceeecHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHH
Q psy9535          89 ELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN  167 (593)
Q Consensus        89 ~~~~~~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~  167 (593)
                      .+-.|+.++|+..             ..||.|+||+|+|-.++ +|+..|||+++....       +.+     .++|..
T Consensus        57 ~~~~F~~~~Lqdl-------------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-------~ke-----q~rll~  111 (361)
T KOG1006|consen   57 HLHTFTSDNLQDL-------------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-------EKE-----QKRLLM  111 (361)
T ss_pred             cccccccchHHHH-------------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-------hHH-----HHHHHH
Confidence            3455676677654             46999999999998765 799999999975421       111     235778


Q ss_pred             HHHHHhc-CCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q psy9535         168 EVQTLSQ-CKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYSIALGVAEALHYLHSLSKPI  243 (593)
Q Consensus       168 Ev~il~~-l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~I  243 (593)
                      |.+...+ -+.||||+++|.+.. +.-|+-||.|. -||..+.+..  -....+++.-.-.|..-++.||.||-+. ..|
T Consensus       112 e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lki  189 (361)
T KOG1006|consen  112 EHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKI  189 (361)
T ss_pred             HHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhh
Confidence            8876544 468999999998755 66788899884 5664433221  1124577877778888899999999752 349


Q ss_pred             EecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc---CCCCCcchhhHHHHHHHHHHhC
Q psy9535         244 IHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---CQISTKTDVFSYGVILLELLTG  320 (593)
Q Consensus       244 iHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~~ksDVwSfGvvl~ElltG  320 (593)
                      ||||+||+|||||..|.+||||||++.....+-.    .+.-.|...|||||.+.   ..|+-+|||||+|++|||+.||
T Consensus       190 IHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG  265 (361)
T KOG1006|consen  190 IHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATG  265 (361)
T ss_pred             hhccCChhheEEecCCCEeeecccchHhHHHHHH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecC
Confidence            9999999999999999999999999876654322    22357999999999763   3488999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         321 MKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       321 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +.||...++.......+....+..-..+.+..++..     .+...+..|+..|..+||...++.+
T Consensus       266 ~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~-----~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  266 NFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF-----SMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             CCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH-----HHHHHHHHHhhcccccCcchhhhhc
Confidence            999988655433333222222222222222222322     2334557999999999999988743

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.9e-33  Score=279.84  Aligned_cols=246  Identities=26%  Similarity=0.417  Sum_probs=189.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||++... ++..||+|++......    ...       ...+.+|++++++++|||++++++.+.. ..
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~-------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~   73 (258)
T cd08215           5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS----EKE-------REDALNEVKILKKLNHPNIIKYYESFEEKGK   73 (258)
T ss_pred             EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC----hHH-------HHHHHHHHHHHHhcCCCChhheEEEEecCCE
Confidence            468999999999999875 6889999998643211    011       1247789999999999999999997765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         192 NCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      .++|+||+++++|.+++.... ....+++..+..++.+++.||.|||+  .+++|+||+|+||+++.++.+||+|||++.
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~~H~dl~~~nil~~~~~~~~l~d~~~~~  151 (258)
T cd08215          74 LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISK  151 (258)
T ss_pred             EEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHHeEEcCCCcEEECCcccee
Confidence            689999999999999997642 13578999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......   .......|++.|+|||.+. ..++.++||||+|+++|+|++|..||................  ....   
T Consensus       152 ~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~---  223 (258)
T cd08215         152 VLSSTV---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--YPPI---  223 (258)
T ss_pred             ecccCc---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC--CCCC---
Confidence            654432   1123357899999999764 457889999999999999999999997654332222221111  1111   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       ..     .....+..++.+||..+|++||++.|+++
T Consensus       224 -~~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 -PS-----QYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -CC-----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             00     11233455677999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.6e-33  Score=283.89  Aligned_cols=249  Identities=25%  Similarity=0.375  Sum_probs=184.1

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.++||+|+||.||+++.. .+..+++|.++......... ..       ...+..|+.++++++||||+++++++.+ .
T Consensus         4 i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (260)
T cd08222           4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNP-NE-------TVQANQEAQLLSKLDHPAIVKFHASFLERD   75 (260)
T ss_pred             eeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCc-ch-------HHHHHHHHHHHHhCCCCcHHHHHHHHhcCC
Confidence            4578999999999999875 34556777665422111111 10       1136679999999999999999998765 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+  .+++|+||||+||+++. +.+||+|||++
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~~l~~~nili~~-~~~~l~d~g~~  152 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--RRILHRDLKAKNIFLKN-NLLKIGDFGVS  152 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH--cCccccCCChhheEeec-CCEeecccCce
Confidence            5689999999999999886532 23568999999999999999999998  56999999999999975 56999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      +.......   ......|++.|+|||.+. ..++.++|+||||+++|+|++|..||.................  +..  
T Consensus       153 ~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~--  225 (260)
T cd08222         153 RLLMGSCD---LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT--PSL--  225 (260)
T ss_pred             eecCCCcc---cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC--CCC--
Confidence            76543221   122356899999999764 4567899999999999999999999976543332222221111  110  


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                             +......+..++.+||..+|++||++.|+++
T Consensus       226 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         226 -------PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -------cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                   1112234555778999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0986|consensus

Probab=100.00  E-value=8.3e-35  Score=297.60  Aligned_cols=245  Identities=24%  Similarity=0.309  Sum_probs=185.8

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      .-++||+||||.||-++.+ +|+.+|+|++.+...-....          ...-.+|-++|.+++.+.||.|--++.. +
T Consensus       189 ~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~g----------e~maLnEk~iL~kV~s~FiVslaYAfeTkd  258 (591)
T KOG0986|consen  189 VYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKG----------ETMALNEKQILEKVSSPFIVSLAYAFETKD  258 (591)
T ss_pred             eeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhh----------hHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence            3688999999999998765 69999999986542211111          1135689999999999999999766655 7


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..|+|+..|.||+|.-+|...+. +.+++...+.++.+|+.||++||+  ..||.|||||+|||||+.|+++|+|+|||.
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~--~~iVYRDLKPeNILLDd~GhvRISDLGLAv  335 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHR--RRIVYRDLKPENILLDDHGHVRISDLGLAV  335 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHh--cceeeccCChhheeeccCCCeEeeccceEE
Confidence            78999999999999988876654 679999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .......    ....+||.+|||||++. ..|+...|+||+||++|||+.|+.||..-..-+.+..+-...     .-+ 
T Consensus       336 ei~~g~~----~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~-----~~~-  405 (591)
T KOG0986|consen  336 EIPEGKP----IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT-----LED-  405 (591)
T ss_pred             ecCCCCc----cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH-----hcc-
Confidence            7665432    22348999999999885 458889999999999999999999997533322221111000     000 


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMR  382 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~  382 (593)
                       ..+++ +...+..+.+.+.-++.||.+|...+
T Consensus       406 -~~ey~-~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  406 -PEEYS-DKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             -hhhcc-cccCHHHHHHHHHHHccCHHHhccCC
Confidence             11111 22223344455566789999997655

>KOG0612|consensus

Probab=100.00  E-value=6.8e-35  Score=324.96  Aligned_cols=255  Identities=24%  Similarity=0.356  Sum_probs=196.6

Q ss_pred             HHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhc
Q psy9535          96 CDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ  174 (593)
Q Consensus        96 ~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~  174 (593)
                      .+|+.-.++|..      .++||+|+||.|...+.+ +++.+|+|++++........          ...|..|-.+|..
T Consensus        68 ~~lrl~~~Dfei------lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~----------tA~F~EERDimv~  131 (1317)
T KOG0612|consen   68 KELRLKAEDFEI------LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAE----------TACFREERDIMVF  131 (1317)
T ss_pred             HHHhCCHHhhHH------HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchh----------HHHHHHHhHHHHc
Confidence            345555566654      578999999999999886 57889999997643221111          1248899999999


Q ss_pred             CCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCe
Q psy9535         175 CKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  253 (593)
Q Consensus       175 l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NI  253 (593)
                      .+.+-||+|+-.+.+ ...|+|||||+||+|..+|.+..   ++++..+..++..|+.||.-||+.+  +|||||||+||
T Consensus       132 ~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNv  206 (1317)
T KOG0612|consen  132 GNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNV  206 (1317)
T ss_pred             CCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCccee
Confidence            999999999877765 67799999999999999998753   5888888899999999999999955  99999999999


Q ss_pred             eecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc------CCCCCcchhhHHHHHHHHHHhCCCCCCCC
Q psy9535         254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDN  327 (593)
Q Consensus       254 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~~ksDVwSfGvvl~ElltG~~P~~~~  327 (593)
                      |||.+|++||+|||.+-....++  ...+...+|||.|++||++.      +.|+..+|+||+||++|||+.|..||..+
T Consensus       207 Lld~~GHikLADFGsClkm~~dG--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad  284 (1317)
T KOG0612|consen  207 LLDKSGHIKLADFGSCLKMDADG--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD  284 (1317)
T ss_pred             EecccCcEeeccchhHHhcCCCC--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence            99999999999999886665444  33345678999999999872      45889999999999999999999999987


Q ss_pred             chHHHHHHHHhhc--CccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCC---hHHH
Q psy9535         328 NTILYYYLVVEQE--VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS---MRDI  384 (593)
Q Consensus       328 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs---m~eV  384 (593)
                      +-...|-.++...  ..+++..+      ...+...+|..+     --+|+.|..   ..++
T Consensus       285 slveTY~KIm~hk~~l~FP~~~~------VSeeakdLI~~l-----l~~~e~RLgrngiedi  335 (1317)
T KOG0612|consen  285 SLVETYGKIMNHKESLSFPDETD------VSEEAKDLIEAL-----LCDREVRLGRNGIEDI  335 (1317)
T ss_pred             HHHHHHHHHhchhhhcCCCcccc------cCHHHHHHHHHH-----hcChhhhcccccHHHH
Confidence            7666666665542  22222111      223344444443     347888877   6555

>KOG0667|consensus

Probab=100.00  E-value=5.6e-34  Score=305.41  Aligned_cols=201  Identities=29%  Similarity=0.378  Sum_probs=162.0

Q ss_pred             CCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CC-----ceeeEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HV-----NLLRLL  184 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-Hp-----NIv~l~  184 (593)
                      .+.+.||+|+||.|-+|.. ++++.||||++++...+-              .+-+.|+.+|..|+ |.     |+|+++
T Consensus       189 ~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~--------------~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~  254 (586)
T KOG0667|consen  189 EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFL--------------RQAQIEIRILELLNKHDPDDKYNIVRML  254 (586)
T ss_pred             EEEEEecccccceeEEEEecCCCcEEEEEeeccChHHH--------------HHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence            3457899999999999975 479999999997642211              12356999999997 43     899999


Q ss_pred             EEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC--CCcc
Q psy9535         185 GLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--NFVP  261 (593)
Q Consensus       185 g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~--~~~~  261 (593)
                      +++.. ...|||+|.+. -+|+++|+... ..+++......|+.||+.||.+||+  .+|||+||||+||||.+  ...+
T Consensus       255 d~F~fr~HlciVfELL~-~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~--l~IIHcDLKPENILL~~~~r~~v  330 (586)
T KOG0667|consen  255 DYFYFRNHLCIVFELLS-TNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHE--LGIIHCDLKPENILLKDPKRSRI  330 (586)
T ss_pred             eccccccceeeeehhhh-hhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCChhheeeccCCcCce
Confidence            98865 67799999874 78999998754 3569999999999999999999998  45999999999999964  3479


Q ss_pred             EEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHH
Q psy9535         262 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  336 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~  336 (593)
                      ||+|||.|......-    +  +..-+..|.|||++ ...|+.+.||||||||+.||++|.+-|.+++.......+
T Consensus       331 KVIDFGSSc~~~q~v----y--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I  400 (586)
T KOG0667|consen  331 KVIDFGSSCFESQRV----Y--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI  400 (586)
T ss_pred             eEEecccccccCCcc----e--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence            999999988654321    1  34568899999965 567999999999999999999998888876654444443

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8e-34  Score=288.26  Aligned_cols=246  Identities=27%  Similarity=0.420  Sum_probs=187.0

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-  189 (593)
                      ..+.||+|+||.||+|+.. +|..||+|.+........    . .     ...+.+|++++++++ ||||+++++++.+ 
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----~-~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   74 (280)
T cd05581           5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE----K-K-----VKYVKIEKEVLTRLNGHPGIIKLYYTFQDE   74 (280)
T ss_pred             EeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccch----H-H-----HHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence            3578999999999999875 689999999864321110    0 0     124778999999999 9999999998765 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df~~~  149 (280)
T cd05581          75 ENLYFVLEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTA  149 (280)
T ss_pred             ceEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCCccc
Confidence            5668999999999999999763   368999999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCc-----------------ceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHH
Q psy9535         270 KMSETSNMK-----------------TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTIL  331 (593)
Q Consensus       270 ~~~~~~~~~-----------------~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~  331 (593)
                      .........                 ........|+..|+|||.+. ...+.++||||||++++|+++|+.||.......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            765432210                 01122346889999999764 457789999999999999999999998654332


Q ss_pred             HHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCCh----HHHH
Q psy9535         332 YYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASM----RDIV  385 (593)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm----~eV~  385 (593)
                      ............+.            .....+..++.+||..+|++||++    .+++
T Consensus       230 ~~~~~~~~~~~~~~------------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll  275 (280)
T cd05581         230 TFQKILKLEYSFPP------------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK  275 (280)
T ss_pred             HHHHHHhcCCCCCC------------ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence            22222211111111            112234556789999999999999    6654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1025|consensus

Probab=100.00  E-value=1.1e-34  Score=313.48  Aligned_cols=250  Identities=26%  Similarity=0.408  Sum_probs=191.7

Q ss_pred             CCcccccCceEEEEEEEc-CC----CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g----~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      ..+||+|+||+||+|.|- .|    -+||||++......+.            ..+|..|+-+|.+++|||+++|+|+|.
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~------------s~e~LdeAl~masldHpnl~RLLgvc~  768 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA------------SIELLDEALRMASLDHPNLLRLLGVCM  768 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh------------hHHHHHHHHHHhcCCCchHHHHhhhcc
Confidence            578999999999999873 33    4689999865321110            125889999999999999999999998


Q ss_pred             cccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         189 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       189 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      .....||++||+.|+|.|+++..+  ..+-....+.+..|||+||.|||+  +.++||||-..|||+.+-..+||.|||+
T Consensus       769 ~s~~qlvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~--qrlVHrdLaaRNVLVksP~hvkitdfgl  844 (1177)
T KOG1025|consen  769 LSTLQLVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEE--QRLVHRDLAARNVLVKSPNHVKITDFGL  844 (1177)
T ss_pred             cchHHHHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHh--cchhhhhhhhhheeecCCCeEEEEecch
Confidence            888889999999999999998744  467888899999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ++........-. .....-.+.|||-|.+ ...++.++|||||||++||++| |..|++.......-.....++ .+   
T Consensus       845 a~ll~~d~~ey~-~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-RL---  919 (1177)
T KOG1025|consen  845 AKLLAPDEKEYS-APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-RL---  919 (1177)
T ss_pred             hhccCccccccc-ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-cC---
Confidence            998766543221 1112224569999966 4578999999999999999998 999998754322211111111 11   


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                            .. +..+..-+..++.+||..|++.||+++++...+.+.
T Consensus       920 ------sq-PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  920 ------SQ-PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             ------CC-CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence                  11 111222244456699999999999999998877663

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.6e-34  Score=299.29  Aligned_cols=249  Identities=25%  Similarity=0.361  Sum_probs=182.5

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c-
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I-  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~-  190 (593)
                      ...||+|+||.||+|+.. ++..||||++.....    ....       ...+.+|+.++++++||||+++++++.. . 
T Consensus        20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~----~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851          20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ----SAIH-------AKRTYRELRLLKHMDHENVIGLLDVFTPASS   88 (343)
T ss_pred             EEEeccCCceEEEEEEECCCCcEEEEEecccccc----hhhH-------HHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence            578999999999999875 588999998753210    0000       1246789999999999999999986643 2 


Q ss_pred             -----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         191 -----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       191 -----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                           ..++|+||+ +++|.+++..    ..+++..+..++.|+++||.|||+  .+|+||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          89 LEDFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             ccccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEcc
Confidence                 257899998 6799988864    358999999999999999999998  5699999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-c
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-P  342 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~  342 (593)
                      ||++......      .....||..|+|||.+.+  .++.++|||||||++|||++|+.||................. +
T Consensus       162 fg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~  235 (343)
T cd07851         162 FGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP  235 (343)
T ss_pred             cccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Confidence            9998765322      123468899999997643  467899999999999999999999976544322222211111 1


Q ss_pred             cccccccc----------------cCCCCH--HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREVLDKE----------------AGEWNE--THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~~~~~----------------~~~~~~--~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ........                ...+..  ......+..++.+|+..+|++|||+.||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            10100000                000000  001234556778999999999999999853

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-33  Score=278.03  Aligned_cols=237  Identities=27%  Similarity=0.359  Sum_probs=183.0

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccceE
Q psy9535         117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  194 (593)
Q Consensus       117 LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~l  194 (593)
                      ||+|+||.||++... +++.+|+|.+........   .       ....+.+|+.++++++||||+++++.+.. ...++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~---~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   70 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR---K-------EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYL   70 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch---H-------HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEE
Confidence            699999999999875 589999999865421110   0       12257889999999999999999987765 56689


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceeccc
Q psy9535         195 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  274 (593)
Q Consensus       195 V~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~  274 (593)
                      ||||+++++|.+++...   ..+++.....++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++.....
T Consensus        71 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          71 VLEYAPGGELFSHLSKE---GRFSEERARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            99999999999999753   358999999999999999999998  5699999999999999999999999999876543


Q ss_pred             CCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCC
Q psy9535         275 SNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGE  353 (593)
Q Consensus       275 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (593)
                      ...   ......|+..|+|||...+ ..+.++|+||||+++|||++|..||.................+.+...      
T Consensus       146 ~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------  216 (250)
T cd05123         146 EGS---RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFL------  216 (250)
T ss_pred             CCC---cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCC------
Confidence            311   1234578999999997643 467889999999999999999999976553322222222111111111      


Q ss_pred             CCHHHHHHHHHHHHHHhhccccCCCCChHH
Q psy9535         354 WNETHVETLIGIVFEKCCVFEKDKRASMRD  383 (593)
Q Consensus       354 ~~~~~~~~~i~~~~~~C~~~dp~~RPsm~e  383 (593)
                            ...+..++.+||..+|++||++.+
T Consensus       217 ------~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 ------SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             ------CHHHHHHHHHHhcCCHhhCCCccc
Confidence                  223445678999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.2e-33  Score=292.96  Aligned_cols=255  Identities=23%  Similarity=0.283  Sum_probs=180.5

Q ss_pred             CCcccccCceEEEEEEEc-C--CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec
Q psy9535         114 GNKLGEGQFGTVYYGKLK-N--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~--g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~  189 (593)
                      .+.||+|+||.||+++.. +  +..||||++......    ...       ...+.+|+.+++++ .||||+++++++..
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~-------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   73 (332)
T cd07857           5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK----KIL-------AKRALRELKLLRHFRGHKNITCLYDMDIV   73 (332)
T ss_pred             EEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc----chh-------HHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence            468999999999999875 3  778999998632110    000       12467899999999 59999999986532


Q ss_pred             -----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         190 -----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       190 -----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                           ...++++||+. ++|.+++..   ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+
T Consensus        74 ~~~~~~~~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili~~~~~~kl~  147 (332)
T cd07857          74 FPGNFNELYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKIC  147 (332)
T ss_pred             ccccCCcEEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEEcCCCCEEeC
Confidence                 23467778775 789988864   2468999999999999999999998  569999999999999999999999


Q ss_pred             ecccceecccCCCc-ceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-
Q psy9535         265 DFGIVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-  340 (593)
Q Consensus       265 DFGla~~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~-  340 (593)
                      |||+++........ ........||+.|+|||.+.+  .++.++|||||||++|+|++|+.||...+............ 
T Consensus       148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  227 (332)
T cd07857         148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG  227 (332)
T ss_pred             cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence            99999865432211 111233578999999997643  47889999999999999999999997654332222211110 


Q ss_pred             Ccccccc----cc-----------c-cCCCC--HHHHHHHHHHHHHHhhccccCCCCChHHHH
Q psy9535         341 VPVREVL----DK-----------E-AGEWN--ETHVETLIGIVFEKCCVFEKDKRASMRDIV  385 (593)
Q Consensus       341 ~~~~~~~----~~-----------~-~~~~~--~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~  385 (593)
                      .+..+..    ++           . ...+.  .......+..++.+|++.+|.+|||+.+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll  290 (332)
T cd07857         228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL  290 (332)
T ss_pred             CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            0000000    00           0 00000  000123455677899999999999999975

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-33  Score=283.10  Aligned_cols=254  Identities=26%  Similarity=0.333  Sum_probs=186.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ...||+|+||.||+|+.. +++.||+|.+......   . ..       ...+.+|+.++++++|+||+++++++.+ ..
T Consensus         4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~-~~-------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   72 (282)
T cd07829           4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE---E-GI-------PSTALREISLLKELKHPNIVKLLDVIHTERK   72 (282)
T ss_pred             ehcccccCcceEEEeeecCCCcEEEEEEecccccc---c-cc-------cHHHHHHHHHHHhcCCCCHHHHHhhhhcCCc
Confidence            468999999999999875 5899999998754210   0 00       1146789999999999999999998765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||++ ++|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||+|+||++++++.+||+|||+++.
T Consensus        73 ~~~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~  147 (282)
T cd07829          73 LYLVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLARA  147 (282)
T ss_pred             eEEEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChheEEEcCCCCEEEecCCcccc
Confidence            789999997 69999997643  368999999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-C-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-cc-----
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-PV-----  343 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~~-----  343 (593)
                      ......   ......++..|+|||.+. . .++.++|||||||++|||++|..||................. +.     
T Consensus       148 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
T cd07829         148 FGIPLR---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP  224 (282)
T ss_pred             cCCCcc---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHH
Confidence            543221   112235678899999763 3 578899999999999999999999976543322222111000 00     


Q ss_pred             --------ccccccccCCCC---HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 --------REVLDKEAGEWN---ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 --------~~~~~~~~~~~~---~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                              ............   .......+..++.+||..+|++||++.+|+.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             hhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                    000000000000   0011234566778999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.4e-33  Score=317.58  Aligned_cols=143  Identities=30%  Similarity=0.377  Sum_probs=121.4

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.++||+|+||.||+|+.. +++.||||++......   ..   .    ....+.+|+.+++.++||||+++++++.. .
T Consensus         8 i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~---~~---~----~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   77 (669)
T cd05610           8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI---NK---N----MVHQVQAERDALALSKSPFIVHLYYSLQSAN   77 (669)
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc---CH---H----HHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence            3578999999999999876 6899999998643211   00   0    12257889999999999999999988765 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+.+|+|.+++...   ..+++.....|+.||+.||.|||+  ++||||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~--~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHR--HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            678999999999999999753   357888999999999999999998  569999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0696|consensus

Probab=100.00  E-value=6.9e-34  Score=287.29  Aligned_cols=236  Identities=28%  Similarity=0.379  Sum_probs=183.9

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-cc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~~  191 (593)
                      .+||+|+||+|.+|..+ +...+|||+++++.....   ++.+..       ..|-.+|.-. +-|.+++|+.++.. +.
T Consensus       355 ~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd---DDvect-------m~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  355 MVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD---DDVECT-------MVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             EEeccCccceeeeecccCcchhhhhhhhccceeeec---Ccccce-------ehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            57999999999999765 456799999987654332   222322       2355566554 56889999988877 66


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+.||+|..++...+   .+.+..++.+|.+||-||-|||+  ++||.||||.+|||||.+|++||+|||+++.
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~--kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhc--CCeeeeeccccceEeccCCceEeeecccccc
Confidence            789999999999998887754   47778888999999999999998  6799999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .-...   ..+.+++|||.|+|||++ ...|+..+|+|||||+||||+.|++||++++....+..+.......+..+..+
T Consensus       500 ni~~~---~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkE  576 (683)
T KOG0696|consen  500 NIFDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKE  576 (683)
T ss_pred             cccCC---cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHH
Confidence            43332   235578999999999966 45678888999999999999999999999888777777777666555444332


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCC
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRAS  380 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs  380 (593)
                                  ...+...-+...|.+|..
T Consensus       577 ------------Av~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  577 ------------AVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ------------HHHHHHHHhhcCCccccC
Confidence                        112233445677877743

>KOG0576|consensus

Probab=100.00  E-value=1.6e-34  Score=306.98  Aligned_cols=388  Identities=24%  Similarity=0.301  Sum_probs=257.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ..++|.|.||.|||++.. ++...|||.++-.....             ....++|+-+++.++|||||.++|.+.. +.
T Consensus        20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-------------~~~iqqei~~~~dc~h~nivay~gsylr~dk   86 (829)
T KOG0576|consen   20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-------------FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK   86 (829)
T ss_pred             eeeecCCcccchhhhcccccCchhhheeeeccCCcc-------------ccccccceeeeecCCCcChHHHHhhhhhhcC
Confidence            568999999999999864 78999999986542111             1135689999999999999999997754 67


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++.||||.+|+|++.-+-   ..++++.+.....+...+||.|||+.+  =+|||||-.|||+++.+.+|++|||.+..
T Consensus        87 lwicMEycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaq  161 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQ  161 (829)
T ss_pred             cEEEEEecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhh
Confidence            7999999999999987653   467999999999999999999999854  78999999999999999999999998765


Q ss_pred             cccCCCcceeeccccCCCCcCCcccc----cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~----~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ....-.   ....+.||++|||||+-    .+.|..++|||+.|+...|+---++|..+.......+.........+..-
T Consensus       162 itati~---KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk  238 (829)
T KOG0576|consen  162 ITATIA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK  238 (829)
T ss_pred             hhhhhh---hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCccc
Confidence            443221   12357899999999953    45688999999999999999998888776555444443333322222222


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhccccccccccccccccccccccccccc---cccccc-
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCNSLANLYVGKVSSRTQENNNIN---WELHYT-  423 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-  423 (593)
                      |+  ..|     ...+..+++.|+..+|++||++..+++    ..++...+......++...-. +++..   .+-... 
T Consensus       239 Dk--~kw-----s~~fh~fvK~altknpKkRptaeklL~----h~fvs~~l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E  306 (829)
T KOG0576|consen  239 DK--TKW-----SEFFHNFVKGALTKNPKKRPTAEKLLQ----HPFVSQTLSRRLAIELLDKVN-NPNPVVRYLEDYDGE  306 (829)
T ss_pred             CC--ccc-----hHHHHHHHHHHhcCCCccCCChhhhee----ceeeccchhhHHHHHHHHHcc-CCCCcccccccCCcc
Confidence            21  223     334556778899999999999987643    333333322221111111100 00000   000000 


Q ss_pred             CcceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccc
Q psy9535         424 GIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  503 (593)
Q Consensus       424 ~~~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~  503 (593)
                      ...++..+.-.+........ .. ..-.+..-+...+.+.-+++++++|+..  =+|||    ||+..+ +..|..||+.
T Consensus       307 ~~~~i~~~i~s~~rs~~~~~-~~-se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v  377 (829)
T KOG0576|consen  307 DYLWIPMRICSTGRSSALEM-TV-SEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAV  377 (829)
T ss_pred             cccchhhhhhcCCccccccC-Ch-hhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccC
Confidence            00011111000000000000 00 0001223344456677789999999732  48999    787665 5689999998


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcccceecchh
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGA  547 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~  547 (593)
                      .......    +...+..|++.|+|||+... .+..+.|+||.|+
T Consensus       378 ~~~L~~~----~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~  418 (829)
T KOG0576|consen  378 PPQLTRT----MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAV  418 (829)
T ss_pred             CcccCcc----cccccCCCCCCCCCchhhcccccccCCCccCCCc
Confidence            6543221    12345679999999997644 5778899999995

>KOG0607|consensus

Probab=100.00  E-value=1.2e-33  Score=278.14  Aligned_cols=258  Identities=26%  Similarity=0.400  Sum_probs=188.8

Q ss_pred             eecHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEE-EcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHH
Q psy9535          92 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ  170 (593)
Q Consensus        92 ~~~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~  170 (593)
                      .-+|.|+-+.|           ++.||+|+||.|--+. ..+|.++|||++.+....+             ..+..+|++
T Consensus        72 ~g~F~d~YkLt-----------~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs-------------R~RvfREVe  127 (463)
T KOG0607|consen   72 SGKFEDMYKLT-----------SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS-------------RSRVFREVE  127 (463)
T ss_pred             cchHHHHHHhH-----------HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchH-------------HHHHHHHHH
Confidence            34577888877           4689999999999886 5689999999997642211             114568999


Q ss_pred             HHhcCC-CCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeccc
Q psy9535         171 TLSQCK-HVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  248 (593)
Q Consensus       171 il~~l~-HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDL  248 (593)
                      ++.+++ |+||++|+.++++ ...|||||-|.||+|..++.+..   .+++.++.++..+||.||.|||.  ++|.||||
T Consensus       128 ~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~--kgIAHRDl  202 (463)
T KOG0607|consen  128 TFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHT--KGIAHRDL  202 (463)
T ss_pred             HHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhh--cCcccccC
Confidence            999996 9999999999987 45689999999999999998743   58899999999999999999998  77999999


Q ss_pred             CCCCeeecCCC---ccEEeecccceecccCCC----cceeeccccCCCCcCCcccc---cC---CCCCcchhhHHHHHHH
Q psy9535         249 KSANVLLDENF---VPKLGDFGIVKMSETSNM----KTMYTENLTGTRPYMPPEAM---HC---QISTKTDVFSYGVILL  315 (593)
Q Consensus       249 Kp~NILl~~~~---~~Kl~DFGla~~~~~~~~----~~~~~~~~~GT~~Y~APE~~---~~---~~~~ksDVwSfGvvl~  315 (593)
                      ||+|||-.+-.   -+|||||.|..-......    .+....+.+|+..|||||+.   .+   .|+.++|.||+|||||
T Consensus       203 KPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlY  282 (463)
T KOG0607|consen  203 KPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILY  282 (463)
T ss_pred             CccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHH
Confidence            99999986433   479999988643221111    11112346899999999964   22   3778999999999999


Q ss_pred             HHHhCCCCCCCCc---------------hHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCC
Q psy9535         316 ELLTGMKPIDDNN---------------TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS  380 (593)
Q Consensus       316 ElltG~~P~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs  380 (593)
                      -||+|.+||.+.-               ....+..+.++...+++   +   +|  ..+....+.++..-+..++..|-+
T Consensus       283 ImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPd---k---dW--ahIS~eakdlisnLlvrda~~rls  354 (463)
T KOG0607|consen  283 IMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPD---K---DW--AHISSEAKDLISNLLVRDAKQRLS  354 (463)
T ss_pred             HHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCCh---h---hh--HHhhHHHHHHHHHHHhccHHhhhh
Confidence            9999999996510               01122222222222211   1   11  223444555666667789999888


Q ss_pred             hHHHHH
Q psy9535         381 MRDIVD  386 (593)
Q Consensus       381 m~eV~~  386 (593)
                      +.++++
T Consensus       355 a~~vln  360 (463)
T KOG0607|consen  355 AAQVLN  360 (463)
T ss_pred             hhhccC
Confidence            877643

>KOG1035|consensus

Probab=100.00  E-value=1.6e-33  Score=316.28  Aligned_cols=256  Identities=24%  Similarity=0.372  Sum_probs=175.4

Q ss_pred             HHHhcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCC
Q psy9535          99 ERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH  177 (593)
Q Consensus        99 ~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~H  177 (593)
                      .+...+|.+      -..||+||||.||+++.+ ||+.+|||+|.-..    ..    ..    .....+|+..|++|+|
T Consensus       475 SRY~~DFEE------L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~----~~----~skI~rEVk~LArLnH  536 (1351)
T KOG1035|consen  475 SRYLNDFEE------LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SD----KL----YSKILREVKLLARLNH  536 (1351)
T ss_pred             hhHhhhhHH------HHHhcCCCCceEEEEeecccchhhhhhhccCch----HH----HH----HHHHHHHHHHHhhcCC
Confidence            445556654      478999999999999976 89999999996432    00    00    1135789999999999


Q ss_pred             CceeeEEEEEec--------------------------------------------------------------------
Q psy9535         178 VNLLRLLGLCNN--------------------------------------------------------------------  189 (593)
Q Consensus       178 pNIv~l~g~~~~--------------------------------------------------------------------  189 (593)
                      ||||+++..+.+                                                                    
T Consensus       537 pNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~  616 (1351)
T KOG1035|consen  537 PNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESST  616 (1351)
T ss_pred             cceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccC
Confidence            999998642100                                                                    


Q ss_pred             ----------------------------------------------------ccceEEEEeccCCCHHHHHhhcCCCCCC
Q psy9535         190 ----------------------------------------------------IMNCIVYEYMCNGSLYDRLARVNNTPPL  217 (593)
Q Consensus       190 ----------------------------------------------------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l  217 (593)
                                                                          ...||=||||+.-.|.+.+++.....  
T Consensus       617 d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--  694 (1351)
T KOG1035|consen  617 DEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--  694 (1351)
T ss_pred             CcccccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--
Confidence                                                                00134578888777777776532111  


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecc----c-----------CCCcceee
Q psy9535         218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE----T-----------SNMKTMYT  282 (593)
Q Consensus       218 ~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~----~-----------~~~~~~~~  282 (593)
                      .....+++.++|++||.|+|+  .+||||||||.||+||++..+||+|||+|....    .           ........
T Consensus       695 ~~d~~wrLFreIlEGLaYIH~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~  772 (1351)
T KOG1035|consen  695 QRDEAWRLFREILEGLAYIHD--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDL  772 (1351)
T ss_pred             hhHHHHHHHHHHHHHHHHHHh--CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccc
Confidence            356678899999999999999  459999999999999999999999999998621    0           00011123


Q ss_pred             ccccCCCCcCCcccccC----CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHH
Q psy9535         283 ENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETH  358 (593)
Q Consensus       283 ~~~~GT~~Y~APE~~~~----~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (593)
                      ++.+||.-|+|||++.+    .|+.|+|+||+|||++||+.   ||...-.......- .+.+.++..     ..+....
T Consensus       773 Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~-LR~g~iP~~-----~~f~~~~  843 (1351)
T KOG1035|consen  773 TSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTN-LRKGSIPEP-----ADFFDPE  843 (1351)
T ss_pred             ccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHh-cccCCCCCC-----ccccccc
Confidence            45789999999998742    58899999999999999995   57653221111111 112222211     1111111


Q ss_pred             HHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         359 VETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       359 ~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +... ..++.+.++.||.+|||+.|++.
T Consensus       844 ~~~e-~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  844 HPEE-ASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             chHH-HHHHHHHhcCCCccCCCHHHHhh
Confidence            2211 23556888999999999999874

>KOG0604|consensus

Probab=100.00  E-value=2.5e-33  Score=273.99  Aligned_cols=240  Identities=25%  Similarity=0.340  Sum_probs=184.7

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEecc-
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNNI-  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~~-  190 (593)
                      ..+||-|--|+|-.+..+ +|+.+|+|.+....                  .-.+|+++.-.. .|||||.+++++.+. 
T Consensus        67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------------------KARrEVeLHw~~s~h~~iV~IidVyeNs~  128 (400)
T KOG0604|consen   67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------------------KARREVELHWMASGHPHIVSIIDVYENSY  128 (400)
T ss_pred             hhhhccccCCceEEEEeccchhhhHHHHHhcCH------------------HHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence            478999999999999765 78899999986421                  135788876555 699999999988652 


Q ss_pred             ----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec---CCCccEE
Q psy9535         191 ----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKL  263 (593)
Q Consensus       191 ----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~---~~~~~Kl  263 (593)
                          -.++|||+|+||.|+..+..++. ..+++.++-.|+.||+.|+.|||+.  +|.||||||+|+|..   .|-.+||
T Consensus       129 ~~rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~--nIAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  129 QGRKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM--NIAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             cCceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc--chhhccCChhheeeecCCCCcceEe
Confidence                23579999999999999987654 5799999999999999999999994  499999999999996   4568999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchH----HHHHHHHh
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI----LYYYLVVE  338 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~----~~~~~~~~  338 (593)
                      +|||+|+.......    ..+.+-||+|.|||++.. +|+..+|+||+||++|-|++|.+||......    -...++..
T Consensus       206 tDfGFAK~t~~~~~----L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~  281 (400)
T KOG0604|consen  206 TDFGFAKETQEPGD----LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT  281 (400)
T ss_pred             cccccccccCCCcc----ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence            99999997654321    234578999999999864 5777779999999999999999999764321    11111222


Q ss_pred             hcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         339 QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +...++      ..+|  ..+.+..++++...+..+|.+|.|+.++++
T Consensus       282 gqy~FP------~pEW--s~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  282 GQYEFP------EPEW--SCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cCccCC------ChhH--hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            221111      1122  346667778887777899999999999854

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.9e-32  Score=273.26  Aligned_cols=218  Identities=20%  Similarity=0.207  Sum_probs=167.3

Q ss_pred             cCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccceEEEE
Q psy9535         120 GQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYE  197 (593)
Q Consensus       120 G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~lV~E  197 (593)
                      |.||.||+++.. +|+.||+|.+....                  .+.+|...+....||||+++++++.+ ...++|||
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   65 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQ   65 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------------------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEe
Confidence            899999999874 68999999986431                  13345555666789999999998765 56689999


Q ss_pred             eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecccCCC
Q psy9535         198 YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM  277 (593)
Q Consensus       198 y~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~  277 (593)
                      |+++|+|.+++.+.   ..+++.....++.|++.||.|||+  ++|+||||||+||+++.++.++++|||++....... 
T Consensus        66 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-  139 (237)
T cd05576          66 HAEGGKLWSHISKF---LNIPEECVKRWAAEMVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-  139 (237)
T ss_pred             cCCCCCHHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-
Confidence            99999999998753   358999999999999999999998  569999999999999999999999999876543221 


Q ss_pred             cceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCH
Q psy9535         278 KTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNE  356 (593)
Q Consensus       278 ~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (593)
                           ....++..|+|||... ..++.++||||+||++|||++|+.|+.......      ...      .......   
T Consensus       140 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~------~~~~~~~---  199 (237)
T cd05576         140 -----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTH------TTLNIPE---  199 (237)
T ss_pred             -----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccc------cccCCcc---
Confidence                 1235678899999774 457889999999999999999998875422110      000      0000011   


Q ss_pred             HHHHHHHHHHHHHhhccccCCCCChH
Q psy9535         357 THVETLIGIVFEKCCVFEKDKRASMR  382 (593)
Q Consensus       357 ~~~~~~i~~~~~~C~~~dp~~RPsm~  382 (593)
                       .....+..++.+|++.||++||++.
T Consensus       200 -~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         200 -WVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             -cCCHHHHHHHHHHccCCHHHhcCCC
Confidence             1223345577899999999999974

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587|consensus

Probab=100.00  E-value=1.1e-32  Score=301.26  Aligned_cols=244  Identities=25%  Similarity=0.410  Sum_probs=192.5

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEe---
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN---  188 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~---  188 (593)
                      ...||+|.+|.||+++. ++|+.+|||++......     +  +       +.+.|.++|+.. .|||++.++|++.   
T Consensus        24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-----d--e-------EiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-----E--E-------EIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             EEEEeeccceeEEEEeeeecCceeeeEeecCCccc-----c--H-------HHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            57899999999999985 57899999998654211     1  1       245688888776 6999999999863   


Q ss_pred             ---cccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         189 ---NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       189 ---~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                         .+..|||||||.+||.-|+++... +..+.|.....|+++++.||.+||.  ..+||||||-.||||+.++.+||+|
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~--nkviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN--NKVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh--cceeeecccCceEEEeccCcEEEee
Confidence               357799999999999999998755 5679999999999999999999997  4599999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCcccccCC------CCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  339 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~------~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~  339 (593)
                      ||++...+..-   ....+..|||.|||||++.+.      |+..+|+||+|++..||.-|.+|+.+.......+.+-. 
T Consensus       167 FGvSaQldsT~---grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR-  242 (953)
T KOG0587|consen  167 FGVSAQLDSTV---GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-  242 (953)
T ss_pred             eeeeeeeeccc---ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC-
Confidence            99987654432   123356899999999988542      56789999999999999999999988765544443222 


Q ss_pred             cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         340 EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       .|.+.+.       .+....+-+...+..|+..|-++||++.++++
T Consensus       243 -NPPPkLk-------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  243 -NPPPKLK-------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             -CCCcccc-------chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence             1222221       12334445666778999999999999998864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.9e-32  Score=305.55  Aligned_cols=252  Identities=20%  Similarity=0.247  Sum_probs=158.0

Q ss_pred             CCCCcccccCceEEEEEEEc-C----CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-N----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~----g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      ...++||+|+||.||+|++. +    +..||||++....   .     .+.       +.+|  .+.+..+.+++.++..
T Consensus       135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~-----~e~-------~~~e--~l~~~~~~~~~~~~~~  197 (566)
T PLN03225        135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---A-----VEI-------WMNE--RVRRACPNSCADFVYG  197 (566)
T ss_pred             EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---h-----hHH-------HHHH--HHHhhchhhHHHHHHh
Confidence            34789999999999999875 4    6899999875321   0     010       1111  1222223333332211


Q ss_pred             -------EecccceEEEEeccCCCHHHHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy9535         187 -------CNNIMNCIVYEYMCNGSLYDRLARVNNT-----------------PPLDSNKRYSIALGVAEALHYLHSLSKP  242 (593)
Q Consensus       187 -------~~~~~~~lV~Ey~~~GsL~~~L~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~  242 (593)
                             ......++||||+.+|+|.+++......                 ..........++.|++.||.|||+  ++
T Consensus       198 ~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~--~g  275 (566)
T PLN03225        198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS--TG  275 (566)
T ss_pred             hhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH--CC
Confidence                   1224568999999999999998753210                 011123355789999999999998  56


Q ss_pred             eEecccCCCCeeecC-CCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-C---------------------
Q psy9535         243 IIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-C---------------------  299 (593)
Q Consensus       243 IiHrDLKp~NILl~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~---------------------  299 (593)
                      |+||||||+|||++. ++.+||+|||+|+......  ........||+.|||||.+. .                     
T Consensus       276 IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~--~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~  353 (566)
T PLN03225        276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ  353 (566)
T ss_pred             EEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccc--ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence            999999999999985 6899999999998643321  11223467999999999542 1                     


Q ss_pred             -CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-cCccc---cccccccCC-----CC-HHHHHHHHHHHHH
Q psy9535         300 -QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVR---EVLDKEAGE-----WN-ETHVETLIGIVFE  368 (593)
Q Consensus       300 -~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~-----~~-~~~~~~~i~~~~~  368 (593)
                       .++.++|||||||+||||+++..|++..  ...+...... ..+..   ....+....     +. ..........++.
T Consensus       354 ~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~  431 (566)
T PLN03225        354 LNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK  431 (566)
T ss_pred             ccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence             1334679999999999999987776532  1111111111 11100   001110000     00 0000112235778


Q ss_pred             HhhccccCCCCChHHHHH
Q psy9535         369 KCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       369 ~C~~~dp~~RPsm~eV~~  386 (593)
                      +|++.||++|||+.|+++
T Consensus       432 ~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        432 SMMRFKGRQRISAKAALA  449 (566)
T ss_pred             HHccCCcccCCCHHHHhC
Confidence            999999999999999865

>KOG4236|consensus

Probab=99.98  E-value=6.6e-33  Score=287.10  Aligned_cols=197  Identities=29%  Similarity=0.489  Sum_probs=160.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI-M  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~-~  191 (593)
                      .+.||.|.||+||-|+++ +|+.||||.|.+.. ....+    +      .+..+|+.||.++.||-||.|--.|+.. .
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlr-Fp~kq----e------sqlR~EVaILq~l~HPGiV~le~M~ET~er  637 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLR-FPTKQ----E------SQLRNEVAILQNLHHPGIVNLECMFETPER  637 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeeccc-CCCch----H------HHHHHHHHHHHhcCCCCeeEEEEeecCCce
Confidence            378999999999999874 79999999997542 22221    1      1478999999999999999999888774 4


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC---CccEEeeccc
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGI  268 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~---~~~Kl~DFGl  268 (593)
                      .+.|||-+. |+..+.+-... ...|++.....++.||+.||.|||.  ++|+|+||||+||||...   -.+||||||+
T Consensus       638 vFVVMEKl~-GDMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~--knIvHCDLKPENVLLas~~~FPQvKlCDFGf  713 (888)
T KOG4236|consen  638 VFVVMEKLH-GDMLEMILSSE-KGRLPERITKFLVTQILVALRYLHF--KNIVHCDLKPENVLLASASPFPQVKLCDFGF  713 (888)
T ss_pred             EEEEehhhc-chHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhh--cceeeccCCchheeeccCCCCCceeeccccc
Confidence            577899875 56656554332 3568888888899999999999998  669999999999999643   4789999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccCC-CCCcchhhHHHHHHHHHHhCCCCCCCCch
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNT  329 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~ksDVwSfGvvl~ElltG~~P~~~~~~  329 (593)
                      ||+......    ..+++|||.|+|||++..+ |...-|+||.|||+|--++|..||..+.+
T Consensus       714 ARiIgEksF----RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd  771 (888)
T KOG4236|consen  714 ARIIGEKSF----RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED  771 (888)
T ss_pred             eeecchhhh----hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence            999876543    3468999999999998665 55556999999999999999999986544

>KOG0608|consensus

Probab=99.97  E-value=2.4e-32  Score=288.06  Aligned_cols=200  Identities=25%  Similarity=0.368  Sum_probs=160.3

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+-||-|+||+|.+++. ++...+|+|.|++.........          .-...|-+||..-..+-||+|+-.+.+ +.
T Consensus       634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQv----------aHVKAERDILAEADn~WVVrLyySFQDkdn  703 (1034)
T KOG0608|consen  634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQV----------AHVKAERDILAEADNEWVVRLYYSFQDKDN  703 (1034)
T ss_pred             EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhh----------hhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence            36799999999999864 4566799999976543322211          124579999999999999999987766 67


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .|+||||++||++..+|.+.+   -+++..+..++.++..|+++.|..  ++|||||||+|||||.+|++||+||||+.-
T Consensus       704 LYFVMdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm--GFIHRDiKPDNILIDrdGHIKLTDFGLCTG  778 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTG  778 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc--cceecccCccceEEccCCceeeeecccccc
Confidence            799999999999999998753   578888888899999999999984  499999999999999999999999999853


Q ss_pred             cccC---------------CCc------------------------ceeeccccCCCCcCCcccc-cCCCCCcchhhHHH
Q psy9535         272 SETS---------------NMK------------------------TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYG  311 (593)
Q Consensus       272 ~~~~---------------~~~------------------------~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfG  311 (593)
                      +.-.               .+.                        .......+||+.|+|||++ ...++.-+|+||.|
T Consensus       779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g  858 (1034)
T KOG0608|consen  779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG  858 (1034)
T ss_pred             ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence            2100               000                        0001235799999999987 45688889999999


Q ss_pred             HHHHHHHhCCCCCCCCc
Q psy9535         312 VILLELLTGMKPIDDNN  328 (593)
Q Consensus       312 vvl~ElltG~~P~~~~~  328 (593)
                      ||||||+.|+.||.+..
T Consensus       859 vil~em~~g~~pf~~~t  875 (1034)
T KOG0608|consen  859 VILYEMLVGQPPFLADT  875 (1034)
T ss_pred             HHHHHHhhCCCCccCCC
Confidence            99999999999997644

>KOG0603|consensus

Probab=99.97  E-value=1.1e-31  Score=286.68  Aligned_cols=229  Identities=24%  Similarity=0.296  Sum_probs=177.7

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      ...+|.|+|+.|-++... +++..|||++.+...   .              -.+|+.++... +||||+++.+.+.+ .
T Consensus       327 ~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~--------------~~~e~~~~~~~~~h~niv~~~~v~~~~~  389 (612)
T KOG0603|consen  327 REELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---D--------------NQDEIPISLLVRDHPNIVKSHDVYEDGK  389 (612)
T ss_pred             ccccCCCCccceeeeeccccccchhheecccccc---c--------------cccccchhhhhcCCCcceeecceecCCc
Confidence            456999999999999764 688899999975411   1              13466555544 79999999999977 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee-cCCCccEEeecccc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-DENFVPKLGDFGIV  269 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl-~~~~~~Kl~DFGla  269 (593)
                      ..++|||++.+|-|.+.+....    ....++..|+.+++.|+.|||+  ++||||||||+|||+ ++.++++|+|||.+
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrltyFG~a  463 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTYFGFW  463 (612)
T ss_pred             eeeeeehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEEechh
Confidence            6689999999999998887533    2236777899999999999998  679999999999999 58899999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhhcCcccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVPVREVL  347 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~  347 (593)
                      +.....-      .+.+=|..|.|||++. ..++.++||||||++|||||+|+.||...... .....+  +.+++.   
T Consensus       464 ~~~~~~~------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i--~~~~~s---  532 (612)
T KOG0603|consen  464 SELERSC------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI--QMPKFS---  532 (612)
T ss_pred             hhCchhh------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh--cCCccc---
Confidence            8765441      1235578999999875 45899999999999999999999999764332 221111  111111   


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV  385 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~  385 (593)
                               ..+....+.++.+|++.||.+||+|.++.
T Consensus       533 ---------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~  561 (612)
T KOG0603|consen  533 ---------ECVSDEAKDLLQQLLQVDPALRLGADEIG  561 (612)
T ss_pred             ---------cccCHHHHHHHHHhccCChhhCcChhhhc
Confidence                     33445567788999999999999999984

>KOG0666|consensus

Probab=99.97  E-value=6.8e-32  Score=264.97  Aligned_cols=199  Identities=25%  Similarity=0.346  Sum_probs=155.5

Q ss_pred             CCcccccCceEEEEEEEcC-----CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         114 GNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~-----g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      ...||+|.||.||+|.-++     ...+|||+++...+....     ..      .-.+|+.+++.++||||+.|..++.
T Consensus        29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi-----S~------SAcREiaL~REl~h~nvi~Lv~Vfl   97 (438)
T KOG0666|consen   29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI-----SM------SACREIALLRELKHPNVISLVKVFL   97 (438)
T ss_pred             cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc-----CH------HHHHHHHHHHHhcCCcchhHHHHHh
Confidence            4579999999999995432     236899999755332111     11      2468999999999999999998764


Q ss_pred             c--ccceEEEEeccCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC----Cc
Q psy9535         189 N--IMNCIVYEYMCNGSLYDRLARVN--NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN----FV  260 (593)
Q Consensus       189 ~--~~~~lV~Ey~~~GsL~~~L~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~----~~  260 (593)
                      +  ...++++||.+ -+|...++...  ....++......|+.||+.|+.|||+  +-|+||||||+|||+..+    |.
T Consensus        98 ~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen   98 SHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             ccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCccCe
Confidence            4  45689999986 57888776432  23568889999999999999999998  459999999999999877    99


Q ss_pred             cEEeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCC
Q psy9535         261 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDD  326 (593)
Q Consensus       261 ~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~  326 (593)
                      +||+|||++|+....-..-.....++-|.+|.|||.+.+  .|+.+.||||.|||+.||+|-.+-|..
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            999999999987654321112334677999999997643  488899999999999999998777754

>KOG0984|consensus

Probab=99.97  E-value=1.1e-31  Score=250.36  Aligned_cols=207  Identities=29%  Similarity=0.354  Sum_probs=159.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEE-ecc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLC-NNI  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~-~~~  190 (593)
                      +..||+|+||.|-+-++. +|+..|||.+.....     ..  +     ..+..+|+.+..+. ..|.+|.++|.. .+.
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-----~q--~-----q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-----SQ--E-----QKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcC-----hH--H-----HHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            467999999999887764 799999999864321     11  1     12467889887665 689999999965 457


Q ss_pred             cceEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ..+|.||.|. -||..+-.+. ..+...++.-.-+||..+..||.|||+. -.|||||+||+|||++.+|.+|+||||++
T Consensus       119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccc
Confidence            7789999885 5665554332 2345678888889999999999999983 24999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc-----CCCCCcchhhHHHHHHHHHHhCCCCCCCCch-HHHHHHHHh
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH-----CQISTKTDVFSYGVILLELLTGMKPIDDNNT-ILYYYLVVE  338 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~-~~~~~~~~~  338 (593)
                      ..+.++-..    +-..|...|||||.+.     ..|+-||||||+|+++.||.+++.||+...+ .....+++.
T Consensus       197 G~L~dSiAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  197 GYLVDSIAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             eeehhhhHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            877654322    2246889999999763     2578899999999999999999999987543 333334443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=5e-31  Score=288.05  Aligned_cols=209  Identities=21%  Similarity=0.232  Sum_probs=147.0

Q ss_pred             CCCcccccCceEEEEEEE-----------------cCCCEEEEEEeecCCCCCCCCCchhHHhh--hcHHHHHHHHHHHh
Q psy9535         113 RGNKLGEGQFGTVYYGKL-----------------KNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQTLS  173 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~-----------------~~g~~vAVK~l~~~~~~~~~~~~~~~~~~--~~~~~f~~Ev~il~  173 (593)
                      ..++||+|+||.||+|.+                 ..++.||||++.......... ...+...  .....+..|+..+.
T Consensus       149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~-fl~e~~~~~~~~e~~~vE~~~l~  227 (507)
T PLN03224        149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQD-FLKTGTLAKGSAETGMVEAYMCA  227 (507)
T ss_pred             EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHH-HHhhhhhhhcccchhHHHHHHHH
Confidence            368999999999999964                 235689999986431100000 0000000  00113456788888


Q ss_pred             cCCCCce-----eeEEEEEec---------ccceEEEEeccCCCHHHHHhhcCC---------------------CCCCC
Q psy9535         174 QCKHVNL-----LRLLGLCNN---------IMNCIVYEYMCNGSLYDRLARVNN---------------------TPPLD  218 (593)
Q Consensus       174 ~l~HpNI-----v~l~g~~~~---------~~~~lV~Ey~~~GsL~~~L~~~~~---------------------~~~l~  218 (593)
                      +++|.|+     ++++|+|..         ...+|||||+++|+|.++|+....                     ...++
T Consensus       228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~  307 (507)
T PLN03224        228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD  307 (507)
T ss_pred             HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence            8877665     677787642         346899999999999999874311                     12346


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc
Q psy9535         219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH  298 (593)
Q Consensus       219 ~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~  298 (593)
                      +..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.......  .......+|+.|+|||.+.
T Consensus       308 ~~~~~~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        308 INVIKGVMRQVLTGLRKLHR--IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN--FNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHHH--CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc--cCccccCCCcceeChhhhc
Confidence            77888999999999999998  5699999999999999999999999999875433211  1111224589999999753


Q ss_pred             CC---------------------C--CCcchhhHHHHHHHHHHhCCC-CCCC
Q psy9535         299 CQ---------------------I--STKTDVFSYGVILLELLTGMK-PIDD  326 (593)
Q Consensus       299 ~~---------------------~--~~ksDVwSfGvvl~ElltG~~-P~~~  326 (593)
                      ..                     +  ..+.||||+||++|||++|.. |+..
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            21                     1  134799999999999999975 7653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.3e-30  Score=257.08  Aligned_cols=237  Identities=30%  Similarity=0.455  Sum_probs=181.0

Q ss_pred             CceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccceEEEEe
Q psy9535         121 QFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEY  198 (593)
Q Consensus       121 ~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~lV~Ey  198 (593)
                      +||.||+|+.. +|+.+|+|.+........            ...|.+|++.+++++|+||+++++++.. ...++++||
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   68 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK------------RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEY   68 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH------------HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeC
Confidence            68999999986 489999999864321100            1258899999999999999999998876 567899999


Q ss_pred             ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecccCCCc
Q psy9535         199 MCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK  278 (593)
Q Consensus       199 ~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  278 (593)
                      +++++|.+++....   .+++..+..++.++++|+.|||+  .+|+|+||+|+||+++.++.++|+|||++.......  
T Consensus        69 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--  141 (244)
T smart00220       69 CDGGDLFDLLKKRG---RLSEDEARFYARQILSALEYLHS--NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--  141 (244)
T ss_pred             CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH--cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--
Confidence            99999999987532   28899999999999999999998  569999999999999999999999999988754432  


Q ss_pred             ceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHH
Q psy9535         279 TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNET  357 (593)
Q Consensus       279 ~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (593)
                        ......|+..|+|||.+. ..++.++||||||+++++|++|..||.....................   .  ..   .
T Consensus       142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~--~~---~  211 (244)
T smart00220      142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP---P--PE---W  211 (244)
T ss_pred             --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---c--cc---c
Confidence              122356889999999764 56788999999999999999999999763222222221111111000   0  00   0


Q ss_pred             HHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         358 HVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       358 ~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .+...+..++.+|+..+|++||++.++++
T Consensus       212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      212 KISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             cCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            01223445667999999999999999975

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0614|consensus

Probab=99.97  E-value=3.2e-32  Score=281.51  Aligned_cols=238  Identities=26%  Similarity=0.370  Sum_probs=186.2

Q ss_pred             CCcccccCceEEEEEEEcCCC-EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGM-EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~-~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ...||-||||.|-+.+..+.. .+|+|++++.......+.   +       ....|-.||..++.|.||+||-.+.+ ..
T Consensus       425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQq---e-------Hv~sEr~Im~~~~s~fIvrLYrTfrd~ky  494 (732)
T KOG0614|consen  425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQ---E-------HVFSERNIMMECRSDFIVRLYRTFRDSKY  494 (732)
T ss_pred             hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHH---H-------HHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence            356999999999988775433 489999876543322211   1       24579999999999999999987765 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .|++||-|-||.|...|..++   .++......++..+.+|++|||+  ++||.|||||+|.|||.+|.+||.|||+|+.
T Consensus       495 vYmLmEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~--k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHR--KGIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHh--cCceeccCChhheeeccCCceEEeehhhHHH
Confidence            688999999999999998643   57888888899999999999998  6799999999999999999999999999998


Q ss_pred             cccCCCcceeeccccCCCCcCCccc-ccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~-~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......    +-+++|||.|.|||+ +....+.++|.||+|+++|||++|.+||...+.+..+..++.+-..+ +     
T Consensus       570 i~~g~K----TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-~-----  639 (732)
T KOG0614|consen  570 IGSGRK----TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-E-----  639 (732)
T ss_pred             hccCCc----eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-h-----
Confidence            766542    335899999999995 56678889999999999999999999999988888877776543211 1     


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCC
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRAS  380 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs  380 (593)
                         ++ ..+.+....++.+-|..+|.+|..
T Consensus       640 ---~P-r~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  640 ---FP-RRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ---cc-cccchhHHHHHHHHHhcCcHhhhc
Confidence               11 111122233445667888888755

>KOG0662|consensus

Probab=99.97  E-value=1.8e-30  Score=237.14  Aligned_cols=195  Identities=28%  Similarity=0.402  Sum_probs=155.3

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      ++||+|.||+||+|+.+ ++..||+|.++-+.+.....           ..-.+|+-+|+.++|.|||++++.... ...
T Consensus         8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvp-----------ssalreicllkelkhknivrl~dvlhsdkkl   76 (292)
T KOG0662|consen    8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVP-----------SSALREICLLKELKHKNIVRLHDVLHSDKKL   76 (292)
T ss_pred             HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCc-----------HHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence            68999999999999864 68889999987553221111           135689999999999999999997655 456


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      .+|+|||. .+|..+....+  ..++......++.|+++||.|+|+  +.++||||||.|.|++.+|++|++|||++|..
T Consensus        77 tlvfe~cd-qdlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchs--hnvlhrdlkpqnllin~ngelkladfglaraf  151 (292)
T KOG0662|consen   77 TLVFEFCD-QDLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHS--HNVLHRDLKPQNLLINRNGELKLADFGLARAF  151 (292)
T ss_pred             EEeHHHhh-HHHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhh--hhhhhccCCcceEEeccCCcEEecccchhhhc
Confidence            79999984 56777766544  358888899999999999999998  56999999999999999999999999999976


Q ss_pred             ccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHh-CCCCCCCCc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLT-GMKPIDDNN  328 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~  328 (593)
                      ...-  ..++ ..+-|.+|.+|.++.+  -|++..|+||-||++.|+.. |++-|.+.+
T Consensus       152 gipv--rcys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d  207 (292)
T KOG0662|consen  152 GIPV--RCYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND  207 (292)
T ss_pred             CCce--Eeee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence            5432  1222 2356899999998754  37888899999999999986 555565543

>KOG0669|consensus

Probab=99.96  E-value=4.6e-31  Score=252.46  Aligned_cols=256  Identities=24%  Similarity=0.357  Sum_probs=178.1

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec----
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN----  189 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~----  189 (593)
                      .+||+|.||.||+|+.+ +|+.||+|++--..          ++.-.++ .-.+|+.+|..++|+|++.++..|..    
T Consensus        23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmen----------eKeGfpi-talreikiL~~lkHenv~nliEic~tk~Tp   91 (376)
T KOG0669|consen   23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMEN----------EKEGFPI-TALREIKILQLLKHENVVNLIEICRTKATP   91 (376)
T ss_pred             HhcCCchHHHHHHHhhcCccchhHHHHHHHhc----------cccCCcH-HHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence            68999999999999875 57889988653210          1111111 13589999999999999999987742    


Q ss_pred             -----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         190 -----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       190 -----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                           ...++|+.+|+ -+|.-.|...  ...++...+.+++.++.+||.|+|.  ..|+|||+||+|+||+.++.+||+
T Consensus        92 ~~r~r~t~ylVf~~ce-hDLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr--~kilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   92 TNRDRATFYLVFDFCE-HDLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHR--NKILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             cccccceeeeeHHHhh-hhHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHH--hhHHhhcccHhhEEEcCCceEEee
Confidence                 13579999986 4676666532  2458888999999999999999998  449999999999999999999999


Q ss_pred             ecccceecccCCC-cceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC
Q psy9535         265 DFGIVKMSETSNM-KTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  341 (593)
Q Consensus       265 DFGla~~~~~~~~-~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~  341 (593)
                      |||++|....+.. ....-+..+-|.+|.+||.+.  ..++++.|||.-|||+.||.||.+-+...........+..-.+
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            9999986544321 111112334599999999663  4589999999999999999999988877554433322221111


Q ss_pred             c-------------cccccccc-cCCCCHHHHH---------HHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 P-------------VREVLDKE-AGEWNETHVE---------TLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~-------------~~~~~~~~-~~~~~~~~~~---------~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .             +-+.+..+ .+.-....+.         .....+++..+..||.+|+.+++++.
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            1             11111000 0000000010         12334667889999999999999864

>KOG0695|consensus

Probab=99.96  E-value=9.3e-30  Score=251.63  Aligned_cols=195  Identities=26%  Similarity=0.382  Sum_probs=158.7

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhc-CCCCceeeEEEEEec-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGLCNN-  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~-l~HpNIv~l~g~~~~-  189 (593)
                      +-++||+|+|.+|-.++++ +.+.+|+|++++.......+.+          -.+.|-.+..+ -+||.+|.|..++.. 
T Consensus       254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedid----------wvqtek~vfe~asn~pflvglhscfqte  323 (593)
T KOG0695|consen  254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDID----------WVQTEKHVFEQASNNPFLVGLHSCFQTE  323 (593)
T ss_pred             eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccch----------hHHhhHHHHHhccCCCeEEehhhhhccc
Confidence            3578999999999999875 6788999998765322221111          12344444443 379999999998876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++|.||++||+|.-++.+.   ..|++..+..+...|..||.|||+  ++||.||||.+|+|||..|.+||+|+|++
T Consensus       324 srlffvieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~--rgiiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhh--cCeeeeeccccceEEccCCceeecccchh
Confidence            4567899999999998777653   458888888899999999999999  66999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCC
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPID  325 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~  325 (593)
                      +..-....   .+.+++|||.|+|||++.+ .|...+|+|++||+++||+.|+.||+
T Consensus       399 ke~l~~gd---~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd  452 (593)
T KOG0695|consen  399 KEGLGPGD---TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD  452 (593)
T ss_pred             hcCCCCCc---ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence            86543332   2557899999999999876 58899999999999999999999996

>KOG1024|consensus

Probab=99.96  E-value=1.8e-29  Score=254.37  Aligned_cols=253  Identities=25%  Similarity=0.365  Sum_probs=189.0

Q ss_pred             CCCCcccccCceEEEEEEEcC------CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  185 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~------g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g  185 (593)
                      +....+-+|.||.||+|.|++      .+.|-||+++..            +..+....|..|--.+..+.|||+.++.|
T Consensus       287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~------------AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH------------ASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc------------ccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            345678999999999997753      345677777532            22234557889999999999999999999


Q ss_pred             EEec--ccceEEEEeccCCCHHHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC
Q psy9535         186 LCNN--IMNCIVYEYMCNGSLYDRLARV-----NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  258 (593)
Q Consensus       186 ~~~~--~~~~lV~Ey~~~GsL~~~L~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~  258 (593)
                      +|.+  ...+.+|.++.-|+|..+|...     .....++..+.+.++.|++.|++|||+  ++|||.||...|.+||+.
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~--~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN--HGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh--cCcccchhhhhcceehhh
Confidence            8865  4567889999999999999732     223457778888999999999999998  669999999999999999


Q ss_pred             CccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHH
Q psy9535         259 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLV  336 (593)
Q Consensus       259 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~  336 (593)
                      ..+||+|=.|+|-........ ....---...||+||.+. ..++.++|||||||+||||+| |+.|+.+-+........
T Consensus       433 LqVkltDsaLSRDLFP~DYhc-LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl  511 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHC-LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL  511 (563)
T ss_pred             eeEEeccchhccccCcccccc-cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence            999999999998654433211 111112245799999774 568999999999999999997 89999876654443332


Q ss_pred             HhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         337 VEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      .. ...+.+.       +   .+.+.+-.++..||+..|++||++.+++.-|.+
T Consensus       512 kd-GyRlaQP-------~---NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  512 KD-GYRLAQP-------F---NCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             hc-cceecCC-------C---CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            22 2222111       1   112223335569999999999999999988875

>KOG1027|consensus

Probab=99.96  E-value=1.3e-29  Score=276.08  Aligned_cols=241  Identities=24%  Similarity=0.318  Sum_probs=174.7

Q ss_pred             CCcccccCceE-EEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGT-VYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~-Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      .+.+|.|+-|+ ||+|.+. |++||||++-...          .      ...++||+.|... .|||||++++.-.+ .
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~----------~------~~A~rEi~lL~eSD~H~NviRyyc~E~d~q  576 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF----------F------DFAQREIQLLQESDEHPNVIRYYCSEQDRQ  576 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC-CceehHHHHhhHh----------H------HHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence            35688998885 7999985 8999999874320          0      0236899999888 59999999987766 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC---C--CccEEe
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---N--FVPKLG  264 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~---~--~~~Kl~  264 (593)
                      ..||..|.| ..+|.|++..... .........+.+..|++.||++||+..  ||||||||.||||+.   +  .+++|+
T Consensus       577 F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iS  653 (903)
T KOG1027|consen  577 FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKIS  653 (903)
T ss_pred             eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEec
Confidence            557888865 6899999976311 111111334567899999999999955  999999999999975   2  579999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCcccccCC-CCCcchhhHHHHHHHHHHhC-CCCCCCCchHHHHHHHHhhcCc
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTG-MKPIDDNNTILYYYLVVEQEVP  342 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~ksDVwSfGvvl~ElltG-~~P~~~~~~~~~~~~~~~~~~~  342 (593)
                      |||+++........-....+..||-+|+|||.+... -+.++||+|+||++|..++| ..||.+....  ...+..+...
T Consensus       654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~  731 (903)
T KOG1027|consen  654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYT  731 (903)
T ss_pred             ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccc
Confidence            999999876554322234567899999999988554 45578999999999999987 9999864321  1222333322


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHH
Q psy9535         343 VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV  385 (593)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~  385 (593)
                      +..+-.     ....    ....++.+++..+|..||++.+|+
T Consensus       732 L~~L~~-----~~d~----eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  732 LVHLEP-----LPDC----EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             eeeecc-----CchH----HHHHHHHHhcCCCcccCCCHHHHh
Confidence            222211     0111    455677899999999999999996

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.5e-27  Score=228.93  Aligned_cols=209  Identities=36%  Similarity=0.556  Sum_probs=171.9

Q ss_pred             ccccCceEEEEEEEcC-CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccceE
Q psy9535         117 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCI  194 (593)
Q Consensus       117 LG~G~fG~Vy~g~~~~-g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~l  194 (593)
                      ||+|++|.||++.... |+.+++|.+.......            ....+.+|++.++.++|++|+++++++.. ...++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~------------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~   68 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS------------LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYL   68 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh------------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEE
Confidence            6899999999998764 8999999986431100            01258899999999999999999998876 56689


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC-CCccEEeecccceecc
Q psy9535         195 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSE  273 (593)
Q Consensus       195 V~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~-~~~~Kl~DFGla~~~~  273 (593)
                      ++||+.+++|.+++....  ..+++..+..++.++++++.|||+  .+++|+||+|.||+++. ++.++|+|||.+....
T Consensus        69 ~~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~--~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~  144 (215)
T cd00180          69 VMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT  144 (215)
T ss_pred             EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHhhEEEeCCCCcEEEecCCceEEcc
Confidence            999999999999987532  358899999999999999999998  56999999999999999 8999999999988654


Q ss_pred             cCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccccc
Q psy9535         274 TSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  351 (593)
Q Consensus       274 ~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (593)
                      ....   ......++..|++||....  ..+.++|+||+|+++++|                                  
T Consensus       145 ~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------  187 (215)
T cd00180         145 SDKS---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------  187 (215)
T ss_pred             CCcc---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence            4321   1123467889999998755  567889999999999999                                  


Q ss_pred             CCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHH
Q psy9535         352 GEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDL  387 (593)
Q Consensus       352 ~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~  387 (593)
                               ..+..++..|+..+|++||++.++++.
T Consensus       188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ---------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ---------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                     123345679999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0671|consensus

Probab=99.96  E-value=4e-29  Score=252.19  Aligned_cols=192  Identities=28%  Similarity=0.403  Sum_probs=153.2

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCC--C----ceeeEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH--V----NLLRLLG  185 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~H--p----NIv~l~g  185 (593)
                      +-..+|+|.||+|-.+... .+..||||+++....+.       ++       -.-|+++|.++.+  |    -+|++.+
T Consensus        93 i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr-------eA-------a~iEi~vLqki~~~DP~g~~rcv~m~~  158 (415)
T KOG0671|consen   93 IVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR-------EA-------ALIEIEVLQKINESDPNGKFRCVQMRD  158 (415)
T ss_pred             hhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHh-------hH-------HHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence            3578999999999998754 47889999997543322       22       2358899999843  2    3677777


Q ss_pred             EEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC-------
Q psy9535         186 LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-------  257 (593)
Q Consensus       186 ~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~-------  257 (593)
                      +++- +..|||+|.+ |-|++++|..++ ..+++......++.|++++++|||+.  .++|-||||+|||+.+       
T Consensus       159 wFdyrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~--kl~HTDLKPENILfvss~~~~~~  234 (415)
T KOG0671|consen  159 WFDYRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDL--KLTHTDLKPENILFVSSEYFKTY  234 (415)
T ss_pred             hhhccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhc--ceeecCCChheEEEeccceEEEe
Confidence            7764 5679999986 559999998744 46899999999999999999999994  4999999999999832       


Q ss_pred             -------------CCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCC
Q psy9535         258 -------------NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKP  323 (593)
Q Consensus       258 -------------~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P  323 (593)
                                   +..+||+|||.|+......      ..++.|..|.|||++ .-..+.++||||+||||+|+.||..-
T Consensus       235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             ccCCccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence                         2357999999988754332      346789999999965 55789999999999999999999999


Q ss_pred             CCCCc
Q psy9535         324 IDDNN  328 (593)
Q Consensus       324 ~~~~~  328 (593)
                      |....
T Consensus       309 FqtHe  313 (415)
T KOG0671|consen  309 FQTHE  313 (415)
T ss_pred             cccCC
Confidence            97644

>KOG0664|consensus

Probab=99.95  E-value=2.8e-29  Score=242.49  Aligned_cols=200  Identities=26%  Similarity=0.387  Sum_probs=154.4

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec---
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~---  189 (593)
                      .+.||-|+||+||.... ++|+.||.|++...      .     .....-+++-+|+.+|...+|.|++..++.-..   
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv------f-----q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~  126 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV------F-----QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP  126 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchH------H-----HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence            57899999999998876 57999999987432      1     111112357789999999999999999886543   


Q ss_pred             ---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         190 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       190 ---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                         .+.|.|+|.|. .+|...+-   ...+++.....-+++||++||.|||+  .+|+||||||.|.|++.|-.+|||||
T Consensus       127 dfFqEiYV~TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHs--A~ILHRDIKPGNLLVNSNCvLKICDF  200 (449)
T KOG0664|consen  127 SFFQELYVLTELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHT--ANILHRDIKPGNLLVNSNCILKICDF  200 (449)
T ss_pred             hHHHHHHHHHHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhh--cchhhccCCCccEEeccCceEEeccc
Confidence               23356777764 34444332   24568888888899999999999999  45999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHH
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILY  332 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~  332 (593)
                      ||||..+......+ + ..+-|.+|.|||++.+  .|+.+.||||.|||+.||+-.+.-|...+....
T Consensus       201 GLARvee~d~~~hM-T-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ  266 (449)
T KOG0664|consen  201 GLARTWDQRDRLNM-T-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ  266 (449)
T ss_pred             ccccccchhhhhhh-H-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH
Confidence            99997655443222 2 2345889999997744  589999999999999999999888876554433

>KOG0590|consensus

Probab=99.95  E-value=1.4e-28  Score=274.18  Aligned_cols=414  Identities=23%  Similarity=0.306  Sum_probs=258.1

Q ss_pred             CCcccccCceEEEEEEEc--CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-
Q psy9535         114 GNKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~--~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-  189 (593)
                      .+.||+|+|+.|-.....  ....+|+|.+.....    .....       .....|..+-..+. |+|++++++...+ 
T Consensus        25 ~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~----~~~~~-------~~i~~e~~~~~~~s~h~n~~~~~~~~~~~   93 (601)
T KOG0590|consen   25 SRSIGKGSFSSSALASNSRDPESSSATKPISIPPK----SEDSS-------EHIDTETDIQKKLSKHSNTVHMIEPSSSP   93 (601)
T ss_pred             cccccccccchhhhhhhcCCCcceeeccCCCCCCC----ccchh-------hhcCccccccccccccccccccCCccCCC
Confidence            456999999999877653  244567776654320    00000       01234677767776 9999999998766 


Q ss_pred             ccceEEEEeccCCCHHHHH-hhcCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCeEecccCCCCeeecCCC-ccEEeec
Q psy9535         190 IMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLH-SLSKPIIHRDVKSANVLLDENF-VPKLGDF  266 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L-~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~IiHrDLKp~NILl~~~~-~~Kl~DF  266 (593)
                      ...+++.+|..+|++.+.+ +..  ....+....-.+..|+..|+.|+| +  .++.||||||+|.+++..+ ..|++||
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~~--~~~~h~~ikP~n~~l~~s~~~l~~~df  169 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHPE--NGVTHRDIKPSNSLLDESGSALKIADF  169 (601)
T ss_pred             cccccccCcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCcc--cccccCCCCCccchhccCCCcccCCCc
Confidence            4567899999999999888 332  123455556678899999999999 6  5699999999999999999 9999999


Q ss_pred             ccceeccc-CCCcceeeccccC-CCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhhcC
Q psy9535         267 GIVKMSET-SNMKTMYTENLTG-TRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQEV  341 (593)
Q Consensus       267 Gla~~~~~-~~~~~~~~~~~~G-T~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~-~~~~~~~~~~  341 (593)
                      |+|..... .+. .......+| ++.|+|||...+  ...+..|+||.|+++.-+++|..|++...... .+........
T Consensus       170 ~~At~~~~~~g~-~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~  248 (601)
T KOG0590|consen  170 GLATAYRNKNGA-ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG  248 (601)
T ss_pred             hhhccccccCCc-ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccc
Confidence            99987655 222 222234578 999999998765  34667899999999999999999987532111 0000000000


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHH--Hhh---c--ccc-ccc----------------
Q psy9535         342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDL--LSK---S--MFV-CNS----------------  397 (593)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~--L~~---~--~~~-~~~----------------  397 (593)
                      ...      ...|..  +..-...++.+++..+|..|.+..++...  +..   .  ... +..                
T Consensus       249 ~~~------~~~~~~--~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~y~  320 (601)
T KOG0590|consen  249 RFT------QLPWNS--ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSSKRNGFSKSNPCADSLTIAKSPIGFSEKYG  320 (601)
T ss_pred             ccc------cCcccc--CChhhhhcccccccCCchhccccccccccccccccccccccccccccccccccCccccccccC
Confidence            000      001110  11111223346777888999888776420  111   0  000 000                


Q ss_pred             -----cccccccccccccc--------cccc--------cc--------------ccccccC-cce--Eee------cCC
Q psy9535         398 -----LANLYVGKVSSRTQ--------ENNN--------IN--------------WELHYTG-IPV--IIL------DTG  433 (593)
Q Consensus       398 -----~~~~~~~~~~~~~~--------~~~~--------~~--------------~~~~~~~-~~v--~~~------~~~  433 (593)
                           +.....|.+.....        ....        ..              ..+++.. +..  +++      ..-
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence                 00000010000000        0000        00              0011111 111  011      111


Q ss_pred             chhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcc
Q psy9535         434 ETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVK  513 (593)
Q Consensus       434 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~  513 (593)
                      |....+||..+...  +.+....+-.++.|+..|++|+|+  .++.|||||++|+++..+|.+||+|||.+.........
T Consensus       401 E~~~~Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~--~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  401 EYCPYDLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHS--MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             hcccHHHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHh--cCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            22222455554432  357778888999999999999999  55999999999999999999999999987654433222


Q ss_pred             -ccccccccCCCCcccccccCC-cCCc-ccceecchhhhhccccc
Q psy9535         514 -TMYTENLTGTRPYMPPEAMHC-QIST-KTDVFSYGAQIKTQHIT  555 (593)
Q Consensus       514 -~~~~~~~~Gt~~y~aPE~~~~-~~~~-ksDvwS~G~~i~~~~~~  555 (593)
                       .......+|+.+|+|||++.+ .|.+ .+||||.|+++.+-...
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~  521 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILG  521 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecC
Confidence             123345789999999999855 4644 58999999988865533

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.7e-26  Score=226.01  Aligned_cols=196  Identities=35%  Similarity=0.534  Sum_probs=161.3

Q ss_pred             CCCcccccCceEEEEEEEcC-CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~-g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      .++.||+|+||.||+|.... +..+|+|.+......            .....+.+|++.+.+++|+|++++++++.. .
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~   70 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE------------KQREEFLREIRILKKLKHPNIVKLYGVFEDPE   70 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch------------HHHHHHHHHHHHHHhCCCCChhhheeeeecCC
Confidence            35789999999999998864 889999998643111            012257899999999999999999998866 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++++||+++++|.+++.....  .+++.....++.+++.++.|||+  .+++|+||+|+||+++.++.++|+|||++.
T Consensus        71 ~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~di~~~ni~v~~~~~~~l~d~g~~~  146 (225)
T smart00221       71 PLYLVMEYCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHS--LGIVHRDLKPENILLGMDGLVKLADFGLAR  146 (225)
T ss_pred             ceEEEEeccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeCceee
Confidence            66899999999999999876432  27899999999999999999998  469999999999999999999999999988


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCC
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDD  326 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~  326 (593)
                      ........  ......|+..|++||.+.  ..++.++||||||++++||++|+.||..
T Consensus       147 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      147 FIHRDLAA--LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             EecCcccc--cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            76443200  112346888999999762  3466799999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152|consensus

Probab=99.94  E-value=7.2e-28  Score=252.80  Aligned_cols=197  Identities=25%  Similarity=0.387  Sum_probs=157.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC---CCceeeEEEEEec
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLLRLLGLCNN  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~---HpNIv~l~g~~~~  189 (593)
                      -..+|+|+||.|+.|.++ +..+|+||.|.+....-..-..+.+-     -..-.|++||..++   |+||+++++++++
T Consensus       566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkL-----GtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKL-----GTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhccccc-----CccchhHHHHHHhhhcCccchhhhhheeec
Confidence            367999999999999886 46789999987654322111111110     01335999999998   9999999999987


Q ss_pred             c-cceEEEEec-cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         190 I-MNCIVYEYM-CNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       190 ~-~~~lV~Ey~-~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      + ..+|+||-- ++-+|++++..+   +.+++.+..-|..|++.|+++||+  .+|||||||-+|+.++.+|-+||+|||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~--~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHD--QGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccc--cCceecccccccEEEecCCeEEEeecc
Confidence            5 456888854 345888888653   568999999999999999999999  459999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccCC-C-CCcchhhHHHHHHHHHHhCCCCCC
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPID  325 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~-~~ksDVwSfGvvl~ElltG~~P~~  325 (593)
                      .|........     ..++||.+|.|||++.+. | +..-|||++||+||.++....||.
T Consensus       716 saa~~ksgpf-----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYTKSGPF-----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhhcCCCc-----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9877655432     347899999999999764 3 556799999999999999999985

>KOG0665|consensus

Probab=99.94  E-value=2.9e-27  Score=233.80  Aligned_cols=247  Identities=23%  Similarity=0.293  Sum_probs=179.8

Q ss_pred             CcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec----
Q psy9535         115 NKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN----  189 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~----  189 (593)
                      ..+|.|.- .|..+-. -.++.||+|++........    .       ..+-.+|...+..+.|+||++++.++..    
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~----~-------akra~rel~l~~~v~~~nii~l~n~ftP~~~l   90 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQT----H-------AKRAYRELKLMKCVNHKNIISLLNVFTPQKTL   90 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCc----c-------chhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence            45677776 4555543 2588999998854311111    1       1134689999999999999999998743    


Q ss_pred             ---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         190 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       190 ---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                         ...++|||||. ++|.+.+..     .++-.....|.+|++.|+.|||+  .+|+||||||+||++..+..+||.||
T Consensus        91 ~~~~e~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~lKi~df  162 (369)
T KOG0665|consen   91 EEFQEVYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCTLKILDF  162 (369)
T ss_pred             HHHHhHHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHh--cceeecccCcccceecchhheeeccc
Confidence               24589999995 788887762     46778888999999999999998  55999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc-
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR-  344 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~-  344 (593)
                      |+|+.....    ...+..+.|..|.|||++ ...+...+||||.||++.||++|+.-|.+...+..|.++...-+... 
T Consensus       163 g~ar~e~~~----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~  238 (369)
T KOG0665|consen  163 GLARTEDTD----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP  238 (369)
T ss_pred             hhhcccCcc----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence            999865443    123346789999999965 44688899999999999999999999987766666665543321110 


Q ss_pred             --------------------------ccccc----ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 --------------------------EVLDK----EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 --------------------------~~~~~----~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                                +.+..    ...+.. ..-..+.+.++.+++..+|++|-+.+++++
T Consensus       239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~-~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGS-KLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCC-ccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                                      00000    000011 111234566777999999999999999753

>KOG0668|consensus

Probab=99.94  E-value=5.1e-27  Score=222.09  Aligned_cols=186  Identities=23%  Similarity=0.361  Sum_probs=150.9

Q ss_pred             CCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-
Q psy9535         113 RGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-  189 (593)
                      +.+++|+|.|+.||.|.. .+...++||.+++..          .      +...+|+.||..|+ ||||++|++...+ 
T Consensus        42 ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----------k------kKIkREikIL~nL~gg~NIi~L~DiV~Dp  105 (338)
T KOG0668|consen   42 IVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----------K------KKIKREIKILQNLRGGPNIIKLLDIVKDP  105 (338)
T ss_pred             HHHHHcCccHhhHhcccccCCCceEEEeeechHH----------H------HHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence            357899999999999974 567889999997531          1      14679999999998 9999999998765 


Q ss_pred             --ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC-CCccEEeec
Q psy9535         190 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDF  266 (593)
Q Consensus       190 --~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~-~~~~Kl~DF  266 (593)
                        ....||+||+.|-+...+..      .|+......++.+++.||.|+|+  .+|+|||+||.|+++|. .-.++|+|+
T Consensus       106 ~SktpaLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS--~GImHRDVKPhNvmIdh~~rkLrlIDW  177 (338)
T KOG0668|consen  106 ESKTPSLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHS--MGIMHRDVKPHNVMIDHELRKLRLIDW  177 (338)
T ss_pred             cccCchhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHh--cCcccccCCcceeeechhhceeeeeec
Confidence              34579999999887765542      36667778899999999999999  56999999999999995 467999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCC
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDD  326 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~  326 (593)
                      |||.+......-.    -.+.+..|--||.+.  ..++..-|+|||||+|.+|+..+.||..
T Consensus       178 GLAEFYHp~~eYn----VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh  235 (338)
T KOG0668|consen  178 GLAEFYHPGKEYN----VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  235 (338)
T ss_pred             chHhhcCCCceee----eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence            9998765433211    124577889999763  4577888999999999999999999964

>KOG0670|consensus

Probab=99.94  E-value=6.5e-27  Score=242.88  Aligned_cols=192  Identities=26%  Similarity=0.352  Sum_probs=154.5

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCC------CceeeEEEEE-
Q psy9535         116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH------VNLLRLLGLC-  187 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~H------pNIv~l~g~~-  187 (593)
                      -.|+|-|+.|.+|+.. .|+.||||+|..+....              +.=+.|+++|++|+.      -|+++|+-.+ 
T Consensus       439 ~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~--------------KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  439 YTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH--------------KTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             ccccceeeeeeeccccCCCCeeEEEEeecchHHh--------------hhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            3599999999999864 58899999997653211              123579999999853      2788887644 


Q ss_pred             ecccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC-CccEEeec
Q psy9535         188 NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDF  266 (593)
Q Consensus       188 ~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~-~~~Kl~DF  266 (593)
                      .....|||+|-+. -+|.+.|++.+....|....+..++.|+.-||..|-.+  +|+|.||||.|||+++. ..+|||||
T Consensus       505 hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c--~vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  505 HKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC--GVLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             hcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc--CeeecccCccceEeccCcceeeeccC
Confidence            4467899999764 68999999988877899999999999999999999884  49999999999999865 67899999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCch
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNT  329 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~  329 (593)
                      |.|..........     ..-+..|.|||++ .-.|+...|+||.||+||||.||+.-|.+..+
T Consensus       582 GSA~~~~eneitP-----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN  640 (752)
T KOG0670|consen  582 GSASFASENEITP-----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN  640 (752)
T ss_pred             ccccccccccccH-----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence            9987765443211     2335679999965 45689999999999999999999999987443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=1.8e-25  Score=212.17  Aligned_cols=165  Identities=22%  Similarity=0.289  Sum_probs=121.7

Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecccCCCccee
Q psy9535         202 GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY  281 (593)
Q Consensus       202 GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~  281 (593)
                      |||.+++...+  .++++..+..|+.|++.||.|||+.+        ||+|||++.++.+|+  ||+++......     
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeecccc-----
Confidence            78999997532  46999999999999999999999832        999999999999999  99988654321     


Q ss_pred             eccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHH
Q psy9535         282 TENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVE  360 (593)
Q Consensus       282 ~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (593)
                         ..||+.|||||++. ..++.++|||||||++|||+||+.||....................   ++.. ........
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~  136 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD---DPRD-RSNLESVS  136 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC---Cccc-cccHHHHH
Confidence               26899999999774 4578899999999999999999999976443222111111111100   0000 01122222


Q ss_pred             H--HHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         361 T--LIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       361 ~--~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      .  .+..++.+||..+|++||++.|+++.+..
T Consensus       137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      137 AARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             hhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            2  35667789999999999999999987754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=2.1e-26  Score=268.31  Aligned_cols=196  Identities=17%  Similarity=0.171  Sum_probs=133.7

Q ss_pred             hcCCC-CceeeEEEEEe-------c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q psy9535         173 SQCKH-VNLLRLLGLCN-------N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPI  243 (593)
Q Consensus       173 ~~l~H-pNIv~l~g~~~-------~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~I  243 (593)
                      +.++| +||++++++|.       . ...++++||+ +++|.++|...  ..++++..+..++.||++||.|||+  ++|
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~--~gI  101 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHS--QGI  101 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHh--CCe
Confidence            34566 68888888772       1 2335677876 67999999743  2468999999999999999999998  569


Q ss_pred             EecccCCCCeeecC-------------------CCccEEeecccceecccCCC------c-------ceeeccccCCCCc
Q psy9535         244 IHRDVKSANVLLDE-------------------NFVPKLGDFGIVKMSETSNM------K-------TMYTENLTGTRPY  291 (593)
Q Consensus       244 iHrDLKp~NILl~~-------------------~~~~Kl~DFGla~~~~~~~~------~-------~~~~~~~~GT~~Y  291 (593)
                      +||||||+||||+.                   ++.+|++|||+++.......      .       ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   45667777777764221000      0       0001124689999


Q ss_pred             CCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHh
Q psy9535         292 MPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKC  370 (593)
Q Consensus       292 ~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C  370 (593)
                      ||||++ ...++.++|||||||+||||++|..|+.......  .......      +.+...    ....... .++.+|
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~--~~~~~~~------~~~~~~----~~~~~~~-~~~~~~  248 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTM--SSLRHRV------LPPQIL----LNWPKEA-SFCLWL  248 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHH--HHHHHhh------cChhhh----hcCHHHH-HHHHHh
Confidence            999976 4568899999999999999999999876422111  1111110      011000    0111122 344589


Q ss_pred             hccccCCCCChHHHHH
Q psy9535         371 CVFEKDKRASMRDIVD  386 (593)
Q Consensus       371 ~~~dp~~RPsm~eV~~  386 (593)
                      |+.+|.+||+|.||++
T Consensus       249 L~~~P~~Rps~~eil~  264 (793)
T PLN00181        249 LHPEPSCRPSMSELLQ  264 (793)
T ss_pred             CCCChhhCcChHHHhh
Confidence            9999999999999974

>KOG1167|consensus

Probab=99.92  E-value=3e-25  Score=227.00  Aligned_cols=192  Identities=28%  Similarity=0.360  Sum_probs=151.6

Q ss_pred             CCCCcccccCceEEEEEEEc----CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGL  186 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~----~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~  186 (593)
                      +..++||+|.|++||++.+.    ..+.||+|.+....     ..          .+..+|++.|..+. +.||+++.++
T Consensus        39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p----------~ri~~El~~L~~~gG~~ni~~~~~~  103 (418)
T KOG1167|consen   39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SP----------SRILNELEMLYRLGGSDNIIKLNGC  103 (418)
T ss_pred             hhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----Cc----------hHHHHHHHHHHHhccchhhhcchhh
Confidence            44789999999999999753    36789999986431     10          13678999999985 8999999998


Q ss_pred             Eec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC-CCccEEe
Q psy9535         187 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLG  264 (593)
Q Consensus       187 ~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~-~~~~Kl~  264 (593)
                      ... +..++|+||++.-.-.+++..      ++......+++.+..||.++|.  ++||||||||+|+|.+. .+.-.|.
T Consensus       104 ~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~--~GIvHRDiKpsNFL~n~~t~rg~Lv  175 (418)
T KOG1167|consen  104 FRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHK--NGIVHRDIKPSNFLYNRRTQRGVLV  175 (418)
T ss_pred             hccCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhc--cCccccCCCccccccccccCCceEE
Confidence            765 677899999999988888753      6678888899999999999998  66999999999999974 4677899


Q ss_pred             ecccceecccC---------------C-Cc-------------------------ceeeccccCCCCcCCccccc--CCC
Q psy9535         265 DFGIVKMSETS---------------N-MK-------------------------TMYTENLTGTRPYMPPEAMH--CQI  301 (593)
Q Consensus       265 DFGla~~~~~~---------------~-~~-------------------------~~~~~~~~GT~~Y~APE~~~--~~~  301 (593)
                      |||||...+..               . ..                         ........||++|.|||++.  ...
T Consensus       176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q  255 (418)
T KOG1167|consen  176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ  255 (418)
T ss_pred             echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence            99998721000               0 00                         00011246999999999874  346


Q ss_pred             CCcchhhHHHHHHHHHHhCCCCCCC
Q psy9535         302 STKTDVFSYGVILLELLTGMKPIDD  326 (593)
Q Consensus       302 ~~ksDVwSfGvvl~ElltG~~P~~~  326 (593)
                      ++++||||-|||++-+++++.||..
T Consensus       256 ttaiDiws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  256 TTAIDIWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             CCccceeeccceeehhhcccccccc
Confidence            8899999999999999999999953

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=2.7e-24  Score=226.02  Aligned_cols=164  Identities=18%  Similarity=0.148  Sum_probs=121.4

Q ss_pred             CCCcccccCceEEEEEEEc--CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         113 RGNKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~--~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      .++.||+|+||+||+|+++  +++.||||++...... ... ..      ....|.+|+++|++++|+|+++.+..+  .
T Consensus        22 ~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~-~~~-~~------~~~~~~~E~~iL~~L~h~~iv~~l~~~--~   91 (365)
T PRK09188         22 ETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPW-WSK-PL------ARHLAAREIRALKTVRGIGVVPQLLAT--G   91 (365)
T ss_pred             EccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccc-ccc-HH------HHHHHHHHHHHHHhccCCCCCcEEEEc--C
Confidence            3789999999999999874  5777899987522100 000 10      122589999999999999999533222  4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeccc-CCCCeeecCCCccEEeecccc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV-KSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDL-Kp~NILl~~~~~~Kl~DFGla  269 (593)
                      ..++||||+++++|.. +..      ..   ...++.|+++||.|||+  ++|+|||| ||+|||++.++.+||+|||+|
T Consensus        92 ~~~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CcEEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            5689999999999963 211      11   14578899999999998  66999999 999999999999999999999


Q ss_pred             eecccCCCccee-----eccccCCCCcCCccccc
Q psy9535         270 KMSETSNMKTMY-----TENLTGTRPYMPPEAMH  298 (593)
Q Consensus       270 ~~~~~~~~~~~~-----~~~~~GT~~Y~APE~~~  298 (593)
                      +...........     .+...|++.|+|||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            876543311111     13567899999999874

>KOG0195|consensus

Probab=99.91  E-value=4.2e-25  Score=213.63  Aligned_cols=246  Identities=25%  Similarity=0.362  Sum_probs=181.9

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc-cce
Q psy9535         115 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI-MNC  193 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~-~~~  193 (593)
                      .+|.+...|..|+|+|. |..+++|++..........           ..|..|.-.|+-+.||||+.++|.|... ...
T Consensus       196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~ris-----------rdfneefp~lrifshpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARIS-----------RDFNEEFPALRIFSHPNILPVLGACNSPPNLV  263 (448)
T ss_pred             hhhccCCCccccccccc-Ccchhhhhhhhhhcchhhc-----------chhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence            46888999999999997 6677788876432221111           1488899999999999999999999884 557


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecc
Q psy9535         194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  273 (593)
Q Consensus       194 lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~  273 (593)
                      ++..||+.|||+..|+...+ -..+..+.++++.++|+|+.|||+..+-|.---|.+..+++|++.+++|+ .|-+++..
T Consensus       264 ~isq~mp~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsf  341 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF  341 (448)
T ss_pred             EeeeeccchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeee
Confidence            89999999999999997543 45788899999999999999999976556667899999999999999985 22222211


Q ss_pred             cCCCcceeeccccCCCCcCCcccccCCC----CCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         274 TSNMKTMYTENLTGTRPYMPPEAMHCQI----STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       274 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .       .....-+|.||+||.+..+.    -.++|+|||++++|||.|...||.+......-..+..+...      .
T Consensus       342 q-------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr------v  408 (448)
T KOG0195|consen  342 Q-------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR------V  408 (448)
T ss_pred             e-------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc------c
Confidence            1       11122368899999886542    34689999999999999999999886654433333222211      1


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ..++-    ...-+..++.-|...||.+||.+..|+-.|++.
T Consensus       409 ~ippg----is~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  409 HIPPG----ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             cCCCC----ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            11111    122234456789999999999999999999874

>KOG0661|consensus

Probab=99.91  E-value=2.3e-25  Score=230.29  Aligned_cols=128  Identities=29%  Similarity=0.512  Sum_probs=111.5

Q ss_pred             chhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcc
Q psy9535         434 ETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVK  513 (593)
Q Consensus       434 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~  513 (593)
                      |...|.||++++.. ..+|++.....|+.||+.||+|+|+  +++.|||+||+|||+..+..+||+|||+||.....   
T Consensus        90 E~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk--~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk---  163 (538)
T KOG0661|consen   90 EFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK--HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK---  163 (538)
T ss_pred             HhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh--cCcccccCChhheEecccceeEecccccccccccC---
Confidence            66788999988776 6789999999999999999999999  66999999999999998889999999999864322   


Q ss_pred             ccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeE
Q psy9535         514 TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV  581 (593)
Q Consensus       514 ~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (593)
                      ..+|+ .+.|.||.|||++..  -|+.++|+||+||++++             .|+|+++|||.+|.||+
T Consensus       164 pPYTe-YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aE-------------l~sLrPLFPG~sE~Dqi  219 (538)
T KOG0661|consen  164 PPYTE-YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAE-------------LYSLRPLFPGASEIDQI  219 (538)
T ss_pred             CCcch-hhhcccccchHHhhhccccCCchHHHHHHHHHHH-------------HHHhcccCCCCcHHHHH
Confidence            22333 468999999998633  37889999999999996             99999999999999985

>KOG1345|consensus

Probab=99.91  E-value=6.4e-25  Score=212.55  Aligned_cols=240  Identities=20%  Similarity=0.333  Sum_probs=165.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEE-ec-
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLC-NN-  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~-~~-  189 (593)
                      .+.||+|.||.+-+++++ +.+.+|+|.+....              ..+..|.+|..---.| .|.||+.-+... .. 
T Consensus        29 ~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--------------tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~   94 (378)
T KOG1345|consen   29 NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--------------TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS   94 (378)
T ss_pred             HHHhcccceeeEEeeeccCCceEEEeeccCcch--------------hhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence            468999999999999986 57789999875321              1133688998765555 489999988643 33 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec--CCCccEEeecc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGDFG  267 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~--~~~~~Kl~DFG  267 (593)
                      +..++++||+|.|+|..-+..    ..+-+....+++.|+++||.|+|+  +++||||||.+|||+-  +..++||||||
T Consensus        95 d~YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             ceEEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEeeecc
Confidence            445679999999999876643    346777888899999999999998  6799999999999993  34589999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCccccc----CC--CCCcchhhHHHHHHHHHHhCCCCCCCC----chHHHHHHHH
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQ--ISTKTDVFSYGVILLELLTGMKPIDDN----NTILYYYLVV  337 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~----~~--~~~ksDVwSfGvvl~ElltG~~P~~~~----~~~~~~~~~~  337 (593)
                      +.+.....-      ....-+..|-|||...    ++  ..+.+|||.||+++|..+||..||...    ..-..|....
T Consensus       169 ~t~k~g~tV------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~  242 (378)
T KOG1345|consen  169 LTRKVGTTV------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL  242 (378)
T ss_pred             cccccCcee------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh
Confidence            976543211      1123456799999652    22  356789999999999999999999742    1222222222


Q ss_pred             hhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHH
Q psy9535         338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDL  387 (593)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~  387 (593)
                      .+..  ..+ ...-..+.+    . +..++.+-+..++++|--..++.++
T Consensus       243 ~rk~--~~~-P~~F~~fs~----~-a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  243 KRKN--PAL-PKKFNPFSE----K-ALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             cccC--ccC-chhhcccCH----H-HHHHHHHhcCCcccccchhHHHHHH
Confidence            2211  111 111111221    1 2224457788899988665555443

>KOG1290|consensus

Probab=99.91  E-value=1.3e-23  Score=217.56  Aligned_cols=128  Identities=31%  Similarity=0.408  Sum_probs=101.6

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-----CC---ceee
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-----HV---NLLR  182 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-----Hp---NIv~  182 (593)
                      .+.++||-|.|++||++... +.+.||+|+.+....+       .++       -..||.+|++++     |+   +||+
T Consensus        81 ~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-------tEa-------AlDEIklL~~v~~~Dp~~~~~~~VV~  146 (590)
T KOG1290|consen   81 HVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-------TEA-------ALDEIKLLQQVREGDPNDPGKKCVVQ  146 (590)
T ss_pred             EEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-------HHH-------HHHHHHHHHHHHhcCCCCCCCceeee
Confidence            34579999999999999764 5678999998643222       122       357999998874     32   6999


Q ss_pred             EEEEEec-----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec
Q psy9535         183 LLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  256 (593)
Q Consensus       183 l~g~~~~-----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~  256 (593)
                      |++.+..     ...|+|+|++ |-+|..+|.... ...++...+..|++||+.||.|||+.+ +|||-||||+||||.
T Consensus       147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLLC  222 (590)
T ss_pred             eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeeee
Confidence            9998753     2458999997 668888887654 356899999999999999999999853 699999999999994

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=3.9e-22  Score=202.64  Aligned_cols=256  Identities=30%  Similarity=0.455  Sum_probs=185.4

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCC-ceeeEEEEEeccc-
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV-NLLRLLGLCNNIM-  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~Hp-NIv~l~g~~~~~~-  191 (593)
                      ...||.|+||.||++...  ..+|+|.+........          .....|.+|+.++..+.|+ |++++.+.+.... 
T Consensus         5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~----------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   72 (384)
T COG0515           5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS----------KEVERFLREIQILASLNHPPNIVKLYDFFQDEGS   72 (384)
T ss_pred             EEeecCCCCeEEEEEEec--cEEEEEeechhhccch----------hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE
Confidence            467999999999999876  7899999875432211          0123588999999999988 7999999886544 


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC-ccEEeecccce
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFGIVK  270 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~-~~Kl~DFGla~  270 (593)
                      .+++++|+.++++.+.+........+.......++.|++.++.|+|+  .+++|||+||+|||++... .+|++|||+++
T Consensus        73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~--~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            48999999999999766543211258889999999999999999998  4599999999999999888 79999999998


Q ss_pred             ecccCCCcce---eeccccCCCCcCCcccccC----CCCCcchhhHHHHHHHHHHhCCCCCCCCch----HHHHHHHHhh
Q psy9535         271 MSETSNMKTM---YTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNT----ILYYYLVVEQ  339 (593)
Q Consensus       271 ~~~~~~~~~~---~~~~~~GT~~Y~APE~~~~----~~~~ksDVwSfGvvl~ElltG~~P~~~~~~----~~~~~~~~~~  339 (593)
                      ..........   ......||..|+|||.+..    ......|+||+|++++++++|..||.....    ..........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  230 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL  230 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence            5544322110   2345689999999997754    567789999999999999999999876542    1222222111


Q ss_pred             cCc-cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHH
Q psy9535         340 EVP-VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDL  387 (593)
Q Consensus       340 ~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~  387 (593)
                      ..+ ..........    ......+..++..|+..+|..|.++.+....
T Consensus       231 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         231 PTPSLASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CCcccccccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            111 1111110000    1112334456678999999999998887653

>KOG0591|consensus

Probab=99.89  E-value=4.4e-24  Score=207.84  Aligned_cols=118  Identities=29%  Similarity=0.426  Sum_probs=97.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCc
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY  526 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~--iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y  526 (593)
                      ...+++..+++++.|+|.||.+||...+.  |+||||||.||+|+.+|.+||+|||++++....   ...++..+|||+|
T Consensus       118 kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~---~tfA~S~VGTPyY  194 (375)
T KOG0591|consen  118 KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK---TTFAHSLVGTPYY  194 (375)
T ss_pred             cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch---hHHHHhhcCCCcc
Confidence            45799999999999999999999985444  999999999999999999999999999976542   3345678999999


Q ss_pred             ccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhh
Q psy9535         527 MPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQT  570 (593)
Q Consensus       527 ~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~  570 (593)
                      |+||.+.. +|+.||||||+||+||+----..|+-++ -+++|+.
T Consensus       195 MSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~  238 (375)
T KOG0591|consen  195 MSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCK  238 (375)
T ss_pred             cCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHH
Confidence            99998865 5899999999999999754445555555 4455553

>KOG0598|consensus

Probab=99.88  E-value=2.6e-23  Score=210.28  Aligned_cols=131  Identities=28%  Similarity=0.333  Sum_probs=109.0

Q ss_pred             hhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcccccc
Q psy9535         438 CQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT  517 (593)
Q Consensus       438 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~  517 (593)
                      +.||..++..  +.+++..+..++.+|+.||.|||+  ++||||||||+|||||..|+++|+|||+++..-..   ...+
T Consensus       110 GeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~---~~~t  182 (357)
T KOG0598|consen  110 GELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD---GDAT  182 (357)
T ss_pred             ccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEeccccchhcccC---CCcc
Confidence            5777777654  469999999999999999999999  66999999999999999999999999999854322   2235


Q ss_pred             ccccCCCCcccccccC-CcCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCC
Q psy9535         518 ENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       518 ~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      ++.+||+.|||||++. .+++..+|+||+||++|+-+++..|+..+...---+..+.|-
T Consensus       183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k  241 (357)
T KOG0598|consen  183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK  241 (357)
T ss_pred             ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc
Confidence            6689999999999875 468899999999999999888988888877665555555544

>KOG0595|consensus

Probab=99.88  E-value=3.4e-23  Score=211.25  Aligned_cols=124  Identities=27%  Similarity=0.419  Sum_probs=100.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCC------CceEEEe
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN------FVPKLGD  500 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~------~~~kl~D  500 (593)
                      ++++++=.  .++|-.+++..  +.+++.....++.|+|.||++||+  ++||||||||.||||+..      ..+||+|
T Consensus        85 ~lVMEyC~--gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~--~~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   85 YLVMEYCN--GGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHE--NNIIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             EEEEEeCC--CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCcceEEeccCCCCCCCceEEecc
Confidence            45554321  25666666554  368999999999999999999999  669999999999999764      5799999


Q ss_pred             cccceecccCCccccccccccCCCCccccccc-CCcCCcccceecchhhhhcccccCCCcc
Q psy9535         501 FGIVKMSETSNVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGAQIKTQHITNVDIA  560 (593)
Q Consensus       501 fG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~-~~~~~~ksDvwS~G~~i~~~~~~~~~~~  560 (593)
                      ||++|....    ....++.+|++.|||||++ ..+|+.|+|+||+|++||+-+..-.|+.
T Consensus       159 FGfAR~L~~----~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  159 FGFARFLQP----GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             cchhhhCCc----hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence            999997653    2345678999999999998 5679999999999999998776666665

>KOG0616|consensus

Probab=99.87  E-value=8.4e-23  Score=200.38  Aligned_cols=138  Identities=28%  Similarity=0.347  Sum_probs=109.7

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      -+++++-+  .+.+|.+++..  +++++..+..++.||+.||+|||+  ..|++|||||+|||||++|.+||+|||+++-
T Consensus       120 ymvmeyv~--GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  120 YMVMEYVP--GGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             EEEEeccC--CccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeeeccCCcEEEEeccceEE
Confidence            35555433  36788887754  579999999999999999999999  5599999999999999999999999999985


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHH  576 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  576 (593)
                      ...      .+-+.||||.|+|||++.. ++..++|+|||||+||+.+-+-.|+-+-.+.-..+..+-|.-
T Consensus       194 v~~------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v  258 (355)
T KOG0616|consen  194 VSG------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV  258 (355)
T ss_pred             ecC------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc
Confidence            332      2445799999999998865 477789999999999997767677666555544454444443

>KOG0581|consensus

Probab=99.87  E-value=6.3e-23  Score=207.51  Aligned_cols=107  Identities=30%  Similarity=0.442  Sum_probs=94.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP  529 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aP  529 (593)
                      +.+++...-.++.+|++||.|||+. +.||||||||+|||++..|.+||||||.++....+     ...+.+||..||||
T Consensus       173 g~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-----~a~tfvGT~~YMsP  246 (364)
T KOG0581|consen  173 GRIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-----IANTFVGTSAYMSP  246 (364)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-----hcccccccccccCh
Confidence            5689999999999999999999952 66999999999999999999999999998754332     34567899999999


Q ss_pred             cccCC-cCCcccceecchhhhhcccccCCCccch
Q psy9535         530 EAMHC-QISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       530 E~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      |.+.+ .|+.++||||||.+|+|..++.+|+.-.
T Consensus       247 ERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~  280 (364)
T KOG0581|consen  247 ERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP  280 (364)
T ss_pred             hhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence            99877 4889999999999999999999998876

>KOG0599|consensus

Probab=99.87  E-value=7.2e-23  Score=198.38  Aligned_cols=144  Identities=26%  Similarity=0.421  Sum_probs=125.3

Q ss_pred             hhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcccccc
Q psy9535         438 CQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT  517 (593)
Q Consensus       438 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~  517 (593)
                      +.||.++..  .-.+++.....|++|+.+|++|||.  +.|+||||||+|||++++..+||+|||++.......    ..
T Consensus       108 GELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa--~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge----kL  179 (411)
T KOG0599|consen  108 GELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHA--RNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE----KL  179 (411)
T ss_pred             chHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHH--hhhhhcccChhheeeccccceEEeccceeeccCCch----hH
Confidence            466766543  3468999999999999999999998  669999999999999999999999999987654432    23


Q ss_pred             ccccCCCCcccccccCC-------cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeEEEeeccCC
Q psy9535         518 ENLTGTRPYMPPEAMHC-------QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVSISNHSTN  589 (593)
Q Consensus       518 ~~~~Gt~~y~aPE~~~~-------~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (593)
                      ...||||+|.|||.+..       +|+..+|.||.||++||.+-+..|+|++-.-+-|....-|.-+|-+--|.|+|..
T Consensus       180 relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~  258 (411)
T KOG0599|consen  180 RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISAT  258 (411)
T ss_pred             HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhcccc
Confidence            45789999999998743       3677899999999999999999999999999999999999999999999999864

>KOG0594|consensus

Probab=99.86  E-value=1.8e-22  Score=203.84  Aligned_cols=135  Identities=25%  Similarity=0.358  Sum_probs=104.9

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.....+........ ..++......+++|++.||+|||+  ++|+||||||.||||+.+|.+||+|||+++.
T Consensus        93 ~lvfe~~d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~--~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   93 YLVFEFLDRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS--HGILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             EEEEEeecccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCcceEEECCCCcEeeeccchHHH
Confidence            3566555554444333322111 347778899999999999999999  6699999999999999999999999999986


Q ss_pred             cccCCccccccccccCCCCcccccccCCc--CCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCe
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDH  580 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (593)
                      ......  .++ ..++|.+|.|||++.+.  |++.+|+||+||++.+             -++-+++|||+.|.||
T Consensus       170 ~~ip~~--~yt-~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaE-------------m~~~~~LFpG~se~~q  229 (323)
T KOG0594|consen  170 FSIPMR--TYT-PEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAE-------------MFTRRPLFPGDSEIDQ  229 (323)
T ss_pred             hcCCcc--ccc-ccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHH-------------HHhCCCCCCCCcHHHH
Confidence            543221  123 34689999999987654  7899999999999985             6668899999999876

>KOG1187|consensus

Probab=99.86  E-value=4.5e-22  Score=210.21  Aligned_cols=127  Identities=35%  Similarity=0.544  Sum_probs=100.7

Q ss_pred             cceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCcEeecCCCceEEEeccc
Q psy9535         425 IPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-SKPIIHRDVKSANVLLDENFVPKLGDFGI  503 (593)
Q Consensus       425 ~~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~-~~~iiHrdlKp~NILl~~~~~~kl~DfG~  503 (593)
                      .++++|++-..  +.|...+......+|+|.+|++||.++|+||+|||+. .++||||||||+|||||.++.+||+|||+
T Consensus       146 ~~~LVYEym~n--GsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGL  223 (361)
T KOG1187|consen  146 HRLLVYEYMPN--GSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGL  223 (361)
T ss_pred             eEEEEEEccCC--CCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccC
Confidence            46889988766  3666655443322899999999999999999999974 34799999999999999999999999999


Q ss_pred             ceecccCCccccccccc-cCCCCcccccccC-CcCCcccceecchhhhhcccccC
Q psy9535         504 VKMSETSNVKTMYTENL-TGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITN  556 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~-~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~~~  556 (593)
                      ++..... ...  .... .||.+|+|||++. +..+.|+|||||||++++..++-
T Consensus       224 a~~~~~~-~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr  275 (361)
T KOG1187|consen  224 AKLGPEG-DTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGR  275 (361)
T ss_pred             cccCCcc-ccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCC
Confidence            9765431 111  1112 7999999999874 56899999999999999865444

>KOG0592|consensus

Probab=99.86  E-value=3e-22  Score=210.23  Aligned_cols=136  Identities=26%  Similarity=0.387  Sum_probs=113.8

Q ss_pred             hhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcc----
Q psy9535         438 CQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVK----  513 (593)
Q Consensus       438 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~----  513 (593)
                      ++|+.++...  +.|++.....++.+|+.||+|||+  ++||||||||+|||||.++++||+|||.++........    
T Consensus       159 Gdll~~i~K~--Gsfde~caR~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~  234 (604)
T KOG0592|consen  159 GDLLDLIKKY--GSFDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENP  234 (604)
T ss_pred             CcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCc
Confidence            5677776654  579999999999999999999999  56999999999999999999999999999876433221    


Q ss_pred             ------ccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCC
Q psy9535         514 ------TMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHE  577 (593)
Q Consensus       514 ------~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  577 (593)
                            ......++||..|.+||++..+ .+..+|+|+|||+||-.+-+.+|+.+.+|+..||..+.=+-+
T Consensus       235 ~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~  305 (604)
T KOG0592|consen  235 VDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE  305 (604)
T ss_pred             cCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence                  0111347999999999998665 578999999999999999999999999999999987654433

>KOG0192|consensus

Probab=99.86  E-value=5.5e-22  Score=208.58  Aligned_cols=132  Identities=30%  Similarity=0.423  Sum_probs=104.9

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC-ceEEEecccce
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFGIVK  505 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~-~~kl~DfG~~~  505 (593)
                      .+++++.+.  +.|..++......+|++..++.++.|||+||+|||+.++ ||||||||+|||++.++ ++||+|||+++
T Consensus       116 ~iVtEy~~~--GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  116 CIVTEYMPG--GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             EEEEEeCCC--CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccce
Confidence            466666544  456666554355789999999999999999999998433 99999999999999997 99999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCC---cCCcccceecchhhhhcccccCCCccchhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      .......   ......||+.|||||++.+   .++.|+||||||+++.+..+.-+|..+-..
T Consensus       193 ~~~~~~~---~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  193 EKVISKT---SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP  251 (362)
T ss_pred             eeccccc---cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence            6543211   1122579999999999974   389999999999999987777777766554

>KOG1164|consensus

Probab=99.86  E-value=1.7e-20  Score=196.21  Aligned_cols=256  Identities=24%  Similarity=0.302  Sum_probs=174.5

Q ss_pred             CCCCcccccCceEEEEEEEcCC--CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCC----CceeeEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKNG--MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH----VNLLRLLG  185 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~g--~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~H----pNIv~l~g  185 (593)
                      ++..+||+|+||.||++.....  ..+|+|.-.........             .+..|+.++..+..    +++.++++
T Consensus        21 ~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-------------~l~~E~~vl~~l~~~~~~~~~~~~~~   87 (322)
T KOG1164|consen   21 KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-------------VLKIEIQVLKKLEKKNGPSHFPKLLD   87 (322)
T ss_pred             EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-------------cchhHHHHHHHHhhhcCCCCCCEEEE
Confidence            3478999999999999987543  47888876543111110             24568888888763    57888887


Q ss_pred             EEe-c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC-----
Q psy9535         186 LCN-N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-----  258 (593)
Q Consensus       186 ~~~-~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~-----  258 (593)
                      ... . ...++||+.+ |-+|.++..... ...++....++|+.|++.+|++||+  .++|||||||+|+++...     
T Consensus        88 ~G~~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~--~G~iHRDiKp~N~~~g~~~~~~~  163 (322)
T KOG1164|consen   88 HGRSTEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS--KGFIHRDIKPENFVVGQSSRSEV  163 (322)
T ss_pred             eccCCCceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh--cCcccCCcCHHHeeecCCCCccc
Confidence            763 3 5678998865 789999776544 4679999999999999999999998  569999999999999754     


Q ss_pred             CccEEeecccce--ecccCCC---cce-e-eccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchH
Q psy9535         259 FVPKLGDFGIVK--MSETSNM---KTM-Y-TENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTI  330 (593)
Q Consensus       259 ~~~Kl~DFGla~--~~~~~~~---~~~-~-~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~  330 (593)
                      ..+.|.|||+++  .......   ... . .....||..|+++.+.. ...+.+.|+||++-++.|++.|..||......
T Consensus       164 ~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~  243 (322)
T KOG1164|consen  164 RTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT  243 (322)
T ss_pred             ceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence            468999999998  3211111   011 1 12356999999999764 45788999999999999999999999653321


Q ss_pred             HHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         331 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .........  ........ .....+..    +..+...+-..+...+|....+...|...
T Consensus       244 ~~~~~~~~~--~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  244 DLKSKFEKD--PRKLLTDR-FGDLKPEE----FAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             chHHHHHHH--hhhhcccc-ccCCChHH----HHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            111111100  00111110 11112222    22333344457889999999988887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=3.1e-21  Score=186.34  Aligned_cols=152  Identities=16%  Similarity=0.163  Sum_probs=108.2

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCC------ch-------hHHhhhcHHHHHHHHHHHhcCCCCce
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS------DN-------TEAAMIPILLFENEVQTLSQCKHVNL  180 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~------~~-------~~~~~~~~~~f~~Ev~il~~l~HpNI  180 (593)
                      ...||+|+||.||+|...+|+.||||+++..........      ..       .....+......+|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            357999999999999987899999999976421110000      00       00000001123469999999988776


Q ss_pred             eeEEEEEecccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeEecccCCCCeeecCCC
Q psy9535         181 LRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYL-HSLSKPIIHRDVKSANVLLDENF  259 (593)
Q Consensus       181 v~l~g~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~IiHrDLKp~NILl~~~~  259 (593)
                      .....+. ....+|||||++++++......   ..+++......++.|++.+|.|| |+  .+|+||||||+|||++ ++
T Consensus        82 ~~p~~~~-~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~--~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPIL-LKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQD--CRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEE-ecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEE-CC
Confidence            4333222 2234899999999877654322   13588899999999999999999 66  4699999999999998 47


Q ss_pred             ccEEeecccceec
Q psy9535         260 VPKLGDFGIVKMS  272 (593)
Q Consensus       260 ~~Kl~DFGla~~~  272 (593)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0575|consensus

Probab=99.85  E-value=6.9e-22  Score=210.60  Aligned_cols=118  Identities=31%  Similarity=0.510  Sum_probs=100.2

Q ss_pred             hHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccc
Q psy9535         439 QLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE  518 (593)
Q Consensus       439 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~  518 (593)
                      .+..+.+  +..+|++..+..+++||+.||.|||+  .+|||||||..|+||+++..+||+|||+|........+   ..
T Consensus       104 sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~--~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er---k~  176 (592)
T KOG0575|consen  104 SLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHS--LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER---KK  176 (592)
T ss_pred             cHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHh--cCceecccchhheeecCcCcEEecccceeeeecCcccc---cc
Confidence            3444444  34689999999999999999999999  56999999999999999999999999998766543222   34


Q ss_pred             cccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchh
Q psy9535         519 NLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       519 ~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      +.||||.|+|||++.. +.+..+||||+||++|+.+++.+|+.+..
T Consensus       177 TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~  222 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT  222 (592)
T ss_pred             eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch
Confidence            5799999999999865 47999999999999999999999998764

>KOG0583|consensus

Probab=99.85  E-value=1.3e-21  Score=207.25  Aligned_cols=140  Identities=24%  Similarity=0.357  Sum_probs=111.0

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCC-CceEEEecccce
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVK  505 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~-~~~kl~DfG~~~  505 (593)
                      .+++++...  +.||.++..  .+++.+.....++.|+++|++|||+  ++|+||||||+|||++.+ +.+||+|||++.
T Consensus        96 ~ivmEy~~g--GdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   96 YIVMEYCSG--GDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEEEEecCC--ccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            455565443  688888766  4679999999999999999999999  669999999999999999 999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCCc--C-CcccceecchhhhhcccccCCCccchhhhchhhhhcCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ--I-STKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~-~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      ....   .....++.+||+.|+|||++.++  | ..++||||+||+||.-+.+-.|+.|.+..--+.....|.
T Consensus       170 ~~~~---~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~  239 (370)
T KOG0583|consen  170 ISPG---EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE  239 (370)
T ss_pred             ccCC---CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC
Confidence            7631   11223567899999999998663  5 468999999999999888888888765544444444443

>KOG0593|consensus

Probab=99.85  E-value=5.2e-22  Score=195.21  Aligned_cols=126  Identities=25%  Similarity=0.385  Sum_probs=100.3

Q ss_pred             hhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcccc
Q psy9535         436 KQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM  515 (593)
Q Consensus       436 ~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~  515 (593)
                      ...+++..+..... -++.....++++|++.|+.|||+  ..+|||||||+||||+.++.+||||||+|+......  ..
T Consensus        83 ~dhTvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d~  157 (396)
T KOG0593|consen   83 CDHTVLHELERYPN-GVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--DN  157 (396)
T ss_pred             cchHHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEEecCCcEEeccchhhHhhcCCc--ch
Confidence            34455555554433 48899999999999999999999  559999999999999999999999999999765322  22


Q ss_pred             ccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCe
Q psy9535         516 YTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDH  580 (593)
Q Consensus       516 ~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (593)
                      ++. .+.|.||.|||.+.+  +|...+||||+||++-+             ..+=++++||.-|.||
T Consensus       158 YTD-YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aE-------------l~~G~pL~PG~SDiDQ  210 (396)
T KOG0593|consen  158 YTD-YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAE-------------LLTGEPLWPGRSDIDQ  210 (396)
T ss_pred             hhh-hhhhhhccChhhhcccCcCCCcccchhhhHHHHH-------------HhcCCcCCCCcchHHH
Confidence            333 467999999998754  68999999999999975             4455667788877776

>KOG0600|consensus

Probab=99.85  E-value=8.6e-22  Score=205.29  Aligned_cols=133  Identities=26%  Similarity=0.407  Sum_probs=102.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .++++|.+..   |-.++.. ..-.|++.+...++.|++.||+|||+  ++|+|||||.+|||||.+|.+||+|||+|++
T Consensus       194 YlVFeYMdhD---L~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  194 YLVFEYMDHD---LSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHS--RGVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             EEEEecccch---hhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhh--cCeeeccccccceEEcCCCCEEeccccceee
Confidence            3566665554   4343332 23469999999999999999999998  6799999999999999999999999999997


Q ss_pred             cccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCe
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDH  580 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (593)
                      ...... ..+|. .+-|+||.|||.+.+  .|+.++|+||.|||+.+             .|.=.++|+|.+|++|
T Consensus       268 y~~~~~-~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~E-------------l~~gkPI~~G~tEveQ  328 (560)
T KOG0600|consen  268 YTPSGS-APYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAE-------------LFLGKPILQGRTEVEQ  328 (560)
T ss_pred             ccCCCC-ccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHH-------------HHcCCCCcCCccHHHH
Confidence            654332 22333 456999999998865  48999999999999986             4444455666666554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=1.6e-20  Score=181.49  Aligned_cols=153  Identities=17%  Similarity=0.200  Sum_probs=110.9

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCc-------h------hHHhhhcHHHHHHHHHHHhcCCCCce
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSD-------N------TEAAMIPILLFENEVQTLSQCKHVNL  180 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~-------~------~~~~~~~~~~f~~Ev~il~~l~HpNI  180 (593)
                      ...||+|+||.||+|+..+|+.||||.++...........       .      ..........+.+|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3579999999999999878999999999765211000000       0      00000111234689999999999987


Q ss_pred             eeEEEEEecccceEEEEeccCCCHHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC
Q psy9535         181 LRLLGLCNNIMNCIVYEYMCNGSLYDR-LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  259 (593)
Q Consensus       181 v~l~g~~~~~~~~lV~Ey~~~GsL~~~-L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~  259 (593)
                      .....+... ..+|||||++++++... +..    ..++......++.|++.++.|||+. .+|+||||||+|||++ ++
T Consensus        82 ~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~-~givHrDlkP~NIll~-~~  154 (190)
T cd05145          82 PVPEPILLK-KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQE-AGLVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCceEEEec-CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCChhhEEEE-CC
Confidence            544333222 35899999998866443 332    3467788899999999999999971 3599999999999999 88


Q ss_pred             ccEEeecccceecc
Q psy9535         260 VPKLGDFGIVKMSE  273 (593)
Q Consensus       260 ~~Kl~DFGla~~~~  273 (593)
                      .++|+|||+++...
T Consensus       155 ~~~liDFG~a~~~~  168 (190)
T cd05145         155 KPYIIDVSQAVELD  168 (190)
T ss_pred             CEEEEEcccceecC
Confidence            99999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0615|consensus

Probab=99.84  E-value=1.3e-21  Score=199.45  Aligned_cols=151  Identities=27%  Similarity=0.402  Sum_probs=118.6

Q ss_pred             EeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCC---CceEEEecccc
Q psy9535         428 IILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGIV  504 (593)
Q Consensus       428 ~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~---~~~kl~DfG~~  504 (593)
                      +++++-+.  +.||...-.+  +.+.+..-..+++|++.|+.|||+  .+|+||||||+||||..+   ..+||+|||+|
T Consensus       253 mVlE~v~G--GeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~--~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  253 MVLEYVEG--GELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHS--QGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             EEEEEecC--ccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHH--cCcccccCCcceEEeccCCcceEEEecccchh
Confidence            44444322  4667665443  467777778899999999999999  559999999999999766   78999999999


Q ss_pred             eecccCCccccccccccCCCCcccccccCCc---C-CcccceecchhhhhcccccCCCccchhhhchhh-hhcCCCCCCC
Q psy9535         505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQ---I-STKTDVFSYGAQIKTQHITNVDIADRERYYSLQ-TMLPGHHEGD  579 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~---~-~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  579 (593)
                      +.....    ....+.||||.|.|||++.+.   + ..++|+||+||++|.-+.+.+|+.+.--..|+. -.+.|.-.+-
T Consensus       327 K~~g~~----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~  402 (475)
T KOG0615|consen  327 KVSGEG----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG  402 (475)
T ss_pred             hccccc----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence            976532    234568999999999998543   3 348999999999999999999999887777664 4678887777


Q ss_pred             eEEEeeccC
Q psy9535         580 HVSISNHST  588 (593)
Q Consensus       580 ~~~~~~~~~  588 (593)
                      +..|--+|.
T Consensus       403 p~~w~~Ise  411 (475)
T KOG0615|consen  403 PLQWDRISE  411 (475)
T ss_pred             ChhhhhhhH
Confidence            777776663

>KOG0590|consensus

Probab=99.84  E-value=1.2e-21  Score=218.93  Aligned_cols=262  Identities=20%  Similarity=0.261  Sum_probs=174.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         109 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       109 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      +|...++.+|.|+||.|+..... .....+.|..... . . ..  +.+...  ...+..|+-+-..++|||++..+..+
T Consensus       318 ~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~-~-~~--~s~~~~--~~~i~sE~~i~~~l~h~~~~e~l~~~  390 (601)
T KOG0590|consen  318 KYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-V-K-PT--ESERKY--NYNITSEFCIGSSLSHPNIIETLDIV  390 (601)
T ss_pred             ccCCccceeeecccCceEEEEecCCCccchhhhhhcc-c-C-Cc--ccHHHH--hhhhhhheeecccccCCchhhhHHHH
Confidence            35566789999999988876543 3333444433211 0 0 00  001100  01145678888899999998777655


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      .+ ....-+||||++ +|+.++...   ..+....+-.+..|+..|+.|+|+  .+|.|||+|++|+|++.++.+||+||
T Consensus       391 ~~~~~~~~~mE~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~--~GiahrdlK~enll~~~~g~lki~Df  464 (601)
T KOG0590|consen  391 QEIDGILQSMEYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHS--MGLAHRDLKLENLLVTENGILKIIDF  464 (601)
T ss_pred             hhcccchhhhhcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHh--cCceeccCccccEEEecCCceEEeec
Confidence            44 222334999999 999998753   246777888899999999999999  55999999999999999999999999


Q ss_pred             ccceecccCCCc-ceeeccccCCCCcCCcccccC-CCCC-cchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc
Q psy9535         267 GIVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC-QIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  343 (593)
Q Consensus       267 Gla~~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~-~~~~-ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~  343 (593)
                      |.+......... ......++|+.+|+|||++.+ .|.+ ..||||.||++..|++|+.||.........+.........
T Consensus       465 g~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~  544 (601)
T KOG0590|consen  465 GAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQR  544 (601)
T ss_pred             CcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccc
Confidence            998765443321 123456789999999998754 5665 5699999999999999999996422110000000000000


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..   ..........+....+.++.+.++.+|.+|.|+.+|++
T Consensus       545 ~~---~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  545 NI---FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cc---ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00   00000111223344556777899999999999999975

>KOG0198|consensus

Probab=99.83  E-value=4.8e-21  Score=196.20  Aligned_cols=129  Identities=29%  Similarity=0.394  Sum_probs=98.6

Q ss_pred             EeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC-CCceEEEeccccee
Q psy9535         428 IILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKM  506 (593)
Q Consensus       428 ~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~-~~~~kl~DfG~~~~  506 (593)
                      |.+++...  +.+..++...+. .|++..+..+.+||++||+|||+  ++++||||||+|||++. ++.+||+|||+++.
T Consensus        93 i~mEy~~~--GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   93 IFMEYAPG--GSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eeeeccCC--CcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence            44444332  456666666555 79999999999999999999998  67999999999999999 79999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCCcCC--cccceecchhhhhcccccCCCccc
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHCQIS--TKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~--~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      ...............||+.|||||++.....  .++|||||||++++-.+...|..+
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence            4421111122334689999999999874433  489999999999986666555554

>KOG0663|consensus

Probab=99.83  E-value=2.6e-21  Score=192.55  Aligned_cols=131  Identities=28%  Similarity=0.410  Sum_probs=101.7

Q ss_pred             EeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceec
Q psy9535         428 IILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  507 (593)
Q Consensus       428 ~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~  507 (593)
                      +++++-|+   +|..++.... .++...++..++.|+++|++|||...  |+||||||+|+|+...|.+||+|||+||..
T Consensus       154 ~VMe~~Eh---DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  154 IVMEYVEH---DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeHHHHHh---hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhh
Confidence            45555444   4555544443 57999999999999999999999944  999999999999999999999999999976


Q ss_pred             ccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCe
Q psy9535         508 ETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDH  580 (593)
Q Consensus       508 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (593)
                      +....  .++ ..+-|+||.|||.+.+  .|++..|+||+|||+-+             ...--|+|||..|.||
T Consensus       228 gsp~k--~~T-~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE-------------~l~~kPlf~G~sE~dQ  286 (419)
T KOG0663|consen  228 GSPLK--PYT-PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAE-------------LLTQKPLFPGKSEIDQ  286 (419)
T ss_pred             cCCcc--cCc-ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHH-------------HHhcCCCCCCCchHHH
Confidence            54322  223 3456999999998755  48999999999999976             4444556666666665

>KOG1035|consensus

Probab=99.83  E-value=9.7e-20  Score=206.05  Aligned_cols=122  Identities=26%  Similarity=0.422  Sum_probs=92.9

Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecc------------cCCc---ccccc
Q psy9535         453 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE------------TSNV---KTMYT  517 (593)
Q Consensus       453 ~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~------------~~~~---~~~~~  517 (593)
                      .-...+.++++|++||.|+|+  .++|||||||.||+|+.+..+||+|||++....            ....   .....
T Consensus       695 ~~d~~wrLFreIlEGLaYIH~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~  772 (1351)
T KOG1035|consen  695 QRDEAWRLFREILEGLAYIHD--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDL  772 (1351)
T ss_pred             hhHHHHHHHHHHHHHHHHHHh--CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccc
Confidence            356678899999999999999  559999999999999999999999999987511            0000   01122


Q ss_pred             ccccCCCCcccccccCC----cCCcccceecchhhhhcccccCCCccch-hhhchhhhhcCCCCCCC
Q psy9535         518 ENLTGTRPYMPPEAMHC----QISTKTDVFSYGAQIKTQHITNVDIADR-ERYYSLQTMLPGHHEGD  579 (593)
Q Consensus       518 ~~~~Gt~~y~aPE~~~~----~~~~ksDvwS~G~~i~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  579 (593)
                      +..+||..|+|||++.+    .|+.|+|+||+|+++++..-+   +.+. |+-..|+++=.|..+.+
T Consensus       773 Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsMERa~iL~~LR~g~iP~~  836 (1351)
T KOG1035|consen  773 TSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSMERASILTNLRKGSIPEP  836 (1351)
T ss_pred             ccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCchHHHHHHHHhcccCCCCCC
Confidence            34579999999998843    478899999999999985443   4333 34467777777777776

>KOG1023|consensus

Probab=99.83  E-value=1.3e-20  Score=202.00  Aligned_cols=210  Identities=26%  Similarity=0.362  Sum_probs=150.5

Q ss_pred             HhcCCCCceeeEEEEEecc-cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCC
Q psy9535         172 LSQCKHVNLLRLLGLCNNI-MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKS  250 (593)
Q Consensus       172 l~~l~HpNIv~l~g~~~~~-~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp  250 (593)
                      |+.+.|.|+.+++|.|.++ ..+.|.+||..|+|.|.+..  ....++|.-...++++++.||.|||+..- -.|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeecc
Confidence            4578999999999999775 45679999999999999976  33568999999999999999999998331 39999999


Q ss_pred             CCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccccCC--------CCCcchhhHHHHHHHHHHhCCC
Q psy9535         251 ANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--------ISTKTDVFSYGVILLELLTGMK  322 (593)
Q Consensus       251 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--------~~~ksDVwSfGvvl~ElltG~~  322 (593)
                      +|.++|..+.+||+|||+..+........ ......-..-|.|||.+...        .+.+.||||||++++|+++...
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~-~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPE-AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             ccceeeeeEEEEechhhhccccccccccc-ccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999987654211000 00111223569999987542        4667999999999999999999


Q ss_pred             CCCCCch----HHHHHHHHh-hcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         323 PIDDNNT----ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       323 P~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ||+....    ......+.. +..+++..+....      +....+..++..||..+|+.||++.+|-..+...
T Consensus       157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~------e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLN------ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             ccccccccCChHHHHHHHHhcCCCCcCcchhhhh------hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            9986321    111111111 1222222221111      1222233455799999999999999998777653

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=3.2e-20  Score=179.00  Aligned_cols=188  Identities=18%  Similarity=0.173  Sum_probs=137.6

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEecccc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNNIMN  192 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~~~~  192 (593)
                      ...|++|+||+||.+.. .+..++.+.+........         ......|.+|+++|++|. |+++.+++++   ...
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~---------~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~   73 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLR---------GVAWWLARREALALRQLDGLPRTPRLLHW---DGR   73 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhh---------hHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCE
Confidence            57899999999997655 577888777754321100         001124789999999995 4889999886   345


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeccc-CCCCeeecCCCccEEeeccccee
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV-KSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDL-Kp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      +++|||+.|.+|.+.+..          ....++.|++++|.++|+  .+|+|||| ||+|||++.++.++|+|||+|..
T Consensus        74 ~lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~--~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~  141 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHR--CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR  141 (218)
T ss_pred             EEEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHH--CcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence            899999999998754321          113467899999999998  56999999 79999999999999999999985


Q ss_pred             cccCCC-----c-c----eeeccccCCCCcCCcccc--cCCCC-CcchhhHHHHHHHHHHhCCCCCCC
Q psy9535         272 SETSNM-----K-T----MYTENLTGTRPYMPPEAM--HCQIS-TKTDVFSYGVILLELLTGMKPIDD  326 (593)
Q Consensus       272 ~~~~~~-----~-~----~~~~~~~GT~~Y~APE~~--~~~~~-~ksDVwSfGvvl~ElltG~~P~~~  326 (593)
                      ......     . .    ........++.|++|+..  ....+ ...++++-|.-+|.++||..|.-.
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            443221     0 0    001112478899999843  22333 567999999999999999988754

>KOG0659|consensus

Probab=99.82  E-value=1.3e-20  Score=182.56  Aligned_cols=133  Identities=26%  Similarity=0.353  Sum_probs=104.1

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-++.   |...++. ...+|...+...++.++.+|++|||+  +.|+||||||.|+|++.+|.+||+|||+++.
T Consensus        77 ~lVfEfm~td---Le~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~--~~IlHRDlKPnNLLis~~g~lKiADFGLAr~  150 (318)
T KOG0659|consen   77 SLVFEFMPTD---LEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHS--KWILHRDLKPNNLLISSDGQLKIADFGLARF  150 (318)
T ss_pred             EEEEEecccc---HHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHh--hhhhcccCCccceEEcCCCcEEeecccchhc
Confidence            4566555544   4333332 34579999999999999999999998  5599999999999999999999999999998


Q ss_pred             cccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeE
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV  581 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (593)
                      .......  .++. +-|.+|.|||.+.+  +|+..+|+||.||++-|.+.             =-|+|||.+|.||.
T Consensus       151 f~~p~~~--~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELll-------------r~P~fpG~sDidQL  211 (318)
T KOG0659|consen  151 FGSPNRI--QTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLL-------------RVPFFPGDSDIDQL  211 (318)
T ss_pred             cCCCCcc--cccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHc-------------cCCCCCCCchHHHH
Confidence            7654332  2222 56999999998754  48999999999999986443             34578888888774

>KOG0033|consensus

Probab=99.82  E-value=1.4e-20  Score=180.05  Aligned_cols=132  Identities=22%  Similarity=0.292  Sum_probs=114.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC---CCceEEEecccceecccCCccccccccccCCCCcc
Q psy9535         451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYM  527 (593)
Q Consensus       451 ~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~---~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~  527 (593)
                      .+++..+-.+++||++||+|+|.  ++|+|||+||.|+||..   ..-+||+|||++...+.    .......+|||.||
T Consensus       106 ~ySEa~aSH~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~----g~~~~G~~GtP~fm  179 (355)
T KOG0033|consen  106 FYSEADASHCIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND----GEAWHGFAGTPGYL  179 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeecccceEEEeCC----ccccccccCCCccc
Confidence            46777888899999999999998  66999999999999953   44699999999986552    22345678999999


Q ss_pred             cccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeEEEeeccC
Q psy9535         528 PPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVSISNHST  588 (593)
Q Consensus       528 aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (593)
                      |||++.. .++..+||||.||+||..+.+-+|+++...---++-...|+-+++.--|+|+|.
T Consensus       180 aPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~  241 (355)
T KOG0033|consen  180 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP  241 (355)
T ss_pred             CHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH
Confidence            9999855 588899999999999999999999999887778889999999999999999985

>KOG0694|consensus

Probab=99.82  E-value=6.9e-21  Score=205.20  Aligned_cols=113  Identities=25%  Similarity=0.341  Sum_probs=97.5

Q ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCc
Q psy9535         447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY  526 (593)
Q Consensus       447 ~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y  526 (593)
                      ...+.+++.++..|+..|+.||+|||+  ++||+||||.+|||||.+|.+||+|||+++.....   ...+.+++|||.|
T Consensus       460 ~~~~~F~e~rarfyaAev~l~L~fLH~--~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~---g~~TsTfCGTpey  534 (694)
T KOG0694|consen  460 IHTDVFSEPRARFYAAEVVLGLQFLHE--NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ---GDRTSTFCGTPEF  534 (694)
T ss_pred             EecccccHHHHHHHHHHHHHHHHHHHh--cCceeeecchhheEEcccCcEEecccccccccCCC---CCccccccCChhh
Confidence            344679999999999999999999999  66999999999999999999999999999864322   2346789999999


Q ss_pred             ccccccCCc-CCcccceecchhhhhcccccCCCccchhh
Q psy9535         527 MPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       527 ~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      ||||++.++ |+..+|+|||||+||+-+++--|+.+..|
T Consensus       535 ~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE  573 (694)
T KOG0694|consen  535 LAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE  573 (694)
T ss_pred             cChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence            999998765 88899999999999998888888773333

>KOG0667|consensus

Probab=99.82  E-value=2.1e-20  Score=201.31  Aligned_cols=136  Identities=26%  Similarity=0.391  Sum_probs=110.5

Q ss_pred             ccCcceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCC--CceEEE
Q psy9535         422 YTGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN--FVPKLG  499 (593)
Q Consensus       422 ~~~~~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~--~~~kl~  499 (593)
                      +++..+|++   |.....|+++++.++...|+......++.||+.||.+||+  .+|||+||||+||||..-  ..+||+
T Consensus       259 fr~HlciVf---ELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~--l~IIHcDLKPENILL~~~~r~~vKVI  333 (586)
T KOG0667|consen  259 FRNHLCIVF---ELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE--LGIIHCDLKPENILLKDPKRSRIKVI  333 (586)
T ss_pred             cccceeeee---hhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCChhheeeccCCcCceeEE
Confidence            455566776   4566788999999988899999999999999999999998  459999999999999643  479999


Q ss_pred             ecccceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCC
Q psy9535         500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG  578 (593)
Q Consensus       500 DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  578 (593)
                      |||.+......    .+  +..-+.+|.|||++.+ .|+.+.|+||||||+.|.+++             .|+|||++|+
T Consensus       334 DFGSSc~~~q~----vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG-------------~PLfpG~ne~  394 (586)
T KOG0667|consen  334 DFGSSCFESQR----VY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTG-------------EPLFPGDNEY  394 (586)
T ss_pred             ecccccccCCc----ce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcC-------------ccccCCCCHH
Confidence            99998753321    12  2456899999998755 689999999999999874433             4589999999


Q ss_pred             CeE
Q psy9535         579 DHV  581 (593)
Q Consensus       579 ~~~  581 (593)
                      ||.
T Consensus       395 DQl  397 (586)
T KOG0667|consen  395 DQL  397 (586)
T ss_pred             HHH
Confidence            984

>KOG0588|consensus

Probab=99.81  E-value=1.2e-20  Score=202.10  Aligned_cols=133  Identities=24%  Similarity=0.345  Sum_probs=109.6

Q ss_pred             hhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcccccc
Q psy9535         438 CQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT  517 (593)
Q Consensus       438 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~  517 (593)
                      +.||.++..  .++|+++.+..++.||..|+.|||.+.  |+||||||+|+|||....+||+|||.|.+-..    .-..
T Consensus        97 GELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~----gklL  168 (786)
T KOG0588|consen   97 GELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVP----GKLL  168 (786)
T ss_pred             chhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccC----Cccc
Confidence            567777654  468999999999999999999999954  99999999999999998999999999865322    2234


Q ss_pred             ccccCCCCcccccccCCc-C-CcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCC
Q psy9535         518 ENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG  578 (593)
Q Consensus       518 ~~~~Gt~~y~aPE~~~~~-~-~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  578 (593)
                      ++.||+|.|.|||++.+. | +.++||||.|||||+.+++..|++|.+=-.-|.-+=.|.-+.
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~M  231 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEM  231 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccC
Confidence            567899999999998765 5 679999999999999999999999877665565565665443

>KOG0582|consensus

Probab=99.81  E-value=3.3e-20  Score=190.95  Aligned_cols=116  Identities=28%  Similarity=0.391  Sum_probs=97.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcccccc-ccccCCCCcccc
Q psy9535         451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT-ENLTGTRPYMPP  529 (593)
Q Consensus       451 ~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~-~~~~Gt~~y~aP  529 (593)
                      -+++.....|.+++++||.|||.  ++.||||||+.||||+.+|.+||+|||.+........+.... .+.+||++||||
T Consensus       122 Gl~E~~Ia~iLre~LkaL~YLH~--~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAP  199 (516)
T KOG0582|consen  122 GLEEASIATILREVLKALDYLHQ--NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAP  199 (516)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHh--cCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccCh
Confidence            49999999999999999999999  569999999999999999999999999976544333222222 567999999999


Q ss_pred             cccC---CcCCcccceecchhhhhcccccCCCccchhhhchh
Q psy9535         530 EAMH---CQISTKTDVFSYGAQIKTQHITNVDIADRERYYSL  568 (593)
Q Consensus       530 E~~~---~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~  568 (593)
                      |++.   .+|+.|+||||||++..+.-.++.|+-+..+---|
T Consensus       200 Evl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL  241 (516)
T KOG0582|consen  200 EVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL  241 (516)
T ss_pred             HHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH
Confidence            9952   35899999999999999988999999888765333

>KOG0193|consensus

Probab=99.81  E-value=1.2e-20  Score=200.56  Aligned_cols=124  Identities=29%  Similarity=0.486  Sum_probs=99.4

Q ss_pred             hhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcccccc
Q psy9535         438 CQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT  517 (593)
Q Consensus       438 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~  517 (593)
                      ..|+.++.+.+ ..|+..+.++|+.|||.||.|||.  +.|||||||+.||+|.+++++||+|||++.....-. .....
T Consensus       472 sSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~-g~~q~  547 (678)
T KOG0193|consen  472 SSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS-GEQQL  547 (678)
T ss_pred             chhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCcEEEecccceeeeeeec-ccccc
Confidence            46777776655 469999999999999999999998  779999999999999999999999999964321100 01112


Q ss_pred             ccccCCCCcccccccCC----cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         518 ENLTGTRPYMPPEAMHC----QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       518 ~~~~Gt~~y~aPE~~~~----~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ....|...|||||++..    .|+..|||||||+++||..+..+|.....+-
T Consensus       548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d  599 (678)
T KOG0193|consen  548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD  599 (678)
T ss_pred             CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh
Confidence            33457889999998843    4799999999999999988888888755544

>KOG0585|consensus

Probab=99.81  E-value=1.3e-20  Score=195.05  Aligned_cols=120  Identities=23%  Similarity=0.323  Sum_probs=96.7

Q ss_pred             CCC-CCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcc--ccccccccCCCC
Q psy9535         449 TPP-LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVK--TMYTENLTGTRP  525 (593)
Q Consensus       449 ~~~-l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~Gt~~  525 (593)
                      ..+ |++.++.+|++++..||+|||.  ++||||||||+|+||+.+|++||+|||.+-........  .......+|||.
T Consensus       203 d~~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPA  280 (576)
T KOG0585|consen  203 DKPELSEQQARKYLRDVVLGLEYLHY--QGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPA  280 (576)
T ss_pred             CcccccHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCcc
Confidence            344 8999999999999999999998  55999999999999999999999999997654222111  111223689999


Q ss_pred             cccccccCC---c-C-CcccceecchhhhhcccccCCCccchhhhchhhh
Q psy9535         526 YMPPEAMHC---Q-I-STKTDVFSYGAQIKTQHITNVDIADRERYYSLQT  570 (593)
Q Consensus       526 y~aPE~~~~---~-~-~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~  570 (593)
                      |||||.+..   . + +.+.||||+|||||+.+.+..|+.+..++.-++-
T Consensus       281 F~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K  330 (576)
T KOG0585|consen  281 FFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK  330 (576)
T ss_pred             ccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence            999998744   2 2 5678999999999999999999999877655443

>KOG0983|consensus

Probab=99.81  E-value=4.5e-20  Score=179.25  Aligned_cols=126  Identities=29%  Similarity=0.408  Sum_probs=99.0

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcc
Q psy9535         448 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYM  527 (593)
Q Consensus       448 ~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~  527 (593)
                      -.+|+++.-.-.+.+.+..||.||-+ .++|||||+||+|||+|..|.+|+||||++...-.+..    .+...|.+.||
T Consensus       184 ik~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA----htrsAGC~~YM  258 (391)
T KOG0983|consen  184 IKGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA----HTRSAGCAAYM  258 (391)
T ss_pred             hcCCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecccccceeecccc----cccccCCcccc
Confidence            35689999999999999999999975 36799999999999999999999999999864432211    12246899999


Q ss_pred             cccccCC----cCCcccceecchhhhhcccccCCCccchhhhc--------hhhhhcCCCCCC
Q psy9535         528 PPEAMHC----QISTKTDVFSYGAQIKTQHITNVDIADRERYY--------SLQTMLPGHHEG  578 (593)
Q Consensus       528 aPE~~~~----~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~  578 (593)
                      |||.+..    .|+.++||||||+++++..+...|.....--+        +.-|.|||+.-|
T Consensus       259 aPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gF  321 (391)
T KOG0983|consen  259 APERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGF  321 (391)
T ss_pred             CccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCc
Confidence            9998843    47889999999999999999988887632111        223677777654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=2.6e-20  Score=183.10  Aligned_cols=174  Identities=12%  Similarity=0.109  Sum_probs=123.3

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec--
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~--  189 (593)
                      +..++||.|+||.||.... ++..+|||.+.+......   .. ......-..|++|+..+.++.||+|.....+...  
T Consensus        34 ~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~---~~-~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         34 KTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTE---RF-LKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             EEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchH---HH-HHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            3457899999999999655 577899999865421110   00 0000001136899999999999999999887432  


Q ss_pred             -------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccE
Q psy9535         190 -------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  262 (593)
Q Consensus       190 -------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~K  262 (593)
                             ...+|||||++|.+|.+...       ++.    ....+++.+|..+|+  .+++|||+||+||+++.++ ++
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~--~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ--HGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH--cCCccCCCChHHEEEeCCC-EE
Confidence                   23689999999999987632       222    245699999999998  5699999999999999988 99


Q ss_pred             EeecccceecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHH
Q psy9535         263 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELL  318 (593)
Q Consensus       263 l~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~Ell  318 (593)
                      |+|||..+..........          |    ++...+..++|+||||+++.-..
T Consensus       175 liDfg~~~~~~e~~a~d~----------~----vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKAKDR----------I----DLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhhHHH----------H----HHHhHhcccccccceeEeehHHH
Confidence            999998764422111000          0    12334567899999999876543

>KOG0666|consensus

Probab=99.81  E-value=1.7e-20  Score=185.02  Aligned_cols=126  Identities=23%  Similarity=0.335  Sum_probs=102.3

Q ss_pred             CcceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCC----CceEEE
Q psy9535         424 GIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN----FVPKLG  499 (593)
Q Consensus       424 ~~~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~----~~~kl~  499 (593)
                      ..-++++||.|...-.....-+......++...+.+|+.||+.|+.|||+..  |+||||||+|||+..+    |.+||+
T Consensus       101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEee
Confidence            3446889999888776666655555567999999999999999999999955  9999999999999776    899999


Q ss_pred             ecccceecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhc
Q psy9535         500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKT  551 (593)
Q Consensus       500 DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~  551 (593)
                      |||+++.....-........++-|.+|.|||.+.+  .|+.+.||||.||++-+
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaE  232 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAE  232 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHH
Confidence            99999976544332223345677999999998755  47889999999998865

>KOG0984|consensus

Probab=99.81  E-value=3.1e-20  Score=173.92  Aligned_cols=129  Identities=29%  Similarity=0.393  Sum_probs=99.0

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      +|.++.-.+....++...... ++..++.-.-+|+..+..||.|||+. -.+||||+||+||||+..|++|+||||++..
T Consensus       121 wIcME~M~tSldkfy~~v~~~-g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  121 WICMELMDTSLDKFYRKVLKK-GGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISGY  198 (282)
T ss_pred             EEeHHHhhhhHHHHHHHHHhc-CCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEccccccee
Confidence            455555555555565554433 45688999999999999999999973 4599999999999999999999999999876


Q ss_pred             cccCCccccccccccCCCCcccccccCC-----cCCcccceecchhhhhcccccCCCccc
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      ...+-.    .+.-.|..+|||||.+..     +|+.||||||+|+++.+.-+.-+|-+.
T Consensus       199 L~dSiA----kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  199 LVDSIA----KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             ehhhhH----HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            543322    222358889999998743     478899999999999886666666544

>KOG0660|consensus

Probab=99.80  E-value=2.9e-20  Score=187.62  Aligned_cols=130  Identities=22%  Similarity=0.424  Sum_probs=100.6

Q ss_pred             chhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcc
Q psy9535         434 ETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVK  513 (593)
Q Consensus       434 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~  513 (593)
                      |...++|.+.++.+  ..|+......+++|+++||.|+|+.+  |+||||||+|+|++.+-.+||+|||+|+..... ..
T Consensus       106 elMetDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-~~  180 (359)
T KOG0660|consen  106 ELMETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-FE  180 (359)
T ss_pred             hHHhhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeecccc-Cc
Confidence            55566777776643  34999999999999999999999955  999999999999999999999999999976532 11


Q ss_pred             ccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeE
Q psy9535         514 TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV  581 (593)
Q Consensus       514 ~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (593)
                      ....+..+.|.||.|||++..  .|+.+.||||.||++.+             .++=.++|||...++|.
T Consensus       181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AE-------------mL~gkplFpG~d~v~Ql  237 (359)
T KOG0660|consen  181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAE-------------MLTGKPLFPGKDYVHQL  237 (359)
T ss_pred             ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHH-------------HHcCCCCCCCCchHHHH
Confidence            222233567999999998633  48889999999999986             44445566666655553

>KOG0986|consensus

Probab=99.80  E-value=2.3e-20  Score=192.05  Aligned_cols=114  Identities=24%  Similarity=0.339  Sum_probs=93.5

Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCC
Q psy9535         446 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP  525 (593)
Q Consensus       446 ~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~  525 (593)
                      ..+.+.+++...+.++.+|+.||++||.  ..|++|||||+|||||+.|+++|+|+|+|.......    .....+||.+
T Consensus       278 n~g~~gF~e~ra~FYAAEi~cGLehlH~--~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~----~~~~rvGT~G  351 (591)
T KOG0986|consen  278 NHGNPGFDEQRARFYAAEIICGLEHLHR--RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK----PIRGRVGTVG  351 (591)
T ss_pred             ccCCCCCchHHHHHHHHHHHhhHHHHHh--cceeeccCChhheeeccCCCeEeeccceEEecCCCC----ccccccCccc
Confidence            3345679999999999999999999998  669999999999999999999999999987544322    1233589999


Q ss_pred             cccccccCC-cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         526 YMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       526 y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      |||||++.+ .|+...|+||+||.||+-.-++-|+..+-++
T Consensus       352 YMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK  392 (591)
T KOG0986|consen  352 YMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK  392 (591)
T ss_pred             ccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence            999999865 4888999999999999955555555555444

>KOG0578|consensus

Probab=99.80  E-value=9.3e-20  Score=193.01  Aligned_cols=117  Identities=26%  Similarity=0.389  Sum_probs=93.3

Q ss_pred             cceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccc
Q psy9535         425 IPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  504 (593)
Q Consensus       425 ~~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~  504 (593)
                      ..|+++++-+.+.  |-....   .-.+++.+...|+++++.||+|||.  ++|||||||..||||+.+|.+||+||||+
T Consensus       344 eLWVVMEym~ggs--LTDvVt---~~~~~E~qIA~Icre~l~aL~fLH~--~gIiHrDIKSDnILL~~~g~vKltDFGFc  416 (550)
T KOG0578|consen  344 ELWVVMEYMEGGS--LTDVVT---KTRMTEGQIAAICREILQGLKFLHA--RGIIHRDIKSDNILLTMDGSVKLTDFGFC  416 (550)
T ss_pred             eeEEEEeecCCCc--hhhhhh---cccccHHHHHHHHHHHHHHHHHHHh--cceeeeccccceeEeccCCcEEEeeeeee
Confidence            3577777765543  333322   2358999999999999999999998  66999999999999999999999999998


Q ss_pred             eecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhc
Q psy9535         505 KMSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKT  551 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~  551 (593)
                      .......   ....+.+|||+|||||++. ..|++|+||||||+...+
T Consensus       417 aqi~~~~---~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIE  461 (550)
T KOG0578|consen  417 AQISEEQ---SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIE  461 (550)
T ss_pred             ecccccc---CccccccCCCCccchhhhhhcccCccccchhhhhHHHH
Confidence            7544322   1334578999999999885 468999999999977654

>KOG0197|consensus

Probab=99.80  E-value=5.2e-20  Score=194.26  Aligned_cols=110  Identities=31%  Similarity=0.506  Sum_probs=90.0

Q ss_pred             hhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcccccc
Q psy9535         438 CQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT  517 (593)
Q Consensus       438 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~  517 (593)
                      +.|..+++..++..+...+.+.++.|||+||+||.+  +++|||||.++|||++++..+||+|||++|....+..    +
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes--~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y----~  359 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES--KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY----T  359 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh--CCccchhhhhhheeeccCceEEEcccccccccCCCce----e
Confidence            567777777667789999999999999999999998  6699999999999999999999999999995433221    1


Q ss_pred             ccccC--CCCccccccc-CCcCCcccceecchhhhhccc
Q psy9535         518 ENLTG--TRPYMPPEAM-HCQISTKTDVFSYGAQIKTQH  553 (593)
Q Consensus       518 ~~~~G--t~~y~aPE~~-~~~~~~ksDvwS~G~~i~~~~  553 (593)
                      ....|  ...|+|||.+ .+.++.|||||||||+|++..
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~f  398 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELF  398 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHh
Confidence            11112  2359999987 556999999999999999744

>KOG4721|consensus

Probab=99.79  E-value=5.7e-20  Score=193.07  Aligned_cols=126  Identities=29%  Similarity=0.483  Sum_probs=99.2

Q ss_pred             cceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccc
Q psy9535         425 IPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  504 (593)
Q Consensus       425 ~~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~  504 (593)
                      +-+|++++-.  ++.|+..++..  .++......+|..+||.||.|||.  +.|||||||+.||||..+..+||+|||-+
T Consensus       186 cyCIiMEfCa--~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~--hKIIHRDLKSPNiLIs~~d~VKIsDFGTS  259 (904)
T KOG4721|consen  186 CYCIIMEFCA--QGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHL--HKIIHRDLKSPNILISYDDVVKISDFGTS  259 (904)
T ss_pred             eeEEeeeccc--cccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHH--hhHhhhccCCCceEeeccceEEeccccch
Confidence            3467776533  34666666643  478889999999999999999998  55999999999999999999999999998


Q ss_pred             eecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCcc
Q psy9535         505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIA  560 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~  560 (593)
                      +........    -.++||..|||||++.++ .+.|+|||||||+|.+.++.-+|-.
T Consensus       260 ~e~~~~STk----MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYk  312 (904)
T KOG4721|consen  260 KELSDKSTK----MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYK  312 (904)
T ss_pred             Hhhhhhhhh----hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcc
Confidence            753322111    136899999999999765 6899999999999998555544443

>KOG0032|consensus

Probab=99.79  E-value=1.6e-19  Score=191.44  Aligned_cols=142  Identities=24%  Similarity=0.314  Sum_probs=124.1

Q ss_pred             hhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC----CCceEEEecccceecccCCcc
Q psy9535         438 CQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE----NFVPKLGDFGIVKMSETSNVK  513 (593)
Q Consensus       438 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~----~~~~kl~DfG~~~~~~~~~~~  513 (593)
                      +.||..+...  . +++..+..++.|++.|+.|||+  .+|+||||||+|+|+..    ++.+|++|||++......   
T Consensus       121 GeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~---  192 (382)
T KOG0032|consen  121 GELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG---  192 (382)
T ss_pred             chHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC---
Confidence            4666665544  2 9999999999999999999999  55999999999999953    358999999999875541   


Q ss_pred             ccccccccCCCCcccccccC-CcCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeEEEeeccC
Q psy9535         514 TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVSISNHST  588 (593)
Q Consensus       514 ~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (593)
                       ......+||+.|+|||++. ..++.++||||+||++|..+....|+++..+...+...+.|..+|+..+|+++|.
T Consensus       193 -~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  193 -ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             -ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence             1245678999999999987 5789999999999999999999999999999999999999999999999999975

>KOG0658|consensus

Probab=99.79  E-value=5.3e-20  Score=186.03  Aligned_cols=112  Identities=28%  Similarity=0.393  Sum_probs=90.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCC-CceEEEecccceecccCCccccccccccCCCCccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMP  528 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~a  528 (593)
                      ..++.-...-++.|+.+||+|||+  .+|.||||||.|+|+|.+ |.+||||||.|+..........    ...|.+|.|
T Consensus       120 ~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniS----YicSRyYRa  193 (364)
T KOG0658|consen  120 QRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNIS----YICSRYYRA  193 (364)
T ss_pred             CCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCcee----EEEeccccC
Confidence            457777777899999999999999  669999999999999965 9999999999987654332221    235889999


Q ss_pred             ccccCC--cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCe
Q psy9535         529 PEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDH  580 (593)
Q Consensus       529 PE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (593)
                      ||.+.+  .|+.+.||||.||++.|             .+-=|++|||....||
T Consensus       194 PELifga~~Yt~~IDiWSaGCV~aE-------------Ll~g~plFpG~s~~dQ  234 (364)
T KOG0658|consen  194 PELIFGATEYTTSIDIWSAGCVMAE-------------LLKGQPLFPGDSSVDQ  234 (364)
T ss_pred             HHHHcCccccCceeEEhhhhHHHHH-------------HhcCCcccCCCCHHHH
Confidence            998755  58999999999999986             3444668888776665

>KOG1165|consensus

Probab=99.78  E-value=3.2e-18  Score=170.48  Aligned_cols=196  Identities=26%  Similarity=0.375  Sum_probs=152.3

Q ss_pred             CCCCCcccccCceEEEEEE-EcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEe
Q psy9535         111 PRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCN  188 (593)
Q Consensus       111 ~~~~~~LG~G~fG~Vy~g~-~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~  188 (593)
                      +++|++||+|+||+.+.|+ +-+++.||||.=...   +.       +     -++..|....+.|. -+.|...+-+-.
T Consensus        30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~-------A-----PQLrdEYr~YKlL~g~~GIP~vYYFGq   94 (449)
T KOG1165|consen   30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SE-------A-----PQLRDEYRTYKLLGGTEGIPQVYYFGQ   94 (449)
T ss_pred             ceeccccccCcceeeecccccccCceEEEEecccc---CC-------c-----chHHHHHHHHHHHcCCCCCCceeeecc
Confidence            4679999999999999997 457899999963211   11       1     03456776666664 578887776555


Q ss_pred             cc-cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC-----CCccE
Q psy9535         189 NI-MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPK  262 (593)
Q Consensus       189 ~~-~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~-----~~~~K  262 (593)
                      .+ .+.||+|.+ |-||.|++.-.+  ..++.....-||.|++.-++|+|+  +..|.|||||+|+||..     ...+.
T Consensus        95 eG~~NiLVidLL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~--k~LIYRDIKPdNFLIGrp~~k~~n~Ih  169 (449)
T KOG1165|consen   95 EGKYNILVIDLL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHE--KDLIYRDIKPDNFLIGRPGTKDANVIH  169 (449)
T ss_pred             ccchhhhhhhhh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHh--cceeecccCccceeecCCCCCCCceEE
Confidence            53 457899976 779988887554  358899999999999999999998  66999999999999964     34678


Q ss_pred             EeecccceecccCCCcce----eeccccCCCCcCCccc-ccCCCCCcchhhHHHHHHHHHHhCCCCCCC
Q psy9535         263 LGDFGIVKMSETSNMKTM----YTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDD  326 (593)
Q Consensus       263 l~DFGla~~~~~~~~~~~----~~~~~~GT~~Y~APE~-~~~~~~~ksDVwSfGvvl~ElltG~~P~~~  326 (593)
                      |.|||+|+...+......    ...+..||..||+--. +....+.+-|.=|+|-++...|.|..||.+
T Consensus       170 iiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG  238 (449)
T KOG1165|consen  170 IIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG  238 (449)
T ss_pred             EEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence            999999998765543222    1235689999999884 455678889999999999999999999986

>KOG0597|consensus

Probab=99.78  E-value=3e-19  Score=187.89  Aligned_cols=120  Identities=31%  Similarity=0.460  Sum_probs=99.1

Q ss_pred             hhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcccc
Q psy9535         436 KQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM  515 (593)
Q Consensus       436 ~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~  515 (593)
                      ..+.|+..+...  +.|+++++..++.++..||.|||+  .+|+|||+||.||||+..+.+|+||||+++.+...   ..
T Consensus        83 a~g~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs--~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~---t~  155 (808)
T KOG0597|consen   83 AVGDLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHS--NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN---TS  155 (808)
T ss_pred             hhhhHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh--cCcccccCCcceeeecCCCceeechhhhhhhcccC---ce
Confidence            345777777654  469999999999999999999999  55999999999999999999999999999976542   22


Q ss_pred             ccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccch
Q psy9535         516 YTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       516 ~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      ......|||.|||||.+.++ |+..+|.||+||++|+.-.+-+|+-.+
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~  203 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR  203 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence            23456899999999988765 788999999999999866665555443

>KOG0611|consensus

Probab=99.78  E-value=3.1e-19  Score=181.14  Aligned_cols=128  Identities=23%  Similarity=0.442  Sum_probs=106.8

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      +|+++|...  +.|+.++-.  .+.|+++....+++||.+|+.|||+  .+++|||||.+|||||.++.+||+|||++-.
T Consensus       129 vivMEYaS~--GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHk--nrVvHRDLKLENILLD~N~NiKIADFGLSNl  202 (668)
T KOG0611|consen  129 VIVMEYASG--GELYDYISE--RGSLSEREARHFFRQIVSAVHYCHK--NRVVHRDLKLENILLDQNNNIKIADFGLSNL  202 (668)
T ss_pred             EEEEEecCC--ccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhh--ccceecccchhheeecCCCCeeeeccchhhh
Confidence            677776543  567777653  4579999999999999999999998  5699999999999999999999999999865


Q ss_pred             cccCCccccccccccCCCCcccccccCCc-C-CcccceecchhhhhcccccCCCccchhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~-~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      .....    ...++||+|-|.+||++++. | .+.+|-||+||+||+.+-+..|++++.-
T Consensus       203 y~~~k----fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh  258 (668)
T KOG0611|consen  203 YADKK----FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH  258 (668)
T ss_pred             hcccc----HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH
Confidence            54322    23568999999999999875 4 6789999999999999988888877643

>KOG1163|consensus

Probab=99.78  E-value=7e-19  Score=168.31  Aligned_cols=196  Identities=24%  Similarity=0.315  Sum_probs=148.3

Q ss_pred             CCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCC-CceeeEEEEEec
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH-VNLLRLLGLCNN  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~H-pNIv~l~g~~~~  189 (593)
                      ++.++||.|+||.+|.|.. .+|.+||||.=+......               +...|..+...|+| .-|..+.-+..+
T Consensus        18 ~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp---------------qL~yEskvY~iL~~g~GiP~i~~y~~e   82 (341)
T KOG1163|consen   18 KLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP---------------QLLYESKVYRILQGGVGIPHIRHYGTE   82 (341)
T ss_pred             EEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc---------------chhHHHHHHHHhccCCCCchhhhhccc
Confidence            4467999999999999974 679999999754332111               24567777777776 455555555544


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC---CCccEEee
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGD  265 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~---~~~~Kl~D  265 (593)
                       ....+|||.+ |-||.+++.-..  ..++..+.+-++-|++.-++|+|.  +++|||||||+|+|..-   ...+-++|
T Consensus        83 ~~ynvlVMdLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~--r~fiHRDIKPdNFLMGlgrh~~kl~LID  157 (341)
T KOG1163|consen   83 KDYNVLVMDLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHL--RNFIHRDIKPDNFLMGLGRHCNKLYLID  157 (341)
T ss_pred             cccceeeeecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHh--hccccccCCccceeeccccccceEEEEe
Confidence             5668999986 779988876543  357888999999999999999998  56999999999999864   34678999


Q ss_pred             cccceecccCCCcce----eeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCC
Q psy9535         266 FGIVKMSETSNMKTM----YTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDN  327 (593)
Q Consensus       266 FGla~~~~~~~~~~~----~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~  327 (593)
                      ||||+...+......    ......||..|.+--+..+ ..+.+-|+=|+|.+|..+..|..||.+-
T Consensus       158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence            999987544322111    1234679999998775543 4577889999999999999999999873

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=1.2e-18  Score=170.39  Aligned_cols=131  Identities=14%  Similarity=0.227  Sum_probs=98.5

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-----CCCceeeEEEEEe
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-----KHVNLLRLLGLCN  188 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-----~HpNIv~l~g~~~  188 (593)
                      ...||+|+||.||. .-.++.. +||++.....   .   .       ...+.+|+.+++++     .||||++++|++.
T Consensus         7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~---~---~-------~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~e   71 (210)
T PRK10345          7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD---G---G-------DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVE   71 (210)
T ss_pred             cceecCCCceEEEE-CCCCcCe-EEEEEecccc---c---h-------HHHHHHHHHHHHHhhccCCCCcccceeeEEEE
Confidence            46899999999996 2233444 6888754311   0   0       11478999999999     6799999999987


Q ss_pred             ccc----ce-EEEEe--ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCeEecccCCCCeeecC---
Q psy9535         189 NIM----NC-IVYEY--MCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL-HYLHSLSKPIIHRDVKSANVLLDE---  257 (593)
Q Consensus       189 ~~~----~~-lV~Ey--~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~IiHrDLKp~NILl~~---  257 (593)
                      ++.    .+ +|+||  +.+|+|.+++.+.    .+++.  ..++.+++.++ +|||+  .+|+||||||+|||++.   
T Consensus        72 t~~g~g~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~--~~IvhrDlKp~NILl~~~~~  143 (210)
T PRK10345         72 TDCGTGYVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLD--NRIVTMELKPQNILCQRISE  143 (210)
T ss_pred             eCCCCeEEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEeccCC
Confidence            642    22 78999  6689999999652    25554  35678888888 99998  56999999999999974   


Q ss_pred             -CCccEEeecc
Q psy9535         258 -NFVPKLGDFG  267 (593)
Q Consensus       258 -~~~~Kl~DFG  267 (593)
                       ++.++|+||+
T Consensus       144 ~~~~~~LiDg~  154 (210)
T PRK10345        144 SEVIPVVCDNI  154 (210)
T ss_pred             CCCcEEEEECC
Confidence             3489999954

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.77  E-value=4.7e-19  Score=181.43  Aligned_cols=131  Identities=20%  Similarity=0.296  Sum_probs=102.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++..   ..+..++.......+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~---~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          84 LTLVFEHVD---QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             EEEEEccCC---CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            345555443   345555555445568999999999999999999998  669999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      .....    .......||+.|+|||++.+ .++.++|||||||++|+..+...|+.+....
T Consensus       159 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~  215 (290)
T cd07862         159 IYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV  215 (290)
T ss_pred             eccCC----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH
Confidence            54322    11234568999999998744 5788999999999999887777777665443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.77  E-value=4.7e-19  Score=188.24  Aligned_cols=140  Identities=20%  Similarity=0.250  Sum_probs=104.9

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  +.|..++..  .+++++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~lv~E~~~g--g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFGla~~  150 (363)
T cd05628          77 YLIMEFLPG--GDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG  150 (363)
T ss_pred             EEEEcCCCC--CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence            456665432  355555543  3579999999999999999999998  6699999999999999999999999999864


Q ss_pred             cccCCcc--------------------------------ccccccccCCCCcccccccCC-cCCcccceecchhhhhccc
Q psy9535         507 SETSNVK--------------------------------TMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQH  553 (593)
Q Consensus       507 ~~~~~~~--------------------------------~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~  553 (593)
                      .......                                .......+||+.|+|||++.+ .++.++|||||||++|+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence            3211000                                000123479999999998754 4788999999999999999


Q ss_pred             ccCCCccchhhhchhhhhc
Q psy9535         554 ITNVDIADRERYYSLQTML  572 (593)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~  572 (593)
                      ++..|+.+......++.+.
T Consensus       231 ~G~~Pf~~~~~~~~~~~i~  249 (363)
T cd05628         231 IGYPPFCSETPQETYKKVM  249 (363)
T ss_pred             hCCCCCCCCCHHHHHHHHH
Confidence            9888987655444444333

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.77  E-value=6.6e-19  Score=184.07  Aligned_cols=142  Identities=19%  Similarity=0.296  Sum_probs=107.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..|+..+..  .+.+++.+...++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~lv~e~~~~--~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DfG~a~  143 (323)
T cd05571          70 LCFVMEYANG--GELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCK  143 (323)
T ss_pred             EEEEEeCCCC--CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            3566665433  345555443  3478999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHH  576 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  576 (593)
                      ......   ......+||+.|+|||++.+ .++.++|||||||++|+..++..|+.+......++.+..+..
T Consensus       144 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  212 (323)
T cd05571         144 EGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI  212 (323)
T ss_pred             ccccCC---CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC
Confidence            432111   11233579999999998754 478899999999999998888888876655544555554443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG2345|consensus

Probab=99.77  E-value=5.4e-19  Score=169.85  Aligned_cols=110  Identities=26%  Similarity=0.379  Sum_probs=84.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccc------cccccccC
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKT------MYTENLTG  522 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~------~~~~~~~G  522 (593)
                      +.-+++.+.+.|+.++++||++||+..++++||||||.|||+.+.+.+++.|||.+......-...      ..+..-..
T Consensus       121 g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~C  200 (302)
T KOG2345|consen  121 GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERC  200 (302)
T ss_pred             CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhC
Confidence            346999999999999999999999977789999999999999999999999999865432111000      01111234


Q ss_pred             CCCcccccccCCc----CCcccceecchhhhhcccccCCC
Q psy9535         523 TRPYMPPEAMHCQ----ISTKTDVFSYGAQIKTQHITNVD  558 (593)
Q Consensus       523 t~~y~aPE~~~~~----~~~ksDvwS~G~~i~~~~~~~~~  558 (593)
                      |.+|.|||.+..+    ++.++|||||||++|+..-..=|
T Consensus       201 t~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sP  240 (302)
T KOG2345|consen  201 TIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESP  240 (302)
T ss_pred             CCcccCchheecccCcccccccchhhhhHHHHHHHHcCCc
Confidence            8899999987543    58899999999999984433333

>KOG0589|consensus

Probab=99.77  E-value=3.1e-19  Score=187.70  Aligned_cols=121  Identities=26%  Similarity=0.443  Sum_probs=99.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..|+++|-+.  +++.+.+...++.-+++++...++.|++.|++|||+  ..|+|||||++||+++.+..+||+|||+++
T Consensus        79 l~Ivm~Y~eG--g~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDfGlaK  154 (426)
T KOG0589|consen   79 LCIVMEYCEG--GDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDFGLAK  154 (426)
T ss_pred             EEEEEeecCC--CCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecchhhhh
Confidence            4566666444  345555544456679999999999999999999997  669999999999999999999999999999


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhccc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQH  553 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~  553 (593)
                      ......   ....+.+||+.||.||++.+ .|..|+|||||||++|+..
T Consensus       155 ~l~~~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~  200 (426)
T KOG0589|consen  155 ILNPED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMC  200 (426)
T ss_pred             hcCCch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHH
Confidence            765432   23456789999999999866 5899999999999999643

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.77  E-value=8.8e-19  Score=183.01  Aligned_cols=139  Identities=22%  Similarity=0.311  Sum_probs=106.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  +.|...+...  ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~lv~E~~~~--g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          77 YFVMEYVNG--GDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEcCCCC--CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence            456665432  3555554432  468999999999999999999998  5699999999999999999999999999874


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~  574 (593)
                      .....   ......+||+.|+|||++.+ .++.++|||||||++|+..+...|+.+......++.+..+
T Consensus       151 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~  216 (323)
T cd05616         151 NMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH  216 (323)
T ss_pred             cCCCC---CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            32211   11234579999999998755 4788999999999999988888888766555444444443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.76  E-value=1.2e-18  Score=183.75  Aligned_cols=140  Identities=26%  Similarity=0.327  Sum_probs=111.0

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-..  +.|..++...  ..+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus       106 ~~lv~Ey~~~--g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG~a~  179 (340)
T PTZ00426        106 LYLVLEFVIG--GEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGFAK  179 (340)
T ss_pred             EEEEEeCCCC--CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence            4566665432  3555555433  468999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHE  577 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  577 (593)
                      .....      .....||+.|||||++.+ .++.++|||||||++|+..++..|+.+.......+.+..|...
T Consensus       180 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~  246 (340)
T PTZ00426        180 VVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY  246 (340)
T ss_pred             ecCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Confidence            54321      123579999999998755 4688999999999999999998999887776666667666543

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.76  E-value=1.2e-18  Score=178.58  Aligned_cols=129  Identities=21%  Similarity=0.271  Sum_probs=99.4

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      ++++++-..  +.+...+.......+++.++..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||++..
T Consensus        76 ~lv~e~~~~--g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  151 (285)
T cd05631          76 CLVLTIMNG--GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQ  151 (285)
T ss_pred             EEEEEecCC--CcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence            455554322  334334333334568999999999999999999998  6699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      .....    ......||+.|||||++.+ .++.++|||||||++|+..+...|+....
T Consensus       152 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  205 (285)
T cd05631         152 IPEGE----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK  205 (285)
T ss_pred             cCCCC----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence            43211    1123468999999998754 57889999999999999888888876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.76  E-value=1.3e-18  Score=185.75  Aligned_cols=141  Identities=18%  Similarity=0.223  Sum_probs=103.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|..++..  .+.+++.....++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||++.
T Consensus        76 ~~lv~E~~~~--g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ikL~DFG~a~  149 (376)
T cd05598          76 LYFVMDYIPG--GDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (376)
T ss_pred             EEEEEeCCCC--CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence            4566665332  355555543  3468899999999999999999998  569999999999999999999999999864


Q ss_pred             ecccCCc----------------------------------------cccccccccCCCCcccccccCC-cCCcccceec
Q psy9535         506 MSETSNV----------------------------------------KTMYTENLTGTRPYMPPEAMHC-QISTKTDVFS  544 (593)
Q Consensus       506 ~~~~~~~----------------------------------------~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS  544 (593)
                      .......                                        ........+||+.|||||++.+ .++.++||||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  229 (376)
T cd05598         150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  229 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence            2110000                                        0000123479999999998755 4788999999


Q ss_pred             chhhhhcccccCCCccchhhhchhhhhc
Q psy9535         545 YGAQIKTQHITNVDIADRERYYSLQTML  572 (593)
Q Consensus       545 ~G~~i~~~~~~~~~~~~~~~~~~~~~~~  572 (593)
                      |||++|+..++..|+.+.........+.
T Consensus       230 lGvilyell~G~~Pf~~~~~~~~~~~i~  257 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPAETQLKVI  257 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHHHHHHHHh
Confidence            9999999888888887666543333333

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.76  E-value=1.7e-18  Score=180.07  Aligned_cols=141  Identities=22%  Similarity=0.252  Sum_probs=107.2

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+  ...|+..+..  .+.+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        69 ~lv~e~~~--~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~  142 (312)
T cd05585          69 YLVLAFIN--GGELFHHLQR--EGRFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKL  142 (312)
T ss_pred             EEEEcCCC--CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence            45555432  2355555543  3468999999999999999999998  6699999999999999999999999999874


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHH  576 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  576 (593)
                      .....   ......+||+.|+|||++.+ .++.++|||||||++|+..+...|+.+......++..+.+..
T Consensus       143 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~  210 (312)
T cd05585         143 NMKDD---DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL  210 (312)
T ss_pred             CccCC---CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC
Confidence            32211   12234579999999998755 478899999999999998888888876555544555554443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0604|consensus

Probab=99.76  E-value=1.6e-18  Score=170.43  Aligned_cols=151  Identities=25%  Similarity=0.281  Sum_probs=113.2

Q ss_pred             cCcceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC---CCceEEE
Q psy9535         423 TGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLG  499 (593)
Q Consensus       423 ~~~~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~---~~~~kl~  499 (593)
                      ..+..|+++.-|.  +.||..++..+..+++++++-.|+.||+.|++|||+  ..|.||||||+|+|-..   +-.+||+
T Consensus       131 rkcLLiVmE~meG--GeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~--~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  131 RKCLLIVMECMEG--GELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS--MNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             ceeeEeeeecccc--hHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh--cchhhccCChhheeeecCCCCcceEec
Confidence            4455677765443  688988888888899999999999999999999999  55999999999999854   5589999


Q ss_pred             ecccceecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhchhhh--------
Q psy9535         500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQT--------  570 (593)
Q Consensus       500 DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~--------  570 (593)
                      |||+++......  .  ..+.+-||+|.|||++..+ |+...|+||+||++|..+-+-+|+      ||-+-        
T Consensus       207 DfGFAK~t~~~~--~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPF------YS~hg~aispgMk  276 (400)
T KOG0604|consen  207 DFGFAKETQEPG--D--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF------YSNHGLAISPGMK  276 (400)
T ss_pred             ccccccccCCCc--c--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcc------cccCCccCChhHH
Confidence            999998644221  1  2335669999999998654 666789999999999755444443      33221        


Q ss_pred             --hcCCCCCCCeEEEeecc
Q psy9535         571 --MLPGHHEGDHVSISNHS  587 (593)
Q Consensus       571 --~~~~~~~~~~~~~~~~~  587 (593)
                        .--|.-+|-+--|++.|
T Consensus       277 ~rI~~gqy~FP~pEWs~VS  295 (400)
T KOG0604|consen  277 RRIRTGQYEFPEPEWSCVS  295 (400)
T ss_pred             hHhhccCccCCChhHhHHH
Confidence              12356666666676665

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.76  E-value=2.1e-18  Score=180.72  Aligned_cols=140  Identities=21%  Similarity=0.308  Sum_probs=104.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ..++..+..  ...+++.++..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~lv~Ey~~~--g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DfG~~~  143 (328)
T cd05593          70 LCFVMEYVNG--GELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCK  143 (328)
T ss_pred             EEEEEeCCCC--CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeEECCCCcEEEecCcCCc
Confidence            3566665433  344444433  3468999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ......   ......+||+.|+|||++.+ .++.++|||||||++|+..++..|+.+......++..+.+
T Consensus       144 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~  210 (328)
T cd05593         144 EGITDA---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME  210 (328)
T ss_pred             cCCCcc---cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC
Confidence            432111   11223579999999998754 4788999999999999988888887654433333333333

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.75  E-value=1.2e-18  Score=185.87  Aligned_cols=139  Identities=22%  Similarity=0.280  Sum_probs=105.3

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.  +.|..++..   ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       119 ~lv~Ey~~g--g~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         119 YMVMEYMPG--GDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             EEEEcCCCC--CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            456654332  344444432   347888899999999999999998  6699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCCc-----CCcccceecchhhhhcccccCCCccchhhhchhhhhcCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-----~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ......  ......+||+.|||||++...     ++.++|||||||++|+..+...|+......-.+..+..+
T Consensus       192 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~  262 (371)
T cd05622         192 MNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH  262 (371)
T ss_pred             cCcCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            432211  112345799999999987432     678999999999999999888998877665555555443

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG1006|consensus

Probab=99.75  E-value=1.9e-19  Score=174.28  Aligned_cols=133  Identities=29%  Similarity=0.377  Sum_probs=102.7

Q ss_pred             EeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceec
Q psy9535         428 IILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  507 (593)
Q Consensus       428 ~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~  507 (593)
                      |-++--......+++.........+++.-.-.|..-+..||+||-+ ...|||||+||+||||+..|.+||||||++...
T Consensus       140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            3333334445566766665555678898888999999999999964 244999999999999999999999999998654


Q ss_pred             ccCCccccccccccCCCCcccccccCC---cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         508 ETSNVKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       508 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ..+-    ..+.-+|..+|||||.+..   +|+.+|||||+|+|||+.-++.+|-+.-...
T Consensus       219 v~Si----AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv  275 (361)
T KOG1006|consen  219 VDSI----AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV  275 (361)
T ss_pred             HHHH----HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH
Confidence            3221    1222468999999998843   4788999999999999999999998765543

>KOG0577|consensus

Probab=99.75  E-value=5.2e-19  Score=186.63  Aligned_cols=109  Identities=34%  Similarity=0.554  Sum_probs=90.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCccc
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMP  528 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~a  528 (593)
                      ..||.+.....|+.+++.||+|||+  .+.||||||+.||||.+.|.+||+|||.+.+...       ...++|||+|||
T Consensus       120 kKplqEvEIAAi~~gaL~gLaYLHS--~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-------AnsFvGTPywMA  190 (948)
T KOG0577|consen  120 KKPLQEVEIAAITHGALQGLAYLHS--HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-------ANSFVGTPYWMA  190 (948)
T ss_pred             hccchHHHHHHHHHHHHHHHHHHHH--hhHHhhhccccceEecCCCeeeeccccchhhcCc-------hhcccCCccccc
Confidence            3579999999999999999999999  5599999999999999999999999998765332       345799999999


Q ss_pred             cccc----CCcCCcccceecchhhhhcccccCCCccchhhh-chhhhhcC
Q psy9535         529 PEAM----HCQISTKTDVFSYGAQIKTQHITNVDIADRERY-YSLQTMLP  573 (593)
Q Consensus       529 PE~~----~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~-~~~~~~~~  573 (593)
                      ||++    .++|+.|+||||+|+|+.       +++.+-++ |+.+-|-+
T Consensus       191 PEVILAMDEGqYdgkvDvWSLGITCI-------ELAERkPPlFnMNAMSA  233 (948)
T KOG0577|consen  191 PEVILAMDEGQYDGKVDVWSLGITCI-------ELAERKPPLFNMNAMSA  233 (948)
T ss_pred             hhHheeccccccCCccceeeccchhh-------hhhhcCCCccCchHHHH
Confidence            9986    357999999999997764       46666555 66665543

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.75  E-value=1.3e-18  Score=185.64  Aligned_cols=138  Identities=22%  Similarity=0.290  Sum_probs=103.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ..|..++..   ..+++.....++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       118 ~~lv~Ey~~g--g~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         118 LYMVMEYMPG--GDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEcCCCC--CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEEecccce
Confidence            3456654322  345554432   258889999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCCc-----CCcccceecchhhhhcccccCCCccchhhhchhhhhc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTML  572 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-----~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~  572 (593)
                      .......  ......+||+.|||||++...     ++.++||||+||++|+..++..|+......-.+....
T Consensus       191 ~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~  260 (370)
T cd05621         191 KMDETGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM  260 (370)
T ss_pred             ecccCCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            5432211  112345799999999987432     5789999999999999888888887665443444443

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>smart00090 RIO RIO-like kinase

Probab=99.75  E-value=4.8e-18  Score=169.69  Aligned_cols=152  Identities=16%  Similarity=0.158  Sum_probs=108.8

Q ss_pred             CCCCcccccCceEEEEEE--EcCCCEEEEEEeecCCCCCCCC------Cch-----hHHhhhcHHHHHHHHHHHhcCCCC
Q psy9535         112 RRGNKLGEGQFGTVYYGK--LKNGMEIAVKTLENNANYSSSN------SDN-----TEAAMIPILLFENEVQTLSQCKHV  178 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~--~~~g~~vAVK~l~~~~~~~~~~------~~~-----~~~~~~~~~~f~~Ev~il~~l~Hp  178 (593)
                      ++.+.||+|+||.||+|.  ..+|+.||||++..........      ...     ..........+.+|+.++.++.+.
T Consensus        31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~  110 (237)
T smart00090       31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA  110 (237)
T ss_pred             HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            456889999999999998  4689999999987542110000      000     000000112467899999999763


Q ss_pred             --ceeeEEEEEecccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-eEecccCCCCeee
Q psy9535         179 --NLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLL  255 (593)
Q Consensus       179 --NIv~l~g~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-IiHrDLKp~NILl  255 (593)
                        .+.+.+++   ...++||||+.+++|...+..   ..++.......++.|++.+|.|||+  .+ |+||||||+|||+
T Consensus       111 ~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~--~g~iiH~Dikp~NIli  182 (237)
T smart00090      111 GVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYK--EGELVHGDLSEYNILV  182 (237)
T ss_pred             CCCCCeeeEe---cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHh--cCCEEeCCCChhhEEE
Confidence              23444443   345899999999888765422   1245566677899999999999998  67 9999999999999


Q ss_pred             cCCCccEEeecccceec
Q psy9535         256 DENFVPKLGDFGIVKMS  272 (593)
Q Consensus       256 ~~~~~~Kl~DFGla~~~  272 (593)
                      + ++.++|+|||++...
T Consensus       183 ~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      183 H-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             E-CCCEEEEEChhhhcc
Confidence            9 889999999987643

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.75  E-value=1.6e-18  Score=180.13  Aligned_cols=109  Identities=21%  Similarity=0.305  Sum_probs=87.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEee----cCCCceEEEecccceecccCCccccccccccCCCC
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP  525 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl----~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~  525 (593)
                      ..+++.....++.|++.||+|||+  .+|+||||||+|||+    +.++.+||+|||+++................||+.
T Consensus       103 ~~l~~~~~~~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~  180 (317)
T cd07868         103 VQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW  180 (317)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCcccccc
Confidence            368999999999999999999998  569999999999999    45678999999998764322111112234578999


Q ss_pred             cccccccCC--cCCcccceecchhhhhcccccCCCcc
Q psy9535         526 YMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIA  560 (593)
Q Consensus       526 y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~  560 (593)
                      |+|||++.+  .++.++||||+||++|+..+...|+.
T Consensus       181 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~  217 (317)
T cd07868         181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             ccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence            999998754  36889999999999998777666654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1.1e-17  Score=163.69  Aligned_cols=141  Identities=19%  Similarity=0.214  Sum_probs=109.6

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe-cccce
Q psy9535         115 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-NIMNC  193 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~-~~~~~  193 (593)
                      +.||+|++|.||+|++ .|..|+||......... ..    .........+.+|+.++..++|+||.....++. ....+
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~-~~----~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~   75 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRH-PE----LDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFI   75 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcC-hH----HHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCE
Confidence            4799999999999988 57889999865321100 00    011111235788999999999999876666553 45678


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       194 lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      +||||++|++|.+.+...      .+ .+..++.+++.+|.+||+  .+++|||++|+|||++ ++.++|+|||+++.
T Consensus        76 lv~e~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         76 IVMEYIEGEPLKDLINSN------GM-EELELSREIGRLVGKLHS--AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHh--CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999999988642      12 788899999999999998  5699999999999999 78999999998764

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.75  E-value=1.3e-18  Score=182.26  Aligned_cols=128  Identities=20%  Similarity=0.363  Sum_probs=98.0

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+   ..+...+..  ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~lv~e~~~---~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          80 YVVFELME---SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEEecCC---CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            45665543   345555443  3468999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCC---cCCcccceecchhhhhcccccCCCccc
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      ...............||+.|+|||++.+   .++.++|||||||++|+..+...|+..
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~  210 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG  210 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            3221111111233578999999998743   478899999999999987777666644

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.75  E-value=3e-18  Score=178.64  Aligned_cols=129  Identities=24%  Similarity=0.357  Sum_probs=100.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.  +.|...+..  ...+++.+...++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        72 ~lv~e~~~g--g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~  145 (316)
T cd05592          72 FFVMEYLNG--GDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKE  145 (316)
T ss_pred             EEEEcCCCC--CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence            456665432  345554443  3468999999999999999999998  6699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      .....   ......+||+.|+|||++.+ .++.++|||||||++|+..++..|+.+...
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~  201 (316)
T cd05592         146 NMNGE---GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE  201 (316)
T ss_pred             CCCCC---CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH
Confidence            32211   12234579999999998755 478899999999999998888788765443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG4236|consensus

Probab=99.75  E-value=1.2e-18  Score=181.60  Aligned_cols=147  Identities=24%  Similarity=0.346  Sum_probs=119.5

Q ss_pred             cCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCC---CceEEEecccceec
Q psy9535         431 DTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGIVKMS  507 (593)
Q Consensus       431 ~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~---~~~kl~DfG~~~~~  507 (593)
                      -.-|..+++.++++-....+.|+++....++.||+.||.|||.  ++|+|+||||+||||...   ..+||||||++++.
T Consensus       640 VVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~--knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI  717 (888)
T KOG4236|consen  640 VVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHF--KNIVHCDLKPENVLLASASPFPQVKLCDFGFARII  717 (888)
T ss_pred             EEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh--cceeeccCCchheeeccCCCCCceeeccccceeec
Confidence            3447778888888887788899999999999999999999998  669999999999999643   48999999999987


Q ss_pred             ccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhh-chhhh---hcCCCCCCCeEE
Q psy9535         508 ETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERY-YSLQT---MLPGHHEGDHVS  582 (593)
Q Consensus       508 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~  582 (593)
                      +...    ....++|||.|.|||++..+ |...-|+||.||+||--+.+-+|++..|+. --.|+   |+|      --|
T Consensus       718 gEks----FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyP------p~P  787 (888)
T KOG4236|consen  718 GEKS----FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYP------PNP  787 (888)
T ss_pred             chhh----hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccC------CCc
Confidence            6432    23457899999999998765 555669999999999999999999988876 23343   444      347


Q ss_pred             EeeccCC
Q psy9535         583 ISNHSTN  589 (593)
Q Consensus       583 ~~~~~~~  589 (593)
                      |+.+|.+
T Consensus       788 W~eis~~  794 (888)
T KOG4236|consen  788 WSEISPE  794 (888)
T ss_pred             hhhcCHH
Confidence            7777753

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.75  E-value=2.7e-18  Score=182.21  Aligned_cols=140  Identities=19%  Similarity=0.239  Sum_probs=103.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|..++..  .+.+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~lv~E~~~~--g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  149 (364)
T cd05599          76 LYLIMEYLPG--GDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFGLCT  149 (364)
T ss_pred             EEEEECCCCC--cHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEeecccce
Confidence            3456654322  355555543  3469999999999999999999998  569999999999999999999999999976


Q ss_pred             ecccCCccc-----------------------------------cccccccCCCCcccccccCC-cCCcccceecchhhh
Q psy9535         506 MSETSNVKT-----------------------------------MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQI  549 (593)
Q Consensus       506 ~~~~~~~~~-----------------------------------~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i  549 (593)
                      .........                                   ......+||+.|+|||++.. .++.++|||||||++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  229 (364)
T cd05599         150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM  229 (364)
T ss_pred             eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence            432110000                                   00112469999999998754 478899999999999


Q ss_pred             hcccccCCCccchhhhchhhhh
Q psy9535         550 KTQHITNVDIADRERYYSLQTM  571 (593)
Q Consensus       550 ~~~~~~~~~~~~~~~~~~~~~~  571 (593)
                      |+..++..|+.+......+..+
T Consensus       230 ~el~~G~~Pf~~~~~~~~~~~i  251 (364)
T cd05599         230 YEMLVGYPPFCSDNPQETYRKI  251 (364)
T ss_pred             HHhhcCCCCCCCCCHHHHHHHH
Confidence            9988888887665544333333

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.75  E-value=2.6e-18  Score=179.62  Aligned_cols=140  Identities=21%  Similarity=0.316  Sum_probs=107.4

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  +.|..++..  .+.+++.++..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++.
T Consensus        77 ~lv~Ey~~~--g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          77 YFVMEYVNG--GDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEcCCCC--CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence            456665432  345555443  3469999999999999999999998  6699999999999999999999999999874


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|+..+...|+.+......++.++.+.
T Consensus       151 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~  217 (323)
T cd05615         151 HMVDG---VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN  217 (323)
T ss_pred             cCCCC---ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            32211   11234569999999998754 47889999999999999888888887766555555555443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.75  E-value=3.2e-18  Score=178.79  Aligned_cols=139  Identities=27%  Similarity=0.313  Sum_probs=104.3

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  ..|+..+..  ...+++.....++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        72 ~lv~e~~~~--g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~  145 (323)
T cd05575          72 YFVLDYVNG--GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (323)
T ss_pred             EEEEcCCCC--CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence            455555332  345555443  3468999999999999999999998  5699999999999999999999999999864


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~  574 (593)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|+..+...|+.+.+....++.++.+
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  211 (323)
T cd05575         146 GIEHS---KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK  211 (323)
T ss_pred             cccCC---CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC
Confidence            32111   11233569999999998755 4788999999999999988888887765444334444433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.75  E-value=3.4e-18  Score=178.48  Aligned_cols=141  Identities=22%  Similarity=0.297  Sum_probs=107.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      .++++++.+.  ..|...+..  ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        71 ~~lv~E~~~~--~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~Nill~~~~~~kL~Dfg~~~  144 (321)
T cd05591          71 LFFVMEYVNG--GDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCK  144 (321)
T ss_pred             EEEEEeCCCC--CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeecccce
Confidence            3566665433  344444433  3468999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      ......   .......||+.|+|||++.+ .++.++|||||||++|+..++..|+....+.--++.++.+.
T Consensus       145 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~  212 (321)
T cd05591         145 EGILNG---VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD  212 (321)
T ss_pred             ecccCC---ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence            432211   11233568999999998755 47889999999999999888888887665555555555543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.75  E-value=3.4e-18  Score=178.46  Aligned_cols=140  Identities=24%  Similarity=0.303  Sum_probs=106.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|...+..  ...+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus        71 ~~iv~Ey~~~--g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli~~~~~~kL~DfG~~~  144 (320)
T cd05590          71 LFFVMEFVNG--GDLMFHIQK--SRRFDEARARFYAAEITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCK  144 (320)
T ss_pred             EEEEEcCCCC--chHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeeCCCCe
Confidence            3566665432  345544443  3468999999999999999999998  669999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ......   .......||+.|+|||++.+ .++.++|||||||++|+..+...|+.+....--++.++.+
T Consensus       145 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~  211 (320)
T cd05590         145 EGIFNG---KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND  211 (320)
T ss_pred             ecCcCC---CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC
Confidence            432111   11234579999999998754 4788999999999999988888887766554444444443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.75  E-value=1.7e-18  Score=184.68  Aligned_cols=141  Identities=21%  Similarity=0.271  Sum_probs=105.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|..++..   ..+++.....++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       118 ~~lv~Ey~~g--g~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         118 LYMVMEYMPG--GDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEcCCCC--CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence            3456655332  345554432   357888899999999999999998  669999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-----cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      .......  ......+||+.|||||++..     .++.++|||||||++|+..++..|+.+......+...+.+.
T Consensus       191 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  263 (370)
T cd05596         191 KMDANGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK  263 (370)
T ss_pred             eccCCCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC
Confidence            5432211  11234579999999998743     26789999999999999888888887766554555555443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.75  E-value=3e-18  Score=183.31  Aligned_cols=133  Identities=20%  Similarity=0.238  Sum_probs=99.1

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  +.|..++...  +.+++.....++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~lv~E~~~g--g~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          77 YFVMDYIPG--GDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             EEEEeCCCC--CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            456654332  3455554432  468899999999999999999998  5699999999999999999999999998642


Q ss_pred             cccCCc--------------------------------------------cccccccccCCCCcccccccCC-cCCcccc
Q psy9535         507 SETSNV--------------------------------------------KTMYTENLTGTRPYMPPEAMHC-QISTKTD  541 (593)
Q Consensus       507 ~~~~~~--------------------------------------------~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksD  541 (593)
                      ......                                            ........+||+.|+|||++.+ .++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  230 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence            110000                                            0000123479999999998754 5788999


Q ss_pred             eecchhhhhcccccCCCccchhhh
Q psy9535         542 VFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       542 vwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ||||||++|+..++..|+......
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~  254 (382)
T cd05625         231 WWSVGVILYEMLVGQPPFLAQTPL  254 (382)
T ss_pred             EEechHHHHHHHhCCCCCCCCCHH
Confidence            999999999988888888765443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.75  E-value=2.9e-18  Score=179.14  Aligned_cols=142  Identities=27%  Similarity=0.311  Sum_probs=109.8

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++..  ...|+..+..  .+.+.+.....++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~lv~e~~~--~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (323)
T cd05584          76 YLILEYLS--GGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKE  149 (323)
T ss_pred             EEEEeCCC--CchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence            45555432  2345555443  3468888999999999999999998  5699999999999999999999999999874


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHE  577 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  577 (593)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|+..+...|+...+....++.++.|..+
T Consensus       150 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~  218 (323)
T cd05584         150 SIHEG---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN  218 (323)
T ss_pred             cccCC---CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence            32211   12234579999999998754 4678999999999999988888888877766667777766544

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.75  E-value=2.7e-18  Score=179.47  Aligned_cols=138  Identities=20%  Similarity=0.334  Sum_probs=103.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      .++++++.+.  +.|+..+..  ...+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus        70 ~~lv~E~~~~--~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  143 (323)
T cd05595          70 LCFVMEYANG--GELFFHLSR--ERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCK  143 (323)
T ss_pred             EEEEEeCCCC--CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEEcCCCCEEecccHHhc
Confidence            4566665443  244444433  3468999999999999999999998  569999999999999999999999999986


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTML  572 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~  572 (593)
                      ......   .......||+.|+|||++.+ .++.++|||||||++|+..++..|+.+......++...
T Consensus       144 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~  208 (323)
T cd05595         144 EGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL  208 (323)
T ss_pred             cccCCC---CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence            422111   11223569999999998754 47889999999999999888888876554433333333

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.75  E-value=4.7e-18  Score=177.71  Aligned_cols=131  Identities=21%  Similarity=0.337  Sum_probs=100.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      .++++++-+.  +.|+..+..  ...+++..+..++.|++.||+|||+. ++|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~lv~E~~~~--~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~  144 (325)
T cd05594          70 LCFVMEYANG--GELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCK  144 (325)
T ss_pred             EEEEEeCCCC--CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCe
Confidence            4566665443  344444433  34689999999999999999999961 469999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      ......   .......||+.|||||++.+ .++.++|||||||++|+..++..|+.....
T Consensus       145 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~  201 (325)
T cd05594         145 EGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH  201 (325)
T ss_pred             ecCCCC---cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH
Confidence            432111   11223569999999998754 578899999999999998888888755443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.75  E-value=3.8e-18  Score=178.31  Aligned_cols=136  Identities=24%  Similarity=0.313  Sum_probs=102.3

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  +.|...+..  ...+++.++..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~lv~E~~~~--g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          77 YFVMEYVNG--GDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             EEEEcCCCC--CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            456655332  345555443  3468999999999999999999998  6699999999999999999999999999864


Q ss_pred             cccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhchhhhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTM  571 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~  571 (593)
                      ......   .....+||+.|+|||++.+. ++.++|||||||++|+..+...|+.+......++.+
T Consensus       151 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i  213 (324)
T cd05587         151 NIFGGK---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI  213 (324)
T ss_pred             cCCCCC---ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            221111   12235699999999987654 788999999999999988877787655443333333

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.74  E-value=2.9e-18  Score=189.01  Aligned_cols=146  Identities=26%  Similarity=0.348  Sum_probs=108.5

Q ss_pred             ceEeecCCchhhhhHHHHHh--hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccc
Q psy9535         426 PVIILDTGETKQCQLFKLAR--VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  503 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~--~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~  503 (593)
                      ..+++++.+.  ..|...+.  .....++++.....++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       140 ~~lv~E~~~g--g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DFgl  215 (478)
T PTZ00267        140 LLLIMEYGSG--GDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGF  215 (478)
T ss_pred             EEEEEECCCC--CCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeCcC
Confidence            4566665433  23333322  2234579999999999999999999998  6699999999999999999999999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCC
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHH  576 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  576 (593)
                      ++....... .......+||+.|+|||++.+ .++.++|||||||++|+..+...|+......--++..+.|..
T Consensus       216 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~  288 (478)
T PTZ00267        216 SKQYSDSVS-LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY  288 (478)
T ss_pred             ceecCCccc-cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence            875432211 111234579999999998755 478899999999999998887788776555444555555543

>KOG0605|consensus

Probab=99.74  E-value=1.7e-18  Score=182.34  Aligned_cols=139  Identities=19%  Similarity=0.252  Sum_probs=101.7

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-..+  ++..++..  .+.|++..+..++.+++.|++-+|+  .++|||||||+|+|||..|++||+||||+.-
T Consensus       217 YLiMEylPGG--D~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~--~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  217 YLIMEYLPGG--DMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQ--LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEEEecCCc--cHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHH--cCcccccCChhheeecCCCCEeeccccccch
Confidence            4566654433  33333332  3579999999999999999999999  5599999999999999999999999999742


Q ss_pred             ccc---------------C-------Ccc------c----------------cccccccCCCCcccccccCC-cCCcccc
Q psy9535         507 SET---------------S-------NVK------T----------------MYTENLTGTRPYMPPEAMHC-QISTKTD  541 (593)
Q Consensus       507 ~~~---------------~-------~~~------~----------------~~~~~~~Gt~~y~aPE~~~~-~~~~ksD  541 (593)
                      ...               .       ...      .                ......+|||-|||||++.+ +|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            100               0       000      0                00113589999999999855 4788999


Q ss_pred             eecchhhhhcccccCCCccchhhhchhhhh
Q psy9535         542 VFSYGAQIKTQHITNVDIADRERYYSLQTM  571 (593)
Q Consensus       542 vwS~G~~i~~~~~~~~~~~~~~~~~~~~~~  571 (593)
                      +||+||++|+-+++-+|+-..........+
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI  400 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQETYRKI  400 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999977777777665555444443

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.74  E-value=4e-18  Score=181.99  Aligned_cols=133  Identities=21%  Similarity=0.242  Sum_probs=98.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+  ...|..++..  ...+++.....++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~lv~E~~~--gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~--~givHrDlkp~NIll~~~~~~kl~DfGla~  149 (377)
T cd05629          76 LYLIMEFLP--GGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHK--LGFIHRDIKPDNILIDRGGHIKLSDFGLST  149 (377)
T ss_pred             eEEEEeCCC--CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence            356666532  2355555443  3468899999999999999999998  569999999999999999999999999985


Q ss_pred             ecccCC-------------cc-------------------------------ccccccccCCCCcccccccCC-cCCccc
Q psy9535         506 MSETSN-------------VK-------------------------------TMYTENLTGTRPYMPPEAMHC-QISTKT  540 (593)
Q Consensus       506 ~~~~~~-------------~~-------------------------------~~~~~~~~Gt~~y~aPE~~~~-~~~~ks  540 (593)
                      ......             ..                               .......+||+.|+|||++.+ .++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  229 (377)
T cd05629         150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC  229 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence            211000             00                               000012469999999998754 478899


Q ss_pred             ceecchhhhhcccccCCCccchhh
Q psy9535         541 DVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       541 DvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      |||||||++|+..++..|+.+...
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~  253 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENS  253 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCH
Confidence            999999999998888888765443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.74  E-value=1.9e-18  Score=181.06  Aligned_cols=142  Identities=23%  Similarity=0.254  Sum_probs=105.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ..++..+..  .+.+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        71 ~~lv~e~~~~--g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~  144 (330)
T cd05586          71 LYLVTDYMSG--GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHK--YDIVYRDLKPENILLDATGHIALCDFGLSK  144 (330)
T ss_pred             EEEEEcCCCC--ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEecCCcCc
Confidence            3566665332  244444433  3468999999999999999999998  569999999999999999999999999986


Q ss_pred             ecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHH  576 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  576 (593)
                      ......   ......+||+.|||||++.+  .++.++|||||||++|+..+...|+...+....++.+..|..
T Consensus       145 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  214 (330)
T cd05586         145 ANLTDN---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV  214 (330)
T ss_pred             CCCCCC---CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC
Confidence            432211   11234579999999998754  368899999999999998888888766554444444444443

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0580|consensus

Probab=99.74  E-value=6.4e-19  Score=168.63  Aligned_cols=135  Identities=24%  Similarity=0.350  Sum_probs=111.6

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .++.++.  ..+.+|+.++......+++.....++.|+|.||.|+|.  +.||||||||+|+|++..+.+|++|||-+..
T Consensus        98 yLilEya--~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen   98 YLILEYA--PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             EEEEEec--CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence            3444443  34688888887777889999999999999999999998  7799999999999999999999999998875


Q ss_pred             cccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhchhhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQT  570 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~  570 (593)
                      ....     ...+.|||..|.|||+..+. .+..+|+|++|+..|+++....|+-..+.-...+.
T Consensus       174 ~p~~-----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkr  233 (281)
T KOG0580|consen  174 APSN-----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKR  233 (281)
T ss_pred             cCCC-----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHH
Confidence            4422     23457899999999998765 68899999999999999999988877664443333

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.74  E-value=3.3e-18  Score=181.49  Aligned_cols=136  Identities=21%  Similarity=0.248  Sum_probs=101.7

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-..  +.|..++..  .+.+++.....++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~lv~E~~~g--g~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~--~givHrDLkp~NIli~~~~~vkL~DfG~~~~  150 (360)
T cd05627          77 YLIMEFLPG--GDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQ--LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG  150 (360)
T ss_pred             EEEEeCCCC--ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence            566665332  355555443  3468999999999999999999998  6699999999999999999999999999763


Q ss_pred             cccCCc--------------------------------cccccccccCCCCcccccccCC-cCCcccceecchhhhhccc
Q psy9535         507 SETSNV--------------------------------KTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQH  553 (593)
Q Consensus       507 ~~~~~~--------------------------------~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~  553 (593)
                      ......                                ........+||+.|+|||++.+ .++.++|||||||++|+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence            221100                                0000113479999999998754 4788999999999999988


Q ss_pred             ccCCCccchhhhchh
Q psy9535         554 ITNVDIADRERYYSL  568 (593)
Q Consensus       554 ~~~~~~~~~~~~~~~  568 (593)
                      ++..|+.+......+
T Consensus       231 tG~~Pf~~~~~~~~~  245 (360)
T cd05627         231 IGYPPFCSETPQETY  245 (360)
T ss_pred             cCCCCCCCCCHHHHH
Confidence            888888665544333

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=1e-17  Score=162.75  Aligned_cols=147  Identities=18%  Similarity=0.190  Sum_probs=106.5

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHH---------hhhcHHHHHHHHHHHhcCCCCc--ee
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEA---------AMIPILLFENEVQTLSQCKHVN--LL  181 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~---------~~~~~~~f~~Ev~il~~l~HpN--Iv  181 (593)
                      ..+.||+|+||.||+|...+|+.||||++................         .......+.+|..++.++.|++  +.
T Consensus        19 ~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~   98 (198)
T cd05144          19 LGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVP   98 (198)
T ss_pred             cCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCC
Confidence            367899999999999998889999999976532110000000000         0001123678999999998874  44


Q ss_pred             eEEEEEecccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCcc
Q psy9535         182 RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  261 (593)
Q Consensus       182 ~l~g~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~  261 (593)
                      +.++   ....++||||+++++|.+....         .....++.+++.++.++|+  .+|+||||||+|||+++++.+
T Consensus        99 ~~~~---~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~--~gi~H~Dl~p~Nill~~~~~~  164 (198)
T cd05144          99 KPID---WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK--HGIIHGDLSEFNILVDDDEKI  164 (198)
T ss_pred             ceee---cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH--CCCCcCCCCcccEEEcCCCcE
Confidence            4444   2345899999999998764321         2345688999999999998  569999999999999999999


Q ss_pred             EEeecccceecc
Q psy9535         262 KLGDFGIVKMSE  273 (593)
Q Consensus       262 Kl~DFGla~~~~  273 (593)
                      +|+|||++....
T Consensus       165 ~liDfg~~~~~~  176 (198)
T cd05144         165 YIIDWPQMVSTD  176 (198)
T ss_pred             EEEECCccccCC
Confidence            999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.74  E-value=3.4e-18  Score=179.22  Aligned_cols=138  Identities=26%  Similarity=0.340  Sum_probs=105.7

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-..  ..|...+..  .+.+++.....++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~e~~~~--~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  167 (329)
T PTZ00263         94 YFLLEFVVG--GELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGFAKK  167 (329)
T ss_pred             EEEEcCCCC--ChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence            455554322  345555443  3468899999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHH  576 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  576 (593)
                      ....      .....||+.|+|||++.+. ++.++|||||||++|+..+...|+.+....-..+....|..
T Consensus       168 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~  232 (329)
T PTZ00263        168 VPDR------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL  232 (329)
T ss_pred             cCCC------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc
Confidence            4321      1234689999999987554 68899999999999998888888876655544455555543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	593
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-47
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-19
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-47
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-19
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-47
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-18
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-44
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-17
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-40
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-17
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-39
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-16
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-29
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-15
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-29
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-26
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-13
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-24
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-24
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-24
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-24
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-24
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-24
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-24
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-24
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-24
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-24
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-23
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-23
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-23
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-05
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-05
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-18
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-06
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-05
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-06
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-06
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-05
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-05
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-18
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-05
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-06
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-06
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-06
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-06
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-04
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-05
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-05
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-05
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-05
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-05
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-05
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-05
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-04
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-05
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-06
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-05
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-05
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-05
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-05
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-05
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-05
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-05
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-05
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-05
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-17
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-05
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-04
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-05
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-04
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-05
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-06
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-04
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-04
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-04
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-04
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-04
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-05
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-04
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-04
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-04
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-04
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-04
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-04
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-05
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-04
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-04
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-17
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-05
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-04
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-04
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-17
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-05
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-04
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-05
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-05
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-06
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-05
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-05
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-04
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-04
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-05
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-05
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-05
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-05
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-04
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-17
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-05
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-06
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-06
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-06
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-06
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-06
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-06
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-06
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-04
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-07
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-06
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-06
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-06
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-06
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-04
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-06
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-06
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-06
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-06
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-06
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-06
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-06
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-05
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-05
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-06
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		9e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-09
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-05
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-07
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-05
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-05
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-05
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-04
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-04
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-05
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-05
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-06
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-05
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-05
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-05
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-05
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-05
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-05
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-05
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-05
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-04
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-05
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-06
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-04
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-04
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-04
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-05
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-04
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-04
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-04
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		8e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-14
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-04
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-14
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		9e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-04
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-04
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-04
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-04
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-04
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-04
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-04
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-13
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-05
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-05
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-05
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-04
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-06
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		9e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		9e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-06
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-05
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-04
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-05
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-06
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-04
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-04
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-04
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-05
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-04
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-05
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-05
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-06
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-05
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-05
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-05
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-05
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-05
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-05
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-04
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-05
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-05
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-04
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-04
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-05
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-04
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-04
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-04
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-04
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-04
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-04
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-04
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-04
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-04
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-04
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-04
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-05
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-04
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-04
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-05
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-05
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-04
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-04
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-04
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-05
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-04
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-04
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-04
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-04
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-09
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-09
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-09
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-09
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-09
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-09
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-04
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-09
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-09
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-09
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-09
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-09
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-09
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-09
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		9e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		9e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		9e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-04
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-04
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-04
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-07
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		4e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		9e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
3soa_A	444	Full-Length Human Camkii Length = 444		2e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-05
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		6e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-05

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  187 bits (476), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 109/310 (35%), Positives = 180/310 (58%), Gaps = 31/310 (10%)
Query: 92  AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 151
           +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKL---------- 62
Query: 152 XXXTEAAMIPILL------FENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSL 204
                AAM+ I        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL
Sbjct: 63  -----AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 205 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 264
            DRL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 175
Query: 265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
           DFG+ + SE    +T+    + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +
Sbjct: 176 DFGLARASEKF-AQTVMXSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 325 DDNNT----ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS 380
           D++      +     + ++E  + + +DK+  + + T VE +  +   +C   +K+KR  
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA-SQCLHEKKNKRPD 293
Query: 381 MRDIVDLLSK 390
           ++ +  LL +
Sbjct: 294 IKKVQQLLQE 303

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 49/125 (39%), Positives = 75/125 (60%), Gaps = 4/125 (3%)
Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L +L+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 175
Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDI 559
           DFG+ + SE    +T+    + GT  YM PEA+  +I+ K+D++S+G  +  + IT +  
Sbjct: 176 DFGLARASEKF-AQTVMXSRIVGTTAYMAPEALRGEITPKSDIYSFGV-VLLEIITGLPA 233
Query: 560 ADRER 564
            D  R
Sbjct: 234 VDEHR 238

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 109/310 (35%), Positives = 180/310 (58%), Gaps = 31/310 (10%)
Query: 92  AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 151
           +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKL---------- 62
Query: 152 XXXTEAAMIPILL------FENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSL 204
                AAM+ I        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL
Sbjct: 63  -----AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 205 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 264
            DRL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 175
Query: 265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
           DFG+ + SE    +T+    + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +
Sbjct: 176 DFGLARASEKF-AQTVMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 325 DDNNT----ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS 380
           D++      +     + ++E  + + +DK+  + + T VE +  +   +C   +K+KR  
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA-SQCLHEKKNKRPD 293
Query: 381 MRDIVDLLSK 390
           ++ +  LL +
Sbjct: 294 IKKVQQLLQE 303

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 49/125 (39%), Positives = 75/125 (60%), Gaps = 4/125 (3%)
Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L +L+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 175
Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDI 559
           DFG+ + SE    +T+    + GT  YM PEA+  +I+ K+D++S+G  +  + IT +  
Sbjct: 176 DFGLARASEKF-AQTVMXXRIVGTTAYMAPEALRGEITPKSDIYSFGV-VLLEIITGLPA 233
Query: 560 ADRER 564
            D  R
Sbjct: 234 VDEHR 238

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  186 bits (473), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 109/310 (35%), Positives = 178/310 (57%), Gaps = 31/310 (10%)
Query: 92  AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 151
           +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct: 8   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKL---------- 56
Query: 152 XXXTEAAMIPILL------FENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSL 204
                AAM+ I        F+ E++ +++C+H NL+ LLG  ++  + C+VY YM NGSL
Sbjct: 57  -----AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 111
Query: 205 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 264
            DRL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 112 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 169
Query: 265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
           DFG+ + SE      M    + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +
Sbjct: 170 DFGLARASEKFAQXVMXXR-IVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 228
Query: 325 DDNNT----ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS 380
           D++      +     + ++E  + + +DK+  + + T VE +  +   +C   +K+KR  
Sbjct: 229 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA-SQCLHEKKNKRPD 287
Query: 381 MRDIVDLLSK 390
           ++ +  LL +
Sbjct: 288 IKKVQQLLQE 297

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 49/125 (39%), Positives = 73/125 (58%), Gaps = 4/125 (3%)
Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L +L+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 112 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 169
Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDI 559
           DFG+ + SE      M    + GT  YM PEA+  +I+ K+D++S+G  +  + IT +  
Sbjct: 170 DFGLARASEKFAQXVM-XXRIVGTTAYMAPEALRGEITPKSDIYSFGV-VLLEIITGLPA 227
Query: 560 ADRER 564
            D  R
Sbjct: 228 VDEHR 232

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  177 bits (450), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 106/310 (34%), Positives = 174/310 (56%), Gaps = 31/310 (10%)
Query: 92  AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 151
           +F+F +L+  T+ F+ +P    GNK GEG FG VY G + N   +AVK L          
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKL---------- 53
Query: 152 XXXTEAAMIPILL------FENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSL 204
                AAM+ I        F+ E++  ++C+H NL+ LLG  ++  + C+VY Y  NGSL
Sbjct: 54  -----AAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL 108
Query: 205 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 264
            DRL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 109 LDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 166
Query: 265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
           DFG+ + SE    + +    + GT  Y  PEA+  +I+ K+D++S+GV+LLE++TG+  +
Sbjct: 167 DFGLARASEKF-AQXVXXSRIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 225
Query: 325 DDNNT----ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS 380
           D++      +     + ++E  + + +DK+  + + T VE    +   +C   +K+KR  
Sbjct: 226 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVA-SQCLHEKKNKRPD 284
Query: 381 MRDIVDLLSK 390
           ++ +  LL +
Sbjct: 285 IKKVQQLLQE 294

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 47/125 (37%), Positives = 73/125 (58%), Gaps = 4/125 (3%)
Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L +L+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 109 LDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 166
Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDI 559
           DFG+ + SE    + +    + GT  Y  PEA+  +I+ K+D++S+G  +  + IT +  
Sbjct: 167 DFGLARASEKF-AQXVXXSRIVGTTAYXAPEALRGEITPKSDIYSFGV-VLLEIITGLPA 224
Query: 560 ADRER 564
            D  R
Sbjct: 225 VDEHR 229

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 115/315 (36%), Positives = 164/315 (52%), Gaps = 33/315 (10%)
Query: 86  YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXX 145
           ++G+L  F+  +L+ A+D F+ K      N LG G FG VY G+L +G  +AVK L+   
Sbjct: 21  HLGQLKRFSLRELQVASDNFSNK------NILGRGGFGKVYKGRLADGTLVAVKRLK--- 71
Query: 146 XXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL 204
                     E      L F+ EV+ +S   H NLLRL G C       +VY YM NGS+
Sbjct: 72  ---------EERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 122
Query: 205 YDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPK 262
              L  R  + PPLD  KR  IALG A  L YLH    P IIHRDVK+AN+LLDE F   
Sbjct: 123 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 182
Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM 321
           +GDFG+ K+ +  +        + GT  ++ PE +   + S KTDVF YGV+LLEL+TG 
Sbjct: 183 VGDFGLAKLMDYKDXHVXXA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 240
Query: 322 KPI-------DDNNTILYYYLVVEQEVPVREVLDKE-AGEWNETHVETLIGIVFEKCCVF 373
           +         DD+  +L +   + +E  +  ++D +  G + +  VE LI +    C   
Sbjct: 241 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL-LCTQS 299
Query: 374 EKDKRASMRDIVDLL 388
              +R  M ++V +L
Sbjct: 300 SPMERPKMSEVVRML 314

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 48/107 (44%), Positives = 62/107 (57%), Gaps = 4/107 (3%)
Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPKLGDFGI 503
           R  + PPLD  KR  IALG A  L YLH    P IIHRDVK+AN+LLDE F   +GDFG+
Sbjct: 129 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 188
Query: 504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQI 549
            K+ +  +        + GT  ++ PE +   + S KTDVF YG  +
Sbjct: 189 AKLMDYKDXHVXXA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 233

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  160 bits (406), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 114/315 (36%), Positives = 162/315 (51%), Gaps = 33/315 (10%)
Query: 86  YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXX 145
           ++G+L  F+  +L+ A+D F  K      N LG G FG VY G+L +G  +AVK L+   
Sbjct: 13  HLGQLKRFSLRELQVASDNFXNK------NILGRGGFGKVYKGRLADGXLVAVKRLK--- 63
Query: 146 XXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL 204
                     E      L F+ EV+ +S   H NLLRL G C       +VY YM NGS+
Sbjct: 64  ---------EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
Query: 205 YDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPK 262
              L  R  + PPLD  KR  IALG A  L YLH    P IIHRDVK+AN+LLDE F   
Sbjct: 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174
Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM 321
           +GDFG+ K+ +  +        + G   ++ PE +   + S KTDVF YGV+LLEL+TG 
Sbjct: 175 VGDFGLAKLMDYKDXHVXXA--VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232
Query: 322 KPI-------DDNNTILYYYLVVEQEVPVREVLDKE-AGEWNETHVETLIGIVFEKCCVF 373
           +         DD+  +L +   + +E  +  ++D +  G + +  VE LI +    C   
Sbjct: 233 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL-LCTQS 291
Query: 374 EKDKRASMRDIVDLL 388
              +R  M ++V +L
Sbjct: 292 SPMERPKMSEVVRML 306

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 47/107 (43%), Positives = 61/107 (57%), Gaps = 4/107 (3%)
Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPKLGDFGI 503
           R  + PPLD  KR  IALG A  L YLH    P IIHRDVK+AN+LLDE F   +GDFG+
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQI 549
            K+ +  +        + G   ++ PE +   + S KTDVF YG  +
Sbjct: 181 AKLMDYKDXHVXXA--VRGXIGHIAPEYLSTGKSSEKTDVFGYGVML 225

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  125 bits (315), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 90/233 (38%), Positives = 129/233 (55%), Gaps = 25/233 (10%)
Query: 95  FCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXX 154
             DLE AT+ F+ K        +G G FG VY G L++G ++A+K               
Sbjct: 31  LVDLEEATNNFDHKFL------IGHGVFGKVYKGVLRDGAKVALKR-------------R 71
Query: 155 TEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVN- 212
           T  +   I  FE E++TLS C+H +L+ L+G C+     I +Y+YM NG+L   L   + 
Sbjct: 72  TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 213 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
            T  +   +R  I +G A  LHYLH+  + IIHRDVKS N+LLDENFVPK+ DFGI K  
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 273 ETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPI 324
            T   +T     + GT  Y+ PE  +  +++ K+DV+S+GV+L E+L     I
Sbjct: 190 -TELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 45/99 (45%), Positives = 62/99 (62%), Gaps = 4/99 (4%)
Query: 449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 508
           T  +   +R  I +G A  LHYLH+  + IIHRDVKS N+LLDENFVPK+ DFGI K   
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKG- 189
Query: 509 TSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
           T   +T     + GT  Y+ PE  +  +++ K+DV+S+G
Sbjct: 190 TELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFG 228

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  125 bits (314), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 90/233 (38%), Positives = 129/233 (55%), Gaps = 25/233 (10%)
Query: 95  FCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXX 154
             DLE AT+ F+ K        +G G FG VY G L++G ++A+K               
Sbjct: 31  LVDLEEATNNFDHKFL------IGHGVFGKVYKGVLRDGAKVALKR-------------R 71
Query: 155 TEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVN- 212
           T  +   I  FE E++TLS C+H +L+ L+G C+     I +Y+YM NG+L   L   + 
Sbjct: 72  TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 213 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
            T  +   +R  I +G A  LHYLH+  + IIHRDVKS N+LLDENFVPK+ DFGI K  
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 273 ETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPI 324
            T   +T     + GT  Y+ PE  +  +++ K+DV+S+GV+L E+L     I
Sbjct: 190 -TELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 45/99 (45%), Positives = 62/99 (62%), Gaps = 4/99 (4%)
Query: 449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 508
           T  +   +R  I +G A  LHYLH+  + IIHRDVKS N+LLDENFVPK+ DFGI K   
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKG- 189
Query: 509 TSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
           T   +T     + GT  Y+ PE  +  +++ K+DV+S+G
Sbjct: 190 TELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFG 228

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 133/279 (47%), Gaps = 35/279 (12%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           K+G G FGTV+  +  +G ++AVK L                       F  EV  + + 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE-----------FLREVAIMKRL 91
Query: 176 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H N++  +G      N  IV EY+  GSLY  L +      LD  +R S+A  VA+ ++
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH+ + PI+HRD+KS N+L+D+ +  K+ DFG+ ++  +     + ++   GT  +M P
Sbjct: 152 YLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASX---FLXSKXAAGTPEWMAP 208
Query: 295 EAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLV----VEQEVPVREVLDK 349
           E +  + S  K+DV+S+GVIL EL T  +P  + N       V       E+P       
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP------- 261
Query: 350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL 388
                   ++   +  + E C   E  KR S   I+DLL
Sbjct: 262 -------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 62/96 (64%), Gaps = 4/96 (4%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           LD  +R S+A  VA+ ++YLH+ + PI+HRD+KS N+L+D+ +  K+ DFG+ ++  +  
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASX- 192
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYG 546
              + ++   GT  +M PE +  + S  K+DV+S+G
Sbjct: 193 --FLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFG 226

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 135/279 (48%), Gaps = 35/279 (12%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           K+G G FGTV+  +  +G ++AVK L                       F  EV  + + 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE-----------FLREVAIMKRL 91
Query: 176 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H N++  +G      N  IV EY+  GSLY  L +      LD  +R S+A  VA+ ++
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH+ + PI+HR++KS N+L+D+ +  K+ DFG+ ++  ++ +    +++  GT  +M P
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS---SKSAAGTPEWMAP 208
Query: 295 EAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLV----VEQEVPVREVLDK 349
           E +  + S  K+DV+S+GVIL EL T  +P  + N       V       E+P       
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP------- 261
Query: 350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL 388
                   ++   +  + E C   E  KR S   I+DLL
Sbjct: 262 -------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 64/96 (66%), Gaps = 4/96 (4%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           LD  +R S+A  VA+ ++YLH+ + PI+HR++KS N+L+D+ +  K+ DFG+ ++  ++ 
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST- 192
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYG 546
              + +++  GT  +M PE +  + S  K+DV+S+G
Sbjct: 193 --FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG 226

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 115/226 (50%), Gaps = 25/226 (11%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 18  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 64
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 65  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 122
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 123 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 179
Query: 294 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 332
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 225

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 456 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM 515
           K   IA   A+ + YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    
Sbjct: 110 KLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 167
Query: 516 YTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYG 546
           + E L+G+  +M PE +  Q     S ++DV+++G
Sbjct: 168 F-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 201

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 115/226 (50%), Gaps = 25/226 (11%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 15  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 61
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 62  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 119
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 120 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 176
Query: 294 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 332
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 222

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 456 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM 515
           K   IA   A+ + YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    
Sbjct: 107 KLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 164
Query: 516 YTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYG 546
           + E L+G+  +M PE +  Q     S ++DV+++G
Sbjct: 165 F-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 198

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 115/226 (50%), Gaps = 25/226 (11%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 40  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 86
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 87  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 144
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 145 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 201
Query: 294 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 332
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 202 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 247

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 456 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM 515
           K   IA   A+ + YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    
Sbjct: 132 KLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 189
Query: 516 YTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYG 546
           + E L+G+  +M PE +  Q     S ++DV+++G
Sbjct: 190 F-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 223

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 115/226 (50%), Gaps = 25/226 (11%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 41  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 87
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 88  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 145
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 146 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 202
Query: 294 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 332
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 248

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 456 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM 515
           K   IA   A+ + YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    
Sbjct: 133 KLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 190
Query: 516 YTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYG 546
           + E L+G+  +M PE +  Q     S ++DV+++G
Sbjct: 191 F-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 224

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 115/226 (50%), Gaps = 25/226 (11%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 18  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 64
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 65  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 122
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 123 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 179
Query: 294 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 332
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 225

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 456 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM 515
           K   IA   A+ + YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    
Sbjct: 110 KLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 167
Query: 516 YTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYG 546
           + E L+G+  +M PE +  Q     S ++DV+++G
Sbjct: 168 F-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 201

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 115/226 (50%), Gaps = 25/226 (11%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 13  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 59
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 60  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 117
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 118 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 174
Query: 294 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 332
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 220

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 456 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM 515
           K   IA   A+ + YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    
Sbjct: 105 KLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162
Query: 516 YTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYG 546
           + E L+G+  +M PE +  Q     S ++DV+++G
Sbjct: 163 F-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/227 (33%), Positives = 116/227 (51%), Gaps = 27/227 (11%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 41  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 87
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 88  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 145
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRPYM 292
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 146 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 201
Query: 293 PPEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 332
            PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 202 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 248

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 456 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM 515
           K   IA   A+ + YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     
Sbjct: 133 KLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLA--TEKSRWSGS 188
Query: 516 YT-ENLTGTRPYMPPEAMHCQ----ISTKTDVFSYG 546
           +  E L+G+  +M PE +  Q     S ++DV+++G
Sbjct: 189 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 224

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/227 (33%), Positives = 116/227 (51%), Gaps = 27/227 (11%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 33  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 79
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 80  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 137
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRPYM 292
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 138 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 193
Query: 293 PPEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 332
            PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 194 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 240

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 456 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM 515
           K   IA   A+ + YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     
Sbjct: 125 KLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLA--TEKSRWSGS 180
Query: 516 YT-ENLTGTRPYMPPEAMHCQ----ISTKTDVFSYG 546
           +  E L+G+  +M PE +  Q     S ++DV+++G
Sbjct: 181 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 216

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/227 (33%), Positives = 116/227 (51%), Gaps = 27/227 (11%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 13  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 59
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 60  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 117
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRPYM 292
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 118 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 173
Query: 293 PPEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 332
            PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 220

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 456 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM 515
           K   IA   A+ + YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     
Sbjct: 105 KLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLA--TEKSRWSGS 160
Query: 516 YT-ENLTGTRPYMPPEAMHCQ----ISTKTDVFSYG 546
           +  E L+G+  +M PE +  Q     S ++DV+++G
Sbjct: 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 115/226 (50%), Gaps = 25/226 (11%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 13  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 59
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 60  KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 117
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 118 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 174
Query: 294 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 332
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 220

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 456 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM 515
           K   IA   A+ + YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    
Sbjct: 105 KLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162
Query: 516 YTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYG 546
           + E L+G+  +M PE +  Q     S ++DV+++G
Sbjct: 163 F-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 17  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 63
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +HVN+L  +G        IV ++    SLY  L    +    +  K   IA   A  +
Sbjct: 64  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGM 121
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 122 DYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 178
Query: 294 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNN 328
           PE +  Q     S ++DV+++G++L EL+TG  P  + N
Sbjct: 179 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 217

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 409 RTQENNNINWELHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEAL 468
           R   + NI   + Y+  P + + T   +   L+     + T   +  K   IA   A  +
Sbjct: 63  RKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGM 121
Query: 469 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMP 528
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 122 DYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 178
Query: 529 PEAMHCQ----ISTKTDVFSYG 546
           PE +  Q     S ++DV+++G
Sbjct: 179 PEVIRMQDSNPYSFQSDVYAFG 200

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 110/220 (50%), Gaps = 24/220 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 29  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 75
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +HVN+L  +G        IV ++    SLY  L    +    +  K   IA   A  +
Sbjct: 76  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGM 133
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRPYM 292
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 134 DYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 189
Query: 293 PPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNN 328
            PE +  Q     S ++DV+++G++L EL+TG  P  + N
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 409 RTQENNNINWELHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEAL 468
           R   + NI   + Y+  P + + T   +   L+     + T   +  K   IA   A  +
Sbjct: 75  RKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGM 133
Query: 469 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT-ENLTGTRPYM 527
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 134 DYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 189
Query: 528 PPEAMHCQ----ISTKTDVFSYG 546
            PE +  Q     S ++DV+++G
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFG 212

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 110/220 (50%), Gaps = 24/220 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 29  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 75
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +HVN+L  +G        IV ++    SLY  L    +    +  K   IA   A  +
Sbjct: 76  KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGM 133
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRPYM 292
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 134 DYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 189
Query: 293 PPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNN 328
            PE +  Q     S ++DV+++G++L EL+TG  P  + N
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 409 RTQENNNINWELHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEAL 468
           R   + NI   + Y+  P + + T   +   L+     + T   +  K   IA   A  +
Sbjct: 75  RKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGM 133
Query: 469 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT-ENLTGTRPYM 527
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 134 DYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 189
Query: 528 PPEAMHCQ----ISTKTDVFSYG 546
            PE +  Q     S ++DV+++G
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFG 212

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 111/224 (49%), Gaps = 25/224 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           ++G G FGTVY GK     ++AVK L+             +        F NEV  L + 
Sbjct: 43  RIGSGSFGTVYKGKWHG--DVAVKILKV-----------VDPTPEQFQAFRNEVAVLRKT 89
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +HVN+L  +G        IV ++    SLY  L  V  T      +   IA   A+ + Y
Sbjct: 90  RHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHL-HVQETK-FQMFQLIDIARQTAQGMDY 147
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 295
           LH+  K IIHRD+KS N+ L E    K+GDFG+  +    +  +   E  TG+  +M PE
Sbjct: 148 LHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS-GSQQVEQPTGSVLWMAPE 204
Query: 296 AMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 332
            +  Q     S ++DV+SYG++L EL+TG  P   I++ + I++
Sbjct: 205 VIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF 248

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 57/111 (51%), Gaps = 15/111 (13%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           IA   A+ + YLH+  K IIHRD+KS N+ L E    K+GDFG+  +    +  +   E 
Sbjct: 137 IARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS-GSQQVEQ 193
Query: 520 LTGTRPYMPPEAMHCQ----ISTKTDVFSYG--------AQIKTQHITNVD 558
            TG+  +M PE +  Q     S ++DV+SYG         ++   HI N D
Sbjct: 194 PTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD 244

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G G FG V   K +   ++A+K +E                      F  E++ LS+  
Sbjct: 17  VGRGAFGVVCKAKWR-AKDVAIKQIESESERKA---------------FIVELRQLSRVN 60
Query: 177 HVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYL 236
           H N+++L G C N + C+V EY   GSLY+ L      P   +    S  L  ++ + YL
Sbjct: 61  HPNIVKLYGACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 237 HSLS-KPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           HS+  K +IHRD+K  N+LL     V K+ DFG        +++T  T N  G+  +M P
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT-----ACDIQTHMTNN-KGSAAWMAP 173
Query: 295 EAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ---EVPVREVLDKE 350
           E       S K DVFS+G+IL E++T  KP D+     +  +         P+ + L K 
Sbjct: 174 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 233
Query: 351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM 392
                   +E+L+     +C   +  +R SM +IV +++  M
Sbjct: 234 --------IESLM----TRCWSKDPSQRPSMEEIVKIMTHLM 263

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 48/91 (52%), Gaps = 9/91 (9%)
Query: 459 SIALGVAEALHYLHSLS-KPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNVKTMY 516
           S  L  ++ + YLHS+  K +IHRD+K  N+LL     V K+ DFG        +++T  
Sbjct: 107 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT-----ACDIQTHM 161
Query: 517 TENLTGTRPYMPPEAMH-CQISTKTDVFSYG 546
           T N  G+  +M PE       S K DVFS+G
Sbjct: 162 TNN-KGSAAWMAPEVFEGSNYSEKCDVFSWG 191

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G G FG V   K +   ++A+K +E                      F  E++ LS+  
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESESERKA---------------FIVELRQLSRVN 59
Query: 177 HVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYL 236
           H N+++L G C N + C+V EY   GSLY+ L      P   +    S  L  ++ + YL
Sbjct: 60  HPNIVKLYGACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 237 HSLS-KPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           HS+  K +IHRD+K  N+LL     V K+ DFG        +++T  T N  G+  +M P
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT-----ACDIQTHMTNN-KGSAAWMAP 172
Query: 295 EAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ---EVPVREVLDKE 350
           E       S K DVFS+G+IL E++T  KP D+     +  +         P+ + L K 
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM 392
                   +E+L+     +C   +  +R SM +IV +++  M
Sbjct: 233 --------IESLM----TRCWSKDPSQRPSMEEIVKIMTHLM 262

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 48/91 (52%), Gaps = 9/91 (9%)
Query: 459 SIALGVAEALHYLHSLS-KPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNVKTMY 516
           S  L  ++ + YLHS+  K +IHRD+K  N+LL     V K+ DFG        +++T  
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT-----ACDIQTHM 160
Query: 517 TENLTGTRPYMPPEAMH-CQISTKTDVFSYG 546
           T N  G+  +M PE       S K DVFS+G
Sbjct: 161 TNN-KGSAAWMAPEVFEGSNYSEKCDVFSWG 190

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 115/219 (52%), Gaps = 25/219 (11%)
Query: 117 LGEGQFGTVYYGKLKNGME----IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK   +    +A+KTL+            +EA++            +
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI------------M 69
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q +H N++RL G+  N M   I+ E+M NG+L D   R+N+       +   +  G+A 
Sbjct: 70  GQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQ-FTVIQLVGMLRGIAS 127
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 290
            + YL  +S   +HRD+ + N+L++ N V K+ DFG+ +  E ++    YT +L G  P 
Sbjct: 128 GMRYLAEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPI 185
Query: 291 -YMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDD 326
            +  PEA+  +  ++ +D +SYG+++ E+++ G +P  D
Sbjct: 186 RWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD 224

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 51/87 (58%), Gaps = 5/87 (5%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +S   +HRD+ + N+L++ N V K+ DFG+ +  E ++    YT +L G
Sbjct: 124 GIASGMRYLAEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGG 181
Query: 523 TRP--YMPPEAMHCQ-ISTKTDVFSYG 546
             P  +  PEA+  +  ++ +D +SYG
Sbjct: 182 KIPIRWTAPEAIAFRKFTSASDAWSYG 208

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + +    I A+K L              E A +   L   EV+  
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVL---------FKTQLEKAGVEHQL-RREVEIQ 66
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELAN 123
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL  N   K+ DFG    + +S   T     L GT  Y
Sbjct: 124 ALSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT-----LCGTLDY 176
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPID 325
           +PPE +  ++   K D++S GV+  E L GM P +
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 55/109 (50%), Gaps = 14/109 (12%)
Query: 439 QLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL 498
           +L KL+R       D  +  +    +A AL Y HS  K +IHRD+K  N+LL  N   K+
Sbjct: 102 ELQKLSR------FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSNGELKI 153
Query: 499 GDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
            DFG    + +S   T     L GT  Y+PPE +  ++   K D++S G
Sbjct: 154 ADFGWSVHAPSSRRDT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 197

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + +    I A+K L              E A +   L   EV+  
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVL---------FKTQLEKAGVEHQL-RREVEIQ 66
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELAN 123
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL  N   K+ DFG    + +S   T     L GT  Y
Sbjct: 124 ALSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTT-----LCGTLDY 176
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPID 325
           +PPE +  ++   K D++S GV+  E L GM P +
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 55/109 (50%), Gaps = 14/109 (12%)
Query: 439 QLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL 498
           +L KL+R       D  +  +    +A AL Y HS  K +IHRD+K  N+LL  N   K+
Sbjct: 102 ELQKLSR------FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSNGELKI 153
Query: 499 GDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
            DFG    + +S   T     L GT  Y+PPE +  ++   K D++S G
Sbjct: 154 ADFGWSVHAPSSRRTT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 197

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 71
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 72  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 131 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 184
Query: 294 PEAM-HCQISTKTDVFSYGVILLELLT 319
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  NK   +A  +AE + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E + 
Sbjct: 112 LTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 169
Query: 512 VKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
               YT       P  +  PEA+ +   + K+DV+S+G
Sbjct: 170 ----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 203

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 70
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 71  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 129
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 183
Query: 294 PEAM-HCQISTKTDVFSYGVILLELLT 319
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 184 PEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  NK   +A  +AE + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E + 
Sbjct: 111 LTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 168
Query: 512 VKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
               YT       P  +  PEA+ +   + K+DV+S+G
Sbjct: 169 ----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 202

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 65
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 66  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 178
Query: 294 PEAM-HCQISTKTDVFSYGVILLELLT 319
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  NK   +A  +AE + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E + 
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
Query: 512 VKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
               YT       P  +  PEA+ +   + K+DV+S+G
Sbjct: 164 ----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 75
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 76  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 134
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 135 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 188
Query: 294 PEAM-HCQISTKTDVFSYGVILLELLT 319
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 189 PEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  NK   +A  +AE + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E + 
Sbjct: 116 LTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 173
Query: 512 VKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
               YT       P  +  PEA+ +   + K+DV+S+G
Sbjct: 174 ----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 207

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 60
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 61  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 119
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 120 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 173
Query: 294 PEAM-HCQISTKTDVFSYGVILLELLT 319
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 174 PEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  NK   +A  +AE + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E + 
Sbjct: 101 LTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 158
Query: 512 VKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
               YT       P  +  PEA+ +   + K+DV+S+G
Sbjct: 159 ----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 192

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 67
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G +Y  L +++     D  +  +    +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELAN 124
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 125 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 177
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 110 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 167
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T     L GT  Y+PPE +  ++   K D++S G
Sbjct: 168 RTT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 198

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 63
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 120
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L+GT  Y
Sbjct: 121 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTT-----LSGTLDY 173
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 106 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR 163
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T     L+GT  Y+PPE +  ++   K D++S G
Sbjct: 164 RTT-----LSGTLDYLPPEMIEGRMHDEKVDLWSLG 194

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 236
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 237 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 296 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 349
Query: 294 PE-AMHCQISTKTDVFSYGVILLELLT 319
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 285 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTAR 338
Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 368

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 236
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 237 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 296 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 349
Query: 294 PE-AMHCQISTKTDVFSYGVILLELLT 319
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 285 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTAR 338
Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 368

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 319
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 320 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 379 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 432
Query: 294 PE-AMHCQISTKTDVFSYGVILLELLT 319
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 368 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTAR 421
Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 451

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V+ G      ++A+KTL+                M P    E E Q + + 
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLK-------------PGTMSPESFLE-EAQIMKKL 61
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRL----ARVNNTPPLDSNKRYSIALGVAE 231
           KH  L++L  + +     IV EYM  GSL D L     R    P L       +A  VA 
Sbjct: 62  KHDKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNL-----VDMAAQVAA 116
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + Y+  ++   IHRD++SAN+L+    + K+ DFG+ ++ E  N  T         +  
Sbjct: 117 GMAYIERMN--YIHRDLRSANILVGNGLICKIADFGLARLIE-DNEXTARQGAKFPIKWT 173
Query: 292 MPPEAMHCQISTKTDVFSYGVILLELLT 319
            P  A++ + + K+DV+S+G++L EL+T
Sbjct: 174 APEAALYGRFTIKSDVWSFGILLTELVT 201

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 48/87 (55%), Gaps = 3/87 (3%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  VA  + Y+  ++   IHRD++SAN+L+    + K+ DFG+ ++ E  N  T     
Sbjct: 110 MAAQVAAGMAYIERMN--YIHRDLRSANILVGNGLICKIADFGLARLIE-DNEXTARQGA 166
Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYG 546
               +   P  A++ + + K+DV+S+G
Sbjct: 167 KFPIKWTAPEAALYGRFTIKSDVWSFG 193

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 30  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 79
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 80  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 136
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 137 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 189
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 226

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 122 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 179
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T     L GT  Y+PPE +  ++   K D++S G
Sbjct: 180 RTT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 210

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 26/221 (11%)
Query: 116 KLGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL-FENEVQTLS 173
           ++G+G FG V+ G+L K+   +A+K+L              E  MI     F+ EV  +S
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSL-------ILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
              H N+++L GL +N    +V E++  G LY RL  ++   P+  + +  + L +A  +
Sbjct: 79  NLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGI 135
Query: 234 HYLHSLSKPIIHRDVKSANVL---LDEN--FVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
            Y+ + + PI+HRD++S N+    LDEN     K+ DFG      TS         L G 
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG------TSQQSVHSVSGLLGN 189
Query: 289 RPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDD 326
             +M PE +  +    + K D +S+ +IL  +LTG  P D+
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/109 (27%), Positives = 51/109 (46%), Gaps = 14/109 (12%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL---LDEN--FVPKLGDFGIVK 505
           P+  + +  + L +A  + Y+ + + PI+HRD++S N+    LDEN     K+ DFG   
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG--- 174
Query: 506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYGAQIKT 551
              TS         L G   +M PE +  +    + K D +S+   + T
Sbjct: 175 ---TSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYT 220

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 66
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 67  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 125
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 295
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 126 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 181
Query: 296 AM-HCQISTKTDVFSYGVILLELLT 319
           A+ +   + K+DV+S+G++L E++T
Sbjct: 182 AINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  NK   +A  +AE + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E + 
Sbjct: 107 LTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 164
Query: 512 VKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYG 546
                 E       +  PEA+ +   + K+DV+S+G
Sbjct: 165 XTA--REGAKFPIKWTAPEAINYGTFTIKSDVWSFG 198

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 65
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 66  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 295
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 180
Query: 296 AM-HCQISTKTDVFSYGVILLELLT 319
           A+ +   + K+DV+S+G++L E++T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  NK   +A  +AE + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E + 
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
Query: 512 VKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYG 546
                 E       +  PEA+ +   + K+DV+S+G
Sbjct: 164 XTA--REGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 73
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 74  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 132
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 295
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 133 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 188
Query: 296 AM-HCQISTKTDVFSYGVILLELLT 319
           A+ +   + K+DV+S+G++L E++T
Sbjct: 189 AINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  NK   +A  +AE + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E + 
Sbjct: 114 LTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 171
Query: 512 VKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYG 546
                 E       +  PEA+ +   + K+DV+S+G
Sbjct: 172 XTA--REGAKFPIKWTAPEAINYGTFTIKSDVWSFG 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 67
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 68  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 126
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 295
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 127 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 182
Query: 296 AM-HCQISTKTDVFSYGVILLELLT 319
           A+ +   + K+DV+S+G++L E++T
Sbjct: 183 AINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  NK   +A  +AE + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E + 
Sbjct: 108 LTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 165
Query: 512 VKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYG 546
                 E       +  PEA+ +   + K+DV+S+G
Sbjct: 166 XTA--REGAKFPIKWTAPEAINYGTFTIKSDVWSFG 199

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 88
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 145
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 146 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 198
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 235

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 131 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 188
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T     L GT  Y+PPE +  ++   K D++S G
Sbjct: 189 RTT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 219

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 65
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 66  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 295
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 180
Query: 296 AM-HCQISTKTDVFSYGVILLELLT 319
           A+ +   + K+DV+S+G++L E++T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  NK   +A  +AE + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E + 
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
Query: 512 VKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYG 546
                 E       +  PEA+ +   + K+DV+S+G
Sbjct: 164 XTA--REGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 71
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 72  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 295
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 131 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 186
Query: 296 AM-HCQISTKTDVFSYGVILLELLT 319
           A+ +   + K+DV+S+G++L E++T
Sbjct: 187 AINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  NK   +A  +AE + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E + 
Sbjct: 112 LTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 169
Query: 512 VKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYG 546
                 E       +  PEA+ +   + K+DV+S+G
Sbjct: 170 XTA--REGAKFPIKWTAPEAINYGTFTIKSDVWSFG 203

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 236
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 237 RHEKLVQLYAVVSEEPIYIVGEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 296 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 349
Query: 294 PE-AMHCQISTKTDVFSYGVILLELLT 319
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 285 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTAR 338
Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 368

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQFG VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 62
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 121
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +   
Sbjct: 122 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 178
Query: 293 PPEAMHCQISTKTDVFSYGVILLELLT-GMKP 323
           P    + + S K+DV+++GV+L E+ T GM P
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/87 (28%), Positives = 46/87 (52%), Gaps = 3/87 (3%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +   
Sbjct: 114 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGA 170
Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYG 546
               +   P    + + S K+DV+++G
Sbjct: 171 KFPIKWTAPESLAYNKFSIKSDVWAFG 197

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-------------GTMSP-EAFLQEAQVMKKL 63
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 64  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 122
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 123 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 176
Query: 294 PE-AMHCQISTKTDVFSYGVILLELLT 319
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 177 PEAALYGRFTIKSDVWSFGILLTELTT 203

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 112 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTAR 165
Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 166 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 195

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 175
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 108 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 165
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T     L GT  Y+PPE +  ++   K D++S G
Sbjct: 166 RTT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 196

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 63
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 120
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 121 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT-----LCGTLDY 173
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 106 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T     L GT  Y+PPE +  ++   K D++S G
Sbjct: 164 RDT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 194

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + KN   I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKNSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 120 ALSYCHS--KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA-----LCGTLDY 172
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 105 FDEQRTATYITELANALSYCHS--KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
                   L GT  Y+PPE +  ++   K D++S G
Sbjct: 163 RAA-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 193

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 74
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 75  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 133
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 295
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 134 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 189
Query: 296 AM-HCQISTKTDVFSYGVILLELLT 319
           A+ +   + K+DV+S+G++L E++T
Sbjct: 190 AINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  NK   +A  +AE + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E + 
Sbjct: 115 LTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 172
Query: 512 VKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYG 546
                 E       +  PEA+ +   + K+DV+S+G
Sbjct: 173 XTA--REGAKFPIKWTAPEAINYGTFTIKSDVWSFG 206

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 67
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 124
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 125 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 177
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 110 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 167
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T     L GT  Y+PPE +  ++   K D++S G
Sbjct: 168 RTT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 198

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 175
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 108 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 165
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T     L GT  Y+PPE +  ++   K D++S G
Sbjct: 166 RTT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 196

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 116 KLGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL-FENEVQTLS 173
           ++G+G FG V+ G+L K+   +A+K+L              E  MI     F+ EV  +S
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSL-------ILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
              H N+++L GL +N    +V E++  G LY RL  ++   P+  + +  + L +A  +
Sbjct: 79  NLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGI 135
Query: 234 HYLHSLSKPIIHRDVKSANVL---LDEN--FVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
            Y+ + + PI+HRD++S N+    LDEN     K+ DFG+ + S  S         L G 
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS------VSGLLGN 189
Query: 289 RPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDD 326
             +M PE +  +    + K D +S+ +IL  +LTG  P D+
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/109 (27%), Positives = 53/109 (48%), Gaps = 14/109 (12%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL---LDEN--FVPKLGDFGIVK 505
           P+  + +  + L +A  + Y+ + + PI+HRD++S N+    LDEN     K+ DFG+ +
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
Query: 506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYGAQIKT 551
            S  S         L G   +M PE +  +    + K D +S+   + T
Sbjct: 178 QSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYT 220

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 88
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 145
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S       ++L GT  Y
Sbjct: 146 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RDDLCGTLDY 198
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 235

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 131 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 188
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
                 ++L GT  Y+PPE +  ++   K D++S G
Sbjct: 189 -----RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 219

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 12  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 61
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 62  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 118
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 119 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 171
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 209

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 104 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 161
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T     L GT  Y+PPE +  ++   K D++S G
Sbjct: 162 RTT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 192

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 67
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G +Y  L +++     D  +  +    +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELAN 124
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 125 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX-----LXGTLDY 177
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 110 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 167
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
                   L GT  Y+PPE +  ++   K D++S G
Sbjct: 168 -----RXXLXGTLDYLPPEMIEGRMHDEKVDLWSLG 198

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 172
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 105 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T     L GT  Y+PPE +  ++   K D++S G
Sbjct: 163 RTT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 193

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 67
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 124
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 125 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 177
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  +    K D++S GV+  E L G  P + N
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 110 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 167
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T     L GT  Y+PPE +  +    K D++S G
Sbjct: 168 RTT-----LCGTLDYLPPEXIEGRXHDEKVDLWSLG 198

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 108/215 (50%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 83
Query: 174 QCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       IV EYM  G+L D L R  N   + +     +A  ++ A
Sbjct: 84  EIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL-RECNREEVTAVVLLYMATQISSA 142
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN V K+ DFG+ ++         YT +     P  
Sbjct: 143 MEYLEK--KNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDT----YTAHAGAKFPIK 196
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ +   S K+DV+++GV+L E+ T GM P
Sbjct: 197 WTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 57/115 (49%), Gaps = 12/115 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN V K+ DFG+ ++         YT +
Sbjct: 135 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDT----YTAH 188
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYGA---QIKTQHITNVDIADRERYYSL 568
                P  +  PE++ +   S K+DV+++G    +I T  ++     D  + Y L
Sbjct: 189 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDL 243

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 17  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 66
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 123
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 124 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 176
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 214

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 109 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 166
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T     L GT  Y+PPE +  ++   K D++S G
Sbjct: 167 RTT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 197

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 69
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 128
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 129 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 182
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +
Sbjct: 121 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAH 174
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 204

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S       ++L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RDDLCGTLDY 175
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 108 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 165
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
                 ++L GT  Y+PPE +  ++   K D++S G
Sbjct: 166 -----RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 294 PE-AMHCQISTKTDVFSYGVILLELLT 319
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTAR 172
Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 202

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-------------GTMSP-EAFLQEAQVMKKL 60
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 61  RHEKLVQLYAVVSEEPIXIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 119
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 295
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E  N  T         +   P  
Sbjct: 120 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPEA 176
Query: 296 AMHCQISTKTDVFSYGVILLELLT 319
           A++ + + K+DV+S+G++L EL T
Sbjct: 177 ALYGRFTIKSDVWSFGILLTELTT 200

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 50/87 (57%), Gaps = 3/87 (3%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E  N  T     
Sbjct: 109 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGA 165
Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYG 546
               +   P  A++ + + K+DV+S+G
Sbjct: 166 KFPIKWTAPEAALYGRFTIKSDVWSFG 192

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 66
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 125
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 126 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 179
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +
Sbjct: 118 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAH 171
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 201

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 66
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 125
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 126 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 179
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +
Sbjct: 118 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAH 171
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 201

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKI 70
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 294 PE-AMHCQISTKTDVFSYGVILLELLT 319
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTAR 172
Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 202

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 69
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 128
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 129 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 182
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +
Sbjct: 121 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAH 174
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 294 PE-AMHCQISTKTDVFSYGVILLELLT 319
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTAR 172
Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 202

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 69
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 128
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 129 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 182
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +
Sbjct: 121 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAH 174
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 204

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 77
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 78  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 136
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 137 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 190
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 191 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 225

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +
Sbjct: 129 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAH 182
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 183 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 212

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 10  GRPLGKGKFGNVYLAREKQRKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 59
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 60  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 116
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 117 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 169
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 207

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 102 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 159
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T     L GT  Y+PPE +  ++   K D++S G
Sbjct: 160 RTT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 190

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 65
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 66  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 124
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +   
Sbjct: 125 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 181
Query: 293 PPEAMHCQISTKTDVFSYGVILLELLT-GMKP 323
           P    + + S K+DV+++GV+L E+ T GM P
Sbjct: 182 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 213

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/87 (28%), Positives = 46/87 (52%), Gaps = 3/87 (3%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +   
Sbjct: 117 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGA 173
Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYG 546
               +   P    + + S K+DV+++G
Sbjct: 174 KFPIKWTAPESLAYNKFSIKSDVWAFG 200

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-------------GTMSP-EAFLQEAQVMKKL 61
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 62  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 120
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 121 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 174
Query: 294 PE-AMHCQISTKTDVFSYGVILLELLT 319
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 175 PEAALYGRFTIKSDVWSFGILLTELTT 201

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 110 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTAR 163
Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 164 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 193

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 123
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +
Sbjct: 116 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAH 169
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 199

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 59
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 60  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 118
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 119 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 172
Query: 294 PE-AMHCQISTKTDVFSYGVILLELLT 319
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 173 PEAALYGRFTIKSDVWSFGILLTELTT 199

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 108 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTAR 161
Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 162 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 191

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 68
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 127
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 128 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 181
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +
Sbjct: 120 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAH 173
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 203

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 123
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +
Sbjct: 116 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAH 169
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 199

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 123
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +
Sbjct: 116 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAH 169
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 199

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 114/219 (52%), Gaps = 25/219 (11%)
Query: 117 LGEGQFGTVYYGKLKNGME----IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK   +    +A+KTL+            +EA++            +
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI------------M 71
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q +H N++RL G+  N M   I+ E+M NG+L D   R+N+       +   +  G+A 
Sbjct: 72  GQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQ-FTVIQLVGMLRGIAS 129
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 290
            + YL  +S   +HRD+ + N+L++ N V K+ DFG+ +  E ++     T +L G  P 
Sbjct: 130 GMRYLAEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPI 187
Query: 291 -YMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDD 326
            +  PEA+  +  ++ +D +SYG+++ E+++ G +P  D
Sbjct: 188 RWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD 226

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 5/87 (5%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +S   +HRD+ + N+L++ N V K+ DFG+ +  E ++     T +L G
Sbjct: 126 GIASGMRYLAEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGG 183
Query: 523 TRP--YMPPEAMHCQ-ISTKTDVFSYG 546
             P  +  PEA+  +  ++ +D +SYG
Sbjct: 184 KIPIRWTAPEAIAFRKFTSASDAWSYG 210

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 123
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +
Sbjct: 116 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAH 169
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 199

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 61
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 62  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 120
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +    +  IHR++++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 121 IEE--RNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 174
Query: 294 PEAM-HCQISTKTDVFSYGVILLELLT 319
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 175 PEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  NK   +A  +AE + ++    +  IHR++++AN+L+ +    K+ DFG+ ++ E + 
Sbjct: 102 LTINKLLDMAAQIAEGMAFIEE--RNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNE 159
Query: 512 VKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
               YT       P  +  PEA+ +   + K+DV+S+G
Sbjct: 160 ----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 193

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 294 PE-AMHCQISTKTDVFSYGVILLELLT 319
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTAR 172
Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 202

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 69
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 128
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 129 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 182
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +
Sbjct: 121 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAH 174
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 204

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 123
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +
Sbjct: 116 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAH 169
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 199

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 67
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 124
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S        +L GT  Y
Sbjct: 125 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----DLCGTLDY 177
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 110 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 167
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
                  +L GT  Y+PPE +  ++   K D++S G
Sbjct: 168 -----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 198

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 69
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 128
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +   
Sbjct: 129 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 185
Query: 293 PPEAMHCQISTKTDVFSYGVILLELLT-GMKP 323
           P    + + S K+DV+++GV+L E+ T GM P
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/87 (28%), Positives = 46/87 (52%), Gaps = 3/87 (3%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +   
Sbjct: 121 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGA 177
Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYG 546
               +   P    + + S K+DV+++G
Sbjct: 178 KFPIKWTAPESLAYNKFSIKSDVWAFG 204

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 62
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 121
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +   
Sbjct: 122 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 178
Query: 293 PPEAMHCQISTKTDVFSYGVILLELLT-GMKP 323
           P    + + S K+DV+++GV+L E+ T GM P
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/87 (28%), Positives = 46/87 (52%), Gaps = 3/87 (3%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +   
Sbjct: 114 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGA 170
Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYG 546
               +   P    + + S K+DV+++G
Sbjct: 171 KFPIKWTAPESLAYNKFSIKSDVWAFG 197

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 63
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 120
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S        +L GT  Y
Sbjct: 121 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----DLCGTLDY 173
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 106 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
                  +L GT  Y+PPE +  ++   K D++S G
Sbjct: 164 -----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 194

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 123
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +
Sbjct: 116 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAH 169
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 199

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S        +L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----DLCGTLDY 172
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 105 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
                  +L GT  Y+PPE +  ++   K D++S G
Sbjct: 163 -----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S        +L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----DLCGTLDY 172
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 105 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
                  +L GT  Y+PPE +  ++   K D++S G
Sbjct: 163 -----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 295
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E  N  T         +   P  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPEA 186
Query: 296 AMHCQISTKTDVFSYGVILLELLT 319
           A++ + + K+DV+S+G++L EL T
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 50/87 (57%), Gaps = 3/87 (3%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E  N  T     
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGA 175
Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYG 546
               +   P  A++ + + K+DV+S+G
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFG 202

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA-----LCGTLDY 172
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 105 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
                   L GT  Y+PPE +  ++   K D++S G
Sbjct: 163 RAA-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 193

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 64
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 121
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 122 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX-----LCGTLDY 174
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 107 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 164
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
                   L GT  Y+PPE +  ++   K D++S G
Sbjct: 165 -----RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLG 195

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 84
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 85  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 142
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 143 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEXXSVHNKTGAKL 198
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 243

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     
Sbjct: 136 GFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEXXSVH 191
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 192 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 224

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA-----LCGTLDY 175
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 108 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 165
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
                   L GT  Y+PPE +  ++   K D++S G
Sbjct: 166 RAA-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 196

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 66
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 125
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT       P  
Sbjct: 126 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAPAGAKFPIK 179
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT  
Sbjct: 118 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAP 171
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 201

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 65
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 66  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 124
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT       P  
Sbjct: 125 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAPAGAKFPIK 178
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 213

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT  
Sbjct: 117 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAP 170
Query: 520 LTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                P  +  PE++ + + S K+DV+++G
Sbjct: 171 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 200

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 64
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 121
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ +FG    + +S   T     L GT  Y
Sbjct: 122 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT-----LCGTLDY 174
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ +FG    + +S 
Sbjct: 107 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR 164
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T     L GT  Y+PPE +  ++   K D++S G
Sbjct: 165 RTT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 195

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX-----LCGTLDY 175
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 108 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 165
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
                   L GT  Y+PPE +  ++   K D++S G
Sbjct: 166 -----RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----ELCGTLDY 172
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 327
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 105 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
                   L GT  Y+PPE +  ++   K D++S G
Sbjct: 163 -----RTELCGTLDYLPPEMIEGRMHDEKVDLWSLG 193

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +  ++   +HRD+ +AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLAAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 294 PE-AMHCQISTKTDVFSYGVILLELLT 319
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 52/90 (57%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+ +AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLAAANILVGENLVCKVADFGLARLIEDNE----YTAR 172
Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 202

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX-----LCGTLDY 172
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 105 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
                   L GT  Y+PPE +  ++   K D++S G
Sbjct: 163 -----RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 62
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 121
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +   
Sbjct: 122 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTA 178
Query: 293 PPEAMHCQISTKTDVFSYGVILLELLT-GMKP 323
           P    + + S K+DV+++GV+L E+ T GM P
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/87 (28%), Positives = 46/87 (52%), Gaps = 3/87 (3%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +   
Sbjct: 114 MATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGA 170
Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYG 546
               +   P    + + S K+DV+++G
Sbjct: 171 KFPIKWTAPESLAYNKFSIKSDVWAFG 197

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTX-----LCGTLDY 172
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S 
Sbjct: 105 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
                   L GT  Y+PPE +  ++   K D++S G
Sbjct: 163 -----RTXLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 32/211 (15%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGNMSP-EAFLQEAQVMKKL 237
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYD----RLARVNNTPPLDSNKRYSIALGVAE 231
           +H  L++L  + +     IV EYM  GSL D     + +    P L       +A  +A 
Sbjct: 238 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-----VDMAAQIAS 292
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 290
            + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P 
Sbjct: 293 GMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLGRLIEDNE----YTARQGAKFPI 346
Query: 291 -YMPPE-AMHCQISTKTDVFSYGVILLELLT 319
            +  PE A++ + + K+DV+S+G++L EL T
Sbjct: 347 KWTAPEAALYGRFTIKSDVWSFGILLTELTT 377

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 286 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLGRLIEDNE----YTAR 339
Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 340 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 369

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-------------GTMSP-EAFLQEAQVMKKL 67
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   ++  +A  + Y
Sbjct: 68  RHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 127 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 180
Query: 294 PE-AMHCQISTKTDVFSYGVILLELLT 319
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 51/86 (59%), Gaps = 9/86 (10%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT      
Sbjct: 120 IASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAK 173
Query: 524 RP--YMPPE-AMHCQISTKTDVFSYG 546
            P  +  PE A++ + + K+DV+S+G
Sbjct: 174 FPIKWTAPEAALYGRFTIKSDVWSFG 199

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ +FG    + +S   T     L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT-----LCGTLDY 175
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ +FG    + +S 
Sbjct: 108 FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR 165
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T     L GT  Y+PPE +  ++   K D++S G
Sbjct: 166 RTT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLG 196

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 83
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 84  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 141
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 142 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 197
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 242

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     
Sbjct: 135 GFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVH 190
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 191 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 223

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 85
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 143
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 144 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 199
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     
Sbjct: 137 GFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVH 192
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 193 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 225

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 84
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 85  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 142
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 143 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 198
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 243

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     
Sbjct: 136 GFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVH 191
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 192 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 224

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 103
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 104 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 161
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 162 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 217
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 218 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 262

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     
Sbjct: 155 GFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVH 210
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 211 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 243

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 85
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 143
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 144 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 199
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     
Sbjct: 137 GFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVH 192
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 193 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 225

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 82
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 83  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 140
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 141 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 196
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     
Sbjct: 134 GFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVH 189
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 222

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 80
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 81  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 138
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 139 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 194
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     
Sbjct: 132 GFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVH 187
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 188 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 220

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            +LG GQFG V YGK +   ++A+K ++             E +M      E E + +  
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMN 59
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H  L++L G+C       I+ EYM NG L + L  + +     + +   +   V EA+
Sbjct: 60  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 117
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 291
            YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++    P  +
Sbjct: 118 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRW 171
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLT 319
            PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 172 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 9/87 (10%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           V EA+ YL S  K  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++   
Sbjct: 113 VCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSK 166
Query: 524 RP--YMPPEA-MHCQISTKTDVFSYGA 547
            P  + PPE  M+ + S+K+D++++G 
Sbjct: 167 FPVRWSPPEVLMYSKFSSKSDIWAFGV 193

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 116 KLGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL-FENEVQTLS 173
           ++G+G FG V+ G+L K+   +A+K+L              E  MI     F+ EV  +S
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSL-------ILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
              H N+++L GL +N    +V E++  G LY RL  ++   P+  + +  + L +A  +
Sbjct: 79  NLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGI 135
Query: 234 HYLHSLSKPIIHRDVKSANVL---LDEN--FVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
            Y+ + + PI+HRD++S N+    LDEN     K+ DF + + S  S         L G 
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHS------VSGLLGN 189
Query: 289 RPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDD 326
             +M PE +  +    + K D +S+ +IL  +LTG  P D+
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/109 (26%), Positives = 52/109 (47%), Gaps = 14/109 (12%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL---LDEN--FVPKLGDFGIVK 505
           P+  + +  + L +A  + Y+ + + PI+HRD++S N+    LDEN     K+ DF + +
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177
Query: 506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYGAQIKT 551
            S  S         L G   +M PE +  +    + K D +S+   + T
Sbjct: 178 QSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYT 220

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  G L D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 294 PE-AMHCQISTKTDVFSYGVILLELLT 319
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTAR 172
Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 202

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            +LG GQFG V+ G   N  ++AVKTL+                 + +  F  E   +  
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLK--------------PGTMSVQAFLEEANLMKT 64
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
            +H  L+RL  +        I+ EYM  GSL D L + +    +   K    +  +AE +
Sbjct: 65  LQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGM 123
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 291
            Y+    K  IHRD+++ANVL+ E+ + K+ DFG+ ++ E +     YT       P  +
Sbjct: 124 AYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE----YTAREGAKFPIKW 177
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT 319
             PEA++    T K+DV+S+G++L E++T
Sbjct: 178 TAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 50/86 (58%), Gaps = 9/86 (10%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +AE + Y+    K  IHRD+++ANVL+ E+ + K+ DFG+ ++ E +     YT      
Sbjct: 119 IAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE----YTAREGAK 172
Query: 524 RP--YMPPEAMHCQIST-KTDVFSYG 546
            P  +  PEA++    T K+DV+S+G
Sbjct: 173 FPIKWTAPEAINFGCFTIKSDVWSFG 198

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  G L D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 293
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 294 PE-AMHCQISTKTDVFSYGVILLELLT 319
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +A  +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT  
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTAR 172
Query: 520 LTGTRP--YMPPE-AMHCQISTKTDVFSYG 546
                P  +  PE A++ + + K+DV+S+G
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG 202

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG GQ G V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 65
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 66  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 295
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTA--REGAKFPIKWTAPE 180
Query: 296 AM-HCQISTKTDVFSYGVILLELLT 319
           A+ +   + K+DV+S+G++L E++T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L  NK   +A  +AE + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E  +
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIE--D 161
Query: 512 VKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYG 546
            +    E       +  PEA+ +   + K+DV+S+G
Sbjct: 162 AEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 104
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 105 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 162
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 163 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 218
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 219 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 263

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     
Sbjct: 156 GFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVH 211
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 212 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 244

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 77
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 78  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 135
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 136 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 191
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 192 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 236

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     
Sbjct: 129 GFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVH 184
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 185 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 217

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            +LG GQFG V YGK +   ++A+K ++             E +M      E E + +  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMN 55
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H  L++L G+C       I+ EYM NG L + L  + +     + +   +   V EA+
Sbjct: 56  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 113
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 291
            YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++    P  +
Sbjct: 114 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRW 167
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLT 319
            PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 9/87 (10%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           V EA+ YL S  K  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++   
Sbjct: 109 VCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSK 162
Query: 524 RP--YMPPEA-MHCQISTKTDVFSYGA 547
            P  + PPE  M+ + S+K+D++++G 
Sbjct: 163 FPVRWSPPEVLMYSKFSSKSDIWAFGV 189

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            +LG GQFG V YGK +   ++A+K ++             E +M      E E + +  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMN 75
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H  L++L G+C       I+ EYM NG L + L  + +     + +   +   V EA+
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 133
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 291
            YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++    P  +
Sbjct: 134 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRW 187
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLT 319
            PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 50/86 (58%), Gaps = 9/86 (10%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           V EA+ YL S  K  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++   
Sbjct: 129 VCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSK 182
Query: 524 RP--YMPPEA-MHCQISTKTDVFSYG 546
            P  + PPE  M+ + S+K+D++++G
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFG 208

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            +LG GQFG V YGK +   ++A+K ++             E +M      E E + +  
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMN 66
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H  L++L G+C       I+ EYM NG L + L  + +     + +   +   V EA+
Sbjct: 67  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 124
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 291
            YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++    P  +
Sbjct: 125 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRW 178
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLT 319
            PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 179 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 9/87 (10%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           V EA+ YL S  K  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++   
Sbjct: 120 VCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSK 173
Query: 524 RP--YMPPEA-MHCQISTKTDVFSYGA 547
            P  + PPE  M+ + S+K+D++++G 
Sbjct: 174 FPVRWSPPEVLMYSKFSSKSDIWAFGV 200

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            +LG GQFG V YGK +   ++A+K ++             E +M      E E + +  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMN 60
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H  L++L G+C       I+ EYM NG L + L  + +     + +   +   V EA+
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 118
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 291
            YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++    P  +
Sbjct: 119 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRW 172
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLT 319
            PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 173 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 9/87 (10%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           V EA+ YL S  K  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++   
Sbjct: 114 VCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSK 167
Query: 524 RP--YMPPEA-MHCQISTKTDVFSYGA 547
            P  + PPE  M+ + S+K+D++++G 
Sbjct: 168 FPVRWSPPEVLMYSKFSSKSDIWAFGV 194

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKP-------------GTMSP-EAFLQEAQVMKKL 67
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           +H  L++L  + +     IV EYM  GSL D L +      L   +   ++  +A  + Y
Sbjct: 68  RHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE----TSNMKTMYTENLTGTRPY 291
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E    T+     +    T     
Sbjct: 127 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTA---- 180
Query: 292 MPPEAMHCQISTKTDVFSYGVILLELLT 319
            P  A++ + + K+DV+S+G++L EL T
Sbjct: 181 -PEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 51/86 (59%), Gaps = 9/86 (10%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     +T      
Sbjct: 120 IASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----WTARQGAK 173
Query: 524 RP--YMPPE-AMHCQISTKTDVFSYG 546
            P  +  PE A++ + + K+DV+S+G
Sbjct: 174 FPIKWTAPEAALYGRFTIKSDVWSFG 199

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 32/208 (15%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G+G+FG V  G  + G ++AVK ++                      F  E   ++Q +
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASVMTQLR 72
Query: 177 HVNLLRLLGLCNNIMNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           H NL++LLG+         IV EYM  GSL D L R      L  +     +L V EA+ 
Sbjct: 73  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 292
           YL       +HRD+ + NVL+ E+ V K+ DFG+ K  E S+ +       TG  P  + 
Sbjct: 132 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD------TGKLPVKWT 181
Query: 293 PPEAMH-CQISTKTDVFSYGVILLELLT 319
            PEA+   + STK+DV+S+G++L E+ +
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 13/90 (14%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
            +L V EA+ YL       +HRD+ + NVL+ E+ V K+ DFG+ K  E S+ +      
Sbjct: 122 FSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD----- 172
Query: 520 LTGTRP--YMPPEAMH-CQISTKTDVFSYG 546
            TG  P  +  PEA+   + STK+DV+S+G
Sbjct: 173 -TGKLPVKWTAPEALREKKFSTKSDVWSFG 201

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 32/206 (15%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G+G+FG V  G  + G ++AVK ++                      F  E   ++Q +
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASVMTQLR 63
Query: 177 HVNLLRLLGLCNNIMNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           H NL++LLG+         IV EYM  GSL D L R      L  +     +L V EA+ 
Sbjct: 64  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 122
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 292
           YL       +HRD+ + NVL+ E+ V K+ DFG+ K  E S+ +       TG  P  + 
Sbjct: 123 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD------TGKLPVKWT 172
Query: 293 PPEAMH-CQISTKTDVFSYGVILLEL 317
            PEA+     STK+DV+S+G++L E+
Sbjct: 173 APEALREAAFSTKSDVWSFGILLWEI 198

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 13/90 (14%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
            +L V EA+ YL       +HRD+ + NVL+ E+ V K+ DFG+ K  E S+ +      
Sbjct: 113 FSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD----- 163
Query: 520 LTGTRP--YMPPEAMH-CQISTKTDVFSYG 546
            TG  P  +  PEA+     STK+DV+S+G
Sbjct: 164 -TGKLPVKWTAPEALREAAFSTKSDVWSFG 192

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 83
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 84  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 141
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 142 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 197
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 242

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  
Sbjct: 135 GFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-- 190
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 191 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 223

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 85
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 143
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 144 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 199
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  
Sbjct: 137 GFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-- 192
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 193 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 225

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 310
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 311 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 369
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHR++ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 370 MEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 423
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 424 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 458

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 114/230 (49%), Gaps = 39/230 (16%)
Query: 116 KLGEGQFGTVYYGKLKN------GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LGEG FG V+  +  N       M +AVK L+             EA+      F+ E 
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-------------EASESARQDFQREA 65
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNT-------------P 215
           + L+  +H +++R  G+C      + V+EYM +G L +R  R +                
Sbjct: 66  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPG 124
Query: 216 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 275
           PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG+ +   ++
Sbjct: 125 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 182
Query: 276 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 323
           +   +    +   R +MPPE+ ++ + +T++DV+S+GV+L E+ T G +P
Sbjct: 183 DYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG+ +   ++
Sbjct: 125 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 182
Query: 511 NVKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYG 546
           +   +    +   R +MPPE+ ++ + +T++DV+S+G
Sbjct: 183 DYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFG 218

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 271
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + KH NL++LLG+C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 272 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 330
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 290
           + YL    K  IHR++ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 331 MEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 384
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 85
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 143
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 144 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 199
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  
Sbjct: 137 GFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-- 192
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 193 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 225

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 90
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 91  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 148
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 149 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 204
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 205 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 249

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  
Sbjct: 142 GFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-- 197
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 198 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 230

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 86
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 87  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 144
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 145 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 200
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 245

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  
Sbjct: 138 GFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-- 193
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 194 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 226

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G+G+FG V  G  + G ++AVK ++                      F  E   ++Q +
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASVMTQLR 244
Query: 177 HVNLLRLLGLCNNIMNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           H NL++LLG+         IV EYM  GSL D L R      L  +     +L V EA+ 
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 292
           YL       +HRD+ + NVL+ E+ V K+ DFG+ K + ++          TG  P  + 
Sbjct: 304 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--------TGKLPVKWT 353
Query: 293 PPEAMH-CQISTKTDVFSYGVILLELLT 319
            PEA+   + STK+DV+S+G++L E+ +
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 13/90 (14%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
            +L V EA+ YL       +HRD+ + NVL+ E+ V K+ DFG+ K  E S+ +      
Sbjct: 294 FSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD----- 344
Query: 520 LTGTRP--YMPPEAMH-CQISTKTDVFSYG 546
            TG  P  +  PEA+   + STK+DV+S+G
Sbjct: 345 -TGKLPVKWTAPEALREKKFSTKSDVWSFG 373

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 32/206 (15%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G+G+FG V  G  + G ++AVK ++                      F  E   ++Q +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASVMTQLR 57
Query: 177 HVNLLRLLGLCNNIMNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           H NL++LLG+         IV EYM  GSL D L R      L  +     +L V EA+ 
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 292
           YL       +HRD+ + NVL+ E+ V K+ DFG+ K  E S+ +       TG  P  + 
Sbjct: 117 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD------TGKLPVKWT 166
Query: 293 PPEAMH-CQISTKTDVFSYGVILLEL 317
            PEA+   + STK+DV+S+G++L E+
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEI 192

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 13/90 (14%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
            +L V EA+ YL       +HRD+ + NVL+ E+ V K+ DFG+ K  E S+ +      
Sbjct: 107 FSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD----- 157
Query: 520 LTGTRP--YMPPEAMH-CQISTKTDVFSYG 546
            TG  P  +  PEA+   + STK+DV+S+G
Sbjct: 158 -TGKLPVKWTAPEALREKKFSTKSDVWSFG 186

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 114/230 (49%), Gaps = 39/230 (16%)
Query: 116 KLGEGQFGTVYYGKLKN------GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LGEG FG V+  +  N       M +AVK L+             EA+      F+ E 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-------------EASESARQDFQREA 94
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNT-------------P 215
           + L+  +H +++R  G+C      + V+EYM +G L +R  R +                
Sbjct: 95  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPG 153
Query: 216 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 275
           PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG+ +   ++
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 276 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 323
           +   +    +   R +MPPE+ ++ + +T++DV+S+GV+L E+ T G +P
Sbjct: 212 DYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG+ +   ++
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 511 NVKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYG 546
           +   +    +   R +MPPE+ ++ + +T++DV+S+G
Sbjct: 212 DYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFG 247

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 115/230 (50%), Gaps = 39/230 (16%)
Query: 116 KLGEGQFGTVYYGKLKN------GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LGEG FG V+  +  N       M +AVK L+             EA+      F+ E 
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-------------EASESARQDFQREA 71
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNN------------TP- 215
           + L+  +H +++R  G+C      + V+EYM +G L +R  R +              P 
Sbjct: 72  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPG 130
Query: 216 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 275
           PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG+ +   ++
Sbjct: 131 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 188
Query: 276 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 323
           +   +    +   R +MPPE+ ++ + +T++DV+S+GV+L E+ T G +P
Sbjct: 189 DYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG+ +   ++
Sbjct: 131 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 188
Query: 511 NVKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYG 546
           +   +    +   R +MPPE+ ++ + +T++DV+S+G
Sbjct: 189 DYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFG 224

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            +LG GQFG V YGK +   ++A+K ++             E +M      E E + +  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMN 60
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H  L++L G+C       I+ EYM NG L + L  + +     + +   +   V EA+
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 118
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 291
            YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT +     P  +
Sbjct: 119 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSRGSKFPVRW 172
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLT 319
            PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 173 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 9/87 (10%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           V EA+ YL S  K  +HRD+ + N L+++  V K+ DFG+ +      +   YT +    
Sbjct: 114 VCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSRGSK 167
Query: 524 RP--YMPPEA-MHCQISTKTDVFSYGA 547
            P  + PPE  M+ + S+K+D++++G 
Sbjct: 168 FPVRWSPPEVLMYSKFSSKSDIWAFGV 194

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 86
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 87  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 144
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 145 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVH--NKTGAKL 200
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 245

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  
Sbjct: 138 GFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVH-- 193
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 194 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 226

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            +LG GQFG V YGK +   ++A+K ++             E +M      E E + +  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMN 75
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H  L++L G+C       I+ EYM NG L + L  + +     + +   +   V EA+
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 133
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM----SETSNMKTMYTENLTGTR 289
            YL   SK  +HRD+ + N L+++  V K+ DFG+ +      ETS++ + +        
Sbjct: 134 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR----- 186
Query: 290 PYMPPEA-MHCQISTKTDVFSYGVILLELLT 319
            + PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 187 -WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 51/88 (57%), Gaps = 13/88 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM----SETSNVKTMYTEN 519
           V EA+ YL S  K  +HRD+ + N L+++  V K+ DFG+ +      ETS+V + +   
Sbjct: 129 VCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR 186
Query: 520 LTGTRPYMPPEA-MHCQISTKTDVFSYG 546
                 + PPE  M+ + S+K+D++++G
Sbjct: 187 ------WSPPEVLMYSKFSSKSDIWAFG 208

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 117 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 144
Query: 173 SQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L LLG+C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 202
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 289
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 203 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 258
Query: 290 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 330
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
              L VA+ + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  
Sbjct: 196 GFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-- 251
Query: 519 NLTGTR---PYMPPEAMHCQ-ISTKTDVFSYGA 547
           N TG +    +M  E++  Q  +TK+DV+S+G 
Sbjct: 252 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 284

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 126/266 (47%), Gaps = 58/266 (21%)
Query: 110 YPRRG----NKLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAM 159
           YPR        +GEG FG V+  +    +       +AVK L+             EA+ 
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK------------EEASA 91
Query: 160 IPILLFENEVQTLSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRL---------- 208
                F+ E   +++  + N+++LLG+C      C+++EYM  G L + L          
Sbjct: 92  DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 151
Query: 209 ---------ARVNNT--PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE 257
                    ARV++   PPL   ++  IA  VA  + YL    +  +HRD+ + N L+ E
Sbjct: 152 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGE 209
Query: 258 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLE 316
           N V K+ DFG+ +   +++       +    R +MPPE++ + + +T++DV++YGV+L E
Sbjct: 210 NMVVKIADFGLSRNIYSADYYKADGNDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWE 268
Query: 317 LLT-GMKPIDDNNTILYYYLVVEQEV 341
           + + G++P         YY +  +EV
Sbjct: 269 IFSYGLQP---------YYGMAHEEV 285

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 61/106 (57%), Gaps = 6/106 (5%)
Query: 444 ARVNNT--PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 501
           ARV++   PPL   ++  IA  VA  + YL    +  +HRD+ + N L+ EN V K+ DF
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIADF 218
Query: 502 GIVKMSETSNVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYG 546
           G+ +   +++       +    R +MPPE++ + + +T++DV++YG
Sbjct: 219 GLSRNIYSADYYKADGNDAIPIR-WMPPESIFYNRYTTESDVWAYG 263

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 102/234 (43%), Gaps = 24/234 (10%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +++G+G FG VY G   +  E+ A+K ++                       + E+  LS
Sbjct: 25  DRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDI------------QQEITVLS 72
Query: 174 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           QC    + R  G    +    I+ EY+  GS  D L       PL+     +I   + + 
Sbjct: 73  QCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKG 128
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLHS  K  IHRD+K+ANVLL E    KL DFG+      + +K        GT  +M
Sbjct: 129 LDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNXFVGTPFWM 183
Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 345
            PE +       K D++S G+  +EL  G  P  D + +   +L+ +   P  E
Sbjct: 184 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLE 237

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 55/113 (48%), Gaps = 11/113 (9%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL+     +I   + + L YLHS  K  IHRD+K+ANVLL E    KL DFG+      +
Sbjct: 112 PLEETYIATILREILKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 169
Query: 511 NVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRE 563
            +K        GT  +M PE +      K   + + A I +  IT +++A  E
Sbjct: 170 QIK---RNXFVGTPFWMAPEVI------KQSAYDFKADIWSLGITAIELAKGE 213

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 138/297 (46%), Gaps = 35/297 (11%)
Query: 113 RGNKLGEGQFGTVYYGKLKNG-----MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 167
           R   +G G+FG VY G LK       + +A+KTL+            TE   +  L    
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---------TEKQRVDFL---G 95
Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           E   + Q  H N++RL G+ +      I+ EYM NG+L D+  R  +       +   + 
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGE-FSVLQLVGML 153
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
            G+A  + YL +++   +HRD+ + N+L++ N V K+ DFG+ ++ E     T  T    
Sbjct: 154 RGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 287 GTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR 344
               +  PEA+ + + ++ +DV+S+G+++ E++T G +P         Y+ +   E  V 
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP---------YWELSNHE--VM 260
Query: 345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCNSLANL 401
           + ++            + I  +  +C   E+ +R    DIV +L K +   +SL  L
Sbjct: 261 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 317

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 49/85 (57%), Gaps = 3/85 (3%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL +++   +HRD+ + N+L++ N V K+ DFG+ ++ E     T  T     
Sbjct: 155 GIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 523 TRPYMPPEAM-HCQISTKTDVFSYG 546
              +  PEA+ + + ++ +DV+S+G
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFG 237

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            KLG GQFG V+ G   N  ++AVKTL+                 + +  F  E   +  
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLK--------------PGTMSVQAFLEEANLMKT 63
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
            +H  L+RL  +        I+ E+M  GSL D L + +    +   K    +  +AE +
Sbjct: 64  LQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGM 122
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 291
            Y+    K  IHRD+++ANVL+ E+ + K+ DFG+ ++ E +     YT       P  +
Sbjct: 123 AYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE----YTAREGAKFPIKW 176
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT 319
             PEA++    T K++V+S+G++L E++T
Sbjct: 177 TAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 50/86 (58%), Gaps = 9/86 (10%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +AE + Y+    K  IHRD+++ANVL+ E+ + K+ DFG+ ++ E +     YT      
Sbjct: 118 IAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE----YTAREGAK 171
Query: 524 RP--YMPPEAMHCQIST-KTDVFSYG 546
            P  +  PEA++    T K++V+S+G
Sbjct: 172 FPIKWTAPEAINFGCFTIKSNVWSFG 197

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            ++G GQFG V+ G   N  ++A+KT+              E AM      E E + + +
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-------------EGAMSEEDFIE-EAEVMMK 58
Query: 175 CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H  L++L G+C      C+V+E+M +G L D L          +     + L V E +
Sbjct: 59  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 116
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 290
            YL   S  +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 117 AYLEEAS--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 169
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN 328
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 170 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 209

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 11/92 (11%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
            + L V E + YL   S  +IHRD+ + N L+ EN V K+ DFG+ +      +   YT 
Sbjct: 107 GMCLDVCEGMAYLEEAS--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTS 160
Query: 519 NLTGTR---PYMPPEAM-HCQISTKTDVFSYG 546
           + TGT+    +  PE     + S+K+DV+S+G
Sbjct: 161 S-TGTKFPVKWASPEVFSFSRYSSKSDVWSFG 191

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            +LG GQFG V  GK K   ++AVK ++             E +M     F+ E QT+ +
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIK-------------EGSMSEDEFFQ-EAQTMMK 59
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H  L++  G+C+      IV EY+ NG L + L   ++   L+ ++   +   V E +
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGM 117
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 291
            +L   S   IHRD+ + N L+D +   K+ DFG+ +      +   Y  ++    P  +
Sbjct: 118 AFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVGTKFPVKW 171
Query: 292 MPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPID 325
             PE  H  + S+K+DV+++G+++ E+ + G  P D
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 38/231 (16%)
Query: 115 NKLGEGQFGTVYYGKL------KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENE 168
            +LGEG FG V+  +       K+ M +AVK L+                      F+ E
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-------------FQRE 67
Query: 169 VQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLY--------DRLARVNNTP---- 215
            + L+  +H ++++  G+C +    I V+EYM +G L         D +  V+  P    
Sbjct: 68  AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 216 -PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 274
             L  ++   IA  +A  + YL   S+  +HRD+ + N L+  N + K+GDFG+ +   +
Sbjct: 128 GELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
Query: 275 SNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 323
           ++   +    +   R +MPPE+ M+ + +T++DV+S+GVIL E+ T G +P
Sbjct: 186 TDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 71/136 (52%), Gaps = 14/136 (10%)
Query: 412 ENNNINWELHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYL 471
           ++ ++N  L   G   +IL  G+ +Q +            L  ++   IA  +A  + YL
Sbjct: 100 KHGDLNKFLRAHGPDAMILVDGQPRQAK----------GELGLSQMLHIASQIASGMVYL 149
Query: 472 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEA 531
              S+  +HRD+ + N L+  N + K+GDFG+ +   +++   +    +   R +MPPE+
Sbjct: 150 --ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR-WMPPES 206
Query: 532 -MHCQISTKTDVFSYG 546
            M+ + +T++DV+S+G
Sbjct: 207 IMYRKFTTESDVWSFG 222

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 109/248 (43%), Gaps = 33/248 (13%)
Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
            ++G G FG VY+ + ++N   +A+K +                          EV+ L 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD----------IIKEVRFLQ 70
Query: 174 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + +H N ++  G         +V EY C GS  D L    +  PL   +  ++  G  + 
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLE--VHKKPLQEVEIAAVTHGALQG 127
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLHS +  +IHRDVK+ N+LL E  + KLGDFG   +   +N          GT  +M
Sbjct: 128 LAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWM 178
Query: 293 PPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 348
            PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + E P      
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---- 234
Query: 349 KEAGEWNE 356
            ++G W+E
Sbjct: 235 -QSGHWSE 241

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 20/117 (17%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL   +  ++  G  + L YLHS +  +IHRDVK+ N+LL E  + KLGDFG   +   +
Sbjct: 111 PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 511 NVKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGAQIKTQHITNVDIADRE 563
           N          GT  +M PE +      Q   K DV+S G       IT +++A+R+
Sbjct: 169 N-------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-------ITCIELAERK 211

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 109/248 (43%), Gaps = 33/248 (13%)
Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
            ++G G FG VY+ + ++N   +A+K +                          EV+ L 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD----------IIKEVRFLQ 109
Query: 174 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + +H N ++  G         +V EY C GS  D L    +  PL   +  ++  G  + 
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLE--VHKKPLQEVEIAAVTHGALQG 166
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLHS +  +IHRDVK+ N+LL E  + KLGDFG   +   +N          GT  +M
Sbjct: 167 LAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-------XFVGTPYWM 217
Query: 293 PPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 348
            PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + E P      
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---- 273
Query: 349 KEAGEWNE 356
            ++G W+E
Sbjct: 274 -QSGHWSE 280

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 20/117 (17%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL   +  ++  G  + L YLHS +  +IHRDVK+ N+LL E  + KLGDFG   +   +
Sbjct: 150 PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207
Query: 511 NVKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGAQIKTQHITNVDIADRE 563
           N          GT  +M PE +      Q   K DV+S G       IT +++A+R+
Sbjct: 208 N-------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-------ITCIELAERK 250

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           K+G+G FG V+ G + N  +  +A+K ++                       + E+  LS
Sbjct: 14  KIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDI------------QQEITVLS 60
Query: 174 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           QC    + +  G    +    I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 116
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      + +K        GT  +M
Sbjct: 117 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWM 171
Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 345
            PE +      +K D++S G+  +EL  G  P  + + +   +L+ +   P  E
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE 225

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 60/118 (50%), Gaps = 13/118 (11%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PLD  +  +I   + + L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      +
Sbjct: 100 PLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157
Query: 511 NVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGAQIKTQHITNVDIADRERYYS 567
            +K        GT  +M PE +      +K D++S G       IT +++A  E  +S
Sbjct: 158 QIK---RNTFVGTPFWMAPEVIKQSAYDSKADIWSLG-------ITAIELARGEPPHS 205

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 106/232 (45%), Gaps = 32/232 (13%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G G FG VY      G E+AVK                            E +  +  K
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIEN---------VRQEAKLFAMLK 64
Query: 177 HVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
           H N++ L G+C    N C+V E+   G L +R+      PP   +   + A+ +A  ++Y
Sbjct: 65  HPNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPP---DILVNWAVQIARGMNY 120
Query: 236 LHSLS-KPIIHRDVKSANVLLDE--------NFVPKLGDFGIVK-MSETSNMKTMYTENL 285
           LH  +  PIIHRD+KS+N+L+ +        N + K+ DFG+ +    T+ M        
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA------ 174
Query: 286 TGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLV 336
            G   +M PE +   + +K +DV+SYGV+L ELLTG  P    + +   Y V
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV 226

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 64/129 (49%), Gaps = 21/129 (16%)
Query: 434 ETKQCQLFKLARVNNTPPLDSNKR------YSIALGVAEALHYLHSLS-KPIIHRDVKSA 486
           E   C + + AR      + S KR       + A+ +A  ++YLH  +  PIIHRD+KS+
Sbjct: 78  EPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137
Query: 487 NVLLDE--------NFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQIST 538
           N+L+ +        N + K+ DFG+ +  E      M   +  G   +M PE +   + +
Sbjct: 138 NILILQKVENGDLSNKILKITDFGLAR--EWHRTTKM---SAAGAYAWMAPEVIRASMFS 192
Query: 539 K-TDVFSYG 546
           K +DV+SYG
Sbjct: 193 KGSDVWSYG 201

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           K+G+G FG V+ G + N  +  +A+K ++                       + E+  LS
Sbjct: 29  KIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDI------------QQEITVLS 75
Query: 174 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           QC    + +  G    +    I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 76  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 131
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      + +K        GT  +M
Sbjct: 132 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNXFVGTPFWM 186
Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 345
            PE +      +K D++S G+  +EL  G  P  + + +   +L+ +   P  E
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE 240

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 60/118 (50%), Gaps = 13/118 (11%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PLD  +  +I   + + L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      +
Sbjct: 115 PLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172
Query: 511 NVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGAQIKTQHITNVDIADRERYYS 567
            +K        GT  +M PE +      +K D++S G       IT +++A  E  +S
Sbjct: 173 QIK---RNXFVGTPFWMAPEVIKQSAYDSKADIWSLG-------ITAIELARGEPPHS 220

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           K+G+G FG V+ G + N  +  +A+K ++                       + E+  LS
Sbjct: 14  KIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDI------------QQEITVLS 60
Query: 174 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           QC    + +  G    +    I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 116
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      + +K        GT  +M
Sbjct: 117 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNXFVGTPFWM 171
Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 345
            PE +      +K D++S G+  +EL  G  P  + + +   +L+ +   P  E
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE 225

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 60/118 (50%), Gaps = 13/118 (11%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PLD  +  +I   + + L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      +
Sbjct: 100 PLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157
Query: 511 NVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGAQIKTQHITNVDIADRERYYS 567
            +K        GT  +M PE +      +K D++S G       IT +++A  E  +S
Sbjct: 158 QIK---RNXFVGTPFWMAPEVIKQSAYDSKADIWSLG-------ITAIELARGEPPHS 205

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            ++G GQFG V+ G   N  ++A+KT+              E AM      E E + + +
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-------------EGAMSEEDFIE-EAEVMMK 61
Query: 175 CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H  L++L G+C      C+V+E+M +G L D L          +     + L V E +
Sbjct: 62  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 119
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 290
            YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 120 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 172
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN 328
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 173 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 11/92 (11%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
            + L V E + YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT 
Sbjct: 110 GMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTS 163
Query: 519 NLTGTR---PYMPPEAM-HCQISTKTDVFSYG 546
           + TGT+    +  PE     + S+K+DV+S+G
Sbjct: 164 S-TGTKFPVKWASPEVFSFSRYSSKSDVWSFG 194

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 108/219 (49%), Gaps = 25/219 (11%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G LK      + +A+KTL+            +EA++            +
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI------------M 88
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++ L G+        I+ E+M NGSL D   R N+       +   +  G+A 
Sbjct: 89  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQ-FTVIQLVGMLRGIAA 146
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 290
            + YL  ++   +HRD+ + N+L++ N V K+ DFG+ +  E       YT  L G  P 
Sbjct: 147 GMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 204
Query: 291 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 326
            +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 205 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 243

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 5/87 (5%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  ++   +HRD+ + N+L++ N V K+ DFG+ +  E       YT  L G
Sbjct: 143 GIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 200
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 201 KIPIRWTAPEAIQYRKFTSASDVWSYG 227

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            ++G GQFG V+ G   N  ++A+KT+              E AM      E E + + +
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-------------EGAMSEEDFIE-EAEVMMK 56
Query: 175 CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H  L++L G+C      C+V+E+M +G L D L          +     + L V E +
Sbjct: 57  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 114
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 290
            YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 115 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 167
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN 328
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 11/92 (11%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
            + L V E + YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT 
Sbjct: 105 GMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTS 158
Query: 519 NLTGTR---PYMPPEAM-HCQISTKTDVFSYG 546
           + TGT+    +  PE     + S+K+DV+S+G
Sbjct: 159 S-TGTKFPVKWASPEVFSFSRYSSKSDVWSFG 189

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            ++G GQFG V+ G   N  ++A+KT+              E AM      E E + + +
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-------------EGAMSEEDFIE-EAEVMMK 58
Query: 175 CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H  L++L G+C      C+V+E+M +G L D L          +     + L V E +
Sbjct: 59  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 116
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 290
            YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 117 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 169
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN 328
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 170 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 209

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 11/92 (11%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
            + L V E + YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT 
Sbjct: 107 GMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTS 160
Query: 519 NLTGTR---PYMPPEAM-HCQISTKTDVFSYG 546
           + TGT+    +  PE     + S+K+DV+S+G
Sbjct: 161 S-TGTKFPVKWASPEVFSFSRYSSKSDVWSFG 191

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 35/228 (15%)
Query: 115 NKLGEGQFGTVYYGKLKN------GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENE 168
            +LGEG FG V+  +  N       + +AVKTL+                      F  E
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD-------------FHRE 65
Query: 169 VQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLY--------DRLARVNNTPP--L 217
            + L+  +H ++++  G+C      I V+EYM +G L         D +      PP  L
Sbjct: 66  AELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTEL 125
Query: 218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 277
             ++   IA  +A  + YL   S+  +HRD+ + N L+ EN + K+GDFG+ +   +++ 
Sbjct: 126 TQSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 183
Query: 278 KTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 323
             +    +   R +MPPE+ M+ + +T++DV+S GV+L E+ T G +P
Sbjct: 184 YRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 59/106 (55%), Gaps = 4/106 (3%)
Query: 443 LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 502
           +A  N    L  ++   IA  +A  + YL   S+  +HRD+ + N L+ EN + K+GDFG
Sbjct: 116 MAEGNPPTELTQSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFG 173
Query: 503 IVKMSETSNVKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGA 547
           + +   +++   +    +   R +MPPE+ M+ + +T++DV+S G 
Sbjct: 174 MSRDVYSTDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSLGV 218

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           K+G+G FG V+ G + N  +  +A+K ++                       + E+  LS
Sbjct: 34  KIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDI------------QQEITVLS 80
Query: 174 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           QC    + +  G    +    I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 81  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 136
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      + +K        GT  +M
Sbjct: 137 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWM 191
Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 345
            PE +      +K D++S G+  +EL  G  P  + + +   +L+ +   P  E
Sbjct: 192 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE 245

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 60/118 (50%), Gaps = 13/118 (11%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PLD  +  +I   + + L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      +
Sbjct: 120 PLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 177
Query: 511 NVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGAQIKTQHITNVDIADRERYYS 567
            +K        GT  +M PE +      +K D++S G       IT +++A  E  +S
Sbjct: 178 QIK---RNTFVGTPFWMAPEVIKQSAYDSKADIWSLG-------ITAIELARGEPPHS 225

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            KLG GQFG V+        ++AVKT++                 + +  F  E   +  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK--------------PGSMSVEAFLAEANVMKT 239
Query: 175 CKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEAL 233
            +H  L++L  +       I+ E+M  GSL D L +   +  PL   K    +  +AE +
Sbjct: 240 LQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGM 297
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 291
            ++    +  IHRD+++AN+L+  + V K+ DFG+ ++ E +     YT       P  +
Sbjct: 298 AFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKW 351
Query: 292 MPPEAMH-CQISTKTDVFSYGVILLELLT 319
             PEA++    + K+DV+S+G++L+E++T
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 49/86 (56%), Gaps = 9/86 (10%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +AE + ++    +  IHRD+++AN+L+  + V K+ DFG+ ++ E +     YT      
Sbjct: 293 IAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAK 346
Query: 524 RP--YMPPEAMH-CQISTKTDVFSYG 546
            P  +  PEA++    + K+DV+S+G
Sbjct: 347 FPIKWTAPEAINFGSFTIKSDVWSFG 372

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K N   +A+K L                          E++  
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ----------LRREIEIQ 69
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LR+    ++     ++ E+   G LY  L +       D  +  +    +A+
Sbjct: 70  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELAD 126
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           ALHY H   + +IHRD+K  N+L+      K+ DFG      + +  ++    + GT  Y
Sbjct: 127 ALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGW-----SVHAPSLRRRXMCGTLDY 179
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPID 325
           +PPE +  +    K D++  GV+  E L GM P D
Sbjct: 180 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 8/97 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A+ALHY H   + +IHRD+K  N+L+      K+ DFG      + +
Sbjct: 112 FDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGW-----SVH 164
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGA 547
             ++    + GT  Y+PPE +  +    K D++  G 
Sbjct: 165 APSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGV 201

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            KLG GQFG V+        ++AVKT++                 + +  F  E   +  
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMK--------------PGSMSVEAFLAEANVMKT 66
Query: 175 CKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEAL 233
            +H  L++L  +       I+ E+M  GSL D L +   +  PL   K    +  +AE +
Sbjct: 67  LQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGM 124
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 291
            ++    +  IHRD+++AN+L+  + V K+ DFG+ ++ E +     YT       P  +
Sbjct: 125 AFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKW 178
Query: 292 MPPEAMHC-QISTKTDVFSYGVILLELLT 319
             PEA++    + K+DV+S+G++L+E++T
Sbjct: 179 TAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 49/86 (56%), Gaps = 9/86 (10%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +AE + ++    +  IHRD+++AN+L+  + V K+ DFG+ ++ E +     YT      
Sbjct: 120 IAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAK 173
Query: 524 RP--YMPPEAMHC-QISTKTDVFSYG 546
            P  +  PEA++    + K+DV+S+G
Sbjct: 174 FPIKWTAPEAINFGSFTIKSDVWSFG 199

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            ++G GQFG V+ G   N  ++A+KT++             E +M      E E + + +
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIK-------------EGSMSEDDFIE-EAEVMMK 78
Query: 175 CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H  L++L G+C      C+V+E+M +G L D L          +     + L V E +
Sbjct: 79  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 136
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 290
            YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 137 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 189
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT 319
           +  PE     + S+K+DV+S+GV++ E+ +
Sbjct: 190 WASPEVFSFSRYSSKSDVWSFGVLMWEVFS 219

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 11/92 (11%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
            + L V E + YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT 
Sbjct: 127 GMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTS 180
Query: 519 NLTGTR---PYMPPEAM-HCQISTKTDVFSYG 546
           + TGT+    +  PE     + S+K+DV+S+G
Sbjct: 181 S-TGTKFPVKWASPEVFSFSRYSSKSDVWSFG 211

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 29/220 (13%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            ++G GQFG V+ G   N  ++A+KT+              E AM      E E + + +
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-------------EGAMSEEDFIE-EAEVMMK 59
Query: 175 CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H  L++L G+C      C+V E+M +G L D L          +     + L V E +
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 117
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 290
            YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 118 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 170
Query: 291 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN 328
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 171 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 11/92 (11%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
            + L V E + YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT 
Sbjct: 108 GMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTS 161
Query: 519 NLTGTR---PYMPPEAM-HCQISTKTDVFSYG 546
           + TGT+    +  PE     + S+K+DV+S+G
Sbjct: 162 S-TGTKFPVKWASPEVFSFSRYSSKSDVWSFG 192

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 45/226 (19%)
Query: 117 LGEGQFGTVYYGKLKNG---MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +GEG FG V   ++K     M+ A+K ++                      F  E++ L 
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD------------FAGELEVL- 69
Query: 174 QCK---HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 216
            CK   H N++ LLG C +     +  EY  +G+L D  R +RV  T P           
Sbjct: 70  -CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 128
Query: 217 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 276
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 129 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 186
Query: 277 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
            KTM      G  P  +M  E+++  + +T +DV+SYGV+L E+++
Sbjct: 187 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 11/98 (11%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 129 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 186
Query: 512 VKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
            KTM      G  P  +M  E+++  + +T +DV+SYG
Sbjct: 187 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYG 218

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 45/226 (19%)
Query: 117 LGEGQFGTVYYGKLKNG---MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +GEG FG V   ++K     M+ A+K ++                      F  E++ L 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD------------FAGELEVL- 79
Query: 174 QCK---HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 216
            CK   H N++ LLG C +     +  EY  +G+L D  R +RV  T P           
Sbjct: 80  -CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 217 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 276
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 196
Query: 277 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
            KTM      G  P  +M  E+++  + +T +DV+SYGV+L E+++
Sbjct: 197 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 11/98 (11%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 196
Query: 512 VKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
            KTM      G  P  +M  E+++  + +T +DV+SYG
Sbjct: 197 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYG 228

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 140/295 (47%), Gaps = 60/295 (20%)
Query: 56  QHNQKIKFKLPDKKWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRK-PYPRR- 113
           ++ QK K+++   +W  ++I+  E N          ++TF D  +    +N K  +PR  
Sbjct: 5   KYKQKPKYQV---RW--KIIESYEGN----------SYTFIDPTQLP--YNEKWEFPRNN 47
Query: 114 ---GNKLGEGQFGTVY------YGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
              G  LG G FG V        GK    +++AVK L+             EA M     
Sbjct: 48  LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-----KEALM----- 97
Query: 165 FENEVQTLSQC-KHVNLLRLLGLCNNIMNCIVY-EYMCNGSLYDRLARVNNTPPLDSNKR 222
             +E++ +S   +H N++ LLG C +    +V  EY C G L + L R +    L+++  
Sbjct: 98  --SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV--LETDPA 153
Query: 223 YSIA---LGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGIVK- 270
           ++IA   L   + LH+   +        SK  IHRDV + NVLL    V K+GDFG+ + 
Sbjct: 154 FAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKP 323
           +   SN   +   N      +M PE++  C  + ++DV+SYG++L E+ + G+ P
Sbjct: 214 IMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 50/86 (58%), Gaps = 8/86 (9%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNVKTMYTENLT 521
           VA+ + +L   SK  IHRDV + NVLL    V K+GDFG+ +  M++++ +      N  
Sbjct: 173 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VKGNAR 227
Query: 522 GTRPYMPPEAMH-CQISTKTDVFSYG 546
               +M PE++  C  + ++DV+SYG
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYG 253

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 137/295 (46%), Gaps = 60/295 (20%)
Query: 56  QHNQKIKFKLPDKKWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRK-PYPRR- 113
           ++ QK K+++   +W  ++I+  E N          ++TF D  +    +N K  +PR  
Sbjct: 5   KYKQKPKYQV---RW--KIIESYEGN----------SYTFIDPTQLP--YNEKWEFPRNN 47
Query: 114 ---GNKLGEGQFGTVY------YGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
              G  LG G FG V        GK    +++AVK L+             EA M     
Sbjct: 48  LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-----KEALM----- 97
Query: 165 FENEVQTLSQC-KHVNLLRLLGLCNNIMNCIVY-EYMCNGSLYDRLARVNNTPPLDSNKR 222
             +E++ +S   +H N++ LLG C +    +V  EY C G L + L R +    L+++  
Sbjct: 98  --SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV--LETDPA 153
Query: 223 YSIALGVAEALHYLHS-----------LSKPIIHRDVKSANVLLDENFVPKLGDFGIVK- 270
           ++IA   A     LH             SK  IHRDV + NVLL    V K+GDFG+ + 
Sbjct: 154 FAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKP 323
           +   SN   +   N      +M PE++  C  + ++DV+SYG++L E+ + G+ P
Sbjct: 214 IMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 50/86 (58%), Gaps = 8/86 (9%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNVKTMYTENLT 521
           VA+ + +L   SK  IHRDV + NVLL    V K+GDFG+ +  M++++ +      N  
Sbjct: 173 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VKGNAR 227
Query: 522 GTRPYMPPEAMH-CQISTKTDVFSYG 546
               +M PE++  C  + ++DV+SYG
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYG 253

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRW 216
Query: 292 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 155 GIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLARVLE-DDPEAAYTTR-GG 210
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYG 237

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 23/214 (10%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+             EA++            +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI------------M 100
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 292 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 155 GIASGMKYLSDMG--FVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GG 210
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYG 237

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G  G V YG+L+      + +A+K L+            +EA++            +
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI------------M 104
Query: 173 SQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++RL G+     +  IV EYM NGSL D   R ++       +   +  GV  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQ-FTIMQLVGMLRGVGA 162
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 290
            + YL  L    +HRD+ + NVL+D N V K+ DFG+ ++ E  +    YT    G  P 
Sbjct: 163 GMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTT-GGKIPI 218
Query: 291 -YMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 323
            +  PEA+  +  S+ +DV+S+GV++ E+L  G +P
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 48/87 (55%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           GV   + YL  L    +HRD+ + NVL+D N V K+ DFG+ ++ E  +    YT    G
Sbjct: 159 GVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTT-GG 214
Query: 523 TRP--YMPPEAMHCQ-ISTKTDVFSYG 546
             P  +  PEA+  +  S+ +DV+S+G
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFG 241

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 26/231 (11%)
Query: 116 KLGEGQFGTVYYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           ++G+G FG V+ G + N  +  +A+K ++                       + E+  LS
Sbjct: 30  RIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDI------------QQEITVLS 76
Query: 174 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           QC    + +  G         I+ EY+  GS  D L       P D  +  ++   + + 
Sbjct: 77  QCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKG 132
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLHS  K  IHRD+K+ANVLL E    KL DFG+      + +K        GT  +M
Sbjct: 133 LDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFWM 187
Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
            PE +      +K D++S G+  +EL  G  P  D + +   +L+ +   P
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP 238

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/114 (33%), Positives = 56/114 (49%), Gaps = 13/114 (11%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           P D  +  ++   + + L YLHS  K  IHRD+K+ANVLL E    KL DFG+      +
Sbjct: 116 PFDEFQIATMLKEILKGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 173
Query: 511 NVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGAQIKTQHITNVDIADRE 563
            +K        GT  +M PE +      +K D++S G       IT +++A  E
Sbjct: 174 QIK---RNTFVGTPFWMAPEVIQQSAYDSKADIWSLG-------ITAIELAKGE 217

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G  G V YG+L+      + +A+K L+            +EA++            +
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI------------M 104
Query: 173 SQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++RL G+     +  IV EYM NGSL D   R ++       +   +  GV  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQ-FTIMQLVGMLRGVGA 162
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL  L    +HRD+ + NVL+D N V K+ DFG+ ++ E        T        +
Sbjct: 163 GMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRW 220
Query: 292 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 323
             PEA+  +  S+ +DV+S+GV++ E+L  G +P
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 3/85 (3%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           GV   + YL  L    +HRD+ + NVL+D N V K+ DFG+ ++ E        T     
Sbjct: 159 GVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI 216
Query: 523 TRPYMPPEAMHCQ-ISTKTDVFSYG 546
              +  PEA+  +  S+ +DV+S+G
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFG 241

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 106/228 (46%), Gaps = 24/228 (10%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG G FG V+  + + NG   A+K L+            T           +E   LS  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN----------DERLMLSIV 63
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H  ++R+ G   +     ++ +Y+  G L+  L R +   P    K Y  A  V  AL 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFY--AAEVCLALE 120
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLHS  K II+RD+K  N+LLD+N   K+ DFG  K           T  L GT  Y+ P
Sbjct: 121 YLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYXLCGTPDYIAP 172
Query: 295 EAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           E +  +   K+ D +S+G+++ E+L G  P  D+NT+  Y  ++  E+
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 220

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/112 (38%), Positives = 56/112 (50%), Gaps = 11/112 (9%)
Query: 439 QLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL 498
           +LF L R +   P    K Y  A  V  AL YLHS  K II+RD+K  N+LLD+N   K+
Sbjct: 92  ELFSLLRKSQRFPNPVAKFY--AAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKI 147
Query: 499 GDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGAQI 549
            DFG  K           T  L GT  Y+ PE +  +   K+ D +S+G  I
Sbjct: 148 TDFGFAKYVPDV------TYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILI 193

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G LK      + +A+KTL+            +EA++            +
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI------------M 62
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++ L G+        I+ E+M NGSL D   R N+       +   +  G+A 
Sbjct: 63  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQ-FTVIQLVGMLRGIAA 120
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 290
            + YL  ++   +HR + + N+L++ N V K+ DFG+ +  E       YT  L G  P 
Sbjct: 121 GMKYLADMN--YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 178
Query: 291 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 326
            +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 179 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 217

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 5/87 (5%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  ++   +HR + + N+L++ N V K+ DFG+ +  E       YT  L G
Sbjct: 117 GIAAGMKYLADMN--YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 174
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 175 KIPIRWTAPEAIQYRKFTSASDVWSYG 201

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 31/218 (14%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 71
Query: 173 SQCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            Q  H N++RL G+      +M  IV EYM NGSL D   R ++       +   +  G+
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVM--IVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGI 127
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G  
Sbjct: 128 ASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GGKI 183
Query: 290 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           P  +  PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 126 GIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GG 181
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYG 208

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 292 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 155 GIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GG 210
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYG 237

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 98
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 156
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 157 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 214
Query: 292 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 215 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 153 GIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GG 208
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 209 KIPIRWTSPEAIAYRKFTSASDVWSYG 235

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 292 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 155 GIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GG 210
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYG 237

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 292 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 155 GIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GG 210
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYG 237

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 292 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 155 GIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GG 210
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYG 237

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G+FG VY  + K N   +A+K L                          E++  S  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ----------LRREIEIQSHL 71
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H N+LR+    ++     ++ E+   G LY  L +       D  +  +    +A+ALH
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALH 128
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           Y H   + +IHRD+K  N+L+      K+ DFG      + +  ++    + GT  Y+PP
Sbjct: 129 YCHE--RKVIHRDIKPENLLMGYKGELKIADFGW-----SVHAPSLRRRXMCGTLDYLPP 181
Query: 295 EAMHCQI-STKTDVFSYGVILLELLTGMKPID 325
           E +  +    K D++  GV+  E L GM P D
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 8/97 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +    +A+ALHY H   + +IHRD+K  N+L+      K+ DFG      + +
Sbjct: 111 FDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGW-----SVH 163
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGA 547
             ++    + GT  Y+PPE +  +    K D++  G 
Sbjct: 164 APSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGV 200

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 41/288 (14%)
Query: 104 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 162
           G  +K Y  R  K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 16  GDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 62
Query: 163 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D    V     +D  
Sbjct: 63  -LIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTD----VVTETCMDEG 116
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMK 278
           +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG       E S   
Sbjct: 117 QIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 279 TMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 337
           TM      GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+ 
Sbjct: 175 TM-----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
Query: 338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
               P  +         N   +  +      +C   + +KR S ++++
Sbjct: 230 TNGTPELQ---------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 10/98 (10%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SET 509
           +D  +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG       E 
Sbjct: 113 MDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 510 SNVKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
           S   TM      GT  +M PE +  +    K D++S G
Sbjct: 171 SKRSTM-----VGTPYWMAPEVVTRKAYGPKVDIWSLG 203

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 32/207 (15%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            KLG GQFG V+        ++AVKT++                 + +  F  E   +  
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMK--------------PGSMSVEAFLAEANVMKT 233
Query: 175 CKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEAL 233
            +H  L++L  +       I+ E+M  GSL D L +   +  PL   K    +  +AE +
Sbjct: 234 LQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGM 291
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            ++    +  IHRD+++AN+L+  + V K+ DFG+ ++     +K            +  
Sbjct: 292 AFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK------------WTA 337
Query: 294 PEAMH-CQISTKTDVFSYGVILLELLT 319
           PEA++    + K+DV+S+G++L+E++T
Sbjct: 338 PEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 23/84 (27%), Positives = 46/84 (54%), Gaps = 15/84 (17%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +AE + ++    +  IHRD+++AN+L+  + V K+ DFG+ ++     +K          
Sbjct: 287 IAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK---------- 334
Query: 524 RPYMPPEAMH-CQISTKTDVFSYG 546
             +  PEA++    + K+DV+S+G
Sbjct: 335 --WTAPEAINFGSFTIKSDVWSFG 356

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 27/216 (12%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 88
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 146
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 290
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G  P 
Sbjct: 147 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GGKIPI 202
Query: 291 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
            +  PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 143 GIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GG 198
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 199 KIPIRWTSPEAIAYRKFTSASDVWSYG 225

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 27/219 (12%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+            +EA++            +
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI------------M 84
Query: 173 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            Q  H N++ L G+   C  +M  I+ EYM NGSL D   R N+       +   +  G+
Sbjct: 85  GQFDHPNIIHLEGVVTKCKPVM--IITEYMENGSL-DAFLRKNDGR-FTVIQLVGMLRGI 140
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
              + YL  +S   +HRD+ + N+L++ N V K+ DFG+ ++ E        T       
Sbjct: 141 GSGMKYLSDMSA--VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 198
Query: 290 PYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 326
            +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 199 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 237

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+   + YL  +S   +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 139 GIGSGMKYLSDMSA--VHRDLAARNILVNSNLVCKVSDFGMSRVLE-DDPEAAYTTR-GG 194
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 195 KIPIRWTAPEAIAYRKFTSASDVWSYG 221

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 136/291 (46%), Gaps = 56/291 (19%)
Query: 56  QHNQKIKFKLPDKKWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRK-PYPRR- 113
           ++ QK K+++   +W  ++I+  E N          ++TF D  +    +N K  +PR  
Sbjct: 5   KYKQKPKYQV---RW--KIIESYEGN----------SYTFIDPTQLP--YNEKWEFPRNN 47
Query: 114 ---GNKLGEGQFGTVY------YGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
              G  LG G FG V        GK    +++AVK L+             EA M     
Sbjct: 48  LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-----KEALM----- 97
Query: 165 FENEVQTLSQC-KHVNLLRLLGLCNNIMNCIVY-EYMCNGSLYDRLARV-------NNTP 215
             +E++ +S   +H N++ LLG C +    +V  EY C G L + L R         +  
Sbjct: 98  --SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGR 155
Query: 216 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSET 274
           PL+       +  VA+ + +L   SK  IHRDV + NVLL    V K+GDFG+ + +   
Sbjct: 156 PLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 213
Query: 275 SNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKP 323
           SN   +   N      +M PE++  C  + ++DV+SYG++L E+ + G+ P
Sbjct: 214 SNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 262

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSE 508
           PL+       +  VA+ + +L   SK  IHRDV + NVLL    V K+GDFG+ +  M++
Sbjct: 156 PLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 213
Query: 509 TSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYG 546
           ++ +      N      +M PE++  C  + ++DV+SYG
Sbjct: 214 SNYI---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 249

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++RL G+        IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 292 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 155 GIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTR-GG 210
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYG 237

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 29/223 (13%)
Query: 108 KPYPRRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 162
           K + +R   LGEG FG V   +        G ++AVK+L+             E+    I
Sbjct: 20  KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK------------PESGGNHI 67
Query: 163 LLFENEVQTLSQCKHVNLLRLLGLC-----NNIMNCIVYEYMCNGSLYDRLARVNNTPPL 217
              + E++ L    H N+++  G+C     N I   ++ E++ +GSL + L +  N   L
Sbjct: 68  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPKNKNKINL 125
Query: 218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 277
               +Y++   + + + YL S  +  +HRD+ + NVL++     K+GDFG+ K  ET   
Sbjct: 126 KQQLKYAVQ--ICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
Query: 278 KTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT 319
                ++      +  PE  M  +    +DV+S+GV L ELLT
Sbjct: 182 XXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 3/90 (3%)
Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A+ + + + YL S  +  +HRD+ + NVL++     K+GDFG+ K  ET        ++ 
Sbjct: 132 AVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDR 189
Query: 521 TGTRPYMPPEA-MHCQISTKTDVFSYGAQI 549
                +  PE  M  +    +DV+S+G  +
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTL 219

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 104 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 162
           G  +K Y R   K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 17  GDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 63
Query: 163 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D    V     +D  
Sbjct: 64  -LIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTD----VVTETCMDEG 117
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
           +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG          K  
Sbjct: 118 QIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 173
Query: 281 YTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
               + GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+   
Sbjct: 174 -RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 232
Query: 340 EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
             P  +         N   +  +      +C   + +KR S ++++
Sbjct: 233 GTPELQ---------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELI 269

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           +D  +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG         
Sbjct: 114 MDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 171
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
            K      + GT  +M PE +  +    K D++S G
Sbjct: 172 SK---RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLG 204

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 29/223 (13%)
Query: 108 KPYPRRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 162
           K + +R   LGEG FG V   +        G ++AVK+L+             E+    I
Sbjct: 8   KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK------------PESGGNHI 55
Query: 163 LLFENEVQTLSQCKHVNLLRLLGLC-----NNIMNCIVYEYMCNGSLYDRLARVNNTPPL 217
              + E++ L    H N+++  G+C     N I   ++ E++ +GSL + L +  N   L
Sbjct: 56  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPKNKNKINL 113
Query: 218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 277
               +Y++   + + + YL S  +  +HRD+ + NVL++     K+GDFG+ K  ET   
Sbjct: 114 KQQLKYAVQ--ICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 169
Query: 278 KTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT 319
                ++      +  PE  M  +    +DV+S+GV L ELLT
Sbjct: 170 XXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 3/90 (3%)
Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A+ + + + YL S  +  +HRD+ + NVL++     K+GDFG+ K  ET        ++ 
Sbjct: 120 AVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDR 177
Query: 521 TGTRPYMPPEA-MHCQISTKTDVFSYGAQI 549
                +  PE  M  +    +DV+S+G  +
Sbjct: 178 DSPVFWYAPECLMQSKFYIASDVWSFGVTL 207

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 27/219 (12%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+            +EA++            +
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI------------M 69
Query: 173 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            Q  H N++ L G+   C  +M  I+ EYM NGSL D   R N+       +   +  G+
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVM--IITEYMENGSL-DAFLRKNDGR-FTVIQLVGMLRGI 125
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
              + YL  +S   +HRD+ + N+L++ N V K+ DFG+ ++ E        T       
Sbjct: 126 GSGMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 183
Query: 290 PYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 326
            +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 184 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 222

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+   + YL  +S   +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 124 GIGSGMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLE-DDPEAAYTTR-GG 179
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 180 KIPIRWTAPEAIAYRKFTSASDVWSYG 206

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 27/219 (12%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+            +EA++            +
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI------------M 63
Query: 173 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            Q  H N++ L G+   C  +M  I+ EYM NGSL D   R N+       +   +  G+
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVM--IITEYMENGSL-DAFLRKNDGR-FTVIQLVGMLRGI 119
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
              + YL  +S   +HRD+ + N+L++ N V K+ DFG+ ++ E        T       
Sbjct: 120 GSGMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 177
Query: 290 PYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 326
            +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 178 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 216

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+   + YL  +S   +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 118 GIGSGMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLE-DDPEAAYTTR-GG 173
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 174 KIPIRWTAPEAIAYRKFTSASDVWSYG 200

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 45/226 (19%)
Query: 117 LGEGQFGTVYYGKLKNG---MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +GEG FG V   ++K     M+ A+K ++                      F  E++ L 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD------------FAGELEVL- 76
Query: 174 QCK---HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 216
            CK   H N++ LLG C +     +  EY  +G+L D  R +RV  T P           
Sbjct: 77  -CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 135
Query: 217 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 276
           L S +    A  VA  + YL    K  IHR++ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 136 LSSQQLLHFAADVARGMDYLSQ--KQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYV 193
Query: 277 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
            KTM      G  P  +M  E+++  + +T +DV+SYGV+L E+++
Sbjct: 194 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 11/98 (11%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L S +    A  VA  + YL    K  IHR++ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 136 LSSQQLLHFAADVARGMDYLSQ--KQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYV 193
Query: 512 VKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
            KTM      G  P  +M  E+++  + +T +DV+SYG
Sbjct: 194 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYG 225

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 104 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 162
           G  +K Y  R  K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 16  GDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 62
Query: 163 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D    V     +D  
Sbjct: 63  -LIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTD----VVTETCMDEG 116
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
           +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG          K  
Sbjct: 117 QIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172
Query: 281 YTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
               + GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+   
Sbjct: 173 -RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 340 EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
             P  +         N   +  +      +C   + +KR S ++++
Sbjct: 232 GTPELQ---------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 268

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           +D  +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG         
Sbjct: 113 MDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
            K      + GT  +M PE +  +    K D++S G
Sbjct: 171 SK---RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 41/288 (14%)
Query: 104 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 162
           G  +K Y R   K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 17  GDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 63
Query: 163 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D    V     +D  
Sbjct: 64  -LIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTD----VVTETCMDEG 117
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMK 278
           +  ++     +AL +LHS    +IHR++KS N+LL  +   KL DFG       E S   
Sbjct: 118 QIAAVCRECLQALEFLHS--NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 175
Query: 279 TMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 337
           TM      GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+ 
Sbjct: 176 TM-----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 230
Query: 338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
               P  +         N   +  +      +C   + +KR S ++++
Sbjct: 231 TNGTPELQ---------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELI 269

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 10/98 (10%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SET 509
           +D  +  ++     +AL +LHS    +IHR++KS N+LL  +   KL DFG       E 
Sbjct: 114 MDEGQIAAVCRECLQALEFLHS--NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQ 171
Query: 510 SNVKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
           S   TM      GT  +M PE +  +    K D++S G
Sbjct: 172 SKRSTM-----VGTPYWMAPEVVTRKAYGPKVDIWSLG 204

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 104 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 162
           G  +K Y  R  K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 16  GDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 62
Query: 163 LLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
            L  NE+  + + K+ N++  L   L  + +  +V EY+  GSL D    V     +D  
Sbjct: 63  -LIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTD----VVTETCMDEG 116
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
           +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG          K  
Sbjct: 117 QIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172
Query: 281 YTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
               + GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+   
Sbjct: 173 -RSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 340 EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
             P  +         N   +  +      +C   + +KR S ++++
Sbjct: 232 GTPELQ---------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           +D  +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG         
Sbjct: 113 MDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
            K      + GT  +M PE +  +    K D++S G
Sbjct: 171 SK---RSEMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 120/255 (47%), Gaps = 41/255 (16%)
Query: 92  AFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY------YGKLKNGMEIAVKT 140
           ++TF D  +    +N K  +PR     G  LG G FG V        GK    +++AVK 
Sbjct: 18  SYTFIDPTQLP--YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 75
Query: 141 LEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNNIMNCIVY-EY 198
           L+             EA M       +E++ +S   +H N++ LLG C +    +V  EY
Sbjct: 76  LKSTAHADE-----KEALM-------SELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 123
Query: 199 MCNGSLYDRLARV-------NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 251
            C G L + L R         +  PL+       +  VA+ + +L   SK  IHRDV + 
Sbjct: 124 CCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAAR 181
Query: 252 NVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFS 309
           NVLL    V K+GDFG+ + +   SN   +   N      +M PE++  C  + ++DV+S
Sbjct: 182 NVLLTNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWS 239
Query: 310 YGVILLELLT-GMKP 323
           YG++L E+ + G+ P
Sbjct: 240 YGILLWEIFSLGLNP 254

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSE 508
           PL+       +  VA+ + +L   SK  IHRDV + NVLL    V K+GDFG+ +  M++
Sbjct: 148 PLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 205
Query: 509 TSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYG 546
           ++ +      N      +M PE++  C  + ++DV+SYG
Sbjct: 206 SNYI---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 241

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G+ LG G FG V  GK +  G ++AVK L                ++  +     E+Q L
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR----------SLDVVGKIRREIQNL 70
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
              +H ++++L  + +   +  +V EY+  G L+D + +      LD  +   +   +  
Sbjct: 71  KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILS 127
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + Y H     ++HRD+K  NVLLD +   K+ DFG+  M         +     G+  Y
Sbjct: 128 GVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRXSCGSPNY 181
Query: 292 MPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNT 329
             PE +  ++    + D++S GVIL  LL G  P DD++ 
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G+ LG G FG V  G+ +  G ++AVK L                ++  +   + E+Q L
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR----------SLDVVGKIKREIQNL 65
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
              +H ++++L  + +   +  +V EY+  G L+D + +      +++ + +   L   +
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
             H        ++HRD+K  NVLLD +   K+ DFG+  M         +  +  G+  Y
Sbjct: 126 YCH-----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRDSCGSPNY 176
Query: 292 MPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNT 329
             PE +  ++    + D++S GVIL  LL G  P DD + 
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 136/299 (45%), Gaps = 66/299 (22%)
Query: 56  QHNQKIKFKLPDKKWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRK-PYPRR- 113
           ++ QK K+++   +W  ++I+  E N          ++TF D  +    +N K  +PR  
Sbjct: 5   KYKQKPKYQV---RW--KIIESYEGN----------SYTFIDPTQLP--YNEKWEFPRNN 47
Query: 114 ---GNKLGEGQFGTVY------YGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
              G  LG G FG V        GK    +++AVK L+             EA M     
Sbjct: 48  LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-----KEALM----- 97
Query: 165 FENEVQTLSQC-KHVNLLRLLGLCNNIMNCIVY-EYMCNGSLYDRLARVNNTPP------ 216
             +E++ +S   +H N++ LLG C +    +V  EY C G L + L R    PP      
Sbjct: 98  --SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR--KRPPGLEYSY 153
Query: 217 ---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 267
                    L S      +  VA+ + +L   SK  IHRDV + NVLL    V K+GDFG
Sbjct: 154 NPSHNPEEQLSSRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFG 211
Query: 268 IVK-MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKP 323
           + + +   SN   +   N      +M PE++  C  + ++DV+SYG++L E+ + G+ P
Sbjct: 212 LARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 268

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 50/86 (58%), Gaps = 8/86 (9%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNVKTMYTENLT 521
           VA+ + +L   SK  IHRDV + NVLL    V K+GDFG+ +  M++++ +      N  
Sbjct: 175 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VKGNAR 229
Query: 522 GTRPYMPPEAMH-CQISTKTDVFSYG 546
               +M PE++  C  + ++DV+SYG
Sbjct: 230 LPVKWMAPESIFDCVYTVQSDVWSYG 255

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 34/221 (15%)
Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 73
Query: 170 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 219
             + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 74  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ +    ++   
Sbjct: 132 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 189
Query: 280 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 319
              + L   R +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 190 KGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           P   +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ +    +
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXET 185
Query: 511 NVKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
           +      + L   R +M PE++   + +T +DV+S+G
Sbjct: 186 DXXRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFG 221

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 34/221 (15%)
Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 64
Query: 170 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 219
             + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 65  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ +    ++   
Sbjct: 123 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 280 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 319
              + L   R +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 181 KGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           P   +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ +    +
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXET 176
Query: 511 NVKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
           +      + L   R +M PE++   + +T +DV+S+G
Sbjct: 177 DXXRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFG 212

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G +LG GQF  V   + K  G E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE-------IEREVNIL 69
Query: 173 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            + +H N++ L  +  N  + + + E +  G L+D LA       L  ++       + +
Sbjct: 70  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---EKESLTEDEATQFLKQILD 126
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 287
            +HYLHS  K I H D+K  N++L +  VP    KL DFGI    E  N      +N+ G
Sbjct: 127 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFG 180
Query: 288 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%), Gaps = 11/88 (12%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNVKTMYTEN 519
           + + +HYLHS  K I H D+K  N++L +  VP    KL DFGI    E  N      +N
Sbjct: 124 ILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKN 177
Query: 520 LTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
           + GT  ++ PE ++ + +  + D++S G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIG 205

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++RL G+        IV E M NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 290
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G  P 
Sbjct: 159 GMKYLSDMGA--VHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GGKIPI 214
Query: 291 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
            +  PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 155 GIASGMKYLSDMGA--VHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GG 210
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYG 237

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G +LG GQF  V   + K  G E A K ++             E         E EV  L
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE-------IEREVNIL 62
Query: 173 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            + +H N++ L  +  N  + + + E +  G L+D LA       L  ++       + +
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---EKESLTEDEATQFLKQILD 119
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 287
            +HYLHS  K I H D+K  N++L +  VP    KL DFGI    E  N      +N+ G
Sbjct: 120 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFG 173
Query: 288 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%), Gaps = 11/88 (12%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNVKTMYTEN 519
           + + +HYLHS  K I H D+K  N++L +  VP    KL DFGI    E  N      +N
Sbjct: 117 ILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKN 170
Query: 520 LTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
           + GT  ++ PE ++ + +  + D++S G
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIG 198

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 116 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 64
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           +    H NL+RL G+       +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 122
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 123 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 292 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 323
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L +  RY++   VAE + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++
Sbjct: 110 LGTLSRYAVQ--VAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQI 549
              +  E+      +  PE++  +  S  +D + +G  +
Sbjct: 166 DHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           GN LG+G F  VY  + +  G+E+A+K ++             +A M+  +  +NEV+  
Sbjct: 16  GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY--------KAGMVQRV--QNEVKIH 65
Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            Q KH ++L L     +     +   MC+    +R  + N   P   N+       +   
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEARHFMHQIITG 124
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + YLHS    I+HRD+  +N+LL  N   K+ DFG+    +  + K  YT  L GT  Y+
Sbjct: 125 MLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT--LCGTPNYI 179
Query: 293 PPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDN 327
            PE A       ++DV+S G +   LL G  P D +
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
           N   P   N+       +   + YLHS    I+HRD+  +N+LL  N   K+ DFG+   
Sbjct: 104 NRVKPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQ 161
Query: 507 SETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGAQIKT 551
            +  + K  YT  L GT  Y+ PE A       ++DV+S G    T
Sbjct: 162 LKMPHEKH-YT--LCGTPNYISPEIATRSAHGLESDVWSLGCMFYT 204

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G+ LG G FG V  G+ +  G ++AVK L                ++  +   + E+Q L
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR----------SLDVVGKIKREIQNL 65
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
              +H ++++L  + +   +  +V EY+  G L+D + +      +++ + +   L   +
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
             H        ++HRD+K  NVLLD +   K+ DFG+  M         +     G+  Y
Sbjct: 126 YCH-----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPNY 176
Query: 292 MPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNT 329
             PE +  ++    + D++S GVIL  LL G  P DD + 
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 116 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 74
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           +    H NL+RL G+       +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 75  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 132
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 133 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 190
Query: 292 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 323
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L +  RY++   VAE + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++
Sbjct: 120 LGTLSRYAVQ--VAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQI 549
              +  E+      +  PE++  +  S  +D + +G  +
Sbjct: 176 DHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 31/218 (14%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 71
Query: 173 SQCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            Q  H N++RL G+      +M  IV E M NGSL D   R ++       +   +  G+
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVM--IVTEXMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGI 127
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G  
Sbjct: 128 ASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GGKI 183
Query: 290 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           P  +  PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 126 GIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GG 181
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYG 208

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G +LG GQF  V   + K  G E A K ++             E         E EV  L
Sbjct: 31  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREE-------IEREVNIL 83
Query: 173 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            + +H N++ L  +  N  + + + E +  G L+D LA       L  ++       + +
Sbjct: 84  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---EKESLTEDEATQFLKQILD 140
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 287
            +HYLHS  K I H D+K  N++L +  VP    KL DFGI    E  N      +N+ G
Sbjct: 141 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFG 194
Query: 288 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 195 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%), Gaps = 11/88 (12%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNVKTMYTEN 519
           + + +HYLHS  K I H D+K  N++L +  VP    KL DFGI    E  N      +N
Sbjct: 138 ILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKN 191
Query: 520 LTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
           + GT  ++ PE ++ + +  + D++S G
Sbjct: 192 IFGTPEFVAPEIVNYEPLGLEADMWSIG 219

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 116 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 68
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           +    H NL+RL G+       +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 69  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 126
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 127 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 292 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 323
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L +  RY++   VAE + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++
Sbjct: 114 LGTLSRYAVQ--VAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 169
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQI 549
              +  E+      +  PE++  +  S  +D + +G  +
Sbjct: 170 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 208

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++RL G+        IV E M NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 292 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 155 GIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GG 210
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYG 237

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 116 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 64
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           +    H NL+RL G+       +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 122
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 123 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 292 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 323
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L +  RY++   VAE + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++
Sbjct: 110 LGTLSRYAVQ--VAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQI 549
              +  E+      +  PE++  +  S  +D + +G  +
Sbjct: 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 116 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 68
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           +    H NL+RL G+       +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 69  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 126
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 127 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 292 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 323
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L +  RY++   VAE + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++
Sbjct: 114 LGTLSRYAVQ--VAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 169
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQI 549
              +  E+      +  PE++  +  S  +D + +G  +
Sbjct: 170 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 208

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 116 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 64
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           +    H NL+RL G+       +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 122
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 123 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 292 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 323
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L +  RY++   VAE + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++
Sbjct: 110 LGTLSRYAVQ--VAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQI 549
              +  E+      +  PE++  +  S  +D + +G  +
Sbjct: 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 116 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 74
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           +    H NL+RL G+       +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 75  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 132
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 133 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 292 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 323
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L +  RY++   VAE + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++
Sbjct: 120 LGTLSRYAVQ--VAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQI 549
              +  E+      +  PE++  +  S  +D + +G  +
Sbjct: 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 46/226 (20%)
Query: 117 LGEGQFGTVYYG----KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G+G FG VY+G    + +N ++ A+K+L             TE   +   L E  +  +
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI----------TEMQQVEAFLREGLL--M 76
Query: 173 SQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
               H N+L L+G  L    +  ++  YMC+G L   +      P +      S  L VA
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVA 134
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-----------VKMSETSNMKT 279
             + YL    +  +HRD+ + N +LDE+F  K+ DFG+           V+    + +  
Sbjct: 135 RGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 280 MYT--ENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKP 323
            +T  E+L   R            +TK+DV+S+GV+L ELLT   P
Sbjct: 193 KWTALESLQTYR-----------FTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 112/225 (49%), Gaps = 40/225 (17%)
Query: 115 NKLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENE 168
            +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE
Sbjct: 18  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNE 65
Query: 169 VQTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLD 218
              + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P  
Sbjct: 66  ASVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNM 277
            +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET   
Sbjct: 124 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-- 179
Query: 278 KTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
              Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 180 --YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 87/183 (47%), Gaps = 37/183 (20%)
Query: 379 ASMRDIVDLLSKSM----FVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVII----L 430
           ASMR+ ++ L+++     F C+ +  L +G VS                G P ++    +
Sbjct: 54  ASMRERIEFLNEASVMKEFNCHHVVRL-LGVVSQ---------------GQPTLVIMELM 97
Query: 431 DTGETKQCQLFKLARVNNTP---PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 487
             G+ K         + N P   P   +K   +A  +A+ + YL++     +HRD+ + N
Sbjct: 98  TRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARN 155
Query: 488 VLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVF 543
            ++ E+F  K+GDFG+ + + ET      Y +   G  P  +M PE++   + +T +DV+
Sbjct: 156 CMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 211
Query: 544 SYG 546
           S+G
Sbjct: 212 SFG 214

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 112/225 (49%), Gaps = 40/225 (17%)
Query: 115 NKLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENE 168
            +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE
Sbjct: 22  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNE 69
Query: 169 VQTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLD 218
              + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P  
Sbjct: 70  ASVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 127
Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNM 277
            +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET   
Sbjct: 128 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-- 183
Query: 278 KTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
              Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 184 --YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 87/183 (47%), Gaps = 37/183 (20%)
Query: 379 ASMRDIVDLLSKSM----FVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVII----L 430
           ASMR+ ++ L+++     F C+ +  L +G VS                G P ++    +
Sbjct: 58  ASMRERIEFLNEASVMKEFNCHHVVRL-LGVVSQ---------------GQPTLVIMELM 101
Query: 431 DTGETKQCQLFKLARVNNTP---PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 487
             G+ K         + N P   P   +K   +A  +A+ + YL++     +HRD+ + N
Sbjct: 102 TRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARN 159
Query: 488 VLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVF 543
            ++ E+F  K+GDFG+ + + ET      Y +   G  P  +M PE++   + +T +DV+
Sbjct: 160 CMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 215
Query: 544 SYG 546
           S+G
Sbjct: 216 SFG 218

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 110/225 (48%), Gaps = 40/225 (17%)
Query: 115 NKLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENE 168
            +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE
Sbjct: 21  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNE 68
Query: 169 VQTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYD-----RLARVNNT--PPLD 218
              + +  C HV  +RLLG+ +      ++ E M  G L       R A  NN    P  
Sbjct: 69  ASVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 126
Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNM 277
            +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET   
Sbjct: 127 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-- 182
Query: 278 KTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
              Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 183 --YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 89/183 (48%), Gaps = 37/183 (20%)
Query: 379 ASMRDIVDLLSKSM----FVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVII----L 430
           ASMR+ ++ L+++     F C+ +  L +G VS                G P ++    +
Sbjct: 57  ASMRERIEFLNEASVMKEFNCHHVVRL-LGVVSQ---------------GQPTLVIMELM 100
Query: 431 DTGETKQ-CQLFKLARVNNT--PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 487
             G+ K   +  + A  NN    P   +K   +A  +A+ + YL++     +HRD+ + N
Sbjct: 101 TRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARN 158
Query: 488 VLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVF 543
            ++ E+F  K+GDFG+ + + ET      Y +   G  P  +M PE++   + +T +DV+
Sbjct: 159 CMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 214
Query: 544 SYG 546
           S+G
Sbjct: 215 SFG 217

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 112/225 (49%), Gaps = 40/225 (17%)
Query: 115 NKLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENE 168
            +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE
Sbjct: 24  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNE 71
Query: 169 VQTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLD 218
              + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P  
Sbjct: 72  ASVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNM 277
            +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET   
Sbjct: 130 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-- 185
Query: 278 KTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
              Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 186 --YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 87/183 (47%), Gaps = 37/183 (20%)
Query: 379 ASMRDIVDLLSKSM----FVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVII----L 430
           ASMR+ ++ L+++     F C+ +  L +G VS                G P ++    +
Sbjct: 60  ASMRERIEFLNEASVMKEFNCHHVVRL-LGVVSQ---------------GQPTLVIMELM 103
Query: 431 DTGETKQCQLFKLARVNNTP---PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 487
             G+ K         + N P   P   +K   +A  +A+ + YL++     +HRD+ + N
Sbjct: 104 TRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARN 161
Query: 488 VLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVF 543
            ++ E+F  K+GDFG+ + + ET      Y +   G  P  +M PE++   + +T +DV+
Sbjct: 162 CMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 217
Query: 544 SYG 546
           S+G
Sbjct: 218 SFG 220

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 112/225 (49%), Gaps = 40/225 (17%)
Query: 115 NKLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENE 168
            +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE
Sbjct: 25  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNE 72
Query: 169 VQTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLD 218
              + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P  
Sbjct: 73  ASVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNM 277
            +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET   
Sbjct: 131 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-- 186
Query: 278 KTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
              Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 187 --YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 87/183 (47%), Gaps = 37/183 (20%)
Query: 379 ASMRDIVDLLSKSM----FVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVII----L 430
           ASMR+ ++ L+++     F C+ +  L +G VS                G P ++    +
Sbjct: 61  ASMRERIEFLNEASVMKEFNCHHVVRL-LGVVSQ---------------GQPTLVIMELM 104
Query: 431 DTGETKQCQLFKLARVNNTP---PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 487
             G+ K         + N P   P   +K   +A  +A+ + YL++     +HRD+ + N
Sbjct: 105 TRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARN 162
Query: 488 VLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVF 543
            ++ E+F  K+GDFG+ + + ET      Y +   G  P  +M PE++   + +T +DV+
Sbjct: 163 CMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 218
Query: 544 SYG 546
           S+G
Sbjct: 219 SFG 221

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
            KLG G FG V+  + ++ G+E  +KT+              + + +P+   E E++ L 
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTIN------------KDRSQVPMEQIEAEIEVLK 75
Query: 174 QCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAE 231
              H N++++  +  +  N  IV E    G L +R+         L       +   +  
Sbjct: 76  SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDEN--FVP-KLGDFGIVKMSETSNMKTMYTENLTGT 288
           AL Y HS  + ++H+D+K  N+L  +     P K+ DFG+ ++ ++    T    N  GT
Sbjct: 136 ALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST----NAAGT 189
Query: 289 RPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
             YM PE     ++ K D++S GV++  LLTG  P 
Sbjct: 190 ALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPF 225

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 45/83 (54%), Gaps = 9/83 (10%)
Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDEN--FVP-KLGDFGIVKMSETSNVKTMYTENLTGT 523
           AL Y HS  + ++H+D+K  N+L  +     P K+ DFG+ ++ ++      ++ N  GT
Sbjct: 136 ALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE----HSTNAAGT 189
Query: 524 RPYMPPEAMHCQISTKTDVFSYG 546
             YM PE     ++ K D++S G
Sbjct: 190 ALYMAPEVFKRDVTFKCDIWSAG 212

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 40/224 (17%)
Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 72
Query: 170 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 219
             + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 73  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 278
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 131 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 185
Query: 279 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 186 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 37/186 (19%)
Query: 376 DKRASMRDIVDLLSKSM----FVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVII-- 429
           ++ ASMR+ ++ L+++     F C+ +  L +G VS                G P ++  
Sbjct: 57  NEAASMRERIEFLNEASVMKEFNCHHVVRL-LGVVSQ---------------GQPTLVIM 100
Query: 430 --LDTGETKQCQLFKLARVNNTP---PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK 484
             +  G+ K         + N P   P   +K   +A  +A+ + YL++     +HRD+ 
Sbjct: 101 ELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLA 158
Query: 485 SANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKT 540
           + N ++ E+F  K+GDFG+ + + ET      Y +   G  P  +M PE++   + +T +
Sbjct: 159 ARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYS 214
Query: 541 DVFSYG 546
           DV+S+G
Sbjct: 215 DVWSFG 220

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 40/224 (17%)
Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 79
Query: 170 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYD-----RLARVNNT--PPLDS 219
             + +  C HV  +RLLG+ +      ++ E M  G L       R A  NN    P   
Sbjct: 80  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 278
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 138 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 192
Query: 279 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 193 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 91/186 (48%), Gaps = 37/186 (19%)
Query: 376 DKRASMRDIVDLLSKSM----FVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVII-- 429
           ++ ASMR+ ++ L+++     F C+ +  L +G VS                G P ++  
Sbjct: 64  NEAASMRERIEFLNEASVMKEFNCHHVVRL-LGVVSQ---------------GQPTLVIM 107
Query: 430 --LDTGETKQ-CQLFKLARVNNT--PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK 484
             +  G+ K   +  + A  NN    P   +K   +A  +A+ + YL++     +HRD+ 
Sbjct: 108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLA 165
Query: 485 SANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKT 540
           + N ++ E+F  K+GDFG+ + + ET      Y +   G  P  +M PE++   + +T +
Sbjct: 166 ARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYS 221
Query: 541 DVFSYG 546
           DV+S+G
Sbjct: 222 DVWSFG 227

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 40/224 (17%)
Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 79
Query: 170 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 219
             + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 80  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 278
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 138 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 192
Query: 279 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 193 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 37/186 (19%)
Query: 376 DKRASMRDIVDLLSKSM----FVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVII-- 429
           ++ ASMR+ ++ L+++     F C+ +  L +G VS                G P ++  
Sbjct: 64  NEAASMRERIEFLNEASVMKEFNCHHVVRL-LGVVSQ---------------GQPTLVIM 107
Query: 430 --LDTGETKQCQLFKLARVNNTP---PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK 484
             +  G+ K         + N P   P   +K   +A  +A+ + YL++     +HRD+ 
Sbjct: 108 ELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLA 165
Query: 485 SANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKT 540
           + N ++ E+F  K+GDFG+ + + ET      Y +   G  P  +M PE++   + +T +
Sbjct: 166 ARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYS 221
Query: 541 DVFSYG 546
           DV+S+G
Sbjct: 222 DVWSFG 227

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           G  +GEGQFG V+ G   +     M +A+KT +                      F  E 
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK------------FLQEA 62
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 120
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 174
Query: 290 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 331
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 9/89 (10%)
Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  ++ AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +  
Sbjct: 117 AYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKAS 170
Query: 521 TGTRP--YMPPEAMHC-QISTKTDVFSYG 546
            G  P  +M PE+++  + ++ +DV+ +G
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFG 199

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           G  +GEGQFG V+ G   +     M +A+KT +                      F  E 
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK------------FLQEA 442
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           A  L YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 503 A--LAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 554
Query: 290 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 331
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 9/89 (10%)
Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  ++ AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +  
Sbjct: 497 AYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKAS 550
Query: 521 TGTRP--YMPPEAMHC-QISTKTDVFSYG 546
            G  P  +M PE+++  + ++ +DV+ +G
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFG 579

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 114 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 165
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 82
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 216
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 83  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNP 131
Query: 217 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 269
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 132 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 189
Query: 270 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 190 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ +  +  +
Sbjct: 139 LSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHH 194
Query: 512 VKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYG 546
           +   Y +   G  P  +M PEA+  +I T ++DV+S+G
Sbjct: 195 I-DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 231

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 40/224 (17%)
Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 54  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 101
Query: 170 QTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 219
             + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 102 SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 278
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 160 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 214
Query: 279 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 215 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 37/186 (19%)
Query: 376 DKRASMRDIVDLLSKSM----FVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVII-- 429
           ++ ASMR+ ++ L+++     F C+ +  L +G VS                G P ++  
Sbjct: 86  NEAASMRERIEFLNEASVMKEFNCHHVVRL-LGVVSQ---------------GQPTLVIM 129
Query: 430 --LDTGETKQCQLFKLARVNNTP---PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK 484
             +  G+ K         + N P   P   +K   +A  +A+ + YL++     +HRD+ 
Sbjct: 130 ELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLA 187
Query: 485 SANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKT 540
           + N ++ E+F  K+GDFG+ + + ET      Y +   G  P  +M PE++   + +T +
Sbjct: 188 ARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYS 243
Query: 541 DVFSYG 546
           DV+S+G
Sbjct: 244 DVWSFG 249

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 114 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 165
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 83
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 216
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 84  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNP 132
Query: 217 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 269
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 133 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 190
Query: 270 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 191 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ +  +  +
Sbjct: 140 LSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHH 195
Query: 512 VKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYG 546
           +   Y +   G  P  +M PEA+  +I T ++DV+S+G
Sbjct: 196 I-DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 232

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 114 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 165
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 79
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 216
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 80  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNP 128
Query: 217 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 269
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 129 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 186
Query: 270 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 187 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ +  +  +
Sbjct: 136 LSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHH 191
Query: 512 VKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYG 546
           +   Y +   G  P  +M PEA+  +I T ++DV+S+G
Sbjct: 192 I-DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 228

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 114 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 165
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 90
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 216
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 91  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--AREPPGLEYSYNP 139
Query: 217 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 269
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 270 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 198 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ +  +  +
Sbjct: 147 LSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHH 202
Query: 512 VKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYG 546
           +   Y +   G  P  +M PEA+  +I T ++DV+S+G
Sbjct: 203 I-DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 114 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 165
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 90
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 216
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 91  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNP 139
Query: 217 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 269
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 270 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 198 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ +  +  +
Sbjct: 147 LSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHH 202
Query: 512 VKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYG 546
           +   Y +   G  P  +M PEA+  +I T ++DV+S+G
Sbjct: 203 I-DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 114 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 165
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 75
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 216
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 76  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYCYNP 124
Query: 217 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 269
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 270 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 183 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ +  +  +
Sbjct: 132 LSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHH 187
Query: 512 VKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYG 546
           +   Y +   G  P  +M PEA+  +I T ++DV+S+G
Sbjct: 188 I-DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 224

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 110/241 (45%), Gaps = 49/241 (20%)
Query: 110 YPRR----GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEA 157
           +PR     G  LGEG FG V           K K  + +AVK L+            +E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 158 AMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP 216
            M+ ++            KH N++ LLG C       ++ EY   G+L + L R    P 
Sbjct: 92  EMMKMI-----------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPG 139
Query: 217 L----DSNK----------RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           +    D N+            S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 197
Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTR---PYMPPEAMHCQIST-KTDVFSYGVILLELL 318
           + DFG+ +  + +N+   Y +N T  R    +M PEA+  ++ T ++DV+S+GV++ E+ 
Sbjct: 198 IADFGLAR--DINNID--YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 319 T 319
           T
Sbjct: 254 T 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 53/87 (60%), Gaps = 10/87 (11%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ +  + +N+   Y +N T  
Sbjct: 166 LARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNID--YYKNTTNG 219
Query: 524 R---PYMPPEAMHCQIST-KTDVFSYG 546
           R    +M PEA+  ++ T ++DV+S+G
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFG 246

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 109/240 (45%), Gaps = 47/240 (19%)
Query: 110 YPRR----GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEA 157
           +PR     G  LGEG FG V           K K  + +AVK L+            +E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 158 AMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP 216
            M+ ++            KH N++ LLG C       ++ EY   G+L + L R    P 
Sbjct: 92  EMMKMI-----------GKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPG 139
Query: 217 L----DSNK----------RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           +    D N+            S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 197
Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           + DFG+ +  + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 198 IADFGLAR--DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 52/86 (60%), Gaps = 8/86 (9%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ +  + +N+   Y +   G 
Sbjct: 166 LARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNID-YYKKTTNGR 220
Query: 524 RP--YMPPEAMHCQIST-KTDVFSYG 546
            P  +M PEA+  ++ T ++DV+S+G
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFG 246

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 167 NEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARV-----NNTPPLDSN 220
            E+Q +SQC H N++             +V + +  GS+ D +  +     + +  LD +
Sbjct: 62  KEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 121
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN--MK 278
              +I   V E L YLH   +  IHRDVK+ N+LL E+   ++ DFG+     T     +
Sbjct: 122 TIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 279 TMYTENLTGTRPYMPPEAMHCQIST---KTDVFSYGVILLELLTGMKPIDDNNTILYYYL 335
               +   GT  +M PE M  Q+     K D++S+G+  +EL TG  P      +    L
Sbjct: 180 NKVRKTFVGTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238
Query: 336 VVEQEVPVRE--VLDKE 350
            ++ + P  E  V DKE
Sbjct: 239 TLQNDPPSLETGVQDKE 255

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 56/114 (49%), Gaps = 15/114 (13%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           LD +   +I   V E L YLH   +  IHRDVK+ N+LL E+   ++ DFG+     T  
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175
Query: 512 --VKTMYTENLTGTRPYMPPEAMHCQIST---KTDVFSYGAQIKTQHITNVDIA 560
              +    +   GT  +M PE M  Q+     K D++S+G       IT +++A
Sbjct: 176 DITRNKVRKTFVGTPCWMAPEVME-QVRGYDFKADIWSFG-------ITAIELA 221

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 167 NEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARV-----NNTPPLDSN 220
            E+Q +SQC H N++             +V + +  GS+ D +  +     + +  LD +
Sbjct: 57  KEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 116
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN--MK 278
              +I   V E L YLH   +  IHRDVK+ N+LL E+   ++ DFG+     T     +
Sbjct: 117 TIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 174
Query: 279 TMYTENLTGTRPYMPPEAMHCQIST---KTDVFSYGVILLELLTGMKPIDDNNTILYYYL 335
               +   GT  +M PE M  Q+     K D++S+G+  +EL TG  P      +    L
Sbjct: 175 NKVRKTFVGTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 233
Query: 336 VVEQEVPVRE--VLDKE 350
            ++ + P  E  V DKE
Sbjct: 234 TLQNDPPSLETGVQDKE 250

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 56/114 (49%), Gaps = 15/114 (13%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           LD +   +I   V E L YLH   +  IHRDVK+ N+LL E+   ++ DFG+     T  
Sbjct: 113 LDESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 170
Query: 512 --VKTMYTENLTGTRPYMPPEAMHCQIST---KTDVFSYGAQIKTQHITNVDIA 560
              +    +   GT  +M PE M  Q+     K D++S+G       IT +++A
Sbjct: 171 DITRNKVRKTFVGTPCWMAPEVME-QVRGYDFKADIWSFG-------ITAIELA 216

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 114 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 165
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 90
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 216
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 91  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYCYNP 139
Query: 217 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 269
                  L S    S A  VA  + YL S  K  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 270 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 198 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L S    S A  VA  + YL S  K  IHRD+ + NVL+ E+ V K+ DFG+ +  +  +
Sbjct: 147 LSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHH 202
Query: 512 VKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYG 546
           +   Y +   G  P  +M PEA+  +I T ++DV+S+G
Sbjct: 203 I-DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 109/240 (45%), Gaps = 47/240 (19%)
Query: 110 YPRR----GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEA 157
           +PR     G  LGEG FG V           K K  + +AVK L+            +E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEM 91
Query: 158 AMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP 216
            M+ ++            KH N++ LLG C       ++ EY   G+L + L R    P 
Sbjct: 92  EMMKMI-----------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPG 139
Query: 217 L----DSNK----------RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           +    D N+            S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 197
Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           + DFG+ +  + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 198 IADFGLAR--DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 52/86 (60%), Gaps = 8/86 (9%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ +  + +N+   Y +   G 
Sbjct: 166 LARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNID-YYKKTTNGR 220
Query: 524 RP--YMPPEAMHCQIST-KTDVFSYG 546
            P  +M PEA+  ++ T ++DV+S+G
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFG 246

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 109/240 (45%), Gaps = 47/240 (19%)
Query: 110 YPRR----GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEA 157
           +PR     G  LGEG FG V           K K  + +AVK L+            +E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 158 AMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP 216
            M+ ++            KH N++ LLG C       ++ EY   G+L + L R    P 
Sbjct: 92  EMMKMI-----------GKHKNIITLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPG 139
Query: 217 L----DSNK----------RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           +    D N+            S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 197
Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           + DFG+ +  + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 198 IADFGLAR--DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 52/86 (60%), Gaps = 8/86 (9%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ +  + +N+   Y +   G 
Sbjct: 166 LARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNID-YYKKTTNGR 220
Query: 524 RP--YMPPEAMHCQIST-KTDVFSYG 546
            P  +M PEA+  ++ T ++DV+S+G
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFG 246

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 106/251 (42%), Gaps = 26/251 (10%)
Query: 99  ERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAA 158
           E  T   N + +     +LG+G FG VY  + K    +A   +              E  
Sbjct: 27  EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV-----IDTKSEEELEDY 81
Query: 159 MIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLD 218
           M+       E+  L+ C H N+++LL       N  +    C G   D +  +    PL 
Sbjct: 82  MV-------EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM-LELERPLT 133
Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 278
            ++   +     +AL+YLH     IIHRD+K+ N+L   +   KL DFG+       N +
Sbjct: 134 ESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTR 187
Query: 279 TMY-TENLTGTRPYMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNTIL 331
           T+   ++  GT  +M PE + C+ S       K DV+S G+ L+E+     P  + N + 
Sbjct: 188 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 247
Query: 332 YYYLVVEQEVP 342
               + + E P
Sbjct: 248 VLLKIAKSEPP 258

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 64/128 (50%), Gaps = 17/128 (13%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL  ++   +     +AL+YLH     IIHRD+K+ N+L   +   KL DFG+       
Sbjct: 131 PLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGV----SAK 184
Query: 511 NVKTMY-TENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQ 569
           N +T+   ++  GT  +M PE + C+ S K   + Y A + +  IT +++A+ E      
Sbjct: 185 NTRTIQRRDSFIGTPYWMAPEVVMCETS-KDRPYDYKADVWSLGITLIEMAEIE------ 237
Query: 570 TMLPGHHE 577
              P HHE
Sbjct: 238 ---PPHHE 242

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 38/222 (17%)
Query: 115 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
            ++G+G++G V+ GK + G ++AVK               TE A       E E+     
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVF-----------FTTEEAS---WFRETEIYQTVL 87
Query: 175 CKHVNLLRLL-----GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            +H N+L  +     G  +     ++ +Y  NGSLYD L     +  LD+     +A   
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSS 143
Query: 230 AEALHYLHS-----LSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYT 282
              L +LH+       KP I HRD+KS N+L+ +N    + D G+ VK    +N   +  
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 283 ENLTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLEL 317
               GT+ YMPPE +       H Q     D++S+G+IL E+
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 14/109 (12%)
Query: 452 LDSNKRYSIALGVAEALHYLHS-----LSKPII-HRDVKSANVLLDENFVPKLGDFGI-V 504
           LD+     +A      L +LH+       KP I HRD+KS N+L+ +N    + D G+ V
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190
Query: 505 KMSETSNVKTMYTENLTGTRPYMPPEAM-------HCQISTKTDVFSYG 546
           K    +N   +      GT+ YMPPE +       H Q     D++S+G
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 34/219 (15%)
Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES------------ASLRERIEFLNEA 68
Query: 170 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 219
             +    C HV  +RLLG+ +      +V E M +G L   L  +     NN   PP   
Sbjct: 69  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 126
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ +    ++   
Sbjct: 127 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 184
Query: 280 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLEL 317
              + L   R +M PE++   + +T +D++S+GV+L E+
Sbjct: 185 KGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 54/98 (55%), Gaps = 4/98 (4%)
Query: 450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 509
           PP    +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ +    
Sbjct: 122 PPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 179
Query: 510 SNVKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
           ++      + L   R +M PE++   + +T +D++S+G
Sbjct: 180 TDXXRKGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFG 216

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 104/250 (41%), Gaps = 24/250 (9%)
Query: 99  ERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAA 158
           E  T   N + +     +LG+G FG VY  + K    +A   +              E  
Sbjct: 27  EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV-----IDTKSEEELEDY 81
Query: 159 MIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLD 218
           M+       E+  L+ C H N+++LL       N  +    C G   D +  +    PL 
Sbjct: 82  MV-------EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM-LELERPLT 133
Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 278
            ++   +     +AL+YLH     IIHRD+K+ N+L   +   KL DFG+   S  +   
Sbjct: 134 ESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGV---SAKNTRX 188
Query: 279 TMYTENLTGTRPYMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNTILY 332
               ++  GT  +M PE + C+ S       K DV+S G+ L+E+     P  + N +  
Sbjct: 189 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV 248
Query: 333 YYLVVEQEVP 342
              + + E P
Sbjct: 249 LLKIAKSEPP 258

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 62/127 (48%), Gaps = 15/127 (11%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL  ++   +     +AL+YLH     IIHRD+K+ N+L   +   KL DFG+   S  +
Sbjct: 131 PLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGV---SAKN 185
Query: 511 NVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQT 570
                  ++  GT  +M PE + C+ S K   + Y A + +  IT +++A+ E       
Sbjct: 186 TRXIQRRDSFIGTPYWMAPEVVMCETS-KDRPYDYKADVWSLGITLIEMAEIE------- 237
Query: 571 MLPGHHE 577
             P HHE
Sbjct: 238 --PPHHE 242

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 103/239 (43%), Gaps = 27/239 (11%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIP--ILLFENEVQ 170
           G  LG G    V+  + L++  ++AVK L              + A  P   L F  E Q
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLR------------ADLARDPSFYLRFRREAQ 64
Query: 171 TLSQCKHVNLLRLLGLCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
             +   H  ++ +            +  IV EY+   +L D    V+   P+   +   +
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPMTPKRAIEV 121
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
                +AL++ H     IIHRDVK AN+L+      K+ DFGI +    S      T  +
Sbjct: 122 IADACQALNFSHQ--NGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAV 179
Query: 286 TGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVP 342
            GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ + + Y  V E  +P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 3/102 (2%)
Query: 446 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 505
           V+   P+   +   +     +AL++ H     IIHRDVK AN+L+      K+ DFGI +
Sbjct: 107 VHTEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANILISATNAVKVVDFGIAR 164
Query: 506 MSETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
               S      T  + GT  Y+ PE A    +  ++DV+S G
Sbjct: 165 AIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 111/225 (49%), Gaps = 40/225 (17%)
Query: 115 NKLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENE 168
            +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE
Sbjct: 18  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNE 65
Query: 169 VQTLSQ--CKHVNLLRLLGLCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLD 218
              + +  C HV  +RLLG+ +      ++ E M  G L  Y R  R  + N P   P  
Sbjct: 66  ASVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNM 277
            +K   +A  +A+ + YL++     +HRD+ + N  + E+F  K+GDFG+ + + ET   
Sbjct: 124 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETD-- 179
Query: 278 KTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
              Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 180 --YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 86/183 (46%), Gaps = 37/183 (20%)
Query: 379 ASMRDIVDLLSKSM----FVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVII----L 430
           ASMR+ ++ L+++     F C+ +  L +G VS                G P ++    +
Sbjct: 54  ASMRERIEFLNEASVMKEFNCHHVVRL-LGVVSQ---------------GQPTLVIMELM 97
Query: 431 DTGETKQCQLFKLARVNNTP---PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 487
             G+ K         + N P   P   +K   +A  +A+ + YL++     +HRD+ + N
Sbjct: 98  TRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARN 155
Query: 488 VLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVF 543
             + E+F  K+GDFG+ + + ET      Y +   G  P  +M PE++   + +T +DV+
Sbjct: 156 CXVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 211
Query: 544 SYG 546
           S+G
Sbjct: 212 SFG 214

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 34/219 (15%)
Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES------------ASLRERIEFLNEA 71
Query: 170 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 219
             +    C HV  +RLLG+ +      +V E M +G L   L  +     NN   PP   
Sbjct: 72  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ +    ++   
Sbjct: 130 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 187
Query: 280 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLEL 317
              + L   R +M PE++   + +T +D++S+GV+L E+
Sbjct: 188 KGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 54/98 (55%), Gaps = 4/98 (4%)
Query: 450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 509
           PP    +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ +    
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 182
Query: 510 SNVKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
           ++      + L   R +M PE++   + +T +D++S+G
Sbjct: 183 TDXXRKGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFG 219

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 59
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 60  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 117
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 118 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 171
Query: 290 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 331
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 9/89 (10%)
Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  ++ AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +  
Sbjct: 114 AYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKAS 167
Query: 521 TGTRP--YMPPEAMHC-QISTKTDVFSYG 546
            G  P  +M PE+++  + ++ +DV+ +G
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFG 196

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 93/182 (51%), Gaps = 13/182 (7%)
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKR 222
           FE EV   SQ  H N++ ++ + +   +C  +V EY+   +L +    + +  PL  +  
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDV-DEEDDCYYLVMEYIEGPTLSEY---IESHGPLSVDTA 113
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMY 281
            +    + + + + H +   I+HRD+K  N+L+D N   K+ DFGI K +SETS  +T +
Sbjct: 114 INFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH 171
Query: 282 TENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
              + GT  Y  PE    + + + TD++S G++L E+L G  P +    +      ++  
Sbjct: 172 ---VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS 228
Query: 341 VP 342
           VP
Sbjct: 229 VP 230

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSET 509
           PL  +   +    + + + + H +   I+HRD+K  N+L+D N   K+ DFGI K +SET
Sbjct: 107 PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164
Query: 510 SNVKTMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYG 546
           S  +T +   + GT  Y  PE    + + + TD++S G
Sbjct: 165 SLTQTNH---VLGTVQYFSPEQAKGEATDECTDIYSIG 199

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 114 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 165
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 131
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 216
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 132 ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA--RRPPGLEYSYNP 180
Query: 217 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 269
                  L S    S A  VA  + YL S  K  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLA 238
Query: 270 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 239 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L S    S A  VA  + YL S  K  IHRD+ + NVL+ E+ V K+ DFG+ +  +  +
Sbjct: 188 LSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHH 243
Query: 512 VKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYG 546
           +   Y +   G  P  +M PEA+  +I T ++DV+S+G
Sbjct: 244 ID-YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 34/219 (15%)
Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES------------ASLRERIEFLNEA 71
Query: 170 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 219
             +    C HV  +RLLG+ +      +V E M +G L   L  +     NN   PP   
Sbjct: 72  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ +    ++   
Sbjct: 130 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 187
Query: 280 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLEL 317
              + L   R +M PE++   + +T +D++S+GV+L E+
Sbjct: 188 KGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 54/98 (55%), Gaps = 4/98 (4%)
Query: 450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 509
           PP    +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ +    
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 182
Query: 510 SNVKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
           ++      + L   R +M PE++   + +T +D++S+G
Sbjct: 183 TDXXRKGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFG 219

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 62
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 120
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 174
Query: 290 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 331
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 9/89 (10%)
Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  ++ AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +  
Sbjct: 117 AYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKAS 170
Query: 521 TGTRP--YMPPEAMHC-QISTKTDVFSYG 546
            G  P  +M PE+++  + ++ +DV+ +G
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFG 199

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 67
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 68  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 125
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 126 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 179
Query: 290 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 331
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 227

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 9/89 (10%)
Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  ++ AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +  
Sbjct: 122 AYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKAS 175
Query: 521 TGTRP--YMPPEAMHC-QISTKTDVFSYG 546
            G  P  +M PE+++  + ++ +DV+ +G
Sbjct: 176 KGKLPIKWMAPESINFRRFTSASDVWMFG 204

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 62
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 120
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+      K  +     
Sbjct: 121 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD--KEFFKVKEP 176
Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 64
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 65  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 122
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 123 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 176
Query: 290 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 331
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 177 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 224

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 9/89 (10%)
Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  ++ AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +  
Sbjct: 119 AYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKAS 172
Query: 521 TGTRP--YMPPEAMHC-QISTKTDVFSYG 546
            G  P  +M PE+++  + ++ +DV+ +G
Sbjct: 173 KGKLPIKWMAPESINFRRFTSASDVWMFG 201

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 65
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 66  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 123
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 124 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 177
Query: 290 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 331
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 178 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 225

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 9/89 (10%)
Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  ++ AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +  
Sbjct: 120 AYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKAS 173
Query: 521 TGTRP--YMPPEAMHC-QISTKTDVFSYG 546
            G  P  +M PE+++  + ++ +DV+ +G
Sbjct: 174 KGKLPIKWMAPESINFRRFTSASDVWMFG 202

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 90
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 91  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 148
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 149 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 202
Query: 290 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 331
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 203 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 250

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 9/89 (10%)
Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  ++ AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +  
Sbjct: 145 AYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKAS 198
Query: 521 TGTRP--YMPPEAMHC-QISTKTDVFSYG 546
            G  P  +M PE+++  + ++ +DV+ +G
Sbjct: 199 KGKLPIKWMAPESINFRRFTSASDVWMFG 227

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRD------------FLGEASIM 77
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++ L G+        IV EYM NGSL   L +  N       +   +  G++ 
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKK--NDGQFTVIQLVGMLRGISA 135
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 136 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 193
Query: 292 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 323
             PEA+  +  ++ +DV+SYG+++ E+++ G +P
Sbjct: 194 TAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 50/87 (57%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G++  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G
Sbjct: 132 GISAGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GG 187
Query: 523 TRP--YMPPEAMHCQ-ISTKTDVFSYG 546
             P  +  PEA+  +  ++ +DV+SYG
Sbjct: 188 KIPIRWTAPEAIAFRKFTSASDVWSYG 214

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 109/240 (45%), Gaps = 47/240 (19%)
Query: 110 YPRR----GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEA 157
           +PR     G  LGEG FG V           K K  + +AVK L+            +E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 158 AMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP 216
            M+ ++            KH N++ LLG C       ++ EY   G+L + L R    P 
Sbjct: 92  EMMKMI-----------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPG 139
Query: 217 L----DSNK----------RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           +    D N+            S    +A  + YL S  +  IHRD+ + NVL+ EN V +
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMR 197
Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           + DFG+ +  + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 198 IADFGLAR--DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 52/86 (60%), Gaps = 8/86 (9%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  + YL S  +  IHRD+ + NVL+ EN V ++ DFG+ +  + +N+   Y +   G 
Sbjct: 166 LARGMEYLAS--QKCIHRDLAARNVLVTENNVMRIADFGLAR--DINNID-YYKKTTNGR 220
Query: 524 RP--YMPPEAMHCQIST-KTDVFSYG 546
            P  +M PEA+  ++ T ++DV+S+G
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFG 246

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 103/250 (41%), Gaps = 24/250 (9%)
Query: 99  ERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAA 158
           E  T   N + +     +LG+G FG VY  + K    +A   +              E  
Sbjct: 27  EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV-----IDTKSEEELEDY 81
Query: 159 MIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLD 218
           M+       E+  L+ C H N+++LL       N  +    C G   D +  +    PL 
Sbjct: 82  MV-------EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM-LELERPLT 133
Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 278
            ++   +     +AL+YLH     IIHRD+K+ N+L   +   KL DFG+   S  +   
Sbjct: 134 ESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGV---SAKNTRX 188
Query: 279 TMYTENLTGTRPYMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNTILY 332
               +   GT  +M PE + C+ S       K DV+S G+ L+E+     P  + N +  
Sbjct: 189 IQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV 248
Query: 333 YYLVVEQEVP 342
              + + E P
Sbjct: 249 LLKIAKSEPP 258

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 61/127 (48%), Gaps = 15/127 (11%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL  ++   +     +AL+YLH     IIHRD+K+ N+L   +   KL DFG+   S  +
Sbjct: 131 PLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGV---SAKN 185
Query: 511 NVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQT 570
                  +   GT  +M PE + C+ S K   + Y A + +  IT +++A+ E       
Sbjct: 186 TRXIQRRDXFIGTPYWMAPEVVMCETS-KDRPYDYKADVWSLGITLIEMAEIE------- 237
Query: 571 MLPGHHE 577
             P HHE
Sbjct: 238 --PPHHE 242

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 106/232 (45%), Gaps = 43/232 (18%)
Query: 114 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 165
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 143
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPL----DSN 220
                     KH N++ LLG C       ++ EY   G+L + L R    P +    D N
Sbjct: 144 ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIN 193
Query: 221 K----------RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
           +            S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ +
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR 251
Query: 271 MSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
             + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 252 --DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 52/86 (60%), Gaps = 8/86 (9%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ +  + +N+   Y +   G 
Sbjct: 212 LARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNID-YYKKTTNGR 266
Query: 524 RP--YMPPEAMHCQIST-KTDVFSYG 546
            P  +M PEA+  ++ T ++DV+S+G
Sbjct: 267 LPVKWMAPEALFDRVYTHQSDVWSFG 292

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 99/231 (42%), Gaps = 41/231 (17%)
Query: 114 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 165
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 90
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 216
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 91  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEFSFNP 139
Query: 217 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 269
                  L S    S A  VA  + YL S  K  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 270 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           +     +     T      + +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 198 RDIHHIDXXKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 4/96 (4%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L S    S A  VA  + YL S  K  IHRD+ + NVL+ E+ V K+ DFG+ +     +
Sbjct: 147 LSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYG 546
                T      + +M PEA+  +I T ++DV+S+G
Sbjct: 205 XXKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSFG 239

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 109/240 (45%), Gaps = 47/240 (19%)
Query: 110 YPRR----GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEA 157
           +PR     G  LGEG FG V           K K  + +AVK L+            +E 
Sbjct: 24  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 83
Query: 158 AMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP 216
            M+ ++            KH N++ LLG C       ++ EY   G+L + L R    P 
Sbjct: 84  EMMKMI-----------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPG 131
Query: 217 L----DSNK----------RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           +    D N+            S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 132 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 189
Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           + DFG+ +  + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 190 IADFGLAR--DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 52/86 (60%), Gaps = 8/86 (9%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ +  + +N+   Y +   G 
Sbjct: 158 LARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNID-YYKKTTNGR 212
Query: 524 RP--YMPPEAMHCQIST-KTDVFSYG 546
            P  +M PEA+  ++ T ++DV+S+G
Sbjct: 213 LPVKWMAPEALFDRVYTHQSDVWSFG 238

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
            +LG+G FG VY  K K  G   A K +E                      +  E++ L+
Sbjct: 17  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-------------YIVEIEILA 63
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYD----RLARVNNTPPLDSNKRYSIALGV 229
            C H  +++LLG   +     +    C G   D     L R    P +    R  +    
Sbjct: 64  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---- 119
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGT 288
            EAL++LHS  K IIHRD+K+ NVL+      +L DFG+       N+KT+   ++  GT
Sbjct: 120 -EALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGT 172
Query: 289 RPYMPPEAMHCQI------STKTDVFSYGVILLEL 317
             +M PE + C+         K D++S G+ L+E+
Sbjct: 173 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 61/113 (53%), Gaps = 17/113 (15%)
Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT-ENLTGTR 524
           EAL++LHS  K IIHRD+K+ NVL+      +L DFG+       N+KT+   ++  GT 
Sbjct: 120 EALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGTP 173
Query: 525 PYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHE 577
            +M PE + C+ + K   + Y A I +  IT +++A  E         P HHE
Sbjct: 174 YWMAPEVVMCE-TMKDTPYDYKADIWSLGITLIEMAQIE---------PPHHE 216

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
            +LG+G FG VY  K K  G   A K +E                      +  E++ L+
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-------------YIVEIEILA 71
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYD----RLARVNNTPPLDSNKRYSIALGV 229
            C H  +++LLG   +     +    C G   D     L R    P +    R  +    
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---- 127
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGT 288
            EAL++LHS  K IIHRD+K+ NVL+      +L DFG+       N+KT+   ++  GT
Sbjct: 128 -EALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGT 180
Query: 289 RPYMPPEAMHCQI------STKTDVFSYGVILLEL 317
             +M PE + C+         K D++S G+ L+E+
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 61/113 (53%), Gaps = 17/113 (15%)
Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT-ENLTGTR 524
           EAL++LHS  K IIHRD+K+ NVL+      +L DFG+       N+KT+   ++  GT 
Sbjct: 128 EALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGTP 181
Query: 525 PYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHE 577
            +M PE + C+ + K   + Y A I +  IT +++A  E         P HHE
Sbjct: 182 YWMAPEVVMCE-TMKDTPYDYKADIWSLGITLIEMAQIE---------PPHHE 224

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 111/222 (50%), Gaps = 40/222 (18%)
Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------------ESASLRERIEFLNEA 71
Query: 170 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 219
             +    C HV  +RLLG+ +      +V E M +G L   L  +     NN   PP   
Sbjct: 72  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 278
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ + + ET+   
Sbjct: 130 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETA--- 184
Query: 279 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLEL 317
             Y +   G  P  +M PE++   + +T +D++S+GV+L E+
Sbjct: 185 -YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 57/101 (56%), Gaps = 10/101 (9%)
Query: 450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSE 508
           PP    +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ + + E
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 509 TSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           T+     Y +   G  P  +M PE++   + +T +D++S+G
Sbjct: 183 TA----YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG 219

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 103/239 (43%), Gaps = 27/239 (11%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIP--ILLFENEVQ 170
           G  LG G    V+  + L++  ++AVK L              + A  P   L F  E Q
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLR------------ADLARDPSFYLRFRREAQ 64
Query: 171 TLSQCKHVNLLRLLGLCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
             +   H  ++ +            +  IV EY+   +L D    V+   P+   +   +
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPMTPKRAIEV 121
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
                +AL++ H     IIHRDVK AN+++      K+ DFGI +    S      T  +
Sbjct: 122 IADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 286 TGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVP 342
            GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ + + Y  V E  +P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 3/102 (2%)
Query: 446 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 505
           V+   P+   +   +     +AL++ H     IIHRDVK AN+++      K+ DFGI +
Sbjct: 107 VHTEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIAR 164
Query: 506 MSETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
               S      T  + GT  Y+ PE A    +  ++DV+S G
Sbjct: 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 31/221 (14%)
Query: 117 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +G G+FG V  G+LK      + +A+KTL+             EA++            +
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASI------------M 98
Query: 173 SQCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            Q  H N++ L G+      +M  IV E+M NG+L D   R ++       +   +  G+
Sbjct: 99  GQFDHPNVVHLEGVVTRGKPVM--IVIEFMENGAL-DAFLRKHDGQ-FTVIQLVGMLRGI 154
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + + +YT    G  
Sbjct: 155 AAGMRYLADMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVIE-DDPEAVYT-TTGGKI 210
Query: 290 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 326
           P  +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 211 PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 251

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 52/87 (59%), Gaps = 7/87 (8%)
Query: 463 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + + +YT    G
Sbjct: 153 GIAAGMRYLADMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVIE-DDPEAVYT-TTGG 208
Query: 523 TRP--YMPPEAM-HCQISTKTDVFSYG 546
             P  +  PEA+ + + ++ +DV+SYG
Sbjct: 209 KIPVRWTAPEAIQYRKFTSASDVWSYG 235

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 109/240 (45%), Gaps = 47/240 (19%)
Query: 110 YPRR----GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEA 157
           +PR     G  LGEG FG V           K K  + +AVK L+            +E 
Sbjct: 21  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 80
Query: 158 AMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP 216
            M+ ++            KH N++ LLG C       ++ EY   G+L + L R    P 
Sbjct: 81  EMMKMI-----------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPG 128
Query: 217 L----DSNK----------RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           +    D N+            S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 129 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 186
Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           + DFG+ +  + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 187 IADFGLAR--DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 52/86 (60%), Gaps = 8/86 (9%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ +  + +N+   Y +   G 
Sbjct: 155 LARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNID-YYKKTTNGR 209
Query: 524 RP--YMPPEAMHCQIST-KTDVFSYG 546
            P  +M PEA+  ++ T ++DV+S+G
Sbjct: 210 LPVKWMAPEALFDRVYTHQSDVWSFG 235

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 108/239 (45%), Gaps = 45/239 (18%)
Query: 110 YPRR----GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEA 157
           +PR     G  LGEG FG V           K K  + +AVK L+            +E 
Sbjct: 19  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 78
Query: 158 AMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSL--YDRLAR---- 210
            M+ ++            KH N++ LLG C       ++ EY   G+L  Y R  R    
Sbjct: 79  EMMKMI-----------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 127
Query: 211 -----VNNTPP--LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL 263
                +N  P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+
Sbjct: 128 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLTARNVLVTENNVMKI 185
Query: 264 GDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
            DFG+ +  + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 186 ADFGLAR--DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 52/86 (60%), Gaps = 8/86 (9%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ +  + +N+   Y +   G 
Sbjct: 153 LARGMEYLAS--QKCIHRDLTARNVLVTENNVMKIADFGLAR--DINNID-YYKKTTNGR 207
Query: 524 RP--YMPPEAMHCQIST-KTDVFSYG 546
            P  +M PEA+  ++ T ++DV+S+G
Sbjct: 208 LPVKWMAPEALFDRVYTHQSDVWSFG 233

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 29/240 (12%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIP--ILLFENEVQ 170
           G  LG G    V+  + L++  ++AVK L              + A  P   L F  E Q
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLR------------ADLARDPSFYLRFRREAQ 64
Query: 171 TLSQCKHVNLLRLLGLCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
             +   H  ++ +            +  IV EY+   +L D    V+   P+   +   +
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPMTPKRAIEV 121
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
                +AL++ H     IIHRDVK AN+++      K+ DFGI +    S      T  +
Sbjct: 122 IADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 286 TGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPI--DDNNTILYYYLVVEQEVP 342
            GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   D  +++ Y + V E  +P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQH-VREDPIP 238

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 3/102 (2%)
Query: 446 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 505
           V+   P+   +   +     +AL++ H     IIHRDVK AN+++      K+ DFGI +
Sbjct: 107 VHTEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIAR 164
Query: 506 MSETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
               S      T  + GT  Y+ PE A    +  ++DV+S G
Sbjct: 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           G  +GEGQFG V+ G   +     M +A+KT +                      F  E 
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK------------FLQEA 62
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL-- 120
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           + AL YL S  K  +HRD+ + NVL+      KLGDFG+ +  E S     Y +   G  
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDST----YYKASKGKL 174
Query: 290 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 331
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 9/89 (10%)
Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  ++ AL YL S  K  +HRD+ + NVL+      KLGDFG+ +  E S     Y +  
Sbjct: 117 AYQLSTALAYLES--KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDST----YYKAS 170
Query: 521 TGTRP--YMPPEAMHC-QISTKTDVFSYG 546
            G  P  +M PE+++  + ++ +DV+ +G
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFG 199

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           G  +GEGQFG V+ G   +     M +A+KT +                      F  E 
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK------------FLQEA 442
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           A  L YL S  K  +HRD+ + NVL+      KLGDFG+ +  E S     Y +   G  
Sbjct: 503 A--LAYLES--KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDST----YYKASKGKL 554
Query: 290 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 331
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 9/89 (10%)
Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  ++ AL YL S  K  +HRD+ + NVL+      KLGDFG+ +  E S     Y +  
Sbjct: 497 AYQLSTALAYLES--KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDST----YYKAS 550
Query: 521 TGTRP--YMPPEAMHC-QISTKTDVFSYG 546
            G  P  +M PE+++  + ++ +DV+ +G
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFG 579

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 65
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 66  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 123
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 124 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 179
Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 69
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 70  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 127
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 128 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 183
Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 184 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 23/215 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKNG-MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K     +A+K L                          E++  
Sbjct: 28  GRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQ----------LRREIEIQ 77
Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           +   H N+LRL     +     ++ EY   G LY  L +       D  +  +I   +A+
Sbjct: 78  AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT---FDEQRTATIMEELAD 134
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y H   K +IHRD+K  N+LL      K+ DFG    + +   KTM      GT  Y
Sbjct: 135 ALMYCHG--KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTM-----CGTLDY 187
Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPID 325
           +PPE +  ++ + K D++  GV+  ELL G  P +
Sbjct: 188 LPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +  +I   +A+AL Y H   K +IHRD+K  N+LL      K+ DFG    + +  
Sbjct: 120 FDEQRTATIMEELADALMYCHG--KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLR 177
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
            KTM      GT  Y+PPE +  ++ + K D++  G
Sbjct: 178 RKTM-----CGTLDYLPPEMIEGRMHNEKVDLWCIG 208

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 61
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 62  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 119
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 120 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 175
Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 176 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 67
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 68  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 125
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 126 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 181
Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 182 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           G  +GEGQFG V+ G   +     M +A+KT +                      F  E 
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK------------FLQEA 62
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            T+ Q  H ++++L+G+       I+ E    G L   L     +  L S   Y+  L  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL-- 120
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S         L    
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK- 177
Query: 290 PYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 331
            +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 178 -WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  ++ AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S         L
Sbjct: 117 AYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL 174
Query: 521 TGTRPYMPPEAMHC-QISTKTDVFSYG 546
                +M PE+++  + ++ +DV+ +G
Sbjct: 175 PIK--WMAPESINFRRFTSASDVWMFG 199

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 62
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 120
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 121 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 176
Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 66
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 67  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 124
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 125 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 180
Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 181 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 68
Query: 170 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 69  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 126
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 127 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 182
Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 183 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 60
Query: 170 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 61  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 118
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 119 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 174
Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 175 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 62
Query: 170 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 120
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 121 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 176
Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 93
Query: 170 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 94  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 151
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 152 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 207
Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 110/222 (49%), Gaps = 40/222 (18%)
Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES------------ASLRERIEFLNEA 71
Query: 170 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 219
             +    C HV  +RLLG+ +      +V E M +G L   L  +     NN   PP   
Sbjct: 72  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 278
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ + + ET    
Sbjct: 130 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD--- 184
Query: 279 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLEL 317
             Y +   G  P  +M PE++   + +T +D++S+GV+L E+
Sbjct: 185 -YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 56/101 (55%), Gaps = 10/101 (9%)
Query: 450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSE 508
           PP    +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ + + E
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 509 TSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           T      Y +   G  P  +M PE++   + +T +D++S+G
Sbjct: 183 TD----YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG 219

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 80
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 81  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 138
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 139 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 194
Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 195 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 80
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 81  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 138
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 139 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 194
Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 195 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 63
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 64  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 121
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL +  K  IHR++ + N+L++     K+GDFG+ K+      K  Y     
Sbjct: 122 SQICKGMEYLGT--KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQD--KEYYKVKEP 177
Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 178 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 107/240 (44%), Gaps = 47/240 (19%)
Query: 110 YPRR----GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEA 157
           +PR     G  LGEG FG V           K K  + +AVK L+            +E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 158 AMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP 216
            M+ ++            KH N++ LLG C       ++ EY   G+L + L R    P 
Sbjct: 92  EMMKMI-----------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPG 139
Query: 217 LDSN--------------KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           ++ +                 S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 140 MEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 197
Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           + DFG+ +  + +N+     +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 198 IADFGLAR--DINNIDXX-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 51/86 (59%), Gaps = 8/86 (9%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ +  + +N+     +   G 
Sbjct: 166 LARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDXX-KKTTNGR 220
Query: 524 RP--YMPPEAMHCQIST-KTDVFSYG 546
            P  +M PEA+  ++ T ++DV+S+G
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFG 246

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 119/267 (44%), Gaps = 52/267 (19%)
Query: 92  AFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY------YGKLKNGMEIAVKT 140
           ++TF D  +    +N K  +PR     G  LG G FG V        GK    +++AVK 
Sbjct: 11  SYTFIDPTQLP--YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 68
Query: 141 LEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNNIMNCIVY-EY 198
           L+             EA M       +E++ +S   +H N++ LLG C +    +V  EY
Sbjct: 69  LKSTAHADE-----KEALM-------SELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 116
Query: 199 MCNGSLYDRLARV--------------------NNTPPLDSNKRYSIALGVAEALHYLHS 238
            C G L + L R                      +  PL+       +  VA+ + +L S
Sbjct: 117 CCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLAS 176
Query: 239 LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH 298
             K  IHRDV + NVLL    V K+GDFG+ +    ++   +   N      +M PE++ 
Sbjct: 177 --KNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKGNARLPVKWMAPESIF 233
Query: 299 -CQISTKTDVFSYGVILLELLT-GMKP 323
            C  + ++DV+SYG++L E+ + G+ P
Sbjct: 234 DCVYTVQSDVWSYGILLWEIFSLGLNP 260

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSE 508
           PL+       +  VA+ + +L S  K  IHRDV + NVLL    V K+GDFG+ +  M++
Sbjct: 154 PLELRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 509 TSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYG 546
           ++ +      N      +M PE++  C  + ++DV+SYG
Sbjct: 212 SNYI---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 247

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 108/240 (45%), Gaps = 47/240 (19%)
Query: 110 YPRR----GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEA 157
           +PR     G  LGEG FG V           K K  + +AVK L+            +E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 158 AMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP 216
            M+ ++            KH N++ LLG C       ++  Y   G+L + L R    P 
Sbjct: 92  EMMKMI-----------GKHKNIINLLGACTQDGPLYVIVAYASKGNLREYL-RARRPPG 139
Query: 217 L----DSNK----------RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           +    D N+            S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 197
Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           + DFG+ +  + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 198 IADFGLAR--DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 52/86 (60%), Gaps = 8/86 (9%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ +  + +N+   Y +   G 
Sbjct: 166 LARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNID-YYKKTTNGR 220
Query: 524 RP--YMPPEAMHCQIST-KTDVFSYG 546
            P  +M PEA+  ++ T ++DV+S+G
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFG 246

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 108/240 (45%), Gaps = 47/240 (19%)
Query: 110 YPRR----GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEA 157
           +PR     G  LGEG FG V           K K  + +AVK L+            +E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 158 AMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP 216
            M+ ++            KH N++ LLG C       ++ EY   G+L + L R    P 
Sbjct: 92  EMMKMI-----------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPG 139
Query: 217 L----DSNK----------RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           +    D N+            S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 197
Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           + DFG+ +  + +N+     +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 198 IADFGLAR--DINNIDXX-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 51/86 (59%), Gaps = 8/86 (9%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ +  + +N+     +   G 
Sbjct: 166 LARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDXX-KKTTNGR 220
Query: 524 RP--YMPPEAMHCQIST-KTDVFSYG 546
            P  +M PEA+  ++ T ++DV+S+G
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFG 246

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 109/224 (48%), Gaps = 40/224 (17%)
Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES------------ASLRERIEFLNEA 70
Query: 170 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARVN-------NTPPLDS 219
             +    C HV  +RLLG+ +      +V E M +G L   L  +          PP   
Sbjct: 71  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 128
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 278
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ + + ET    
Sbjct: 129 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD--- 183
Query: 279 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
             Y +   G  P  +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 184 -YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 56/101 (55%), Gaps = 10/101 (9%)
Query: 450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSE 508
           PP    +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ + + E
Sbjct: 124 PPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 181
Query: 509 TSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           T      Y +   G  P  +M PE++   + +T +D++S+G
Sbjct: 182 TD----YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG 218

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   K K  G E AVK +              E+ +        EVQ L Q 
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVI---SKRQVKQKTDKESLL-------REVQLLKQL 89
Query: 176 KHVNLLRLLGLCNNI-MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L     +     +V E    G L+D +        +D+ +   I   V   + 
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 146
Query: 235 YLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           Y+H     I+HRD+K  N+LL     D N   ++ DFG+    E S  K M  ++  GT 
Sbjct: 147 YMHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEAS--KKM--KDKIGTA 198
Query: 290 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
            Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 199 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 237

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 163 LLFENEVQTLSQCKHVNLLRLLGLCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPL 217
           L F  E Q  +   H  ++ +            +  IV EY+   +L D    V+   P+
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPM 113
Query: 218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 277
              +   +     +AL++ H     IIHRDVK AN+++      K+ DFGI +    S  
Sbjct: 114 TPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 278 KTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYL 335
               T  + GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ + + Y  
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 231
Query: 336 VVEQEVP 342
           V E  +P
Sbjct: 232 VREDPIP 238

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 3/102 (2%)
Query: 446 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 505
           V+   P+   +   +     +AL++ H     IIHRDVK AN+++      K+ DFGI +
Sbjct: 107 VHTEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIAR 164
Query: 506 MSETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
               S      T  + GT  Y+ PE A    +  ++DV+S G
Sbjct: 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 65
Query: 170 QTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L   +H N+++  G+C +       ++ EY+  GSL D L    +   +D  K     
Sbjct: 66  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--AHAERIDHIKLLQYT 123
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 124 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 179
Query: 287 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 108/240 (45%), Gaps = 47/240 (19%)
Query: 110 YPRR----GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEA 157
           +PR     G  LGEG FG V           K K  + +AVK L+            +E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 158 AMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP 216
            M+ ++            KH N++ LLG C       ++  Y   G+L + L R    P 
Sbjct: 92  EMMKMI-----------GKHKNIINLLGACTQDGPLYVIVGYASKGNLREYL-RARRPPG 139
Query: 217 L----DSNK----------RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           +    D N+            S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 197
Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 319
           + DFG+ +  + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 198 IADFGLAR--DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 52/86 (60%), Gaps = 8/86 (9%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ +  + +N+   Y +   G 
Sbjct: 166 LARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNID-YYKKTTNGR 220
Query: 524 RP--YMPPEAMHCQIST-KTDVFSYG 546
            P  +M PEA+  ++ T ++DV+S+G
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFG 246

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K     +  GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGTAQY 200
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + ++K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 250

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K     +  GT
Sbjct: 141 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGT 197
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + ++K +D+++ G  I
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCII 224

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 137/315 (43%), Gaps = 60/315 (19%)
Query: 110 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAM 159
           +PR     G  LG G FG V     YG +K+   M +AVK L+             EA M
Sbjct: 36  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALM 90
Query: 160 IPILLFENEVQTLSQC-KHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLAR------V 211
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R       
Sbjct: 91  -------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 143
Query: 212 NNTPP---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           + T P         LD     S +  VA+ + +L S  K  IHRD+ + N+LL    + K
Sbjct: 144 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITK 201
Query: 263 LGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELL 318
           + DFG+ + +   SN    Y        P  +M PE++ +C  + ++DV+SYG+ L EL 
Sbjct: 202 ICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 257
Query: 319 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDK 377
           + G  P         +Y ++++      +L  E       H    +  + + C   +  K
Sbjct: 258 SLGSSPYPGMPVDSKFYKMIKEGF---RMLSPE-------HAPAEMYDIMKTCWDADPLK 307
Query: 378 RASMRDIVDLLSKSM 392
           R + + IV L+ K +
Sbjct: 308 RPTFKQIVQLIEKQI 322

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 10/92 (10%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYT 517
           S +  VA+ + +L S  K  IHRD+ + N+LL    + K+ DFG+ + +   SN    Y 
Sbjct: 165 SFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN----YV 218
Query: 518 ENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                  P  +M PE++ +C  + ++DV+SYG
Sbjct: 219 VKGNARLPVKWMAPESIFNCVYTFESDVWSYG 250

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           KLGEG +G+VY    K  G  +A+K +              E+ +  I+    E+  + Q
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVP------------VESDLQEII---KEISIMQQ 80
Query: 175 CKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           C   ++++  G    N    IV EY   GS+ D +   N T  L  ++  +I     + L
Sbjct: 81  CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLH + K  IHRD+K+ N+LL+     KL DFG+         K      + GT  +M 
Sbjct: 139 EYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK---RNXVIGTPFWMA 193
Query: 294 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV 336
           PE +     +   D++S G+  +E+  G  P  D + +   +++
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 13/103 (12%)
Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           + L YLH + K  IHRD+K+ N+LL+     KL DFG+         K      + GT  
Sbjct: 136 KGLEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK---RNXVIGTPF 190
Query: 526 YMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVDIADRERYYS 567
           +M PE +     +   D++S G       IT +++A+ +  Y+
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLG-------ITAIEMAEGKPPYA 226

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 137/315 (43%), Gaps = 60/315 (19%)
Query: 110 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAM 159
           +PR     G  LG G FG V     YG +K+   M +AVK L+             EA M
Sbjct: 43  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALM 97
Query: 160 IPILLFENEVQTLSQC-KHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLAR------V 211
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R       
Sbjct: 98  -------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 150
Query: 212 NNTPP---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           + T P         LD     S +  VA+ + +L S  K  IHRD+ + N+LL    + K
Sbjct: 151 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITK 208
Query: 263 LGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELL 318
           + DFG+ + +   SN    Y        P  +M PE++ +C  + ++DV+SYG+ L EL 
Sbjct: 209 ICDFGLARHIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 319 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDK 377
           + G  P         +Y ++++      +L  E       H    +  + + C   +  K
Sbjct: 265 SLGSSPYPGMPVDSKFYKMIKEGF---RMLSPE-------HAPAEMYDIMKTCWDADPLK 314
Query: 378 RASMRDIVDLLSKSM 392
           R + + IV L+ K +
Sbjct: 315 RPTFKQIVQLIEKQI 329

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 10/92 (10%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYT 517
           S +  VA+ + +L S  K  IHRD+ + N+LL    + K+ DFG+ + +   SN    Y 
Sbjct: 172 SFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSN----YV 225
Query: 518 ENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                  P  +M PE++ +C  + ++DV+SYG
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYG 257

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   K K  G E AVK +                     LL   EVQ L Q 
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES--------LL--REVQLLKQL 83
Query: 176 KHVNLLRLLGLCNNI-MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L     +     +V E    G L+D +        +D+ +   I   V   + 
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 140
Query: 235 YLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           Y+H     I+HRD+K  N+LL     D N   ++ DFG+    E S  K M  ++  GT 
Sbjct: 141 YMHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEAS--KKM--KDKIGTA 192
Query: 290 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
            Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 193 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 231

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 50/104 (48%), Gaps = 19/104 (18%)
Query: 454 SNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFG 502
           S KR+S      I   V   + Y+H     I+HRD+K  N+LL     D N   ++ DFG
Sbjct: 119 SRKRFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFG 174
Query: 503 IVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYG 546
           +    E S  K M  ++  GT  Y+ PE +H     K DV+S G
Sbjct: 175 LSTHFEAS--KKM--KDKIGTAYYIAPEVLHGTYDEKCDVWSTG 214

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 137/315 (43%), Gaps = 60/315 (19%)
Query: 110 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAM 159
           +PR     G  LG G FG V     YG +K+   M +AVK L+             EA M
Sbjct: 43  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALM 97
Query: 160 IPILLFENEVQTLSQC-KHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLAR------V 211
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R       
Sbjct: 98  -------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 150
Query: 212 NNTPP---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           + T P         LD     S +  VA+ + +L S  K  IHRD+ + N+LL    + K
Sbjct: 151 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITK 208
Query: 263 LGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELL 318
           + DFG+ + +   SN    Y        P  +M PE++ +C  + ++DV+SYG+ L EL 
Sbjct: 209 ICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 319 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDK 377
           + G  P         +Y ++++      +L  E       H    +  + + C   +  K
Sbjct: 265 SLGSSPYPGMPVDSKFYKMIKEGF---RMLSPE-------HAPAEMYDIMKTCWDADPLK 314
Query: 378 RASMRDIVDLLSKSM 392
           R + + IV L+ K +
Sbjct: 315 RPTFKQIVQLIEKQI 329

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 10/92 (10%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYT 517
           S +  VA+ + +L S  K  IHRD+ + N+LL    + K+ DFG+ + +   SN    Y 
Sbjct: 172 SFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN----YV 225
Query: 518 ENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                  P  +M PE++ +C  + ++DV+SYG
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYG 257

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 137/315 (43%), Gaps = 60/315 (19%)
Query: 110 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAM 159
           +PR     G  LG G FG V     YG +K+   M +AVK L+             EA M
Sbjct: 38  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALM 92
Query: 160 IPILLFENEVQTLSQC-KHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLAR------V 211
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R       
Sbjct: 93  -------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 145
Query: 212 NNTPP---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           + T P         LD     S +  VA+ + +L S  K  IHRD+ + N+LL    + K
Sbjct: 146 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITK 203
Query: 263 LGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELL 318
           + DFG+ + +   SN    Y        P  +M PE++ +C  + ++DV+SYG+ L EL 
Sbjct: 204 ICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 259
Query: 319 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDK 377
           + G  P         +Y ++++      +L  E       H    +  + + C   +  K
Sbjct: 260 SLGSSPYPGMPVDSKFYKMIKEGF---RMLSPE-------HAPAEMYDIMKTCWDADPLK 309
Query: 378 RASMRDIVDLLSKSM 392
           R + + IV L+ K +
Sbjct: 310 RPTFKQIVQLIEKQI 324

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 10/92 (10%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYT 517
           S +  VA+ + +L S  K  IHRD+ + N+LL    + K+ DFG+ + +   SN    Y 
Sbjct: 167 SFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN----YV 220
Query: 518 ENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                  P  +M PE++ +C  + ++DV+SYG
Sbjct: 221 VKGNARLPVKWMAPESIFNCVYTFESDVWSYG 252

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 110/243 (45%), Gaps = 27/243 (11%)
Query: 109 PYPRR--------GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAM 159
           P PR+        G  LGEG F TV   + L    E A+K LE             +   
Sbjct: 2   PQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENK 53
Query: 160 IPILLFENEVQTLSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLD 218
           +P +  E +V  +S+  H   ++L     ++        Y  NG L   + ++ +    +
Sbjct: 54  VPYVTRERDV--MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--E 109
Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 278
           +  R+  A  +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K
Sbjct: 110 TCTRFYTA-EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESK 165
Query: 279 TMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 337
                   GT  Y+ PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  ++
Sbjct: 166 QARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 225
Query: 338 EQE 340
           + E
Sbjct: 226 KLE 228

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 119 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 175
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCII 202

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 110/243 (45%), Gaps = 27/243 (11%)
Query: 109 PYPRR--------GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAM 159
           P PR+        G  LGEG F TV   + L    E A+K LE             +   
Sbjct: 1   PQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENK 52
Query: 160 IPILLFENEVQTLSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLD 218
           +P +  E +V  +S+  H   ++L     ++        Y  NG L   + ++ +    +
Sbjct: 53  VPYVTRERDV--MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--E 108
Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 278
           +  R+  A  +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K
Sbjct: 109 TCTRFYTA-EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESK 164
Query: 279 TMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 337
                   GT  Y+ PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  ++
Sbjct: 165 QARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 224
Query: 338 EQE 340
           + E
Sbjct: 225 KLE 227

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 118 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 174
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCII 201

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   K K  G E AVK +                     LL   EVQ L Q 
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES--------LL--REVQLLKQL 106
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L     +     +V E    G L+D +        +D+ +   I   V   + 
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 163
Query: 235 YLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           Y+H     I+HRD+K  N+LL     D N   ++ DFG+    E S  K M  ++  GT 
Sbjct: 164 YMHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEAS--KKM--KDKIGTA 215
Query: 290 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
            Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 216 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 254

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 133/291 (45%), Gaps = 45/291 (15%)
Query: 112 RRGNKLGEGQFGTVYYG-KLKNG----MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 166
           +R   LG G FGTVY G  +  G    + +A+K L                       F 
Sbjct: 41  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE------------FM 88
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           +E   ++   H +L+RLLG+C +    +V + M +G L + +    +   + S    +  
Sbjct: 89  DEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWC 146
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
           + +A+ + YL    + ++HRD+ + NVL+      K+ DFG+ ++ E    +  Y  +  
Sbjct: 147 VQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE--YNAD-G 201
Query: 287 GTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP 342
           G  P  +M  E +H +  T ++DV+SYGV + EL+T G KP D               +P
Sbjct: 202 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG--------------IP 247
Query: 343 VREVLD-KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            RE+ D  E GE   +  + T+ + +V  KC + + D R   +++    S+
Sbjct: 248 TREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 298

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 137/315 (43%), Gaps = 60/315 (19%)
Query: 110 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAM 159
           +PR     G  LG G FG V     YG +K+   M +AVK L+             EA M
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALM 74
Query: 160 IPILLFENEVQTLSQC-KHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLAR------V 211
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R       
Sbjct: 75  -------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 212 NNTPP---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
           + T P         LD     S +  VA+ + +L S  K  IHRD+ + N+LL    + K
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITK 185
Query: 263 LGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELL 318
           + DFG+ + +   SN    Y        P  +M PE++ +C  + ++DV+SYG+ L EL 
Sbjct: 186 ICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 319 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDK 377
           + G  P         +Y ++++      +L  E       H    +  + + C   +  K
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGF---RMLSPE-------HAPAEMYDIMKTCWDADPLK 291
Query: 378 RASMRDIVDLLSKSM 392
           R + + IV L+ K +
Sbjct: 292 RPTFKQIVQLIEKQI 306

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 10/92 (10%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYT 517
           S +  VA+ + +L S  K  IHRD+ + N+LL    + K+ DFG+ + +   SN    Y 
Sbjct: 149 SFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN----YV 202
Query: 518 ENLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
                  P  +M PE++ +C  + ++DV+SYG
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYG 234

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 90/159 (56%), Gaps = 9/159 (5%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           ++ +++  G L+ RL++       + + ++ +A  +A AL +LHSL   II+RD+K  N+
Sbjct: 104 LILDFLRGGDLFTRLSK--EVMFTEEDVKFYLA-ELALALDHLHSLG--IIYRDLKPENI 158
Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGV 312
           LLDE    KL DFG+ K S   + K  Y+    GT  YM PE ++ +  T++ D +S+GV
Sbjct: 159 LLDEEGHIKLTDFGLSKES-IDHEKKAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGV 215
Query: 313 ILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           ++ E+LTG  P    +      ++++ ++ + + L  EA
Sbjct: 216 LMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEA 254

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/84 (42%), Positives = 51/84 (60%), Gaps = 6/84 (7%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A AL +LHSL   II+RD+K  N+LLDE    KL DFG+ K S   + K  Y+    GT
Sbjct: 136 LALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYS--FCGT 190
Query: 524 RPYMPPEAMHCQISTKT-DVFSYG 546
             YM PE ++ +  T++ D +S+G
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFG 214

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 133/291 (45%), Gaps = 45/291 (15%)
Query: 112 RRGNKLGEGQFGTVYYG-KLKNG----MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 166
           +R   LG G FGTVY G  +  G    + +A+K L                       F 
Sbjct: 18  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE------------FM 65
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           +E   ++   H +L+RLLG+C +    +V + M +G L + +    +   + S    +  
Sbjct: 66  DEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWC 123
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
           + +A+ + YL    + ++HRD+ + NVL+      K+ DFG+ ++ E    +  Y  +  
Sbjct: 124 VQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE--YNAD-G 178
Query: 287 GTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP 342
           G  P  +M  E +H +  T ++DV+SYGV + EL+T G KP D               +P
Sbjct: 179 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG--------------IP 224
Query: 343 VREVLD-KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            RE+ D  E GE   +  + T+ + +V  KC + + D R   +++    S+
Sbjct: 225 TREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 275

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 27/239 (11%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIP--ILLFENEVQ 170
           G  LG G    V+  + L+   ++AVK L              + A  P   L F  E Q
Sbjct: 17  GEILGFGGMSEVHLARDLRLHRDVAVKVLR------------ADLARDPSFYLRFRREAQ 64
Query: 171 TLSQCKHVNLLRLLGLCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
             +   H  ++ +            +  IV EY+   +L D    V+   P+   +   +
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPMTPKRAIEV 121
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
                +AL++ H     IIHRDVK AN+++      K+ DFGI +    S      T  +
Sbjct: 122 IADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 286 TGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVP 342
            GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ + + Y  V E  +P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 3/102 (2%)
Query: 446 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 505
           V+   P+   +   +     +AL++ H     IIHRDVK AN+++      K+ DFGI +
Sbjct: 107 VHTEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIAR 164
Query: 506 MSETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
               S      T  + GT  Y+ PE A    +  ++DV+S G
Sbjct: 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   K K  G E AVK +                     LL   EVQ L Q 
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES--------LL--REVQLLKQL 107
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L     +     +V E    G L+D +        +D+ +   I   V   + 
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 164
Query: 235 YLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           Y+H     I+HRD+K  N+LL     D N   ++ DFG+    E S  K M  ++  GT 
Sbjct: 165 YMHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEAS--KKM--KDKIGTA 216
Query: 290 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
            Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 217 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 255

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 177 ELLKRREFHAEPVDVWSCG 195

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 87
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 88  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 144
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K     +  GT  Y
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGTAQY 201
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 251

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 48/87 (55%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K     +  GT
Sbjct: 142 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGT 198
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCII 225

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 90/159 (56%), Gaps = 9/159 (5%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           ++ +++  G L+ RL++       + + ++ +A  +A AL +LHSL   II+RD+K  N+
Sbjct: 103 LILDFLRGGDLFTRLSK--EVMFTEEDVKFYLA-ELALALDHLHSLG--IIYRDLKPENI 157
Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGV 312
           LLDE    KL DFG+ K S   + K  Y+    GT  YM PE ++ +  T++ D +S+GV
Sbjct: 158 LLDEEGHIKLTDFGLSKES-IDHEKKAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGV 214
Query: 313 ILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           ++ E+LTG  P    +      ++++ ++ + + L  EA
Sbjct: 215 LMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEA 253

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/84 (42%), Positives = 51/84 (60%), Gaps = 6/84 (7%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A AL +LHSL   II+RD+K  N+LLDE    KL DFG+ K S   + K  Y+    GT
Sbjct: 135 LALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYS--FCGT 189
Query: 524 RPYMPPEAMHCQISTKT-DVFSYG 546
             YM PE ++ +  T++ D +S+G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFG 213

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 21/231 (9%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 42  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 91
Query: 173 SQCKHVNLLRLLGLCNNIMNCIVY--EYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           S+  H   ++L   C      + +   Y  NG L   + ++ +    ++  R+  A  + 
Sbjct: 92  SRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIV 147
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
            AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  
Sbjct: 148 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 204
Query: 291 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           Y+ PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 255

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 146 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 202
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCII 229

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 92/160 (57%), Gaps = 11/160 (6%)
Query: 194 IVYEYMCNGSLYDRLAR-VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           ++ +++  G L+ RL++ V  T   + + ++ +A  +A AL +LHSL   II+RD+K  N
Sbjct: 103 LILDFLRGGDLFTRLSKEVMFT---EEDVKFYLA-ELALALDHLHSLG--IIYRDLKPEN 156
Query: 253 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYG 311
           +LLDE    KL DFG+ K S   + K  Y+    GT  YM PE ++ +  T++ D +S+G
Sbjct: 157 ILLDEEGHIKLTDFGLSKES-IDHEKKAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFG 213
Query: 312 VILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           V++ E+LTG  P    +      ++++ ++ + + L  EA
Sbjct: 214 VLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEA 253

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/84 (42%), Positives = 51/84 (60%), Gaps = 6/84 (7%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A AL +LHSL   II+RD+K  N+LLDE    KL DFG+ K S   + K  Y+    GT
Sbjct: 135 LALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYS--FCGT 189
Query: 524 RPYMPPEAMHCQISTKT-DVFSYG 546
             YM PE ++ +  T++ D +S+G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFG 213

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 176 ELLKRREFHAEPVDVWSCG 194

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 73  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 117
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 118 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 174
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 118 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 174
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 175 ELLKRREFHAEPVDVWSCG 193

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 176 ELLKRREFHAEPVDVWSCG 194

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 132/276 (47%), Gaps = 38/276 (13%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG  G V   + K +G ++AVK ++                    LLF NEV  +  
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE------------LLF-NEVVIMRD 98
Query: 175 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            +H N++ +    L    +  ++ E++  G+L D +++V     L+  +  ++   V +A
Sbjct: 99  YQHFNVVEMYKSYLVGEEL-WVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQA 153
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLH+  + +IHRD+KS ++LL  +   KL DFG          K    + L GT  +M
Sbjct: 154 LAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKXLVGTPYWM 208
Query: 293 PPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
            PE +   + +T+ D++S G++++E++ G  P   ++ +            ++ + D   
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----------QAMKRLRDSPP 258
Query: 352 GEWNETH-VETLIGIVFEKCCVFEKDKRASMRDIVD 386
            +   +H V  ++    E+  V +  +RA+ ++++D
Sbjct: 259 PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L+  +  ++   V +AL YLH+  + +IHRD+KS ++LL  +   KL DFG         
Sbjct: 138 LNEEQIATVCEAVLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGAQI 549
            K    + L GT  +M PE +   + +T+ D++S G  +
Sbjct: 196 PK---RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMV 231

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 176 ELLKRREFHAEPVDVWSCG 194

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 176 ELLKRREFHAEPVDVWSCG 194

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 177 ELLKRREFHAEPVDVWSCG 195

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 176 ELLKRREFHAEPVDVWSCG 194

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 177 ELLKRREFHAEPVDVWSCG 195

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 163 LLFENEVQTLSQCKHVNLLRLLGLCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPL 217
           L F  E Q  +   H  ++ +            +  IV EY+   +L D    V+   P+
Sbjct: 74  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPM 130
Query: 218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 277
              +   +     +AL++ H     IIHRDVK AN+++      K+ DFGI +    S  
Sbjct: 131 TPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 188
Query: 278 KTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYL 335
               T  + GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ + + Y  
Sbjct: 189 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 248
Query: 336 VVEQEVP 342
           V E  +P
Sbjct: 249 VREDPIP 255

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 3/102 (2%)
Query: 446 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 505
           V+   P+   +   +     +AL++ H     IIHRDVK AN+++      K+ DFGI +
Sbjct: 124 VHTEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIAR 181
Query: 506 MSETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
               S      T  + GT  Y+ PE A    +  ++DV+S G
Sbjct: 182 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 223

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 176 ELLKRREFHAEPVDVWSCG 194

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69
Query: 173 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++ L  +  N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 287
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 288 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 176 ELLKRREFHAEPVDVWSCG 194

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 13  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 62
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 119
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 120 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 176
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 226

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 117 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 173
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCII 200

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 176 ELLKRREFHAEPVDVWSCG 194

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 34  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 83
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 140
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K     +  GT  Y
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGTAQY 197
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 247

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 48/87 (55%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K     +  GT
Sbjct: 138 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGT 194
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCII 221

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 176 ELLKRREFHAEPVDVWSCG 194

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 176
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 176
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 177 ELLKRREFHAEPVDVWSCG 195

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 176 ELLKRREFHAEPVDVWSCG 194

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 177 ELLKRREFHAEPVDVWSCG 195

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69
Query: 173 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++ L  +  N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 287
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 288 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 12  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 61
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 118
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 119 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 175
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 225

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 116 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 172
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCII 199

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 19  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 68
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 69  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 125
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 126 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 182
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 232

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 123 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 179
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCII 206

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE-------IEREVSIL 69
Query: 173 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++ L  +  N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 287
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 288 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69
Query: 173 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++ L  +  N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 287
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 288 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69
Query: 173 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++ L  +  N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 287
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 288 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 177 ELLKRREFHAEPVDVWSCG 195

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 177 ELLKRREFHAEPVDVWSCG 195

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 176 ELLKRREFHAEPVDVWSCG 194

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 177 ELLKRREFHAEPVDVWSCG 195

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 14/180 (7%)
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
           ENE+  L + KH N++ L  +  +  +  ++ + +  G L+DR+         D+++   
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--- 120
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNMKTMY 281
           +   V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  ++ +  
Sbjct: 121 LIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-- 176
Query: 282 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
                GT  Y+ PE +  +  +K  D +S GVI   LL G  P  D N    +  +++ E
Sbjct: 177 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 234

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  +V +      
Sbjct: 125 VLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS----TA 178
Query: 521 TGTRPYMPPEAMHCQISTKT-DVFSYG 546
            GT  Y+ PE +  +  +K  D +S G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIG 205

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 110/222 (49%), Gaps = 40/222 (18%)
Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES------------ASLRERIEFLNEA 72
Query: 170 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 219
             +    C HV  +RLLG+ +      +V E M +G L   L  +     NN   PP   
Sbjct: 73  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 130
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 278
            +   +A  +A+ + YL++  K  +HR++ + N ++  +F  K+GDFG+ + + ET    
Sbjct: 131 QEMIQMAAEIADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD--- 185
Query: 279 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLEL 317
             Y +   G  P  +M PE++   + +T +D++S+GV+L E+
Sbjct: 186 -YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 56/101 (55%), Gaps = 10/101 (9%)
Query: 450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSE 508
           PP    +   +A  +A+ + YL++  K  +HR++ + N ++  +F  K+GDFG+ + + E
Sbjct: 126 PPPTLQEMIQMAAEIADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE 183
Query: 509 TSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           T      Y +   G  P  +M PE++   + +T +D++S+G
Sbjct: 184 TD----YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG 220

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 110/222 (49%), Gaps = 40/222 (18%)
Query: 116 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES------------ASLRERIEFLNEA 71
Query: 170 QTLS--QCKHVNLLRLLGLCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 219
             +    C HV  +RLLG+ +      +V E M +G L   L  +     NN   PP   
Sbjct: 72  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 278
            +   +A  +A+ + YL++  K  +HR++ + N ++  +F  K+GDFG+ + + ET    
Sbjct: 130 QEMIQMAAEIADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD--- 184
Query: 279 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLEL 317
             Y +   G  P  +M PE++   + +T +D++S+GV+L E+
Sbjct: 185 -YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 56/101 (55%), Gaps = 10/101 (9%)
Query: 450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSE 508
           PP    +   +A  +A+ + YL++  K  +HR++ + N ++  +F  K+GDFG+ + + E
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 509 TSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           T      Y +   G  P  +M PE++   + +T +D++S+G
Sbjct: 183 TD----YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG 219

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69
Query: 173 SQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++ L  +  N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 287
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 288 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V++ M  G L+D L        L   +  SI   + EA+ +LH+    I+HRD+K  N+
Sbjct: 177 LVFDLMRKGELFDYL---TEKVALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENI 231
Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-------STKTD 306
           LLD+N   +L DFG     E           L GT  Y+ PE + C +         + D
Sbjct: 232 LLDDNMQIRLSDFGFSCHLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 307 VFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
           +++ GVIL  LL G  P      IL   +++E
Sbjct: 288 LWACGVILFTLLAGSPPFWHRRQILMLRMIME 319

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 60/133 (45%), Gaps = 13/133 (9%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L   +  SI   + EA+ +LH+    I+HRD+K  N+LLD+N   +L DFG     E   
Sbjct: 197 LSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQI-------STKTDVFSYGAQIKTQHITNVDIADRER 564
                   L GT  Y+ PE + C +         + D+++ G  + T    +     R +
Sbjct: 255 ----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ 310
Query: 565 YYSLQTMLPGHHE 577
              L+ ++ G ++
Sbjct: 311 ILMLRMIMEGQYQ 323

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 200
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 250

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 141 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 197
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCII 224

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 84
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 141
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 198
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 139 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 195
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCII 222

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 14/180 (7%)
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
           ENE+  L + KH N++ L  +  +  +  ++ + +  G L+DR+         D+++   
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--- 120
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNMKTMY 281
           +   V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  ++ +  
Sbjct: 121 LIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-- 176
Query: 282 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
                GT  Y+ PE +  +  +K  D +S GVI   LL G  P  D N    +  +++ E
Sbjct: 177 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 234

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  +V +      
Sbjct: 125 VLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS----TA 178
Query: 521 TGTRPYMPPEAMHCQISTKT-DVFSYG 546
            GT  Y+ PE +  +  +K  D +S G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIG 205

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 200
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 250

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 141 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 197
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCII 224

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 84
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 141
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 198
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 139 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 195
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCII 222

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 84
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 141
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANAFVGTAQY 198
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 139 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANAFVGT 195
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCII 222

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 14/180 (7%)
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
           ENE+  L + KH N++ L  +  +  +  ++ + +  G L+DR+         D+++   
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--- 120
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNMKTMY 281
           +   V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  ++ +  
Sbjct: 121 LIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-- 176
Query: 282 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
                GT  Y+ PE +  +  +K  D +S GVI   LL G  P  D N    +  +++ E
Sbjct: 177 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 234

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  +V +      
Sbjct: 125 VLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS----TA 178
Query: 521 TGTRPYMPPEAMHCQISTKT-DVFSYG 546
            GT  Y+ PE +  +  +K  D +S G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIG 205

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 87
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 88  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 144
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 201
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 251

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 142 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 198
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCII 225

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G+G F  V   + +  G E+AVK ++            T+     +     EV+ +   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDK-----------TQLNPTSLQKLFREVRIMKIL 71
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 72  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 128
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 129 YCHQ--KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK----LDTFCGSPPYAAP 182
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 328
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 8/90 (8%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  A+ Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+
Sbjct: 123 IVSAVQYCHQ--KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGN----KLDTFCGS 176
Query: 524 RPYMPPEAMHCQI--STKTDVFSYGAQIKT 551
            PY  PE    +     + DV+S G  + T
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYT 206

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 34  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 83
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 140
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 197
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 247

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 138 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 194
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCII 221

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 200
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 250

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 141 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 197
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCII 224

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 40  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 89
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 90  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 146
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 147 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 203
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 253

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+    + K        GT
Sbjct: 144 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 200
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCII 227

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 14/180 (7%)
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
           ENE+  L + KH N++ L  +  +  +  ++ + +  G L+DR+         D+++   
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--- 120
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNMKTMY 281
           +   V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  ++ +  
Sbjct: 121 LIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-- 176
Query: 282 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
                GT  Y+ PE +  +  +K  D +S GVI   LL G  P  D N    +  +++ E
Sbjct: 177 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 234

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  +V +      
Sbjct: 125 VLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS----TA 178
Query: 521 TGTRPYMPPEAMHCQISTKT-DVFSYG 546
            GT  Y+ PE +  +  +K  D +S G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIG 205

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 55
Query: 177 HVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 56  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 111
Query: 232 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 284
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171
Query: 285 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELLT--GMKPIDDNNTILYYYL 335
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231
Query: 336 V 336
           V
Sbjct: 232 V 232

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 14/101 (13%)
Query: 460 IALGVAEALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNV 512
           +AL  A  L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++ 
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 513 KTMYTENLTGTRPYMPPEAM-------HCQISTKTDVFSYG 546
             +   +  GT+ YM PE +       H +   + D+++ G
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 56
Query: 177 HVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 57  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 112
Query: 232 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 284
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 113 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 172
Query: 285 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELLT--GMKPIDDNNTILYYYL 335
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 173 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 232
Query: 336 V 336
           V
Sbjct: 233 V 233

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 14/101 (13%)
Query: 460 IALGVAEALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNV 512
           +AL  A  L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++ 
Sbjct: 106 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 165
Query: 513 KTMYTENLTGTRPYMPPEAM-------HCQISTKTDVFSYG 546
             +   +  GT+ YM PE +       H +   + D+++ G
Sbjct: 166 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 206

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPIL--LFENEVQT 171
            K+GEG +G V+  + ++ G  +A+K                E+   P++  +   E++ 
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKF-------------LESEDDPVIKKIALREIRM 55
Query: 172 LSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L Q KH NL+ LL +        +V+EY C+ ++   L R     P    K  SI     
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEY-CDHTVLHELDRYQRGVPEHLVK--SITWQTL 112
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           +A+++ H  +   IHRDVK  N+L+ ++ V KL DFG  ++       + Y ++   TR 
Sbjct: 113 QAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGP---SDYYDDEVATRW 167
Query: 291 YMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV 336
           Y  PE +    Q     DV++ G +  ELL+G+      + +   YL+
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI 215

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 94
Query: 177 HVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 95  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 150
Query: 232 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 284
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 285 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELLT--GMKPIDDNNTILYYYL 335
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 336 V 336
           V
Sbjct: 271 V 271

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 14/101 (13%)
Query: 460 IALGVAEALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNV 512
           +AL  A  L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++ 
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203
Query: 513 KTMYTENLTGTRPYMPPEAM-------HCQISTKTDVFSYG 546
             +   +  GT+ YM PE +       H +   + D+++ G
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 89/160 (55%), Gaps = 11/160 (6%)
Query: 194 IVYEYMCNGSLYDRLAR-VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           ++ +++  G L+ RL++ V  T   + + ++ +A  +A  L +LHSL   II+RD+K  N
Sbjct: 107 LILDFLRGGDLFTRLSKEVMFT---EEDVKFYLA-ELALGLDHLHSLG--IIYRDLKPEN 160
Query: 253 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 311
           +LLDE    KL DFG+ K +   + K  Y+    GT  YM PE ++ Q  S   D +SYG
Sbjct: 161 ILLDEEGHIKLTDFGLSKEA-IDHEKKAYS--FCGTVEYMAPEVVNRQGHSHSADWWSYG 217
Query: 312 VILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           V++ E+LTG  P    +      L+++ ++ + + L  EA
Sbjct: 218 VLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEA 257

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/84 (42%), Positives = 48/84 (57%), Gaps = 6/84 (7%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  L +LHSL   II+RD+K  N+LLDE    KL DFG+ K +   + K  Y+    GT
Sbjct: 139 LALGLDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKEA-IDHEKKAYS--FCGT 193
Query: 524 RPYMPPEAMHCQI-STKTDVFSYG 546
             YM PE ++ Q  S   D +SYG
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYG 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 58
Query: 177 HVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 59  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 114
Query: 232 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 284
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 115 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 174
Query: 285 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELLT--GMKPIDDNNTILYYYL 335
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 175 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 234
Query: 336 V 336
           V
Sbjct: 235 V 235

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 14/101 (13%)
Query: 460 IALGVAEALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNV 512
           +AL  A  L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++ 
Sbjct: 108 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 167
Query: 513 KTMYTENLTGTRPYMPPEAM-------HCQISTKTDVFSYG 546
             +   +  GT+ YM PE +       H +   + D+++ G
Sbjct: 168 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 208

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/289 (22%), Positives = 118/289 (40%), Gaps = 39/289 (13%)
Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           G  +G+G+FG VY+G+     E+A++ ++                   +  F+ EV    
Sbjct: 38  GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQ-----------LKAFKREVMAYR 84
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           Q +H N++  +G C +  +  +   +C G     + R +    LD NK   IA  + + +
Sbjct: 85  QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGM 143
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET--SNMKTMYTENLTGTRPY 291
            YLH  +K I+H+D+KS NV  D   V  + DFG+  +S    +  +        G   +
Sbjct: 144 GYLH--AKGILHKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 292 MPPEAMH----------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           + PE +              S  +DVF+ G I  EL     P                E 
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----------EA 250
Query: 342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            + ++        ++  +   I  +   C  FE+++R +   ++D+L K
Sbjct: 251 IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G+G F  V   + +  G E+AVK ++                     LF  EV+ +   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK----------LFR-EVRIMKVL 70
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 127
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAP 181
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 328
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 8/90 (8%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  A+ Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+
Sbjct: 122 IVSAVQYCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN----KLDTFCGS 175
Query: 524 RPYMPPEAMHCQI--STKTDVFSYGAQIKT 551
            PY  PE    +     + DV+S G  + T
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYT 205

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 116 KLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E++
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREIE 66
Query: 171 TLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
            L   +H N+++  G+C +       ++ E++  GSL + L +  +   +D  K      
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK--HKERIDHIKLLQYTS 124
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
            + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   G
Sbjct: 125 QICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--PG 180
Query: 288 TRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 319
             P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 181 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G+G F  V   + +  G E+AVK ++                     LF  EV+ +   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK----------LF-REVRIMKVL 70
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 127
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAP 181
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 328
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 8/90 (8%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  A+ Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+
Sbjct: 122 IVSAVQYCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN----KLDTFCGS 175
Query: 524 RPYMPPEAMHCQI--STKTDVFSYGAQIKT 551
            PY  PE    +     + DV+S G  + T
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYT 205

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 61
Query: 177 HVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 62  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 117
Query: 232 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 284
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 118 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 177
Query: 285 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELL--TGMKPIDDNNTILYYYL 335
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 178 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 237
Query: 336 V 336
           V
Sbjct: 238 V 238

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 14/101 (13%)
Query: 460 IALGVAEALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNV 512
           +AL  A  L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++ 
Sbjct: 111 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 170
Query: 513 KTMYTENLTGTRPYMPPEAM-------HCQISTKTDVFSYG 546
             +   +  GT+ YM PE +       H +   + D+++ G
Sbjct: 171 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 211

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 21/238 (8%)
Query: 100 RATDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAA 158
           R   G+N     R   K+G GQF  VY    L +G+ +A+K ++              A 
Sbjct: 23  RPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK----ARAD 78
Query: 159 MIPILLFENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPP 216
            I       E+  L Q  H N+++     + +N +N IV E    G L   +        
Sbjct: 79  CI------KEIDLLKQLNHPNVIKYYASFIEDNELN-IVLELADAGDLSRMIKHFKKQKR 131
Query: 217 LDSNKR-YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 275
           L   +  +   + +  AL ++HS  + ++HRD+K ANV +    V KLGD G+ +   + 
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS- 188
Query: 276 NMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILY 332
             KT    +L GT  YM PE +H    + K+D++S G +L E+     P   +   LY
Sbjct: 189 --KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 244

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 48/84 (57%), Gaps = 6/84 (7%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL ++HS  + ++HRD+K ANV +    V KLGD G+ +   +   KT    +L GT
Sbjct: 145 LCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGT 199
Query: 524 RPYMPPEAMHCQ-ISTKTDVFSYG 546
             YM PE +H    + K+D++S G
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLG 223

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 200
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE 250

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 141 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 197
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCII 224

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 81
Query: 177 HVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 82  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 137
Query: 232 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 284
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 138 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 197
Query: 285 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELLT--GMKPIDDNNTILYYYL 335
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 198 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 257
Query: 336 V 336
           V
Sbjct: 258 V 258

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 14/101 (13%)
Query: 460 IALGVAEALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNV 512
           +AL  A  L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++ 
Sbjct: 131 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 190
Query: 513 KTMYTENLTGTRPYMPPEAM-------HCQISTKTDVFSYG 546
             +   +  GT+ YM PE +       H +   + D+++ G
Sbjct: 191 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 231

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G+G++G V+ G L +G  +AVK                          E E+      +
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQS--------------WFRETEIYNTVLLR 60
Query: 177 HVNLLRLLGLCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           H N+L  +       N      ++  Y  +GSLYD L R    P L      S A G+A 
Sbjct: 61  HDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAH 120
Query: 232 ALHY--LHSLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMYTENLTG 287
            LH     +  KP I HRD KS NVL+  N    + D G+  M S+ S+   +      G
Sbjct: 121 -LHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVG 179
Query: 288 TRPYMPPEAMHCQISTK-------TDVFSYGVILLEL 317
           T+ YM PE +  QI T        TD++++G++L E+
Sbjct: 180 TKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 61/127 (48%), Gaps = 18/127 (14%)
Query: 460 IALGVAEALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKM-SETSNV 512
           +A+  A  L +LH     +  KP I HRD KS NVL+  N    + D G+  M S+ S+ 
Sbjct: 110 LAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDY 169
Query: 513 KTMYTENLTGTRPYMPPEAMHCQISTK-------TDVFSYG---AQIKTQHITNVDIAD- 561
             +      GT+ YM PE +  QI T        TD++++G    +I  + I N  + D 
Sbjct: 170 LDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDY 229
Query: 562 RERYYSL 568
           R  +Y +
Sbjct: 230 RPPFYDV 236

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   K K  G E AVK +              E+ +        EVQ L Q 
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVI---SKRQVKQKTDKESLL-------REVQLLKQL 83
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+ +L     +     +V E    G L+D +        +D+ +   I   V   + 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 140
Query: 235 YLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           Y H     I+HRD+K  N+LL     D N   ++ DFG+    E S       ++  GT 
Sbjct: 141 YXHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASKK----XKDKIGTA 192
Query: 290 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
            Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 193 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 231

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 200
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE 250

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 141 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 197
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCII 224

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 59
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 116
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 279
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 117 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 172
Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 173 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 39/222 (17%)
Query: 116 KLGEGQFGTV---YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +LG G FG+V    Y   K  +++A+K L+            TE  M        E Q +
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-----TEEMM-------REAQIM 64
Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            Q  +  ++RL+G+C      +V E    G L+  L       P+ +         VAE 
Sbjct: 65  HQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSN---------VAEL 115
Query: 233 LH-------YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           LH       YL    K  +HRD+ + NVLL      K+ DFG+ K     +  + YT   
Sbjct: 116 LHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARS 171
Query: 286 TGTRP--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKP 323
            G  P  +  PE ++  + S+++DV+SYGV + E L+ G KP
Sbjct: 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 63/141 (44%), Gaps = 18/141 (12%)
Query: 420 LHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDS---NKRYSIALG-VAEALH------ 469
           +H    P I+   G  +   L  +  +    PL      KR  I +  VAE LH      
Sbjct: 64  MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 470 -YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP--Y 526
            YL    K  +HRD+ + NVLL      K+ DFG+ K     +  + YT    G  P  +
Sbjct: 124 KYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLKW 179
Query: 527 MPPEAMHC-QISTKTDVFSYG 546
             PE ++  + S+++DV+SYG
Sbjct: 180 YAPECINFRKFSSRSDVWSYG 200

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R+   LG G FGTV+ G       + +   E             ++         + +  
Sbjct: 34  RKLKVLGSGVFGTVHKG-------VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 86
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           +    H +++RLLGLC      +V +Y+  GSL D + +      L      +  + +A+
Sbjct: 87  IGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAK 144
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL      ++HR++ + NVLL      ++ DFG+  +    + + +Y+E  T  + +
Sbjct: 145 GMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK-W 201
Query: 292 MPPEAMH-CQISTKTDVFSYGVILLELLT-GMKP 323
           M  E++H  + + ++DV+SYGV + EL+T G +P
Sbjct: 202 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 28/109 (25%), Positives = 58/109 (53%), Gaps = 14/109 (12%)
Query: 452 LDSNKRYSIALG----------VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 501
           LD  +++  ALG          +A+ ++YL      ++HR++ + NVLL      ++ DF
Sbjct: 120 LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADF 177
Query: 502 GIVKMSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQI 549
           G+  +    + + +Y+E  T  + +M  E++H  + + ++DV+SYG  +
Sbjct: 178 GVADLLPPDDKQLLYSEAKTPIK-WMALESIHFGKYTHQSDVWSYGVTV 225

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 59
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 116
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 279
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 117 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 172
Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 173 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 279
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G+G F  V   + +  G E+A+K ++            T+     +     EV+ +   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDK-----------TQLNPTSLQKLFREVRIMKIL 68
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L  +        ++ EY   G ++D L         ++  ++     +  A+ 
Sbjct: 69  NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQ 125
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM--YTENLTGTRPYM 292
           Y H   K I+HRD+K+ N+LLD +   K+ DFG       SN  T+    +   G+ PY 
Sbjct: 126 YCHQ--KRIVHRDLKAENLLLDADMNIKIADFGF------SNEFTVGGKLDTFCGSPPYA 177
Query: 293 PPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 328
            PE    +     + DV+S GVIL  L++G  P D  N
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 12/92 (13%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM--YTENLT 521
           +  A+ Y H   K I+HRD+K+ N+LLD +   K+ DFG       SN  T+    +   
Sbjct: 120 IVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGF------SNEFTVGGKLDTFC 171
Query: 522 GTRPYMPPEAMHCQI--STKTDVFSYGAQIKT 551
           G+ PY  PE    +     + DV+S G  + T
Sbjct: 172 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYT 203

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 34/220 (15%)
Query: 117 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 88
Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 225
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 89  --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 282
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M++     + Y 
Sbjct: 147 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MAQDIYRASYYR 201
Query: 283 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 319
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 108 KPYPRRGNKLGEGQFGTVY---YGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPI 162
           K Y ++   LGEG FG V    Y    +G    +AVK L+                    
Sbjct: 30  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG---------- 79
Query: 163 LLFENEVQTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDS 219
             ++ E+  L    H ++++  G C +       +V EY+  GSL D L R +    +  
Sbjct: 80  --WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGL 133
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
            +    A  + E + YLH+  +  IHRD+ + NVLLD + + K+GDFG+ K     +   
Sbjct: 134 AQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXY 191
Query: 280 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 319
              E+      +  PE +   +    +DV+S+GV L ELLT
Sbjct: 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 51/106 (48%), Gaps = 11/106 (10%)
Query: 453 DSNKRYSIALG--------VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
           D   R+SI L         + E + YLH+  +  IHRD+ + NVLLD + + K+GDFG+ 
Sbjct: 124 DYLPRHSIGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
Query: 505 KMSETSNVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGAQI 549
           K     +      E+      +  PE +   +    +DV+S+G  +
Sbjct: 182 KAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 103/239 (43%), Gaps = 22/239 (9%)
Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V     K   E+ A+K L+             E  M+       E + L+  
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDD---VECTMV-------EKRVLALL 76
Query: 176 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
                L  L  C   ++ +  V EY+  G L   + +V         +    A  ++  L
Sbjct: 77  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISIGL 133
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            +LH   + II+RD+K  NV+LD     K+ DFG   M +   M  + T    GT  Y+ 
Sbjct: 134 FFLHK--RGIIYRDLKLDNVMLDSEGHIKIADFG---MCKEHMMDGVTTREFCGTPDYIA 188
Query: 294 PEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           PE +  Q   K+ D ++YGV+L E+L G  P D  +    +  ++E  V   + L KEA
Sbjct: 189 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 247

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 44/88 (50%), Gaps = 6/88 (6%)
Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  ++  L +LH   + II+RD+K  NV+LD     K+ DFG+ K      V    T   
Sbjct: 126 AAEISIGLFFLHK--RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVT---TREF 180
Query: 521 TGTRPYMPPEAMHCQISTKT-DVFSYGA 547
            GT  Y+ PE +  Q   K+ D ++YG 
Sbjct: 181 CGTPDYIAPEIIAYQPYGKSVDWWAYGV 208

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R+   LG G FGTV+ G       + +   E             ++         + +  
Sbjct: 16  RKLKVLGSGVFGTVHKG-------VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           +    H +++RLLGLC      +V +Y+  GSL D + +      L      +  + +A+
Sbjct: 69  IGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAK 126
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL      ++HR++ + NVLL      ++ DFG+  +    + + +Y+E  T  + +
Sbjct: 127 GMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK-W 183
Query: 292 MPPEAMH-CQISTKTDVFSYGVILLELLT-GMKP 323
           M  E++H  + + ++DV+SYGV + EL+T G +P
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 28/109 (25%), Positives = 58/109 (53%), Gaps = 14/109 (12%)
Query: 452 LDSNKRYSIALG----------VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 501
           LD  +++  ALG          +A+ ++YL      ++HR++ + NVLL      ++ DF
Sbjct: 102 LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADF 159
Query: 502 GIVKMSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQI 549
           G+  +    + + +Y+E  T  + +M  E++H  + + ++DV+SYG  +
Sbjct: 160 GVADLLPPDDKQLLYSEAKTPIK-WMALESIHFGKYTHQSDVWSYGVTV 207

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/317 (24%), Positives = 128/317 (40%), Gaps = 65/317 (20%)
Query: 110 YPRR----GNKLGEGQFGTVY----YGKLKNG--MEIAVKTLEXXXXXXXXXXXXTEAAM 159
           +PR     G  LG G FG V     YG  K G  +++AVK L+            +E  M
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 160 IPILLFENEVQTLSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYD------------ 206
           +  L             H N++ LLG C  +    +++EY C G L +            
Sbjct: 102 MTQL-----------GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 207 --------RLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 258
                   RL    +   L        A  VA+ + +L    K  +HRD+ + NVL+   
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHG 208
Query: 259 FVPKLGDFGIVK--MSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVI 313
            V K+ DFG+ +  MS+++     Y        P  +M PE++   I T K+DV+SYG++
Sbjct: 209 KVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263
Query: 314 LLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCV 372
           L E+ + G+ P         +Y +++    + +            +    I I+ + C  
Sbjct: 264 LWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF----------YATEEIYIIMQSCWA 313
Query: 373 FEKDKRASMRDIVDLLS 389
           F+  KR S  ++   L 
Sbjct: 314 FDSRKRPSFPNLTSFLG 330

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 8/90 (8%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNVKTMYT 517
            A  VA+ + +L    K  +HRD+ + NVL+    V K+ DFG+ +  MS+++ V     
Sbjct: 177 FAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV---VR 231
Query: 518 ENLTGTRPYMPPEAMHCQIST-KTDVFSYG 546
            N      +M PE++   I T K+DV+SYG
Sbjct: 232 GNARLPVKWMAPESLFEGIYTIKSDVWSYG 261

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G+G F  V   + +  G E+AVK ++                     LF  EV+ +   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK----------LF-REVRIMKVL 70
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 127
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G  PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDAFCGAPPYAAP 181
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 328
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG  G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 234
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 470 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP 529
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 530 EAMHCQI--STKTDVFSYG 546
           E +  +   +   DV+S G
Sbjct: 176 ELLKRREFHAEPVDVWSCG 194

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G+G F  V   + +  G E+AV+ ++                     LF  EV+ +   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQK----------LF-REVRIMKVL 70
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 127
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAP 181
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 328
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 8/90 (8%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  A+ Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+
Sbjct: 122 IVSAVQYCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN----KLDTFCGS 175
Query: 524 RPYMPPEAMHCQI--STKTDVFSYGAQIKT 551
            PY  PE    +     + DV+S G  + T
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYT 205

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G+G F  V   + +  G E+AV+ ++                     LF  EV+ +   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQK----------LF-REVRIMKVL 70
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 127
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDEFCGSPPYAAP 181
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 328
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 8/90 (8%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  A+ Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+
Sbjct: 122 IVSAVQYCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN----KLDEFCGS 175
Query: 524 RPYMPPEAMHCQI--STKTDVFSYGAQIKT 551
            PY  PE    +     + DV+S G  + T
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYT 205

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/141 (35%), Positives = 70/141 (49%), Gaps = 9/141 (6%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
            V +Y+  G L+  L R      L+   R+  A  +A AL YLHSL+  I++RD+K  N+
Sbjct: 116 FVLDYINGGELFYHLQRERCF--LEPRARF-YAAEIASALGYLHSLN--IVYRDLKPENI 170
Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGV 312
           LLD      L DFG+ K +   N     T    GT  Y+ PE +H Q   +T D +  G 
Sbjct: 171 LLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 227
Query: 313 ILLELLTGMKPIDDNNTILYY 333
           +L E+L G+ P    NT   Y
Sbjct: 228 VLYEMLYGLPPFYSRNTAEMY 248

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           L+   R+  A  +A AL YLHSL+  I++RD+K  N+LLD      L DFG+ K +   N
Sbjct: 137 LEPRARF-YAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGA 547
                T    GT  Y+ PE +H Q   +T D +  GA
Sbjct: 194 ST---TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 227

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 279
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 279
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 279
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LGEG F T    + L    E A+K LE             +   +P +  E +V  +
Sbjct: 35  GKILGEGSFSTTVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 84
Query: 173 SQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S+  H   ++L     ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 141
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 198
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT
Sbjct: 139 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGT 195
Query: 524 RPYMPPEAMHCQISTK-TDVFSYGAQI 549
             Y+ PE +  + + K +D+++ G  I
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCII 222

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 279
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 279
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 279
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G+G F  V   + +  G E+AVK ++                     LF  EV+ +   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK----------LF-REVRIMKVL 63
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 64  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR---QIVSAVQ 120
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 121 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAP 174
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 328
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 175 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 8/90 (8%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  A+ Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+
Sbjct: 115 IVSAVQYCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGS 168
Query: 524 RPYMPPEAMHCQI--STKTDVFSYGAQIKT 551
            PY  PE    +     + DV+S G  + T
Sbjct: 169 PPYAAPELFQGKKYDGPEVDVWSLGVILYT 198

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 117 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 88
Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 225
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 89  --SKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 282
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 147 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 201
Query: 283 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 319
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 279
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 117 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 114
Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 225
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 115 --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 172
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 282
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 173 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 227
Query: 283 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 319
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 228 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 279
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES---LTEEEAT 117
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 279
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 117 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 88
Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 225
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 89  --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 282
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 147 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 201
Query: 283 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 319
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/104 (40%), Positives = 60/104 (57%), Gaps = 12/104 (11%)
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSETSNMKTMYTE 283
           I L +AEA+ +LHS  K ++HRD+K +N+    + V K+GDFG+V  M +    +T+ T 
Sbjct: 123 IFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 284 --------NLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELL 318
                      GT+ YM PE +H    S K D+FS G+IL ELL
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 54/97 (55%), Gaps = 12/97 (12%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSETSNVKTMYTE 518
           I L +AEA+ +LHS  K ++HRD+K +N+    + V K+GDFG+V  M +    +T+ T 
Sbjct: 123 IFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 519 --------NLTGTRPYMPPEAMHC-QISTKTDVFSYG 546
                      GT+ YM PE +H    S K D+FS G
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLG 217

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 117 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 87
Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 225
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 88  --SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 282
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 146 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 200
Query: 283 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 319
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 117 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 102
Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 225
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 103 --SKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 282
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 161 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 215
Query: 283 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 319
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 28/218 (12%)
Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G+G F  V   + +  G E+A+K ++            T+     +     EV+ +   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDK-----------TQLNPTSLQKLFREVRIMKIL 71
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L  +        ++ EY   G ++D L         ++  ++     +  A+ 
Sbjct: 72  NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQ 128
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM--YTENLTGTRPYM 292
           Y H   K I+HRD+K+ N+LLD +   K+ DFG       SN  T+    +   G  PY 
Sbjct: 129 YCHQ--KRIVHRDLKAENLLLDADMNIKIADFGF------SNEFTVGGKLDAFCGAPPYA 180
Query: 293 PPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 328
            PE    +     + DV+S GVIL  L++G  P D  N
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 12/92 (13%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTM--YTENLT 521
           +  A+ Y H   K I+HRD+K+ N+LLD +   K+ DFG       SN  T+    +   
Sbjct: 123 IVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGF------SNEFTVGGKLDAFC 174
Query: 522 GTRPYMPPEAMHCQI--STKTDVFSYGAQIKT 551
           G  PY  PE    +     + DV+S G  + T
Sbjct: 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYT 206

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 117 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 87
Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 225
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 88  --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 282
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 146 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 200
Query: 283 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 319
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 117 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALII---------- 102
Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 225
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 103 --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 282
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 161 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 215
Query: 283 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 319
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 117 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 104
Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 225
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 105 --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 162
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 282
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 163 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 217
Query: 283 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 319
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 218 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 117 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 94
Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 225
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 95  --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 152
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 282
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 153 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 207
Query: 283 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 319
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 208 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 117 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 102
Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 225
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 103 --SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 282
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 161 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 215
Query: 283 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 319
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 111/233 (47%), Gaps = 32/233 (13%)
Query: 165 FENEVQTLSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 222
           F  EV+ +   +H N+L+ +G+   +  +N I  EY+  G+L   +  +++  P   ++R
Sbjct: 54  FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT-EYIKGGTLRGIIKSMDSQYPW--SQR 110
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS---------- 272
            S A  +A  + YLHS++  IIHRD+ S N L+ EN    + DFG+ ++           
Sbjct: 111 VSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 273 ---ETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 328
              +  + K  YT  + G   +M PE ++ +    K DVFS+G++L E++  +    D  
Sbjct: 169 RSLKKPDRKKRYT--VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD-- 224
Query: 329 TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASM 381
              Y    ++  + VR  LD+    +   +       +  +CC  + +KR S 
Sbjct: 225 ---YLPRTMDFGLNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSF 270

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 455 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS------- 507
           ++R S A  +A  + YLHS++  IIHRD+ S N L+ EN    + DFG+ ++        
Sbjct: 108 SQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165
Query: 508 ------ETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
                 +  + K  YT  + G   +M PE ++ +    K DVFS+G
Sbjct: 166 EGLRSLKKPDRKKRYT--VVGNPYWMAPEMINGRSYDEKVDVFSFG 209

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 115/285 (40%), Gaps = 37/285 (12%)
Query: 110 YPRRGNK--LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 166
           Y   G++  LG+G +G VY G+ L N + IA+K +                         
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-------------LH 67
Query: 167 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            E+      KH N+++ LG    N    I  E +  GSL   L R    P  D+ +    
Sbjct: 68  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGF 126
Query: 226 -ALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTE 283
               + E L YLH     I+HRD+K  NVL++  + V K+ DFG  K     N     TE
Sbjct: 127 YTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---PCTE 181
Query: 284 NLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
             TGT  YM PE +           D++S G  ++E+ TG  P        +Y L   Q 
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP--------FYELGEPQA 233
Query: 341 VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
              +  + K   E  E+        +  KC   + DKRA   D++
Sbjct: 234 AMFKVGMFKVHPEIPESMSAEAKAFIL-KCFEPDPDKRACANDLL 277

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 43/90 (47%), Gaps = 9/90 (10%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           + E L YLH     I+HRD+K  NVL++  + V K+ DFG  K     N     TE  TG
Sbjct: 131 ILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP---CTETFTG 185
Query: 523 TRPYMPPEAMHC---QISTKTDVFSYGAQI 549
           T  YM PE +           D++S G  I
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTI 215

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 117 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 79
Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 225
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 80  --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 137
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 282
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 138 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 192
Query: 283 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 319
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 193 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G+G F  V   + +  G E+AVK ++            T+     +     EV+     
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-----------TQLNSSSLQKLFREVRIXKVL 70
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L  +        +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR---QIVSAVQ 127
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G  PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK----LDAFCGAPPYAAP 181
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 328
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 115/285 (40%), Gaps = 37/285 (12%)
Query: 110 YPRRGNK--LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 166
           Y   G++  LG+G +G VY G+ L N + IA+K +                         
Sbjct: 7   YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-------------LH 53
Query: 167 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            E+      KH N+++ LG    N    I  E +  GSL   L R    P  D+ +    
Sbjct: 54  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGF 112
Query: 226 -ALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTE 283
               + E L YLH     I+HRD+K  NVL++  + V K+ DFG  K     N     TE
Sbjct: 113 YTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---PCTE 167
Query: 284 NLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
             TGT  YM PE +           D++S G  ++E+ TG  P        +Y L   Q 
Sbjct: 168 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP--------FYELGEPQA 219
Query: 341 VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
              +  + K   E  E+        +  KC   + DKRA   D++
Sbjct: 220 AMFKVGMFKVHPEIPESMSAEAKAFIL-KCFEPDPDKRACANDLL 263

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 43/90 (47%), Gaps = 9/90 (10%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           + E L YLH     I+HRD+K  NVL++  + V K+ DFG  K     N     TE  TG
Sbjct: 117 ILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP---CTETFTG 171
Query: 523 TRPYMPPEAMHC---QISTKTDVFSYGAQI 549
           T  YM PE +           D++S G  I
Sbjct: 172 TLQYMAPEIIDKGPRGYGKAADIWSLGCTI 201

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 108 KPYPRRGNKLGEGQFGTV---YYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPI 162
           K Y ++   LGEG FG V    Y    +G    +AVK L+                    
Sbjct: 8   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG---------- 57
Query: 163 LLFENEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDS 219
             ++ E++ L    H ++++  G C +       +V EY+  GSL D L R      +  
Sbjct: 58  --WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGL 111
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
            +    A  + E + YLH+  +  IHR + + NVLLD + + K+GDFG+ K     +   
Sbjct: 112 AQLLLFAQQICEGMAYLHA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 169
Query: 280 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 319
              E+      +  PE +  C+    +DV+S+GV L ELLT
Sbjct: 170 RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
            A  + E + YLH+  +  IHR + + NVLLD + + K+GDFG+ K     +      E+
Sbjct: 117 FAQQICEGMAYLHA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 174
Query: 520 LTGTRPYMPPEAM-HCQISTKTDVFSYGAQI 549
                 +  PE +  C+    +DV+S+G  +
Sbjct: 175 GDSPVFWYAPECLKECKFYYASDVWSFGVTL 205

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 108 KPYPRRGNKLGEGQFGTV---YYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPI 162
           K Y ++   LGEG FG V    Y    +G    +AVK L+                    
Sbjct: 7   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG---------- 56
Query: 163 LLFENEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDS 219
             ++ E++ L    H ++++  G C +       +V EY+  GSL D L R      +  
Sbjct: 57  --WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGL 110
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
            +    A  + E + YLH+  +  IHR + + NVLLD + + K+GDFG+ K     +   
Sbjct: 111 AQLLLFAQQICEGMAYLHA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 168
Query: 280 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 319
              E+      +  PE +  C+    +DV+S+GV L ELLT
Sbjct: 169 RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
            A  + E + YLH+  +  IHR + + NVLLD + + K+GDFG+ K     +      E+
Sbjct: 116 FAQQICEGMAYLHA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 173
Query: 520 LTGTRPYMPPEAM-HCQISTKTDVFSYGAQI 549
                 +  PE +  C+    +DV+S+G  +
Sbjct: 174 GDSPVFWYAPECLKECKFYYASDVWSFGVTL 204

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
           N   Y   G +LG G+F  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 279
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/104 (39%), Positives = 60/104 (57%), Gaps = 12/104 (11%)
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSETSNMKTMYT- 282
           I + +AEA+ +LHS  K ++HRD+K +N+    + V K+GDFG+V  M +    +T+ T 
Sbjct: 169 IFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 283 -------ENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELL 318
                      GT+ YM PE +H    S K D+FS G+IL ELL
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 54/97 (55%), Gaps = 12/97 (12%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSETSNVKTMYT- 517
           I + +AEA+ +LHS  K ++HRD+K +N+    + V K+GDFG+V  M +    +T+ T 
Sbjct: 169 IFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 518 -------ENLTGTRPYMPPEAMHC-QISTKTDVFSYG 546
                      GT+ YM PE +H    S K D+FS G
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLG 263

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 106/239 (44%), Gaps = 22/239 (9%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   K K  G   A+K L+            T        L EN V   S+ 
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRVLQNSRH 207
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
             +  L+     ++ + C V EY   G L+  L+R       D  + Y     +  AL Y
Sbjct: 208 PFLTALKYSFQTHDRL-CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALDY 263
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMP 293
           LHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MKT       GT  Y+ 
Sbjct: 264 LHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FCGTPEYLA 317
Query: 294 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 376

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 42/71 (59%), Gaps = 8/71 (11%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNVKTMYTENLT 521
           +  AL YLHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + +KT       
Sbjct: 257 IVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FC 310
Query: 522 GTRPYMPPEAM 532
           GT  Y+ PE +
Sbjct: 311 GTPEYLAPEVL 321

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 34/220 (15%)
Query: 117 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 128
Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 225
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 129 --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 282
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+        Y 
Sbjct: 187 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRAGYYR 241
Query: 283 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 319
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 106/239 (44%), Gaps = 22/239 (9%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   K K  G   A+K L+            T        L EN V   S+ 
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRVLQNSRH 210
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
             +  L+     ++ + C V EY   G L+  L+R       D  + Y     +  AL Y
Sbjct: 211 PFLTALKYSFQTHDRL-CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALDY 266
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMP 293
           LHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MKT       GT  Y+ 
Sbjct: 267 LHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FCGTPEYLA 320
Query: 294 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 321 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 379

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 42/71 (59%), Gaps = 8/71 (11%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNVKTMYTENLT 521
           +  AL YLHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + +KT       
Sbjct: 260 IVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FC 313
Query: 522 GTRPYMPPEAM 532
           GT  Y+ PE +
Sbjct: 314 GTPEYLAPEVL 324

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 34/220 (15%)
Query: 117 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 105
Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 225
             S+  H N++R +G+   ++   I+ E M  G L   L      P   S+        +
Sbjct: 106 --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 163
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 282
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+        Y 
Sbjct: 164 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRAGYYR 218
Query: 283 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 319
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 219 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 11/164 (6%)
Query: 167 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   +
Sbjct: 72  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---V 128
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           ++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      + 
Sbjct: 129 SIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSF 182
Query: 286 TGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNN 328
            GTR YM PE +     S ++D++S G+ L+E+  G  PI   +
Sbjct: 183 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGS 226

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 7/88 (7%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +
Sbjct: 128 VSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANS 181
Query: 520 LTGTRPYMPPEAMH-CQISTKTDVFSYG 546
             GTR YM PE +     S ++D++S G
Sbjct: 182 FVGTRSYMSPERLQGTHYSVQSDIWSMG 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V+  + K   +  A+K L+             E  M+     E  V +L+  
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VECTMV-----EKRVLSLA-W 76
Query: 176 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H  L  +        N   V EY+  G L   +  + +    D ++    A  +   L 
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQ 133
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           +LHS  K I++RD+K  N+LLD++   K+ DFG+ K +   + K   T    GT  Y+ P
Sbjct: 134 FLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNEFCGTPDYIAP 188
Query: 295 EAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
           E +  Q  +   D +S+GV+L E+L G  P 
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D ++    A  +   L +LHS  K I++RD+K  N+LLD++   K+ DFG+ K +   +
Sbjct: 116 FDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 173
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGA 547
            K   T    GT  Y+ PE +  Q  +   D +S+G 
Sbjct: 174 AK---TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGV 207

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V+  + K   +  A+K L+             E  M+     E  V +L+  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VECTMV-----EKRVLSLA-W 75
Query: 176 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H  L  +        N   V EY+  G L   +  + +    D ++    A  +   L 
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           +LHS  K I++RD+K  N+LLD++   K+ DFG+ K +   + K   T    GT  Y+ P
Sbjct: 133 FLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNXFCGTPDYIAP 187
Query: 295 EAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
           E +  Q  +   D +S+GV+L E+L G  P 
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D ++    A  +   L +LHS  K I++RD+K  N+LLD++   K+ DFG+ K +   +
Sbjct: 115 FDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGA 547
            K   T    GT  Y+ PE +  Q  +   D +S+G 
Sbjct: 173 AK---TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGV 206

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 118/243 (48%), Gaps = 38/243 (15%)
Query: 114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           G  LGEG+FG+V  G LK      +++AVKT++              ++   I  F +E 
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMK-----------LDNSSQREIEEFLSEA 87
Query: 170 QTLSQCKHVNLLRLLGLCNNIMN------CIVYEYMCNGSLYDRL--ARVNNTP---PLD 218
             +    H N++RLLG+C  + +       ++  +M  G L+  L  +R+   P   PL 
Sbjct: 88  ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 278
           +  ++ +   +A  + YL   ++  +HRD+ + N +L ++    + DFG+ K   + +  
Sbjct: 148 TLLKFMV--DIALGMEYLS--NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD-- 201
Query: 279 TMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDD-NNTILYY 333
             Y +      P  ++  E++  ++ T K+DV+++GV + E+ T GM P     N  +Y 
Sbjct: 202 -YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260
Query: 334 YLV 336
           YL+
Sbjct: 261 YLL 263

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEGQF TVY  + KN  +I A+K ++              A          E++ L + 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL--------REIKLLQEL 69
Query: 176 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N++ LL    +  N  +V+++M        +   +N+  L  +   +  L   + L 
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLH     I+HRD+K  N+LLDEN V KL DFG+ K   + N    Y   +  TR Y  P
Sbjct: 127 YLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYXHQVV-TRWYRAP 181
Query: 295 EAMHC--QISTKTDVFSYGVILLELL 318
           E +          D+++ G IL ELL
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 37/67 (55%), Gaps = 5/67 (7%)
Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           + L YLH     I+HRD+K  N+LLDEN V KL DFG+ K   + N    Y   +  TR 
Sbjct: 123 QGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYXHQVV-TRW 177
Query: 526 YMPPEAM 532
           Y  PE +
Sbjct: 178 YRAPELL 184

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 11/160 (6%)
Query: 167 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   +
Sbjct: 80  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---V 136
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           ++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      + 
Sbjct: 137 SIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSF 190
Query: 286 TGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 324
            GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +
Sbjct: 136 VSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANS 189
Query: 520 LTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG 578
             GTR YM PE +     S ++D++S G  +    +    I   +    L+ M     EG
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD-AKELELMFGCQVEG 248
Query: 579 D 579
           D
Sbjct: 249 D 249

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 88/173 (50%), Gaps = 15/173 (8%)
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
           ENE+  L + KH N++ L  +  +  +  +V + +  G L+DR+         D++   +
Sbjct: 68  ENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS---T 124
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMY 281
           +   V +A++YLH +   I+HRD+K  N+L    DE     + DFG+ KM    ++ +  
Sbjct: 125 LIRQVLDAVYYLHRMG--IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMS-- 180
Query: 282 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPI-DDNNTILY 332
                GT  Y+ PE +  +  +K  D +S GVI   LL G  P  D+N++ L+
Sbjct: 181 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLF 231

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 134/291 (46%), Gaps = 45/291 (15%)
Query: 112 RRGNKLGEGQFGTVYYG-KLKNG----MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 166
           R+   LG G FGTVY G  + +G    + +A+K L             +  A   IL   
Sbjct: 20  RKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---------SPKANKEIL--- 67
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           +E   ++      + RLLG+C      +V + M  G L D +    N   L S    +  
Sbjct: 68  DEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVR--ENRGRLGSQDLLNWC 125
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
           + +A+ + YL  +   ++HRD+ + NVL+      K+ DFG+ ++ +    +T Y  +  
Sbjct: 126 MQIAKGMSYLEDVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDID--ETEYHAD-G 180
Query: 287 GTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP 342
           G  P  +M  E+ +  + + ++DV+SYGV + EL+T G KP D               +P
Sbjct: 181 GKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDG--------------IP 226
Query: 343 VREVLD-KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            RE+ D  E GE   +  + T+ + ++  KC + + + R   R++V   S+
Sbjct: 227 AREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSR 277

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           +R  KLG G +G V   K K  G E A+K ++               A++      +EV 
Sbjct: 7   QRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTS----NSGALL------DEVA 56
Query: 171 TLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            L Q  H N+++L     +  N  +V E    G L+D +        +D+     I   V
Sbjct: 57  VLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQV 113
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSN-MKTMYTENL 285
                YLH  +  I+HRD+K  N+LL+    + + K+ DFG+    E    MK    E L
Sbjct: 114 LSGTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMK----ERL 167
Query: 286 TGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
            GT  Y+ PE +  +   K DV+S GVIL  LL G  P 
Sbjct: 168 -GTAYYIAPEVLRKKYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           +R  KLG G +G V   K K  G E A+K ++               A++      +EV 
Sbjct: 24  QRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTS----NSGALL------DEVA 73
Query: 171 TLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            L Q  H N+++L     +  N  +V E    G L+D +        +D+     I   V
Sbjct: 74  VLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQV 130
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
                YLH  +  I+HRD+K  N+LL+    + + K+ DFG+    E         +   
Sbjct: 131 LSGTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK----MKERL 184
Query: 287 GTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
           GT  Y+ PE +  +   K DV+S GVIL  LL G  P 
Sbjct: 185 GTAYYIAPEVLRKKYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 75/166 (45%), Gaps = 11/166 (6%)
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLAR-VNNTPPLDSNKR 222
           +EV  L + KH N++R      +  N    IV EY   G L   + +       LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 223 YSIALGVAEALHYLHSLSK---PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
             +   +  AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++    N  T
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDT 170
Query: 280 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPI 324
            + +   GT  YM PE M     + K+D++S G +L EL   M P 
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/70 (40%), Positives = 40/70 (57%), Gaps = 4/70 (5%)
Query: 478 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAM-HCQI 536
           ++HRD+K ANV LD     KLGDFG+ ++    N  T + +   GT  YM PE M     
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDTSFAKTFVGTPYYMSPEQMNRMSY 193
Query: 537 STKTDVFSYG 546
           + K+D++S G
Sbjct: 194 NEKSDIWSLG 203

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G ++G G FG V+ G+L+ +   +AVK+                        F  E + L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK------------FLQEARIL 166
Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            Q  H N++RL+G+C       +   +  G  +    R      L       +    A  
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAG 225
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + YL S  K  IHRD+ + N L+ E  V K+ DFG+ +  E   +             + 
Sbjct: 226 MEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVXAASGGLRQVPVKWT 282
Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
            PEA+ + + S+++DV+S+G++L E  + G  P
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASP 315

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 168 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 172
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 173 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 226
Query: 287 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 324
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 227 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +
Sbjct: 171 VSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANS 224
Query: 520 LTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG 578
             GTR YM PE +     S ++D++S G  +    +    I   +    L+ M     EG
Sbjct: 225 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD-AKELELMFGCQVEG 283
Query: 579 D 579
           D
Sbjct: 284 D 284

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG  G V     K+ G ++AVK ++                    LLF NEV  +  
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 98
Query: 175 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
             H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V  A
Sbjct: 99  YHHDNVVDMYSSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRA 153
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLH+  + +IHRD+KS ++LL  +   KL DFG          K    + L GT  +M
Sbjct: 154 LSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKXLVGTPYWM 208
Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 323
            PE +      T+ D++S G++++E++ G  P
Sbjct: 209 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 6/92 (6%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
           ++ L V  AL YLH+  + +IHRD+KS ++LL  +   KL DFG          K    +
Sbjct: 145 TVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RK 199
Query: 519 NLTGTRPYMPPEAM-HCQISTKTDVFSYGAQI 549
            L GT  +M PE +      T+ D++S G  +
Sbjct: 200 XLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 231

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 168 EVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 164
Query: 287 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 324
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 7/88 (7%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +
Sbjct: 109 VSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANS 162
Query: 520 LTGTRPYMPPEAMH-CQISTKTDVFSYG 546
             GTR YM PE +     S ++D++S G
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMG 190

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 11/160 (6%)
Query: 167 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---V 109
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           ++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      + 
Sbjct: 110 SIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSF 163
Query: 286 TGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 324
            GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +
Sbjct: 109 VSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANS 162
Query: 520 LTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG 578
             GTR YM PE +     S ++D++S G  +    +    I   +    L+ M     EG
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA-KELELMFGCQVEG 221
Query: 579 D 579
           D
Sbjct: 222 D 222

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 11/160 (6%)
Query: 167 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---V 109
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           ++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      + 
Sbjct: 110 SIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSF 163
Query: 286 TGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 324
            GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +
Sbjct: 109 VSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANS 162
Query: 520 LTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG 578
             GTR YM PE +     S ++D++S G  +    +    I   +    L+ M     EG
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA-KELELMFGCQVEG 221
Query: 579 D 579
           D
Sbjct: 222 D 222

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 67
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +AE
Sbjct: 68  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAE 125
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 126 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 182
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 228
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 229 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 272

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 11/160 (6%)
Query: 167 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---V 109
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           ++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      + 
Sbjct: 110 SIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSF 163
Query: 286 TGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 324
            GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +
Sbjct: 109 VSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANS 162
Query: 520 LTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG 578
             GTR YM PE +     S ++D++S G  +    +    I   +    L+ M     EG
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA-KELELMFGCQVEG 221
Query: 579 D 579
           D
Sbjct: 222 D 222

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 11/160 (6%)
Query: 167 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---V 109
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           ++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      + 
Sbjct: 110 SIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSF 163
Query: 286 TGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 324
            GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +
Sbjct: 109 VSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANS 162
Query: 520 LTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG 578
             GTR YM PE +     S ++D++S G  +    +    I   +    L+ M     EG
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA-KELELMFGCQVEG 221
Query: 579 D 579
           D
Sbjct: 222 D 222

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 100/223 (44%), Gaps = 41/223 (18%)
Query: 116 KLGEGQFGTVYYG---KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           +LG G FG+V  G     K  +++A+K L+            TE  M        E Q +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-----TEEMM-------REAQIM 390
Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG-VAE 231
            Q  +  ++RL+G+C      +V E    G L+  L            KR  I +  VAE
Sbjct: 391 HQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLV----------GKREEIPVSNVAE 440
Query: 232 ALH-------YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
            LH       YL    K  +HR++ + NVLL      K+ DFG+ K     +  + YT  
Sbjct: 441 LLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTAR 496
Query: 285 LTGTRP--YMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 323
             G  P  +  PE ++ +  S+++DV+SYGV + E L+ G KP
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
           N   Y   G +LG G F  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E EV  L + +H N++ L  +  N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 279
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 104/239 (43%), Gaps = 22/239 (9%)
Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   + K   E+ AVK L+             E  M+       E + L+  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD---VECTMV-------EKRVLALP 398
Query: 176 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
                L  L  C   M+ +  V EY+  G L   + +V              A  +A  L
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGL 455
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            +L S  K II+RD+K  NV+LD     K+ DFG+ K    +    + T+   GT  Y+ 
Sbjct: 456 FFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYIA 510
Query: 294 PEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           PE +  Q   K+ D +++GV+L E+L G  P +  +    +  ++E  V   + + KEA
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 569

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 88/180 (48%), Gaps = 24/180 (13%)
Query: 161 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
           P L  E E++ L +  H  ++++    +     IV E M  G L+D++  V N    ++ 
Sbjct: 57  PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEAT 114
Query: 221 KR---YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSE 273
            +   Y + L    A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + E
Sbjct: 115 CKLYFYQMLL----AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 168
Query: 274 TSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 329
           TS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 169 TSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 223

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/70 (42%), Positives = 41/70 (58%), Gaps = 11/70 (15%)
Query: 467 ALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSETSNVKTMYTENLTG 522
           A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + ETS ++T     L G
Sbjct: 125 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-----LCG 177
Query: 523 TRPYMPPEAM 532
           T  Y+ PE +
Sbjct: 178 TPTYLAPEVL 187

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 73
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 131
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 132 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 188
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 234
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 235 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 278

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 88/180 (48%), Gaps = 24/180 (13%)
Query: 161 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
           P L  E E++ L +  H  ++++    +     IV E M  G L+D++  V N    ++ 
Sbjct: 58  PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEAT 115
Query: 221 KR---YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSE 273
            +   Y + L    A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + E
Sbjct: 116 CKLYFYQMLL----AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 274 TSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 329
           TS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 170 TSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/70 (42%), Positives = 41/70 (58%), Gaps = 11/70 (15%)
Query: 467 ALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSETSNVKTMYTENLTG 522
           A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + ETS ++T     L G
Sbjct: 126 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-----LCG 178
Query: 523 TRPYMPPEAM 532
           T  Y+ PE +
Sbjct: 179 TPTYLAPEVL 188

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 80
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 81  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 138
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 139 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 195
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 241
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 242 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 285

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 75/166 (45%), Gaps = 11/166 (6%)
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLAR-VNNTPPLDSNKR 222
           +EV  L + KH N++R      +  N    IV EY   G L   + +       LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 223 YSIALGVAEALHYLHSLSK---PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
             +   +  AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++    N  T
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDT 170
Query: 280 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPI 324
            + +   GT  YM PE M     + K+D++S G +L EL   M P 
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/70 (40%), Positives = 40/70 (57%), Gaps = 4/70 (5%)
Query: 478 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAM-HCQI 536
           ++HRD+K ANV LD     KLGDFG+ ++    N  T + +   GT  YM PE M     
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDTSFAKAFVGTPYYMSPEQMNRMSY 193
Query: 537 STKTDVFSYG 546
           + K+D++S G
Sbjct: 194 NEKSDIWSLG 203

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 88/180 (48%), Gaps = 24/180 (13%)
Query: 161 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
           P L  E E++ L +  H  ++++    +     IV E M  G L+D++  V N    ++ 
Sbjct: 58  PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEAT 115
Query: 221 KR---YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSE 273
            +   Y + L    A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + E
Sbjct: 116 CKLYFYQMLL----AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 274 TSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 329
           TS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 170 TSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/70 (42%), Positives = 41/70 (58%), Gaps = 11/70 (15%)
Query: 467 ALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSETSNVKTMYTENLTG 522
           A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + ETS ++T     L G
Sbjct: 126 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-----LCG 178
Query: 523 TRPYMPPEAM 532
           T  Y+ PE +
Sbjct: 179 TPTYLAPEVL 188

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 88/180 (48%), Gaps = 24/180 (13%)
Query: 161 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
           P L  E E++ L +  H  ++++    +     IV E M  G L+D++  V N    ++ 
Sbjct: 58  PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEAT 115
Query: 221 KR---YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSE 273
            +   Y + L    A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + E
Sbjct: 116 CKLYFYQMLL----AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 274 TSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 329
           TS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 170 TSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/70 (42%), Positives = 41/70 (58%), Gaps = 11/70 (15%)
Query: 467 ALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSETSNVKTMYTENLTG 522
           A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + ETS ++T     L G
Sbjct: 126 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-----LCG 178
Query: 523 TRPYMPPEAM 532
           T  Y+ PE +
Sbjct: 179 TPTYLAPEVL 188

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 82/174 (47%), Gaps = 25/174 (14%)
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSL--YDRLARVNNTPPLDSNK 221
           F+NE+Q ++  K+   L   G+  N     I+YEYM N S+  +D    V     LD N 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV-----LDKNY 144
Query: 222 RYSIALGVAE--------ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 273
              I + V +        +  Y+H+  K I HRDVK +N+L+D+N   KL DFG     E
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFG-----E 198
Query: 274 TSNMKTMYTENLTGTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKPI 324
           +  M     +   GT  +MPPE    + S    K D++S G+ L  +   + P 
Sbjct: 199 SEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 9/90 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           I   V  +  Y+H+  K I HRDVK +N+L+D+N   KL DFG     E+  +     + 
Sbjct: 156 IIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFG-----ESEYMVDKKIKG 209
Query: 520 LTGTRPYMPPEAMHCQIS---TKTDVFSYG 546
             GT  +MPPE    + S    K D++S G
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLG 239

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 112/235 (47%), Gaps = 39/235 (16%)
Query: 112 RRGNKLGEGQFGTVYYGKL------KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL- 164
           R   +LGE +FG VY G L      +    +A+KTL+             + A  P+   
Sbjct: 29  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-------------DKAEGPLREE 75
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTP-----PLD 218
           F +E    ++ +H N++ LLG+        +++ Y  +G L++ L  V  +P       D
Sbjct: 76  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFL--VMRSPHSDVGSTD 133
Query: 219 SNKRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
            ++    AL   + +H +  +        S  ++H+D+ + NVL+ +    K+ D G+ +
Sbjct: 134 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 193
Query: 271 MSETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 323
               ++   +   +L   R +M PEA M+ + S  +D++SYGV+L E+ + G++P
Sbjct: 194 EVYAADYYKLLGNSLLPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G ++G G FG V+ G+L+ +   +AVK+                        F  E + L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK------------FLQEARIL 166
Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            Q  H N++RL+G+C       +   +  G  +    R      L       +    A  
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAG 225
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + YL S  K  IHRD+ + N L+ E  V K+ DFG+ +  E   +             + 
Sbjct: 226 MEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWT 282
Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
            PEA+ + + S+++DV+S+G++L E  + G  P
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASP 315

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 88/180 (48%), Gaps = 24/180 (13%)
Query: 161 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
           P L  E E++ L +  H  ++++    +     IV E M  G L+D++  V N    ++ 
Sbjct: 64  PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEAT 121
Query: 221 KR---YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSE 273
            +   Y + L    A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + E
Sbjct: 122 CKLYFYQMLL----AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 175
Query: 274 TSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 329
           TS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 176 TSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 230

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/70 (42%), Positives = 41/70 (58%), Gaps = 11/70 (15%)
Query: 467 ALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSETSNVKTMYTENLTG 522
           A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + ETS ++T     L G
Sbjct: 132 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-----LCG 184
Query: 523 TRPYMPPEAM 532
           T  Y+ PE +
Sbjct: 185 TPTYLAPEVL 194

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 111/233 (47%), Gaps = 35/233 (15%)
Query: 112 RRGNKLGEGQFGTVYYGKL------KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL- 164
           R   +LGE +FG VY G L      +    +A+KTL+             + A  P+   
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-------------DKAEGPLREE 58
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVN---NTPPLDSN 220
           F +E    ++ +H N++ LLG+        +++ Y  +G L++ L   +   +    D +
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 221 KRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
           +    AL   + +H +  +        S  ++H+D+ + NVL+ +    K+ D G+ +  
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 273 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 323
             ++   +   +L   R +M PEA M+ + S  +D++SYGV+L E+ + G++P
Sbjct: 179 YAADYYKLLGNSLLPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 161 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
           P L  E E++ L +  H  ++++    +     IV E M  G L+D++           N
Sbjct: 197 PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GN 247
Query: 221 KRYSIA------LGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK- 270
           KR   A        +  A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K 
Sbjct: 248 KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 305
Query: 271 MSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDD 326
           + ETS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  +
Sbjct: 306 LGETSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 360
Query: 327 NNT 329
           + T
Sbjct: 361 HRT 363

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/70 (42%), Positives = 41/70 (58%), Gaps = 11/70 (15%)
Query: 467 ALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSETSNVKTMYTENLTG 522
           A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + ETS ++T     L G
Sbjct: 265 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-----LCG 317
Query: 523 TRPYMPPEAM 532
           T  Y+ PE +
Sbjct: 318 TPTYLAPEVL 327

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 161 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
           P L  E E++ L +  H  ++++    +     IV E M  G L+D++           N
Sbjct: 183 PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GN 233
Query: 221 KRYSIA------LGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK- 270
           KR   A        +  A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K 
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291
Query: 271 MSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDD 326
           + ETS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  +
Sbjct: 292 LGETSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346
Query: 327 NNT 329
           + T
Sbjct: 347 HRT 349

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/70 (42%), Positives = 41/70 (58%), Gaps = 11/70 (15%)
Query: 467 ALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSETSNVKTMYTENLTG 522
           A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + ETS ++T     L G
Sbjct: 251 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-----LCG 303
Query: 523 TRPYMPPEAM 532
           T  Y+ PE +
Sbjct: 304 TPTYLAPEVL 313

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           C V EY   G L+  L+R       +   R+  A  +  AL YLHS  + +++RD+K  N
Sbjct: 84  CFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALEYLHS--RDVVYRDIKLEN 138
Query: 253 VLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFS 309
           ++LD++   K+ DFG+ K  +S+ + MKT       GT  Y+ PE +         D + 
Sbjct: 139 LMLDKDGHIKITDFGLCKEGISDGATMKT-----FCGTPEYLAPEVLEDNDYGRAVDWWG 193
Query: 310 YGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
            GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 194 LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 235

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 43/71 (60%), Gaps = 9/71 (12%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNVKTMYTENLT 521
           +  AL YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + +KT       
Sbjct: 117 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-----FC 169
Query: 522 GTRPYMPPEAM 532
           GT  Y+ PE +
Sbjct: 170 GTPEYLAPEVL 180

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           C V EY   G L+  L+R       +   R+  A  +  AL YLHS  + +++RD+K  N
Sbjct: 81  CFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALEYLHS--RDVVYRDIKLEN 135
Query: 253 VLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFS 309
           ++LD++   K+ DFG+ K  +S+ + MKT       GT  Y+ PE +         D + 
Sbjct: 136 LMLDKDGHIKITDFGLCKEGISDGATMKT-----FCGTPEYLAPEVLEDNDYGRAVDWWG 190
Query: 310 YGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
            GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 191 LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 43/71 (60%), Gaps = 9/71 (12%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNVKTMYTENLT 521
           +  AL YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + +KT       
Sbjct: 114 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-----FC 166
Query: 522 GTRPYMPPEAM 532
           GT  Y+ PE +
Sbjct: 167 GTPEYLAPEVL 177

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 30/237 (12%)
Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+G+G FG V+  +  K G ++A+K +              E    PI     E++ L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKV----------LMENEKEGFPITALR-EIKILQL 73
Query: 175 CKHVNLLRLLGLCNNIMN----C-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            KH N++ L+ +C    +    C     +V+++ C   L   L+ V     L   KR  +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLSEIKR--V 130
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTEN 284
              +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N
Sbjct: 131 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 285 LTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
              T  Y PPE +  +       D++  G I+ E+ T   PI   NT  +   ++ Q
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQ 244

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/67 (38%), Positives = 37/67 (55%), Gaps = 3/67 (4%)
Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP 525
            L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N   T  
Sbjct: 137 GLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 526 YMPPEAM 532
           Y PPE +
Sbjct: 195 YRPPELL 201

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           C V EY   G L+  L+R       +   R+  A  +  AL YLHS  + +++RD+K  N
Sbjct: 81  CFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALEYLHS--RDVVYRDIKLEN 135
Query: 253 VLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFS 309
           ++LD++   K+ DFG+ K  +S+ + MKT       GT  Y+ PE +         D + 
Sbjct: 136 LMLDKDGHIKITDFGLCKEGISDGATMKT-----FCGTPEYLAPEVLEDNDYGRAVDWWG 190
Query: 310 YGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
            GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 191 LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 43/71 (60%), Gaps = 9/71 (12%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNVKTMYTENLT 521
           +  AL YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + +KT       
Sbjct: 114 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-----FC 166
Query: 522 GTRPYMPPEAM 532
           GT  Y+ PE +
Sbjct: 167 GTPEYLAPEVL 177

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 108 KPYPRRGNKLGEGQFGTVY---YGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPI 162
           K Y ++   LGEG FG V    Y    +G    +AVK L+                    
Sbjct: 13  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG---------- 62
Query: 163 LLFENEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDS 219
             ++ E+  L    H ++++  G C +       +V EY+  GSL D L R +    +  
Sbjct: 63  --WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IGL 116
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
            +    A  + E + YLHS  +  IHR++ + NVLLD + + K+GDFG+ K     +   
Sbjct: 117 AQLLLFAQQICEGMAYLHS--QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 174
Query: 280 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 319
              E+      +  PE +   +    +DV+S+GV L ELLT
Sbjct: 175 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 51/106 (48%), Gaps = 11/106 (10%)
Query: 453 DSNKRYSIALG--------VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
           D   R+SI L         + E + YLHS  +  IHR++ + NVLLD + + K+GDFG+ 
Sbjct: 107 DYLPRHSIGLAQLLLFAQQICEGMAYLHS--QHYIHRNLAARNVLLDNDRLVKIGDFGLA 164
Query: 505 KMSETSNVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGAQI 549
           K     +      E+      +  PE +   +    +DV+S+G  +
Sbjct: 165 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 210

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 23/221 (10%)
Query: 109 PYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 167
           PY  R   LGEG FG V      K   ++A+K +                     +  E 
Sbjct: 10  PYIIR-ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMH----------MRVER 58
Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           E+  L   +H ++++L  +     + ++      G L+D +         D  +R+    
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE-DEGRRF--FQ 115
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
            +  A+ Y H     I+HRD+K  N+LLD+N   K+ DFG+  +    N    + +   G
Sbjct: 116 QIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSCG 169
Query: 288 TRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDD 326
           +  Y  PE ++ ++    + DV+S G++L  +L G  P DD
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/82 (31%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           A+ Y H     I+HRD+K  N+LLD+N   K+ DFG+  +    N    + +   G+  Y
Sbjct: 120 AIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSCGSPNY 173
Query: 527 MPPEAMHCQI--STKTDVFSYG 546
             PE ++ ++    + DV+S G
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCG 195

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   +G G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EYM  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    K+ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 275

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 71
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDN--IGSQYLLNWCVQIAK 129
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 130 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 186
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 232
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 233 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 276

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   +G G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EYM  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    K+ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 104/239 (43%), Gaps = 22/239 (9%)
Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   + K   E+ AVK L+             E  M+       E + L+  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD---VECTMV-------EKRVLALP 77
Query: 176 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
                L  L  C   M+ +  V EY+  G L   + +V              A  +A  L
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGL 134
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            +L S  K II+RD+K  NV+LD     K+ DFG+ K +    +    T+   GT  Y+ 
Sbjct: 135 FFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKXFCGTPDYIA 189
Query: 294 PEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           PE +  Q   K+ D +++GV+L E+L G  P +  +    +  ++E  V   + + KEA
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 248

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 461 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           A  +A  L +L S  K II+RD+K  NV+LD     K+ DFG+ K +    V    T+  
Sbjct: 127 AAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKXF 181
Query: 521 TGTRPYMPPEAMHCQISTKT-DVFSYG 546
            GT  Y+ PE +  Q   K+ D +++G
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFG 208

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 74
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 132
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 133 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 189
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 235
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 236 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 279

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+G+G FG V+  +  K G ++A+K +              E    PI     E++ L  
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKV----------LMENEKEGFPITALR-EIKILQL 72
Query: 175 CKHVNLLRLLGLCNNIMN----C-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            KH N++ L+ +C    +    C     +V+++ C   L   L+ V     L   KR  +
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLSEIKR--V 129
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTEN 284
              +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N
Sbjct: 130 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 187
Query: 285 LTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNT 329
              T  Y PPE +  +       D++  G I+ E+ T   PI   NT
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNT 233

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 3/82 (3%)
Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP 525
            L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N   T  
Sbjct: 136 GLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 193
Query: 526 YMPPEAMHCQISTKTDVFSYGA 547
           Y PPE +  +      +  +GA
Sbjct: 194 YRPPELLLGERDYGPPIDLWGA 215

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 71
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 129
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 130 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 186
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 232
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 233 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 276

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 36/236 (15%)
Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ-TLSQ 174
           LG+G FG V   ++K   ++ AVK L+                   ++L +++V+ T+++
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKD-----------------VILQDDDVECTMTE 73
Query: 175 CKHVNLLRLLGLCNNIMNCI--------VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
            + ++L R       +  C         V E++  G L   +  +  +   D  +    A
Sbjct: 74  KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYA 130
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             +  AL +LH   K II+RD+K  NVLLD     KL DFG+ K    + + T       
Sbjct: 131 AEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA---TFC 185
Query: 287 GTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           GT  Y+ PE +   +     D ++ GV+L E+L G  P +  N    +  ++  EV
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 241

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/82 (36%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
            D  +    A  +  AL +LH   K II+RD+K  NVLLD     KL DFG+ K    + 
Sbjct: 121 FDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178
Query: 512 VKTMYTENLTGTRPYMPPEAMH 533
           V T       GT  Y+ PE + 
Sbjct: 179 VTTA---TFCGTPDYIAPEILQ 197

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 58/112 (51%), Gaps = 10/112 (8%)
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
           I L   +AL++L    K IIHRD+K +N+LLD +   KL DFGI      S  KT     
Sbjct: 130 ITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT----R 184
Query: 285 LTGTRPYMPPEAMHCQIS-----TKTDVFSYGVILLELLTGMKPIDDNNTIL 331
             G RPYM PE +    S      ++DV+S G+ L EL TG  P    N++ 
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 48/92 (52%), Gaps = 10/92 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           I L   +AL++L    K IIHRD+K +N+LLD +   KL DFGI      S  KT     
Sbjct: 130 ITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT----R 184
Query: 520 LTGTRPYMPPEAMHCQIS-----TKTDVFSYG 546
             G RPYM PE +    S      ++DV+S G
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 30/237 (12%)
Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+G+G FG V+  +  K G ++A+K +              E    PI     E++ L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKV----------LMENEKEGFPITALR-EIKILQL 73
Query: 175 CKHVNLLRLLGLCNNIMN----C-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            KH N++ L+ +C    +    C     +V+++ C   L   L+ V     L   KR  +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLSEIKR--V 130
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTEN 284
              +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N
Sbjct: 131 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 285 LTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
              T  Y PPE +  +       D++  G I+ E+ T   PI   NT  +   ++ Q
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQ 244

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 3/82 (3%)
Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP 525
            L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N   T  
Sbjct: 137 GLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 526 YMPPEAMHCQISTKTDVFSYGA 547
           Y PPE +  +      +  +GA
Sbjct: 195 YRPPELLLGERDYGPPIDLWGA 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 72
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 130
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 131 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 187
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 233
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 234 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 277

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 73
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 131
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 132 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 188
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 234
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 235 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 278

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+G+G FG V+  +  K G ++A+K +              E    PI     E++ L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKV----------LMENEKEGFPITALR-EIKILQL 73
Query: 175 CKHVNLLRLLGLCNNIMN----C-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            KH N++ L+ +C    +    C     +V+++ C   L   L+ V     L   KR  +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDF-CEHDLAGLLSNVLVKFTLSEIKR--V 130
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTEN 284
              +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N
Sbjct: 131 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 285 LTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNT 329
              T  Y PPE +  +       D++  G I+ E+ T   PI   NT
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNT 234

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 3/82 (3%)
Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTGTRP 525
            L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N   T  
Sbjct: 137 GLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 526 YMPPEAMHCQISTKTDVFSYGA 547
           Y PPE +  +      +  +GA
Sbjct: 195 YRPPELLLGERDYGPPIDLWGA 216

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 95
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 96  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 153
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 154 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 210
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 256
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 257 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 300

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 22/239 (9%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   K K  G   A+K L+            T        L EN V   S+ 
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRVLQNSRH 68
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
             +  L+     ++ + C V EY   G L+  L+R       D  + Y     +  AL Y
Sbjct: 69  PFLTALKYSFQTHDRL-CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALDY 124
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMP 293
           LHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MK        GT  Y+ 
Sbjct: 125 LHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-----FCGTPEYLA 178
Query: 294 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 237

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 76
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 77  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 134
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 135 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 191
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 237
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 238 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 281

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 22/239 (9%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   K K  G   A+K L+            T        L EN V   S+ 
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRVLQNSRH 67
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
             +  L+     ++ + C V EY   G L+  L+R       D  + Y     +  AL Y
Sbjct: 68  PFLTALKYSFQTHDRL-CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALDY 123
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMP 293
           LHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MK        GT  Y+ 
Sbjct: 124 LHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-----FCGTPEYLA 177
Query: 294 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 178 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 236

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 34/224 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG +  V     L+NG E AVK +E             +A      +F  EV+TL QC
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIE------------KQAGHSRSRVF-REVETLYQC 67
Query: 176 K-HVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + + N+L L+    ++    +V+E +  GS+   LA +      +  +   +   VA AL
Sbjct: 68  QGNKNILELIEFFEDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVRDVAAAL 124
Query: 234 HYLHSLSKPIIHRDVKSANVLLD--ENFVP-KLGDFGIVKMSETSNMKT-MYTENLT--- 286
            +LH+  K I HRD+K  N+L +  E   P K+ DF +    + +N  T + T  LT   
Sbjct: 125 DFLHT--KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 287 GTRPYMPPEAMHCQISTKT------DVFSYGVILLELLTGMKPI 324
           G+  YM PE +       T      D++S GV+L  +L+G  P 
Sbjct: 183 GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 72
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 130
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 131 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 187
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 233
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 234 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 277

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 17/189 (8%)
Query: 167 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            E+Q L +C    ++   G   ++    I  E+M  GSL   L      P     K   +
Sbjct: 63  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---V 119
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           ++ V   L YL    + I+HRDVK +N+L++     KL DFG+     +  +      + 
Sbjct: 120 SIAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSF 173
Query: 286 TGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 344
            GTR YM PE +     S ++D++S G+ L+EL  G  PI   +          + +  R
Sbjct: 174 VGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKEL------EAIFGR 227
Query: 345 EVLDKEAGE 353
            V+D E GE
Sbjct: 228 PVVDGEEGE 236

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +++ V   L YL    + I+HRDVK +N+L++     KL DFG+     +  +      +
Sbjct: 119 VSIAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANS 172
Query: 520 LTGTRPYMPPEAMH-CQISTKTDVFSYG 546
             GTR YM PE +     S ++D++S G
Sbjct: 173 FVGTRSYMAPERLQGTHYSVQSDIWSMG 200

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 84/195 (43%), Gaps = 26/195 (13%)
Query: 166 ENEVQTLSQCKHVNLLRLLGL-----CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
           E EV +L   KH N+L+ +G        ++   ++  +   GSL D L        +  N
Sbjct: 66  EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWN 121
Query: 221 KRYSIALGVAEALHYLH-------SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKMS 272
           +   IA  +A  L YLH          KP I HRD+KS NVLL  N    + DFG+    
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 273 ETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVF------SYGVILLELLTGMKPIDD 326
           E        T    GTR YM PE +   I+ + D F      + G++L EL +     D 
Sbjct: 182 EAGK-SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD- 239
Query: 327 NNTILYYYLVVEQEV 341
              +  Y L  E+E+
Sbjct: 240 -GPVDEYMLPFEEEI 253

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 44/97 (45%), Gaps = 9/97 (9%)
Query: 455 NKRYSIALGVAEALHYLH-------SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKM 506
           N+   IA  +A  L YLH          KP I HRD+KS NVLL  N    + DFG+   
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 507 SETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVF 543
            E        T    GTR YM PE +   I+ + D F
Sbjct: 181 FEAGK-SAGDTHGQVGTRRYMAPEVLEGAINFQRDAF 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 73
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 131
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 132 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 188
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 234
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 235 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 278

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 73
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 131
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 132 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 188
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 234
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 235 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 278

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 22/239 (9%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   K K  G   A+K L+            T        L EN V   S+ 
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRVLQNSRH 69
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
             +  L+     ++ + C V EY   G L+  L+R       D  + Y     +  AL Y
Sbjct: 70  PFLTALKYSFQTHDRL-CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALDY 125
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMP 293
           LHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MK        GT  Y+ 
Sbjct: 126 LHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-----FCGTPEYLA 179
Query: 294 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 180 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 238

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/319 (23%), Positives = 128/319 (40%), Gaps = 46/319 (14%)
Query: 77  QEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGME 135
           QEE N + + I EL         +A    N   + +   ++G G F TVY G   +  +E
Sbjct: 1   QEERNQQQDDIEELET-------KAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVE 53
Query: 136 IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN--- 192
           +A   L+                      F+ E + L   +H N++R      + +    
Sbjct: 54  VAWCELQDRKLTKSERQR-----------FKEEAEXLKGLQHPNIVRFYDSWESTVKGKK 102
Query: 193 CIVY--EYMCNGSLYDRLAR--VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV 248
           CIV   E   +G+L   L R  V     L S  R      + + L +LH+ + PIIHRD+
Sbjct: 103 CIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ-----ILKGLQFLHTRTPPIIHRDL 157
Query: 249 KSANVLL-DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDV 307
           K  N+ +       K+GD G+  +   S     + + + GT  +  PE    +     DV
Sbjct: 158 KCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFXAPEXYEEKYDESVDV 212
Query: 308 FSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVF 367
           +++G   LE  T   P  +       Y  V   V        +   +++  +  +  I+ 
Sbjct: 213 YAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGV--------KPASFDKVAIPEVKEII- 263
Query: 368 EKCCVFEKDKRASMRDIVD 386
           E C    KD+R S++D+++
Sbjct: 264 EGCIRQNKDERYSIKDLLN 282

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/84 (27%), Positives = 42/84 (50%), Gaps = 6/84 (7%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           + + L +LH+ + PIIHRD+K  N+ +       K+GD G+  +   S     + + + G
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIG 192
Query: 523 TRPYMPPEAMHCQISTKTDVFSYG 546
           T  +  PE    +     DV+++G
Sbjct: 193 TPEFXAPEXYEEKYDESVDVYAFG 216

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 108 KPYPRRGNKLGEGQFGTVY---YGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPI 162
           K Y ++   LGEG FG V    Y    +G    +AVK L+                    
Sbjct: 13  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG---------- 62
Query: 163 LLFENEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDS 219
             ++ E+  L    H ++++  G C +       +V EY+  GSL D L R +    +  
Sbjct: 63  --WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IGL 116
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
            +    A  + E + YLH+  +  IHR++ + NVLLD + + K+GDFG+ K     +   
Sbjct: 117 AQLLLFAQQICEGMAYLHA--QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 174
Query: 280 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 319
              E+      +  PE +   +    +DV+S+GV L ELLT
Sbjct: 175 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 51/106 (48%), Gaps = 11/106 (10%)
Query: 453 DSNKRYSIALG--------VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
           D   R+SI L         + E + YLH+  +  IHR++ + NVLLD + + K+GDFG+ 
Sbjct: 107 DYLPRHSIGLAQLLLFAQQICEGMAYLHA--QHYIHRNLAARNVLLDNDRLVKIGDFGLA 164
Query: 505 KMSETSNVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGAQI 549
           K     +      E+      +  PE +   +    +DV+S+G  +
Sbjct: 165 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 210

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 77
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 135
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 136 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 192
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 238
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 282

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 64
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 122
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 123 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 179
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 225
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 96/218 (44%), Gaps = 25/218 (11%)
Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           +R  KLG G +G V   + K   +E A+K +              E           EV 
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-----------EVA 88
Query: 171 TLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            L    H N+++L     +  N  +V E    G L+D +        +D+     I   V
Sbjct: 89  VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA---VIIKQV 145
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
              + YLH  +  I+HRD+K  N+LL+   ++ + K+ DFG+  + E  N K M  E L 
Sbjct: 146 LSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKM-KERL- 199
Query: 287 GTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
           GT  Y+ PE +  +   K DV+S GVIL  LL G  P 
Sbjct: 200 GTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 72
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 130
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 131 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 187
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 233
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 234 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 277

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 11/159 (6%)
Query: 167 NEVQTLSQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            E+Q L +C    ++   G   ++    I  E+M  GSL   L +    P     K   +
Sbjct: 56  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---V 112
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           ++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +        
Sbjct: 113 SIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDEMANEF 166
Query: 286 TGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKP 323
            GTR YM PE +     S ++D++S G+ L+E+  G  P
Sbjct: 167 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +++ V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +       
Sbjct: 112 VSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDEMANE 165
Query: 520 LTGTRPYMPPEAMH-CQISTKTDVFSYG 546
             GTR YM PE +     S ++D++S G
Sbjct: 166 FVGTRSYMSPERLQGTHYSVQSDIWSMG 193

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 31/191 (16%)
Query: 168 EVQTLSQC--KHVNLLRLLGLCNNIMNC-----------IVYEYMCNGSLYDRLARVNNT 214
           EVQ L +   K V++LR +    NI+             +V++ M  G L+D L      
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 215 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSE 273
              ++ K     L V  ALH L+     I+HRD+K  N+LLD++   KL DFG   ++  
Sbjct: 122 SEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 274 TSNMKTMYTENLTGTRPYMPPEAMHCQI-------STKTDVFSYGVILLELLTGMKPIDD 326
              +++     + GT  Y+ PE + C +         + D++S GVI+  LL G  P   
Sbjct: 177 GEKLRS-----VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
Query: 327 NNTILYYYLVV 337
              +L   +++
Sbjct: 232 RKQMLMLRMIM 242

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 15/134 (11%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETS 510
           L   +   I   + E +  LH L+  I+HRD+K  N+LLD++   KL DFG   ++    
Sbjct: 121 LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 511 NVKTMYTENLTGTRPYMPPEAMHCQI-------STKTDVFSYGAQIKTQHITNVDIADRE 563
            +++     + GT  Y+ PE + C +         + D++S G  + T    +     R+
Sbjct: 179 KLRS-----VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233
Query: 564 RYYSLQTMLPGHHE 577
           +   L+ ++ G+++
Sbjct: 234 QMLMLRMIMSGNYQ 247

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 32  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 81
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 82  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 138
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+DE    ++ DFG  K  +        T  L GT  
Sbjct: 139 LTFEYLHSLD--LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR------TWXLCGTPE 190
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 191 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 242

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 108/243 (44%), Gaps = 54/243 (22%)
Query: 117 LGEGQFGTVYYGKLKNGME---IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           LG+G FG V   K +N ++    A+K +             TE  +  IL   +EV  L+
Sbjct: 14  LGQGAFGQVV--KARNALDSRYYAIKKIRH-----------TEEKLSTIL---SEVMLLA 57
Query: 174 QCKHVNLLRLLGLCNNIMNC--------------IVYEYMCNGSLYDRLARVNNTPPLDS 219
              H  ++R         N               I  EY  NG+LYD +   N     D 
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 278
             R  +   + EAL Y+HS  + IIHRD+K  N+ +DE+   K+GDFG+ K +  + ++ 
Sbjct: 118 YWR--LFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 279 TMYTENL----------TGTRPYMPPEAMH--CQISTKTDVFSYGVILLELL----TGMK 322
            + ++NL           GT  Y+  E +      + K D++S G+I  E++    TGM+
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 323 PID 325
            ++
Sbjct: 234 RVN 236

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/61 (39%), Positives = 41/61 (67%), Gaps = 3/61 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTG 522
           + EAL Y+HS  + IIHRD+K  N+ +DE+   K+GDFG+ K +  + ++  + ++NL G
Sbjct: 125 ILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 523 T 523
           +
Sbjct: 183 S 183

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 72
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 130
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 131 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 187
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 233
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 234 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 277

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V EYM  G L + ++  N   P    K Y+    V  AL  +HS+   +IHRDVK  N+
Sbjct: 152 MVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAE--VVLALDAIHSMG--LIHRDVKPDNM 205
Query: 254 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 307
           LLD++   KL DFG  +KM ET     ++ +   GT  Y+ PE +  Q        + D 
Sbjct: 206 LLDKHGHLKLADFGTCMKMDETG---MVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 262
Query: 308 FSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVF 367
           +S GV L E+L G  P   ++ +  Y  +++ +  +    D E  +    H + LI    
Sbjct: 263 WSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISK----HAKNLI---- 314
Query: 368 EKCCVFEKDKRASM-RDIVDLLSKSMFVCNSLAN 400
              C F  D+   + R+ V+ + +  F  N   N
Sbjct: 315 ---CAFLTDREVRLGRNGVEEIKQHPFFKNDQWN 345

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/73 (42%), Positives = 42/73 (57%), Gaps = 6/73 (8%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTG 522
           V  AL  +HS+   +IHRDVK  N+LLD++   KL DFG  +KM ET  V   + +   G
Sbjct: 183 VVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV---HCDTAVG 237
Query: 523 TRPYMPPEAMHCQ 535
           T  Y+ PE +  Q
Sbjct: 238 TPDYISPEVLKSQ 250

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 66  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 115
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 172
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  + +      T  L GT  
Sbjct: 173 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA------TWTLCGTPE 224
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 276

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 13/162 (8%)
Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           C V EY   G L+  L+R       +   R+  A  +  AL YLHS  + +++RD+K  N
Sbjct: 81  CFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALEYLHS--RDVVYRDIKLEN 135
Query: 253 VLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFS 309
           ++LD++   K+ DFG+ K  +S+ + MK        GT  Y+ PE +         D + 
Sbjct: 136 LMLDKDGHIKITDFGLCKEGISDGATMKX-----FCGTPEYLAPEVLEDNDYGRAVDWWG 190
Query: 310 YGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
            GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 191 LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/69 (36%), Positives = 41/69 (59%), Gaps = 5/69 (7%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLHS  + +++RD+K  N++LD++   K+ DFG+ K    S+  TM  +   GT
Sbjct: 114 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATM--KXFCGT 168
Query: 524 RPYMPPEAM 532
             Y+ PE +
Sbjct: 169 PEYLAPEVL 177

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 74/166 (44%), Gaps = 11/166 (6%)
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLAR-VNNTPPLDSNKR 222
           +EV  L + KH N++R      +  N    IV EY   G L   + +       LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 223 YSIALGVAEALHYLHSLSK---PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
             +   +  AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++    N   
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDE 170
Query: 280 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPI 324
            + +   GT  YM PE M     + K+D++S G +L EL   M P 
Sbjct: 171 DFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/70 (38%), Positives = 39/70 (55%), Gaps = 4/70 (5%)
Query: 478 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAM-HCQI 536
           ++HRD+K ANV LD     KLGDFG+ ++    N    + +   GT  YM PE M     
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDEDFAKEFVGTPYYMSPEQMNRMSY 193
Query: 537 STKTDVFSYG 546
           + K+D++S G
Sbjct: 194 NEKSDIWSLG 203

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 117 LGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           LGEG FG VY G   N     + +AVKT +            +EA +            +
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVI------------M 63
Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
               H ++++L+G+       I+ E    G L   L R  N+  + +   YS  L + +A
Sbjct: 64  KNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKA 121
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + YL S++   +HRD+   N+L+      KLGDFG+ +  E  +        L     +M
Sbjct: 122 MAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK--WM 177
Query: 293 PPEAMHC-QISTKTDVFSYGVILLELLT-GMKPI 324
            PE+++  + +T +DV+ + V + E+L+ G +P 
Sbjct: 178 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 86/191 (45%), Gaps = 31/191 (16%)
Query: 168 EVQTLSQC--KHVNLLRLLGLCNNIMNC-----------IVYEYMCNGSLYDRLARVNNT 214
           EVQ L +   K V++LR +    NI+             +V++ M  G L+D L      
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 215 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSE 273
              ++ K     L V  ALH L+     I+HRD+K  N+LLD++   KL DFG   ++  
Sbjct: 122 SEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 274 TSNMKTMYTENLTGTRPYMPPEAMHCQI-------STKTDVFSYGVILLELLTGMKPIDD 326
              ++      + GT  Y+ PE + C +         + D++S GVI+  LL G  P   
Sbjct: 177 GEKLR-----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
Query: 327 NNTILYYYLVV 337
              +L   +++
Sbjct: 232 RKQMLMLRMIM 242

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETS 510
           L   +   I   + E +  LH L+  I+HRD+K  N+LLD++   KL DFG   ++    
Sbjct: 121 LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 511 NVKTMYTENLTGTRPYMPPEAMHCQI-------STKTDVFSYGAQIKTQHITNVDIADRE 563
            ++      + GT  Y+ PE + C +         + D++S G  + T    +     R+
Sbjct: 179 KLR-----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233
Query: 564 RYYSLQTMLPGHHE 577
           +   L+ ++ G+++
Sbjct: 234 QMLMLRMIMSGNYQ 247

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 13/162 (8%)
Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           C V EY   G L+  L+R       +   R+  A  +  AL YLHS  + +++RD+K  N
Sbjct: 86  CFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALEYLHS--RDVVYRDIKLEN 140
Query: 253 VLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFS 309
           ++LD++   K+ DFG+ K  +S+ + MK        GT  Y+ PE +         D + 
Sbjct: 141 LMLDKDGHIKITDFGLCKEGISDGATMKX-----FCGTPEYLAPEVLEDNDYGRAVDWWG 195
Query: 310 YGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
            GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 196 LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 237

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/69 (36%), Positives = 41/69 (59%), Gaps = 5/69 (7%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLHS  + +++RD+K  N++LD++   K+ DFG+ K    S+  TM  +   GT
Sbjct: 119 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATM--KXFCGT 173
Query: 524 RPYMPPEAM 532
             Y+ PE +
Sbjct: 174 PEYLAPEVL 182

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 86/191 (45%), Gaps = 31/191 (16%)
Query: 168 EVQTLSQC--KHVNLLRLLGLCNNIMNC-----------IVYEYMCNGSLYDRLARVNNT 214
           EVQ L +   K V++LR +    NI+             +V++ M  G L+D L      
Sbjct: 49  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 108
Query: 215 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSE 273
              ++ K     L V  ALH L+     I+HRD+K  N+LLD++   KL DFG   ++  
Sbjct: 109 SEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 163
Query: 274 TSNMKTMYTENLTGTRPYMPPEAMHCQI-------STKTDVFSYGVILLELLTGMKPIDD 326
              ++      + GT  Y+ PE + C +         + D++S GVI+  LL G  P   
Sbjct: 164 GEKLR-----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 218
Query: 327 NNTILYYYLVV 337
              +L   +++
Sbjct: 219 RKQMLMLRMIM 229

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETS 510
           L   +   I   + E +  LH L+  I+HRD+K  N+LLD++   KL DFG   ++    
Sbjct: 108 LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 165
Query: 511 NVKTMYTENLTGTRPYMPPEAMHCQI-------STKTDVFSYGAQIKTQHITNVDIADRE 563
            ++      + GT  Y+ PE + C +         + D++S G  + T    +     R+
Sbjct: 166 KLR-----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 220
Query: 564 RYYSLQTMLPGHHE 577
           +   L+ ++ G+++
Sbjct: 221 QMLMLRMIMSGNYQ 234

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G+G++G V+ G  + G  +AVK                          E E+      +
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKS--------------WFRETELYNTVMLR 60
Query: 177 HVNLLRLLG-----LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           H N+L  +        ++    ++  Y   GSLYD L        LD+     I L +A 
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIAS 116
Query: 232 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMYTEN 284
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+  M S+++N   +    
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 285 LTGTRPYMPPEAMHCQIST-------KTDVFSYGVILLELLTGM 321
             GT+ YM PE +   I         + D++++G++L E+   M
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 14/109 (12%)
Query: 452 LDSNKRYSIALGVAEALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVK 505
           LD+     I L +A  L +LH     +  KP I HRD+KS N+L+ +N    + D G+  
Sbjct: 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161
Query: 506 M-SETSNVKTMYTENLTGTRPYMPPEAMHCQIST-------KTDVFSYG 546
           M S+++N   +      GT+ YM PE +   I         + D++++G
Sbjct: 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG 210

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G+G++G V+ G  + G  +AVK                          E E+      +
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKS--------------WFRETELYNTVMLR 60
Query: 177 HVNLLRLLG-----LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           H N+L  +        ++    ++  Y   GSLYD L        LD+     I L +A 
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIAS 116
Query: 232 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMYTEN 284
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+  M S+++N   +    
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 285 LTGTRPYMPPEAMHCQIST-------KTDVFSYGVILLELLTGM 321
             GT+ YM PE +   I         + D++++G++L E+   M
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 14/109 (12%)
Query: 452 LDSNKRYSIALGVAEALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVK 505
           LD+     I L +A  L +LH     +  KP I HRD+KS N+L+ +N    + D G+  
Sbjct: 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161
Query: 506 M-SETSNVKTMYTENLTGTRPYMPPEAMHCQIST-------KTDVFSYG 546
           M S+++N   +      GT+ YM PE +   I         + D++++G
Sbjct: 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG 210

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLAGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 13/162 (8%)
Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           C V EY   G L+  L+R       +   R+  A  +  AL YLHS  + +++RD+K  N
Sbjct: 81  CFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALEYLHS--RDVVYRDIKLEN 135
Query: 253 VLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFS 309
           ++LD++   K+ DFG+ K  +S+ + MK        GT  Y+ PE +         D + 
Sbjct: 136 LMLDKDGHIKITDFGLCKEGISDGATMKX-----FCGTPEYLAPEVLEDNDYGRAVDWWG 190
Query: 310 YGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
            GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 191 LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/69 (36%), Positives = 41/69 (59%), Gaps = 5/69 (7%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLHS  + +++RD+K  N++LD++   K+ DFG+ K    S+  TM  +   GT
Sbjct: 114 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATM--KXFCGT 168
Query: 524 RPYMPPEAM 532
             Y+ PE +
Sbjct: 169 PEYLAPEVL 177

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 13/162 (8%)
Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
           C V EY   G L+  L+R       +   R+  A  +  AL YLHS  + +++RD+K  N
Sbjct: 81  CFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALEYLHS--RDVVYRDIKLEN 135
Query: 253 VLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFS 309
           ++LD++   K+ DFG+ K  +S+ + MK        GT  Y+ PE +         D + 
Sbjct: 136 LMLDKDGHIKITDFGLCKEGISDGATMKX-----FCGTPEYLAPEVLEDNDYGRAVDWWG 190
Query: 310 YGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
            GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 191 LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/69 (36%), Positives = 41/69 (59%), Gaps = 5/69 (7%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLHS  + +++RD+K  N++LD++   K+ DFG+ K    S+  TM  +   GT
Sbjct: 114 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATM--KXFCGT 168
Query: 524 RPYMPPEAM 532
             Y+ PE +
Sbjct: 169 PEYLAPEVL 177

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 14/218 (6%)
Query: 116 KLGEGQFGTVYYGKLKNG-MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           KLG G +G V   K KNG  E A+K ++             +          NE+  L  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++L  +  +     +V E+   G L++++    N    D     +I   +   +
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGI 159
Query: 234 HYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
            YLH  +  I+HRD+K  N+LL+        K+ DFG+         K     +  GT  
Sbjct: 160 CYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS----KDYKLRDRLGTAY 213
Query: 291 YMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
           Y+ PE +  + + K DV+S GVI+  LL G  P    N
Sbjct: 214 YIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 74
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 132
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 133 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 189
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 235
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 236 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 279

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 117 LGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           LGEG FG VY G   N     + +AVKT +            +EA +            +
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVI------------M 67
Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
               H ++++L+G+       I+ E    G L   L R  N+  + +   YS  L + +A
Sbjct: 68  KNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKA 125
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + YL S++   +HRD+   N+L+      KLGDFG+ +  E  +        L     +M
Sbjct: 126 MAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK--WM 181
Query: 293 PPEAMHC-QISTKTDVFSYGVILLELLT-GMKPI 324
            PE+++  + +T +DV+ + V + E+L+ G +P 
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 72
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 130
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 131 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 187
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 233
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 234 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 277

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 117 LGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           LGEG FG VY G   N     + +AVKT +            +EA +            +
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVI------------M 79
Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
               H ++++L+G+       I+ E    G L   L R  N+  + +   YS  L + +A
Sbjct: 80  KNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKA 137
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + YL S++   +HRD+   N+L+      KLGDFG+ +  E  +        L     +M
Sbjct: 138 MAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK--WM 193
Query: 293 PPEAMHC-QISTKTDVFSYGVILLELLT-GMKPI 324
            PE+++  + +T +DV+ + V + E+L+ G +P 
Sbjct: 194 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   +G G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    K+ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   K +    E AVK +                          EV+ L + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-----------REVELLKKL 78
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L  +  +  +  IV E    G L+D + +       D+ +   I   V   + 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGIT 135
Query: 235 YLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           Y+H  +  I+HRD+K  N+LL+   ++   K+ DFG+     T   +    ++  GT  Y
Sbjct: 136 YMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGL----STCFQQNTKMKDRIGTAYY 189
Query: 292 MPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
           + PE +      K DV+S GVIL  LL+G  P    N
Sbjct: 190 IAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLXGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   K +    E AVK +                          EV+ L + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-----------REVELLKKL 78
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L  +  +  +  IV E    G L+D + +       D+ +   I   V   + 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGIT 135
Query: 235 YLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           Y+H  +  I+HRD+K  N+LL+   ++   K+ DFG+     T   +    ++  GT  Y
Sbjct: 136 YMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGL----STCFQQNTKMKDRIGTAYY 189
Query: 292 MPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
           + PE +      K DV+S GVIL  LL+G  P    N
Sbjct: 190 IAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFA--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 204
Query: 175 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +A
Sbjct: 205 YQHENVVEMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQA 259
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L  LH+    +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M
Sbjct: 260 LSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWM 314
Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 323
            PE +       + D++S G++++E++ G  P
Sbjct: 315 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 40  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 89
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 90  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--XEPHARF-YAAQIV 146
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 147 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 198
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 199 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 250

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 129/282 (45%), Gaps = 37/282 (13%)
Query: 117 LGEGQFGTVYYG-KLKNG--MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           LG G FGTVY G  +  G  ++I V  +E            +  A   IL   +E   ++
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREAT-------SPKANKEIL---DEAYVMA 106
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
              + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+ +
Sbjct: 107 SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGM 164
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
           +YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +M 
Sbjct: 165 NYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKWMA 221
Query: 294 PEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD-KE 350
            E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+    E
Sbjct: 222 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSILE 267
Query: 351 AGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 268 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 309

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   K +    E AVK +                    IL    EV+ L + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST--------IL---REVELLKKL 78
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
            H N+++L  +  +  +  IV E    G L+D + +       D+ +   I   V   + 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGIT 135
Query: 235 YLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRP 290
           Y+H  +  I+HRD+K  N+LL+   ++   K+ DFG+     + + MK     +  GT  
Sbjct: 136 YMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK-----DRIGTAY 188
Query: 291 YMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
           Y+ PE +      K DV+S GVIL  LL+G  P 
Sbjct: 189 YIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 82
Query: 175 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +A
Sbjct: 83  YQHENVVEMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQA 137
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L  LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M
Sbjct: 138 LSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWM 192
Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 323
            PE +       + D++S G++++E++ G  P
Sbjct: 193 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
           ++ L V +AL  LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    +
Sbjct: 129 AVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRK 183
Query: 519 NLTGTRPYMPPEAM-HCQISTKTDVFSYGAQI 549
            L GT  +M PE +       + D++S G  +
Sbjct: 184 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 215

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 176
           +G+G++G V+ G  + G  +AVK                          E E+      +
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKS--------------WFRETELYNTVMLR 89
Query: 177 HVNLLRLLG-----LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           H N+L  +        ++    ++  Y   GSLYD L        LD+     I L +A 
Sbjct: 90  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIAS 145
Query: 232 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMYTEN 284
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+  M S+++N   +    
Sbjct: 146 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 205
Query: 285 LTGTRPYMPPEAMHCQIST-------KTDVFSYGVILLELLTGM 321
             GT+ YM PE +   I         + D++++G++L E+   M
Sbjct: 206 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 249

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 14/109 (12%)
Query: 452 LDSNKRYSIALGVAEALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVK 505
           LD+     I L +A  L +LH     +  KP I HRD+KS N+L+ +N    + D G+  
Sbjct: 131 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 190
Query: 506 M-SETSNVKTMYTENLTGTRPYMPPEAMHCQIST-------KTDVFSYG 546
           M S+++N   +      GT+ YM PE +   I         + D++++G
Sbjct: 191 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG 239

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 77
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 135
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 136 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 192
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 238
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 282

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 38/222 (17%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           KLG G + TVY G  K  G+ +A+K ++            T +  I       E+  + +
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG------TPSTAI------REISLMKE 59
Query: 175 CKHVNLLRLLGLCNNIMN-CIVYEYMCNG-SLYDRLARVNNTP-PLDSNKRYSIALGVAE 231
            KH N++RL  + +      +V+E+M N    Y     V NTP  L+ N        + +
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM---------SETSNMKTMYT 282
            L + H     I+HRD+K  N+L+++    KLGDFG+ +          SE   +     
Sbjct: 120 GLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAP 177
Query: 283 ENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
           + L G+R Y          ST  D++S G IL E++TG KP+
Sbjct: 178 DVLMGSRTY----------STSIDIWSCGCILAEMITG-KPL 208

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 72/136 (52%), Gaps = 12/136 (8%)
Query: 225 IALGVAEALHYLHS-LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
           IA+ + +AL +LHS LS  +IHRDVK +NVL++     K+ DFGI      S  KT+   
Sbjct: 158 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTID-- 213
Query: 284 NLTGTRPYMPPEAMHCQI-----STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              G +PYM PE ++ ++     S K+D++S G+ ++EL     P D   T       V 
Sbjct: 214 --AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 271
Query: 339 QEVPVREVLDKEAGEW 354
           +E   +   DK + E+
Sbjct: 272 EEPSPQLPADKFSAEF 287

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 55/93 (59%), Gaps = 12/93 (12%)
Query: 460 IALGVAEALHYLHS-LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
           IA+ + +AL +LHS LS  +IHRDVK +NVL++     K+ DFGI      S  KT+   
Sbjct: 158 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTID-- 213
Query: 519 NLTGTRPYMPPEAMHCQI-----STKTDVFSYG 546
              G +PYM PE ++ ++     S K+D++S G
Sbjct: 214 --AGCKPYMAPERINPELNQKGYSVKSDIWSLG 244

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKV 255

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 66  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 115
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--XEPHARF-YAAQIV 172
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 173 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 224
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 276

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 84
Query: 175 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +A
Sbjct: 85  YQHENVVEMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQA 139
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L  LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M
Sbjct: 140 LSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWM 194
Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 323
            PE +       + D++S G++++E++ G  P
Sbjct: 195 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
           ++ L V +AL  LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    +
Sbjct: 131 AVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRK 185
Query: 519 NLTGTRPYMPPEAM-HCQISTKTDVFSYGAQI 549
            L GT  +M PE +       + D++S G  +
Sbjct: 186 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 217

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 73
Query: 175 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +A
Sbjct: 74  YQHENVVEMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQA 128
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L  LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M
Sbjct: 129 LSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWM 183
Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 323
            PE +       + D++S G++++E++ G  P
Sbjct: 184 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
           ++ L V +AL  LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    +
Sbjct: 120 AVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRK 174
Query: 519 NLTGTRPYMPPEAM-HCQISTKTDVFSYGAQI 549
            L GT  +M PE +       + D++S G  +
Sbjct: 175 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 206

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 96/242 (39%), Gaps = 42/242 (17%)
Query: 120 GQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVN 179
           G+FG V+  +L N   +AVK                          E E+ +    KH N
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS--------------EREIFSTPGMKHEN 70
Query: 180 LLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           LL+ +       N      ++  +   GSL D L    N   +  N+   +A  ++  L 
Sbjct: 71  LLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLK--GNI--ITWNELCHVAETMSRGLS 126
Query: 235 YLHS--------LSKP-IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
           YLH           KP I HRD KS NVLL  +    L DFG+    E        T   
Sbjct: 127 YLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGK-PPGDTHGQ 185
Query: 286 TGTRPYMPPEAMHCQISTKTDVF------SYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
            GTR YM PE +   I+ + D F      + G++L EL++  K  D    +  Y L  E+
Sbjct: 186 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD--GPVDEYMLPFEE 243
Query: 340 EV 341
           E+
Sbjct: 244 EI 245

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 43/98 (43%), Gaps = 10/98 (10%)
Query: 455 NKRYSIALGVAEALHYLHS--------LSKP-IIHRDVKSANVLLDENFVPKLGDFGIVK 505
           N+   +A  ++  L YLH           KP I HRD KS NVLL  +    L DFG+  
Sbjct: 112 NELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAV 171
Query: 506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVF 543
             E        T    GTR YM PE +   I+ + D F
Sbjct: 172 RFEPGKPPG-DTHGQVGTRRYMAPEVLEGAINFQRDAF 208

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 31  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 80
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 81  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 137
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 138 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPE 189
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 190 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 241

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 77
Query: 175 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +A
Sbjct: 78  YQHENVVEMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQA 132
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L  LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M
Sbjct: 133 LSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWM 187
Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 323
            PE +       + D++S G++++E++ G  P
Sbjct: 188 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
           ++ L V +AL  LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    +
Sbjct: 124 AVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRK 178
Query: 519 NLTGTRPYMPPEAM-HCQISTKTDVFSYGAQI 549
            L GT  +M PE +       + D++S G  +
Sbjct: 179 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 210

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG FG V        G ++A+K +                        E E+  L   
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR----------IEREISYLRLL 61
Query: 176 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H ++++L  +  +    I V EY  N  L+D + + +     ++ + +     +  A+ 
Sbjct: 62  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQ---QIISAVE 117
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           Y H     I+HRD+K  N+LLDE+   K+ DFG+  +    N    + +   G+  Y  P
Sbjct: 118 YCHR--HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAP 171
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 328
           E +  ++    + DV+S GVIL  +L    P DD +
Sbjct: 172 EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 127/284 (44%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           L  G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 127/284 (44%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           L  G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 77
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 135
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 136 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 192
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 238
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 282

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+++D+    K+ DFG+ K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPE 204
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           ++LG+G FG+V    Y  L +  G  +AVK L+                      F+ E+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-------------FQREI 62
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           Q L       +++  G+          +V EY+ +G L D L R      LD+++    +
Sbjct: 63  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYS 120
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+      K  Y     
Sbjct: 121 SQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREP 176
Query: 287 GTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
           G  P  +  PE++   I S ++DV+S+GV+L EL T
Sbjct: 177 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 127
Query: 175 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            +H N++ +    L  + +  +V E++  G+L D +        ++  +  ++ L V +A
Sbjct: 128 YQHENVVEMYNSYLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQA 182
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L  LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M
Sbjct: 183 LSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWM 237
Query: 293 PPEAM-HCQISTKTDVFSYGVILLELLTGMKP 323
            PE +       + D++S G++++E++ G  P
Sbjct: 238 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
           ++ L V +AL  LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    +
Sbjct: 174 AVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRK 228
Query: 519 NLTGTRPYMPPEAM-HCQISTKTDVFSYGAQI 549
            L GT  +M PE +       + D++S G  +
Sbjct: 229 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 260

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG FG V        G ++A+K +                        E E+  L   
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR----------IEREISYLRLL 70
Query: 176 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H ++++L  +  +    I V EY  N  L+D + + +     ++ + +     +  A+ 
Sbjct: 71  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQ---QIISAVE 126
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           Y H     I+HRD+K  N+LLDE+   K+ DFG+  +    N    + +   G+  Y  P
Sbjct: 127 YCHR--HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAP 180
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 328
           E +  ++    + DV+S GVIL  +L    P DD +
Sbjct: 181 EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 111/245 (45%), Gaps = 52/245 (21%)
Query: 110 YPRR----GNKLGEGQFG-----TVYYGKLKNG-MEIAVKTLEXXXXXXXXXXXXTEAAM 159
           +PR+    G  LGEG+FG     T ++ K + G   +AVK L+            + + +
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---------SPSEL 70
Query: 160 IPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPP-- 216
             +L   +E   L Q  H ++++L G C+     + + EY   GSL   L       P  
Sbjct: 71  RDLL---SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 217 -----------LDSNKRYSIALG--------VAEALHYLHSLSKPIIHRDVKSANVLLDE 257
                      LD     ++ +G        +++ + YL  +   ++HRD+ + N+L+ E
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAE 185
Query: 258 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVIL 314
               K+ DFG   +S     +  Y +   G  P  +M  E++   I +T++DV+S+GV+L
Sbjct: 186 GRKMKISDFG---LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 315 LELLT 319
            E++T
Sbjct: 243 WEIVT 247

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG FG V        G ++A+K +                        E E+  L   
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR----------IEREISYLRLL 71
Query: 176 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H ++++L  +  +    I V EY  N  L+D + + +     ++ + +     +  A+ 
Sbjct: 72  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQ---QIISAVE 127
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           Y H     I+HRD+K  N+LLDE+   K+ DFG+  +    N    + +   G+  Y  P
Sbjct: 128 YCHR--HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAP 181
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 328
           E +  ++    + DV+S GVIL  +L    P DD +
Sbjct: 182 EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 152
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 127/284 (44%), Gaps = 41/284 (14%)
Query: 117 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           L  G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 77
Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 135
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 136 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 192
Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 348
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 238
Query: 349 KEAGE-WNETHVETL-IGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 282

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 173 SQCKHVNLLRLLGLCNNI---MNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 72  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 128
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 284
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 129 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 184
Query: 285 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 330
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 185 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 229

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           ++LG+G FG+V    Y  L +  G  +AVK L+                      F+ E+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-------------FQREI 63
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           Q L       +++  G+          +V EY+ +G L D L R      LD+++    +
Sbjct: 64  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYS 121
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+      K  Y     
Sbjct: 122 SQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREP 177
Query: 287 GTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
           G  P  +  PE++   I S ++DV+S+GV+L EL T
Sbjct: 178 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           ++LG+G FG+V    Y  L +  G  +AVK L+                      F+ E+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-------------FQREI 75
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           Q L       +++  G+          +V EY+ +G L D L R      LD+++    +
Sbjct: 76  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYS 133
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+      K  Y     
Sbjct: 134 SQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREP 189
Query: 287 GTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
           G  P  +  PE++   I S ++DV+S+GV+L EL T
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 173 SQCKHVNLLRLLGLCNNI---MNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 82  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 138
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 284
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 139 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 194
Query: 285 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 330
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 195 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 239

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 173 SQCKHVNLLRLLGLCNNI---MNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 73  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 129
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 284
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 130 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 185
Query: 285 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 330
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 186 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 230

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LGEG FG V        G ++A+K +                        E E+  L   
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR----------IEREISYLRLL 65
Query: 176 KHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H ++++L  +  +    I V EY  N  L+D + + +     ++ + +     +  A+ 
Sbjct: 66  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQ---QIISAVE 121
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           Y H     I+HRD+K  N+LLDE+   K+ DFG+  +    N    + +   G+  Y  P
Sbjct: 122 YCHR--HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAP 175
Query: 295 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 328
           E +  ++    + DV+S GVIL  +L    P DD +
Sbjct: 176 EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 173 SQCKHVNLLRLLGLCNNI---MNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 74  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 130
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 284
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 131 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 186
Query: 285 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 330
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 187 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 231

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 173 SQCKHVNLLRLLGLCNNI---MNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 68  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 124
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 284
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 125 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 180
Query: 285 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 330
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 181 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 225

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 57/122 (46%), Gaps = 15/122 (12%)
Query: 430 LDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 489
           LD GE     LF   +          +   I   + EA+ YLHS++  I HRDVK  N+L
Sbjct: 97  LDGGE-----LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLL 149
Query: 490 LDE---NFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSY 545
                 N + KL DFG  K  ET++  ++ T   T    Y+ PE +  +   K+ D++S 
Sbjct: 150 YTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPY--YVAPEVLGPEKYDKSCDMWSL 205
Query: 546 GA 547
           G 
Sbjct: 206 GV 207

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+++D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 38  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 87
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 144
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 145 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 196
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 197 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 248

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 173 SQCKHVNLLRLLGLCNNI---MNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 112 SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 168
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 284
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 169 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 224
Query: 285 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 330
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 225 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 57/122 (46%), Gaps = 15/122 (12%)
Query: 430 LDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 489
           LD GE     LF   +          +   I   + EA+ YLHS++  I HRDVK  N+L
Sbjct: 141 LDGGE-----LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLL 193
Query: 490 LDE---NFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSY 545
                 N + KL DFG  K  ET++  ++ T   T    Y+ PE +  +   K+ D++S 
Sbjct: 194 YTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPY--YVAPEVLGPEKYDKSCDMWSL 249
Query: 546 GA 547
           G 
Sbjct: 250 GV 251

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ ++  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 111/243 (45%), Gaps = 48/243 (19%)
Query: 110 YPRR----GNKLGEGQFG-----TVYYGKLKNG-MEIAVKTLEXXXXXXXXXXXXTEAAM 159
           +PR+    G  LGEG+FG     T ++ K + G   +AVK L+            + + +
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---------SPSEL 70
Query: 160 IPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPP-- 216
             +L   +E   L Q  H ++++L G C+     + + EY   GSL   L       P  
Sbjct: 71  RDLL---SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 217 -----------LDSNKRYSIALG--------VAEALHYLHSLSKPIIHRDVKSANVLLDE 257
                      LD     ++ +G        +++ + YL  +S  ++HRD+ + N+L+ E
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS--LVHRDLAARNILVAE 185
Query: 258 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLE 316
               K+ DFG+ +     +     ++     + +M  E++   I +T++DV+S+GV+L E
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK-WMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 317 LLT 319
           ++T
Sbjct: 245 IVT 247

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 173 SQCKHVNLLRLLGLCNNI---MNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 68  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 124
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 284
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 125 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 180
Query: 285 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 330
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 181 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 225

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 38  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 87
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 144
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 145 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 196
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 197 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 248

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 173 SQCKHVNLLRLLGLCNNI---MNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 67  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 123
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 284
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 124 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 179
Query: 285 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 330
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 180 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 224

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 173 SQCKHVNLLRLLGLCNNI---MNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 66  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 122
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 284
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 123 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 178
Query: 285 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 330
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 179 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 223

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 173 SQCKHVNLLRLLGLCNNI---MNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 118 SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 174
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 284
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 175 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 230
Query: 285 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 330
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 231 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 275

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 57/122 (46%), Gaps = 15/122 (12%)
Query: 430 LDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 489
           LD GE     LF   +          +   I   + EA+ YLHS++  I HRDVK  N+L
Sbjct: 147 LDGGE-----LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLL 199
Query: 490 LDE---NFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSY 545
                 N + KL DFG  K  ET++  ++ T   T    Y+ PE +  +   K+ D++S 
Sbjct: 200 YTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPY--YVAPEVLGPEKYDKSCDMWSL 255
Query: 546 GA 547
           G 
Sbjct: 256 GV 257

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 66  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 115
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 172
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 173 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 224
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 276

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L +L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 107/243 (44%), Gaps = 54/243 (22%)
Query: 117 LGEGQFGTVYYGKLKNGME---IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           LG+G FG V   K +N ++    A+K +             TE  +  IL   +EV  L+
Sbjct: 14  LGQGAFGQVV--KARNALDSRYYAIKKIRH-----------TEEKLSTIL---SEVMLLA 57
Query: 174 QCKHVNLLRLLGLCNNIMNC--------------IVYEYMCNGSLYDRLARVNNTPPLDS 219
              H  ++R         N               I  EY  N +LYD +   N     D 
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE 117
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 278
             R  +   + EAL Y+HS  + IIHRD+K  N+ +DE+   K+GDFG+ K +  + ++ 
Sbjct: 118 YWR--LFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 279 TMYTENL----------TGTRPYMPPEAMH--CQISTKTDVFSYGVILLELL----TGMK 322
            + ++NL           GT  Y+  E +      + K D++S G+I  E++    TGM+
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 323 PID 325
            ++
Sbjct: 234 RVN 236

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/61 (39%), Positives = 41/61 (67%), Gaps = 3/61 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTG 522
           + EAL Y+HS  + IIHRD+K  N+ +DE+   K+GDFG+ K +  + ++  + ++NL G
Sbjct: 125 ILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 523 T 523
           +
Sbjct: 183 S 183

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G FG V   K+KN   I A+K L              + A       E +V     C
Sbjct: 82  IGRGAFGEVAVVKMKNTERIYAMKILNKWEM--------LKRAETACFREERDVLVNGDC 133
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA-EALH 234
           + +  L       N +  +V +Y   G L   L++  +  P D  + Y   + +A +++H
Sbjct: 134 QWITALHYAFQDENHLY-LVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 192
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMP 293
            LH      +HRD+K  NVLLD N   +L DFG  +KM++   +++       GT  Y+ 
Sbjct: 193 QLH-----YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA---VGTPDYIS 244
Query: 294 PEAMHC------QISTKTDVFSYGVILLELLTGMKPI 324
           PE +        +   + D +S GV + E+L G  P 
Sbjct: 245 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 10/94 (10%)
Query: 443 LARVNNTPPLDSNKRYSIALGVA-EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 501
           L++  +  P D  + Y   + +A +++H LH      +HRD+K  NVLLD N   +L DF
Sbjct: 165 LSKFEDKLPEDMARFYIGEMVLAIDSIHQLH-----YVHRDIKPDNVLLDVNGHIRLADF 219
Query: 502 G-IVKMSETSNVKTMYTENLTGTRPYMPPEAMHC 534
           G  +KM++   V++       GT  Y+ PE +  
Sbjct: 220 GSCLKMNDDGTVQSSVA---VGTPDYISPEILQA 250

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L +L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L +L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 152
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V EY   G ++  L R+      + + R+  A  +     YLHSL   +I+RD+K  N+
Sbjct: 119 MVLEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYLHSLD--LIYRDLKPENL 173
Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGV 312
           L+D+    K+ DFG  K  +        T  L GT  Y+ PE +  +   K  D ++ GV
Sbjct: 174 LIDQQGYIKVADFGFAKRVKGR------TWXLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 313 ILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           ++ E+  G  P   +  I  Y  +V  +V
Sbjct: 228 LIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 15/165 (9%)
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            ENE+  L + KH N++ L  +  +  +  +V + +  G L+DR+         D++   
Sbjct: 53  LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS--- 109
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTM 280
            +   V  A+ YLH     I+HRD+K  N+L    +EN    + DFG+ KM +   M T 
Sbjct: 110 LVIQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA 167
Query: 281 YTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPI 324
                 GT  Y+ PE +  +  +K  D +S GVI   LL G  P 
Sbjct: 168 -----CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 28  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 87
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 88  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 132
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 133 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 183
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 184 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243
Query: 339 QEV 341
           Q V
Sbjct: 244 QRV 246

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+++D+    ++ DFG+ K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 45/223 (20%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           K+GEG +G VY  K   G  +A+K +              E   IP      E+  L + 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLD----------AEDEGIPSTAI-REISLLKEL 76
Query: 176 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKR---YSIALGVA 230
            H N++ L+ + ++   C+  V+E+M       ++   N T   DS  +   Y +  GVA
Sbjct: 77  HHPNIVSLIDVIHS-ERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------SETSNMKTMY--- 281
                 H     I+HRD+K  N+L++ +   KL DFG+ +       S T  + T++   
Sbjct: 134 ------HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 282 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
            + L G++ Y          ST  D++S G I  E++TG KP+
Sbjct: 188 PDVLMGSKKY----------STSVDIWSIGCIFAEMITG-KPL 219

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G FG V   K+KN   I A+K L              + A       E +V     C
Sbjct: 98  IGRGAFGEVAVVKMKNTERIYAMKILNKWEM--------LKRAETACFREERDVLVNGDC 149
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA-EALH 234
           + +  L       N +  +V +Y   G L   L++  +  P D  + Y   + +A +++H
Sbjct: 150 QWITALHYAFQDENHLY-LVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 208
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMP 293
            LH      +HRD+K  NVLLD N   +L DFG  +KM++   +++       GT  Y+ 
Sbjct: 209 QLH-----YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA---VGTPDYIS 260
Query: 294 PEAMHC------QISTKTDVFSYGVILLELLTGMKPI 324
           PE +        +   + D +S GV + E+L G  P 
Sbjct: 261 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 10/94 (10%)
Query: 443 LARVNNTPPLDSNKRYSIALGVA-EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 501
           L++  +  P D  + Y   + +A +++H LH      +HRD+K  NVLLD N   +L DF
Sbjct: 181 LSKFEDKLPEDMARFYIGEMVLAIDSIHQLH-----YVHRDIKPDNVLLDVNGHIRLADF 235
Query: 502 G-IVKMSETSNVKTMYTENLTGTRPYMPPEAMHC 534
           G  +KM++   V++       GT  Y+ PE +  
Sbjct: 236 GSCLKMNDDGTVQSSVA---VGTPDYISPEILQA 266

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/124 (35%), Positives = 58/124 (46%), Gaps = 11/124 (8%)
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
           + + + +AL+YL      +IHRDVK +N+LLDE    KL DFGI         K    + 
Sbjct: 129 MTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK----DR 183
Query: 285 LTGTRPYMPPEAMHCQISTK------TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
             G   YM PE +     TK       DV+S G+ L+EL TG  P  +  T       V 
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL 243
Query: 339 QEVP 342
           QE P
Sbjct: 244 QEEP 247

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 63/150 (42%), Gaps = 23/150 (15%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           + + + +AL+YL      +IHRDVK +N+LLDE    KL DFGI         K    + 
Sbjct: 129 MTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK----DR 183
Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYS------------ 567
             G   YM PE +     TK D +   A + +  I+ V++A  +  Y             
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPD-YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
Query: 568 LQ---TMLPGH--HEGDHVSISNHSTNNSH 592
           LQ    +LPGH    GD  S         H
Sbjct: 243 LQEEPPLLPGHMGFSGDFQSFVKDCLTKDH 272

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 13  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 72
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 73  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 117
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 118 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 168
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 169 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 228
Query: 339 QEV 341
           Q V
Sbjct: 229 QRV 231

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 17/232 (7%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 13  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 72
Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S      ++RLL       +  ++ E M    + D    +     L      S    V E
Sbjct: 73  S-----GVIRLLDWFERPDSFVLILERM--EPVQDLFDFITERGALQEELARSFFWQVLE 125
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           A+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K     +  GTR Y
Sbjct: 126 AVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDTVYTDFDGTRVY 179
Query: 292 MPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
            PPE +  H        V+S G++L +++ G  P + +  I+   +   Q V
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 231

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 28  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 87
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 88  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 132
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 133 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 183
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 184 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243
Query: 339 QEV 341
           Q V
Sbjct: 244 QRV 246

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +KLGEG + TVY GK K     +A+K +              E A    +    EV  L 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---------EGAPCTAI---REVSLLK 55
Query: 174 QCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
             KH N++ L  + +   +  +V+EY+ +  L   L    N   + + K +   L     
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQL--LRG 112
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L Y H   + ++HRD+K  N+L++E    KL DFG+ +     ++ T   +N   T  Y 
Sbjct: 113 LAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYR 167
Query: 293 PPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 330
           PP+ +      ST+ D++  G I  E+ TG +P+   +T+
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGSTV 206

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 45/223 (20%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           K+GEG +G VY  K   G  +A+K +              E   IP      E+  L + 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLD----------AEDEGIPSTAI-REISLLKEL 76
Query: 176 KHVNLLRLLGLCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKR---YSIALGVA 230
            H N++ L+ + ++   C+  V+E+M       ++   N T   DS  +   Y +  GVA
Sbjct: 77  HHPNIVSLIDVIHS-ERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------SETSNMKTMY--- 281
                 H     I+HRD+K  N+L++ +   KL DFG+ +       S T  + T++   
Sbjct: 134 ------HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 282 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
            + L G++ Y          ST  D++S G I  E++TG KP+
Sbjct: 188 PDVLMGSKKY----------STSVDIWSIGCIFAEMITG-KPL 219

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 14  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 73
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 74  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 118
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 119 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 169
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229
Query: 339 QEV 341
           Q V
Sbjct: 230 QRV 232

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 29  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 88
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 89  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 133
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 134 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 184
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244
Query: 339 QEV 341
           Q V
Sbjct: 245 QRV 247

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ P  +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 29  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 88
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 89  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 133
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 134 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 184
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244
Query: 339 QEV 341
           Q V
Sbjct: 245 QRV 247

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+++D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 18/167 (10%)
Query: 173 SQCKHVNLLRLLGLCNNI---MNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 112 SQCPHI--VRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQA-FTEREASEIXK 168
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 284
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 169 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 224
Query: 285 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 330
            T    Y+ PE +  +   K+ D +S GVI   LL G  P   N+ +
Sbjct: 225 YTPY--YVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGL 269

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 29  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 88
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 89  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 133
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 134 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 184
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244
Query: 339 QEV 341
           Q V
Sbjct: 245 QRV 247

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 115 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           ++LG+G FG+V    Y  L +  G  +AVK L+                      F+ E+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-------------FQREI 59
Query: 170 QTLSQCKHVNLLRLLGLCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           Q L       +++  G+          +V EY+ +G L D L R      LD+++    +
Sbjct: 60  QILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYS 117
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
             + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+        +  E   
Sbjct: 118 SQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQ 175
Query: 287 GTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 319
               +  PE++   I S ++DV+S+GV+L EL T
Sbjct: 176 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 14  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 73
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 74  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 118
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 119 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 169
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229
Query: 339 QEV 341
           Q V
Sbjct: 230 QRV 232

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 14  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 73
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 74  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 118
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 119 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 169
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229
Query: 339 QEV 341
           Q V
Sbjct: 230 QRV 232

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 41  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 100
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 101 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 145
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 146 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 196
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 256
Query: 339 QEV 341
           Q V
Sbjct: 257 QRV 259

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 69  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 113
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 114 ---SFFWQVLEAVRHCHNXG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 164
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 224
Query: 339 QEV 341
           Q V
Sbjct: 225 QRV 227

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 48  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 108 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 152
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 153 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 203
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 204 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 263
Query: 339 QEV 341
           Q V
Sbjct: 264 QRV 266

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 12  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 71
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 72  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 116
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 117 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 167
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 168 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 227
Query: 339 QEV 341
           Q V
Sbjct: 228 QRV 230

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 110/243 (45%), Gaps = 48/243 (19%)
Query: 110 YPRR----GNKLGEGQFG-----TVYYGKLKNG-MEIAVKTLEXXXXXXXXXXXXTEAAM 159
           +PR+    G  LGEG+FG     T ++ K + G   +AVK L+            + + +
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---------SPSEL 70
Query: 160 IPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPP-- 216
             +L   +E   L Q  H ++++L G C+     + + EY   GSL   L       P  
Sbjct: 71  RDLL---SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 217 -----------LDSNKRYSIALG--------VAEALHYLHSLSKPIIHRDVKSANVLLDE 257
                      LD     ++ +G        +++ + YL  +   ++HRD+ + N+L+ E
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAE 185
Query: 258 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLE 316
               K+ DFG+ +     +     ++     + +M  E++   I +T++DV+S+GV+L E
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK-WMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 317 LLT 319
           ++T
Sbjct: 245 IVT 247

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 69  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 113
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 114 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 164
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 224
Query: 339 QEV 341
           Q V
Sbjct: 225 QRV 227

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 61  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 120
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 121 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 165
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 166 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 216
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 217 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 276
Query: 339 QEV 341
           Q V
Sbjct: 277 QRV 279

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 36  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 95
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 96  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 140
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 141 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 191
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 192 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 251
Query: 339 QEV 341
           Q V
Sbjct: 252 QRV 254

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 101/252 (40%), Gaps = 57/252 (22%)
Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G VY G+ +K G   A+K ++                       E E++     
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------------------EEEIK----- 68
Query: 176 KHVNLLRLLGLCNNIMN-----------------CIVYEYMCNGSLYDRLARVNNTPPLD 218
           + +N+L+      NI                    +V E+   GS+ D +         +
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG----N 124
Query: 219 SNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSN 276
           + K   IA    E L  L  L +  +IHRD+K  NVLL EN   KL DFG+  ++  T  
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184
Query: 277 MKTMYTENLTGTRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDDNNTI 330
            +  +     GT  +M PE + C          K+D++S G+  +E+  G  P+ D + +
Sbjct: 185 RRNTF----IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240
Query: 331 LYYYLVVEQEVP 342
              +L+     P
Sbjct: 241 RALFLIPRNPAP 252

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 20/105 (19%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTG 522
           +   L +LH     +IHRD+K  NVLL EN   KL DFG+  ++  T   +  +     G
Sbjct: 138 ILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----IG 191
Query: 523 TRPYMPPEAMHCQ------ISTKTDVFSYGAQIKTQHITNVDIAD 561
           T  +M PE + C          K+D++S G       IT +++A+
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLG-------ITAIEMAE 229

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 56  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 115
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 116 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 160
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 161 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 211
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271
Query: 339 QEV 341
           Q V
Sbjct: 272 QRV 274

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           K+GEG +GTV+  K +   EI    L+            + A          E+  L + 
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIV--ALKRVRLDDDDEGVPSSAL--------REICLLKEL 58
Query: 176 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           KH N++RL  + ++     +V+E+ C+  L       N    LD     S    + + L 
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEF-CDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLG 115
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           + HS  + ++HRD+K  N+L++ N   KL DFG+ +      ++    E +T    Y PP
Sbjct: 116 FCHS--RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-VRCYSAEVVTLW--YRPP 170
Query: 295 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTI 330
           + +      ST  D++S G I  EL    +P+   N +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDV 208

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 56  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 115
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 116 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 160
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 161 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 211
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271
Query: 339 QEV 341
           Q V
Sbjct: 272 QRV 274

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 18/167 (10%)
Query: 173 SQCKHVNLLRLLGLCNNI---MNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 66  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 122
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 284
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K + + N  T     
Sbjct: 123 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT----E 176
Query: 285 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 330
              T  Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 177 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 17/171 (9%)
Query: 168 EVQTLSQCKHVNLLR-------LLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
           E+Q + +  H N++        L  L  N +  +  EY   G L   L +  N   L   
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 122
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNM 277
              ++   ++ AL YLH     IIHRD+K  N++L    +  + K+ D G  K  +   +
Sbjct: 123 PIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 180
Query: 278 KTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDN 327
            T +     GT  Y+ PE +  +  T T D +S+G +  E +TG +P   N
Sbjct: 181 CTEFV----GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 227

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 17/171 (9%)
Query: 168 EVQTLSQCKHVNLLR-------LLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
           E+Q + +  H N++        L  L  N +  +  EY   G L   L +  N   L   
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNM 277
              ++   ++ AL YLH     IIHRD+K  N++L    +  + K+ D G  K  +   +
Sbjct: 122 PIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 278 KTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDN 327
            T +     GT  Y+ PE +  +  T T D +S+G +  E +TG +P   N
Sbjct: 180 CTEFV----GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 42  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 101
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 102 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 146
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 147 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 197
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 339 QEV 341
           Q V
Sbjct: 258 QRV 260

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 41  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 100
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 101 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 145
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 146 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 196
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 256
Query: 339 QEV 341
           Q V
Sbjct: 257 QRV 259

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 42  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 101
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 102 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 146
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 147 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 197
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 339 QEV 341
           Q V
Sbjct: 258 QRV 260

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/173 (32%), Positives = 83/173 (47%), Gaps = 25/173 (14%)
Query: 165 FENEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSL-YDRLARVNNTPPLDSNKR 222
            + E       KH +++ LL    ++ M  +V+E+M    L ++ + R       D+   
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA------DAGFV 126
Query: 223 YSIALG------VAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGI-VKMS 272
           YS A+       + EAL Y H     IIHRDVK  NVLL   EN  P KLGDFG+ +++ 
Sbjct: 127 YSEAVASHYMRQILEALRYCHD--NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG 184
Query: 273 ETSNMKTMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI 324
           E+     +      GT  +M PE +  +   K  DV+  GVIL  LL+G  P 
Sbjct: 185 ESG----LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 46/88 (52%), Gaps = 11/88 (12%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGI-VKMSETSNVKTMYTEN 519
           + EAL Y H     IIHRDVK  NVLL   EN  P KLGDFG+ +++ E+  V       
Sbjct: 139 ILEALRYCHD--NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAG----G 192
Query: 520 LTGTRPYMPPEAMHCQISTK-TDVFSYG 546
             GT  +M PE +  +   K  DV+  G
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCG 220

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 42  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 101
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 102 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 146
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 147 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 197
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 339 QEV 341
           Q V
Sbjct: 258 QRV 260

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 41  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 100
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 101 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 145
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 146 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 196
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 256
Query: 339 QEV 341
           Q V
Sbjct: 257 QRV 259

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 41  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 100
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 101 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 145
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 146 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 196
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 256
Query: 339 QEV 341
           Q V
Sbjct: 257 QRV 259

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 42  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 101
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 102 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 146
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 147 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 197
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 339 QEV 341
           Q V
Sbjct: 258 QRV 260

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/320 (22%), Positives = 134/320 (41%), Gaps = 45/320 (14%)
Query: 117 LGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +GEG +G V   + K+ G  +A+K                + AM        E++ L Q 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKF----LESDDDKMVKKIAM-------REIKLLKQL 81
Query: 176 KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H NL+ LL +C       +V+E++ + ++ D L    N   LD          +   + 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNG--LDYQVVQKYLFQIINGIG 138
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           + HS +  IIHRD+K  N+L+ ++ V KL DFG  +   T        ++   TR Y  P
Sbjct: 139 FCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFAR---TLAAPGEVYDDEVATRWYRAP 193
Query: 295 EAM--HCQISTKTDVFSYGVILLELLTG--MKPIDDNNTILYYYLV-------------- 336
           E +    +     DV++ G ++ E+  G  + P D +   LY+ ++              
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253
Query: 337 ---VEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMF 393
              V   V + E+ ++E  E     +  ++  + +KC   + DKR       +LL    F
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF---CAELLHHDFF 310
Query: 394 VCNSLANLYVGKVSSRTQEN 413
             +  A  +  ++  + Q++
Sbjct: 311 QMDGFAERFSQELQLKVQKD 330

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 172 LSQCKHVNLLRL-LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L       L++L     +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 291 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
            + PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 39/243 (16%)
Query: 114 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 173 SQCKHVNLLRLLGLCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 220
           S      ++RLL       + ++           ++++   G+L + LAR          
Sbjct: 69  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 113
Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 114 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 164
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 224
Query: 339 QEV 341
           Q V
Sbjct: 225 QRV 227

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 115 NKLGEGQFGTVYYG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 172
           + LG G FG V+    K KN  E+ VK ++             +   + +     E+  L
Sbjct: 30  SPLGSGAFGFVWTAVDKEKN-KEVVVKFIKKEKVLEDCWIEDPKLGKVTL-----EIAIL 83
Query: 173 SQCKHVNLLRLLGLCNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           S+ +H N++++L +  N      ++ ++   GS  D  A ++  P LD      I   + 
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKH---GSGLDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
            A+ YL    K IIHRD+K  N+++ E+F  KL DFG     E    K  YT    GT  
Sbjct: 141 SAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYT--FCGTIE 194
Query: 291 YMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPI 324
           Y  PE +        + +++S GV L  L+    P 
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 42/90 (46%), Gaps = 6/90 (6%)
Query: 443 LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 502
            A ++  P LD      I   +  A+ YL    K IIHRD+K  N+++ E+F  KL DFG
Sbjct: 118 FAFIDRHPRLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFG 175
Query: 503 IVKMSETSNVKTMYTENLTGTRPYMPPEAM 532
                E    K  YT    GT  Y  PE +
Sbjct: 176 SAAYLERG--KLFYT--FCGTIEYCAPEVL 201

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 18/169 (10%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
            V EY+  G L   + R    P  + + R+  A  ++ AL+YLH   + II+RD+K  NV
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNYLHE--RGIIYRDLKLDNV 184
Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGV 312
           LLD     KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV
Sbjct: 185 LLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 241
Query: 313 ILLELLTGMKPID--------DNNTILYYYLVV-EQEVPVREVLDKEAG 352
           ++ E++ G  P D        D NT  Y + V+ E+++ +   L  +A 
Sbjct: 242 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 290

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 19/226 (8%)
Query: 112 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           R G  LG+G FGTV+ G +L + +++A+K +             +    + + L     +
Sbjct: 34  RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL---WK 90
Query: 171 TLSQCKHVNLLRLLGL--CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
             +   H  ++RLL           ++   +    L+D    +    PL           
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDY---ITEKGPLGEGPSRCFFGQ 147
Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
           V  A+ + HS  + ++HRD+K  N+L+D      KL DFG    S        YT +  G
Sbjct: 148 VVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFG----SGALLHDEPYT-DFDG 200
Query: 288 TRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTIL 331
           TR Y PPE +  H   +    V+S G++L +++ G  P + +  IL
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL 246

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 71/153 (46%), Gaps = 17/153 (11%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
            V EY+  G L   + R    P  + + R+  A  ++ AL+YLH   + II+RD+K  NV
Sbjct: 98  FVIEYVNGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNYLHE--RGIIYRDLKLDNV 152
Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGV 312
           LLD     KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV
Sbjct: 153 LLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNYIAPEILRGEDYGFSVDWWALGV 209
Query: 313 ILLELLTGMKPID--------DNNTILYYYLVV 337
           ++ E++ G  P D        D NT  Y + V+
Sbjct: 210 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 242

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 18/169 (10%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
            V EY+  G L   + R    P  + + R+  A  ++ AL+YLH   + II+RD+K  NV
Sbjct: 83  FVIEYVNGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNYLHE--RGIIYRDLKLDNV 137
Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGV 312
           LLD     KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV
Sbjct: 138 LLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNYIAPEILRGEDYGFSVDWWALGV 194
Query: 313 ILLELLTGMKPID--------DNNTILYYYLVV-EQEVPVREVLDKEAG 352
           ++ E++ G  P D        D NT  Y + V+ E+++ +   L  +A 
Sbjct: 195 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 243

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 107/223 (47%), Gaps = 35/223 (15%)
Query: 117 LGEGQFGTVYY-GKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           LG G+FG V+   +   G+++A K ++                M      +NE+  ++Q 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTR-------------GMKDKEEVKNEISVMNQL 143
Query: 176 KHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            H NL++L       N+I+  +V EY+  G L+DR+  ++ +  L           + E 
Sbjct: 144 DHANLIQLYDAFESKNDIV--LVMEYVDGGELFDRI--IDESYNLTELDTILFMKQICEG 199
Query: 233 LHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSE-TSNMKTMYTENLTGT 288
           + ++H +   I+H D+K  N+L    D   + K+ DFG+ +  +    +K  +     GT
Sbjct: 200 IRHMHQMY--ILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNF-----GT 251
Query: 289 RPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP-IDDNNT 329
             ++ PE ++   +S  TD++S GVI   LL+G+ P + DN+ 
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 18/169 (10%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
            V EY+  G L   + R    P  + + R+  A  ++ AL+YLH   + II+RD+K  NV
Sbjct: 87  FVIEYVNGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNYLHE--RGIIYRDLKLDNV 141
Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGV 312
           LLD     KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV
Sbjct: 142 LLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNYIAPEILRGEDYGFSVDWWALGV 198
Query: 313 ILLELLTGMKPID--------DNNTILYYYLVV-EQEVPVREVLDKEAG 352
           ++ E++ G  P D        D NT  Y + V+ E+++ +   L  +A 
Sbjct: 199 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 247

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 83
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGY----VATRWYRA 195
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 303

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 118/286 (41%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 85
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T++  T Y      TR Y  
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGY----VATRWYRA 197
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 303

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 296

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 37/231 (16%)
Query: 114 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 167
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL------- 84
Query: 168 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
               +    H+N++ LLG C      +M  + +    N S Y R  R    P  D  K +
Sbjct: 85  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF 140
Query: 224 -------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 276
                    +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +      
Sbjct: 141 LTLEHLIXYSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR---DIY 195
Query: 277 MKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
               Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 196 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG-VAEALHYLHSLSKPIIHRDVKSAN 252
           ++ +Y+  G L+  L++        +     I +G +  AL +LH L   II+RD+K  N
Sbjct: 136 LILDYINGGELFTHLSQRERF----TEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLEN 189
Query: 253 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS---TKTDVFS 309
           +LLD N    L DFG+ K       +  Y  +  GT  YM P+ +    S      D +S
Sbjct: 190 ILLDSNGHVVLTDFGLSKEFVADETERAY--DFCGTIEYMAPDIVRGGDSGHDKAVDWWS 247
Query: 310 YGVILLELLTGMKPI 324
            GV++ ELLTG  P 
Sbjct: 248 LGVLMYELLTGASPF 262

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 118/286 (41%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +  +  L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 296

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 118/286 (41%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 85
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T++  T Y      TR Y  
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGY----VATRWYRA 197
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 303

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 89
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGY----VATRWYRA 201
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 261
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 262 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 307

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 83
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGY----VATRWYRA 195
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 301

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 20/210 (9%)
Query: 113 RGNKLGEGQFG-TVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           R  K+GEG FG  +     ++G +  +K +                          EV  
Sbjct: 28  RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-----------RREVAV 76
Query: 172 LSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L+  KH N+++       N    IV +Y   G L+ R+           ++     + + 
Sbjct: 77  LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQIC 135
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
            AL ++H   + I+HRD+KS N+ L ++   +LGDFGI ++    N          GT  
Sbjct: 136 LALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARV---LNSTVELARACIGTPY 190
Query: 291 YMPPEAMHCQ-ISTKTDVFSYGVILLELLT 319
           Y+ PE    +  + K+D+++ G +L EL T
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCT 220

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 44/81 (54%), Gaps = 6/81 (7%)
Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           AL ++H   + I+HRD+KS N+ L ++   +LGDFGI ++    N          GT  Y
Sbjct: 137 ALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARV---LNSTVELARACIGTPYY 191
Query: 527 MPPEAMHCQ-ISTKTDVFSYG 546
           + PE    +  + K+D+++ G
Sbjct: 192 LSPEICENKPYNNKSDIWALG 212

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 118/286 (41%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 85
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T++  T Y      TR Y  
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGY----VATRWYRA 197
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 303

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 59/110 (53%), Gaps = 10/110 (9%)
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
           IA+ + +AL +LHS    +IHRDVK +NVL++     K+ DFGI         K +    
Sbjct: 114 IAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--- 169
Query: 285 LTGTRPYMPPEAMHCQI-----STKTDVFSYGVILLELLTGMKPIDDNNT 329
             G +PYM PE ++ ++     S K+D++S G+ ++EL     P D   T
Sbjct: 170 -AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           IA+ + +AL +LHS    +IHRDVK +NVL++     K+ DFGI        V  +  + 
Sbjct: 114 IAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGI----SGYLVDDVAKDI 168
Query: 520 LTGTRPYMPPEAMHCQI-----STKTDVFSYG 546
             G +PYM PE ++ ++     S K+D++S G
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLG 200

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 63/142 (44%), Gaps = 13/142 (9%)
Query: 199 MCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 258
           +C G L + L ++ +  PL  +    I      A+ ++H    PIIHRD+K  N+LL   
Sbjct: 115 LCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ 174
Query: 259 FVPKLGDFGIVKM-------SETSNMKTMYTENLT-GTRP-YMPPEAM----HCQISTKT 305
              KL DFG           S ++  + +  E +T  T P Y  PE +    +  I  K 
Sbjct: 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234
Query: 306 DVFSYGVILLELLTGMKPIDDN 327
           D+++ G IL  L     P +D 
Sbjct: 235 DIWALGCILYLLCFRQHPFEDG 256

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 84
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 196
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 302

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/110 (36%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 221 KRYSIALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 277
           K  ++ L + E   AL YL +  + IIHRD+K  N+LLDE+    + DF I  M      
Sbjct: 113 KEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 278 KTMYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKP 323
            T     + GT+PYM PE    +     S   D +S GV   ELL G +P
Sbjct: 171 IT----TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 58/119 (48%), Gaps = 14/119 (11%)
Query: 456 KRYSIALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM-SETSN 511
           K  ++ L + E   AL YL +  + IIHRD+K  N+LLDE+    + DF I  M    + 
Sbjct: 113 KEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQT 570
           + TM      GT+PYM PE      S K   +S+     +  +T  ++    R Y +++
Sbjct: 171 ITTM-----AGTKPYMAPEMFS---SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 80
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGY----VATRWYRA 192
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 298

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 80
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 192
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 298

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 97
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 209
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 269
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 270 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 317

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 84
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGY----VATRWYRA 196
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 302

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 119/288 (41%), Gaps = 47/288 (16%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PE----AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLD 348
           PE    AMH   +   D++S G I+ ELLTG       + I    L++     P  E+L 
Sbjct: 191 PEIMLNAMH--YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 349 KEAGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           K + E    ++++L            IG       + EK  V + DKR
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 296

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 83
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 195
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 303

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 90
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 202
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 308

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 90
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 202
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 308

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 80
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 192
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 298

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQ-----------SIIHAKRTYRELRLLKHM 90
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 202
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 308

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 83
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 195
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 303

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 18/165 (10%)
Query: 177 HVNLLRLLGLCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPP-LDSNKRYSIALGVA 230
           H N+LRL+  C           ++  +   G+L++ + R+ +    L  ++   + LG+ 
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS---ETSNMKTMYTENLTG 287
             L  +H+  K   HRD+K  N+LL +   P L D G +  +      + + +  ++   
Sbjct: 145 RGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 288 TR---PYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPID 325
            R    Y  PE      HC I  +TDV+S G +L  ++ G  P D
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 84
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 196
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 304

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 98
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 210
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 271 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 318

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 77
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 78  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 137
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 138 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 189
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 249
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 250 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 297

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 89
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 201
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 261
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 262 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 309

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 41/220 (18%)
Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G FG V+  K + +G    +K ++             E A       E EV+ L++ 
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYN----------NEKA-------EREVKALAKL 61
Query: 176 KHVNLLRLLGLCNNI---------------MNCIVYEY-MCNGSLYDRLARVNNTPPLDS 219
            HVN++   G  +                   C+  +   C+    ++         LD 
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
                +   + + + Y+HS  K +I+RD+K +N+ L +    K+GDFG+V    TS    
Sbjct: 122 VLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLV----TSLKND 175
Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELL 318
                  GT  YM PE +  Q    + D+++ G+IL ELL
Sbjct: 176 GKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 7/84 (8%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           + + + Y+HS  K +I+RD+K +N+ L +    K+GDFG+V    TS           GT
Sbjct: 131 ITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLV----TSLKNDGKRXRSKGT 184
Query: 524 RPYMPPEAMHCQ-ISTKTDVFSYG 546
             YM PE +  Q    + D+++ G
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALG 208

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 80
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 192
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 300

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 58/105 (55%), Gaps = 4/105 (3%)
Query: 216 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 275
           P+      S +  VA  + +L S  +  IHRD+ + N+LL EN V K+ DFG+ +     
Sbjct: 195 PITMEDLISYSFQVARGMEFLSS--RKCIHRDLAARNILLSENNVVKICDFGLAR-DIYK 251
Query: 276 NMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 319
           N   +   +      +M PE++  +I STK+DV+SYGV+L E+ +
Sbjct: 252 NPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           P+      S +  VA  + +L S  +  IHRD+ + N+LL EN V K+ DFG+ +     
Sbjct: 195 PITMEDLISYSFQVARGMEFLSS--RKCIHRDLAARNILLSENNVVKICDFGLAR-DIYK 251
Query: 511 NVKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYG 546
           N   +   +      +M PE++  +I STK+DV+SYG
Sbjct: 252 NPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYG 288

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/137 (33%), Positives = 68/137 (49%), Gaps = 15/137 (10%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V EYM  G L + ++  N   P    + Y+    V  AL  +HS+    IHRDVK  N+
Sbjct: 151 MVMEYMPGGDLVNLMS--NYDVPEKWARFYTAE--VVLALDAIHSMG--FIHRDVKPDNM 204
Query: 254 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 307
           LLD++   KL DFG  +KM++   ++    +   GT  Y+ PE +  Q        + D 
Sbjct: 205 LLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDW 261
Query: 308 FSYGVILLELLTGMKPI 324
           +S GV L E+L G  P 
Sbjct: 262 WSVGVFLYEMLVGDTPF 278

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/73 (39%), Positives = 41/73 (56%), Gaps = 6/73 (8%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTG 522
           V  AL  +HS+    IHRDVK  N+LLD++   KL DFG  +KM++   V+    +   G
Sbjct: 182 VVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVG 236
Query: 523 TRPYMPPEAMHCQ 535
           T  Y+ PE +  Q
Sbjct: 237 TPDYISPEVLKSQ 249

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 85
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 197
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 303

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/137 (33%), Positives = 68/137 (49%), Gaps = 15/137 (10%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V EYM  G L + ++  N   P    + Y+    V  AL  +HS+    IHRDVK  N+
Sbjct: 146 MVMEYMPGGDLVNLMS--NYDVPEKWARFYTAE--VVLALDAIHSMG--FIHRDVKPDNM 199
Query: 254 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 307
           LLD++   KL DFG  +KM++   ++    +   GT  Y+ PE +  Q        + D 
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDW 256
Query: 308 FSYGVILLELLTGMKPI 324
           +S GV L E+L G  P 
Sbjct: 257 WSVGVFLYEMLVGDTPF 273

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/73 (39%), Positives = 41/73 (56%), Gaps = 6/73 (8%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTG 522
           V  AL  +HS+    IHRDVK  N+LLD++   KL DFG  +KM++   V+    +   G
Sbjct: 177 VVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVG 231
Query: 523 TRPYMPPEAMHCQ 535
           T  Y+ PE +  Q
Sbjct: 232 TPDYISPEVLKSQ 244

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 74
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 186
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 37/231 (16%)
Query: 114 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 167
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL------- 84
Query: 168 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
               +    H+N++ LLG C      +M  + +    N S Y R  R    P  D  K +
Sbjct: 85  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF 140
Query: 224 -------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 276
                    +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +      
Sbjct: 141 LTLEHLICYSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLAR---DIY 195
Query: 277 MKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
               Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 196 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 76
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 77  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 136
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 137 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 188
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 248
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 249 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 296

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 28/218 (12%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KL E   G ++ G+ + G +I VK L+                      F  E   L   
Sbjct: 17  KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRD-----------FNEECPRLRIF 64
Query: 176 KHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            H N+L +LG C +       ++  +M  GSLY+ L    N   +D ++    AL +A  
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARG 123
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + +LH+L   I    + S +V++DE+   ++     VK S  S  + MY         ++
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARIS-MADVKFSFQSPGR-MYAPA------WV 175
Query: 293 PPEAMHCQIS----TKTDVFSYGVILLELLTGMKPIDD 326
            PEA+  +         D++S+ V+L EL+T   P  D
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/137 (33%), Positives = 68/137 (49%), Gaps = 15/137 (10%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V EYM  G L + ++  N   P    + Y+    V  AL  +HS+    IHRDVK  N+
Sbjct: 151 MVMEYMPGGDLVNLMS--NYDVPEKWARFYTAE--VVLALDAIHSMG--FIHRDVKPDNM 204
Query: 254 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 307
           LLD++   KL DFG  +KM++   ++    +   GT  Y+ PE +  Q        + D 
Sbjct: 205 LLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDW 261
Query: 308 FSYGVILLELLTGMKPI 324
           +S GV L E+L G  P 
Sbjct: 262 WSVGVFLYEMLVGDTPF 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/73 (39%), Positives = 41/73 (56%), Gaps = 6/73 (8%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTG 522
           V  AL  +HS+    IHRDVK  N+LLD++   KL DFG  +KM++   V+    +   G
Sbjct: 182 VVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVG 236
Query: 523 TRPYMPPEAMHCQ 535
           T  Y+ PE +  Q
Sbjct: 237 TPDYISPEVLKSQ 249

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 75
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 187
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 247
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 295

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 101
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 161
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 213
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 273
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 274 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 321

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 75
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 187
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 247
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 295

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 112/257 (43%), Gaps = 35/257 (13%)
Query: 117 LGEGQFGTV---YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +G G +G+V   Y  +L+   ++AVK L                ++I       E++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQ-----------SLIHARRTYRELRLLK 82
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
             KH N++ LL +     +   +   Y+    +   L  +  +  L       +   +  
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLR 142
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---T 288
            L Y+HS    IIHRD+K +NV ++E+   ++ DFG+ + ++         E +TG   T
Sbjct: 143 GLKYIHSAG--IIHRDLKPSNVAVNEDSELRILDFGLARQAD---------EEMTGYVAT 191
Query: 289 RPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE 345
           R Y  PE M      +   D++S G I+ ELL G      ++ I     ++E    P  E
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 251
Query: 346 VLDKEAGEWNETHVETL 362
           VL K + E   T++++L
Sbjct: 252 VLAKISSEHARTYIQSL 268

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 75/171 (43%), Gaps = 16/171 (9%)
Query: 164 LFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKR 222
           +   E+  L +  H N+++L  +        +V E +  G L+DR+         D+   
Sbjct: 94  IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA 153
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMK 278
               L   EA+ YLH     I+HRD+K  N LL     P    K+ DFG+ K+ E     
Sbjct: 154 VKQIL---EAVAYLHE--NGIVHRDLKPEN-LLYATPAPDAPLKIADFGLSKIVE----H 203
Query: 279 TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNN 328
            +  + + GT  Y  PE +  C    + D++S G+I   LL G +P  D  
Sbjct: 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 7/91 (7%)
Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           + + + Y+HS  K +IHRD+K +N+ L +    K+GDFG+V   +    +T       GT
Sbjct: 145 ITKGVDYIHS--KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS----KGT 198
Query: 289 RPYMPPEAMHCQ-ISTKTDVFSYGVILLELL 318
             YM PE +  Q    + D+++ G+IL ELL
Sbjct: 199 LRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 7/84 (8%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           + + + Y+HS  K +IHRD+K +N+ L +    K+GDFG+V   +    +T       GT
Sbjct: 145 ITKGVDYIHS--KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS----KGT 198
Query: 524 RPYMPPEAMHCQ-ISTKTDVFSYG 546
             YM PE +  Q    + D+++ G
Sbjct: 199 LRYMSPEQISSQDYGKEVDLYALG 222

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V     +K+G++IAVK L                ++I       E++ L   
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 107
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 108 KHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 167
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 168 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 219
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTG 320
           PE M      +   D++S G I+ ELLTG
Sbjct: 220 PEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 114 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 167
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL------- 86
Query: 168 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP--PLDSNK 221
               +    H+N++ LLG C      +M  + +    N S Y R  R    P  P D  K
Sbjct: 87  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYK 142
Query: 222 RY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 274
            +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +    
Sbjct: 143 DFLTLEHLIXYSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLAR-DIX 199
Query: 275 SNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
            +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G FG V   KLKN  ++ A+K L              + A       E +V      
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEML--------KRAETACFREERDVLVNGDS 133
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA-EALH 234
           K +  L      +N +  +V +Y   G L   L++  +  P +  + Y   + +A +++H
Sbjct: 134 KWITTLHYAFQDDNNLY-LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMP 293
            LH      +HRD+K  N+L+D N   +L DFG  +K+ E   +++       GT  Y+ 
Sbjct: 193 QLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA---VGTPDYIS 244
Query: 294 PEAMHC------QISTKTDVFSYGVILLELLTGMKPI 324
           PE +        +   + D +S GV + E+L G  P 
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           K+GEG +GTV+  K +   EI    L+            + A          E+  L + 
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIV--ALKRVRLDDDDEGVPSSAL--------REICLLKEL 58
Query: 176 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           KH N++RL  + ++     +V+E+ C+  L       N    LD     S    + + L 
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEF-CDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLG 115
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           + HS  + ++HRD+K  N+L++ N   KL +FG+ +      ++    E +T    Y PP
Sbjct: 116 FCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLW--YRPP 170
Query: 295 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTI 330
           + +      ST  D++S G I  EL    +P+   N +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 120/291 (41%), Gaps = 49/291 (16%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---TRP 290
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++         + +TG   TR 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD---------DEMTGXVATRW 187
Query: 291 YMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVL 347
           Y  PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 348 DKEAGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
            K + E    ++++L            IG       + EK  V + DKR +
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 84
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 196
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 257 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 302

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 50/232 (21%)
Query: 117 LGEGQFGTVYYGKLKNGME---IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           LG+G FG V   K +N ++    A+K +             TE  +  IL   +EV  L+
Sbjct: 14  LGQGAFGQVV--KARNALDSRYYAIKKIRH-----------TEEKLSTIL---SEVXLLA 57
Query: 174 QCKHVNLLRLLGLCNNIMNC--------------IVYEYMCNGSLYDRLARVNNTPPLDS 219
              H  ++R         N               I  EY  N +LYD +   N     D 
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE 117
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 278
             R  +   + EAL Y+HS  + IIHR++K  N+ +DE+   K+GDFG+ K +  + ++ 
Sbjct: 118 YWR--LFRQILEALSYIHS--QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 279 TMYTENL----------TGTRPYMPPEAMH--CQISTKTDVFSYGVILLELL 318
            + ++NL           GT  Y+  E +      + K D +S G+I  E +
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 23/61 (37%), Positives = 41/61 (67%), Gaps = 3/61 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTG 522
           + EAL Y+HS  + IIHR++K  N+ +DE+   K+GDFG+ K +  + ++  + ++NL G
Sbjct: 125 ILEALSYIHS--QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 523 T 523
           +
Sbjct: 183 S 183

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 101
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 161
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++              TR Y  
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MXGYVATRWYRA 213
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 273
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 274 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 319

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 36/232 (15%)
Query: 114 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 167
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 85
Query: 168 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP---PLDSN 220
               +    H+N++ LLG C      +M  + +    N S Y R  R    P   P D  
Sbjct: 86  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLY 141
Query: 221 KRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 273
           K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +   
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DI 198
Query: 274 TSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
             +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 199 XKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 74
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGL 134
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 186
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 296

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 97
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 209
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 269
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 270 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 315

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 111/257 (43%), Gaps = 35/257 (13%)
Query: 117 LGEGQFGTV---YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +G G +G+V   Y  +L+   ++AVK L                ++I       E++ L 
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQ-----------SLIHARRTYRELRLLK 74
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
             KH N++ LL +     +   +   Y+    +   L  +     L       +   +  
Sbjct: 75  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLR 134
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---T 288
            L Y+HS    IIHRD+K +NV ++E+   ++ DFG+ + ++         E +TG   T
Sbjct: 135 GLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQAD---------EEMTGYVAT 183
Query: 289 RPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE 345
           R Y  PE M      +   D++S G I+ ELL G      ++ I     ++E    P  E
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 243
Query: 346 VLDKEAGEWNETHVETL 362
           VL K + E   T++++L
Sbjct: 244 VLAKISSEHARTYIQSL 260

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 118/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ D+G+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 98
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 210
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 271 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 316

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 66/136 (48%), Gaps = 9/136 (6%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           ++ EY+  G L+ +L R      ++    + +A  ++ AL +LH   K II+RD+K  N+
Sbjct: 98  LILEYLSGGELFMQLEREGIF--MEDTACFYLA-EISMALGHLHQ--KGIIYRDLKPENI 152
Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGV 312
           +L+     KL DFG+ K S         T    GT  YM PE  M    +   D +S G 
Sbjct: 153 MLNHQGHVKLTDFGLCKESIHDG---TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGA 209
Query: 313 ILLELLTGMKPIDDNN 328
           ++ ++LTG  P    N
Sbjct: 210 LMYDMLTGAPPFTGEN 225

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 114 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 167
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 75
Query: 168 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 219
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 76  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 220 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-D 188
Query: 273 ETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
              +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 222
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 71  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 126
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 127 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFL 184
Query: 283 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 133 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVAT 190
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 237
Query: 582 S 582
           +
Sbjct: 238 N 238

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 111/257 (43%), Gaps = 35/257 (13%)
Query: 117 LGEGQFGTV---YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           +G G +G+V   Y  +L+   ++AVK L                ++I       E++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQ-----------SLIHARRTYRELRLLK 82
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
             KH N++ LL +     +   +   Y+    +   L  +     L       +   +  
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLR 142
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---T 288
            L Y+HS    IIHRD+K +NV ++E+   ++ DFG+ + ++         E +TG   T
Sbjct: 143 GLKYIHSAG--IIHRDLKPSNVAVNEDSELRILDFGLARQAD---------EEMTGYVAT 191
Query: 289 RPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE 345
           R Y  PE M      +   D++S G I+ ELL G      ++ I     ++E    P  E
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 251
Query: 346 VLDKEAGEWNETHVETL 362
           VL K + E   T++++L
Sbjct: 252 VLAKISSEHARTYIQSL 268

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++              TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MAGFVATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 296

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++              TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MAGFVATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 296

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 88
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 89  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 148
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 149 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 200
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 260
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 261 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 306

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 31/225 (13%)
Query: 111 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 166
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYXQRTL------------ 73
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 221
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 74  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 129
Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 281
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 130 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 187
Query: 282 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 137 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 241
Query: 582 S 582
           +
Sbjct: 242 N 242

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 74
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 186
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 66/136 (48%), Gaps = 9/136 (6%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           ++ EY+  G L+ +L R      ++    + +A  ++ AL +LH   K II+RD+K  N+
Sbjct: 98  LILEYLSGGELFMQLEREGIF--MEDTACFYLA-EISMALGHLHQ--KGIIYRDLKPENI 152
Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGV 312
           +L+     KL DFG+ K S         T    GT  YM PE  M    +   D +S G 
Sbjct: 153 MLNHQGHVKLTDFGLCKESIHDG---TVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGA 209
Query: 313 ILLELLTGMKPIDDNN 328
           ++ ++LTG  P    N
Sbjct: 210 LMYDMLTGAPPFTGEN 225

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 19/139 (13%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V E M  G L D++ R          +  ++   + + + YLH+  + ++HRD+K +N+
Sbjct: 93  VVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNI 147
Query: 254 L-LDENFVP---KLGDFGIVKMSETSN---MKTMYTENLTGTRPYMPPEAMHCQ-ISTKT 305
           L +DE+  P   ++ DFG  K     N   M   YT N      ++ PE +  Q      
Sbjct: 148 LYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN------FVAPEVLERQGYDAAC 201
Query: 306 DVFSYGVILLELLTGMKPI 324
           D++S GV+L  +LTG  P 
Sbjct: 202 DIWSLGVLLYTMLTGYTPF 220

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 114 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 167
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 84
Query: 168 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 219
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 85  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 220 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-D 197
Query: 273 ETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
              +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 198 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 74
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++              TR Y  
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MAGFVATRWYRA 186
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 41/235 (17%)
Query: 114 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 167
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 84
Query: 168 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 219
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 85  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 220 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 196
Query: 273 ETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
                   Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 197 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 41/235 (17%)
Query: 114 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 167
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 86
Query: 168 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 219
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 87  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDL 142
Query: 220 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 143 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 198
Query: 273 ETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
                   Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 199 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 222
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 71  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 126
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 127 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 184
Query: 283 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 133 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 237
Query: 582 S 582
           +
Sbjct: 238 N 238

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 222
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 71  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 126
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 127 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 184
Query: 283 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 133 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 237
Query: 582 S 582
           +
Sbjct: 238 N 238

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 111 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 166
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 73
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 221
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 74  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 129
Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 281
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 130 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 187
Query: 282 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 137 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 241
Query: 582 S 582
           +
Sbjct: 242 N 242

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL +LHS  + ++H DVK AN+ L      KLGDFG++    T+       E   G   Y
Sbjct: 169 ALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA----GEVQEGDPRY 222
Query: 292 MPPEAMHCQISTKTDVFSYGVILLELLTGMK 322
           M PE +     T  DVFS G+ +LE+   M+
Sbjct: 223 MAPELLQGSYGTAADVFSLGLTILEVACNME 253

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 41/83 (49%), Gaps = 6/83 (7%)
Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
           AL +LHS  + ++H DVK AN+ L      KLGDFG++    T+       E   G   Y
Sbjct: 169 ALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA----GEVQEGDPRY 222
Query: 527 MPPEAMHCQISTKTDVFSYGAQI 549
           M PE +     T  DVFS G  I
Sbjct: 223 MAPELLQGSYGTAADVFSLGLTI 245

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 114 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 167
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 84
Query: 168 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 219
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 85  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 220 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-D 197
Query: 273 ETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
              +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 198 IYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 41/235 (17%)
Query: 114 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 167
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 121
Query: 168 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 219
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 122 ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 177
Query: 220 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 178 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 233
Query: 273 ETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
                   Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 234 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 39/220 (17%)
Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFE--NEVQTLS 173
           LGEG +G V     K   EI A+K +E                  P+       E++ L 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--------------PLFALRTLREIKILK 64
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
             KH N++ +     NI     +E     Y+    +   L RV +T  L  +        
Sbjct: 65  HFKHENIITIF----NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--------SETSNMKTM 280
              A+  LH  +  +IHRD+K +N+L++ N   K+ DFG+ ++        SE +  ++ 
Sbjct: 121 TLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELL 318
            TE +  TR Y  PE M    + S   DV+S G IL EL 
Sbjct: 179 MTEXV-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 111 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 166
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 73
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 221
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 74  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 129
Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 281
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 130 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 282 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 188 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 137 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 241
Query: 582 S 582
           +
Sbjct: 242 N 242

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 111 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 166
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 28  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 74
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 221
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 75  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 130
Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 281
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 131 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 282 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 189 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 138 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 242
Query: 582 S 582
           +
Sbjct: 243 N 243

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 111 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 166
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 21  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 67
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 221
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 68  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 123
Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 281
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 124 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 282 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 131 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 235
Query: 582 S 582
           +
Sbjct: 236 N 236

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 163 LLFENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNK 221
           +L + E+  L+  +H N+L L     ++   + ++E++    +++R+    NT   + N+
Sbjct: 46  VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI----NTSAFELNE 101
Query: 222 R--YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
           R   S    V EAL +LHS    I H D++  N++       +     I++  +   +K 
Sbjct: 102 REIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTR---RSSTIKIIEFGQARQLKP 156
Query: 280 MYTENLTGTRP--YMPPEAMHCQISTKTDVFSYGVILLELLTGMKP 323
                L  T P  Y P    H  +ST TD++S G ++  LL+G+ P
Sbjct: 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 222
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 79  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 134
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 135 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 192
Query: 283 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 193 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 235

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 141 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 198
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 199 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 245
Query: 582 S 582
           +
Sbjct: 246 N 246

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 222
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 71  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 126
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 127 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 184
Query: 283 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 133 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 237
Query: 582 S 582
           +
Sbjct: 238 N 238

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 222
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 73  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 128
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 129 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 186
Query: 283 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 187 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 135 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 239
Query: 582 S 582
           +
Sbjct: 240 N 240

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 111 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 166
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 28  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 74
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 221
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 75  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 130
Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 281
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 131 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 282 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 189 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 232

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 138 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 242
Query: 582 S 582
           +
Sbjct: 243 N 243

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 111 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 166
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 29  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 75
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 221
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 76  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 131
Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 281
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 132 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 189
Query: 282 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 190 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 139 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 197 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 243
Query: 582 S 582
           +
Sbjct: 244 N 244

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 111 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 166
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 20  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 66
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 221
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 67  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 122
Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 281
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 123 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 180
Query: 282 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 181 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 224

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 130 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 188 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 234
Query: 582 S 582
           +
Sbjct: 235 N 235

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 111 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 166
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 73
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 221
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 74  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 129
Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 281
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 130 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 282 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 137 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 241
Query: 582 S 582
           +
Sbjct: 242 N 242

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 111 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 166
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 21  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 67
Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 221
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 68  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 123
Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 281
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 124 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 282 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 131 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 235
Query: 582 S 582
           +
Sbjct: 236 N 236

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 98
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++              TR Y  
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MXGXVATRWYRA 210
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 271 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 316

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 222
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 75  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 130
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 131 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 283 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 137 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 241
Query: 582 S 582
           +
Sbjct: 242 N 242

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 222
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 71  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 126
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 127 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 184
Query: 283 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 133 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 237
Query: 582 S 582
           +
Sbjct: 238 N 238

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 222
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 91  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 146
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 147 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 204
Query: 283 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 205 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 57/104 (54%), Gaps = 5/104 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 153 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERY 565
           R Y  PE M + +  TK+ D++S G  I  + ++N  I   + Y
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSNRPIFPGKHY 253

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 92/220 (41%), Gaps = 39/220 (17%)
Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFE--NEVQTLS 173
           LGEG +G V     K   EI A+K +E                  P+       E++ L 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--------------PLFALRTLREIKILK 64
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
             KH N++ +     NI     +E     Y+    +   L RV +T  L  +        
Sbjct: 65  HFKHENIITIF----NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--------SETSNMKTM 280
              A+  LH  +  +IHRD+K +N+L++ N   K+ DFG+ ++        SE +  ++ 
Sbjct: 121 TLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELL 318
            TE    TR Y  PE M    + S   DV+S G IL EL 
Sbjct: 179 MTE-YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 113/244 (46%), Gaps = 39/244 (15%)
Query: 114 GNKLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 169
           G  LG+G+FG+V   +LK    + +++AVK L+               A   I  F  E 
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-----------ASSDIEEFLREA 76
Query: 170 QTLSQCKHVNLLRLLGLCNNI-------MNCIVYEYMCNGSLYDRL--ARVNNTP---PL 217
             + +  H ++ +L+G+           +  ++  +M +G L+  L  +R+   P   PL
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 277
            +  R+ +   +A  + YL S  +  IHRD+ + N +L E+    + DFG+ +   + + 
Sbjct: 137 QTLVRFMV--DIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD- 191
Query: 278 KTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDD-NNTILY 332
              Y +      P  ++  E++   + T  +DV+++GV + E++T G  P     N  +Y
Sbjct: 192 --YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 333 YYLV 336
            YL+
Sbjct: 250 NYLI 253

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 222
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 91  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHI 146
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 147 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 204
Query: 283 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 205 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 57/104 (54%), Gaps = 5/104 (4%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 153 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERY 565
           R Y  PE M + +  TK+ D++S G  I  + ++N  I   + Y
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSNRPIFPGKHY 253

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 37/233 (15%)
Query: 114 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 167
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 75
Query: 168 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 219
               +    H+N++ LLG C      +M    +    N S Y R  R    P    P D 
Sbjct: 76  ----IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 220 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-D 188
Query: 273 ETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
              +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 137 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 289 RPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
           R Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 137 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 241
Query: 582 S 582
           +
Sbjct: 242 N 242

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+  FG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 123/296 (41%), Gaps = 55/296 (18%)
Query: 118 GEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENE----VQTL 172
           G+G FGTV  GK K+ GM +A+K +                  I    F N     +Q L
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKV------------------IQDPRFRNRELQIMQDL 73
Query: 173 SQCKHVNLLRL------LGLCN--NIMNCIVYEYM------CNGSLYDRLARVNNTPPLD 218
           +   H N+++L      LG  +  +I   +V EY+      C  + Y R       PP  
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQV----APPPI 129
Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNM 277
             K +   L    ++  LH  S  + HRD+K  NVL++E +   KL DFG  K    S  
Sbjct: 130 LIKVFLFQL--IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 278 KTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI--DDNNTILYY 333
              Y      +R Y  PE +  +   +T  D++S G I  E++ G +PI   DN+    +
Sbjct: 188 NVAY----ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGDNSAGQLH 242
Query: 334 YLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS 389
            +V     P REVL K      +  +    GI +    VF        ++  DLLS
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSN--VFSDHSLKDAKEAYDLLS 296

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 88/216 (40%), Gaps = 29/216 (13%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G FG     + K   E +AVK +E                       + E+      
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN--------------VQREIINHRSL 73
Query: 176 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H N++R   +     +  I+ EY   G LY+R+    N      ++       +   + 
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERIC---NAGRFSEDEARFFFQQLLSGVS 130
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLG--DFGIVKMSETSNMKTMYTENLTGTRPYM 292
           Y HS+   I HRD+K  N LLD +  P+L   DFG  K    S++     ++  GT  Y+
Sbjct: 131 YCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYI 184
Query: 293 PPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 326
            PE +  Q       DV+S GV L  +L G  P +D
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 135 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 289 RPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
           R Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 135 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 239
Query: 582 S 582
           +
Sbjct: 240 N 240

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 135 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 289 RPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
           R Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 135 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 239
Query: 582 S 582
           +
Sbjct: 240 N 240

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 41/235 (17%)
Query: 114 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 167
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 75
Query: 168 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 219
               +    H+N++ LLG C      +M    +    N S Y R  R    P    P D 
Sbjct: 76  ----IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 220 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 187
Query: 273 ETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
                   Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 188 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 41/235 (17%)
Query: 114 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 167
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 75
Query: 168 EVQTLSQCKHVNLLRLLGLCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 219
               +    H+N++ LLG C      +M    +    N S Y R  R    P    P D 
Sbjct: 76  ----IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 220 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 187
Query: 273 ETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
                   Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 188 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEA 232
             H N+++LL + +      +V+E++ +  L D + A      PL   K Y   L   + 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQL--LQG 115
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y 
Sbjct: 116 LAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YR 170
Query: 293 PPEA-MHCQ-ISTKTDVFSYGVILLELLT 319
            PE  + C+  ST  D++S G I  E++T
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 25/218 (11%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G+G F  V    KL  G E A K +                A I  LL           
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL----------- 60
Query: 176 KHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           KH N++RL   +     + +V++ +  G L++ +         D++        + EA+ 
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAVL 117
Query: 235 YLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           + H +   ++HRD+K  N+LL    +    KL DFG+  +    + +  +     GT  Y
Sbjct: 118 HCHQMG--VVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWF--GFAGTPGY 172
Query: 292 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNN 328
           + PE +  +   K  D+++ GVIL  LL G  P  D +
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDED 210

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           + + YLH+    +IHRD+K  N+ L+++   K+GDFG+    E    +    ++L GT  
Sbjct: 137 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPN 191
Query: 291 YMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           Y+ PE + C+   S + D++S G IL  LL G  P +
Sbjct: 192 YIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           + + YLH+    +IHRD+K  N+ L+++   K+GDFG+    E    +    ++L GT  
Sbjct: 137 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPN 191
Query: 526 YMPPEAMHCQI--STKTDVFSYGAQIKT 551
           Y+ PE + C+   S + D++S G  + T
Sbjct: 192 YIAPEVL-CKKGHSFEVDIWSLGCILYT 218

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           + + YLH+    +IHRD+K  N+ L+++   K+GDFG+    E    +    ++L GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPN 207
Query: 291 YMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           Y+ PE + C+   S + D++S G IL  LL G  P +
Sbjct: 208 YIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           + + YLH+    +IHRD+K  N+ L+++   K+GDFG+    E    +    ++L GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPN 207
Query: 526 YMPPEAMHCQI--STKTDVFSYGAQIKT 551
           Y+ PE + C+   S + D++S G  + T
Sbjct: 208 YIAPEVL-CKKGHSFEVDIWSLGCILYT 234

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ D G+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 296

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 62
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 120
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 121 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 175
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 117 SFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 171
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 59
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 118 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 172
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 115
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 170
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 171
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 115
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 170
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 171
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 83/161 (51%), Gaps = 6/161 (3%)
Query: 167 NEVQTLSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            E+Q L + +H N++ +  +   + +  +   Y+    +   L ++  +  L ++     
Sbjct: 90  REIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYF 149
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
              +   L Y+HS +  ++HRD+K +N+L++     K+ DFG+ ++++  +  T +    
Sbjct: 150 LYQILRGLKYIHSAN--VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEX 207
Query: 286 TGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
             TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 62/121 (51%), Gaps = 17/121 (14%)
Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +   L Y+HS +  ++HRD+K +N+L++     K+ DFG+ ++++  +  T +      T
Sbjct: 153 ILRGLKYIHSAN--VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVAT 210
Query: 524 RPYMPPEAM-HCQISTKT-DVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV 581
           R Y  PE M + +  TK+ D++S G  I  + ++N            + + PG H  D +
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGC-ILAEMLSN------------RPIFPGKHYLDQL 257
Query: 582 S 582
           +
Sbjct: 258 N 258

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 60
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEA 232
             H N+++LL + +      +V+E++ +  L D + A      PL   K Y   L   + 
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL--LQG 117
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y 
Sbjct: 118 LAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YR 172
Query: 293 PPEA-MHCQ-ISTKTDVFSYGVILLELLT 319
            PE  + C+  ST  D++S G I  E++T
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 217 LDSNKRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGI 268
           L+ +KR   AL   EA +YL  +           +IHRD+K  N+ L+E+   K+GDFG+
Sbjct: 105 LELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPID 325
               E    +    + L GT  Y+ PE +  +  S + DV+S G I+  LL G  P +
Sbjct: 164 ATKVEYDGER---KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 13/109 (11%)
Query: 452 LDSNKRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGI 503
           L+ +KR   AL   EA +YL  +           +IHRD+K  N+ L+E+   K+GDFG+
Sbjct: 105 LELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGAQIKT 551
               E    +    + L GT  Y+ PE +  +  S + DV+S G  + T
Sbjct: 164 ATKVEYDGER---KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 209

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G FG     + K   E +AVK +E                       + E+      
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDEN--------------VKREIINHRSL 72
Query: 176 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H N++R   +     +  IV EY   G L++R+    N      ++       +   + 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVS 129
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKL--GDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           Y H++   + HRD+K  N LLD +  P+L   DFG  K S   +      ++  GT  Y+
Sbjct: 130 YAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQ----PKSAVGTPAYI 183
Query: 293 PPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 326
            PE +  +       DV+S GV L  +L G  P +D
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ D G+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 61
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSIALGVAE 231
             H N+++LL + +      +V+E++     +  D  A      PL  +  + +  G+A 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA- 120
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
              + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y
Sbjct: 121 ---FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--Y 172
Query: 292 MPPEA-MHCQ-ISTKTDVFSYGVILLELLT 319
             PE  + C+  ST  D++S G I  E++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 65
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 123
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 124 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 178
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 217 LDSNKRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGI 268
           L+ +KR   AL   EA +YL  +           +IHRD+K  N+ L+E+   K+GDFG+
Sbjct: 105 LELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPID 325
               E    +    + L GT  Y+ PE +  +  S + DV+S G I+  LL G  P +
Sbjct: 164 ATKVEYDGER---KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 13/109 (11%)
Query: 452 LDSNKRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGI 503
           L+ +KR   AL   EA +YL  +           +IHRD+K  N+ L+E+   K+GDFG+
Sbjct: 105 LELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 163
Query: 504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGAQIKT 551
               E    +    + L GT  Y+ PE +  +  S + DV+S G  + T
Sbjct: 164 ATKVEYDGER---KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 209

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 217 LDSNKRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGI 268
           L+ +KR   AL   EA +YL  +           +IHRD+K  N+ L+E+   K+GDFG+
Sbjct: 109 LELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 167
Query: 269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPID 325
               E    +    + L GT  Y+ PE +  +  S + DV+S G I+  LL G  P +
Sbjct: 168 ATKVEYDGER---KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 13/109 (11%)
Query: 452 LDSNKRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGI 503
           L+ +KR   AL   EA +YL  +           +IHRD+K  N+ L+E+   K+GDFG+
Sbjct: 109 LELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 167
Query: 504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGAQIKT 551
               E    +    + L GT  Y+ PE +  +  S + DV+S G  + T
Sbjct: 168 ATKVEYDGER---KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 213

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 171
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 60
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 118
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 119 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 173
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 21/143 (14%)
Query: 201 NGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV 260
            G+L + LAR             S    V EA+ + H+    ++HRD+K  N+L+D N  
Sbjct: 151 RGALQEELAR-------------SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN-- 193
Query: 261 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELL 318
              G+  ++     + +K     +  GTR Y PPE +  H        V+S G++L +++
Sbjct: 194 --RGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251
Query: 319 TGMKPIDDNNTILYYYLVVEQEV 341
            G  P + +  I+   +   Q V
Sbjct: 252 CGDIPFEHDEEIIRGQVFFRQRV 274

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 61
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEA 232
             H N+++LL + +      +V+E++ +  L D + A      PL   K Y   L   + 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL--LQG 118
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y 
Sbjct: 119 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YR 173
Query: 293 PPEA-MHCQ-ISTKTDVFSYGVILLELLT 319
            PE  + C+  ST  D++S G I  E++T
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 39/220 (17%)
Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFE--NEVQTLS 173
           LGEG +G V     K   EI A+K +E                  P+       E++ L 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--------------PLFALRTLREIKILK 64
Query: 174 QCKHVNLLRLLGLCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
             KH N++ +     NI     +E     Y+    +   L RV +T  L  +        
Sbjct: 65  HFKHENIITIF----NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--------SETSNMKTM 280
              A+  LH  +  +IHRD+K +N+L++ N   K+ DFG+ ++        SE +  ++ 
Sbjct: 121 TLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 281 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELL 318
             E    TR Y  PE M    + S   DV+S G IL EL 
Sbjct: 179 MVE-FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 43/286 (15%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ D G+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKR 378
           + E    ++++L            IG       + EK  V + DKR
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 296

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 58/111 (52%), Gaps = 12/111 (10%)
Query: 225 IALGVAEALHYLHS-LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
           IA+ + +AL +LHS LS  +IHRDVK +NVL++     K  DFGI         K +   
Sbjct: 141 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID-- 196
Query: 284 NLTGTRPYMPPEAMHCQI-----STKTDVFSYGVILLELLTGMKPIDDNNT 329
              G +PY  PE ++ ++     S K+D++S G+  +EL     P D   T
Sbjct: 197 --AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGT 245

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/107 (34%), Positives = 58/107 (54%), Gaps = 19/107 (17%)
Query: 460 IALGVAEALHYLHS-LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
           IA+ + +AL +LHS LS  +IHRDVK +NVL++     K  DFGI        V  +  +
Sbjct: 141 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYL----VDDVAKD 194
Query: 519 NLTGTRPYMPPEAMHCQI-----STKTDVFSYGAQIKTQHITNVDIA 560
              G +PY  PE ++ ++     S K+D++S G       IT +++A
Sbjct: 195 IDAGCKPYXAPERINPELNQKGYSVKSDIWSLG-------ITXIELA 234

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 117 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 171
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 84/181 (46%), Gaps = 25/181 (13%)
Query: 165 FENEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSL-YDRLARVNNTPPLDSNKR 222
            + E       KH +++ LL    ++ M  +V+E+M    L ++ + R       D+   
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA------DAGFV 128
Query: 223 YSIALG------VAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGI-VKMS 272
           YS A+       + EAL Y H  +  IIHRDVK   VLL   EN  P KLG FG+ +++ 
Sbjct: 129 YSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 186
Query: 273 ETSNMKTMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTIL 331
           E+     +      GT  +M PE +  +   K  DV+  GVIL  LL+G  P       L
Sbjct: 187 ESG----LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL 242
Query: 332 Y 332
           +
Sbjct: 243 F 243

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 60
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 118
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 119 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 173
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 115
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 170
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 61
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 174
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 59
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 118 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 172
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 60
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 118
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 119 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 173
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 59
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 118 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 172
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           ++  K+GEG +G VY  + K  G  +A+K +             TE   +P      E+ 
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REIS 54
Query: 171 TLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            L +  H N+++LL + +      +V+E++         A      PL   K Y   L  
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL-- 112
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
            + L + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T   
Sbjct: 113 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW- 168
Query: 290 PYMPPEA-MHCQ-ISTKTDVFSYGVILLELLT 319
            Y  PE  + C+  ST  D++S G I  E++T
Sbjct: 169 -YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 171
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 59
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 118 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 172
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 61
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 174
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 82/173 (47%), Gaps = 25/173 (14%)
Query: 165 FENEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSL-YDRLARVNNTPPLDSNKR 222
            + E       KH +++ LL    ++ M  +V+E+M    L ++ + R       D+   
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA------DAGFV 126
Query: 223 YSIALG------VAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGI-VKMS 272
           YS A+       + EAL Y H  +  IIHRDVK   VLL   EN  P KLG FG+ +++ 
Sbjct: 127 YSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184
Query: 273 ETSNMKTMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI 324
           E+     +      GT  +M PE +  +   K  DV+  GVIL  LL+G  P 
Sbjct: 185 ESG----LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 170
           ++  K+GEG +G VY  + K  G  +A+K +             TE   +P      E+ 
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REIS 53
Query: 171 TLSQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            L +  H N+++LL + +      +V+E++         A      PL   K Y   L  
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL-- 111
Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
            + L + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T   
Sbjct: 112 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW- 167
Query: 290 PYMPPEA-MHCQ-ISTKTDVFSYGVILLELLT 319
            Y  PE  + C+  ST  D++S G I  E++T
Sbjct: 168 -YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           + + YLH+    +IHRD+K  N+ L+++   K+GDFG+    E    +    + L GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKTLCGTPN 207
Query: 291 YMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           Y+ PE + C+   S + D++S G IL  LL G  P +
Sbjct: 208 YIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 62
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 120
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 121 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 175
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 69
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 225
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 284
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 182
Query: 285 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 183 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 82
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 225
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 83  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 142
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 284
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 143 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 195
Query: 285 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 196 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 235

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA------------------FKNRELQIMRK 69
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 225
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 284
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 182
Query: 285 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 183 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 59
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 118 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 172
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSIALGVAE 231
             H N+++LL + +      +V+E++     +  D  A      PL  +  + +  G+A 
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA- 116
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
              + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y
Sbjct: 117 ---FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWY 168
Query: 292 MPPEA-MHCQ-ISTKTDVFSYGVILLELLT 319
             PE  + C+  ST  D++S G I  E++T
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA------------------FKNRELQIMRK 69
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 225
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 284
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 182
Query: 285 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 183 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 61
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 120 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 174
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 45/224 (20%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 97
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLYDRLAR----VNNTPPLDSNKRY 223
             H N++RL           + +   +V +Y+   ++Y R+AR       T P+   K Y
Sbjct: 98  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY-RVARHYSRAKQTLPVIYVKLY 155
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 282
              L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y 
Sbjct: 156 MYQL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY- 210
Query: 283 ENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
                +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 211 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 250

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           + + YLH+    +IHRD+K  N+ L+++   K+GDFG+    E    +    + L GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPN 207
Query: 291 YMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPID 325
           Y+ PE + C+   S + D++S G IL  LL G  P +
Sbjct: 208 YIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 45/224 (20%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 103
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLYDRLAR----VNNTPPLDSNKRY 223
             H N++RL           + +   +V +Y+   ++Y R+AR       T P+   K Y
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY-RVARHYSRAKQTLPVIYVKLY 161
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 282
              L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y 
Sbjct: 162 MYQL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY- 216
Query: 283 ENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
                +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 217 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 45/224 (20%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 74
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLYDRLAR----VNNTPPLDSNKRY 223
             H N++RL           + +   +V +Y+   ++Y R+AR       T P+   K Y
Sbjct: 75  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY-RVARHYSRAKQTLPVIYVKLY 132
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 282
              L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y 
Sbjct: 133 MYQL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY- 187
Query: 283 ENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
                +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 188 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 227

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 217 LDSNKRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGI 268
           L+ +KR   AL   EA +YL  +           +IHRD+K  N+ L+E+   K+GDFG+
Sbjct: 103 LELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161
Query: 269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPID 325
               E    +    + L GT  Y+ PE +  +  S + DV+S G I+  LL G  P +
Sbjct: 162 ATKVEYDGER---KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 13/109 (11%)
Query: 452 LDSNKRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGI 503
           L+ +KR   AL   EA +YL  +           +IHRD+K  N+ L+E+   K+GDFG+
Sbjct: 103 LELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161
Query: 504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGAQIKT 551
               E    +    + L GT  Y+ PE +  +  S + DV+S G  + T
Sbjct: 162 ATKVEYDGER---KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 207

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 36/230 (15%)
Query: 116 KLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           KLG+G +G V+     + G  +AVK +                 MI   L  +E      
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE------ 69
Query: 175 CKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
              VNLL +L   N+    +V++YM   +    + R N   P+  +K+Y +   + + + 
Sbjct: 70  -NIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPV--HKQY-VVYQLIKVIK 123
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMKTMYTEN----- 284
           YLHS    ++HRD+K +N+LL+     K+ DFG+ +        T+N+     EN     
Sbjct: 124 YLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 285 --------LTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 324
                      TR Y  PE +    + +   D++S G IL E+L G KPI
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           K+GEG +G VY  +   G   A+K +              E   IP      E+  L + 
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLE----------KEDEGIPSTTI-REISILKEL 57
Query: 176 KHVNLLRLLGLCNNIMNCI-VYEYM----------CNGSLYDRLARVNNTPPLDSNKRYS 224
           KH N+++L  + +     + V+E++          C G L    A+             S
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-------------S 104
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
             L +   + Y H   + ++HRD+K  N+L++     K+ DFG+ +       K  YT  
Sbjct: 105 FLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHE 160
Query: 285 LTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTG 320
           +  T  Y  P+ +    + ST  D++S G I  E++ G
Sbjct: 161 IV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 45/224 (20%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 105
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLYDRLAR----VNNTPPLDSNKRY 223
             H N++RL           + +   +V +Y+   ++Y R+AR       T P+   K Y
Sbjct: 106 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY-RVARHYSRAKQTLPVIYVKLY 163
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 282
              L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y 
Sbjct: 164 MYQL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY- 218
Query: 283 ENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
                +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 219 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 258

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 21/140 (15%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL-GVAEALHYLHSLSKPIIHRDVKSAN 252
           +V E M  G L D++ R        S +  S  L  + + + YLHS  + ++HRD+K +N
Sbjct: 98  LVTELMRGGELLDKILRQK----FFSEREASFVLHTIGKTVEYLHS--QGVVHRDLKPSN 151
Query: 253 VL-LDENFVP---KLGDFGIVKMSETSN---MKTMYTENLTGTRPYMPPEAMHCQ-ISTK 304
           +L +DE+  P   ++ DFG  K     N   M   YT N      ++ PE +  Q     
Sbjct: 152 ILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN------FVAPEVLKRQGYDEG 205
Query: 305 TDVFSYGVILLELLTGMKPI 324
            D++S G++L  +L G  P 
Sbjct: 206 CDIWSLGILLYTMLAGYTPF 225

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 21/140 (15%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL-GVAEALHYLHSLSKPIIHRDVKSAN 252
           +V E M  G L D++ R        S +  S  L  + + + YLHS  + ++HRD+K +N
Sbjct: 98  LVTELMRGGELLDKILRQK----FFSEREASFVLHTIGKTVEYLHS--QGVVHRDLKPSN 151
Query: 253 VL-LDENFVP---KLGDFGIVKMSETSN---MKTMYTENLTGTRPYMPPEAMHCQ-ISTK 304
           +L +DE+  P   ++ DFG  K     N   M   YT N      ++ PE +  Q     
Sbjct: 152 ILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN------FVAPEVLKRQGYDEG 205
Query: 305 TDVFSYGVILLELLTGMKPI 324
            D++S G++L  +L G  P 
Sbjct: 206 CDIWSLGILLYTMLAGYTPF 225

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 171
Query: 294 PEAMHCQ--ISTKTDVFSYGVILLELLT 319
           PE +      ST  D++S G I  E++T
Sbjct: 172 PEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 45/224 (20%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 107
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLYDRLAR----VNNTPPLDSNKRY 223
             H N++RL           + +   +V +Y+   ++Y R+AR       T P+   K Y
Sbjct: 108 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY-RVARHYSRAKQTLPVIYVKLY 165
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 282
              L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y 
Sbjct: 166 MYQL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY- 220
Query: 283 ENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
                +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 221 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 260

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           K+GEG +G VY  +   G   A+K +              E   IP      E+  L + 
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLE----------KEDEGIPSTTI-REISILKEL 57
Query: 176 KHVNLLRLLGLCNNIMNCI-VYEYM----------CNGSLYDRLARVNNTPPLDSNKRYS 224
           KH N+++L  + +     + V+E++          C G L    A+             S
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-------------S 104
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
             L +   + Y H   + ++HRD+K  N+L++     K+ DFG+ +       K  YT  
Sbjct: 105 FLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHE 160
Query: 285 LTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTG 320
           +  T  Y  P+ +    + ST  D++S G I  E++ G
Sbjct: 161 VV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY-TENLTGTRP 290
            L Y+HS    +IHRD+K +N+L++EN   K+GDFG+ +   TS  +  Y       TR 
Sbjct: 171 GLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 228
Query: 291 YMPPEAMHC--QISTKTDVFSYGVILLELLT 319
           Y  PE M    + +   D++S G I  E+L 
Sbjct: 229 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 60/122 (49%), Gaps = 10/122 (8%)
Query: 428 IILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 487
           ++LD  E+   Q+     ++++ PL           +   L Y+HS    +IHRD+K +N
Sbjct: 137 VVLDLMESDLHQI-----IHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSN 189
Query: 488 VLLDENFVPKLGDFGIVKMSETSNVKTMY-TENLTGTRPYMPPEAMHC--QISTKTDVFS 544
           +L++EN   K+GDFG+ +   TS  +  Y       TR Y  PE M    + +   D++S
Sbjct: 190 LLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWS 249
Query: 545 YG 546
            G
Sbjct: 250 VG 251

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 217 LDSNKRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGI 268
           L+ +KR   AL   EA +YL  +           +IHRD+K  N+ L+E+   K+GDFG+
Sbjct: 127 LELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 185
Query: 269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPID 325
               E    +    + L GT  Y+ PE +  +  S + DV+S G I+  LL G  P +
Sbjct: 186 ATKVEYDGER---KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           K+GEG +G VY  +   G   A+K +              E   IP      E+  L + 
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLE----------KEDEGIPSTTI-REISILKEL 57
Query: 176 KHVNLLRLLGLCNNIMNCI-VYEYM----------CNGSLYDRLARVNNTPPLDSNKRYS 224
           KH N+++L  + +     + V+E++          C G L    A+             S
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-------------S 104
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
             L +   + Y H   + ++HRD+K  N+L++     K+ DFG+ +       K  YT  
Sbjct: 105 FLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHE 160
Query: 285 LTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTG 320
           +  T  Y  P+ +    + ST  D++S G I  E++ G
Sbjct: 161 VV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 45/224 (20%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 148
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLYDRLAR----VNNTPPLDSNKRY 223
             H N++RL           + +   +V +Y+   ++Y R+AR       T P+   K Y
Sbjct: 149 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY-RVARHYSRAKQTLPVIYVKLY 206
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 282
              L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y 
Sbjct: 207 MYQL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY- 261
Query: 283 ENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
                +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 262 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 301

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 67/140 (47%), Gaps = 14/140 (10%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           I+ E M  G L+ R+    +       +   I   +  A+ +LHS +  I HRDVK  N+
Sbjct: 84  IIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENL 140
Query: 254 LL---DENFVPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQISTKT-DVF 308
           L    +++ V KL DFG  K +  + ++T  YT        Y+ PE +  +   K+ D++
Sbjct: 141 LYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY------YVAPEVLGPEKYDKSCDMW 194
Query: 309 SYGVILLELLTGMKPIDDNN 328
           S GVI+  LL G  P   N 
Sbjct: 195 SLGVIMYILLCGFPPFYSNT 214

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 165 FENEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
           F+ E++ +    H N++RL     +N    +V E    G L++R+         D+ +  
Sbjct: 53  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR-- 110
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGIVKMSETSNMKTM 280
            I   V  A+ Y H L+  + HRD+K  N L   D    P KL DFG+    +   M  M
Sbjct: 111 -IMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--M 165
Query: 281 YTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
            T+   GT  Y+ P+ +      + D +S GV++  LL G  P 
Sbjct: 166 RTK--VGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPF 207

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 165 FENEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
           F+ E++ +    H N++RL     +N    +V E    G L++R+         D+ +  
Sbjct: 70  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR-- 127
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGIVKMSETSNMKTM 280
            I   V  A+ Y H L+  + HRD+K  N L   D    P KL DFG+    +   M  M
Sbjct: 128 -IMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--M 182
Query: 281 YTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
            T+   GT  Y+ P+ +      + D +S GV++  LL G  P 
Sbjct: 183 RTK--VGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPF 224

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 217 LDSNKRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGI 268
           L+ +KR   AL   EA +YL  +           +IHRD+K  N+ L+E+   K+GDFG+
Sbjct: 129 LELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 187
Query: 269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPID 325
               E    +    + L GT  Y+ PE +  +  S + DV+S G I+  LL G  P +
Sbjct: 188 ATKVEYDGER---KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 67/140 (47%), Gaps = 14/140 (10%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           I+ E M  G L+ R+    +       +   I   +  A+ +LHS +  I HRDVK  N+
Sbjct: 103 IIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENL 159
Query: 254 LL---DENFVPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQISTKT-DVF 308
           L    +++ V KL DFG  K +  + ++T  YT        Y+ PE +  +   K+ D++
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY------YVAPEVLGPEKYDKSCDMW 213
Query: 309 SYGVILLELLTGMKPIDDNN 328
           S GVI+  LL G  P   N 
Sbjct: 214 SLGVIMYILLCGFPPFYSNT 233

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 105 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 1   LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 54
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 55  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 109
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 283
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 110 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 167
Query: 284 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 323
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 168 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 120/292 (41%), Gaps = 25/292 (8%)
Query: 41  SMPKSKH-KSASNLVNQHNQKIKFKLPDKK---WLQEVIQQEEANNKTEYIGELIAFTFC 96
           S PK  H KS+    N+    + F   + +   W  +   Q EA        E+    F 
Sbjct: 297 SFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREA---LPMDTEVFESPFA 353
Query: 97  DLE--RATDGF-NRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXX 153
           D E  R  + + +RK       +LG G FGTV  G  +      +K +            
Sbjct: 354 DPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNE 407
Query: 154 XTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNN 213
             + A+   LL E  V  + Q  +  ++R++G+C      +V E    G L   L +  N
Sbjct: 408 ANDPALKDELLAEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--N 463
Query: 214 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MS 272
               D N    +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K + 
Sbjct: 464 RHVKDKNI-IELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALR 520
Query: 273 ETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 323
              N     T      + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 105 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 13  LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 66
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 67  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 121
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 283
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 122 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179
Query: 284 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 323
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 65
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 123
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 124 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 178
Query: 294 PEAMHCQ--ISTKTDVFSYGVILLELLT 319
           PE +      ST  D++S G I  E++T
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 105 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 21  LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 74
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 75  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 129
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 283
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 130 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 187
Query: 284 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 323
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 188 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY-TENLTGTRP 290
            L Y+HS    +IHRD+K +N+L++EN   K+GDFG+ +   TS  +  Y       TR 
Sbjct: 170 GLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 227
Query: 291 YMPPEAMHC--QISTKTDVFSYGVILLELLT 319
           Y  PE M    + +   D++S G I  E+L 
Sbjct: 228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 258

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 60/122 (49%), Gaps = 10/122 (8%)
Query: 428 IILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 487
           ++LD  E+   Q+     ++++ PL           +   L Y+HS    +IHRD+K +N
Sbjct: 136 VVLDLMESDLHQI-----IHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSN 188
Query: 488 VLLDENFVPKLGDFGIVKMSETSNVKTMY-TENLTGTRPYMPPEAMHC--QISTKTDVFS 544
           +L++EN   K+GDFG+ +   TS  +  Y       TR Y  PE M    + +   D++S
Sbjct: 189 LLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWS 248
Query: 545 YG 546
            G
Sbjct: 249 VG 250

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 105 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 23  LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 76
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 77  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 131
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 283
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 132 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 284 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 323
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 105 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 23  LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 76
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 77  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 131
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 283
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 132 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 284 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 323
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 120/294 (40%), Gaps = 50/294 (17%)
Query: 116 KLGEGQFGTVYYGK-LKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           ++GEG +G V+  + LKNG   +A+K +                  +        ++ L 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV--------LRHLE 69
Query: 174 QCKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
             +H N++RL  +C            +V+E++ +  L   L +V   P + +     +  
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-PGVPTETIKDMMF 127
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMKTMYT 282
            +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ +     M+ TS + T++ 
Sbjct: 128 QLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW- 184
Query: 283 ENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL-YYY 334
                   Y  PE  +    +T  D++S G I  E      L  G   +D    IL    
Sbjct: 185 --------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 335 LVVEQEVPVREVLDKEAG--------EWNETHVETLIGIVFEKCCVFEKDKRAS 380
           L  E++ P    L ++A         E   T ++ L   +  KC  F   KR S
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 105 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 60
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 61  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 115
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 283
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 116 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTH 173
Query: 284 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 323
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 105 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 56
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 57  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 111
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 283
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 112 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169
Query: 284 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 323
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 16/177 (9%)
Query: 161 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPL 217
           PI     E+  L +  H N+++L+ + ++       +V+E +  G + +    V    PL
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME----VPTLKPL 134
Query: 218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 277
             ++       + + + YLH   + IIHRD+K +N+L+ E+   K+ DFG+    + S+ 
Sbjct: 135 SEDQARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD- 191
Query: 278 KTMYTENLTGTRPYMPPEAMHCQ---ISTKT-DVFSYGVILLELLTGMKPIDDNNTI 330
                 N  GT  +M PE++       S K  DV++ GV L   + G  P  D   +
Sbjct: 192 --ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 25/82 (30%), Positives = 43/82 (52%), Gaps = 5/82 (6%)
Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL  ++       + + + YLH   + IIHRD+K +N+L+ E+   K+ DFG+    + S
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 511 NVKTMYTENLTGTRPYMPPEAM 532
           +       N  GT  +M PE++
Sbjct: 191 DA---LLSNTVGTPAFMAPESL 209

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           +LG+G F  V     K  G+E A K +                        E E +   +
Sbjct: 12  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----------LEREARICRK 60
Query: 175 CKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
            +H N++RL   +     + +V++ +  G L++ +         D++        + E++
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESI 117
Query: 234 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
            Y HS    I+HR++K  N+LL    +    KL DFG+    E ++ +  +     GT  
Sbjct: 118 AYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH--GFAGTPG 171
Query: 291 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNN 328
           Y+ PE +     +K  D+++ GVIL  LL G  P  D +
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 105 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 164
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 60
Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
            E  V  + Q  +  ++R++G+C      +V E    G L   L +  N    D N    
Sbjct: 61  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 115
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 283
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 116 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 173
Query: 284 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 323
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 117 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 176 KHVNLLRLLGLCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           KH N++ LL +     +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            Y+HS    IIHRD+K +N+ ++E+   K+ DF + +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLAR--HTDDEMTGY----VATRWYRA 190
Query: 294 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 350
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 351 AGEWNETHVETL------------IGI------VFEKCCVFEKDKRAS 380
           + E    ++++L            IG       + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           +LG+G F  V     K  G+E A K +                        E E +   +
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----------LEREARICRK 61
Query: 175 CKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
            +H N++RL   +     + +V++ +  G L++ +         D++        + E++
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESI 118
Query: 234 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
            Y HS    I+HR++K  N+LL    +    KL DFG+    E ++ +  +     GT  
Sbjct: 119 AYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH--GFAGTPG 172
Query: 291 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNN 328
           Y+ PE +     +K  D+++ GVIL  LL G  P  D +
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 61
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 174
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 53/228 (23%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA------------------FKNRELQIMRK 69
Query: 175 CKHVNLLRL---------------LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDS 219
             H N++RL               L L  + +   VY       +    +R   T P+  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYR------VARHYSRAKQTLPVIY 123
Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMK 278
            K Y   L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG    S    ++
Sbjct: 124 VKLYMYQL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG----SAKQLVR 175
Query: 279 TMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
                +   +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 176 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G FG     + K   E +AVK +E              AA +     + E+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKI---------AANV-----KREIINHRSL 72
Query: 176 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H N++R   +     +  IV EY   G L++R+    N      ++       +   + 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVS 129
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLG--DFGIVKMSETSNMKTMYTENLTGTRPYM 292
           Y H++   + HRD+K  N LLD +  P+L   DFG  K    S++     ++  GT  Y+
Sbjct: 130 YCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYI 183
Query: 293 PPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 326
            PE +  +       DV+S GV L  +L G  P +D
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 18/177 (10%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 349
             PE  +        D++S GVI+ E++ G       + I  +  V+EQ   P  E + K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM-K 250
Query: 350 EAGEWNETHVET---LIGIVFEKC---CVFEKDK---RASMRDIVDLLSKSMFVCNS 397
           +      T+VE      G  FEK     +F  D    +       DLLSK + +  S
Sbjct: 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 18/177 (10%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 349
             PE  +        D++S GVI+ E++ G       + I  +  V+EQ   P  E + K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM-K 250
Query: 350 EAGEWNETHVET---LIGIVFEKC---CVFEKDK---RASMRDIVDLLSKSMFVCNS 397
           +      T+VE      G  FEK     +F  D    +       DLLSK + +  S
Sbjct: 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 100/241 (41%), Gaps = 37/241 (15%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           +LG G FG V+  + K  G + AVK +                    + +F  E   L  
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVR-------------------LEVFRAE--ELMA 138
Query: 175 CKHVNLLRLLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           C  +   R++ L   +       I  E +  GSL  +L +     P D    Y   LG A
Sbjct: 139 CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYY---LGQA 194
Query: 231 -EALHYLHSLSKPIIHRDVKSANVLLDENFV-PKLGDFG-IVKMSETSNMKTMYTEN-LT 286
            E L YLHS  + I+H DVK+ NVLL  +     L DFG  V +      K++ T + + 
Sbjct: 195 LEGLEYLHS--RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIP 252
Query: 287 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 345
           GT  +M PE  +      K DV+S   ++L +L G  P            +  +  PVRE
Sbjct: 253 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVRE 312
Query: 346 V 346
           +
Sbjct: 313 I 313

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +LG G FGTV  G  +      +K +              + A+   LL E  V  + Q 
Sbjct: 377 ELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELLAEANV--MQQL 428
Query: 176 KHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 235
            +  ++R++G+C      +V E    G L   L +  N    D N    +   V+  + Y
Sbjct: 429 DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IELVHQVSMGMKY 485
Query: 236 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPP 294
           L   +   +HRD+ + NVLL      K+ DFG+ K +    N     T      + Y P 
Sbjct: 486 LEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 543
Query: 295 EAMHCQISTKTDVFSYGVILLELLT-GMKP 323
              + + S+K+DV+S+GV++ E  + G KP
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 41/218 (18%)
Query: 117 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQC 175
           +G G FG V+  KL    E+A+K +                       F+N E+Q +   
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKR------------------FKNRELQIMRIV 89
Query: 176 KHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLY---DRLARVNNTPPLDSNKRYSI 225
           KH N++ L           + +   +V EY+   ++Y      A++  T P+   K Y  
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 284
            L    +L Y+HS+   I HRD+K  N+LLD  + V KL DFG  K+            +
Sbjct: 149 QL--LRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV----S 200
Query: 285 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTG 320
              +R Y  PE +      +T  D++S G ++ EL+ G
Sbjct: 201 XICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           +LG+G F  V     K  G+E A K +                        E E +   +
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----------LEREARICRK 61
Query: 175 CKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
            +H N++RL   +     + +V++ +  G L++ +         D++        + E++
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESI 118
Query: 234 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
            Y HS    I+HR++K  N+LL    +    KL DFG+    E ++ +  +     GT  
Sbjct: 119 AYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH--GFAGTPG 172
Query: 291 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNN 328
           Y+ PE +     +K  D+++ GVIL  LL G  P  D +
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 53/111 (47%), Gaps = 11/111 (9%)
Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDEN--FVPKLGDFGIVKMSETSNMKTMYTENLT 286
           +  ALHYLH+  + I HRD+K  N L   N  F  KL DFG+ K     N    Y     
Sbjct: 177 IFSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234
Query: 287 GTRPY-MPPEAMHC---QISTKTDVFSYGVILLELLTGMKP---IDDNNTI 330
              PY + PE ++        K D +S GV+L  LL G  P   ++D +TI
Sbjct: 235 AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI 285

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 120/294 (40%), Gaps = 50/294 (17%)
Query: 116 KLGEGQFGTVYYGK-LKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           ++GEG +G V+  + LKNG   +A+K +                  +        ++ L 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV--------LRHLE 69
Query: 174 QCKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
             +H N++RL  +C            +V+E++ +  L   L +V   P + +     +  
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-PGVPTETIKDMMF 127
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMKTMYT 282
            +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ +     M+ TS + T++ 
Sbjct: 128 QLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW- 184
Query: 283 ENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL-YYY 334
                   Y  PE  +    +T  D++S G I  E      L  G   +D    IL    
Sbjct: 185 --------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 335 LVVEQEVPVREVLDKEAG--------EWNETHVETLIGIVFEKCCVFEKDKRAS 380
           L  E++ P    L ++A         E   T ++ L   +  KC  F   KR S
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+  +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 171
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           K+GEG +G VY  + K  G  +A+  +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 175 CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             H N+++LL + +      +V+E++         A      PL   K Y   L   + L
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 115
Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 170
Query: 294 PEA-MHCQ-ISTKTDVFSYGVILLELLT 319
           PE  + C+  ST  D++S G I  E++T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 120/294 (40%), Gaps = 50/294 (17%)
Query: 116 KLGEGQFGTVYYGK-LKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
           ++GEG +G V+  + LKNG   +A+K +                  +        ++ L 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV--------LRHLE 69
Query: 174 QCKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
             +H N++RL  +C            +V+E++ +  L   L +V   P + +     +  
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-PGVPTETIKDMMF 127
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMKTMYT 282
            +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ +     M+ TS + T++ 
Sbjct: 128 QLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW- 184
Query: 283 ENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL-YYY 334
                   Y  PE  +    +T  D++S G I  E      L  G   +D    IL    
Sbjct: 185 --------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 335 LVVEQEVPVREVLDKEAG--------EWNETHVETLIGIVFEKCCVFEKDKRAS 380
           L  E++ P    L ++A         E   T ++ L   +  KC  F   KR S
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 45/224 (20%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 81
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLYDRLAR----VNNTPPLDSNKRY 223
             H N++RL           + +   +V +Y+   ++Y R+AR       T P+   K Y
Sbjct: 82  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY-RVARHYSRAKQTLPVIYVKLY 139
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 282
              L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++    
Sbjct: 140 MYQL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPN 191
Query: 283 ENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
            +   +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 192 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 234

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 88
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 225
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 89  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 148
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 284
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 149 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 200
Query: 285 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 201 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 241

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 77
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 225
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 78  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 137
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 284
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 138 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 189
Query: 285 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 190 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 230

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 69
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 225
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 284
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 181
Query: 285 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 81
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 225
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 82  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 284
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 142 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 193
Query: 285 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 194 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 234

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 29/216 (13%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G FG     + K   E +AVK +E                       + E+      
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN--------------VKREIINHRSL 71
Query: 176 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H N++R   +     +  IV EY   G L++R+    N      ++       +   + 
Sbjct: 72  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVS 128
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLG--DFGIVKMSETSNMKTMYTENLTGTRPYM 292
           Y H++   + HRD+K  N LLD +  P+L   DFG  K    S++     ++  GT  Y+
Sbjct: 129 YCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYI 182
Query: 293 PPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 326
            PE +  +       DV+S GV L  +L G  P +D
Sbjct: 183 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 218

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 23/175 (13%)
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYM--CNGSLYDRLARVNNTPPLDSNKRY 223
           + E+Q L + +H N+++L+ +  N     +Y  M  C   + + L  V         KR+
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-------PEKRF 106
Query: 224 SIALG------VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSN 276
            +         + + L YLHS  + I+H+D+K  N+LL      K+   G+ + +   + 
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 277 MKTMYTENLTGTRPYMPPE---AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
             T  T    G+  + PPE    +      K D++S GV L  + TG+ P + +N
Sbjct: 165 DDTCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 9/100 (9%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            L ++H+  + +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  Y
Sbjct: 303 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGY 355
Query: 292 MPPEAMHCQIS--TKTDVFSYGVILLELLTGMKPIDDNNT 329
           M PE +   ++  +  D FS G +L +LL G  P   + T
Sbjct: 356 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 395

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 9/100 (9%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            L ++H+  + +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  Y
Sbjct: 304 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGY 356
Query: 292 MPPEAMHCQIS--TKTDVFSYGVILLELLTGMKPIDDNNT 329
           M PE +   ++  +  D FS G +L +LL G  P   + T
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 26/228 (11%)
Query: 165 FENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
           F      +S+  H +L+   G+C     N +V E++  GSL   L +  N   ++   + 
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKL 116
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
            +A  +A A+H+L      +IH +V + N+LL      K G+   +K+S+     T+  +
Sbjct: 117 EVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 284 NLTGTR-PYMPPEAMHC--QISTKTDVFSYGVILLELLTGM-KPID--DNNTILYYYLVV 337
           ++   R P++PPE +     ++  TD +S+G  L E+ +G  KP+   D+   L +Y   
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
Query: 338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
            Q +P  +  +              +  +   C  +E D R S R I+
Sbjct: 235 HQ-LPAPKAAE--------------LANLINNCMDYEPDHRPSFRAII 267

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 69
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 225
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 284
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 181
Query: 285 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 70
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 225
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 71  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 130
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 284
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 131 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 182
Query: 285 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 183 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 223

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 9/100 (9%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            L ++H+  + +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  Y
Sbjct: 304 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGY 356
Query: 292 MPPEAMHCQIS--TKTDVFSYGVILLELLTGMKPIDDNNT 329
           M PE +   ++  +  D FS G +L +LL G  P   + T
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 9/100 (9%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            L ++H+  + +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  Y
Sbjct: 304 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGY 356
Query: 292 MPPEAMHCQIS--TKTDVFSYGVILLELLTGMKPIDDNNT 329
           M PE +   ++  +  D FS G +L +LL G  P   + T
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 71/166 (42%), Gaps = 37/166 (22%)
Query: 173 SQCKHVNLLRLLGLCNNI---MNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           SQC H+  +R++ +  N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 68  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 124
Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 284
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET+  K      
Sbjct: 125 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTGEK------ 174
Query: 285 LTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 330
                                D++S GVI+  LL G  P   N+ +
Sbjct: 175 ----------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGL 204

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 76/158 (48%), Gaps = 12/158 (7%)
Query: 167 NEVQTLSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
            E++ L   +H N++ LL +   +  ++     Y+    +   L ++     L  ++   
Sbjct: 73  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 132
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
           +   + + L Y+H+    IIHRD+K  N+ ++E+   K+ DFG+ + +++     +    
Sbjct: 133 LVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV--- 187
Query: 285 LTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTG 320
              TR Y  PE +    + +   D++S G I+ E++TG
Sbjct: 188 ---TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 45/224 (20%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 103
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLYDRLAR----VNNTPPLDSNKRY 223
             H N++RL           + +   +V +Y+   ++Y R+AR       T P+   K Y
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY-RVARHYSRAKQTLPVIYVKLY 161
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 282
              L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++    
Sbjct: 162 MYQL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPN 213
Query: 283 ENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
            +   +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 214 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 26/228 (11%)
Query: 165 FENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
           F      +S+  H +L+   G+C     N +V E++  GSL   L +  N   ++   + 
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKL 116
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
            +A  +A A+H+L      +IH +V + N+LL      K G+   +K+S+     T+  +
Sbjct: 117 EVAKQLAWAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 284 NLTGTR-PYMPPEAMHC--QISTKTDVFSYGVILLELLTGM-KPID--DNNTILYYYLVV 337
           ++   R P++PPE +     ++  TD +S+G  L E+ +G  KP+   D+   L +Y   
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
Query: 338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
            Q +P  +  +              +  +   C  +E D R S R I+
Sbjct: 235 HQ-LPAPKAAE--------------LANLINNCMDYEPDHRPSFRAII 267

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 99/241 (41%), Gaps = 37/241 (15%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           +LG G FG V+  + K  G + AVK +                    + +F  E   L  
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVR-------------------LEVFRAE--ELMA 119
Query: 175 CKHVNLLRLLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           C  +   R++ L   +       I  E +  GSL  +L +     P D    Y   LG A
Sbjct: 120 CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYY---LGQA 175
Query: 231 -EALHYLHSLSKPIIHRDVKSANVLLDENFV-PKLGDFG-IVKMSETSNMKTMYTEN-LT 286
            E L YLHS  + I+H DVK+ NVLL  +     L DFG  V +      K + T + + 
Sbjct: 176 LEGLEYLHS--RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP 233
Query: 287 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 345
           GT  +M PE  +      K DV+S   ++L +L G  P            +  +  PVRE
Sbjct: 234 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVRE 293
Query: 346 V 346
           +
Sbjct: 294 I 294

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 73
Query: 175 CKHVNLLRLLGLC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 225
             H N++RL           + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 74  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 133
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 284
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 134 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 185
Query: 285 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 186 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 226

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 87/220 (39%), Gaps = 25/220 (11%)
Query: 115 NKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 173
            +LG+G F  V    K+  G E A K +                A I  LL         
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLL--------- 78
Query: 174 QCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
             KH N++RL   +     + ++++ +  G L++ +         D++      L   EA
Sbjct: 79  --KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL---EA 133
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           + + H +   ++HRD+K  N+LL         KL DFG+    E             GT 
Sbjct: 134 VLHCHQMG--VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTP 188
Query: 290 PYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNN 328
            Y+ PE +      K  D+++ GVIL  LL G  P  D +
Sbjct: 189 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 228

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 27/224 (12%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           +LG+G F  V     K  G+E A K +                        E E +   +
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----------LEREARICRK 84
Query: 175 CKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
            +H N++RL   +     + +V++ +  G L++ +         D++      L   E++
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ESI 141
Query: 234 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
            Y HS    I+HR++K  N+LL    +    KL DFG+    E ++ +  +     GT  
Sbjct: 142 AYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH--GFAGTPG 195
Query: 291 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 332
           Y+ PE +     +K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 239

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 41/222 (18%)
Query: 117 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 174
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 69
Query: 175 CKHVNLLRLL------GLCNNIMNC-IVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 225
             H N++RL       G   +++   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 284
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG    S    ++     +
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG----SAKQLVRGEPNVS 181
Query: 285 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 324
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 168 EVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           E+QT+S  +H  L+ L     ++    ++YE+M  G L++++A  +N    D    Y   
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--M 155
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGIVK-MSETSNMKTMYTE 283
             V + L ++H  +   +H D+K  N++     +   KL DFG+   +    ++K     
Sbjct: 156 RQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--- 210
Query: 284 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 328
             TGT  +  PE    + +   TD++S GV+   LL+G+ P    N
Sbjct: 211 --TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 254

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 21/174 (12%)
Query: 165 FENEVQTLSQCKHVN--LLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 222
           + NE+  L++ +  +  ++RL      I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 157
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  
Sbjct: 158 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQP-DTTSVVK 213
Query: 283 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKPI 324
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P 
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 4/88 (4%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           +D  +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +
Sbjct: 152 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQP-D 207
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQISTK 539
             ++  ++  GT  YMPPEA+    S++
Sbjct: 208 TTSVVKDSQVGTVNYMPPEAIKDMSSSR 235

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 21/173 (12%)
Query: 165 FENEVQTLSQCKHVN--LLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 222
           + NE+  L++ +  +  ++RL      I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 73  YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 129
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  
Sbjct: 130 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDTTSVVK 185
Query: 283 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKP 323
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 4/88 (4%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           +D  +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PD 179
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQISTK 539
             ++  ++  GT  YMPPEA+    S++
Sbjct: 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 168 EVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           E+QT+S  +H  L+ L     ++    ++YE+M  G L++++A  +N    D    Y   
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--M 261
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGIVK-MSETSNMKTMYTE 283
             V + L ++H  +   +H D+K  N++     +   KL DFG+   +    ++K     
Sbjct: 262 RQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--- 316
Query: 284 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 328
             TGT  +  PE    + +   TD++S GV+   LL+G+ P    N
Sbjct: 317 --TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 21/174 (12%)
Query: 165 FENEVQTLSQCKHVN--LLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 222
           + NE+  L++ +  +  ++RL      I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 54  YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 110
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  
Sbjct: 111 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQP-DTTSVVK 166
Query: 283 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKPI 324
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P 
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 45/81 (55%), Gaps = 4/81 (4%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           +D  +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +
Sbjct: 105 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQP-D 160
Query: 512 VKTMYTENLTGTRPYMPPEAM 532
             ++  ++  GT  YMPPEA+
Sbjct: 161 TTSVVKDSQVGTVNYMPPEAI 181

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 21/174 (12%)
Query: 165 FENEVQTLSQCKHVN--LLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 222
           + NE+  L++ +  +  ++RL      I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 157
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  
Sbjct: 158 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQP-DTTSVVK 213
Query: 283 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKPI 324
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P 
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 4/88 (4%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           +D  +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +
Sbjct: 152 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQP-D 207
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQISTK 539
             ++  ++  GT  YMPPEA+    S++
Sbjct: 208 TTSVVKDSQVGTVNYMPPEAIKDMSSSR 235

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 59/119 (49%), Gaps = 16/119 (13%)
Query: 217 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 276
           +D  +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +
Sbjct: 108 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PD 163
Query: 277 MKTMYTENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKP 323
             ++  ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P
Sbjct: 164 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 222

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 4/88 (4%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           +D  +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +
Sbjct: 108 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PD 163
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQISTK 539
             ++  ++  GT  YMPPEA+    S++
Sbjct: 164 TTSVVKDSQVGTVNYMPPEAIKDMSSSR 191

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 7/109 (6%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + T+ M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY----VVTRYY 191
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
             PE  +    +   D++S G I+ EL+ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQ 240

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 21/173 (12%)
Query: 165 FENEVQTLSQCKHVN--LLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 222
           + NE+  L++ +  +  ++RL      I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 73  YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 129
Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +   +  
Sbjct: 130 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDXXXVVK 185
Query: 283 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKP 323
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 4/88 (4%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           +D  +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PD 179
Query: 512 VKTMYTENLTGTRPYMPPEAMHCQISTK 539
              +  ++  GT  YMPPEA+    S++
Sbjct: 180 XXXVVKDSQVGTVNYMPPEAIKDMSSSR 207

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 59/119 (49%), Gaps = 16/119 (13%)
Query: 217 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 276
           +D  +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +
Sbjct: 104 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PD 159
Query: 277 MKTMYTENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKP 323
             ++  ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P
Sbjct: 160 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 218

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 45/81 (55%), Gaps = 4/81 (4%)
Query: 452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 511
           +D  +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +
Sbjct: 104 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PD 159
Query: 512 VKTMYTENLTGTRPYMPPEAM 532
             ++  ++  GT  YMPPEA+
Sbjct: 160 TTSVVKDSQVGTVNYMPPEAI 180

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 13/169 (7%)
Query: 165 FENEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E E +     KH N++RL   +     + +V++ +  G L++ +         D++   
Sbjct: 77  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS--- 133
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTM 280
                + E+++++H     I+HRD+K  N+LL    +    KL DFG+    +       
Sbjct: 134 HCIHQILESVNHIHQ--HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF 191
Query: 281 YTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNN 328
                 GT  Y+ PE +      K  D+++ GVIL  LL G  P  D +
Sbjct: 192 ---GFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDED 237

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + T+ M T Y      TR Y
Sbjct: 136 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPY----VVTRYY 189
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
             PE  +        D++S G I+ EL+ G       + I  +  V+EQ
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 238

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 28/218 (12%)
Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           KL E   G ++ G+ + G +I VK L+                      F  E   L   
Sbjct: 17  KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRD-----------FNEECPRLRIF 64
Query: 176 KHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            H N+L +LG C +       ++  +   GSLY+ L    N   +D ++    AL  A  
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFV-VDQSQAVKFALDXARG 123
Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
             +LH+L   I    + S +V +DE+   ++     VK S  S  +            ++
Sbjct: 124 XAFLHTLEPLIPRHALNSRSVXIDEDXTARISX-ADVKFSFQSPGRXYAPA-------WV 175
Query: 293 PPEAMHCQIS----TKTDVFSYGVILLELLTGMKPIDD 326
            PEA+  +         D +S+ V+L EL+T   P  D
Sbjct: 176 APEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFAD 213

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 116 KLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           +LG+G F  V    K+  G E A K +                A I  LL          
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL---------- 60
Query: 175 CKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
            KH N++RL   +     + +V++ +  G L++ +         D++        + E++
Sbjct: 61  -KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESV 116
Query: 234 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           ++ H     I+HRD+K  N+LL    +    KL DFG+  +    + +  +     GT  
Sbjct: 117 NHCHL--NGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWF--GFAGTPG 171
Query: 291 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNN 328
           Y+ PE +      K  D+++ GVIL  LL G  P  D +
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDED 210

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 192
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 349
             PE  +        D++S G I+ E++ G       + I  +  V+EQ   P  E + K
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 349
             PE  +        D++S G I+ E++ G       + I  +  V+EQ   P  E + K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 64/139 (46%), Gaps = 19/139 (13%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V E    G L D++ R          +  ++   + + + YLH+  + ++HRD+K +N+
Sbjct: 93  VVTELXKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNI 147
Query: 254 L-LDENFVP---KLGDFGIVKMSETSN---MKTMYTENLTGTRPYMPPEAMHCQ-ISTKT 305
           L +DE+  P   ++ DFG  K     N       YT N      ++ PE +  Q      
Sbjct: 148 LYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTAN------FVAPEVLERQGYDAAC 201
Query: 306 DVFSYGVILLELLTGMKPI 324
           D++S GV+L   LTG  P 
Sbjct: 202 DIWSLGVLLYTXLTGYTPF 220

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 80/177 (45%), Gaps = 18/177 (10%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 349
             PE  +        D++S G I+ E++ G       + I  +  V+EQ   P  E + K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM-K 250
Query: 350 EAGEWNETHVET---LIGIVFEKC---CVFEKDK---RASMRDIVDLLSKSMFVCNS 397
           +      T+VE      G  FEK     +F  D    +       DLLSK + +  S
Sbjct: 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
             PE  +        D++S G I+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 80/177 (45%), Gaps = 18/177 (10%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 349
             PE  +        D++S G I+ E++ G       + I  +  V+EQ   P  E + K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM-K 250
Query: 350 EAGEWNETHVET---LIGIVFEKC---CVFEKDK---RASMRDIVDLLSKSMFVCNS 397
           +      T+VE      G  FEK     +F  D    +       DLLSK + +  S
Sbjct: 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           +LG G FG V+  K K  G + AVK                      + L    V+ L  
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKK---------------------VRLEVFRVEELVA 117
Query: 175 CKHVNLLRLLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           C  ++  R++ L   +       I  E +  GSL   + ++   P      R    LG A
Sbjct: 118 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP----EDRALYYLGQA 173
Query: 231 -EALHYLHSLSKPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNM-KTMYTEN-LT 286
            E L YLH+  + I+H DVK+ NVLL  +     L DFG     +   + K++ T + + 
Sbjct: 174 LEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 231
Query: 287 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 323
           GT  +M PE  M      K D++S   ++L +L G  P
Sbjct: 232 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 27/215 (12%)
Query: 112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 171
           RR  KLGEG +G VY          A+ T+              E   +P      EV  
Sbjct: 37  RRITKLGEGTYGEVYK---------AIDTVTNETVAIKRIRLEHEEEGVPGTAI-REVSL 86
Query: 172 LSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L + +H N++ L  + + N    +++EY  N    D    ++  P +      S    + 
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLI 142
Query: 231 EALHYLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENL 285
             +++ HS  +  +HRD+K  N+LL      E  V K+GDFG+ +       +  +T  +
Sbjct: 143 NGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEI 198
Query: 286 TGTRPYMPPEAM--HCQISTKTDVFSYGVILLELL 318
             T  Y PPE +      ST  D++S   I  E+L
Sbjct: 199 I-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 116 KLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           +LG+G F  V    K+  G E A K +                A I  LL          
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL---------- 60
Query: 175 CKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
            KH N++RL   +     + +V++ +  G L++ +         D++        + E++
Sbjct: 61  -KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESV 116
Query: 234 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           ++ H     I+HRD+K  N+LL    +    KL DFG+  +    + +  +     GT  
Sbjct: 117 NHCHL--NGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWF--GFAGTPG 171
Query: 291 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNN 328
           Y+ PE +      K  D+++ GVIL  LL G  P  D +
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDED 210

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
             PE  +        D++S G I+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
             PE  +        D++S G I+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           ++G G +GTVY  +   +G  +A+K++                  +        ++ L  
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL--------LRRLEA 62
Query: 175 CKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIA 226
            +H N++RL+ +C        I   +V+E++      D    ++  PP  L +     + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETIKDLM 118
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
                 L +LH+    I+HRD+K  N+L+      KL DFG+ ++        M  + + 
Sbjct: 119 RQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ----MALDPVV 172
Query: 287 GTRPYMPPEA-MHCQISTKTDVFSYGVILLELL 318
            T  Y  PE  +    +T  D++S G I  E+ 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 18/144 (12%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V+E M  GS+   + +  +   L+++    +   VA AL +LH+  K I HRD+K  N+
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEAS---VVVQDVASALDFLHN--KGIAHRDLKPENI 142
Query: 254 LLDE--NFVP-KLGDFGI---VKM-SETSNMKTMYTENLTGTRPYMPPEAMHC------Q 300
           L +      P K+ DFG+   +K+  + S + T       G+  YM PE +         
Sbjct: 143 LCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI 202
Query: 301 ISTKTDVFSYGVILLELLTGMKPI 324
              + D++S GVIL  LL+G  P 
Sbjct: 203 YDKRCDLWSLGVILYILLSGYPPF 226

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 7/134 (5%)
Query: 193 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 251
           C+V   M  G +   +  V+ + P     +       +   L +LH   + II+RD+K  
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPE 318
Query: 252 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSY 310
           NVLLD++   ++ D G+    +    K   T+   GT  +M PE +   +     D F+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 311 GVILLELLTGMKPI 324
           GV L E++    P 
Sbjct: 376 GVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 7/134 (5%)
Query: 193 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 251
           C+V   M  G +   +  V+ + P     +       +   L +LH   + II+RD+K  
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPE 318
Query: 252 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSY 310
           NVLLD++   ++ D G+    +    K   T+   GT  +M PE +   +     D F+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 311 GVILLELLTGMKPI 324
           GV L E++    P 
Sbjct: 376 GVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 7/134 (5%)
Query: 193 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 251
           C+V   M  G +   +  V+ + P     +       +   L +LH   + II+RD+K  
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPE 318
Query: 252 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSY 310
           NVLLD++   ++ D G+    +    K   T+   GT  +M PE +   +     D F+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 311 GVILLELLTGMKPI 324
           GV L E++    P 
Sbjct: 376 GVTLYEMIAARGPF 389

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 7/134 (5%)
Query: 193 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 251
           C+V   M  G +   +  V+ + P     +       +   L +LH   + II+RD+K  
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPE 318
Query: 252 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSY 310
           NVLLD++   ++ D G+    +    K   T+   GT  +M PE +   +     D F+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 311 GVILLELLTGMKPI 324
           GV L E++    P 
Sbjct: 376 GVTLYEMIAARGPF 389

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           ++G G FG V+  K K  G + AVK                      + L    V+ L  
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKK---------------------VRLEVFRVEELVA 119
Query: 175 CKHVNLLRLLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           C  ++  R++ L   +       I  E +  GSL   + ++   P      R    LG A
Sbjct: 120 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP----EDRALYYLGQA 175
Query: 231 -EALHYLHSLSKPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNM-KTMYTEN-LT 286
            E L YLH+  + I+H DVK+ NVLL  +     L DFG     +   + K++ T + + 
Sbjct: 176 LEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 233
Query: 287 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 323
           GT  +M PE  M      K D++S   ++L +L G  P
Sbjct: 234 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 13/169 (7%)
Query: 165 FENEVQTLSQCKHVNLLRLL-GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E E +     KH N++RL   +     + ++++ +  G L++ +         D++   
Sbjct: 57  LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI 116
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFGIVKMSETSNMKTM 280
              L   EA+ + H +   ++HR++K  N+LL         KL DFG+    E       
Sbjct: 117 QQIL---EAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 281 YTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNN 328
                 GT  Y+ PE +      K  D+++ GVIL  LL G  P  D +
Sbjct: 172 ---GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 116 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           ++G G FG V+  K K  G + AVK                      + L    V+ L  
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKK---------------------VRLEVFRVEELVA 103
Query: 175 CKHVNLLRLLGLCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           C  ++  R++ L   +       I  E +  GSL   + ++   P      R    LG A
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP----EDRALYYLGQA 159
Query: 231 -EALHYLHSLSKPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNM-KTMYTEN-LT 286
            E L YLH+  + I+H DVK+ NVLL  +     L DFG     +   + K++ T + + 
Sbjct: 160 LEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 287 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 323
           GT  +M PE  M      K D++S   ++L +L G  P
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G FG     + K   E +AVK +E                       + E+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN--------------VKREIINHRSL 72
Query: 176 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H N++R   +     +  IV EY   G L++R+    N      ++       +   + 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVS 129
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLG--DFGIVKMSETSNMKTMYTENLTGTRPYM 292
           Y H++   + HRD+K  N LLD +  P+L    FG  K    S++     ++  GT  Y+
Sbjct: 130 YCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSK----SSVLHSQPKDTVGTPAYI 183
Query: 293 PPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 326
            PE +  +       DV+S GV L  +L G  P +D
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 86/179 (48%), Gaps = 14/179 (7%)
Query: 166 ENEVQTLSQCK-HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
           + E+  L  C+ H N+++L  + ++ ++  +V E +  G L++R+ +  +    +++   
Sbjct: 53  QKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--- 109
Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTM 280
            I   +  A+ ++H +   ++HRD+K  N+L    ++N   K+ DFG  ++    N    
Sbjct: 110 YIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL- 166
Query: 281 YTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
             +    T  Y  PE ++        D++S GVIL  +L+G  P   ++  L     VE
Sbjct: 167 --KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE 223

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 63/131 (48%), Gaps = 12/131 (9%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           IV EYM        LA V    PL           +   L Y+HS +  ++HRD+K AN+
Sbjct: 99  IVQEYMETD-----LANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANL 151
Query: 254 LLD-ENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFS 309
            ++ E+ V K+GDFG+ + M    + K   +E L  T+ Y  P  +      +   D+++
Sbjct: 152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWA 210
Query: 310 YGVILLELLTG 320
            G I  E+LTG
Sbjct: 211 AGCIFAEMLTG 221

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 28/213 (13%)
Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           ++G G +GTVY  +   +G  +A+K++                  +        ++ L  
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL--------LRRLEA 62
Query: 175 CKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIA 226
            +H N++RL+ +C        I   +V+E++      D    ++  PP  L +     + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETIKDLM 118
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
                 L +LH+    I+HRD+K  N+L+      KL DFG+ ++        M    + 
Sbjct: 119 RQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ----MALAPVV 172
Query: 287 GTRPYMPPEA-MHCQISTKTDVFSYGVILLELL 318
            T  Y  PE  +    +T  D++S G I  E+ 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 65/153 (42%), Gaps = 16/153 (10%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V EY   G L   L++     P +  + Y     +  A+  +H L    +HRD+K  N+
Sbjct: 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE--IVMAIDSVHRLG--YVHRDIKPDNI 193
Query: 254 LLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--------QISTK 304
           LLD     +L DFG  +K+     ++++      GT  Y+ PE +              +
Sbjct: 194 LLDRCGHIRLADFGSCLKLRADGTVRSLVA---VGTPDYLSPEILQAVGGGPGTGSYGPE 250
Query: 305 TDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 337
            D ++ GV   E+  G  P   ++T   Y  +V
Sbjct: 251 CDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 117 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 175
           +G G FG     + K   E +AVK +E                       + E+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN--------------VKREIINHRSL 72
Query: 176 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
           +H N++R   +     +  IV EY   G L++R+    N      ++       +   + 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVS 129
Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLG--DFGIVKMSETSNMKTMYTENLTGTRPYM 292
           Y H++   + HRD+K  N LLD +  P+L    FG  K    S++     ++  GT  Y+
Sbjct: 130 YCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSK----SSVLHSQPKSTVGTPAYI 183
Query: 293 PPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 326
            PE +  +       DV+S GV L  +L G  P +D
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 35/218 (16%)
Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           ++G G +GTVY  +   +G  +A+K++                     LL     + L  
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL-----RRLEA 70
Query: 175 CKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIA 226
            +H N++RL+ +C        I   +V+E++      D    ++  PP  L +     + 
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETIKDLM 126
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMKTMY 281
                 L +LH+    I+HRD+K  N+L+      KL DFG+ +     M+ T  + T++
Sbjct: 127 RQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLW 184
Query: 282 TENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELL 318
                    Y  PE  +    +T  D++S G I  E+ 
Sbjct: 185 ---------YRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 18/144 (12%)
Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +V+E M  GS+   + +  +   L+++    +   VA AL +LH+  K I HRD+K  N+
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEAS---VVVQDVASALDFLHN--KGIAHRDLKPENI 142
Query: 254 LLDE--NFVP-KLGDF----GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------Q 300
           L +      P K+ DF    GI    + S + T       G+  YM PE +         
Sbjct: 143 LCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI 202
Query: 301 ISTKTDVFSYGVILLELLTGMKPI 324
              + D++S GVIL  LL+G  P 
Sbjct: 203 YDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 57/122 (46%), Gaps = 13/122 (10%)
Query: 217 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 276
           LD  +   +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS 
Sbjct: 116 LDHERMSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 173
Query: 277 MKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNT 329
           M T Y      TR Y  PE  +        D++S G I+ E      L  G   ID  N 
Sbjct: 174 MMTPY----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229
Query: 330 IL 331
           ++
Sbjct: 230 VI 231

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +          Y       
Sbjct: 200 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKGDAR 254
Query: 289 RP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
            P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 255 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 293

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +          Y       
Sbjct: 207 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKGDAR 261
Query: 289 RP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
            P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 262 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 300

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +          Y       
Sbjct: 209 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKGDAR 263
Query: 289 RP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
            P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 264 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 302

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 57/122 (46%), Gaps = 13/122 (10%)
Query: 217 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 276
           LD  +   +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS 
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 277 MKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNT 329
           M T Y      TR Y  PE  +        D++S G I+ E      L  G   ID  N 
Sbjct: 181 MMTPY----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236
Query: 330 IL 331
           ++
Sbjct: 237 VI 238

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +          Y       
Sbjct: 202 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKGDAR 256
Query: 289 RP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 323
            P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 57/122 (46%), Gaps = 13/122 (10%)
Query: 217 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 276
           LD  +   +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS 
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 277 MKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNT 329
           M T Y      TR Y  PE  +        D++S G I+ E      L  G   ID  N 
Sbjct: 181 MMTPY----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236
Query: 330 IL 331
           ++
Sbjct: 237 VI 238

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 28/213 (13%)
Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 174
           ++G G +GTVY  +   +G  +A+K++                  +        ++ L  
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL--------LRRLEA 62
Query: 175 CKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIA 226
            +H N++RL+ +C        I   +V+E++      D    ++  PP  L +     + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETIKDLM 118
Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
                 L +LH+    I+HRD+K  N+L+      KL DFG+ ++        M    + 
Sbjct: 119 RQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ----MALFPVV 172
Query: 287 GTRPYMPPEA-MHCQISTKTDVFSYGVILLELL 318
            T  Y  PE  +    +T  D++S G I  E+ 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 74/149 (49%), Gaps = 26/149 (17%)
Query: 193 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 251
           C+++E +   SLY+ + R N N   ++  K Y I   + +AL+YL  +S  + H D+K  
Sbjct: 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIE--ILKALNYLRKMS--LTHTDLKPE 166
Query: 252 NVLLDENF-------VPKLGDFGIVKMSET------------SNMKTMYTENLTGTRPYM 292
           N+LLD+ +       V ++ D   +++  T            +  K+ Y  ++  TR Y 
Sbjct: 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR 226
Query: 293 PPEA-MHCQISTKTDVFSYGVILLELLTG 320
            PE  ++      +D++S+G +L EL TG
Sbjct: 227 APEVILNLGWDVSSDMWSFGCVLAELYTG 255

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL 331
             PE  +        D++S G I+ E      L  G   ID  N ++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL 331
             PE  +        D++S G I+ E      L  G   ID  N ++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 176 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 229
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL 331
             PE  +        D++S G I+ E      L  G   ID  N ++
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 276

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 54/109 (49%), Gaps = 7/109 (6%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M   +      TR Y
Sbjct: 140 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV----TRYY 193
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
             PE  +        D++S G I+ E++ G       + I  +  V+EQ
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 242

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 176 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 229
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL 331
             PE  +        D++S G I+ E      L  G   ID  N ++
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 276

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 137 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY----VVTRYY 190
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL 331
             PE  +        D++S G I+ E      L  G   ID  N ++
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 237

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY----VVTRYY 191
Query: 292 MPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL 331
             PE  +        D++S G I+ E      L  G   ID  N ++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 81/173 (46%), Gaps = 17/173 (9%)
Query: 166 ENEVQTLSQCKHVNLLRLLGLCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
           +NE+  ++Q  H  L+ L     +    + + E++  G L+DR+A  +    +   +  +
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVIN 153
Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIV-KMSETSNMKTMY 281
                 E L ++H  S  I+H D+K  N++ +       K+ DFG+  K++    +K   
Sbjct: 154 YMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT- 210
Query: 282 TENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI---DDNNTI 330
               T T  +  PE +  + +   TD+++ GV+   LL+G+ P    DD  T+
Sbjct: 211 ----TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 259
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	593
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-90
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-33
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	6e-82
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-31
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-76
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-28
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-66
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-28
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-26
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-26
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-24
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-60
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-26
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-59
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-23
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-59
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-24
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-23
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-58
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-22
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-55
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-21
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-52
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-24
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-23
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-50
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-23
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-49
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-22
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-47
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-20
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-43
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-16
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-41
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-11
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-40
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-12
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-40
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-12
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-40
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-17
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-12
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-11
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-13
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-11
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-11
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-11
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-11
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-38
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-11
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-12
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-38
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-10
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-11
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-11
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-12
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-11
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-12
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-38
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-12
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-38
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-12
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-38
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-13
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-37
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-12
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-12
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-37
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-19
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-11
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-11
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-11
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-12
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-10
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-37
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-10
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-12
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-18
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-10
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-10
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-11
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-35
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-11
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-11
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-10
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-11
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-11
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-17
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-09
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-09
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-34
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-09
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-34
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-12
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-12
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-12
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-33
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-16
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-14
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-08
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-11
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-11
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-32
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-11
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-12
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-09
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-32
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-12
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-11
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-11
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-16
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-12
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-14
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-14
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-12
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-30
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-16
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-12
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-12
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-30
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-09
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-12
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-12
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-16
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-08
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-13
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-10
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-15
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-09
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-16
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-12
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-09
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-10
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-09
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-15
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-08
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-12
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-07
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-08
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-17
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-16
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-08
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-09
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-09
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-08
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-09
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-11
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-10
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-07
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-12
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-08
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-12
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-11
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-08
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-11
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-08
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-07
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-08
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-07
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-08
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-15
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-08
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-09
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-08
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-07
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-15
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-09
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-07
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-08
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-08
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-07
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-07
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-11
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-08
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-07
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-07
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-07
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-07
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-09
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-07
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-08
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-07
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-08
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-06
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-07
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-06
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-05
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-06
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-06
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-05
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-05
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-17
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-05
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-07
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-11
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-06
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-08
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-05
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-08
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-05
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-08
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-06
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-09
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-05
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-06
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-08
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-09
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-06
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-06
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-07
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-05
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-05
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-07
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-08
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-07
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-05
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-05
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-05
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-07
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-06
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-07
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-08
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-07
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-14
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-07
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-07
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-14
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-07
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-07
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-08
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-08
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-07
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-07
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-06
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  279 bits (717), Expect = 4e-90
 Identities = 106/307 (34%), Positives = 177/307 (57%), Gaps = 19/307 (6%)

Query: 88  GELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANY 147
               +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L    + 
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI 68

Query: 148 SSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD 206
           ++      +        F+ E++ +++C+H NL+ LLG   +    C+VY YM NGSL D
Sbjct: 69  TTEELKQ-Q--------FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119

Query: 207 RLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 266
           RL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ DF
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILLDEAFTAKISDF 177

Query: 267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDD 326
           G+ + SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D+
Sbjct: 178 GLARASEKFA-QTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 327 N----NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMR 382
           +      +     + ++E  + + +DK+  + + T VE +  +   +C   +K+KR  ++
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVAS-QCLHEKKNKRPDIK 295

Query: 383 DIVDLLS 389
            +  LL 
Sbjct: 296 KVQQLLQ 302

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  127 bits (322), Expect = 5e-33
 Identities = 45/104 (43%), Positives = 67/104 (64%), Gaps = 3/104 (2%)

Query: 443 LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 502
           L+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ DFG
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILLDEAFTAKISDFG 178

Query: 503 IVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYG 546
           + + SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+G
Sbjct: 179 LARASEKFA-QTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFG 221

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  259 bits (663), Expect = 6e-82
 Identities = 114/315 (36%), Positives = 162/315 (51%), Gaps = 33/315 (10%)

Query: 86  YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNA 145
           ++G+L  F+  +L+ A+D F+ K      N LG G FG VY G+L +G  +AVK L+   
Sbjct: 13  HLGQLKRFSLRELQVASDNFSNK------NILGRGGFGKVYKGRLADGTLVAVKRLKEE- 65

Query: 146 NYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL 204
               +     +        F+ EV+ +S   H NLLRL G C       +VY YM NGS+
Sbjct: 66  ---RTQGGELQ--------FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114

Query: 205 YDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPK 262
              L  R  + PPLD  KR  IALG A  L YLH    P IIHRDVK+AN+LLDE F   
Sbjct: 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174

Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGM 321
           +GDFG+ K+ +  +  T  T  + GT  ++ PE     + S KTDVF YGV+LLEL+TG 
Sbjct: 175 VGDFGLAKLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232

Query: 322 KPIDDNNTIL--YYYLV-----VEQEVPVREVLDKE-AGEWNETHVETLIGIVFEKCCVF 373
           +  D           L+     + +E  +  ++D +  G + +  VE LI +    C   
Sbjct: 233 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL-LCTQS 291

Query: 374 EKDKRASMRDIVDLL 388
              +R  M ++V +L
Sbjct: 292 SPMERPKMSEVVRML 306

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  124 bits (314), Expect = 1e-31
 Identities = 50/106 (47%), Positives = 63/106 (59%), Gaps = 8/106 (7%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPKLGDFGI 503
           R  + PPLD  KR  IALG A  L YLH    P IIHRDVK+AN+LLDE F   +GDFG+
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180

Query: 504 VKM--SETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
            K+   + ++V T     + GT  ++ PE     + S KTDVF YG
Sbjct: 181 AKLMDYKDTHVTT----AVRGTIGHIAPEYLSTGKSSEKTDVFGYG 222

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  243 bits (623), Expect = 5e-76
 Identities = 98/305 (32%), Positives = 149/305 (48%), Gaps = 32/305 (10%)

Query: 93  FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS 152
               DLE AT+ F+ K        +G G FG VY G L++G ++A+K          S+ 
Sbjct: 29  VPLVDLEEATNNFDHK------FLIGHGVFGKVYKGVLRDGAKVALKRRTPE-----SSQ 77

Query: 153 DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-NIMNCIVYEYMCNGSLYDRL-AR 210
              E        FE E++TLS C+H +L+ L+G C+      ++Y+YM NG+L   L   
Sbjct: 78  GIEE--------FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129

Query: 211 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
              T  +   +R  I +G A  LHYLH+  + IIHRDVKS N+LLDENFVPK+ DFGI K
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISK 187

Query: 271 MSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 329
                + +T  +  + GT  Y+ PE  +  +++ K+DV+S+GV+L E+L     I  +  
Sbjct: 188 KGTELD-QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246

Query: 330 ILYYYLV-----VEQEVPVREVLDKE-AGEWNETHVETLIGIVFEKCCVFEKDKRASMRD 383
                L            + +++D   A +     +         KC     + R SM D
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTA-VKCLALSSEDRPSMGD 305

Query: 384 IVDLL 388
           ++  L
Sbjct: 306 VLWKL 310

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  113 bits (284), Expect = 9e-28
 Identities = 44/106 (41%), Positives = 64/106 (60%), Gaps = 10/106 (9%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
               T  +   +R  I +G A  LHYLH+  + IIHRDVKS N+LLDENFVPK+ DFGI 
Sbjct: 129 SDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGIS 186

Query: 505 KM---SETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
           K     + +++ T     + GT  Y+ PE  +  +++ K+DV+S+G
Sbjct: 187 KKGTELDQTHLST----VVKGTLGYIDPEYFIKGRLTEKSDVYSFG 228

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  218 bits (557), Expect = 2e-66
 Identities = 84/279 (30%), Positives = 134/279 (48%), Gaps = 31/279 (11%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             K+G G FGTV+  +   G ++AVK L                       F  EV  + 
Sbjct: 42  KEKIGAGSFGTVHRAEWH-GSDVAVKILME-----QDFHAERVNE------FLREVAIMK 89

Query: 174 QCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + +H N++  +G      N  IV EY+  GSLY  L +      LD  +R S+A  VA+ 
Sbjct: 90  RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           ++YLH+ + PI+HR++KS N+L+D+ +  K+ DFG+ ++  ++ + +    +  GT  +M
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK---SAAGTPEWM 206

Query: 293 PPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV--PVREVLDK 349
            PE +  + S  K+DV+S+GVIL EL T  +P  + N       V  +     +   L+ 
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266

Query: 350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL 388
           +        V  +I    E C   E  KR S   I+DLL
Sbjct: 267 Q--------VAAII----EGCWTNEPWKRPSFATIMDLL 293

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  115 bits (290), Expect = 1e-28
 Identities = 36/109 (33%), Positives = 68/109 (62%), Gaps = 5/109 (4%)

Query: 440 LFK-LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL 498
           L++ L +      LD  +R S+A  VA+ ++YLH+ + PI+HR++KS N+L+D+ +  K+
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180

Query: 499 GDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYG 546
            DFG+ ++  ++ + +    +  GT  +M PE +  + S  K+DV+S+G
Sbjct: 181 CDFGLSRLKASTFLSSK---SAAGTPEWMAPEVLRDEPSNEKSDVYSFG 226

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  210 bits (536), Expect = 1e-63
 Identities = 69/290 (23%), Positives = 125/290 (43%), Gaps = 44/290 (15%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
             ++G+G FG V+ G+L  +   +A+K+L    +   +              F+ EV  +
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE------FQREVFIM 77

Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           S   H N+++L GL +N    +V E++  G LY RL   +   P+  + +  + L +A  
Sbjct: 78  SNLNHPNIVKLYGLMHNPP-RMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALG 134

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
           + Y+ + + PI+HRD++S N+ L           K+ DFG+ +     ++  +      G
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSVSGL-----LG 188

Query: 288 TRPYMPPEAM---HCQISTKTDVFSYGVILLELLTGMKPIDD--NNTILYYYLVVEQ--- 339
              +M PE +       + K D +S+ +IL  +LTG  P D+     I +  ++ E+   
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248

Query: 340 -EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL 388
             +P          E     +  +I    E C   +  KR     IV  L
Sbjct: 249 PTIP----------EDCPPRLRNVI----ELCWSGDPKKRPHFSYIVKEL 284

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  108 bits (271), Expect = 2e-26
 Identities = 24/108 (22%), Positives = 48/108 (44%), Gaps = 14/108 (12%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGDF 501
           +   P+  + +  + L +A  + Y+ + + PI+HRD++S N+ L           K+ DF
Sbjct: 114 DKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 502 GIVKMSETSNVKTMYTENLTGTRPYMPPEAM---HCQISTKTDVFSYG 546
           G+ + S      ++      G   +M PE +       + K D +S+ 
Sbjct: 174 GLSQQSVH----SVSGL--LGNFQWMAPETIGAEEESYTEKADTYSFA 215

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  207 bits (530), Expect = 1e-62
 Identities = 78/285 (27%), Positives = 126/285 (44%), Gaps = 45/285 (15%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
              +G G FG V   K +   ++A+K +          S++   A      F  E++ LS
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQI---------ESESERKA------FIVELRQLS 56

Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           +  H N+++L G C N + C+V EY   GSLY+ L      P   +    S  L  ++ +
Sbjct: 57  RVNHPNIVKLYGACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115

Query: 234 HYLHSLS-KPIIHRDVKSANVLLDENF-VPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            YLHS+  K +IHRD+K  N+LL     V K+ DFG     +T     M      G+  +
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNN--KGSAAW 169

Query: 292 MPPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILY-YYLVVEQ----EVPVRE 345
           M PE       + K DVFS+G+IL E++T  KP D+     +     V       +    
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI--- 226

Query: 346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
                  +     +E+L+     +C   +  +R SM +IV +++ 
Sbjct: 227 -------KNLPKPIESLM----TRCWSKDPSQRPSMEEIVKIMTH 260

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  109 bits (274), Expect = 1e-26
 Identities = 34/107 (31%), Positives = 48/107 (44%), Gaps = 9/107 (8%)

Query: 443 LARVNNTPPLDSNKRYSIALGVAEALHYLHSLS-KPIIHRDVKSANVLLDENF-VPKLGD 500
           L      P   +    S  L  ++ + YLHS+  K +IHRD+K  N+LL     V K+ D
Sbjct: 90  LHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 149

Query: 501 FGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYG 546
           FG     +T     M      G+  +M PE       + K DVFS+G
Sbjct: 150 FGTACDIQT----HMTNN--KGSAAWMAPEVFEGSNYSEKCDVFSWG 190

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  201 bits (514), Expect = 2e-60
 Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 28/279 (10%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           G ++G G FGTVY GK     ++AVK L       ++ +     A      F+NEV  L 
Sbjct: 29  GQRIGSGSFGTVYKGKWHG--DVAVKMLN-----VTAPTPQQLQA------FKNEVGVLR 75

Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +HVN+L  +G        IV ++    SLY  L    +    +  K   IA   A  +
Sbjct: 76  KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGM 133

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+       +    + +  +G+  +M 
Sbjct: 134 DYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL-SGSILWMA 190

Query: 294 PEAMHCQI----STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 349
           PE +  Q     S ++DV+++G++L EL+TG  P  + N       +V +          
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG--SLSPDLS 248

Query: 350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL 388
           +        ++ L+     +C   ++D+R S   I+  +
Sbjct: 249 KVRSNCPKRMKRLM----AECLKKKRDERPSFPRILAEI 283

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  103 bits (258), Expect = 1e-24
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 8/111 (7%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L+     +     +  K   IA   A  + YLH+  K IIHRD+KS N+ L E+   K+G
Sbjct: 106 LYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIG 162

Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQI----STKTDVFSYG 546
           DFG+       +    + +  +G+  +M PE +  Q     S ++DV+++G
Sbjct: 163 DFGLATEKSRWSGSHQFEQL-SGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  199 bits (508), Expect = 7e-60
 Identities = 62/288 (21%), Positives = 109/288 (37%), Gaps = 46/288 (15%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             KL E   G ++ G+ + G +I VK L+     +  + D           F  E   L 
Sbjct: 15  LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRD-----------FNEECPRLR 62

Query: 174 QCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
              H N+L +LG C +       ++  +M  GSLY+ L        +D ++    AL +A
Sbjct: 63  IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMA 121

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
             + +LH+L   I    + S +V++DE+   ++       +  +                
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMAD---VKFSFQSPGR-----MYAPA 173

Query: 291 YMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ----EVP 342
           ++ PEA+            D++S+ V+L EL+T   P  D + +     V  +     +P
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233

Query: 343 VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
                          HV  L+    + C   +  KR     IV +L K
Sbjct: 234 ----------PGISPHVSKLM----KICMNEDPAKRPKFDMIVPILEK 267

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  106 bits (268), Expect = 4e-26
 Identities = 18/111 (16%), Positives = 40/111 (36%), Gaps = 12/111 (10%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L+ +        +D ++    AL +A  + +LH+L   I    + S +V++DE+   ++ 
Sbjct: 96  LYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARIS 155

Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYG 546
                                     ++ PEA+            D++S+ 
Sbjct: 156 MAD------VKFSFQSPGR--MYAPAWVAPEALQKKPEDTNRRSADMWSFA 198

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  198 bits (506), Expect = 6e-59
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 45/292 (15%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           G  +G+G+FG VY+G+     E+A++ +    +    N D  +A       F+ EV    
Sbjct: 38  GELIGKGRFGQVYHGRWHG--EVAIRLI----DIERDNEDQLKA-------FKREVMAYR 84

Query: 174 QCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           Q +H N++  +G C +  +  I+       +LY  +   +    LD NK   IA  + + 
Sbjct: 85  QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR--DAKIVLDVNKTRQIAQEIVKG 142

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI--VKMSETSNMKTMYTENLTGTRP 290
           + YLH+  K I+H+D+KS NV  D   V  + DFG+  +     +  +        G   
Sbjct: 143 MGYLHA--KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLC 199

Query: 291 YMPPEAMHCQI----------STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
           ++ PE +              S  +DVF+ G I  EL     P          + +    
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259

Query: 341 VPV--REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            P   +  + KE        +  ++      C  FE+++R +   ++D+L K
Sbjct: 260 KPNLSQIGMGKE--------ISDIL----LFCWAFEQEERPTFTKLMDMLEK 299

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 32/119 (26%), Positives = 51/119 (42%), Gaps = 16/119 (13%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L+ + R      LD NK   IA  + + + YLH+  K I+H+D+KS NV  D   V  + 
Sbjct: 116 LYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYDNGKV-VIT 171

Query: 500 DFGI--VKMSETSNVKTMYTENLTGTRPYMPPEAMHCQI----------STKTDVFSYG 546
           DFG+  +     +  +        G   ++ PE +              S  +DVF+ G
Sbjct: 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  198 bits (505), Expect = 9e-59
 Identities = 73/329 (22%), Positives = 121/329 (36%), Gaps = 58/329 (17%)

Query: 93  FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS 152
               +L   +         +       G+FG V+  +L     +AVK        S    
Sbjct: 14  LGTENLYFQSMPL------QLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS---- 62

Query: 153 DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDR 207
                        E EV +L   KH N+L+ +G      +      ++  +   GSL D 
Sbjct: 63  ----------WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF 112

Query: 208 LARVNNTPPLDSNKRYSIALGVAEALHYLHS-------LSKP-IIHRDVKSANVLLDENF 259
           L        +  N+   IA  +A  L YLH          KP I HRD+KS NVLL  N 
Sbjct: 113 LKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168

Query: 260 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST------KTDVFSYGVI 313
              + DFG+    E +      T    GTR YM PE +   I+       + D+++ G++
Sbjct: 169 TACIADFGLALKFE-AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227

Query: 314 LLELLTGMKPIDDNNT--ILYYYLVVEQEVPVRE----VLDKEA-----GEWNETHVETL 362
           L EL +     D      +L +   + Q   + +    V+ K+        W +     +
Sbjct: 228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAM 287

Query: 363 IGIVFEKCCVFEK-DKRASMRDIVDLLSK 390
           +    E+ C     + R S   + + +++
Sbjct: 288 LCETIEE-CWDHDAEARLSAGCVGERITQ 315

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  102 bits (256), Expect = 4e-24
 Identities = 36/113 (31%), Positives = 49/113 (43%), Gaps = 19/113 (16%)

Query: 450 PPLDSNKRYSIALGVAEALHYLHS-------LSKP-IIHRDVKSANVLLDENFVPKLGDF 501
             +  N+   IA  +A  L YLH          KP I HRD+KS NVLL  N    + DF
Sbjct: 116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175

Query: 502 G--IVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQIST------KTDVFSYG 546
           G  +   +  S   T       GTR YM PE +   I+       + D+++ G
Sbjct: 176 GLALKFEAGKSAGDTH---GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG 225

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  196 bits (500), Expect = 1e-58
 Identities = 75/292 (25%), Positives = 122/292 (41%), Gaps = 48/292 (16%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
              +G G FG VY      G E+AVK   ++ +   S +         I     E +  +
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQT---------IENVRQEAKLFA 61

Query: 174 QCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
             KH N++ L G+C    N C+V E+   G L   L+       +  +   + A+ +A  
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARG 117

Query: 233 LHYLHSL-SKPIIHRDVKSANVLLDE--------NFVPKLGDFGIVKMSETSNMKTMYTE 283
           ++YLH     PIIHRD+KS+N+L+ +        N + K+ DFG+ +    +   +    
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA--- 174

Query: 284 NLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ--- 339
              G   +M PE +   + +  +DV+SYGV+L ELLTG  P    + +   Y V      
Sbjct: 175 --AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232

Query: 340 -EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
             +P                   L+    E C   +   R S  +I+D L+ 
Sbjct: 233 LPIP----------STCPEPFAKLM----EDCWNPDPHSRPSFTNILDQLTT 270

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 32/114 (28%), Positives = 57/114 (50%), Gaps = 15/114 (13%)

Query: 443 LARVNNTPPLDSNKRYSIALGVAEALHYLHSL-SKPIIHRDVKSANVLLDE--------N 493
           L RV +   +  +   + A+ +A  ++YLH     PIIHRD+KS+N+L+ +        N
Sbjct: 93  LNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152

Query: 494 FVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYG 546
            + K+ DFG+ +    +   +       G   +M PE +   + +  +DV+SYG
Sbjct: 153 KILKITDFGLAREWHRTTKMSA-----AGAYAWMAPEVIRASMFSKGSDVWSYG 201

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  189 bits (482), Expect = 1e-55
 Identities = 64/294 (21%), Positives = 111/294 (37%), Gaps = 46/294 (15%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G  LG+G FG       +  G  + +K L     +                 F  EV+ +
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRT----------FLKEVKVM 61

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
              +H N+L+ +G+         + EY+  G+L   +   +       ++R S A  +A 
Sbjct: 62  RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIAS 119

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL------ 285
            + YLHS    IIHRD+ S N L+ EN    + DFG+ ++      +     +L      
Sbjct: 120 GMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177

Query: 286 -----TGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
                 G   +M PE ++ +    K DVFS+G++L E++  +              +   
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--------DPDYLPRT 229

Query: 340 E---VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
               + VR  LD+            +      +CC  + +KR S   +   L  
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFFPIT----VRCCDLDPEKRPSFVKLEHWLET 279

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 14/112 (12%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
           +       ++R S A  +A  + YLHS    IIHRD+ S N L+ EN    + DFG+ ++
Sbjct: 100 SMDSQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLARL 157

Query: 507 SETSNVKTMYTENL-----------TGTRPYMPPEAMHCQIST-KTDVFSYG 546
                 +     +L            G   +M PE ++ +    K DVFS+G
Sbjct: 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFG 209

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  179 bits (455), Expect = 8e-52
 Identities = 68/306 (22%), Positives = 115/306 (37%), Gaps = 48/306 (15%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
              +G+G++G V+ G    G  +AVK          S+ D            E E+    
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIF--------SSRDEKSW------FRETELYNTV 57

Query: 174 QCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
             +H N+L  +       +      ++  Y   GSLYD L        LD+     I L 
Sbjct: 58  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLS 113

Query: 229 VAEALHYLHSLSK------PIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMY 281
           +A  L +LH           I HRD+KS N+L+ +N    + D G+ V  S+++N   + 
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173

Query: 282 TENLTGTRPYMPPEAMHCQIST-------KTDVFSYGVILLELLTGMKPIDDNNT--ILY 332
                GT+ YM PE +   I         + D++++G++L E+   M            +
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233

Query: 333 YYLVVEQ---EVPVREVLDKEA-----GEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
           Y +V      E   + V   +        W      T +  + ++C       R +   I
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293

Query: 385 VDLLSK 390
              L+K
Sbjct: 294 KKTLTK 299

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  101 bits (254), Expect = 5e-24
 Identities = 31/113 (27%), Positives = 51/113 (45%), Gaps = 14/113 (12%)

Query: 448 NTPPLDSNKRYSIALGVAEALHYLHSLSK------PIIHRDVKSANVLLDENFVPKLGDF 501
               LD+     I L +A  L +LH           I HRD+KS N+L+ +N    + D 
Sbjct: 98  QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157

Query: 502 GI-VKMSETSNVKTMYTENLTGTRPYMPPEAMHCQIST-------KTDVFSYG 546
           G+ V  S+++N   +      GT+ YM PE +   I         + D++++G
Sbjct: 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG 210

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  176 bits (449), Expect = 1e-50
 Identities = 71/306 (23%), Positives = 117/306 (38%), Gaps = 48/306 (15%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             ++G+G++G V+ GK + G ++AVK        S                 E E+    
Sbjct: 42  VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEAS--------------WFRETEIYQTV 86

Query: 174 QCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
             +H N+L  +              ++ +Y  NGSLYD L     +  LD+     +A  
Sbjct: 87  LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYS 142

Query: 229 VAEALHYLHSLSK------PIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMY 281
               L +LH+          I HRD+KS N+L+ +N    + D G+ VK    +N   + 
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202

Query: 282 TENLTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELLTGMKPIDDNNT--ILY 332
                GT+ YMPPE +       H Q     D++S+G+IL E+              + Y
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262

Query: 333 YYLVVEQ---EVPVREVLDKEA-----GEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
           + LV      E     V  K+        W+       +G +  +C       R +   +
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322

Query: 385 VDLLSK 390
              L+K
Sbjct: 323 KKTLAK 328

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  101 bits (253), Expect = 1e-23
 Identities = 32/113 (28%), Positives = 50/113 (44%), Gaps = 14/113 (12%)

Query: 448 NTPPLDSNKRYSIALGVAEALHYLHSLSK------PIIHRDVKSANVLLDENFVPKLGDF 501
            +  LD+     +A      L +LH+          I HRD+KS N+L+ +N    + D 
Sbjct: 127 KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186

Query: 502 GI-VKMSETSNVKTMYTENLTGTRPYMPPEAM-------HCQISTKTDVFSYG 546
           G+ VK    +N   +      GT+ YMPPE +       H Q     D++S+G
Sbjct: 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  173 bits (439), Expect = 4e-49
 Identities = 70/306 (22%), Positives = 123/306 (40%), Gaps = 48/306 (15%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
              +G+G+FG V+ GK + G E+AVK          S+ +            E E+    
Sbjct: 47  QESIGKGRFGEVWRGKWR-GEEVAVKIF--------SSREERSW------FREAEIYQTV 91

Query: 174 QCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
             +H N+L  +   N          +V +Y  +GSL+D L    N   +       +AL 
Sbjct: 92  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALS 147

Query: 229 VAEALHYLHS-----LSKP-IIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMY 281
            A  L +LH        KP I HRD+KS N+L+ +N    + D G+ V+    ++   + 
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207

Query: 282 TENLTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELLTGMKP--IDDNNTILY 332
             +  GT+ YM PE +       H +   + D+++ G++  E+        I ++  + Y
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267

Query: 333 YYLVVEQ---EVPVREVLDKEA-----GEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
           Y LV      E   + V +++        W       ++  +  +C       R +   I
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327

Query: 385 VDLLSK 390
              LS+
Sbjct: 328 KKTLSQ 333

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 30/113 (26%), Positives = 51/113 (45%), Gaps = 14/113 (12%)

Query: 448 NTPPLDSNKRYSIALGVAEALHYLHS-----LSKP-IIHRDVKSANVLLDENFVPKLGDF 501
           N   +       +AL  A  L +LH        KP I HRD+KS N+L+ +N    + D 
Sbjct: 132 NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191

Query: 502 GI-VKMSETSNVKTMYTENLTGTRPYMPPEAM-------HCQISTKTDVFSYG 546
           G+ V+    ++   +   +  GT+ YM PE +       H +   + D+++ G
Sbjct: 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  169 bits (429), Expect = 1e-47
 Identities = 56/278 (20%), Positives = 97/278 (34%), Gaps = 51/278 (18%)

Query: 91  IAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSS 150
           +     +     D        +    +G G++G VY G L +   +AVK        +  
Sbjct: 1   MEAAASEPSLDLDNL------KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-- 51

Query: 151 NSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN------CIVYEYMCNGSL 204
                        + E  +  +   +H N+ R +     +         +V EY  NGSL
Sbjct: 52  ------------FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSL 99

Query: 205 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHS------LSKP-IIHRDVKSANVLLDE 257
              L+        D      +A  V   L YLH+        KP I HRD+ S NVL+  
Sbjct: 100 XKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155

Query: 258 NFVPKLGDFGIVKM-----SETSNMKTMYTENLTGTRPYMPPEAMHCQIST--------K 304
           +    + DFG+              +     +  GT  YM PE +   ++         +
Sbjct: 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ 215

Query: 305 TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
            D+++ G+I  E+      +    ++  Y +  + EV 
Sbjct: 216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVG 253

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 92.6 bits (230), Expect = 1e-20
 Identities = 29/124 (23%), Positives = 47/124 (37%), Gaps = 20/124 (16%)

Query: 443 LARVNNTPPLDSNKRYSIALGVAEALHYLHS------LSKP-IIHRDVKSANVLLDENFV 495
           L +  +    D      +A  V   L YLH+        KP I HRD+ S NVL+  +  
Sbjct: 99  LXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158

Query: 496 PKLGDFGIVKM-----SETSNVKTMYTENLTGTRPYMPPEAMHCQIST--------KTDV 542
             + DFG+              +     +  GT  YM PE +   ++         + D+
Sbjct: 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDM 218

Query: 543 FSYG 546
           ++ G
Sbjct: 219 YALG 222

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  158 bits (403), Expect = 2e-43
 Identities = 73/292 (25%), Positives = 113/292 (38%), Gaps = 54/292 (18%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G ++G G FG V+ G+L+ +   +AVK+             + +A       F  E + L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL------PPDLKAK------FLQEARIL 166

Query: 173 SQCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            Q  H N++RL+G+C     I   IV E +  G     L        L       +    
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIY--IVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDA 222

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           A  + YL S  K  IHRD+ + N L+ E  V K+ DFG   MS                 
Sbjct: 223 AAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFG---MSREEADGVYAASGGLRQV 277

Query: 290 PY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE 345
           P     PEA++    S+++DV+S+G++L E  + G  P        Y        +  ++
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP--------Y------PNLSNQQ 323

Query: 346 VLDK-EAGEWNE------THVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
             +  E G            V  L+    E+C  +E  +R S   I   L  
Sbjct: 324 TREFVEKGGRLPCPELCPDAVFRLM----EQCWAYEPGQRPSFSTIYQELQS 371

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 80.0 bits (198), Expect = 3e-16
 Identities = 29/103 (28%), Positives = 42/103 (40%), Gaps = 8/103 (7%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
                L       +    A  + YL S  K  IHRD+ + N L+ E  V K+ DFG   M
Sbjct: 205 TEGARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFG---M 259

Query: 507 SETSNVKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
           S                 P     PEA++    S+++DV+S+G
Sbjct: 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFG 302

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  150 bits (380), Expect = 7e-41
 Identities = 61/255 (23%), Positives = 110/255 (43%), Gaps = 32/255 (12%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 166
           +  ++LG+G FG+V   +        G  +AVK L+++        D           F+
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRD-----------FQ 72

Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E+Q L       +++  G+          +V EY+ +G L D L R  +   LD+++  
Sbjct: 73  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLL 130

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
             +  + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+      K  Y  
Sbjct: 131 LYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVV 186

Query: 284 NLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ 339
              G  P  +  PE+      S ++DV+S+GV+L EL T   K    +   L        
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246

Query: 340 EVPVREVLDK-EAGE 353
              +  +L+  E G+
Sbjct: 247 VPALSRLLELLEEGQ 261

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 26/103 (25%), Positives = 50/103 (48%), Gaps = 7/103 (6%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            +   LD+++    +  + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+
Sbjct: 119 RHRARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKL 176

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYG 546
                 K  Y     G  P  +  PE+      S ++DV+S+G
Sbjct: 177 LPLD--KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFG 217

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  147 bits (373), Expect = 2e-40
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 25/214 (11%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             +LG GQFG V+ G      ++AVK+L+  +    S              F  E   + 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDA-----------FLAEANLMK 63

Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           Q +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE +
Sbjct: 64  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGM 122

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY-- 291
            ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E       YT       P   
Sbjct: 123 AFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE----DNEYTAREGAKFPIKW 176

Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
             PEA++    + K+DV+S+G++L E++T G  P
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 29/105 (27%), Positives = 53/105 (50%), Gaps = 9/105 (8%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
           +  +   L  NK   +A  +AE + ++    +  IHRD+++AN+L+ +    K+ DFG+ 
Sbjct: 99  KTPSGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLA 156

Query: 505 KMSETSNVKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
           ++ E       YT       P     PEA++    + K+DV+S+G
Sbjct: 157 RLIE----DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  147 bits (372), Expect = 5e-40
 Identities = 63/255 (24%), Positives = 113/255 (44%), Gaps = 31/255 (12%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 166
           +R   LGEG FG V   +        G ++AVK+L+  +  +                 +
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD------------LK 71

Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E++ L    H N+++  G+C         ++ E++ +GSL + L +  N   ++  ++ 
Sbjct: 72  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQL 129

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
             A+ + + + YL S  +  +HRD+ + NVL++     K+GDFG+ K  ET   K  YT 
Sbjct: 130 KYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD--KEYYTV 185

Query: 284 NLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ 339
                 P  +  PE  M  +    +DV+S+GV L ELLT            L        
Sbjct: 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245

Query: 340 EVPVREVLDK-EAGE 353
           ++ V  +++  + G+
Sbjct: 246 QMTVTRLVNTLKEGK 260

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 65.4 bits (160), Expect = 7e-12
 Identities = 30/103 (29%), Positives = 51/103 (49%), Gaps = 7/103 (6%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            N   ++  ++   A+ + + + YL S  +  +HRD+ + NVL++     K+GDFG+ K 
Sbjct: 118 KNKNKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYG 546
            ET   K  YT       P  +  PE  M  +    +DV+S+G
Sbjct: 176 IETD--KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFG 216

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  146 bits (370), Expect = 6e-40
 Identities = 66/285 (23%), Positives = 113/285 (39%), Gaps = 43/285 (15%)

Query: 110 YPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 168
           + +   ++G G F TVY G   +  +E+A   L++     S               F+ E
Sbjct: 27  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-----------RQRFKEE 75

Query: 169 VQTLSQCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            + L   +H N++R      + +       +V E M +G+L   L R      +   + +
Sbjct: 76  AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSW 134

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 282
                + + L +LH+ + PIIHRD+K  N+ +       K+GD G+  +   S  K +  
Sbjct: 135 --CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-- 190

Query: 283 ENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
               GT  +M PE    +     DV+++G+ +LE+ T   P  +       Y  V   V 
Sbjct: 191 ---IGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247

Query: 343 ---VREVLDKEAGEWNETHVETLIGIVF-EKCCVFEKDKRASMRD 383
                +V   E  E               E C    KD+R S++D
Sbjct: 248 PASFDKVAIPEVKE-------------IIEGCIRQNKDERYSIKD 279

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 25/84 (29%), Positives = 42/84 (50%), Gaps = 6/84 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           + + L +LH+ + PIIHRD+K  N+ +       K+GD G+  +   S  K +      G
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-----IG 192

Query: 523 TRPYMPPEAMHCQISTKTDVFSYG 546
           T  +M PE    +     DV+++G
Sbjct: 193 TPEFMAPEMYEEKYDESVDVYAFG 216

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  145 bits (368), Expect = 2e-39
 Identities = 59/256 (23%), Positives = 112/256 (43%), Gaps = 33/256 (12%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 166
           +   +LG+G FG+V   +        G  +AVK L+              +    +  FE
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-------------HSTEEHLRDFE 59

Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E++ L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K  
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLL 117

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
                + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+      K  +  
Sbjct: 118 QYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD--KEFFKV 173

Query: 284 NLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-- 338
              G  P  +  PE+    + S  +DV+S+GV+L EL T ++            +  +  
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233

Query: 339 QEVPVREVLDK-EAGE 353
            ++ V  +++  +   
Sbjct: 234 GQMIVFHLIELLKNNG 249

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 7/103 (6%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            +   +D  K       + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+
Sbjct: 106 KHKERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKV 163

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYG 546
                 K  +     G  P  +  PE+    + S  +DV+S+G
Sbjct: 164 LPQD--KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFG 204

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  145 bits (368), Expect = 4e-39
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 45/253 (17%)

Query: 112 RRGNKLGEGQFGTVYYGKLKNGME-----IAVKTLENNANYSSSNSDNTEAAMIPILLFE 166
           ++   LG G FGTVY G      E     +A+K L       +S   N E          
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKE--------IL 65

Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           +E   ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWC 123

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
           + +A+ ++YL    + ++HRD+ + NVL+      K+ DFG+ K+            +  
Sbjct: 124 VQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAE 177

Query: 287 GTR---PYMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 341
           G +    +M  E++  +I + ++DV+SYGV + EL+T G KP        Y        +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--------Y------DGI 223

Query: 342 PVREVLDK-EAGE 353
           P  E+    E GE
Sbjct: 224 PASEISSILEKGE 236

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 24/104 (23%), Positives = 51/104 (49%), Gaps = 10/104 (9%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            +   + S    +  + +A+ ++YL    + ++HRD+ + NVL+      K+ DFG+ K+
Sbjct: 109 EHKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

Query: 507 SETSNVKTMYTENLTGTR---PYMPPEAMHCQI-STKTDVFSYG 546
                       +  G +    +M  E++  +I + ++DV+SYG
Sbjct: 167 LGAEE----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  145 bits (367), Expect = 4e-39
 Identities = 52/228 (22%), Positives = 101/228 (44%), Gaps = 34/228 (14%)

Query: 114 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           G  LG+G+FG+V   +LK      +++AVK L+ +   SS   +           F  E 
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-----------FLREA 76

Query: 170 QTLSQCKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSL--YDRLARVNNTP-PLDS 219
             + +  H ++ +L+G+           +  ++  +M +G L  +   +R+   P  L  
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136

Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
                  + +A  + YL S  +  IHRD+ + N +L E+    + DFG   +S       
Sbjct: 137 QTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCVADFG---LSRKIYSGD 191

Query: 280 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
            Y +      P  ++  E++   + +  +DV+++GV + E++T G  P
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 68.5 bits (168), Expect = 9e-13
 Identities = 23/103 (22%), Positives = 44/103 (42%), Gaps = 8/103 (7%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            N   L         + +A  + YL S  +  IHRD+ + N +L E+    + DFG   +
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCVADFG---L 183

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           S        Y +      P  ++  E++   + +  +DV+++G
Sbjct: 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFG 226

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  143 bits (362), Expect = 9e-39
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 31/217 (14%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             +LG GQFG V YGK +   ++A+K ++  +    S  +           F  E + + 
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDE-----------FIEEAKVMM 74

Query: 174 QCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
              H  L++L G+C     I   I+ EYM NG L + L R        + +   +   V 
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIF--IITEYMANGCLLNYL-R-EMRHRFQTQQLLEMCKDVC 130

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           EA+ YL   SK  +HRD+ + N L+++  V K+ DFG+ +          YT ++    P
Sbjct: 131 EAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL----DDEYTSSVGSKFP 184

Query: 291 Y--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
               PPE +     S+K+D++++GV++ E+ + G  P
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 27/91 (29%), Positives = 47/91 (51%), Gaps = 9/91 (9%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
            +   V EA+ YL S  K  +HRD+ + N L+++  V K+ DFG+ +          YT 
Sbjct: 124 EMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL----DDEYTS 177

Query: 519 NLTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
           ++    P    PPE +     S+K+D++++G
Sbjct: 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 208

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  144 bits (364), Expect = 1e-38
 Identities = 67/255 (26%), Positives = 107/255 (41%), Gaps = 33/255 (12%)

Query: 112 RRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 166
           ++   LGEG FG V            G  +AVK L+ +A     +             ++
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG------------WK 81

Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E+  L    H ++++  G C +       +V EY+  GSL D L R      +   +  
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR----HSIGLAQLL 137

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
             A  + E + YLH+  +  IHRD+ + NVLLD + + K+GDFG+ K          Y  
Sbjct: 138 LFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG--HEYYRV 193

Query: 284 NLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ 339
              G  P  +  PE +   +    +DV+S+GV L ELLT            L    + + 
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253

Query: 340 EVPVREVLDK-EAGE 353
           ++ V  + +  E GE
Sbjct: 254 QMTVLRLTELLERGE 268

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 62.7 bits (153), Expect = 7e-11
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 7/91 (7%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
             A  + E + YLH+  +  IHRD+ + NVLLD + + K+GDFG+ K          Y  
Sbjct: 138 LFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG--HEYYRV 193

Query: 519 NLTGTRP--YMPPEAM-HCQISTKTDVFSYG 546
              G  P  +  PE +   +    +DV+S+G
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFG 224

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  142 bits (360), Expect = 1e-38
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 31/217 (14%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             ++G GQFG V+ G   N  ++A+KT+   A    S  D           F  E + + 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEED-----------FIEEAEVMM 58

Query: 174 QCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           +  H  L++L G+C     I   +V E+M +G L D L R        +     + L V 
Sbjct: 59  KLSHPKLVQLYGVCLEQAPIC--LVTEFMEHGCLSDYL-R-TQRGLFAAETLLGMCLDVC 114

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           E + YL      +IHRD+ + N L+ EN V K+ DFG+ +          YT +     P
Sbjct: 115 EGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL----DDQYTSSTGTKFP 168

Query: 291 Y--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
                PE       S+K+DV+S+GV++ E+ + G  P
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 64.5 bits (158), Expect = 1e-11
 Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 9/91 (9%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
            + L V E + YL      +IHRD+ + N L+ EN V K+ DFG+ +          YT 
Sbjct: 108 GMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL----DDQYTS 161

Query: 519 NLTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
           +     P     PE       S+K+DV+S+G
Sbjct: 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFG 192

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  144 bits (364), Expect = 1e-38
 Identities = 60/256 (23%), Positives = 112/256 (43%), Gaps = 33/256 (12%)

Query: 112 RRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 166
           +   +LG+G FG+V   +        G  +AVK L+              +    +  FE
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-------------HSTEEHLRDFE 90

Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            E++ L   +H N+++  G+C +       ++ EY+  GSL D L +  +   +D  K  
Sbjct: 91  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLL 148

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
                + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+      K  Y  
Sbjct: 149 QYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD--KEYYKV 204

Query: 284 NLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-- 338
              G  P  +  PE+    + S  +DV+S+GV+L EL T ++            +  +  
Sbjct: 205 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264

Query: 339 QEVPVREVLDK-EAGE 353
            ++ V  +++  +   
Sbjct: 265 GQMIVFHLIELLKNNG 280

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 28/103 (27%), Positives = 48/103 (46%), Gaps = 7/103 (6%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            +   +D  K       + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+
Sbjct: 137 KHKERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKV 194

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYG 546
                 K  Y     G  P  +  PE+    + S  +DV+S+G
Sbjct: 195 LPQD--KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFG 235

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  141 bits (359), Expect = 1e-38
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 31/217 (14%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             +LG GQFG V  GK K   ++AVK ++  +    S  +           F  E QT+ 
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDE-----------FFQEAQTMM 58

Query: 174 QCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           +  H  L++  G+C+    I   IV EY+ NG L + L   ++   L+ ++   +   V 
Sbjct: 59  KLSHPKLVKFYGVCSKEYPIY--IVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVC 114

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           E + +L   S   IHRD+ + N L+D +   K+ DFG+ +          Y  ++    P
Sbjct: 115 EGMAFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL----DDQYVSSVGTKFP 168

Query: 291 Y--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
                PE  H    S+K+DV+++G+++ E+ + G  P
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 64.1 bits (157), Expect = 2e-11
 Identities = 25/91 (27%), Positives = 42/91 (46%), Gaps = 9/91 (9%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
            +   V E + +L S     IHRD+ + N L+D +   K+ DFG+ +          Y  
Sbjct: 108 EMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL----DDQYVS 161

Query: 519 NLTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
           ++    P     PE  H    S+K+DV+++G
Sbjct: 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFG 192

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  141 bits (359), Expect = 2e-38
 Identities = 74/237 (31%), Positives = 112/237 (47%), Gaps = 43/237 (18%)

Query: 101 ATDGFNRKPY--PRR----GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDN 154
           A D F R  +    +       +G+G+FG V  G  + G ++AVK +          +D 
Sbjct: 7   AQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI---------KNDA 56

Query: 155 TEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC----NNIMNCIVYEYMCNGSLYDRLAR 210
           T  A      F  E   ++Q +H NL++LLG+       +   IV EYM  GSL D L R
Sbjct: 57  TAQA------FLAEASVMTQLRHSNLVQLLGVIVEEKGGLY--IVTEYMAKGSLVDYL-R 107

Query: 211 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
                 L  +     +L V EA+ YL       +HRD+ + NVL+ E+ V K+ DFG   
Sbjct: 108 SRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFG--- 162

Query: 271 MSETSNMKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
           ++     K   +   TG  P     PEA+  +  STK+DV+S+G++L E+ + G  P
Sbjct: 163 LT-----KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 64.9 bits (159), Expect = 9e-12
 Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 13/105 (12%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
           R      L  +     +L V EA+ YL       +HRD+ + NVL+ E+ V K+ DFG  
Sbjct: 107 RSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFG-- 162

Query: 505 KMSETSNVKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
            ++     K   +   TG  P     PEA+  +  STK+DV+S+G
Sbjct: 163 -LT-----KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFG 201

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  141 bits (358), Expect = 3e-38
 Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 24/220 (10%)

Query: 112 RRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
           R   KLG+G FG V  G+        + +AVK L    +  S      +        F  
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL--KPDVLSQPEAMDD--------FIR 70

Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           EV  +    H NL+RL G+       +V E    GSL DRL    +            A+
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRYAV 128

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
            VAE + YL   SK  IHRD+ + N+LL    + K+GDFG+++    ++    Y      
Sbjct: 129 QVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND--DHYVMQEHR 184

Query: 288 TRPY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
             P+    PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 27/103 (26%), Positives = 47/103 (45%), Gaps = 7/103 (6%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            +            A+ VAE + YL S  K  IHRD+ + N+LL    + K+GDFG+++ 
Sbjct: 113 KHQGHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170

Query: 507 SETSNVKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
              ++    Y        P+    PE++  +  S  +D + +G
Sbjct: 171 LPQND--DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 211

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  142 bits (361), Expect = 3e-38
 Identities = 61/253 (24%), Positives = 111/253 (43%), Gaps = 45/253 (17%)

Query: 112 RRGNKLGEGQFGTVYYGKLKNGME-----IAVKTLENNANYSSSNSDNTEAAMIPILLFE 166
           R+   LG G FGTV+ G      E     + +K +E+ +    S                
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQA-----------VT 63

Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + +  +    H +++RLLGLC      +V +Y+  GSL D +    +   L      +  
Sbjct: 64  DHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWG 121

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
           + +A+ ++YL      ++HR++ + NVLL      ++ DFG+  +    + + +Y    +
Sbjct: 122 VQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY----S 175

Query: 287 GTR---PYMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 341
             +    +M  E++H    + ++DV+SYGV + EL+T G +P        Y        +
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP--------Y------AGL 221

Query: 342 PVREVLDK-EAGE 353
            + EV D  E GE
Sbjct: 222 RLAEVPDLLEKGE 234

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 22/104 (21%), Positives = 50/104 (48%), Gaps = 10/104 (9%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            +   L      +  + +A+ ++YL      ++HR++ + NVLL      ++ DFG+  +
Sbjct: 107 QHRGALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADL 164

Query: 507 SETSNVKTMYTENLTGTR---PYMPPEAMHCQI-STKTDVFSYG 546
               + + +Y    +  +    +M  E++H    + ++DV+SYG
Sbjct: 165 LPPDDKQLLY----SEAKTPIKWMALESIHFGKYTHQSDVWSYG 204

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  141 bits (357), Expect = 3e-38
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 28/218 (12%)

Query: 114 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
              LGEG FG VY G   N     + +AVKT     + +  N +           F +E 
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEK----------FMSEA 64

Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
             +    H ++++L+G+       I+ E    G L   L    N   L        +L +
Sbjct: 65  VIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLE--RNKNSLKVLTLVLYSLQI 122

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
            +A+ YL   S   +HRD+   N+L+      KLGDFG+ +  E  +    Y +      
Sbjct: 123 CKAMAYLE--SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRL 176

Query: 290 P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
           P  +M PE+++ +  +T +DV+ + V + E+L+ G +P
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 9/103 (8%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            N   L        +L + +A+ YL S     +HRD+   N+L+      KLGDFG+ + 
Sbjct: 105 RNKNSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDFGLSRY 162

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
            E  +    Y +      P  +M PE+++ +  +T +DV+ + 
Sbjct: 163 IEDED----YYKASVTRLPIKWMSPESINFRRFTTASDVWMFA 201

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  145 bits (367), Expect = 5e-38
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 25/214 (11%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             KLG GQFG V+        ++AVKT+            +          F  E   + 
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM---------KPGSMSVEA-----FLAEANVMK 238

Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
             +H  L++L  +       I+ E+M  GSL D L + +        K    +  +AE +
Sbjct: 239 TLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGM 297

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY-- 291
            ++    +  IHRD+++AN+L+  + V K+ DFG+ ++ E +     YT       P   
Sbjct: 298 AFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKW 351

Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
             PEA++    + K+DV+S+G++L+E++T G  P
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 66.6 bits (163), Expect = 9e-12
 Identities = 27/105 (25%), Positives = 52/105 (49%), Gaps = 9/105 (8%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
           + +        K    +  +AE + ++    +  IHRD+++AN+L+  + V K+ DFG+ 
Sbjct: 274 KSDEGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLA 331

Query: 505 KMSETSNVKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
           ++ E +     YT       P     PEA++    + K+DV+S+G
Sbjct: 332 RVIEDNE----YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG 372

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  140 bits (356), Expect = 5e-38
 Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 28/218 (12%)

Query: 114 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           G  +GEGQFG V+ G   +     + +A+KT       S S  +           F  E 
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREK----------FLQEA 67

Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            T+ Q  H ++++L+G+       I+ E    G L   L        LD       A  +
Sbjct: 68  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQL 125

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 126 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 179

Query: 290 P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
           P  +M PE+++ +  ++ +DV+ +GV + E+L  G+KP
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 9/103 (8%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
                LD       A  ++ AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ + 
Sbjct: 108 VRKYSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
            E S     Y +   G  P  +M PE+++ +  ++ +DV+ +G
Sbjct: 166 MEDST----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 204

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  141 bits (357), Expect = 5e-38
 Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 33/225 (14%)

Query: 112 RRGNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
                +G+G FG VY+G+  +     ++ A+K+L          +            F  
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA------------FLR 71

Query: 168 EVQTLSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
           E   +    H N+L L+G+      +  ++  YMC+G L   +   +           S 
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR--SPQRNPTVKDLISF 129

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
            L VA  + YL    +  +HRD+ + N +LDE+F  K+ DFG+ +          Y    
Sbjct: 130 GLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE----YYSVQ 183

Query: 286 TGTR---P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
                  P  +   E++     +TK+DV+S+GV+L ELLT G  P
Sbjct: 184 QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 27/106 (25%), Positives = 45/106 (42%), Gaps = 12/106 (11%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
           +           S  L VA  + YL    +  +HRD+ + N +LDE+F  K+ DFG+ + 
Sbjct: 116 SPQRNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLARD 173

Query: 507 SETSNVKTMYTENLTGTR---P--YMPPEAMHCQI-STKTDVFSYG 546
                    Y           P  +   E++     +TK+DV+S+G
Sbjct: 174 ILDRE----YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFG 215

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  140 bits (356), Expect = 6e-38
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 31/218 (14%)

Query: 114 GNKLGEGQFGTVYYGKLKNG-MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
            +KLG GQ+G VY G  K   + +AVKTL+ +        +           F  E   +
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEE-----------FLKEAAVM 63

Query: 173 SQCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            + KH NL++LLG+C         I+ E+M  G+L D L R  N   + +     +A  +
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFY--IITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQI 120

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           + A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     
Sbjct: 121 SSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKF 174

Query: 290 PY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
           P     PE++     S K+DV+++GV+L E+ T GM P
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 65.3 bits (160), Expect = 7e-12
 Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 9/105 (8%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
           R  N   + +     +A  ++ A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ 
Sbjct: 101 RECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLS 158

Query: 505 KMSETSNVKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
           ++         YT +     P     PE++     S K+DV+++G
Sbjct: 159 RLMTGDT----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 199

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  141 bits (357), Expect = 6e-38
 Identities = 70/222 (31%), Positives = 104/222 (46%), Gaps = 31/222 (13%)

Query: 114 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
              +G G FG VY+G L +     +  AVK+L           + ++        F  E 
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQ--------FLTEG 77

Query: 170 QTLSQCKHVNLLRLLGLCNNIMN--CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
             +    H N+L LLG+C        +V  YM +G L + + R N T            L
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-R-NETHNPTVKDLIGFGL 135

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY-TENLT 286
            VA+ + YL S  K  +HRD+ + N +LDE F  K+ DFG   ++     K  Y   N T
Sbjct: 136 QVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEYYSVHNKT 190

Query: 287 GTR-P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
           G + P  +M  E++  Q  +TK+DV+S+GV+L EL+T G  P
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 10/105 (9%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
           N T            L VA+ + YL S  K  +HRD+ + N +LDE F  K+ DFG   +
Sbjct: 120 NETHNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADFG---L 174

Query: 507 SETSNVKTMY-TENLTGTR-P--YMPPEAMHCQI-STKTDVFSYG 546
           +     K  Y   N TG + P  +M  E++  Q  +TK+DV+S+G
Sbjct: 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 219

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  141 bits (357), Expect = 8e-38
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 33/227 (14%)

Query: 114 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           G  LGEG+FG+V  G LK      +++AVKT++ +   +SS  +  E        F +E 
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD---NSSQREIEE--------FLSEA 87

Query: 170 QTLSQCKHVNLLRLLGLC------NNIMNCIVYEYMCNGSL--YDRLARVNNTP-PLDSN 220
             +    H N++RLLG+C            ++  +M  G L  Y   +R+   P  +   
Sbjct: 88  ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147

Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
                 + +A  + YL +  +  +HRD+ + N +L ++    + DFG   +S+       
Sbjct: 148 TLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDDMTVCVADFG---LSKKIYSGDY 202

Query: 281 YTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
           Y +      P  ++  E++  ++ ++K+DV+++GV + E+ T GM P
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 68.8 bits (169), Expect = 7e-13
 Identities = 19/103 (18%), Positives = 47/103 (45%), Gaps = 8/103 (7%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
                +         + +A  + YL +  +  +HRD+ + N +L ++    + DFG   +
Sbjct: 139 TGPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDDMTVCVADFG---L 193

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           S+       Y +      P  ++  E++  ++ ++K+DV+++G
Sbjct: 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 236

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  140 bits (355), Expect = 2e-37
 Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 33/222 (14%)

Query: 114 GNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
              +G G  G V YG+L+      + +A+K L   A Y+     +          F +E 
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRD----------FLSEA 101

Query: 170 QTLSQCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
             + Q  H N++RL G+       M  IV EYM NGSL   L    +       +   + 
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAM--IVTEYMENGSLDTFLR--THDGQFTIMQLVGML 157

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
            GV   + YL       +HRD+ + NVL+D N V K+ DFG   +S             T
Sbjct: 158 RGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFG---LSRVLEDDPDAAYTTT 212

Query: 287 GTR-PY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
           G + P     PEA+  +  S+ +DV+S+GV++ E+L  G +P
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 29/104 (27%), Positives = 46/104 (44%), Gaps = 9/104 (8%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            +       +   +  GV   + YL       +HRD+ + NVL+D N V K+ DFG   +
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFG---L 197

Query: 507 SETSNVKTMYTENLTGTR-PY--MPPEAMHCQI-STKTDVFSYG 546
           S             TG + P     PEA+  +  S+ +DV+S+G
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFG 241

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  143 bits (362), Expect = 3e-37
 Identities = 70/218 (32%), Positives = 106/218 (48%), Gaps = 37/218 (16%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
              +G+G+FG V  G  + G ++AVK +          +D T  A      F  E   ++
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCI---------KNDATAQA------FLAEASVMT 241

Query: 174 QCKHVNLLRLLGLC----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
           Q +H NL++LLG+       +   IV EYM  GSL D L R      L  +     +L V
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLY--IVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDV 298

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
            EA+ YL       +HRD+ + NVL+ E+ V K+ DFG   ++     K   +   TG  
Sbjct: 299 CEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFG---LT-----KEASSTQDTGKL 348

Query: 290 PY--MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 323
           P     PEA+   + STK+DV+S+G++L E+ + G  P
Sbjct: 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 13/105 (12%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
           R      L  +     +L V EA+ YL       +HRD+ + NVL+ E+ V K+ DFG  
Sbjct: 279 RSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFG-- 334

Query: 505 KMSETSNVKTMYTENLTGTRPY--MPPEAM-HCQISTKTDVFSYG 546
            ++     K   +   TG  P     PEA+   + STK+DV+S+G
Sbjct: 335 -LT-----KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFG 373

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  139 bits (352), Expect = 3e-37
 Identities = 54/217 (24%), Positives = 85/217 (39%), Gaps = 27/217 (12%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           +R ++LG G +G V+  + K +G   AVK              +    +        EV 
Sbjct: 60  QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS----MSPFRGPKDRARKL-------AEVG 108

Query: 171 TLSQ-CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           +  +  +H   +RL        I+  +  E  C  SL            L   + +    
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGIL-YLQTEL-CGPSLQQHCEAWGA--SLPEAQVWGYLR 164

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLT 286
               AL +LHS  + ++H DVK AN+ L      KLGDFG++  +      +        
Sbjct: 165 DTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ-----E 217

Query: 287 GTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKP 323
           G   YM PE +     T  DVFS G+ +LE+   M+ 
Sbjct: 218 GDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMEL 254

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 86.6 bits (215), Expect = 9e-19
 Identities = 29/84 (34%), Positives = 39/84 (46%), Gaps = 8/84 (9%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTG 522
              AL +LHS  + ++H DVK AN+ L      KLGDFG++  +      +        G
Sbjct: 166 TLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ-----EG 218

Query: 523 TRPYMPPEAMHCQISTKTDVFSYG 546
              YM PE +     T  DVFS G
Sbjct: 219 DPRYMAPELLQGSYGTAADVFSLG 242

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  142 bits (360), Expect = 5e-37
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 25/214 (11%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             KLG+G FG V+ G       +A+KTL       S  +            F  E Q + 
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEA------------FLQEAQVMK 234

Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  +
Sbjct: 235 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGM 293

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY-- 291
            Y+       +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P   
Sbjct: 294 AYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKW 347

Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
             PEA      + K+DV+S+G++L EL T G  P
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 9/105 (8%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
           +      L   +   +A  +A  + Y+       +HRD+++AN+L+ EN V K+ DFG+ 
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLA 327

Query: 505 KMSETSNVKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
           ++ E +     YT       P     PEA      + K+DV+S+G
Sbjct: 328 RLIEDNE----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 368

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  143 bits (362), Expect = 6e-37
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 25/214 (11%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             KLG+G FG V+ G       +A+KTL       S  +            F  E Q + 
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEA------------FLQEAQVMK 317

Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +H  L++L  + +     IV EYM  GSL D L +      L   +   +A  +A  +
Sbjct: 318 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGM 376

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY-- 291
            Y+       +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P   
Sbjct: 377 AYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKW 430

Query: 292 MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
             PEA      + K+DV+S+G++L EL T G  P
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 9/105 (8%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
           +      L   +   +A  +A  + Y+       +HRD+++AN+L+ EN V K+ DFG+ 
Sbjct: 353 KGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLA 410

Query: 505 KMSETSNVKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
           ++ E +     YT       P     PEA      + K+DV+S+G
Sbjct: 411 RLIEDNE----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 451

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  139 bits (352), Expect = 6e-37
 Identities = 63/223 (28%), Positives = 107/223 (47%), Gaps = 34/223 (15%)

Query: 114 GNKLGEGQFGTVYYGKLKNG-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 168
              +G G+FG VY G LK       + +A+KTL   A Y+     +          F  E
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVD----------FLGE 96

Query: 169 VQTLSQCKHVNLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
              + Q  H N++RL G+ +    +M  I+ EYM NG+L   L            +   +
Sbjct: 97  AGIMGQFSHHNIIRLEGVISKYKPMM--IITEYMENGALDKFLR--EKDGEFSVLQLVGM 152

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
             G+A  + YL +     +HRD+ + N+L++ N V K+ DFG+ ++ E     T  T   
Sbjct: 153 LRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-- 208

Query: 286 TGTR-PY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
            G + P     PEA+  +  ++ +DV+S+G+++ E++T G +P
Sbjct: 209 -GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 9/104 (8%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
                    +   +  G+A  + YL +     +HRD+ + N+L++ N V K+ DFG+ ++
Sbjct: 139 EKDGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196

Query: 507 SETSNVKTMYTENLTGTR-PY--MPPEAMHCQI-STKTDVFSYG 546
            E  + +  YT   +G + P     PEA+  +  ++ +DV+S+G
Sbjct: 197 LE-DDPEATYTT--SGGKIPIRWTAPEAISYRKFTSASDVWSFG 237

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  140 bits (354), Expect = 6e-37
 Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 29/221 (13%)

Query: 114 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
              +G G FG VY+G L +     +  AVK+L           + ++        F  E 
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQ--------FLTEG 141

Query: 170 QTLSQCKHVNLLRLLGLCNNIMN--CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
             +    H N+L LLG+C        +V  YM +G L + + R N T            L
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-R-NETHNPTVKDLIGFGL 199

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
            VA+ + +L S  K  +HRD+ + N +LDE F  K+ DFG+ +        +++ +  TG
Sbjct: 200 QVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK--TG 255

Query: 288 TR-P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
            + P  +M  E++  Q  +TK+DV+S+GV+L EL+T G  P
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 8/104 (7%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
           N T            L VA+ + +L S  K  +HRD+ + N +LDE F  K+ DFG+ + 
Sbjct: 184 NETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARD 241

Query: 507 SETSNVKTMYTENLTGTR-P--YMPPEAMHCQI-STKTDVFSYG 546
                  +++ +  TG + P  +M  E++  Q  +TK+DV+S+G
Sbjct: 242 MYDKEFDSVHNK--TGAKLPVKWMALESLQTQKFTTKSDVWSFG 283

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  137 bits (348), Expect = 7e-37
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 25/215 (11%)

Query: 116 KLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           +LG G FG+V  G  +     +++A+K L+     + +                 E Q +
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE------------MMREAQIM 64

Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            Q  +  ++RL+G+C      +V E    G L+  L        +  +    +   V+  
Sbjct: 65  HQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMG 122

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY- 291
           + YL    K  +HRD+ + NVLL      K+ DFG+ K     +  + YT    G  P  
Sbjct: 123 MKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLK 178

Query: 292 -MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
              PE ++ +  S+++DV+SYGV + E L+ G KP
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 60.7 bits (148), Expect = 2e-10
 Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 7/90 (7%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +   V+  + YL    K  +HRD+ + NVLL      K+ DFG+ K     +  + YT  
Sbjct: 115 LLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTAR 170

Query: 520 LTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
             G  P     PE ++ +  S+++DV+SYG
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYG 200

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  137 bits (348), Expect = 8e-37
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 25/215 (11%)

Query: 116 KLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           +LG G FGTV  G  +       +AVK L+N AN  +   +              E   +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE-----------LLAEANVM 72

Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            Q  +  ++R++G+C      +V E    G L   L        +       +   V+  
Sbjct: 73  QQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMG 129

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY- 291
           + YL       +HRD+ + NVLL      K+ DFG+ K          Y     G  P  
Sbjct: 130 MKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQTHGKWPVK 185

Query: 292 -MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
              PE ++    S+K+DV+S+GV++ E  + G KP
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 26/91 (28%), Positives = 40/91 (43%), Gaps = 7/91 (7%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE 518
            +   V+  + YL       +HRD+ + NVLL      K+ DFG+ K          Y  
Sbjct: 121 ELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKA 176

Query: 519 NLTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
              G  P     PE ++    S+K+DV+S+G
Sbjct: 177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFG 207

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  141 bits (357), Expect = 2e-36
 Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 31/218 (14%)

Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
            +KLG GQ+G VY G  K   + +AVKTL+ +        +           F  E   +
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEE-----------FLKEAAVM 270

Query: 173 SQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            + KH NL++LLG+C         I+ E+M  G+L D L R  N   + +     +A  +
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFY--IITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQI 327

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           + A+ YL    K  IHR++ + N L+ EN + K+ DFG+ ++         YT +     
Sbjct: 328 SSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKF 381

Query: 290 PY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
           P     PE++     S K+DV+++GV+L E+ T GM P
Sbjct: 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 28/105 (26%), Positives = 50/105 (47%), Gaps = 9/105 (8%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
           R  N   + +     +A  ++ A+ YL    K  IHR++ + N L+ EN + K+ DFG+ 
Sbjct: 308 RECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLS 365

Query: 505 KMSETSNVKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
           ++         YT +     P     PE++     S K+DV+++G
Sbjct: 366 RLMTGDT----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 406

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  137 bits (347), Expect = 2e-36
 Identities = 57/240 (23%), Positives = 94/240 (39%), Gaps = 33/240 (13%)

Query: 106 NRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL 164
           + K Y     KLGEG F  V   + L +G   A+K +            + E A      
Sbjct: 27  DNKHY-LFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL------CHEQQDREEAQ----- 74

Query: 165 FENEVQTLSQCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRL-ARVNNTPPLD 218
              E        H N+LRL+  C           ++  +   G+L++ +    +    L 
Sbjct: 75  --READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132

Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE---TS 275
            ++   + LG+   L  +H+  K   HRD+K  N+LL +   P L D G +  +      
Sbjct: 133 EDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190

Query: 276 NMKTMYTENL---TGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
           + + +  ++      T  Y  PE      HC I  +TDV+S G +L  ++ G  P D   
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 28/97 (28%), Positives = 44/97 (45%), Gaps = 12/97 (12%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE---TSNVKTMY 516
           + LG+   L  +H+  K   HRD+K  N+LL +   P L D G +  +      + + + 
Sbjct: 139 LLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196

Query: 517 TENL---TGTRPYMPPE----AMHCQISTKTDVFSYG 546
            ++      T  Y  PE      HC I  +TDV+S G
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG 233

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  137 bits (346), Expect = 3e-36
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 45/253 (17%)

Query: 112 RRGNKLGEGQFGTVYYGKLKNGME-----IAVKTLENNANYSSSNSDNTEAAMIPILLFE 166
           ++   LG G FGTVY G      E     +A+K L       +S   N E          
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKE--------IL 65

Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           +E   ++   + ++ RLLG+C      ++ + M  G L D +    +   + S    +  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWC 123

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
           + +A+ ++YL    + ++HRD+ + NVL+      K+ DFG+ K+            +  
Sbjct: 124 VQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAE 177

Query: 287 GTR---PYMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 341
           G +    +M  E++  +I + ++DV+SYGV + EL+T G KP        Y        +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--------Y------DGI 223

Query: 342 PVREVLDK-EAGE 353
           P  E+    E GE
Sbjct: 224 PASEISSILEKGE 236

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 24/104 (23%), Positives = 51/104 (49%), Gaps = 10/104 (9%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            +   + S    +  + +A+ ++YL    + ++HRD+ + NVL+      K+ DFG+ K+
Sbjct: 109 EHKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

Query: 507 SETSNVKTMYTENLTGTR---PYMPPEAMHCQI-STKTDVFSYG 546
                       +  G +    +M  E++  +I + ++DV+SYG
Sbjct: 167 LGAEE----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  135 bits (343), Expect = 4e-36
 Identities = 54/234 (23%), Positives = 97/234 (41%), Gaps = 41/234 (17%)

Query: 114 GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
             +LGE +FG VY G L           +A+KTL++ A                   F +
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA------EGPLREE------FRH 61

Query: 168 EVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRL-------------ARVNN 213
           E    ++ +H N++ LLG+   +    +++ Y  +G L++ L                  
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121

Query: 214 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 273
              L+      +   +A  + YL S    ++H+D+ + NVL+ +    K+ D G   +  
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLG---LFR 176

Query: 274 TSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
                  Y        P  +M PEA+     S  +D++SYGV+L E+ + G++P
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 24/103 (23%), Positives = 42/103 (40%), Gaps = 8/103 (7%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
                L+      +   +A  + YL S    ++H+D+ + NVL+ +    K+ D G   +
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLG---L 174

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
                    Y        P  +M PEA+     S  +D++SYG
Sbjct: 175 FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG 217

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  136 bits (344), Expect = 4e-36
 Identities = 66/243 (27%), Positives = 112/243 (46%), Gaps = 48/243 (19%)

Query: 110 YPRR----GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAM 159
             RR      +LGEG FG V+  +  N       M +AVK L+             +  +
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-------------DPTL 58

Query: 160 IPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD--RLARVNNTPP 216
                F+ E + L+  +H ++++  G+C +     +V+EYM +G L    R    +    
Sbjct: 59  AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 118

Query: 217 LDSNKR-----------YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 265
           +D   R             IA  +A  + YL S     +HRD+ + N L+  N + K+GD
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGD 176

Query: 266 FGIVKMSETSNMKTMYTENLTGTR-P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-G 320
           FG+ +   +++    Y      T  P  +MPPE++  +  +T++DV+S+GVIL E+ T G
Sbjct: 177 FGMSRDVYSTD----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 232

Query: 321 MKP 323
            +P
Sbjct: 233 KQP 235

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 63.0 bits (154), Expect = 5e-11
 Identities = 30/104 (28%), Positives = 54/104 (51%), Gaps = 10/104 (9%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
                L  ++   IA  +A  + YL S     +HRD+ + N L+  N + K+GDFG+ + 
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRD 182

Query: 507 SETSNVKTMYTENLTGTR-P--YMPPEAMHCQI-STKTDVFSYG 546
             +++    Y      T  P  +MPPE++  +  +T++DV+S+G
Sbjct: 183 VYSTD----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 222

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  135 bits (341), Expect = 1e-35
 Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 35/228 (15%)

Query: 114 GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
             +LG+G FG VY G  K          +A+KT+   A    S  +  E        F N
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIE--------FLN 77

Query: 168 EVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD-------RLARVNNTPPLDS 219
           E   + +    +++RLLG+        ++ E M  G L          +A      P   
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137

Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG   M+       
Sbjct: 138 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFG---MTRDIYETD 192

Query: 280 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
            Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T   +P
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 29/103 (28%), Positives = 53/103 (51%), Gaps = 8/103 (7%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
               P   +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG   M
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFG---M 184

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           +        Y +   G  P  +M PE++   + +T +DV+S+G
Sbjct: 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 227

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  135 bits (343), Expect = 2e-35
 Identities = 65/247 (26%), Positives = 108/247 (43%), Gaps = 38/247 (15%)

Query: 93  FTFCDLERATDGFNRKPYPRR----GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENN 144
            TF D  +    F ++            +G G+FG V  G+LK      + +A+KTL   
Sbjct: 26  HTFEDPTQTVHEFAKE-LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--K 82

Query: 145 ANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---IMNCIVYEYMCN 201
             Y+     +          F  E   + Q  H N++RL G+      +M  IV EYM N
Sbjct: 83  VGYTEKQRRD----------FLGEASIMGQFDHPNIIRLEGVVTKSKPVM--IVTEYMEN 130

Query: 202 GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP 261
           GSL   L    +       +   +  G+A  + YL  +    +HRD+ + N+L++ N V 
Sbjct: 131 GSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVC 186

Query: 262 KLGDFGIVKMSETSNMKTMYTENLTGTR-PY--MPPEAMHCQI-STKTDVFSYGVILLEL 317
           K+ DFG   +               G + P     PEA+  +  ++ +DV+SYG++L E+
Sbjct: 187 KVSDFG---LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243

Query: 318 LT-GMKP 323
           ++ G +P
Sbjct: 244 MSYGERP 250

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 25/104 (24%), Positives = 46/104 (44%), Gaps = 9/104 (8%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            +       +   +  G+A  + YL  +    +HRD+ + N+L++ N V K+ DFG   +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFG---L 193

Query: 507 SETSNVKTMYTENLTGTR-PY--MPPEAMHCQI-STKTDVFSYG 546
                          G + P     PEA+  +  ++ +DV+SYG
Sbjct: 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYG 237

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  133 bits (337), Expect = 2e-35
 Identities = 53/240 (22%), Positives = 93/240 (38%), Gaps = 45/240 (18%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           +    +G G FG V+  K   +G    +K +     Y++  +             E EV+
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKA-------------EREVK 56

Query: 171 TLSQCKHVNLLRLLG-----------------LCNNIMNCIVYEYMCNGSLYDRLARVNN 213
            L++  HVN++   G                         I  E+   G+L   + +   
Sbjct: 57  ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116

Query: 214 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MS 272
              LD      +   + + + Y+HS  K +I+RD+K +N+ L +    K+GDFG+V  + 
Sbjct: 117 EK-LDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173

Query: 273 ETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTIL 331
                         GT  YM PE +  Q    + D+++ G+IL ELL       + +   
Sbjct: 174 NDGKRTRS-----KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 228

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 28/109 (25%), Positives = 48/109 (44%), Gaps = 9/109 (8%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L +         LD      +   + + + Y+HS  K +I+RD+K +N+ L +    K+G
Sbjct: 107 LEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIG 164

Query: 500 DFGIVK-MSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
           DFG+V  +               GT  YM PE +  Q    + D+++ G
Sbjct: 165 DFGLVTSLKNDGKRTRS-----KGTLRYMSPEQISSQDYGKEVDLYALG 208

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  133 bits (338), Expect = 5e-35
 Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 41/233 (17%)

Query: 114 GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
             +LGEG FG V+  +  N       M +AVK L+             EA+      F+ 
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-------------EASESARQDFQR 92

Query: 168 EVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRL------------ARVNNT 214
           E + L+  +H +++R  G+C       +V+EYM +G L   L                  
Sbjct: 93  EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152

Query: 215 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 274
            PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG   MS  
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFG---MSRD 207

Query: 275 SNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
                 Y        P  +MPPE++  +  +T++DV+S+GV+L E+ T G +P
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 8/103 (7%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
               PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG   M
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFG---M 204

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           S        Y        P  +MPPE++  +  +T++DV+S+G
Sbjct: 205 SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG 247

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  139 bits (351), Expect = 6e-35
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 28/220 (12%)

Query: 112 RRGNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
             G  +GEGQFG V+ G   +     M +A+KT       S S  +           F  
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREK----------FLQ 440

Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           E  T+ Q  H ++++L+G+       I+ E    G L   L        LD       A 
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAY 498

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
            ++ AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G
Sbjct: 499 QLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKG 552

Query: 288 TRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
             P  +M PE+++ +  ++ +DV+ +GV + E+L  G+KP
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 64.5 bits (157), Expect = 5e-11
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 9/103 (8%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
                LD       A  ++ AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ + 
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
            E S     Y +   G  P  +M PE+++ +  ++ +DV+ +G
Sbjct: 541 MEDST----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 579

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  133 bits (336), Expect = 1e-34
 Identities = 68/232 (29%), Positives = 111/232 (47%), Gaps = 42/232 (18%)

Query: 114 GNKLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
            + +GEG FG V   ++K     M+ A+K ++  A    S  D+ +        F  E++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRD--------FAGELE 77

Query: 171 TLSQ-CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD--RLARVNNTPPLDSNKRY--- 223
            L +   H N++ LLG C +     +  EY  +G+L D  R +RV  T P  +       
Sbjct: 78  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137

Query: 224 --------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 275
                     A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E  
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV- 194

Query: 276 NMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
                Y +   G  P  +M  E+++  + +T +DV+SYGV+L E+++ G  P
Sbjct: 195 -----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 11/103 (10%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
           +    L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG   +
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFG---L 188

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           S    V   Y +   G  P  +M  E+++  + +T +DV+SYG
Sbjct: 189 SRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 228

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  132 bits (333), Expect = 1e-34
 Identities = 62/255 (24%), Positives = 100/255 (39%), Gaps = 40/255 (15%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
                LG G FG V+  K K +    A+K +       +      +           EV+
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKV--------MREVK 55

Query: 171 TLSQCKHVNLLRLLG-------------LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPL 217
            L++ +H  ++R                    +   I  +     +L D +         
Sbjct: 56  ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115

Query: 218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSN 276
           + +    I L +AEA+ +LHS  K ++HRD+K +N+    + V K+GDFG+V  M +   
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173

Query: 277 MKTMYTENLT--------GTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDN 327
            +T+ T            GT+ YM PE +H    S K D+FS G+IL ELL         
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQM 231

Query: 328 NTILYYYLVVEQEVP 342
             +     V   + P
Sbjct: 232 ERVRTLTDVRNLKFP 246

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 37/115 (32%), Positives = 57/115 (49%), Gaps = 12/115 (10%)

Query: 442 KLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 501
            +         + +    I L +AEA+ +LHS  K ++HRD+K +N+    + V K+GDF
Sbjct: 105 WMNGRCTIEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDF 162

Query: 502 GIVK-MSETSNVKTMYTENLT--------GTRPYMPPEAMHCQ-ISTKTDVFSYG 546
           G+V  M +    +T+ T            GT+ YM PE +H    S K D+FS G
Sbjct: 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLG 217

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  129 bits (327), Expect = 6e-34
 Identities = 54/231 (23%), Positives = 96/231 (41%), Gaps = 46/231 (19%)

Query: 114 GNKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 165
              LG+G F  ++ G  +           E+ +K L+             +A       F
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-------------KAHRNYSESF 59

Query: 166 ENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
                 +S+  H +L+   G+C     N +V E++  GSL   L +  N   ++   +  
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLE 117

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLD--------ENFVPKLGDFGIVKMSETSN 276
           +A  +A A+H+L      +IH +V + N+LL              KL D G   +S    
Sbjct: 118 VAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG---IS---- 168

Query: 277 MKTMYTENLTGTR-PYMPPEA-MHCQI-STKTDVFSYGVILLELLT-GMKP 323
             T+  +++   R P++PPE   + +  +  TD +S+G  L E+ + G KP
Sbjct: 169 -ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 56.5 bits (137), Expect = 7e-09
 Identities = 27/111 (24%), Positives = 50/111 (45%), Gaps = 21/111 (18%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--------ENFVPKL 498
            N   ++   +  +A  +A A+H+L      +IH +V + N+LL              KL
Sbjct: 105 KNKNCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162

Query: 499 GDFGIVKMSETSNVKTMYTENLTGTR-PYMPPEA-MHCQI-STKTDVFSYG 546
            D G   +S      T+  +++   R P++PPE   + +  +  TD +S+G
Sbjct: 163 SDPG---IS-----ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFG 205

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  135 bits (341), Expect = 7e-34
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 25/225 (11%)

Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPI 162
            R        +LG G FG+V  G  +     +++A+K L+      +  +D  E      
Sbjct: 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEE------ 382

Query: 163 LLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 222
                E Q + Q  +  ++RL+G+C      +V E    G L+  L        +  +  
Sbjct: 383 --MMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNV 438

Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
             +   V+  + YL    K  +HR++ + NVLL      K+ DFG+ K     +  + YT
Sbjct: 439 AELLHQVSMGMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD--SYYT 494

Query: 283 ENLTGTRPY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
               G  P     PE ++ +  S+++DV+SYGV + E L+ G KP
Sbjct: 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 27/90 (30%), Positives = 45/90 (50%), Gaps = 7/90 (7%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +   V+  + YL    K  +HR++ + NVLL      K+ DFG+ K     +  + YT  
Sbjct: 441 LLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTAR 496

Query: 520 LTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
             G  P     PE ++ +  S+++DV+SYG
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYG 526

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  130 bits (329), Expect = 8e-34
 Identities = 58/240 (24%), Positives = 92/240 (38%), Gaps = 36/240 (15%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           R    L EG F  VY  + + +G E A+K L       S+  +   A          EV 
Sbjct: 31  RVRRVLAEGGFAFVYEAQDVGSGREYALKRL------LSNEEEKNRAI-------IQEVC 77

Query: 171 TLSQCK-HVNLLRLLG--------LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 221
            + +   H N+++                   ++   +C G L + L ++ +  PL  + 
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137

Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-------KMSET 274
              I      A+ ++H    PIIHRD+K  N+LL      KL DFG           S +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197

Query: 275 SNMKTMYTENLT--GTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
           +  + +  E +T   T  Y  PE      +  I  K D+++ G IL  L     P +D  
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 84.4 bits (209), Expect = 6e-18
 Identities = 29/100 (29%), Positives = 43/100 (43%), Gaps = 13/100 (13%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-------KMSETSNV 512
           I      A+ ++H    PIIHRD+K  N+LL      KL DFG           S ++  
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200

Query: 513 KTMYTENLT--GTRPYMPPE----AMHCQISTKTDVFSYG 546
           + +  E +T   T  Y  PE      +  I  K D+++ G
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG 240

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  130 bits (329), Expect = 8e-34
 Identities = 64/228 (28%), Positives = 98/228 (42%), Gaps = 35/228 (15%)

Query: 114 GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
              LG G FG VY G++         +++AVKTL        S  D  +        F  
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELD--------FLM 82

Query: 168 EVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD----RLARVNNTPPLDSNKR 222
           E   +S+  H N++R +G+   ++   I+ E M  G L         R +    L     
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142

Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKT 279
             +A  +A    YL       IHRD+ + N LL       V K+GDFG+ +    ++   
Sbjct: 143 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--- 197

Query: 280 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
            Y +      P  +MPPEA    I ++KTD +S+GV+L E+ + G  P
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 31/106 (29%), Positives = 47/106 (44%), Gaps = 11/106 (10%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGI 503
           +    L       +A  +A    YL       IHRD+ + N LL       V K+GDFG+
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189

Query: 504 VKMSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
            +    ++    Y +      P  +MPPEA    I ++KTD +S+G
Sbjct: 190 ARDIYRASY---YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 232

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  130 bits (328), Expect = 9e-34
 Identities = 61/244 (25%), Positives = 101/244 (41%), Gaps = 47/244 (19%)

Query: 110 YPRR----GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAM 159
           +PR     G  LG G FG V                +AVK L+  A    ++S++     
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRA--- 76

Query: 160 IPILLFENEVQTLSQ-CKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYD--RLARVNNT 214
                  +E++ L     H+N++ LLG C        ++ E+   G+L    R  R    
Sbjct: 77  -----LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131

Query: 215 P-----------PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL 263
           P            L        +  VA+ + +L S  +  IHRD+ + N+LL E  V K+
Sbjct: 132 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKI 189

Query: 264 GDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT- 319
            DFG   ++        Y        P  +M PE +  ++ + ++DV+S+GV+L E+ + 
Sbjct: 190 CDFG---LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246

Query: 320 GMKP 323
           G  P
Sbjct: 247 GASP 250

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 65.4 bits (160), Expect = 9e-12
 Identities = 27/100 (27%), Positives = 47/100 (47%), Gaps = 8/100 (8%)

Query: 450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 509
             L        +  VA+ + +L S  +  IHRD+ + N+LL E  V K+ DFG+ +    
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

Query: 510 SNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
                 Y        P  +M PE +  ++ + ++DV+S+G
Sbjct: 201 DPD---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  129 bits (327), Expect = 2e-33
 Identities = 65/246 (26%), Positives = 103/246 (41%), Gaps = 54/246 (21%)

Query: 110 YPRR----GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAM 159
           +PR     G  LG G FG V              +++AVK L++ A       +      
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----HADEKEA--- 95

Query: 160 IPILLFENEVQTLSQ-CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRL--------- 208
                  +E++ +S   +H N++ LLG C +     ++ EY C G L + L         
Sbjct: 96  -----LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET 150

Query: 209 --ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 266
             A         +      +  VA+ + +L S  K  IHRDV + NVLL    V K+GDF
Sbjct: 151 DPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDF 208

Query: 267 G----IVKMSETSNMKTMYTENLTGTR-P--YMPPEAMHCQI-STKTDVFSYGVILLELL 318
           G    I        M           R P  +M PE++   + + ++DV+SYG++L E+ 
Sbjct: 209 GLARDI--------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

Query: 319 T-GMKP 323
           + G+ P
Sbjct: 261 SLGLNP 266

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 10/101 (9%)

Query: 450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSE 508
               +      +  VA+ + +L S  K  IHRDV + NVLL    V K+GDFG+   +  
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216

Query: 509 TSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
            SN    Y        P  +M PE++   + + ++DV+SYG
Sbjct: 217 DSN----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 253

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  127 bits (322), Expect = 2e-33
 Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 23/236 (9%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
            +G G +G     +   +G  +  K L    +Y S      +  +       +EV  L +
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKEL----DYGSMTEAEKQMLV-------SEVNLLRE 61

Query: 175 CKHVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVA 230
            KH N++R      +  N    IV EY   G L   + +       LD      +   + 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121

Query: 231 EALHYLHSLSKP---IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
            AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++       T + +   G
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD---TSFAKTFVG 178

Query: 288 TRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
           T  YM PE M+    + K+D++S G +L EL   M P    +       + E +  
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 7/87 (8%)

Query: 464 VAEALHYLHSLSKP---IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           +  AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++       T + +  
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD---TSFAKTF 176

Query: 521 TGTRPYMPPEAMHCQI-STKTDVFSYG 546
            GT  YM PE M+    + K+D++S G
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLG 203

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  128 bits (324), Expect = 3e-33
 Identities = 66/263 (25%), Positives = 108/263 (41%), Gaps = 56/263 (21%)

Query: 110 YPRR----GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAM 159
           +PR     G  LG G FG V              M +AVK L+ +A+ +   +       
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA------- 72

Query: 160 IPILLFENEVQTLSQ-CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRL--------- 208
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L         
Sbjct: 73  -----LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 209 ------ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
                    ++   LD     S +  VA+ + +L S  K  IHRD+ + N+LL    + K
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITK 185

Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYGVILLELLT 319
           + DFG   ++      + Y        P   M PE++   + + ++DV+SYG+ L EL +
Sbjct: 186 ICDFG---LARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

Query: 320 -GMKPIDDNNTILYYYLVVEQEV 341
            G  P        Y  + V+ + 
Sbjct: 243 LGSSP--------YPGMPVDSKF 257

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 29/103 (28%), Positives = 50/103 (48%), Gaps = 8/103 (7%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
           ++   LD     S +  VA+ + +L S  K  IHRD+ + N+LL    + K+ DFG   +
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFG---L 191

Query: 507 SETSNVKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYG 546
           +      + Y        P   M PE++   + + ++DV+SYG
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 234

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  129 bits (326), Expect = 4e-33
 Identities = 35/301 (11%), Positives = 89/301 (29%), Gaps = 39/301 (12%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSD--NTEAAMIPILLFENE 168
           +    L  G    V+  + ++   + A+K     A  S S  +  +        LL E+ 
Sbjct: 65  KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124

Query: 169 VQTLSQCKHVNLLRLLGLCN--------------NIMN-CIVYEYMCNGSLYDRLARVNN 213
            +   + + +     + + +               + N  ++     +  L    + ++ 
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDF 183

Query: 214 TP----PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 269
                        + +   +      L S    ++H      N+ +  +    LGD   +
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 270 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDD 326
                +          +    Y P E ++      +   + +  G+ +  +     P   
Sbjct: 242 W-KVGTRGPAS-----SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295

Query: 327 -NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
               I   +      VP  + L   +       V+TLI     +   F++ +R    + +
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLI----GRFLNFDRRRRLLPLEAM 351

Query: 386 D 386
           +
Sbjct: 352 E 352

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 80.1 bits (197), Expect = 3e-16
 Identities = 14/125 (11%), Positives = 33/125 (26%), Gaps = 13/125 (10%)

Query: 427 VIILDTGETKQCQLFKL--ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK 484
           ++++         LF                  + +   +      L S    ++H    
Sbjct: 164 LLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFT 221

Query: 485 SANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ---ISTKTD 541
             N+ +  +    LGD   +    T           +    Y P E ++      +   +
Sbjct: 222 PDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALN 275

Query: 542 VFSYG 546
            +  G
Sbjct: 276 AWQLG 280

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  128 bits (324), Expect = 5e-33
 Identities = 58/237 (24%), Positives = 104/237 (43%), Gaps = 26/237 (10%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
            R  K+GEG FG     K  ++G +  +K +    N S  +S   E +         EV 
Sbjct: 27  VRLQKIGEGSFGKAILVKSTEDGRQYVIKEI----NISRMSSKEREESR-------REVA 75

Query: 171 TLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
            L+  KH N+++       N  +  IV +Y   G L+ R+           ++     + 
Sbjct: 76  VLANMKHPNIVQYRESFEENGSL-YIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQ 133

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNM-KTMYTENLT 286
           +  AL ++H   + I+HRD+KS N+ L ++   +LGDFGI + ++ T  + +        
Sbjct: 134 ICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC-----I 186

Query: 287 GTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
           GT  Y+ PE    +  + K+D+++ G +L EL T     +  +       ++    P
Sbjct: 187 GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP 243

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 25/84 (29%), Positives = 46/84 (54%), Gaps = 6/84 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL ++H   + I+HRD+KS N+ L ++   +LGDFGI ++  ++           GT
Sbjct: 134 ICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST---VELARACIGT 188

Query: 524 RPYMPPEAMHCQ-ISTKTDVFSYG 546
             Y+ PE    +  + K+D+++ G
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALG 212

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  128 bits (324), Expect = 8e-33
 Identities = 66/228 (28%), Positives = 97/228 (42%), Gaps = 35/228 (15%)

Query: 114 GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
              LG G FG VY G++         +++AVKTL        S  D  +        F  
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELD--------FLM 123

Query: 168 EVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRL----ARVNNTPPLDSNKR 222
           E   +S+  H N++R +G+   ++   I+ E M  G L   L     R +    L     
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183

Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKT 279
             +A  +A    YL       IHRD+ + N LL       V K+GDFG   M+       
Sbjct: 184 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRAG 238

Query: 280 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
            Y +      P  +MPPEA    I ++KTD +S+GV+L E+ + G  P
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 32/106 (30%), Positives = 45/106 (42%), Gaps = 11/106 (10%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGI 503
           +    L       +A  +A    YL       IHRD+ + N LL       V K+GDFG 
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG- 229

Query: 504 VKMSETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
             M+        Y +      P  +MPPEA    I ++KTD +S+G
Sbjct: 230 --MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 273

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  127 bits (321), Expect = 1e-32
 Identities = 66/245 (26%), Positives = 109/245 (44%), Gaps = 48/245 (19%)

Query: 110 YPRR----GNKLGEGQFGTVYYGKL--------KNGMEIAVKTLENNANYSSSNSDNTEA 157
           +PR     G  LGEG FG V   +         K  + +AVK L+++A    +  D ++ 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSD- 86

Query: 158 AMIPILLFENEVQTLSQ-CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL----------- 204
                    +E++ +    KH N++ LLG C  +    ++ EY   G+L           
Sbjct: 87  -------LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139

Query: 205 --YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
             Y           +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 197

Query: 263 LGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 319
           + DFG   ++   N    Y +   G  P  +M PEA+  ++ + ++DV+S+GV++ E+ T
Sbjct: 198 IADFG---LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

Query: 320 -GMKP 323
            G  P
Sbjct: 255 LGGSP 259

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 30/100 (30%), Positives = 51/100 (51%), Gaps = 8/100 (8%)

Query: 450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 509
             +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ +    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

Query: 510 SNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
            +    Y +   G  P  +M PEA+  ++ + ++DV+S+G
Sbjct: 210 IDY---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  127 bits (320), Expect = 1e-32
 Identities = 60/278 (21%), Positives = 103/278 (37%), Gaps = 44/278 (15%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
               ++G G FG V+  K  + G + AVK +                  + +     E+ 
Sbjct: 61  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR-----------------LEVFR-VEELV 102

Query: 171 TLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
             +      ++ L G       +N I  E +  GSL   + ++     L  ++       
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVN-IFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQ 158

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-KLGDFGIVK-MSETSNMKTMYTEN-L 285
             E L YLH+  + I+H DVK+ NVLL  +     L DFG    +      K++ T + +
Sbjct: 159 ALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216

Query: 286 TGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 344
            GT  +M PE +  +    K D++S   ++L +L G  P            +  +  P+R
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR 276

Query: 345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKD--KRAS 380
           E+    A                 +     K+   RAS
Sbjct: 277 EIPPSCAPL----------TAQAIQEG-LRKEPVHRAS 303

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 72.5 bits (178), Expect = 6e-14
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 6/85 (7%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVP-KLGDFGIVK-MSETSNVKTMYTEN-LTG 522
           E L YLH+  + I+H DVK+ NVLL  +     L DFG    +      K++ T + + G
Sbjct: 161 EGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218

Query: 523 TRPYMPPEAMHCQ-ISTKTDVFSYG 546
           T  +M PE +  +    K D++S  
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSC 243

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  126 bits (319), Expect = 2e-32
 Identities = 66/250 (26%), Positives = 108/250 (43%), Gaps = 53/250 (21%)

Query: 110 YPRR----GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAM 159
           +PR+    G  LGEG+FG V      +         +AVK L+ NA    S S+  +   
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA----SPSELRD--- 72

Query: 160 IPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD--RLARVNNTPP 216
                  +E   L Q  H ++++L G C  +    ++ EY   GSL    R +R      
Sbjct: 73  -----LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127

Query: 217 LDSNKRY-------------------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE 257
           L S                       S A  +++ + YL      ++HRD+ + N+L+ E
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHRDLAARNILVAE 185

Query: 258 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVIL 314
               K+ DFG   +S     +  Y +   G  P  +M  E++   I +T++DV+S+GV+L
Sbjct: 186 GRKMKISDFG---LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242

Query: 315 LELLT-GMKP 323
            E++T G  P
Sbjct: 243 WEIVTLGGNP 252

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 63.0 bits (154), Expect = 6e-11
 Identities = 26/102 (25%), Positives = 50/102 (49%), Gaps = 8/102 (7%)

Query: 448 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 507
           +   L      S A  +++ + YL      ++HRD+ + N+L+ E    K+ DFG+ +  
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAE--MKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200

Query: 508 ETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
              +    Y +   G  P  +M  E++   I +T++DV+S+G
Sbjct: 201 YEEDS---YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  125 bits (317), Expect = 2e-32
 Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 25/219 (11%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           R   K+G GQF  VY    L +G+ +A+K ++    +   ++      +        E+ 
Sbjct: 35  RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI---FDLMDAKARADCI-------KEID 84

Query: 171 TLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIAL 227
            L Q  H N+++     + +N +  IV E    G L   +         +     +   +
Sbjct: 85  LLKQLNHPNVIKYYASFIEDNEL-NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMKTMYTENL 285
            +  AL ++HS  + ++HRD+K ANV +    V KLGD G+ +   S+T+   ++     
Sbjct: 144 QLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL----- 196

Query: 286 TGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 323
            GT  YM PE +H    + K+D++S G +L E+     P
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 10/86 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNVKTMYTENLT 521
           +  AL ++HS  + ++HRD+K ANV +    V KLGD G+ +   S+T+   ++      
Sbjct: 145 LCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-----V 197

Query: 522 GTRPYMPPEAMHCQ-ISTKTDVFSYG 546
           GT  YM PE +H    + K+D++S G
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLG 223

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  127 bits (320), Expect = 3e-32
 Identities = 66/250 (26%), Positives = 112/250 (44%), Gaps = 58/250 (23%)

Query: 110 YPRR----GNKLGEGQFGTVYYGKL--------KNGMEIAVKTLENNANYSSSNSDNTEA 157
           +PR     G  LGEG FG V   +         K  + +AVK L+++A    +  D ++ 
Sbjct: 78  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSD- 132

Query: 158 AMIPILLFENEVQTLSQ-CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD--RLARVNN 213
                    +E++ +    KH N++ LLG C  +    ++ EY   G+L +  R  R   
Sbjct: 133 -------LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185

Query: 214 T-----------PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 262
                         +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 243

Query: 263 LGDFGIVKMSETSNMKTMYTENL----TGTR-P--YMPPEAMHCQI-STKTDVFSYGVIL 314
           + DFG   ++     + +   +     T  R P  +M PEA+  ++ + ++DV+S+GV++
Sbjct: 244 IADFG---LA-----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295

Query: 315 LELLT-GMKP 323
            E+ T G  P
Sbjct: 296 WEIFTLGGSP 305

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 30/100 (30%), Positives = 51/100 (51%), Gaps = 8/100 (8%)

Query: 450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 509
             +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ +    
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255

Query: 510 SNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
            +    Y +   G  P  +M PEA+  ++ + ++DV+S+G
Sbjct: 256 IDY---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 292

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  124 bits (314), Expect = 3e-32
 Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 27/225 (12%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  +  ++   +A+K L       +                  EV+  
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR----------REVEIQ 63

Query: 173 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
           S  +H N+LRL G       +   ++ EY   G++Y  L +++     D  +  +    +
Sbjct: 64  SHLRHPNILRLYGYFHDATRVY--LILEYAPLGTVYRELQKLS---KFDEQRTATYITEL 118

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S    +      GT 
Sbjct: 119 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL-----CGTL 171

Query: 290 PYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYY 333
            Y+PPE         K D++S GV+  E L G  P + N     Y
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 216

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 26/67 (38%), Positives = 35/67 (52%), Gaps = 7/67 (10%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S    +      GT
Sbjct: 118 LANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL-----CGT 170

Query: 524 RPYMPPE 530
             Y+PPE
Sbjct: 171 LDYLPPE 177

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  124 bits (314), Expect = 4e-32
 Identities = 46/243 (18%), Positives = 89/243 (36%), Gaps = 47/243 (19%)

Query: 112 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
               K+G G+FG+V+   K  +G   A+K          + S + + A+        EV 
Sbjct: 14  HELEKIGSGEFGSVFKCVKRLDGCIYAIKRS----KKPLAGSVDEQNAL-------REVY 62

Query: 171 TLSQ-CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIA 226
             +   +H +++R       ++ M  I  EY   GSL D ++            +   + 
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHM-LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-------------------KLGDFG 267
           L V   L Y+HS    ++H D+K +N+ +    +P                   K+GD G
Sbjct: 122 LQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS--TKTDVFSYGVILLELLTGMKPID 325
            V     S+ +        G   ++  E +    +   K D+F+  + ++          
Sbjct: 180 HVTR--ISSPQVE-----EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232

Query: 326 DNN 328
           + +
Sbjct: 233 NGD 235

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 21/104 (20%), Positives = 38/104 (36%), Gaps = 30/104 (28%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-------------------KLGDFGIV 504
           V   L Y+HS    ++H D+K +N+ +    +P                   K+GD G V
Sbjct: 124 VGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181

Query: 505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQIS--TKTDVFSYG 546
                S+ +        G   ++  E +    +   K D+F+  
Sbjct: 182 TR--ISSPQVE-----EGDSRFLANEVLQENYTHLPKADIFALA 218

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  125 bits (317), Expect = 4e-32
 Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 63/255 (24%)

Query: 110 YPRR----GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAM 159
           YPR        +GEG FG V+  +            +AVK L+  A      S + +A  
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA------SADMQAD- 96

Query: 160 IPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL-------------- 204
                F+ E   +++  + N+++LLG+C      C+++EYM  G L              
Sbjct: 97  -----FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 151

Query: 205 -------YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE 257
                            PPL   ++  IA  VA  + YL       +HRD+ + N L+ E
Sbjct: 152 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGE 209

Query: 258 NFVPKLGDFGIVKMSETSNMKTMYTEN--LTGTR---P--YMPPEAMHCQI-STKTDVFS 309
           N V K+ DFG   +S     + +Y+ +          P  +MPPE++     +T++DV++
Sbjct: 210 NMVVKIADFG---LS-----RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 261

Query: 310 YGVILLELLT-GMKP 323
           YGV+L E+ + G++P
Sbjct: 262 YGVVLWEIFSYGLQP 276

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 8/103 (7%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
              PPL   ++  IA  VA  + YL       +HRD+ + N L+ EN V K+ DFG+ + 
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRN 223

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
             +++    Y  +     P  +MPPE++     +T++DV++YG
Sbjct: 224 IYSADY---YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 263

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  125 bits (316), Expect = 6e-32
 Identities = 57/236 (24%), Positives = 98/236 (41%), Gaps = 24/236 (10%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLE----NNANYSSSNSDNTEAAMIPILLFENEV 169
              L +G+F  +   + K+    A+K  E          + ++++  +       F+NE+
Sbjct: 36  IRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 170 QTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARV-------NNTPPLDSNK 221
           Q ++  K+   L   G+  N     I+YEYM N S+                  P+   K
Sbjct: 95  QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 281
                  V  +  Y+H+  K I HRDVK +N+L+D+N   KL DFG  +      +K   
Sbjct: 155 CI--IKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS- 210

Query: 282 TENLTGTRPYMPPEAMHCQIST---KTDVFSYGVILLELLTGMKPIDDNNTILYYY 334
                GT  +MPPE    + S    K D++S G+ L  +   + P     +++  +
Sbjct: 211 ----RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 28/97 (28%), Positives = 40/97 (41%), Gaps = 12/97 (12%)

Query: 440 LFKLARVNNTPPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 493
           + K          +            I   V  +  Y+H+  K I HRDVK +N+L+D+N
Sbjct: 130 ILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKN 188

Query: 494 FVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPE 530
              KL DFG  +      +K        GT  +MPPE
Sbjct: 189 GRVKLSDFGESEYMVDKKIKGS-----RGTYEFMPPE 220

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  126 bits (318), Expect = 7e-32
 Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 44/237 (18%)

Query: 114 GNKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 165
           G  LGEG FG V   +             ++AVK L+++A    +  D ++         
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSD--------L 121

Query: 166 ENEVQTLSQ-CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSL-------------YDRLAR 210
            +E++ +    KH N++ LLG C  +    ++ EY   G+L             Y     
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181

Query: 211 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
            N    L S    S A  VA  + YL S  K  IHRD+ + NVL+ E+ V K+ DFG   
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFG--- 236

Query: 271 MSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 323
           ++   +    Y +   G  P  +M PEA+  +I + ++DV+S+GV+L E+ T G  P
Sbjct: 237 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 8/103 (7%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
           N    L S    S A  VA  + YL S  K  IHRD+ + NVL+ E+ V K+ DFG+ + 
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARD 240

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
               +    Y +   G  P  +M PEA+  +I + ++DV+S+G
Sbjct: 241 IHHIDY---YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  123 bits (312), Expect = 2e-31
 Identities = 65/268 (24%), Positives = 109/268 (40%), Gaps = 61/268 (22%)

Query: 110 YPRR----GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAM 159
           +PR     G  LG G FG V              +++AVK L+  A     +S+      
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREA--- 94

Query: 160 IPILLFENEVQTLSQ-CKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYD----------- 206
                  +E++ ++Q   H N++ LLG C  +    +++EY C G L +           
Sbjct: 95  -----LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 149

Query: 207 ---------RLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE 257
                    RL    +   L        A  VA+ + +L    K  +HRD+ + NVL+  
Sbjct: 150 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTH 207

Query: 258 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVIL 314
             V K+ DFG   ++      + Y        P  +M PE++   I + K+DV+SYG++L
Sbjct: 208 GKVVKICDFG---LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264

Query: 315 LELLT-GMKPIDDNNTILYYYLVVEQEV 341
            E+ + G+ P        Y  + V+   
Sbjct: 265 WEIFSLGVNP--------YPGIPVDANF 284

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 29/103 (28%), Positives = 47/103 (45%), Gaps = 8/103 (7%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            +   L        A  VA+ + +L    K  +HRD+ + NVL+    V K+ DFG   +
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFG---L 218

Query: 507 SETSNVKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYG 546
           +      + Y        P  +M PE++   I + K+DV+SYG
Sbjct: 219 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 261

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  125 bits (314), Expect = 2e-31
 Identities = 36/275 (13%), Positives = 78/275 (28%), Gaps = 46/275 (16%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
            RG  LG+            + G    V          S+     +  ++ + L      
Sbjct: 81  VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 140

Query: 171 TLSQCKHVNLLRLLGLCNN-----------------IMNCIVYEYMCNGSLYDRL----A 209
                 H+  +    L  +                 +++          +L        +
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200

Query: 210 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 269
             +    L  + R  + L V   L  LH     ++H  ++  +++LD+     L  F  +
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 270 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-----------STKTDVFSYGVILLELL 318
                S +           R + PPE    ++           +   D ++ G+ +  + 
Sbjct: 259 VRDGASAV-------SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311

Query: 319 TGMKPIDDNNTILYYYLVVEQEV----PVREVLDK 349
               P  D+  +     +         PVR +L+ 
Sbjct: 312 CADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEG 346

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 78.9 bits (194), Expect = 6e-16
 Identities = 20/119 (16%), Positives = 39/119 (32%), Gaps = 22/119 (18%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L   +  + +       R  + L V   L  LH     ++H  ++  +++LD+     L 
Sbjct: 198 LLSHSSTHKSLVHH--ARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLT 253

Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQI-----------STKTDVFSYGA 547
            F  +     S V           R + PPE    ++           +   D ++ G 
Sbjct: 254 GFEHLVRDGASAV-------SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  122 bits (309), Expect = 3e-31
 Identities = 65/299 (21%), Positives = 120/299 (40%), Gaps = 54/299 (18%)

Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 165
             + Y     ++G G    V+    +     A+K +      +   +DN           
Sbjct: 26  KGRIY-SILKQIGSGGSSKVFQVLNEKKQIYAIKYV------NLEEADNQTLDSY----- 73

Query: 166 ENEVQTLSQCKHVNL--LRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
            NE+  L++ +  +   +RL         I   +V E   N  L   L +      +D  
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITDQYI--YMVMEC-GNIDLNSWLKKKK---SIDPW 127

Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
           +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++
Sbjct: 128 ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQP-DTTSV 183

Query: 281 YTENLTGTRPYMPPEAMHCQ------------ISTKTDVFSYGVILLELLTGMKP---ID 325
             ++  GT  YMPPEA+               IS K+DV+S G IL  +  G  P   I 
Sbjct: 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243

Query: 326 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
           +  + L+  +    E+   ++ +K+  +        ++    + C   +  +R S+ ++
Sbjct: 244 NQISKLHAIIDPNHEIEFPDIPEKDLQD--------VL----KCCLKRDPKQRISIPEL 290

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 16/95 (16%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  ++  GT
Sbjct: 136 MLEAVHTIHQ--HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQP-DTTSVVKDSQVGT 191

Query: 524 RPYMPPEAMHCQ------------ISTKTDVFSYG 546
             YMPPEA+               IS K+DV+S G
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  122 bits (308), Expect = 3e-31
 Identities = 57/250 (22%), Positives = 90/250 (36%), Gaps = 54/250 (21%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              LG+G FG V   +   +    A+K +           +             +EV  L
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKI-------RHTEEKLSTI-------LSEVMLL 56

Query: 173 SQCKHVNLLRLLGLCNNIMN--------------CIVYEYMCNGSLYDRLARVNNTPPLD 218
           +   H  ++R         N               I  EY  NG+LYD +   N      
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL--NQQ 114

Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 278
            ++ + +   + EAL Y+HS  + IIHRD+K  N+ +DE+   K+GDFG+ K    S   
Sbjct: 115 RDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 279 TMYTENLT-----------GTRPYMPPEAMHCQIS------TKTDVFSYGVILLELLTGM 321
                              GT  Y+  E     +        K D++S G+I  E++   
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATE----VLDGTGHYNEKIDMYSLGIIFFEMIYPF 228

Query: 322 KPIDDNNTIL 331
               +   IL
Sbjct: 229 STGMERVNIL 238

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 30/100 (30%), Positives = 43/100 (43%), Gaps = 23/100 (23%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLT-- 521
           + EAL Y+HS  + IIHRD+K  N+ +DE+   K+GDFG+ K    S             
Sbjct: 125 ILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 522 ---------GTRPYMPPEAMHCQIS------TKTDVFSYG 546
                    GT  Y+  E     +        K D++S G
Sbjct: 183 SSDNLTSAIGTAMYVATE----VLDGTGHYNEKIDMYSLG 218

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  123 bits (310), Expect = 8e-31
 Identities = 43/224 (19%), Positives = 86/224 (38%), Gaps = 27/224 (12%)

Query: 112 RRGNKLGEGQ--FGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 168
                +G+G     TV   +    G  + V+ +         N +     M+  L    E
Sbjct: 28  ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI---------NLEACSNEMVTFLQ--GE 76

Query: 169 VQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           +       H N++      + +N +  +V  +M  GS  D L   +    ++      I 
Sbjct: 77  LHVSKLFNHPNIVPYRATFIADNEL-WVVTSFMAYGSAKD-LICTHFMDGMNELAIAYIL 134

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG----IVKMSETSNMKTMYT 282
            GV +AL Y+H +    +HR VK++++L+  +    L        ++   +   +   + 
Sbjct: 135 QGVLKALDYIHHMGY--VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192

Query: 283 ENLTGTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKP 323
           +      P++ PE +   +     K+D++S G+   EL  G  P
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 21/94 (22%), Positives = 43/94 (45%), Gaps = 9/94 (9%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG----IVKMSETSNVKTM 515
           I  GV +AL Y+H +    +HR VK++++L+  +    L        ++   +   V   
Sbjct: 133 ILQGVLKALDYIHHMGY--VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190

Query: 516 YTENLTGTRPYMPPEAMHCQIS---TKTDVFSYG 546
           + +      P++ PE +   +     K+D++S G
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 224

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  122 bits (308), Expect = 8e-31
 Identities = 65/299 (21%), Positives = 120/299 (40%), Gaps = 54/299 (18%)

Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 165
             + Y     ++G G    V+    +     A+K +      +   +DN           
Sbjct: 7   KGRIY-SILKQIGSGGSSKVFQVLNEKKQIYAIKYV------NLEEADNQTLDSY----- 54

Query: 166 ENEVQTLSQCKHVNL--LRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
            NE+  L++ +  +   +RL         I   +V E   N  L   L +      +D  
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYI--YMVMEC-GNIDLNSWLKKKK---SIDPW 108

Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
           +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++
Sbjct: 109 ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDTTSV 164

Query: 281 YTENLTGTRPYMPPEAMHCQ------------ISTKTDVFSYGVILLELLTGMKP---ID 325
             ++  GT  YMPPEA+               IS K+DV+S G IL  +  G  P   I 
Sbjct: 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224

Query: 326 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
           +  + L+  +    E+   ++ +K+         + ++    + C   +  +R S+ ++
Sbjct: 225 NQISKLHAIIDPNHEIEFPDIPEKDL--------QDVL----KCCLKRDPKQRISIPEL 271

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 66.3 bits (162), Expect = 6e-12
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 16/95 (16%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  ++  GT
Sbjct: 117 MLEAVHTIHQ--HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDTTSVVKDSQVGT 172

Query: 524 RPYMPPEAMHCQ------------ISTKTDVFSYG 546
             YMPPEA+               IS K+DV+S G
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 207

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  122 bits (308), Expect = 1e-30
 Identities = 35/310 (11%), Positives = 87/310 (28%), Gaps = 61/310 (19%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN--- 167
            RG  LG+            + G    V          S+     +  ++ + L      
Sbjct: 76  VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135

Query: 168 ------------EVQTLSQCKHVNLLRLLGLCNN--IMNCIVYEYMCNGSLYDRL----A 209
                           +   +   ++R+     +  +++          +L        +
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195

Query: 210 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 269
             +    L  + R  + L V   L  LH     ++H  ++  +++LD+     L  F  +
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 270 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQI------------STKTDVFSYGVILLEL 317
                  +        + +R + PPE    +             +   D ++ G+++  +
Sbjct: 254 VRDGARVV-------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306

Query: 318 LTGMKPIDDNNTILYYYLVVEQEVPV-REVLDKEAGEWNETHVETLIGIVFEKCCVFEKD 376
                PI  +  +     +      + + V               L+    E    + K+
Sbjct: 307 WCADLPITKDAALGGSEWIFRSCKNIPQPVRA-------------LL----EGFLRYPKE 349

Query: 377 KRASMRDIVD 386
            R      ++
Sbjct: 350 DRLLPLQAME 359

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 78.5 bits (193), Expect = 7e-16
 Identities = 22/120 (18%), Positives = 42/120 (35%), Gaps = 16/120 (13%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L   +  +    L  + R  + L V   L  LH     ++H  ++  +++LD+     L 
Sbjct: 193 LLSHSSTH--KSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGVFLT 248

Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDI 559
            F  +       V        + +R + PPE    + +      SY    +T    + D 
Sbjct: 249 GFEHLVRDGARVV-------SSVSRGFEPPELEARRATI-----SYHRDRRTLMTFSFDA 296

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  122 bits (308), Expect = 3e-30
 Identities = 45/222 (20%), Positives = 82/222 (36%), Gaps = 32/222 (14%)

Query: 113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
             + LG G  GT+ Y  + +  ++AVK +           +    A       + EVQ L
Sbjct: 28  PKDVLGHGAEGTIVYRGMFDNRDVAVKRI---------LPECFSFA-------DREVQLL 71

Query: 173 SQC-KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
            +  +H N++R      +     I  E  C  +L + +            +  ++     
Sbjct: 72  RESDEHPNVIRYFCTEKDRQFQYIAIEL-CAATLQEYV--EQKDFAHLGLEPITLLQQTT 128

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGDFGIVKMSETSNMKTMYTENL 285
             L +LHSL+  I+HRD+K  N+L+            + DFG+ K              +
Sbjct: 129 SGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186

Query: 286 TGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKP 323
            GT  ++ PE          +   D+FS G +   +++    
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 67.1 bits (164), Expect = 5e-12
 Identities = 24/92 (26%), Positives = 37/92 (40%), Gaps = 11/92 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGDFGIVKMSETSNVKTMYTE 518
               L +LHSL+  I+HRD+K  N+L+            + DFG+ K             
Sbjct: 127 TTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184

Query: 519 NLTGTRPYMPPE----AMHCQISTKTDVFSYG 546
            + GT  ++ PE          +   D+FS G
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  119 bits (300), Expect = 3e-30
 Identities = 62/219 (28%), Positives = 91/219 (41%), Gaps = 26/219 (11%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
                LG+G +G VY G+ L N + IA+K +         +S  ++           E+ 
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP------ERDSRYSQP-------LHEEIA 71

Query: 171 TLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
                KH N+++ LG    N  +  I  E +  GSL   L         +          
Sbjct: 72  LHKHLKHKNIVQYLGSFSENGFIK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 130

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
           + E L YLH     I+HRD+K  NVL++  + V K+ DFG  K     N     TE  TG
Sbjct: 131 ILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTG 185

Query: 288 TRPYMPPEAMHCQI---STKTDVFSYGVILLELLTGMKP 323
           T  YM PE +           D++S G  ++E+ TG  P
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 32/85 (37%), Positives = 41/85 (48%), Gaps = 9/85 (10%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNVKTMYTENLTGTR 524
           E L YLH     I+HRD+K  NVL++  + V K+ DFG  K     N     TE  TGT 
Sbjct: 133 EGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTL 187

Query: 525 PYMPPEAMHCQI---STKTDVFSYG 546
            YM PE +           D++S G
Sbjct: 188 QYMAPEIIDKGPRGYGKAADIWSLG 212

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  123 bits (310), Expect = 3e-30
 Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 28/227 (12%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
             KLG G +G V   K K    E A+K ++ +       SD+ +          NE+  L
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
               H N+++L  +  +     +V E+   G L++++          +  ++       I
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---------INRHKFDECDAANI 151

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 281
              +   + YLH  +  I+HRD+K  N+LL   +     K+ DFG+    S+   ++   
Sbjct: 152 MKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR- 208

Query: 282 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
                GT  Y+ PE +  + + K DV+S GVI+  LL G  P    N
Sbjct: 209 ----LGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 11/87 (12%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNVKTMYTEN 519
           +   + YLH  +  I+HRD+K  N+LL   +     K+ DFG+    S+   ++      
Sbjct: 155 ILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---- 208

Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYG 546
             GT  Y+ PE +  + + K DV+S G
Sbjct: 209 -LGTAYYIAPEVLKKKYNEKCDVWSCG 234

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  121 bits (304), Expect = 4e-30
 Identities = 61/266 (22%), Positives = 107/266 (40%), Gaps = 42/266 (15%)

Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 165
             + Y     ++G G    V+    +     A+K +      +   +DN           
Sbjct: 54  KGRIY-SILKQIGSGGSSKVFQVLNEKKQIYAIKYV------NLEEADNQTLDSY----- 101

Query: 166 ENEVQTLSQCKHVNL--LRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 220
            NE+  L++ +  +   +RL         I   +V E   N  L   L +      +D  
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYI--YMVMEC-GNIDLNSWLKKKK---SIDPW 155

Query: 221 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 280
           +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++
Sbjct: 156 ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDTTSV 211

Query: 281 YTENLTGTRPYMPPEAMHCQ------------ISTKTDVFSYGVILLELLTGMKP---ID 325
             ++  G   YMPPEA+               IS K+DV+S G IL  +  G  P   I 
Sbjct: 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

Query: 326 DNNTILYYYLVVEQEVPVREVLDKEA 351
           +  + L+  +    E+   ++ +K+ 
Sbjct: 272 NQISKLHAIIDPNHEIEFPDIPEKDL 297

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 16/95 (16%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  ++  G 
Sbjct: 164 MLEAVHTIHQ--HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDTTSVVKDSQVGA 219

Query: 524 RPYMPPEAMHCQ------------ISTKTDVFSYG 546
             YMPPEA+               IS K+DV+S G
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 254

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  118 bits (298), Expect = 5e-30
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 35/229 (15%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  +  +N   +A+K L  +                       E++  
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR----------REIEIQ 68

Query: 173 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
           S  +H N+LR+         I   ++ E+   G LY  L +        S   +     +
Sbjct: 69  SHLRHPNILRMYNYFHDRKRI--YLMLEFAPRGELYKELQKHGRFDEQRS-ATF--MEEL 123

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           A+ALHY H   + +IHRD+K  N+L+      K+ DFG    + +   +TM      GT 
Sbjct: 124 ADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM-----CGTL 176

Query: 290 PYMPPEAMHCQISTKT-----DVFSYGVILLELLTGMKPIDDNNTILYY 333
            Y+PPE     I  KT     D++  GV+  E L GM P D  +    +
Sbjct: 177 DYLPPEM----IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 64.9 bits (159), Expect = 9e-12
 Identities = 25/67 (37%), Positives = 37/67 (55%), Gaps = 7/67 (10%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A+ALHY H   + +IHRD+K  N+L+      K+ DFG    + +   +TM      GT
Sbjct: 123 LADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM-----CGT 175

Query: 524 RPYMPPE 530
             Y+PPE
Sbjct: 176 LDYLPPE 182

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  117 bits (295), Expect = 3e-29
 Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 38/280 (13%)

Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT-LS 173
           ++G G +G+V     K +G  +AVK +          S   E     +L    ++   + 
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRI---------RSTVDEKEQKQLL---MDLDVVMR 76

Query: 174 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY--SIALGVA 230
                 +++  G L       I  E M + S       V +       +     I L   
Sbjct: 77  SSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATV 135

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           +AL++L    K IIHRD+K +N+LLD +   KL DFGI      S  KT       G RP
Sbjct: 136 KALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT----RDAGCRP 190

Query: 291 YMPPEAMHCQI-----STKTDVFSYGVILLELLTGMKPIDDNNTILYY-YLVVEQEVPVR 344
           YM PE +           ++DV+S G+ L EL TG  P    N++      VV+ + P  
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP-- 248

Query: 345 EVLDKEAGEWNETHVETLIGIVF-EKCCVFEKDKRASMRD 383
           ++ + E  E++ + +       F   C   ++ KR   ++
Sbjct: 249 QLSNSEEREFSPSFIN------FVNLCLTKDESKRPKYKE 282

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 36/92 (39%), Positives = 47/92 (51%), Gaps = 10/92 (10%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           I L   +AL++L    K IIHRD+K +N+LLD +   KL DFGI      S  KT     
Sbjct: 130 ITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT----R 184

Query: 520 LTGTRPYMPPEAMHCQI-----STKTDVFSYG 546
             G RPYM PE +           ++DV+S G
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  121 bits (305), Expect = 4e-29
 Identities = 55/242 (22%), Positives = 95/242 (39%), Gaps = 32/242 (13%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
             +LG G FG V        G ++A+K           +  N E        +  E+Q +
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCR-----QELSPKNRER-------WCLEIQIM 66

Query: 173 SQCKHVNLLRLL-------GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            +  H N++           L  N +  +  EY   G L   L +  N   L      ++
Sbjct: 67  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVK-MSETSNMKTMY 281
              ++ AL YLH     IIHRD+K  N++L    +  + K+ D G  K + +        
Sbjct: 127 LSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184

Query: 282 TENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
                GT  Y+ PE +  +  +   D +S+G +  E +TG +P   N   + ++  V ++
Sbjct: 185 -----GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 239

Query: 341 VP 342
             
Sbjct: 240 SN 241

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 12/88 (13%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVK-MSETSNVKTMYTEN 519
           ++ AL YLH     IIHRD+K  N++L    +  + K+ D G  K + +           
Sbjct: 130 ISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--- 184

Query: 520 LTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             GT  Y+ PE +  +  +   D +S+G
Sbjct: 185 --GTLQYLAPELLEQKKYTVTVDYWSFG 210

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  116 bits (293), Expect = 4e-29
 Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 32/232 (13%)

Query: 106 NRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL 164
           NR  Y      +G G    V          ++A+K +            N E     +  
Sbjct: 13  NRDDY-ELQEVIGSGATAVVQAAYCAPKKEKVAIKRI------------NLEKCQTSMDE 59

Query: 165 FENEVQTLSQCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYD-----RLARVNNTPPL 217
              E+Q +SQC H N++      +  + +  +V + +  GS+ D          + +  L
Sbjct: 60  LLKEIQAMSQCHHPNIVSYYTSFVVKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 118

Query: 218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSN 276
           D +   +I   V E L YLH   +  IHRDVK+ N+LL E+   ++ DFG+   ++   +
Sbjct: 119 DESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176

Query: 277 MKTMYTEN-LTGTRPY-MPPEAMHCQIS---TKTDVFSYGVILLELLTGMKP 323
           +          GT P  M PE M  Q+     K D++S+G+  +EL TG  P
Sbjct: 177 ITRNKVRKTFVGT-PCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAP 226

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 10/89 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTEN-LT 521
           V E L YLH   +  IHRDVK+ N+LL E+   ++ DFG+   ++   ++          
Sbjct: 130 VLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 522 GTRPY-MPPEAMHCQIS---TKTDVFSYG 546
           GT P  M PE M  Q+     K D++S+G
Sbjct: 188 GT-PCWMAPEVME-QVRGYDFKADIWSFG 214

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  116 bits (293), Expect = 4e-29
 Identities = 50/234 (21%), Positives = 88/234 (37%), Gaps = 37/234 (15%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
            + LG+G    V+ G+ K  G   A+K   N      S     +       +   E + L
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVD-------VQMREFEVL 61

Query: 173 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            +  H N+++L  +          ++ E+   GSLY  L   +N   L  ++   +   V
Sbjct: 62  KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVK-MSETSNMKTMYTEN 284
              +++L      I+HR++K  N++     D   V KL DFG  + + +     ++Y   
Sbjct: 122 VGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176

Query: 285 LTGTRPYMPPE---------AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 329
             GT  Y+ P+             +     D++S GV      TG  P      
Sbjct: 177 --GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 23/90 (25%), Positives = 39/90 (43%), Gaps = 12/90 (13%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVK-MSETSNVKTMYTE 518
           V   +++L      I+HR++K  N++     D   V KL DFG  + + +     ++Y  
Sbjct: 121 VVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-- 176

Query: 519 NLTGTRPYMPPEAMHCQISTKTDVFSYGAQ 548
              GT  Y+ P+     +  K     YGA 
Sbjct: 177 ---GTEEYLHPDMYERAVLRKDHQKKYGAT 203

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  116 bits (292), Expect = 1e-28
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 24/218 (11%)

Query: 115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           ++LG G  G V+    K +G+ +A K +         + +   A    I+    E+Q L 
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQII---RELQVLH 86

Query: 174 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           +C    ++   G   ++    I  E+M  GSL   L +      +       +++ V + 
Sbjct: 87  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKG 143

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YL    K I+HRDVK +N+L++     KL DFG+      S   +       GTR YM
Sbjct: 144 LTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----VGTRSYM 197

Query: 293 PPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNT 329
            PE +     S ++D++S G+ L+E+  G  PI   + 
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 7/88 (7%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +++ V + L YL    K I+HRDVK +N+L++     KL DFG+      S   +     
Sbjct: 136 VSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---- 190

Query: 520 LTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             GTR YM PE +     S ++D++S G
Sbjct: 191 -VGTRSYMSPERLQGTHYSVQSDIWSMG 217

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  118 bits (298), Expect = 1e-28
 Identities = 66/227 (29%), Positives = 96/227 (42%), Gaps = 38/227 (16%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              LG+G FG V   K K  G E AVK +        ++ ++             EVQ L
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES----------LLREVQLL 80

Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
            Q  H N+++L     +     +V E    G L+D +          S KR+S      I
Sbjct: 81  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII---------SRKRFSEVDAARI 131

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 281
              V   + Y+H     I+HRD+K  N+LL    ++   ++ DFG+      +  MK   
Sbjct: 132 IRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK- 188

Query: 282 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
                GT  Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 189 ----IGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 231

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 11/87 (12%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNVKTMYTEN 519
           V   + Y+H     I+HRD+K  N+LL    ++   ++ DFG+      +  +K      
Sbjct: 135 VLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---- 188

Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYG 546
             GT  Y+ PE +H     K DV+S G
Sbjct: 189 -IGTAYYIAPEVLHGTYDEKCDVWSTG 214

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  114 bits (288), Expect = 1e-28
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 25/225 (11%)

Query: 115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
            +LG G +G V   +   +G  +AVK +    N          +     LL + ++ ++ 
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN----------SQEQKRLLMDLDI-SMR 61

Query: 174 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIALGVAE 231
                  +   G L       I  E M + SL     +V +    +  +    IA+ + +
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL +LHS    +IHRDVK +NVL++     K+ DFGI         K +      G +PY
Sbjct: 121 ALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID----AGCKPY 175

Query: 292 MPPEAMHCQI-----STKTDVFSYGVILLELLTGMKPIDDNNTIL 331
           M PE ++ ++     S K+D++S G+ ++EL     P D   T  
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF 220

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 78.4 bits (194), Expect = 4e-16
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 10/92 (10%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           IA+ + +AL +LHS    +IHRDVK +NVL++     K+ DFGI         K +    
Sbjct: 114 IAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--- 169

Query: 520 LTGTRPYMPPEAMHCQI-----STKTDVFSYG 546
             G +PYM PE ++ ++     S K+D++S G
Sbjct: 170 -AGCKPYMAPERINPELNQKGYSVKSDIWSLG 200

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  114 bits (288), Expect = 1e-28
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 36/221 (16%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
            +LG+G FG VY  K  + G   A K +E  +       +  E        +  E++ L+
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSE------EELE-------DYIVEIEILA 71

Query: 174 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            C H  +++LLG    +  +  I+ E+   G++   +  ++    L   +   +   + E
Sbjct: 72  TCDHPYIVKLLGAYYHDGKL-WIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLE 128

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSET-SNMKTMYTENLTGTR 289
           AL++LHS     IHRD+K+ NVL+      +L DFG+  K  +T     +       GT 
Sbjct: 129 ALNFLHSKRI--IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-----IGT- 180

Query: 290 PY-MPPEAMHCQIS------TKTDVFSYGVILLELLTGMKP 323
           PY M PE + C+         K D++S G+ L+E+     P
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 36/113 (31%), Positives = 55/113 (48%), Gaps = 24/113 (21%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVK-TMYT 517
           +   + EAL++LHS     IHRD+K+ NVL+      +L DFG+  K  +T   + +   
Sbjct: 122 VCRQMLEALNFLHSKRI--IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-- 177

Query: 518 ENLTGTRPY-MPPEAMHCQIS------TKTDVFSYGAQIKTQHITNVDIADRE 563
               GT PY M PE + C+         K D++S G       IT +++A  E
Sbjct: 178 ---IGT-PYWMAPEVVMCETMKDTPYDYKADIWSLG-------ITLIEMAQIE 219

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  117 bits (296), Expect = 2e-28
 Identities = 62/227 (27%), Positives = 94/227 (41%), Gaps = 39/227 (17%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
             KLG G +G V   + K   +E A+K +   +  +SSNS               EV  L
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-----------LLEEVAVL 90

Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
               H N+++L     +  N  +V E    G L+D +             +++      I
Sbjct: 91  KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII---------HRMKFNEVDAAVI 141

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 281
              V   + YLH  +  I+HRD+K  N+LL   +++ + K+ DFG+         MK   
Sbjct: 142 IKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER- 198

Query: 282 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
                GT  Y+ PE +  +   K DV+S GVIL  LL G  P     
Sbjct: 199 ----LGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQT 241

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 57.8 bits (140), Expect = 6e-09
 Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 11/87 (12%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNVKTMYTEN 519
           V   + YLH  +  I+HRD+K  N+LL   +++ + K+ DFG+         +K      
Sbjct: 145 VLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER---- 198

Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYG 546
             GT  Y+ PE +  +   K DV+S G
Sbjct: 199 -LGTAYYIAPEVLRKKYDEKCDVWSIG 224

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  112 bits (283), Expect = 5e-28
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 34/227 (14%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           + GN LG+G F  VY  + +  G+E+A+K ++  A Y +                +NEV+
Sbjct: 14  KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR----------VQNEVK 63

Query: 171 TLSQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
              Q KH ++L L       N +   +V E   NG +   L   N   P   N+      
Sbjct: 64  IHCQLKHPSILELYNYFEDSNYVY--LVLEMCHNGEMNRYL--KNRVKPFSENEARHFMH 119

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG--IVKMSETSNMKTMYTENL 285
            +   + YLHS    I+HRD+  +N+LL  N   K+ DFG             T+     
Sbjct: 120 QIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL----- 172

Query: 286 TGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
            GT  Y+ PE    + H     ++DV+S G +   LL G  P D + 
Sbjct: 173 CGTPNYISPEIATRSAH---GLESDVWSLGCMFYTLLIGRPPFDTDT 216

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 59.9 bits (146), Expect = 5e-10
 Identities = 22/69 (31%), Positives = 31/69 (44%), Gaps = 9/69 (13%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG--IVKMSETSNVKTMYTENLT 521
           +   + YLHS    I+HRD+  +N+LL  N   K+ DFG             T+      
Sbjct: 121 IITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-----C 173

Query: 522 GTRPYMPPE 530
           GT  Y+ PE
Sbjct: 174 GTPNYISPE 182

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  114 bits (288), Expect = 6e-28
 Identities = 50/234 (21%), Positives = 88/234 (37%), Gaps = 37/234 (15%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
            + LG+G    V+ G+ K  G   A+K   N      S     +       +   E + L
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVD-------VQMREFEVL 61

Query: 173 SQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            +  H N+++L  +          ++ E+   GSLY  L   +N   L  ++   +   V
Sbjct: 62  KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVK-MSETSNMKTMYTEN 284
              +++L      I+HR++K  N++     D   V KL DFG  + + +     ++Y   
Sbjct: 122 VGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176

Query: 285 LTGTRPYMPPE---------AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 329
             GT  Y+ P+             +     D++S GV      TG  P      
Sbjct: 177 --GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 23/91 (25%), Positives = 40/91 (43%), Gaps = 12/91 (13%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVK-MSETSNVKTMYTE 518
           V   +++L      I+HR++K  N++     D   V KL DFG  + + +     ++Y  
Sbjct: 121 VVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-- 176

Query: 519 NLTGTRPYMPPEAMHCQISTKTDVFSYGAQI 549
              GT  Y+ P+     +  K     YGA +
Sbjct: 177 ---GTEEYLHPDMYERAVLRKDHQKKYGATV 204

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  111 bits (281), Expect = 1e-27
 Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 36/227 (15%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
             KLG G FG V+  + + +G+E  +KT+            N + + +P+   E E++ L
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTI------------NKDRSQVPMEQIEAEIEVL 74

Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
               H N++++  +  +  N  IV E    G L +R+            K  S      +
Sbjct: 75  KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA-----RGKALSEGYVAEL 129

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 281
              +  AL Y HS    ++H+D+K  N+L      +   K+ DFG+        +     
Sbjct: 130 MKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA- 186

Query: 282 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
                GT  YM PE     ++ K D++S GV++  LLTG  P    +
Sbjct: 187 ----AGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 54.5 bits (132), Expect = 3e-08
 Identities = 24/87 (27%), Positives = 38/87 (43%), Gaps = 11/87 (12%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNVKTMYTEN 519
           +  AL Y HS    ++H+D+K  N+L      +   K+ DFG+        +        
Sbjct: 133 MMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA---- 186

Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYG 546
             GT  YM PE     ++ K D++S G
Sbjct: 187 -AGTALYMAPEVFKRDVTFKCDIWSAG 212

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  112 bits (282), Expect = 1e-27
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 32/215 (14%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           K+G+G FG V+ G   +    +A+K +    +   +  +        I   + E+  LSQ
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKII----DLEEAEDE--------IEDIQQEITVLSQ 76

Query: 175 CKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           C    + +  G  L +  +  I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 77  CDSPYVTKYYGSYLKDTKL-WIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 131

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSETSNMK-TMYTENLTGTRP 290
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+  ++++T   + T       GT P
Sbjct: 132 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-----VGT-P 183

Query: 291 Y-MPPEAM-HCQISTKTDVFSYGVILLELLTGMKP 323
           + M PE +      +K D++S G+  +EL  G  P
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 19/108 (17%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSETSNVK-TMYT 517
           I   + + L YLHS  K  IHRD+K+ANVLL E+   KL DFG+  ++++T   + T   
Sbjct: 124 ILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-- 179

Query: 518 ENLTGTRPY-MPPEAM-HCQISTKTDVFSYGAQIKTQHITNVDIADRE 563
               GT P+ M PE +      +K D++S G       IT +++A  E
Sbjct: 180 ---VGT-PFWMAPEVIKQSAYDSKADIWSLG-------ITAIELARGE 216

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  112 bits (282), Expect = 1e-27
 Identities = 56/225 (24%), Positives = 85/225 (37%), Gaps = 29/225 (12%)

Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL-S 173
           ++G G  G V+  + +  G  IAVK +              +     IL    ++  +  
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQM---------RRSGNKEENKRIL---MDLDVVLK 79

Query: 174 QCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
                 +++  G    N    I  E M          R+    P+       + + + +A
Sbjct: 80  SHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG--PIPERILGKMTVAIVKA 136

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L+YL      +IHRDVK +N+LLDE    KL DFGI         K        G   YM
Sbjct: 137 LYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS----AGCAAYM 191

Query: 293 PPEAMHCQI------STKTDVFSYGVILLELLTGMKPIDDNNTIL 331
            PE +            + DV+S G+ L+EL TG  P  +  T  
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF 236

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 31/93 (33%), Positives = 42/93 (45%), Gaps = 11/93 (11%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           + + + +AL+YL      +IHRDVK +N+LLDE    KL DFGI         K      
Sbjct: 129 MTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS--- 184

Query: 520 LTGTRPYMPPEAMHCQI------STKTDVFSYG 546
             G   YM PE +            + DV+S G
Sbjct: 185 -AGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 216

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  114 bits (286), Expect = 2e-27
 Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 36/231 (15%)

Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              LG G  G V     +    ++A++ +        S  +   A  +     E E++ L
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNV-----ETEIEIL 194

Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------IA 226
            +  H  ++++    +     IV E M  G L+D++           NKR          
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GNKRLKEATCKLYF 245

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMYT 282
             +  A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG    + ETS M+T+  
Sbjct: 246 YQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 301

Query: 283 ENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 329
               GT  Y+ PE          +   D +S GVIL   L+G  P  ++ T
Sbjct: 302 ---CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 28/70 (40%), Positives = 40/70 (57%), Gaps = 9/70 (12%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           +  A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K+   +++  M T  L
Sbjct: 248 MLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRT--L 301

Query: 521 TGTRPYMPPE 530
            GT  Y+ PE
Sbjct: 302 CGTPTYLAPE 311

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  114 bits (288), Expect = 2e-27
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              LG+G FG V   K +    E AVK +   +  +   S               EV+ L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-----------ILREVELL 75

Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
            +  H N+++L  +  +  +  IV E    G L+D +            KR+S      I
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---------KRKRFSEHDAARI 126

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 281
              V   + Y+H  +  I+HRD+K  N+LL   +++   K+ DFG+     + + MK   
Sbjct: 127 IKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR- 183

Query: 282 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
                GT  Y+ PE +      K DV+S GVIL  LL+G  P    N
Sbjct: 184 ----IGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 11/87 (12%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNVKTMYTEN 519
           V   + Y+H  +  I+HRD+K  N+LL   +++   K+ DFG+     + + +K      
Sbjct: 130 VFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---- 183

Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYG 546
             GT  Y+ PE +      K DV+S G
Sbjct: 184 -IGTAYYIAPEVLRGTYDEKCDVWSAG 209

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  116 bits (291), Expect = 2e-27
 Identities = 47/218 (21%), Positives = 86/218 (39%), Gaps = 39/218 (17%)

Query: 116 KLGEGQFGTVYYGK---LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
            +  G  G +Y      + NG  + +K L         +S + EA  +       E Q L
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGL--------VHSGDAEAQAM----AMAERQFL 133

Query: 173 SQCKHVNLLRLL------GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           ++  H +++++           + +  IV EY+   SL     +      L   +  +  
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYL 188

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENL 285
           L +  AL YLHS    +++ D+K  N++L E  + KL D G V  ++    +        
Sbjct: 189 LEILPALSYLHS--IGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYL-------- 237

Query: 286 TGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKP 323
            GT  +  PE +    +  TD+++ G  L  L   +  
Sbjct: 238 YGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPT 275

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 85.7 bits (212), Expect = 1e-17
 Identities = 24/90 (26%), Positives = 42/90 (46%), Gaps = 12/90 (13%)

Query: 459 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYT 517
           +  L +  AL YLHS    +++ D+K  N++L E  + KL D G V  ++    +     
Sbjct: 186 AYLLEILPALSYLHS--IGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYL----- 237

Query: 518 ENLTGTRPYMPPEAMHCQISTKTDVFSYGA 547
               GT  +  PE +    +  TD+++ G 
Sbjct: 238 ---YGTPGFQAPEIVRTGPTVATDIYTVGR 264

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  110 bits (277), Expect = 6e-27
 Identities = 59/273 (21%), Positives = 96/273 (35%), Gaps = 59/273 (21%)

Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV----- 169
            +G G FG V+  K K +    A+K +       +      E   +  L     V     
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 170 -------------------------------QTLSQCKHVNLLRLLGLCNNIMN------ 192
                                             +    +  +      N +        
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 193 ----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV 248
                I  +     +L D + R  +    +      I + +AEA+ +LHS  K ++HRD+
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDL 190

Query: 249 KSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLT--------GTRPYMPPEAMHC 299
           K +N+    + V K+GDFG+V  M +    +T+ T            GT+ YM PE +H 
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250

Query: 300 QI-STKTDVFSYGVILLELLTGMKPIDDNNTIL 331
              S K D+FS G+IL ELL       +   I+
Sbjct: 251 NNYSHKVDIFSLGLILFELLYSFSTQMERVRII 283

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 78.4 bits (193), Expect = 5e-16
 Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 12/115 (10%)

Query: 442 KLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 501
            + R  +    +      I + +AEA+ +LHS  K ++HRD+K +N+    + V K+GDF
Sbjct: 151 WMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDF 208

Query: 502 GIVK-MSETSNVKTMYTENLT--------GTRPYMPPEAMHCQI-STKTDVFSYG 546
           G+V  M +    +T+ T            GT+ YM PE +H    S K D+FS G
Sbjct: 209 GLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLG 263

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  109 bits (274), Expect = 1e-26
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              LG+G FG V   K +    E AVK +   +  +   S               EV+ L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-----------ILREVELL 75

Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
            +  H N+++L  +  +  +  IV E    G L+D +            KR+S      I
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---------KRKRFSEHDAARI 126

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 281
              V   + Y+H  +  I+HRD+K  N+LL   +++   K+ DFG+     + + MK   
Sbjct: 127 IKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR- 183

Query: 282 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
                GT  Y+ PE +      K DV+S GVIL  LL+G  P    N
Sbjct: 184 ----IGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 54.9 bits (133), Expect = 2e-08
 Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 11/87 (12%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNVKTMYTEN 519
           V   + Y+H  +  I+HRD+K  N+LL   +++   K+ DFG+     + + +K      
Sbjct: 130 VFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---- 183

Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYG 546
             GT  Y+ PE +      K DV+S G
Sbjct: 184 -IGTAYYIAPEVLRGTYDEKCDVWSAG 209

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  109 bits (274), Expect = 1e-26
 Identities = 56/248 (22%), Positives = 87/248 (35%), Gaps = 48/248 (19%)

Query: 102 TDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMI 160
            D  +R+ Y  RG  LG+G F   +           A K +      S     +    M 
Sbjct: 9   VDPRSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIV----PKSLLLKPHQREKM- 62

Query: 161 PILLFENEVQTLSQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPL 217
                  E+       H +++   G     + +   +V E     SL +   R       
Sbjct: 63  -----SMEISIHRSLAHQHVVGFHGFFEDNDFV--FVVLELCRRRSLLELHKR------- 108

Query: 218 DSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI--V 269
              K  +          +     YLH     +IHRD+K  N+ L+E+   K+GDFG+   
Sbjct: 109 --RKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164

Query: 270 KMSETSNMKTMYTENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPID 325
              +    K +      GT  Y+ PE      H   S + DV+S G I+  LL G  P +
Sbjct: 165 VEYDGERKKVL-----CGTPNYIAPEVLSKKGH---SFEVDVWSIGCIMYTLLVGKPPFE 216

Query: 326 DNNTILYY 333
            +     Y
Sbjct: 217 TSCLKETY 224

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 56.0 bits (136), Expect = 8e-09
 Identities = 22/69 (31%), Positives = 33/69 (47%), Gaps = 9/69 (13%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI--VKMSETSNVKTMYTENLT 521
           +     YLH     +IHRD+K  N+ L+E+   K+GDFG+      +    K +      
Sbjct: 124 IVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-----C 176

Query: 522 GTRPYMPPE 530
           GT  Y+ PE
Sbjct: 177 GTPNYIAPE 185

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (281), Expect = 1e-26
 Identities = 56/247 (22%), Positives = 93/247 (37%), Gaps = 52/247 (21%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
              LG G  GTV +     G  +AVK +           D  + A         E++ L+
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRM---------LIDFCDIA-------LMEIKLLT 63

Query: 174 QCK-HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV-- 229
           +   H N++R            I  E  CN +L D +   N +      ++    + +  
Sbjct: 64  ESDDHPNVIRYYCSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLR 122

Query: 230 --AEALHYLHSLSKPIIHRDVKSANVLLD-------------ENFVPKLGDFGIVKM--- 271
             A  + +LHSL   IIHRD+K  N+L+              EN    + DFG+ K    
Sbjct: 123 QIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 272 SETSNMKTMYTENLTGTRPYMPPE--------AMHCQISTKTDVFSYGVILLELLT-GMK 322
            ++S    +     +GT  +  PE            +++   D+FS G +   +L+ G  
Sbjct: 181 GQSSFRTNLNN--PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

Query: 323 PIDDNNT 329
           P  D  +
Sbjct: 239 PFGDKYS 245

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 28/107 (26%), Positives = 45/107 (42%), Gaps = 28/107 (26%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLD-------------ENFVPKLGDFGIVKM---S 507
           +A  + +LHSL   IIHRD+K  N+L+              EN    + DFG+ K     
Sbjct: 124 IASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 508 ETSNVKTMYTENLTGTRPYMPPE--------AMHCQISTKTDVFSYG 546
           ++S    +     +GT  +  PE            +++   D+FS G
Sbjct: 182 QSSFRTNLNN--PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  108 bits (273), Expect = 1e-26
 Identities = 50/227 (22%), Positives = 86/227 (37%), Gaps = 41/227 (18%)

Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
            N +G G +G V     K   +  A K +           ++ +        F+ E++ +
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKI------PKYFVEDVDR-------FKQEIEIM 60

Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
               H N++RL     +  +  +V E    G L++R+            + +       I
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV---------HKRVFRESDAARI 111

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 281
              V  A+ Y H L+  + HRD+K  N L      +   KL DFG+  +      M+T  
Sbjct: 112 MKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK- 168

Query: 282 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
                GT  Y+ P+ +      + D +S GV++  LL G  P     
Sbjct: 169 ----VGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPT 211

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 54.5 bits (132), Expect = 2e-08
 Identities = 24/87 (27%), Positives = 38/87 (43%), Gaps = 11/87 (12%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNVKTMYTEN 519
           V  A+ Y H L+  + HRD+K  N L      +   KL DFG+  +      ++T     
Sbjct: 115 VLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---- 168

Query: 520 LTGTRPYMPPEAMHCQISTKTDVFSYG 546
             GT  Y+ P+ +      + D +S G
Sbjct: 169 -VGTPYYVSPQVLEGLYGPECDEWSAG 194

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  110 bits (276), Expect = 1e-26
 Identities = 55/251 (21%), Positives = 87/251 (34%), Gaps = 48/251 (19%)

Query: 99  ERATDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEA 157
           E   D  +R+ Y  RG  LG+G F   +           A K +  +        +    
Sbjct: 32  EVLVDPRSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--- 87

Query: 158 AMIPILLFENEVQTLSQCKHVNLLRLLGL---CNNIMNCIVYEYMCNGSLYDRLARVNNT 214
                     E+       H +++   G     + +   +V E     SL +   R    
Sbjct: 88  -------MSMEISIHRSLAHQHVVGFHGFFEDNDFV--FVVLELCRRRSLLELHKR---- 134

Query: 215 PPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI 268
                 K  +          +     YLH     +IHRD+K  N+ L+E+   K+GDFG+
Sbjct: 135 -----RKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGL 187

Query: 269 --VKMSETSNMKTMYTENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMK 322
                 +    K +      GT  Y+ PE      H   S + DV+S G I+  LL G  
Sbjct: 188 ATKVEYDGERKKVL-----CGTPNYIAPEVLSKKGH---SFEVDVWSIGCIMYTLLVGKP 239

Query: 323 PIDDNNTILYY 333
           P + +     Y
Sbjct: 240 PFETSCLKETY 250

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 22/69 (31%), Positives = 33/69 (47%), Gaps = 9/69 (13%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI--VKMSETSNVKTMYTENLT 521
           +     YLH     +IHRD+K  N+ L+E+   K+GDFG+      +    K +      
Sbjct: 150 IVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-----C 202

Query: 522 GTRPYMPPE 530
           GT  Y+ PE
Sbjct: 203 GTPNYIAPE 211

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  109 bits (274), Expect = 3e-26
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 32/217 (14%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
            ++G G FG VY+ + ++N   +A+K +  +           + +         EV+ L 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYS----------GKQSNEKWQDIIKEVRFLQ 109

Query: 174 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           + +H N ++  G  L  +    +V EY C GS  D L    +  PL   +  ++  G  +
Sbjct: 110 KLRHPNTIQYRGCYLREHTA-WLVMEY-CLGSASDLL--EVHKKPLQEVEIAAVTHGALQ 165

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            L YLHS +   IHRDVK+ N+LL E  + KLGDFG    S  +   +       GT PY
Sbjct: 166 GLAYLHSHNM--IHRDVKAGNILLSEPGLVKLGDFGSA--SIMAPANSF-----VGT-PY 215

Query: 292 -MPPEAMHCQIST----KTDVFSYGVILLELLTGMKP 323
            M PE +          K DV+S G+  +EL     P
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 39/109 (35%), Positives = 54/109 (49%), Gaps = 22/109 (20%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +  G  + L YLHS +   IHRDVK+ N+LL E  + KLGDFG    S  +   +     
Sbjct: 159 VTHGALQGLAYLHSHNM--IHRDVKAGNILLSEPGLVKLGDFGSA--SIMAPANSF---- 210

Query: 520 LTGTRPY-MPPEAMHCQIST----KTDVFSYGAQIKTQHITNVDIADRE 563
             GT PY M PE +          K DV+S G       IT +++A+R+
Sbjct: 211 -VGT-PYWMAPEVILAMDEGQYDGKVDVWSLG-------ITCIELAERK 250

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  108 bits (272), Expect = 4e-26
 Identities = 57/262 (21%), Positives = 85/262 (32%), Gaps = 59/262 (22%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              +G+G +G V            A+K +  N     +  D            + EV+ +
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI--------KTEVRLM 82

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG--- 228
            +  H N+ RL  +  +    C+V E    G L D+L    +                  
Sbjct: 83  KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 229 ----------------------------------VAEALHYLHSLSKPIIHRDVKSANVL 254
                                             +  ALHYLH+    I HRD+K  N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFL 200

Query: 255 L--DENFVPKLGDFG---IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ---ISTKTD 306
              +++F  KL DFG               M T    GT  ++ PE ++        K D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT--KAGTPYFVAPEVLNTTNESYGPKCD 258

Query: 307 VFSYGVILLELLTGMKPIDDNN 328
            +S GV+L  LL G  P    N
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVN 280

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 29/91 (31%), Positives = 40/91 (43%), Gaps = 12/91 (13%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFG---IVKMSETSNVKTMYTE 518
           +  ALHYLH+    I HRD+K  N L   +++F  KL DFG               M T 
Sbjct: 177 IFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT- 233

Query: 519 NLTGTRPYMPPEAMHCQ---ISTKTDVFSYG 546
              GT  ++ PE ++        K D +S G
Sbjct: 234 -KAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  107 bits (270), Expect = 6e-26
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 36/231 (15%)

Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              LG G  G V     +    ++A+K +        S  +   A  +     E E++ L
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNV-----ETEIEIL 69

Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------IA 226
            +  H  ++++    +     IV E M  G L+D++           NKR          
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GNKRLKEATCKLYF 120

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMYT 282
             +  A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG    + ETS M+T+  
Sbjct: 121 YQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 176

Query: 283 ENLTGTRPYMPPEAMHCQI----STKTDVFSYGVILLELLTGMKPIDDNNT 329
               GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 177 ---CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 28/71 (39%), Positives = 40/71 (56%), Gaps = 11/71 (15%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNVKTMYTEN 519
           +  A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG    + ETS ++T+    
Sbjct: 123 MLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL---- 176

Query: 520 LTGTRPYMPPE 530
             GT  Y+ PE
Sbjct: 177 -CGTPTYLAPE 186

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  107 bits (269), Expect = 6e-26
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 33/216 (15%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
            KLGEG +G+VY     + G  +A+K +   ++                     E+  + 
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE---------------IIKEISIMQ 79

Query: 174 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           QC   ++++  G    N  +  IV EY   GS+ D +   N    L  ++  +I     +
Sbjct: 80  QCDSPHVVKYYGSYFKNTDL-WIVMEYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLK 136

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSET-SNMKTMYTENLTGTR 289
            L YLH + K  IHRD+K+ N+LL+     KL DFG+  ++++T +   T+      GT 
Sbjct: 137 GLEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV-----IGT- 188

Query: 290 PY-MPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 323
           P+ M PE       +   D++S G+  +E+  G  P
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 65.5 bits (160), Expect = 8e-12
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 19/108 (17%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSET-SNVKTMYT 517
           I     + L YLH + K  IHRD+K+ N+LL+     KL DFG+  ++++T +   T+  
Sbjct: 130 ILQSTLKGLEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV-- 185

Query: 518 ENLTGTRPY-MPPE-AMHCQISTKTDVFSYGAQIKTQHITNVDIADRE 563
               GT P+ M PE       +   D++S G       IT +++A+ +
Sbjct: 186 ---IGT-PFWMAPEVIQEIGYNCVADIWSLG-------ITAIEMAEGK 222

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  106 bits (268), Expect = 6e-26
 Identities = 63/246 (25%), Positives = 95/246 (38%), Gaps = 39/246 (15%)

Query: 100 RATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAA 158
            +T GF    Y      LG G    V     K    E AVK ++     S S  +  E  
Sbjct: 10  HSTHGFYEN-Y-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR 67

Query: 159 MIPILLFENEVQTLSQ-CKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP 216
                    EV  L +   H N+++L           +V++ M  G L+D L        
Sbjct: 68  E----ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT------- 116

Query: 217 LDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-V 269
                  S      I   + E +  LH L+  I+HRD+K  N+LLD++   KL DFG   
Sbjct: 117 --EKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 172

Query: 270 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT-------DVFSYGVILLELLTGMK 322
           ++     ++      + GT  Y+ PE + C ++          D++S GVI+  LL G  
Sbjct: 173 QLDPGEKLRE-----VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

Query: 323 PIDDNN 328
           P     
Sbjct: 228 PFWHRK 233

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 23/68 (33%), Positives = 37/68 (54%), Gaps = 8/68 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTG 522
           + E +  LH L+  I+HRD+K  N+LLD++   KL DFG   ++     ++      + G
Sbjct: 133 LLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-----VCG 185

Query: 523 TRPYMPPE 530
           T  Y+ PE
Sbjct: 186 TPSYLAPE 193

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  107 bits (270), Expect = 7e-26
 Identities = 62/226 (27%), Positives = 92/226 (40%), Gaps = 41/226 (18%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
            +G G +G VY G+ +K G   A+K ++          D  E         + E+  L +
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-------GDEEE-------EIKQEINMLKK 76

Query: 175 -CKHVNLLRLLG--LCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
              H N+    G  +  N         +V E+   GS+ D L +      L       I 
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYIC 135

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSET-SNMKTMYTEN 284
             +   L +LH      IHRD+K  NVLL EN   KL DFG+  ++  T     T     
Sbjct: 136 REILRGLSHLHQHKV--IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF---- 189

Query: 285 LTGTRPY-MPPEAMHCQIS------TKTDVFSYGVILLELLTGMKP 323
             GT PY M PE + C  +       K+D++S G+  +E+  G  P
Sbjct: 190 -IGT-PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 37/113 (32%), Positives = 53/113 (46%), Gaps = 24/113 (21%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVK-TMYT 517
           I   +   L +LH      IHRD+K  NVLL EN   KL DFG+  ++  T   + T   
Sbjct: 134 ICREILRGLSHLHQHKV--IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-- 189

Query: 518 ENLTGTRPY-MPPEAMHCQIS------TKTDVFSYGAQIKTQHITNVDIADRE 563
               GT PY M PE + C  +       K+D++S G       IT +++A+  
Sbjct: 190 ---IGT-PYWMAPEVIACDENPDATYDFKSDLWSLG-------ITAIEMAEGA 231

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  106 bits (267), Expect = 1e-25
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 33/216 (15%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
            K+GEG  G V   +   +G ++AVK ++             E       L  NEV  + 
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLR------KQQRRE-------LLFNEVVIMR 97

Query: 174 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
             +H N++ +    L    +  ++ E++  G+L D +++V     L+  +  ++   V +
Sbjct: 98  DYQHFNVVEMYKSYLVGEEL-WVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQ 152

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSET-SNMKTMYTENLTGTR 289
           AL YLH+     IHRD+KS ++LL  +   KL DFG   ++S+     K++      GT 
Sbjct: 153 ALAYLHAQGV--IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-----VGT- 204

Query: 290 PY-MPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 323
           PY M PE       +T+ D++S G++++E++ G  P
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 19/108 (17%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSET-SNVKTMYT 517
           +   V +AL YLH+     IHRD+KS ++LL  +   KL DFG   ++S+     K++  
Sbjct: 146 VCEAVLQALAYLHAQGV--IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-- 201

Query: 518 ENLTGTRPY-MPPE-AMHCQISTKTDVFSYGAQIKTQHITNVDIADRE 563
               GT PY M PE       +T+ D++S G       I  +++ D E
Sbjct: 202 ---VGT-PYWMAPEVISRSLYATEVDIWSLG-------IMVIEMVDGE 238

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  105 bits (264), Expect = 2e-25
 Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 37/229 (16%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G +LG GQF  V   + K  G E A K ++     SS    + E         E EV  L
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE-------IEREVNIL 62

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
            + +H N++ L  +  N  +  ++ E +  G L+D LA           +  +       
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---------EKESLTEDEATQF 113

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGI-VKMSETSNMKTM 280
              + + +HYLHS    I H D+K  N++L      N   KL DFGI  K+   +  K +
Sbjct: 114 LKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171

Query: 281 YTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 328
           +     GT  ++ PE ++ + +  + D++S GVI   LL+G  P     
Sbjct: 172 F-----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 54.9 bits (133), Expect = 2e-08
 Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 13/89 (14%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGI-VKMSETSNVKTMYTE 518
           + + +HYLHS    I H D+K  N++L      N   KL DFGI  K+   +  K ++  
Sbjct: 117 ILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-- 172

Query: 519 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
              GT  ++ PE ++ + +  + D++S G
Sbjct: 173 ---GTPEFVAPEIVNYEPLGLEADMWSIG 198

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (265), Expect = 2e-25
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 33/216 (15%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
            K+G+G  GTVY    +  G E+A++ +              E       L  NE+  + 
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ------QQPKKE-------LIINEILVMR 72

Query: 174 QCKHVNLLRLLG--LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           + K+ N++  L   L  + +  +V EY+  GSL D +        +D  +  ++     +
Sbjct: 73  ENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQ 127

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSET-SNMKTMYTENLTGTR 289
           AL +LHS     IHRD+KS N+LL  +   KL DFG   +++   S   TM      GT 
Sbjct: 128 ALEFLHSNQV--IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-----VGT- 179

Query: 290 PY-MPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 323
           PY M PE         K D++S G++ +E++ G  P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 35/108 (32%), Positives = 50/108 (46%), Gaps = 19/108 (17%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSET-SNVKTMYT 517
           +     +AL +LHS     IHRD+KS N+LL  +   KL DFG   +++   S   TM  
Sbjct: 121 VCRECLQALEFLHSNQV--IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-- 176

Query: 518 ENLTGTRPY-MPPE-AMHCQISTKTDVFSYGAQIKTQHITNVDIADRE 563
               GT PY M PE         K D++S G       I  +++ + E
Sbjct: 177 ---VGT-PYWMAPEVVTRKAYGPKVDIWSLG-------IMAIEMIEGE 213

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  105 bits (264), Expect = 4e-25
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 25/223 (11%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G +LG GQF  V   + K  G+E A K ++   + +S    + E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            Q  H N++ L  +  N  +  ++ E +  G L+D LA+  +    ++         + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS---FIKQILD 126

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGI-VKMSETSNMKTMYTENLT 286
            ++YLH+    I H D+K  N++L +  +P    KL DFG+  ++ +    K ++     
Sbjct: 127 GVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----- 179

Query: 287 GTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 328
           GT  ++ PE ++ + +  + D++S GVI   LL+G  P   + 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 23/89 (25%), Positives = 48/89 (53%), Gaps = 13/89 (14%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGI-VKMSETSNVKTMYTE 518
           + + ++YLH+    I H D+K  N++L +  +P    KL DFG+  ++ +    K ++  
Sbjct: 124 ILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-- 179

Query: 519 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
              GT  ++ PE ++ + +  + D++S G
Sbjct: 180 ---GTPEFVAPEIVNYEPLGLEADMWSIG 205

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  105 bits (263), Expect = 8e-25
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 22/227 (9%)

Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              +G+G F  V     +  G + AVK + + A ++SS   +TE         + E    
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIV-DVAKFTSSPGLSTED-------LKREASIC 80

Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVA 230
              KH +++ LL   ++     +V+E+M    L   +  R +                + 
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140

Query: 231 EALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMYTENLT 286
           EAL Y H  +  IIHRDVK   VLL   + +   KLG FG+ +++ E+            
Sbjct: 141 EALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGG--RV 194

Query: 287 GTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILY 332
           GT  +M PE +  +      DV+  GVIL  LL+G  P       L+
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 241

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 30/88 (34%), Positives = 43/88 (48%), Gaps = 11/88 (12%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNVKTMYTEN 519
           + EAL Y H  +  IIHRDVK   VLL   + +   KLG FG+ +++ E+  V       
Sbjct: 139 ILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV--AGG-- 192

Query: 520 LTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             GT  +M PE +  +      DV+  G
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCG 220

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (259), Expect = 2e-24
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 37/229 (16%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G +LG GQF  V   + K  G++ A K ++     SS    + E         E EV  L
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-------IEREVSIL 68

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
            + +H N++ L  +  N  +  ++ E +  G L+D LA           +  +       
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---------EKESLTEEEATEF 119

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGI-VKMSETSNMKTM 280
              +   ++YLHSL   I H D+K  N++L          K+ DFG+  K+   +  K +
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177

Query: 281 YTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 328
           +     GT  ++ PE ++ + +  + D++S GVI   LL+G  P   + 
Sbjct: 178 F-----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 53.8 bits (130), Expect = 7e-08
 Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 13/89 (14%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGI-VKMSETSNVKTMYTE 518
           +   ++YLHSL   I H D+K  N++L          K+ DFG+  K+   +  K ++  
Sbjct: 123 ILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178

Query: 519 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
              GT  ++ PE ++ + +  + D++S G
Sbjct: 179 ---GTPEFVAPEIVNYEPLGLEADMWSIG 204

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  102 bits (256), Expect = 2e-24
 Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 40/228 (17%)

Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
             +LG+G F  V     K  G+E A K +    N    ++ + +         E E +  
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKII----NTKKLSARDFQK-------LEREARIC 59

Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
            + +H N++RL           +V++ +  G L++ +          + + YS       
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---------AREFYSEADASHC 110

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 281
              + E++ Y HS    I+HR++K  N+LL    +    KL DFG+ ++++++       
Sbjct: 111 IQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF- 167

Query: 282 TENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
                GT  Y+ PE +     S   D+++ GVIL  LL G  P  D +
Sbjct: 168 ----AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 49.9 bits (120), Expect = 8e-07
 Identities = 24/88 (27%), Positives = 44/88 (50%), Gaps = 12/88 (13%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNVKTMYTEN 519
           + E++ Y HS    I+HR++K  N+LL    +    KL DFG+ ++++++          
Sbjct: 114 ILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF---- 167

Query: 520 LTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             GT  Y+ PE +     S   D+++ G
Sbjct: 168 -AGTPGYLSPEVLKKDPYSKPVDIWACG 194

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  103 bits (259), Expect = 3e-24
 Identities = 58/232 (25%), Positives = 91/232 (39%), Gaps = 38/232 (16%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
            + +G G    V     +  G E AVK +E  A   S                  E   L
Sbjct: 99  KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT-----RRETHIL 153

Query: 173 SQCK-HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------ 224
            Q   H +++ L+    +     +V++ M  G L+D L               S      
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT---------EKVALSEKETRS 204

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTE 283
           I   + EA+ +LH+ +  I+HRD+K  N+LLD+N   +L DFG    +     ++     
Sbjct: 205 IMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---- 258

Query: 284 NLTGTRPYMPPEAMHCQI-------STKTDVFSYGVILLELLTGMKPIDDNN 328
            L GT  Y+ PE + C +         + D+++ GVIL  LL G  P     
Sbjct: 259 -LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 53.6 bits (129), Expect = 8e-08
 Identities = 24/68 (35%), Positives = 38/68 (55%), Gaps = 8/68 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTG 522
           + EA+ +LH+ +  I+HRD+K  N+LLD+N   +L DFG    +     ++      L G
Sbjct: 209 LLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-----LCG 261

Query: 523 TRPYMPPE 530
           T  Y+ PE
Sbjct: 262 TPGYLAPE 269

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  102 bits (256), Expect = 3e-24
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 22/232 (9%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           KLG G   TVY  +     +++A+K +           +  E     +  FE EV   SQ
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAI--FIPPR----EKEET----LKRFEREVHNSSQ 67

Query: 175 CKHVNLLRLL--GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
             H N++ ++     ++    +V EY+   +L + +       PL  +   +    + + 
Sbjct: 68  LSHQNIVSMIDVDEEDDC-YYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDG 123

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + + H     I+HRD+K  N+L+D N   K+ DFGI K    +++    T ++ GT  Y 
Sbjct: 124 IKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL--TQTNHVLGTVQYF 179

Query: 293 PPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 343
            PE A        TD++S G++L E+L G  P +    +      ++  VP 
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN 231

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 75.3 bits (186), Expect = 4e-15
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 5/97 (5%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL  +   +    + + + + H     I+HRD+K  N+L+D N   K+ DFGI K    +
Sbjct: 107 PLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164

Query: 511 NVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
           ++    T ++ GT  Y  PE A        TD++S G
Sbjct: 165 SL--TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIG 199

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  103 bits (258), Expect = 4e-24
 Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 37/229 (16%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G +LG GQF  V   + K  G+E A K ++   + +S      E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE-------IEREVSIL 69

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
            Q  H N++ L  +  N  +  ++ E +  G L+D LA           +  S       
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA---------QKESLSEEEATSF 120

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGI-VKMSETSNMKTM 280
              + + ++YLH+    I H D+K  N++L +  +P    KL DFG+  ++ +    K +
Sbjct: 121 IKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178

Query: 281 YTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 328
           +     GT  ++ PE ++ + +  + D++S GVI   LL+G  P   + 
Sbjct: 179 F-----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 23/89 (25%), Positives = 48/89 (53%), Gaps = 13/89 (14%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGI-VKMSETSNVKTMYTE 518
           + + ++YLH+    I H D+K  N++L +  +P    KL DFG+  ++ +    K ++  
Sbjct: 124 ILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-- 179

Query: 519 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
              GT  ++ PE ++ + +  + D++S G
Sbjct: 180 ---GTPEFVAPEIVNYEPLGLEADMWSIG 205

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  101 bits (254), Expect = 5e-24
 Identities = 57/267 (21%), Positives = 100/267 (37%), Gaps = 44/267 (16%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLE-------------NNANYSSSNSDNTEAAM 159
            +++G+G +G V       +    A+K L                   +           
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 160 IPILLFENEVQTLSQCKHVNLLRL---LGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPP 216
            PI     E+  L +  H N+++L   L   N     +V+E +  G + +         P
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KP 133

Query: 217 LDSNK--RY--SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
           L  ++   Y   +  G+     YLH     IIHRD+K +N+L+ E+   K+ DFG   +S
Sbjct: 134 LSEDQARFYFQDLIKGI----EYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFG---VS 184

Query: 273 ETSNMKTMYTENLTGTRPYMPPEAMHCQISTK------TDVFSYGVILLELLTGMKPIDD 326
                      N  GT  +M PE+     + K       DV++ GV L   + G  P  D
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPES--LSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242

Query: 327 NNTILYYYLVVEQEV--PVREVLDKEA 351
              +  +  +  Q +  P +  + ++ 
Sbjct: 243 ERIMCLHSKIKSQALEFPDQPDIAEDL 269

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 23/64 (35%), Positives = 32/64 (50%), Gaps = 5/64 (7%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
            + YLH     IIHRD+K +N+L+ E+   K+ DFG   +S           N  GT  +
Sbjct: 149 GIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFG---VSNEFKGSDALLSNTVGTPAF 203

Query: 527 MPPE 530
           M PE
Sbjct: 204 MAPE 207

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 41/227 (18%)

Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              LG G F  V+  K +  G   A+K ++ +    +    +           ENE+  L
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS---PAFRDSS----------LENEIAVL 60

Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
            + KH N++ L  +  +  +  +V + +  G L+DR+              Y+      +
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL---------ERGVYTEKDASLV 111

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 282
              V  A+ YLH     I+HRD+K  N+L    +EN    + DFG+ KM +   M T   
Sbjct: 112 IQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA-- 167

Query: 283 ENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
               GT  Y+ PE +  +  S   D +S GVI   LL G  P  +  
Sbjct: 168 ---CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 55.3 bits (134), Expect = 2e-08
 Identities = 29/87 (33%), Positives = 42/87 (48%), Gaps = 11/87 (12%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           V  A+ YLH     I+HRD+K  N+L    +EN    + DFG+ KM +   + T      
Sbjct: 115 VLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA----- 167

Query: 521 TGTRPYMPPEAMHCQI-STKTDVFSYG 546
            GT  Y+ PE +  +  S   D +S G
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIG 194

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  100 bits (250), Expect = 2e-23
 Identities = 46/227 (20%), Positives = 89/227 (39%), Gaps = 41/227 (18%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              LG G+FG V+      +      K +          +D            + E+  L
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFV------KVKGTDQVL--------VKKEISIL 55

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
           +  +H N+L L     ++    +++E++    +++R+          S    +       
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERI--------NTSAFELNEREIVSY 107

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGI-VKMSETSNMKTMYT 282
              V EAL +LHS +  I H D++  N++     +   K+ +FG   ++    N + ++ 
Sbjct: 108 VHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF- 164

Query: 283 ENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
                   Y  PE   H  +ST TD++S G ++  LL+G+ P     
Sbjct: 165 ----TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 25/87 (28%), Positives = 42/87 (48%), Gaps = 11/87 (12%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGI-VKMSETSNVKTMYTENL 520
           V EAL +LHS +  I H D++  N++     +   K+ +FG   ++    N + ++    
Sbjct: 111 VCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---- 164

Query: 521 TGTRPYMPPE-AMHCQISTKTDVFSYG 546
                Y  PE   H  +ST TD++S G
Sbjct: 165 -TAPEYYAPEVHQHDVVSTATDMWSLG 190

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 99.6 bits (249), Expect = 3e-23
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 22/217 (10%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G  LG G    V+  + L++  ++AVK L   A+ +     +        L F  E Q  
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVL--RADLA----RDPSF----YLRFRREAQNA 66

Query: 173 SQCKHVNLLRLL--GLCNNIMNCIVY---EYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
           +   H  ++ +   G        + Y   EY+   +L D +       P+   +   +  
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIA 123

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 287
              +AL++ H     IIHRDVK AN+++      K+ DFGI +    S      T  + G
Sbjct: 124 DACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

Query: 288 TRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 323
           T  Y+ PE A    +  ++DV+S G +L E+LTG  P
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 3/97 (3%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           P+   +   +     +AL++ H     IIHRDVK AN+++      K+ DFGI +    S
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169

Query: 511 NVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
                 T  + GT  Y+ PE A    +  ++DV+S G
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 99.7 bits (249), Expect = 4e-23
 Identities = 57/251 (22%), Positives = 97/251 (38%), Gaps = 59/251 (23%)

Query: 105 FNRKPYPRRGN----------KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSD 153
             + P P++             LG G  G V     +  G + A+K L ++         
Sbjct: 15  LFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------- 66

Query: 154 NTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNNIMNC-----IVYEYMCNGSLYDR 207
                         EV    Q     +++ +L +  N+ +      I+ E M  G L+ R
Sbjct: 67  ----------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR 116

Query: 208 LARVNNTPPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DEN 258
           +           ++ ++      I   +  A+ +LHS +  I HRDVK  N+L    +++
Sbjct: 117 IQER-------GDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKD 167

Query: 259 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLEL 317
            V KL DFG  K +  + ++T        T  Y+ PE +  +      D++S GVI+  L
Sbjct: 168 AVLKLTDFGFAKETTQNALQTP-----CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 222

Query: 318 LTGMKPIDDNN 328
           L G  P   N 
Sbjct: 223 LCGFPPFYSNT 233

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 24/70 (34%), Positives = 37/70 (52%), Gaps = 10/70 (14%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           +  A+ +LHS +  I HRDVK  N+L    +++ V KL DFG  K +  + ++T      
Sbjct: 137 IGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP----- 189

Query: 521 TGTRPYMPPE 530
             T  Y+ PE
Sbjct: 190 CYTPYYVAPE 199

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  100 bits (250), Expect = 4e-23
 Identities = 53/228 (23%), Positives = 95/228 (41%), Gaps = 40/228 (17%)

Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
             +LG+G F  V     K  G+E A K +      ++      +   +     E E +  
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKII------NTKKLSARDFQKL-----EREARIC 82

Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
            + +H N++RL           +V++ +  G L++ +            + YS       
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---------EFYSEADASHC 133

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 281
              + E++ Y HS    I+HR++K  N+LL    +    KL DFG+ ++++++       
Sbjct: 134 IQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF- 190

Query: 282 TENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
                GT  Y+ PE +     S   D+++ GVIL  LL G  P  D +
Sbjct: 191 ----AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 24/88 (27%), Positives = 44/88 (50%), Gaps = 12/88 (13%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNVKTMYTEN 519
           + E++ Y HS    I+HR++K  N+LL    +    KL DFG+ ++++++          
Sbjct: 137 ILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF---- 190

Query: 520 LTGTRPYMPPEAMHCQI-STKTDVFSYG 546
             GT  Y+ PE +     S   D+++ G
Sbjct: 191 -AGTPGYLSPEVLKKDPYSKPVDIWACG 217

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 98.9 bits (247), Expect = 8e-23
 Identities = 53/235 (22%), Positives = 90/235 (38%), Gaps = 43/235 (18%)

Query: 110 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 168
           Y     +LG G+F  V     K  G E A K L           D             +E
Sbjct: 30  YILTSKELGRGKFAVVRQCISKSTGQEYAAKFL----KKRRRGQDCRAE-------ILHE 78

Query: 169 VQTLSQCKHV-NLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
           +  L   K    ++ L  +    + I   ++ EY   G ++            +  +  S
Sbjct: 79  IAVLELAKSCPRVINLHEVYENTSEI--ILILEYAAGGEIFSLCLP-------ELAEMVS 129

Query: 225 ------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSET 274
                 +   + E ++YLH  +  I+H D+K  N+LL         K+ DFG+  K+   
Sbjct: 130 ENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187

Query: 275 SNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 328
             ++ +      GT  Y+ PE ++   I+T TD+++ G+I   LLT   P    +
Sbjct: 188 CELREI-----MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 53.8 bits (130), Expect = 6e-08
 Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 12/88 (13%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNVKTMYTEN 519
           + E ++YLH  +  I+H D+K  N+LL         K+ DFG+  K+     ++ +    
Sbjct: 140 ILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI---- 193

Query: 520 LTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
             GT  Y+ PE ++   I+T TD+++ G
Sbjct: 194 -MGTPEYLAPEILNYDPITTATDMWNIG 220

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 99.4 bits (248), Expect = 1e-22
 Identities = 47/227 (20%), Positives = 90/227 (39%), Gaps = 40/227 (17%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
             +LG G FG V+    K  G     K +      ++    +           +NE+  +
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKFI------NTPYPLDKYT-------VKNEISIM 102

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
           +Q  H  L+ L     +     ++ E++  G L+DR+           + + S       
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI--------AAEDYKMSEAEVINY 154

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGI-VKMSETSNMKTMYT 282
                E L ++H  S  I+H D+K  N++    +    K+ DFG+  K++    +K    
Sbjct: 155 MRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT- 211

Query: 283 ENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 328
                T  +  PE +  + +   TD+++ GV+   LL+G+ P    +
Sbjct: 212 ----ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 11/87 (12%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGI-VKMSETSNVKTMYTENL 520
             E L ++H  S  I+H D+K  N++    +    K+ DFG+  K++    VK       
Sbjct: 158 ACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---- 211

Query: 521 TGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
             T  +  PE +  + +   TD+++ G
Sbjct: 212 -ATAEFAAPEIVDREPVGFYTDMWAIG 237

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 55/229 (24%), Positives = 103/229 (44%), Gaps = 42/229 (18%)

Query: 113 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
           +   LG G+FG V+  +    G+++A K +       +    + E         +NE+  
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKII------KTRGMKDKEE-------VKNEISV 139

Query: 172 LSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------ 224
           ++Q  H NL++L     +  +  +V EY+  G L+DR+        +D +   +      
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--------IDESYNLTELDTIL 191

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTM 280
               + E + ++H +   I+H D+K  N+L    D   + K+ DFG+  +      +K  
Sbjct: 192 FMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVN 248

Query: 281 YTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 328
           +     GT  ++ PE   +  +S  TD++S GVI   LL+G+ P   +N
Sbjct: 249 F-----GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 23/88 (26%), Positives = 43/88 (48%), Gaps = 13/88 (14%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNVKTMYTEN 519
           + E + ++H +   I+H D+K  N+L    D   + K+ DFG+  +      +K  +   
Sbjct: 196 ICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNF--- 249

Query: 520 LTGTRPYMPPE-AMHCQISTKTDVFSYG 546
             GT  ++ PE   +  +S  TD++S G
Sbjct: 250 --GTPEFLAPEVVNYDFVSFPTDMWSVG 275

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 38/153 (24%), Positives = 61/153 (39%), Gaps = 12/153 (7%)

Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 253
           +    +    L   L R     PL   +  +I   +  AL   H+      HRDVK  N+
Sbjct: 111 VDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENI 165

Query: 254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGV 312
           L+  +    L DFGI   +    + T    N  GT  YM PE       + + D+++   
Sbjct: 166 LVSADDFAYLVDFGIASATTDEKL-TQ-LGNTVGTLYYMAPERFSESHATYRADIYALTC 223

Query: 313 ILLELLTGMKPID-DNNTILYYYLVVEQEVPVR 344
           +L E LTG  P   D  +++  ++    +   R
Sbjct: 224 VLYECLTGSPPYQGDQLSVMGAHI---NQAIPR 253

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 27/97 (27%), Positives = 41/97 (42%), Gaps = 5/97 (5%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL   +  +I   +  AL   H+      HRDVK  N+L+  +    L DFGI   +   
Sbjct: 130 PLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187

Query: 511 NVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
            + T    N  GT  YM PE       + + D+++  
Sbjct: 188 KL-TQ-LGNTVGTLYYMAPERFSESHATYRADIYALT 222

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  101 bits (252), Expect = 1e-22
 Identities = 52/228 (22%), Positives = 94/228 (41%), Gaps = 42/228 (18%)

Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
             +LG G FG V+    +  G   A K +       + +  + E           E+QT+
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFV------MTPHESDKET-------VRKEIQTM 208

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
           S  +H  L+ L     +     ++YE+M  G L++++         D + + S       
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV--------ADEHNKMSEDEAVEY 260

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 281
              V + L ++H  +   +H D+K  N++      N + KL DFG+   +    ++K   
Sbjct: 261 MRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQSVKVTT 317

Query: 282 TENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 328
                GT  +  PE    + +   TD++S GV+   LL+G+ P    N
Sbjct: 318 -----GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 23/88 (26%), Positives = 40/88 (45%), Gaps = 13/88 (14%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNVKTMYTEN 519
           V + L ++H  +   +H D+K  N++      N + KL DFG+   +    +VK      
Sbjct: 264 VCKGLCHMHENN--YVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQSVKVTT--- 317

Query: 520 LTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
             GT  +  PE    + +   TD++S G
Sbjct: 318 --GTAEFAAPEVAEGKPVGYYTDMWSVG 343

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 97.4 bits (243), Expect = 9e-22
 Identities = 49/229 (21%), Positives = 86/229 (37%), Gaps = 41/229 (17%)

Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
             +LG+G F  V        G E A   +      +  +              E E +  
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-----------LEREARIC 64

Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
              KH N++RL    +   +  ++++ +  G L++ +          + + YS       
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV---------AREYYSEADASHC 115

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKM--SETSNMKTM 280
              + EA+ + H +   ++HR++K  N+LL    +    KL DFG+      E       
Sbjct: 116 IQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 173

Query: 281 YTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
                 GT  Y+ PE +         D+++ GVIL  LL G  P  D +
Sbjct: 174 A-----GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 51.5 bits (124), Expect = 5e-07
 Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 9/87 (10%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           + EA+ + H +   ++HR++K  N+LL    +    KL DFG+    E    +  +    
Sbjct: 119 ILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFG--F 173

Query: 521 TGTRPYMPPEAMHCQI-STKTDVFSYG 546
            GT  Y+ PE +         D+++ G
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACG 200

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 96.2 bits (239), Expect = 1e-21
 Identities = 61/287 (21%), Positives = 93/287 (32%), Gaps = 72/287 (25%)

Query: 114 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAA-MIPILLFE 166
           G  LG G FG V                +AVK L+  A +S   +  +E   +I I    
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 167 NEVQTLSQC--------------KHVNLLRLLGLCNNIMNCIV-----------YEYMCN 201
           N V  L  C              K  NL   L    N                 Y     
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146

Query: 202 GSLYDRLARVNNTPPLDSNKRY----------------------------SIALGVAEAL 233
             L  RL  + ++    S+                                 +  VA+ +
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY-- 291
            +L S  +  IHRD+ + N+LL E  V K+ DFG   ++        Y        P   
Sbjct: 207 EFLAS--RKCIHRDLAARNILLSEKNVVKICDFG---LARDIYKDPDYVRKGDARLPLKW 261

Query: 292 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP---IDDNNTILYY 333
           M PE +     + ++DV+S+GV+L E+ + G  P   +  +      
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 308

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 27/100 (27%), Positives = 44/100 (44%), Gaps = 8/100 (8%)

Query: 450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 509
             L        +  VA+ + +L S  +  IHRD+ + N+LL E  V K+ DFG+ +    
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245

Query: 510 SNVKTMYTENLTGTRPY--MPPEAM-HCQISTKTDVFSYG 546
                 Y        P   M PE +     + ++DV+S+G
Sbjct: 246 DPD---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 282

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 95.6 bits (238), Expect = 2e-21
 Identities = 59/238 (24%), Positives = 95/238 (39%), Gaps = 52/238 (21%)

Query: 110 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 168
           Y      LG G  G V     K    + A+K L++                        E
Sbjct: 63  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------------------KARRE 104

Query: 169 VQTLSQC-KHVNLLRLLGLCNNIMNC-----IVYEYMCNGSLYDR-LARVNNTPPLDSNK 221
           V+   +  +  +++R++ +  N+        IV E +  G L+ R   R         ++
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--------GDQ 156

Query: 222 RYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMS 272
            ++      I   + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K +
Sbjct: 157 AFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214

Query: 273 ETSN-MKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
            + N + T        T  Y+ PE +  +      D++S GVI+  LL G  P   N+
Sbjct: 215 TSHNSLTTP-----CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 54.0 bits (130), Expect = 8e-08
 Identities = 27/70 (38%), Positives = 37/70 (52%), Gaps = 9/70 (12%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K + + N   + T   
Sbjct: 170 IGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTT--P 223

Query: 521 TGTRPYMPPE 530
             T  Y+ PE
Sbjct: 224 CYTPYYVAPE 233

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 95.0 bits (236), Expect = 3e-21
 Identities = 41/243 (16%), Positives = 70/243 (28%), Gaps = 39/243 (16%)

Query: 114 GNKLGEGQFGTVYYGK------LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
            + LGEG F  VY          KN  +  +K  +              A      +   
Sbjct: 70  HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-------------PANPWEFYIGTQ 116

Query: 168 EVQTLSQCKHVNLLRLLGL-CNNIMNCIVYEYMCNGSLYDRLARVNNTP--PLDSNKRYS 224
            ++ L        ++          + +V E    G+L + +    NTP   +      S
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-----------KLGDFGI-VKMS 272
            A+ +   +  +H     IIH D+K  N +L   F+             L D G  + M 
Sbjct: 177 FAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 273 ETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTIL 331
                          T  +   E +  +    + D F     +  +L G      N    
Sbjct: 235 LFPKGTIFTA--KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292

Query: 332 YYY 334
              
Sbjct: 293 CKP 295

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 21/119 (17%), Positives = 35/119 (29%), Gaps = 17/119 (14%)

Query: 442 KLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----- 496
            L +      +      S A+ +   +  +H     IIH D+K  N +L   F+      
Sbjct: 159 NLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDED 216

Query: 497 ------KLGDFGI-VKMSETSNVKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGA 547
                  L D G  + M                T  +   E +  +    + D F   A
Sbjct: 217 DLSAGLALIDLGQSIDMKLFPKGTIFTA--KCETSGFQCVEMLSNKPWNYQIDYFGVAA 273

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 43/232 (18%)

Query: 110 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 168
              +   LGEG F        K +    AVK +          S   EA        + E
Sbjct: 12  LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII----------SKRMEANT------QKE 55

Query: 169 VQTLSQCK-HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS-- 224
           +  L  C+ H N+++L  + ++ ++  +V E +  G L++R+ +          K +S  
Sbjct: 56  ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK---------KKHFSET 106

Query: 225 ----IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNM 277
               I   +  A+ ++H +   ++HRD+K  N+L    ++N   K+ DFG  ++    N 
Sbjct: 107 EASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN- 163

Query: 278 KTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 328
           + + T     T  Y  PE ++        D++S GVIL  +L+G  P   ++
Sbjct: 164 QPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 22/87 (25%), Positives = 42/87 (48%), Gaps = 9/87 (10%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           +  A+ ++H +   ++HRD+K  N+L    ++N   K+ DFG  ++    N + + T   
Sbjct: 115 LVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKT--P 169

Query: 521 TGTRPYMPPEAMHCQI-STKTDVFSYG 546
             T  Y  PE ++        D++S G
Sbjct: 170 CFTLHYAAPELLNQNGYDESCDLWSLG 196

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 21/224 (9%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
            + LG G FG V+     +   E+ VK ++          ++ +   + +     E+  L
Sbjct: 29  MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-----EIAIL 83

Query: 173 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGS-LYDRLARVNNTPPLDSNKRYSIALGVA 230
           S+ +H N++++L    N     +V E   +G  L+  + R    P LD      I   + 
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLV 140

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTR 289
            A+ YL    K IIHRD+K  N+++ E+F  KL DFG    +       T       GT 
Sbjct: 141 SAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-----GTI 193

Query: 290 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTIL 331
            Y  PE +        + +++S GV L  L+    P  +    +
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV 237

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 24/68 (35%), Positives = 32/68 (47%), Gaps = 8/68 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTG 522
           +  A+ YL    K IIHRD+K  N+++ E+F  KL DFG    +       T       G
Sbjct: 139 LVSAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-----G 191

Query: 523 TRPYMPPE 530
           T  Y  PE
Sbjct: 192 TIEYCAPE 199

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 62/253 (24%), Positives = 98/253 (38%), Gaps = 49/253 (19%)

Query: 101 ATDGFN---RKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTE 156
           +TD F+      Y  + + LGEG    V          E AVK +E    +  S      
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR----- 56

Query: 157 AAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNT 214
                      EV+ L QC+ H N+L L+          +V+E M  GS+   + +    
Sbjct: 57  --------VFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK---- 104

Query: 215 PPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGD 265
                 + ++      +   VA AL +LH+    I HRD+K  N+L    ++    K+ D
Sbjct: 105 -----RRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICD 157

Query: 266 FGI-VKMSETSNMKTMYTENLT---GTRPYMPPEAMHCQISTKT------DVFSYGVILL 315
           F +   +    +   + T  L    G+  YM PE +       +      D++S GVIL 
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217

Query: 316 ELLTGMKPIDDNN 328
            LL+G  P     
Sbjct: 218 ILLSGYPPFVGRC 230

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 23/74 (31%), Positives = 35/74 (47%), Gaps = 9/74 (12%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNVKTMYTEN 519
           VA AL +LH+    I HRD+K  N+L    ++    K+ DF +   +    +   + T  
Sbjct: 120 VASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177

Query: 520 LT---GTRPYMPPE 530
           L    G+  YM PE
Sbjct: 178 LLTPCGSAEYMAPE 191

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 60/241 (24%), Positives = 100/241 (41%), Gaps = 25/241 (10%)

Query: 117 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LGEG F TV   +      E A+K LE       +                 E   +S+ 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR----------ERDVMSRL 87

Query: 176 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE--- 231
            H   ++L     +         Y  NG L   + ++  +      + Y+     AE   
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYT-----AEIVS 141

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL YLH     IIHRD+K  N+LL+E+   ++ DFG  K+    + K     +  GT  Y
Sbjct: 142 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANSFVGTAQY 198

Query: 292 MPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 350
           + PE +  + + K+ D+++ G I+ +L+ G+ P    N  L +  +++ E    E    +
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 258

Query: 351 A 351
           A
Sbjct: 259 A 259

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 57.6 bits (140), Expect = 3e-09
 Identities = 25/67 (37%), Positives = 36/67 (53%), Gaps = 3/67 (4%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLH     IIHRD+K  N+LL+E+   ++ DFG  K+    + K     +  GT
Sbjct: 139 IVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANSFVGT 195

Query: 524 RPYMPPE 530
             Y+ PE
Sbjct: 196 AQYVSPE 202

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 56/226 (24%), Positives = 87/226 (38%), Gaps = 44/226 (19%)

Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
            ++LG G    VY  K K      A+K L+   +                     E+  L
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI---------------VRTEIGVL 102

Query: 173 SQCKHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 225
            +  H N+++L  +        +V E +  G L+DR+              YS       
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV---------EKGYYSERDAADA 153

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 281
              + EA+ YLH     I+HRD+K  N+L      +   K+ DFG+   +     MKT+ 
Sbjct: 154 VKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV- 210

Query: 282 TENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDD 326
                GT  Y  PE +       + D++S G+I   LL G +P  D
Sbjct: 211 ----CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 10/87 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           + EA+ YLH     I+HRD+K  N+L      +   K+ DFG+ K+ E   +  M T  +
Sbjct: 157 ILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKT--V 210

Query: 521 TGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
            GT  Y  PE +       + D++S G
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVG 237

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 66/281 (23%), Positives = 109/281 (38%), Gaps = 45/281 (16%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G  LG+G FGTV+ G  L + +++A+K +  N     S   ++     P+     EV  L
Sbjct: 36  GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSV--TCPL-----EVALL 88

Query: 173 SQC----KHVNLLRLLGLC-NNIMNCIVYEYMCNGS-LYDRLARVNNTPPLDSNKRYSIA 226
            +      H  ++RLL          +V E       L+D +        L         
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFF 145

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENL 285
             V  A+ + HS  + ++HRD+K  N+L+D      KL DFG   +              
Sbjct: 146 GQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-----F 198

Query: 286 TGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 343
            GTR Y PPE +      +    V+S G++L +++ G  P + +  IL      E E+  
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL------EAELHF 252

Query: 344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
              +  +           LI     +C   +   R S+ +I
Sbjct: 253 PAHVSPDC--------CALI----RRCLAPKPSSRPSLEEI 281

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 23/68 (33%), Positives = 32/68 (47%), Gaps = 8/68 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           V  A+ + HS  + ++HRD+K  N+L+D      KL DFG   +               G
Sbjct: 148 VVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-----FDG 200

Query: 523 TRPYMPPE 530
           TR Y PPE
Sbjct: 201 TRVYSPPE 208

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 35/234 (14%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G+ LGEG +G V      +     AVK L+        N +            + E+Q L
Sbjct: 10  GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN---------VKKEIQLL 60

Query: 173 SQCKHVNLLRL---LGLCNNIMNCIVYEYMCNGS--LYDRLARVNNTPPLDSNKRYSIAL 227
            + +H N+++L   L         +V EY   G   + D +       P+     Y   L
Sbjct: 61  RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQL 118

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT- 286
              + L YLHS    I+H+D+K  N+LL      K+   G+      +     +  + T 
Sbjct: 119 --IDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGV------AEALHPFAADDTC 168

Query: 287 ----GTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKPIDDNNTILYY 333
               G+  + PPE  +   +    K D++S GV L  + TG+ P + +N    +
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF 222

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 19/69 (27%), Positives = 30/69 (43%), Gaps = 13/69 (18%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLT----- 521
            L YLHS    I+H+D+K  N+LL      K+   G+      +     +  + T     
Sbjct: 121 GLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGV------AEALHPFAADDTCRTSQ 172

Query: 522 GTRPYMPPE 530
           G+  + PPE
Sbjct: 173 GSPAFQPPE 181

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 25/226 (11%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G  LG G FG+VY G  + + + +A+K +E +         N     +P+     EV  L
Sbjct: 48  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT--RVPM-----EVVLL 100

Query: 173 SQCKHV--NLLRLLGLC-NNIMNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALG 228
            +       ++RLL          ++ E       L+D +        L      S    
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQ 157

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-KLGDFGIVKMSETSNMKTMYTENLTG 287
           V EA+ + H+    ++HRD+K  N+L+D N    KL DFG   + + +           G
Sbjct: 158 VLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-----FDG 210

Query: 288 TRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTIL 331
           TR Y PPE +           V+S G++L +++ G  P + +  I+
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 256

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 24/68 (35%), Positives = 35/68 (51%), Gaps = 8/68 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-KLGDFGIVKMSETSNVKTMYTENLTG 522
           V EA+ + H+    ++HRD+K  N+L+D N    KL DFG   + + +           G
Sbjct: 158 VLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-----FDG 210

Query: 523 TRPYMPPE 530
           TR Y PPE
Sbjct: 211 TRVYSPPE 218

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 89.7 bits (223), Expect = 8e-20
 Identities = 59/276 (21%), Positives = 108/276 (39%), Gaps = 38/276 (13%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              +G+G F  V   + +  G E+A+K ++       +  + T    +       EV+ +
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDK------TQLNPTSLQKL-----FREVRIM 68

Query: 173 SQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
               H N+++L  +        ++ EY   G ++D L         ++         +  
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS---KFRQIVS 125

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRP 290
           A+ Y H     I+HRD+K+ N+LLD +   K+ DFG   + +    +         G  P
Sbjct: 126 AVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-----FCGAPP 178

Query: 291 YMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 348
           Y  PE    +     + DV+S GVIL  L++G  P D  N       V+  +  +   + 
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 238

Query: 349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
            +         E L+    ++  V    KR ++  I
Sbjct: 239 TDC--------ENLL----KRFLVLNPIKRGTLEQI 262

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 21/65 (32%), Positives = 31/65 (47%), Gaps = 8/65 (12%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTGTRP 525
           A+ Y H     I+HRD+K+ N+LLD +   K+ DFG   + +    +         G  P
Sbjct: 126 AVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-----FCGAPP 178

Query: 526 YMPPE 530
           Y  PE
Sbjct: 179 YAAPE 183

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 45/224 (20%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              +G G +        K   ME AVK +        S  D TE           E++ L
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTE-----------EIEIL 69

Query: 173 SQC-KHVNLLRLLGLCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------ 224
            +  +H N++ L  + ++     +V E M  G L D++ R          K +S      
Sbjct: 70  LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ---------KFFSEREASA 120

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVP-KLGDFGIVKMSETSNMKTM 280
           +   + + + YLH+    ++HRD+K +N+L      N    ++ DFG  K     N   +
Sbjct: 121 VLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLL 177

Query: 281 YTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKP 323
            T     T  ++ PE +  Q      D++S GV+L  +LTG  P
Sbjct: 178 MT--PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 19/71 (26%), Positives = 33/71 (46%), Gaps = 9/71 (12%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVP-KLGDFGIVKMSETSNVKTMYTEN 519
           + + + YLH+    ++HRD+K +N+L      N    ++ DFG  K     N   + T  
Sbjct: 125 ITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMT-- 179

Query: 520 LTGTRPYMPPE 530
              T  ++ PE
Sbjct: 180 PCYTANFVAPE 190

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 28/227 (12%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              LGEG +G V           +AVK ++         +             + E+   
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN------------IKKEICIN 59

Query: 173 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--IALGV 229
               H N+++  G      +  +  EY   G L+DR+      P  D+ + +   +A   
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 116

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
              + YLH +   I HRD+K  N+LLDE    K+ DFG+  +    N +      + GT 
Sbjct: 117 --GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTL 171

Query: 290 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD--NNTILY 332
           PY+ PE +  +   +   DV+S G++L  +L G  P D   ++   Y
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 48.3 bits (116), Expect = 3e-06
 Identities = 24/64 (37%), Positives = 34/64 (53%), Gaps = 3/64 (4%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
            + YLH +   I HRD+K  N+LLDE    K+ DFG+  +    N +      + GT PY
Sbjct: 117 GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPY 173

Query: 527 MPPE 530
           + PE
Sbjct: 174 VAPE 177

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 37/231 (16%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G+ LG G FG V  G+    G ++AVK L      S       +           E+Q L
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK----------REIQNL 65

Query: 173 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG--- 228
              +H ++++L   +       +V EY+  G L+D + +         + R         
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK---------HGRVEEMEARRL 116

Query: 229 ---VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 284
              +  A+ Y H     ++HRD+K  NVLLD +   K+ DFG+   MS+   ++T     
Sbjct: 117 FQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT----- 169

Query: 285 LTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYY 333
             G+  Y  PE +  +     + D++S GVIL  LL G  P DD +    +
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF 220

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 46.0 bits (110), Expect = 1e-05
 Identities = 16/36 (44%), Positives = 22/36 (61%), Gaps = 2/36 (5%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 502
           A+ Y H     ++HRD+K  NVLLD +   K+ DFG
Sbjct: 123 AVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFG 156

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 58/238 (24%), Positives = 99/238 (41%), Gaps = 33/238 (13%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              LGEG +G V           +AVK ++         +             + E+   
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN------------IKKEICIN 59

Query: 173 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--IALGV 229
               H N+++  G      +  +  EY   G L+DR+      P  D+ + +   +A   
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 116

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT--- 286
              + YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +    L    
Sbjct: 117 --GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL----LNKMC 168

Query: 287 GTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD-NNTILYYYLVVEQEV 341
           GT PY+ PE +  +   +   DV+S G++L  +L G  P D  +++   Y    E++ 
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 24/64 (37%), Positives = 34/64 (53%), Gaps = 3/64 (4%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
            + YLH +   I HRD+K  N+LLDE    K+ DFG+  +    N +      + GT PY
Sbjct: 117 GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPY 173

Query: 527 MPPE 530
           + PE
Sbjct: 174 VAPE 177

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 84.7 bits (210), Expect = 6e-18
 Identities = 59/241 (24%), Positives = 86/241 (35%), Gaps = 59/241 (24%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              +G G FG     +       +AVK +E  A    +               + E+   
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN--------------VQREIINH 70

Query: 173 SQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
              +H N++R   +        I+ EY   G LY+R+             R        E
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN---------AGR----FSEDE 117

Query: 232 A----------LHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIVKMSETSNM-K 278
           A          + Y HS+   I HRD+K  N LLD +  P  K+ DFG  K S   +  K
Sbjct: 118 ARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175

Query: 279 TMYTENLTGTRPYMPPEAMHCQISTK------TDVFSYGVILLELLTGMKPIDDNNTILY 332
           +       GT  Y+ PE     +  +       DV+S GV L  +L G  P +D      
Sbjct: 176 S-----TVGTPAYIAPEV----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226

Query: 333 Y 333
           Y
Sbjct: 227 Y 227

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 26/67 (38%), Positives = 33/67 (49%), Gaps = 10/67 (14%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIVKMSET-SNVKTMYTENLTGT 523
            + Y HS+   I HRD+K  N LLD +  P  K+ DFG  K S   S  K+       GT
Sbjct: 128 GVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-----TVGT 180

Query: 524 RPYMPPE 530
             Y+ PE
Sbjct: 181 PAYIAPE 187

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 85.6 bits (212), Expect = 8e-18
 Identities = 73/280 (26%), Positives = 117/280 (41%), Gaps = 45/280 (16%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G+ LG G FG V  GK    G ++AVK L      S                   E+Q L
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR----------REIQNL 70

Query: 173 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS-IALGVA 230
              +H ++++L   +       +V EY+  G L+D + +       +S + +  I  GV 
Sbjct: 71  KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV- 129

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL--T-- 286
               Y H     ++HRD+K  NVLLD +   K+ DFG+      SNM  M       T  
Sbjct: 130 ---DYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGL------SNM--MSDGEFLRTSC 176

Query: 287 GTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 344
           G+  Y  PE +  +     + D++S GVIL  LL G  P DD++    +  + +      
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP 236

Query: 345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
           + L+            +L+    +     +  KRA+++DI
Sbjct: 237 QYLNPSV--------ISLL----KHMLQVDPMKRATIKDI 264

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 23/68 (33%), Positives = 32/68 (47%), Gaps = 14/68 (20%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL--T--G 522
            + Y H     ++HRD+K  NVLLD +   K+ DFG+      SN+  M       T  G
Sbjct: 128 GVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGL------SNM--MSDGEFLRTSCG 177

Query: 523 TRPYMPPE 530
           +  Y  PE
Sbjct: 178 SPNYAAPE 185

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 56/223 (25%), Positives = 89/223 (39%), Gaps = 35/223 (15%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQTL 172
           KLG G F TV+  K + N   +A+K +  +  Y       TEAA   I +L   N+    
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-------TEAAEDEIKLLQRVNDADNT 78

Query: 173 SQCK--HVNLLRLLG---LCNNIMN--CIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYS 224
            +      ++L+LL              +V+E +   +L   + +  +   PL   K+ S
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQIS 137

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP------KLGDFGIVKMSETSNMK 278
             L     L Y+H     IIH D+K  NVL++    P      K+ D G    +     +
Sbjct: 138 KQL--LLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLG----NACWYDE 190

Query: 279 TMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 320
                    TR Y  PE  +        D++S   ++ EL+TG
Sbjct: 191 HYTNSI--QTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 26/117 (22%), Positives = 40/117 (34%), Gaps = 14/117 (11%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP--- 496
           L  L +      +       I+  +   L Y+H     IIH D+K  NVL++    P   
Sbjct: 116 LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENL 174

Query: 497 ---KLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGAQI 549
              K+ D G    +     +         TR Y  PE  +        D++S    I
Sbjct: 175 IQIKIADLG----NACWYDEHYTNSI--QTREYRSPEVLLGAPWGCGADIWSTACLI 225

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 45/243 (18%)

Query: 99  ERATDGFNRKPYPRR---GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNT 155
             A+DG   +           +G G FG V+  KL    E+A+K +  +  +        
Sbjct: 27  VLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------- 78

Query: 156 EAAMIPILLFEN-EVQTLSQCKHVNLLRLL-------GLCNNIMNCIVYEYMCNGSLY-- 205
                     +N E+Q +   KH N++ L           + +   +V EY+   ++Y  
Sbjct: 79  ----------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRA 127

Query: 206 -DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKL 263
               A++  T P+   K Y   L    +L Y+HS+   I HRD+K  N+LLD    V KL
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQL--LRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKL 183

Query: 264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGM 321
            DFG  K+         Y      +R Y  PE +      +T  D++S G ++ EL+ G 
Sbjct: 184 IDFGSAKILIAGEPNVSYIC----SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG- 238

Query: 322 KPI 324
           +P+
Sbjct: 239 QPL 241

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 29/83 (34%), Positives = 40/83 (48%), Gaps = 9/83 (10%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           +L Y+HS+   I HRD+K  N+LLD    V KL DFG  K+         Y      +R 
Sbjct: 153 SLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC----SRY 206

Query: 526 YMPPEAMHC--QISTKTDVFSYG 546
           Y  PE +      +T  D++S G
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTG 229

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 58/256 (22%), Positives = 95/256 (37%), Gaps = 52/256 (20%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G+G FG V   +  +  ++ A+K +        +   N             E+Q +   
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF----------KELQIMQGL 72

Query: 176 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
           +H   VNL         +          +V + +  G L   L + N     ++ K +  
Sbjct: 73  EHPFLVNLWYSFQDEEDM---------FMVVDLLLGGDLRYHLQQ-NVHFKEETVKLF-- 120

Query: 226 ALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
              + E   AL YL +    IIHRD+K  N+LLDE+    + DF I           + T
Sbjct: 121 ---ICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITT 173

Query: 283 ENLTGTRPYMPPEAMHCQIS---TKT-DVFSYGVILLELLTGMKP---IDDNNTILYYYL 335
             + GT+PYM PE    +     +   D +S GV   ELL G +P       ++    + 
Sbjct: 174 --MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231

Query: 336 VVEQEVPVREVLDKEA 351
                V       +E 
Sbjct: 232 FETTVVTYPSAWSQEM 247

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 27/75 (36%), Positives = 37/75 (49%), Gaps = 9/75 (12%)

Query: 464 VAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENL 520
           + E   AL YL +    IIHRD+K  N+LLDE+    + DF I           + T  +
Sbjct: 121 ICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITT--M 174

Query: 521 TGTRPYMPPEAMHCQ 535
            GT+PYM PE    +
Sbjct: 175 AGTKPYMAPEMFSSR 189

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 32/220 (14%)

Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEV 169
           +  K+GEG +G V+  +    G  +A+K                  +  +I  +    E+
Sbjct: 7   KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE------------DDPVIKKIALR-EI 53

Query: 170 QTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L Q KH NL+ LL +      +   +V+EY  + ++   L R     P    K  +  
Sbjct: 54  RMLKQLKHPNLVNLLEVFRRKRRLH--LVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQ 110

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
               +A+++ H      IHRDVK  N+L+ ++ V KL DFG  ++  T      Y + + 
Sbjct: 111 T--LQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDY-YDDEVA 164

Query: 287 GTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 324
            TR Y  PE  +         DV++ G +  ELL+G  P+
Sbjct: 165 -TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPL 202

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 47.6 bits (114), Expect = 6e-06
 Identities = 23/65 (35%), Positives = 35/65 (53%), Gaps = 5/65 (7%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           +A+++ H      IHRDVK  N+L+ ++ V KL DFG  ++  T      Y + +  TR 
Sbjct: 113 QAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDY-YDDEVA-TRW 167

Query: 526 YMPPE 530
           Y  PE
Sbjct: 168 YRSPE 172

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.5 bits (209), Expect = 2e-17
 Identities = 70/337 (20%), Positives = 118/337 (35%), Gaps = 59/337 (17%)

Query: 41  SMPKSKHKSASNLVNQHNQKIKFKLPDKKWLQEVIQQEEANNKTEYIGELIAFTFCDLER 100
           + P    +    LV    Q+++ + P K   QE+ +        EY+       + D   
Sbjct: 113 TGPDLIPEVPRQLVTNCTQRLE-QGPCKDLFQELTRLT-----HEYLSVAPFADYLDSIY 166

Query: 101 ATDGFNRKPYPRRGNK---------LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSS 150
                  K   R+            LG+G FG V   +++   ++ A K LE        
Sbjct: 167 FNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR---IK 223

Query: 151 NSDNTEAAMIPILLFENEVQTLSQCKH---VNLL-------RLLGLCNNIMNCIVYEYMC 200
                  A+       NE Q L +      V+L         L         C+V   M 
Sbjct: 224 KRKGEAMAL-------NEKQILEKVNSRFVVSLAYAYETKDAL---------CLVLTLMN 267

Query: 201 NGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV 260
            G L   +  +      ++   +  A  +   L  LH     I++RD+K  N+LLD++  
Sbjct: 268 GGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDLHRER--IVYRDLKPENILLDDHGH 324

Query: 261 PKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELL 318
            ++ D G+   + E   +K        GT  YM PE +  +  T + D ++ G +L E++
Sbjct: 325 IRISDLGLAVHVPEGQTIKGR-----VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379

Query: 319 TGMKPIDDNNTILY----YYLVVEQEVPVREVLDKEA 351
            G  P       +       LV E      E    +A
Sbjct: 380 AGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 24/85 (28%), Positives = 41/85 (48%), Gaps = 9/85 (10%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNVKTMYTENLTG 522
           +   L  LH     I++RD+K  N+LLD++   ++ D G+   + E   +K        G
Sbjct: 295 ICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-----VG 347

Query: 523 TRPYMPPEAMHCQISTKT-DVFSYG 546
           T  YM PE +  +  T + D ++ G
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALG 372

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 64/277 (23%), Positives = 113/277 (40%), Gaps = 40/277 (14%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              LGEG FG V      K   ++A+K +       S      E           E+  L
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE----------REISYL 63

Query: 173 SQCKHVNLLRLLG-LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS-IALGVA 230
              +H ++++L   +       +V EY   G L+D +         +  + +  I   + 
Sbjct: 64  KLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAI- 121

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTR 289
               Y H     I+HRD+K  N+LLD+N   K+ DFG+   M++ + +KT       G+ 
Sbjct: 122 ---EYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-----SCGSP 171

Query: 290 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL 347
            Y  PE ++ +     + DV+S G++L  +L G  P DD      +  V      + + L
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFL 231

Query: 348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
              A        ++LI     +  V +  +R ++++I
Sbjct: 232 SPGA--------QSLI----RRMIVADPMQRITIQEI 256

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 24/65 (36%), Positives = 36/65 (55%), Gaps = 8/65 (12%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNVKTMYTENLTGTRP 525
           A+ Y H     I+HRD+K  N+LLD+N   K+ DFG+   M++ + +KT       G+  
Sbjct: 120 AIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-----SCGSPN 172

Query: 526 YMPPE 530
           Y  PE
Sbjct: 173 YAAPE 177

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 67/249 (26%), Positives = 105/249 (42%), Gaps = 42/249 (16%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   K K      A+K L+     +     +T          EN V  L   
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT--------ENRV--LQNS 205

Query: 176 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
           +H     L        RL         C V EY   G L+  L+R       D  + Y  
Sbjct: 206 RHPFLTALKYSFQTHDRL---------CFVMEYANGGELFFHLSRER-VFSEDRARFY-- 253

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTE 283
              +  AL YLHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MKT    
Sbjct: 254 GAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF--- 309

Query: 284 NLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
              GT  Y+ PE +      +  D +  GV++ E++ G  P  + +    + L++ +E+ 
Sbjct: 310 --CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 367

Query: 343 VREVLDKEA 351
               L  EA
Sbjct: 368 FPRTLGPEA 376

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 54.0 bits (130), Expect = 9e-08
 Identities = 24/67 (35%), Positives = 36/67 (53%), Gaps = 4/67 (5%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL YLHS  K +++RD+K  N++LD++   K+ DFG+ K           T    GT
Sbjct: 257 IVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-KT--FCGT 312

Query: 524 RPYMPPE 530
             Y+ PE
Sbjct: 313 PEYLAPE 319

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 83.3 bits (206), Expect = 3e-17
 Identities = 56/248 (22%), Positives = 89/248 (35%), Gaps = 48/248 (19%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G G FG V   KLKN  ++ A+K L        + +             E +V  L   
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE--------ERDV--LVNG 131

Query: 176 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
                  L         L          +V +Y   G L   L++  +  P +  + Y  
Sbjct: 132 DSKWITTLHYAFQDDNNL---------YLVMDYYVGGDLLTLLSKFEDRLPEEMARFY-- 180

Query: 226 ALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
              +AE   A+  +H L    +HRD+K  N+L+D N   +L DFG               
Sbjct: 181 ---LAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235

Query: 283 ENLTGTRPYMPPEAMHCQISTKT------DVFSYGVILLELLTGMKPIDDNNTILYYYLV 336
               GT  Y+ PE +      K       D +S GV + E+L G  P    + +  Y  +
Sbjct: 236 --AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293

Query: 337 VEQEVPVR 344
           +  +   +
Sbjct: 294 MNHKERFQ 301

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 20/67 (29%), Positives = 29/67 (43%), Gaps = 4/67 (5%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  A+  +H L    +HRD+K  N+L+D N   +L DFG                   GT
Sbjct: 184 MVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVGT 239

Query: 524 RPYMPPE 530
             Y+ PE
Sbjct: 240 PDYISPE 246

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 54/248 (21%), Positives = 87/248 (35%), Gaps = 70/248 (28%)

Query: 98  LERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTE 156
           L+   +      Y      LG G  G V     K    + A+K L++             
Sbjct: 8   LQIKKNAIIDD-YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----------- 55

Query: 157 AAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNNIMNC-----IVYEYMCNGSLYDR-LA 209
                      EV+   +  +  +++R++ +  N+        IV E +  G L+ R   
Sbjct: 56  -------KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD 108

Query: 210 RVNNTPPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFV 260
           R         ++ ++      I   + EA+ YLHS++  I HRDVK  N+L      N +
Sbjct: 109 R--------GDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAI 158

Query: 261 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTG 320
            KL DFG                           E    +     D++S GVI+  LL G
Sbjct: 159 LKLTDFGFA------------------------KETTGEKYDKSCDMWSLGVIMYILLCG 194

Query: 321 MKPIDDNN 328
             P   N+
Sbjct: 195 YPPFYSNH 202

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 20/43 (46%), Positives = 26/43 (60%), Gaps = 5/43 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI 503
           + EA+ YLHS++  I HRDVK  N+L      N + KL DFG 
Sbjct: 126 IGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 166

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 81.6 bits (202), Expect = 6e-17
 Identities = 59/238 (24%), Positives = 98/238 (41%), Gaps = 24/238 (10%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG G FG V   K K      A+K L+          ++T           NE + L   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----------LNEKRILQAV 98

Query: 176 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 234
               L++L     +  N  +V EY+  G ++  L R+      + + R+  A  +     
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARFYAA-QIVLTFE 155

Query: 235 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 294
           YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +       +T  L GT   + P
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWT--LCGTPEALAP 207

Query: 295 EAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
           E +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V        + 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 53.8 bits (130), Expect = 6e-08
 Identities = 22/67 (32%), Positives = 34/67 (50%), Gaps = 8/67 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +     YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +       +T  L GT
Sbjct: 150 IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWT--LCGT 201

Query: 524 RPYMPPE 530
              + PE
Sbjct: 202 PEALAPE 208

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 81.5 bits (202), Expect = 6e-17
 Identities = 64/254 (25%), Positives = 107/254 (42%), Gaps = 49/254 (19%)

Query: 89  ELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNA 145
           + +   FC        +       +  K+G+G FG V+  +  K G ++A+K   +EN  
Sbjct: 6   DSVECPFC---DEVSKY------EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-- 54

Query: 146 NYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-------NNIMNCI--VY 196
                     E    PI     E++ L   KH N++ L+ +C       N     I  V+
Sbjct: 55  ----------EKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 103

Query: 197 EYMCNGSLYDRLARV--NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 254
           ++      +D LA +  N       ++   +   +   L+Y+H     I+HRD+K+ANVL
Sbjct: 104 DFCE----HD-LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVL 156

Query: 255 LDENFVPKLGDFGIVKM--SETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSY 310
           +  + V KL DFG+ +      ++    YT N   T  Y PPE +          D++  
Sbjct: 157 ITRDGVLKLADFGLARAFSLAKNSQPNRYT-NRVVTLWYRPPELLLGERDYGPPIDLWGA 215

Query: 311 GVILLELLTGMKPI 324
           G I+ E+ T   PI
Sbjct: 216 GCIMAEMWTR-SPI 228

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 49.9 bits (120), Expect = 1e-06
 Identities = 26/67 (38%), Positives = 37/67 (55%), Gaps = 5/67 (7%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNVKTMYTENLTGT 523
             L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +      ++    YT N   T
Sbjct: 135 NGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT-NRVVT 191

Query: 524 RPYMPPE 530
             Y PPE
Sbjct: 192 LWYRPPE 198

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 80.6 bits (199), Expect = 6e-17
 Identities = 24/221 (10%), Positives = 49/221 (22%), Gaps = 58/221 (26%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
             G       +         ++A+  ++           +            +    LS+
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVD-----PQGVLPDDVLQE-----TLSRTLRLSR 87

Query: 175 CKHVNLLRLL------GLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
                + R+L               +V E++  GSL +                      
Sbjct: 88  IDKPGVARVLDVVHTRAGG-----LVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQS 137

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           +A A    H     +       + V +  +    L                         
Sbjct: 138 LAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA--------------------- 174

Query: 289 RPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 329
              MP        + + D+   G  L  LL    P+ +   
Sbjct: 175 --TMPDA------NPQDDIRGIGASLYALLVNRWPLPEAGV 207

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 12/89 (13%), Positives = 25/89 (28%), Gaps = 9/89 (10%)

Query: 443 LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 502
           L  V +T P            +A A    H     +       + V +  +    L    
Sbjct: 118 LQEVADTSP-SPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA 174

Query: 503 IVK-MSETSNVK----TMYTENLTGTRPY 526
            +   +   +++    ++Y   L    P 
Sbjct: 175 TMPDANPQDDIRGIGASLY-ALLVNRWPL 202

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 80.3 bits (199), Expect = 9e-17
 Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 39/223 (17%)

Query: 113 RGNKLGEGQFGTVYYGKLKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPI--LLFENE 168
           +  K+GEG +G VY  K   G  +A+K   L+             E   IP   +    E
Sbjct: 25  KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA------------EDEGIPSTAI---RE 69

Query: 169 VQTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARV--NNTPPLDSNKRY 223
           +  L +  H N++ L+ +      +   +V+E+M      D L +V   N   L  ++  
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLT--LVFEFM----EKD-LKKVLDENKTGLQDSQIK 122

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
                +   + + H     I+HRD+K  N+L++ +   KL DFG+ +      +++ YT 
Sbjct: 123 IYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRS-YT- 177

Query: 284 NLTGTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 324
           +   T  Y  P+  M  +  ST  D++S G I  E++TG KP+
Sbjct: 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPL 219

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 46.4 bits (111), Expect = 1e-05
 Identities = 13/37 (35%), Positives = 21/37 (56%), Gaps = 2/37 (5%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 502
             + + H     I+HRD+K  N+L++ +   KL DFG
Sbjct: 130 RGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFG 164

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 80.3 bits (199), Expect = 9e-17
 Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 44/231 (19%)

Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVKT--LENNANYSSSNSDNTEAAMIPI------- 162
              ++G G +GTVY  +   +G  +A+K+  + N                +PI       
Sbjct: 13  PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---------GGGGGGGLPISTVREVA 63

Query: 163 LLFENEVQTLSQCKHVNLLRLLGLCNNIMNC------IVYEYMCNGSLYD--RLARVNNT 214
           LL     + L   +H N++RL+ +C            +V+E++      D          
Sbjct: 64  LL-----RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV----DQDLRTYLDKAPP 114

Query: 215 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 274
           P L +     +       L +LH+    I+HRD+K  N+L+      KL DFG+ ++  +
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARIY-S 171

Query: 275 SNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPI 324
             M    T  +  T  Y  PE  +    +T  D++S G I  E+    KP+
Sbjct: 172 YQMA--LT-PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPL 218

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 49.9 bits (120), Expect = 1e-06
 Identities = 27/108 (25%), Positives = 44/108 (40%), Gaps = 7/108 (6%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L         P L +     +       L +LH+    I+HRD+K  N+L+      KL 
Sbjct: 105 LRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLA 162

Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYG 546
           DFG   ++   + +   T  +  T  Y  PE  +    +T  D++S G
Sbjct: 163 DFG---LARIYSYQMALT-PVVVTLWYRAPEVLLQSTYATPVDMWSVG 206

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 81.7 bits (202), Expect = 9e-17
 Identities = 51/250 (20%), Positives = 79/250 (31%), Gaps = 50/250 (20%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G G F  V   K+K   ++ A+K +                        E +V  L   
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE--------ERDV--LVNG 118

Query: 176 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
                  L         L          +V EY   G L   L++     P +  + Y  
Sbjct: 119 DRRWITQLHFAFQDENYL---------YLVMEYYVGGDLLTLLSKFGERIPAEMARFY-- 167

Query: 226 ALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
              +AE   A+  +H L    +HRD+K  N+LLD     +L DFG               
Sbjct: 168 ---LAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222

Query: 283 ENLTGTRPYMPPEAMHCQISTKTDVF--------SYGVILLELLTGMKPIDDNNTILYYY 334
               GT  Y+ PE +                   + GV   E+  G  P   ++T   Y 
Sbjct: 223 --AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280

Query: 335 LVVEQEVPVR 344
            +V  +  + 
Sbjct: 281 KIVHYKEHLS 290

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 20/67 (29%), Positives = 28/67 (41%), Gaps = 4/67 (5%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  A+  +H L    +HRD+K  N+LLD     +L DFG                   GT
Sbjct: 171 IVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVGT 226

Query: 524 RPYMPPE 530
             Y+ PE
Sbjct: 227 PDYLSPE 233

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 46/230 (20%), Positives = 85/230 (36%), Gaps = 46/230 (20%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN-------- 167
            +  G +G V  G    G+ +A+K + N  +   + +           +  +        
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVN-----------ILSDSFLCKRVL 77

Query: 168 -EVQTLSQCKHVNLLRLLGLCNNIMNC----------IVYEYMCNGSLYDRLARVNNTPP 216
            E++ L+   H N+L L     +I             +V E M   +   ++        
Sbjct: 78  REIRLLNHFHHPNILGLR----DIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVI 131

Query: 217 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 276
              + +Y     +   LH LH     ++HRD+   N+LL +N    + DF + +      
Sbjct: 132 SPQHIQY-FMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 277 MKTMYTENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
            KT Y       R Y  PE +   +  TK  D++S G ++ E+    K +
Sbjct: 189 NKTHY----VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 57.3 bits (139), Expect = 6e-09
 Identities = 25/82 (30%), Positives = 37/82 (45%), Gaps = 8/82 (9%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
            LH LH     ++HRD+   N+LL +N    + DF + +       KT Y       R Y
Sbjct: 146 GLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHY----VTHRWY 199

Query: 527 MPPEAM-HCQISTKT-DVFSYG 546
             PE +   +  TK  D++S G
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAG 221

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 33/222 (14%)

Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPI--LLFEN 167
           + + LGEGQF TVY  +       +A+K   L + +              I    L    
Sbjct: 14  KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG---------INRTAL---R 61

Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYS 224
           E++ L +  H N++ LL    +  N  +V+++M      D L  +  +N+  L  +   +
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM----ETD-LEVIIKDNSLVLTPSHIKA 116

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
             L   + L YLH     I+HRD+K  N+LLDEN V KL DFG+ K S  S  +  YT +
Sbjct: 117 YMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRA-YT-H 171

Query: 285 LTGTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 324
              TR Y  PE     ++     D+++ G IL ELL    P 
Sbjct: 172 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPF 212

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 47.6 bits (114), Expect = 6e-06
 Identities = 21/37 (56%), Positives = 25/37 (67%), Gaps = 2/37 (5%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 502
           + L YLH     I+HRD+K  N+LLDEN V KL DFG
Sbjct: 123 QGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFG 157

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 32/220 (14%)

Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEV 169
               +GEG +G V   +    G  +A+K     +            +  M+  +    E+
Sbjct: 29  NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD------------DDKMVKKIAMR-EI 75

Query: 170 QTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           + L Q +H NL+ LL +C         +V+E++ + ++ D L    N       ++Y   
Sbjct: 76  KLLKQLRHENLVNLLEVCKKKKRWY--LVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQ 132

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
           +     + + H  S  IIHRD+K  N+L+ ++ V KL DFG  +    +  +  Y  +  
Sbjct: 133 I--INGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEV-YD-DEV 185

Query: 287 GTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 324
            TR Y  PE  +         DV++ G ++ E+  G +P+
Sbjct: 186 ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPL 224

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 47.2 bits (113), Expect = 7e-06
 Identities = 22/65 (33%), Positives = 33/65 (50%), Gaps = 5/65 (7%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
             + + HS    IIHRD+K  N+L+ ++ V KL DFG  +    +  +  Y  +   TR 
Sbjct: 135 NGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEV-YD-DEVATRW 189

Query: 526 YMPPE 530
           Y  PE
Sbjct: 190 YRAPE 194

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 65/252 (25%), Positives = 106/252 (42%), Gaps = 49/252 (19%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   + K      A+K L      +     +T          E+ V  L   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT--------ESRV--LQNT 62

Query: 176 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 224
           +H     L        RL         C V EY   G L+  L+R       +  + Y  
Sbjct: 63  RHPFLTALKYAFQTHDRL---------CFVMEYANGGELFFHLSRER-VFTEERARFYGA 112

Query: 225 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVK--MSETSNMKTM 280
            I      AL YLHS  + +++RD+K  N++LD++  + K+ DFG+ K  +S+ + MKT 
Sbjct: 113 EIVS----ALEYLHS--RDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGATMKTF 165

Query: 281 YTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
                 GT  Y+ PE +      +  D +  GV++ E++ G  P  + +    + L++ +
Sbjct: 166 -----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220

Query: 340 EVPVREVLDKEA 351
           E+     L  EA
Sbjct: 221 EIRFPRTLSPEA 232

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 25/70 (35%), Positives = 43/70 (61%), Gaps = 11/70 (15%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVK--MSETSNVKTMYTENL 520
           +  AL YLHS  + +++RD+K  N++LD++  + K+ DFG+ K  +S+ + +KT      
Sbjct: 114 IVSALEYLHS--RDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGATMKTF----- 165

Query: 521 TGTRPYMPPE 530
            GT  Y+ PE
Sbjct: 166 CGTPEYLAPE 175

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 79.1 bits (196), Expect = 2e-16
 Identities = 55/224 (24%), Positives = 99/224 (44%), Gaps = 39/224 (17%)

Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPI--LLFEN 167
           +  K+GEG +GTV+  K  +    +A+K   L++            +   +P   L    
Sbjct: 6   KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD------------DDEGVPSSAL---R 50

Query: 168 EVQTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARV--NNTPPLDSNKR 222
           E+  L + KH N++RL  +      +   +V+E+       D L +   +    LD    
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLT--LVFEFC----DQD-LKKYFDSCNGDLDPEIV 103

Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 282
            S    + + L + HS  + ++HRD+K  N+L++ N   KL +FG+ +      ++  Y+
Sbjct: 104 KSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRC-YS 159

Query: 283 ENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 324
                T  Y PP+ +      ST  D++S G I  EL    +P+
Sbjct: 160 -AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 46.0 bits (110), Expect = 2e-05
 Identities = 14/37 (37%), Positives = 24/37 (64%), Gaps = 2/37 (5%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 502
           + L + HS  + ++HRD+K  N+L++ N   KL +FG
Sbjct: 112 KGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFG 146

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 32/222 (14%)

Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEV 169
           +  KLG G + TVY G     G+ +A+K   L++     S+       A+        E+
Sbjct: 9   QLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST-------AI-------REI 54

Query: 170 QTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCN--GSLYDRLARVNNTPPLDSNKRYS 224
             + + KH N++RL  +    N +   +V+E+M N      D     N    L+ N    
Sbjct: 55  SLMKELKHENIVRLYDVIHTENKLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
               + + L + H     I+HRD+K  N+L+++    KLGDFG+ +      + T ++ +
Sbjct: 113 FQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNT-FS-S 167

Query: 285 LTGTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 324
              T  Y  P+  M  +  ST  D++S G IL E++TG KP+
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPL 208

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 45.7 bits (109), Expect = 3e-05
 Identities = 15/37 (40%), Positives = 23/37 (62%), Gaps = 2/37 (5%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 502
           + L + H     I+HRD+K  N+L+++    KLGDFG
Sbjct: 119 QGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFG 153

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 81.4 bits (201), Expect = 2e-16
 Identities = 62/351 (17%), Positives = 116/351 (33%), Gaps = 59/351 (16%)

Query: 29  EKLTSCPENICLSMPKSKHKSASNLVNQHNQKIKFKLPDKKWLQEVIQQEEANNKTEYIG 88
                  + +  +  + + +   + ++                Q +++   A+       
Sbjct: 101 ALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQ 160

Query: 89  ELIAFTFCDLERATDGFNRKPYPRRGNK----LGEGQFGTVYYGKLKNGMEI-AVKTLEN 143
           E +   +            +P           LG G FG V+  ++K   ++ A K L  
Sbjct: 161 EFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNK 220

Query: 144 NANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH---VNLL-------RLLGLCNNIMNC 193
                       + AM        E + L++      V+L         L         C
Sbjct: 221 KR---LKKRKGYQGAM-------VEKKILAKVHSRFIVSLAYAFETKTDL---------C 261

Query: 194 IVYEYMCNGSLYDRLARVNNTPPLDSNKR---YSIALGVAE---ALHYLHSLSKPIIHRD 247
           +V   M  G +   +  V+   P     R   Y+     A+    L +LH  +  II+RD
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT-----AQIVSGLEHLHQRN--IIYRD 314

Query: 248 VKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT 305
           +K  NVLLD++   ++ D G+     +  +  K        GT  +M PE +  +    +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-----AGTPGFMAPELLLGEEYDFS 369

Query: 306 -DVFSYGVILLELLTGMKPIDDNNTILY----YYLVVEQEVPVREVLDKEA 351
            D F+ GV L E++    P       +        V+EQ V   +     +
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 24/83 (28%), Positives = 40/83 (48%), Gaps = 10/83 (12%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNVKTMYTENLTGTR 524
            L +LH  +  II+RD+K  NVLLD++   ++ D G+     +  +  K        GT 
Sbjct: 301 GLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-----AGTP 353

Query: 525 PYMPPEAMHCQISTKT-DVFSYG 546
            +M PE +  +    + D F+ G
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALG 376

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 37/224 (16%)

Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
             G+G FGTV  GK K  GM +A+K +  +  +      N E            +Q L+ 
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-----NRELQ---------IMQDLAV 75

Query: 175 CKHVNLLRLL--------GLCNNIMNCIVYEYMCNGSLY---DRLARVNNTPPLDSNKRY 223
             H N+++L             +I   +V EY+   +L+       R    PP    K +
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVF 134

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 282
              L    ++  LH  S  + HRD+K  NVL++  +   KL DFG  K    S     Y 
Sbjct: 135 LFQL--IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY- 191

Query: 283 ENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 324
                +R Y  PE +  +   +T  D++S G I  E++ G +PI
Sbjct: 192 ---ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 7/83 (8%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           ++  LH  S  + HRD+K  NVL++  +   KL DFG  K    S     Y      +R 
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY----ICSRY 196

Query: 526 YMPPEAM--HCQISTKTDVFSYG 546
           Y  PE +  +   +T  D++S G
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVG 219

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 80.1 bits (198), Expect = 3e-16
 Identities = 63/224 (28%), Positives = 97/224 (43%), Gaps = 43/224 (19%)

Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN-EVQTLS 173
            +G G FG VY  KL  +G  +A+K +  +  +                  +N E+Q + 
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------------------KNRELQIMR 102

Query: 174 QCKHVNLLRLL-------GLCNNIMNCIVYEYMCNGSLY---DRLARVNNTPPLDSNKRY 223
           +  H N++RL           + +   +V +Y+   ++Y      +R   T P+   K Y
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLY 161

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYT 282
              L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y 
Sbjct: 162 MYQL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217

Query: 283 ENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 324
                +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 218 C----SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 29/83 (34%), Positives = 39/83 (46%), Gaps = 9/83 (10%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y      +R 
Sbjct: 168 SLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC----SRY 221

Query: 526 YMPPEAMHC--QISTKTDVFSYG 546
           Y  PE +      ++  DV+S G
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAG 244

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 78.3 bits (194), Expect = 3e-16
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 35/221 (15%)

Query: 113 RGNKLGEGQFGTVYYGKLKNGMEIAVKT--LENNANYSSSNSDNTEAAMIPI--LLFENE 168
              K+GEG +G VY  +   G   A+K   LE             E   IP   +    E
Sbjct: 6   GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK------------EDEGIPSTTI---RE 50

Query: 169 VQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYSI 225
           +  L + KH N+++L  + +      +V+E++      D L ++       L+S    S 
Sbjct: 51  ISILKELKHSNIVKLYDVIHTKKRLVLVFEHL----DQD-LKKLLDVCEGGLESVTAKSF 105

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
            L +   + Y H   + ++HRD+K  N+L++     K+ DFG+ +      ++  YT + 
Sbjct: 106 LLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRK-YT-HE 160

Query: 286 TGTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 324
             T  Y  P+  M  +  ST  D++S G I  E++ G  P+
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPL 200

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 46.0 bits (110), Expect = 2e-05
 Identities = 12/37 (32%), Positives = 21/37 (56%), Gaps = 2/37 (5%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 502
             + Y H   + ++HRD+K  N+L++     K+ DFG
Sbjct: 111 NGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFG 145

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 46.8 bits (112), Expect = 1e-05
 Identities = 17/63 (26%), Positives = 28/63 (44%), Gaps = 2/63 (3%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L K    +    +      S    + + L + HS    ++HRD+K  N+L++     KL 
Sbjct: 88  LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLA 145

Query: 500 DFG 502
           DFG
Sbjct: 146 DFG 148

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 44/228 (19%)

Query: 113 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPI--LLFEN 167
           R  KLGEG +G VY          +A+K   LE+            E   +P   +    
Sbjct: 38  RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH------------EEEGVPGTAI---R 82

Query: 168 EVQTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRY 223
           EV  L + +H N++ L  +    + +   +++EY       D L +  +  P +      
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLH--LIFEYA----END-LKKYMDKNPDVSMRVIK 135

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-----KLGDFGIVKMSETSNMK 278
           S    +   +++ HS  +  +HRD+K  N+LL  +        K+GDFG+ +      ++
Sbjct: 136 SFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIR 192

Query: 279 TMYTENLTGTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 324
             +T +   T  Y PPE  +  +  ST  D++S   I  E+L    P+
Sbjct: 193 Q-FT-HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPL 237

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 44.9 bits (107), Expect = 4e-05
 Identities = 22/89 (24%), Positives = 40/89 (44%), Gaps = 10/89 (11%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-----KLGDF 501
           +  P +      S    +   +++ HS  +  +HRD+K  N+LL  +        K+GDF
Sbjct: 124 DKNPDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181

Query: 502 GIVKMSETSNVKTMYTENLTGTRPYMPPE 530
           G+ +      ++  +T +   T  Y PPE
Sbjct: 182 GLARAF-GIPIRQ-FT-HEIITLWYRPPE 207

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 45/237 (18%)

Query: 110 YPRRGNKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 166
           +   G K+G G +G VY  K K   +  + A+K +E     S S                
Sbjct: 22  FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSAC-------------- 66

Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVY---EYMCN--GSLYDRL---ARVNNTPPLD 218
            E+  L + KH N++ L  +  +  +  V+   +Y  +    +               L 
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126

Query: 219 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVKMSET 274
                S+   + + +HYLH  +  ++HRD+K AN+L+     E    K+ D G  ++   
Sbjct: 127 RGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-N 183

Query: 275 SNMKTMYTENLTG---TRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPI 324
           S +K +   +L     T  Y  PE    A H   +   D+++ G I  ELLT  +PI
Sbjct: 184 SPLKPLA--DLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTS-EPI 235

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 15/41 (36%), Positives = 24/41 (58%), Gaps = 6/41 (14%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFG 502
           + +HYLH+    ++HRD+K AN+L+     E    K+ D G
Sbjct: 139 DGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMG 177

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 76.0 bits (188), Expect = 3e-15
 Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 28/240 (11%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG G FG V+  + ++     A+K L+          ++T           +E   LS  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN----------DERLMLSIV 63

Query: 176 KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--IALGVAEA 232
            H  ++R+ G   +     ++ +Y+  G L+  L +    P     K Y+  + L    A
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN-PVAKFYAAEVCL----A 118

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLHS    II+RD+K  N+LLD+N   K+ DFG  K          YT  L GT  Y+
Sbjct: 119 LEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYT--LCGTPDYI 170

Query: 293 PPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 351
            PE +  +   K+ D +S+G+++ E+L G  P  D+NT+  Y  ++  E+      +++ 
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 230

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 52.9 bits (128), Expect = 1e-07
 Identities = 30/67 (44%), Positives = 36/67 (53%), Gaps = 8/67 (11%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           V  AL YLHS    II+RD+K  N+LLD+N   K+ DFG  K          YT  L GT
Sbjct: 115 VCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYT--LCGT 166

Query: 524 RPYMPPE 530
             Y+ PE
Sbjct: 167 PDYIAPE 173

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 52/230 (22%), Positives = 94/230 (40%), Gaps = 48/230 (20%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEI-AVK--TLENNANYSSSNSDNTEAAMIPI-------L 163
            ++GEG +G V+  + LKNG    A+K   ++                 +P+       +
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT------------GEEGMPLSTIREVAV 64

Query: 164 LFENEVQTLSQCKHVNLLRLLGLCNNIMNC------IVYEYMCNGSLYD--RLARVNNTP 215
           L       L   +H N++RL  +C            +V+E++      D          P
Sbjct: 65  LRH-----LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV----DQDLTTYLDKVPEP 115

Query: 216 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 275
            + +     +   +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ ++  + 
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SF 172

Query: 276 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPI 324
            M    T ++  T  Y  PE  +    +T  D++S G I  E+    KP+
Sbjct: 173 QMA--LT-SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPL 218

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 49.5 bits (119), Expect = 1e-06
 Identities = 26/108 (24%), Positives = 47/108 (43%), Gaps = 7/108 (6%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L         P + +     +   +   L +LHS    ++HRD+K  N+L+  +   KL 
Sbjct: 105 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLA 162

Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYG 546
           DFG   ++   + +   T ++  T  Y  PE  +    +T  D++S G
Sbjct: 163 DFG---LARIYSFQMALT-SVVVTLWYRAPEVLLQSSYATPVDLWSVG 206

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 75.7 bits (187), Expect = 4e-15
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 37/222 (16%)

Query: 113 RGNKLGEGQFGTVYYGKLK-NGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEV 169
           + +KLGEG + TVY GK K     +A+K   LE+      +       A+        EV
Sbjct: 6   KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT-------AI-------REV 51

Query: 170 QTLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYS 224
             L   KH N++ L  +     ++   +V+EY+      D L +   +    ++ +    
Sbjct: 52  SLLKDLKHANIVTLHDIIHTEKSLT--LVFEYL----DKD-LKQYLDDCGNIINMHNVKL 104

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
               +   L Y H   + ++HRD+K  N+L++E    KL DFG+ +   +   KT Y  N
Sbjct: 105 FLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKT-YD-N 159

Query: 285 LTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 324
              T  Y PP+ +      ST+ D++  G I  E+ TG +P+
Sbjct: 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPL 200

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 46.4 bits (111), Expect = 1e-05
 Identities = 15/37 (40%), Positives = 22/37 (59%), Gaps = 2/37 (5%)

Query: 466 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 502
             L Y H   + ++HRD+K  N+L++E    KL DFG
Sbjct: 111 RGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFG 145

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 75.3 bits (186), Expect = 6e-15
 Identities = 63/254 (24%), Positives = 107/254 (42%), Gaps = 49/254 (19%)

Query: 117 LGEGQFGTVY---YGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           LG+G +G V+        N  +I A+K L         N+ +T          E  +  L
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVL--KKAMIVRNAKDTAHTKA-----ERNI--L 75

Query: 173 SQCKH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 222
            + KH   V+L+       +L          ++ EY+  G L+ +L R       D+   
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKL---------YLILEYLSGGELFMQLEREGIFM-EDTACF 125

Query: 223 YS--IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMK 278
           Y   I++    AL +LH     II+RD+K  N++L+     KL DFG+ K  + + +   
Sbjct: 126 YLAEISM----ALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179

Query: 279 TMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVV 337
           T       GT  YM PE +      +  D +S G ++ ++LTG  P    N       ++
Sbjct: 180 TF-----CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234

Query: 338 EQEVPVREVLDKEA 351
           + ++ +   L +EA
Sbjct: 235 KCKLNLPPYLTQEA 248

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 52.9 bits (128), Expect = 1e-07
 Identities = 28/69 (40%), Positives = 36/69 (52%), Gaps = 8/69 (11%)

Query: 465 AE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLT 521
           AE   AL +LH     II+RD+K  N++L+     KL DFG+ K S      T +T    
Sbjct: 128 AEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HT--FC 182

Query: 522 GTRPYMPPE 530
           GT  YM PE
Sbjct: 183 GTIEYMAPE 191

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 75.9 bits (187), Expect = 7e-15
 Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 25/210 (11%)

Query: 117 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQTLS 173
           +G+G FG V      K    +A+K + N   +          A   I IL    +    +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF-------HRQAAEEIRILEHLRKQDKDN 157

Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
               +++L      N+I  C+ +E + + +LY+ L + N             A  + + L
Sbjct: 158 TMNVIHMLENFTFRNHI--CMTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSILQCL 213

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
             LH     IIH D+K  N+LL +      K+ DFG    S     + +YT     +R Y
Sbjct: 214 DALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFG----SSCYEHQRVYTY--IQSRFY 265

Query: 292 MPPE-AMHCQISTKTDVFSYGVILLELLTG 320
             PE  +  +     D++S G IL ELLTG
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTG 295

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 74.1 bits (183), Expect = 2e-14
 Identities = 69/258 (26%), Positives = 115/258 (44%), Gaps = 59/258 (22%)

Query: 117 LGEGQFGTVY---YGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT- 171
           LG+G FG V+        +  ++ A+K L+                    L   + V+T 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKA-----------------TLKVRDRVRTK 74

Query: 172 -----LSQCKH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPP 216
                L +  H   V L        +L          ++ +++  G L+ RL++      
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKL---------YLILDFLRGGDLFTRLSKEVMFT- 124

Query: 217 LDSNKRYS--IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 274
            +  K Y   +AL    AL +LHSL   II+RD+K  N+LLDE    KL DFG+ K S  
Sbjct: 125 EEDVKFYLAELAL----ALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178

Query: 275 SNMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYY 333
              K  Y+    GT  YM PE ++ +  T++ D +S+GV++ E+LTG  P    +     
Sbjct: 179 HEKKA-YS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235

Query: 334 YLVVEQEVPVREVLDKEA 351
            ++++ ++ + + L  EA
Sbjct: 236 TMILKAKLGMPQFLSPEA 253

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 52.9 bits (128), Expect = 1e-07
 Identities = 32/67 (47%), Positives = 39/67 (58%), Gaps = 5/67 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A AL +LHSL   II+RD+K  N+LLDE    KL DFG+ K S     K  Y+    GT
Sbjct: 135 LALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA-YS--FCGT 189

Query: 524 RPYMPPE 530
             YM PE
Sbjct: 190 VEYMAPE 196

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 69/249 (27%), Positives = 103/249 (41%), Gaps = 42/249 (16%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G+G FG V   + K      AVK L+  A        +  +        E  V   +  
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMS--------ERNVLLKN-V 96

Query: 176 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 224
           KH   V L        +L           V +Y+  G L+  L R          + Y+ 
Sbjct: 97  KHPFLVGLHFSFQTADKL---------YFVLDYINGGELFYHLQRER-CFLEPRARFYAA 146

Query: 225 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
            IA     AL YLHSL+  I++RD+K  N+LLD      L DFG+ K +   N  T  T 
Sbjct: 147 EIAS----ALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT-ST- 198

Query: 284 NLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
              GT  Y+ PE +H Q   +T D +  G +L E+L G+ P    NT   Y  ++ + + 
Sbjct: 199 -FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ 257

Query: 343 VREVLDKEA 351
           ++  +   A
Sbjct: 258 LKPNITNSA 266

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 53.4 bits (129), Expect = 8e-08
 Identities = 29/67 (43%), Positives = 38/67 (56%), Gaps = 5/67 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A AL YLHSL+  I++RD+K  N+LLD      L DFG+ K +   N  T  T    GT
Sbjct: 148 IASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT-ST--FCGT 202

Query: 524 RPYMPPE 530
             Y+ PE
Sbjct: 203 PEYLAPE 209

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 52/238 (21%), Positives = 88/238 (36%), Gaps = 39/238 (16%)

Query: 116 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSS----------------------SNS 152
            LG G FG V       +G   A+K +  +  Y +                      +  
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTG 73

Query: 153 DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLY---DRLA 209
           D       P           +   + +   ++    N    ++ EY+   +L+       
Sbjct: 74  DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFI 132

Query: 210 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGI 268
           R   + P++    Y   L    A+ ++HSL   I HRD+K  N+L++ ++   KL DFG 
Sbjct: 133 RSGRSIPMNLISIYIYQL--FRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGS 188

Query: 269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 324
            K    S     Y      +R Y  PE M    + +   D++S G +  EL+ G KP+
Sbjct: 189 AKKLIPSEPSVAY----ICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG-KPL 241

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 9/83 (10%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           A+ ++HSL   I HRD+K  N+L++ ++   KL DFG  K    S     Y      +R 
Sbjct: 153 AVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAY----ICSRF 206

Query: 526 YMPPEAMHC--QISTKTDVFSYG 546
           Y  PE M    + +   D++S G
Sbjct: 207 YRAPELMLGATEYTPSIDLWSIG 229

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 64/250 (25%), Positives = 106/250 (42%), Gaps = 44/250 (17%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V+  + K   +  A+K L+ +      + + T          E  V +L+  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV--------EKRVLSLA-W 75

Query: 176 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 224
           +H    ++         L           V EY+  G L   +   +    L     Y+ 
Sbjct: 76  EHPFLTHMFCTFQTKENL---------FFVMEYLNGGDLMYHIQSCHKFD-LSRATFYAA 125

Query: 225 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYT 282
            I L     L +LHS    I++RD+K  N+LLD++  + K+ DFG+ K +   + KT  T
Sbjct: 126 EIIL----GLQFLHSKG--IVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKT-NT 177

Query: 283 ENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
               GT  Y+ PE +  Q    + D +S+GV+L E+L G  P    +    ++ +     
Sbjct: 178 --FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 235

Query: 342 PVREVLDKEA 351
                L+KEA
Sbjct: 236 FYPRWLEKEA 245

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 51.8 bits (125), Expect = 3e-07
 Identities = 25/68 (36%), Positives = 39/68 (57%), Gaps = 7/68 (10%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           +   L +LHS    I++RD+K  N+LLD++  + K+ DFG+ K +   + KT  T    G
Sbjct: 127 IILGLQFLHSKG--IVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKT-NT--FCG 180

Query: 523 TRPYMPPE 530
           T  Y+ PE
Sbjct: 181 TPDYIAPE 188

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 43/166 (25%), Positives = 73/166 (43%), Gaps = 23/166 (13%)

Query: 168 EVQTLSQCKHVNLLRLLGL---CNNIMNC----IVYEYM-CNGSLYDRLARVNNTPPLDS 219
           E+  +    H N++ LL +     ++       IV E M  N      L +V        
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN------LCQVIQMELDHE 127

Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
              Y +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T
Sbjct: 128 RMSY-LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184

Query: 280 MYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPI 324
            Y      TR Y  PE +      +  D++S G I+ E++ G   +
Sbjct: 185 PY----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 7/81 (8%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS + T Y      TR Y
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY----VVTRYY 192

Query: 527 MPPEAMHCQISTKT-DVFSYG 546
             PE +      +  D++S G
Sbjct: 193 RAPEVILGMGYKENVDIWSVG 213

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 75.7 bits (185), Expect = 2e-14
 Identities = 79/591 (13%), Positives = 164/591 (27%), Gaps = 183/591 (30%)

Query: 66  PDKKWLQEVIQQEE---ANNKTEYIGELIAFTFCDLERATDGF-NR-KPYPRRGNKLGE- 119
            + K+L   I+ E+   +     YI E     + D +       +R +PY +    L E 
Sbjct: 89  INYKFLMSPIKTEQRQPSMMTRMYI-EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLEL 147

Query: 120 --GQFGTVYYGKLKNGMEIAVKT-LENNANYSSSNSDNTEAAMIPILLFENEVQ--TLSQ 174
              +   +       G+  + KT +  +       S   +         + ++    L  
Sbjct: 148 RPAKNVLID------GVLGSGKTWVALDV----CLSYKVQCK------MDFKIFWLNLKN 191

Query: 175 CKHVN--LLRLLGLCNNIMN--CIVYEYMCN-----GSLYDRLARVNNTPPLDSNKRYSI 225
           C      L  L  L   I        ++  N      S+   L R      L  +K Y  
Sbjct: 192 CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR------LLKSKPYEN 245

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVL---------L----DENFVPKLGDFGIVKMS 272
            L               ++  +V++A            L     +     L       +S
Sbjct: 246 CL---------------LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290

Query: 273 ETSNMKTMY---TENL----TGTRPY-MPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 324
              +  T+     ++L       RP  +P E      +         +I           
Sbjct: 291 LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV--LTTNP----RRLSII------AESIR 338

Query: 325 DDNNTILYY-YLVVEQEVPVREV-LDK-EAGEWNETHVETLIGIVFEKCCVFEKD----- 376
           D   T   + ++  ++   + E  L+  E  E+ +         +F++  VF        
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK---------MFDRLSVFPPSAHIPT 389

Query: 377 ----------KRASMRDIVDLL-SKSMFVCN------SLANLYVGKVSSRTQENNNINWE 419
                      ++ +  +V+ L   S+          S+ ++Y+     + +  N     
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL---ELKVKLENEY--A 444

Query: 420 LHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYL--HSLSKP 477
           LH +     I+D     +         ++        +Y           ++  H  +  
Sbjct: 445 LHRS-----IVDHYNIPKT------FDSDDLIPPYLDQYF--------YSHIGHHLKNIE 485

Query: 478 IIHRDVKSANVLLDENFVP-KLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQI 536
              R      V LD  F+  K+                        T       A    +
Sbjct: 486 HPERMTLFRMVFLDFRFLEQKI--------------------RHDST----AWNASGSIL 521

Query: 537 STKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVSISNHS 587
           +T   +  Y       +I + D        ++   LP     +++  S ++
Sbjct: 522 NTLQQLKFYK-----PYICDNDPKYERLVNAILDFLPKI--EENLICSKYT 565

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 23/212 (10%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQT 171
           + +G+G FG V           +A+K ++N   +          A   + +L   N+  T
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-------LNQAQIEVRLLELMNKHDT 112

Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
             +   V+L R     N++  C+V+E M + +LYD L R  N   +  N     A  +  
Sbjct: 113 EMKYYIVHLKRHFMFRNHL--CLVFE-MLSYNLYDLL-RNTNFRGVSLNLTRKFAQQMCT 168

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIVKMSETSNMKTMYTENLTGTR 289
           AL +L +    IIH D+K  N+LL        K+ DFG    S     + +Y      +R
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQRIYQ--YIQSR 222

Query: 290 PYMPPEA-MHCQISTKTDVFSYGVILLELLTG 320
            Y  PE  +        D++S G IL+E+ TG
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 60/250 (24%), Positives = 94/250 (37%), Gaps = 55/250 (22%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G G FG V   + K+  ++ A+K L        S+S             E ++  ++  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE--------ERDI--MAFA 126

Query: 176 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
                V L         L          +V EYM  G L + +          SN     
Sbjct: 127 NSPWVVQLFYAFQDDRYL---------YMVMEYMPGGDLVNLM----------SNYDVPE 167

Query: 226 ALG---VAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
                  AE   AL  +HS+    IHRDVK  N+LLD++   KL DFG     + +    
Sbjct: 168 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGM 223

Query: 280 MYTENLTGTRPYMPPEAMHCQISTKT-----DVFSYGVILLELLTGMKPIDDNNTILYYY 334
           +  +   GT  Y+ PE +  Q          D +S GV L E+L G  P   ++ +  Y 
Sbjct: 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 283

Query: 335 LVVEQEVPVR 344
            ++  +  + 
Sbjct: 284 KIMNHKNSLT 293

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 27/83 (32%), Positives = 40/83 (48%), Gaps = 8/83 (9%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           V  AL  +HS+    IHRDVK  N+LLD++   KL DFG     + +    +  +   GT
Sbjct: 177 VVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGT 232

Query: 524 RPYMPPEAMHCQISTKTDVFSYG 546
             Y+ PE     + ++     YG
Sbjct: 233 PDYISPEV----LKSQGGDGYYG 251

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 68/252 (26%), Positives = 104/252 (41%), Gaps = 48/252 (19%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   + K   E+ AVK L+ +      + + T          E  V  L   
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV--------EKRVLALP-G 78

Query: 176 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 224
           K      L        RL           V EY+  G L   + +V           Y+ 
Sbjct: 79  KPPFLTQLHSCFQTMDRL---------YFVMEYVNGGDLMYHIQQVGRFK-EPHAVFYAA 128

Query: 225 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVK--MSETSNMKTM 280
            IA+     L +L S    II+RD+K  NV+LD    + K+ DFG+ K  + +    KT 
Sbjct: 129 EIAI----GLFFLQSKG--IIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGVTTKTF 181

Query: 281 YTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
                 GT  Y+ PE +  Q   K+ D +++GV+L E+L G  P +  +    +  ++E 
Sbjct: 182 -----CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236

Query: 340 EVPVREVLDKEA 351
            V   + + KEA
Sbjct: 237 NVAYPKSMSKEA 248

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 51.1 bits (123), Expect = 4e-07
 Identities = 26/68 (38%), Positives = 36/68 (52%), Gaps = 7/68 (10%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNVKTMYTENLTG 522
           +A  L +L S    II+RD+K  NV+LD    + K+ DFG+ K +    V T  T    G
Sbjct: 130 IAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGVTT-KT--FCG 183

Query: 523 TRPYMPPE 530
           T  Y+ PE
Sbjct: 184 TPDYIAPE 191

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 75.1 bits (184), Expect = 3e-14
 Identities = 69/249 (27%), Positives = 103/249 (41%), Gaps = 42/249 (16%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   + K   E+ AVK L+ +      + + T          E  V  L   
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV--------EKRVLALP-G 399

Query: 176 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
           K      L        RL           V EY+  G L   + +V           Y  
Sbjct: 400 KPPFLTQLHSCFQTMDRL---------YFVMEYVNGGDLMYHIQQVGRFK-EPHAVFY-- 447

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTE 283
           A  +A  L +L S  K II+RD+K  NV+LD     K+ DFG+ K  + +    KT    
Sbjct: 448 AAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF--- 502

Query: 284 NLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
              GT  Y+ PE +  Q   K+ D +++GV+L E+L G  P +  +    +  ++E  V 
Sbjct: 503 --CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 560

Query: 343 VREVLDKEA 351
             + + KEA
Sbjct: 561 YPKSMSKEA 569

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 27/67 (40%), Positives = 36/67 (53%), Gaps = 5/67 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +A  L +L S  K II+RD+K  NV+LD     K+ DFG+ K +    V T  T    GT
Sbjct: 451 IAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT-KT--FCGT 505

Query: 524 RPYMPPE 530
             Y+ PE
Sbjct: 506 PDYIAPE 512

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 74.2 bits (182), Expect = 6e-14
 Identities = 38/164 (23%), Positives = 68/164 (41%), Gaps = 15/164 (9%)

Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 252
             + + M  G L+  L++       D   R+  A  +   L ++H+    +++RD+K AN
Sbjct: 268 SFILDLMNGGDLHYHLSQHGVFSEADM--RFYAA-EIILGLEHMHNRF--VVYRDLKPAN 322

Query: 253 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS-TKT-DVFSY 310
           +LLDE+   ++ D G+                  GT  YM PE +   ++   + D FS 
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVAYDSSADWFSL 377

Query: 311 GVILLELLTGMKPIDDNNTI---LYYYLVVEQEVPVREVLDKEA 351
           G +L +LL G  P   + T        + +   V + +    E 
Sbjct: 378 GCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 19/64 (29%), Positives = 31/64 (48%), Gaps = 7/64 (10%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
            L ++H+    +++RD+K AN+LLDE+   ++ D G+                  GT  Y
Sbjct: 304 GLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGY 356

Query: 527 MPPE 530
           M PE
Sbjct: 357 MAPE 360

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 72.7 bits (179), Expect = 6e-14
 Identities = 64/252 (25%), Positives = 101/252 (40%), Gaps = 48/252 (19%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           LG+G FG V   ++K   ++ AVK L+ +      + + T          E  + +L++ 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMT--------EKRILSLAR- 81

Query: 176 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            H     L        RL           V E++  G L   + +          + Y+ 
Sbjct: 82  NHPFLTQLFCCFQTPDRL---------FFVMEFVNGGDLMFHIQKSR-RFDEARARFYA- 130

Query: 226 ALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTM 280
               AE   AL +LH     II+RD+K  NVLLD     KL DFG+ K  +       T 
Sbjct: 131 ----AEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF 184

Query: 281 YTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 339
                 GT  Y+ PE +   +     D ++ GV+L E+L G  P +  N    +  ++  
Sbjct: 185 -----CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239

Query: 340 EVPVREVLDKEA 351
           EV     L ++A
Sbjct: 240 EVVYPTWLHEDA 251

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 28/67 (41%), Positives = 35/67 (52%), Gaps = 5/67 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           +  AL +LH     II+RD+K  NVLLD     KL DFG+ K    + V T  T    GT
Sbjct: 133 IISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT-AT--FCGT 187

Query: 524 RPYMPPE 530
             Y+ PE
Sbjct: 188 PDYIAPE 194

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 23/166 (13%)

Query: 168 EVQTLSQCKHVNLLRLLGL---CNNIMNC----IVYEYM-CNGSLYDRLARVNNTPPLDS 219
           E+  +    H N++ LL +      +       +V E M  N      L +V        
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN------LCQVIQMELDHE 164

Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
              Y +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T
Sbjct: 165 RMSY-LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 221

Query: 280 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPI 324
            Y      TR Y  PE +         D++S G I+ E++   K +
Sbjct: 222 PY----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 7/81 (8%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS + T Y      TR Y
Sbjct: 176 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY----VVTRYY 229

Query: 527 MPPEAM-HCQISTKTDVFSYG 546
             PE +         D++S G
Sbjct: 230 RAPEVILGMGYKENVDIWSVG 250

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 49/237 (20%), Positives = 96/237 (40%), Gaps = 70/237 (29%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN------ 167
             +G G +G+V      ++G ++A+K L                       F++      
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------------------PFQSEIFAKR 69

Query: 168 ---EVQTLSQCKHVNLLRLLGLCNNIMNC-----------IVYEYM-CNGSLYDRLARVN 212
              E+  L   +H N++ LL    ++              +V  +M  +      L ++ 
Sbjct: 70  AYRELLLLKHMQHENVIGLL----DVFTPASSLRNFYDFYLVMPFMQTD------LQKIM 119

Query: 213 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
                +   +Y +   + + L Y+HS    ++HRD+K  N+ ++E+   K+ DFG+ + +
Sbjct: 120 GLKFSEEKIQY-LVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHA 176

Query: 273 ETSNMKTMYTENLTG---TRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 324
           +           +TG   TR Y  PE +      +   D++S G I+ E+LTG K +
Sbjct: 177 D---------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 24/82 (29%), Positives = 39/82 (47%), Gaps = 10/82 (12%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
            L Y+HS    ++HRD+K  N+ ++E+   K+ DFG+ +        T Y      TR Y
Sbjct: 138 GLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGY----VVTRWY 189

Query: 527 MPPEAM--HCQISTKTDVFSYG 546
             PE +      +   D++S G
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVG 211

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 55/238 (23%), Positives = 91/238 (38%), Gaps = 33/238 (13%)

Query: 116 KLGEGQFGTVY--YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQT 171
            LGEG FG V       +   ++A+K + N   Y        EAA   I +L    E   
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY-------REAARLEINVLKKIKEKDK 78

Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            ++   V +        ++  CI +E +   + ++ L + NN  P        +A  +  
Sbjct: 79  ENKFLCVLMSDWFNFHGHM--CIAFE-LLGKNTFEFL-KENNFQPYPLPHVRHMAYQLCH 134

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGIVKMSETSNMK-------TMY 281
           AL +LH     + H D+K  N+L   +    +         K  + ++++       T  
Sbjct: 135 ALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192

Query: 282 TENLTG---TRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG--MKPIDDNNTILYY 333
            E+ T    TR Y PPE  +    +   DV+S G IL E   G  +    +N   L  
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 65/237 (27%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN------ 167
           + +GEG +G V       N + +A+K +                       FE+      
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP---------------------FEHQTYCQR 71

Query: 168 ---EVQTLSQCKHVNLLRLLGLCNNIMNC----------IVYEYM-CNGSLYDRLARVNN 213
              E++ L + +H N++ +     +I+            IV + M  +      L ++  
Sbjct: 72  TLREIKILLRFRHENIIGIN----DIIRAPTIEQMKDVYIVQDLMETD------LYKLLK 121

Query: 214 TPPL-DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 272
           T  L + +  Y     +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG   ++
Sbjct: 122 TQHLSNDHICY-FLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFG---LA 175

Query: 273 ETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
             ++    +T  LT    TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 10/85 (11%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG---T 523
            L Y+HS +  ++HRD+K +N+LL+     K+ DFG   ++  ++    +T  LT    T
Sbjct: 140 GLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFG---LARVADPDHDHTGFLTEYVAT 194

Query: 524 RPYMPPEAM-HCQISTKT-DVFSYG 546
           R Y  PE M + +  TK+ D++S G
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVG 219

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 61/240 (25%), Positives = 94/240 (39%), Gaps = 66/240 (27%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN------- 167
            LGEG +G V        G  +A+K +E                      F+        
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEP---------------------FDKPLFALRT 56

Query: 168 --EVQTLSQCKHVNLLRLLGLCNNIMNC----------IVYEYM-CNGSLYDRLARVNNT 214
             E++ L   KH N++ +     NI             I+ E M  +      L RV +T
Sbjct: 57  LREIKILKHFKHENIITIF----NIQRPDSFENFNEVYIIQELMQTD------LHRVIST 106

Query: 215 PPL-DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG----IV 269
             L D + +Y        A+  LH  +  +IHRD+K +N+L++ N   K+ DFG    I 
Sbjct: 107 QMLSDDHIQY-FIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163

Query: 270 KMSETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 324
           + +  ++  T     +     TR Y  PE M      ++  DV+S G IL EL    +PI
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 54.9 bits (133), Expect = 3e-08
 Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 11/89 (12%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG----IVKMSETSNVKTMYTENLTG 522
           A+  LH  +  +IHRD+K +N+L++ N   K+ DFG    I + +  ++  T     +  
Sbjct: 124 AVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 523 ---TRPYMPPEAM-HCQISTKT-DVFSYG 546
              TR Y  PE M      ++  DV+S G
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCG 210

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 49/168 (29%), Positives = 75/168 (44%), Gaps = 18/168 (10%)

Query: 193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--IALGVAEALHYLHSLSKPIIHRDVKS 250
            ++ +Y+  G L+  L++          + Y   I L    AL +LH L   II+RD+K 
Sbjct: 135 HLILDYINGGELFTHLSQRERFT-EHEVQIYVGEIVL----ALEHLHKLG--IIYRDIKL 187

Query: 251 ANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS--TKT-DV 307
            N+LLD N    L DFG+ K       +  Y     GT  YM P+ +    S   K  D 
Sbjct: 188 ENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTIEYMAPDIVRGGDSGHDKAVDW 245

Query: 308 FSYGVILLELLTGMKP----IDDNNTILYYYLVVEQEVPVREVLDKEA 351
           +S GV++ ELLTG  P     + N+       +++ E P  + +   A
Sbjct: 246 WSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 293

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 27/69 (39%), Positives = 34/69 (49%), Gaps = 7/69 (10%)

Query: 465 AE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLT 521
            E   AL +LH L   II+RD+K  N+LLD N    L DFG+ K       +  Y     
Sbjct: 166 GEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FC 221

Query: 522 GTRPYMPPE 530
           GT  YM P+
Sbjct: 222 GTIEYMAPD 230

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 61/241 (25%), Positives = 93/241 (38%), Gaps = 46/241 (19%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G G +  V   +LK    I A+K ++        + D  +         E  V   +  
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT--------EKHVFEQA-S 67

Query: 176 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 224
            H   V L        RL           V EY+  G L   + R     P +  + YS 
Sbjct: 68  NHPFLVGLHSCFQTESRL---------FFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSA 117

Query: 225 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMY 281
            I+L    AL+YLH     II+RD+K  NVLLD     KL D+G+ K  +       T  
Sbjct: 118 EISL----ALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF- 170

Query: 282 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
                GT  Y+ PE +  +    + D ++ GV++ E++ G  P D   +        E  
Sbjct: 171 ----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226

Query: 341 V 341
           +
Sbjct: 227 L 227

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 52.2 bits (126), Expect = 2e-07
 Identities = 27/67 (40%), Positives = 35/67 (52%), Gaps = 5/67 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           ++ AL+YLH     II+RD+K  NVLLD     KL D+G+ K        T  T    GT
Sbjct: 119 ISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-ST--FCGT 173

Query: 524 RPYMPPE 530
             Y+ PE
Sbjct: 174 PNYIAPE 180

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 40/170 (23%), Positives = 81/170 (47%), Gaps = 31/170 (18%)

Query: 168 EVQTLSQCKHVNLLRLLGL---CNNIMNC----IVYEYM-CNGSLYDRLARVNNTPPLDS 219
           E++ L   +H N++ LL +      + +     +V  +M  +      L ++     L  
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD------LGKLMKHEKLGE 127

Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
           ++   +   + + L Y+H+    IIHRD+K  N+ ++E+   K+ DFG+ + +++     
Sbjct: 128 DRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADS----- 180

Query: 280 MYTENLTG---TRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 324
                +TG   TR Y  PE +    + +   D++S G I+ E++TG K +
Sbjct: 181 ----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 53.5 bits (129), Expect = 9e-08
 Identities = 25/85 (29%), Positives = 44/85 (51%), Gaps = 16/85 (18%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTG---T 523
            L Y+H+    IIHRD+K  N+ ++E+   K+ DFG+ + +++          +TG   T
Sbjct: 140 GLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADS---------EMTGYVVT 188

Query: 524 RPYMPPEAM--HCQISTKTDVFSYG 546
           R Y  PE +    + +   D++S G
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVG 213

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 63/229 (27%), Positives = 93/229 (40%), Gaps = 43/229 (18%)

Query: 116 KLGEGQFGTVY--YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQT 171
            LGEG FG V         G  +AVK ++N   Y        EAA   I +L   N    
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY-------CEAARSEIQVLEHLNTTDP 73

Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            S  + V +L       +I  CIV+E +   S YD + + N   P   +    +A  + +
Sbjct: 74  NSTFRCVQMLEWFEHHGHI--CIVFE-LLGLSTYDFI-KENGFLPFRLDHIRKMAYQICK 129

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVP-------------------KLGDFGIVKMS 272
           ++++LHS    + H D+K  N+L  ++                      K+ DFG    S
Sbjct: 130 SVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG----S 183

Query: 273 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 320
            T + +   T  L  TR Y  PE  +    S   DV+S G IL+E   G
Sbjct: 184 ATYDDEHHST--LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 33/171 (19%)

Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNC-----------IVYEYM-CNGSLYDRLARVNNTP 215
           E++ L   KH N++ LL    ++              +V   M  +      L  +    
Sbjct: 78  ELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGAD------LNNIVKCQ 127

Query: 216 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 275
            L  +    +   +   L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T+
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTA 183

Query: 276 NMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 324
           +  T Y      TR Y  PE M      +   D++S G I+ ELLTG + +
Sbjct: 184 DEMTGY----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 28/82 (34%), Positives = 43/82 (52%), Gaps = 10/82 (12%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPY 526
            L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T++  T Y      TR Y
Sbjct: 144 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGY----VATRWY 195

Query: 527 MPPEAM--HCQISTKTDVFSYG 546
             PE M      +   D++S G
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVG 217

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 60/241 (24%), Positives = 93/241 (38%), Gaps = 46/241 (19%)

Query: 117 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 175
           +G G +  V   +LK    I A++ ++        + D  +         E  V   +  
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT--------EKHVFEQA-S 110

Query: 176 KH---VNLL-------RLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 224
            H   V L        RL           V EY+  G L   + R     P +  + YS 
Sbjct: 111 NHPFLVGLHSCFQTESRL---------FFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSA 160

Query: 225 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMY 281
            I+L    AL+YLH     II+RD+K  NVLLD     KL D+G+ K  +       T  
Sbjct: 161 EISL----ALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF- 213

Query: 282 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
                GT  Y+ PE +  +    + D ++ GV++ E++ G  P D   +        E  
Sbjct: 214 ----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 269

Query: 341 V 341
           +
Sbjct: 270 L 270

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 27/67 (40%), Positives = 35/67 (52%), Gaps = 5/67 (7%)

Query: 464 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGT 523
           ++ AL+YLH     II+RD+K  NVLLD     KL D+G+ K        T  T    GT
Sbjct: 162 ISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-ST--FCGT 216

Query: 524 RPYMPPE 530
             Y+ PE
Sbjct: 217 PNYIAPE 223

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 52/234 (22%), Positives = 88/234 (37%), Gaps = 49/234 (20%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 174
           K+G+G FG V   + + N    AVK + N   Y       T +A I       E   L +
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY-------TRSAKI-------EADILKK 87

Query: 175 CKH--------VNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
            ++        V         +++  C+++E     SLY+ +   NN             
Sbjct: 88  IQNDDINNNNIVKYHGKFMYYDHM--CLIFE-PLGPSLYEII-TRNNYNGFHIEDIKLYC 143

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK-------- 278
           + + +AL+YL  +S  + H D+K  N+LLD+ +  K                        
Sbjct: 144 IEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 279 --------TMYTENLTG---TRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 320
                   T  ++       TR Y  PE  ++      +D++S+G +L EL TG
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 66.1 bits (162), Expect = 6e-12
 Identities = 45/183 (24%), Positives = 79/183 (43%), Gaps = 42/183 (22%)

Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMNC-------------------IVYEYM-CNGSLYDR 207
           E++ + +  H N++++      I+                     IV EYM  +      
Sbjct: 58  EIKIIRRLDHDNIVKVF----EILGPSGSQLTDDVGSLTELNSVYIVQEYMETD------ 107

Query: 208 LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDF 266
           LA V    PL           +   L Y+HS +  ++HRD+K AN+ ++ E+ V K+GDF
Sbjct: 108 LANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDF 165

Query: 267 GIVKMSETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGM 321
           G+ ++ +       +   L+    T+ Y  P  +      TK  D+++ G I  E+LTG 
Sbjct: 166 GLARIMDPHYSHKGH---LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG- 221

Query: 322 KPI 324
           K +
Sbjct: 222 KTL 224

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 25/86 (29%), Positives = 46/86 (53%), Gaps = 11/86 (12%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNVKTMYTENLTG--- 522
            L Y+HS +  ++HRD+K AN+ ++ E+ V K+GDFG+ ++ +       +   L+    
Sbjct: 132 GLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH---LSEGLV 186

Query: 523 TRPYMPPEAM-HCQISTKT-DVFSYG 546
           T+ Y  P  +      TK  D+++ G
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAG 212

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 33/222 (14%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QT 171
           G K+G G FG +Y G  +  G E+A+K       +             P L  E+++ + 
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------------PQLHIESKIYKM 60

Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVA 230
           +     +  +R  G   +  N +V E +  G SL D     +    L +     +A  + 
Sbjct: 61  MQGGVGIPTIRWCGAEGD-YNVMVMELL--GPSLEDLFNFCSRKFSLKTVLL--LADQMI 115

Query: 231 EALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVKM--SETSNMKTMYTEN 284
             + Y+HS  K  IHRDVK  N L+      N V  + DFG+ K      ++    Y EN
Sbjct: 116 SRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPYREN 172

Query: 285 --LTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKP 323
             LTGT  Y      +  + S + D+ S G +L+    G  P
Sbjct: 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 12/102 (11%)

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           AL Y HS    I+HRDVK  NV++D E+   +L D+G   ++E  +    Y   +  +R 
Sbjct: 142 ALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG---LAEFYHPGQEYNVRVA-SRY 195

Query: 291 YMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI---DDN 327
           +  PE +  +       D++S G +L  ++   +P     DN
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 9/83 (10%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP 525
           AL Y HS    I+HRDVK  NV++D E+   +L D+G   ++E  +    Y   +  +R 
Sbjct: 142 ALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG---LAEFYHPGQEYNVRVA-SRY 195

Query: 526 YMPPEAM--HCQISTKTDVFSYG 546
           +  PE +  +       D++S G
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLG 218

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 62/249 (24%), Positives = 98/249 (39%), Gaps = 72/249 (28%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
            KLG+G +G V+     + G  +AVK + +                     F+N      
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--------------------AFQNSTD--- 51

Query: 174 QCKH----VNLLRLLGLCNNIMNC-------------IVYEYMCNGSLYDRLARVNNTPP 216
             +     + +L  L    NI+N              +V++YM      D L  V     
Sbjct: 52  -AQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM----ETD-LHAVIRANI 105

Query: 217 L-DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-------- 267
           L   +K+Y +   + + + YLHS    ++HRD+K +N+LL+     K+ DFG        
Sbjct: 106 LEPVHKQY-VVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162

Query: 268 -------IVKMSETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYGVILL 315
                   + ++E +         LT    TR Y  PE +      TK  D++S G IL 
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222

Query: 316 ELLTGMKPI 324
           E+L G KPI
Sbjct: 223 EILCG-KPI 230

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 23/84 (27%), Positives = 36/84 (42%), Gaps = 20/84 (23%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG---------------IVKMSETSN 511
            + YLHS    ++HRD+K +N+LL+     K+ DFG                + ++E + 
Sbjct: 121 VIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 512 VKTMYTENLTG---TRPYMPPEAM 532
                   LT    TR Y  PE +
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEIL 202

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 63.6 bits (155), Expect = 6e-11
 Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 67/247 (27%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN------- 167
            +G G +G VY          +A+K +                      +FE+       
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNR--------------------MFEDLIDCKRI 72

Query: 168 --EVQTLSQCKHVNLLRLLGLC--NNIMNC----IVYEYMCNGSLYDRLARVNNTP-PL- 217
             E+  L++ K   ++RL  L   ++++      IV E        D L ++  TP  L 
Sbjct: 73  LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA----DSD-LKKLFKTPIFLT 127

Query: 218 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG---------- 267
           + + +  I   +    +++H     IIHRD+K AN LL+++   K+ DFG          
Sbjct: 128 EEHIKT-ILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184

Query: 268 ------IVKMSETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYGVILLE 316
                 + +  E         + LT    TR Y  PE +   +  TK+ D++S G I  E
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244

Query: 317 LLTGMKP 323
           LL  ++ 
Sbjct: 245 LLNMLQS 251

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 28/101 (27%), Positives = 44/101 (43%), Gaps = 23/101 (22%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG----------------IVKMSETS 510
             +++H     IIHRD+K AN LL+++   K+ DFG                + +  E  
Sbjct: 141 GENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198

Query: 511 NVKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYG 546
                  + LT    TR Y  PE +   +  TK+ D++S G
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 50/226 (22%), Positives = 88/226 (38%), Gaps = 45/226 (19%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QT 171
           G ++GEG FG ++ G  L N  ++A+K     ++              P L  E    + 
Sbjct: 15  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------------PQLRDEYRTYKL 61

Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYS------ 224
           L+ C  +  +   G      N +V + +  G SL D L            +++S      
Sbjct: 62  LAGCTGIPNVYYFGQEGL-HNVLVIDLL--GPSLEDLLDL--------CGRKFSVKTVAM 110

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK-----LGDFGIVKM--SETSNM 277
            A  +   +  +H   K +++RD+K  N L+            + DFG+VK      +  
Sbjct: 111 AAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 168

Query: 278 KTMYTEN--LTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 320
              Y E   L+GT  YM     +  + S + D+ + G + +  L G
Sbjct: 169 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 53/227 (23%), Positives = 87/227 (38%), Gaps = 47/227 (20%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QT 171
           G K+G G FG +  GK L     +A+K     +                 L  E    + 
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ-------------LHLEYRFYKQ 60

Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYS------ 224
           L     +  +   G C    N +V E +  G SL D             ++ +S      
Sbjct: 61  LGSGDGIPQVYYFGPCGK-YNAMVLELL--GPSLEDLFDL--------CDRTFSLKTVLM 109

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLL------DENFVPKLGDFGIVK--MSETSN 276
           IA+ +   + Y+HS  K +I+RDVK  N L+       +  +  + DF + K  +   + 
Sbjct: 110 IAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAKEYIDPETK 166

Query: 277 MKTMYTEN--LTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 320
               Y E+  LTGT  YM     +  + S + D+ + G + +  L G
Sbjct: 167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 33/219 (15%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QT 171
           G K+G G FG +Y G  ++   E+A+K       +             P LL+E+++ + 
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------------PQLLYESKIYRI 58

Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVA 230
           L     +  +R  G+  +  N +V + +  G SL D     +    L +     +A  + 
Sbjct: 59  LQGGTGIPNVRWFGVEGD-YNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLM--LADQMI 113

Query: 231 EALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVK--MSETSNMKTMYTEN 284
             + ++H  SK  +HRD+K  N L+      N V  + DFG+ K     +++    Y EN
Sbjct: 114 NRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKKYRDTSTHQHIPYREN 170

Query: 285 --LTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 320
             LTGT  Y      +  + S + D+ S G +L+  L G
Sbjct: 171 KNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 53/256 (20%), Positives = 92/256 (35%), Gaps = 80/256 (31%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN------- 167
            +G G +G V           +A+K +                      +FE+       
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILR--------------------VFEDLIDCKRI 99

Query: 168 --EVQTLSQCKHVNLLRLLGLCNNIMNC----------IVYEYMCNGSLYDRLARVNNTP 215
             E+  L++  H +++++L    +I+            +V E        D   ++  TP
Sbjct: 100 LREIAILNRLNHDHVVKVL----DIVIPKDVEKFDELYVVLEIA----DSD-FKKLFRTP 150

Query: 216 -PL-DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG------ 267
             L + + +  +   +   + Y+HS    I+HRD+K AN L++++   K+ DFG      
Sbjct: 151 VYLTELHIKT-LLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207

Query: 268 ---------------IVKMSETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DV 307
                                T          LTG   TR Y  PE +   +  T+  DV
Sbjct: 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDV 267

Query: 308 FSYGVILLELLTGMKP 323
           +S G I  ELL  +K 
Sbjct: 268 WSIGCIFAELLNMIKE 283

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 47.5 bits (113), Expect = 7e-06
 Identities = 24/90 (26%), Positives = 34/90 (37%), Gaps = 26/90 (28%)

Query: 467 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG---------------------IVK 505
            + Y+HS    I+HRD+K AN L++++   K+ DFG                        
Sbjct: 168 GVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 506 MSETSNVKTMYTENLTG---TRPYMPPEAM 532
              T          LTG   TR Y  PE +
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELI 255

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 50/265 (18%), Positives = 89/265 (33%), Gaps = 79/265 (29%)

Query: 116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANY--------------SSSNSDNTEAAMI 160
           KLG G F TV+    ++    +A+K +++  +Y               +S+ ++    M+
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 161 PILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTP-PLDS 219
             LL + ++       H+              C+V+E + +  L   + + N    PL  
Sbjct: 104 VQLLDDFKISG-VNGTHI--------------CMVFEVLGH-HLLKWIIKSNYQGLPLPC 147

Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-----------------DENFVPK 262
            K+  I   V + L YLH+  + IIH D+K  N+LL                   +  P 
Sbjct: 148 VKK--IIQQVLQGLDYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204

Query: 263 LGDFGIVKMSETSNMKTMYTENLTG--------------------------TRPYMPPEA 296
                +     T+    +                                 TR Y   E 
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEV 264

Query: 297 M-HCQISTKTDVFSYGVILLELLTG 320
           +     +T  D++S   +  EL TG
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATG 289

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 39/228 (17%), Positives = 77/228 (33%), Gaps = 25/228 (10%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTL-ENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G  +G+G FG +Y   + +   +            S +    TE           ++Q  
Sbjct: 40  GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99

Query: 173 SQCKHVNLL--------RLLGLCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRY 223
            + + +  L         L          ++ +    G  L              +    
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTV--L 155

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTM 280
            ++L + + L Y+H      +H D+K++N+LL   + + V  L D+G+        +   
Sbjct: 156 QLSLRILDILEYIHE--HEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAYRYCPEGVHKA 212

Query: 281 YTE----NLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKP 323
           Y         GT  +   +A      S + D+   G  +++ LTG  P
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 18/75 (24%), Positives = 33/75 (44%), Gaps = 10/75 (13%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNVKTMY 516
           ++L + + L Y+H      +H D+K++N+LL   + + V  L D+G+        V   Y
Sbjct: 157 LSLRILDILEYIHE--HEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAYRYCPEGVHKAY 213

Query: 517 TE----NLTGTRPYM 527
                    GT  + 
Sbjct: 214 AADPKRCHDGTIEFT 228

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 38/231 (16%), Positives = 77/231 (33%), Gaps = 31/231 (13%)

Query: 114 GNKLGEGQFGTVYYGK---------LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL 164
            +       G +Y                 + ++K    +    +  +    AA    + 
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 165 FENEVQTLSQCKHVNLLRLL--GLCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNK 221
              ++        + +   +  G+  +    +V   +  G SL      V+    L    
Sbjct: 107 KWKKLY---STPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERS 160

Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMK 278
              +A  + +AL +LH      +H +V + N+ +   D++ V  L  +G       S   
Sbjct: 161 VLQVACRLLDALEFLHE--NEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRYCPSGKH 217

Query: 279 TMYTEN----LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKP 323
             Y E       G   ++  +  H  C  S ++D+ S G  +L+ L G  P
Sbjct: 218 VAYVEGSRSPHEGDLEFISMDL-HKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 16/75 (21%), Positives = 30/75 (40%), Gaps = 10/75 (13%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNVKTMY 516
           +A  + +AL +LH      +H +V + N+ +   D++ V  L  +G       S     Y
Sbjct: 164 VACRLLDALEFLHE--NEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRYCPSGKHVAY 220

Query: 517 TEN----LTGTRPYM 527
            E       G   ++
Sbjct: 221 VEGSRSPHEGDLEFI 235

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 53.7 bits (128), Expect = 7e-08
 Identities = 37/269 (13%), Positives = 76/269 (28%), Gaps = 56/269 (20%)

Query: 116 KLGEGQFGTVYYGKLKNGMEIAVKTL----ENNANYSSSNSDNTEAAMIPILLFENEVQT 171
           K+GEG FG V+     +   +A+K +     +  N S   +       I I    + +  
Sbjct: 27  KIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 172 LSQCKHVNLLRLLGLCNNIMNC-------------------------------IVYEYMC 200
               +    + L  +     +                                IV E+  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 201 NGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV 260
            G   +++    ++         SI   +  +L    +  +   HRD+   NVLL +  +
Sbjct: 146 GGIDLEQMRTKLSSLAT----AKSILHQLTASLAVAEASLR-FEHRDLHWGNVLLKKTSL 200

Query: 261 PKLGDFG------------IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVF 308
            KL                 V + + +  +      +      M  +        + D++
Sbjct: 201 KKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIY 260

Query: 309 SY-GVILLELLTGMKPIDDNNTILYYYLV 336
                          P   +N +  +YL 
Sbjct: 261 RLMKKENNNRWGEYHPY--SNVLWLHYLT 287

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 47/247 (19%), Positives = 81/247 (32%), Gaps = 66/247 (26%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKT--LENNANYSSSNSDNTEAAMIPILLFENEV- 169
           G K+G G FG +Y         + A     +E   N                L  E +  
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN--------------GPLFSELKFY 87

Query: 170 QTLSQCKHVNLLRLLGLCNNI-----------------MNCIVYEYMCNG-SLYDRLARV 211
           Q +++   +         + +                    +V E +  G  L       
Sbjct: 88  QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS--- 142

Query: 212 NNTPPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPK 262
                   N  +       + + + + L Y+H      +H D+K+AN+LL   + + V  
Sbjct: 143 ------GQNGTFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYKNPDQV-Y 193

Query: 263 LGDFGIVKMSETSNMKTMYTEN----LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLE 316
           L D+G+      +     Y EN      GT  +   +A H    +S ++DV   G  +L 
Sbjct: 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDA-HKGVALSRRSDVEILGYCMLR 252

Query: 317 LLTGMKP 323
            L G  P
Sbjct: 253 WLCGKLP 259

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 20/89 (22%), Positives = 36/89 (40%), Gaps = 16/89 (17%)

Query: 452 LDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFG 502
              N  +       + + + + L Y+H      +H D+K+AN+LL   + + V  L D+G
Sbjct: 142 SGQNGTFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYKNPDQV-YLADYG 198

Query: 503 IVKMSETSNVKTMYTEN----LTGTRPYM 527
           +      +     Y EN      GT  + 
Sbjct: 199 LSYRYCPNGNHKQYQENPRKGHNGTIEFT 227

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	593
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.92
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.92
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.92
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.91
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.91
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.91
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.91
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.9
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.9
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.89
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.89
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.89
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.89
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.88
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.88
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.86
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.86
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.84
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.81
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.79
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.79
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.79
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.79
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.78
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.78
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.78
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.78
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.78
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.78
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.78
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.78
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.78
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.78
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.77
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.77
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.77
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.77
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.77
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.77
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.77
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.77
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.77
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.77
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.77
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.76
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.76
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.76
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.76
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.76
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.76
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.76
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.76
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.76
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.76
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.76
3niz_A	311	Rhodanese family protein; structural genomics, str	99.76
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.76
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.76
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.76
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.76
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.76
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.75
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.75
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.75
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.75
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.75
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.75
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.75
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.75
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.75
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.75
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.75
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.75
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.75
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.75
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.75
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.75
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.75
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.74
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.74
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.74
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.74
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.74
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.74
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.74
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.74
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.74
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.74
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.74
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.74
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.74
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.74
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.74
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.74
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.74
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.74
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.74
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.74
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.74
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.74
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.74
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.73
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.73
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.73
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.73
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.73
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.73
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.73
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.73
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.73
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.73
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.73
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.73
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.73
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.73
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.73
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.73
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.73
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.73
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.72
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.72
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.72
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.72
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.72
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.72
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.72
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.72
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.72
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.72
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.72
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.72
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.72
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.72
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.72
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.72
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.72
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.71
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.71
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.71
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.71
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.71
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.71
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.71
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.71
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.71
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.71
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.71
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.71
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.71
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.71
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.71
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.71
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.71
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.71
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.71
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.71
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.71
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.71
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.71
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.71
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.7
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.7
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.7
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.7
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.7
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.7
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.7
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.7
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.7
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.7
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.7
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.7
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.7
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.7
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.7
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.7
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.7
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.7
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.7
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.7
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.7
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.7
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.7
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.7
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.7
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.69
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.69
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.69
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.69
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.69
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.69
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.69
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.69
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.69
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.69
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.69
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.69
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.69
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.69
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.68
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.68
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.68
3bhy_A	283	Death-associated protein kinase 3; death associate	99.68
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.68
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.68
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.68
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.68
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.68
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.68
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.68
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.68
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.68
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.68
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.68
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.68
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.68
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.68
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.67
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.67
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.67
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.67
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.67
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.67
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.67
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.67
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.67
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.67
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.67
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.67
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.67
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.67
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.67
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.66
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.66
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.66
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.66
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.66
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.65
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.65
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.65
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.65
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.65
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.65
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.65
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.65

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-56  Score=462.44  Aligned_cols=254  Identities=30%  Similarity=0.472  Sum_probs=194.9

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      ++++||+|+||+||+|+++  ..||||+++...    .. .  +    ....|.+|+.+|++++|||||+++|+|.++..
T Consensus        40 l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~----~~-~--~----~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~  106 (307)
T 3omv_A           40 LSTRIGSGSFGTVYKGKWH--GDVAVKILKVVD----PT-P--E----QFQAFRNEVAVLRKTRHVNILLFMGYMTKDNL  106 (307)
T ss_dssp             EEEECCCCSSSEEEEEESS--SEEEEEECCCSS----CC-H--H----HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSC
T ss_pred             EeeEEeeCCCcEEEEEEEC--CcEEEEEEEecC----CC-H--H----HHHHHHHHHHHHHhCCCCCEeeEEEEEECCeE
Confidence            4678999999999999875  369999986431    11 1  1    12369999999999999999999999988888


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      +||||||++|+|.++|+...  .+++|.+++.|+.|||+||+|||+  ++||||||||+||||++++.+||+|||+|+..
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEEEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            99999999999999997643  469999999999999999999998  56999999999999999999999999999875


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~----~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ..... .......+||+.|||||++.    +.++.|+|||||||+||||+||+.||.+.+...............+.. .
T Consensus       183 ~~~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~-~  260 (307)
T 3omv_A          183 SRWSG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL-S  260 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS-T
T ss_pred             ccCCc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc-c
Confidence            43221 12234568999999999874    247889999999999999999999998755443333333222111111 0


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ....     .+...+..++.+||+.||++||||.||++.|+.
T Consensus       261 ~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          261 KLYK-----NCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             TSCT-----TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             cccc-----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            0011     122334556779999999999999999988865

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.1e-56  Score=460.88  Aligned_cols=251  Identities=24%  Similarity=0.394  Sum_probs=198.6

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .++||+|+||+||+|++.      +++.||||+++....   .  ..       ...|.+|+.+|++++|||||+++|+|
T Consensus        31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~---~--~~-------~~~f~~E~~il~~l~HpNIV~l~g~~   98 (308)
T 4gt4_A           31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE---G--PL-------REEFRHEAMLRARLQHPNVVCLLGVV   98 (308)
T ss_dssp             EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC---C---C-------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC---h--HH-------HHHHHHHHHHHHhCCCCCCCCcceEE
Confidence            368999999999999873      467899999964311   1  11       12599999999999999999999999


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCe
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  253 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NI  253 (593)
                      .+ ...+||||||++|+|.++|.....             ...++|..++.|+.|||+||+|||+  ++||||||||+||
T Consensus        99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~NI  176 (308)
T 4gt4_A           99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNV  176 (308)
T ss_dssp             CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccce
Confidence            76 566899999999999999975321             2468999999999999999999998  5699999999999


Q ss_pred             eecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHH
Q psy9535         254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTIL  331 (593)
Q Consensus       254 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~  331 (593)
                      ||++++++||+|||+|+....... ........||+.|||||++ .+.++.++|||||||+||||+| |+.||.+.+...
T Consensus       177 Ll~~~~~~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~  255 (308)
T 4gt4_A          177 LVYDKLNVKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  255 (308)
T ss_dssp             EECGGGCEEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred             EECCCCCEEECCcccceeccCCCc-eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999987644322 1123456899999999976 5679999999999999999999 899998866544


Q ss_pred             HHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         332 YYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ....+..+..+  ..    ...     +...+..++.+||+.||++||||.||++.|+.
T Consensus       256 ~~~~i~~~~~~--~~----p~~-----~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          256 VVEMIRNRQVL--PC----PDD-----CPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HHHHHHTTCCC--CC----CTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHcCCCC--CC----ccc-----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            44443332211  10    111     12234556779999999999999999999975

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.2e-56  Score=455.85  Aligned_cols=251  Identities=27%  Similarity=0.431  Sum_probs=198.3

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      +++||+|+||+||+|++.      +|..||||+++..      . ...      ...|.+|+++|++++|||||+++|+|
T Consensus        18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~------~-~~~------~~~f~~E~~il~~l~HpnIV~l~g~~   84 (299)
T 4asz_A           18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA------S-DNA------RKDFHREAELLTNLQHEHIVKFYGVC   84 (299)
T ss_dssp             EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC------C-HHH------HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC------C-hHH------HHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            578999999999999874      4778999999632      1 111      23699999999999999999999999


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVN----------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  256 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~  256 (593)
                      .+ ...+||||||++|+|.++|+..+          ....++|.+++.|+.|||+||.|||+  ++||||||||+||||+
T Consensus        85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NILl~  162 (299)
T 4asz_A           85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVG  162 (299)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEC
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEEEC
Confidence            87 56689999999999999997642          23469999999999999999999998  5699999999999999


Q ss_pred             CCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHH
Q psy9535         257 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY  334 (593)
Q Consensus       257 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~  334 (593)
                      +++.+||+|||+|+....... ...+....||+.|||||++ ...++.|+|||||||+||||+| |+.||.+.+......
T Consensus       163 ~~~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  241 (299)
T 4asz_A          163 ENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE  241 (299)
T ss_dssp             GGGCEEECCCSCHHHHTGGGC-EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred             CCCcEEECCcccceecCCCCc-eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            999999999999986544322 1122345799999999977 4678999999999999999999 899998866554444


Q ss_pred             HHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         335 LVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .+..+..+.      ....     +...+..++.+||+.||++||||.||++.|++.
T Consensus       242 ~i~~~~~~~------~p~~-----~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          242 CITQGRVLQ------RPRT-----CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             HHHHTCCCC------CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCCCCC------CCcc-----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            443332211      0011     122345567799999999999999999999863

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.8e-55  Score=457.90  Aligned_cols=251  Identities=26%  Similarity=0.426  Sum_probs=192.5

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .++||+|+||+||+|+++      +++.||||+++..      . ..      ....|.+|+++|++++|||||+++|+|
T Consensus        46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~------~-~~------~~~~f~~E~~il~~l~HpnIV~l~g~~  112 (329)
T 4aoj_A           46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------S-ES------ARQDFQREAELLTMLQHQHIVRFFGVC  112 (329)
T ss_dssp             EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC------S-HH------HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC------C-HH------HHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            468999999999999874      4788999999632      1 11      123699999999999999999999999


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCee
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNN------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  254 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NIL  254 (593)
                      .+ ...+||||||++|+|.++|+....            ..+++|.+++.|+.|||+||.|||+  ++||||||||+|||
T Consensus       113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NIL  190 (329)
T 4aoj_A          113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNCL  190 (329)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhEE
Confidence            87 556899999999999999976431            2469999999999999999999998  56999999999999


Q ss_pred             ecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHH
Q psy9535         255 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILY  332 (593)
Q Consensus       255 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~  332 (593)
                      |++++.+||+|||+|+....... ........||+.|||||++. ..++.++|||||||+||||+| |+.||.+......
T Consensus       191 l~~~~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~  269 (329)
T 4aoj_A          191 VGQGLVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA  269 (329)
T ss_dssp             EETTTEEEECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred             ECCCCcEEEcccccceeccCCCc-ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence            99999999999999987544322 11233468999999999775 468999999999999999999 8999988665544


Q ss_pred             HHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         333 YYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ...+..+..+.       ....    +...+..++.+||+.||++||||.||++.|+..
T Consensus       270 ~~~i~~g~~~~-------~p~~----~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          270 IDCITQGRELE-------RPRA----CPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             HHHHHHTCCCC-------CCTT----CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHcCCCCC-------Cccc----ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            44443332110       0111    122345567799999999999999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.5e-55  Score=445.45  Aligned_cols=247  Identities=26%  Similarity=0.413  Sum_probs=194.5

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +.+++||+|+||+||+|++. ++..||||++.....    . ..      ....|.+|+.+|++++|||||++++++.+ 
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~-~~------~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   97 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL----T-KS------ERQRFKEEAEMLKGLQHPNIVRFYDSWEST   97 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS----C-HH------HHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC----C-HH------HHHHHHHHHHHHHhCCCCCCCcEEEEEeec
Confidence            44568999999999999975 689999999975321    1 10      12368999999999999999999998854 


Q ss_pred             ----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec-CCCccEEe
Q psy9535         190 ----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLG  264 (593)
Q Consensus       190 ----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~-~~~~~Kl~  264 (593)
                          ...+||||||++|+|.++|.+.   ..+++..+..++.||+.||+|||+.+++||||||||+||||+ .++.+||+
T Consensus        98 ~~~~~~~~lvmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~  174 (290)
T 3fpq_A           98 VKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             ETTEEEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred             cCCCcEEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEE
Confidence                2358999999999999999864   368999999999999999999998555599999999999998 47999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      |||+|+......     ..+.+||+.|||||++.+.++.++|||||||+||||+||+.||.+..................
T Consensus       175 DFGla~~~~~~~-----~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~  249 (290)
T 3fpq_A          175 DLGLATLKRASF-----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA  249 (290)
T ss_dssp             CTTGGGGCCTTS-----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred             eCcCCEeCCCCc-----cCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC
Confidence            999998643322     234689999999999988899999999999999999999999986544333333222221111


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       ..+.    ...    ..+..++.+||+.||++|||+.|+++
T Consensus       250 -~~~~----~~~----~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 -SFDK----VAI----PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -GGGG----CCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -CCCc----cCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence             1111    111    12455678999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.6e-54  Score=450.09  Aligned_cols=260  Identities=23%  Similarity=0.316  Sum_probs=202.4

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..++||+|+||+||+|+.+ +|+.||||+++...                  .+.+|+.+|++++|||||++++++.+ .
T Consensus        62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~------------------~~~~E~~il~~l~HpnIV~l~~~~~~~~  123 (336)
T 4g3f_A           62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV------------------FRVEELVACAGLSSPRIVPLYGAVREGP  123 (336)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT------------------CCTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred             eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH------------------hHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            3568999999999999975 69999999996431                  12479999999999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC-ccEEeecccc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFGIV  269 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~-~~Kl~DFGla  269 (593)
                      ..+||||||+||+|.++|.+.   ..+++..+..++.||+.||+|||+  ++||||||||+||||+.++ .+||+|||+|
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~~vKl~DFGla  198 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHA  198 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred             EEEEEEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence            568999999999999999864   359999999999999999999998  5699999999999999987 6999999999


Q ss_pred             eecccCCCcc--eeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         270 KMSETSNMKT--MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       270 ~~~~~~~~~~--~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      +.........  .....++||+.|||||++.+ .++.++|||||||+||||+||+.||.+.........+.....+..++
T Consensus       199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  278 (336)
T 4g3f_A          199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREI  278 (336)
T ss_dssp             EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGS
T ss_pred             eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhc
Confidence            9765432211  12234689999999998754 58999999999999999999999998754433333444433332221


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcccccccccccccc
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCNSLANLYVG  404 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~~~~~~~~~~~~  404 (593)
                      .    .     .+...+..++.+||+.||++|||+.|+++.|.........+.+.+..
T Consensus       279 ~----~-----~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~  327 (336)
T 4g3f_A          279 P----P-----SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKG  327 (336)
T ss_dssp             C----T-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSS
T ss_pred             C----c-----cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcC
Confidence            1    1     12234556778999999999999999999988765544455555443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.4e-54  Score=448.75  Aligned_cols=249  Identities=23%  Similarity=0.340  Sum_probs=194.5

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         110 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       110 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      .+++.++||+|+||+||+|+.. +|+.||||++.....    ...  .     ...|.+|+.+|++|+|||||++++++.
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~----~~~--~-----~~~~~~E~~il~~l~HpnIV~~~~~~~   93 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM----SSK--E-----REESRREVAVLANMKHPNIVQYRESFE   93 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS----CHH--H-----HHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC----CHH--H-----HHHHHHHHHHHHHCCCCCCCcEEEEEE
Confidence            3455689999999999999875 699999999975421    111  1     235899999999999999999999887


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      + ...|||||||+||+|.++|...+ ...+++..+..|+.||+.||+|||+  ++||||||||+||||+.++.+||+|||
T Consensus        94 ~~~~~yiVmEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFG  170 (350)
T 4b9d_A           94 ENGSLYIVMDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFG  170 (350)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEEECSTT
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEEEcccc
Confidence            6 56689999999999999997643 3467899999999999999999999  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      +|+......   ......+||+.|||||++.+ .++.++|||||||+||||+||+.||...+.......+.....+.   
T Consensus       171 la~~~~~~~---~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---  244 (350)
T 4b9d_A          171 IARVLNSTV---ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---  244 (350)
T ss_dssp             EESCCCHHH---HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---
T ss_pred             cceeecCCc---ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---
Confidence            998764321   12334689999999998865 58899999999999999999999998876655555555443221   


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         ....+     ...+..++.+||+.||++|||+.|+++
T Consensus       245 ---~~~~~-----s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          245 ---VSLHY-----SYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ---CCTTS-----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCccC-----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               01111     223455778999999999999999865

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.4e-53  Score=444.22  Aligned_cols=245  Identities=23%  Similarity=0.363  Sum_probs=197.4

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         111 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       111 ~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      ++..++||+|+||+||+|+.+ +|+.||||++.....   ..          ...+.+|+.+|++++|||||++++++.+
T Consensus        76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~----------~~~~~~Ei~il~~l~HpnIV~l~~~~~~  142 (346)
T 4fih_A           76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QR----------RELLFNEVVIMRDYQHENVVEMYNSYLV  142 (346)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SS----------GGGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hH----------HHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            344578999999999999985 699999999975321   11          1137899999999999999999998876


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...|||||||++|+|.+++.+    ..+++..+..++.||+.||+|||+  ++||||||||+||||+.++.+||+|||+
T Consensus       143 ~~~~~ivmEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGl  216 (346)
T 4fih_A          143 GDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGF  216 (346)
T ss_dssp             TTEEEEEECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEECCCCCEEEecCcC
Confidence             567899999999999999975    358999999999999999999999  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      |+.......   ...+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.+....+..+.....+.... 
T Consensus       217 a~~~~~~~~---~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~-  292 (346)
T 4fih_A          217 CAQVSKEVP---RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKN-  292 (346)
T ss_dssp             CEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSC-
T ss_pred             ceecCCCCC---cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCc-
Confidence            987654321   2345789999999998754 58999999999999999999999998876655555444332111110 


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                              ...+...+..++.+||+.||++|||+.|+++
T Consensus       293 --------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          293 --------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             --------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                    1112233556778999999999999999854

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.6e-54  Score=443.09  Aligned_cols=255  Identities=24%  Similarity=0.377  Sum_probs=189.0

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc--
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~--  190 (593)
                      ++++||+|+||+||+|+++ |+.||||+++...          ..    ...++.|+..+.+++|||||+++|+|.+.  
T Consensus         7 L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~----------~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~   71 (303)
T 3hmm_A            7 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE----------ER----SWFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             EEEEEEECSSSEEEEEEET-TEEEEEEEECGGG----------HH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             EEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc----------hh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence            3578999999999999984 8999999985321          11    01345677777899999999999999753  


Q ss_pred             ---cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeEecccCCCCeeecCCCcc
Q psy9535         191 ---MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------SKPIIHRDVKSANVLLDENFVP  261 (593)
Q Consensus       191 ---~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~IiHrDLKp~NILl~~~~~~  261 (593)
                         ..+||||||++|+|.++|+.    .+++|..+.+++.|+|+||+|||+.      .++||||||||+|||||.++++
T Consensus        72 ~~~~~~lV~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~  147 (303)
T 3hmm_A           72 TWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CceEEEEEecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence               35899999999999999986    3589999999999999999999974      2379999999999999999999


Q ss_pred             EEeecccceecccCCCcc-eeeccccCCCCcCCcccccCC-------CCCcchhhHHHHHHHHHHhCCCCCCCCc-----
Q psy9535         262 KLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGVILLELLTGMKPIDDNN-----  328 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~-------~~~ksDVwSfGvvl~ElltG~~P~~~~~-----  328 (593)
                      ||+|||+|+......... ......+||+.|||||++.+.       ++.|+|||||||+||||+||..||....     
T Consensus       148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p  227 (303)
T 3hmm_A          148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence            999999998765433211 122346899999999987543       4678999999999999999987764211     


Q ss_pred             ---------hHHHHHHHHhhcCccccccccccC-CCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         329 ---------TILYYYLVVEQEVPVREVLDKEAG-EWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       329 ---------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                               ............ .    +++... .+....+...+..++.+||+.||++||||.||++.|++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~-~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          228 YYDLVPSDPSVEEMRKVVCEQ-K----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTS-C----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             chhcccccchHHHHHHHHhcc-c----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                     111111111111 1    111111 111223444566677899999999999999999999763

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.5e-53  Score=435.86  Aligned_cols=245  Identities=25%  Similarity=0.386  Sum_probs=200.1

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.+.||+|+||+||+|+.+ +|+.||||++.+......          .....+.+|+++|++++|||||++++++.+ .
T Consensus        36 i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~----------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           36 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE----------NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             EEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCH----------HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            3679999999999999875 699999999975321111          112358899999999999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..+||||||+||+|.++|.+.   ..+++..+..++.||+.||+|||+  ++||||||||+||||+.++.+||+|||+|+
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl~~~g~vKl~DFGla~  180 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAK  180 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence            568999999999999999864   358999999999999999999999  569999999999999999999999999999


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ....... .....+.+||+.|||||++. ..++.++||||+||+||||+||+.||...+....+..+......+++.+  
T Consensus       181 ~~~~~~~-~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~--  257 (311)
T 4aw0_A          181 VLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKF--  257 (311)
T ss_dssp             ECCTTTT-CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTC--
T ss_pred             ecCCCCC-cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc--
Confidence            7654322 12234578999999999875 4588999999999999999999999988776666666655544333211  


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV  385 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~  385 (593)
                                ...+..++.+|++.||++|||+.|+.
T Consensus       258 ----------s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          258 ----------FPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ----------CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ----------CHHHHHHHHHHccCCHhHCcChHHHc
Confidence                      12345677899999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.6e-52  Score=424.04  Aligned_cols=243  Identities=24%  Similarity=0.396  Sum_probs=183.9

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.+.||+|+||+||+|+.. +|+.||||++.+.......          ....|.+|+++|++++|||||++++++.+ 
T Consensus        16 ~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~----------~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   85 (275)
T 3hyh_A           16 QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD----------MQGRIEREISYLRLLRHPHIIKLYDVIKSK   85 (275)
T ss_dssp             EEEEEEEC---CCEEEEECTTTCCEEEEEEEECC----------------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHH----------HHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence            34678999999999999875 6999999999754221111          12258899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||| +|+|.+++.+.   .++++..+..++.|++.||+|||+  ++|+||||||+||||+.++.+||+|||+|
T Consensus        86 ~~~~ivmEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl~~~~~vkl~DFGla  159 (275)
T 3hyh_A           86 DEIIMVIEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFGLS  159 (275)
T ss_dssp             SEEEEEEECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTCCEEECCSSCC
T ss_pred             CEEEEEEeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEECCCCCEEEeecCCC
Confidence            5568999998 78999999764   369999999999999999999999  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccCC-C-CCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      +.......    ..+.+||+.|||||++.+. + +.++||||+||++|||+||+.||.+.+.......+.....+++..+
T Consensus       160 ~~~~~~~~----~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~  235 (275)
T 3hyh_A          160 NIMTDGNF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFL  235 (275)
T ss_dssp             -------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTS
T ss_pred             eecCCCCc----cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            87544321    2346899999999988654 4 5799999999999999999999988766555555544443332211


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                  ...+..++.+||+.||++|||+.|+++
T Consensus       236 ------------s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          236 ------------SPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ------------CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------------CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                        123455678999999999999999875

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.8e-52  Score=445.61  Aligned_cols=248  Identities=23%  Similarity=0.378  Sum_probs=199.2

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         108 KPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       108 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      ..+++..++||+|+||.||+|+.+ +|+.||||++.....   ..    .      ..+.+|+.+|++++|||||+++++
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~----~------~~~~~Ei~il~~l~HpnIV~l~~~  216 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QR----R------ELLFNEVVIMRDYQHENVVEMYNS  216 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SS----G------GGHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hH----H------HHHHHHHHHHHhCCCCCCCceEEE
Confidence            334555789999999999999985 699999999975321   11    1      147899999999999999999998


Q ss_pred             Eec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         187 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       187 ~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                      +.+ ...|||||||++|+|.+++..    ..+++..+..|+.||+.||+|||+  ++||||||||+||||+.++.+||+|
T Consensus       217 ~~~~~~~~iVmEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl~~~g~vKl~D  290 (423)
T 4fie_A          217 YLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSD  290 (423)
T ss_dssp             EEETTEEEEEEECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEECTTCCEEECC
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEec
Confidence            876 567899999999999999875    348999999999999999999999  5699999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      ||+|+.......   .....+||+.|||||++. ..|+.++|||||||++|||++|+.||.+.+....+..+.....+..
T Consensus       291 FGla~~~~~~~~---~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~  367 (423)
T 4fie_A          291 FGFCAQVSKEVP---RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL  367 (423)
T ss_dssp             CTTCEECCSSCC---CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred             CccceECCCCCc---cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence            999987654321   234578999999999875 4589999999999999999999999988776655555443322111


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..    ..     .+...+..++.+||+.||++|||+.|+++
T Consensus       368 ~~----~~-----~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          368 KN----LH-----KVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             SC----TT-----SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cc----cc-----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            10    01     11233556778999999999999999854

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-52  Score=441.67  Aligned_cols=255  Identities=25%  Similarity=0.377  Sum_probs=196.9

Q ss_pred             CCCCcccccCceEEEEEEEcC------CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCC-CceeeEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH-VNLLRLL  184 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~------g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~H-pNIv~l~  184 (593)
                      +++++||+|+||+||+|++..      ++.||||++....     . .. +     ...|.+|+.+|++++| ||||+++
T Consensus        67 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-----~-~~-~-----~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           67 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----T-HS-E-----HRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-----C-HH-H-----HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-----C-hH-H-----HHHHHHHHHHHHHcCCCCcEEEEE
Confidence            346889999999999998642      3579999996431     1 11 1     2358999999999976 8999999


Q ss_pred             EEEec--ccceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccC
Q psy9535         185 GLCNN--IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  249 (593)
Q Consensus       185 g~~~~--~~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLK  249 (593)
                      |+|.+  ...+||||||++|+|.++|+....             ...+++..++.++.|||+||+|||+  ++|||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHRDLK  212 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLA  212 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCS
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh--CCeecCccC
Confidence            99965  346899999999999999976321             2458999999999999999999999  569999999


Q ss_pred             CCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCC
Q psy9535         250 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDN  327 (593)
Q Consensus       250 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~  327 (593)
                      |+||||++++.+||+|||+|+....... ...+...+||+.|||||++ ...++.++|||||||+||||+| |+.||.+.
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999987644332 2234456899999999976 4568999999999999999998 99999875


Q ss_pred             chHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         328 NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .................      .....+    ..+..++.+||+.||++||||.||++.|++.
T Consensus       292 ~~~~~~~~~i~~g~~~~------~p~~~~----~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          292 KIDEEFCRRLKEGTRMR------APDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             CCSHHHHHHHHHTCCCC------CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCCC------CCccCC----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            43222222222211110      111111    2244566799999999999999999998764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.3e-52  Score=428.09  Aligned_cols=238  Identities=24%  Similarity=0.315  Sum_probs=186.1

Q ss_pred             CCCcccccCceEEEEEEEc----CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~----~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      +.+.||+|+||+||+|+..    +++.||||++++.......           ...|.+|+++|++++|||||++++++.
T Consensus        28 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~~E~~il~~l~HpnIv~l~~~~~   96 (304)
T 3ubd_A           28 LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-----------RVRTKMERDILVEVNHPFIVKLHYAFQ   96 (304)
T ss_dssp             EEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-----------CC------CCCCCCCCTTEECEEEEEE
T ss_pred             EEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-----------HHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            4678999999999999863    4789999999753211100           114788999999999999999999887


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      + ...+||||||+||+|.++|.+.   ..+++..+..++.|++.||+|||+  ++||||||||+|||++.++.+||+|||
T Consensus        97 ~~~~~~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFG  171 (304)
T 3ubd_A           97 TEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFG  171 (304)
T ss_dssp             ETTEEEEEECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEEcCCCCEEecccc
Confidence            6 5668999999999999999864   358999999999999999999999  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      +|+.......   ...+.+||+.|||||++. ..++.++||||+||+||||+||+.||.+.+.......+.....+++..
T Consensus       172 la~~~~~~~~---~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~  248 (304)
T 3ubd_A          172 LSKESIDHEK---KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF  248 (304)
T ss_dssp             EEEC-----C---CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred             cceeccCCCc---cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCc
Confidence            9986543321   123578999999999875 458999999999999999999999999877665555555444333222


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCCh
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASM  381 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm  381 (593)
                      +            ...+..++.+||+.||++|||+
T Consensus       249 ~------------s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          249 L------------SPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             S------------CHHHHHHHHHHTCSSGGGSTTC
T ss_pred             C------------CHHHHHHHHHHcccCHHHCCCC
Confidence            1            2234557789999999999995

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-50  Score=417.79  Aligned_cols=246  Identities=25%  Similarity=0.357  Sum_probs=177.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc--
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~--  190 (593)
                      .+.||+|+||+||+|+.+ +|+.||||+++...     . ..      ....|.+|+.+|++++|||||++++++.+.  
T Consensus        10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~-~~------~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   77 (299)
T 4g31_A           10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-----R-EL------AREKVMREVKALAKLEHPGIVRYFNAWLEKNT   77 (299)
T ss_dssp             EEEEEECC--EEEEEEETTTCCEEEEEEEEECS-----S-HH------HHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-----C-HH------HHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence            578999999999999975 68999999996431     1 11      122588999999999999999999987542  


Q ss_pred             -----------cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC
Q psy9535         191 -----------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  259 (593)
Q Consensus       191 -----------~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~  259 (593)
                                 ..++|||||++|+|.+++.........++..+..|+.|+++||+|||+  ++||||||||+||||+.++
T Consensus        78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl~~~~  155 (299)
T 4g31_A           78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDD  155 (299)
T ss_dssp             ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTC
T ss_pred             cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEECCCC
Confidence                       247999999999999999875544456777788999999999999999  5699999999999999999


Q ss_pred             ccEEeecccceecccCCCcc---------eeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCch
Q psy9535         260 VPKLGDFGIVKMSETSNMKT---------MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT  329 (593)
Q Consensus       260 ~~Kl~DFGla~~~~~~~~~~---------~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~  329 (593)
                      .+||+|||+|+.........         ...+..+||+.|||||++.+ .++.++|||||||++|||++   ||.....
T Consensus       156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~  232 (299)
T 4g31_A          156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME  232 (299)
T ss_dssp             CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH
Confidence            99999999998764432111         11234679999999998754 58999999999999999996   8865332


Q ss_pred             HHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         330 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ........ .....+...         .........++.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~-~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          233 RVRTLTDV-RNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHH-HTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHH-hcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            21111111 111111110         111122345678999999999999999865

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-48  Score=415.08  Aligned_cols=259  Identities=22%  Similarity=0.295  Sum_probs=193.1

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         111 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       111 ~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      +++.++||+|+||+||+|+.+ +|+.||||+++....    . .  .    ....+.+|+++|++++|||||++++++..
T Consensus        56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~----~-~--~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  124 (398)
T 4b99_A           56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD----V-V--T----NAKRTLRELKILKHFKHDNIIAIKDILRP  124 (398)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS----S-H--H----HHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc----c-h--H----HHHHHHHHHHHHHhcCCCCcceEeeeeec
Confidence            455689999999999999975 799999999964311    1 1  1    12257899999999999999999998753


Q ss_pred             -------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccE
Q psy9535         190 -------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  262 (593)
Q Consensus       190 -------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~K  262 (593)
                             ...|||||||. |+|.+++...   .++++..+..++.||+.||.|||+  ++||||||||+|||++.++.+|
T Consensus       125 ~~~~~~~~~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~~~~~~~K  198 (398)
T 4b99_A          125 TVPYGEFKSVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLVNENCELK  198 (398)
T ss_dssp             SSCTTTCCCEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEE
T ss_pred             ccccccCCEEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCccccccCCCCCEE
Confidence                   34589999995 7899998753   469999999999999999999999  5699999999999999999999


Q ss_pred             EeecccceecccCCC-cceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh
Q psy9535         263 LGDFGIVKMSETSNM-KTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  339 (593)
Q Consensus       263 l~DFGla~~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~  339 (593)
                      |+|||+|+....... ......+.+||+.|||||++.+  .++.++||||+||++|||++|+.||.+.+.......+...
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~  278 (398)
T 4b99_A          199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV  278 (398)
T ss_dssp             ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred             EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence            999999986543321 1122345789999999998654  4688999999999999999999999887665554444332


Q ss_pred             cCccc-cccccc--------------cCCCCHH----HHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         340 EVPVR-EVLDKE--------------AGEWNET----HVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       340 ~~~~~-~~~~~~--------------~~~~~~~----~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..... ......              ....+..    .+...+..++.+||..||++|||+.|+++
T Consensus       279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            22111 111000              0000000    01223455778999999999999999753

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.3e-45  Score=379.33  Aligned_cols=289  Identities=36%  Similarity=0.670  Sum_probs=228.4

Q ss_pred             cceeecHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHH
Q psy9535          89 ELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE  168 (593)
Q Consensus        89 ~~~~~~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~E  168 (593)
                      ....|++.++..+|++|+...+...+++||+|+||.||+|+. +++.||||++.........  ..       ...|.+|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~--~~-------~~~~~~E   80 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE--EL-------KQQFDQE   80 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTT--TH-------HHHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchH--HH-------HHHHHHH
Confidence            457799999999999999988888889999999999999987 5889999998653221111  11       2258899


Q ss_pred             HHHHhcCCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q psy9535         169 VQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  247 (593)
Q Consensus       169 v~il~~l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrD  247 (593)
                      +.++++++||||+++++++.+ ...++||||+++|+|.+++.......++++..+..++.|++.||.|||+  ++|+|||
T Consensus        81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~d  158 (307)
T 2nru_A           81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRD  158 (307)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSC
T ss_pred             HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecCC
Confidence            999999999999999999976 5668999999999999999865555679999999999999999999998  5699999


Q ss_pred             cCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCC
Q psy9535         248 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDN  327 (593)
Q Consensus       248 LKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~  327 (593)
                      |||+|||++.++.+||+|||+++....... ........||+.|+|||.+.+.++.++|||||||++|||++|..||...
T Consensus       159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  237 (307)
T 2nru_A          159 IKSANILLDEAFTAKISDFGLARASEKFAQ-TVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEH  237 (307)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSCSS-CEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred             CCHHHEEEcCCCcEEEeecccccccccccc-cccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccC
Confidence            999999999999999999999987544322 1223346799999999988888899999999999999999999999764


Q ss_pred             chH---HHH-HHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         328 NTI---LYY-YLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       328 ~~~---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ...   ..+ .........+...+++...... ......+..++.+||+.+|.+||++.+|++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          238 REPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             BSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC-HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHhhhhhhhhhhhccccccccc-hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            321   111 1111122223333333333333 33344556677899999999999999999999863

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.6e-46  Score=385.12  Aligned_cols=285  Identities=38%  Similarity=0.579  Sum_probs=219.5

Q ss_pred             cCcceeecHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHH
Q psy9535          87 IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE  166 (593)
Q Consensus        87 ~~~~~~~~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~  166 (593)
                      .+.+..|++.++..++++|..      .+.||+|+||.||+|+..+|+.||||++.........            ..|.
T Consensus        14 ~~~~~~~~~~~~~~~~~~y~~------~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~------------~~~~   75 (326)
T 3uim_A           14 LGQLKRFSLRELQVASDNFSN------KNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE------------LQFQ   75 (326)
T ss_dssp             -CCCEECCTHHHHTTTTSSCS------TTEEECCSSSEEEEECCSSSCCEEEEECCC-----CC------------CHHH
T ss_pred             cCccceecHHHHHHHhhcccc------ceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHH------------HHHH
Confidence            456788999999999999976      6899999999999999888999999998653211110            1478


Q ss_pred             HHHHHHhcCCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCC-CCe
Q psy9535         167 NEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLS-KPI  243 (593)
Q Consensus       167 ~Ev~il~~l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~I  243 (593)
                      +|+.++++++||||++++++|.. ...++||||+++|+|.+++..... ..++++..+..++.|++.||.|||+.. .+|
T Consensus        76 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i  155 (326)
T 3uim_A           76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI  155 (326)
T ss_dssp             HHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCE
T ss_pred             HHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Confidence            99999999999999999999976 566899999999999999986542 346999999999999999999999841 169


Q ss_pred             EecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCC
Q psy9535         244 IHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMK  322 (593)
Q Consensus       244 iHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~  322 (593)
                      +||||||+|||++.++.+||+|||+++.......  .......||+.|+|||++ ...++.++|||||||++|||++|+.
T Consensus       156 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  233 (326)
T 3uim_A          156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR  233 (326)
T ss_dssp             ECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS--CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCC
T ss_pred             EeCCCchhhEEECCCCCEEeccCccccccCcccc--cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCC
Confidence            9999999999999999999999999987654332  223345799999999977 4567889999999999999999999


Q ss_pred             CCCC-------CchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         323 PIDD-------NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       323 P~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ||..       ......+..............+..............+..++.+||+.||.+|||+.||++.|++.
T Consensus       234 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          234 AFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             SBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             cccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            9962       11122222111122223333333322222233334455566799999999999999999999873

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.8e-46  Score=396.53  Aligned_cols=194  Identities=27%  Similarity=0.387  Sum_probs=158.5

Q ss_pred             CCCCcccccCceEEEEEEEc----CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGL  186 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~----~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~  186 (593)
                      ++.++||+|+||+||+|+.+    +++.||||.+....     .    .      ..+.+|+++|+++ +|||||+++++
T Consensus        24 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~----~------~~~~~E~~~l~~~~~h~nIv~l~~~   88 (361)
T 4f9c_A           24 KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----H----P------IRIAAELQCLTVAGGQDNVMGVKYC   88 (361)
T ss_dssp             EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----C----H------HHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred             EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----C----H------HHHHHHHHHHHHhcCCCCCceEEEE
Confidence            44789999999999999753    46789999985421     1    1      1467899999998 69999999998


Q ss_pred             Eec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC-CccEEe
Q psy9535         187 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLG  264 (593)
Q Consensus       187 ~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~-~~~Kl~  264 (593)
                      +.+ ...++|||||++|+|.+++.      .+++..+..++.|++.||+|||+  ++||||||||+|||++.+ +.+||+
T Consensus        89 ~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~~~~~~kl~  160 (361)
T 4f9c_A           89 FRKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNRRLKKYALV  160 (361)
T ss_dssp             EEETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             EEECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeCCCCeEEEC
Confidence            866 56689999999999999984      38899999999999999999999  569999999999999876 799999


Q ss_pred             ecccceecccCCCc-------------------------ceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHH
Q psy9535         265 DFGIVKMSETSNMK-------------------------TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLEL  317 (593)
Q Consensus       265 DFGla~~~~~~~~~-------------------------~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~El  317 (593)
                      |||+|+........                         .......+||+.|||||++.+  .++.++||||+||++|||
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~el  240 (361)
T 4f9c_A          161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL  240 (361)
T ss_dssp             CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred             cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHH
Confidence            99999865332110                         011234579999999998754  478899999999999999


Q ss_pred             HhCCCCCCCCc
Q psy9535         318 LTGMKPIDDNN  328 (593)
Q Consensus       318 ltG~~P~~~~~  328 (593)
                      +||+.||....
T Consensus       241 l~G~~Pf~~~~  251 (361)
T 4f9c_A          241 LSGRYPFYKAS  251 (361)
T ss_dssp             HHTCSSSSCCS
T ss_pred             HHCCCCCCCCC
Confidence            99999996543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.1e-46  Score=417.56  Aligned_cols=240  Identities=21%  Similarity=0.267  Sum_probs=186.0

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      .+.++||+|+||+||+|+.+ +|+.||||++.+........    ..   ......+++.+++.++|||||++++++.+ 
T Consensus       192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~----~~---~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG----ET---LALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC----HH---HHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhh----HH---HHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            44688999999999999975 69999999997542111111    00   01123345778889999999999998876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...|||||||+||+|.++|.+.   ..+++..+..++.||+.||+|||+  ++||||||||+||||+.+|.+||+|||+|
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~--~gIiHRDLKPeNILld~~G~vKL~DFGlA  339 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA  339 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHeEEeCCCCEEeccccee
Confidence            5668999999999999999864   358999999999999999999998  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc-C-CCCCcchhhHHHHHHHHHHhCCCCCCCCch---HHHHHHHHhhcCccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNT---ILYYYLVVEQEVPVR  344 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~---~~~~~~~~~~~~~~~  344 (593)
                      +......     +.+.+||+.|||||++. + .|+.++||||+||+||||++|+.||.+...   ..............+
T Consensus       340 ~~~~~~~-----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p  414 (689)
T 3v5w_A          340 CDFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP  414 (689)
T ss_dssp             EECSSCC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC
T ss_pred             eecCCCC-----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC
Confidence            8764432     23468999999999884 3 588999999999999999999999975321   122222222222222


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCC
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS  380 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs  380 (593)
                      ..            +...+..++.+||+.||.+|++
T Consensus       415 ~~------------~S~~a~dLI~~lL~~dP~~Rl~  438 (689)
T 3v5w_A          415 DS------------FSPELRSLLEGLLQRDVNRRLG  438 (689)
T ss_dssp             TT------------SCHHHHHHHHHHTCSCGGGCTT
T ss_pred             cc------------CCHHHHHHHHHHccCCHhHCCC
Confidence            11            1223456778999999999998

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.1e-46  Score=413.64  Aligned_cols=246  Identities=21%  Similarity=0.319  Sum_probs=196.8

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.+.||+|+||+||+|+.+ +|+.||||++....      ..  .     ...+.+|+.+|++++|||||++++++.+ 
T Consensus       160 ~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~------~~--~-----~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  226 (573)
T 3uto_A          160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH------ES--D-----KETVRKEIQTMSVLRHPTLVNLHDAFEDD  226 (573)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------HH--H-----HHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred             EEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc------hh--h-----HHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            34678999999999999875 69999999996431      11  1     1247899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC--CccEEeecc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN--FVPKLGDFG  267 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~--~~~Kl~DFG  267 (593)
                      ...+||||||+||+|.++|....  ..+++..+..++.||+.||.|||+  ++|+||||||+|||++.+  +.+||+|||
T Consensus       227 ~~~~iv~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~DFG  302 (573)
T 3uto_A          227 NEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFG  302 (573)
T ss_dssp             SEEEEEEECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred             CEEEEEEeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEeecc
Confidence            56689999999999999996432  468999999999999999999999  569999999999999854  899999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      +|+.......    ....+||+.|||||++.+ .++.++||||+||++|||++|+.||.+.+....+..+......+...
T Consensus       303 ~a~~~~~~~~----~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  378 (573)
T 3uto_A          303 LTAHLDPKQS----VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS  378 (573)
T ss_dssp             SCEECCTTSE----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG
T ss_pred             ceeEccCCCc----eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc
Confidence            9998654331    234689999999998754 57889999999999999999999999877665555554443322211


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         ....     +...+..++.+||+.||.+|||+.|+++
T Consensus       379 ---~~~~-----~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          379 ---AFSG-----ISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ---GGTT-----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---cccC-----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               1111     1223455678999999999999999865

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.7e-45  Score=377.75  Aligned_cols=280  Identities=34%  Similarity=0.580  Sum_probs=215.0

Q ss_pred             eecHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHH
Q psy9535          92 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT  171 (593)
Q Consensus        92 ~~~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~i  171 (593)
                      .+++.++..++++|..      .+.||+|+||.||+|++++|+.||||++....      ...       ...|.+|+.+
T Consensus        28 ~~~~~~~~~~~~~y~~------~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~-------~~~~~~E~~~   88 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDH------KFLIGHGVFGKVYKGVLRDGAKVALKRRTPES------SQG-------IEEFETEIET   88 (321)
T ss_dssp             --CCSCCCCCCCCCSC------CCCSCBCSSSEEEEEECTTCCEEEEEECCSCC------SSH-------HHHHHHHHHG
T ss_pred             eecHHHHHHHHhccCc------cceeecCCCeeEEEEEECCCCEEEEEEecccC------hHH-------HHHHHHHHHH
Confidence            3445566677788865      68999999999999998889999999875421      111       1258899999


Q ss_pred             HhcCCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccC
Q psy9535         172 LSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  249 (593)
Q Consensus       172 l~~l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLK  249 (593)
                      +++++||||+++++++.+ ...++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+  ++|+|||||
T Consensus        89 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlk  166 (321)
T 2qkw_B           89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVK  166 (321)
T ss_dssp             GGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCC
T ss_pred             HHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC--CCeecCCCC
Confidence            999999999999999876 566899999999999999865432 2358999999999999999999998  569999999


Q ss_pred             CCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCc
Q psy9535         250 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNN  328 (593)
Q Consensus       250 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~  328 (593)
                      |+|||++.++.+||+|||+++....... ........||+.|+|||++ ...++.++|||||||++|||++|+.||....
T Consensus       167 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~  245 (321)
T 2qkw_B          167 SINILLDENFVPKITDFGISKKGTELDQ-THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL  245 (321)
T ss_dssp             STTEEECTTCCEEECCCTTCEECSSSSC-CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred             HHHEEECCCCCEEEeecccccccccccc-cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence            9999999999999999999986543221 1112345699999999976 5568899999999999999999999997532


Q ss_pred             -----hHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhccc
Q psy9535         329 -----TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMF  393 (593)
Q Consensus       329 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~  393 (593)
                           ....+.........+...+++.............+..++.+||+.||++|||+.||++.|+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence                 12222222222333334444433333334455556667789999999999999999999987543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.2e-44  Score=370.27  Aligned_cols=254  Identities=32%  Similarity=0.509  Sum_probs=189.3

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      +.++||+|+||.||+|+. +|+.||||++.....    . .  +    ....|.+|+.++++++||||+++++++.+ ..
T Consensus        41 i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~----~-~--~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF----H-A--E----RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC----S-H--H----HHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             eeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC----C-H--H----HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            357899999999999987 488999999864311    1 1  1    12358899999999999999999999876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++........+++..+..++.|++.||.|||+.+.+|+||||||+|||++.++.+||+|||+++.
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            68999999999999999864322348999999999999999999998444499999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||................... ..    
T Consensus       189 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~----  260 (309)
T 3p86_A          189 KASTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL-EI----  260 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC-CC----
T ss_pred             cccccc---ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CC----
Confidence            443221   1234579999999998754 57889999999999999999999998765443333222111110 00    


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ...     +...+..++.+||+.+|++|||+.+|++.|+..
T Consensus       261 ~~~-----~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          261 PRN-----LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             CTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             Ccc-----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            011     112345577899999999999999999999874

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.9e-43  Score=363.09  Aligned_cols=244  Identities=27%  Similarity=0.452  Sum_probs=194.7

Q ss_pred             CCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +..++||+|+||.||+|+. .+|+.||||++.....   ..          ...+.+|+.++++++||||+++++++.. 
T Consensus        23 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~----------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (297)
T 3fxz_A           23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PK----------KELIINEILVMRENKNPNIVNYLDSYLVG   89 (297)
T ss_dssp             CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SC----------HHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cH----------HHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence            3468999999999999986 4689999999864321   10          1247899999999999999999998865 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++...    .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC  163 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CEEEEEEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            5668999999999999999763    58999999999999999999999  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      +.......   ......||+.|+|||++. ..++.++|||||||++|||++|+.||.................+...   
T Consensus       164 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---  237 (297)
T 3fxz_A          164 AQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ---  237 (297)
T ss_dssp             EECCSTTC---CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS---
T ss_pred             eecCCccc---ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---
Confidence            87554322   123467999999999774 45789999999999999999999999876654444333332221110   


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                            .+..+...+..++.+||+.||++|||+.|+++
T Consensus       238 ------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          238 ------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                  01122334556778999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.2e-43  Score=366.79  Aligned_cols=265  Identities=24%  Similarity=0.363  Sum_probs=205.9

Q ss_pred             eeecHHHHHHHhcCCCCCCC----CCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHH
Q psy9535          91 IAFTFCDLERATDGFNRKPY----PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF  165 (593)
Q Consensus        91 ~~~~~~~l~~at~~f~~~~~----~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f  165 (593)
                      ..|++++++.+++++.....    ....++||+|+||.||+|+.. +|+.||||++.....    .  .       ...|
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~--~-------~~~~   89 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----Q--R-------RELL   89 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----C--S-------HHHH
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----h--H-------HHHH
Confidence            45889999999987543221    123468999999999999986 799999999864311    1  1       1247


Q ss_pred             HHHHHHHhcCCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q psy9535         166 ENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPII  244 (593)
Q Consensus       166 ~~Ev~il~~l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~Ii  244 (593)
                      .+|+.++++++||||+++++++.. ...++||||+++|+|.+++..    ..+++..+..++.|++.||.|||+  .+|+
T Consensus        90 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~--~~iv  163 (321)
T 2c30_A           90 FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHA--QGVI  163 (321)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTEE
T ss_pred             HHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCee
Confidence            899999999999999999998866 567899999999999998864    358999999999999999999998  5699


Q ss_pred             ecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCC
Q psy9535         245 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKP  323 (593)
Q Consensus       245 HrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P  323 (593)
                      ||||||+|||++.++.+||+|||+++.......   ......||+.|+|||++. ..++.++|||||||++|||++|+.|
T Consensus       164 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p  240 (321)
T 2c30_A          164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP  240 (321)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCCCCHHHEEECCCCcEEEeeeeeeeecccCcc---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999987544321   123467999999999774 4578899999999999999999999


Q ss_pred             CCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         324 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      |.................+  ....       ...+...+..++.+||+.||++|||+.|+++
T Consensus       241 f~~~~~~~~~~~~~~~~~~--~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          241 YFSDSPVQAMKRLRDSPPP--KLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             TTTSCHHHHHHHHHHSSCC--CCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCCHHHHHHHHhcCCCC--CcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            9876554433333222111  1100       1112233556778999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=367.58  Aligned_cols=273  Identities=26%  Similarity=0.378  Sum_probs=197.7

Q ss_pred             cHHHHHHHhcCCCCCC---CCCCCCcccccCceEEEEEEEc----CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHH
Q psy9535          94 TFCDLERATDGFNRKP---YPRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE  166 (593)
Q Consensus        94 ~~~~l~~at~~f~~~~---~~~~~~~LG~G~fG~Vy~g~~~----~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~  166 (593)
                      ++.+...++..|....   .+++.+.||+|+||.||+|++.    .+..||||.++...     . ...      ...|.
T Consensus        31 ~~~~~~~~~~~~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-----~-~~~------~~~~~   98 (325)
T 3kul_A           31 TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-----T-ERQ------RRDFL   98 (325)
T ss_dssp             ------------CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-----C-HHH------HHHHH
T ss_pred             cccCccccchhhccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-----C-HHH------HHHHH
Confidence            4455555665554321   1244678999999999999974    34569999986421     1 111      12588


Q ss_pred             HHHHHHhcCCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q psy9535         167 NEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIH  245 (593)
Q Consensus       167 ~Ev~il~~l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiH  245 (593)
                      +|+.++++++||||+++++++.+ ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+|
T Consensus        99 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH  174 (325)
T 3kul_A           99 SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSD--LGYVH  174 (325)
T ss_dssp             HHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTEEC
T ss_pred             HHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCeeC
Confidence            99999999999999999999976 45689999999999999997532  468999999999999999999998  56999


Q ss_pred             cccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCC
Q psy9535         246 RDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKP  323 (593)
Q Consensus       246 rDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P  323 (593)
                      |||||+|||++.++.+||+|||+++................||+.|+|||++. ..++.++|||||||++|||++ |..|
T Consensus       175 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p  254 (325)
T 3kul_A          175 RDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP  254 (325)
T ss_dssp             SCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999987654332222233346788999999775 557889999999999999999 9999


Q ss_pred             CCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhccc
Q psy9535         324 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMF  393 (593)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~  393 (593)
                      |.................. .     ....     +...+..++.+||..||++||++.+|++.|+....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~-~-----~~~~-----~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          255 YWNMTNRDVISSVEEGYRL-P-----APMG-----CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             TTTSCHHHHHHHHHTTCCC-C-----CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCCHHHHHHHHHcCCCC-C-----CCCC-----cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9876554433333222111 0     0011     12234556789999999999999999999987543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.4e-43  Score=369.71  Aligned_cols=242  Identities=25%  Similarity=0.408  Sum_probs=194.0

Q ss_pred             CCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.+.||+|+||.||+|+. .+|+.||||++.....    ...       ....+.+|+.+|++++||||+++++++.. .
T Consensus        19 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~-------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A           19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL----NPT-------SLQKLFREVRIMKILNHPNIVKLFEVIETEK   87 (328)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS----CHH-------HHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC----CHH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            467899999999999997 4799999999975321    101       12357899999999999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  162 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGFSN  162 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred             EEEEEEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEEcCCCCEEEeeccCce
Confidence            668999999999999999764   358999999999999999999998  569999999999999999999999999997


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccCC-C-CCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      .......    ....+||+.|+|||++.+. + +.++|||||||++|||++|+.||.+.+.......+.......+..  
T Consensus       163 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~--  236 (328)
T 3fe3_A          163 EFTVGGK----LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY--  236 (328)
T ss_dssp             GGSSSCG----GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--
T ss_pred             ecCCCCc----cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC--
Confidence            6543321    2346899999999987543 4 468999999999999999999998876554444444333222211  


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                            .    ...+..++.+||..||.+|||+.|+++
T Consensus       237 ------~----s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          237 ------M----STDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             ------S----CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             ------C----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                  1    122445678999999999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-43  Score=368.88  Aligned_cols=255  Identities=27%  Similarity=0.355  Sum_probs=192.3

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEeccc-
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM-  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~-  191 (593)
                      ..++||+|+||.||+|++. ++.||||++....       .  .     ...+++|+.++++++|||||++++++.... 
T Consensus        28 ~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-------~--~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (322)
T 3soc_A           28 LLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-------K--Q-----SWQNEYEVYSLPGMKHENILQFIGAEKRGTS   92 (322)
T ss_dssp             EEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-------H--H-----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             hhheecccCceEEEEEEEC-CCEEEEEEeecCc-------h--H-----HHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence            3678999999999999886 7899999985321       0  1     124667999999999999999999987632 


Q ss_pred             ----ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCeEecccCCCCeeecCCC
Q psy9535         192 ----NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENF  259 (593)
Q Consensus       192 ----~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------~~~IiHrDLKp~NILl~~~~  259 (593)
                          .++||||+++|+|.+++..    ..+++..+..++.|++.||.|||+.        .++|+||||||+|||++.++
T Consensus        93 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           93 VDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CCceEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence                4899999999999999976    3489999999999999999999984        11699999999999999999


Q ss_pred             ccEEeecccceecccCCCcceeeccccCCCCcCCcccccC------CCCCcchhhHHHHHHHHHHhCCCCCCCCch----
Q psy9535         260 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNT----  329 (593)
Q Consensus       260 ~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~~ksDVwSfGvvl~ElltG~~P~~~~~~----  329 (593)
                      .+||+|||+++....... ........||+.|+|||++.+      .++.++|||||||++|||+||+.||.....    
T Consensus       169 ~~kL~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          169 TACIADFGLALKFEAGKS-AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             CEEECCCTTCEEECTTSC-CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             eEEEccCCcccccccccC-ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            999999999987654332 112234679999999998754      245688999999999999999999965321    


Q ss_pred             -----------HHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         330 -----------ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       330 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                                 ............ ....+.   ..+........+..++.+||+.||++|||+.||++.|++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKK-KRPVLR---DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSC-CCCCCC---GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhccc-CCCCcc---ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                       001111111100 000000   1111222334466677899999999999999999999874

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.1e-43  Score=372.15  Aligned_cols=255  Identities=26%  Similarity=0.423  Sum_probs=196.6

Q ss_pred             CCCCcccccCceEEEEEEEc--------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceee
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLR  182 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~--------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~  182 (593)
                      ++++.||+|+||.||+|++.        ++..||||+++...     . .  .    ....|.+|+.+++++ +|||||+
T Consensus        84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-----~-~--~----~~~~~~~E~~~l~~l~~hpnIv~  151 (370)
T 2psq_A           84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----T-E--K----DLSDLVSEMEMMKMIGKHKNIIN  151 (370)
T ss_dssp             EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-----B-H--H----HHHHHHHHHHHHHHSCCCTTBCC
T ss_pred             EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-----C-H--H----HHHHHHHHHHHHHHhcCCCCEee
Confidence            34678999999999999862        35679999986431     1 1  1    123588999999999 8999999


Q ss_pred             EEEEEec-ccceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeccc
Q psy9535         183 LLGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  248 (593)
Q Consensus       183 l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDL  248 (593)
                      ++++|.+ ...++||||+++|+|.+++.....             ...+++..+..++.|++.||.|||+  ++|+||||
T Consensus       152 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDl  229 (370)
T 2psq_A          152 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDL  229 (370)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCC
T ss_pred             EEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeecccc
Confidence            9999976 566899999999999999986431             2358999999999999999999998  56999999


Q ss_pred             CCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCC
Q psy9535         249 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDD  326 (593)
Q Consensus       249 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~  326 (593)
                      ||+|||++.++.+||+|||+++........ .......||+.|+|||++. ..++.++|||||||++|||+| |..||..
T Consensus       230 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~  308 (370)
T 2psq_A          230 AARNVLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  308 (370)
T ss_dssp             CGGGEEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             chhhEEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999999999999999865433211 1123356789999999764 458889999999999999999 9999987


Q ss_pred             CchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         327 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      ...............+  .    ...     .+...+..++.+||+.+|++||++.|+++.|++..
T Consensus       309 ~~~~~~~~~~~~~~~~--~----~~~-----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          309 IPVEELFKLLKEGHRM--D----KPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             CCGGGHHHHHHTTCCC--C----CCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHhcCCCC--C----CCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            5443332222222111  0    001     11223555678999999999999999999998753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-42  Score=367.42  Aligned_cols=251  Identities=27%  Similarity=0.368  Sum_probs=197.1

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      .+++.||+|+||.||+|+.. +|+.||||.+.............       ...+.+|+.+|++++||||+++++++.+ 
T Consensus        15 ~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~   87 (361)
T 2yab_A           15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVC-------REEIEREVSILRQVLHPNIITLHDVYENR   87 (361)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBC-------HHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             EEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhH-------HHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence            34688999999999999976 68999999997653222111111       1258899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC----ccEEee
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLGD  265 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~----~~Kl~D  265 (593)
                      ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++    .+||+|
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            4568999999999999999652   468999999999999999999998  5699999999999998776    799999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      ||+++.......    .....||+.|+|||++.+ .++.++|||||||++|||++|..||...........+......+.
T Consensus       163 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~  238 (361)
T 2yab_A          163 FGLAHEIEDGVE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD  238 (361)
T ss_dssp             CSSCEECCTTCC----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             cCCceEcCCCCc----cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            999987654321    234679999999998754 588899999999999999999999988665554444433332221


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...   ..     .+...+..++.+||..||++|||+.|+++
T Consensus       239 ~~~---~~-----~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          239 EEF---FS-----QTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHH---HT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chh---cc-----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            100   01     11233556778999999999999998864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2e-43  Score=384.64  Aligned_cols=249  Identities=24%  Similarity=0.393  Sum_probs=198.3

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      +.++||+|+||.||+|++.++..||||+++....       .       ...|.+|+.+|++++|||||++++++.....
T Consensus       192 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-------~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  257 (454)
T 1qcf_A          192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-------S-------VEAFLAEANVMKTLQHDKLVKLHAVVTKEPI  257 (454)
T ss_dssp             EEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-------C-------HHHHHHHHHHHTTCCCTTBCCEEEEECSSSC
T ss_pred             EEEEcccCCceEEEEEEECCccEEEEEEecCCCc-------c-------HHHHHHHHHHHhhCCCCCEeeEEEEEeCCcc
Confidence            3578999999999999998889999999964310       1       1258999999999999999999999988888


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.++|.... ...+++..+..++.|+|.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            99999999999999997532 1357899999999999999999998  56999999999999999999999999999865


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .....  .......+|+.|+|||++. ..++.++|||||||+||||+| |+.||...........+.... ...     .
T Consensus       335 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~-----~  406 (454)
T 1qcf_A          335 EDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RMP-----R  406 (454)
T ss_dssp             CCHHH--HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCC-----C
T ss_pred             CCCce--eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC-----C
Confidence            43211  1112345788999999774 668999999999999999999 999998765443333322221 110     0


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ...     +...+..++.+||+.||++|||+.+|++.|+..
T Consensus       407 ~~~-----~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~  442 (454)
T 1qcf_A          407 PEN-----CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  442 (454)
T ss_dssp             CTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCC-----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            011     122345567899999999999999999999874

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.8e-43  Score=360.65  Aligned_cols=253  Identities=25%  Similarity=0.403  Sum_probs=190.8

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      .+++||+|+||.||+|+.. +|..||+|.+...      ...       ....|.+|+.++++++||||+++++++.+ .
T Consensus        14 ~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~------~~~-------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   80 (310)
T 3s95_A           14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF------DEE-------TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK   80 (310)
T ss_dssp             EEEEEECCSSEEEEEEEETTTCCEEEEEEESCC------CHH-------HHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             ccceecCCCCEEEEEEEECCCCcEEEEEEeccC------CHH-------HHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence            3678999999999999975 6899999998432      111       12358899999999999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  156 (310)
T 3s95_A           81 RLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLAR  156 (310)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred             eeEEEEEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEECCCCCEEEeecccce
Confidence            5689999999999999998643  468999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcc-----------eeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Q psy9535         271 MSETSNMKT-----------MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  338 (593)
Q Consensus       271 ~~~~~~~~~-----------~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~  338 (593)
                      .........           .......||+.|+|||++.+ .++.++|||||||++|||++|..|+........     .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~-----~  231 (310)
T 3s95_A          157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM-----D  231 (310)
T ss_dssp             ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT-----T
T ss_pred             ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH-----H
Confidence            754332111           00114579999999998754 578899999999999999999999865211000     0


Q ss_pred             hcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         339 QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .........+.....    .+...+..++.+||+.||++|||+.++++.|+..
T Consensus       232 ~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          232 FGLNVRGFLDRYCPP----NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             SSBCHHHHHHHTCCT----TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhhhhhccccccCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            000000000000000    0111244566799999999999999999998864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.2e-42  Score=369.18  Aligned_cols=254  Identities=26%  Similarity=0.416  Sum_probs=184.9

Q ss_pred             CCCCcccccCceEEEEEEEc----CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~----~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      ...+.||+|+||.||+|++.    ++..||||.++...     . ..      ....|.+|+.++++++||||++++|++
T Consensus        48 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-----~-~~------~~~~~~~E~~~l~~l~h~niv~~~~~~  115 (373)
T 2qol_A           48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-----T-EK------QRRDFLGEASIMGQFDHPNIIRLEGVV  115 (373)
T ss_dssp             CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-----C-HH------HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-----C-HH------HHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            44789999999999999865    46789999986421     1 11      123589999999999999999999999


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      .+ ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus       116 ~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Df  191 (373)
T 2qol_A          116 TKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILINSNLVCKVSDF  191 (373)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             eeCCceEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEEcCCCCEEECcC
Confidence            76 45689999999999999997532  468999999999999999999998  56999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      |+++................||+.|+|||++. ..++.++|||||||++|||++ |+.||................ ...
T Consensus       192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~-~~~  270 (373)
T 2qol_A          192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY-RLP  270 (373)
T ss_dssp             ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-ECC
T ss_pred             ccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC
Confidence            99987654322111122235678999999764 568899999999999999998 999998765443332222111 100


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                           ....     +...+..++.+||+.+|++||++.+|++.|++..
T Consensus       271 -----~~~~-----~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          271 -----PPMD-----CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             -----CCTT-----CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCcc-----ccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence                 0011     1123455677999999999999999999998754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.3e-43  Score=356.86  Aligned_cols=253  Identities=25%  Similarity=0.368  Sum_probs=187.6

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhc--CCCCceeeEEEEEec-
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ--CKHVNLLRLLGLCNN-  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~--l~HpNIv~l~g~~~~-  189 (593)
                      ..+.||+|+||.||+|++ +|+.||||++....          .      ..+.+|.+++..  ++||||+++++++.. 
T Consensus        12 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~----------~------~~~~~e~~~~~~~~l~h~niv~~~~~~~~~   74 (301)
T 3q4u_A           12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD----------E------KSWFRETELYNTVMLRHENILGFIASDMTS   74 (301)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG----------H------HHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred             EEEeeccCCCcEEEEEEE-CCEEEEEEEecccc----------c------hhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence            367899999999999988 58999999985320          1      134556666555  899999999998643 


Q ss_pred             ----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeEecccCCCCeeecCCC
Q psy9535         190 ----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------SKPIIHRDVKSANVLLDENF  259 (593)
Q Consensus       190 ----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~IiHrDLKp~NILl~~~~  259 (593)
                          ...++||||+++|+|.+++..    ..+++..+..++.|++.||.|||+.      .++|+||||||+|||++.++
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~  150 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG  150 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred             cCCCceeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence                235899999999999999953    3689999999999999999999921      26699999999999999999


Q ss_pred             ccEEeecccceecccCCCcc-eeeccccCCCCcCCcccccCC-------CCCcchhhHHHHHHHHHHhC----------C
Q psy9535         260 VPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGVILLELLTG----------M  321 (593)
Q Consensus       260 ~~Kl~DFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~-------~~~ksDVwSfGvvl~ElltG----------~  321 (593)
                      .+||+|||+++......... .......||+.|+|||++.+.       ++.++|||||||++|||+||          .
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            99999999998755433211 112335799999999987553       33689999999999999999          8


Q ss_pred             CCCCCCc----hHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         322 KPIDDNN----TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       322 ~P~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      .||....    ..................    ...+........+..++.+||+.||++|||+.||++.|++
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccccCCCCcchhhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            8886421    111111111111111111    1111223344556677789999999999999999999976

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=359.15  Aligned_cols=250  Identities=25%  Similarity=0.349  Sum_probs=195.0

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|+.. +|+.||||.+............       ....|.+|+.+|++++||||+++++++.+ .
T Consensus        15 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~-------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   87 (326)
T 2y0a_A           15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-------SREDIEREVSILKEIQHPNVITLHEVYENKT   87 (326)
T ss_dssp             EEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSB-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             eceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchh-------hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            3678999999999999975 6899999999765322111111       12258899999999999999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC----ccEEeec
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLGDF  266 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~----~~Kl~DF  266 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++    .+||+||
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            568999999999999999652   468999999999999999999998  5699999999999999877    8999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      |+++.......    .....||+.|+|||++. ..++.++|||||||++|||++|..||.....................
T Consensus       163 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  238 (326)
T 2y0a_A          163 GLAHKIDFGNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  238 (326)
T ss_dssp             TTCEECCTTSC----CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred             CCCeECCCCCc----cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc
Confidence            99987643321    22357999999999875 45788999999999999999999999876544433333322221111


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .   ....     +...+..++.+||+.||++|||+.|+++
T Consensus       239 ~---~~~~-----~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          239 E---YFSN-----TSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             H---HHTT-----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             c---cccc-----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0   0011     1233556778999999999999999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.5e-42  Score=363.46  Aligned_cols=243  Identities=23%  Similarity=0.359  Sum_probs=193.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.+ +|+.||||++++.....          ......+.+|+.+|++++||||+++++++.+ ..
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~   79 (337)
T 1o6l_A           10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA----------KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR   79 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhh----------hhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCE
Confidence            578999999999999875 68999999996531100          0112357899999999999999999998876 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  154 (337)
T 1o6l_A           80 LCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence            68999999999999999764   358999999999999999999998  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   .....+||+.|+|||++. ..++.++|||||||++|||++|+.||...+.......+......++..    
T Consensus       155 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~----  227 (337)
T 1o6l_A          155 GISDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----  227 (337)
T ss_dssp             SCCTTC---CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT----
T ss_pred             cccCCC---cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC----
Confidence            432221   123468999999999875 457889999999999999999999998766554444444333222211    


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~~  386 (593)
                              +...+..++.+||+.||++||     ++.||++
T Consensus       228 --------~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          228 --------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --------CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                    122345567899999999999     7888754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.8e-42  Score=348.92  Aligned_cols=248  Identities=25%  Similarity=0.423  Sum_probs=197.4

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ..+.||+|+||.||+|+++++..||||.+.....    .          ...|.+|++++++++||||+++++++.+ ..
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   77 (268)
T 3sxs_A           12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM----S----------EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP   77 (268)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB----C----------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             eeeeeccCCCceEEEEEecCceeEEEEEeccCCC----c----------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence            3578999999999999998888999999864311    0          1247899999999999999999999976 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           78 IYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             EEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             eEEEEEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEECCCCCEEEccCcccee
Confidence            689999999999999997643  358999999999999999999998  5699999999999999999999999999987


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......  .......||+.|+|||.+.+ .++.++||||||+++|||+| |+.||....................     
T Consensus       154 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----  226 (268)
T 3sxs_A          154 VLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-----  226 (268)
T ss_dssp             CCTTCE--EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-----
T ss_pred             cchhhh--hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC-----
Confidence            654332  11233457788999997744 57889999999999999999 9999987654443333322221111     


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                        ....    ...+..++.+||+.+|++|||+.|+++.|+..
T Consensus       227 --~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (268)
T 3sxs_A          227 --PHLA----SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL  262 (268)
T ss_dssp             --CTTS----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred             --CCcC----hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence              0111    12345567899999999999999999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.2e-43  Score=372.82  Aligned_cols=251  Identities=26%  Similarity=0.412  Sum_probs=194.3

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|++. +|+.||||.++...     . ...      ...|.+|+.+|++++|||||+++|+|.. .
T Consensus       118 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~-~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  185 (377)
T 3cbl_A          118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-----P-PDL------KAKFLQEARILKQYSHPNIVRLIGVCTQKQ  185 (377)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-----C-HHH------HTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             EeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-----C-HHH------HHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence            4678999999999999986 78999999986321     1 111      1147899999999999999999999976 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...+  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             CcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            5689999999999999997643  358999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ....... ........+|+.|+|||++. +.++.++|||||||++|||+| |..||................ ...    
T Consensus       262 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~----  335 (377)
T 3cbl_A          262 EEADGVY-AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RLP----  335 (377)
T ss_dssp             ECTTSEE-ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-CCC----
T ss_pred             ecCCCce-eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC----
Confidence            6433211 11111123577899999774 567889999999999999998 999998765443322222211 100    


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                        ....    +...+..++.+||+.||++|||+.+|++.|+..
T Consensus       336 --~~~~----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          336 --CPEL----CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             --CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence              0011    112345567899999999999999999999763

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=358.02  Aligned_cols=263  Identities=22%  Similarity=0.319  Sum_probs=201.7

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      ++.++||+|+||.||+|+.. +|+.||||++.......            ....+.+|++++++++||||+++++++...
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   79 (319)
T 4euu_A           12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR------------PVDVQMREFEVLKKLNHKNIVKLFAIEEET   79 (319)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS------------CHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred             EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc------------hHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence            44678999999999999986 58999999986432110            122478999999999999999999988653


Q ss_pred             ---cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee----cCCCccEE
Q psy9535         191 ---MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKL  263 (593)
Q Consensus       191 ---~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl----~~~~~~Kl  263 (593)
                         ..++||||+++|+|.+++........+++..+..++.|++.||.|||+  .+|+||||||+|||+    +.++.+||
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL  157 (319)
T 4euu_A           80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKL  157 (319)
T ss_dssp             TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred             CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceEEE
Confidence               458999999999999999875544559999999999999999999998  569999999999999    78888999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCccccc---------CCCCCcchhhHHHHHHHHHHhCCCCCCCCc----hH
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---------CQISTKTDVFSYGVILLELLTGMKPIDDNN----TI  330 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~----~~  330 (593)
                      +|||+++.......    .....||+.|+|||++.         ..++.++|||||||++|||++|+.||....    ..
T Consensus       158 ~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  233 (319)
T 4euu_A          158 TDFGAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (319)
T ss_dssp             CCCTTCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH
T ss_pred             ccCCCceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH
Confidence            99999987654332    22357999999999763         457889999999999999999999996421    12


Q ss_pred             HHHHHHHhhcCc-c-cccccc-----------ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         331 LYYYLVVEQEVP-V-REVLDK-----------EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       331 ~~~~~~~~~~~~-~-~~~~~~-----------~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      ...........+ . ..+...           .........+...+..++.+||+.||++|||+.|+++..++..
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            222222222211 0 000000           0011223456677788889999999999999999999887643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-42  Score=350.31  Aligned_cols=247  Identities=25%  Similarity=0.416  Sum_probs=196.5

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      .+.||+|+||.||+|++.+++.||||++.....    .    .      ..|.+|+.++++++||||+++++++.+ ...
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~----~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A           15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----S----E------EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             EEEEEECSSCEEEEEEETTTEEEEEEEECTTSB----C----H------HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             eheecCCCccEEEEEEecCCCeEEEEEeccccc----C----H------HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence            578999999999999998889999999964311    0    1      148899999999999999999999976 456


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  156 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             EEEEEeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEEcCCCCEEeccccccccc
Confidence            89999999999999997533  468999999999999999999998  56999999999999999999999999999865


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .....  .......||+.|+|||.+. ..++.++|||||||++|||++ |+.||...................       
T Consensus       157 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~-------  227 (269)
T 4hcu_A          157 LDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------  227 (269)
T ss_dssp             CCHHH--HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-------
T ss_pred             ccccc--ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC-------
Confidence            43211  1122346788999999774 568899999999999999999 999998765544333332221110       


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .....    ...+..++.+||+.+|++||++.|+++.|++.
T Consensus       228 ~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          228 KPRLA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence            01111    12345567899999999999999999999864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.2e-43  Score=362.67  Aligned_cols=250  Identities=25%  Similarity=0.396  Sum_probs=188.9

Q ss_pred             CCcccccCceEEEEEEEc-CCCE----EEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGME----IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~----vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      .++||+|+||.||+|++. +|+.    ||+|.+.....  .   .       ....|.+|+.++++++||||++++++|.
T Consensus        20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~---~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~   87 (327)
T 3poz_A           20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--P---K-------ANKEILDEAYVMASVDNPHVCRLLGICL   87 (327)
T ss_dssp             EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------------------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred             ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--H---H-------HHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence            578999999999999864 4444    57787753210  0   0       1225889999999999999999999999


Q ss_pred             cccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         189 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       189 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      +...++|+||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~  163 (327)
T 3poz_A           88 TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred             cCCeEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEECCCCCEEEccCcc
Confidence            888899999999999999998643  468999999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ++....... ........||+.|+|||.+ ...++.++|||||||++|||+| |+.||.................. .  
T Consensus       164 a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~--  239 (327)
T 3poz_A          164 AKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-P--  239 (327)
T ss_dssp             HHHHTTTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-C--
T ss_pred             eeEccCCcc-cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC-C--
Confidence            987644332 1122335678899999976 4568899999999999999999 99999875443322222211110 0  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                         .....     ...+..++.+||+.+|++||++.||++.|++.
T Consensus       240 ---~~~~~-----~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          240 ---QPPIC-----TIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             ---CCTTB-----CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             ---CCccC-----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence               00111     12244566799999999999999999999874

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.3e-42  Score=349.70  Aligned_cols=253  Identities=28%  Similarity=0.473  Sum_probs=192.5

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEeccc
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~  191 (593)
                      ..+.||+|+||.||+|+.. +++.||||++.......   .   .........|.+|+.++++++||||+++++++.+..
T Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG---E---TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             EEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTC---C---HHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             ehhccccCCceeEEEEEEcCCceEEEEEEeecccccc---c---hhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            3578999999999999974 78999999986432111   0   111111236889999999999999999999986644


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc-----cEEeec
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-----PKLGDF  266 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~-----~Kl~DF  266 (593)
                       ++||||+++|+|.+.+....  ..+++..+..++.|++.||.|||+.+.+|+||||||+|||++.++.     +||+||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence             79999999999999987533  4689999999999999999999984444999999999999987776     999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCccccc---CCCCCcchhhHHHHHHHHHHhCCCCCCCCch--HHHHHHHHhhcC
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---CQISTKTDVFSYGVILLELLTGMKPIDDNNT--ILYYYLVVEQEV  341 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~--~~~~~~~~~~~~  341 (593)
                      |+++.....      .....||+.|+|||++.   ..++.++|||||||++|||++|+.||.....  ............
T Consensus       174 g~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          174 GLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             TTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             Ccccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            998754321      23467999999999873   2367899999999999999999999976432  111111111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                        .....   .     .+...+..++.+||+.||++|||+.|+++.|++
T Consensus       248 --~~~~~---~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          248 --RPTIP---E-----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             --CCCCC---T-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             --CCCCC---c-----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence              11110   1     112335567789999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7.4e-42  Score=350.50  Aligned_cols=256  Identities=25%  Similarity=0.409  Sum_probs=193.3

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.+.||+|+||.||+|+.. ++..||||.+.....   .. .  .    ....|.+|+.++++++||||+++++++.+ 
T Consensus        14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~-~--~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~   83 (294)
T 4eqm_A           14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR---EK-E--E----TLKRFEREVHNSSQLSHQNIVSMIDVDEED   83 (294)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS---CC-H--H----HHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred             EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc---cc-H--H----HHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence            34678999999999999875 689999999864321   11 1  1    12358899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++...   .++++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  158 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFGIA  158 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred             CeEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence            4568999999999999999764   358999999999999999999998  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      +.......  .......||+.|+|||.+.+ .++.++|||||||++|||+||+.||.................+.  ...
T Consensus       159 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~  234 (294)
T 4eqm_A          159 KALSETSL--TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN--VTT  234 (294)
T ss_dssp             TTC---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCC--HHH
T ss_pred             cccccccc--cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCC--cch
Confidence            86543321  11234579999999997754 57889999999999999999999998766544333322222111  100


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCC-ChHHHHHHHhhc
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRA-SMRDIVDLLSKS  391 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-sm~eV~~~L~~~  391 (593)
                      .....     +...+..++.+||+.||.+|| ++.++.+.|+..
T Consensus       235 ~~~~~-----~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          235 DVRKD-----IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             HSCTT-----SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             hcccC-----CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            00111     123355567799999999998 899999988764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8e-43  Score=374.91  Aligned_cols=258  Identities=23%  Similarity=0.312  Sum_probs=198.3

Q ss_pred             HHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC
Q psy9535          97 DLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC  175 (593)
Q Consensus        97 ~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l  175 (593)
                      +++...++|..      .++||+|+||.||+|+.+ +|+.||||++.+........          ...+.+|+.+++.+
T Consensus        63 ~~~~~~~~y~~------~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~----------~~~~~~E~~il~~l  126 (410)
T 3v8s_A           63 DLRMKAEDYEV------VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD----------SAFFWEERDIMAFA  126 (410)
T ss_dssp             HHSCCGGGEEE------EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCC----------CSTHHHHHHHHHHC
T ss_pred             hcccCccccEE------EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHH----------HHHHHHHHHHHHhC
Confidence            44444555543      689999999999999986 58899999996532111111          11378899999999


Q ss_pred             CCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCee
Q psy9535         176 KHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  254 (593)
Q Consensus       176 ~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NIL  254 (593)
                      +|||||++++++.+ ...++||||+++|+|.+++..    ..+++..+..++.|++.||.|||+  .+|+||||||+|||
T Consensus       127 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NIL  200 (410)
T 3v8s_A          127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNML  200 (410)
T ss_dssp             CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEE
T ss_pred             CCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHee
Confidence            99999999999877 456899999999999999975    248899999999999999999999  56999999999999


Q ss_pred             ecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccccCC-----CCCcchhhHHHHHHHHHHhCCCCCCCCch
Q psy9535         255 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDVFSYGVILLELLTGMKPIDDNNT  329 (593)
Q Consensus       255 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~~~ksDVwSfGvvl~ElltG~~P~~~~~~  329 (593)
                      ++.++.+||+|||+++.......  ......+||+.|+|||++...     ++.++|||||||++|||++|+.||...+.
T Consensus       201 l~~~g~ikL~DFG~a~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~  278 (410)
T 3v8s_A          201 LDKSGHLKLADFGTCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL  278 (410)
T ss_dssp             ECTTSCEEECCCTTCEECCTTSE--EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             ECCCCCEEEeccceeEeeccCCc--ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence            99999999999999987654321  123456899999999987532     67899999999999999999999988765


Q ss_pred             HHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCC--CCChHHHHH
Q psy9535         330 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDK--RASMRDIVD  386 (593)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~--RPsm~eV~~  386 (593)
                      ...+..+........-   +....     +...+..++.+|+..+|.+  ||++.||++
T Consensus       279 ~~~~~~i~~~~~~~~~---p~~~~-----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          279 VGTYSKIMNHKNSLTF---PDDND-----ISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHHHHHTHHHHCCC---CTTCC-----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             hhHHHHHHhccccccC---CCccc-----ccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            5554444432211100   00011     1223455677999999998  999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.2e-42  Score=359.30  Aligned_cols=252  Identities=23%  Similarity=0.427  Sum_probs=192.2

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCE----EEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGME----IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~----vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      +..++||+|+||.||+|++. +|..    ||+|.+........            ...+.+|+.++++++||||++++++
T Consensus        16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv~~~~~   83 (325)
T 3kex_A           16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS------------FQAVTDHMLAIGSLDHAHIVRLLGL   83 (325)
T ss_dssp             EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC------------BCSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred             eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH------------HHHHHHHHHHHhcCCCCCcCeEEEE
Confidence            44678999999999999875 4444    78887753321110            0136789999999999999999999


Q ss_pred             EecccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         187 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       187 ~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      |.+...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+||
T Consensus        84 ~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Df  159 (325)
T 3kex_A           84 CPGSSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADF  159 (325)
T ss_dssp             ECBSSEEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEESSSSCEEECSC
T ss_pred             EcCCccEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEECCCCeEEECCC
Confidence            98888899999999999999997532  368899999999999999999998  56999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcC-cc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV-PV  343 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~-~~  343 (593)
                      |+++........ .......||+.|+|||++. ..++.++|||||||++|||+| |+.||................. ..
T Consensus       160 g~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  238 (325)
T 3kex_A          160 GVADLLPPDDKQ-LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ  238 (325)
T ss_dssp             SGGGGSCCCTTC-CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC
T ss_pred             CcccccCccccc-ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC
Confidence            999876443321 1223457889999999774 568899999999999999999 9999987543332222222211 11


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      .....            ..+..++.+||+.||.+||++.|+++.|++..
T Consensus       239 ~~~~~------------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          239 PQICT------------IDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             CTTBC------------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             CCcCc------------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11110            11334667999999999999999999998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=363.66  Aligned_cols=238  Identities=26%  Similarity=0.335  Sum_probs=187.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      .++||+|+||.||+|+.+ +|+.||||++++....          .......+.+|..+++.+ +||||+++++++.+ .
T Consensus        28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~----------~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL----------QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH----------HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc----------chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence            578999999999999975 6899999999743110          001123477899999988 69999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~g~ikL~DFG~a~  172 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCK  172 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEECCCCCEEEcccccee
Confidence            568999999999999999764   358999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......   ......+||+.|+|||++. ..++.++|||||||++|||++|+.||...+....+..+.......+..   
T Consensus       173 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~---  246 (353)
T 3txo_A          173 EGICNG---VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW---  246 (353)
T ss_dssp             CSCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT---
T ss_pred             ecccCC---ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC---
Confidence            543222   1233468999999999774 458899999999999999999999998876665555555443332221   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCCh
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASM  381 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm  381 (593)
                               +...+..++.+|++.||.+||++
T Consensus       247 ---------~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          247 ---------LHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             ---------SCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             ---------CCHHHHHHHHHHhhhCHHHccCC
Confidence                     11224456789999999999998

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1e-42  Score=356.01  Aligned_cols=261  Identities=25%  Similarity=0.402  Sum_probs=188.7

Q ss_pred             CCCCcccccCceEEEEEEE-----cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-----~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      +..++||+|+||.||+|++     .+|+.||||++...      ..   .    ....|.+|+.++++++||||++++++
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~------~~---~----~~~~~~~E~~~l~~l~h~~iv~~~~~   79 (295)
T 3ugc_A           13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TE---E----HLRDFEREIEILKSLQHDNIVKYKGV   79 (295)
T ss_dssp             EEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC------CH---H----HHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC------CH---H----HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3457899999999999985     25889999998532      11   1    12358899999999999999999999


Q ss_pred             Eec---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         187 CNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       187 ~~~---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                      +..   ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||
T Consensus        80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl  155 (295)
T 3ugc_A           80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKI  155 (295)
T ss_dssp             ECHHHHTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEE
T ss_pred             EecCCCCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEEcCCCeEEE
Confidence            854   34689999999999999997643  358999999999999999999998  56999999999999999999999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCc
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  342 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~  342 (593)
                      +|||+++................||+.|+|||++. ..++.++|||||||++|||+||..|+........  ........
T Consensus       156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~  233 (295)
T 3ugc_A          156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM--RMIGNDKQ  233 (295)
T ss_dssp             CCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHH--HHHCTTCC
T ss_pred             ccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHH--hhhcCccc
Confidence            99999987644322112223345788899999764 5688999999999999999999999865321110  00000000


Q ss_pred             -------cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         343 -------VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       343 -------~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                             ..+.+........+..+...+..++.+||+.||++|||+.||++.|+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          234 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                   0000000000000111223355577899999999999999999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-42  Score=356.21  Aligned_cols=239  Identities=28%  Similarity=0.408  Sum_probs=193.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +|+.||||++++.....          ......+.+|+.+++.++||||+++++++.+ ..
T Consensus        11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~   80 (318)
T 1fot_A           11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR----------LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ   80 (318)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCE
Confidence            578999999999999875 68999999996531100          0112357789999999999999999999876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~  155 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKY  155 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChheEEEcCCCCEEEeecCccee
Confidence            68999999999999999863   358999999999999999999998  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ....      ....+||+.|+|||++. ..++.++|||||||++|||++|+.||...+....+..+.......+..    
T Consensus       156 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~----  225 (318)
T 1fot_A          156 VPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF----  225 (318)
T ss_dssp             CSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTT----
T ss_pred             cCCc------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC----
Confidence            5432      23468999999999775 457889999999999999999999998876655555554443322211    


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIV  385 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~  385 (593)
                              ....+..++.+|+..||.+||     ++.||+
T Consensus       226 --------~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~  257 (318)
T 1fot_A          226 --------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK  257 (318)
T ss_dssp             --------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred             --------CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence                    112345567899999999999     777775

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5e-42  Score=351.67  Aligned_cols=255  Identities=21%  Similarity=0.311  Sum_probs=187.0

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCch-------------hHHhhhcHHHHHHHHHHHhcCCCC
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDN-------------TEAAMIPILLFENEVQTLSQCKHV  178 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~-------------~~~~~~~~~~f~~Ev~il~~l~Hp  178 (593)
                      +.+.||+|+||.||+|+.. +|+.||||++.............             ..........|.+|++++++++||
T Consensus        17 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   96 (298)
T 2zv2_A           17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP   96 (298)
T ss_dssp             EEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCT
T ss_pred             EEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCC
Confidence            4678999999999999875 68899999997543211100000             000000122588999999999999


Q ss_pred             ceeeEEEEEec---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee
Q psy9535         179 NLLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  255 (593)
Q Consensus       179 NIv~l~g~~~~---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl  255 (593)
                      ||+++++++.+   ...++||||+++|+|.+++.    ..++++..+..++.|++.||.|||+  .+|+||||||+|||+
T Consensus        97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLV  170 (298)
T ss_dssp             TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE
T ss_pred             CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEE
Confidence            99999999875   35689999999999987543    2468999999999999999999998  569999999999999


Q ss_pred             cCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccccCC----CCCcchhhHHHHHHHHHHhCCCCCCCCchHH
Q psy9535         256 DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNNTIL  331 (593)
Q Consensus       256 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~  331 (593)
                      +.++.+||+|||+++.......   ......||+.|+|||++.+.    .+.++|||||||++|||++|+.||.......
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          171 GEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             CTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             CCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            9999999999999987654321   12345799999999987543    2678999999999999999999998765443


Q ss_pred             HHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         332 YYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ............+.     ....     ...+..++.+||+.||++||++.|+++
T Consensus       248 ~~~~~~~~~~~~~~-----~~~~-----~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          248 LHSKIKSQALEFPD-----QPDI-----AEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHCCCCCCS-----SSCC-----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHhcccCCCCC-----cccc-----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            33333222211111     1111     123455678999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.4e-42  Score=375.87  Aligned_cols=262  Identities=20%  Similarity=0.268  Sum_probs=201.1

Q ss_pred             cHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHH
Q psy9535          94 TFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL  172 (593)
Q Consensus        94 ~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il  172 (593)
                      .+.+++..+++|..      .++||+|+||+||+|+.+ +|+.||||++.+.......          ....|.+|+.++
T Consensus        65 ~~~~~~~~~~~y~~------~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~----------~~~~~~~E~~il  128 (437)
T 4aw2_A           65 KVKQMRLHREDFEI------LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA----------ETACFREERDVL  128 (437)
T ss_dssp             HHHHHSCCGGGEEE------EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTT----------TTCCHHHHHHHH
T ss_pred             hhhcccCChhheEE------EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHH----------HHHHHHHHHHHH
Confidence            34455555666654      689999999999999986 4788999999653111110          011378899999


Q ss_pred             hcCCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCC
Q psy9535         173 SQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA  251 (593)
Q Consensus       173 ~~l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~  251 (593)
                      ..++|||||+++++|.+ ...++|||||++|+|.++|....  ..+++..+..++.|++.||.|||+  .+||||||||+
T Consensus       129 ~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~  204 (437)
T 4aw2_A          129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPD  204 (437)
T ss_dssp             HHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGG
T ss_pred             HhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHH
Confidence            99999999999999876 45689999999999999997632  468999999999999999999998  56999999999


Q ss_pred             CeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc------CCCCCcchhhHHHHHHHHHHhCCCCCC
Q psy9535         252 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPID  325 (593)
Q Consensus       252 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~~ksDVwSfGvvl~ElltG~~P~~  325 (593)
                      ||||+.++.+||+|||+|+.......  ......+||+.|||||++.      ..++.++|||||||++|||++|+.||.
T Consensus       205 NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~  282 (437)
T 4aw2_A          205 NILMDMNGHIRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY  282 (437)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             HeeEcCCCCEEEcchhhhhhcccCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999986544332  2233468999999999774      347889999999999999999999998


Q ss_pred             CCchHHHHHHHHhhc--CccccccccccCCCCHHHHHHHHHHHHHHhhccccCC--CCChHHHHH
Q psy9535         326 DNNTILYYYLVVEQE--VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDK--RASMRDIVD  386 (593)
Q Consensus       326 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~--RPsm~eV~~  386 (593)
                      ..+....+..+....  ...+..    ...     +...+..++.+|+..+|++  ||++.|+++
T Consensus       283 ~~~~~~~~~~i~~~~~~~~~p~~----~~~-----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          283 AESLVETYGKIMNHKERFQFPTQ----VTD-----VSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CSSHHHHHHHHHTHHHHCCCCSS----CCC-----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             CCChhHHHHhhhhccccccCCcc----ccc-----CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            876555544443321  111111    011     1123445667888888888  999998853

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=8.7e-42  Score=353.78  Aligned_cols=256  Identities=22%  Similarity=0.302  Sum_probs=182.8

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..++||+|+||.||+|+.. +|+.||||++.......  .          ...+.+|+.++++++|||||++++++.. .
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~----------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   76 (317)
T 2pmi_A            9 QLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--T----------PSTAIREISLMKELKHENIVRLYDVIHTEN   76 (317)
T ss_dssp             ----------CEEEEEECSSSCCEEEEEEEECCSTTC--S----------CHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred             EeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--c----------HHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence            4688999999999999875 68999999997542110  0          1147789999999999999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVN---NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      ..++||||+. |+|.+++....   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  153 (317)
T 2pmi_A           77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFG  153 (317)
T ss_dssp             EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCS
T ss_pred             eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEECcCc
Confidence            5689999998 69999987532   12358999999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc-
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR-  344 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~-  344 (593)
                      +++.......   ......||+.|+|||++.+  .++.++|||||||++|||++|+.||...........+........ 
T Consensus       154 ~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  230 (317)
T 2pmi_A          154 LARAFGIPVN---TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE  230 (317)
T ss_dssp             SCEETTSCCC---CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCT
T ss_pred             cceecCCCcc---cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9987543221   1223579999999998754  478999999999999999999999987655443333322111000 


Q ss_pred             ccc---------cccc----CC--------CCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVL---------DKEA----GE--------WNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~---------~~~~----~~--------~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...         .+..    ..        .....+...+..++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            000         0000    00        000011234556778999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-42  Score=359.56  Aligned_cols=245  Identities=21%  Similarity=0.321  Sum_probs=194.7

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.+.||+|+||.||+|+.. +|+.||+|.+....       ..       ...+.+|+.++++++||||+++++++.+ 
T Consensus         8 ~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-------~~-------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   73 (321)
T 1tki_A            8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-------TD-------QVLVKKEISILNIARHRNILHLHESFESM   73 (321)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-------HH-------HHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred             EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-------cc-------HHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence            44678999999999999875 68899999985321       11       1247899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC--CCccEEeecc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--NFVPKLGDFG  267 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~--~~~~Kl~DFG  267 (593)
                      ...++||||+++|+|.+++...  ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.  ++.+||+|||
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           74 EELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             CEEEEEEEeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence            5668999999999999999653  2468999999999999999999998  56999999999999987  7899999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccCC-CCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      +++.......    .....||+.|+|||++.+. ++.++|||||||++|||++|..||...........+..........
T Consensus       150 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  225 (321)
T 1tki_A          150 QARQLKPGDN----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE  225 (321)
T ss_dssp             TCEECCTTCE----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH
T ss_pred             CCeECCCCCc----cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh
Confidence            9987654321    2235799999999987654 6889999999999999999999998766554444444333222110


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         ....     +...+..++.+||..||.+|||+.|+++
T Consensus       226 ---~~~~-----~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          226 ---AFKE-----ISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---HHTT-----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---hhcc-----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               0011     1223456778999999999999999976

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.6e-42  Score=350.62  Aligned_cols=256  Identities=31%  Similarity=0.489  Sum_probs=187.2

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEeccc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  191 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~  191 (593)
                      ++.++||+|+||.||+|++.  ..||||.++....    . .  .    ....|.+|+.++++++||||+++++++....
T Consensus        27 ~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~----~-~--~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (289)
T 3og7_A           27 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP----T-P--Q----QLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ   93 (289)
T ss_dssp             EEEEEEEECSSEEEEEEESS--SEEEEEEESCSSC----C-H--H----HHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             eeeeEecCCCCeEEEEEEEc--CceEEEEEeccCC----C-H--H----HHHHHHHHHHHHHhCCCCcEEEEEeeccCCc
Confidence            44689999999999999864  3699999864311    1 1  1    1235889999999999999999999988888


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+.+|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE  169 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred             cEEEEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEEccceeccc
Confidence            899999999999999996532  468999999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~----~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ...... ........||+.|+|||++.    ..++.++|||||||++|||++|+.||.................. ....
T Consensus       170 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~  247 (289)
T 3og7_A          170 KSRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL-SPDL  247 (289)
T ss_dssp             ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC-CCCT
T ss_pred             cccccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc-Ccch
Confidence            443221 11123457999999999763    34677999999999999999999999875443332222222111 1111


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ......     +...+..++.+||+.+|++||++.++++.|++.
T Consensus       248 ~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          248 SKVRSN-----CPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             TSSCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             hhcccc-----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            111111     122355567899999999999999999999874

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.7e-42  Score=357.43  Aligned_cols=246  Identities=25%  Similarity=0.343  Sum_probs=185.1

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc--
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~--  190 (593)
                      .+.||+|+||.||+|+.. +|+.||||++....     ....       ...|.+|+.+|++++|||||++++++.+.  
T Consensus        11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B           11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-----RELA-------REKVMREVKALAKLEHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             EEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-----TTTH-------HHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred             eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-----chhH-------HHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence            578999999999999986 79999999996431     1111       12588999999999999999999987442  


Q ss_pred             --------------------------------------------------------cceEEEEeccCCCHHHHHhhcCCC
Q psy9535         191 --------------------------------------------------------MNCIVYEYMCNGSLYDRLARVNNT  214 (593)
Q Consensus       191 --------------------------------------------------------~~~lV~Ey~~~GsL~~~L~~~~~~  214 (593)
                                                                              ..++||||+++|+|.+++......
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    158999999999999999876555


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecccCCCcc---------eeeccc
Q psy9535         215 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT---------MYTENL  285 (593)
Q Consensus       215 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~---------~~~~~~  285 (593)
                      ...++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.........         ......
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ  236 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence            566777889999999999999998  569999999999999999999999999998765432110         112335


Q ss_pred             cCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHH
Q psy9535         286 TGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIG  364 (593)
Q Consensus       286 ~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  364 (593)
                      .||+.|+|||++. ..++.++|||||||++|||++|..|+......  .....  ....+.         ........+.
T Consensus       237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~--~~~~~--~~~~~~---------~~~~~~~~~~  303 (332)
T 3qd2_B          237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI--ITDVR--NLKFPL---------LFTQKYPQEH  303 (332)
T ss_dssp             C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH--HHHHH--TTCCCH---------HHHHHCHHHH
T ss_pred             CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH--HHHhh--ccCCCc---------ccccCChhHH
Confidence            7999999999774 46789999999999999999998775321111  11111  111110         0111122335


Q ss_pred             HHHHHhhccccCCCCChHHHHH
Q psy9535         365 IVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       365 ~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .++.+||+.||++|||+.|+++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCCCcCCCHHHHhh
Confidence            5778999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9e-42  Score=352.87  Aligned_cols=255  Identities=22%  Similarity=0.275  Sum_probs=187.4

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ..++||+|+||.||+|+..+|+.||||++.....    ...       ....+.+|+.++++++||||+++++++.+ ..
T Consensus        25 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~-------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   93 (311)
T 3niz_A           25 KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE----DEG-------IPSTAIREISLLKELHHPNIVSLIDVIHSERC   93 (311)
T ss_dssp             EEEEEEECSSCEEEEEEETTSCEEEEEEEC----------C-------HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred             hhhhccCCCCeEEEEEEECCCCEEEEEEEecccc----cch-------hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence            4578999999999999998899999999864311    100       01257899999999999999999999876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||++ |+|.+.+....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  168 (311)
T 3niz_A           94 LTLVFEFME-KDLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLARA  168 (311)
T ss_dssp             EEEEEECCS-EEHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEcCCC-CCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEECCCCCEEEccCcCcee
Confidence            689999998 58888887533  458999999999999999999998  5699999999999999999999999999987


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--hcCcccc--
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPVRE--  345 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~--~~~~~~~--  345 (593)
                      ......   ......||+.|+|||++.+  .++.++|||||||++|||++|+.||..............  +......  
T Consensus       169 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          169 FGIPVR---SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             TTSCCC------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred             cCCCcc---cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence            543321   1223578999999998743  478899999999999999999999976433222222211  1111000  


Q ss_pred             -ccc------cc---cCCCCH----HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 -VLD------KE---AGEWNE----THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 -~~~------~~---~~~~~~----~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       ..+      ..   ......    ......+..++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             000      00   000000    001123445678999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.1e-42  Score=361.69  Aligned_cols=245  Identities=23%  Similarity=0.370  Sum_probs=193.1

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.+ +|+.||||++.....    . .. .     ...+.+|+.++++++|||||++++++.+ ..
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~-~~-~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL----S-AR-D-----FQKLEREARICRKLQHPNIVRLHDSIQEESF  102 (362)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----C-HH-H-----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC----C-HH-H-----HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            578999999999999875 689999999975321    1 10 1     2258899999999999999999999876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC---CccEEeeccc
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGI  268 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~---~~~Kl~DFGl  268 (593)
                      .++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.+   +.+||+|||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            68999999999999998753   468999999999999999999999  569999999999999864   4599999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ++.......    .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+......+..+.......+.. 
T Consensus       178 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-  252 (362)
T 2bdw_A          178 AIEVNDSEA----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP-  252 (362)
T ss_dssp             CBCCTTCCS----CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-
T ss_pred             ceEecCCcc----cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc-
Confidence            986543321    234679999999998754 58899999999999999999999998766555444444333222110 


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        ..     ..+...+..++.+||+.||++||++.|+++
T Consensus       253 --~~-----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          253 --EW-----DTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             --GG-----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --cc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              00     111233456778999999999999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.4e-42  Score=377.94  Aligned_cols=249  Identities=26%  Similarity=0.375  Sum_probs=193.2

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      +.++||+|+||.||+|++..+..||||+++....    .          ...|.+|+.+|++++||||+++++++.+...
T Consensus       188 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~----------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  253 (452)
T 1fmk_A          188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----S----------PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI  253 (452)
T ss_dssp             EEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS----C----------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             eeeeecCCCCeEEEEEEECCCceEEEEEeccCCC----C----------HHHHHHHHHHHHhCCCCCEeeEEEEEcCCce
Confidence            4578999999999999998888899999864311    0          1258899999999999999999999988788


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.++|.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             EEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            99999999999999997532 2358999999999999999999998  56999999999999999999999999999875


Q ss_pred             ccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .....  .......||+.|+|||++ ...++.++|||||||++|||+| |+.||...........+..+. ...     .
T Consensus       331 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~-----~  402 (452)
T 1fmk_A          331 EDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMP-----C  402 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCC-----C
T ss_pred             CCCce--ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC-----C
Confidence            43221  112234578899999976 4668999999999999999999 999998765443333322211 100     0


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ..     .+...+..++.+||+.+|++|||+.+|++.|+..
T Consensus       403 ~~-----~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~  438 (452)
T 1fmk_A          403 PP-----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  438 (452)
T ss_dssp             CT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             CC-----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            01     1123345567899999999999999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.5e-41  Score=346.49  Aligned_cols=248  Identities=25%  Similarity=0.400  Sum_probs=192.9

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         111 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       111 ~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      ++..+.||+|+||.||+|... ++..||+|.+.....    . ..      ....|.+|+.++++++||||+++++++..
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~----~-~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL----T-KS------ERQRFKEEAEMLKGLQHPNIVRFYDSWES   96 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS----C-HH------HHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh----C-HH------HHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence            345678999999999999875 688999999864311    1 10      12358899999999999999999998754


Q ss_pred             -----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec-CCCccEE
Q psy9535         190 -----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKL  263 (593)
Q Consensus       190 -----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~-~~~~~Kl  263 (593)
                           ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+.+.+|+||||||+|||++ .++.+||
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl  173 (290)
T 1t4h_A           97 TVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI  173 (290)
T ss_dssp             ESSSCEEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred             ccCCCceEEEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEE
Confidence                 2358999999999999999764   358999999999999999999998444499999999999998 7899999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  343 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~  343 (593)
                      +|||++.......     .....||+.|+|||++.+.++.++|||||||++|||++|+.||...................
T Consensus       174 ~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  248 (290)
T 1t4h_A          174 GDLGLATLKRASF-----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP  248 (290)
T ss_dssp             CCTTGGGGCCTTS-----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred             eeCCCcccccccc-----cccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc
Confidence            9999987544322     22357999999999988889999999999999999999999998754433333322222111


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .. .+   ... .    ..+..++.+||+.||++|||+.|+++
T Consensus       249 ~~-~~---~~~-~----~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          249 AS-FD---KVA-I----PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GG-GG---GCC-C----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc-cC---CCC-C----HHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11 11   011 1    22455677999999999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.9e-42  Score=350.18  Aligned_cols=255  Identities=20%  Similarity=0.288  Sum_probs=188.0

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ..+.||+|+||.||+|+..+|+.||||++........           ....+.+|+.++++++||||+++++++.+ ..
T Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-----------IPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC-----------CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             hhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccc-----------cchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            4578999999999999988899999999864321110           01247899999999999999999999876 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+.+ +|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (288)
T 1ob3_A           75 LVLVFEHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARA  149 (288)
T ss_dssp             EEEEEECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             EEEEEEecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEeECccccc
Confidence            6899999975 9999887533  468999999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-Ccccc---
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-VPVRE---  345 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~-~~~~~---  345 (593)
                      ......   ......||+.|+|||++.+  .++.++|||||||++|||++|+.||................ .+...   
T Consensus       150 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  226 (288)
T 1ob3_A          150 FGIPVR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP  226 (288)
T ss_dssp             HCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cCcccc---ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhch
Confidence            543211   1223578999999998743  47899999999999999999999998765443333222210 00000   


Q ss_pred             ------ccccccC-----CC--CHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 ------VLDKEAG-----EW--NETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ------~~~~~~~-----~~--~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                            ..++...     .+  ....+...+..++.+||+.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                  0000000     00  00112233455778999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.1e-42  Score=349.27  Aligned_cols=250  Identities=28%  Similarity=0.398  Sum_probs=185.1

Q ss_pred             CCCcccccCceEEEEEEEcC----CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~----g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      +.+.||+|+||.||+|+...    +..||||.+....      ...      ....|.+|+.++++++||||+++++++.
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~------~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A           19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT------SDS------VREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT------SHH------HHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC------CHH------HHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            46789999999999998742    4569999875321      111      1225889999999999999999999998


Q ss_pred             cccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         189 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       189 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      +...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  162 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGL  162 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred             cCccEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEECCCCCEEECcccc
Confidence            888899999999999999997642  468999999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ++.......  .......||+.|+|||++. ..++.++|||||||++|||++ |..||..................  . 
T Consensus       163 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~--~-  237 (281)
T 1mp8_A          163 SRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--P-  237 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--C-
T ss_pred             ccccCcccc--cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC--C-
Confidence            987543321  1122346788999999774 567889999999999999997 99999875443332222221110  0 


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                         ....     +...+..++.+||+.||++|||+.|+++.|+..
T Consensus       238 ---~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          238 ---MPPN-----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             ---CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCC-----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               0011     122345567899999999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.6e-42  Score=362.66  Aligned_cols=254  Identities=25%  Similarity=0.380  Sum_probs=193.0

Q ss_pred             CCCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  185 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g  185 (593)
                      +++.||+|+||.||+|++.      +++.||||++....     . .. .     ...|.+|+.++.++ +|||||++++
T Consensus        26 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~-~~-~-----~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----T-HS-E-----HRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-----C-HH-H-----HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             eceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-----C-HH-H-----HHHHHHHHHHHHhhcCCcceeeeee
Confidence            3689999999999999742      45789999996421     1 11 1     22588999999999 7899999999


Q ss_pred             EEecc--cceEEEEeccCCCHHHHHhhcCC--------------------------------------------------
Q psy9535         186 LCNNI--MNCIVYEYMCNGSLYDRLARVNN--------------------------------------------------  213 (593)
Q Consensus       186 ~~~~~--~~~lV~Ey~~~GsL~~~L~~~~~--------------------------------------------------  213 (593)
                      +|.+.  ..++||||+++|+|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            98763  36899999999999999976432                                                  


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceecccCCCcce
Q psy9535         214 -------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM  280 (593)
Q Consensus       214 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~  280 (593)
                                   ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~  250 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YV  250 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CE
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-ch
Confidence                         1128899999999999999999999  5699999999999999999999999999986543322 12


Q ss_pred             eeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHH
Q psy9535         281 YTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETH  358 (593)
Q Consensus       281 ~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (593)
                      ......||+.|+|||++ ...++.++|||||||++|||+| |..||....................      ......  
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~--  322 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR------APDYTT--  322 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC------CCTTCC--
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC------CCCCCC--
Confidence            23346789999999976 4568899999999999999998 9999976442222222222111100      001111  


Q ss_pred             HHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         359 VETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       359 ~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                        ..+..++.+||+.||.+|||+.||++.|+..
T Consensus       323 --~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          323 --PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence              2244566799999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.1e-42  Score=372.03  Aligned_cols=244  Identities=29%  Similarity=0.455  Sum_probs=192.2

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI-  190 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~-  190 (593)
                      +..++||+|+||.||+|++. |+.||||+++...     .          ...|.+|+.+|++++|||||+++|+|.+. 
T Consensus       196 ~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-----~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  259 (450)
T 1k9a_A          196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----T----------AQAFLAEASVMTQLRHSNLVQLLGVIVEEK  259 (450)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-----T----------SHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred             EEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-----H----------HHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence            34678999999999999986 7899999996431     1          12588999999999999999999998653 


Q ss_pred             -cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         191 -MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       191 -~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                       ..++||||+++|+|.+++..... ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       260 ~~~~iv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          260 GGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLT  336 (450)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence             56899999999999999987532 347899999999999999999998  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      +......      ....+|+.|+|||++ ...++.++|||||||++|||+| |+.||...........+..+. ..    
T Consensus       337 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~----  405 (450)
T 1k9a_A          337 KEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KM----  405 (450)
T ss_dssp             EECC------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-CC----
T ss_pred             ccccccc------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC----
Confidence            8543221      123678999999977 4568899999999999999998 999998644322222222111 10    


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                        ...    ..+...+..++.+||+.||++|||+.+|++.|+..
T Consensus       406 --~~p----~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          406 --DAP----DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             --CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCC----CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              000    11123345567899999999999999999999763

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-42  Score=357.42  Aligned_cols=254  Identities=27%  Similarity=0.463  Sum_probs=196.6

Q ss_pred             CCCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      ..+.||+|+||.||+|+..      +++.||||.++...     . ..      ....|.+|+.++++++||||++++++
T Consensus        51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~-~~------~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-----S-AD------MQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-----C-HH------HHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-----C-HH------HHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3678999999999999874      34789999986431     1 11      12258899999999999999999999


Q ss_pred             Eec-ccceEEEEeccCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q psy9535         187 CNN-IMNCIVYEYMCNGSLYDRLARVNN---------------------TPPLDSNKRYSIALGVAEALHYLHSLSKPII  244 (593)
Q Consensus       187 ~~~-~~~~lV~Ey~~~GsL~~~L~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~Ii  244 (593)
                      +.+ ...++||||+++|+|.+++.....                     ...+++..++.++.|+++||.|||+  ++|+
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~iv  196 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFV  196 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCC
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCee
Confidence            976 566899999999999999986421                     1568999999999999999999998  5699


Q ss_pred             ecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCC
Q psy9535         245 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMK  322 (593)
Q Consensus       245 HrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~  322 (593)
                      ||||||+|||++.++.+||+|||+++....... ........||+.|+|||++ ...++.++|||||||++|||+| |..
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCcc-ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            999999999999999999999999976543221 1112335689999999976 4568899999999999999999 999


Q ss_pred             CCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         323 PIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       323 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      ||..................  ..    ....     ...+..++.+||+.||++||++.+|++.|++..
T Consensus       276 p~~~~~~~~~~~~~~~~~~~--~~----~~~~-----~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          276 PYYGMAHEEVIYYVRDGNIL--AC----PENC-----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             TTTTSCHHHHHHHHHTTCCC--CC----CTTC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cCCCCChHHHHHHHhCCCcC--CC----CCCC-----CHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence            99876544433333222211  00    0111     123455678999999999999999999998743

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.5e-42  Score=380.15  Aligned_cols=249  Identities=28%  Similarity=0.469  Sum_probs=196.3

Q ss_pred             CCCcccccCceEEEEEEEcC-CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~-g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..++||+|+||.||+|++.. +..||||.++....    .          ...|.+|+.+|++++|||||+++|+|.. .
T Consensus       224 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~----------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  289 (495)
T 1opk_A          224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----E----------VEEFLKEAAVMKEIKHPNLVQLLGVCTREP  289 (495)
T ss_dssp             EEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----C----------HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             eeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----c----------hHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            35789999999999999864 88999999864311    0          1258999999999999999999999976 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.++|.... ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSR  366 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             cEEEEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEECCCCcEEEeecccce
Confidence            6789999999999999998643 2468999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ......  ........||+.|+|||++. ..++.++|||||||+||||+| |..||.............. ....     
T Consensus       367 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~-----  438 (495)
T 1opk_A          367 LMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DYRM-----  438 (495)
T ss_dssp             CCTTCC--EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-TCCC-----
T ss_pred             eccCCc--eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCC-----
Confidence            764332  11122345778999999774 557889999999999999999 9999987543332222211 1110     


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                       ...    ..+...+..++.+||+.||++|||+.+|++.|+..
T Consensus       439 -~~~----~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          439 -ERP----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             -CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -CCC----CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence             000    11122345567899999999999999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-42  Score=387.67  Aligned_cols=249  Identities=22%  Similarity=0.366  Sum_probs=191.8

Q ss_pred             cccccCceEEEEEEEc---CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         116 KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~---~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      +||+|+||.||+|.++   ++..||||+++....     ...       ...|.+|+.+|++++|||||+++|+|.....
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-----~~~-------~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  410 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-----KAD-------TEEMMREAQIMHQLDNPYIVRLIGVCQAEAL  410 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-----STT-------HHHHHHHHHHHTTCCCTTBCCEEEEEESSSE
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-----hHH-------HHHHHHHHHHHHhCCCCCEeeEEEEeccCCe
Confidence            6999999999999874   456799999864311     111       1258899999999999999999999988888


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.++|...  ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus       411 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             EEEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence            9999999999999999753  3468999999999999999999998  56999999999999999999999999999865


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ..............||+.|+|||++. ..++.++|||||||++|||+| |+.||...........+..+...  .     
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~--~-----  559 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM--E-----  559 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC--C-----
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--C-----
Confidence            43321111122235678999999774 678999999999999999998 99999876544433333222110  0     


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ...    .+...+..++.+||+.+|++||++.+|++.|+..
T Consensus       560 ~p~----~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          560 CPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             CCT----TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCC----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            000    1122345567899999999999999999999874

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=369.86  Aligned_cols=246  Identities=22%  Similarity=0.298  Sum_probs=193.7

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|... +|+.||+|.+.....     ..  .    ....+.+|+.++++++|||||++++++.+ ..
T Consensus        16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-----~~--~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A           16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-----SA--R----DHQKLEREARICRLLKHPNIVRLHDSISEEGH   84 (444)
T ss_dssp             EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-----HH--H----HHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred             EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-----CH--H----HHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence            578999999999999875 689999999875321     00  0    12358899999999999999999999876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec---CCCccEEeeccc
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGI  268 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~---~~~~~Kl~DFGl  268 (593)
                      .++||||+.+|+|.+.+...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++   .++.+||+|||+
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             EEEEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            68999999999999999864   358999999999999999999999  5699999999999998   467899999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ++.......   ......||+.|+|||++.+ .++.++|||||||++|||++|..||.+......+..+..+....+.  
T Consensus       160 a~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--  234 (444)
T 3soa_A          160 AIEVEGEQQ---AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS--  234 (444)
T ss_dssp             CBCCCTTCC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT--
T ss_pred             eEEecCCCc---eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc--
Confidence            976544321   1234689999999998755 5889999999999999999999999887665555554444332211  


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       +....     +...+..++.+||+.||++|||+.|+++
T Consensus       235 -~~~~~-----~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          235 -PEWDT-----VTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             -TTTTT-----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -ccccc-----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             11111     1223455678999999999999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1e-41  Score=364.49  Aligned_cols=238  Identities=23%  Similarity=0.344  Sum_probs=184.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      .++||+|+||+||+|+.+ +++.||||++++........          ...+.+|..++.++ +|||||++++++.+ .
T Consensus        57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~----------~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED----------IDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC--------------CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHH----------HHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            578999999999999986 57889999997643221111          11367899999876 89999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++.+.   ..+++..+..++.||+.||.|||+  ++|+||||||+||||+.++.+||+|||+++
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEECCCCCEEEeecceee
Confidence            568999999999999999864   358999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCc---------hHHHHHHHHhhc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN---------TILYYYLVVEQE  340 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~---------~~~~~~~~~~~~  340 (593)
                      .......   .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||....         .......+....
T Consensus       202 ~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~  278 (396)
T 4dc2_A          202 EGLRPGD---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ  278 (396)
T ss_dssp             CCCCTTC---CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred             ecccCCC---ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence            5332221   2345789999999998754 57889999999999999999999996321         111222222222


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCCh
Q psy9535         341 VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASM  381 (593)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm  381 (593)
                      ..++..            +...+..++.+||+.||.+||++
T Consensus       279 ~~~p~~------------~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 IRIPRS------------LSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CCCCTT------------SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             cCCCCc------------CCHHHHHHHHHHhcCCHhHcCCC
Confidence            222111            12234556789999999999996

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.4e-42  Score=355.52  Aligned_cols=252  Identities=24%  Similarity=0.354  Sum_probs=184.7

Q ss_pred             CCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      ++.+.||+|+||.||+|+. .+|+.||||++.....   .. .  .    ....|.+|+.++++++||||+++++++...
T Consensus        15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~-~--~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   84 (311)
T 3ork_A           15 ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA---RD-P--S----FYLRFRREAQNAAALNHPAIVAVYDTGEAE   84 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT---TS-H--H----HHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred             EEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc---CC-H--H----HHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence            3467899999999999997 4789999999964311   11 0  1    123588999999999999999999987652


Q ss_pred             -c----ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         191 -M----NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       191 -~----~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                       .    .++||||+++|+|.+++...   .++++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~D  159 (311)
T 3ork_A           85 TPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMD  159 (311)
T ss_dssp             ETTEEEEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEETTSCEEECC
T ss_pred             CCCCcccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEcCCCCEEEee
Confidence             2    28999999999999999764   358999999999999999999998  5699999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      ||+++................||+.|+|||++.+ .++.++|||||||++|||++|+.||....................
T Consensus       160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (311)
T 3ork_A          160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP  239 (311)
T ss_dssp             CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH
T ss_pred             ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc
Confidence            9999865443222222334679999999997754 578899999999999999999999987665443333332221111


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...   ...     +...+..++.+||+.||++||+..+++.
T Consensus       240 ~~~---~~~-----~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          240 SAR---HEG-----LSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             HHH---STT-----CCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             ccc---cCC-----CCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            100   011     1223455678999999999998776653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.5e-42  Score=347.66  Aligned_cols=247  Identities=24%  Similarity=0.431  Sum_probs=193.1

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      .+.||+|+||.||+|++.++..||||++.....    .    .      ..|.+|+.++++++||||+++++++.+ ...
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~----~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   94 (283)
T 3gen_A           29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----S----E------DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI   94 (283)
T ss_dssp             EEECC---CEEEEEEEETTTEEEEEEEECTTSB----C----H------HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC----C----H------HHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence            578999999999999998888999999964311    0    1      248899999999999999999999976 456


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             EEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEEcCCCCEEEccccccccc
Confidence            89999999999999997532  358999999999999999999998  56999999999999999999999999999865


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .....  .......||+.|+|||++. ..++.++|||||||++|||+| |+.||....................      
T Consensus       171 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~------  242 (283)
T 3gen_A          171 LDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------  242 (283)
T ss_dssp             CCHHH--HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC------
T ss_pred             ccccc--ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC------
Confidence            43211  1122345788999999764 568889999999999999998 9999987654443333322211110      


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                       ....    ...+..++.+||+.+|++|||+.|+++.|...
T Consensus       243 -~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          243 -PHLA----SEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             -CTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCcC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence             1111    12345567899999999999999999998763

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.7e-41  Score=341.27  Aligned_cols=248  Identities=23%  Similarity=0.349  Sum_probs=193.6

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc--
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~--  190 (593)
                      ..+.||+|+||.||+|+++ |+.||||.+....     .... .     ...|.+|+.++++++||||+++++++.+.  
T Consensus        14 ~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~-----~~~~-~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A           14 FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRD-----WSTR-K-----SRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             EEEEEEEETTEEEEEEEET-TEEEEEEEECCTT-----CCHH-H-----HHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             HHHHhcCCCcceEEEEEEC-CeeEEEEEecccc-----cCHH-H-----HHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            4578999999999999986 8899999986431     1111 1     22588999999999999999999998763  


Q ss_pred             -cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         191 -MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       191 -~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                       ..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+.+|+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCeEeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence             4589999999999999998643 24689999999999999999999985444999999999999999999999999986


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccCC----CCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      .....        ....||+.|+|||++.+.    ++.++|||||||++|||++|+.||................... .
T Consensus       161 ~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~  231 (271)
T 3kmu_A          161 FSFQS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-T  231 (271)
T ss_dssp             CTTSC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC-C
T ss_pred             eeecc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC-C
Confidence            54222        234789999999987543    2337999999999999999999998765544333333222111 0


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                       .   ...     +...+..++.+||+.||++|||+.|+++.|++.
T Consensus       232 -~---~~~-----~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          232 -I---PPG-----ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             -C---CTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -C---CCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence             0   011     122355567899999999999999999999863

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=8.6e-42  Score=355.42  Aligned_cols=251  Identities=20%  Similarity=0.211  Sum_probs=191.9

Q ss_pred             CCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-
Q psy9535         113 RGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-  189 (593)
                      +.+.||+|+||.||+|+. .+|+.||||.+......        .       .|.+|+.+++++ +||||+++++++.. 
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~-------~~~~E~~~l~~l~~h~~i~~~~~~~~~~   77 (330)
T 2izr_A           13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--------P-------QLHLEYRFYKQLGSGDGIPQVYYFGPCG   77 (330)
T ss_dssp             EEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--------C-------CHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred             EEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--------H-------HHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence            467899999999999987 47899999998643210        0       378899999999 99999999998876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc-----cEEe
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-----PKLG  264 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~-----~Kl~  264 (593)
                      ...++||||+ +|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.     +||+
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill~~~~~~~~~~~kl~  152 (330)
T 2izr_A           78 KYNAMVLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHII  152 (330)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred             CccEEEEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeeccCCCCCCceEEEE
Confidence            4568999999 999999998642  469999999999999999999998  56999999999999998887     9999


Q ss_pred             ecccceecccCCCcce----eeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCc---hHHHHHHH
Q psy9535         265 DFGIVKMSETSNMKTM----YTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN---TILYYYLV  336 (593)
Q Consensus       265 DFGla~~~~~~~~~~~----~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~---~~~~~~~~  336 (593)
                      |||+++..........    ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....   ....+..+
T Consensus       153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i  232 (330)
T 2izr_A          153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI  232 (330)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred             EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence            9999987544322110    1235689999999997754 57889999999999999999999998632   11112222


Q ss_pred             HhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         337 VEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .....+...   .......    . .+..++..||..+|.+||++.+|++.|+..
T Consensus       233 ~~~~~~~~~---~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          233 GDTKRATPI---EVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             HHHHHHSCH---HHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HhhhccCCH---HHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            111111000   0000111    1 345567799999999999999999999763

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.6e-42  Score=358.07  Aligned_cols=247  Identities=24%  Similarity=0.357  Sum_probs=188.5

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.+.||+|+||.||+|+.. +++.||||++........            ...+.+|+.++++++|||||++++++.+ 
T Consensus        10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   77 (323)
T 3tki_A           10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC------------PENIKKEICINKMLNHENVVKFYGHRREG   77 (323)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------------------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccch------------HHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            44688999999999999876 789999999864321110            1147899999999999999999999877 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg~a  152 (323)
T 3tki_A           78 NIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLA  152 (323)
T ss_dssp             SEEEEEEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CeEEEEEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEeecc
Confidence            4568999999999999988642   458999999999999999999998  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC-CC-CCcchhhHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhhcCccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQEVPVREV  346 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~~-~~~~~~~~~~~~~~~  346 (593)
                      +....... ........||+.|+|||++.+ .+ +.++|||||||++|||++|+.||....... .+...........  
T Consensus       153 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--  229 (323)
T 3tki_A          153 TVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--  229 (323)
T ss_dssp             EECEETTE-ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTST--
T ss_pred             ceeccCCc-ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCC--
Confidence            86543321 112234689999999998754 33 668999999999999999999997643321 1111111111100  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        +      ...+...+..++.+||+.||++|||+.|+++
T Consensus       230 --~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          230 --P------WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             --T------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --c------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence              0      0111223445678999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.1e-42  Score=349.81  Aligned_cols=250  Identities=23%  Similarity=0.339  Sum_probs=193.2

Q ss_pred             CcccccCceEEEEEEEc---CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEeccc
Q psy9535         115 NKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  191 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~---~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~  191 (593)
                      +.||+|+||.||+|.+.   +++.||||.+.....    ...       ....|.+|+.++++++||||+++++++....
T Consensus        23 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~----~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   91 (291)
T 1xbb_A           23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN----DPA-------LKDELLAEANVMQQLDNPYIVRMIGICEAES   91 (291)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC---------CH-------HHHHHHHHHHHHHTCCCTTBCCEEEEEESSS
T ss_pred             CccccccCeeeEeeeecCCCceeeEEEEeeccccc----CHH-------HHHHHHHHHHHHHhCCCCCEEEEEEEECCCC
Confidence            38999999999999653   468899999864311    111       1225889999999999999999999997777


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             cEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            89999999999999999863   358999999999999999999998  5699999999999999999999999999987


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ...............||+.|+|||.+. ..++.++|||||||++|||++ |+.||.................+  ..   
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~---  241 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--GC---  241 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--CC---
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CC---
Confidence            654332222222345788999999774 457889999999999999999 99999876544333332222111  00   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                       ...     +...+..++.+||+.||++||++.+|++.|+..
T Consensus       242 -~~~-----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          242 -PAG-----CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             -CTT-----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -CCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             011     122355577899999999999999999999874

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-42  Score=353.86  Aligned_cols=246  Identities=31%  Similarity=0.512  Sum_probs=186.4

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      +.+.||+|+||.||+|++. ++.||||.+...        ..       ...|.+|+.++++++||||++++|++.+ ..
T Consensus        12 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--------~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~   74 (307)
T 2eva_A           12 VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--------SE-------RKAFIVELRQLSRVNHPNIVKLYGACLN-PV   74 (307)
T ss_dssp             EEEEEECCSSSEEEEEEET-TEEEEEEECSST--------TH-------HHHHHHHHHHHHHCCCTTBCCEEEBCTT-TT
T ss_pred             eeeEeecCCCceEEEEEEC-CeeEEEEEecCh--------hH-------HHHHHHHHHHHhcCCCCCcCeEEEEEcC-Cc
Confidence            3578999999999999985 788999998521        01       1258899999999999999999998874 47


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCeEecccCCCCeeecCCCc-cEEeecccce
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS-KPIIHRDVKSANVLLDENFV-PKLGDFGIVK  270 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~IiHrDLKp~NILl~~~~~-~Kl~DFGla~  270 (593)
                      ++||||+++|+|.+++........+++..++.++.|+++||.|||+.. ++|+||||||+|||++.++. +||+|||+++
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            899999999999999986544345789999999999999999999854 46999999999999998876 7999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCch--HHHHHHHHhhcCcccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT--ILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~--~~~~~~~~~~~~~~~~~~  347 (593)
                      .....      .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.....  ............  ... 
T Consensus       155 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~-  225 (307)
T 2eva_A          155 DIQTH------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR--PPL-  225 (307)
T ss_dssp             ----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC--CCC-
T ss_pred             ccccc------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC--CCc-
Confidence            54322      123469999999997754 578899999999999999999999975322  111111111111  111 


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                         ....     ...+..++.+||+.||++|||+.++++.|+...
T Consensus       226 ---~~~~-----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          226 ---IKNL-----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             ---BTTC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             ---cccc-----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence               1111     123455678999999999999999999998743

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-42  Score=364.24  Aligned_cols=253  Identities=25%  Similarity=0.378  Sum_probs=194.7

Q ss_pred             CCCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      +.++||+|+||.||+|++.      ++..||||++....     . ...      ...|.+|+.++++++|||||+++++
T Consensus        75 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~-~~~------~~~~~~E~~~l~~l~hpnIv~~~~~  142 (367)
T 3l9p_A           75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----S-EQD------ELDFLMEALIISKFNHQNIVRCIGV  142 (367)
T ss_dssp             EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-----C-HHH------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-----C-hhh------HHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            3578999999999999853      46789999985321     1 111      1258899999999999999999999


Q ss_pred             Eec-ccceEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC--
Q psy9535         187 CNN-IMNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF--  259 (593)
Q Consensus       187 ~~~-~~~~lV~Ey~~~GsL~~~L~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~--  259 (593)
                      +.+ ...++||||+++|+|.+++.....    ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++  
T Consensus       143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~  220 (367)
T 3l9p_A          143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPG  220 (367)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTT
T ss_pred             EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCCCC
Confidence            976 456899999999999999986532    2358999999999999999999999  5699999999999999544  


Q ss_pred             -ccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHH
Q psy9535         260 -VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLV  336 (593)
Q Consensus       260 -~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~  336 (593)
                       .+||+|||+++......... ......||+.|+|||++ ...++.++|||||||++|||++ |..||............
T Consensus       221 ~~~kL~DFG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i  299 (367)
T 3l9p_A          221 RVAKIGDFGMARDIYRAGYYR-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV  299 (367)
T ss_dssp             CCEEECCCHHHHHHHHHSSCT-TCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             ceEEECCCccccccccccccc-cCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             59999999997543222111 12235689999999976 5568899999999999999998 99999876654443333


Q ss_pred             HhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         337 VEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ........      ...     +...+..++.+||+.+|++||++.+|++.|+..
T Consensus       300 ~~~~~~~~------~~~-----~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          300 TSGGRMDP------PKN-----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             HTTCCCCC------CTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCCCC------Ccc-----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            32221100      011     112345567899999999999999999999764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=356.04  Aligned_cols=254  Identities=26%  Similarity=0.457  Sum_probs=194.3

Q ss_pred             CCCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  185 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g  185 (593)
                      .++.||+|+||.||+|+..      ++..||||.+......     ..       ...|.+|+.+++++ +||||+++++
T Consensus        49 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~-------~~~~~~E~~~l~~l~~hp~iv~~~~  116 (344)
T 1rjb_A           49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-----SE-------REALMSELKMMTQLGSHENIVNLLG  116 (344)
T ss_dssp             EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------------------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             eeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH-----HH-------HHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3678999999999999862      3568999999643110     00       12588999999999 8999999999


Q ss_pred             EEec-ccceEEEEeccCCCHHHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q psy9535         186 LCNN-IMNCIVYEYMCNGSLYDRLARVNNT--------------------PPLDSNKRYSIALGVAEALHYLHSLSKPII  244 (593)
Q Consensus       186 ~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~Ii  244 (593)
                      ++.. ...++||||+++|+|.+++......                    ..+++..+..++.|++.||.|||+  ++|+
T Consensus       117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~iv  194 (344)
T 1rjb_A          117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCV  194 (344)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEE
T ss_pred             EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCcc
Confidence            9876 5668999999999999999764321                    247999999999999999999999  5699


Q ss_pred             ecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCC
Q psy9535         245 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMK  322 (593)
Q Consensus       245 HrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~  322 (593)
                      ||||||+|||++.++.+||+|||+++....... ........||+.|+|||++ ...++.++|||||||++|||+| |..
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  273 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN  273 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCcc-ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence            999999999999999999999999986544322 1223345688999999976 4568899999999999999998 999


Q ss_pred             CCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         323 PIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       323 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ||...................      .....    +...+..++.+||..||.+|||+.||++.|+..
T Consensus       274 p~~~~~~~~~~~~~~~~~~~~------~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  332 (344)
T 1rjb_A          274 PYPGIPVDANFYKLIQNGFKM------DQPFY----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  332 (344)
T ss_dssp             SSTTCCCSHHHHHHHHTTCCC------CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcccCCcHHHHHHHHhcCCCC------CCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            997754322222222221111      00111    122345567899999999999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.9e-42  Score=364.31  Aligned_cols=267  Identities=17%  Similarity=0.229  Sum_probs=191.9

Q ss_pred             CCCcccccCceEEEEEEEcC------CCEEEEEEeecCCCCCCCCCchhHHhh---hcHHHHHHHHHHHhcCCCCceeeE
Q psy9535         113 RGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAM---IPILLFENEVQTLSQCKHVNLLRL  183 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~------g~~vAVK~l~~~~~~~~~~~~~~~~~~---~~~~~f~~Ev~il~~l~HpNIv~l  183 (593)
                      +.++||+|+||.||+|++..      ++.||||.+.....     ....+...   .....+..|+..++.++||||+++
T Consensus        39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG-----PLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             EEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH-----HHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             EEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch-----hHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            46789999999999998764      47899999864311     00111110   011234567778899999999999


Q ss_pred             EEEEecc-----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec--
Q psy9535         184 LGLCNNI-----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--  256 (593)
Q Consensus       184 ~g~~~~~-----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~--  256 (593)
                      ++++...     ..++||||+ +|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++  
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~--~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEESS
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEEecCCHHHEEEecC
Confidence            9988652     358999999 999999997642  469999999999999999999999  5699999999999999  


Q ss_pred             CCCccEEeecccceecccCCCcce----eeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHH
Q psy9535         257 ENFVPKLGDFGIVKMSETSNMKTM----YTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTIL  331 (593)
Q Consensus       257 ~~~~~Kl~DFGla~~~~~~~~~~~----~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~  331 (593)
                      .++.+||+|||+++..........    ......||+.|+|||++.+ .++.++|||||||++|||+||+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            889999999999987543321111    1133569999999998754 48899999999999999999999997522111


Q ss_pred             HHH--HHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         332 YYY--LVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       332 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      .+.  ............+++...   ...+...+..++..||+.+|++||++.+|++.|+...
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence            111  111111122222222110   0011223455678999999999999999999998743

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7e-42  Score=348.73  Aligned_cols=246  Identities=24%  Similarity=0.391  Sum_probs=188.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|+.. +|..||+|++......   .         ....+.+|++++++++||||+++++++.+ ..
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~---------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ---V---------PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC---S---------CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             cceeccCCCeEEEEEEEccCCceEEEEEeeccccc---h---------hHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence            578999999999999875 6899999998754211   0         12258899999999999999999999876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee---cCCCccEEeecc
Q psy9535         192 NCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFG  267 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl---~~~~~~Kl~DFG  267 (593)
                      .++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+  ++|+||||||+|||+   +.++.+||+|||
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            689999999999999986431 23568999999999999999999998  569999999999999   456889999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      +++.......    .....||+.|+|||++.+.++.++|||||||++|||++|+.||.....................  
T Consensus       173 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--  246 (285)
T 3is5_A          173 LAELFKSDEH----STNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV--  246 (285)
T ss_dssp             CCCC--------------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--
T ss_pred             cceecCCccc----CcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc--
Confidence            9976543321    2345799999999998888899999999999999999999999876543333222222211111  


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        ......     ..+..++.+||+.||++|||+.||++
T Consensus       247 --~~~~~~-----~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          247 --ECRPLT-----PQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ----CCCC-----HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             --ccCcCC-----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence              111111     22345667999999999999999874

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1e-41  Score=345.54  Aligned_cols=249  Identities=26%  Similarity=0.392  Sum_probs=197.6

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      ..+.||+|+||.||+|+..++..||||.+.....    .          ...|.+|++++++++||||+++++++.+...
T Consensus        17 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (279)
T 1qpc_A           17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----S----------PDAFLAEANLMKQLQHQRLVRLYAVVTQEPI   82 (279)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----C----------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             heeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc----c----------HHHHHHHHHHHHhCCCcCcceEEEEEcCCCc
Confidence            3578999999999999988888999999864311    0          1258899999999999999999999988888


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            99999999999999986432 1258999999999999999999998  56999999999999999999999999999876


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .....  .......||+.|+|||++. ..++.++|||||||++|||++ |+.||..................   ..   
T Consensus       160 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~---  231 (279)
T 1qpc_A          160 EDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---VR---  231 (279)
T ss_dssp             SSSCE--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CC---
T ss_pred             cCccc--ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC---CC---
Confidence            54321  1123356788999999774 457889999999999999999 99999875544333322221110   00   


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ...     +...+..++.+||..+|++|||+.++++.|+..
T Consensus       232 ~~~-----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          232 PDN-----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             CTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccc-----ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            011     122345567799999999999999999999874

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.9e-41  Score=353.11  Aligned_cols=244  Identities=23%  Similarity=0.309  Sum_probs=183.2

Q ss_pred             CCCcccccCceEEEEEEE----cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~----~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      ..+.||+|+||.||+++.    .+|+.||||+++.........         ....+.+|+.+|++++||||+++++++.
T Consensus        21 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           21 LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK---------DTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             EEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-----------------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             EEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhh---------HHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            357899999999999987    468999999997542111100         0124678999999999999999999987


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      . ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEECCCCcEEEEeCC
Confidence            6 5668999999999999999764   358899999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      +++......   .......||+.|+|||++. ..++.++|||||||++|||++|+.||...........+.......+..
T Consensus       167 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~  243 (327)
T 3a62_A          167 LCKESIHDG---TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY  243 (327)
T ss_dssp             CC-------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             cccccccCC---ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence            987543222   1123467999999999764 457889999999999999999999998766554444444333222211


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIV  385 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~  385 (593)
                                  +...+..++.+||..||.+||     ++.|++
T Consensus       244 ------------~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l  275 (327)
T 3a62_A          244 ------------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ  275 (327)
T ss_dssp             ------------SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHH
T ss_pred             ------------CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHH
Confidence                        122345567899999999999     555554

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-41  Score=352.64  Aligned_cols=275  Identities=26%  Similarity=0.388  Sum_probs=191.7

Q ss_pred             ecHHHHHHHhcCCCCCCC---CCCCCcccccCceEEEEEEEcC-----CCEEEEEEeecCCCCCCCCCchhHHhhhcHHH
Q psy9535          93 FTFCDLERATDGFNRKPY---PRRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILL  164 (593)
Q Consensus        93 ~~~~~l~~at~~f~~~~~---~~~~~~LG~G~fG~Vy~g~~~~-----g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~  164 (593)
                      +...+..+++..|.....   +...+.||+|+||.||+|+...     +..||||.+....     . ...      ...
T Consensus        25 ~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-----~-~~~------~~~   92 (333)
T 1mqb_A           25 AMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-----T-EKQ------RVD   92 (333)
T ss_dssp             -------------CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-----C-HHH------HHH
T ss_pred             cccCChhhhhhhccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-----C-HHH------HHH
Confidence            344455556666654211   2345789999999999998652     2359999986421     1 111      125


Q ss_pred             HHHHHHHHhcCCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q psy9535         165 FENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPI  243 (593)
Q Consensus       165 f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~I  243 (593)
                      |.+|+.++++++||||+++++++.+ ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+|
T Consensus        93 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~i  168 (333)
T 1mqb_A           93 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLAN--MNY  168 (333)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTC
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCe
Confidence            8899999999999999999999976 45689999999999999997642  468999999999999999999998  569


Q ss_pred             EecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CC
Q psy9535         244 IHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GM  321 (593)
Q Consensus       244 iHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~  321 (593)
                      +||||||+|||++.++.+||+|||+++................||+.|+|||++. ..++.++|||||||++|||++ |+
T Consensus       169 vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~  248 (333)
T 1mqb_A          169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE  248 (333)
T ss_dssp             CCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             eCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999987544322111122345788999999774 567889999999999999999 99


Q ss_pred             CCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcccc
Q psy9535         322 KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFV  394 (593)
Q Consensus       322 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~~  394 (593)
                      .||.................. .     ....     +...+..++.+||+.+|++||++.+|++.|++....
T Consensus       249 ~pf~~~~~~~~~~~~~~~~~~-~-----~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          249 RPYWELSNHEVMKAINDGFRL-P-----TPMD-----CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             CTTTTCCHHHHHHHHHTTCCC-C-----CCTT-----CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCcccCCHHHHHHHHHCCCcC-C-----Cccc-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            999875544333332222110 0     0011     122345567899999999999999999999875443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.2e-41  Score=358.34  Aligned_cols=239  Identities=25%  Similarity=0.338  Sum_probs=193.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +|+.||||++.......          ......+.+|+.+|++++||||+++++++.+ ..
T Consensus        46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  115 (350)
T 1rdq_E           46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK----------LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc----------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            578999999999999975 68999999996431110          1112357899999999999999999998876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~  190 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEECCCCCEEEccccccee
Confidence            68999999999999999864   358999999999999999999998  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ....      ....+||+.|+|||++. ..++.++|||||||++|||++|+.||...+....+..+......++..    
T Consensus       191 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~----  260 (350)
T 1rdq_E          191 VKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----  260 (350)
T ss_dssp             CSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT----
T ss_pred             ccCC------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCC----
Confidence            5432      22457999999999774 457889999999999999999999998876655555544443322211    


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCC-----hHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRAS-----MRDIV  385 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs-----m~eV~  385 (593)
                              +...+..++.+||+.||.+||+     +.||+
T Consensus       261 --------~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~  292 (350)
T 1rdq_E          261 --------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK  292 (350)
T ss_dssp             --------CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH
T ss_pred             --------CCHHHHHHHHHHhhcCHHhccCCccCCHHHHH
Confidence                    1123455778999999999998     77764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.1e-41  Score=358.59  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=191.4

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.+.||+|+||.||+|+.+ +|+.||||++..........        .....|.+|+.++++++|||||++++++.+ .
T Consensus        28 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   99 (351)
T 3c0i_A           28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPG--------LSTEDLKREASICHMLKHPHIVELLETYSSDG   99 (351)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSS--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             EeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccccc--------chHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            3578999999999999875 68999999986431111100        012258899999999999999999998876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc---cEEeec
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---PKLGDF  266 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~---~Kl~DF  266 (593)
                      ..++||||+++|+|.+.+.... ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.   +||+||
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~~vkl~Df  177 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGF  177 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCCcEEEecC
Confidence            5689999999999998886532 23458999999999999999999998  56999999999999986554   999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      |+++.......   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ....+.........
T Consensus       178 g~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~i~~~~~~~~~  253 (351)
T 3c0i_A          178 GVAIQLGESGL---VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNP  253 (351)
T ss_dssp             TTCEECCTTSC---BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-HHHHHHHTCCCCCH
T ss_pred             cceeEecCCCe---eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-HHHHHHcCCCCCCc
Confidence            99987654321   1234579999999998754 5789999999999999999999999875432 22222222211110


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         ....     .+...+..++.+||+.||++|||+.|+++
T Consensus       254 ---~~~~-----~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          254 ---RQWS-----HISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ---HHHT-----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---cccc-----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               0001     11233556778999999999999999874

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-41  Score=345.91  Aligned_cols=252  Identities=22%  Similarity=0.360  Sum_probs=197.6

Q ss_pred             CCcccccCceEEEEEEEc---CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         114 GNKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~---~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      +..||+|+||.||+|.+.   ++..||||.+....     ...       ....|.+|+.++++++||||+++++++...
T Consensus        15 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-----~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   82 (287)
T 1u59_A           15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-----EKA-------DTEEMMREAQIMHQLDNPYIVRLIGVCQAE   82 (287)
T ss_dssp             EEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-----CHH-------HHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hccccccCceeEEEeEeccCCCcceEEEEecCCcc-----chh-------HHHHHHHHHHHHHhCCCCCEeEEEEEecCC
Confidence            348999999999999864   57889999986431     111       122588999999999999999999999777


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...  ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CcEEEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEEcCCCCEEECccccee
Confidence            789999999999999999643  3468999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ................||+.|+|||++. ..++.++|||||||++|||++ |+.||.................+  . . 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~--~-~-  234 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM--E-C-  234 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC--C-C-
T ss_pred             eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC--C-C-
Confidence            7644332112223346789999999774 457889999999999999998 99999875544333332222111  0 0 


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                        ...     +...+..++.+||..+|++||++.++++.|+...
T Consensus       235 --~~~-----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          235 --PPE-----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             --CTT-----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCC-----cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              011     1223555678999999999999999999998753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.1e-42  Score=364.40  Aligned_cols=243  Identities=24%  Similarity=0.394  Sum_probs=187.7

Q ss_pred             CCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.+.||+|+||.||+|+. .+|+.||||++.........          ....+.+|+.+++.++||||+++++++.. 
T Consensus        12 ~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~----------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   81 (336)
T 3h4j_B           12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSD----------MHMRVEREISYLKLLRHPHIIKLYDVITTP   81 (336)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTT----------CSHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchh----------HHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            3467899999999999997 47899999998643110000          11257899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+ +|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~DFG~s  155 (336)
T 3h4j_B           82 TDIVMVIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLS  155 (336)
T ss_dssp             SEEEEEECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCSTTTEEECTTCCEEECCSSCT
T ss_pred             CEEEEEEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCchhhEEEcCCCCEEEEEeccc
Confidence            4568999999 79999998764   358999999999999999999998  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccCC-C-CCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      +.......    ....+||+.|+|||++.+. + +.++|||||||++|||++|+.||.+......          ...+ 
T Consensus       156 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------~~~i-  220 (336)
T 3h4j_B          156 NIMTDGNF----LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------FKKV-  220 (336)
T ss_dssp             BTTTTSBT----TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------BCCC-
T ss_pred             eeccCCcc----cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------HHHH-
Confidence            86544321    2345799999999988654 3 6799999999999999999999976421100          0000 


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...... .+..+...+..++.+||+.||.+|||+.|+++
T Consensus       221 ~~~~~~-~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          221 NSCVYV-MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CSSCCC-CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             HcCCCC-CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            000000 01112233456778999999999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=7.5e-42  Score=386.87  Aligned_cols=250  Identities=23%  Similarity=0.339  Sum_probs=192.5

Q ss_pred             CcccccCceEEEEEEEc---CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEeccc
Q psy9535         115 NKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  191 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~---~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~  191 (593)
                      ++||+|+||.||+|.+.   .++.||||+++....    ...       ....|.+|+++|++++|||||+++++|....
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~----~~~-------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  443 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN----DPA-------LKDELLAEANVMQQLDNPYIVRMIGICEAES  443 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG----CGG-------GHHHHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC----CHH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            47999999999999763   467899999964311    000       1235889999999999999999999998888


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++...   ..+++..+..|+.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       444 ~~lv~E~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl~~~~~~kL~DFGla~~  518 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKA  518 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEEEccCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence            89999999999999999753   458999999999999999999998  5699999999999999999999999999987


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ...............||+.|+|||++. ..++.++|||||||++|||++ |+.||...........+......  ..   
T Consensus       519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~--~~---  593 (635)
T 4fl3_A          519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--GC---  593 (635)
T ss_dssp             TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--CC---
T ss_pred             cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CC---
Confidence            644322112223346788999999774 468999999999999999998 99999876554433333222111  00   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                       ...     +...+..++.+||+.||++||++.+|++.|+..
T Consensus       594 -p~~-----~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          594 -PAG-----CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             -CTT-----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -CCC-----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             011     122345567799999999999999999999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.5e-42  Score=353.77  Aligned_cols=240  Identities=24%  Similarity=0.275  Sum_probs=182.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      .++||+|+||+||+|+.. +|+.||||++.....    . .. .     ...+..|+..+.++ +|||||+++++|.+ .
T Consensus        62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~-~~-~-----~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR----G-PK-D-----RARKLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC----S-HH-H-----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             eheeccCCCeEEEEEEECCCCeEEEEEEeccccc----C-hH-H-----HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            578999999999999986 799999999854311    1 11 1     11345566665555 99999999999976 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+ +|+|.+++...+  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~DFG~a~  205 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLV  205 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred             EEEEEEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEccceeee
Confidence            568999999 789999987653  469999999999999999999998  569999999999999999999999999988


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .......    .....||+.|+|||++.+.++.++|||||||++|||++|..|+......   ........+      +.
T Consensus       206 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~~------~~  272 (311)
T 3p1a_A          206 ELGTAGA----GEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLP------PE  272 (311)
T ss_dssp             ECC----------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCCC------HH
T ss_pred             ecccCCC----CcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCCC------cc
Confidence            6543321    2345799999999998888999999999999999999997777543221   111111100      00


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..    ..+...+..++.+||+.||++|||+.|+++
T Consensus       273 ~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          273 FT----AGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            00    111233555678999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-41  Score=359.24  Aligned_cols=254  Identities=28%  Similarity=0.419  Sum_probs=196.9

Q ss_pred             CCCcccccCceEEEEEEEc--------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  183 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~--------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l  183 (593)
                      ++++||+|+||.||+|+..        .+..||||++....     ...       ....+.+|+++++++ +|||||++
T Consensus        73 i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-----~~~-------~~~~~~~E~~~l~~l~~hpnIv~~  140 (382)
T 3tt0_A           73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-----TEK-------DLSDLISEMEMMKMIGKHKNIINL  140 (382)
T ss_dssp             EEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-----CHH-------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             eeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-----CHH-------HHHHHHHHHHHHHHhcCCchhhhh
Confidence            4578999999999999863        23579999986431     111       123588999999999 99999999


Q ss_pred             EEEEec-ccceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccC
Q psy9535         184 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  249 (593)
Q Consensus       184 ~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLK  249 (593)
                      +++|.. ...++||||+++|+|.+++.....             ...+++..+..++.|++.||.|||+  .+|+|||||
T Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlk  218 (382)
T 3tt0_A          141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLA  218 (382)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCC
T ss_pred             eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCCCC
Confidence            999976 466899999999999999986432             2358999999999999999999998  569999999


Q ss_pred             CCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCC
Q psy9535         250 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDN  327 (593)
Q Consensus       250 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~  327 (593)
                      |+|||++.++.+||+|||+++........ .......||+.|+|||++. ..++.++|||||||++|||++ |..||...
T Consensus       219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          219 ARNVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             GGGEEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cceEEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999865433211 1123356789999999764 457889999999999999999 99999876


Q ss_pred             chHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         328 NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      .................      ....     ...+..++.+||+.+|++|||+.||++.|++..
T Consensus       298 ~~~~~~~~~~~~~~~~~------~~~~-----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          298 PVEELFKLLKEGHRMDK------PSNC-----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             CHHHHHHHHHTTCCCCC------CSSC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHcCCCCCC------CccC-----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            54433333222211100      0111     123455678999999999999999999998854

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.8e-41  Score=341.86  Aligned_cols=249  Identities=29%  Similarity=0.470  Sum_probs=184.1

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ..+.||+|+||.||+|++. |+.||||++.........         .....|.+|+.++++++||||+++++++.+ ..
T Consensus        11 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A           11 LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDIS---------QTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             EEEEEEEETTEEEEEEEET-TEEEEEEEC-------------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             eeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHH---------HHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            4678999999999999975 889999998643211100         012358899999999999999999999876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeEecccCCCCeeecC--------CCccE
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDE--------NFVPK  262 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~IiHrDLKp~NILl~~--------~~~~K  262 (593)
                      .++||||+++|+|.+++..    ..+++..+..++.|++.||.|||+.+. +|+||||||+|||++.        ++.+|
T Consensus        81 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             eEEEEEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence            6899999999999998853    468999999999999999999998432 2999999999999986        77899


Q ss_pred             EeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC
Q psy9535         263 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  341 (593)
Q Consensus       263 l~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~  341 (593)
                      |+|||+++......     .....||+.|+|||.+. ..++.++||||||+++|||++|+.||.................
T Consensus       157 l~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  231 (271)
T 3dtc_A          157 ITDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL  231 (271)
T ss_dssp             ECCCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC
T ss_pred             EccCCccccccccc-----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC
Confidence            99999997654322     12357999999999764 4578899999999999999999999987654433333222221


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ...     ....     +...+..++.+||+.+|++|||+.|+++.|++
T Consensus       232 ~~~-----~~~~-----~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          232 ALP-----IPST-----CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             CCC-----CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCC-----CCcc-----cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            110     0011     12235556789999999999999999999875

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.8e-42  Score=360.73  Aligned_cols=239  Identities=26%  Similarity=0.385  Sum_probs=189.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      .+.||+|+||.||+|+.+ +|+.||||++++......          .....+.+|..++..+ +||||+++++++.+ .
T Consensus        22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD----------DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhh----------hhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            678999999999999986 689999999975311100          0122467899999876 99999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            668999999999999999764   358999999999999999999999  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .......   .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||...+....+..+.......+.    
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----  239 (345)
T 1xjd_A          167 ENMLGDA---KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----  239 (345)
T ss_dssp             CCCCTTC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----
T ss_pred             hcccCCC---cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----
Confidence            6432221   1345689999999997754 5789999999999999999999999876655544444433322211    


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMR  382 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~  382 (593)
                          .    +...+..++.+||..||++||++.
T Consensus       240 ----~----~s~~~~~li~~lL~~dp~~R~~~~  264 (345)
T 1xjd_A          240 ----W----LEKEAKDLLVKLFVREPEKRLGVR  264 (345)
T ss_dssp             ----T----SCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred             ----c----cCHHHHHHHHHHhcCCHhHcCCCh
Confidence                1    122345567899999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.7e-42  Score=353.67  Aligned_cols=255  Identities=21%  Similarity=0.326  Sum_probs=184.4

Q ss_pred             CCCCcccccCceEEEEEEEcC-C---CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKN-G---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~-g---~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      +..+.||+|+||.||+|+... +   ..||||.+.....    ....       ...|.+|+.++++++||||+++++++
T Consensus        26 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~----~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII----ASSD-------IEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             EEEEEEEEETTEEEEEEEC-------CEEEEEEC----------CHH-------HHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             EEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc----CHHH-------HHHHHHHHHHHHHCCCCceehhhcee
Confidence            346899999999999998653 3   2799999864311    1111       23588999999999999999999988


Q ss_pred             ecc-cc------eEEEEeccCCCHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC
Q psy9535         188 NNI-MN------CIVYEYMCNGSLYDRLARVNN---TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  257 (593)
Q Consensus       188 ~~~-~~------~lV~Ey~~~GsL~~~L~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~  257 (593)
                      ... ..      ++||||+++|+|.+++.....   ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIli~~  172 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAE  172 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECT
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEEEcC
Confidence            653 22      899999999999999965321   2258999999999999999999999  56999999999999999


Q ss_pred             CCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHH
Q psy9535         258 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYL  335 (593)
Q Consensus       258 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~  335 (593)
                      ++.+||+|||+++......... ......||+.|+|||.+. ..++.++|||||||++|||++ |..||...........
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~  251 (323)
T 3qup_A          173 DMTVCVADFGLSRKIYSGDYYR-QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY  251 (323)
T ss_dssp             TSCEEECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred             CCCEEEeecccccccccccccc-ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence            9999999999998654332111 122345788999999764 457889999999999999999 9999987554433333


Q ss_pred             HHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         336 VVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ........      .....     ...+..++.+||+.||++|||+.++++.|++.
T Consensus       252 ~~~~~~~~------~~~~~-----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          252 LIGGNRLK------QPPEC-----MEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             HHTTCCCC------CCTTC-----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcCCCCC------CCCcc-----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            32222110      00111     12345567899999999999999999999874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.2e-41  Score=361.39  Aligned_cols=249  Identities=27%  Similarity=0.352  Sum_probs=189.5

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHH-HhcCCCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT-LSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~i-l~~l~HpNIv~l~g~~~~-~  190 (593)
                      .+.||+|+||.||+|+.+ +++.||||++.+........          ...+.+|..+ ++.++|||||++++++.+ .
T Consensus        43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~----------~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE----------EKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-----------------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHH----------HHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            578999999999999986 58899999997643221111          1135567776 577899999999998876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++.+.   ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~ikL~DFG~a~  187 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCK  187 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred             EEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence            668999999999999999764   358899999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .......   .....+||+.|+|||++.+ .++.++|||||||++|||++|..||...+....+..+......++.    
T Consensus       188 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----  260 (373)
T 2r5t_A          188 ENIEHNS---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----  260 (373)
T ss_dssp             GGBCCCC---CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS----
T ss_pred             ccccCCC---ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC----
Confidence            6432221   2345689999999998754 5788999999999999999999999887665555555443322211    


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                         .     +...+..++.+||+.||.+||++.+.++.+.++.
T Consensus       261 ---~-----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~  295 (373)
T 2r5t_A          261 ---N-----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV  295 (373)
T ss_dssp             ---S-----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSG
T ss_pred             ---C-----CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCc
Confidence               1     1123455678999999999999976555555443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.4e-41  Score=362.11  Aligned_cols=202  Identities=21%  Similarity=0.297  Sum_probs=166.5

Q ss_pred             CCCccccc--CceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         113 RGNKLGEG--QFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       113 ~~~~LG~G--~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      +.++||+|  +||.||+|+.. +|+.||||++.....    . .  +    ....+.+|+.++++++|||||++++++.+
T Consensus        29 ~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~----~-~--~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC----S-N--E----MVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             EEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS----C-H--H----HHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             EEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc----C-h--H----HHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            35789999  99999999986 699999999975321    0 1  1    12357889999999999999999998876


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~kl~dfg~  174 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRS  174 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEccccc
Confidence             56689999999999999998643 2458999999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCc----ceeeccccCCCCcCCcccccC---CCCCcchhhHHHHHHHHHHhCCCCCCCCc
Q psy9535         269 VKMSETSNMK----TMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNN  328 (593)
Q Consensus       269 a~~~~~~~~~----~~~~~~~~GT~~Y~APE~~~~---~~~~ksDVwSfGvvl~ElltG~~P~~~~~  328 (593)
                      +.........    ........||+.|+|||++.+   .++.++|||||||++|||++|+.||.+..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  241 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  241 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence            8654322111    111223479999999998754   57889999999999999999999997643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.7e-41  Score=355.00  Aligned_cols=238  Identities=24%  Similarity=0.355  Sum_probs=185.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      .+.||+|+||.||+|+.+ +|+.||||++.+....   . .  .    ....+.+|+.++.++ +|||||++++++.+ .
T Consensus        14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---~-~--~----~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   83 (345)
T 3a8x_A           14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN---D-D--E----DIDWVQTEKHVFEQASNHPFLVGLHSCFQTES   83 (345)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC---S-H--H----HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc---c-h--H----HHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence            578999999999999986 5889999999754211   1 1  1    122477899999988 89999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFG~a~  158 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  158 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred             EEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEEeccccc
Confidence            668999999999999999764   358999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCC---------chHHHHHHHHhhc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDN---------NTILYYYLVVEQE  340 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~---------~~~~~~~~~~~~~  340 (593)
                      .......   .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||...         .....+..+....
T Consensus       159 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~  235 (345)
T 3a8x_A          159 EGLRPGD---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ  235 (345)
T ss_dssp             CSCCTTC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC
T ss_pred             cccCCCC---cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC
Confidence            5432221   1334689999999997754 5788999999999999999999999642         1111122222222


Q ss_pred             CccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCCh
Q psy9535         341 VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASM  381 (593)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm  381 (593)
                      ..++.            .+...+..++.+||+.||.+||++
T Consensus       236 ~~~p~------------~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 IRIPR------------SLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CCCCT------------TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCCC------------CCCHHHHHHHHHHhcCCHhHCCCC
Confidence            21111            112234556789999999999996

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.5e-41  Score=349.73  Aligned_cols=254  Identities=26%  Similarity=0.370  Sum_probs=195.7

Q ss_pred             CCCCcccccCceEEEEEEE------cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKL------KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  185 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~------~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g  185 (593)
                      +..+.||+|+||.||+|+.      .++..||||.+....     ...       ....+.+|+.++++++||||+++++
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~-------~~~~~~~E~~~l~~l~hp~iv~~~~   93 (314)
T 2ivs_A           26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-----SPS-------ELRDLLSEFNVLKQVNHPHVIKLYG   93 (314)
T ss_dssp             EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-----CHH-------HHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-----CHH-------HHHHHHHHHHHHhhCCCCceeeEEE
Confidence            3467899999999999986      235789999986321     111       1235889999999999999999999


Q ss_pred             EEec-ccceEEEEeccCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q psy9535         186 LCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------------TPPLDSNKRYSIALGVAEALHYLHSLSKPI  243 (593)
Q Consensus       186 ~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~I  243 (593)
                      ++.+ ...++||||+++|+|.+++.....                     ...+++..+..++.|+++||.|||+  ++|
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i  171 (314)
T 2ivs_A           94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKL  171 (314)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--TTE
T ss_pred             EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--CCC
Confidence            9876 566899999999999999986432                     1248899999999999999999998  569


Q ss_pred             EecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CC
Q psy9535         244 IHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GM  321 (593)
Q Consensus       244 iHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~  321 (593)
                      +||||||+|||++.++.+||+|||+++....... ........||+.|+|||.+. ..++.++|||||||++|||++ |.
T Consensus       172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  250 (314)
T 2ivs_A          172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG  250 (314)
T ss_dssp             ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             cccccchheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999987644322 11123356789999999764 457889999999999999999 99


Q ss_pred             CCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         322 KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       322 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .||..................  .    ....     +...+..++.+||+.||++||++.||++.|++.
T Consensus       251 ~p~~~~~~~~~~~~~~~~~~~--~----~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          251 NPYPGIPPERLFNLLKTGHRM--E----RPDN-----CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             CSSTTCCGGGHHHHHHTTCCC--C----CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHhhcCCcC--C----CCcc-----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            999875543333222221110  0    0011     122345567899999999999999999999874

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=361.21  Aligned_cols=242  Identities=24%  Similarity=0.305  Sum_probs=188.1

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.+.||+|+||.||+|+.. +|+.||||.+.......          ......+.+|+.+|++++|||||++++++.+ .
T Consensus        19 i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~----------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A           19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE----------RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             EEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc----------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            3578999999999999875 58899999986431111          1112357899999999999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+.+|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEECCCCCEEEeccceee
Confidence            668999999999999999753   458999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC----CCCCcchhhHHHHHHHHHHhCCCCCCCCch---HHHHHHHHhhcCcc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNT---ILYYYLVVEQEVPV  343 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~----~~~~ksDVwSfGvvl~ElltG~~P~~~~~~---~~~~~~~~~~~~~~  343 (593)
                      ......    .....+||+.|+|||++..    .++.++|||||||++|||++|+.||.....   ..............
T Consensus       164 ~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  239 (384)
T 4fr4_A          164 MLPRET----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY  239 (384)
T ss_dssp             ECCTTC----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCC
T ss_pred             eccCCC----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCC
Confidence            764332    1234689999999998742    478899999999999999999999975321   11111111111111


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCC-hHHHH
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS-MRDIV  385 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs-m~eV~  385 (593)
                      +.       .+     ...+..++.+||+.||.+||+ +.+|.
T Consensus       240 p~-------~~-----s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          240 PS-------AW-----SQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             CT-------TS-----CHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             CC-------cC-----CHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence            11       11     223455678999999999999 55553

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.1e-41  Score=354.89  Aligned_cols=241  Identities=29%  Similarity=0.476  Sum_probs=190.0

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+. .+|+.||||++.....    . .. +    ....|.+|+.++++++|||||++++++.+ ..
T Consensus        59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~----~-~~-~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  128 (348)
T 1u5q_A           59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK----Q-SN-E----KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT  128 (348)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS----C-HH-H----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             eeEEccCCCEEEEEEEEccCCeEEEEEEEccccc----c-ch-H----HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCe
Confidence            57899999999999987 4789999999964311    1 11 1    12358899999999999999999998876 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+. |+|.+.+....  .++++..+..++.|+++||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus       129 ~~lv~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          129 AWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EEEEEecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence            689999997 78988886533  468999999999999999999999  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCcccc----cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~----~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ....       ....||+.|+|||++    ...++.++|||||||++|||++|+.||.................+..  .
T Consensus       204 ~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~  274 (348)
T 1u5q_A          204 MAPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--Q  274 (348)
T ss_dssp             SSSB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--C
T ss_pred             cCCC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--C
Confidence            5322       235799999999976    34578899999999999999999999987655444333333222111  0


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         ...+     ...+..++.+||+.+|++|||+.++++
T Consensus       275 ---~~~~-----~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          275 ---SGHW-----SEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             ---CTTS-----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCC-----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence               1112     223455678999999999999999865

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=369.56  Aligned_cols=260  Identities=20%  Similarity=0.269  Sum_probs=198.3

Q ss_pred             cHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHH
Q psy9535          94 TFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL  172 (593)
Q Consensus        94 ~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il  172 (593)
                      .+.+++..+++|..      .+.||+|+||.||+|+.+ +|+.||||++.+....        .  ......+.+|+.++
T Consensus        52 ~~~~~~~~~~~f~~------~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~--------~--~~~~~~~~~E~~il  115 (412)
T 2vd5_A           52 RLKEVRLQRDDFEI------LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML--------K--RGEVSCFREERDVL  115 (412)
T ss_dssp             HHHHHSCCGGGEEE------EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--------H--HGGGCCHHHHHHHH
T ss_pred             hhhhccCChhhEEE------EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh--------h--HHHHHHHHHHHHHH
Confidence            34444445566654      688999999999999985 6999999999642110        0  00112478899999


Q ss_pred             hcCCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCC
Q psy9535         173 SQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA  251 (593)
Q Consensus       173 ~~l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~  251 (593)
                      .+++||||+++++++.+ ...++||||+++|+|.++|.+.+  ..+++..+..++.|++.||+|||+  .+|+||||||+
T Consensus       116 ~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~  191 (412)
T 2vd5_A          116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPD  191 (412)
T ss_dssp             HHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGG
T ss_pred             HhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHH
Confidence            99999999999999876 45689999999999999998643  358999999999999999999998  56999999999


Q ss_pred             CeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc--------CCCCCcchhhHHHHHHHHHHhCCCC
Q psy9535         252 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--------CQISTKTDVFSYGVILLELLTGMKP  323 (593)
Q Consensus       252 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--------~~~~~ksDVwSfGvvl~ElltG~~P  323 (593)
                      |||++.++.+||+|||+++.......  ......+||+.|+|||++.        ..++.++|||||||++|||++|+.|
T Consensus       192 NILld~~g~vkL~DFGla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P  269 (412)
T 2vd5_A          192 NILLDRCGHIRLADFGSCLKLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP  269 (412)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred             HeeecCCCCEEEeechhheeccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCC
Confidence            99999999999999999987654332  1223468999999999774        3478899999999999999999999


Q ss_pred             CCCCchHHHHHHHHhhc--CccccccccccCCCCHHHHHHHHHHHHHHhhccccCCC---CChHHHH
Q psy9535         324 IDDNNTILYYYLVVEQE--VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKR---ASMRDIV  385 (593)
Q Consensus       324 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~R---Psm~eV~  385 (593)
                      |...+....+..+....  ...+..         ...+...+..++.+||. +|.+|   |++.||+
T Consensus       270 f~~~~~~~~~~~i~~~~~~~~~p~~---------~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~  326 (412)
T 2vd5_A          270 FYADSTAETYGKIVHYKEHLSLPLV---------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR  326 (412)
T ss_dssp             TCCSSHHHHHHHHHTHHHHCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHH
T ss_pred             CCCCCHHHHHHHHHhcccCcCCCcc---------ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence            98876555444443321  111100         01112335556789998 99988   5777774

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6e-41  Score=339.50  Aligned_cols=244  Identities=21%  Similarity=0.314  Sum_probs=194.7

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.+.||+|+||.||+|+.. ++..||+|++.....   ..          ...|.+|++++++++||||+++++++.+ .
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (277)
T 3f3z_A           13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---ED----------VDRFKQEIEIMKSLDHPNIIRLYETFEDNT   79 (277)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SC----------HHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             eeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---ch----------HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            3578999999999999876 578899999865321   10          1258899999999999999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee---cCCCccEEeecc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFG  267 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl---~~~~~~Kl~DFG  267 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||+   +.++.+||+|||
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg  154 (277)
T 3f3z_A           80 DIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFG  154 (277)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             eEEEEEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence            568999999999999998764   358999999999999999999998  569999999999999   788999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      +++.......    .....||+.|+|||++.+.++.++|||||||++|||++|+.||...................+.. 
T Consensus       155 ~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  229 (277)
T 3f3z_A          155 LAARFKPGKM----MRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK-  229 (277)
T ss_dssp             TCEECCTTSC----BCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH-
T ss_pred             cceeccCccc----hhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch-
Confidence            9987544321    23357999999999988889999999999999999999999998766544444433332221110 


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        ....     +...+..++.+||+.||++|||+.|+++
T Consensus       230 --~~~~-----~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          230 --DWLN-----VSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             --HHTT-----SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --hhhc-----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0001     1233455678999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=358.69  Aligned_cols=244  Identities=24%  Similarity=0.347  Sum_probs=187.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +|+.||||++....      ...       ...|.+|+.+|++++|||||++++++.+ ..
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~------~~~-------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  160 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG------MKD-------KEEVKNEISVMNQLDHANLIQLYDAFESKND  160 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCS------HHH-------HHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc------ccc-------HHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            357999999999999875 68999999986431      011       1258899999999999999999999876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee--cCCCccEEeecccc
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGIV  269 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl--~~~~~~Kl~DFGla  269 (593)
                      .++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||+  +.++.+||+|||++
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a  236 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLA  236 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence            689999999999999987532  358999999999999999999998  569999999999999  56789999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      +.......    .....||+.|+|||++.. .++.++|||||||++|||++|+.||...........+.........   
T Consensus       237 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~---  309 (373)
T 2x4f_A          237 RRYKPREK----LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED---  309 (373)
T ss_dssp             EECCTTCB----CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS---
T ss_pred             eecCCccc----cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh---
Confidence            87654321    223579999999997754 4788999999999999999999999876655444444333222111   


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .....     +...+..++.+||+.||.+|||+.|+++
T Consensus       310 ~~~~~-----~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          310 EEFQD-----ISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GGGTT-----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhcc-----CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11111     1233455778999999999999999976

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.1e-41  Score=347.66  Aligned_cols=250  Identities=27%  Similarity=0.367  Sum_probs=195.2

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|+.. +|+.||||.+............       ....|.+|+.++++++||||+++++++.+ .
T Consensus        16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (321)
T 2a2a_A           16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV-------SREEIEREVSILRQVLHHNVITLHDVYENRT   88 (321)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSB-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccch-------hHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            3678999999999999975 6899999999765332211111       12258899999999999999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC----ccEEeec
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLGDF  266 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~----~~Kl~DF  266 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++    .+||+||
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            568999999999999999753   468999999999999999999998  5699999999999999887    7999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      |+++.......    .....||+.|+|||++. ..++.++|||||||++|||++|..||.....................
T Consensus       164 g~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  239 (321)
T 2a2a_A          164 GLAHEIEDGVE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE  239 (321)
T ss_dssp             TTCEECCTTCC----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             ccceecCcccc----ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh
Confidence            99987654321    23457999999999775 45788999999999999999999999876554443333322211111


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..   ...     ....+..++.+||+.||++|||+.|+++
T Consensus       240 ~~---~~~-----~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          240 EF---FSH-----TSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HH---HTT-----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             hh---hcc-----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00   011     1233556778999999999999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.7e-41  Score=357.74  Aligned_cols=238  Identities=25%  Similarity=0.312  Sum_probs=189.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      .+.||+|+||.||+|+.+ +|+.||||++++......          .....+.+|..++..+ +||||+++++++.+ .
T Consensus        25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~----------~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   94 (353)
T 2i0e_A           25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD----------DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   94 (353)
T ss_dssp             EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcc----------hHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence            578999999999999986 478899999975321110          1123477899999988 79999999998876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence            668999999999999999864   358999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .......   .....+||+.|+|||++. ..++.++|||||||++|||++|+.||...+....+..+......++..   
T Consensus       170 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~---  243 (353)
T 2i0e_A          170 ENIWDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS---  243 (353)
T ss_dssp             CCCCTTC---CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT---
T ss_pred             ccccCCc---ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCC---
Confidence            6432221   133568999999999875 457889999999999999999999998876555555544433322211   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCCh
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASM  381 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm  381 (593)
                               +...+..++.+||..||.+||++
T Consensus       244 ---------~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          244 ---------MSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             ---------SCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             ---------CCHHHHHHHHHHhhcCHHHcCCC
Confidence                     12234556789999999999975

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-41  Score=370.66  Aligned_cols=244  Identities=27%  Similarity=0.458  Sum_probs=194.6

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      .+++.||+|+||.||+|+.. +|+.||||++.......          ......+.+|+.+++.++||||+++++++.. 
T Consensus        19 ~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~----------~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~   88 (476)
T 2y94_A           19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS----------LDVVGKIRREIQNLKLFRHPHIIKLYQVISTP   88 (476)
T ss_dssp             EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH----------TTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC----------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            34678999999999999986 79999999996431100          0112358899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDLkp~NIll~~~~~vkL~DFG~a  163 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLS  163 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcccccHHHEEEecCCCeEEEeccch
Confidence            5668999999999999999652   468999999999999999999998  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccCC-C-CCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      +.......    ....+||+.|+|||++.+. + +.++|||||||++|||++|+.||.+.........+.......+.. 
T Consensus       164 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~-  238 (476)
T 2y94_A          164 NMMSDGEF----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY-  238 (476)
T ss_dssp             EECCTTCC----BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTT-
T ss_pred             hhcccccc----ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCcc-
Confidence            87644321    2345799999999987654 3 678999999999999999999998765544444433332221111 


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                 +...+..++.+||+.||++|||+.|+++
T Consensus       239 -----------~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          239 -----------LNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -----------CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----------CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                       1123455678999999999999999975

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-41  Score=351.86  Aligned_cols=254  Identities=25%  Similarity=0.399  Sum_probs=185.4

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhc--CCCCceeeEEEEEecc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ--CKHVNLLRLLGLCNNI  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~--l~HpNIv~l~g~~~~~  190 (593)
                      +.++||+|+||.||+|+.. |+.||||++....          ..      .+.+|.+++..  ++||||+++++++...
T Consensus        41 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----------~~------~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----------EA------SWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             EEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG----------HH------HHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             EEeEeecCCCeEEEEEEEC-CceEEEEEEeccc----------cc------hhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            3689999999999999986 8999999985321          11      24455555554  4999999999988653


Q ss_pred             -----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeEecccCCCCeeecCCC
Q psy9535         191 -----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------SKPIIHRDVKSANVLLDENF  259 (593)
Q Consensus       191 -----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~IiHrDLKp~NILl~~~~  259 (593)
                           ..++||||+++|+|.+++..    ..+++..+..++.|++.||.|||+.      .++|+||||||+|||++.++
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence                 45899999999999999975    3589999999999999999999984      12799999999999999999


Q ss_pred             ccEEeecccceecccCCCcc-eeeccccCCCCcCCcccccCC-CCC------cchhhHHHHHHHHHHhC----------C
Q psy9535         260 VPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQ-IST------KTDVFSYGVILLELLTG----------M  321 (593)
Q Consensus       260 ~~Kl~DFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~-~~~------ksDVwSfGvvl~ElltG----------~  321 (593)
                      .+||+|||+++......... .......||+.|+|||++.+. ...      ++|||||||++|||+||          .
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            99999999997654332111 112245799999999987543 333      48999999999999999          6


Q ss_pred             CCCCCCc----hHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         322 KPIDDNN----TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       322 ~P~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .||....    ............ .....   ....+....+...+..++.+||+.||++|||+.||++.|++.
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  329 (337)
T 3mdy_A          260 LPYHDLVPSDPSYEDMREIVCIK-KLRPS---FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM  329 (337)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTS-CCCCC---CCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccHhhhcCCCCchhhhHHHHhhh-ccCcc---ccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence            6765421    111111111110 00000   011122334555667778899999999999999999999874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-41  Score=339.49  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=196.3

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ..+.||+|+||.||+|++.+++.||||.+.....    .    .      ..|.+|+.++++++||||+++++++.+ ..
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~----~----~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   77 (267)
T 3t9t_A           12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----S----E------EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   77 (267)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB----C----H------HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             eeeEecCCCceeEEEEEecCCCeEEEEEccccCC----C----H------HHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3578999999999999998888999999964311    0    1      248899999999999999999999876 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  153 (267)
T 3t9t_A           78 ICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRF  153 (267)
T ss_dssp             CEEEECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred             eEEEEeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEECCCCCEEEcccccccc
Confidence            689999999999999997643  458999999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .....  ........||+.|+|||++. ..++.++||||||+++|||++ |+.||...................      
T Consensus       154 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~------  225 (267)
T 3t9t_A          154 VLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY------  225 (267)
T ss_dssp             BCCHH--HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------
T ss_pred             ccccc--ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC------
Confidence            53321  11122346788999999774 567889999999999999999 899998765443333322221110      


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                       ....    ....+..++.+||+.+|++||++.++++.|+..
T Consensus       226 -~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          226 -KPRL----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             -CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCcc----CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             0011    122345567899999999999999999999863

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.4e-41  Score=346.81  Aligned_cols=255  Identities=29%  Similarity=0.474  Sum_probs=196.3

Q ss_pred             CCCcccccCceEEEEEEE------cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKL------KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  185 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~------~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g  185 (593)
                      .++.||+|+||.||+|++      .+++.||||.+....     ...  .     ...|.+|+.+++++ +||||+++++
T Consensus        27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~--~-----~~~~~~E~~~l~~l~~h~~i~~~~~   94 (313)
T 1t46_A           27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-----HLT--E-----REALMSELKVLSYLGNHMNIVNLLG   94 (313)
T ss_dssp             EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-----CHH--H-----HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-----hHH--H-----HHHHHHHHHHHhhcccCCCeeeEEE
Confidence            357899999999999985      246789999986431     101  1     12588999999999 9999999999


Q ss_pred             EEec-ccceEEEEeccCCCHHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccC
Q psy9535         186 LCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  249 (593)
Q Consensus       186 ~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLK  249 (593)
                      ++.. ...++||||+++|+|.+++.....               ...+++..+..++.|++.||.|||+  ++|+|||||
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlk  172 (313)
T 1t46_A           95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLA  172 (313)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCS
T ss_pred             EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCc
Confidence            9876 566899999999999999986432               1258999999999999999999998  569999999


Q ss_pred             CCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCC
Q psy9535         250 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDN  327 (593)
Q Consensus       250 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~  327 (593)
                      |+|||++.++.+||+|||+++....... ........||+.|+|||++ ...++.++|||||||++|||+| |+.||...
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cceEEEcCCCCEEEcccccccccccccc-ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            9999999999999999999987654332 1122345688999999976 4568889999999999999999 99999764


Q ss_pred             chHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         328 NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      ................      .....    +...+..++.+||+.||.+|||+.|+++.|++..
T Consensus       252 ~~~~~~~~~~~~~~~~------~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          252 PVDSKFYKMIKEGFRM------LSPEH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             CSSHHHHHHHHHTCCC------CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchhHHHHHhccCCCC------CCccc----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            4322222222211110      00011    1223455678999999999999999999998743

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.2e-41  Score=344.57  Aligned_cols=242  Identities=24%  Similarity=0.359  Sum_probs=186.8

Q ss_pred             CCCcccccCceEEEEEEEc-CC-------CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NG-------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  184 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g-------~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~  184 (593)
                      ..+.||+|+||.||+|+.. ++       ..||+|.+....      ..       ....|.+|+.++++++||||++++
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~------~~-------~~~~~~~E~~~l~~l~h~~iv~~~   78 (289)
T 4fvq_A           12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH------RN-------YSESFFEAASMMSKLSHKHLVLNY   78 (289)
T ss_dssp             EEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG------GG-------GHHHHHHHHHHHHTSCCTTBCCEE
T ss_pred             eeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc------HH-------HHHHHHHHHHHHHhCCCCCEeEEE
Confidence            3578999999999999865 33       479999985421      00       122588999999999999999999


Q ss_pred             EEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc---
Q psy9535         185 GLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---  260 (593)
Q Consensus       185 g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~---  260 (593)
                      +++.+ ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.   
T Consensus        79 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~  154 (289)
T 4fvq_A           79 GVCVCGDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKT  154 (289)
T ss_dssp             EEECCTTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEEECCBGGG
T ss_pred             EEEEeCCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEecCCcccc
Confidence            99976 56689999999999999998642  348999999999999999999998  56999999999999998887   


Q ss_pred             -----cEEeecccceecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCC-CCCCchHHH
Q psy9535         261 -----PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKP-IDDNNTILY  332 (593)
Q Consensus       261 -----~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P-~~~~~~~~~  332 (593)
                           +||+|||+++.....       ....||+.|+|||++.  ..++.++|||||||++|||++|..| +....... 
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-  226 (289)
T 4fvq_A          155 GNPPFIKLSDPGISITVLPK-------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-  226 (289)
T ss_dssp             TBCCEEEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-
T ss_pred             cccceeeeccCcccccccCc-------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-
Confidence                 999999998654221       2246899999999875  4578899999999999999996554 44433222 


Q ss_pred             HHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         333 YYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ...........+....            ..+..++.+||+.||++|||+.|+++.|++.
T Consensus       227 ~~~~~~~~~~~~~~~~------------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l  273 (289)
T 4fvq_A          227 KLQFYEDRHQLPAPKA------------AELANLINNCMDYEPDHRPSFRAIIRDLNSL  273 (289)
T ss_dssp             HHHHHHTTCCCCCCSS------------CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHHhhccCCCCCCCC------------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            2222222211111111            1134566799999999999999999999874

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.1e-41  Score=369.84  Aligned_cols=246  Identities=24%  Similarity=0.359  Sum_probs=186.8

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +..++||+|+||.||+|+.. +|+.||||++.........          ....+.+|+.++++++||||+++++++.. 
T Consensus       151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~  220 (446)
T 4ejn_A          151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD----------EVAHTLTENRVLQNSRHPFLTALKYSFQTH  220 (446)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-----------------------CCCCCSCTTSCCEEEEEEET
T ss_pred             EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhH----------HHHHHHHHHHHHHhCCCCeEeeEEEEEeeC
Confidence            34678999999999999875 6899999999753111110          01246789999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+ .++|+||||||+|||++.++.+||+|||++
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlkp~NIll~~~~~~kl~DFG~a  296 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLC  296 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred             CEEEEEEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhh-cCCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence            5568999999999999999764   358999999999999999999996 135999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      +.......   .....+||+.|+|||++. ..++.++|||||||++|||++|+.||...........+......++..+ 
T Consensus       297 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~-  372 (446)
T 4ejn_A          297 KEGIKDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL-  372 (446)
T ss_dssp             CTTCC--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS-
T ss_pred             eeccCCCc---ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccC-
Confidence            85432221   123468999999999774 5689999999999999999999999987665554444444333322211 


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~~  386 (593)
                                 ...+..++.+||+.||.+||     ++.|+++
T Consensus       373 -----------~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          373 -----------GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -----------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----------CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                       12345567899999999999     8888764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.1e-41  Score=341.67  Aligned_cols=250  Identities=24%  Similarity=0.373  Sum_probs=192.1

Q ss_pred             CCCcccccCceEEEEEEEcC----CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~----g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      ..+.||+|+||.||+|++..    +..||||.+....     ....       ...|.+|+.++++++||||+++++++.
T Consensus        16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-----~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A           16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-----TLDN-------KEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-----CHHH-------HHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             EEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-----CchH-------HHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            35789999999999998642    3459999986431     1111       225889999999999999999999998


Q ss_pred             cccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         189 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       189 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      +...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        84 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  159 (281)
T 3cc6_A           84 EEPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDFGL  159 (281)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred             CCCCEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEECCCCcEEeCccCC
Confidence            888899999999999999997643  458999999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ++.......  .......||+.|+|||++. ..++.++|||||||++|||++ |+.||.................. .  
T Consensus       160 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~-~--  234 (281)
T 3cc6_A          160 SRYIEDEDY--YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL-P--  234 (281)
T ss_dssp             GGCC-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-C--
T ss_pred             Ccccccccc--cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-C--
Confidence            986543321  1122346788999999774 567889999999999999998 99999764332222222221111 0  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                         ....     +...+..++.+||..+|++||++.|+++.|+..
T Consensus       235 ---~~~~-----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          235 ---KPDL-----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             ---CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCC-----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence               0011     122355567899999999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.9e-41  Score=339.63  Aligned_cols=242  Identities=29%  Similarity=0.450  Sum_probs=189.6

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.+.||+|+||.||+|+.. ++..||||.+......          .......+.+|+.++++++||||+++++++.+ .
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (279)
T 3fdn_A           13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE----------KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   82 (279)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH----------HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             EeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc----------hhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence            3678999999999999875 5789999998642100          00112358899999999999999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             EEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEeccccc
Confidence            568999999999999999764   358999999999999999999998  569999999999999999999999999986


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......     .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||...................+..   
T Consensus       158 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---  229 (279)
T 3fdn_A          158 HAPSSR-----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF---  229 (279)
T ss_dssp             CC-------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTT---
T ss_pred             cCCccc-----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCc---
Confidence            543322     233579999999997754 46789999999999999999999998766544444333322222211   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                               ....+..++.+||+.||++||++.|+++
T Consensus       230 ---------~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          230 ---------VTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ---------SCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---------CCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                     1123445678999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8.7e-41  Score=341.36  Aligned_cols=250  Identities=21%  Similarity=0.296  Sum_probs=193.1

Q ss_pred             CCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-
Q psy9535         113 RGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-  189 (593)
                      ..+.||+|+||.||+|+. .+|+.||||++.....   .     .       .+.+|+.+++++ +|+|++++++++.+ 
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~-----~-------~~~~e~~~~~~l~~~~~i~~~~~~~~~~   78 (298)
T 1csn_A           14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---A-----P-------QLRDEYRTYKLLAGCTGIPNVYYFGQEG   78 (298)
T ss_dssp             EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---S-----C-------CHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred             EEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---c-----H-------HHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence            467899999999999986 4789999999864311   0     0       377899999999 79999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc-----cEEe
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-----PKLG  264 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~-----~Kl~  264 (593)
                      ...++||||+ +|+|.+++....  .++++..+..++.|++.||.|||+  ++|+||||||+|||++.++.     +||+
T Consensus        79 ~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~  153 (298)
T 1csn_A           79 LHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVV  153 (298)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             ceeEEEEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence            4568999999 999999998643  358999999999999999999998  56999999999999987766     9999


Q ss_pred             ecccceecccCCCcc----eeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCc---hHHHHHHH
Q psy9535         265 DFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN---TILYYYLV  336 (593)
Q Consensus       265 DFGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~---~~~~~~~~  336 (593)
                      |||+++.........    .......||+.|+|||++.+ .++.++|||||||++|||++|+.||....   ........
T Consensus       154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (298)
T 1csn_A          154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  233 (298)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence            999998765432211    11234679999999998754 57889999999999999999999997632   22222221


Q ss_pred             Hhh--cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         337 VEQ--EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       337 ~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ...  ..+.....    ...     ...+..++.+||+.+|++||++.+|++.|++.
T Consensus       234 ~~~~~~~~~~~~~----~~~-----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          234 GEKKQSTPLRELC----AGF-----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             HHHHHHSCHHHHT----TTS-----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HhhccCccHHHHH----hhC-----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            111  11111110    111     22355567899999999999999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.3e-41  Score=352.52  Aligned_cols=262  Identities=26%  Similarity=0.393  Sum_probs=192.3

Q ss_pred             CCCCcccccCceEEEEEEEc-----CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-----~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      +..++||+|+||.||++.+.     +|+.||||++....     ...       ....|.+|+.++++++||||++++++
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-----~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~  101 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-----GPQ-------HRSGWKQEIDILRTLYHEHIIKYKGC  101 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-----CHH-------HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-----ChH-------HHHHHHHHHHHHHhCCCcchhhEEEE
Confidence            45688999999999998753     57889999986431     111       12258899999999999999999999


Q ss_pred             Eec---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         187 CNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       187 ~~~---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                      +.+   ...++||||+++|+|.+++...    .+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||
T Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~~~~~~~kl  175 (318)
T 3lxp_A          102 CEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKI  175 (318)
T ss_dssp             EEETTTTEEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEE
T ss_pred             EecCCCceEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEEcCCCCEEE
Confidence            876   3458999999999999999753    48999999999999999999999  56999999999999999999999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHH----h
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV----E  338 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~----~  338 (593)
                      +|||+++................||+.|+|||++. ..++.++|||||||++|||+||..||.............    .
T Consensus       176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  255 (318)
T 3lxp_A          176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM  255 (318)
T ss_dssp             CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred             CCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence            99999987654432222233456889999999774 457889999999999999999999997532110000000    0


Q ss_pred             hcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         339 QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ......+.+........+..+...+..++.+||+.||++|||+.|+++.|+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          256 TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            00000000000000000111223355667899999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-41  Score=345.37  Aligned_cols=259  Identities=21%  Similarity=0.288  Sum_probs=189.6

Q ss_pred             CCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC---CCceeeEEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLLRLLGLC  187 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~---HpNIv~l~g~~  187 (593)
                      ++.++||+|+||.||+|+. .+|+.||||++............        ...+.+|+.++++++   ||||++++++|
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~--------~~~~~~e~~~l~~l~~~~h~niv~~~~~~   83 (308)
T 3g33_A           12 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL--------PISTVREVALLRRLEAFEHPNVVRLMDVC   83 (308)
T ss_dssp             EEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCC--------CHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccccc--------chhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence            3468899999999999996 46899999998754221111100        113567777776664   99999999998


Q ss_pred             ecc------cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCcc
Q psy9535         188 NNI------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  261 (593)
Q Consensus       188 ~~~------~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~  261 (593)
                      ...      ..++||||+. |+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             EECCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEEECTTSCE
T ss_pred             eccCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCE
Confidence            653      2579999997 69999998643 2458999999999999999999999  569999999999999999999


Q ss_pred             EEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q psy9535         262 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  340 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~  340 (593)
                      ||+|||+++.......    .....||+.|+|||++ ...++.++|||||||++|||++|+.||................
T Consensus       160 kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  235 (308)
T 3g33_A          160 KLADFGLARIYSYQMA----LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI  235 (308)
T ss_dssp             EECSCSCTTTSTTCCC----SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEeeCccccccCCCcc----cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999999986543221    2346799999999976 5568999999999999999999999998766544443333221


Q ss_pred             Cc-cccccccc----------cCCCCH----HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         341 VP-VREVLDKE----------AGEWNE----THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       341 ~~-~~~~~~~~----------~~~~~~----~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .. ........          ......    ..+...+..++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            11 00000000          000000    012233455678999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.6e-41  Score=368.10  Aligned_cols=246  Identities=26%  Similarity=0.388  Sum_probs=191.6

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.++||+|+||.||+|+.. ++..||||++.........           ...+.+|+.++++++|||||++++++.+ .
T Consensus        41 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  109 (494)
T 3lij_A           41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-----------NSKLLEEVAVLKLLDHPNIMKLYDFFEDKR  109 (494)
T ss_dssp             EEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-----------THHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             EeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-----------HHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            3578999999999999986 6899999999754211111           1247899999999999999999999977 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC---CCccEEeecc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFG  267 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~---~~~~Kl~DFG  267 (593)
                      ..++|||||++|+|.+.+...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.   ++.+||+|||
T Consensus       110 ~~~lv~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          110 NYYLVMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            568999999999999998764   358999999999999999999998  56999999999999975   4569999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      +++.......    .....||+.|+|||++...++.++|||||||++|||++|..||...........+.........  
T Consensus       185 ~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--  258 (494)
T 3lij_A          185 LSAVFENQKK----MKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS--  258 (494)
T ss_dssp             TCEECBTTBC----BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS--
T ss_pred             CCeECCCCcc----ccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--
Confidence            9987654321    2345799999999998888999999999999999999999999886655544444433322211  


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       +....     +...+..++.+||+.+|.+|||+.|+++
T Consensus       259 -~~~~~-----~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          259 -PEWKN-----VSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -GGGTT-----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -hhccc-----CCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence             11111     1223455678999999999999999874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.6e-41  Score=359.84  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=184.8

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC--CCceeeEEEEEec
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--HVNLLRLLGLCNN  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~--HpNIv~l~g~~~~  189 (593)
                      ++.+.||+|+||.||+|...+|+.||||++.....    . .  .    ....|.+|+.+|++++  |||||++++++..
T Consensus        59 ~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~----~-~--~----~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~  127 (390)
T 2zmd_A           59 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA----D-N--Q----TLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT  127 (390)
T ss_dssp             EEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC----C-H--H----HHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             EEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc----c-H--H----HHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence            34678999999999999988899999999865311    1 1  1    1235889999999997  5999999998876


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...++||| +.+|+|.+++...   ..+++..+..++.||+.||.|||+  .+|+||||||+|||++ ++.+||+|||+
T Consensus       128 ~~~~~lv~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~-~~~~kl~DFG~  200 (390)
T 2zmd_A          128 DQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGI  200 (390)
T ss_dssp             SSEEEEEEE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCCGGGEEES-SSCEEECCCSS
T ss_pred             CCEEEEEEe-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEEE-CCeEEEEecCc
Confidence             45689999 6789999999864   368899999999999999999998  5699999999999996 57999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccC------------CCCCcchhhHHHHHHHHHHhCCCCCCCCchH-HHHHH
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC------------QISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYL  335 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~------------~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~-~~~~~  335 (593)
                      ++....... ........||+.|+|||++.+            .++.++|||||||++|||++|+.||...... .....
T Consensus       201 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~  279 (390)
T 2zmd_A          201 ANQMQPDTT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA  279 (390)
T ss_dssp             SCCC----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH
T ss_pred             cccccCCCc-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHH
Confidence            986543321 111234679999999998743            5788999999999999999999999864332 22222


Q ss_pred             HHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         336 VVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ........      .......    ..+..++.+||+.||++||++.|+++
T Consensus       280 ~~~~~~~~------~~~~~~~----~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          280 IIDPNHEI------EFPDIPE----KDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HHCTTSCC------CCCCCSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhCccccC------CCCccch----HHHHHHHHHHcccChhhCCCHHHHhh
Confidence            21111110      0111112    23445677999999999999999875

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-41  Score=358.76  Aligned_cols=245  Identities=22%  Similarity=0.322  Sum_probs=192.3

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.+.||+|+||.||+|+.. +|+.||+|.+....      ..  .     ...+.+|+.+|++++|||||++++++.+ .
T Consensus        55 i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~------~~--~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  121 (387)
T 1kob_A           55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY------PL--D-----KYTVKNEISIMNQLHHPKLINLHDAFEDKY  121 (387)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------HH--H-----HHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred             EEEEEecCCCEEEEEEEECCCCCEEEEEEecccc------hh--h-----HHHHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence            4678999999999999875 68999999986421      01  1     1257899999999999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC--CCccEEeeccc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--NFVPKLGDFGI  268 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~--~~~~Kl~DFGl  268 (593)
                      ..++||||+++|+|.+++...  ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.  ++.+||+|||+
T Consensus       122 ~~~lv~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~DFG~  197 (387)
T 1kob_A          122 EMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGL  197 (387)
T ss_dssp             EEEEEEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             EEEEEEEcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEeccc
Confidence            668999999999999998753  2468999999999999999999998  56999999999999974  57899999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ++.......    .....||+.|+|||++.+ .++.++|||||||++|||++|..||...........+.........  
T Consensus       198 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--  271 (387)
T 1kob_A          198 ATKLNPDEI----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE--  271 (387)
T ss_dssp             CEECCTTSC----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS--
T ss_pred             ceecCCCcc----eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--
Confidence            987654322    123479999999998754 5788999999999999999999999876654443333332221111  


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        ...    ..+...+..++.+||+.||++|||+.|+++
T Consensus       272 --~~~----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          272 --DAF----SSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             --STT----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --ccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence              000    111223456778999999999999999865

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.5e-41  Score=369.03  Aligned_cols=257  Identities=23%  Similarity=0.350  Sum_probs=193.2

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..++||+|+||.||+|+.. +++.||||++.......................+.+|+.+|++++|||||++++++.+ .
T Consensus        40 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  119 (504)
T 3q5i_A           40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK  119 (504)
T ss_dssp             EEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             EEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            3678999999999999975 5889999999754321110000000000112358899999999999999999999977 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC---ccEEeecc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFG  267 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~---~~Kl~DFG  267 (593)
                      ..++|||||++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++   .+||+|||
T Consensus       120 ~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  194 (504)
T 3q5i_A          120 YFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHK--HNIVHRDIKPENILLENKNSLLNIKIVDFG  194 (504)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred             EEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence            568999999999999999764   358999999999999999999998  5699999999999998765   69999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      +++.......    .....||+.|+|||++.+.++.++|||||||++|||++|..||...........+.........  
T Consensus       195 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--  268 (504)
T 3q5i_A          195 LSSFFSKDYK----LRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF--  268 (504)
T ss_dssp             TCEECCTTSC----BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH--
T ss_pred             CCEEcCCCCc----cccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--
Confidence            9987654321    2345799999999998888999999999999999999999999886655444444333221110  


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       +....     +...+..++.+||+.||.+|||+.|+++
T Consensus       269 -~~~~~-----~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          269 -NDWKN-----ISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             -HHHTT-----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -cccCC-----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             00011     1233556778999999999999999975

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.9e-42  Score=380.10  Aligned_cols=249  Identities=26%  Similarity=0.375  Sum_probs=197.4

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      +.++||+|+||.||+|++..+..||||+++....    .          ...|.+|+.+|++++|||||+++++|.+...
T Consensus       271 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~----------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  336 (535)
T 2h8h_A          271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----S----------PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI  336 (535)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS----C----------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             hheecccCCCeEEEEEEECCCceEEEEEeCCCCC----C----------HHHHHHHHHHHHhCCCCCEeeEEEEEeeccc
Confidence            4578999999999999998888899999964311    0          1258899999999999999999999988888


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      +|||||+.+|+|.++|.... ...+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             eEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            99999999999999997532 2358999999999999999999998  56999999999999999999999999999865


Q ss_pred             ccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      .....  .......||+.|+|||++ ...++.++|||||||+||||++ |+.||...........+.... ...     .
T Consensus       414 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~-----~  485 (535)
T 2h8h_A          414 EDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMP-----C  485 (535)
T ss_dssp             CCHHH--HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC-CCC-----C
T ss_pred             CCCce--ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC-----C
Confidence            43211  111234578899999976 4668999999999999999999 999998765443333322211 100     0


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ..     .+...+..++.+||+.||++|||+.+|++.|+..
T Consensus       486 ~~-----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  521 (535)
T 2h8h_A          486 PP-----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  521 (535)
T ss_dssp             CT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CC-----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            01     1122345567899999999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=362.32  Aligned_cols=262  Identities=22%  Similarity=0.313  Sum_probs=199.9

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      ++.++||+|+||.||+|+.. +|+.||||++.......            ....+.+|++++++++||||+++++++...
T Consensus        12 ~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   79 (396)
T 4eut_A           12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR------------PVDVQMREFEVLKKLNHKNIVKLFAIEEET   79 (396)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS------------CHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred             EEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc------------hHHHHHHHHHHHHhcCCCCCCeEEEeeccC
Confidence            44678999999999999986 58999999986431110            122478999999999999999999998753


Q ss_pred             ---cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee----cCCCccEE
Q psy9535         191 ---MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKL  263 (593)
Q Consensus       191 ---~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl----~~~~~~Kl  263 (593)
                         ..++||||+++|+|.+++........+++..+..++.|++.||.|||+  .+|+||||||+|||+    +.++.+||
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL  157 (396)
T 4eut_A           80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKL  157 (396)
T ss_dssp             TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred             CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeEEE
Confidence               458999999999999999865444459999999999999999999999  569999999999999    78888999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCccccc---------CCCCCcchhhHHHHHHHHHHhCCCCCCCC----chH
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---------CQISTKTDVFSYGVILLELLTGMKPIDDN----NTI  330 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---------~~~~~ksDVwSfGvvl~ElltG~~P~~~~----~~~  330 (593)
                      +|||+++.......    .....||+.|+|||++.         ..++.++|||||||++|||++|+.||...    ...
T Consensus       158 ~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~  233 (396)
T 4eut_A          158 TDFGAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (396)
T ss_dssp             CCGGGCEECCCGGG----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH
T ss_pred             ecCCCceEccCCCc----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH
Confidence            99999987644321    22457999999999764         34577999999999999999999999641    122


Q ss_pred             HHHHHHHhhcCc-cc-ccccc-----------ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         331 LYYYLVVEQEVP-VR-EVLDK-----------EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       331 ~~~~~~~~~~~~-~~-~~~~~-----------~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ........+..+ .. .....           .........+...+..++.+||+.||++||++.|+++.+...
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            222232222211 00 00000           001112245667777888999999999999999999988764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-41  Score=354.36  Aligned_cols=255  Identities=24%  Similarity=0.296  Sum_probs=189.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. ++..||||++......... .       .....|.+|+.++++++|||||++++++.+ ..
T Consensus        31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~-------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  102 (345)
T 3hko_A           31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN-P-------KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY  102 (345)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC-----------CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccC-H-------HHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence            678999999999999875 6889999998653111000 0       112358899999999999999999999976 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCC-------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNN-------------------------------------TPPLDSNKRYSIALGVAEALH  234 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~gL~  234 (593)
                      .++||||+++|+|.+++.....                                     ...+++..+..++.|++.||.
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            6899999999999999852100                                     112356778889999999999


Q ss_pred             HHhcCCCCeEecccCCCCeeecCCC--ccEEeecccceecccCCCcc-eeeccccCCCCcCCccccc---CCCCCcchhh
Q psy9535         235 YLHSLSKPIIHRDVKSANVLLDENF--VPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMH---CQISTKTDVF  308 (593)
Q Consensus       235 yLH~~~~~IiHrDLKp~NILl~~~~--~~Kl~DFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~~~---~~~~~ksDVw  308 (593)
                      |||+  .+|+||||||+|||++.++  .+||+|||+++......... .......||+.|+|||++.   ..++.++|||
T Consensus       183 ~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw  260 (345)
T 3hko_A          183 YLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW  260 (345)
T ss_dssp             HHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred             HHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence            9999  5699999999999998766  89999999998654322111 1123457999999999874   4578899999


Q ss_pred             HHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         309 SYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       309 SfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ||||++|||++|+.||.....................   +...     .+...+..++.+||+.+|.+||++.|+++
T Consensus       261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN---PNYN-----VLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS---GGGG-----GSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC---cccc-----cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            9999999999999999876655444444333222111   1111     12233556778999999999999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=354.92  Aligned_cols=242  Identities=25%  Similarity=0.368  Sum_probs=177.0

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.+.||+|+||.||+|+.. +++.||||++.....         .      ..+.+|+.++++++||||+++++++.+ .
T Consensus        57 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  121 (349)
T 2w4o_A           57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD---------K------KIVRTEIGVLLRLSHPNIIKLKEIFETPT  121 (349)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred             EeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh---------H------HHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence            3578999999999999986 588999999974310         0      137789999999999999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC---CCccEEeecc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFG  267 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~---~~~~Kl~DFG  267 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.   ++.+||+|||
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg  196 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFG  196 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEccCc
Confidence            568999999999999999753   458999999999999999999998  56999999999999975   8899999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhhcCcccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQEVPVRE  345 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~-~~~~~~~~~~~~~~  345 (593)
                      +++......    ......||+.|+|||++.+ .++.++|||||||++|||++|..||....... ............. 
T Consensus       197 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~-  271 (349)
T 2w4o_A          197 LSKIVEHQV----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI-  271 (349)
T ss_dssp             --------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC-
T ss_pred             cccccCccc----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC-
Confidence            998654322    1234579999999998754 58899999999999999999999997654432 2222222221111 


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        .+....     +...+..++.+||+.||++|||+.|+++
T Consensus       272 --~~~~~~-----~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          272 --SPWWDE-----VSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             --TTTTTT-----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --Cchhhh-----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              111111     1223455778999999999999999865

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=351.96  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=188.4

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCE----EEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGME----IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~----vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      +..++||+|+||.||+|++. +++.    ||+|.+.....  ..   .       ...|.+|+.++++++||||++++++
T Consensus        18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~---~-------~~~~~~E~~~l~~l~hp~iv~~~~~   85 (327)
T 3lzb_A           18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PK---A-------NKEILDEAYVMASVDNPHVCRLLGI   85 (327)
T ss_dssp             EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CC---C-------HHHHHHHHHHHTTCCBTTBCCCCEE
T ss_pred             eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HH---H-------HHHHHHHHHHHHhCCCCCeeEEEEE
Confidence            34678999999999999874 4544    57777643211  11   1       1258899999999999999999999


Q ss_pred             EecccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         187 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       187 ~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      |.....++|+||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kL~Df  161 (327)
T 3lzb_A           86 CLTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDF  161 (327)
T ss_dssp             EESSSEEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCT
T ss_pred             EecCCceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEEcCCCCEEEccC
Confidence            99888899999999999999998643  468999999999999999999998  56999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      |+++....... ........||+.|+|||.+ ...++.++|||||||++|||++ |+.||.................. .
T Consensus       162 G~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-~  239 (327)
T 3lzb_A          162 GLAKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-P  239 (327)
T ss_dssp             TC-----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-C
T ss_pred             cceeEccCccc-cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-C
Confidence            99987543322 1112334678899999976 4568889999999999999999 99999875443332222221111 0


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                           .....     ...+..++.+||+.||.+||++.|+++.|++..
T Consensus       240 -----~~~~~-----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          240 -----QPPIC-----TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             -----CCTTB-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCccC-----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                 00111     122445678999999999999999999998753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.3e-41  Score=341.58  Aligned_cols=255  Identities=22%  Similarity=0.270  Sum_probs=186.9

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..++||+|+||.||+|+.. +|+.||||++......    ...       ...+.+|+.++++++||||+++++++.+ .
T Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   74 (292)
T 3o0g_A            6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD----EGV-------PSSALREICLLKELKHKNIVRLHDVLHSDK   74 (292)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS----TTH-------HHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             eeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc----CCc-------chHHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence            4578999999999999985 6899999999754211    111       1247899999999999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+.+ +|.+.+....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  149 (292)
T 3o0g_A           75 KLTLVFEFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLAR  149 (292)
T ss_dssp             EEEEEEECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence            56899999975 6666665432  468999999999999999999999  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-C-CCCcchhhHHHHHHHHHHhCCCCCCCCch-HHHHHHHHhhc-Cccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-Q-ISTKTDVFSYGVILLELLTGMKPIDDNNT-ILYYYLVVEQE-VPVREV  346 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~-~~~ksDVwSfGvvl~ElltG~~P~~~~~~-~~~~~~~~~~~-~~~~~~  346 (593)
                      .......   ......||+.|+|||++.+ . ++.++|||||||++|||++|..||..... ........... .+....
T Consensus       150 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~  226 (292)
T 3o0g_A          150 AFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ  226 (292)
T ss_dssp             ECCSCCS---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ecCCccc---cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            7543321   1234578999999998744 3 78999999999999999999888654332 22222221111 110000


Q ss_pred             ccc-------c-------c--CCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDK-------E-------A--GEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~-------~-------~--~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...       .       .  .......+...+..++.+|++.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            000       0       0  00000112234556778999999999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=353.64  Aligned_cols=246  Identities=24%  Similarity=0.338  Sum_probs=183.1

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCC--CceeeEEEEEec
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH--VNLLRLLGLCNN  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~H--pNIv~l~g~~~~  189 (593)
                      ++.+.||+|+||.||+|...+++.||||++.....    . .  .    ....|.+|+.+|++++|  |||+++++++.+
T Consensus        12 ~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~-~--~----~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   80 (343)
T 3dbq_A           12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA----D-N--Q----TLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   80 (343)
T ss_dssp             EEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC----C-H--H----HHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             EEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc----c-h--H----HHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence            34678999999999999988899999999864311    1 1  1    12358899999999987  999999999876


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...++||| +.+|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++ ++.+||+|||+
T Consensus        81 ~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~-~~~~kl~DFG~  153 (343)
T 3dbq_A           81 DQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGI  153 (343)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred             CCEEEEEEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE-CCcEEEeeccc
Confidence             45688999 6789999999863   468999999999999999999998  5699999999999997 57899999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc------------CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHH-HHHH
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH------------CQISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYL  335 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~------------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~-~~~~  335 (593)
                      ++....... ........||+.|+|||++.            ..++.++|||||||++|||++|+.||....... ....
T Consensus       154 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  232 (343)
T 3dbq_A          154 ANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA  232 (343)
T ss_dssp             SCCC-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred             ccccCcccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH
Confidence            986543321 11223467999999999763            457889999999999999999999998643322 2121


Q ss_pred             HHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         336 VVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ....... .     ......+    ..+..++.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~-~-----~~~~~~~----~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          233 IIDPNHE-I-----EFPDIPE----KDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             HHCTTSC-C-----CCCCCSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhcCCcc-c-----CCcccCC----HHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            1111110 0     0011111    23445677999999999999999975

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.7e-42  Score=350.16  Aligned_cols=262  Identities=24%  Similarity=0.423  Sum_probs=192.2

Q ss_pred             CCCCcccccCceEEEEEEE-----cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-----~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      +..++||+|+||.||+|++     .+|+.||||++.....  .   .       ....+.+|+.++++++||||++++++
T Consensus        24 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~---~-------~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (302)
T 4e5w_A           24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--G---N-------HIADLKKEIEILRNLYHENIVKYKGI   91 (302)
T ss_dssp             EEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC----------C-------CHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--c---h-------hHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence            3457899999999999984     3588999999864321  0   0       12258899999999999999999999


Q ss_pred             Eecc---cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         187 CNNI---MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       187 ~~~~---~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                      +...   ..++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||
T Consensus        92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl  167 (302)
T 4e5w_A           92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKI  167 (302)
T ss_dssp             EEC---CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEE
T ss_pred             EecCCCceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEEcCCCCEEE
Confidence            8653   3589999999999999996543  458999999999999999999998  56999999999999999999999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh---
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ---  339 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~---  339 (593)
                      +|||+++................||+.|+|||++. ..++.++|||||||++|||++|..|+........  .....   
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~  245 (302)
T 4e5w_A          168 GDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFL--KMIGPTHG  245 (302)
T ss_dssp             CCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHHCSCCG
T ss_pred             CcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHh--hccCCccc
Confidence            99999987655432222234467899999999764 4578899999999999999999998753211100  00000   


Q ss_pred             cCccccc---cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         340 EVPVREV---LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       340 ~~~~~~~---~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .......   +........+..+...+..++.+||+.||.+|||+.|+++.|+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             GGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            0000000   000000000111223355677899999999999999999999763

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.8e-41  Score=349.75  Aligned_cols=254  Identities=26%  Similarity=0.422  Sum_probs=195.1

Q ss_pred             CCCcccccCceEEEEEEEc--------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  183 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~--------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l  183 (593)
                      +++.||+|+||.||+|++.        ++..||||++....     ...       ....+.+|+.+++++ +||||+++
T Consensus        39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~-------~~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEK-------DLSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             EEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-----CHH-------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             EeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-----cHH-------HHHHHHHHHHHHHHhhcCCCEeeE
Confidence            4678999999999999863        46789999986421     111       123588999999999 89999999


Q ss_pred             EEEEec-ccceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccC
Q psy9535         184 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  249 (593)
Q Consensus       184 ~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLK  249 (593)
                      ++++.+ ...++||||+++|+|.+++.....             ...+++..+..++.|++.||.|||+  .+|+|||||
T Consensus       107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlk  184 (334)
T 2pvf_A          107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLA  184 (334)
T ss_dssp             EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCS
T ss_pred             EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCc
Confidence            999976 566899999999999999986432             1248999999999999999999998  569999999


Q ss_pred             CCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCC
Q psy9535         250 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDN  327 (593)
Q Consensus       250 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~  327 (593)
                      |+|||++.++.+||+|||+++....... ........||+.|+|||++. ..++.++|||||||++|||++ |..||...
T Consensus       185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          185 ARNVLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cceEEEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            9999999999999999999987654322 11123346789999999764 457889999999999999999 99999876


Q ss_pred             chHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         328 NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      ...............  .    .....     ...+..++.+||+.+|.+||++.||++.|++..
T Consensus       264 ~~~~~~~~~~~~~~~--~----~~~~~-----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          264 PVEELFKLLKEGHRM--D----KPANC-----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             CHHHHHHHHHHTCCC--C----CCTTC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHhcCCCC--C----CCccC-----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            544333322222111  0    00111     123455678999999999999999999998753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5e-41  Score=368.28  Aligned_cols=247  Identities=28%  Similarity=0.384  Sum_probs=196.8

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..++||+|+||.||+|+.. +|+.||||++..........          ...+.+|+.++++++|||||++++++.+ .
T Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~----------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   99 (484)
T 3nyv_A           30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD----------KESLLREVQLLKQLDHPNIMKLYEFFEDKG   99 (484)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC----------HHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             EeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH----------HHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            3578999999999999986 78999999997542211111          1258899999999999999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee---cCCCccEEeecc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFG  267 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl---~~~~~~Kl~DFG  267 (593)
                      ..++||||+.+|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||+   +.++.+||+|||
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             EEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence            568999999999999999753   458999999999999999999999  569999999999999   467899999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      +++.......    .....||+.|+|||++.+.++.++||||+||++|||++|..||...........+.........  
T Consensus       175 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--  248 (484)
T 3nyv_A          175 LSTHFEASKK----MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL--  248 (484)
T ss_dssp             HHHHBCCCCS----HHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--
T ss_pred             eeEEcccccc----cccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence            9986544321    2235799999999998888999999999999999999999999887655444444333222110  


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       +..     ..+...+..++.+||+.+|.+|||+.|+++
T Consensus       249 -~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          249 -PQW-----KKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -GGG-----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -ccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence             000     112233556778999999999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.1e-41  Score=356.64  Aligned_cols=256  Identities=23%  Similarity=0.333  Sum_probs=180.3

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-  189 (593)
                      ..+.||+|+||.||+|+.. +|+.||||++....    ....  .     ...+.+|+.+++++. |||||++++++.. 
T Consensus        13 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~----~~~~--~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~   81 (388)
T 3oz6_A           13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF----QNST--D-----AQRTFREIMILTELSGHENIVNLLNVLRAD   81 (388)
T ss_dssp             EEEC-------CEEEEEETTTCCEEEEEEECC------CCHH--H-----HHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred             EEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc----cChH--H-----HHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence            3578999999999999875 68999999985321    1111  1     224678999999997 9999999999864 


Q ss_pred             --ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         190 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       190 --~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                        ...++|||||. |+|.+++..    ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG  154 (388)
T 3oz6_A           82 NDRDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFG  154 (388)
T ss_dssp             TSSCEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             CCCEEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEEcCCCCEEecCCc
Confidence              24689999997 689998875    358899999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCC------------------cceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCC
Q psy9535         268 IVKMSETSNM------------------KTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDN  327 (593)
Q Consensus       268 la~~~~~~~~------------------~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~  327 (593)
                      +|+.......                  ........+||+.|+|||++.+  .++.++|||||||++|||++|+.||.+.
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9986532110                  0111234689999999998743  5789999999999999999999999886


Q ss_pred             chHHHHHHHHhhc-CccccccccccC----------------------CCCH------------HHHHHHHHHHHHHhhc
Q psy9535         328 NTILYYYLVVEQE-VPVREVLDKEAG----------------------EWNE------------THVETLIGIVFEKCCV  372 (593)
Q Consensus       328 ~~~~~~~~~~~~~-~~~~~~~~~~~~----------------------~~~~------------~~~~~~i~~~~~~C~~  372 (593)
                      +.......+.... .+..+.+.....                      ...+            ..+...+..++.+||+
T Consensus       235 ~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             CHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            6544443332211 111100000000                      0000            0112235567789999


Q ss_pred             cccCCCCChHHHHH
Q psy9535         373 FEKDKRASMRDIVD  386 (593)
Q Consensus       373 ~dp~~RPsm~eV~~  386 (593)
                      .||++|||+.|+++
T Consensus       315 ~dP~~R~t~~e~l~  328 (388)
T 3oz6_A          315 FNPNKRISANDALK  328 (388)
T ss_dssp             SSGGGSCCHHHHTT
T ss_pred             cCcccCCCHHHHhC
Confidence            99999999999854

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.5e-41  Score=357.40  Aligned_cols=266  Identities=22%  Similarity=0.329  Sum_probs=195.6

Q ss_pred             eeecHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHH
Q psy9535          91 IAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV  169 (593)
Q Consensus        91 ~~~~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev  169 (593)
                      ..|++.+.....++|.      +.++||+|+||.||+|+.. +|+.||||++....       ..       ...+..|+
T Consensus        23 ~~~~~~~g~~~~~~y~------~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~-------~~~~~~e~   82 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFL------VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-------KY-------TRSAKIEA   82 (360)
T ss_dssp             GSCCCCTTCEETTTEE------EEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-------HH-------HHHHHHHH
T ss_pred             eeeeeecceEecCEEE------EEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-------hh-------hhhhHHHH
Confidence            3344444333444443      3689999999999999984 68999999985310       00       12467899


Q ss_pred             HHHhcCC-----CCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q psy9535         170 QTLSQCK-----HVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPI  243 (593)
Q Consensus       170 ~il~~l~-----HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~I  243 (593)
                      .++++++     |||||++++++.. ...++||||+ +|+|.+++.... ...+++..+..++.|++.||.|||+  ++|
T Consensus        83 ~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~i  158 (360)
T 3llt_A           83 DILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRK--MSL  158 (360)
T ss_dssp             HHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH--TTE
T ss_pred             HHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCe
Confidence            9999987     9999999998876 5668999999 999999998643 2458999999999999999999998  569


Q ss_pred             EecccCCCCeeecC-------------------------CCccEEeecccceecccCCCcceeeccccCCCCcCCccccc
Q psy9535         244 IHRDVKSANVLLDE-------------------------NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH  298 (593)
Q Consensus       244 iHrDLKp~NILl~~-------------------------~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~  298 (593)
                      +||||||+|||++.                         ++.+||+|||+++.....      .....||+.|+|||++.
T Consensus       159 vHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~  232 (360)
T 3llt_A          159 THTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVIL  232 (360)
T ss_dssp             ECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHT
T ss_pred             eeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHc
Confidence            99999999999975                         789999999999864432      12457999999999764


Q ss_pred             -CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc-------------cccc--cCCCC-----HH
Q psy9535         299 -CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV-------------LDKE--AGEWN-----ET  357 (593)
Q Consensus       299 -~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~--~~~~~-----~~  357 (593)
                       ..++.++|||||||++|||++|+.||.................+.+..             .+..  ...++     ..
T Consensus       233 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~  312 (360)
T 3llt_A          233 NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSIN  312 (360)
T ss_dssp             TCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHH
T ss_pred             CCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchh
Confidence             468899999999999999999999998765443333322221111100             0000  00000     00


Q ss_pred             HH--------------HHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         358 HV--------------ETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       358 ~~--------------~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..              ...+..++.+||+.||++|||+.|+++
T Consensus       313 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          313 SIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00              133456778999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.1e-40  Score=336.21  Aligned_cols=250  Identities=27%  Similarity=0.369  Sum_probs=191.9

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|+.. +|+.||||.+............       ....|.+|+.++++++||||+++++++.+ .
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGV-------SREEIEREVNILREIRHPNIITLHDIFENKT   81 (283)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSB-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccch-------HHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence            3578999999999999986 6899999999765322211111       12258899999999999999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC----ccEEeec
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLGDF  266 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~----~~Kl~DF  266 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++    .+||+||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             eEEEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCCCceEEEec
Confidence            568999999999999999763   358999999999999999999998  5699999999999998876    8999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      |+++.......    .....||+.|+|||++. ..++.++||||||+++|||++|..||.....................
T Consensus       157 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T 3bhy_A          157 GIAHKIEAGNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE  232 (283)
T ss_dssp             TTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH
T ss_pred             ccceeccCCCc----ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc
Confidence            99986543321    22357999999999775 45788999999999999999999999876554433333222211110


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .   ....     ....+..++.+||..||++||++.|+++
T Consensus       233 ~---~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          233 E---YFSN-----TSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             H---HHTT-----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             h---hccc-----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            0   0011     1233556778999999999999999976

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4e-41  Score=350.48  Aligned_cols=240  Identities=22%  Similarity=0.364  Sum_probs=170.2

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-~  190 (593)
                      ++.||+|+||.||+|+.. +|+.||||++....          .      ..+.+|+.+++++. ||||+++++++.+ .
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~------~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----------E------ANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG----------H------HHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhh----------h------hhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            578999999999999985 68999999986420          1      14678999999997 9999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC---ccEEeecc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFG  267 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~---~~Kl~DFG  267 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++   .+||+|||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg  154 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFG  154 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred             EEEEEEEccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence            568999999999999999863   468999999999999999999998  5699999999999997665   89999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCch-------HHHHHHHHhh
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNT-------ILYYYLVVEQ  339 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~-------~~~~~~~~~~  339 (593)
                      +++.......   ......||+.|+|||++. ..++.++|||||||++|||++|+.||.....       ......+...
T Consensus       155 ~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~  231 (325)
T 3kn6_A          155 FARLKPPDNQ---PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG  231 (325)
T ss_dssp             TCEECCC-------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred             cceecCCCCC---cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence            9986543321   123457899999999874 4578899999999999999999999975322       1111111111


Q ss_pred             cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHH
Q psy9535         340 EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV  385 (593)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~  385 (593)
                      ......   ..     ...+...+..++.+||+.||++|||+.|++
T Consensus       232 ~~~~~~---~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          232 DFSFEG---EA-----WKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             CCCCCS---HH-----HHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             CCCCCc---cc-----ccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            111100   00     011223455677899999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.1e-41  Score=348.22  Aligned_cols=253  Identities=25%  Similarity=0.431  Sum_probs=195.6

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .+.||+|+||.||+|++.      +++.||||.+....     . .. .     ...|.+|+.++++++||||+++++++
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-----~-~~-~-----~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-----S-MR-E-----RIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-----C-HH-H-----HHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             eeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-----C-HH-H-----HHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            678999999999999764      36789999986321     1 11 1     12588999999999999999999999


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVN-------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  259 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~  259 (593)
                      .+ ...++||||+++|+|.+++....       ...++++..+..++.|++.||.|||+  ++|+||||||+|||++.++
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTC
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEEEcCCC
Confidence            76 55689999999999999997532       12457899999999999999999998  5699999999999999999


Q ss_pred             ccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHH
Q psy9535         260 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVV  337 (593)
Q Consensus       260 ~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~  337 (593)
                      .+||+|||+++....... ........||+.|+|||++. ..++.++|||||||++|||++ |..||.............
T Consensus       176 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  254 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  254 (322)
T ss_dssp             CEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             eEEECcCccccccccccc-cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence            999999999986543321 11122346789999999764 568889999999999999999 899998765443333322


Q ss_pred             hhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      .....  .    ....     +...+..++.+||+.+|.+|||+.|+++.|++..
T Consensus       255 ~~~~~--~----~~~~-----~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          255 EGGLL--D----KPDN-----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             TTCCC--C----CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             cCCcC--C----CCCC-----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            22111  0    0111     1223455678999999999999999999998753

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.2e-41  Score=366.60  Aligned_cols=245  Identities=25%  Similarity=0.353  Sum_probs=194.1

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|+.. +|+.||||++........           ....+.+|+.+|++++|||||++++++.+ ..
T Consensus        27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   95 (486)
T 3mwu_A           27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-----------DTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (486)
T ss_dssp             EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-----------HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence            578999999999999975 789999999864321110           12257899999999999999999999876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec---CCCccEEeeccc
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGI  268 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~---~~~~~Kl~DFGl  268 (593)
                      .++||||+.+|+|.+.+...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++   .++.+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            68999999999999998764   358999999999999999999998  5699999999999995   456899999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ++.......    .....||+.|+|||++.+.++.++|||||||++|||++|+.||...........+.........   
T Consensus       171 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---  243 (486)
T 3mwu_A          171 STCFQQNTK----MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL---  243 (486)
T ss_dssp             TTTBCCC--------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS---
T ss_pred             CeECCCCCc----cCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---
Confidence            976543321    2345799999999999888999999999999999999999999886655444444433322111   


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +...     .+...+..++.+||+.+|.+|||+.|+++
T Consensus       244 ~~~~-----~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          244 PQWR-----TISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             GGGG-----GSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cccC-----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0001     11233556778999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-41  Score=357.59  Aligned_cols=251  Identities=29%  Similarity=0.452  Sum_probs=181.7

Q ss_pred             CCcccccCceEEEEEEEc--CC--CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         114 GNKLGEGQFGTVYYGKLK--NG--MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~--~g--~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      .+.||+|+||.||+|++.  ++  ..||||.++...     ....       ...|.+|+.++++++|||||+++++|..
T Consensus        94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-----~~~~-------~~~~~~E~~il~~l~hpnIv~~~~~~~~  161 (373)
T 3c1x_A           94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-----DIGE-------VSQFLTEGIIMKDFSHPNVLSLLGICLR  161 (373)
T ss_dssp             EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-----CSHH-------HHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred             CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-----CHHH-------HHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence            468999999999999864  22  358999885321     1111       2358899999999999999999998854


Q ss_pred             --ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         190 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       190 --~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                        ...++||||+++|+|.+++...  ...+++..+..++.|+++||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus       162 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DFG  237 (373)
T 3c1x_A          162 SEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFG  237 (373)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             CCCCeEEEEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEECCCCCEEEeecc
Confidence              4568999999999999999753  2458899999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCcc-eeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccc
Q psy9535         268 IVKMSETSNMKT-MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       268 la~~~~~~~~~~-~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      +++......... .......||+.|+|||++ ...++.++|||||||++|||+| |.+||................... 
T Consensus       238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~-  316 (373)
T 3c1x_A          238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-  316 (373)
T ss_dssp             --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC-
T ss_pred             ccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC-
Confidence            998654322111 112335678899999976 4568899999999999999999 677887643322222222221110 


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                         .   ...    +...+..++.+||+.+|++||++.|+++.|+..
T Consensus       317 ---~---p~~----~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          317 ---Q---PEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             ---C---CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---C---CCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               0   011    112345567799999999999999999999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.3e-41  Score=363.52  Aligned_cols=252  Identities=24%  Similarity=0.359  Sum_probs=183.2

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEeccc
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~  191 (593)
                      ..+.||+|+||.||+|... +++.||||.+............. .    ....|.+|+.+|++++|||||++++++....
T Consensus       139 ~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~-~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  213 (419)
T 3i6u_A          139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREA-D----PALNVETEIEILKKLNHPCIIKIKNFFDAED  213 (419)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC-------------CCHHHHHHHHHHCCCTTBCCCCEEEESSE
T ss_pred             EEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccc-h----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCc
Confidence            3678999999999999875 68999999997542211111000 0    0114789999999999999999999998877


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC---CccEEeeccc
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGI  268 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~---~~~Kl~DFGl  268 (593)
                      .++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.+   +.+||+|||+
T Consensus       214 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             eEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            89999999999999988643   468999999999999999999998  569999999999999654   4699999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhhcCcc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQEVPV  343 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~----~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~-~~~~~~~~~~~~  343 (593)
                      ++......    ......||+.|+|||++.    ..++.++|||||||++|||++|+.||....... ............
T Consensus       289 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~  364 (419)
T 3i6u_A          289 SKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF  364 (419)
T ss_dssp             TTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC
T ss_pred             ceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC
Confidence            98754322    123467999999999863    356789999999999999999999997643211 111111111111


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..   .....     +...+..++.+||+.||++||++.|+++
T Consensus       365 ~~---~~~~~-----~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          365 IP---EVWAE-----VSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CH---HHHTT-----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             Cc---hhhcc-----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            00   00011     1233555678999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.8e-41  Score=348.94  Aligned_cols=254  Identities=28%  Similarity=0.504  Sum_probs=194.0

Q ss_pred             CCCcccccCceEEEEEEEcC-C-----CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLKN-G-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  185 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~-g-----~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g  185 (593)
                      ..+.||+|+||.||+|+... +     ..||||.+....     ....       ...|.+|+.+++++ +||||+++++
T Consensus        50 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~-------~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-----HADE-------KEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             EEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-----CHHH-------HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             eeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-----ChHH-------HHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            36789999999999998742 3     479999986431     1111       12588999999999 8999999999


Q ss_pred             EEec-ccceEEEEeccCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCe
Q psy9535         186 LCNN-IMNCIVYEYMCNGSLYDRLARVNN-----------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  253 (593)
Q Consensus       186 ~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NI  253 (593)
                      ++.. ...++||||+++|+|.+++.....           ...+++..+..++.|++.||.|||+  ++|+||||||+||
T Consensus       118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NI  195 (333)
T 2i1m_A          118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNV  195 (333)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGC
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCcccceE
Confidence            9976 566899999999999999975321           2458999999999999999999998  5699999999999


Q ss_pred             eecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHH
Q psy9535         254 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTIL  331 (593)
Q Consensus       254 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~  331 (593)
                      |++.++.+||+|||+++....... ........||+.|+|||++ ...++.++|||||||++|||+| |..||.......
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  274 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS  274 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred             EECCCCeEEECccccccccccccc-eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence            999999999999999986543322 1122345678999999976 4568899999999999999999 999997643322


Q ss_pred             HHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         332 YYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .............      .....+    ..+..++.+||+.||.+|||+.||++.|+..
T Consensus       275 ~~~~~~~~~~~~~------~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          275 KFYKLVKDGYQMA------QPAFAP----KNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             HHHHHHHHTCCCC------CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCC------CCCCCC----HHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            2222222211110      011111    2344567799999999999999999999764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-40  Score=357.41  Aligned_cols=239  Identities=25%  Similarity=0.346  Sum_probs=178.5

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHH-hcCCCCceeeEEEEEec---
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL-SQCKHVNLLRLLGLCNN---  189 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il-~~l~HpNIv~l~g~~~~---  189 (593)
                      ++||+|+||+||+|+.. +|+.||||++...           .       .+.+|+.++ +..+||||+++++++..   
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------~-------~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------P-------KARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------H-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----------h-------hHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            57999999999999875 6899999998531           1       366888887 45589999999998753   


Q ss_pred             --ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC---CCccEEe
Q psy9535         190 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLG  264 (593)
Q Consensus       190 --~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~---~~~~Kl~  264 (593)
                        ...++||||+++|+|.+++.... ...+++..+..|+.|++.||.|||+  .+|+||||||+|||++.   ++.+||+
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccEEEE
Confidence              34689999999999999997643 2468999999999999999999998  56999999999999997   7899999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHH----HHHHHHhh
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTIL----YYYLVVEQ  339 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~----~~~~~~~~  339 (593)
                      |||+++.......    ....+||+.|+|||++. ..++.++|||||||++|||++|+.||.......    ....+...
T Consensus       207 DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~  282 (400)
T 1nxk_A          207 DFGFAKETTSHNS----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG  282 (400)
T ss_dssp             CCTTCEECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT
T ss_pred             ecccccccCCCCc----cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC
Confidence            9999986543221    23467999999999874 468899999999999999999999997643211    11112222


Q ss_pred             cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         340 EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ......   +...     .+...+..++.+||+.||++|||+.|+++
T Consensus       283 ~~~~~~---~~~~-----~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          283 QYEFPN---PEWS-----EVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             CCCCCT---TTTT-----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cccCCC---cccc-----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111110   0001     12233556778999999999999999976

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2e-40  Score=336.55  Aligned_cols=247  Identities=23%  Similarity=0.352  Sum_probs=193.1

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +..+.||+|+||.||+|... +|+.||+|++.....    ...       ....+.+|+.++++++||||+++++++.+ 
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (284)
T 3kk8_A            9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL----SAR-------DFQKLEREARICRKLQHPNIVRLHDSIQEE   77 (284)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----CHH-------HHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC----CHH-------HHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence            34678999999999999875 689999999865321    101       12357899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc---cEEeec
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---PKLGDF  266 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~---~Kl~DF  266 (593)
                      ...++||||+++|+|.+.+...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.   +||+||
T Consensus        78 ~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~Df  152 (284)
T 3kk8_A           78 SFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADF  152 (284)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEECCC
T ss_pred             CEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEeec
Confidence            4568999999999999988764   358999999999999999999998  56999999999999986654   999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      |++........    .....||+.|+|||++.+ .++.++|||||||++|||++|+.||...................+.
T Consensus       153 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  228 (284)
T 3kk8_A          153 GLAIEVNDSEA----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS  228 (284)
T ss_dssp             TTCEECCSSCB----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             eeeEEcccCcc----ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc
Confidence            99976544321    223579999999997754 5788999999999999999999999876655444443333222111


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         +.....     ...+..++.+||+.||++|||+.|+++
T Consensus       229 ---~~~~~~-----~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          229 ---PEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ---TTTTTS-----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---hhhccc-----CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               111111     123455678999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.2e-41  Score=349.02  Aligned_cols=253  Identities=25%  Similarity=0.410  Sum_probs=191.8

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhc--CCCCceeeEEEEEecc-
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ--CKHVNLLRLLGLCNNI-  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~--l~HpNIv~l~g~~~~~-  190 (593)
                      .+.||+|+||.||+|++. |+.||||++....          .      ..+.+|++++..  ++||||+++++++... 
T Consensus        47 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~----------~------~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE----------E------RSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             EEEEEEETTEEEEEEEET-TEEEEEEEECGGG----------H------HHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             EeeecCCCCcEEEEEEEc-CccEEEEEeCchh----------H------HHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            678999999999999984 8999999985320          1      146778888877  7999999999998764 


Q ss_pred             ----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeEecccCCCCeeecCCCc
Q psy9535         191 ----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------SKPIIHRDVKSANVLLDENFV  260 (593)
Q Consensus       191 ----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~IiHrDLKp~NILl~~~~~  260 (593)
                          ..++||||+++|+|.+++..    ..+++..+..++.|++.||.|||..      .++|+||||||+|||++.++.
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~  185 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  185 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred             CccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence                46899999999999999975    3589999999999999999999921      256999999999999999999


Q ss_pred             cEEeecccceecccCCCcc-eeeccccCCCCcCCcccccCCC-------CCcchhhHHHHHHHHHHhC----------CC
Q psy9535         261 PKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQI-------STKTDVFSYGVILLELLTG----------MK  322 (593)
Q Consensus       261 ~Kl~DFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~-------~~ksDVwSfGvvl~ElltG----------~~  322 (593)
                      +||+|||+++......... .......||+.|+|||++.+..       +.++|||||||++|||+||          ..
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            9999999998765433211 1123457999999999876542       2589999999999999999          78


Q ss_pred             CCCCCc----hHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         323 PIDDNN----TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       323 P~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ||....    ....+........ ....+   ...+....+...+..++.+||+.||++|||+.||++.|+..
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRKVVCEQK-LRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSC-CCCCC---CGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CccccCcCcccHHHHHHHHHHHH-hCCCC---cccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            886531    1122121111111 11101   01112234455667778899999999999999999999874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.1e-41  Score=348.49  Aligned_cols=255  Identities=24%  Similarity=0.332  Sum_probs=184.4

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +..++||+|+||.||+|+.. +|+.||||++..........            .+.+|+.++++++||||+++++++.+ 
T Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~------------~~~~E~~~l~~l~h~~iv~~~~~~~~~   72 (324)
T 3mtl_A            5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC------------TAIREVSLLKDLKHANIVTLHDIIHTE   72 (324)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CC------------CCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred             EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccch------------hHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence            34578999999999999986 78999999986432111100            24579999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+. |+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  147 (324)
T 3mtl_A           73 KSLTLVFEYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLA  147 (324)
T ss_dssp             SCEEEEEECCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred             CEEEEEecccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEECCCCCEEEccCccc
Confidence            55689999997 69999987643  468999999999999999999998  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-Cccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-VPVREV  346 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~-~~~~~~  346 (593)
                      +.......   ......||+.|+|||++.+  .++.++|||||||++|||++|+.||................ .+....
T Consensus       148 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  224 (324)
T 3mtl_A          148 RAKSIPTK---TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET  224 (324)
T ss_dssp             ECC---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccCCcc---ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHh
Confidence            86543221   1223578999999998743  47889999999999999999999998765443333322211 111111


Q ss_pred             ccccc----------CCC---C----HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEA----------GEW---N----ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~----------~~~---~----~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .....          ...   .    ...+...+..++.+|++.||++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000          000   0    0011233456778999999999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.3e-41  Score=343.02  Aligned_cols=249  Identities=28%  Similarity=0.466  Sum_probs=196.2

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|++. ++..||||.+....       ..       ...|.+|+.++++++||||+++++++.+ .
T Consensus        17 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A           17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-------ME-------VEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             EEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-------TH-------HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             EEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-------HH-------HHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            3578999999999999986 48889999986321       11       1258899999999999999999999976 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSR  159 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHH--HTCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred             CEEEEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHH--CCccCCCCCcceEEEcCCCCEEEccCccce
Confidence            5689999999999999998643 3568999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      .......  .......||+.|+|||.+. ..++.++|||||||++|||++ |..||................ ..     
T Consensus       160 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~-~~-----  231 (288)
T 3kfa_A          160 LMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-RM-----  231 (288)
T ss_dssp             TSCSSSS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CC-----
T ss_pred             eccCCcc--ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC-CC-----
Confidence            6554332  1223456789999999764 568889999999999999999 999998654333222222111 10     


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .....     +...+..++.+||..||.+||++.|+++.|+..
T Consensus       232 ~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          232 ERPEG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             CCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCC-----CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            00011     122345567899999999999999999998764

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.5e-41  Score=353.02  Aligned_cols=264  Identities=23%  Similarity=0.352  Sum_probs=194.4

Q ss_pred             CCCCcccccCceEEEEEEE-----cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-----~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      +..+.||+|+||.||+|++     .+++.||||++...      ....       ...|.+|++++++++||||++++++
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~------~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~   92 (327)
T 3lxl_A           26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS------GPDQ-------QRDFQREIQILKALHSDFIVKYRGV   92 (327)
T ss_dssp             EEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC------CHHH-------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC------CHHH-------HHHHHHHHHHHHhcCCCceeEEEEE
Confidence            4467899999999999985     35889999998632      1111       1258899999999999999999998


Q ss_pred             Eec---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         187 CNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       187 ~~~---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                      +..   ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~kl  168 (327)
T 3lxl_A           93 SYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKI  168 (327)
T ss_dssp             EECSSSCEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEE
T ss_pred             EecCCCceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCCEEE
Confidence            853   34689999999999999997643  358999999999999999999998  56999999999999999999999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCc
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  342 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~  342 (593)
                      +|||+++................||+.|+|||++. ..++.++|||||||++|||++|..||.................+
T Consensus       169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  248 (327)
T 3lxl_A          169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP  248 (327)
T ss_dssp             CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CC
T ss_pred             cccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccc
Confidence            99999987654432222233456899999999774 44688999999999999999999998653221100000000000


Q ss_pred             -cc---cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         343 -VR---EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       343 -~~---~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                       ..   +.+........+..+...+..++.+||+.||++|||+.|+++.|+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             cHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             00   000000000001112233555678999999999999999999998753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.9e-41  Score=354.44  Aligned_cols=242  Identities=24%  Similarity=0.343  Sum_probs=177.3

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +..+.||+|+||.||+++.. +|+.||||++......   .           ..+.+|+.++++++|||||++++++.+ 
T Consensus        23 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~-----------~~~~~E~~~l~~l~hpniv~~~~~~~~~   88 (361)
T 3uc3_A           23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---D-----------ENVQREIINHRSLRHPNIVRFKEVILTP   88 (361)
T ss_dssp             EEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---C-----------HHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             EEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---c-----------HHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence            34678999999999999986 7899999999653211   0           147899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc--cEEeecc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV--PKLGDFG  267 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~--~Kl~DFG  267 (593)
                      ...++||||+.+|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.  +||+|||
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg  163 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFG  163 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred             CEEEEEEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEeecC
Confidence            5568999999999999999764   358999999999999999999998  56999999999999987765  9999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccC-CCCCc-chhhHHHHHHHHHHhCCCCCCCCch----HHHHHHHHhhcC
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTK-TDVFSYGVILLELLTGMKPIDDNNT----ILYYYLVVEQEV  341 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~k-sDVwSfGvvl~ElltG~~P~~~~~~----~~~~~~~~~~~~  341 (593)
                      +++......    ......||+.|+|||++.+ .++.+ +|||||||++|||++|+.||.....    ............
T Consensus       164 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~  239 (361)
T 3uc3_A          164 YSKSSVLHS----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY  239 (361)
T ss_dssp             CC-------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC
T ss_pred             ccccccccC----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC
Confidence            987533221    1223579999999997744 45555 8999999999999999999976322    111111111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..+.     ....     ...+..++.+||+.||++|||+.|+++
T Consensus       240 ~~~~-----~~~~-----s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          240 SIPD-----DIRI-----SPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CCCT-----TSCC-----CHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCC-----cCCC-----CHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            1110     0011     123445678999999999999999864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.6e-41  Score=340.63  Aligned_cols=255  Identities=27%  Similarity=0.380  Sum_probs=188.3

Q ss_pred             CCCcccccCceEEEEEEEc--CCC--EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLK--NGM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~--~g~--~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      ..+.||+|+||.||+|++.  +++  .||||++......   ...       ....|.+|+.++++++||||+++++++.
T Consensus        22 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (291)
T 1u46_A           22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS---QPE-------AMDDFIREVNAMHSLDHRNLIRLYGVVL   91 (291)
T ss_dssp             EEEECC----CCCEEEEEECTTSCEEEEEEEC-----------CH-------HHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             eeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC---CHH-------HHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            3578999999999999863  333  6899998643111   111       1235889999999999999999999998


Q ss_pred             cccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         189 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       189 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      ....++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A           92 TPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             cCCceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEEcCCCCEEEccccc
Confidence            877899999999999999997643  358899999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ++................||+.|+|||++. ..++.++|||||||++|||++ |+.||....................  
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--  245 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--  245 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--
T ss_pred             cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC--
Confidence            987654432222233456888999999774 447889999999999999999 9999987654443333322211111  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                         ....     +...+..++.+||..+|++||++.++++.|++.
T Consensus       246 ---~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  282 (291)
T 1u46_A          246 ---RPED-----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  282 (291)
T ss_dssp             ---CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCcC-----cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence               0111     122345567799999999999999999999874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.9e-40  Score=362.14  Aligned_cols=252  Identities=23%  Similarity=0.271  Sum_probs=184.7

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      +..++||+|+||.||+|+.. +|+.||||++.....    . .      .....+.+|+.+|++++|||||++++++...
T Consensus        65 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~----~-~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (464)
T 3ttj_A           65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ----N-Q------THAKRAYRELVLMKCVNHKNIISLLNVFTPQ  133 (464)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG----S-H------HHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             EEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc----C-h------HHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence            34678999999999999875 689999999964310    0 0      1123578999999999999999999998542


Q ss_pred             -------cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         191 -------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       191 -------~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                             ..++||||+.++ |.+.+..     .+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||
T Consensus       134 ~~~~~~~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDlkp~NIll~~~~~~kl  205 (464)
T 3ttj_A          134 KTLEEFQDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKI  205 (464)
T ss_dssp             CSTTTCCEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEE
T ss_pred             CccccCCeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChHhEEEeCCCCEEE
Confidence                   348999999764 6666642     48899999999999999999999  56999999999999999999999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-  341 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-  341 (593)
                      +|||+++.......    .....||+.|+|||++. ..++.++|||||||++|||++|+.||.+.+....+..+....+ 
T Consensus       206 ~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~  281 (464)
T 3ttj_A          206 LDFGLARTAGTSFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  281 (464)
T ss_dssp             CCCCCC-----CCC----C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred             EEEEeeeecCCCcc----cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999987544321    23468999999999764 4688999999999999999999999988765554444433211 


Q ss_pred             ccccccc--------------------------cccCC-C--CHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVLD--------------------------KEAGE-W--NETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~~--------------------------~~~~~-~--~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +..+...                          ..... .  ........+..++.+||+.||++|||+.|+++
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1111100                          00000 0  01111344567788999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.3e-41  Score=352.72  Aligned_cols=267  Identities=17%  Similarity=0.181  Sum_probs=187.8

Q ss_pred             CCCcccccCceEEEEEEEc----CCCEEEEEEeecCCCCCCCCCchhHHh---hhcHHHHHHHHHHHhcCCCCceeeEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAA---MIPILLFENEVQTLSQCKHVNLLRLLG  185 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~----~g~~vAVK~l~~~~~~~~~~~~~~~~~---~~~~~~f~~Ev~il~~l~HpNIv~l~g  185 (593)
                      +.+.||+|+||.||+|+..    ++..||||.+.....     ....+..   ......+.+|+.+++.++||||+++++
T Consensus        41 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG-----PLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             EEEEC------CEEEEEESSSCGGGCCEEEEEEECC-C-----HHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             EEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCc-----chHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            4678999999999999975    578899999864311     1111111   111234778999999999999999999


Q ss_pred             EEec-----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC-
Q psy9535         186 LCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-  259 (593)
Q Consensus       186 ~~~~-----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~-  259 (593)
                      ++..     ...++||||+ +|+|.+++....   .+++..+..++.|++.||.|||+  .+|+||||||+|||++.++ 
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEESSST
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHEEEccCCC
Confidence            8765     3458999999 999999987543   68999999999999999999998  5699999999999999887 


Q ss_pred             -ccEEeecccceecccCCCcc----eeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCC--chHH
Q psy9535         260 -VPKLGDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDN--NTIL  331 (593)
Q Consensus       260 -~~Kl~DFGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~--~~~~  331 (593)
                       .+||+|||+++.........    .......||+.|+|||++.+ .++.++|||||||++|||++|+.||...  ....
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             99999999998754322111    11134579999999998754 4788999999999999999999999542  2111


Q ss_pred             HHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhccc
Q psy9535         332 YYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMF  393 (593)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~  393 (593)
                      ............+..+.....   ...+...+..++.+||..||++||++.+|++.|+....
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHHhhcccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            111111111111111111000   00112235556789999999999999999999987543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.3e-40  Score=338.74  Aligned_cols=252  Identities=29%  Similarity=0.433  Sum_probs=189.0

Q ss_pred             CCCcccccCceEEEEEEEcC----CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~----g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      ..++||+|+||.||+|++.+    +..||||.+....     ...       ....|.+|+.++++++||||++++++|.
T Consensus        29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-----~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~   96 (298)
T 3f66_A           29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-----DIG-------EVSQFLTEGIIMKDFSHPNVLSLLGICL   96 (298)
T ss_dssp             EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-----SHH-------HHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred             hcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-----CHH-------HHHHHHHHHHHHHhCCCCCEeeeeeEEE
Confidence            35789999999999998642    2358999985321     111       1235889999999999999999999875


Q ss_pred             c--ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         189 N--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       189 ~--~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      .  ...++||||+++|+|.+++...  ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus        97 ~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Df  172 (298)
T 3f66_A           97 RSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADF  172 (298)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSC
T ss_pred             cCCCceEEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEECCCCCEEECcc
Confidence            4  4568999999999999999753  3468999999999999999999998  56999999999999999999999999


Q ss_pred             ccceecccCCCc-ceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcc
Q psy9535         267 GIVKMSETSNMK-TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  343 (593)
Q Consensus       267 Gla~~~~~~~~~-~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~  343 (593)
                      |+++........ ........||+.|+|||.+. ..++.++|||||||++|||++ |.+||...................
T Consensus       173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (298)
T 3f66_A          173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL  252 (298)
T ss_dssp             GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC
T ss_pred             cccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC
Confidence            999865433211 11123456889999999774 567889999999999999999 566666543322222222221111


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .       ...    +...+..++.+||+.+|++||++.|+++.|+..
T Consensus       253 ~-------~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          253 Q-------PEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             C-------CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-------Ccc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0       011    112345567799999999999999999999874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=343.41  Aligned_cols=255  Identities=23%  Similarity=0.348  Sum_probs=185.7

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..++||+|+||.||+|+.. +|+.||||++....     .....      ...+.+|+.++++++||||+++++++.+ .
T Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (311)
T 4agu_A            7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-----DDPVI------KKIALREIRMLKQLKHPNLVNLLEVFRRKR   75 (311)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-----C-HHH------HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             EeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-----cchHH------HHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence            4678999999999999985 58999999985431     11111      1257899999999999999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  150 (311)
T 4agu_A           76 RLHLVFEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFAR  150 (311)
T ss_dssp             EEEEEEECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eEEEEEEeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEEcCCCCEEEeeCCCch
Confidence            568999999999999887643   458999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc-----
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV-----  343 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~-----  343 (593)
                      .......   ......||+.|+|||++.  ..++.++|||||||++|||++|+.||...................     
T Consensus       151 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  227 (311)
T 4agu_A          151 LLTGPSD---YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ  227 (311)
T ss_dssp             ECC---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hccCccc---ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc
Confidence            7543321   123457999999999774  357899999999999999999999998765433322222110000     


Q ss_pred             ---------ccccccccCCCCH-----HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 ---------REVLDKEAGEWNE-----THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ---------~~~~~~~~~~~~~-----~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                               ....-+.......     ..+...+..++.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                     0000000000000     011223455778999999999999999874

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.8e-40  Score=337.79  Aligned_cols=244  Identities=22%  Similarity=0.339  Sum_probs=193.1

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|+.. +++.||+|.+......   . ..      ....|.+|+.++++++||||+++++++.+ .
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---~-~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   88 (294)
T 2rku_A           19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL---K-PH------QREKMSMEISIHRSLAHQHVVGFHGFFEDND   88 (294)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC---S-HH------HHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             EEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc---C-HH------HHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence            4678999999999999986 5889999998653211   1 11      12257899999999999999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+.+|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEcCCCCEEEEeccCce
Confidence            568999999999999988763   358999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .......   ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||........+..........+.    
T Consensus       164 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----  236 (294)
T 2rku_A          164 KVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----  236 (294)
T ss_dssp             ECCSTTC---CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----
T ss_pred             ecccCcc---ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc----
Confidence            7543321   1233579999999997754 5788999999999999999999999876544433333322222111    


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         .     +...+..++.+||+.||++|||+.|+++
T Consensus       237 ---~-----~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          237 ---H-----INPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ---T-----SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---c-----cCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence               1     1123455678999999999999999865

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.2e-40  Score=343.77  Aligned_cols=247  Identities=26%  Similarity=0.338  Sum_probs=182.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      ++.||+|+||.||+|+.. +|+.||||++.....   .   .       ...+.+|++++.++ +||||+++++++.+ .
T Consensus        18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~---~-------~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A           18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---H---I-------RSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---C---C-------HHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---h---h-------HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            578999999999999864 689999999965311   1   0       12478999999985 79999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc---cEEeecc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---PKLGDFG  267 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~---~Kl~DFG  267 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.   +||+|||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             EEEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            668999999999999999764   358999999999999999999999  56999999999999988765   9999999


Q ss_pred             cceecccCCCc----ceeeccccCCCCcCCccccc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCch--------
Q psy9535         268 IVKMSETSNMK----TMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNT--------  329 (593)
Q Consensus       268 la~~~~~~~~~----~~~~~~~~GT~~Y~APE~~~------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~--------  329 (593)
                      +++........    ........||+.|+|||++.      ..++.++|||||||++|||++|+.||.....        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            98764322110    11112356999999999874      3478899999999999999999999976321        


Q ss_pred             -------HHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         330 -------ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       330 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                             ......+.......+.   ....     .+...+..++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~i~~~~~~~~~---~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          240 EACPACQNMLFESIQEGKYEFPD---KDWA-----HISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             -CCHHHHHHHHHHHHHCCCCCCH---HHHT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccchhHHHHHHHHHhccCcccCc---hhcc-----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                   1111111111111110   0001     12234556778999999999999999875

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=352.54  Aligned_cols=251  Identities=22%  Similarity=0.352  Sum_probs=184.5

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      +..+.||+|+||.||+|+.. +|+.||||++....    .. ..      ....+.+|+.+|++++||||+++++++...
T Consensus        28 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~-~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   96 (367)
T 1cm8_A           28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF----QS-EL------FAKRAYRELRLLKHMRHENVIGLLDVFTPD   96 (367)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEECSSTT----SS-HH------HHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc----cC-HH------HHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence            34678999999999999874 69999999985421    11 11      123578999999999999999999998653


Q ss_pred             -------cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         191 -------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       191 -------~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                             ..++||||+ +++|.+++..    ..+++..+..++.|+++||.|||+  .+|+||||||+|||++.++.+||
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl  169 (367)
T 1cm8_A           97 ETLDDFTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKI  169 (367)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEE
T ss_pred             CccccCceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEEcCCCCEEE
Confidence                   248999999 8899999875    358999999999999999999998  56999999999999999999999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  341 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~  341 (593)
                      +|||+++.....      .....||+.|+|||++.  ..++.++||||+||++|||++|+.||...+.......+.....
T Consensus       170 ~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g  243 (367)
T 1cm8_A          170 LDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG  243 (367)
T ss_dssp             CCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             Eeeecccccccc------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999875432      22357999999999764  3688999999999999999999999987665443333322111


Q ss_pred             -cccccccc----------------ccCCCC--HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 -PVREVLDK----------------EAGEWN--ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 -~~~~~~~~----------------~~~~~~--~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       +..+....                ....+.  .......+..++.+|++.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence             11110000                000000  0011233556778999999999999999865

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.6e-41  Score=339.90  Aligned_cols=245  Identities=27%  Similarity=0.412  Sum_probs=171.4

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.+.||+|+||.||+|+.. +|+.||||.+.......          ......+.+|+.++++++||||+++++++.+ .
T Consensus        15 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (278)
T 3cok_A           15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK----------AGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN   84 (278)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred             eeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhh----------hhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence            3678999999999999874 78999999986431100          0112358899999999999999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...  ..++++..+..++.|+++||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~  160 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLAT  160 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEEeeccee
Confidence            568999999999999999753  2468999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ........   .....||+.|+|||.+.+ .++.++|||||||++|||++|+.||................        .
T Consensus       161 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~  229 (278)
T 3cok_A          161 QLKMPHEK---HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--------Y  229 (278)
T ss_dssp             ECC-------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC--------C
T ss_pred             eccCCCCc---ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc--------c
Confidence            65432211   123579999999997754 57889999999999999999999997643211111100000        0


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .....    ....+..++.+||+.||++||++.++++
T Consensus       230 ~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          230 EMPSF----LSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCccc----cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            01111    1223455678999999999999999864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.2e-41  Score=344.42  Aligned_cols=255  Identities=22%  Similarity=0.372  Sum_probs=185.9

Q ss_pred             CCCCcccccCceEEEEEEEc----CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~----~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      ..++.||+|+||.||+|+..    ++..||||.+.....    . .  .    ....|.+|+.++++++||||+++++++
T Consensus        37 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~----~-~--~----~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS----S-Q--R----EIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             EEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC----C-H--H----HHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             eeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc----c-h--h----HHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            34678999999999999864    345899999864311    1 1  1    123588999999999999999999998


Q ss_pred             ecc------cceEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC
Q psy9535         188 NNI------MNCIVYEYMCNGSLYDRLARVN---NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  258 (593)
Q Consensus       188 ~~~------~~~lV~Ey~~~GsL~~~L~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~  258 (593)
                      ...      ..++||||+++|+|.+++....   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.+
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCSGGGEEECTT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCC
Confidence            652      2389999999999999985421   23569999999999999999999998  569999999999999999


Q ss_pred             CccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHH
Q psy9535         259 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLV  336 (593)
Q Consensus       259 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~  336 (593)
                      +.+||+|||+++........ .......||+.|+|||.+. ..++.++|||||||++|||++ |..||............
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  262 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL  262 (313)
T ss_dssp             SCEEECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             CcEEEeecCcceeccccccc-CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence            99999999999865433211 1122346788999999774 457889999999999999999 89999875543333332


Q ss_pred             HhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         337 VEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .....+  .    .....     ...+..++.+||..+|++||++.++++.|++.
T Consensus       263 ~~~~~~--~----~~~~~-----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          263 LHGHRL--K----QPEDC-----LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             HTTCCC--C----CBTTC-----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCC--C----CCccc-----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            222111  0    01111     12345567799999999999999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.8e-40  Score=341.90  Aligned_cols=254  Identities=25%  Similarity=0.384  Sum_probs=193.3

Q ss_pred             CCCcccccCceEEEEEEE------cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKL------KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  185 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~------~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g  185 (593)
                      +.+.||+|+||.||+|++      .+++.||||.+....     . .. .     ...|.+|+.++.++ +||||+++++
T Consensus        31 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~-~~-~-----~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----T-HS-E-----HRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-----C-HH-H-----HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             eeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-----C-cH-H-----HHHHHHHHHHHHhcccCCCeeeEEE
Confidence            468999999999999975      246889999986431     1 11 1     12588999999999 7999999999


Q ss_pred             EEecc--cceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCC
Q psy9535         186 LCNNI--MNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKS  250 (593)
Q Consensus       186 ~~~~~--~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp  250 (593)
                      ++...  ..++||||+++|+|.+++.....             ...+++..+..++.|++.||.|||+  ++|+||||||
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp  176 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAA  176 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSG
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh--CCcccccCcc
Confidence            98753  46899999999999999986432             1237899999999999999999998  5699999999


Q ss_pred             CCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCc
Q psy9535         251 ANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN  328 (593)
Q Consensus       251 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~  328 (593)
                      +|||++.++.+||+|||+++....... ........||+.|+|||++ ...++.++|||||||++|||+| |..||....
T Consensus       177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          177 RNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            999999999999999999986543322 1223345689999999976 4568889999999999999998 999997643


Q ss_pred             hHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         329 TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ................      ......    ..+..++.+||+.+|.+|||+.||++.|+..
T Consensus       256 ~~~~~~~~~~~~~~~~------~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          256 IDEEFCRRLKEGTRMR------APDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CSHHHHHHHHHTCCCC------CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHHHhccCccCC------CCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2221112111111100      011111    2244566799999999999999999999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.2e-40  Score=344.63  Aligned_cols=245  Identities=22%  Similarity=0.325  Sum_probs=193.8

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      .+.+.||+|+||.||+++.. +++.||+|.+......   . ..      ....|.+|+.++++++||||+++++++.+ 
T Consensus        44 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---~-~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  113 (335)
T 2owb_A           44 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL---K-PH------QREKMSMEISIHRSLAHQHVVGFHGFFEDN  113 (335)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC---S-HH------HHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc---C-HH------HHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            34688999999999999975 5889999998653211   1 01      12258899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+.+++|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  188 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLA  188 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CeEEEEEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEEcCCCCEEEeeccCc
Confidence            4568999999999999988763   358999999999999999999998  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      +.......   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||........+.............  
T Consensus       189 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  263 (335)
T 2owb_A          189 TKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--  263 (335)
T ss_dssp             EECCSTTC---CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTT--
T ss_pred             eecccCcc---cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCcc--
Confidence            87543321   1234579999999997744 57889999999999999999999998765444333333332222111  


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                           .     ...+..++.+||+.||++||++.|+++
T Consensus       264 -----~-----~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          264 -----I-----NPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -----S-----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -----C-----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 1     123455678999999999999999865

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.5e-40  Score=347.15  Aligned_cols=258  Identities=21%  Similarity=0.306  Sum_probs=190.8

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI-  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~-  190 (593)
                      +.++||+|+||.||+|+.. +|+.||||++.........           ...+.+|+.++++++||||+++++++... 
T Consensus        21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   89 (351)
T 3mi9_A           21 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-----------PITALREIKILQLLKHENVVNLIEICRTKA   89 (351)
T ss_dssp             EEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS-----------CHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred             EEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc-----------hHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence            3578999999999999984 7899999998644211110           11477899999999999999999988652 


Q ss_pred             --------cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccE
Q psy9535         191 --------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  262 (593)
Q Consensus       191 --------~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~K  262 (593)
                              ..++||||+. |+|.+.+....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+|
T Consensus        90 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~k  164 (351)
T 3mi9_A           90 SPYNRCKGSIYLVFDFCE-HDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLK  164 (351)
T ss_dssp             -------CEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEE
T ss_pred             cccccCCceEEEEEeccC-CCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCCEE
Confidence                    3589999997 57888876532  458999999999999999999998  5699999999999999999999


Q ss_pred             EeecccceecccCCCc-ceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh
Q psy9535         263 LGDFGIVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  339 (593)
Q Consensus       263 l~DFGla~~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~  339 (593)
                      |+|||+++........ ........||+.|+|||++.+  .++.++|||||||++|||++|+.||...............
T Consensus       165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  244 (351)
T 3mi9_A          165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL  244 (351)
T ss_dssp             ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             EccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            9999999875432211 111234579999999997753  4789999999999999999999999876554433333222


Q ss_pred             cCccccccccc---------------cCCCCHHHH-----HHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         340 EVPVREVLDKE---------------AGEWNETHV-----ETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       340 ~~~~~~~~~~~---------------~~~~~~~~~-----~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ........-+.               ........+     ...+..++.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            11111100000               000001111     123556778999999999999999865

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.4e-40  Score=349.05  Aligned_cols=251  Identities=26%  Similarity=0.414  Sum_probs=194.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      .+.||+|+||.||+|+.. +|+.||||++.......  . .  .........|.+|+.+++++ +||||+++++++.. .
T Consensus        99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~--~-~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL--S-P--EQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCC--C-H--HHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             ceEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--C-H--HHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            578999999999999986 79999999997542111  0 0  11011123578999999999 79999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence            668999999999999999753   358999999999999999999998  569999999999999999999999999988


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-------CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  343 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-------~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~  343 (593)
                      .......    .....||+.|+|||++.+       .++.++|||||||++|||++|+.||...........+.......
T Consensus       249 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  324 (365)
T 2y7j_A          249 HLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF  324 (365)
T ss_dssp             ECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             ccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            7654321    234679999999997642       36789999999999999999999998765544433333322211


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..   +.....     ...+..++.+||+.||++|||+.|+++
T Consensus       325 ~~---~~~~~~-----~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          325 SS---PEWDDR-----SSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             CH---HHHSSS-----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CC---cccccC-----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            10   000111     123455778999999999999999975

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.3e-40  Score=336.65  Aligned_cols=242  Identities=25%  Similarity=0.426  Sum_probs=192.1

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|+.. ++..||||.+........          .....+.+|+.++++++||||+++++++.+ .
T Consensus        18 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (284)
T 2vgo_A           18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE----------GVEHQLRREIEIQSHLRHPNILRMYNYFHDRK   87 (284)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             eeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchH----------HHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence            3578999999999999876 578899999864311000          012358899999999999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEEcCCCCEEEecccccc
Confidence            568999999999999999764   358999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......     .....||+.|+|||++.+ .++.++||||||+++|||++|..||...................+.    
T Consensus       163 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----  233 (284)
T 2vgo_A          163 HAPSLR-----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----  233 (284)
T ss_dssp             ECSSSC-----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----
T ss_pred             cCcccc-----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC----
Confidence            654322     223579999999997754 5788999999999999999999999876554443333322221111    


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                          .    +...+..++.+||+.||.+||++.|+++
T Consensus       234 ----~----~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          234 ----F----LSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ----T----SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----c----CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                1    1123455778999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-40  Score=347.80  Aligned_cols=258  Identities=24%  Similarity=0.290  Sum_probs=189.4

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|+.. +|+.||||++..........  .      ....+.+|+.++++++||||+++++++.+ .
T Consensus        14 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A           14 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKD--G------INRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC--------------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             EEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhh--h------hhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            4688999999999999975 68999999986432111000  0      01147899999999999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+.+ +|.+++...  ...+++..+..++.|+++||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             ceEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            66899999985 898888653  2468899999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-cccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-PVREVL  347 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~~~~~~  347 (593)
                      .......   ......||+.|+|||++.+  .++.++|||||||++|||++|..||...........+..... +..+..
T Consensus       161 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          161 SFGSPNR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             TTTSCCC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             eccCCcc---cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence            6543321   1234579999999998743  378899999999999999999999987665444443332211 111000


Q ss_pred             cc----------c-cCCCCH----HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DK----------E-AGEWNE----THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~----------~-~~~~~~----~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..          . ....+.    ......+..++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00          0 000000    111234556778999999999999999865

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=8.5e-41  Score=347.88  Aligned_cols=257  Identities=23%  Similarity=0.318  Sum_probs=183.8

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHH--HHHHHhcCCCCceeeEEEEEec
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN--EVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~--Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      ++.+.||+|+||.||+|+. +++.||||++....          .      ..+..  |+..+..++||||+++++.+..
T Consensus        16 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----------~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~   78 (336)
T 3g2f_A           16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----------R------QNFINEKNIYRVPLMEHDNIARFIVGDER   78 (336)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----------H------HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             heeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----------h------hhHHHHHHHHHHHhccCcchhhheecccc
Confidence            3467899999999999987 58999999986421          0      12333  4444556899999999986542


Q ss_pred             ------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCeEecccCCCCeeec
Q psy9535         190 ------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-------SKPIIHRDVKSANVLLD  256 (593)
Q Consensus       190 ------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~IiHrDLKp~NILl~  256 (593)
                            ...++||||+++|+|.+++...    ..++..+..++.|++.||.|||+.       .++|+||||||+|||++
T Consensus        79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~  154 (336)
T 3g2f_A           79 VTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK  154 (336)
T ss_dssp             ECTTSCEEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred             cccCCCceEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence                  1347999999999999999763    358899999999999999999984       11699999999999999


Q ss_pred             CCCccEEeecccceecccCCCc-----ceeeccccCCCCcCCcccccC--------CCCCcchhhHHHHHHHHHHhCCCC
Q psy9535         257 ENFVPKLGDFGIVKMSETSNMK-----TMYTENLTGTRPYMPPEAMHC--------QISTKTDVFSYGVILLELLTGMKP  323 (593)
Q Consensus       257 ~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~~GT~~Y~APE~~~~--------~~~~ksDVwSfGvvl~ElltG~~P  323 (593)
                      .++.+||+|||+++........     ........||+.|+|||++.+        .++.++|||||||++|||++|..|
T Consensus       155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p  234 (336)
T 3g2f_A          155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD  234 (336)
T ss_dssp             TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred             CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence            9999999999999875432210     111224579999999998764        245689999999999999999777


Q ss_pred             CCCCch-----------------HHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         324 IDDNNT-----------------ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       324 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      |.....                 ............ ....+....  .........+..++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK-QRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-CCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCccchhHHHHhhhcccCCCchHHHHHhhhcccc-cCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            643211                 000000000000 000000000  011223445666778999999999999999999


Q ss_pred             HHhhcc
Q psy9535         387 LLSKSM  392 (593)
Q Consensus       387 ~L~~~~  392 (593)
                      .|+...
T Consensus       312 ~L~~ll  317 (336)
T 3g2f_A          312 RMAELM  317 (336)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            998854

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.3e-40  Score=334.74  Aligned_cols=244  Identities=26%  Similarity=0.460  Sum_probs=185.0

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.+.||+|+||.||+|+.. +|+.||||.+......          .......+.+|+.++++++||||+++++++.. 
T Consensus        14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   83 (276)
T 2h6d_A           14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR----------SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP   83 (276)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH----------HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             EEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc----------chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            34678999999999999986 7899999998643110          01112358899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~  158 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLS  158 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--HCSSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred             CeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChhhEEECCCCCEEEeecccc
Confidence            5568999999999999999764   358999999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccCC-C-CCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      +.......    .....||+.|+|||.+.+. + +.++||||||+++|||++|+.||...................+.  
T Consensus       159 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  232 (276)
T 2h6d_A          159 NMMSDGEF----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE--  232 (276)
T ss_dssp             GCCCC-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--
T ss_pred             cccCCCcc----eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCch--
Confidence            76543221    2235799999999987654 3 57899999999999999999999876544433333222211111  


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                            .    +...+..++.+||+.||++|||+.|+++
T Consensus       233 ------~----~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          233 ------Y----LNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             ------T----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------h----cCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                  1    1123455678999999999999999976

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-40  Score=353.45  Aligned_cols=251  Identities=23%  Similarity=0.327  Sum_probs=186.3

Q ss_pred             CCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      +..+.||+|+||.||+|+. .+|+.||||++.....                 .+.+|+++|+.++|||||++++++...
T Consensus        10 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----------------~~~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A           10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----------------YKNRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             EEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----------------SCCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             EEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----------------hHHHHHHHHHHcCCCCccchhheeeec
Confidence            3468999999999999987 4789999999864311                 124699999999999999999987331


Q ss_pred             ---------------------------------------cceEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHH
Q psy9535         191 ---------------------------------------MNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVA  230 (593)
Q Consensus       191 ---------------------------------------~~~lV~Ey~~~GsL~~~L~~~-~~~~~l~~~~~~~i~~~ia  230 (593)
                                                             ..++||||++ |+|.+.+... .....+++..+..++.|++
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence                                                   2579999998 6888877642 2235689999999999999


Q ss_pred             HHHHHHhcCCCCeEecccCCCCeeec-CCCccEEeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchh
Q psy9535         231 EALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDV  307 (593)
Q Consensus       231 ~gL~yLH~~~~~IiHrDLKp~NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDV  307 (593)
                      +||.|||+  .+|+||||||+|||++ .++.+||+|||+++.......    .....||+.|+|||++.+  .++.++||
T Consensus       152 ~aL~~LH~--~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di  225 (383)
T 3eb0_A          152 RAVGFIHS--LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGATEYTPSIDL  225 (383)
T ss_dssp             HHHHHHHT--TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred             HHHHHHHH--CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCCCCCCcchhh
Confidence            99999998  5699999999999998 689999999999987544332    223578999999997644  47899999


Q ss_pred             hHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-cCccccccc-----------cc--cCCC---CHHHHHHHHHHHHHHh
Q psy9535         308 FSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLD-----------KE--AGEW---NETHVETLIGIVFEKC  370 (593)
Q Consensus       308 wSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-~~~~~~~~~-----------~~--~~~~---~~~~~~~~i~~~~~~C  370 (593)
                      |||||++|||++|+.||...........+... ..+..+.+.           +.  ...+   .+......+..++.+|
T Consensus       226 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  305 (383)
T 3eb0_A          226 WSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI  305 (383)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred             hhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence            99999999999999999886654443333221 111100000           00  0000   0011223355677899


Q ss_pred             hccccCCCCChHHHHH
Q psy9535         371 CVFEKDKRASMRDIVD  386 (593)
Q Consensus       371 ~~~dp~~RPsm~eV~~  386 (593)
                      |+.||++|||+.|+++
T Consensus       306 L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          306 LRYEPDLRINPYEAMA  321 (383)
T ss_dssp             CCSSGGGSCCHHHHHT
T ss_pred             ccCChhhCCCHHHHhc
Confidence            9999999999999864

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.5e-42  Score=362.18  Aligned_cols=239  Identities=16%  Similarity=0.189  Sum_probs=177.4

Q ss_pred             CCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHH---HHHhcCCCCceeeEE---
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV---QTLSQCKHVNLLRLL---  184 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev---~il~~l~HpNIv~l~---  184 (593)
                      ++.+.||+|+||.||+|+. .+|+.||||++........   ..       ...|.+|+   .+|++++|||||+++   
T Consensus        76 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~---~~-------~~~~~~E~~~l~~l~~l~hpniv~~~~~~  145 (377)
T 3byv_A           76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS---NA-------IKQMKEEVLRLRLLRGIKNQKQAKVHLRF  145 (377)
T ss_dssp             EEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCT---TH-------HHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred             EEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccch---HH-------HHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence            3468899999999999996 4699999999975321111   11       12588999   566677899999998   


Q ss_pred             ----EEEecc------------------cceEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhc
Q psy9535         185 ----GLCNNI------------------MNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYLHS  238 (593)
Q Consensus       185 ----g~~~~~------------------~~~lV~Ey~~~GsL~~~L~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~  238 (593)
                          +++.+.                  ..++||||+ +|+|.+++.....    ...+++..+..|+.|++.||.|||+
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  224 (377)
T 3byv_A          146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH  224 (377)
T ss_dssp             CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence                555432                  257999999 7899999976421    1124468888999999999999999


Q ss_pred             CCCCeEecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccccC------------CCCCcch
Q psy9535         239 LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------------QISTKTD  306 (593)
Q Consensus       239 ~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~------------~~~~ksD  306 (593)
                        ++|+||||||+|||++.++.+||+|||+++....      ......| +.|+|||++.+            .++.++|
T Consensus       225 --~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  295 (377)
T 3byv_A          225 --YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD  295 (377)
T ss_dssp             --TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred             --CCeecCCCCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence              5699999999999999999999999999986332      1234578 99999997743            4889999


Q ss_pred             hhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         307 VFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       307 VwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ||||||++|||++|+.||.......          ....+.. .....+     ..+..++.+||+.||++|||+.|+++
T Consensus       296 vwSlG~il~elltg~~Pf~~~~~~~----------~~~~~~~-~~~~~~-----~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          296 AWALGLVIYWIWCADLPITKDAALG----------GSEWIFR-SCKNIP-----QPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHHHHHHHSSCCC------C----------CSGGGGS-SCCCCC-----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHHHHHHHCCCCCccccccc----------chhhhhh-hccCCC-----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999999999997533211          0111111 011111     23455677999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=350.71  Aligned_cols=244  Identities=17%  Similarity=0.129  Sum_probs=187.2

Q ss_pred             CCCcccccCceEEEEEE------EcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC---CCceeeE
Q psy9535         113 RGNKLGEGQFGTVYYGK------LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLLRL  183 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~------~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~---HpNIv~l  183 (593)
                      +.++||+|+||.||+|.      ..+++.||||++....                ...|.+|++++.+++   |+||+++
T Consensus        69 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----------------PWEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             EEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----------------HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             EEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----------------hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence            35789999999999994      3468899999985321                114778888888887   9999999


Q ss_pred             EEEEec-ccceEEEEeccCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC---
Q psy9535         184 LGLCNN-IMNCIVYEYMCNGSLYDRLARVN--NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---  257 (593)
Q Consensus       184 ~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~---  257 (593)
                      ++++.. ...++||||+++|+|.+++....  ....+++..+..|+.|++.||+|||+  ++|+||||||+|||++.   
T Consensus       133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGGGT
T ss_pred             heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEeccccc
Confidence            998865 56789999999999999997532  23569999999999999999999998  56999999999999998   


Q ss_pred             --------CCccEEeecccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCc
Q psy9535         258 --------NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN  328 (593)
Q Consensus       258 --------~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~  328 (593)
                              ++.+||+|||+|+....... ........||+.|||||++.+ .++.++|||||||++|||+||+.||....
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  289 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE  289 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred             CccccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence                    89999999999986543222 122345689999999998754 47899999999999999999999996422


Q ss_pred             hHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCC-CChHHHHHHHhhc
Q psy9535         329 TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKR-ASMRDIVDLLSKS  391 (593)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~R-Psm~eV~~~L~~~  391 (593)
                      .         ........+.   ..+..    ..+..++..|+..+|.+| |++.++.+.|++.
T Consensus       290 ~---------~~~~~~~~~~---~~~~~----~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          290 G---------GECKPEGLFR---RLPHL----DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             T---------TEEEECSCCT---TCSSH----HHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             C---------Cceeechhcc---ccCcH----HHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            1         0000111111   11122    234456679999999988 6788888777663

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-40  Score=360.31  Aligned_cols=192  Identities=22%  Similarity=0.292  Sum_probs=144.9

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         111 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       111 ~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      +++.++||+|+||.||+|+.. +|+.||||++....    ..  ..     ....+.+|+.+|++++|||||++++++..
T Consensus        55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~----~~--~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~  123 (458)
T 3rp9_A           55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF----ED--LI-----DCKRILREIAILNRLNHDHVVKVLDIVIP  123 (458)
T ss_dssp             EEECCC-------CEEEEEECC--CEEEEEEECSTT----SS--HH-----HHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred             eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh----cC--HH-----HHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence            455789999999999999875 68999999985421    11  10     12358899999999999999999999843


Q ss_pred             ------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         190 ------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       190 ------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                            ...++||||+ +|+|.+++...   ..+++..+..++.||+.||.|||+  .+||||||||+||||+.++.+||
T Consensus       124 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~~iiHrDlKp~NILl~~~~~~kl  197 (458)
T 3rp9_A          124 KDVEKFDELYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKV  197 (458)
T ss_dssp             SCTTTCCCEEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEE
T ss_pred             CCcccCceEEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHh--CCcCCCCCChhhEEECCCCCEee
Confidence                  2458999987 58999988752   468999999999999999999998  56999999999999999999999


Q ss_pred             eecccceecccCCCc------------------------ceeeccccCCCCcCCcccc--cCCCCCcchhhHHHHHHHHH
Q psy9535         264 GDFGIVKMSETSNMK------------------------TMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLEL  317 (593)
Q Consensus       264 ~DFGla~~~~~~~~~------------------------~~~~~~~~GT~~Y~APE~~--~~~~~~ksDVwSfGvvl~El  317 (593)
                      +|||+++........                        .......+||+.|+|||++  ...++.++|||||||+||||
T Consensus       198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el  277 (458)
T 3rp9_A          198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL  277 (458)
T ss_dssp             CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred             cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence            999999875422110                        0112346799999999965  34589999999999999999


Q ss_pred             Hh
Q psy9535         318 LT  319 (593)
Q Consensus       318 lt  319 (593)
                      ++
T Consensus       278 lt  279 (458)
T 3rp9_A          278 LN  279 (458)
T ss_dssp             HT
T ss_pred             HH
Confidence            99

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.4e-40  Score=355.65  Aligned_cols=251  Identities=22%  Similarity=0.290  Sum_probs=184.4

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc--
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~--  190 (593)
                      ..++||+|+||.||+|+...+..||+|++.....                 ...+|+++++.++|||||++++++...  
T Consensus        44 ~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----------------~~~~E~~il~~l~h~niv~l~~~~~~~~~  106 (394)
T 4e7w_A           44 NCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----------------FKNRELQIMRIVKHPNVVDLKAFFYSNGD  106 (394)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----------------SCCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred             EeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----------------hHHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence            3578999999999999998777799999864311                 123699999999999999999988432  


Q ss_pred             -----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec-CCCccEEe
Q psy9535         191 -----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLG  264 (593)
Q Consensus       191 -----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~-~~~~~Kl~  264 (593)
                           ..++||||++++.+............+++..+..++.|+++||.|||+  .+|+||||||+|||++ .++.+||+
T Consensus       107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~kL~  184 (394)
T 4e7w_A          107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVLKLI  184 (394)
T ss_dssp             SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEcCCCCcEEEe
Confidence                 157999999875444333222223568999999999999999999998  5699999999999999 79999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-cC
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EV  341 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-~~  341 (593)
                      |||+++.......    .....||+.|+|||++.+  .++.++|||||||++|||++|+.||.+.........+... ..
T Consensus       185 DFG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  260 (394)
T 4e7w_A          185 DFGSAKILIAGEP----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT  260 (394)
T ss_dssp             CCTTCEECCTTCC----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             eCCCcccccCCCC----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999987644322    224578999999997743  4789999999999999999999999886654333332221 11


Q ss_pred             cccccc--------c---cccCCCC-----HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVL--------D---KEAGEWN-----ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~--------~---~~~~~~~-----~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +..+.+        .   +......     ...+...+..++.+||+.||.+|||+.|+++
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            100000        0   0000000     0012234556778999999999999999864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=336.75  Aligned_cols=245  Identities=29%  Similarity=0.373  Sum_probs=186.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ...||+|+||.||+|+.. ++..||||.+.....      ..       ...|.+|+.++++++||||+++++++.. ..
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   93 (295)
T 2clq_A           27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS------RY-------SQPLHEEIALHKHLKHKNIVQYLGSFSENGF   93 (295)
T ss_dssp             BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----------------HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cEEEeecCcEEEEEEEECCCCeEEEEEEccCCch------HH-------HHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence            358999999999999974 688999999864311      00       1248899999999999999999999876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC-CCccEEeecccce
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVK  270 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~-~~~~Kl~DFGla~  270 (593)
                      .++||||+++|+|.+++........+++..+..++.|++.||.|||+  .+|+||||||+|||++. ++.+||+|||+++
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~  171 (295)
T 2clq_A           94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSK  171 (295)
T ss_dssp             EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred             EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEECCCCCEEEeeccccc
Confidence            68999999999999999875444567889999999999999999998  56999999999999987 8999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC---CCCCcchhhHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhhcCccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQEVPVREV  346 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~-~~~~~~~~~~~~~~~  346 (593)
                      .......   ......||+.|+|||++.+   .++.++|||||||++|||++|+.||....... ..........     
T Consensus       172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----  243 (295)
T 2clq_A          172 RLAGINP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV-----  243 (295)
T ss_dssp             ESCC--------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-----
T ss_pred             ccCCCCC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-----
Confidence            6543221   1234579999999998743   37889999999999999999999997532211 1111111100     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       .+....    .+...+..++.+||+.||++||++.|+++
T Consensus       244 -~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          244 -HPEIPE----SMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -CCCCCT----TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -cccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             000011    11223455678999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.7e-41  Score=348.45  Aligned_cols=254  Identities=22%  Similarity=0.271  Sum_probs=182.6

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.++||+|+||.||+|+.. +|+.||||++........    .       ...+.+|+.++++++||||+++++++.+ .
T Consensus        38 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           38 RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG----V-------PGTAIREVSLLKELQHRNIIELKSVIHHNH  106 (329)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-------------------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred             EEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccc----c-------chhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            4678999999999999865 689999999864321110    0       1146789999999999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee-----cCCCccEEee
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-----DENFVPKLGD  265 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl-----~~~~~~Kl~D  265 (593)
                      ..++||||+. |+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||+     +.++.+||+|
T Consensus       107 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          107 RLHLIFEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             EEEEEEECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             EEEEEEecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccceEEECc
Confidence            5689999997 5999999764   358999999999999999999999  569999999999999     4556699999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-c
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-P  342 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~  342 (593)
                      ||+++.......   ......||+.|+|||++.+  .++.++|||||||++|||++|+.||................. +
T Consensus       181 fg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  257 (329)
T 3gbz_A          181 FGLARAFGIPIR---QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP  257 (329)
T ss_dssp             TTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             CCCccccCCccc---ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            999986543221   1233578999999998754  478999999999999999999999987665444333332211 1


Q ss_pred             ccccccc---------ccCC---CC-----HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREVLDK---------EAGE---WN-----ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~~~~---------~~~~---~~-----~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .......         ....   ..     ...+...+..++.+||+.||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            1000000         0000   00     0002234556778999999999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2e-40  Score=357.51  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=183.7

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI-  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~-  190 (593)
                      ..+.||+|+||.||+|++. +|+.||||++.....                 .+.+|+++|++++|||||++++++... 
T Consensus        58 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----------------~~~~E~~il~~l~hpniv~l~~~~~~~~  120 (420)
T 1j1b_A           58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----------------FKNRELQIMRKLDHCNIVRLRYFFYSSG  120 (420)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----------------SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             eeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----------------hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence            3578999999999999985 689999999864311                 134699999999999999999987431 


Q ss_pred             ------cceEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC-CccE
Q psy9535         191 ------MNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPK  262 (593)
Q Consensus       191 ------~~~lV~Ey~~~GsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~-~~~K  262 (593)
                            ..++||||+++ +|.+.+... .....+++..+..++.|+++||.|||+  .+|+||||||+|||++.+ +.+|
T Consensus       121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~~k  197 (420)
T 1j1b_A          121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLK  197 (420)
T ss_dssp             TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEEETTTTEEE
T ss_pred             CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEeCCCCeEE
Confidence                  24689999985 666665432 223568999999999999999999998  569999999999999955 6789


Q ss_pred             EeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-
Q psy9535         263 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-  339 (593)
Q Consensus       263 l~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-  339 (593)
                      |+|||+++.......    .....||+.|+|||++.+  .++.++|||||||++|||++|+.||...........+... 
T Consensus       198 l~DFG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~l  273 (420)
T 1j1b_A          198 LCDFGSAKQLVRGEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL  273 (420)
T ss_dssp             ECCCTTCEECCTTCC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             eccchhhhhcccCCC----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999987543321    223579999999997743  5889999999999999999999999876544333332221 


Q ss_pred             cCcccccc---c--------cccC--CCC---HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         340 EVPVREVL---D--------KEAG--EWN---ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       340 ~~~~~~~~---~--------~~~~--~~~---~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..+..+.+   +        +...  .|.   .......+..++.+||+.||++||++.|+++
T Consensus       274 g~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          274 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            11110000   0        0000  000   0011233556778999999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.3e-40  Score=368.34  Aligned_cols=245  Identities=22%  Similarity=0.293  Sum_probs=190.4

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +..+.||+|+||.||+|+.+ +|+.||||++........          .....+.+|+.+|++++|||||++++++.+ 
T Consensus       187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~----------~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  256 (576)
T 2acx_A          187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR----------KGEAMALNEKQILEKVNSRFVVSLAYAYETK  256 (576)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhh----------HHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC
Confidence            34578999999999999985 699999999965311111          112247899999999999999999998876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILld~~g~vKL~DFGla  333 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLGLA  333 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEEeCCCCeEEEecccc
Confidence            56689999999999999997643 2458999999999999999999999  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCch----HHHHHHHHhhcCccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT----ILYYYLVVEQEVPVR  344 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~----~~~~~~~~~~~~~~~  344 (593)
                      +.......    ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.....    ......+.......+
T Consensus       334 ~~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p  409 (576)
T 2acx_A          334 VHVPEGQT----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS  409 (576)
T ss_dssp             EECCTTCC----EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC
T ss_pred             eecccCcc----ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC
Confidence            87644321    234589999999998754 578999999999999999999999976421    112222221111111


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIV  385 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~  385 (593)
                      .            .+...+..++.+||+.||.+||     ++.||+
T Consensus       410 ~------------~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil  443 (576)
T 2acx_A          410 E------------RFSPQARSLCSQLLCKDPAERLGCRGGSAREVK  443 (576)
T ss_dssp             T------------TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHH
T ss_pred             c------------cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHH
Confidence            1            1122345577899999999999     566664

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9.5e-41  Score=347.71  Aligned_cols=256  Identities=23%  Similarity=0.325  Sum_probs=187.4

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +..+.||+|+||.||+|+.. +|+.||||++....     .....      ...+.+|+.++++++||||+++++++.+ 
T Consensus        28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   96 (331)
T 4aaa_A           28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-----DDKMV------KKIAMREIKLLKQLRHENLVNLLEVCKKK   96 (331)
T ss_dssp             EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-----SCHHH------HHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-----CchHH------HHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence            34678999999999999986 58999999986431     11111      1247899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+.+++|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  171 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFA  171 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEEcCCCcEEEEeCCCc
Confidence            4568999999999998876542   358999999999999999999999  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc----
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV----  343 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~----  343 (593)
                      +.......   ......||+.|+|||++.+  .++.++|||||||++|||++|+.||...................    
T Consensus       172 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (331)
T 4aaa_A          172 RTLAAPGE---VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH  248 (331)
T ss_dssp             ---------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eeecCCcc---ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence            76543221   1223579999999998754  57889999999999999999999998765443333222111100    


Q ss_pred             ----------ccccccccCC-CCH----HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 ----------REVLDKEAGE-WNE----THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ----------~~~~~~~~~~-~~~----~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                .....+.... ...    ..+...+..++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                      0000000000 000    012334556778999999999999999864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.8e-40  Score=365.13  Aligned_cols=242  Identities=23%  Similarity=0.300  Sum_probs=189.1

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.+ +|+.||||++.+.....          ......+.+|+.+|++++|||||++++++.+ ..
T Consensus       190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~----------~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK----------RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh----------hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            467999999999999985 69999999996531110          0112357899999999999999999998876 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      .++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl~~~g~vkL~DFGla~  337 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAV  337 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEEeCCCCEEEeecceee
Confidence            6899999999999999976432 3469999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCc----hHHHHHHHHhhcCcccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN----TILYYYLVVEQEVPVRE  345 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~----~~~~~~~~~~~~~~~~~  345 (593)
                      .......   .+...+||+.|+|||++.+ .++.++|||||||++|||++|+.||....    .......+.......+.
T Consensus       338 ~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~  414 (543)
T 3c4z_A          338 ELKAGQT---KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD  414 (543)
T ss_dssp             ECCTTCC---CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT
T ss_pred             eccCCCc---ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc
Confidence            7644321   1234689999999998754 58899999999999999999999997642    12222222222221111


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMR  382 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~  382 (593)
                                  .+...+..++.+||+.||.+||++.
T Consensus       415 ------------~~s~~~~~li~~lL~~dP~~R~~~~  439 (543)
T 3c4z_A          415 ------------KFSPASKDFCEALLQKDPEKRLGFR  439 (543)
T ss_dssp             ------------TSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred             ------------ccCHHHHHHHHHhccCCHhHCCCCc
Confidence                        1122345567899999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=355.50  Aligned_cols=196  Identities=25%  Similarity=0.376  Sum_probs=147.1

Q ss_pred             CCcccccCceEEEEEEEc---CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         114 GNKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~---~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +++||+|+||.||+|+++   +++.||||++....     ..          ..+.+|+.+|++++|||||++++++.. 
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~----------~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-----IS----------MSACREIALLRELKHPNVISLQKVFLSH   90 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-----CC----------HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-----CC----------HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence            678999999999999975   57889999986321     10          147789999999999999999998843 


Q ss_pred             --ccceEEEEeccCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee----cC
Q psy9535         190 --IMNCIVYEYMCNGSLYDRLARVN------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DE  257 (593)
Q Consensus       190 --~~~~lV~Ey~~~GsL~~~L~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl----~~  257 (593)
                        ...++||||+. |+|.+++....      ....+++..+..++.|++.||.|||+  .+|+||||||+|||+    +.
T Consensus        91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~~~  167 (405)
T 3rgf_A           91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPE  167 (405)
T ss_dssp             TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSSTT
T ss_pred             CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCCCC
Confidence              45689999986 68888875321      12358999999999999999999999  569999999999999    77


Q ss_pred             CCccEEeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCC
Q psy9535         258 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDN  327 (593)
Q Consensus       258 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~  327 (593)
                      ++.+||+|||+++................||+.|+|||++.+  .++.++|||||||++|||++|+.||...
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            899999999999876433211122234689999999998754  3788999999999999999999999753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.2e-40  Score=349.55  Aligned_cols=240  Identities=21%  Similarity=0.351  Sum_probs=184.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      .+.||+|+||.||+|+.+ +|+.||||.+.....                 .+.+|++++.++ +||||+++++++.+ .
T Consensus        27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----------------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----------------DPTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----------------CCHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----------------ChHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            578999999999999876 688999999975311                 134688888887 79999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC----CccEEeec
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN----FVPKLGDF  266 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~----~~~Kl~DF  266 (593)
                      ..++||||+.+|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||+..+    +.+||+||
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~kl~Df  164 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDF  164 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence            568999999999999999753   358999999999999999999998  569999999999998432    35999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCC---chHHHHHHHHhhcCc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDN---NTILYYYLVVEQEVP  342 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~---~~~~~~~~~~~~~~~  342 (593)
                      |+++.......   .....+||+.|+|||++.+ .++.++|||||||++|||++|..||...   ........+......
T Consensus       165 g~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  241 (342)
T 2qr7_A          165 GFAKQLRAENG---LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS  241 (342)
T ss_dssp             TTCEECBCTTC---CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC
T ss_pred             CCcccCcCCCC---ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc
Confidence            99987544321   1234689999999998754 4788999999999999999999999752   222222222222221


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...   .   .+  ..+...+..++.+||..||++||++.|+++
T Consensus       242 ~~~---~---~~--~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          242 LSG---G---YW--NSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CCS---T---TT--TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cCc---c---cc--ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111   0   00  112233556778999999999999998754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=348.68  Aligned_cols=241  Identities=24%  Similarity=0.362  Sum_probs=186.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +|+.||||.+...............     ...|.+|+.++++++||||+++++++.+ ..
T Consensus        29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPK-----LGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETT-----TEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            578999999999999864 6889999999765322111000000     1136789999999999999999999876 45


Q ss_pred             ceEEEEeccCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         192 NCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       192 ~~lV~Ey~~~G-sL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      .++||||+.+| +|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence            68999999877 999998753   358999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccCC-C-CCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      .......    .....||+.|+|||++.+. + +.++|||||||++|||++|+.||.......            .....
T Consensus       179 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------~~~~~  242 (335)
T 3dls_A          179 YLERGKL----FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------EAAIH  242 (335)
T ss_dssp             ECCTTCC----BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------TTCCC
T ss_pred             ECCCCCc----eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------hhccC
Confidence            7654322    2235799999999987543 3 678999999999999999999997522110            00000


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .  ...    +...+..++.+||+.||++|||+.|+++
T Consensus       243 ~--~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          243 P--PYL----VSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             C--SSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C--Ccc----cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0  001    1223455678999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-41  Score=351.73  Aligned_cols=246  Identities=24%  Similarity=0.316  Sum_probs=186.2

Q ss_pred             CCCcccccCceEEEEEEE----cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLC  187 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~----~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~  187 (593)
                      +.++||+|+||.||+|+.    .+|+.||||+++.........  .       ...+.+|+++|+++ +||||+++++++
T Consensus        58 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~-------~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK--T-------TEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES--S-------GGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             EEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhh--H-------HHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            357899999999999987    368999999986432110000  0       11356799999999 699999999988


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      .. ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Df  203 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDF  203 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCcEEEeeC
Confidence            66 5668999999999999999864   358999999999999999999998  56999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccccC---CCCCcchhhHHHHHHHHHHhCCCCCCCCc---hHHHHH-HHHhh
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNN---TILYYY-LVVEQ  339 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~~ksDVwSfGvvl~ElltG~~P~~~~~---~~~~~~-~~~~~  339 (593)
                      |+++.......  .......||+.|+|||++.+   .++.++|||||||++|||++|+.||....   ...... .....
T Consensus       204 G~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  281 (355)
T 1vzo_A          204 GLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  281 (355)
T ss_dssp             SEEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             CCCeecccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc
Confidence            99986543221  11234679999999998753   36789999999999999999999996422   111111 11111


Q ss_pred             cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHHH
Q psy9535         340 EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIVD  386 (593)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~~  386 (593)
                      ..+.+            ..+...+..++.+||..||++||     ++.|+++
T Consensus       282 ~~~~~------------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          282 EPPYP------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             CCCCC------------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CCCCC------------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence            11111            11223355677899999999999     8888765

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7.6e-40  Score=334.06  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=190.8

Q ss_pred             CCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +..+.||+|+||.||+|+. .+|+.||||++.....   .     .       .+.+|+.++++++|+|++..++++.. 
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~-----~-------~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 3uzp_A           12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---H-----P-------QLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---C-----C-------HHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---h-----h-------HHHHHHHHHHHhhcCCCCCccccccCC
Confidence            3467899999999999997 4789999999864321   0     1       37899999999999998887776643 


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee---cCCCccEEee
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGD  265 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl---~~~~~~Kl~D  265 (593)
                       ...++||||+ +|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||+   +.++.+||+|
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~D  151 (296)
T 3uzp_A           77 GDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred             CCceEEEEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEEee
Confidence             4558999999 999999997533  468999999999999999999998  569999999999999   5889999999


Q ss_pred             cccceecccCCCcc----eeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCch---HHHHHHHH
Q psy9535         266 FGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT---ILYYYLVV  337 (593)
Q Consensus       266 FGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~---~~~~~~~~  337 (593)
                      ||+++.........    .......||+.|+|||++.+ .++.++|||||||++|||++|+.||.....   ...+....
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 3uzp_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             CCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence            99998765432211    11234679999999998754 578899999999999999999999975221   11111111


Q ss_pred             hh--cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         338 EQ--EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       338 ~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ..  ..+....    ....+     ..+..++.+||+.||++||++.+|++.|+..
T Consensus       232 ~~~~~~~~~~~----~~~~~-----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          232 EKKMSTPIEVL----CKGYP-----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHHHHSCHHHH----TTTSC-----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             ccccCCchHHH----HhhCC-----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            11  1111100    01111     2345567899999999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.9e-40  Score=332.56  Aligned_cols=238  Identities=24%  Similarity=0.392  Sum_probs=189.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec---
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~---  189 (593)
                      .+.||+|+||.||+|+.. +|+.||||.+....          +       .+.+|++++++++||||+++++++..   
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~-------~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B           16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----------E-------KAEREVKALAKLDHVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----------G-------GGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred             eeeeccCCceEEEEEEEcCCCeEEEEEEecccc----------H-------HHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence            578999999999999986 79999999986431          1       36789999999999999999998743   


Q ss_pred             --------------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee
Q psy9535         190 --------------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  255 (593)
Q Consensus       190 --------------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl  255 (593)
                                    ...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+|||+
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~  155 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFL  155 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHEEE
Confidence                          23579999999999999997643 2468999999999999999999998  569999999999999


Q ss_pred             cCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHH
Q psy9535         256 DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  334 (593)
Q Consensus       256 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~  334 (593)
                      +.++.+||+|||+++.......    .....||+.|+|||++. ..++.++|||||||++|||++|..|+......  +.
T Consensus       156 ~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--~~  229 (284)
T 2a19_B          156 VDTKQVKIGDFGLVTSLKNDGK----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF--FT  229 (284)
T ss_dssp             EETTEEEECCCTTCEESSCCSC----CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH--HH
T ss_pred             cCCCCEEECcchhheecccccc----ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH--HH
Confidence            9999999999999987654321    22357999999999774 45788999999999999999999987532111  11


Q ss_pred             HHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         335 LVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ...  ......       .+     ...+..++.+||+.||++||++.|+++.|...
T Consensus       230 ~~~--~~~~~~-------~~-----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          230 DLR--DGIISD-------IF-----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             HHH--TTCCCT-------TS-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             Hhh--cccccc-------cC-----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            111  111111       11     12244567899999999999999999998763

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.7e-40  Score=343.53  Aligned_cols=251  Identities=27%  Similarity=0.436  Sum_probs=190.7

Q ss_pred             CCCcccccCceEEEEEEEc-CCCE--EEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGME--IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~--vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~  188 (593)
                      ..+.||+|+||.||+|+.. +|..  ||||.+.......     .       ...|.+|+.+++++ +||||+++++++.
T Consensus        29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~-----~-------~~~~~~E~~~l~~l~~hp~iv~~~~~~~   96 (327)
T 1fvr_A           29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----D-------HRDFAGELEVLCKLGHHPNIINLLGACE   96 (327)
T ss_dssp             EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------------------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred             ceeeeecCCCceEEEEEEccCCcccceeeeeeccccchH-----H-------HHHHHHHHHHHHhccCCCchhhhceeee
Confidence            3678999999999999875 5664  4999986431110     0       11478999999999 8999999999987


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCee
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVN-------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  254 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NIL  254 (593)
                      + ...++||||+++|+|.+++....             ....+++..+..++.|++.||.|||+  ++|+||||||+|||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl  174 (327)
T 1fvr_A           97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNIL  174 (327)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEE
T ss_pred             eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccceEE
Confidence            6 55689999999999999997642             12468999999999999999999998  56999999999999


Q ss_pred             ecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHH
Q psy9535         255 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILY  332 (593)
Q Consensus       255 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~  332 (593)
                      ++.++.+||+|||+++......    ......||+.|+|||++.+ .++.++|||||||++|||+| |+.||........
T Consensus       175 ~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~  250 (327)
T 1fvr_A          175 VGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL  250 (327)
T ss_dssp             ECGGGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             EcCCCeEEEcccCcCccccccc----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH
Confidence            9999999999999987433211    1123467899999997754 47889999999999999998 9999987654433


Q ss_pred             HHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         333 YYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      ........ ..     .....     +...+..++.+||..+|++||++.|+++.|.+..
T Consensus       251 ~~~~~~~~-~~-----~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          251 YEKLPQGY-RL-----EKPLN-----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             HHHGGGTC-CC-----CCCTT-----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhhcCC-CC-----CCCCC-----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            22221110 00     00011     1223555678999999999999999999998743

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4e-40  Score=338.49  Aligned_cols=242  Identities=24%  Similarity=0.365  Sum_probs=190.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +|+.||||.+.......             ...+.+|+.++++++||||+++++++.+ ..
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A           14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR-------------DSSLENEIAVLKKIKHENIVTLEDIYESTTH   80 (304)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------------------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             eeeccCCCCceEEEEEECCCCCEEEEEEEecccccc-------------hHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence            578999999999999975 68999999997432110             1147899999999999999999999876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee---cCCCccEEeeccc
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI  268 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl---~~~~~~Kl~DFGl  268 (593)
                      .++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||+   +.++.+||+|||+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~  155 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGL  155 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred             EEEEEEcCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence            68999999999999998764   358999999999999999999998  569999999999999   7889999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ++......     .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.......................
T Consensus       156 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  230 (304)
T 2jam_A          156 SKMEQNGI-----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF  230 (304)
T ss_dssp             TCCCCCBT-----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTT
T ss_pred             ceecCCCc-----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence            87643321     123469999999998754 578899999999999999999999987655444333333322211110


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         ...     +...+..++.+||..||++||++.|+++
T Consensus       231 ---~~~-----~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          231 ---WDD-----ISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ---TTT-----SCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ---ccc-----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               011     1223555678999999999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.9e-40  Score=343.82  Aligned_cols=251  Identities=25%  Similarity=0.342  Sum_probs=186.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      .+.||+|+||.||+|+.. +|+.||||.+............     ......|.+|+.++++++||||+++++++.....
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   89 (322)
T 2ycf_A           15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE-----ADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY   89 (322)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECC--------------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred             eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhccccc-----chhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence            578999999999999875 5889999998653211000000     0011247899999999999999999999988778


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc---cEEeecccc
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---PKLGDFGIV  269 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~---~Kl~DFGla  269 (593)
                      ++||||+++|+|.+++...   ..+++.....++.|++.||.|||+  ++|+||||||+|||++.++.   +||+|||++
T Consensus        90 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             EEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             EEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            9999999999999988642   468999999999999999999998  56999999999999987654   999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccc----cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhhcCccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVPVR  344 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~----~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~-~~~~~~~~~~~~~~  344 (593)
                      +......    ......||+.|+|||++    ...++.++|||||||++|||++|..||...... ..............
T Consensus       165 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (322)
T 2ycf_A          165 KILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI  240 (322)
T ss_dssp             EECCCCH----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred             eeccccc----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence            8754321    12235799999999976    345788999999999999999999999763321 11111111111110


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .   .....     +...+..++.+||+.||++||++.|+++
T Consensus       241 ~---~~~~~-----~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          241 P---EVWAE-----VSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             H---HHHTT-----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             c---hhhhh-----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            0   00011     1233455778999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.1e-40  Score=342.72  Aligned_cols=246  Identities=24%  Similarity=0.314  Sum_probs=188.5

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-cc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-IM  191 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-~~  191 (593)
                      +.||+|+||.||+|+.. +|+.||||++......    ..       ....+.+|+.++.+++ ||||+++++++.+ ..
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~-------~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG----QD-------CRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETT----EE-------CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc----hH-------HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            68999999999999876 6899999998753211    01       1125789999999995 6999999999876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC---CCccEEeeccc
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGI  268 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~---~~~~Kl~DFGl  268 (593)
                      .++||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.   ++.+||+|||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            689999999999999886432 3568999999999999999999998  56999999999999987   78999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ++.......    .....||+.|+|||++. ..++.++|||||||++|||++|+.||...................... 
T Consensus       181 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-  255 (327)
T 3lm5_A          181 SRKIGHACE----LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE-  255 (327)
T ss_dssp             CEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-
T ss_pred             ccccCCccc----cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch-
Confidence            987643321    23357999999999775 457889999999999999999999998766544443333322221111 


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        ...     .+...+..++.+||+.||++|||+.|+++
T Consensus       256 --~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          256 --TFS-----SVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             --TTT-----TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --hhc-----ccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence              001     12233556778999999999999999854

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.3e-41  Score=351.74  Aligned_cols=255  Identities=13%  Similarity=0.118  Sum_probs=190.0

Q ss_pred             CCCCcccccCceEEEEEEEcC---------CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceee
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKN---------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR  182 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~---------g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~  182 (593)
                      ++.+.||+|+||.||+|+...         ++.||||.+...      .            .+.+|+.++++++|||||+
T Consensus        45 ~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~------------~~~~E~~~l~~l~h~niv~  106 (352)
T 2jii_A           45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------G------------RLFNEQNFFQRAAKPLQVN  106 (352)
T ss_dssp             EEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------S------------THHHHHHHHHHHCCHHHHH
T ss_pred             EEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------c------------hHHHHHHHHHHhcccchhh
Confidence            346789999999999998763         788999998642      0            3788999999999999998


Q ss_pred             ---------------EEEEEec--ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q psy9535         183 ---------------LLGLCNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIH  245 (593)
Q Consensus       183 ---------------l~g~~~~--~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiH  245 (593)
                                     +++++..  ...++||||+ +|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+|
T Consensus       107 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH  182 (352)
T 2jii_A          107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHE--NEYVH  182 (352)
T ss_dssp             HHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH--TTCBC
T ss_pred             hhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHh--CCccC
Confidence                           5676654  5568999999 999999998642 2469999999999999999999999  56999


Q ss_pred             cccCCCCeeecCCC--ccEEeecccceecccCCCcc----eeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHH
Q psy9535         246 RDVKSANVLLDENF--VPKLGDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELL  318 (593)
Q Consensus       246 rDLKp~NILl~~~~--~~Kl~DFGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~Ell  318 (593)
                      |||||+|||++.++  .+||+|||+++.........    .......||+.|+|||++.+ .++.++|||||||++|||+
T Consensus       183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  262 (352)
T 2jii_A          183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL  262 (352)
T ss_dssp             SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence            99999999999998  99999999998654332111    11133579999999998754 6788999999999999999


Q ss_pred             hCCCCCCCCc--hHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         319 TGMKPIDDNN--TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       319 tG~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      +|+.||....  ...................+....   ...+...+..++.+||..||++||++.+|++.|++.
T Consensus       263 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          263 YGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             HSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             hCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            9999997642  111111111001111111111000   001112345567899999999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.3e-40  Score=338.26  Aligned_cols=256  Identities=23%  Similarity=0.357  Sum_probs=182.6

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.+.||+|+||.||+|+.. +|+.||||++.....   .. .  .    ....|.+|+.++++++||||+++++++.. 
T Consensus        35 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~-~--~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  104 (310)
T 2wqm_A           35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL---MD-A--K----ARADCIKEIDLLKQLNHPNVIKYYASFIED  104 (310)
T ss_dssp             EEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS---CC-H--H----HHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             EEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc---cC-H--H----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            34678999999999999874 789999999864311   11 1  1    12258899999999999999999998866 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      ...++||||+.+|+|.+++.... ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~~~~~~~kl~Dfg~  182 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGL  182 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence            56689999999999999986522 23568999999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCch-HHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNT-ILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~-~~~~~~~~~~~~~~~~~  346 (593)
                      ++.......   ......||+.|+|||.+. ..++.++|||||||++|||++|+.||..... .......... ......
T Consensus       183 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~  258 (310)
T 2wqm_A          183 GRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPPL  258 (310)
T ss_dssp             -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSCCC
T ss_pred             eeeecCCCc---cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCCCC
Confidence            876543221   122357999999999764 4578899999999999999999999975321 1111111111 111111


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .   ..     .+...+..++.+||..||++||++.+|++.|++.
T Consensus       259 ~---~~-----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l  295 (310)
T 2wqm_A          259 P---SD-----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM  295 (310)
T ss_dssp             C---TT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             c---cc-----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            0   01     1122355567899999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=334.66  Aligned_cols=249  Identities=24%  Similarity=0.327  Sum_probs=191.0

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.+.||+|+||.||+|+.. +++.||||.+........         ......|.+|+.++++++||||+++++++.. 
T Consensus         8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (305)
T 2wtk_C            8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI---------PNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE   78 (305)
T ss_dssp             CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHS---------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred             eEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccccc---------chhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            45789999999999999874 689999999864311000         0112358899999999999999999998843 


Q ss_pred             --ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         190 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       190 --~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                        ...++||||+.+| |.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~~~~~~~kl~dfg  154 (305)
T 2wtk_C           79 EKQKMYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALG  154 (305)
T ss_dssp             ---CEEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCeEEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEcCCCcEEeeccc
Confidence              3568999999877 777776543 3568999999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccCC---CCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      +++....... ........||+.|+|||++.+.   .+.++|||||||++|||++|+.||....................
T Consensus       155 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  233 (305)
T 2wtk_C          155 VAEALHPFAA-DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP  233 (305)
T ss_dssp             TCEECCTTCS-SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC
T ss_pred             cccccCcccc-ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC
Confidence            9987543221 1122345799999999987542   36789999999999999999999987654443333332222111


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                             ...     ...+..++.+||..||++|||+.|+++
T Consensus       234 -------~~~-----~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          234 -------GDC-----GPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             -------SSS-----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------Ccc-----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   111     123445678999999999999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.3e-40  Score=338.92  Aligned_cols=255  Identities=20%  Similarity=0.270  Sum_probs=187.9

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.+.||+|+||.||+|+.. +++.||||.+......   . .  .    ....|.+|+.++++++||||+++++++.. 
T Consensus        37 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~-~--~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 2h34_A           37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS---D-P--V----FRTRMQREARTAGRLQEPHVVPIHDFGEID  106 (309)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG---S-H--H----HHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc---C-H--H----HHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence            34678999999999999975 6889999998643110   0 0  0    12358899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++...   .++++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~  181 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLVDFGIA  181 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred             CeEEEEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEEcCCCCEEEecCccC
Confidence            5668999999999999999864   358999999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      +.......  .......||+.|+|||++. ..++.++|||||||++|||++|+.||........... .....+......
T Consensus       182 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~  258 (309)
T 2h34_A          182 SATTDEKL--TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH-INQAIPRPSTVR  258 (309)
T ss_dssp             -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH-HHSCCCCGGGTS
T ss_pred             cccccccc--ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH-hccCCCCccccC
Confidence            76543321  1122357999999999774 4578899999999999999999999987654322222 222211111111


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCC-ChHHHHHHHhhcc
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRA-SMRDIVDLLSKSM  392 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-sm~eV~~~L~~~~  392 (593)
                         ...     ...+..++.+||..||++|| ++.++++.|+...
T Consensus       259 ---~~~-----~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          259 ---PGI-----PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             ---TTC-----CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             ---CCC-----CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence               111     12345567899999999999 9999999998743

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-40  Score=334.66  Aligned_cols=251  Identities=24%  Similarity=0.402  Sum_probs=188.6

Q ss_pred             CCcccccCceEEEEEEEc-CC---CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g---~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      +++||+|+||.||+|++. ++   ..||+|.+....     . ..      ....|.+|+.++++++||||+++++++.+
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-----~-~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   93 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-----E-MQ------QVEAFLREGLLMRGLNHPNVLALIGIMLP   93 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-----S-HH------HHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeeccccc-----c-HH------HHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence            578999999999999864 22   379999985321     1 11      12358899999999999999999999865


Q ss_pred             c--cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         190 I--MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       190 ~--~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      .  ..++||||+++|+|.+++...  ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili~~~~~~kl~Dfg  169 (298)
T 3pls_A           94 PEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFG  169 (298)
T ss_dssp             SSSCCEEEECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred             CCCCcEEEEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEeCcCC
Confidence            3  348999999999999999753  3468999999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCc-ceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCC-CCCCchHHHHHHHHhhcCccc
Q psy9535         268 IVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKP-IDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       268 la~~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P-~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      +++........ ........||+.|+|||.+.+ .++.++|||||||++|||++|..| |................ ...
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~  248 (298)
T 3pls_A          170 LARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-RLP  248 (298)
T ss_dssp             SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-CCC
T ss_pred             CcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-CCC
Confidence            99754332211 111234568899999998754 578899999999999999996555 44433222222221111 100


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                            ....    +...+..++.+||+.+|.+|||+.++++.|++.
T Consensus       249 ------~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          249 ------QPEY----CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             ------CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCcc----chHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                  0011    112345567899999999999999999999874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.4e-40  Score=340.67  Aligned_cols=248  Identities=25%  Similarity=0.377  Sum_probs=188.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         110 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       110 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      .+++.+.||+|+||.||+|+.. +|..||+|.+....   .   .       ....|.+|+.++++++||||+++++++.
T Consensus        20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~---~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (302)
T 2j7t_A           20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---E---E-------ELEDYIVEIEILATCDHPYIVKLLGAYY   86 (302)
T ss_dssp             TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----------C-------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---H---H-------HHHHHHHHHHHHhcCCCCCEeeeeeeee
Confidence            3445688999999999999986 58999999986431   0   0       1225889999999999999999999887


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      . ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg  162 (302)
T 2j7t_A           87 HDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFG  162 (302)
T ss_dssp             CC-CEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred             eCCeEEEEEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEECCCCCEEEEECC
Confidence            6 56689999999999999987643  358999999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccc------cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAM------HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  341 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~------~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~  341 (593)
                      ++.......   .......||+.|+|||++      ...++.++|||||||++|||++|..||.................
T Consensus       163 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  239 (302)
T 2j7t_A          163 VSAKNLKTL---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP  239 (302)
T ss_dssp             HHHHHHHHH---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             CCccccccc---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC
Confidence            976432111   011235799999999976      34578899999999999999999999987654433333322221


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +.  ...       +..+...+..++.+||..||++|||+.++++
T Consensus       240 ~~--~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          240 PT--LLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CC--CSS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cc--cCC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11  100       1112233556778999999999999999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=8.9e-41  Score=346.71  Aligned_cols=251  Identities=23%  Similarity=0.300  Sum_probs=174.0

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-  189 (593)
                      +.++||+|+||.||+|+.. +|+.||||++....       .. .     ...+.+|+.++.++. ||||+++++++.. 
T Consensus        32 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~-~-----~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-------EE-K-----NRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             EEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-------HH-H-----HHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             EEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-------hH-H-----HHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            4678999999999999975 68999999985431       11 0     125789999999996 9999999998831 


Q ss_pred             --------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCcc
Q psy9535         190 --------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  261 (593)
Q Consensus       190 --------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~  261 (593)
                              ...++||||+. |+|.+++.......++++..+..++.|++.||.|||+.+.+|+||||||+|||++.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence                    23478999985 899999876444457999999999999999999999844449999999999999999999


Q ss_pred             EEeecccceecccCCCcc---------eeeccccCCCCcCCcccc----cCCCCCcchhhHHHHHHHHHHhCCCCCCCCc
Q psy9535         262 KLGDFGIVKMSETSNMKT---------MYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNN  328 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~~---------~~~~~~~GT~~Y~APE~~----~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~  328 (593)
                      ||+|||+++.........         .......||+.|+|||++    ...++.++|||||||++|||++|+.||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998654322110         001134699999999976    2346789999999999999999999997643


Q ss_pred             hHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         329 TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .....    .......     ......     ..+..++.+||+.||++||++.|+++.|...
T Consensus       258 ~~~~~----~~~~~~~-----~~~~~~-----~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          258 KLRIV----NGKYSIP-----PHDTQY-----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             ------------CCCC-----TTCCSS-----GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhh----cCcccCC-----cccccc-----hHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            32111    1111000     001111     1244567899999999999999999999874

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.4e-40  Score=336.93  Aligned_cols=252  Identities=25%  Similarity=0.355  Sum_probs=191.0

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec--
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~--  189 (593)
                      ..+.||+|+||.||+|+.. +|+.||+|.+.....    . .. .     ...|.+|+.++++++||||+++++++.+  
T Consensus        10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~-~~-~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A           10 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM----T-EA-E-----KQMLVSEVNLLRELKHPNIVRYYDRIIDRT   78 (279)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC----C-HH-H-----HHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred             eehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC----C-HH-H-----HHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence            3578999999999999885 689999999964311    1 11 1     2358899999999999999999998743  


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---CCeEecccCCCCeeecCCCccEEe
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLS---KPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~---~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                       ...++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   .+|+||||||+|||++.++.+||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence             45689999999999999997532 2345899999999999999999999833   229999999999999999999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  343 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~  343 (593)
                      |||+++.......   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.................+ 
T Consensus       159 dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-  234 (279)
T 2w5a_A          159 DFGLARILNHDTS---FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-  234 (279)
T ss_dssp             CCCHHHHC---CH---HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-
T ss_pred             cCchheeeccccc---cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc-
Confidence            9999876543221   1123579999999997744 5788999999999999999999999876544333333222211 


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHh
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS  389 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~  389 (593)
                       ..    ....     ...+..++.+||+.+|++||++.||++.+.
T Consensus       235 -~~----~~~~-----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          235 -RI----PYRY-----SDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             -CC----CTTS-----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             -cC----Cccc-----CHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence             10    0111     223455678999999999999999987553

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.6e-40  Score=336.16  Aligned_cols=251  Identities=23%  Similarity=0.320  Sum_probs=190.1

Q ss_pred             CCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +..+.||+|+||.||+|+. .+|+.||||.+......   .            .+.+|+.++++++|+|++..++++.. 
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~------------~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 4hgt_A           12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---P------------QLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---C------------CHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             EEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---h------------HHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence            3468999999999999987 47899999987543211   0            37789999999999998888877643 


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee---cCCCccEEee
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGD  265 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl---~~~~~~Kl~D  265 (593)
                       ...++||||+ +|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||+   +.++.+||+|
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL~D  151 (296)
T 4hgt_A           77 GDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred             CCceEEEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEEec
Confidence             4558999999 999999997533  358999999999999999999998  569999999999999   7899999999


Q ss_pred             cccceecccCCCcc----eeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCch---HHHHHHHH
Q psy9535         266 FGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT---ILYYYLVV  337 (593)
Q Consensus       266 FGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~---~~~~~~~~  337 (593)
                      ||+++.........    .......||+.|+|||++.+ .++.++|||||||++|||++|+.||.....   ........
T Consensus       152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 4hgt_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence            99998765432211    11234679999999997754 578899999999999999999999975321   11111111


Q ss_pred             hh--cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         338 EQ--EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       338 ~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ..  ..+....    ....     ...+..++.+||+.+|++||++.+|++.|++.
T Consensus       232 ~~~~~~~~~~~----~~~~-----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          232 EKKMSTPIEVL----CKGY-----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHHHHSCHHHH----TTTS-----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             cccccchhhhh----hccC-----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            11  1111100    0111     12355567899999999999999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.5e-40  Score=375.69  Aligned_cols=239  Identities=25%  Similarity=0.312  Sum_probs=192.3

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-  189 (593)
                      ..++||+|+||.||+|+.+ +++.||||++++.......          ....+..|..+|..+ +||||+++++++.+ 
T Consensus       345 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~----------~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~  414 (674)
T 3pfq_A          345 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD----------DVECTMVEKRVLALPGKPPFLTQLHSCFQTM  414 (674)
T ss_dssp             EEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTT----------TTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred             EEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHH----------HHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence            3578999999999999975 6889999999753111110          122467899999988 79999999998876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...+|||||+++|+|.++|...   ..+++..+..++.||+.||.|||+  ++||||||||+||||+.++.+||+|||++
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl~~~g~ikL~DFGla  489 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMC  489 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred             CEEEEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEEcCCCcEEEeeccee
Confidence            5568999999999999999864   358999999999999999999998  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      +.......   .....+||+.|||||++. ..++.++|||||||+||||++|+.||...+....+..+......++..  
T Consensus       490 ~~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--  564 (674)
T 3pfq_A          490 KENIWDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS--  564 (674)
T ss_dssp             EECCCTTC---CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTT--
T ss_pred             eccccCCc---ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCcc--
Confidence            86433221   134578999999999875 468899999999999999999999999877666555555444333221  


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCCh
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASM  381 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm  381 (593)
                                +...+..++.+||+.||++||++
T Consensus       565 ----------~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          565 ----------MSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             ----------SCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             ----------CCHHHHHHHHHHccCCHHHCCCC
Confidence                      12234556789999999999997

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.7e-40  Score=342.49  Aligned_cols=253  Identities=25%  Similarity=0.380  Sum_probs=189.8

Q ss_pred             CCCcccccCceEEEEEEE------cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKL------KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~------~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      +.+.||+|+||.||+|++      .++..||||.+....     . ...      ...|.+|+.++++++||||++++++
T Consensus        34 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~-~~~------~~~~~~E~~~l~~l~h~~iv~~~~~  101 (327)
T 2yfx_A           34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----S-EQD------ELDFLMEALIISKFNHQNIVRCIGV  101 (327)
T ss_dssp             EEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-----C-HHH------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             EEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-----c-hhh------HHHHHHHHHHHhhCCCCCCCeEEEE
Confidence            367899999999999984      257789999985321     1 111      1258899999999999999999999


Q ss_pred             Eec-ccceEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC---C
Q psy9535         187 CNN-IMNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---N  258 (593)
Q Consensus       187 ~~~-~~~~lV~Ey~~~GsL~~~L~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~---~  258 (593)
                      +.+ ...++||||+++|+|.+++.....    ...+++..++.++.|++.||.|||+  .+|+||||||+|||++.   +
T Consensus       102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~~~~  179 (327)
T 2yfx_A          102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPG  179 (327)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTT
T ss_pred             EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecCCCc
Confidence            876 456899999999999999986532    1358999999999999999999998  56999999999999984   4


Q ss_pred             CccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHH
Q psy9535         259 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLV  336 (593)
Q Consensus       259 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~  336 (593)
                      ..+||+|||+++........ .......||+.|+|||++ ...++.++|||||||++|||+| |..||............
T Consensus       180 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  258 (327)
T 2yfx_A          180 RVAKIGDFGMARDIYRASYY-RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV  258 (327)
T ss_dssp             CCEEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             ceEEECcccccccccccccc-ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence            56999999998754332211 112235689999999976 4568899999999999999998 99999876544333332


Q ss_pred             HhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         337 VEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .......      ....     +...+..++.+||+.||.+||++.+|++.|...
T Consensus       259 ~~~~~~~------~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          259 TSGGRMD------PPKN-----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HTTCCCC------CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCCCCC------CCCC-----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            2221110      0011     122345567899999999999999999998764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.1e-40  Score=345.95  Aligned_cols=256  Identities=21%  Similarity=0.319  Sum_probs=189.4

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      +..+.||+|+||.||+|+.. ++..||||++....     . ..      ....+.+|+.++++++||||+++++++...
T Consensus        30 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~-~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   97 (364)
T 3qyz_A           30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-----H-QT------YCQRTLREIKILLRFRHENIIGINDIIRAP   97 (364)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-----C-HH------HHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred             EEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-----C-cH------HHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence            44678999999999999875 68889999986321     1 11      112588999999999999999999998642


Q ss_pred             ------cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         191 ------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       191 ------~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                            ..++||||+. |+|.+++..    ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~  170 (364)
T 3qyz_A           98 TIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKIC  170 (364)
T ss_dssp             STTTCCCEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEEC
T ss_pred             CccccceEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEECCCCCEEEE
Confidence                  3589999987 699998875    358999999999999999999998  569999999999999999999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCccccc-C-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-C
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-V  341 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~-~  341 (593)
                      |||+++................||+.|+|||++. . .++.++|||||||++|||++|+.||...........+.... .
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  250 (364)
T 3qyz_A          171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS  250 (364)
T ss_dssp             CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred             eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999987654322221223458999999999753 3 47889999999999999999999998754433322222111 0


Q ss_pred             ccccccc--------------cccCCCCH----HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVLD--------------KEAGEWNE----THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~~--------------~~~~~~~~----~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +..+.+.              +.......    ..+...+..++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1000000              00000000    011223456778999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.4e-40  Score=335.68  Aligned_cols=242  Identities=29%  Similarity=0.486  Sum_probs=191.5

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|+.. +|+.||||.+......     ..       ...|.+|+.++++++||||+++++++.+ .
T Consensus        26 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   93 (303)
T 3a7i_A           26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-----DE-------IEDIQQEITVLSQCDSPYVTKYYGSYLKDT   93 (303)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-----TT-------HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-----HH-------HHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            3578999999999999875 6899999998654211     11       2258899999999999999999998866 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++..    .++++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  167 (303)
T 3a7i_A           94 KLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAG  167 (303)
T ss_dssp             EEEEEEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eEEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEECCCCCEEEeecccce
Confidence            56899999999999999864    468999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .......   ......||+.|+|||++. ..++.++|||||||++|||++|+.||.................+  . +  
T Consensus       168 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~-~--  239 (303)
T 3a7i_A          168 QLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP--T-L--  239 (303)
T ss_dssp             ECBTTBC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--C-C--
T ss_pred             ecCcccc---ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC--C-C--
Confidence            7544321   123457999999999774 45788999999999999999999999876544333322221111  0 0  


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                       ....+     ..+..++.+||..+|++|||+.|+++
T Consensus       240 -~~~~~-----~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          240 -EGNYS-----KPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             -CSSCC-----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -ccccC-----HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             11111     23455678999999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-40  Score=337.79  Aligned_cols=243  Identities=30%  Similarity=0.451  Sum_probs=185.2

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec--c
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~--~  190 (593)
                      ..+.||+|+||.||+|+.. |+.||||.+....     .          ...|.+|+.++++++||||+++++++.+  .
T Consensus        25 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (278)
T 1byg_A           25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----T----------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   88 (278)
T ss_dssp             EEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----------------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             EEeEEecCCCceEEEEEEc-CCEEEEEEecchh-----H----------HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence            3578999999999999875 8899999985321     0          1248899999999999999999998754  3


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++..... ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  165 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK  165 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEEeCCCcEEEeeccccc
Confidence            56899999999999999976421 237889999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ......      ....||+.|+|||++. ..++.++|||||||++|||+| |+.||................ .      
T Consensus       166 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~------  232 (278)
T 1byg_A          166 EASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-K------  232 (278)
T ss_dssp             ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-C------
T ss_pred             cccccc------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-C------
Confidence            543321      1246889999999774 568889999999999999998 999998654332222221111 0      


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .....    .+...+..++.+||+.||++||++.|+++.|+..
T Consensus       233 ~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          233 MDAPD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcc----cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence            00001    1123355567899999999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=7.6e-40  Score=343.99  Aligned_cols=265  Identities=23%  Similarity=0.292  Sum_probs=181.3

Q ss_pred             HHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC
Q psy9535          97 DLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC  175 (593)
Q Consensus        97 ~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l  175 (593)
                      +.....++|..      .+.||+|+||.||+|+.. +|+.||||++.......       .       .+.+|++.++.+
T Consensus        17 ~~~~~~~~y~~------~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~-------~~~~~~~~l~~l   76 (360)
T 3e3p_A           17 RSRKEMDRFQV------ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------N-------RELQIMQDLAVL   76 (360)
T ss_dssp             HHHHHHTTEEE------C----------CEEEEETTTCCEEEEEEEECCTTCC-------C-------HHHHHHHHHHHH
T ss_pred             hchhhccceEE------EEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-------H-------HHHHHHHHHHhc
Confidence            34444555543      689999999999999985 68999999986432111       0       356788889999


Q ss_pred             CCCceeeEEEEEec-cc-------ceEEEEeccCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q psy9535         176 KHVNLLRLLGLCNN-IM-------NCIVYEYMCNGSLYDRLAR-VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHR  246 (593)
Q Consensus       176 ~HpNIv~l~g~~~~-~~-------~~lV~Ey~~~GsL~~~L~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHr  246 (593)
                      +||||+++++++.. ..       .++||||+.+ +|.+.+.. ......+++..+..++.|++.||.|||...++|+||
T Consensus        77 ~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~  155 (360)
T 3e3p_A           77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHR  155 (360)
T ss_dssp             CCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCS
T ss_pred             CCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecC
Confidence            99999999998854 11       5789999986 55544432 233456899999999999999999999333679999


Q ss_pred             ccCCCCeeecC-CCccEEeecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCC
Q psy9535         247 DVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKP  323 (593)
Q Consensus       247 DLKp~NILl~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P  323 (593)
                      ||||+|||++. ++.+||+|||+++.......    .....||+.|+|||++.+  .++.++|||||||++|||++|+.|
T Consensus       156 Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~p  231 (360)
T 3e3p_A          156 DIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPI  231 (360)
T ss_dssp             CCCGGGEEEETTTTEEEECCCTTCBCCCTTSC----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCHHHEEEeCCCCcEEEeeCCCceecCCCCC----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            99999999996 89999999999986654321    224579999999997743  378999999999999999999999


Q ss_pred             CCCCchHHHHHHHHhhc-Ccccccc-------------ccccCCC------CHHHHHHHHHHHHHHhhccccCCCCChHH
Q psy9535         324 IDDNNTILYYYLVVEQE-VPVREVL-------------DKEAGEW------NETHVETLIGIVFEKCCVFEKDKRASMRD  383 (593)
Q Consensus       324 ~~~~~~~~~~~~~~~~~-~~~~~~~-------------~~~~~~~------~~~~~~~~i~~~~~~C~~~dp~~RPsm~e  383 (593)
                      |................ .+..+.+             +.....+      ........+..++.+||+.||.+|||+.|
T Consensus       232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  311 (360)
T 3e3p_A          232 FRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE  311 (360)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHH
Confidence            98765544333332211 1111100             0000000      00012234556778999999999999999


Q ss_pred             HHH
Q psy9535         384 IVD  386 (593)
Q Consensus       384 V~~  386 (593)
                      +++
T Consensus       312 ~l~  314 (360)
T 3e3p_A          312 ALC  314 (360)
T ss_dssp             HTT
T ss_pred             Hhc
Confidence            864

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.4e-40  Score=345.30  Aligned_cols=276  Identities=17%  Similarity=0.230  Sum_probs=193.4

Q ss_pred             cHHHHHHHhcCCCCCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHh
Q psy9535          94 TFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS  173 (593)
Q Consensus        94 ~~~~l~~at~~f~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~  173 (593)
                      ...++...+++|..      .+.||+|+||.||+|+..+|..||||++..........  ...........|.+|+.+++
T Consensus        13 ~~~~~~~~~~~y~~------~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~~~~~~E~~~l~   84 (362)
T 3pg1_A           13 LIAELHAMQSPYTV------QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV--NILSDSFLCKRVLREIRLLN   84 (362)
T ss_dssp             HHHHHHHTTCSCEE------EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCE--EGGGSHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccceEE------eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchh--hhhhhhhHHHHHHHHHHHHH
Confidence            34577777777754      68999999999999998889999999986542211110  00001111246889999999


Q ss_pred             cCCCCceeeEEEEEec------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q psy9535         174 QCKHVNLLRLLGLCNN------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  247 (593)
Q Consensus       174 ~l~HpNIv~l~g~~~~------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrD  247 (593)
                      +++||||+++++++..      ...++||||+. |+|.+.+...  ...+++..+..++.|++.||.|||+  .+|+|||
T Consensus        85 ~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~D  159 (362)
T 3pg1_A           85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHE--AGVVHRD  159 (362)
T ss_dssp             HCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCC
T ss_pred             hCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH--CcCEecC
Confidence            9999999999998843      13489999998 7898888753  3468999999999999999999999  5699999


Q ss_pred             cCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCC
Q psy9535         248 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPID  325 (593)
Q Consensus       248 LKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~  325 (593)
                      |||+|||++.++.+||+|||+++.......    .....||+.|+|||++.  ..++.++|||||||++|||++|+.||.
T Consensus       160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  235 (362)
T 3pg1_A          160 LHPGNILLADNNDITICDFNLAREDTADAN----KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR  235 (362)
T ss_dssp             CCGGGEEECTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CChHHEEEcCCCCEEEEecCcccccccccc----cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence            999999999999999999999975433221    23357999999999764  457889999999999999999999998


Q ss_pred             CCchHHHHHHHHhhc--Ccccc-----------ccccccCC---CCH----HHHHHHHHHHHHHhhccccCCCCChHHHH
Q psy9535         326 DNNTILYYYLVVEQE--VPVRE-----------VLDKEAGE---WNE----THVETLIGIVFEKCCVFEKDKRASMRDIV  385 (593)
Q Consensus       326 ~~~~~~~~~~~~~~~--~~~~~-----------~~~~~~~~---~~~----~~~~~~i~~~~~~C~~~dp~~RPsm~eV~  385 (593)
                      ...............  .+...           .+......   ...    ......+..++.+||+.||++|||+.|++
T Consensus       236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  315 (362)
T 3pg1_A          236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL  315 (362)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence            765443333322211  11000           00000000   000    01123355677899999999999999986


Q ss_pred             H
Q psy9535         386 D  386 (593)
Q Consensus       386 ~  386 (593)
                      +
T Consensus       316 ~  316 (362)
T 3pg1_A          316 R  316 (362)
T ss_dssp             T
T ss_pred             c
Confidence            4

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=344.63  Aligned_cols=261  Identities=25%  Similarity=0.406  Sum_probs=192.6

Q ss_pred             CCCCcccccCceEEEEEEE-----cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-----~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      ++.+.||+|+||.||+|++     .+|+.||||++...      ....       ...|.+|+.++++++||||++++++
T Consensus        44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~------~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~  110 (326)
T 2w1i_A           44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TEEH-------LRDFEREIEILKSLQHDNIVKYKGV  110 (326)
T ss_dssp             EEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC------CSHH-------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC------CHHH-------HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            3467899999999999984     35889999998642      1111       2258899999999999999999998


Q ss_pred             Eecc---cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         187 CNNI---MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       187 ~~~~---~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                      +...   ..++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||
T Consensus       111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kL  186 (326)
T 2w1i_A          111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKI  186 (326)
T ss_dssp             ECC----CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEE
T ss_pred             EEecCCCceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcEEE
Confidence            8652   5689999999999999998643  358999999999999999999998  56999999999999999999999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-  341 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-  341 (593)
                      +|||+++................||+.|+|||.+. ..++.++|||||||++|||+||..|+.......  ........ 
T Consensus       187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~--~~~~~~~~~  264 (326)
T 2w1i_A          187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF--MRMIGNDKQ  264 (326)
T ss_dssp             CCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHH--HHHHCTTCC
T ss_pred             ecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHH--HHhhccccc
Confidence            99999987654432112223346788899999764 457889999999999999999999986421110  00000000 


Q ss_pred             ------ccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         342 ------PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       342 ------~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                            ...+.+........+..+...+..++.+||+.||++||++.||++.|+..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          265 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                  00000000000000111223355677899999999999999999999863

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.5e-40  Score=333.08  Aligned_cols=245  Identities=24%  Similarity=0.372  Sum_probs=188.3

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +|+.||||.+.....     ...       ...+.+|+.++++++||||+++++++.+ ..
T Consensus        12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (276)
T 2yex_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-----VDC-------PENIKKEICINKMLNHENVVKFYGHRREGNI   79 (276)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-----TTH-------HHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-----hhh-------hHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence            578999999999999976 689999999864321     011       1257899999999999999999999876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  154 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATV  154 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence            6899999999999998864   2458999999999999999999998  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccCC-C-CCcchhhHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhhcCccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~~  348 (593)
                      ...... ........||+.|+|||++.+. + +.++|||||||++|||++|+.||...... ..+..........    .
T Consensus       155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~  229 (276)
T 2yex_A          155 FRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL----N  229 (276)
T ss_dssp             CEETTE-ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS----T
T ss_pred             cCCCcc-hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc----C
Confidence            543321 1112346799999999987543 3 66899999999999999999999764322 1111111111110    0


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .      .......+..++.+||+.||++|||+.|+++
T Consensus       230 ~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 P------WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             T------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            0      0111223455778999999999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-40  Score=340.59  Aligned_cols=257  Identities=25%  Similarity=0.366  Sum_probs=175.5

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.+.||+|+||.||+|+.. +|+.||||.+.......            ....+.+|+.++++++||||+++++++.. 
T Consensus        18 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   85 (303)
T 2vwi_A           18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT------------SMDELLKEIQAMSQCHHPNIVSYYTSFVVK   85 (303)
T ss_dssp             EEEEECC---CCCEEEEEC----CEEEEECCC----------------------------CCCCCCCTTBCCEEEEEESS
T ss_pred             hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcch------------hHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence            34688999999999999864 68999999885431100            01247889999999999999999998876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARV-----NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                      ...++||||+++|+|.+++...     .....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~  163 (303)
T 2vwi_A           86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSVQIA  163 (303)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEEcCCCCEEEE
Confidence            5668999999999999998642     123468999999999999999999998  569999999999999999999999


Q ss_pred             ecccceecccCCCc--ceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q psy9535         265 DFGIVKMSETSNMK--TMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  340 (593)
Q Consensus       265 DFGla~~~~~~~~~--~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~  340 (593)
                      |||+++........  ........||+.|+|||++.  ..++.++|||||||++|||++|+.||................
T Consensus       164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  243 (303)
T 2vwi_A          164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND  243 (303)
T ss_dssp             CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred             eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence            99998765432110  11123457999999999874  357899999999999999999999998754433222222221


Q ss_pred             Ccc-cc-ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         341 VPV-RE-VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       341 ~~~-~~-~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .+. .. ..+......    ....+..++.+||+.||.+||++.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCCTTC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCccccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            111 00 001111011    1123455678999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.6e-39  Score=332.18  Aligned_cols=254  Identities=24%  Similarity=0.338  Sum_probs=195.0

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~  189 (593)
                      +..+.||+|+||.||+|+.. +|+.||||.+..........    +........+.+|+.+++++. ||||+++++++..
T Consensus        20 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA----EEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCH----HHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCH----HHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            34678999999999999985 68999999997542211110    111111235789999999996 9999999999876


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEcCCCcEEEecccc
Confidence             4568999999999999999763   358999999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-------CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  341 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~  341 (593)
                      ++.......    .....||+.|+|||++.       ..++.++|||||||++|||++|+.||.................
T Consensus       171 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  246 (298)
T 1phk_A          171 SCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY  246 (298)
T ss_dssp             CEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             hhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence            987543321    23357999999999763       3467899999999999999999999987655444333333322


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ....   +..     ......+..++.+||+.||++|||+.|+++
T Consensus       247 ~~~~---~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          247 QFGS---PEW-----DDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CCCT---TTG-----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccCc---ccc-----cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1111   100     112233556778999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=340.57  Aligned_cols=251  Identities=22%  Similarity=0.330  Sum_probs=188.4

Q ss_pred             CCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec--
Q psy9535         113 RGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~--  189 (593)
                      ..+.||+|+||.||+++. .+|+.||||++....      ..       ....+.+|+.++++++||||+++++++..  
T Consensus        33 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (317)
T 2buj_A           33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE------QQ-------DREEAQREADMHRLFNHPNILRLVAYCLRER   99 (317)
T ss_dssp             EEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS------HH-------HHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred             EEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC------HH-------HHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence            357899999999999997 478999999986421      01       12258899999999999999999998852  


Q ss_pred             ---ccceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         190 ---IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       190 ---~~~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                         ...++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|
T Consensus       100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~d  177 (317)
T 2buj_A          100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMD  177 (317)
T ss_dssp             TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECC
T ss_pred             CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCCEEEEe
Confidence               35589999999999999997632 23568999999999999999999998  5699999999999999999999999


Q ss_pred             cccceecccCCCcc------eeeccccCCCCcCCcccccCC----CCCcchhhHHHHHHHHHHhCCCCCCCC----chHH
Q psy9535         266 FGIVKMSETSNMKT------MYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDN----NTIL  331 (593)
Q Consensus       266 FGla~~~~~~~~~~------~~~~~~~GT~~Y~APE~~~~~----~~~ksDVwSfGvvl~ElltG~~P~~~~----~~~~  331 (593)
                      ||+++.........      .......||+.|+|||++...    ++.++|||||||++|||++|+.||...    ....
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  257 (317)
T 2buj_A          178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA  257 (317)
T ss_dssp             CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred             cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence            99987643211000      001224689999999987543    588999999999999999999999531    1111


Q ss_pred             HHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         332 YYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      .   ........     +.....     ...+..++.+||+.||.+||++.+|++.|+..
T Consensus       258 ~---~~~~~~~~-----~~~~~~-----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          258 L---AVQNQLSI-----PQSPRH-----SSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             H---HHHCC--C-----CCCTTS-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             H---HhhccCCC-----CccccC-----CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence            0   01111000     001111     22355567899999999999999999999874

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-40  Score=342.62  Aligned_cols=244  Identities=24%  Similarity=0.398  Sum_probs=185.1

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-  189 (593)
                      +.+.||+|+||.||+|+.. +|+.||||++.....    .          ...+.+|+.+++++ +||||+++++++.. 
T Consensus        28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~----------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----E----------EEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----T----------THHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----c----------HHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            3689999999999999974 689999999864311    1          11478999999998 79999999998854 


Q ss_pred             ------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         190 ------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       190 ------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                            ...++||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEEcCCCCEEE
Confidence                  34689999999999999997643 2468999999999999999999998  56999999999999999999999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCccccc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  337 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~  337 (593)
                      +|||++........   ......||+.|+|||++.      ..++.++|||||||++|||++|..||.............
T Consensus       171 ~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  247 (326)
T 2x7f_A          171 VDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP  247 (326)
T ss_dssp             CCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             eeCcCceecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence            99999876543211   122357999999999774      347889999999999999999999998765443333322


Q ss_pred             hhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ....  ....   ...+     ...+..++.+||..||.+||++.++++
T Consensus       248 ~~~~--~~~~---~~~~-----~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          248 RNPA--PRLK---SKKW-----SKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HSCC--CCCS---CSCS-----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cCcc--ccCC---cccc-----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            2211  1111   1111     123555678999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.7e-39  Score=351.53  Aligned_cols=198  Identities=24%  Similarity=0.296  Sum_probs=156.9

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         110 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       110 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      .+++.+.||+|+||.||+|+.. +|+.||||++....    .. .      .....+.+|+.+|++++||||+++++++.
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~----~~-~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~   95 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF----ED-L------IDCKRILREITILNRLKSDYIIRLYDLII   95 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT----TS-H------HHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh----cC-h------HHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence            3455789999999999999875 68899999996421    11 0      11235889999999999999999999986


Q ss_pred             cc------cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccE
Q psy9535         189 NI------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  262 (593)
Q Consensus       189 ~~------~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~K  262 (593)
                      ..      ..++||||+. |+|.+++...   ..+++..+..++.||+.||.|||+  .+|+||||||+|||++.++.+|
T Consensus        96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl~~~~~~k  169 (432)
T 3n9x_A           96 PDDLLKFDELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQDCSVK  169 (432)
T ss_dssp             CSCTTTCCCEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEE
T ss_pred             cCCCCcCCeEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEECCCCCEE
Confidence            43      3589999976 6999998752   458999999999999999999999  5699999999999999999999


Q ss_pred             EeecccceecccCCCcc-------------------eeeccccCCCCcCCcccc--cCCCCCcchhhHHHHHHHHHHhCC
Q psy9535         263 LGDFGIVKMSETSNMKT-------------------MYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGM  321 (593)
Q Consensus       263 l~DFGla~~~~~~~~~~-------------------~~~~~~~GT~~Y~APE~~--~~~~~~ksDVwSfGvvl~ElltG~  321 (593)
                      |+|||+++.........                   ......+||+.|+|||++  ...++.++|||||||++|||++|.
T Consensus       170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~  249 (432)
T 3n9x_A          170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML  249 (432)
T ss_dssp             ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred             EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence            99999998764332110                   112456899999999975  345889999999999999999855


Q ss_pred             CCC
Q psy9535         322 KPI  324 (593)
Q Consensus       322 ~P~  324 (593)
                      .||
T Consensus       250 ~p~  252 (432)
T 3n9x_A          250 QSH  252 (432)
T ss_dssp             TTT
T ss_pred             ccc
Confidence            444

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-39  Score=345.40  Aligned_cols=251  Identities=23%  Similarity=0.274  Sum_probs=182.0

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI-  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~-  190 (593)
                      ..+.||+|+||.||+|+.. +|+.||||++....    .. .  .    ....+.+|+.++++++||||+++++++... 
T Consensus        29 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~-~--~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           29 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF----QN-Q--T----HAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT----SS-H--H----HHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred             EeeeeEecCCEEEEEEEECCCCceEEEEEecccc----CC-h--H----HHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence            3678999999999999875 68899999996431    11 1  1    122578999999999999999999998653 


Q ss_pred             ------cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         191 ------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       191 ------~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                            ..++||||+. |+|.+.+..     .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~  169 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKIL  169 (371)
T ss_dssp             STTTCCEEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccccccceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEE
Confidence                  3589999997 578888852     48899999999999999999998  569999999999999999999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-c
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-P  342 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~  342 (593)
                      |||+++......    ......||+.|+|||++. ..++.++|||||||++|||++|+.||...+....+..+..... +
T Consensus       170 Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  245 (371)
T 2xrw_A          170 DFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP  245 (371)
T ss_dssp             CCCC--------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCC
T ss_pred             Eeeccccccccc----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999998654322    123457999999999774 4578999999999999999999999988665544444332211 1


Q ss_pred             cccccc--------------------------cccCC---CCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREVLD--------------------------KEAGE---WNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~~~--------------------------~~~~~---~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .++...                          .....   .........+..++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            110000                          00000   001122445667788999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1e-39  Score=330.57  Aligned_cols=239  Identities=18%  Similarity=0.268  Sum_probs=184.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      .+.||+|+||.||+|+.. +|+.||||.+.....    ....       ...+.+|+..+.++ +||||+++++++.+ .
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~-------~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A           16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA----GSVD-------EQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT----TSHH-------HHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             hhhhcCCCceEEEEEEEcCCCceEEEEEeccccc----ccHH-------HHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            578999999999999986 799999999875311    1111       12578899999999 99999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC-----------
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-----------  258 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~-----------  258 (593)
                      ..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.+           
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC-------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCcccccccc
Confidence            66899999999999999976421 2468999999999999999999999  569999999999999844           


Q ss_pred             --------CccEEeecccceecccCCCcceeeccccCCCCcCCcccccCC--CCCcchhhHHHHHHHHHHhCCCCCCCCc
Q psy9535         259 --------FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNN  328 (593)
Q Consensus       259 --------~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~~ksDVwSfGvvl~ElltG~~P~~~~~  328 (593)
                              ..+||+|||+++......       ...||+.|+|||++.+.  ++.++|||||||++|||++|.+|+....
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  235 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSPQ-------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD  235 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCSC-------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred             cccccCCceEEEEcccccccccCCcc-------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence                    478999999988754322       23699999999987554  4569999999999999999998876543


Q ss_pred             hHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         329 TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...   .......  ...    ....     ...+..++.+||+.||++|||+.|+++
T Consensus       236 ~~~---~~~~~~~--~~~----~~~~-----~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 QWH---EIRQGRL--PRI----PQVL-----SQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HHH---HHHTTCC--CCC----SSCC-----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHH---HHHcCCC--CCC----Cccc-----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            221   1111111  111    0111     123455678999999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.6e-40  Score=334.01  Aligned_cols=246  Identities=26%  Similarity=0.319  Sum_probs=174.8

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|+.. +|+.||||++....     ...  ..    ...+.++...++.++||||+++++++.+ .
T Consensus        11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~--~~----~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~   79 (290)
T 3fme_A           11 PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-----NSQ--EQ----KRLLMDLDISMRTVDCPFTVTFYGALFREG   79 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEC--------CHH--HH----HHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             hHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-----CcH--HH----HHHHHHHHHHHHhCCCCeEEEEeeeeeccC
Confidence            3578999999999999974 78999999986431     111  11    1134455666888999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeEecccCCCCeeecCCCccEEeeccc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      ..++||||+. |+|.+++... .....+++..+..++.|++.||.|||+  + +|+||||||+|||++.++.+||+|||+
T Consensus        80 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T 3fme_A           80 DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGI  156 (290)
T ss_dssp             SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred             CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence            6689999997 5888877642 223579999999999999999999998  4 699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccc-----cCCCCCcchhhHHHHHHHHHHhCCCCCCCCch-HHHHHHHHhhcCc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAM-----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT-ILYYYLVVEQEVP  342 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~-----~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~-~~~~~~~~~~~~~  342 (593)
                      ++.......    .....||+.|+|||++     ...++.++|||||||++|||++|+.||..... ............+
T Consensus       157 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  232 (290)
T 3fme_A          157 SGYLVDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP  232 (290)
T ss_dssp             -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC
T ss_pred             ccccccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC
Confidence            986544321    2234799999999985     23478899999999999999999999986332 2222222222111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                        ..        ....+...+..++.+||+.||++|||+.|+++
T Consensus       233 --~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          233 --QL--------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             --CC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --Cc--------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence              00        00111223455677999999999999999865

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.1e-40  Score=348.90  Aligned_cols=250  Identities=26%  Similarity=0.348  Sum_probs=171.8

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec--
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~--  189 (593)
                      ..+.||+|+||.||+|+.. +|+.||||++....    .. ..      ....+.+|+.+|++++||||+++++++..  
T Consensus        33 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~-~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  101 (367)
T 2fst_X           33 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QS-II------HAKRTYRELRLLKHMKHENVIGLLDVFTPAR  101 (367)
T ss_dssp             EEEECC----CCEEEEEETTTTEEEEEEECSSTT----SS-HH------HHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             EeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc----cC-HH------HHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            3578999999999999864 68999999985421    11 10      12357899999999999999999999854  


Q ss_pred             -----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         190 -----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       190 -----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                           ...++|+||+ +++|.+++..    ..+++..+..++.|+++||.|||+  .+|+||||||+|||++.++.+||+
T Consensus       102 ~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kL~  174 (367)
T 2fst_X          102 SLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKIL  174 (367)
T ss_dssp             SGGGCCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             ccccCCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEECCCCCEEEe
Confidence                 2358899998 7899888864    458999999999999999999998  569999999999999999999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-C
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-V  341 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~-~  341 (593)
                      |||+++.....      .....||+.|+|||++.+  .++.++|||||||++|||++|+.||.+.+.......+.... .
T Consensus       175 DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  248 (367)
T 2fst_X          175 DFGLARHTADE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  248 (367)
T ss_dssp             C---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             ecccccccccc------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999864332      223579999999997754  57889999999999999999999998766544333332211 1


Q ss_pred             ccccccccc--------------cCCCCHH----HHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVLDKE--------------AGEWNET----HVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~~~~--------------~~~~~~~----~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +..+.+...              .......    .....+..++.+||+.||++|||+.|+++
T Consensus       249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            111110000              0000000    01233556778999999999999999864

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.1e-40  Score=347.66  Aligned_cols=194  Identities=28%  Similarity=0.414  Sum_probs=162.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||.||+|+.. +|..||+|.+....     . ...      ...+.+|+.++++++||||+++++++.+ ..
T Consensus        38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-----~-~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-----K-PAI------RNQIIRELQVLHECNSPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-----C-HHH------HHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEecccc-----C-HHH------HHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence            578999999999999986 68999999986431     1 111      1258899999999999999999998876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++....   .+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEEEEECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHh-CCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence            689999999999999997643   588999999999999999999972 1599999999999999999999999999875


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN  328 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~  328 (593)
                      .....     .....||+.|+|||++.+ .++.++|||||||++|||++|+.||....
T Consensus       182 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          182 LIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             HHHHC---------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             ccccc-----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            43221     223579999999997754 57889999999999999999999997644

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=333.06  Aligned_cols=243  Identities=25%  Similarity=0.396  Sum_probs=187.7

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||.||+|+.. +|+.||||.+....     .          ...+.+|+.++++++||||+++++++.. .
T Consensus        33 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           33 VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----D----------LQEIIKEISIMQQCDSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             EEEECC----CEEEEEEETTTCCEEEEEEEETTS-----C----------CHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             hheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----H----------HHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence            3578999999999999886 58999999986431     1          1147899999999999999999998865 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+.+|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  173 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVAG  173 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEECCCCCEEEeecccch
Confidence            5689999999999999987432  468999999999999999999998  569999999999999999999999999997


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .......   ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||.................+  .... 
T Consensus       174 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~-  247 (314)
T 3com_A          174 QLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP--TFRK-  247 (314)
T ss_dssp             ECBTTBS---CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--CCSS-
T ss_pred             hhhhhcc---ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc--ccCC-
Confidence            6543321   1234579999999997744 5788999999999999999999999876544333322222111  1000 


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                            +......+..++.+||..||.+|||+.++++
T Consensus       248 ------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          248 ------PELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                  1111233556778999999999999999865

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=336.87  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=188.1

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +..+.||+|+||.||+|+...  .||||.+..........           ..|.+|+.++++++||||+++++++.+ .
T Consensus        36 ~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           36 EIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQL-----------KAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             ECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCC-----------CCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             EEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHH-----------HHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            347899999999999998853  49999986542211110           136789999999999999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+++|+|.+++...  ...+++..+..++.|++.||.|||+  ++|+||||||+|||++ ++.+||+|||+++
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             ceEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence            568999999999999999753  2468999999999999999999998  5699999999999998 6799999999987


Q ss_pred             ecccCCC--cceeeccccCCCCcCCcccccC----------CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Q psy9535         271 MSETSNM--KTMYTENLTGTRPYMPPEAMHC----------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  338 (593)
Q Consensus       271 ~~~~~~~--~~~~~~~~~GT~~Y~APE~~~~----------~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~  338 (593)
                      .......  .........||+.|+|||++..          .++.++|||||||++|||++|+.||..............
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  257 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT  257 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence            6432111  0111223469999999997743          367899999999999999999999987654433333322


Q ss_pred             hcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         339 QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      ...+.  ...   ...+     ..+..++.+||..+|++|||+.++++.|+...
T Consensus       258 ~~~~~--~~~---~~~~-----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~  301 (319)
T 2y4i_B          258 GMKPN--LSQ---IGMG-----KEISDILLFCWAFEQEERPTFTKLMDMLEKLP  301 (319)
T ss_dssp             TCCCC--CCC---SSCC-----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred             CCCCC--CCc---CCCC-----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            21111  100   0111     12445677999999999999999999998754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.3e-39  Score=369.79  Aligned_cols=250  Identities=28%  Similarity=0.400  Sum_probs=193.0

Q ss_pred             CCCcccccCceEEEEEEEcC----CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~----g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      +++.||+|+||.||+|++..    +..||||.+....      ....      ...|.+|+.++++++|||||+++|++.
T Consensus       394 i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~------~~~~------~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT------SDSV------REKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             EEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT------CHHH------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             EeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC------CHHH------HHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            35779999999999998742    4579999875321      1111      125889999999999999999999998


Q ss_pred             cccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         189 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       189 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                      +...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             cCceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEEeCCCCEEEEecCC
Confidence            878899999999999999997642  468999999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      ++.......  .......||+.|+|||++. ..++.++|||||||++|||++ |..||.+.........+.......   
T Consensus       538 a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---  612 (656)
T 2j0j_A          538 SRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---  612 (656)
T ss_dssp             CCSCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---
T ss_pred             CeecCCCcc--eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence            987543321  1122346788999999764 568889999999999999997 999998765444333332221110   


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                         ....     +...+..++.+||..||++||++.||++.|+..
T Consensus       613 ---~~~~-----~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          613 ---MPPN-----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ---CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCcc-----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               0011     122345567899999999999999999999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.6e-39  Score=344.44  Aligned_cols=249  Identities=22%  Similarity=0.335  Sum_probs=184.1

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEeccc
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~  191 (593)
                      ..+.||+|+||.||+|+.. +|+.||||++....     ....      ....+.+|+.++++++||||+++++++....
T Consensus        46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  114 (371)
T 4exu_A           46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-----QSEI------FAKRAYRELLLLKHMQHENVIGLLDVFTPAS  114 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-----SSHH------HHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             EEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-----cchh------HHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence            3678999999999999875 68999999986431     1111      1235789999999999999999999986532


Q ss_pred             -------ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         192 -------NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       192 -------~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                             .++||||+. |+|.+.+.     ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+
T Consensus       115 ~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kL~  186 (371)
T 4exu_A          115 SLRNFYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKIL  186 (371)
T ss_dssp             SSTTCCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             CcccceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEECCCCCEEEE
Confidence                   289999997 68887773     248999999999999999999999  569999999999999999999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-C
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-V  341 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~-~  341 (593)
                      |||+++.....      .....||+.|+|||++.+  .++.++|||||||++|||++|+.||................ .
T Consensus       187 Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~  260 (371)
T 4exu_A          187 DFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV  260 (371)
T ss_dssp             STTCC--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ecCcccccccC------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999865332      234579999999997754  57889999999999999999999998765444333332211 1


Q ss_pred             ccccccccc--------------cCCCCH----HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVLDKE--------------AGEWNE----THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~~~~--------------~~~~~~----~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +..+.....              ......    ......+..++.+||+.||++|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            111100000              000000    011234556778999999999999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2e-39  Score=336.75  Aligned_cols=246  Identities=20%  Similarity=0.276  Sum_probs=184.9

Q ss_pred             CCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-
Q psy9535         113 RGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-  189 (593)
                      +.++||+|+||.||+|+. .+|+.||||++....                ...+.+|+.++++++ ||||+++++++.+ 
T Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~  103 (330)
T 3nsz_A           40 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----------------KKKIKREIKILENLRGGPNIITLADIVKDP  103 (330)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----------------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             EEEEecccCCeEEEEEEECCCCcEEEEEEecccc----------------hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence            467899999999999987 468999999985321                114789999999997 9999999999875 


Q ss_pred             --ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC-ccEEeec
Q psy9535         190 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDF  266 (593)
Q Consensus       190 --~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~-~~Kl~DF  266 (593)
                        ...++||||+.+|+|.+++..      +++..+..++.|++.||.|||+  ++|+||||||+|||++.++ .+||+||
T Consensus       104 ~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~~kl~Df  175 (330)
T 3nsz_A          104 VSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDW  175 (330)
T ss_dssp             TTCCEEEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CCCceEEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence              345899999999999998853      7889999999999999999998  5699999999999999776 8999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchH-HHHHHHHh--hcC
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVE--QEV  341 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~-~~~~~~~~--~~~  341 (593)
                      |+++.......    .....||+.|+|||++.+  .++.++|||||||++|||++|+.||...... ........  ...
T Consensus       176 g~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~  251 (330)
T 3nsz_A          176 GLAEFYHPGQE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  251 (330)
T ss_dssp             TTCEECCTTCC----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred             CCceEcCCCCc----cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCc
Confidence            99987544321    223579999999997743  5788999999999999999999999653221 11111100  000


Q ss_pred             ccccccc-----------------------cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVLD-----------------------KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~~-----------------------~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...+.++                       ..........+...+..++.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000                       00000011112344566778999999999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.5e-39  Score=329.73  Aligned_cols=245  Identities=25%  Similarity=0.344  Sum_probs=192.1

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +++.||||++........           ....|.+|+.++++++||||+++++++.+ ..
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-----------DTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-----------CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-----------HHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            578999999999999985 689999999865421110           11257899999999999999999999876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC---CccEEeeccc
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGI  268 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~---~~~Kl~DFGl  268 (593)
                      .++||||+++|+|.+.+...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.+   +.+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            68999999999999998764   358999999999999999999998  569999999999999754   4799999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ++.......    .....||+.|+|||.+.+.++.++||||||+++|||++|+.||.....................   
T Consensus       171 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  243 (287)
T 2wei_A          171 STCFQQNTK----MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL---  243 (287)
T ss_dssp             GGTBCCCSS----CSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS---
T ss_pred             ceeecCCCc----cccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---
Confidence            876543221    1234689999999998888999999999999999999999999876554433333332221110   


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +.....     ...+..++.+||..+|++|||+.|+++
T Consensus       244 ~~~~~~-----~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          244 PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             GGGTTS-----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhhc-----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            001111     223455678999999999999999976

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.7e-40  Score=336.42  Aligned_cols=255  Identities=21%  Similarity=0.298  Sum_probs=181.8

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +..+.||+|+||.||+|+.. +|+.||||++....      ..       ....+.+|+.++++++||||+++++++.. 
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   80 (320)
T 2i6l_A           14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD------PQ-------SVKHALREIKIIRRLDHDNIVKVFEILGPS   80 (320)
T ss_dssp             EEEEECC-----CEEEEEETTTTEEEEEEEEECCS------HH-------HHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred             eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC------hH-------HHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence            44678999999999999986 58999999986321      11       12358899999999999999999998732 


Q ss_pred             --------------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee
Q psy9535         190 --------------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  255 (593)
Q Consensus       190 --------------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl  255 (593)
                                    ...++||||+. |+|.+++..    .++++..+..++.|++.||.|||+  .+|+||||||+|||+
T Consensus        81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~  153 (320)
T 2i6l_A           81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFI  153 (320)
T ss_dssp             SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEE
T ss_pred             ccccccccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEE
Confidence                          34579999997 699998864    458999999999999999999998  569999999999999


Q ss_pred             c-CCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHH
Q psy9535         256 D-ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILY  332 (593)
Q Consensus       256 ~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~  332 (593)
                      + .++.+||+|||+++................||+.|+|||.+.  ..++.++|||||||++|||++|+.||........
T Consensus       154 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  233 (320)
T 2i6l_A          154 NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ  233 (320)
T ss_dssp             ETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             cCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            7 567999999999986543221111123356899999999763  4578899999999999999999999987665443


Q ss_pred             HHHHHhhcCccccc------------ccccc--CCCCH----HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         333 YYLVVEQEVPVREV------------LDKEA--GEWNE----THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       333 ~~~~~~~~~~~~~~------------~~~~~--~~~~~----~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..............            +....  .....    ..+...+..++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            33332221110000            00000  00000    012234556778999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.9e-39  Score=337.66  Aligned_cols=256  Identities=24%  Similarity=0.300  Sum_probs=187.1

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      +..+.||+|+||.||+|+.. +|+.||||++....     . ..      ....+.+|+.++++++||||+++++++.. 
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~-~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   81 (353)
T 2b9h_A           14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-----K-PL------FALRTLREIKILKHFKHENIITIFNIQRPD   81 (353)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-----S-HH------HHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-----c-ch------HHHHHHHHHHHHHhCcCCCcCCeeeeeccc
Confidence            34688999999999999975 68999999985321     1 11      11257899999999999999999998754 


Q ss_pred             -----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         190 -----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       190 -----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                           ...++||||+. |+|.+++..    ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+
T Consensus        82 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~~~~~~~kl~  154 (353)
T 2b9h_A           82 SFENFNEVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVC  154 (353)
T ss_dssp             CSTTCCCEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEEC
T ss_pred             ccCccceEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEcCCCcEEEE
Confidence                 34589999997 699998875    358999999999999999999998  569999999999999999999999


Q ss_pred             ecccceecccCCCcc-------eeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHH
Q psy9535         265 DFGIVKMSETSNMKT-------MYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  335 (593)
Q Consensus       265 DFGla~~~~~~~~~~-------~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~  335 (593)
                      |||+++.........       .......||+.|+|||++.  ..++.++|||||||++|||++|+.||...........
T Consensus       155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  234 (353)
T 2b9h_A          155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL  234 (353)
T ss_dssp             CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999998754322110       0122357999999999763  4578899999999999999999999987654332222


Q ss_pred             HHhh-cCcc-ccccc----c----------ccCCCCH----HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         336 VVEQ-EVPV-REVLD----K----------EAGEWNE----THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       336 ~~~~-~~~~-~~~~~----~----------~~~~~~~----~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .... ..+. .....    .          .......    ..+...+..++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            2111 0000 00000    0          0000000    012233456778999999999999999865

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3e-40  Score=349.72  Aligned_cols=249  Identities=11%  Similarity=0.050  Sum_probs=168.7

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHH---HHHhcCCCCceeeEE----
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV---QTLSQCKHVNLLRLL----  184 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev---~il~~l~HpNIv~l~----  184 (593)
                      ..+.||+|+||.||+|++. +|+.||||++......     ..     .....+.+|+   .+|+. +||||++++    
T Consensus        66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~-----~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~  134 (371)
T 3q60_A           66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-----SR-----SELERLHEATFAAARLLG-ESPEEARDRRRLL  134 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT-----HH-----HHHHHHHHHHHHHHHHHC-----------CBC
T ss_pred             eeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc-----cc-----cHHHHHHHHHHHHHHhcc-cChhhhhhceeEE
Confidence            4678999999999999975 7899999999754210     00     1122467774   55566 799988755    


Q ss_pred             ---EEEec------------------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHh
Q psy9535         185 ---GLCNN------------------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR------YSIALGVAEALHYLH  237 (593)
Q Consensus       185 ---g~~~~------------------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH  237 (593)
                         +++..                  ...++||||++ |+|.+++...+.  .+++..+      ..++.|++.||.|||
T Consensus       135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH  211 (371)
T 3q60_A          135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQ  211 (371)
T ss_dssp             CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence               33322                  22589999999 999999986432  3456666      788899999999999


Q ss_pred             cCCCCeEecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccccC---CCCCcchhhHHHHHH
Q psy9535         238 SLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVIL  314 (593)
Q Consensus       238 ~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~~ksDVwSfGvvl  314 (593)
                      +  ++|+||||||+|||++.++.+||+|||+++.....      .....||+.|+|||++.+   .++.++|||||||++
T Consensus       212 ~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il  283 (371)
T 3q60_A          212 S--KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI  283 (371)
T ss_dssp             H--TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred             H--CCCccCcCCHHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence            8  56999999999999999999999999999865321      113467799999998754   578999999999999


Q ss_pred             HHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         315 LELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       315 ~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      |||++|+.||.........   ......................+...+..++.+||+.||++|||+.|+++
T Consensus       284 ~elltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          284 YRVWCLFLPFGLVTPGIKG---SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHHSSCSTTBCCTTCTT---CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHHhCCCCCCCcCccccc---chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9999999999764211000   00000000000000000000112234556778999999999999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.6e-39  Score=333.11  Aligned_cols=255  Identities=23%  Similarity=0.332  Sum_probs=188.1

Q ss_pred             CCCcccccCceEEEEEEE--cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC---CCCceeeEEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKL--KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLLGLC  187 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~--~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l---~HpNIv~l~g~~  187 (593)
                      ..+.||+|+||.||+|+.  .+|+.||||++..........    .       .+.+|+.+++++   +||||+++++++
T Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~----~-------~~~~e~~~l~~l~~~~h~~i~~~~~~~   83 (326)
T 1blx_A           15 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----L-------STIREVAVLRHLETFEHPNVVRLFDVC   83 (326)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB----C-------THHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCC----c-------hhhHHHHHHHhhhccCCCCeEeeeeee
Confidence            367899999999999997  368899999987542211100    0       256677776665   899999999988


Q ss_pred             e-----c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCcc
Q psy9535         188 N-----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  261 (593)
Q Consensus       188 ~-----~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~  261 (593)
                      .     . ...++||||+. |+|.+++..... ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili~~~~~~  159 (326)
T 1blx_A           84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQI  159 (326)
T ss_dssp             EEEECSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCE
T ss_pred             eecccCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEEcCCCCE
Confidence            5     2 34589999998 799999986442 458999999999999999999998  569999999999999999999


Q ss_pred             EEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q psy9535         262 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  340 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~  340 (593)
                      ||+|||+++......    ......||+.|+|||++. ..++.++|||||||++|||++|+.||...........+....
T Consensus       160 kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  235 (326)
T 1blx_A          160 KLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI  235 (326)
T ss_dssp             EECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEecCcccccccCCC----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc
Confidence            999999987654322    123457999999999764 467889999999999999999999998766544333333211


Q ss_pred             C-cccccc-----------cccc-C--CCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         341 V-PVREVL-----------DKEA-G--EWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       341 ~-~~~~~~-----------~~~~-~--~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      . +.....           .... .  ......+...+..++.+||..||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0 000000           0000 0  0000112234556778999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-39  Score=352.25  Aligned_cols=196  Identities=23%  Similarity=0.315  Sum_probs=161.1

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC------CCCceeeEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC------KHVNLLRLL  184 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l------~HpNIv~l~  184 (593)
                      ++.++||+|+||.||+|+.. +++.||||++....        ..      ...+.+|+.+++.+      +|+||++++
T Consensus       100 ~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--------~~------~~~~~~E~~~l~~l~~~~~~~~~~iv~~~  165 (429)
T 3kvw_A          100 EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--------RF------HRQAAEEIRILEHLRKQDKDNTMNVIHML  165 (429)
T ss_dssp             EEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--------HH------HHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred             EEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--------ch------HHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence            34678999999999999875 58899999985320        00      12466788777766      677999999


Q ss_pred             EEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc--c
Q psy9535         185 GLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV--P  261 (593)
Q Consensus       185 g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~--~  261 (593)
                      +++.. ...++||||+. |+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.  +
T Consensus       166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NILl~~~~~~~v  241 (429)
T 3kvw_A          166 ENFTFRNHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRSGI  241 (429)
T ss_dssp             EEEEETTEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH--HTEECSCCSGGGEEESSTTSCCE
T ss_pred             eecccCCeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEccCCCcce
Confidence            98875 56689999996 79999998643 2458999999999999999999998  56999999999999999887  9


Q ss_pred             EEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHH
Q psy9535         262 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTIL  331 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~  331 (593)
                      ||+|||+++.....      .....||+.|+|||++. ..++.++|||||||++|||++|+.||.......
T Consensus       242 kL~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  306 (429)
T 3kvw_A          242 KVIDFGSSCYEHQR------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD  306 (429)
T ss_dssp             EECCCTTCEETTCC------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEeecccceecCCc------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999764332      12357999999999764 468999999999999999999999998765443

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.9e-39  Score=341.50  Aligned_cols=250  Identities=24%  Similarity=0.298  Sum_probs=185.1

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC--------CCceee
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--------HVNLLR  182 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~--------HpNIv~  182 (593)
                      ++.++||+|+||.||+|+.. +|+.||||++...        ..      ....+.+|+.++++++        ||||++
T Consensus        40 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~------~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           40 HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--------EH------YTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--------HH------HHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             EEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--------Cc------chHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            34678999999999999874 6889999998532        00      0124788999999886        888999


Q ss_pred             EEEEEe----c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeEecccCCCCeeec
Q psy9535         183 LLGLCN----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLD  256 (593)
Q Consensus       183 l~g~~~----~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~IiHrDLKp~NILl~  256 (593)
                      +++++.    + ...++||||+ +|+|.+.+.... ...+++..+..++.|++.||.|||+  + +|+||||||+|||++
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIll~  181 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILLS  181 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEEEC
T ss_pred             eecceeecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHeeEe
Confidence            999875    2 3568999999 677877776543 2468999999999999999999998  4 699999999999999


Q ss_pred             CCC-------------------------------------------------ccEEeecccceecccCCCcceeeccccC
Q psy9535         257 ENF-------------------------------------------------VPKLGDFGIVKMSETSNMKTMYTENLTG  287 (593)
Q Consensus       257 ~~~-------------------------------------------------~~Kl~DFGla~~~~~~~~~~~~~~~~~G  287 (593)
                      .++                                                 .+||+|||+++.....      .....|
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~g  255 (397)
T 1wak_A          182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQ  255 (397)
T ss_dssp             CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCS
T ss_pred             ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCC
Confidence            775                                                 8999999999875432      123579


Q ss_pred             CCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCc------hHHHHHHHHh--hcCccc---------ccccc
Q psy9535         288 TRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNN------TILYYYLVVE--QEVPVR---------EVLDK  349 (593)
Q Consensus       288 T~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~------~~~~~~~~~~--~~~~~~---------~~~~~  349 (593)
                      |+.|+|||++. ..++.++|||||||++|||++|+.||....      ..........  +..+..         .....
T Consensus       256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  335 (397)
T 1wak_A          256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK  335 (397)
T ss_dssp             CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred             CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence            99999999774 458899999999999999999999997532      1111111111  111100         00000


Q ss_pred             c--------------------cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 E--------------------AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~--------------------~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .                    ...+ .......+..++.+||+.||++|||+.|+++
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          336 KGDLKHITKLKPWGLFEVLVEKYEW-SQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             TSSBSSCCCCCCCCHHHHHHHTSCC-CHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhHhhhhhccc-chhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0                    0011 2233445666778999999999999999874

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5e-39  Score=333.47  Aligned_cols=251  Identities=24%  Similarity=0.339  Sum_probs=188.1

Q ss_pred             CCCCcccccCceEEEEEEE-c-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCc------eeeE
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-K-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN------LLRL  183 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpN------Iv~l  183 (593)
                      ++.+.||+|+||.||+|.. . +|+.||||++....       ..       ...+.+|+.++++++|+|      ++++
T Consensus        17 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------~~-------~~~~~~e~~~l~~l~~~~~~~~~~i~~~   82 (339)
T 1z57_A           17 EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-------RY-------CEAARSEIQVLEHLNTTDPNSTFRCVQM   82 (339)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-------HH-------HHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred             EEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-------ch-------hHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence            3467899999999999987 3 68899999985320       00       124778999998887765      9999


Q ss_pred             EEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC-----
Q psy9535         184 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----  257 (593)
Q Consensus       184 ~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~-----  257 (593)
                      ++++.. ...++||||+ +|+|.+++.... ..++++..+..++.|++.||.|||+  ++|+||||||+|||++.     
T Consensus        83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~  158 (339)
T 1z57_A           83 LEWFEHHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTE  158 (339)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCEEE
T ss_pred             ecccccCCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEecccccc
Confidence            998866 5668999999 899999997643 2468999999999999999999998  56999999999999987     


Q ss_pred             --------------CCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCC
Q psy9535         258 --------------NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMK  322 (593)
Q Consensus       258 --------------~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~  322 (593)
                                    ++.+||+|||+++.....      .....||+.|+|||++. ..++.++|||||||++|||++|..
T Consensus       159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  232 (339)
T 1z57_A          159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT  232 (339)
T ss_dssp             EEC----CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCCccccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence                          678999999999864432      12357999999999774 468899999999999999999999


Q ss_pred             CCCCCchHHHHHHHHhhcCcccccc----------ccccC----------------------CCCHHHHHHHHHHHHHHh
Q psy9535         323 PIDDNNTILYYYLVVEQEVPVREVL----------DKEAG----------------------EWNETHVETLIGIVFEKC  370 (593)
Q Consensus       323 P~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~----------------------~~~~~~~~~~i~~~~~~C  370 (593)
                      ||.................+.+..+          .....                      ..........+..++.+|
T Consensus       233 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  312 (339)
T 1z57_A          233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM  312 (339)
T ss_dssp             SCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence            9987554332222211111111000          00000                      001122334456677899


Q ss_pred             hccccCCCCChHHHHH
Q psy9535         371 CVFEKDKRASMRDIVD  386 (593)
Q Consensus       371 ~~~dp~~RPsm~eV~~  386 (593)
                      |+.||.+|||+.|+++
T Consensus       313 L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          313 LEYDPAKRITLREALK  328 (339)
T ss_dssp             TCSSTTTSCCHHHHTT
T ss_pred             hCcCcccccCHHHHhc
Confidence            9999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.8e-39  Score=339.54  Aligned_cols=266  Identities=21%  Similarity=0.257  Sum_probs=192.5

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCC----chhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS----DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~----~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      +.+.||+|+||.||+|+. +|+.||||.+...........    ............|.+|+.++++++||||+++++++.
T Consensus        35 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~  113 (348)
T 2pml_X           35 IIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT  113 (348)
T ss_dssp             EEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred             EEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            467899999999999998 899999999865321110000    000000000136899999999999999999999987


Q ss_pred             c-ccceEEEEeccCCCHHHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCcc
Q psy9535         189 N-IMNCIVYEYMCNGSLYDR------LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  261 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~------L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~  261 (593)
                      + ...++||||+++|+|.++      +... ....+++..+..++.|++.||.|||+ .++|+||||||+|||++.++.+
T Consensus       114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dl~p~Nil~~~~~~~  191 (348)
T 2pml_X          114 NYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRV  191 (348)
T ss_dssp             SSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCCCCGGGEEECTTSCE
T ss_pred             eCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecCCChHhEEEcCCCcE
Confidence            6 566899999999999998      5432 13579999999999999999999997 2359999999999999999999


Q ss_pred             EEeecccceecccCCCcceeeccccCCCCcCCcccccCC--CCC-cchhhHHHHHHHHHHhCCCCCCCCch-HHHHHHHH
Q psy9535         262 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--IST-KTDVFSYGVILLELLTGMKPIDDNNT-ILYYYLVV  337 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~~-ksDVwSfGvvl~ElltG~~P~~~~~~-~~~~~~~~  337 (593)
                      ||+|||+++.....     ......||+.|+|||++.+.  ++. ++|||||||++|||++|+.||..... ........
T Consensus       192 kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~  266 (348)
T 2pml_X          192 KLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR  266 (348)
T ss_dssp             EECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred             EEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence            99999999875432     12346799999999987654  445 89999999999999999999987544 33333332


Q ss_pred             hhcCccccccccc-------cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         338 EQEVPVREVLDKE-------AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       338 ~~~~~~~~~~~~~-------~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ......+......       ........+...+..++.+||+.||.+||++.|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            2222211100000       000000112234556778999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.2e-39  Score=331.51  Aligned_cols=245  Identities=24%  Similarity=0.334  Sum_probs=181.2

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC--CCceeeEEEEEec-
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--HVNLLRLLGLCNN-  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~--HpNIv~l~g~~~~-  189 (593)
                      +.+.||+|+||.||+|+..+|+.||||.+.....    . .  .    ....|.+|+.++++++  ||||+++++++.+ 
T Consensus        32 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~-~--~----~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA----D-N--Q----TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             EEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC----C-H--H----HHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             EEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc----c-c--c----chHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            3578999999999999988899999999864311    1 1  1    1235889999999997  5999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||| +.+|+|.+++...   ..+++..+..++.|+++||.|||+  .+|+||||||+|||+++ +.+||+|||++
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~  173 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVD-GMLKLIDFGIA  173 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred             CEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEEC-CeEEEeecccc
Confidence            45678999 6789999999863   368999999999999999999998  56999999999999964 89999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC------------CCCCcchhhHHHHHHHHHHhCCCCCCCCchHH-HHHHH
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC------------QISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLV  336 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~------------~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~-~~~~~  336 (593)
                      +....... ........||+.|+|||++.+            .++.++|||||||++|||++|+.||....... .....
T Consensus       174 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  252 (313)
T 3cek_A          174 NQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  252 (313)
T ss_dssp             CC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             ccccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence            86543321 111234579999999998753            57789999999999999999999997643322 11111


Q ss_pred             HhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         337 VEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...... .     ......+    ..+..++.+||+.||++||++.|+++
T Consensus       253 ~~~~~~-~-----~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          253 IDPNHE-I-----EFPDIPE----KDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HCTTSC-C-----CCCCCSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             Hhcccc-c-----CCcccch----HHHHHHHHHHccCCcccCcCHHHHhc
Confidence            111110 0     0011111    23445677999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.7e-39  Score=347.57  Aligned_cols=248  Identities=21%  Similarity=0.282  Sum_probs=176.7

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~  190 (593)
                      ..+.||+|+||+||.+...+|+.||||++....          .      ..+.+|+.+|+++ +|||||++++++.+ .
T Consensus        19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----------~------~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----------C------DIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             EEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----------H------HHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----------H------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            357899999999987666679999999986420          0      1367899999876 89999999998876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCC-C---CCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC--------
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTP-P---LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN--------  258 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~-~---l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~--------  258 (593)
                      ..++||||+. |+|.+++....... .   .++..+..++.|++.||.|||+  .+|+||||||+|||++.+        
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~~~  159 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQ  159 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSCCT
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCcccccccc
Confidence            5689999995 79999997643211 1   1333457899999999999998  569999999999999754        


Q ss_pred             -----CccEEeecccceecccCCCc-ceeeccccCCCCcCCccccc--------CCCCCcchhhHHHHHHHHHHh-CCCC
Q psy9535         259 -----FVPKLGDFGIVKMSETSNMK-TMYTENLTGTRPYMPPEAMH--------CQISTKTDVFSYGVILLELLT-GMKP  323 (593)
Q Consensus       259 -----~~~Kl~DFGla~~~~~~~~~-~~~~~~~~GT~~Y~APE~~~--------~~~~~ksDVwSfGvvl~Ellt-G~~P  323 (593)
                           +.+||+|||+++........ ........||+.|+|||++.        ..++.++|||||||++|||+| |+.|
T Consensus       160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P  239 (434)
T 2rio_A          160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP  239 (434)
T ss_dssp             TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence                 48999999999876543211 11123457999999999774        347889999999999999999 9999


Q ss_pred             CCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         324 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      |.+......  ............     .......+...+..++.+||+.||.+|||+.||++
T Consensus       240 f~~~~~~~~--~i~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          240 FGDKYSRES--NIIRGIFSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             TCSTTTHHH--HHHHTCCCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCchhhHH--HHhcCCCCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            976433221  111221111111     11122334455667788999999999999999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.7e-39  Score=337.24  Aligned_cols=248  Identities=22%  Similarity=0.347  Sum_probs=183.1

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEeccc-
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM-  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~-  191 (593)
                      .+.||+|+||.||+|+.. +|+.||||++....     ....      ....+.+|+.++++++||||+++++++.... 
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   97 (353)
T 3coi_A           29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-----QSEI------FAKRAYRELLLLKHMQHENVIGLLDVFTPASS   97 (353)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-----SSHH------HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             eeeEecCCCeEEEEEEECCCCCEEEEEEecccc-----cchH------HHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence            578999999999999875 68999999986421     1111      1225789999999999999999999986532 


Q ss_pred             ------ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         192 ------NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       192 ------~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                            .++||||+. |+|.+++.     ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             GGGCCCCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTCCEEECS
T ss_pred             cccceeEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeECCCCcEEEee
Confidence                  389999997 68887764     248999999999999999999998  5699999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-Cc
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-VP  342 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~-~~  342 (593)
                      ||+++.....      .....||+.|+|||++.+  .++.++|||||||++|||++|+.||................ .+
T Consensus       170 fg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  243 (353)
T 3coi_A          170 FGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  243 (353)
T ss_dssp             TTCTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBC
T ss_pred             cccccCCCCC------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9998764322      123578999999997754  57889999999999999999999998765433333222211 11


Q ss_pred             cccccc---------------cc-cCCCC--HHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREVLD---------------KE-AGEWN--ETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~~~---------------~~-~~~~~--~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..+...               .. ...+.  .......+..++.+|+..||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000000               00 00000  0112234556778999999999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.6e-38  Score=346.53  Aligned_cols=253  Identities=22%  Similarity=0.299  Sum_probs=189.1

Q ss_pred             CCCCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCcee-eEEEEEec
Q psy9535         112 RRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLL-RLLGLCNN  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv-~l~g~~~~  189 (593)
                      ++.++||+|+||.||+|+. .+|+.||||++......   .            .+.+|+.+++.++|++.+ .+..++..
T Consensus        10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~------------~~~~E~~il~~L~~~~~i~~i~~~~~~   74 (483)
T 3sv0_A           10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---P------------QLLYESKIYRILQGGTGIPNVRWFGVE   74 (483)
T ss_dssp             ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---C------------CHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---H------------HHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence            4578999999999999997 46899999987643211   0            367899999999885544 44444444


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee---cCCCccEEee
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGD  265 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl---~~~~~~Kl~D  265 (593)
                       ...+|||||+ +|+|.+++....  ..+++..++.|+.||+.||.|||+  ++||||||||+|||+   +.++.+||+|
T Consensus        75 ~~~~~lvme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL~D  149 (483)
T 3sv0_A           75 GDYNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIID  149 (483)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred             CCEEEEEEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEEEe
Confidence             4568999999 999999997543  468999999999999999999998  569999999999999   6889999999


Q ss_pred             cccceecccCCCcc----eeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCch---HHHHHHHH
Q psy9535         266 FGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNT---ILYYYLVV  337 (593)
Q Consensus       266 FGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~---~~~~~~~~  337 (593)
                      ||+++.........    .......||+.|+|||++. ..++.++|||||||+||||++|+.||.....   ...+....
T Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (483)
T 3sv0_A          150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (483)
T ss_dssp             CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH
T ss_pred             CCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh
Confidence            99998765432211    1122468999999999775 4578899999999999999999999976322   11111111


Q ss_pred             hhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         338 EQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ...  ....+......++     ..+..++..||+.+|++||++.+|++.|+..
T Consensus       230 ~~~--~~~~~~~l~~~~p-----~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          230 EKK--VATSIEALCRGYP-----TEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHH--HHSCHHHHHTTSC-----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             hcc--ccccHHHHhcCCc-----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            111  0011111111111     2345567899999999999999999998874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-38  Score=325.54  Aligned_cols=244  Identities=24%  Similarity=0.362  Sum_probs=178.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec---
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~---  189 (593)
                      .+.||+|+||.||+|+.. +|+.||||.+....          .    ....+.+|+.++++++||||+++++++.+   
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (303)
T 1zy4_A           11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----------E----KLSTILSEVMLLASLNHQYVVRYYAAWLERRN   76 (303)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----------H----HHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred             hheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----------H----HHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence            578999999999999975 78999999985320          0    12258899999999999999999998743   


Q ss_pred             -----------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC
Q psy9535         190 -----------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  258 (593)
Q Consensus       190 -----------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~  258 (593)
                                 ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.+
T Consensus        77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil~~~~  152 (303)
T 1zy4_A           77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDES  152 (303)
T ss_dssp             CCC------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTT
T ss_pred             hhhhhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEEEcCC
Confidence                       34579999999999999998633  357888999999999999999998  569999999999999999


Q ss_pred             CccEEeecccceecccCCC-----------cceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCC
Q psy9535         259 FVPKLGDFGIVKMSETSNM-----------KTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPID  325 (593)
Q Consensus       259 ~~~Kl~DFGla~~~~~~~~-----------~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~  325 (593)
                      +.+||+|||+++.......           .........||+.|+|||++.+  .++.++|||||||++|||++   ||.
T Consensus       153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~  229 (303)
T 1zy4_A          153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS  229 (303)
T ss_dssp             SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence            9999999999876532110           0011234579999999998753  57889999999999999998   665


Q ss_pred             CCchHHHH-HHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         326 DNNTILYY-YLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       326 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ........ ..........+...       . ......+..++.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~-------~-~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          230 TGMERVNILKKLRSVSIEFPPDF-------D-DNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             SHHHHHHHHHHHHSTTCCCCTTC-------C-TTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CchhHHHHHHhccccccccCccc-------c-ccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            43221111 11111111111111       1 111223455778999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.3e-38  Score=338.53  Aligned_cols=201  Identities=25%  Similarity=0.294  Sum_probs=161.9

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CC-----ceeeEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HV-----NLLRLLG  185 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-Hp-----NIv~l~g  185 (593)
                      +.++||+|+||.||+|+.. +|+.||||+++...       ..       ...+.+|+.++..++ |+     +|+++++
T Consensus        58 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~-------~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-------AF-------LNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-------HH-------HHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             EEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-------HH-------HHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            3678999999999999875 68899999986320       00       124677888888775 44     4999999


Q ss_pred             EEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec--CCCccE
Q psy9535         186 LCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPK  262 (593)
Q Consensus       186 ~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~--~~~~~K  262 (593)
                      ++.. ...++||||+. |+|.+++..... ..+++..+..++.|++.||.|||+...+|+||||||+|||++  .++.+|
T Consensus       124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k  201 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK  201 (382)
T ss_dssp             EEEETTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred             eeccCCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence            8865 56789999995 699999986432 458999999999999999999996446799999999999994  578899


Q ss_pred             EeecccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHH
Q psy9535         263 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  335 (593)
Q Consensus       263 l~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~  335 (593)
                      |+|||+++.....      .....||+.|+|||++.+ .++.++|||||||++|||+||+.||...........
T Consensus       202 L~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~  269 (382)
T 2vx3_A          202 IVDFGSSCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK  269 (382)
T ss_dssp             ECCCTTCEETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEeccCceecccc------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999876432      123579999999997754 588999999999999999999999987655443333

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=344.92  Aligned_cols=243  Identities=21%  Similarity=0.338  Sum_probs=175.4

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||+||.....+|+.||||++.....         .       .+.+|+.+|+++ +|||||++++++.+ ..
T Consensus        29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---------~-------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~   92 (432)
T 3p23_A           29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---------S-------FADREVQLLRESDEHPNVIRYFCTEKDRQF   92 (432)
T ss_dssp             EEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---------E-------ECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred             CCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---------H-------HHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence            478999999997655556799999999854210         0       246899999999 79999999998876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC-----CCccEEeec
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGDF  266 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~-----~~~~Kl~DF  266 (593)
                      .++|||||. |+|.+++....  ..+.+..+..++.|++.||.|||+  .+|+||||||+|||++.     ...+||+||
T Consensus        93 ~~lv~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF  167 (432)
T 3p23_A           93 QYIAIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDF  167 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred             EEEEEECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence            689999996 69999997643  234555667899999999999999  56999999999999943     346789999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCccccc----CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcC
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  341 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~----~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~  341 (593)
                      |+++................||+.|+|||++.    ..++.++|||||||++|||++ |..||..........  .....
T Consensus       168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--~~~~~  245 (432)
T 3p23_A          168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--LLGAC  245 (432)
T ss_dssp             TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--HTTCC
T ss_pred             cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--HhccC
Confidence            99987654321112233467999999999875    346779999999999999999 999997543322211  11111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .... .      .........+..++.+||+.||.+|||+.||++
T Consensus       246 ~~~~-~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          246 SLDC-L------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCTT-S------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Cccc-c------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1110 0      011223344566778999999999999999974

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.6e-38  Score=330.64  Aligned_cols=239  Identities=23%  Similarity=0.301  Sum_probs=160.7

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHH-HHHHhcCCCCceeeEEEEEec--
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE-VQTLSQCKHVNLLRLLGLCNN--  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~E-v~il~~l~HpNIv~l~g~~~~--  189 (593)
                      .+.||+|+||.||+|+.. +|+.||||++...           .       ...+| ...++.++||||+++++++..  
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----------P-------KARQEVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----------H-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----------H-------HHHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence            356999999999999986 6899999998632           0       12223 334667899999999998854  


Q ss_pred             ---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC---CCccEE
Q psy9535         190 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKL  263 (593)
Q Consensus       190 ---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~---~~~~Kl  263 (593)
                         ...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.   ++.+||
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~~~kl  172 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKL  172 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCceEEE
Confidence               23589999999999999998643 2469999999999999999999999  56999999999999975   456999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHH----HHHh
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY----LVVE  338 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~----~~~~  338 (593)
                      +|||+++......     .....||+.|+|||++. ..++.++|||||||++|||++|+.||..........    ....
T Consensus       173 ~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (336)
T 3fhr_A          173 TDFGFAKETTQNA-----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL  247 (336)
T ss_dssp             CCCTTCEEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred             eccccceeccccc-----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc
Confidence            9999998654322     22357899999999874 447789999999999999999999997543221100    0000


Q ss_pred             hcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         339 QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ......   .+...     .+...+..++.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~---~~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          248 GQYGFP---NPEWS-----EVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ---CCC---TTTST-----TCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cccccC---chhhc-----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000000   00001     12233455678999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.9e-38  Score=330.16  Aligned_cols=250  Identities=21%  Similarity=0.324  Sum_probs=185.8

Q ss_pred             CCCcccccCceEEEEEEEc-CC-CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCc------eeeEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NG-MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN------LLRLL  184 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g-~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpN------Iv~l~  184 (593)
                      +.+.||+|+||.||+|+.. ++ +.||||+++...       ..       ...+.+|+.++++++|+|      ++.++
T Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------~~-------~~~~~~E~~~l~~l~~~~~~~~~~~~~~~   88 (355)
T 2eu9_A           23 IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-------KY-------REAARLEINVLKKIKEKDKENKFLCVLMS   88 (355)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-------HH-------HHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred             EEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-------cc-------hhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence            4578999999999999875 34 689999985320       10       124778999999988776      89999


Q ss_pred             EEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeee--------
Q psy9535         185 GLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL--------  255 (593)
Q Consensus       185 g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl--------  255 (593)
                      +++.. ...++||||+ +|+|.+.+.... ..++++..+..++.|++.||.|||+  ++|+||||||+|||+        
T Consensus        89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~~~  164 (355)
T 2eu9_A           89 DWFNFHGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEFETL  164 (355)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEESCCCEEEE
T ss_pred             eeeeeCCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeccccccc
Confidence            98765 5678999999 778888887643 2468999999999999999999998  569999999999999        


Q ss_pred             -----------cCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCC
Q psy9535         256 -----------DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKP  323 (593)
Q Consensus       256 -----------~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P  323 (593)
                                 +.++.+||+|||+++......      ....||+.|+|||++. ..++.++|||||||++|||++|+.|
T Consensus       165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  238 (355)
T 2eu9_A          165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEHH------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL  238 (355)
T ss_dssp             ECCC-CCCEEEESCCCEEECCCTTCEETTSCC------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccccccCCCcEEEeecCccccccccc------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence                       678899999999998643321      2357999999999774 4688999999999999999999999


Q ss_pred             CCCCchHHHHHHHHhhcCcccc-ccc---------cc----------------------cCCCCHHHHHHHHHHHHHHhh
Q psy9535         324 IDDNNTILYYYLVVEQEVPVRE-VLD---------KE----------------------AGEWNETHVETLIGIVFEKCC  371 (593)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~-~~~---------~~----------------------~~~~~~~~~~~~i~~~~~~C~  371 (593)
                      |.................+.+. ...         ..                      ............+..++.+||
T Consensus       239 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  318 (355)
T 2eu9_A          239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML  318 (355)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence            9875543322222111111110 000         00                      000011122334566778999


Q ss_pred             ccccCCCCChHHHHH
Q psy9535         372 VFEKDKRASMRDIVD  386 (593)
Q Consensus       372 ~~dp~~RPsm~eV~~  386 (593)
                      +.||++|||+.|+++
T Consensus       319 ~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          319 EFDPAQRITLAEALL  333 (355)
T ss_dssp             CSSTTTSCCHHHHTT
T ss_pred             cCChhhCcCHHHHhc
Confidence            999999999999853

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-38  Score=328.99  Aligned_cols=249  Identities=25%  Similarity=0.322  Sum_probs=165.4

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHH-HHhcCCCCceeeEEEEEec-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ-TLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~-il~~l~HpNIv~l~g~~~~-  189 (593)
                      ..+.||+|+||.||+|+.. +|+.||||++....     . .. .     ...+..|+. +++.++||||+++++++.. 
T Consensus        26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~-~~-~-----~~~~~~e~~~~~~~~~h~niv~~~~~~~~~   93 (327)
T 3aln_A           26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-----D-EK-E-----QKQLLMDLDVVMRSSDCPYIVQFYGALFRE   93 (327)
T ss_dssp             C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-----C-HH-H-----HHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred             ehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-----C-ch-H-----HHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence            4678999999999999985 68999999996431     1 11 1     113455665 7788899999999998876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeEecccCCCCeeecCCCccEEeec
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      ...++||||+.+ +|.+++...  .....+++..+..++.|++.||.|||+  . +|+||||||+|||++.++.+||+||
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll~~~~~~kl~Df  170 (327)
T 3aln_A           94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDF  170 (327)
T ss_dssp             SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEEcCCCCEEEccC
Confidence            556899999985 887777531  123568999999999999999999998  4 6999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccc-----cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  341 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-----~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~  341 (593)
                      |+++.......    .....||+.|+|||++     ...++.++|||||||++|||++|+.||.............. ..
T Consensus       171 g~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~  245 (327)
T 3aln_A          171 GISGQLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-KG  245 (327)
T ss_dssp             SSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-CS
T ss_pred             CCceecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-cC
Confidence            99976543221    1234799999999987     23478899999999999999999999976432111000000 00


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ............     +...+..++.+||+.||++||++.||++
T Consensus       246 ~~~~~~~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          246 DPPQLSNSEERE-----FSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCCCCSSCC-----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCccccc-----CCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            000000000011     1223455678999999999999999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.3e-38  Score=330.41  Aligned_cols=240  Identities=25%  Similarity=0.375  Sum_probs=184.8

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC--CCceeeEEEEEe
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--HVNLLRLLGLCN  188 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~--HpNIv~l~g~~~  188 (593)
                      ++.+.||+|+||.||+|+.. +|+.||||.+.............       ...+.+|+.++++++  ||||+++++++.
T Consensus        46 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~-------~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-------GTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             EEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTT-------CCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhh-------hhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            34678999999999999874 68899999997643211000000       013668999999996  599999999987


Q ss_pred             c-ccceEEEEeccC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec-CCCccEEee
Q psy9535         189 N-IMNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGD  265 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~-GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~-~~~~~Kl~D  265 (593)
                      . ...++||||+.+ |+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++ .++.+||+|
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            6 456899999986 8999999763   358999999999999999999998  5699999999999999 789999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCcccccC-CC-CCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  343 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~  343 (593)
                      ||+++......     .....||+.|+|||++.+ .+ +.++|||||||++|||++|+.||......      .......
T Consensus       194 fg~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~~~  262 (320)
T 3a99_A          194 FGSGALLKDTV-----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVFF  262 (320)
T ss_dssp             CTTCEECCSSC-----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------HHCCCCC
T ss_pred             Ccccccccccc-----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh------hcccccc
Confidence            99998765332     223579999999997643 33 57889999999999999999999763221      1111111


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .       ...     ...+..++.+||+.||++|||+.||++
T Consensus       263 ~-------~~~-----~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          263 R-------QRV-----SSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             S-------SCC-----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             c-------ccC-----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1       111     123455678999999999999999865

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=325.98  Aligned_cols=239  Identities=27%  Similarity=0.416  Sum_probs=181.8

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC----CCCceeeEEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC----KHVNLLRLLGLC  187 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l----~HpNIv~l~g~~  187 (593)
                      ..+.||+|+||.||+|+.. +|+.||||.+.............       ...+.+|+.++.++    +||||+++++++
T Consensus        35 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSD-------SVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             EEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC---------------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             EeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchh-------hHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            4689999999999999874 68999999986542211100000       11356789999888    899999999988


Q ss_pred             ec-ccceEEEEe-ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec-CCCccEEe
Q psy9535         188 NN-IMNCIVYEY-MCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLG  264 (593)
Q Consensus       188 ~~-~~~~lV~Ey-~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~-~~~~~Kl~  264 (593)
                      .. ...++|||| +.+|+|.+++...   ..+++..+..++.|++.||.|||+  .+|+||||||+|||++ .++.+||+
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--HTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChhhEEEeCCCCeEEEE
Confidence            65 566899999 7899999999864   358999999999999999999998  5699999999999999 88999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCccccc-CCC-CCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCc
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  342 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~  342 (593)
                      |||+++......     .....||+.|+|||++. ..+ +.++|||||||++|||++|+.||......      ......
T Consensus       183 dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~  251 (312)
T 2iwi_A          183 DFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI------LEAELH  251 (312)
T ss_dssp             CCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------HHTCCC
T ss_pred             EcchhhhcccCc-----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH------hhhccC
Confidence            999998765432     22357999999999764 344 34899999999999999999999753221      111111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..       ..     +...+..++.+||+.+|++||++.|+++
T Consensus       252 ~~-------~~-----~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          252 FP-------AH-----VSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             CC-------TT-----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             Cc-------cc-----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11       11     1123455678999999999999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.9e-39  Score=337.22  Aligned_cols=251  Identities=22%  Similarity=0.273  Sum_probs=183.7

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-----------CCc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-----------HVN  179 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-----------HpN  179 (593)
                      ++.+.||+|+||.||+|+.. +|+.||||++....       ..       ...+.+|+.++++++           |||
T Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~-------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   87 (373)
T 1q8y_A           22 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-------VY-------TEAAEDEIKLLQRVNDADNTKEDSMGANH   87 (373)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-------HH-------HHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             EEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-------cc-------hhhhhHHHHHHHHhhcccccchhccccch
Confidence            34678999999999999874 68999999985320       00       124778999998886           899


Q ss_pred             eeeEEEEEecc-----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeEecccCCCCe
Q psy9535         180 LLRLLGLCNNI-----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANV  253 (593)
Q Consensus       180 Iv~l~g~~~~~-----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~IiHrDLKp~NI  253 (593)
                      |+++++++...     ..++||||+ +|+|.+++..... ..+++..+..++.|++.||.|||+  + +|+||||||+||
T Consensus        88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~NI  163 (373)
T 1q8y_A           88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENV  163 (373)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGE
T ss_pred             HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChHHe
Confidence            99999988642     457899999 9999999986432 458999999999999999999998  4 699999999999


Q ss_pred             eec------CCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCC
Q psy9535         254 LLD------ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDD  326 (593)
Q Consensus       254 Ll~------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~  326 (593)
                      |++      ..+.+||+|||+++......      ....||+.|+|||++. ..++.++|||||||++|||++|+.||..
T Consensus       164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  237 (373)
T 1q8y_A          164 LMEIVDSPENLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  237 (373)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             EEeccCCCcCcceEEEcccccccccCCCC------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            994      44589999999998754321      2357999999999775 4578999999999999999999999975


Q ss_pred             Cch------HHHHHHHHhhcCccccc-----------cccc-------------------cCCCCHHHHHHHHHHHHHHh
Q psy9535         327 NNT------ILYYYLVVEQEVPVREV-----------LDKE-------------------AGEWNETHVETLIGIVFEKC  370 (593)
Q Consensus       327 ~~~------~~~~~~~~~~~~~~~~~-----------~~~~-------------------~~~~~~~~~~~~i~~~~~~C  370 (593)
                      ...      ..............+..           ++..                   .....+......+..++.+|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  317 (373)
T 1q8y_A          238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM  317 (373)
T ss_dssp             -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred             CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHH
Confidence            321      11111111110000000           0000                   00001233455566778899


Q ss_pred             hccccCCCCChHHHHH
Q psy9535         371 CVFEKDKRASMRDIVD  386 (593)
Q Consensus       371 ~~~dp~~RPsm~eV~~  386 (593)
                      |+.||++|||+.|+++
T Consensus       318 L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          318 LQLDPRKRADAGGLVN  333 (373)
T ss_dssp             GCSSTTTCBCHHHHHT
T ss_pred             hccCccccCCHHHHhh
Confidence            9999999999999865

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.4e-38  Score=323.09  Aligned_cols=245  Identities=24%  Similarity=0.362  Sum_probs=167.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||.||+|+.. +|+.||||++....     .... .     ...+..+..+++.++||||+++++++.+ ..
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~-~-----~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~   98 (318)
T 2dyl_A           30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-----NKEE-N-----KRILMDLDVVLKSHDCPYIVQCFGTFITNTD   98 (318)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEETTS-----CHHH-H-----HHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             cceeeecCCeeEEEEEEecCCeEEEEEEecccc-----cchH-H-----HHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence            468999999999999985 68999999996431     1111 1     1134455567888999999999999876 55


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+ ++.+..+....  ...+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHH-HCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             EEEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhh-CCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            68999999 45555444432  24689999999999999999999972 1599999999999999999999999999876


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCch-HHHHHHHHhhcCccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNT-ILYYYLVVEQEVPVR  344 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~-~~~~~~~~~~~~~~~  344 (593)
                      ......    .....||+.|+|||++.      ..++.++|||||||++|||++|+.||..... ............+..
T Consensus       175 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (318)
T 2dyl_A          175 LVDDKA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL  250 (318)
T ss_dssp             ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC
T ss_pred             ccCCcc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC
Confidence            543221    22357999999999873      3478899999999999999999999986432 222222222221110


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                          +.....+     ..+..++.+||+.||.+||++.|+++
T Consensus       251 ----~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          251 ----PGHMGFS-----GDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             ----CSSSCCC-----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ----CccCCCC-----HHHHHHHHHHccCChhHCcCHHHHhh
Confidence                0001111     23445677999999999999999864

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.7e-37  Score=354.47  Aligned_cols=234  Identities=21%  Similarity=0.298  Sum_probs=180.6

Q ss_pred             CCCCcccccCceEEEEEEEc--CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~--~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      ++.++||+|+||.||+|++.  +|+.||||++....     . .  +.    ...|.+|+.++++++|||||++++++..
T Consensus        83 ~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-----~-~--~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~  150 (681)
T 2pzi_A           83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-----D-A--EA----QAMAMAERQFLAEVVHPSIVQIFNFVEH  150 (681)
T ss_dssp             EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-----C-H--HH----HHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred             EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-----C-H--HH----HHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence            34678999999999999975  58999999885321     1 1  11    2258899999999999999999999875


Q ss_pred             cc------ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         190 IM------NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       190 ~~------~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                      ..      .+|||||+++|+|.+++..     .+++..+..++.|++.||.|||+  ++||||||||+|||++.+ .+||
T Consensus       151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~--~giiHrDlkp~NIll~~~-~~kl  222 (681)
T 2pzi_A          151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QLKL  222 (681)
T ss_dssp             ECTTSCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSS-CEEE
T ss_pred             cCCCCCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH--CCCeecccChHHeEEeCC-cEEE
Confidence            32      4899999999999887643     58999999999999999999998  569999999999999986 8999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  343 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~  343 (593)
                      +|||+++.....       ....||+.|+|||++.+..+.++|||||||++|||++|..||.....         ..  .
T Consensus       223 ~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~--~  284 (681)
T 2pzi_A          223 IDLGAVSRINSF-------GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV---------DG--L  284 (681)
T ss_dssp             CCCTTCEETTCC-------SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SS--C
T ss_pred             EecccchhcccC-------CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc---------cc--c
Confidence            999999875432       23579999999998877778899999999999999999998864210         00  0


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCC-hHHHHHHHhh
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS-MRDIVDLLSK  390 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs-m~eV~~~L~~  390 (593)
                      .       ...........+..++.+||+.||++||+ +.++...|..
T Consensus       285 ~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          285 P-------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             C-------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             c-------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            0       00111122234566778999999999996 4555555543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.4e-37  Score=349.70  Aligned_cols=255  Identities=22%  Similarity=0.319  Sum_probs=187.4

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.++||+|+||.||+|+.. +|+.||||++....     ....       ...|.+|+.++++++||||+++++++.. 
T Consensus        17 ~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-----~~~~-------~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~   84 (676)
T 3qa8_A           17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-----SPKN-------RERWCLEIQIMKKLNHPNVVSAREVPDGL   84 (676)
T ss_dssp             CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-----CHHH-------HHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-----CHHH-------HHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence            44789999999999999874 68999999985321     1111       2258899999999999999999998643 


Q ss_pred             ------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc---
Q psy9535         190 ------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---  260 (593)
Q Consensus       190 ------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~---  260 (593)
                            ...++||||+++|+|.+++........+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.   
T Consensus        85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs--~gIVHrDLKP~NILl~~~g~~~~  162 (676)
T 3qa8_A           85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLI  162 (676)
T ss_dssp             CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH--TTBCCCCCCSTTEEEECCSSSCE
T ss_pred             ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEeecCCCcee
Confidence                  3458999999999999999876555578999999999999999999998  56999999999999996654   


Q ss_pred             cEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh
Q psy9535         261 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  339 (593)
Q Consensus       261 ~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~  339 (593)
                      +||+|||+++.......    .....||+.|+|||++. ..++.++|||||||++|||++|..||........|......
T Consensus       163 vKL~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~  238 (676)
T 3qa8_A          163 HKIIDLGYAKELDQGEL----CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE  238 (676)
T ss_dssp             EEECSCCCCCBTTSCCC----CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-
T ss_pred             EEEcccccccccccccc----cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc
Confidence            89999999987644321    23467999999999775 56888999999999999999999999764332221111000


Q ss_pred             cCc----cccccc------cc--cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHH
Q psy9535         340 EVP----VREVLD------KE--AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI  384 (593)
Q Consensus       340 ~~~----~~~~~~------~~--~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV  384 (593)
                      ...    ......      ..  ........+...+..++.+||..||++|||+.|+
T Consensus       239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            000    000000      00  0011122244556677789999999999999763

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.5e-36  Score=308.72  Aligned_cols=221  Identities=25%  Similarity=0.361  Sum_probs=167.9

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHH-hcCCCCceeeEEEEEec--
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL-SQCKHVNLLRLLGLCNN--  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il-~~l~HpNIv~l~g~~~~--  189 (593)
                      ++.||+|+||.||+|+.. +|+.||||.++..           .       .+.+|+.++ +.++||||+++++++..  
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   84 (299)
T 3m2w_A           23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------P-------KARREVELHWRASQCPHIVRIVDVYENLY   84 (299)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------H-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----------H-------HHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence            367999999999999874 6899999998532           1       367888888 66799999999998754  


Q ss_pred             ---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC---CCccEE
Q psy9535         190 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKL  263 (593)
Q Consensus       190 ---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~---~~~~Kl  263 (593)
                         ...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.   ++.+||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~kl  161 (299)
T 3m2w_A           85 AGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKL  161 (299)
T ss_dssp             TTEEEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred             CCCceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEecCCCCCcEEE
Confidence               34589999999999999998743 2469999999999999999999998  56999999999999998   789999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  343 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~  343 (593)
                      +|||+++....                        ..++.++|||||||++|||++|+.||.........       ...
T Consensus       162 ~Dfg~a~~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------~~~  210 (299)
T 3m2w_A          162 TDFGFAKETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGM  210 (299)
T ss_dssp             CCCTTCEECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------CCS
T ss_pred             ecccccccccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------HHH
Confidence            99999864321                        23567899999999999999999999764322110       000


Q ss_pred             ccccccccCCCCH---HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 REVLDKEAGEWNE---THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~~~~~~~~~~~~~---~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...........+.   ..+...+..++.+||+.||++|||+.|+++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          211 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0000000011111   112334556778999999999999999975

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.8e-37  Score=329.72  Aligned_cols=238  Identities=16%  Similarity=0.181  Sum_probs=168.8

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCC-Cce----------
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH-VNL----------  180 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~H-pNI----------  180 (593)
                      .+++||+|+||.||+|++. +|+.||||++.........          ....|.+|+.+++.++| +|.          
T Consensus        82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~----------~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~  151 (413)
T 3dzo_A           82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN----------AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  151 (413)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC--------------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred             EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHH----------HHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence            4678999999999999964 6999999998633211110          12358899999999987 221          


Q ss_pred             -----eeEE------EEEec-----c-cceEEEEeccCCCHHHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q psy9535         181 -----LRLL------GLCNN-----I-MNCIVYEYMCNGSLYDRLARV----NNTPPLDSNKRYSIALGVAEALHYLHSL  239 (593)
Q Consensus       181 -----v~l~------g~~~~-----~-~~~lV~Ey~~~GsL~~~L~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~  239 (593)
                           +.+.      .+...     . ..+++|+ +.+|+|.+++...    .....+++..++.++.|+++||.|||+ 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-  229 (413)
T 3dzo_A          152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP-RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-  229 (413)
T ss_dssp             CCCEEEECCC---------------CCSEEEEEE-CCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             cchhhcccCCCCccccccCCCccccccceEEEee-hhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence                 1111      11111     1 1234454 5679999988521    123457888999999999999999998 


Q ss_pred             CCCeEecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc----------C-CCCCcchhh
Q psy9535         240 SKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH----------C-QISTKTDVF  308 (593)
Q Consensus       240 ~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~----------~-~~~~ksDVw  308 (593)
                       ++|+||||||+|||++.++.+||+|||+++.....      .....| +.|+|||++.          . .++.++|||
T Consensus       230 -~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw  301 (413)
T 3dzo_A          230 -YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW  301 (413)
T ss_dssp             -TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred             -CCcccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence             56999999999999999999999999998864332      234578 9999999762          2 267799999


Q ss_pred             HHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         309 SYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       309 SfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ||||++|||++|+.||.......          ....++... ...+     ..+..++.+||+.||++||++.++++
T Consensus       302 SlGvil~elltg~~Pf~~~~~~~----------~~~~~~~~~-~~~~-----~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          302 TLGLAIYWIWCADLPNTDDAALG----------GSEWIFRSC-KNIP-----QPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHHHHHHSSCCCCTTGGGS----------CSGGGGSSC-CCCC-----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHHCCCCCCCcchhh----------hHHHHHhhc-ccCC-----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999999999999997643211          111111111 1111     23555678999999999999888753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.7e-36  Score=314.72  Aligned_cols=243  Identities=15%  Similarity=0.132  Sum_probs=176.4

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC---------CCceeeEE
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---------HVNLLRLL  184 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~---------HpNIv~l~  184 (593)
                      .++||+|+||.||+|+. +|+.||||++............     ......+.+|+.++++++         |||||++.
T Consensus        25 ~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           25 CEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH-----QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             CEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBC-----CBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             eeeecccCceEEEEEEe-CCceEEEEEEecCCcccccccc-----chhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            57899999999999998 6899999999765321100000     001225788999888885         88888888


Q ss_pred             EEEe-------------------------------cccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q psy9535         185 GLCN-------------------------------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL  233 (593)
Q Consensus       185 g~~~-------------------------------~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL  233 (593)
                      +.+.                               ....++||||+++|++.+.+.+    ..+++..+..++.|++.||
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence            7542                               3566899999999988777743    3589999999999999999


Q ss_pred             HHHh-cCCCCeEecccCCCCeeecCCC--------------------ccEEeecccceecccCCCcceeeccccCCCCcC
Q psy9535         234 HYLH-SLSKPIIHRDVKSANVLLDENF--------------------VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM  292 (593)
Q Consensus       234 ~yLH-~~~~~IiHrDLKp~NILl~~~~--------------------~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~  292 (593)
                      .||| +  .+|+||||||+|||++.++                    .+||+|||+|+.....        ...||+.||
T Consensus       175 ~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~y~  244 (336)
T 2vuw_A          175 AVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDVSM  244 (336)
T ss_dssp             HHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCCTT
T ss_pred             HHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeeccc
Confidence            9999 7  5699999999999999887                    8999999999875432        247999999


Q ss_pred             CcccccCCCCCcchhhHHHHH-HHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhh
Q psy9535         293 PPEAMHCQISTKTDVFSYGVI-LLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCC  371 (593)
Q Consensus       293 APE~~~~~~~~ksDVwSfGvv-l~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~  371 (593)
                      |||++.+..+.++||||+|++ .+++++|..||....................    ..........+...+..++.+||
T Consensus       245 aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~dli~~~L  320 (336)
T 2vuw_A          245 DEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRKIQEFHRTML  320 (336)
T ss_dssp             CSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHHHHHHHHHGG
T ss_pred             ChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC----cccchhhhhhcCHHHHHHHHHHh
Confidence            999987777889999998777 7889999999853211000110111010000    00011112345566777888999


Q ss_pred             ccccCCCCChHHHH
Q psy9535         372 VFEKDKRASMRDIV  385 (593)
Q Consensus       372 ~~dp~~RPsm~eV~  385 (593)
                      +.|     |+.|++
T Consensus       321 ~~d-----sa~e~l  329 (336)
T 2vuw_A          321 NFS-----SATDLL  329 (336)
T ss_dssp             GSS-----SHHHHH
T ss_pred             ccC-----CHHHHH
Confidence            966     888876

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1e-35  Score=304.16  Aligned_cols=226  Identities=15%  Similarity=0.084  Sum_probs=169.2

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.+.||+|+||.||+|+.. +|+.||||.+......   . .  +    ....|.+|+.++++++||||+++++++.. 
T Consensus        34 ~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~---~-~--~----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  103 (286)
T 3uqc_A           34 RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL---P-D--D----VLQETLSRTLRLSRIDKPGVARVLDVVHTR  103 (286)
T ss_dssp             EEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS---C-H--H----HHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             EEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc---C-H--H----HHHHHHHHHHHHhcCCCCCcceeeEEEEEC
Confidence            34578999999999999985 5899999998643211   0 0  1    12358899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++..    . ....+..+++.|++.||.|||+  ++|+||||||+|||++.++.+||+++|  
T Consensus       104 ~~~~lv~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~--~givH~Dikp~NIll~~~g~~kl~~~~--  174 (286)
T 3uqc_A          104 AGGLVVAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA--  174 (286)
T ss_dssp             TEEEEEEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEETTSCEEECSCC--
T ss_pred             CcEEEEEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHH--CCCccCCCCcccEEEcCCCCEEEEecc--
Confidence            566899999999999999853    1 3455788899999999999999  569999999999999999999997443  


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                                           |++|      ++.++|||||||++|||+||+.||..........       ........
T Consensus       175 ---------------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-------~~~~~~~~  220 (286)
T 3uqc_A          175 ---------------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-------PAERDTAG  220 (286)
T ss_dssp             ---------------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-------ECCBCTTS
T ss_pred             ---------------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-------HHHHHhcc
Confidence                                 3443      5779999999999999999999998643210000       00000000


Q ss_pred             ccCC--CCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         350 EAGE--WNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       350 ~~~~--~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ....  .....+...+..++.+||+.||++| |+.|+++.|...
T Consensus       221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence            0000  0001122335667789999999999 999999999874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2e-32  Score=305.69  Aligned_cols=194  Identities=19%  Similarity=0.097  Sum_probs=131.3

Q ss_pred             cccccCceEEEEEE-EcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEec-ccc
Q psy9535         116 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~-~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~~-~~~  192 (593)
                      ..+.|++|.+..++ .-.|..+|||.+...........   +........|.+|+++|+++ .|+||+++++++++ ...
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~---~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~  317 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTA---EESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG  317 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCH---HHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchh---hhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence            35677777776654 33588999999976543322221   22233445799999999999 69999999999977 567


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ||||||++||+|.++|.+.   .+++..   +|+.||+.||+|||+  ++||||||||+||||+.++.+||+|||+|+..
T Consensus       318 yLVMEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~--~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~  389 (569)
T 4azs_A          318 WLVMEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEK--QGFWHDDVRPWNVMVDARQHARLIDFGSIVTT  389 (569)
T ss_dssp             EEEEECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHH--TTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred             EEEEecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHH--CCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence            9999999999999999763   346654   488999999999999  56999999999999999999999999999876


Q ss_pred             ccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCC
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKP  323 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P  323 (593)
                      .....   ...+.+||++|||||++.+++..++|+||+|++++++.+|..|
T Consensus       390 ~~~~~---~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          390 PQDCS---WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             C---C---CSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred             CCCCc---cccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence            44321   2344689999999999988888899999999999888766443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=3.7e-28  Score=269.69  Aligned_cols=191  Identities=16%  Similarity=0.166  Sum_probs=142.2

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE-ecccc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMN  192 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~-~~~~~  192 (593)
                      .++||+|+||.||+|+. .+..+|+|+...... .    ............|.+|+++|++++||||+++..++ .....
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~-~----~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~  414 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGY-R----DERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK  414 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTT-S----CHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccc-c----chhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc
Confidence            46899999999999955 478899998754211 1    11111111234689999999999999999554444 33566


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      +|||||+++|+|.+++..           +..++.|+++||.|||+  ++|+||||||+|||++.  .+||+|||+++..
T Consensus       415 ~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~--~gIiHrDiKp~NILl~~--~~kL~DFGla~~~  479 (540)
T 3en9_A          415 RIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK--NDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS  479 (540)
T ss_dssp             EEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH--TTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred             EEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH--CcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence            999999999999999864           45789999999999998  56999999999999998  9999999999976


Q ss_pred             ccCCCcc----eeeccccCCCCcCCcccccC---CCCCcchhhHHHHHHHHHHhCCCCCC
Q psy9535         273 ETSNMKT----MYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPID  325 (593)
Q Consensus       273 ~~~~~~~----~~~~~~~GT~~Y~APE~~~~---~~~~ksDVwSfGvvl~ElltG~~P~~  325 (593)
                      .......    .......||+.|||||++..   .|+..+|+||..+-.++.+.++.+|.
T Consensus       480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            5432111    01235689999999998753   46778899999999999988887774

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.92  E-value=6.4e-26  Score=233.43  Aligned_cols=145  Identities=23%  Similarity=0.329  Sum_probs=117.7

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  ++|+.++...  +.+++..+..|+.||+.||+|||+  ++|+||||||+||||+.++.+||+|||+++.
T Consensus       108 yivmEy~~g--G~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          108 YFGLSYAKN--GELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             EEEECCCTT--EEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCC--CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence            566665433  4677776554  469999999999999999999999  6699999999999999999999999999986


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG  578 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  578 (593)
                      ..... ......+.+||+.|||||++.+ .++.++||||+||++|+.++...|+.+.....-++..+.|..++
T Consensus       182 ~~~~~-~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~  253 (311)
T 4aw0_A          182 LSPES-KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF  253 (311)
T ss_dssp             CCTTT-TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             cCCCC-CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            54322 1223445789999999999865 47889999999999999999999998877776677777666554

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.92  E-value=1.6e-25  Score=228.77  Aligned_cols=129  Identities=21%  Similarity=0.392  Sum_probs=105.4

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC-CCceEEEecccce
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVK  505 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~-~~~~kl~DfG~~~  505 (593)
                      .+++++-+.  ++|+.++...  +++++..+..|+.||+.||+|||+.+++||||||||+||||+. ++.+||+|||+|+
T Consensus       105 ~lvmEy~~g--g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          105 VLVTELMTS--GTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCS--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEeCCCC--CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            566665433  3566666543  4799999999999999999999985555999999999999984 7899999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCCcCCcccceecchhhhhcccccCCCccchhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      .....     ...+.+||+.|||||++.++++.++|||||||++|+.++...|+.+...
T Consensus       181 ~~~~~-----~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~  234 (290)
T 3fpq_A          181 LKRAS-----FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQN  234 (290)
T ss_dssp             GCCTT-----SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred             eCCCC-----ccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence            54322     2334689999999999988899999999999999999999999876443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.92  E-value=5.3e-26  Score=237.74  Aligned_cols=144  Identities=22%  Similarity=0.362  Sum_probs=116.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ++|+.++...+...+++.++..|+.||+.||+|||+  ++||||||||+||||+.++.+||+|||+++
T Consensus        98 ~yiVmEy~~g--g~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~  173 (350)
T 4b9d_A           98 LYIVMDYCEG--GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIAR  173 (350)
T ss_dssp             EEEEEECCTT--CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEEECSTTEES
T ss_pred             EEEEEeCCCC--CcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEEEcccccce
Confidence            4567765432  477777776666788999999999999999999999  669999999999999999999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHH  576 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  576 (593)
                      ......   ......+||+.|||||++.+ .|+.++|||||||++|+.++...|+.+....--++..+.|..
T Consensus       174 ~~~~~~---~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~  242 (350)
T 4b9d_A          174 VLNSTV---ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF  242 (350)
T ss_dssp             CCCHHH---HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred             eecCCc---ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence            643211   12234679999999999866 488899999999999999999999987766655555555543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.91  E-value=2.3e-25  Score=229.38  Aligned_cols=132  Identities=30%  Similarity=0.456  Sum_probs=102.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ++|+.++... ..++++.+++.|+.|||.||+|||+  ++||||||||+||||+.++.+||+|||+|+
T Consensus       106 ~~iVmEy~~g--GsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  180 (307)
T 3omv_A          106 LAIVTQWCEG--SSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLAT  180 (307)
T ss_dssp             CEEEEECCSS--CBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred             EEEEEEcCCC--CCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEECCCCcEEEeeccCce
Confidence            3577766443  4667666543 3579999999999999999999998  669999999999999999999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCC----cCCcccceecchhhhhcccccCCCccchh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~----~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      ....... .......+||+.|||||++.+    .++.++|||||||++|+.++...|+.+..
T Consensus       181 ~~~~~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~  241 (307)
T 3omv_A          181 VKSRWSG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN  241 (307)
T ss_dssp             C-------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ecccCCc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence            6432211 112344689999999998742    47889999999999999999888887644

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.91  E-value=4e-25  Score=224.04  Aligned_cols=142  Identities=21%  Similarity=0.378  Sum_probs=106.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+   +.++.++...  +++++.++..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        88 ~~ivmEy~~---g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~  160 (275)
T 3hyh_A           88 IIMVIEYAG---NELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFGLSN  160 (275)
T ss_dssp             EEEEEECCC---EEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred             EEEEEeCCC---CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEECCCCCEEEeecCCCe
Confidence            356777642   5677766543  479999999999999999999999  669999999999999999999999999997


Q ss_pred             ecccCCccccccccccCCCCcccccccCCc-C-CcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG  578 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~-~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  578 (593)
                      ......    ...+.+||+.|||||++.+. + +.++||||+||++|+.++...|+.+.....-++....|..++
T Consensus       161 ~~~~~~----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~  231 (275)
T 3hyh_A          161 IMTDGN----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL  231 (275)
T ss_dssp             ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             ecCCCC----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            643221    12346899999999998664 4 568999999999999999999998876666566665555443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.91  E-value=4.5e-25  Score=229.64  Aligned_cols=140  Identities=23%  Similarity=0.225  Sum_probs=106.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC-ceEEEecccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFGIV  504 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~-~~kl~DfG~~  504 (593)
                      ..+++++-+.  ++|+.++...  ++|++.++..|+.||+.||+|||+  ++||||||||+||||+.++ .+||+|||++
T Consensus       125 ~~ivmEy~~g--g~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~~vKl~DFGla  198 (336)
T 4g3f_A          125 VNIFMELLEG--GSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHA  198 (336)
T ss_dssp             EEEEECCCTT--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred             EEEEEeccCC--CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence            3566665432  4666666544  479999999999999999999998  6699999999999999987 6999999999


Q ss_pred             eecccCCcc--ccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhchhhhh
Q psy9535         505 KMSETSNVK--TMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTM  571 (593)
Q Consensus       505 ~~~~~~~~~--~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~  571 (593)
                      +........  .......+||+.|||||++.++ ++.++|||||||++|+.++...|+.+.....-++.+
T Consensus       199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i  268 (336)
T 4g3f_A          199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI  268 (336)
T ss_dssp             EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH
T ss_pred             eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence            865432211  1122346899999999998654 889999999999999999998998765554333333

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.91  E-value=4.4e-25  Score=226.87  Aligned_cols=143  Identities=27%  Similarity=0.307  Sum_probs=112.7

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ++|+.++...  +++++.++..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+|+
T Consensus       101 ~~ivmEy~~g--g~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~  174 (304)
T 3ubd_A          101 LYLILDFLRG--GDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSK  174 (304)
T ss_dssp             EEEEECCCTT--CEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred             EEEEEEcCCC--CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEEcCCCCEEecccccce
Confidence            3566665432  3566666543  479999999999999999999999  669999999999999999999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHE  577 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  577 (593)
                      ......   ....+.+||+.|||||++.+ .++.++||||+||++|+.++...|+.+.....-++..+.+..+
T Consensus       175 ~~~~~~---~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~  244 (304)
T 3ubd_A          175 ESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG  244 (304)
T ss_dssp             C--------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             eccCCC---ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC
Confidence            543221   12334689999999998854 5889999999999999999999999887776666666655544

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.91  E-value=8.7e-25  Score=228.23  Aligned_cols=135  Identities=22%  Similarity=0.325  Sum_probs=108.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|+.++..   +.+++.++..|+.||+.||+|||+  ++||||||||+||||+.++.+||+|||+++
T Consensus       146 ~~ivmEy~~g--g~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~  218 (346)
T 4fih_A          146 LWVVMEFLEG--GALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCA  218 (346)
T ss_dssp             EEEEECCCTT--EEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeCCCC--CcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEECCCCCEEEecCcCce
Confidence            3567766443  356665543   359999999999999999999999  669999999999999999999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQT  570 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~  570 (593)
                      ......   ....+.+||+.|||||++.+ .|+.++|||||||++|+.++...|+.+....-.++.
T Consensus       219 ~~~~~~---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~  281 (346)
T 4fih_A          219 QVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM  281 (346)
T ss_dssp             ECCSSS---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             ecCCCC---CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence            654321   12345789999999999865 588999999999999999999999877655444433

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=1e-24  Score=222.39  Aligned_cols=156  Identities=17%  Similarity=0.128  Sum_probs=116.4

Q ss_pred             CCCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhH-----HhhhcHHHHHHHHHHHhcCCCCceeeEEE
Q psy9535         111 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTE-----AAMIPILLFENEVQTLSQCKHVNLLRLLG  185 (593)
Q Consensus       111 ~~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~-----~~~~~~~~f~~Ev~il~~l~HpNIv~l~g  185 (593)
                      +.+++.||+|+||.||+|++.+|+.||||.++.............+     -.......|.+|+++|++++  | +++.+
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~  168 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK  168 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred             EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence            3456899999999999999977999999998643211110000000     00011235889999999999  5 67777


Q ss_pred             EEecccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         186 LCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       186 ~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                      ++.....++||||+++|+|.+ +..         .....++.|++.||.|||+  .+|+||||||+|||++ ++.+||+|
T Consensus       169 ~~~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~--~giiHrDlkp~NILl~-~~~vkl~D  235 (282)
T 1zar_A          169 VYAWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVS-EEGIWIID  235 (282)
T ss_dssp             EEEEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEE-TTEEEECC
T ss_pred             EEeccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH--CCCEeCCCCHHHEEEE-CCcEEEEE
Confidence            666677799999999999988 421         1234699999999999998  5699999999999999 99999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCccccc
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH  298 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~  298 (593)
                      ||+|+.                +..|+|||.+.
T Consensus       236 FG~a~~----------------~~~~~a~e~l~  252 (282)
T 1zar_A          236 FPQSVE----------------VGEEGWREILE  252 (282)
T ss_dssp             CTTCEE----------------TTSTTHHHHHH
T ss_pred             CCCCeE----------------CCCCCHHHHHH
Confidence            999753                34578999763

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.90  E-value=7.1e-25  Score=225.22  Aligned_cols=145  Identities=22%  Similarity=0.356  Sum_probs=109.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC
Q psy9535         426 PVIILDTGETKQCQLFKLARVN-----------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  494 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~  494 (593)
                      ..+++++-+.  ++|..++...           ...+|+|.+++.|+.|||+||+|||+  ++||||||||+||||+.++
T Consensus        90 ~~lV~Ey~~~--G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           90 LIMVFEYMKH--GDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             EEEEEECCTT--CBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEcCCC--CcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEEECCCC
Confidence            3567766443  3555555432           34579999999999999999999998  6699999999999999999


Q ss_pred             ceEEEecccceecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhc
Q psy9535         495 VPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTML  572 (593)
Q Consensus       495 ~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~  572 (593)
                      .+||+|||+++........ .......||+.|||||++. ..++.++|||||||++|+..+ ...|+.+.....-++.+.
T Consensus       166 ~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCce-eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999854332211 1123346899999999875 458999999999999998776 677776655444444444


Q ss_pred             CCC
Q psy9535         573 PGH  575 (593)
Q Consensus       573 ~~~  575 (593)
                      .|.
T Consensus       245 ~~~  247 (299)
T 4asz_A          245 QGR  247 (299)
T ss_dssp             HTC
T ss_pred             cCC
Confidence            443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.90  E-value=2.3e-24  Score=224.35  Aligned_cols=144  Identities=21%  Similarity=0.349  Sum_probs=101.7

Q ss_pred             ceEeecCCchhhhhHHHHHhhc-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC
Q psy9535         426 PVIILDTGETKQCQLFKLARVN-------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  492 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~-------------~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~  492 (593)
                      ..+++++-+.  ++|..++...             ..++|+|.+++.|+.|||+||+|||+  ++||||||||+||||+.
T Consensus       118 ~~lV~Ey~~~--G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          118 LLMVFEYMRH--GDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             EEEEEECCTT--CBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEET
T ss_pred             EEEEEEcCCC--CcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhEEECC
Confidence            3567766543  3455544332             24579999999999999999999998  66999999999999999


Q ss_pred             CCceEEEecccceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhh
Q psy9535         493 NFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQT  570 (593)
Q Consensus       493 ~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~  570 (593)
                      ++.+||+|||+++........ ......+||+.|||||++.+ .++.++|||||||++|+..+ ...|+.+......++.
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  272 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC  272 (329)
T ss_dssp             TTEEEECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcc-eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999999999864332211 12234579999999998755 58999999999999998776 6777766554444444


Q ss_pred             hcCC
Q psy9535         571 MLPG  574 (593)
Q Consensus       571 ~~~~  574 (593)
                      +..|
T Consensus       273 i~~g  276 (329)
T 4aoj_A          273 ITQG  276 (329)
T ss_dssp             HHHT
T ss_pred             HHcC
Confidence            4444

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.89  E-value=2.4e-24  Score=222.25  Aligned_cols=144  Identities=17%  Similarity=0.267  Sum_probs=108.0

Q ss_pred             ceEeecCCchhhhhHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec
Q psy9535         426 PVIILDTGETKQCQLFKLARVNN--------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  491 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~--------------~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~  491 (593)
                      ..+++++-+.  ++|..++...+              ...|++.+++.|+.|||+||+|||+  ++||||||||+||||+
T Consensus       104 ~~lV~Ey~~~--G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          104 LSMIFSYCSH--GDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVY  179 (308)
T ss_dssp             CEEEEECCSS--CBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEC
T ss_pred             EEEEEEcCCC--CcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccceEEC
Confidence            3567766443  35555553321              2469999999999999999999999  6699999999999999


Q ss_pred             CCCceEEEecccceecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhh
Q psy9535         492 ENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQ  569 (593)
Q Consensus       492 ~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~  569 (593)
                      .++.+||+|||+++........ ......+||+.|||||++. +.++.++|||||||++|+..+ ...|..+.....-++
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCce-eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999864332211 1233457999999999874 468999999999999998776 567776655443344


Q ss_pred             hhcCC
Q psy9535         570 TMLPG  574 (593)
Q Consensus       570 ~~~~~  574 (593)
                      .+..|
T Consensus       259 ~i~~~  263 (308)
T 4gt4_A          259 MIRNR  263 (308)
T ss_dssp             HHHTT
T ss_pred             HHHcC
Confidence            44444

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.89  E-value=4.2e-24  Score=228.57  Aligned_cols=134  Identities=22%  Similarity=0.329  Sum_probs=107.7

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      .++++++-+.  +.|+.++..   ..+++.++..|+.||+.||+|||+  ++||||||||+||||+.++.+||+|||+++
T Consensus       223 ~~iVmEy~~g--G~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl~~~g~vKl~DFGla~  295 (423)
T 4fie_A          223 LWVVMEFLEG--GALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCA  295 (423)
T ss_dssp             EEEEEECCTT--EEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeCCCC--CcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEecCccce
Confidence            3567766443  356665543   359999999999999999999999  669999999999999999999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQ  569 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~  569 (593)
                      ......   ....+.+||+.|||||++.+ .|+.++|||||||++|+.+....|+.+....--++
T Consensus       296 ~~~~~~---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~  357 (423)
T 4fie_A          296 QVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK  357 (423)
T ss_dssp             ECCSSC---CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             ECCCCC---ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence            654321   12345689999999999865 58999999999999999999999987765543333

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.89  E-value=4.7e-24  Score=219.68  Aligned_cols=127  Identities=23%  Similarity=0.305  Sum_probs=95.8

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCceecCCCCCcEeecCCCceEEEe
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------SKPIIHRDVKSANVLLDENFVPKLGD  500 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~------~~~iiHrdlKp~NILl~~~~~~kl~D  500 (593)
                      .+++++-+.  ++|+.++..   .++++..+..++.|+|.||+|||+.      .++||||||||+||||+.++.+||+|
T Consensus        77 ~lV~Ey~~~--gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           77 WLVSDYHEH--GSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEEEECCTT--CBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEecCCCC--CcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence            567776543  456666654   3699999999999999999999974      23799999999999999999999999


Q ss_pred             cccceecccCCcc-ccccccccCCCCcccccccCCc-------CCcccceecchhhhhcccccCCC
Q psy9535         501 FGIVKMSETSNVK-TMYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGAQIKTQHITNVD  558 (593)
Q Consensus       501 fG~~~~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~-------~~~ksDvwS~G~~i~~~~~~~~~  558 (593)
                      ||+++........ .......+||+.|||||++.+.       ++.++|||||||++|+..+...+
T Consensus       152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~  217 (303)
T 3hmm_A          152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI  217 (303)
T ss_dssp             CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCB
T ss_pred             CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCC
Confidence            9999865432211 1122345799999999988542       56799999999999986654433

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.89  E-value=4.7e-24  Score=224.00  Aligned_cols=111  Identities=23%  Similarity=0.314  Sum_probs=92.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCccc
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMP  528 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~a  528 (593)
                      ...|++.+++.++.|||+||+|||+  ++||||||||+||||+.++.+||+|||+|+....... ...+...+||+.|||
T Consensus       179 ~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymA  255 (353)
T 4ase_A          179 KDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMA  255 (353)
T ss_dssp             TTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCC
T ss_pred             cccCCHHHHHHHHHHHHHHHHhHhh--CCeecCccCccceeeCCCCCEEECcchhhhhcccCCC-ceeeccccccccccC
Confidence            3468999999999999999999999  6699999999999999999999999999986533221 122344679999999


Q ss_pred             ccccC-CcCCcccceecchhhhhcccc-cCCCccch
Q psy9535         529 PEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADR  562 (593)
Q Consensus       529 PE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~  562 (593)
                      ||++. ..++.++|||||||++|+..+ ...|+.+.
T Consensus       256 PE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          256 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             HHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99875 458999999999999998765 56777654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.88  E-value=1.7e-23  Score=215.05  Aligned_cols=129  Identities=29%  Similarity=0.420  Sum_probs=90.2

Q ss_pred             eEeecCCchhhhhHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         427 VIILDTGETKQCQLFKLARVNNT-PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      .+++++-+.  +.|..++..... ...++.....|+.||+.||+|||+  ++|+||||||+||||+.++.+||+|||+++
T Consensus        91 ~ivmE~~~g--g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl~~~~~vKl~DFGla~  166 (299)
T 4g31_A           91 YIQMQLCRK--ENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVT  166 (299)
T ss_dssp             EEEEECCCS--CCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCCCC-
T ss_pred             EEEEecCCC--CcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEECCCCcEEEccCccce
Confidence            456655432  356665544322 235566788999999999999999  669999999999999999999999999998


Q ss_pred             ecccCCccc---------cccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccch
Q psy9535         506 MSETSNVKT---------MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       506 ~~~~~~~~~---------~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      .........         ....+.+||+.|||||++.+ .++.++|||||||++|+.+.   |+.+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~  230 (299)
T 4g31_A          167 AMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ  230 (299)
T ss_dssp             -------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             ecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence            653321110         11233579999999999865 48899999999999998663   55544

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.88  E-value=3.2e-23  Score=221.17  Aligned_cols=139  Identities=27%  Similarity=0.400  Sum_probs=108.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+   +.|+.++..  .+++++..+..|+.||+.||+|||+  ++||||||||+|||++.++.+||+|||+++
T Consensus       134 ~~ivmE~~~---g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME---SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS---EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC---CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCccccccCCCCCEEEeecceee
Confidence            457777654   357776654  4579999999999999999999999  569999999999999999999999999997


Q ss_pred             ecccCC-ccccccccccCCCCcccccccCC-c-CCcccceecchhhhhcccccCCCccchhhhchhhhh
Q psy9535         506 MSETSN-VKTMYTENLTGTRPYMPPEAMHC-Q-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTM  571 (593)
Q Consensus       506 ~~~~~~-~~~~~~~~~~Gt~~y~aPE~~~~-~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~  571 (593)
                      ...... .......+.+||+.|||||++.+ . ++.++||||+||++|+.++...|+.+.....-++.+
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I  275 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI  275 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            543221 11122345689999999998754 3 588999999999999999998898876665444443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.86  E-value=1.8e-22  Score=226.00  Aligned_cols=126  Identities=22%  Similarity=0.275  Sum_probs=104.3

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-..  ++|+.++...  +.|++..+..|+.||+.||+|||+  ++||||||||+||||+.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~G--GdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~--~gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNG--GDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCS--CBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCC--CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHeEEeCCCCEEecccceeee
Confidence            456665432  4667666544  469999999999999999999999  6699999999999999999999999999986


Q ss_pred             cccCCccccccccccCCCCcccccccC-C-cCCcccceecchhhhhcccccCCCccchh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      ....     ...+.+||+.|||||++. + .|+.++||||+||+||+.+++..|+.+..
T Consensus       342 ~~~~-----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~  395 (689)
T 3v5w_A          342 FSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  395 (689)
T ss_dssp             CSSC-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred             cCCC-----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            5332     134568999999999985 3 47899999999999999999999997643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.86  E-value=1.9e-22  Score=212.72  Aligned_cols=128  Identities=22%  Similarity=0.277  Sum_probs=97.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCC-CceEEEecccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIV  504 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~-~~~kl~DfG~~  504 (593)
                      .++++++-+.  +.|+..+.     .+++.++..++.|++.||+|||+  ++|+||||||+|||++.+ +.+||+|||+|
T Consensus        95 ~~lvmE~~~g--~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           95 VVIAMPYLEH--ESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEEECCCC--CCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEeCCCc--ccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            3566666432  35555542     48999999999999999999999  569999999999999876 79999999999


Q ss_pred             eecccCCcc-------------------------ccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCC
Q psy9535         505 KMSETSNVK-------------------------TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNV  557 (593)
Q Consensus       505 ~~~~~~~~~-------------------------~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~  557 (593)
                      +........                         .......+||+.|||||++.+  .++.++||||+||++|+.+++..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            754322110                         011234579999999998754  36889999999999999888888


Q ss_pred             Cccch
Q psy9535         558 DIADR  562 (593)
Q Consensus       558 ~~~~~  562 (593)
                      |+...
T Consensus       246 Pf~~~  250 (361)
T 4f9c_A          246 PFYKA  250 (361)
T ss_dssp             SSSCC
T ss_pred             CCCCC
Confidence            88543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.84  E-value=4.5e-22  Score=222.15  Aligned_cols=152  Identities=19%  Similarity=0.231  Sum_probs=121.3

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCC--CceEEEecccc
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN--FVPKLGDFGIV  504 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~--~~~kl~DfG~~  504 (593)
                      .+++++-+.  +.|+.++.. ..+.|++.++..++.||+.||+|||+  ++|+||||||+|||++.+  +.+||+|||++
T Consensus       230 ~iv~E~~~g--g~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a  304 (573)
T 3uto_A          230 VMIYEFMSG--GELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLT  304 (573)
T ss_dssp             EEEEECCCC--CBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred             EEEEeecCC--CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEeeccce
Confidence            566665432  356666543 23579999999999999999999999  569999999999999854  89999999999


Q ss_pred             eecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeEEE
Q psy9535         505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVSI  583 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (593)
                      +......    .....+||+.|||||++.+. ++.++||||+||++|+.++...|+.+......++.+..+...+....|
T Consensus       305 ~~~~~~~----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  380 (573)
T 3uto_A          305 AHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF  380 (573)
T ss_dssp             EECCTTS----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGG
T ss_pred             eEccCCC----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccc
Confidence            8654322    12345799999999998654 788999999999999999999999988888778888887776666555


Q ss_pred             eecc
Q psy9535         584 SNHS  587 (593)
Q Consensus       584 ~~~~  587 (593)
                      +++|
T Consensus       381 ~~~s  384 (573)
T 3uto_A          381 SGIS  384 (573)
T ss_dssp             TTSC
T ss_pred             cCCC
Confidence            5554

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.81  E-value=1.6e-20  Score=197.58  Aligned_cols=133  Identities=16%  Similarity=0.097  Sum_probs=102.0

Q ss_pred             ceEeecCCchhhhhHHHHHh---hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC----------
Q psy9535         426 PVIILDTGETKQCQLFKLAR---VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE----------  492 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~---~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~----------  492 (593)
                      .++++++-+.  ++|..++.   ......+++..+..++.|++.||+|||+  ++|+||||||+|||++.          
T Consensus       142 ~~lv~e~~~~--g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          142 SVLVGELYSY--GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             EEEEECCCCS--CBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGGGTCC-----
T ss_pred             cEEEEeccCC--CcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEecccccCcccccc
Confidence            3567765432  34444443   2234679999999999999999999999  56999999999999988          


Q ss_pred             -CCceEEEecccceecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchh
Q psy9535         493 -NFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       493 -~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                       ++.+||+|||+++....... .......+||+.|||||++.+. ++.++|||||||++|+.++...|+....
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  289 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE  289 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred             ccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence             89999999999975432211 1123346799999999988654 7899999999999999887777665443

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=5.6e-20  Score=184.64  Aligned_cols=147  Identities=17%  Similarity=0.215  Sum_probs=104.2

Q ss_pred             CCCcccccCceEEEEEEE-cCCCE--EEEEEeecCCCCCCCCCch---------h--HHhhhcHHHHHHHHHHHhcCCCC
Q psy9535         113 RGNKLGEGQFGTVYYGKL-KNGME--IAVKTLENNANYSSSNSDN---------T--EAAMIPILLFENEVQTLSQCKHV  178 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~-~~g~~--vAVK~l~~~~~~~~~~~~~---------~--~~~~~~~~~f~~Ev~il~~l~Hp  178 (593)
                      +.+.||+|+||.||+|+. .+|+.  ||||.++............         .  .........+.+|+.+|.+++|+
T Consensus        51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~  130 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA  130 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence            457899999999999998 67989  9999875431110000000         0  00001123578999999999887


Q ss_pred             ce--eeEEEEEecccceEEEEeccC-C----CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCeEecccCC
Q psy9535         179 NL--LRLLGLCNNIMNCIVYEYMCN-G----SLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH-SLSKPIIHRDVKS  250 (593)
Q Consensus       179 NI--v~l~g~~~~~~~~lV~Ey~~~-G----sL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~IiHrDLKp  250 (593)
                      |+  ...+++   ...+|||||+.+ |    +|.+....      .++.....++.|++.||.||| +  .+|+||||||
T Consensus       131 ~i~~p~~~~~---~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~--~givHrDlkp  199 (258)
T 1zth_A          131 GVSVPQPYTY---MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE--AELVHADLSE  199 (258)
T ss_dssp             TCCCCCEEEE---ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT--SCEECSSCST
T ss_pred             CCCCCeEEEc---CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCH
Confidence            64  344432   356899999953 5    66665432      234456789999999999999 7  5699999999


Q ss_pred             CCeeecCCCccEEeecccceec
Q psy9535         251 ANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       251 ~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      +|||++.  .++|+|||+|...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999998  9999999998754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.79  E-value=1.1e-19  Score=186.36  Aligned_cols=134  Identities=20%  Similarity=0.285  Sum_probs=106.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++..   +.+..++.......+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        95 ~lv~e~~~---~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  169 (308)
T 3g33_A           95 TLVFEHVD---QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARI  169 (308)
T ss_dssp             EEEEECCC---CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEEECTTSCEEECSCSCTTT
T ss_pred             EEEehhhh---cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEEeeCccccc
Confidence            45555543   366666666655669999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCccccccc-CCcCCcccceecchhhhhcccccCCCccchhhhchhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQ  569 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~-~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~  569 (593)
                      .....    ......||+.|+|||++ ...++.++|||||||++|+..+...|+.+..+...++
T Consensus       170 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  229 (308)
T 3g33_A          170 YSYQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG  229 (308)
T ss_dssp             STTCC----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH
T ss_pred             cCCCc----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            43221    12345789999999987 4457889999999999999888888876655544333

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.79  E-value=3.7e-20  Score=194.57  Aligned_cols=142  Identities=23%  Similarity=0.300  Sum_probs=106.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ..|+.++...  +.+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        99 ~~lv~E~~~g--g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~g~ikL~DFG~a~  172 (353)
T 3txo_A           99 LFFVMEFVNG--GDLMFHIQKS--RRFDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCK  172 (353)
T ss_dssp             EEEEEECCCS--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCC--CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEECCCCCEEEcccccee
Confidence            3566665432  3555555443  469999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHH  576 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  576 (593)
                      ......   ......+||+.|+|||++.+ .++.++|||||||++|+.++...|+.+.....-++.++.+..
T Consensus       173 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~  241 (353)
T 3txo_A          173 EGICNG---VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV  241 (353)
T ss_dssp             CSCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             ecccCC---ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence            532211   12344679999999998754 478899999999999998888888877766655555555443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.79  E-value=1.2e-19  Score=189.46  Aligned_cols=140  Identities=19%  Similarity=0.324  Sum_probs=107.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  +.|+..+...  +.+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        80 ~~lv~E~~~g--g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~a~  153 (337)
T 1o6l_A           80 LCFVMEYANG--GELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             EEEEEECCTT--CBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCC--CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEECCCCCEEEeeccchh
Confidence            3566665433  3455554433  468999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ......   ......+||+.|+|||++.+ .++.++|||||||++|+.++...|+.+......++.++.+
T Consensus       154 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~  220 (337)
T 1o6l_A          154 EGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME  220 (337)
T ss_dssp             CSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             hcccCC---CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            532211   12334679999999998855 4788999999999999988888888766554444444433

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.79  E-value=9.9e-20  Score=191.38  Aligned_cols=141  Identities=21%  Similarity=0.290  Sum_probs=109.0

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|..++...  +.+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~E~~~g--g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A           96 LYFVMEYVNG--GDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             EEEEEECCCS--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCC--CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence            3566665432  3555555443  369999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      ......   ......+||+.|+|||++.+ .++.++|||||||++|+.++...|+.+.....-++.++.+.
T Consensus       170 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~  237 (353)
T 2i0e_A          170 ENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN  237 (353)
T ss_dssp             CCCCTT---CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             ccccCC---cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC
Confidence            532211   12345689999999998754 47889999999999999888888887766555555554443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.78  E-value=9.7e-20  Score=196.82  Aligned_cols=138  Identities=19%  Similarity=0.225  Sum_probs=106.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  +.|+.++... .+.+++..+..++.|++.||+|||+  .+|+||||||+||||+.++.+||+|||+++.
T Consensus       150 ~lV~Ey~~g--g~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          150 YLVMDYYVG--GDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLK  224 (437)
T ss_dssp             EEEECCCTT--CBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCC--CcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence            456655322  4566665542 3569999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccC------CcCCcccceecchhhhhcccccCCCccchhhhchhhhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTM  571 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~------~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~  571 (593)
                      ......  ......+||+.|||||++.      ..++.++|||||||++|+.++...|+.+......++.+
T Consensus       225 ~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i  293 (437)
T 4aw2_A          225 LMEDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  293 (437)
T ss_dssp             CCTTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             cccCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence            433221  1223457999999999874      34788999999999999988888888765544333333

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.78  E-value=9.8e-20  Score=191.66  Aligned_cols=130  Identities=20%  Similarity=0.248  Sum_probs=102.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec--CCCceEEEeccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGDFGI  503 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~--~~~~~kl~DfG~  503 (593)
                      .++++++.   .+.|..++.. ...++++..++.++.|++.||+|||+  ++|+||||||+|||++  .++.+||+|||+
T Consensus       127 ~~lv~e~~---g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~--~~iiHrDlkp~Nill~~~~~~~~kl~DFG~  200 (364)
T 3op5_A          127 RFMIMDRF---GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLLLNYKNPDQVYLVDYGL  200 (364)
T ss_dssp             EEEEEECE---EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEESSCTTCEEECCCTT
T ss_pred             EEEEEeCC---CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeEEecCCHHHEEEecCCCCeEEEEECCc
Confidence            45666654   3456555544 33579999999999999999999999  5699999999999998  889999999999


Q ss_pred             ceecccCCccc----cccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccc
Q psy9535         504 VKMSETSNVKT----MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       504 ~~~~~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      ++.........    .......||+.|||||++.+. ++.++|||||||++|+..+...|+.+
T Consensus       201 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          201 AYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             CEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             ceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            97643221111    111234699999999987654 78899999999999998888888875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.78  E-value=7.1e-20  Score=195.68  Aligned_cols=130  Identities=25%  Similarity=0.352  Sum_probs=96.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC---CCceEEEecc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFG  502 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~---~~~~kl~DfG  502 (593)
                      .++++++-+.  +.|+.++...+...+++..+..++.|++.||+|||+  .+|+||||||+|||++.   ++.+||+|||
T Consensus       134 ~~lv~E~~~g--g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          134 LLIVMECLDG--GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEEECCCS--EEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEeCCC--CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccEEEEecc
Confidence            3566665332  366666665545579999999999999999999999  56999999999999987   7899999999


Q ss_pred             cceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchh
Q psy9535         503 IVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      +++......    .....+||+.|+|||++.+ .++.++|||||||++|+.++...|+.+..
T Consensus       210 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  267 (400)
T 1nxk_A          210 FAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_dssp             TCEECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred             cccccCCCC----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            988543221    1234578999999998854 57889999999999999888888876543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.78  E-value=1.8e-19  Score=205.05  Aligned_cols=143  Identities=21%  Similarity=0.278  Sum_probs=113.8

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  ..|+.++...  +.+++..+..|+.||+.||+|||+  ++|+||||||+||||+.++.+||+|||+++.
T Consensus       418 ~lV~E~~~g--g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          418 YFVMEYVNG--GDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEEECCCS--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEEeCcCC--CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            355554332  3566665543  469999999999999999999999  5699999999999999999999999999985


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG  578 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  578 (593)
                      .....   ......+||+.|||||++.+ .++.++|||||||+||+.++...|+.+..+..-++.++.+...+
T Consensus       492 ~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  561 (674)
T 3pfq_A          492 NIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY  561 (674)
T ss_dssp             CCCTT---CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC
T ss_pred             cccCC---cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            33221   12345689999999998854 57899999999999999999999998877777777777665443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.78  E-value=1.7e-19  Score=185.65  Aligned_cols=127  Identities=27%  Similarity=0.270  Sum_probs=98.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      .++++++..   ..+...+... ..++++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus       132 ~~lv~e~~~---~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~DFG~a~  205 (311)
T 3p1a_A          132 LYLQTELCG---PSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLV  205 (311)
T ss_dssp             EEEEEECCC---CBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred             EEEEEeccC---CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEccceeee
Confidence            456666542   3455444433 3469999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCCcCCcccceecchhhhhcccccCCCccch
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      ......    ......||+.|+|||++.+.++.++|||||||++|+..+...+..+.
T Consensus       206 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~  258 (311)
T 3p1a_A          206 ELGTAG----AGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGG  258 (311)
T ss_dssp             ECC----------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred             ecccCC----CCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            543321    12335699999999998888899999999999999876664444433

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.78  E-value=1.2e-19  Score=196.48  Aligned_cols=152  Identities=19%  Similarity=0.230  Sum_probs=118.7

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec---CCCceEEEeccc
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGI  503 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~---~~~~~kl~DfG~  503 (593)
                      .+++++-+.  ..|+..+...  +.+++..+..++.|++.||+|||+  ++|+||||||+|||++   .++.+||+|||+
T Consensus        86 ~lv~E~~~g--g~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           86 YLIFDLVTG--GELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             EEEECCCBC--CBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             EEEEEeCCC--CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            455554332  3555555443  469999999999999999999999  5699999999999998   467899999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeEE
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVS  582 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (593)
                      ++.......   ......||+.|+|||++.+ .++.++|||||||++|+.++...|+.+......++.+..|..++....
T Consensus       160 a~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  236 (444)
T 3soa_A          160 AIEVEGEQQ---AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE  236 (444)
T ss_dssp             CBCCCTTCC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             eEEecCCCc---eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc
Confidence            875433211   1234579999999999865 478899999999999999999999988887777787777777766555


Q ss_pred             Eeecc
Q psy9535         583 ISNHS  587 (593)
Q Consensus       583 ~~~~~  587 (593)
                      |++.|
T Consensus       237 ~~~~s  241 (444)
T 3soa_A          237 WDTVT  241 (444)
T ss_dssp             TTTSC
T ss_pred             cccCC
Confidence            55444

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.78  E-value=6.1e-20  Score=190.19  Aligned_cols=153  Identities=20%  Similarity=0.255  Sum_probs=119.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC--CCceEEEeccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--NFVPKLGDFGI  503 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~--~~~~kl~DfG~  503 (593)
                      ..+++++.+.  ..|+..+... ..++++..+..++.|++.||+|||+  ++|+||||||+|||++.  ++.+||+|||+
T Consensus        76 ~~lv~e~~~g--~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~  150 (321)
T 1tki_A           76 LVMIFEFISG--LDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             EEEEECCCCC--CBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             EEEEEEeCCC--CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence            3456655332  3566655432 3469999999999999999999999  56999999999999987  78999999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeEE
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVS  582 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (593)
                      ++......    ......||+.|+|||++.+. ++.++|||||||++|+..+...|+.+......++.+..+...++...
T Consensus       151 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  226 (321)
T 1tki_A          151 ARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA  226 (321)
T ss_dssp             CEECCTTC----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             CeECCCCC----ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh
Confidence            87654321    12235689999999988665 68899999999999999999999988777777777777777666555


Q ss_pred             Eeecc
Q psy9535         583 ISNHS  587 (593)
Q Consensus       583 ~~~~~  587 (593)
                      |+++|
T Consensus       227 ~~~~s  231 (321)
T 1tki_A          227 FKEIS  231 (321)
T ss_dssp             HTTSC
T ss_pred             hccCC
Confidence            55544

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.78  E-value=4.4e-20  Score=197.96  Aligned_cols=139  Identities=22%  Similarity=0.272  Sum_probs=107.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|+.++..   ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       144 ~~lV~E~~~g--g~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          144 LYMVMEYMPG--GDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EEEEECCCTT--EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEeCCCC--CcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            3466665432  455555543   358999999999999999999999  569999999999999999999999999997


Q ss_pred             ecccCCccccccccccCCCCcccccccCCc-----CCcccceecchhhhhcccccCCCccchhhhchhhhhcC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLP  573 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-----~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~  573 (593)
                      ......  .......+||+.|+|||++.+.     ++.++|||||||++|+.++...|+.+......++.++.
T Consensus       217 ~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~  287 (410)
T 3v8s_A          217 KMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN  287 (410)
T ss_dssp             ECCTTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             eeccCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHh
Confidence            644322  1123356899999999987432     57899999999999999988888877665544444443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.78  E-value=1.5e-19  Score=191.87  Aligned_cols=136  Identities=22%  Similarity=0.339  Sum_probs=102.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.   .+...+..   ..+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~~---~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYMET---DLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCSE---EHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccCc---CHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            3566766553   45555543   368999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCc------------------cccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         506 MSETSNV------------------KTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       506 ~~~~~~~------------------~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      .......                  ........+||++|+|||++.+  .++.++|||||||++|+.++...|+.+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            5422100                  0111233579999999998754  4788999999999999988888777665544


Q ss_pred             chhh
Q psy9535         566 YSLQ  569 (593)
Q Consensus       566 ~~~~  569 (593)
                      ..++
T Consensus       238 ~~~~  241 (388)
T 3oz6_A          238 NQLE  241 (388)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            3333

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.78  E-value=1.4e-19  Score=194.26  Aligned_cols=138  Identities=17%  Similarity=0.199  Sum_probs=106.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|+.++...+ ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       136 ~~lVmE~~~g--g~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILld~~g~vkL~DFGla~  210 (412)
T 2vd5_A          136 LYLVMEYYVG--GDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGHIRLADFGSCL  210 (412)
T ss_dssp             EEEEECCCCS--CBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEcCCCC--CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeeecCCCCEEEeechhhe
Confidence            3566665322  35565554432 369999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccC--------CcCCcccceecchhhhhcccccCCCccchhhhchhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH--------CQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQT  570 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~--------~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~  570 (593)
                      .......  ......+||+.|+|||++.        ..++.++|||||||++|+.++...|+.+......++.
T Consensus       211 ~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~  281 (412)
T 2vd5_A          211 KLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK  281 (412)
T ss_dssp             ECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             eccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            6433221  1123457999999999874        2478899999999999999888888876654433333

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.77  E-value=1.5e-19  Score=189.48  Aligned_cols=139  Identities=22%  Similarity=0.324  Sum_probs=107.2

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  +.|+.++...  +.+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~g--g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNG--GDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTT--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCC--CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            466665332  3555555443  468999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~  574 (593)
                      .....   ......+||+.|+|||++.+ .++.++|||||||++|+..++..|+.+......++.+..+
T Consensus       168 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~  233 (345)
T 1xjd_A          168 NMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD  233 (345)
T ss_dssp             CCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             cccCC---CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence            32211   12345689999999998755 4788999999999999988888888766554444444333

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.77  E-value=2e-19  Score=190.48  Aligned_cols=141  Identities=27%  Similarity=0.300  Sum_probs=109.0

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|+.++...  ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       114 ~~lv~E~~~g--g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~ikL~DFG~a~  187 (373)
T 2r5t_A          114 LYFVLDYING--GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCK  187 (373)
T ss_dssp             EEEEEECCCS--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred             EEEEEeCCCC--CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence            3566665432  3455555443  468999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      ......   ......+||+.|+|||++.+ .++.++|||||||++|+.++...|+.+......++.++.+.
T Consensus       188 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~  255 (373)
T 2r5t_A          188 ENIEHN---STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP  255 (373)
T ss_dssp             GGBCCC---CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC
T ss_pred             ccccCC---CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc
Confidence            532211   12345689999999998765 47889999999999999888888887766655555555443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.77  E-value=2.6e-19  Score=187.68  Aligned_cols=129  Identities=22%  Similarity=0.351  Sum_probs=104.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC-------------
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-------------  492 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~-------------  492 (593)
                      .++++++.   .+.|..++.......+++..+..++.|++.||+|||+  ++|+||||||+|||++.             
T Consensus       111 ~~lv~e~~---~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          111 MCLIFEPL---GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             EEEEECCC---CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             eEEEEcCC---CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCcccEEEccccccccccchhcc
Confidence            45666653   4566777666666679999999999999999999999  56999999999999975             


Q ss_pred             ------------CCceEEEecccceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCc
Q psy9535         493 ------------NFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDI  559 (593)
Q Consensus       493 ------------~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~  559 (593)
                                  ++.+||+|||+++.....      .....||+.|+|||++.+ .++.++|||||||++|+..+...|+
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence                        789999999998754321      123578999999998754 5789999999999999988888887


Q ss_pred             cchhhh
Q psy9535         560 ADRERY  565 (593)
Q Consensus       560 ~~~~~~  565 (593)
                      ...+..
T Consensus       260 ~~~~~~  265 (360)
T 3llt_A          260 RTHEHM  265 (360)
T ss_dssp             CCSSHH
T ss_pred             CCCcHH
Confidence            665544

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.77  E-value=2.2e-19  Score=185.88  Aligned_cols=136  Identities=32%  Similarity=0.413  Sum_probs=107.1

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  +.|..++...  ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~lv~e~~~g--g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~  155 (318)
T 1fot_A           82 FMIMDYIEG--GELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKY  155 (318)
T ss_dssp             EEEECCCCS--CBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCC--CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChheEEEcCCCCEEEeecCccee
Confidence            456655332  3555555443  468999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ....      ....+||+.|+|||++.+ .++.++|||||||++|+..+...|+.+......++.++.+
T Consensus       156 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  218 (318)
T 1fot_A          156 VPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA  218 (318)
T ss_dssp             CSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC
T ss_pred             cCCc------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            4321      234579999999998755 4788999999999999988888888766555445544444

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.77  E-value=1e-19  Score=191.83  Aligned_cols=152  Identities=23%  Similarity=0.301  Sum_probs=119.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC----ceEEEec
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLGDF  501 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~----~~kl~Df  501 (593)
                      ..+++++.+.  +.|+.++..  .+++++..+..++.|++.||+|||+  .+|+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~g--g~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSG--GELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCS--CBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCC--CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            3456655322  456665543  3579999999999999999999999  5699999999999998776    7999999


Q ss_pred             ccceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCe
Q psy9535         502 GIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDH  580 (593)
Q Consensus       502 G~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (593)
                      |+++......    .....+||+.|+|||++.+ .++.++|||||||++|+.++...|+.+......++.+..+..+++.
T Consensus       164 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~  239 (361)
T 2yab_A          164 GLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE  239 (361)
T ss_dssp             SSCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             CCceEcCCCC----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            9987644321    1234579999999998865 5788999999999999999999999888777778888888777765


Q ss_pred             EEEeecc
Q psy9535         581 VSISNHS  587 (593)
Q Consensus       581 ~~~~~~~  587 (593)
                      ..|++.|
T Consensus       240 ~~~~~~s  246 (361)
T 2yab_A          240 EFFSQTS  246 (361)
T ss_dssp             HHHTTSC
T ss_pred             hhccCCC
Confidence            5555444

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.77  E-value=1.5e-19  Score=194.02  Aligned_cols=119  Identities=19%  Similarity=0.250  Sum_probs=98.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCccc
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMP  528 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~a  528 (593)
                      ..++++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.....      ....+| +.|||
T Consensus       205 ~~~l~~~~~~~i~~qi~~aL~~LH~--~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~a  275 (413)
T 3dzo_A          205 HKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAP  275 (413)
T ss_dssp             SHHHHHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeC
Confidence            4568889999999999999999998  56999999999999999999999999998754321      234568 99999


Q ss_pred             cccc----------CC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCC
Q psy9535         529 PEAM----------HC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHH  576 (593)
Q Consensus       529 PE~~----------~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  576 (593)
                      ||++          .. .++.++|||||||++|+..+...|+.+.......+..+++..
T Consensus       276 PE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~  334 (413)
T 3dzo_A          276 PETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCK  334 (413)
T ss_dssp             HHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSSCC
T ss_pred             chhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhhcc
Confidence            9987          32 257799999999999998888888887776666666666543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.77  E-value=3.1e-19  Score=193.72  Aligned_cols=141  Identities=22%  Similarity=0.303  Sum_probs=97.1

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+   +.+..++..  ...+++..+..++.||+.||+|||+  .+|+||||||+||||+.++.+||+|||+++.
T Consensus       133 ~lv~e~~~---~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~--~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          133 YVVLEIAD---SDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEECCCS---EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEeccc---cchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            45665543   455555543  3579999999999999999999999  5699999999999999999999999999976


Q ss_pred             cccCCcc------------------------ccccccccCCCCccccccc-C-CcCCcccceecchhhhhcccccCCCcc
Q psy9535         507 SETSNVK------------------------TMYTENLTGTRPYMPPEAM-H-CQISTKTDVFSYGAQIKTQHITNVDIA  560 (593)
Q Consensus       507 ~~~~~~~------------------------~~~~~~~~Gt~~y~aPE~~-~-~~~~~ksDvwS~G~~i~~~~~~~~~~~  560 (593)
                      .......                        .......+||++|+|||++ . ..++.++|||||||++|+.++...+..
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            4321110                        0012345789999999975 3 347889999999999998665333222


Q ss_pred             chhhhchhhhhcCCCC
Q psy9535         561 DRERYYSLQTMLPGHH  576 (593)
Q Consensus       561 ~~~~~~~~~~~~~~~~  576 (593)
                      ..  ...-.++|||..
T Consensus       286 ~~--~~~~~p~f~g~~  299 (458)
T 3rp9_A          286 AY--HADRGPLFPGSS  299 (458)
T ss_dssp             SS--GGGCCCSCC---
T ss_pred             cc--cccccccCCCCc
Confidence            11  122345666654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.77  E-value=2.9e-19  Score=187.59  Aligned_cols=138  Identities=20%  Similarity=0.267  Sum_probs=108.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  +.|+.++...  +.+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       116 ~~lv~e~~~g--g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          116 LYMVMEYVAG--GEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EEEEEECCTT--CBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEcCCCC--CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEECCCCCEEEcccccce
Confidence            3566665432  3555555543  369999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      .....      ....+||+.|+|||++.+ .++.++|||||||++|+..+...|+.+......++.+..|.
T Consensus       190 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  254 (350)
T 1rdq_E          190 RVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK  254 (350)
T ss_dssp             ECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             eccCC------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence            54321      224579999999998755 47889999999999999888888887766555555555443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.77  E-value=2.7e-19  Score=192.87  Aligned_cols=129  Identities=20%  Similarity=0.242  Sum_probs=104.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCc--eEEEeccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV--PKLGDFGI  503 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~--~kl~DfG~  503 (593)
                      .++++++..   +.++.++.......+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.  +||+|||+
T Consensus       174 ~~lv~e~~~---~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          174 ICMTFELLS---MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEECCCC---CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--HTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEeccC---CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            456666543   467777666666679999999999999999999998  56999999999999999887  99999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ++.....      ....+||+.|+|||++.+ .++.++|||||||++|+..+...|+.+..+.
T Consensus       249 a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  305 (429)
T 3kvw_A          249 SCYEHQR------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG  305 (429)
T ss_dssp             CEETTCC------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ceecCCc------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            8753321      223578999999998744 5889999999999999988887777665543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.77  E-value=5.6e-19  Score=186.62  Aligned_cols=122  Identities=25%  Similarity=0.309  Sum_probs=94.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP  529 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aP  529 (593)
                      ..+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++....... ........||+.|+||
T Consensus       198 ~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aP  274 (370)
T 2psq_A          198 EQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAP  274 (370)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCT-TCTTTTTTSCGGGCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchhhEEECCCCCEEEccccCCcccCcccc-eecccCCCcccceECH
Confidence            458999999999999999999999  5699999999999999999999999999875433211 1112334578899999


Q ss_pred             cccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         530 EAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       530 E~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      |++.+ .++.++|||||||++|+..+ ...|+.+.....-++.+..|
T Consensus       275 E~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~  321 (370)
T 2psq_A          275 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG  321 (370)
T ss_dssp             HHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred             hHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence            98744 57889999999999998776 66776654433333444444

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.77  E-value=2.3e-19  Score=191.39  Aligned_cols=126  Identities=24%  Similarity=0.301  Sum_probs=100.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|+..+...  +.+++..+..++.|++.||+|||+  ++|+||||||+||||+.++.+||+|||+++
T Consensus       128 ~~lV~E~~~g--g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          128 LFFVIEYVNG--GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             EEEEEECCTT--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEEcCCC--CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEECCCCCEEEeecceee
Confidence            3566665432  3455555443  469999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCcc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIA  560 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~  560 (593)
                      ......   ......+||+.|+|||++.+ .++.++|||||||++|+.++...|+.
T Consensus       202 ~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~  254 (396)
T 4dc2_A          202 EGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  254 (396)
T ss_dssp             CCCCTT---CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred             ecccCC---CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence            532211   12345689999999998865 47889999999999999888888874

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.76  E-value=5.3e-19  Score=187.38  Aligned_cols=131  Identities=22%  Similarity=0.264  Sum_probs=104.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec--CCCceEEEeccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGDFGI  503 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~--~~~~~kl~DfG~  503 (593)
                      .++++++..   +.|..++.......+++..+..++.|++.||+|||+...+|+||||||+|||++  .++.+||+|||+
T Consensus       131 ~~lv~e~~~---~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          131 LCLVFEMLS---YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEECCC---CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEecCC---CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            456666543   466776666555679999999999999999999995446799999999999994  478899999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ++.....      .....||+.|+|||++.+ .++.++|||||||++|+..+...|+.+....
T Consensus       208 a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~  264 (382)
T 2vx3_A          208 SCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV  264 (382)
T ss_dssp             CEETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ceecccc------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            8764321      123578999999998755 5789999999999999988888888765443

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.76  E-value=4.5e-19  Score=196.33  Aligned_cols=131  Identities=20%  Similarity=0.289  Sum_probs=103.7

Q ss_pred             ceEeecCCchhhhhHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  503 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~  503 (593)
                      ..+++++-+.  +.|..++....  ...+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       260 l~lVmE~~~g--g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl~~~g~vkL~DFGl  335 (543)
T 3c4z_A          260 LCLVMTIMNG--GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGL  335 (543)
T ss_dssp             EEEEECCCTT--CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEeccC--CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEEeCCCCEEEeecce
Confidence            3466665432  34555544332  4579999999999999999999999  5699999999999999999999999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchh
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      ++......   ......+||+.|+|||++.+ .++.++|||||||++|+.++...|+....
T Consensus       336 a~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~  393 (543)
T 3c4z_A          336 AVELKAGQ---TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG  393 (543)
T ss_dssp             CEECCTTC---CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred             eeeccCCC---cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence            97643321   11234589999999998865 47889999999999999888888887653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.76  E-value=1.4e-19  Score=191.46  Aligned_cols=136  Identities=16%  Similarity=0.184  Sum_probs=99.2

Q ss_pred             eEeecCCchhhhhHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEec
Q psy9535         427 VIILDTGETKQCQLFKLARVNN-----TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  501 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~Df  501 (593)
                      .+++++..   +.|..++...+     ..++++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+||
T Consensus       176 ~lv~E~~~---g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DF  250 (377)
T 3byv_A          176 FFLYPRMQ---SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGVFLTGF  250 (377)
T ss_dssp             EEEEECCS---EEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCG
T ss_pred             EEEEeccC---CCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEec
Confidence            45665543   35555544321     1234458888999999999999999  56999999999999999999999999


Q ss_pred             ccceecccCCccccccccccCCCCcccccccCC------------cCCcccceecchhhhhcccccCCCccchhhhchhh
Q psy9535         502 GIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC------------QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQ  569 (593)
Q Consensus       502 G~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~------------~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~  569 (593)
                      |+++....      .....+| +.|+|||++.+            .++.++|||||||++|+..+...|+.+......++
T Consensus       251 G~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~  323 (377)
T 3byv_A          251 EHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE  323 (377)
T ss_dssp             GGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG
T ss_pred             hhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh
Confidence            99885322      1234568 99999998754            47889999999999999888888887766655555


Q ss_pred             hhcCC
Q psy9535         570 TMLPG  574 (593)
Q Consensus       570 ~~~~~  574 (593)
                      .++++
T Consensus       324 ~~~~~  328 (377)
T 3byv_A          324 WIFRS  328 (377)
T ss_dssp             GGGSS
T ss_pred             hhhhh
Confidence            55554

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.76  E-value=5.5e-19  Score=184.45  Aligned_cols=130  Identities=23%  Similarity=0.414  Sum_probs=103.0

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.   .+.++.++...  +.+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        84 ~~lv~E~~---~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           84 IVMVIEYA---GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSN  156 (336)
T ss_dssp             EEEEECCC---CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred             EEEEEECC---CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCchhhEEEcCCCCEEEEEeccce
Confidence            35666654   34566655443  469999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCCc-C-CcccceecchhhhhcccccCCCccchhhhc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGAQIKTQHITNVDIADRERYY  566 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~-~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~  566 (593)
                      ......    .....+||+.|+|||++.+. + +.++|||||||++|+.++...|+.+.....
T Consensus       157 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~  215 (336)
T 3h4j_B          157 IMTDGN----FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN  215 (336)
T ss_dssp             TTTTSB----TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT
T ss_pred             eccCCc----ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH
Confidence            543221    12345799999999998664 3 678999999999999888888887654433

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.76  E-value=3e-19  Score=187.21  Aligned_cols=125  Identities=24%  Similarity=0.303  Sum_probs=97.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC---ceEEEecccceecccCCccccccccccCCCC
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFGIVKMSETSNVKTMYTENLTGTRP  525 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~---~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~  525 (593)
                      ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.++   .+||+|||+++......   ......+||+.
T Consensus       124 ~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~gt~~  198 (351)
T 3c0i_A          124 GFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG---LVAGGRVGTPH  198 (351)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS---CBCCCCCSCGG
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC---eeecCCcCCcC
Confidence            4568999999999999999999999  5699999999999997654   49999999987654321   11234579999


Q ss_pred             cccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCC
Q psy9535         526 YMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGD  579 (593)
Q Consensus       526 y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (593)
                      |+|||++.+ .++.++|||||||++|+.++...|+.+..+ ..++.+..|.....
T Consensus       199 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~~  252 (351)
T 3c0i_A          199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMN  252 (351)
T ss_dssp             GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCCC
T ss_pred             ccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCCC
Confidence            999998855 478899999999999998888888876433 23444444544443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.76  E-value=4.5e-19  Score=183.84  Aligned_cols=129  Identities=22%  Similarity=0.237  Sum_probs=100.1

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCc-----eEEEec
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-----PKLGDF  501 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~-----~kl~Df  501 (593)
                      .+++++.   .+.|..++... ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.     +||+||
T Consensus        81 ~lv~e~~---~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill~~~~~~~~~~~kl~DF  154 (330)
T 2izr_A           81 AMVLELL---GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHIIDF  154 (330)
T ss_dssp             EEEEECC---CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred             EEEEEeC---CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence            4666554   24455554433 3579999999999999999999999  56999999999999998887     999999


Q ss_pred             ccceecccCCccc----cccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccc
Q psy9535         502 GIVKMSETSNVKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       502 G~~~~~~~~~~~~----~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      |+++.........    .......||+.|+|||++.+ .++.++||||||+++|+..+...|+.+
T Consensus       155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~  219 (330)
T 2izr_A          155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG  219 (330)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccc
Confidence            9998643322111    01234679999999998765 478899999999999998887777765

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.76  E-value=2.4e-19  Score=189.02  Aligned_cols=150  Identities=20%  Similarity=0.276  Sum_probs=113.9

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCC---CceEEEeccc
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGI  503 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~---~~~kl~DfG~  503 (593)
                      .+++++-+.  ..|+..+..  ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.+   +.+||+|||+
T Consensus       104 ~lv~e~~~g--g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          104 YLVFDLVTG--GELFEDIVA--REFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EEEECCCCS--CBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEecCCC--CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            456655332  355555443  3579999999999999999999999  569999999999999764   4599999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeEE
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVS  582 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (593)
                      ++......    ......||+.|+|||++.+ .++.++|||||||++|+.++...|+.+......++.+..|..++....
T Consensus       178 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  253 (362)
T 2bdw_A          178 AIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE  253 (362)
T ss_dssp             CBCCTTCC----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG
T ss_pred             ceEecCCc----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence            87543221    1234579999999998865 578899999999999999999999888776666666666665555444


Q ss_pred             Eeec
Q psy9535         583 ISNH  586 (593)
Q Consensus       583 ~~~~  586 (593)
                      |+++
T Consensus       254 ~~~~  257 (362)
T 2bdw_A          254 WDTV  257 (362)
T ss_dssp             GGGS
T ss_pred             ccCC
Confidence            4443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.76  E-value=3.6e-19  Score=186.37  Aligned_cols=127  Identities=24%  Similarity=0.288  Sum_probs=100.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|..++...  +.+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        85 ~~lv~e~~~g--g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFG~a~  158 (345)
T 3a8x_A           85 LFFVIEYVNG--GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  158 (345)
T ss_dssp             EEEEECCCCS--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred             EEEEEeCCCC--CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEEeccccc
Confidence            3566665432  3455554433  469999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      ......   ......+||+.|+|||++.+ .++.++|||||||++|+.++...|+..
T Consensus       159 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          159 EGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             CSCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccCCC---CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            532211   12344689999999998765 478899999999999998888777743

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.76  E-value=3.3e-19  Score=190.39  Aligned_cols=135  Identities=21%  Similarity=0.309  Sum_probs=93.2

Q ss_pred             ceEeecCCchhhhhHHHHHhh----cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEee----cCCCceE
Q psy9535         426 PVIILDTGETKQCQLFKLARV----NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPK  497 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~----~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl----~~~~~~k  497 (593)
                      .++++++.+.....+......    ....++++..+..++.|++.||+|||+  .+|+||||||+|||+    +.++.+|
T Consensus        95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            356666655433333322221    122359999999999999999999999  569999999999999    6778999


Q ss_pred             EEecccceecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccch
Q psy9535         498 LGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       498 l~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      |+|||+++...............+||+.|+|||++.+  .++.++|||||||++|+.++...|+...
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            9999998764332111122234679999999998754  3788999999999999988877777544

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.76  E-value=6.6e-19  Score=189.31  Aligned_cols=131  Identities=24%  Similarity=0.273  Sum_probs=99.3

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCC-CceEEEecccce
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVK  505 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~-~~~kl~DfG~~~  505 (593)
                      .+++++.+.....+..... .....+++..+..++.|++.||+|||+  .+|+||||||+|||++.+ +.+||+|||+++
T Consensus       129 ~lv~e~~~~~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          129 NLVLDYVPETVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEECCCEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EeehhcccccHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            4566665433222222211 234579999999999999999999998  569999999999999955 678999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      .......    .....||+.|+|||++.+  .++.++|||||||++|+.++...|+.+...
T Consensus       206 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~  262 (420)
T 1j1b_A          206 QLVRGEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG  262 (420)
T ss_dssp             ECCTTCC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             hcccCCC----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            6432211    123578999999998754  478899999999999998888888766543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.76  E-value=7.4e-19  Score=180.94  Aligned_cols=132  Identities=20%  Similarity=0.218  Sum_probs=102.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.   .+...+... ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        94 ~~lv~e~~~~---~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           94 LTLVFEFMEK---DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             EEEEEECCSE---EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCC---CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEECCCCCEEEccCcCce
Confidence            4567766543   455544433 3569999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhhc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERYY  566 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~  566 (593)
                      .......   ......||+.|+|||++.+  .++.++|||||||++|+..+...|+.+.....
T Consensus       168 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  227 (311)
T 3niz_A          168 AFGIPVR---SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD  227 (311)
T ss_dssp             ETTSCCC------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT
T ss_pred             ecCCCcc---cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH
Confidence            6432211   1223568999999998754  46889999999999999888777776554443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.76  E-value=8.7e-19  Score=180.83  Aligned_cols=132  Identities=20%  Similarity=0.258  Sum_probs=101.7

Q ss_pred             ceEeecCCchhhhhHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEec
Q psy9535         426 PVIILDTGETKQCQLFKLARVN----NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  501 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~----~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~Df  501 (593)
                      ..+++++.+.   .|..++...    ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+||
T Consensus        78 ~~lv~e~~~~---~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Df  152 (317)
T 2pmi_A           78 LTLVFEFMDN---DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDF  152 (317)
T ss_dssp             EEEEEECCCC---BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEEecCC---CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEECcC
Confidence            3566666553   444443221    23468999999999999999999999  56999999999999999999999999


Q ss_pred             ccceecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         502 GIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       502 G~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      |+++.......   ......||+.|+|||++.+  .++.++|||||||++|+..+...|+.+....
T Consensus       153 g~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  215 (317)
T 2pmi_A          153 GLARAFGIPVN---TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE  215 (317)
T ss_dssp             SSCEETTSCCC---CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccceecCCCcc---cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            99876432211   1223578999999998754  4688999999999999988888777655443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.76  E-value=5.1e-19  Score=196.66  Aligned_cols=130  Identities=19%  Similarity=0.244  Sum_probs=104.6

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|..++...+...+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       259 l~lVmEy~~g--g~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILld~~g~vKL~DFGla~  334 (576)
T 2acx_A          259 LCLVLTLMNG--GDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLGLAV  334 (576)
T ss_dssp             EEEEECCCCS--CBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEcCCC--CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEEeCCCCeEEEecccce
Confidence            3566665322  456666655555569999999999999999999999  569999999999999999999999999997


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      ......    .....+||+.|+|||++.+ .++.++|||||||++|+.++...|+....
T Consensus       335 ~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~  389 (576)
T 2acx_A          335 HVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  389 (576)
T ss_dssp             ECCTTC----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred             ecccCc----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            653321    1233579999999998865 47889999999999999888888887653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.76  E-value=1.4e-19  Score=183.85  Aligned_cols=131  Identities=22%  Similarity=0.278  Sum_probs=99.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.   .+..++... .+.+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~lv~e~~~~---~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  148 (288)
T 1ob3_A           75 LVLVFEHLDQ---DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLAR  148 (288)
T ss_dssp             EEEEEECCSE---EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred             EEEEEEecCC---CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEeECcccc
Confidence            4566665443   455554432 3569999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      .......   ......||+.|+|||++.+  .++.++|||||||++|+..+...|+.+....
T Consensus       149 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  207 (288)
T 1ob3_A          149 AFGIPVR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA  207 (288)
T ss_dssp             HHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccCcccc---ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            5432111   1123468999999998754  3788999999999999988888777665444

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.76  E-value=6.6e-19  Score=182.70  Aligned_cols=140  Identities=26%  Similarity=0.291  Sum_probs=104.7

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|+..+...  +.+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~--~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSG--GELFMQLERE--GIFMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTT--EEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCC--CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            4566665432  3555555433  468999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ......   ......+||+.|+|||++.+ .++.++||||||+++|+..+...|+.+......++.++.+
T Consensus       170 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  236 (327)
T 3a62_A          170 ESIHDG---TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC  236 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred             ccccCC---ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence            432211   12234579999999998754 4788999999999999988888888776655555555444

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.76  E-value=8.8e-19  Score=178.17  Aligned_cols=125  Identities=22%  Similarity=0.306  Sum_probs=97.6

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.   .+...... ..+++++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~lv~e~~~~---~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  149 (292)
T 3o0g_A           76 LTLVFEFCDQ---DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLAR  149 (292)
T ss_dssp             EEEEEECCSE---EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEecCCC---CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence            3566665543   34443333 23579999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-c-CCcccceecchhhhhcccccCCCc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-Q-ISTKTDVFSYGAQIKTQHITNVDI  559 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~-~~~ksDvwS~G~~i~~~~~~~~~~  559 (593)
                      ......   .......||+.|+|||++.+ . ++.++|||||||++|+..++..|.
T Consensus       150 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~  202 (292)
T 3o0g_A          150 AFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_dssp             ECCSCC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred             ecCCcc---ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence            643221   11234578999999998754 3 688999999999999887666664

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.75  E-value=8.6e-19  Score=186.00  Aligned_cols=144  Identities=18%  Similarity=0.194  Sum_probs=106.8

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+  .+.+..++.......+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||++..
T Consensus       102 ~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          102 WVVTSFMA--YGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEEECCT--TCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEccC--CCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            45665433  2455666655545679999999999999999999999  5699999999999999999999999998754


Q ss_pred             cccCCcc----ccccccccCCCCcccccccCC---cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCC
Q psy9535         507 SETSNVK----TMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       507 ~~~~~~~----~~~~~~~~Gt~~y~aPE~~~~---~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~  574 (593)
                      .......    ........||+.|+|||++.+   .++.++|||||||++|+..+...|+.+......+...+.|
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            3211110    111123478999999998754   4788999999999999988888888776555444444433

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.75  E-value=3.5e-19  Score=189.63  Aligned_cols=143  Identities=27%  Similarity=0.414  Sum_probs=103.6

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..++++++   ...|..++...  .++++..+..++.|++.||+|||+  .+|+||||||+|||++ ++.+||+|||+++
T Consensus       131 ~~lv~E~~---~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~-~~~~kl~DFG~a~  202 (390)
T 2zmd_A          131 IYMVMECG---NIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIAN  202 (390)
T ss_dssp             EEEEEECC---SEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred             EEEEEecC---CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence            34566543   34566665543  378999999999999999999998  5699999999999996 5789999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC------------cCCcccceecchhhhhcccccCCCccchhhh-chhhhhc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC------------QISTKTDVFSYGAQIKTQHITNVDIADRERY-YSLQTML  572 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~------------~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~-~~~~~~~  572 (593)
                      ....... .......+||+.|+|||++.+            .++.++|||||||++|+.++...|+.+..+. ..+..++
T Consensus       203 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~  281 (390)
T 2zmd_A          203 QMQPDTT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  281 (390)
T ss_dssp             CC----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred             cccCCCc-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence            5432211 111234579999999998743            4778999999999999988888888664332 3455555


Q ss_pred             CCCCC
Q psy9535         573 PGHHE  577 (593)
Q Consensus       573 ~~~~~  577 (593)
                      .+..+
T Consensus       282 ~~~~~  286 (390)
T 2zmd_A          282 DPNHE  286 (390)
T ss_dssp             CTTSC
T ss_pred             Ccccc
Confidence            54443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.75  E-value=2.4e-19  Score=189.10  Aligned_cols=125  Identities=13%  Similarity=0.095  Sum_probs=98.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEE
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKR------YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  499 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~------~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~  499 (593)
                      .++++++.+   ++|..++...+ ..+++..+      +.++.|++.||+|||+  ++|+||||||+|||++.++.+||+
T Consensus       163 ~~lv~e~~~---~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~  236 (371)
T 3q60_A          163 YLLLMPAAS---VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQS--KGLVHGHFTPDNLFIMPDGRLMLG  236 (371)
T ss_dssp             EEEEECCCS---EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH--TTEEETTCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCC---CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHH--CCCccCcCCHHHEEECCCCCEEEE
Confidence            457777655   45665554432 23566666      7888999999999998  569999999999999999999999


Q ss_pred             ecccceecccCCccccccccccCCCCcccccccCC---cCCcccceecchhhhhcccccCCCccch
Q psy9535         500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       500 DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      |||+++.....      .....||+.|+|||++.+   .++.++|||||||++|+..+...|+.+.
T Consensus       237 DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          237 DVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             CGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             ecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            99998854321      112456799999998864   4788999999999999988888777665

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.75  E-value=9.3e-19  Score=177.90  Aligned_cols=130  Identities=21%  Similarity=0.223  Sum_probs=100.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCc-----eEEEe
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-----PKLGD  500 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~-----~kl~D  500 (593)
                      .++++++.   .+.|..++... ..++++..+..++.|++.||+|||+  ++|+||||||+|||++.++.     +||+|
T Consensus        81 ~~lv~e~~---~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D  154 (298)
T 1csn_A           81 NVLVIDLL---GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVD  154 (298)
T ss_dssp             EEEEEECC---CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             eEEEEEec---CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence            34666554   34566655543 3469999999999999999999998  56999999999999987765     99999


Q ss_pred             cccceecccCCccc----cccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccc
Q psy9535         501 FGIVKMSETSNVKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       501 fG~~~~~~~~~~~~----~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      ||+++.........    .......||+.|+|||++.+ .++.++||||||+++|+..+...|+.+
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  220 (298)
T 1csn_A          155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG  220 (298)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcch
Confidence            99987654322110    11234579999999998755 478899999999999998877777755

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.75  E-value=3.1e-19  Score=185.58  Aligned_cols=139  Identities=23%  Similarity=0.385  Sum_probs=107.1

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.  ..++.++...  +++++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~~--~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  163 (328)
T 3fe3_A           90 YLIMEYASG--GEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGFSNE  163 (328)
T ss_dssp             EEEECCCTT--CBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred             EEEEECCCC--CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence            456655332  3555555443  469999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCCc-C-CcccceecchhhhhcccccCCCccchhhhchhhhhcCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~-~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      .....    .....+||+.|+|||++.+. + +.++|||||||++|+.++...|+.+.....-.+.++.|.
T Consensus       164 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  230 (328)
T 3fe3_A          164 FTVGG----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK  230 (328)
T ss_dssp             GSSSC----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             cCCCC----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            43221    22346799999999987544 4 468999999999999888888887765554455555443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.75  E-value=8.5e-19  Score=178.92  Aligned_cols=131  Identities=23%  Similarity=0.348  Sum_probs=97.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ..|..++...  +++++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~g--~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  159 (294)
T 4eqm_A           86 YYLVMEYIEG--PTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFGIAK  159 (294)
T ss_dssp             EEEEEECCCS--CBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred             EEEEEeCCCC--CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence            4566665432  2455554433  469999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      ......  ........||+.|+|||++.+ .++.++||||||+++|+..+...|+.+...
T Consensus       160 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  217 (294)
T 4eqm_A          160 ALSETS--LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA  217 (294)
T ss_dssp             TC---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH
T ss_pred             cccccc--ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            543221  112233579999999998754 468899999999999998888888766544

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.75  E-value=5.8e-19  Score=192.27  Aligned_cols=124  Identities=23%  Similarity=0.361  Sum_probs=94.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+..   +.....    ..+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus       143 ~lv~E~~~~~---l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          143 YLVMELMDAN---LCQVIQ----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEECCSEE---HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             EEEEeCCCCC---HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            5666665443   443332    248999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      .....    .....+||+.|+|||++.+ .++.++|||||||++|+.++...|+.+..
T Consensus       214 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~  267 (464)
T 3ttj_A          214 AGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  267 (464)
T ss_dssp             ---CC----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCCc----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            43321    1234579999999998755 57889999999999999887777776543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.75  E-value=8.9e-19  Score=188.97  Aligned_cols=144  Identities=22%  Similarity=0.276  Sum_probs=104.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+   +.|...+..  ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~---~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD---SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS---EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC---cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            356666544   356666543  3569999999999999999999999  569999999999999999999999999998


Q ss_pred             ecccCCccc-------------------cccccccCCCCccccccc-CC-cCCcccceecchhhhhcccccCCCccchhh
Q psy9535         506 MSETSNVKT-------------------MYTENLTGTRPYMPPEAM-HC-QISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       506 ~~~~~~~~~-------------------~~~~~~~Gt~~y~aPE~~-~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      .........                   ......+||++|+|||++ .. .++.++|||||||++|+.++...|...  .
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~--~  255 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN--D  255 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS--S
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc--c
Confidence            643221100                   012346799999999975 33 478899999999999987765554433  2


Q ss_pred             hchhhhhcCCCCCC
Q psy9535         565 YYSLQTMLPGHHEG  578 (593)
Q Consensus       565 ~~~~~~~~~~~~~~  578 (593)
                      +..=.++|+|...+
T Consensus       256 ~~~~~p~f~g~~~~  269 (432)
T 3n9x_A          256 PTNRFPLFPGSSCF  269 (432)
T ss_dssp             GGGCCCSCCCSCSC
T ss_pred             cccccccCCCcccc
Confidence            33445677776654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.75  E-value=8.6e-19  Score=186.27  Aligned_cols=124  Identities=26%  Similarity=0.322  Sum_probs=99.3

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-..  +.|..++..  ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~lv~e~~~g--g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~a~~  164 (384)
T 4fr4_A           91 FMVVDLLLG--GDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAM  164 (384)
T ss_dssp             EEEECCCTT--EEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCC--CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEECCCCCEEEeccceeee
Confidence            455554322  355555543  3569999999999999999999999  5699999999999999999999999999986


Q ss_pred             cccCCccccccccccCCCCcccccccCC----cCCcccceecchhhhhcccccCCCcc
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGAQIKTQHITNVDIA  560 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~----~~~~ksDvwS~G~~i~~~~~~~~~~~  560 (593)
                      .....    .....+||+.|+|||++..    .++.++|||||||++|+.++...|+.
T Consensus       165 ~~~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~  218 (384)
T 4fr4_A          165 LPRET----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH  218 (384)
T ss_dssp             CCTTC----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccCCC----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence            43221    2234679999999998743    36889999999999999888877775

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.75  E-value=1.1e-18  Score=180.09  Aligned_cols=127  Identities=22%  Similarity=0.348  Sum_probs=101.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC-------------
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-------------  492 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~-------------  492 (593)
                      ..+++++.   .+.+..++...+..++++..+..++.|++.||+|||+  ++|+||||||+|||++.             
T Consensus        92 ~~lv~e~~---~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC---CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC---CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            45666654   3556666666555679999999999999999999999  56999999999999987             


Q ss_pred             ------CCceEEEecccceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchh
Q psy9535         493 ------NFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       493 ------~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                            ++.+||+|||+++.....      .....||+.|+|||++.+ .++.++|||||||++|+..+...|+....
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             ccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                  668999999998754321      223578999999998755 57889999999999998887766665443

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.75  E-value=6.7e-19  Score=182.49  Aligned_cols=144  Identities=22%  Similarity=0.305  Sum_probs=104.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..|..++.. ....+++..++.++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus       125 ~~lv~e~~~~--~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          125 AMIVTEYMEN--GSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             CEEEEECCTT--CBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             cEEEeeCCCC--CcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence            4566665433  345555543 23569999999999999999999999  569999999999999999999999999988


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ................||+.|+|||++.+ .++.++||||||+++|+..+ ...|+.+......++.+..|
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  270 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG  270 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence            65432221112223356778999998754 57889999999999998776 77777665555444444443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.75  E-value=4.5e-19  Score=188.69  Aligned_cols=149  Identities=19%  Similarity=0.240  Sum_probs=113.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC--CCceEEEeccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--NFVPKLGDFGI  503 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~--~~~~kl~DfG~  503 (593)
                      .++++++-+.  +.|+..+... ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.  .+.+||+|||+
T Consensus       123 ~~lv~E~~~g--g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~DFG~  197 (387)
T 1kob_A          123 MVLILEFLSG--GELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGL  197 (387)
T ss_dssp             EEEEEECCCC--CBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             EEEEEEcCCC--CcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEeccc
Confidence            3556654332  3555555432 3469999999999999999999999  56999999999999974  57899999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeEE
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVS  582 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (593)
                      ++.......    .....||+.|+|||++.+ .++.++|||||||++|+.++...|+.+......++.+..+..+++...
T Consensus       198 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  273 (387)
T 1kob_A          198 ATKLNPDEI----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA  273 (387)
T ss_dssp             CEECCTTSC----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST
T ss_pred             ceecCCCcc----eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence            876543211    123469999999998865 478899999999999999999999888776666666666655554433


Q ss_pred             E
Q psy9535         583 I  583 (593)
Q Consensus       583 ~  583 (593)
                      |
T Consensus       274 ~  274 (387)
T 1kob_A          274 F  274 (387)
T ss_dssp             T
T ss_pred             c
Confidence            3

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.75  E-value=1.1e-18  Score=186.03  Aligned_cols=110  Identities=25%  Similarity=0.295  Sum_probs=92.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec-CCCceEEEecccceecccCCccccccccccCCCCcc
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYM  527 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~  527 (593)
                      ...+++..+..++.|++.||+|||+  ++|+||||||+|||++ .++.+||+|||+++.......    .....||+.|+
T Consensus       135 ~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~----~~~~~~t~~y~  208 (394)
T 4e7w_A          135 KQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP----NVSYICSRYYR  208 (394)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC----CCSSCSCGGGC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC----CcccccCcCcc
Confidence            4579999999999999999999999  5699999999999999 799999999999986432221    22356899999


Q ss_pred             cccccCC--cCCcccceecchhhhhcccccCCCccchhh
Q psy9535         528 PPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       528 aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      |||++.+  .++.++|||||||++|+..+...|+.+...
T Consensus       209 aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  247 (394)
T 4e7w_A          209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG  247 (394)
T ss_dssp             CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9998754  478899999999999998888888766543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.75  E-value=1.1e-18  Score=177.08  Aligned_cols=130  Identities=23%  Similarity=0.289  Sum_probs=99.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEee---cCCCceEEEecc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFG  502 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl---~~~~~~kl~DfG  502 (593)
                      .++++++.   .+.|..++... ..++++..+..++.|++.||+|||+  ++|+||||||+|||+   +.++.+||+|||
T Consensus        80 ~~lv~e~~---~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg  153 (296)
T 4hgt_A           80 NVMVMELL---GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             EEEEEECC---CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred             eEEEEEcc---CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence            35666554   33455544432 3469999999999999999999999  569999999999999   788999999999


Q ss_pred             cceecccCCccc----cccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccc
Q psy9535         503 IVKMSETSNVKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       503 ~~~~~~~~~~~~----~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      +++.........    .......||+.|+|||++.+ .++.++|||||||++|+..+...|+.+
T Consensus       154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  217 (296)
T 4hgt_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG  217 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcc
Confidence            987644322110    11234579999999998755 478899999999999987777777654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.75  E-value=1.7e-19  Score=185.44  Aligned_cols=133  Identities=24%  Similarity=0.432  Sum_probs=95.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      +.+++++-+.  ..|..++...  +++++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g--~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDG--VTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCE--EEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCC--CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            3566665432  3455554433  469999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      ................||+.|+|||++.+ .++.++||||||+++|+..+...|+.+...
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  224 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP  224 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            54332222222334569999999998754 578899999999999998888777765543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.75  E-value=8.8e-19  Score=189.66  Aligned_cols=139  Identities=20%  Similarity=0.336  Sum_probs=104.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..|...+...  ..+++..+..++.|++.||+|||+ .++|+||||||+|||++.++.+||+|||+++
T Consensus       223 ~~lv~e~~~~--~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          223 LCFVMEYANG--GELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             EEEEECCCSS--CBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             EEEEEeeCCC--CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh-cCCEEECCCCHHHEEECCCCCEEEccCCCce
Confidence            3566665443  3444444433  469999999999999999999996 1349999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccccCCCccchhhhchhhhhc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTML  572 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~  572 (593)
                      ......   ......+||+.|+|||++. ..++.++|||||||++|+.++...|+.+......++.++
T Consensus       298 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~  362 (446)
T 4ejn_A          298 EGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL  362 (446)
T ss_dssp             TTCC--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eccCCC---cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            432211   1223467999999999874 457899999999999999888888887665544444333

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.75  E-value=4.7e-19  Score=185.16  Aligned_cols=134  Identities=22%  Similarity=0.274  Sum_probs=102.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.   .+...+.. ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        99 ~~lv~e~~~~---~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           99 IYLVFDFCEH---DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             EEEEEECCSE---EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEeccCC---CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            4566666543   34444332 23469999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCc-cccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         506 MSETSNV-KTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       506 ~~~~~~~-~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ....... .........||+.|+|||++.+  .++.++|||||||++|+..+...|+....+.
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  235 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ  235 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            6432211 1112234578999999998754  3688999999999999988777777665544

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.74  E-value=6.8e-19  Score=180.01  Aligned_cols=130  Identities=23%  Similarity=0.320  Sum_probs=101.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|..++..   ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        92 ~~lv~e~~~~--~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  164 (297)
T 3fxz_A           92 LWVVMEYLAG--GSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (297)
T ss_dssp             EEEEEECCTT--CBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEECCCC--CCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence            3566665332  345555443   258999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      .......   ......||+.|+|||++.+ .++.++|||||||++|+..+...|+.+....
T Consensus       165 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  222 (297)
T 3fxz_A          165 QITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL  222 (297)
T ss_dssp             ECCSTTC---CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             ecCCccc---ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            5433221   1234579999999998744 5788999999999999988888887655443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.74  E-value=4.8e-19  Score=183.68  Aligned_cols=143  Identities=21%  Similarity=0.280  Sum_probs=108.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC----ceEEEec
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLGDF  501 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~----~~kl~Df  501 (593)
                      ..+++++.+.  +.|..++..  ..++++..+..++.|++.||+|||+  .+|+||||||+|||++.++    .+||+||
T Consensus        89 ~~lv~e~~~~--~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           89 VILILELVAG--GELFDFLAE--KESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEEECCCS--CBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCC--CCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            3456655332  355555543  3579999999999999999999998  5699999999999998877    7999999


Q ss_pred             ccceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCC
Q psy9535         502 GIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG  578 (593)
Q Consensus       502 G~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  578 (593)
                      |+++......    ......||+.|+|||++.+ .++.++|||||||++|+..+...|+.+......++.+..+..++
T Consensus       163 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  236 (326)
T 2y0a_A          163 GLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF  236 (326)
T ss_dssp             TTCEECCTTS----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             CCCeECCCCC----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence            9987653221    1233579999999998864 57889999999999999888888887665554554444444333

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.74  E-value=1.2e-18  Score=177.73  Aligned_cols=110  Identities=26%  Similarity=0.433  Sum_probs=91.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCccc
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMP  528 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~a  528 (593)
                      ..++++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.......   ......||+.|+|
T Consensus       131 ~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~a  205 (298)
T 2zv2_A          131 LKPLSEDQARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMA  205 (298)
T ss_dssp             SSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEECCCCCEEEecCCCccccccccc---cccCCcCCccccC
Confidence            4579999999999999999999999  5699999999999999999999999999876433211   1234579999999


Q ss_pred             ccccCCc----CCcccceecchhhhhcccccCCCccchh
Q psy9535         529 PEAMHCQ----ISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       529 PE~~~~~----~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      ||++.+.    .+.++|||||||++|+..+...|+.+..
T Consensus       206 PE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          206 PESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             hhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            9988543    2668999999999999888888876544

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.74  E-value=1.1e-18  Score=181.48  Aligned_cols=128  Identities=23%  Similarity=0.339  Sum_probs=101.6

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEee---------------
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---------------  490 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl---------------  490 (593)
                      .++++++.   .+.+...+......++++..+..++.|++.||+|||+  ++|+||||||+|||+               
T Consensus        97 ~~lv~e~~---~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC---CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc---CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecccccccccccccc
Confidence            45666554   3345555555555679999999999999999999998  569999999999999               


Q ss_pred             ----cCCCceEEEecccceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhh
Q psy9535         491 ----DENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       491 ----~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                          +.++.+||+|||+++.....      .....||+.|+|||++.+ .++.++|||||||++|+..+...|+.....
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                56789999999998754321      123579999999998754 578899999999999998888777765443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.74  E-value=5.6e-19  Score=186.97  Aligned_cols=144  Identities=19%  Similarity=0.224  Sum_probs=109.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEee--cCCCceEEEeccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGI  503 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl--~~~~~~kl~DfG~  503 (593)
                      .++++++-+.  ..|...+.. ....+++..+..++.|++.||+|||+  .+|+||||||+|||+  +.++.+||+|||+
T Consensus       161 ~~lv~E~~~~--~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~  235 (373)
T 2x4f_A          161 IVLVMEYVDG--GELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGL  235 (373)
T ss_dssp             EEEEEECCTT--CEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSS
T ss_pred             EEEEEeCCCC--CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCC
Confidence            3566665432  244444332 23468999999999999999999999  569999999999999  5678999999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCC
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG  578 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  578 (593)
                      ++......    ......||+.|+|||++.. .++.++|||||||++|+..+...|+.+......++.++.+..++
T Consensus       236 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  307 (373)
T 2x4f_A          236 ARRYKPRE----KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL  307 (373)
T ss_dssp             CEECCTTC----BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCS
T ss_pred             ceecCCcc----ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Confidence            87654321    1223469999999998755 46889999999999999888888888777666666666554443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.74  E-value=1.6e-18  Score=182.30  Aligned_cols=131  Identities=24%  Similarity=0.411  Sum_probs=101.9

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+   +.+..++..   ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~---~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME---TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS---EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC---cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            45665544   355555543   359999999999999999999999  5699999999999999999999999999876


Q ss_pred             cccCCccccccccccCCCCcccccccC-C-cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ...............||+.|+|||++. . .++.++|||||||++|+..+...|+.+....
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  238 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL  238 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH
Confidence            543222222223457999999999763 3 3788999999999999988877777655443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.74  E-value=7.1e-19  Score=183.67  Aligned_cols=129  Identities=18%  Similarity=0.257  Sum_probs=100.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC--ceEEEeccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF--VPKLGDFGI  503 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~--~~kl~DfG~  503 (593)
                      ..+++++.   .+.|..++...+  ++++..++.++.|++.||+|||+  ++|+||||||+|||++.++  .+||+|||+
T Consensus       127 ~~lv~e~~---~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~  199 (345)
T 2v62_A          127 RFMVMERL---GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYKNPDQVYLADYGL  199 (345)
T ss_dssp             EEEEEECE---EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEESSSTTSEEECCCTT
T ss_pred             EEEEEecc---CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHEEEccCCCCcEEEEeCCC
Confidence            35666553   356666655433  79999999999999999999999  5699999999999998877  999999999


Q ss_pred             ceecccCCcc----ccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccc
Q psy9535         504 VKMSETSNVK----TMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       504 ~~~~~~~~~~----~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      ++........    ........||+.|+|||++.+ .++.++|||||||++|+..+...|+.+
T Consensus       200 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          200 SYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             CEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             ceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            9764322111    111134579999999998755 478899999999999998888888754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.74  E-value=5.6e-19  Score=179.80  Aligned_cols=123  Identities=26%  Similarity=0.380  Sum_probs=94.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCceecCCCCCcEeecCCCceE
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLH--------SLSKPIIHRDVKSANVLLDENFVPK  497 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH--------~~~~~iiHrdlKp~NILl~~~~~~k  497 (593)
                      .++++++.+.  +.|..++.   ...+++..++.++.|++.||+|||        +  ++|+||||||+|||++.++.+|
T Consensus        81 ~~lv~e~~~~--g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           81 LWLITHYHEM--GSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK--PAIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEEECCCTT--CBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB--CEEECSCCCGGGEEECTTSCEE
T ss_pred             eEEehhhccC--CCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC--CCeecCCCChHhEEEcCCCCEE
Confidence            3456655332  35555553   346999999999999999999999        6  6699999999999999999999


Q ss_pred             EEecccceecccCCcc-ccccccccCCCCcccccccCCc-------CCcccceecchhhhhccccc
Q psy9535         498 LGDFGIVKMSETSNVK-TMYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGAQIKTQHIT  555 (593)
Q Consensus       498 l~DfG~~~~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~-------~~~ksDvwS~G~~i~~~~~~  555 (593)
                      |+|||+++........ ........||+.|+|||++.+.       ++.++|||||||++|+..+.
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg  219 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR  219 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence            9999998754332211 1112334799999999987553       34689999999999987766

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.74  E-value=1.3e-18  Score=183.94  Aligned_cols=125  Identities=24%  Similarity=0.236  Sum_probs=99.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCcEeecCCC----------
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENF----------  494 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~-~iiHrdlKp~NILl~~~~----------  494 (593)
                      .++++++.   .+.+...+.......+++..+..++.|++.||+|||+  + +|+||||||+|||++.++          
T Consensus       120 ~~lv~e~~---~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIll~~~~~~~~~~~~~~  194 (397)
T 1wak_A          120 ICMVFEVL---GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEA  194 (397)
T ss_dssp             EEEEECCC---CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred             EEEEEecc---CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence            35666554   3445555544455679999999999999999999998  5 699999999999998775          


Q ss_pred             ---------------------------------------ceEEEecccceecccCCccccccccccCCCCcccccccCC-
Q psy9535         495 ---------------------------------------VPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-  534 (593)
Q Consensus       495 ---------------------------------------~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-  534 (593)
                                                             .+||+|||+++.....      .....||+.|+|||++.+ 
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~~~~  268 (397)
T 1wak_A          195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVLIGS  268 (397)
T ss_dssp             C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHHHTS
T ss_pred             HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhhcCC
Confidence                                                   7999999998764321      123478999999998754 


Q ss_pred             cCCcccceecchhhhhcccccCCCccc
Q psy9535         535 QISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       535 ~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      .++.++|||||||++|+..+...|+..
T Consensus       269 ~~~~~~DiwslG~il~elltg~~pf~~  295 (397)
T 1wak_A          269 GYNTPADIWSTACMAFELATGDYLFEP  295 (397)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCCcHHHHHHHHHHHHHHhhCCCCCCC
Confidence            478899999999999998887777753

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.74  E-value=8.7e-19  Score=181.58  Aligned_cols=128  Identities=23%  Similarity=0.333  Sum_probs=94.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCceecCCCCCcEeecCCCceEEE
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-------SKPIIHRDVKSANVLLDENFVPKLG  499 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~-------~~~iiHrdlKp~NILl~~~~~~kl~  499 (593)
                      ++++++.+.  +.|..++...   .+++..+..++.|++.||+|||+.       .++|+||||||+|||++.++.+||+
T Consensus        88 ~lv~e~~~~--g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPN--GSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTT--CBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCC--CcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            466665432  3566655443   358899999999999999999984       1169999999999999999999999


Q ss_pred             ecccceecccCCc-----cccccccccCCCCcccccccCC--------cCCcccceecchhhhhcccccCCCc
Q psy9535         500 DFGIVKMSETSNV-----KTMYTENLTGTRPYMPPEAMHC--------QISTKTDVFSYGAQIKTQHITNVDI  559 (593)
Q Consensus       500 DfG~~~~~~~~~~-----~~~~~~~~~Gt~~y~aPE~~~~--------~~~~ksDvwS~G~~i~~~~~~~~~~  559 (593)
                      |||+++.......     .........||+.|+|||++.+        .++.++|||||||++|+..+...|.
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            9999875432211     0111223569999999998864        2456899999999999877654444

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.74  E-value=7.7e-19  Score=182.14  Aligned_cols=151  Identities=19%  Similarity=0.274  Sum_probs=92.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC---ceEEEecc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFG  502 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~---~~kl~DfG  502 (593)
                      ..+++++-+.  ..|...+...  .++++..+..++.|++.||+|||+  ++|+||||||+|||++.++   .+||+|||
T Consensus        81 ~~lv~e~~~~--~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg  154 (325)
T 3kn6_A           81 TFLVMELLNG--GELFERIKKK--KHFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFG  154 (325)
T ss_dssp             EEEEECCCCS--CBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred             EEEEEEccCC--CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence            3466665432  3555555543  579999999999999999999998  5699999999999997665   89999999


Q ss_pred             cceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhh-------chhhhhcCC
Q psy9535         503 IVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERY-------YSLQTMLPG  574 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~-------~~~~~~~~~  574 (593)
                      +++.......   .....+||+.|+|||++.+ .++.++||||||+++|+..+...|+.+....       ..++.+..|
T Consensus       155 ~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~  231 (325)
T 3kn6_A          155 FARLKPPDNQ---PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG  231 (325)
T ss_dssp             TCEECCC-------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred             cceecCCCCC---cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence            9875433211   1234568999999998754 4788999999999999988888887664432       234445555


Q ss_pred             CCCCCeEEEee
Q psy9535         575 HHEGDHVSISN  585 (593)
Q Consensus       575 ~~~~~~~~~~~  585 (593)
                      ...+....|++
T Consensus       232 ~~~~~~~~~~~  242 (325)
T 3kn6_A          232 DFSFEGEAWKN  242 (325)
T ss_dssp             CCCCCSHHHHT
T ss_pred             CCCCCcccccC
Confidence            55544444433

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.74  E-value=9.6e-19  Score=183.11  Aligned_cols=133  Identities=16%  Similarity=0.168  Sum_probs=104.2

Q ss_pred             cceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC--ceEEEecc
Q psy9535         425 IPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF--VPKLGDFG  502 (593)
Q Consensus       425 ~~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~--~~kl~DfG  502 (593)
                      ...+++++.   .+.|..++......++++..++.++.|++.||+|||+  ++|+||||||+|||++.++  .+||+|||
T Consensus       132 ~~~lv~e~~---~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg  206 (352)
T 2jii_A          132 YRFLVLPSL---GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE--NEYVHGNVTAENIFVDPEDQSQVTLAGYG  206 (352)
T ss_dssp             EEEEEEECC---CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCGGGEEEETTEEEEEEECCGG
T ss_pred             EEEEEecCC---CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEEcCCCCceEEEecCc
Confidence            345666654   3566666665444679999999999999999999999  5699999999999999988  89999999


Q ss_pred             cceecccCCcc----ccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccch
Q psy9535         503 IVKMSETSNVK----TMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       503 ~~~~~~~~~~~----~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      +++........    ........||+.|+|||++.+ .++.++||||||+++|+..+...|+...
T Consensus       207 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          207 FAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             GCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             ceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            98754322111    011133479999999998765 5788999999999999988887777654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.74  E-value=1.2e-18  Score=182.60  Aligned_cols=127  Identities=29%  Similarity=0.435  Sum_probs=100.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-.   +.+...+... ..++++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       129 ~~lv~e~~~---g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  202 (348)
T 1u5q_A          129 AWLVMEYCL---GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSAS  202 (348)
T ss_dssp             EEEEEECCS---EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred             EEEEEecCC---CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEeeccCce
Confidence            456666654   2344444332 3579999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCccccccc----CCcCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~----~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ....       .....||+.|+|||++    .+.++.++|||||||++|+..+...|+.+....
T Consensus       203 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  259 (348)
T 1u5q_A          203 IMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM  259 (348)
T ss_dssp             SSSS-------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             ecCC-------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            5432       1235799999999986    235788999999999999988887777654433

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.74  E-value=6.9e-19  Score=181.99  Aligned_cols=129  Identities=28%  Similarity=0.355  Sum_probs=98.2

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCceecCCCCCcEeecCCCceEE
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKL  498 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~--------~~~iiHrdlKp~NILl~~~~~~kl  498 (593)
                      .+++++.+.  +.|..++..   .++++..+..++.|++.||+|||+.        .++|+||||||+|||++.++.+||
T Consensus        98 ~lv~e~~~~--g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           98 WLITAFHEK--GSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EEEEECCTT--CBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEecCCC--CCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence            456655432  355555543   3599999999999999999999983        116999999999999999999999


Q ss_pred             EecccceecccCCccccccccccCCCCcccccccCC------cCCcccceecchhhhhcccccCCCccc
Q psy9535         499 GDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC------QISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       499 ~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~------~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      +|||+++....... ........||+.|+|||++.+      .++.++|||||||++|+..+...|+.+
T Consensus       173 ~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  240 (322)
T 3soc_A          173 ADFGLALKFEAGKS-AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG  240 (322)
T ss_dssp             CCCTTCEEECTTSC-CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred             ccCCcccccccccC-ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence            99999976443221 112233579999999998764      245689999999999997777666544

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.74  E-value=1.6e-18  Score=181.98  Aligned_cols=129  Identities=25%  Similarity=0.249  Sum_probs=99.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ..|..++...  .++++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~--~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYING--GELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCS--CBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCC--CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            3466665432  3555555433  368999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC---cCCcccceecchhhhhcccccCCCccch
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      .......  ......+||+.|+|||++.+   .++.++|||||||++|+.++...|+...
T Consensus       208 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  265 (355)
T 1vzo_A          208 EFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  265 (355)
T ss_dssp             ECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             ecccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence            5432211  11233579999999998864   2578999999999999988877777543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.74  E-value=1.7e-18  Score=177.60  Aligned_cols=130  Identities=25%  Similarity=0.316  Sum_probs=96.7

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ..|..++... ...+++.++..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        82 ~~lv~e~~~~--~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  156 (310)
T 3s95_A           82 LNFITEYIKG--GTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLAR  156 (310)
T ss_dssp             EEEEEECCTT--CBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred             eEEEEEecCC--CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEECCCCCEEEeecccce
Confidence            3456654332  3555555543 3569999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccc-----------cccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCcc
Q psy9535         506 MSETSNVKT-----------MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIA  560 (593)
Q Consensus       506 ~~~~~~~~~-----------~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~  560 (593)
                      .........           .......||+.|+|||++.+ .++.++||||||+++|+......|..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~  223 (310)
T 3s95_A          157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP  223 (310)
T ss_dssp             ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSST
T ss_pred             ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCc
Confidence            543221110           00114579999999998765 47889999999999998765544443

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.74  E-value=1.3e-18  Score=179.58  Aligned_cols=131  Identities=37%  Similarity=0.535  Sum_probs=100.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCcEeecCCCceEEEecc
Q psy9535         426 PVIILDTGETKQCQLFKLARVN--NTPPLDSNKRYSIALGVAEALHYLHSL-SKPIIHRDVKSANVLLDENFVPKLGDFG  502 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~~ia~gl~ylH~~-~~~iiHrdlKp~NILl~~~~~~kl~DfG  502 (593)
                      ..+++++.+.  ..|..++...  ...++++..+..++.|++.||+|||+. ..+++||||||+|||++.++.+||+|||
T Consensus       102 ~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  179 (326)
T 3uim_A          102 RLLVYPYMAN--GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG  179 (326)
T ss_dssp             CEEEEECCTT--CBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred             eEEEEEeccC--CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence            3566665432  3455444432  234699999999999999999999983 1169999999999999999999999999


Q ss_pred             cceecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccccCCCcc
Q psy9535         503 IVKMSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVDIA  560 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~~~~~~~  560 (593)
                      +++.......  .......||+.|+|||++. ..++.++||||||+++|+..+...|+.
T Consensus       180 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          180 LAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             SCEECCSSSS--CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             cccccCcccc--cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence            9876543221  1223456999999999874 457889999999999999888777774

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.74  E-value=5.9e-19  Score=193.15  Aligned_cols=151  Identities=23%  Similarity=0.295  Sum_probs=116.3

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec---CCCceEEEeccc
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGI  503 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~---~~~~~kl~DfG~  503 (593)
                      .+++++.+.  ..|+..+...  .++++..+..++.|++.||+|||+  ++|+||||||+|||++   .++.+||+|||+
T Consensus        97 ~lv~e~~~~--~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           97 YIVGELYTG--GELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             EEEECCCCS--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EEEEEcCCC--CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            455554322  3454444333  469999999999999999999999  5699999999999995   456799999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCCcCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeEEE
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVSI  583 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (593)
                      ++......    .....+||+.|+|||++.+.++.++||||+||++|+..+...|+.+......++.+..|...++...|
T Consensus       171 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (486)
T 3mwu_A          171 STCFQQNT----KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW  246 (486)
T ss_dssp             TTTBCCC--------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG
T ss_pred             CeECCCCC----ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence            87543221    12345799999999999888899999999999999999999999888777777777777766665555


Q ss_pred             eecc
Q psy9535         584 SNHS  587 (593)
Q Consensus       584 ~~~~  587 (593)
                      +++|
T Consensus       247 ~~~s  250 (486)
T 3mwu_A          247 RTIS  250 (486)
T ss_dssp             GGSC
T ss_pred             CCCC
Confidence            5544

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.74  E-value=7.4e-19  Score=192.82  Aligned_cols=151  Identities=23%  Similarity=0.305  Sum_probs=117.9

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC---CCceEEEeccc
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGI  503 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~---~~~~kl~DfG~  503 (593)
                      .+++++-+.  ..|+..+...  .++++..+..++.|++.||+|||+  ++|+||||||+|||++.   ++.+||+|||+
T Consensus       112 ~lv~e~~~~--g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          112 YLVMECYKG--GELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             EEEEECCCS--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEecCCC--CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            456655332  2444444333  468999999999999999999999  56999999999999976   45699999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCCcCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeEEE
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVSI  583 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (593)
                      ++......    .....+||+.|+|||++...++.++||||+||++|+..+...|+.+......++.+..|...++...|
T Consensus       186 a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  261 (494)
T 3lij_A          186 SAVFENQK----KMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW  261 (494)
T ss_dssp             CEECBTTB----CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGG
T ss_pred             CeECCCCc----cccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhc
Confidence            87654321    12335799999999998888899999999999999998999999887777777777777777666556


Q ss_pred             eecc
Q psy9535         584 SNHS  587 (593)
Q Consensus       584 ~~~~  587 (593)
                      ++.|
T Consensus       262 ~~~s  265 (494)
T 3lij_A          262 KNVS  265 (494)
T ss_dssp             TTSC
T ss_pred             ccCC
Confidence            5554

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.74  E-value=2.1e-18  Score=177.74  Aligned_cols=134  Identities=19%  Similarity=0.277  Sum_probs=106.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+   +.+..++.......+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus        94 ~~lv~e~~~---~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           94 LTLVFEHVD---QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             EEEEEECCS---CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             EEEEEecCC---CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            456666544   356666666555679999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSL  568 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~  568 (593)
                      ......    ......||+.|+|||++.+ .++.++||||||+++|+..+...|+.+..+...+
T Consensus       169 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  228 (326)
T 1blx_A          169 IYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL  228 (326)
T ss_dssp             CCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccCCC----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence            543211    1234578999999998754 5788999999999999988888787665544333

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.74  E-value=2.4e-18  Score=174.74  Aligned_cols=130  Identities=23%  Similarity=0.289  Sum_probs=99.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEee---cCCCceEEEecc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFG  502 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl---~~~~~~kl~DfG  502 (593)
                      ..+++++.   .+.|..++... ..++++..+..++.|++.||+|||+  ++++||||||+|||+   +.++.+||+|||
T Consensus        80 ~~lv~e~~---~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  153 (296)
T 3uzp_A           80 NVMVMELL---GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             EEEEEECC---CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             eEEEEEec---CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence            35666654   34555555432 3469999999999999999999999  569999999999999   478899999999


Q ss_pred             cceecccCCccc----cccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccc
Q psy9535         503 IVKMSETSNVKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       503 ~~~~~~~~~~~~----~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      +++.........    .......||+.|+|||++.+ .++.++||||||+++|+..+...|+.+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  217 (296)
T 3uzp_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG  217 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             CcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            987644322110    11234579999999998765 478899999999999988777777654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.74  E-value=7.1e-19  Score=182.32  Aligned_cols=122  Identities=20%  Similarity=0.309  Sum_probs=93.8

Q ss_pred             hhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcccccc
Q psy9535         438 CQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT  517 (593)
Q Consensus       438 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~  517 (593)
                      +.+..++... ...+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++....... ....
T Consensus       101 g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~  176 (327)
T 3poz_A          101 GCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-EYHA  176 (327)
T ss_dssp             CBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-----
T ss_pred             CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc-cccc
Confidence            4555555443 3569999999999999999999999  5699999999999999999999999999875433221 1112


Q ss_pred             ccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchh
Q psy9535         518 ENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRE  563 (593)
Q Consensus       518 ~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~  563 (593)
                      ....||+.|+|||++.+ .++.++|||||||++|+..+ ...|+....
T Consensus       177 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  224 (327)
T 3poz_A          177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  224 (327)
T ss_dssp             ---CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence            23457889999998744 57889999999999998777 666665443

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.73  E-value=7.4e-19  Score=181.93  Aligned_cols=132  Identities=19%  Similarity=0.243  Sum_probs=98.7

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+   +.+..++... ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~lv~e~~~---~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  148 (324)
T 3mtl_A           75 LTLVFEYLD---KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLAR  148 (324)
T ss_dssp             EEEEEECCS---EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred             EEEEecccc---cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEECCCCCEEEccCcccc
Confidence            456666654   3555555443 3469999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhhc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERYY  566 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~  566 (593)
                      ......   .......||+.|+|||++.+  .++.++|||||||++|+..+...|+.+.....
T Consensus       149 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  208 (324)
T 3mtl_A          149 AKSIPT---KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE  208 (324)
T ss_dssp             CC---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccCCc---cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            543221   11223468999999998754  46889999999999999888888776654443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.73  E-value=1.9e-18  Score=178.37  Aligned_cols=135  Identities=23%  Similarity=0.323  Sum_probs=84.8

Q ss_pred             eEeecCCchhhhhHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         427 VIILDTGETKQCQLFKLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~-~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ++++++.+   +.|..++.. ...+++++..++.++.|++.||+|||+.+++|+||||||+|||++.++.+||+|||+++
T Consensus       110 ~lv~e~~~---g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  186 (337)
T 3ll6_A          110 LLLTELCK---GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT  186 (337)
T ss_dssp             EEEEECCS---EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred             EEEEEecC---CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence            45555543   344444332 23457999999999999999999999844449999999999999999999999999987


Q ss_pred             ecccCCccc---------cccccccCCCCcccccccC----CcCCcccceecchhhhhcccccCCCccchhh
Q psy9535         506 MSETSNVKT---------MYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       506 ~~~~~~~~~---------~~~~~~~Gt~~y~aPE~~~----~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      .........         .......||+.|+|||++.    ..++.++||||||+++|+..+...|+.+...
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            543221100         0011346899999999872    2367899999999999998887777765544

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.73  E-value=1e-18  Score=180.80  Aligned_cols=131  Identities=18%  Similarity=0.306  Sum_probs=97.2

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-.  .+.|..++... .+++++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~~v~e~~~--~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           90 QLVTQYLP--LGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEEECCT--TCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEEeCC--CCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEECCCCeEEECCCCcccc
Confidence            34554432  23455544432 3468999999999999999999999  5699999999999999999999999999876


Q ss_pred             cccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRE  563 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~  563 (593)
                      ....... .......||+.|+|||++. ..++.++||||||+++|+..+ ...|+.+..
T Consensus       165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  222 (325)
T 3kex_A          165 LPPDDKQ-LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR  222 (325)
T ss_dssp             SCCCTTC-CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             cCccccc-ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence            5332211 1123346788999999875 457889999999999998777 777766544

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.73  E-value=2.8e-18  Score=175.47  Aligned_cols=134  Identities=34%  Similarity=0.562  Sum_probs=103.0

Q ss_pred             ceEeecCCchhhhhHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccc
Q psy9535         426 PVIILDTGETKQCQLFKLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  504 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~-~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~  504 (593)
                      ..+++++.+.  +.|..++.. ....++++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg~~  180 (307)
T 2nru_A          105 LCLVYVYMPN--GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILLDEAFTAKISDFGLA  180 (307)
T ss_dssp             CEEEEECCTT--CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecCC--CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEcCCCcEEEeecccc
Confidence            3556654322  344444432 234579999999999999999999998  56999999999999999999999999998


Q ss_pred             eecccCCccccccccccCCCCcccccccCCcCCcccceecchhhhhcccccCCCccchhh
Q psy9535         505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      +....... ........||+.|+|||++.+.++.++||||||+++|+..+...|+.+...
T Consensus       181 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          181 RASEKFAQ-TVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             EECCSCSS-CEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             cccccccc-cccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            76443211 112234579999999999888888999999999999998877777765443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.73  E-value=2.2e-18  Score=181.91  Aligned_cols=123  Identities=22%  Similarity=0.362  Sum_probs=98.7

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++..   +.|..++..   .++++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~lv~e~~~---~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          106 YLVMPFMG---TDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             EEEEECCS---EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecCC---CCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            45665542   345444443   368999999999999999999999  5699999999999999999999999999986


Q ss_pred             cccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      ....      ....+||+.|+|||++.+  .++.++||||+||++++..+...|+.+..
T Consensus       178 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  230 (367)
T 1cm8_A          178 ADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD  230 (367)
T ss_dssp             CCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccc------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            4321      223578999999998744  57889999999999999888777776543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.73  E-value=9.8e-19  Score=176.13  Aligned_cols=143  Identities=18%  Similarity=0.225  Sum_probs=109.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEee---cCCCceEEEecc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFG  502 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl---~~~~~~kl~DfG  502 (593)
                      ..+++++-+.  ..+...+...  .++++..+..++.|++.||+|||+  ++++||||||+|||+   +.++.+||+|||
T Consensus        81 ~~lv~e~~~~--~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg  154 (277)
T 3f3z_A           81 IYLVMELCTG--GELFERVVHK--RVFRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFG  154 (277)
T ss_dssp             EEEEEECCCS--CBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeccCC--CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence            3556655322  3444444433  468999999999999999999999  569999999999999   788899999999


Q ss_pred             cceecccCCccccccccccCCCCcccccccCCcCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCC
Q psy9535         503 IVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG  578 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  578 (593)
                      ++.......    ......||+.|+|||++.+.++.++||||||+++|+..+...|+.+......+..+..|....
T Consensus       155 ~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  226 (277)
T 3f3z_A          155 LAARFKPGK----MMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTF  226 (277)
T ss_dssp             TCEECCTTS----CBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             cceeccCcc----chhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            987543321    123356999999999988788999999999999999888888887665555455454444443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.73  E-value=1.6e-18  Score=180.91  Aligned_cols=128  Identities=29%  Similarity=0.440  Sum_probs=94.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.   ...|..++...  .++++..+..++.|++.||+|||+  ++|+||||||+|||++ ++.+||+|||+++
T Consensus        84 ~~lv~e~~---~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~-~~~~kl~DFG~a~  155 (343)
T 3dbq_A           84 IYMVMECG---NIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIAN  155 (343)
T ss_dssp             EEEEECCC---SEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             EEEEEeCC---CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence            34566543   34566665543  479999999999999999999999  5699999999999997 5789999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccC------------CcCCcccceecchhhhhcccccCCCccch
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH------------CQISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~------------~~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      ....... .......+||+.|+|||++.            ..++.++|||||||++|+..+...|+.+.
T Consensus       156 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  223 (343)
T 3dbq_A          156 QMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  223 (343)
T ss_dssp             CC-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccCcccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence            5432211 11223457999999999873            34678999999999999988888887653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.73  E-value=2.1e-18  Score=177.76  Aligned_cols=128  Identities=21%  Similarity=0.331  Sum_probs=99.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEee----cCCCceEEEe
Q psy9535         426 PVIILDTGETKQCQLFKLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGD  500 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl----~~~~~~kl~D  500 (593)
                      .++++++.+.  ..|..++.... ...+++..+..++.|++.||+|||+  .+|+||||||+|||+    +.++.+||+|
T Consensus        84 ~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           84 KVLIMEFCPC--GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             EEEEEECCTT--CBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             EEEEEeCCCC--CCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence            3566665432  34554444322 2349999999999999999999999  569999999999999    7888899999


Q ss_pred             cccceecccCCccccccccccCCCCcccccccC---------CcCCcccceecchhhhhcccccCCCccc
Q psy9535         501 FGIVKMSETSNVKTMYTENLTGTRPYMPPEAMH---------CQISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       501 fG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---------~~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      ||+++.......    .....||+.|+|||++.         ..++.++|||||||++|+..+...|+..
T Consensus       160 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  225 (319)
T 4euu_A          160 FGAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (319)
T ss_dssp             CTTCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             CCCceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999976543221    22356999999999863         4578899999999999998888888764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.73  E-value=1.5e-18  Score=183.71  Aligned_cols=135  Identities=21%  Similarity=0.312  Sum_probs=90.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  +.|..++... ...+++.+++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       121 ~~lv~e~~~~--~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  195 (373)
T 2qol_A          121 VMIVTEYMEN--GSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILINSNLVCKVSDFGLGR  195 (373)
T ss_dssp             CEEEEECCTT--CBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEeCCCC--CcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence            4566665432  3555555432 3569999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERY  565 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~  565 (593)
                      ................+++.|+|||++. ..++.++||||||+++|+..+ +..|+.+....
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~  257 (373)
T 2qol_A          196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ  257 (373)
T ss_dssp             ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH
T ss_pred             ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            6433221111122234577899999875 457889999999999998765 67776654443

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.73  E-value=3.1e-18  Score=181.51  Aligned_cols=144  Identities=25%  Similarity=0.303  Sum_probs=105.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec
Q psy9535         426 PVIILDTGETKQCQLFKLARVNN--------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  491 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~--------------~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~  491 (593)
                      ..+++++.+.  +.|..++....              ...+++..++.++.|++.||+|||+  ++|+||||||+|||++
T Consensus       150 ~~lv~e~~~~--g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          150 LYVIVEYASK--GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVT  225 (382)
T ss_dssp             CEEEEECCTT--CBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEC
T ss_pred             eEEEEEecCC--CcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCcceEEEc
Confidence            3566665432  35555554432              2469999999999999999999999  5699999999999999


Q ss_pred             CCCceEEEecccceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhh
Q psy9535         492 ENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQ  569 (593)
Q Consensus       492 ~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~  569 (593)
                      .++.+||+|||+++........ .......||+.|+|||++.+ .++.++|||||||++|+..+ ...|+.+......++
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~  304 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  304 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             CCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999998754332111 11233457889999998754 47889999999999998776 667766554444444


Q ss_pred             hhcCC
Q psy9535         570 TMLPG  574 (593)
Q Consensus       570 ~~~~~  574 (593)
                      .+..|
T Consensus       305 ~~~~~  309 (382)
T 3tt0_A          305 LLKEG  309 (382)
T ss_dssp             HHHTT
T ss_pred             HHHcC
Confidence            44444

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.73  E-value=4e-19  Score=194.21  Aligned_cols=151  Identities=23%  Similarity=0.291  Sum_probs=117.4

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEee---cCCCceEEEeccc
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI  503 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl---~~~~~~kl~DfG~  503 (593)
                      .+++++..  ...|+..+..  ..++++..+..++.|++.||+|||+  ++|+||||||+|||+   +.++.+||+|||+
T Consensus       102 ~lv~e~~~--~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  175 (484)
T 3nyv_A          102 YLVGEVYT--GGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGL  175 (484)
T ss_dssp             EEEECCCC--SCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred             EEEEecCC--CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence            45555432  2345555443  3569999999999999999999999  569999999999999   4678999999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCCcCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeEEE
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVSI  583 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (593)
                      ++.......    .....||+.|+|||++.+.++.++||||+||++|+..+...|+.+..+...++.+..|...+....|
T Consensus       176 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  251 (484)
T 3nyv_A          176 STHFEASKK----MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW  251 (484)
T ss_dssp             HHHBCCCCS----HHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG
T ss_pred             eEEcccccc----cccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            875433211    2234699999999998888899999999999999999999999888777777777777666655555


Q ss_pred             eecc
Q psy9535         584 SNHS  587 (593)
Q Consensus       584 ~~~~  587 (593)
                      ++.|
T Consensus       252 ~~~s  255 (484)
T 3nyv_A          252 KKVS  255 (484)
T ss_dssp             GGSC
T ss_pred             ccCC
Confidence            5444

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.73  E-value=1.9e-18  Score=182.16  Aligned_cols=145  Identities=26%  Similarity=0.439  Sum_probs=110.7

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      .++++++-+.  ..|..++...  ..+++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||++.
T Consensus       175 ~~lv~e~~~g--~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          175 MFLVFDLMRK--GELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             EEEEECCCTT--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEeCCC--CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence            4566665433  2444444332  469999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-------cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-------QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG  578 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-------~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  578 (593)
                      ......    ......||+.|+|||++.+       .++.++|||||||++|+..+...|+.+......++.+..|...+
T Consensus       249 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  324 (365)
T 2y7j_A          249 HLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF  324 (365)
T ss_dssp             ECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             ccCCCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            543221    1234579999999998732       36789999999999999888888887766665555555555444


Q ss_pred             Ce
Q psy9535         579 DH  580 (593)
Q Consensus       579 ~~  580 (593)
                      ..
T Consensus       325 ~~  326 (365)
T 2y7j_A          325 SS  326 (365)
T ss_dssp             CH
T ss_pred             CC
Confidence            43

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.73  E-value=1.3e-18  Score=179.06  Aligned_cols=134  Identities=27%  Similarity=0.505  Sum_probs=93.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  504 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~  504 (593)
                      ..+++++-+.  +.|..++...+ ..++++..++.++.|++.||+|||+.+.+|+||||||+|||++.++.+||+|||++
T Consensus       109 ~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          109 LSIVTEYLSR--GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             CEEEEECCTT--CBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             eEEEEecCCC--CcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            3466655332  34555544322 12489999999999999999999984444999999999999999999999999998


Q ss_pred             eecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhh
Q psy9535         505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      +......   .......||+.|+|||++.+. ++.++||||||+++|+..+...|+.+...
T Consensus       187 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~  244 (309)
T 3p86_A          187 RLKASTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP  244 (309)
T ss_dssp             ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred             ccccccc---cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            7533221   112345799999999987654 78899999999999998887777765443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.73  E-value=3.6e-18  Score=181.00  Aligned_cols=133  Identities=21%  Similarity=0.256  Sum_probs=100.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec-CCCceEEEecccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIV  504 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~-~~~~~kl~DfG~~  504 (593)
                      ..+++++.+.......... ......+++..+..++.|++.||+|||+  .+|+||||||+|||++ .++.+||+|||++
T Consensus       113 ~~lv~e~~~~~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a  189 (383)
T 3eb0_A          113 LNVIMEYVPDTLHKVLKSF-IRSGRSIPMNLISIYIYQLFRAVGFIHS--LGICHRDIKPQNLLVNSKDNTLKLCDFGSA  189 (383)
T ss_dssp             EEEEECCCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEecCCccHHHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHH--CcCccCccCHHHEEEcCCCCcEEEEECCCC
Confidence            3466666553322222221 1234579999999999999999999998  5699999999999997 6889999999999


Q ss_pred             eecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         505 KMSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      +.......    .....||+.|+|||++.+  .++.++|||||||++|+..+...|+.+....
T Consensus       190 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  248 (383)
T 3eb0_A          190 KKLIPSEP----SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSI  248 (383)
T ss_dssp             EECCTTSC----CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cccCCCCC----CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH
Confidence            85433221    223468999999998754  3788999999999999988888777665443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.73  E-value=2e-18  Score=182.31  Aligned_cols=131  Identities=22%  Similarity=0.319  Sum_probs=94.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.   .+...+.    ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~~---~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          105 VYIVMELMDA---NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEECCSE---EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             eEEEEEcCCC---CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            3566666543   3444443    258999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQ  569 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~  569 (593)
                      ......    ......||+.|+|||++.+ .++.++|||||||++|+..+...|+.+......++
T Consensus       176 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  236 (371)
T 2xrw_A          176 TAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN  236 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             cccccc----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            543211    1223578999999998755 47889999999999999888888876655443333

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.73  E-value=2.4e-18  Score=177.97  Aligned_cols=129  Identities=24%  Similarity=0.330  Sum_probs=100.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ..|..++.   ...+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus       117 ~~lv~e~~~~--~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  189 (321)
T 2c30_A          117 LWVLMEFLQG--GALTDIVS---QVRLNEEQIATVCEAVLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCA  189 (321)
T ss_dssp             EEEEECCCCS--CBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCCC--CCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCcEEEeeeeeee
Confidence            3566665332  23444433   2469999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      .......   ......||+.|+|||++.+ .++.++||||||+++|+..+...|+.+...
T Consensus       190 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~  246 (321)
T 2c30_A          190 QISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP  246 (321)
T ss_dssp             ECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             ecccCcc---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            5433211   1234579999999998755 478899999999999998887777765443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.73  E-value=2.1e-18  Score=180.13  Aligned_cols=135  Identities=28%  Similarity=0.330  Sum_probs=102.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.   .+...+.. ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~---~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET---DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE---EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC---CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            3566665543   34444433 33568999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhhchhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQ  569 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~  569 (593)
                      .......   ......||+.|+|||++.+  .++.++|||||||++|+..+...++.+......+.
T Consensus       161 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~  223 (346)
T 1ua2_A          161 SFGSPNR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT  223 (346)
T ss_dssp             TTTSCCC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             eccCCcc---cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            5432211   1233578999999998754  36789999999999999887777766655443333

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.73  E-value=1.2e-18  Score=191.61  Aligned_cols=152  Identities=22%  Similarity=0.282  Sum_probs=119.0

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC---ceEEEecc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFG  502 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~---~~kl~DfG  502 (593)
                      ..+++++-+.  ..|+..+...  .++++..+..++.|++.||+|||+  ++|+||||||+|||++.++   .+||+|||
T Consensus       121 ~~lv~e~~~g--g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  194 (504)
T 3q5i_A          121 FYLVTEFYEG--GELFEQIINR--HKFDECDAANIMKQILSGICYLHK--HNIVHRDIKPENILLENKNSLLNIKIVDFG  194 (504)
T ss_dssp             EEEEEECCTT--CBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred             EEEEEecCCC--CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence            3456655332  3455554433  469999999999999999999999  5699999999999998765   69999999


Q ss_pred             cceecccCCccccccccccCCCCcccccccCCcCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeEE
Q psy9535         503 IVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVS  582 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (593)
                      +++......    ......||+.|+|||++.+.++.++||||+||++|+.++...|+.+......++.+..|...++...
T Consensus       195 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  270 (504)
T 3q5i_A          195 LSSFFSKDY----KLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND  270 (504)
T ss_dssp             TCEECCTTS----CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred             CCEEcCCCC----ccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence            987654321    1234579999999999888889999999999999998888999988777777777777776666555


Q ss_pred             Eeecc
Q psy9535         583 ISNHS  587 (593)
Q Consensus       583 ~~~~~  587 (593)
                      |+++|
T Consensus       271 ~~~~s  275 (504)
T 3q5i_A          271 WKNIS  275 (504)
T ss_dssp             HTTSC
T ss_pred             cCCCC
Confidence            55544

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.72  E-value=4.5e-18  Score=184.48  Aligned_cols=139  Identities=25%  Similarity=0.351  Sum_probs=103.7

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|..++...+...+++..++.++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus       262 ~~iv~e~~~~--g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  337 (450)
T 1k9a_A          262 LYIVTEYMAK--GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK  337 (450)
T ss_dssp             EEEEEECCTT--CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             eEEEEEecCC--CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence            3466655332  356666665555568999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      .....      .....+++.|+|||++. ..++.++||||||+++++..+ ...|..+.....-++.+..|
T Consensus       338 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~  402 (450)
T 1k9a_A          338 EASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG  402 (450)
T ss_dssp             ECC------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT
T ss_pred             ccccc------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            53221      11235788999999874 457899999999999998776 66776654433333444444

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.72  E-value=3.1e-18  Score=178.39  Aligned_cols=129  Identities=26%  Similarity=0.411  Sum_probs=100.4

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++...+ ..+..++..  ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~lv~e~~~~g-~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          105 QLVMEKHGSG-LDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             EEEEECCTTS-CBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEeCCCC-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence            4555532221 245555543  3469999999999999999999999  5699999999999999999999999999876


Q ss_pred             cccCCccccccccccCCCCcccccccCCc-C-CcccceecchhhhhcccccCCCccchhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~-~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      ......    .....||+.|+|||++.+. + +.++||||||+++|+..+...|+.+.++
T Consensus       180 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  235 (335)
T 3dls_A          180 LERGKL----FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE  235 (335)
T ss_dssp             CCTTCC----BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG
T ss_pred             CCCCCc----eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH
Confidence            543221    2235699999999987554 4 6789999999999998888888766544

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.72  E-value=2.5e-18  Score=177.36  Aligned_cols=109  Identities=39%  Similarity=0.657  Sum_probs=89.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP  529 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aP  529 (593)
                      .++++.+++.++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++........ .......||+.|+||
T Consensus       134 ~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aP  210 (321)
T 2qkw_B          134 MSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT-HLSTVVKGTLGYIDP  210 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC-CCBCCCEEETTTCCH
T ss_pred             cccCHHHHHHHHHHHHHHHHHhcC--CCeecCCCCHHHEEECCCCCEEEeeccccccccccccc-ccccccCCCccccCH
Confidence            369999999999999999999999  66999999999999999999999999998754322111 112334689999999


Q ss_pred             cccC-CcCCcccceecchhhhhcccccCCCccc
Q psy9535         530 EAMH-CQISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       530 E~~~-~~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      |++. ..++.++||||||+++|+..+...|+..
T Consensus       211 E~~~~~~~~~~~Di~slG~il~ell~g~~p~~~  243 (321)
T 2qkw_B          211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ  243 (321)
T ss_dssp             HHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSC
T ss_pred             HHhcCCCCCcccchHhHHHHHHHHHhCCCcccc
Confidence            9874 4578899999999999987777666544

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.72  E-value=4.8e-18  Score=177.69  Aligned_cols=139  Identities=20%  Similarity=0.209  Sum_probs=102.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC-CCceEEEecccce
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVK  505 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~-~~~~kl~DfG~~~  505 (593)
                      .+++++.+......... .......+++..+..++.|++.||.|||...++|+||||||+|||++. ++.+||+|||+++
T Consensus       102 ~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~  180 (360)
T 3e3p_A          102 NVVMEYVPDTLHRCCRN-YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK  180 (360)
T ss_dssp             EEEEECCSCBHHHHHHH-HHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred             EEEeecccccHHHHHHH-HhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence            45666554332222111 122445789999999999999999999932267999999999999996 8999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-c-CCcccceecchhhhhcccccCCCccchhhhchhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-Q-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQT  570 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~  570 (593)
                      .......    .....||+.|+|||++.+ . ++.++|||||||++|+..+...|+.+......++.
T Consensus       181 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  243 (360)
T 3e3p_A          181 KLSPSEP----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE  243 (360)
T ss_dssp             CCCTTSC----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             ecCCCCC----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence            5433211    223568999999998743 3 68899999999999998888888876655444433

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.72  E-value=2.7e-18  Score=177.05  Aligned_cols=121  Identities=18%  Similarity=0.267  Sum_probs=89.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCccccc
Q psy9535         451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPE  530 (593)
Q Consensus       451 ~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE  530 (593)
                      .+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++......... ......|++.|+|||
T Consensus       133 ~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE  209 (323)
T 3qup_A          133 NLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR-QGCASKLPVKWLALE  209 (323)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC------------------CCGGGCCHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEEEcCCCCEEEeecccccccccccccc-ccccccCcccccCch
Confidence            69999999999999999999999  569999999999999999999999999987543221111 112335678899999


Q ss_pred             ccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         531 AMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       531 ~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ++.+ .++.++||||||+++|+..+ ...|+.+......++.+..+
T Consensus       210 ~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          210 SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             hhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            8754 47889999999999998777 67777665555444444443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.72  E-value=2e-18  Score=182.28  Aligned_cols=107  Identities=24%  Similarity=0.399  Sum_probs=82.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP  529 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aP  529 (593)
                      ..+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.....      .....||+.|+||
T Consensus       127 ~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aP  198 (367)
T 2fst_X          127 QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE------MTGYVATRWYRAP  198 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECC---------------------CCCTTCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEECCCCCEEEeecccccccccc------CCCcCcCcCccCh
Confidence            469999999999999999999999  56999999999999999999999999998753321      1235789999999


Q ss_pred             cccCC--cCCcccceecchhhhhcccccCCCccchhh
Q psy9535         530 EAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       530 E~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      |++.+  .++.++|||||||++|+..+...|+.+...
T Consensus       199 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  235 (367)
T 2fst_X          199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH  235 (367)
T ss_dssp             HHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             HHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            98754  478899999999999998888777765543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.72  E-value=1.8e-18  Score=182.56  Aligned_cols=143  Identities=24%  Similarity=0.300  Sum_probs=103.6

Q ss_pred             eEeecCCchhhhhHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC---ceEE
Q psy9535         427 VIILDTGETKQCQLFKLARVNN-----TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKL  498 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~---~~kl  498 (593)
                      .+++++-+.  +.|..++...+     ...+++..++.++.|++.||+|||+  ++|+||||||+|||++.++   .+||
T Consensus       150 ~lv~e~~~~--g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          150 FILLELMAG--GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             EEEEECCTT--EEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             EEEEEeCCC--CCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCCCCceEEE
Confidence            566655432  35555554432     2458999999999999999999999  5699999999999998554   5999


Q ss_pred             EecccceecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         499 GDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       499 ~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      +|||+++....... ........||+.|+|||++. ..++.++|||||||++|+..+ ...|+.+......++.+..|
T Consensus       226 ~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          226 GDFGMARDIYRAGY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             CCCHHHHHHHHHSS-CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             CCCccccccccccc-cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999874322111 11122346889999999874 457889999999999998776 66777665555444444444

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.72  E-value=2.3e-18  Score=178.55  Aligned_cols=124  Identities=20%  Similarity=0.297  Sum_probs=90.6

Q ss_pred             hhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcccccc
Q psy9535         438 CQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT  517 (593)
Q Consensus       438 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~  517 (593)
                      +.+..++... ...+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++....... ....
T Consensus       101 g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~-~~~~  176 (327)
T 3lzb_A          101 GCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-EYHA  176 (327)
T ss_dssp             CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTC--------------
T ss_pred             CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc-cccc
Confidence            4455555443 3569999999999999999999999  5699999999999999999999999999875432221 1112


Q ss_pred             ccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchhhh
Q psy9535         518 ENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERY  565 (593)
Q Consensus       518 ~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~  565 (593)
                      ....||+.|+|||++.+ .++.++||||||+++|+..+ ...|+.+....
T Consensus       177 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~  226 (327)
T 3lzb_A          177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  226 (327)
T ss_dssp             ---CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             cCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence            23457888999998754 47889999999999999777 67776654443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.72  E-value=7.3e-18  Score=174.37  Aligned_cols=125  Identities=25%  Similarity=0.371  Sum_probs=92.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCceecCCCCCcEeecCCCceEEE
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------SKPIIHRDVKSANVLLDENFVPKLG  499 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~------~~~iiHrdlKp~NILl~~~~~~kl~  499 (593)
                      ..+++++.+.  +.|..++..   ..+++..++.++.|++.||+|||+.      .++|+||||||+|||++.++.+||+
T Consensus       110 ~~lv~e~~~~--g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          110 LYLITDYHEN--GSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             EEEEECCCTT--CBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEeccCC--CcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence            3566665433  355655543   3599999999999999999999984      1279999999999999999999999


Q ss_pred             ecccceecccCCcc-ccccccccCCCCcccccccCCc-CCc------ccceecchhhhhccccc
Q psy9535         500 DFGIVKMSETSNVK-TMYTENLTGTRPYMPPEAMHCQ-IST------KTDVFSYGAQIKTQHIT  555 (593)
Q Consensus       500 DfG~~~~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~-~~~------ksDvwS~G~~i~~~~~~  555 (593)
                      |||+++........ ........||+.|+|||++.+. .+.      ++|||||||++|+..+.
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            99998654322111 1112245799999999988654 233      48999999999987666

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.72  E-value=2.9e-18  Score=180.14  Aligned_cols=125  Identities=22%  Similarity=0.268  Sum_probs=97.6

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCcEeec------CCCceEEE
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLD------ENFVPKLG  499 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~-~iiHrdlKp~NILl~------~~~~~kl~  499 (593)
                      ++++++.   .+.|..++.......+++..+..++.|++.||+|||+  + +|+||||||+|||++      ..+.+||+
T Consensus       106 ~lv~e~~---~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~  180 (373)
T 1q8y_A          106 VMVFEVL---GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIA  180 (373)
T ss_dssp             EEEECCC---CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred             EEEEecC---CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChHHeEEeccCCCcCcceEEEc
Confidence            4555543   3456666655555679999999999999999999998  4 699999999999994      44589999


Q ss_pred             ecccceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccch
Q psy9535         500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       500 DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      |||+++.....      .....||+.|+|||++.+ .++.++|||||||++|+..+...|+...
T Consensus       181 Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          181 DLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             CCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ccccccccCCC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            99998764321      123478999999998754 4788999999999999988877777643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.72  E-value=1.6e-18  Score=179.62  Aligned_cols=131  Identities=23%  Similarity=0.354  Sum_probs=97.9

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC---CCceEEEeccc
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGI  503 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~---~~~~kl~DfG~  503 (593)
                      .+++++-+.  ..|..++.......+++..+..++.|++.||+|||+  ++|+||||||+|||++.   ++.+||+|||+
T Consensus       105 ~lv~e~~~~--~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          105 ILILEYAAG--GEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEECCTT--EEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEecCC--CcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            455554332  244444443444679999999999999999999999  56999999999999987   78999999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ++......    ......||+.|+|||++.+ .++.++||||||+++|+..+...|+......
T Consensus       181 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  239 (327)
T 3lm5_A          181 SRKIGHAC----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ  239 (327)
T ss_dssp             CEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ccccCCcc----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Confidence            87643221    1223579999999998754 4788999999999999988877777554443

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.72  E-value=3.2e-18  Score=178.00  Aligned_cols=111  Identities=24%  Similarity=0.314  Sum_probs=89.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP  529 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aP  529 (593)
                      ..+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++....... ........||+.|+||
T Consensus       167 ~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aP  243 (344)
T 1rjb_A          167 NVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAP  243 (344)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHHHH--TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEEcCCCcEEeCCCccCcccccCcc-ceeccCccCccCccCH
Confidence            358999999999999999999999  5699999999999999999999999999875433221 1122334578899999


Q ss_pred             cccC-CcCCcccceecchhhhhcccc-cCCCccchh
Q psy9535         530 EAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRE  563 (593)
Q Consensus       530 E~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~  563 (593)
                      |++. ..++.++||||||+++|+..+ ...|+.+..
T Consensus       244 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          244 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             HHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9874 457889999999999999776 666765544

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.72  E-value=3.7e-18  Score=173.12  Aligned_cols=109  Identities=24%  Similarity=0.402  Sum_probs=88.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEee---cCCCceEEEecccceecccCCccccccccccCCCC
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRP  525 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~  525 (593)
                      ..++++..+..++.|++.||+|||+  ++|+||||||+|||+   +.++.+||+|||+++......    ......||+.
T Consensus       118 ~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~  191 (285)
T 3is5_A          118 GKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE----HSTNAAGTAL  191 (285)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--------------CTTGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc----cCcCcccccC
Confidence            3579999999999999999999998  569999999999999   456789999999987543221    1233568999


Q ss_pred             cccccccCCcCCcccceecchhhhhcccccCCCccchh
Q psy9535         526 YMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       526 y~aPE~~~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      |+|||++.+.++.++||||||+++|+..+...|+.+..
T Consensus       192 y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~  229 (285)
T 3is5_A          192 YMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS  229 (285)
T ss_dssp             GCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence            99999988788999999999999999888777776543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.72  E-value=4.7e-18  Score=173.99  Aligned_cols=121  Identities=18%  Similarity=0.243  Sum_probs=93.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP  529 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aP  529 (593)
                      ..+++..++.++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++....... ........||+.|+||
T Consensus       145 ~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aP  221 (314)
T 2ivs_A          145 RALTMGDLISFAWQISQGMQYLAE--MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAI  221 (314)
T ss_dssp             CEECHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCH
T ss_pred             cCcCHHHHHHHHHHHHHHHHHHHH--CCCcccccchheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccCh
Confidence            358999999999999999999999  5699999999999999999999999999875433221 1112234578889999


Q ss_pred             cccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcC
Q psy9535         530 EAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLP  573 (593)
Q Consensus       530 E~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~  573 (593)
                      |++.+ .++.++||||||+++|+..+ ...|+.+......++.+..
T Consensus       222 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  267 (314)
T 2ivs_A          222 ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT  267 (314)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred             hhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhc
Confidence            98754 47889999999999998777 6677655444333333333

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.72  E-value=3.7e-18  Score=177.20  Aligned_cols=121  Identities=26%  Similarity=0.390  Sum_probs=92.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP  529 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aP  529 (593)
                      .++++.+++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++........ .......||+.|+||
T Consensus       169 ~~l~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aP  245 (343)
T 1luf_A          169 PPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPP  245 (343)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecCh
Confidence            579999999999999999999999  56999999999999999999999999998654322111 112234678899999


Q ss_pred             cccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcC
Q psy9535         530 EAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLP  573 (593)
Q Consensus       530 E~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~  573 (593)
                      |++. ..++.++||||||+++|+..+ ...|+.+......++.+..
T Consensus       246 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  291 (343)
T 1luf_A          246 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD  291 (343)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred             hhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhC
Confidence            9874 457889999999999998776 6667655444333333333

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.72  E-value=2.8e-18  Score=177.98  Aligned_cols=134  Identities=25%  Similarity=0.293  Sum_probs=97.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEee-----cCCCceEEEe
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-----DENFVPKLGD  500 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl-----~~~~~~kl~D  500 (593)
                      ..+++++.+   +.+..++...  ..+++..+..++.|++.||+|||+  ++|+||||||+|||+     +.++.+||+|
T Consensus       108 ~~lv~e~~~---~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          108 LHLIFEYAE---NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             EEEEEECCS---EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             EEEEEecCC---CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccceEEECc
Confidence            456666654   3566665543  469999999999999999999999  569999999999999     4556699999


Q ss_pred             cccceecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhhchhh
Q psy9535         501 FGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQ  569 (593)
Q Consensus       501 fG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~  569 (593)
                      ||+++.......   ......||+.|+|||++.+  .++.++|||||||++|+..+...|+....+...+.
T Consensus       181 fg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  248 (329)
T 3gbz_A          181 FGLARAFGIPIR---QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF  248 (329)
T ss_dssp             TTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCccccCCccc---ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH
Confidence            999875432211   1223468999999998754  36889999999999999888888877665543333

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.71  E-value=6.4e-18  Score=172.44  Aligned_cols=140  Identities=16%  Similarity=0.254  Sum_probs=105.6

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.+   +...+.......+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||++.
T Consensus        83 ~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           83 MYMVMEYCVCG---MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEEECCSEE---HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEehhccCC---HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEcCCCcEEeecccccc
Confidence            45677665544   4444444445679999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCCc---CCcccceecchhhhhcccccCCCccchhhhchhhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTM  571 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~---~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~  571 (593)
                      ........ .......||+.|+|||++.+.   .+.++||||||+++|+..+...|+.+......++.+
T Consensus       158 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i  225 (305)
T 2wtk_C          158 ALHPFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI  225 (305)
T ss_dssp             ECCTTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             ccCccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH
Confidence            54322111 112345689999999987542   367899999999999988888887665444333433

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.71  E-value=3.6e-18  Score=187.55  Aligned_cols=131  Identities=21%  Similarity=0.299  Sum_probs=101.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|..++.......+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       291 ~~lv~E~~~~--g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          291 FYIITEFMTY--GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSR  366 (495)
T ss_dssp             CEEEEECCTT--CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             EEEEEEccCC--CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEECCCCcEEEeecccce
Confidence            3566665332  466677666556679999999999999999999999  569999999999999999999999999988


Q ss_pred             ecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccch
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADR  562 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~  562 (593)
                      .......  .......+++.|+|||++. ..++.++|||||||++|+..+ ...|..+.
T Consensus       367 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~  423 (495)
T 1opk_A          367 LMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  423 (495)
T ss_dssp             CCTTCCE--ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             eccCCce--eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence            6432211  1122335677899999875 457889999999999998776 55665543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.71  E-value=5.3e-18  Score=172.08  Aligned_cols=127  Identities=21%  Similarity=0.393  Sum_probs=100.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec-CCCceEEEecccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIV  504 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~-~~~~~kl~DfG~~  504 (593)
                      .++++++.+.  ..|..++...  .++++..+..++.|++.||+|||+.+.+++||||||+|||++ .++.+||+|||++
T Consensus       104 ~~lv~e~~~~--~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          104 IVLVTELMTS--GTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEECCCS--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEEecCC--CCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            3566655432  3455554432  468999999999999999999998444499999999999997 7889999999998


Q ss_pred             eecccCCccccccccccCCCCcccccccCCcCCcccceecchhhhhcccccCCCccc
Q psy9535         505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      ......     ......||+.|+|||++.+.++.++||||||+++|+..+...|+.+
T Consensus       180 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  231 (290)
T 1t4h_A          180 TLKRAS-----FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             GGCCTT-----SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccccc-----ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence            643322     1223568999999999887889999999999999998887777765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.71  E-value=2.4e-18  Score=178.26  Aligned_cols=130  Identities=24%  Similarity=0.364  Sum_probs=98.9

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.  ..|...+.  ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~--~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~  154 (323)
T 3tki_A           81 YLFLEYCSG--GELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATV  154 (323)
T ss_dssp             EEEEECCTT--EEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEcCCC--CcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEeeccce
Confidence            455554332  23444433  33469999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cC-CcccceecchhhhhcccccCCCccchh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~-~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      ...... ........||+.|+|||++.+ .+ +.++|||||||++|+.++...|+.+..
T Consensus       155 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  212 (323)
T 3tki_A          155 FRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS  212 (323)
T ss_dssp             CEETTE-ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred             eccCCc-ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            432221 112234579999999998754 33 678999999999999888777775443

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.71  E-value=6.6e-18  Score=184.70  Aligned_cols=130  Identities=22%  Similarity=0.260  Sum_probs=100.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEee---cCCCceEEEecc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFG  502 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl---~~~~~~kl~DfG  502 (593)
                      .++++++.   .+.|..++... ...+++..++.|+.||+.||+|||+  ++|+||||||+||||   +.++.+||+|||
T Consensus        78 ~~lvme~~---g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL~DFG  151 (483)
T 3sv0_A           78 NVLVMDLL---GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (483)
T ss_dssp             EEEEEECC---CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             EEEEEECC---CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEEEeCC
Confidence            35666554   34455554432 3469999999999999999999999  569999999999999   588899999999


Q ss_pred             cceecccCCccc----cccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccc
Q psy9535         503 IVKMSETSNVKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       503 ~~~~~~~~~~~~----~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      +++.........    .......||+.|+|||++.+ .++.++|||||||+||+.++...|+.+
T Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~  215 (483)
T 3sv0_A          152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG  215 (483)
T ss_dssp             TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            987654322111    11224679999999998755 478899999999999998877777654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.71  E-value=1.1e-18  Score=189.48  Aligned_cols=140  Identities=20%  Similarity=0.339  Sum_probs=103.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|..++.......+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       257 ~~lv~e~~~~--g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  332 (454)
T 1qcf_A          257 IYIITEFMAK--GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLAR  332 (454)
T ss_dssp             CEEEECCCTT--CBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred             cEEEEeecCC--CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence            3466655332  355555544333468899999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTM  571 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~  571 (593)
                      ......  ........+++.|+|||++. ..++.++|||||||++|+..+ ...|+.+......++.+
T Consensus       333 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i  398 (454)
T 1qcf_A          333 VIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL  398 (454)
T ss_dssp             GBCCHH--HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             EcCCCc--eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            543211  11112334677899999875 457889999999999998777 77777654443333333

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.71  E-value=1.2e-18  Score=182.17  Aligned_cols=127  Identities=19%  Similarity=0.310  Sum_probs=98.0

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCC----CceEEEec
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN----FVPKLGDF  501 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~----~~~kl~Df  501 (593)
                      ..+++++-+.  +.|+..+..  .+.+++..+..++.|++.||+|||+  ++|+||||||+|||+...    +.+||+||
T Consensus        91 ~~lv~E~~~g--g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~kl~Df  164 (342)
T 2qr7_A           91 VYVVTELMKG--GELLDKILR--QKFFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDF  164 (342)
T ss_dssp             EEEEECCCCS--CBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred             EEEEEeCCCC--CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence            3456655332  355555443  3569999999999999999999999  569999999999998432    35999999


Q ss_pred             ccceecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccc
Q psy9535         502 GIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       502 G~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      |+++.......   .....+||+.|+|||++.+. ++.++|||||||++|+..+...|+..
T Consensus       165 g~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  222 (342)
T 2qr7_A          165 GFAKQLRAENG---LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN  222 (342)
T ss_dssp             TTCEECBCTTC---CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             CCcccCcCCCC---ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence            99876433211   22345799999999988554 78899999999999998888888764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.71  E-value=4.9e-18  Score=185.44  Aligned_cols=139  Identities=21%  Similarity=0.383  Sum_probs=108.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+  .+.|+.++..  .+++++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~lv~E~~~--gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDLkp~NIll~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           92 FMVMEYVS--GGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNM  165 (476)
T ss_dssp             EEEEECCS--SEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEEeCCC--CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence            45665532  2456666543  3579999999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCccccccccccCCCCcccccccCCc-C-CcccceecchhhhhcccccCCCccchhhhchhhhhcCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~-~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      .....    .....+||+.|+|||++.+. + +.++|||||||++|+.++...|+.+.....-++.+..|.
T Consensus       166 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~  232 (476)
T 2y94_A          166 MSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI  232 (476)
T ss_dssp             CCTTC----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC
T ss_pred             ccccc----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC
Confidence            43321    12345799999999988664 3 678999999999999888888887766555555555443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.71  E-value=5.8e-18  Score=179.18  Aligned_cols=145  Identities=23%  Similarity=0.363  Sum_probs=96.1

Q ss_pred             cceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccc
Q psy9535         425 IPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  504 (593)
Q Consensus       425 ~~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~  504 (593)
                      ...+++++.+.  +.|..++.. ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       165 ~~~lv~e~~~~--g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DFG~a  239 (373)
T 3c1x_A          165 SPLVVLPYMKH--GDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLA  239 (373)
T ss_dssp             CCEEEEECCTT--CBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             CeEEEEECCCC--CCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEECCCCCEEEeecccc
Confidence            34566665433  356665543 33468999999999999999999999  56999999999999999999999999998


Q ss_pred             eecccCCccc-cccccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         505 KMSETSNVKT-MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       505 ~~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      +......... .......||+.|+|||++.+ .++.++||||||+++|+..+ ...|..+....-..+.+..|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~  312 (373)
T 3c1x_A          240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG  312 (373)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT
T ss_pred             ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC
Confidence            7543221111 11123457788999998754 57889999999999998777 45555544433333333333

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.71  E-value=2.4e-18  Score=173.92  Aligned_cols=141  Identities=24%  Similarity=0.318  Sum_probs=94.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ..|..++... ..++++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus        90 ~~lv~e~~~~--~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           90 VWIIMELCTL--GELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             CEEEEECCTT--EEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             cEEEEecCCC--CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEECCCCCEEECcccccc
Confidence            3466655332  3555555443 3469999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLP  573 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~  573 (593)
                      .......  .......|++.|+|||++. ..++.++||||||+++|+..+ ...|+.+......++.+..
T Consensus       165 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~  232 (281)
T 1mp8_A          165 YMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN  232 (281)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             ccCcccc--cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc
Confidence            5432211  1122345678899999875 457889999999999998775 5666655444433344433

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.71  E-value=4.2e-18  Score=172.37  Aligned_cols=129  Identities=29%  Similarity=0.393  Sum_probs=91.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCcEeecCCCceEEEecccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDFGIV  504 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~-~iiHrdlKp~NILl~~~~~~kl~DfG~~  504 (593)
                      ..+++++.+.....++.... ....++++..+..++.|++.||+|||+  + +++||||||+|||++.++.+||+|||++
T Consensus        81 ~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           81 VWICMELMDTSLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGIS  157 (290)
T ss_dssp             EEEEEECCSEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--HSCCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred             EEEEEehhccchHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecCCc
Confidence            45677665543333333222 234679999999999999999999998  4 6999999999999999999999999998


Q ss_pred             eecccCCccccccccccCCCCcccccccC-----CcCCcccceecchhhhhcccccCCCccc
Q psy9535         505 KMSETSNVKTMYTENLTGTRPYMPPEAMH-----CQISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      +......    ......||+.|+|||++.     ..++.++||||||+++|+..+...|+..
T Consensus       158 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (290)
T 3fme_A          158 GYLVDDV----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS  215 (290)
T ss_dssp             ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             ccccccc----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence            7543221    122346899999999862     2367899999999999998877777754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.71  E-value=3.3e-18  Score=181.08  Aligned_cols=133  Identities=21%  Similarity=0.299  Sum_probs=97.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  +.|..++... ...+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus       187 ~~lv~e~~~~--g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          187 IYIVMELVQG--GDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             CEEEEECCTT--CBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             cEEEEEcCCC--CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            3566665432  3455554432 2358999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRER  564 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~  564 (593)
                      ....... ........+++.|+|||++. +.++.++|||||||++|+..+ ...|..+...
T Consensus       262 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~  321 (377)
T 3cbl_A          262 EEADGVY-AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN  321 (377)
T ss_dssp             ECTTSEE-ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred             ecCCCce-eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            5432111 11111123567799999875 457889999999999998775 6666655433

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.71  E-value=6.3e-18  Score=172.07  Aligned_cols=144  Identities=24%  Similarity=0.364  Sum_probs=102.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  +.|..++.. ....+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus       102 ~~~v~e~~~~--~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          102 PLVVLPYMKH--GDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             CEEEEECCTT--CBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             eEEEEeCCCC--CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEECCCCCEEECcccccc
Confidence            4566665432  355555543 34568999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCcc-ccccccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         506 MSETSNVK-TMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       506 ~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ........ ........||+.|+|||++.+ .++.++||||||+++|+..+ ...|..+....-....+..+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~  248 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG  248 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC
Confidence            54322111 111223457889999998754 57889999999999998777 45555544444333333333

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.71  E-value=1.7e-18  Score=176.22  Aligned_cols=129  Identities=21%  Similarity=0.300  Sum_probs=92.9

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  ..|..++... ...+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~--~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPY--GSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTT--CBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCC--CCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            456654322  3555555443 2358999999999999999999998  5699999999999999999999999999876


Q ss_pred             cccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccccCCCcc
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVDIA  560 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~~~~~~~  560 (593)
                      ...............|++.|+|||++. ..++.++||||||+++|+..+...|..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~  218 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK  218 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence            433221111222345778899999874 457889999999999998776554443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.71  E-value=2.8e-18  Score=179.78  Aligned_cols=140  Identities=22%  Similarity=0.312  Sum_probs=97.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC---CCceEEEecc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFG  502 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~---~~~~kl~DfG  502 (593)
                      ..+++++.+.  +.|...+..  .+.+++..+..++.|++.||+|||+  .+|+||||||+|||++.   ++.+||+|||
T Consensus       123 ~~lv~e~~~~--~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg  196 (349)
T 2w4o_A          123 ISLVLELVTG--GELFDRIVE--KGYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFG  196 (349)
T ss_dssp             EEEEECCCCS--CBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred             EEEEEEeCCC--CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEccCc
Confidence            3456655432  355555443  3569999999999999999999999  56999999999999975   8899999999


Q ss_pred             cceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhh-chhhhhcCCC
Q psy9535         503 IVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERY-YSLQTMLPGH  575 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~  575 (593)
                      +++......    ......||+.|+|||++.+ .++.++|||||||++|+..+...|+.+.... ..++.++.+.
T Consensus       197 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~  267 (349)
T 2w4o_A          197 LSKIVEHQV----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE  267 (349)
T ss_dssp             --------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC
T ss_pred             cccccCccc----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC
Confidence            987543221    1233579999999998765 4788999999999999988887887654433 2444444443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.71  E-value=1.9e-18  Score=180.77  Aligned_cols=110  Identities=23%  Similarity=0.316  Sum_probs=89.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP  529 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aP  529 (593)
                      ..+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++....... ........||+.|+||
T Consensus       188 ~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~t~~y~aP  264 (359)
T 3vhe_A          188 DFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAP  264 (359)
T ss_dssp             TCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC--CEECGGGCCH
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhccccCCCceeECh
Confidence            458999999999999999999999  5699999999999999999999999999875432211 1122345688999999


Q ss_pred             cccC-CcCCcccceecchhhhhcccc-cCCCccch
Q psy9535         530 EAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADR  562 (593)
Q Consensus       530 E~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~  562 (593)
                      |++. ..++.++||||||+++|+..+ ...|+.+.
T Consensus       265 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  299 (359)
T 3vhe_A          265 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  299 (359)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence            9874 457889999999999998776 66666543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.71  E-value=3.9e-18  Score=171.87  Aligned_cols=129  Identities=22%  Similarity=0.346  Sum_probs=100.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..|..++......++++..++.++.|++.||.|||+  .+++||||||+|||++.++.+||+|||+++
T Consensus        95 ~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  170 (284)
T 2a19_B           95 LFIQMEFCDK--GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVT  170 (284)
T ss_dssp             EEEEECCCCS--CBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeccCC--CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHEEEcCCCCEEECcchhhe
Confidence            3566655432  355555554445679999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccch
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      .......    .....||+.|+|||++.+ .++.++||||||+++|+..+...|..+.
T Consensus       171 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  224 (284)
T 2a19_B          171 SLKNDGK----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET  224 (284)
T ss_dssp             ESSCCSC----CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH
T ss_pred             ecccccc----ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH
Confidence            6443211    223468999999998754 4788999999999999877666555443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.71  E-value=7.5e-18  Score=175.73  Aligned_cols=130  Identities=25%  Similarity=0.365  Sum_probs=98.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+   +.|...+..   ..+++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||+++
T Consensus        89 ~~lv~e~~~---~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           89 VYIIQELMQ---TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEEECCCS---EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeccC---ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            356666654   345555443   369999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccc-------cccccccCCCCcccccccC--CcCCcccceecchhhhhcccccCCCccchh
Q psy9535         506 MSETSNVKT-------MYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       506 ~~~~~~~~~-------~~~~~~~Gt~~y~aPE~~~--~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      .........       .......||+.|+|||++.  ..++.++|||||||++|+..+...|+.+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  227 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD  227 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            543221110       0112347899999999763  357889999999999999887777776554

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.71  E-value=3.7e-18  Score=175.86  Aligned_cols=129  Identities=27%  Similarity=0.391  Sum_probs=93.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         427 VIILDTGETKQCQLFKLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      .+++++-+.  ..|..++.... ....++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       137 ~lv~e~~~~--~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  212 (332)
T 3qd2_B          137 YIQMQLCRK--ENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVT  212 (332)
T ss_dssp             EEEEECCCS--SCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC--CCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEEeCCCCEEEeecCccc
Confidence            455554333  24444444322 2345667789999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCccc---------cccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCc
Q psy9535         506 MSETSNVKT---------MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDI  559 (593)
Q Consensus       506 ~~~~~~~~~---------~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~  559 (593)
                      .........         .......||+.|+|||++.+ .++.++||||||+++|+..++..+.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             ECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             ccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence            654321110         11223569999999998754 5788999999999999877655443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.71  E-value=9.3e-18  Score=172.16  Aligned_cols=125  Identities=16%  Similarity=0.270  Sum_probs=91.6

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcc
Q psy9535         448 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYM  527 (593)
Q Consensus       448 ~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~  527 (593)
                      ....+++..++.++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++........ .......|++.|+
T Consensus       140 ~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~  216 (313)
T 3brb_A          140 GPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY-RQGRIAKMPVKWI  216 (313)
T ss_dssp             SCCCCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCSGGGEEECTTSCEEECSCSCC-----------------CCGGGS
T ss_pred             CCccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEEeecCcceeccccccc-CcccccCCCcccc
Confidence            34679999999999999999999998  56999999999999999999999999998754322111 1112345788899


Q ss_pred             cccccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCCC
Q psy9535         528 PPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       528 aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      |||++.+ .++.++||||||+++|+..+ ...|+.+.......+.+..|.
T Consensus       217 aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  266 (313)
T 3brb_A          217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH  266 (313)
T ss_dssp             CHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             CchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence            9998744 47889999999999998777 666666555444444444443

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.71  E-value=7.2e-18  Score=174.24  Aligned_cols=131  Identities=27%  Similarity=0.327  Sum_probs=87.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCcEeecCCCceEEEecccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDFGIV  504 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~-~iiHrdlKp~NILl~~~~~~kl~DfG~~  504 (593)
                      ..+++++.+.....++..........+++..+..++.|++.||.|||+  . +++||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            356666665544455554444445679999999999999999999998  4 6999999999999999999999999998


Q ss_pred             eecccCCccccccccccCCCCcccccccC-----CcCCcccceecchhhhhcccccCCCccch
Q psy9535         505 KMSETSNVKTMYTENLTGTRPYMPPEAMH-----CQISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      +......    ......||+.|+|||++.     ..++.++||||||+++|+..+...|+.+.
T Consensus       174 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (327)
T 3aln_A          174 GQLVDSI----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW  232 (327)
T ss_dssp             CC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred             eeccccc----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            7543221    112236899999999873     23688999999999999988877777653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.71  E-value=7.8e-18  Score=170.43  Aligned_cols=126  Identities=21%  Similarity=0.396  Sum_probs=96.1

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCc-----eEEEec
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-----PKLGDF  501 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~-----~kl~Df  501 (593)
                      .+++++.+.  ..+...+.. ...++++..+..++.|++.||+|||+.+++++||||||+|||++.++.     +||+||
T Consensus        97 ~lv~e~~~~--~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPC--GDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTT--CBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCC--CCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            355554322  344444433 345799999999999999999999984444999999999999987776     999999


Q ss_pred             ccceecccCCccccccccccCCCCcccccccCC---cCCcccceecchhhhhcccccCCCccc
Q psy9535         502 GIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       502 G~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      |+++....      ......||+.|+|||++..   .++.++||||||+++|+..+...|+.+
T Consensus       174 g~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  230 (287)
T 4f0f_A          174 GLSQQSVH------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE  230 (287)
T ss_dssp             TTCBCCSS------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             Cccccccc------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            99874322      1233579999999998732   357899999999999998877777654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.70  E-value=3.6e-18  Score=176.28  Aligned_cols=142  Identities=23%  Similarity=0.320  Sum_probs=108.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC----ceEEEec
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLGDF  501 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~----~~kl~Df  501 (593)
                      ..+++++.+.  ..|..++..  ..++++..+..++.|++.||+|||+  .+++||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~~--~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSG--GELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCS--CBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCC--CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            3566655322  355555543  3578999999999999999999999  5699999999999999887    7999999


Q ss_pred             ccceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCC
Q psy9535         502 GIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHE  577 (593)
Q Consensus       502 G~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  577 (593)
                      |+++......    ......||+.|+|||++.+ .++.++||||||+++|+..+...|+.+......++.+..+..+
T Consensus       164 g~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  236 (321)
T 2a2a_A          164 GLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD  236 (321)
T ss_dssp             TTCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred             ccceecCccc----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc
Confidence            9987644321    1233569999999998754 4788999999999999988888888766555555555444433

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.70  E-value=7.8e-18  Score=172.51  Aligned_cols=132  Identities=21%  Similarity=0.333  Sum_probs=99.0

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec-CCCceEEEecccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIV  504 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~-~~~~~kl~DfG~~  504 (593)
                      ..+++++.+   +.+...+.   .+++++..+..++.|++.||+|||+  ++++||||||+|||++ .++.+||+|||++
T Consensus        97 ~~lv~e~~~---~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~  168 (320)
T 2i6l_A           97 VYIVQEYME---TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFINTEDLVLKIGDFGLA  168 (320)
T ss_dssp             EEEEEECCS---EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eeEEeeccC---CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCeEEEccCccc
Confidence            456666654   34555543   3579999999999999999999999  5699999999999997 5679999999998


Q ss_pred             eecccCCccccccccccCCCCcccccccC--CcCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         505 KMSETSNVKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~--~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      +................||+.|+|||++.  ..++.++||||||+++|+..+...|+.+....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  231 (320)
T 2i6l_A          169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL  231 (320)
T ss_dssp             BCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence            75432211111223346799999999763  35788999999999999988887777665543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.70  E-value=2.5e-18  Score=178.79  Aligned_cols=125  Identities=26%  Similarity=0.285  Sum_probs=94.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC--ceEEEecccceecccCCc-cccccccccCCCCccc
Q psy9535         452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF--VPKLGDFGIVKMSETSNV-KTMYTENLTGTRPYMP  528 (593)
Q Consensus       452 l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~--~~kl~DfG~~~~~~~~~~-~~~~~~~~~Gt~~y~a  528 (593)
                      +++..+..++.|++.||+|||+  ++|+||||||+|||++.++  .+||+|||+++....... .........||+.|+|
T Consensus       165 ~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a  242 (345)
T 3hko_A          165 QREKLISNIMRQIFSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA  242 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCC
T ss_pred             ccHHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccC
Confidence            4667788999999999999999  5699999999999998766  899999999875432111 1111234579999999


Q ss_pred             ccccC---CcCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCC
Q psy9535         529 PEAMH---CQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG  578 (593)
Q Consensus       529 PE~~~---~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  578 (593)
                      ||++.   ..++.++||||||+++|+..+...|+.+......+..++.+...+
T Consensus       243 PE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (345)
T 3hko_A          243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF  295 (345)
T ss_dssp             HHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCT
T ss_pred             chhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccccc
Confidence            99875   347889999999999999888888887766655555555544433

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.70  E-value=4.5e-18  Score=172.47  Aligned_cols=142  Identities=18%  Similarity=0.271  Sum_probs=104.3

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  ..|..++.. ...++++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||+++.
T Consensus        85 ~lv~e~~~~--~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           85 MLVMEMAGG--GPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             EEEEECCTT--EEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCC--CCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEEcCCCCEEECcccceee
Confidence            455554332  355555433 34569999999999999999999999  5699999999999999999999999999876


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLP  573 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~  573 (593)
                      ...............||+.|+|||++.+ .++.++||||||+++|+..+ ...|+.+.......+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~  228 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ  228 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc
Confidence            5432221112223457889999998753 47889999999999998776 7777765544433333333

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.70  E-value=4.9e-18  Score=191.26  Aligned_cols=143  Identities=18%  Similarity=0.275  Sum_probs=100.9

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  +.|..++... ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       411 ~lv~E~~~~--g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          411 MLVMEMAGG--GPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             EEEEECCTT--CBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             EEEEEeCCC--CcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence            455554332  3555555432 4569999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ...............|++.|+|||++. ..++.++|||||||++|+..+ ...|+.+......++.+..|
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~  555 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG  555 (613)
T ss_dssp             CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence            432211111112234568899999875 457889999999999998776 67777654444334444444

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.70  E-value=5.6e-18  Score=172.63  Aligned_cols=127  Identities=21%  Similarity=0.359  Sum_probs=97.1

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.  ..|..++... ..++++..++.++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++.
T Consensus       101 ~lv~e~~~~--~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPS--GSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTT--CBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCC--CcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEEcCCCCEEECccccccc
Confidence            455554332  3555555333 2469999999999999999999999  5699999999999999999999999999876


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVD  558 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~  558 (593)
                      ...............||..|+|||++.+ .++.++||||||+++|+..+...|
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  228 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDS  228 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCC
Confidence            5433222222334568889999998744 478899999999999987765544

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.70  E-value=1.2e-17  Score=169.57  Aligned_cols=131  Identities=22%  Similarity=0.339  Sum_probs=97.7

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++..  .+.+..++.. ....+++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||+++
T Consensus        98 ~~~v~e~~~--~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  172 (298)
T 3pls_A           98 PHVLLPYMC--HGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLAR  172 (298)
T ss_dssp             CEEEECCCT--TCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred             cEEEEeccc--CCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence            355655432  2355555543 34568999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCc-cccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccc
Q psy9535         506 MSETSNV-KTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       506 ~~~~~~~-~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      ....... .........|++.|+|||.+.+ .++.++||||||+++|+..+...|...
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~  230 (298)
T 3pls_A          173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR  230 (298)
T ss_dssp             TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred             cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc
Confidence            4332111 1111223467889999998755 478899999999999987774444333

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.70  E-value=3.8e-18  Score=177.64  Aligned_cols=130  Identities=25%  Similarity=0.332  Sum_probs=84.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC---CCceEEEecc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFG  502 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~---~~~~kl~DfG  502 (593)
                      ..+++++.+.  ..|..++......++++.++..++.|++.||+|||+  ++|+||||||+|||++.   ++.+||+|||
T Consensus       101 ~~lv~e~~~g--g~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          101 LLIIMECMEG--GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEECCTT--EEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEeccCC--CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            4566665432  366666666555689999999999999999999999  56999999999999976   4569999999


Q ss_pred             cceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhh
Q psy9535         503 IVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      +++.....     ......||+.|+|||++.. .++.++||||||+++|+..+...|+.+...
T Consensus       177 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  234 (336)
T 3fhr_A          177 FAKETTQN-----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG  234 (336)
T ss_dssp             TCEEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             cceecccc-----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence            98754321     1223568999999998754 468899999999999998877777755443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.70  E-value=3.5e-18  Score=172.27  Aligned_cols=142  Identities=23%  Similarity=0.384  Sum_probs=104.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  +.|..++.......+++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~v~e~~~~--~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           83 YIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             EEEEECCTT--CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCC--CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            455554322  355555443322368999999999999999999999  5699999999999999999999999999876


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ......  .......|++.|+|||++.+ .++.++||||||+++|+..+ ...|+.+......++.+..|
T Consensus       159 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  226 (279)
T 1qpc_A          159 IEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG  226 (279)
T ss_dssp             CSSSCE--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred             ccCccc--ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc
Confidence            543221  11223457889999998753 47889999999999998777 67777655444444444444

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.70  E-value=4e-18  Score=192.61  Aligned_cols=143  Identities=19%  Similarity=0.284  Sum_probs=102.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  ..|..++..  ...+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       445 ~lv~E~~~~--g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl~~~~~~kL~DFGla~~  518 (635)
T 4fl3_A          445 MLVMEMAEL--GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKA  518 (635)
T ss_dssp             EEEEECCTT--EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEEccCC--CCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence            355554332  356665543  3469999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      ...............||+.|+|||++.. .++.++|||||||++|+..+ ...|+.+......++.+..|.
T Consensus       519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~  589 (635)
T 4fl3_A          519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE  589 (635)
T ss_dssp             TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            4332211111223356788999998754 57889999999999999876 777877655554444444443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.70  E-value=1.1e-17  Score=169.09  Aligned_cols=139  Identities=22%  Similarity=0.344  Sum_probs=105.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..|...+...  .++++..+..++.|++.||+|||+  ++++||||||+||+++.++.+||+|||++.
T Consensus        89 ~~lv~e~~~~--~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           89 IYLMLEFAPR--GELYKELQKH--GRFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             EEEEECCCTT--EEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEeCCC--CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEEcCCCCEEEecccccc
Confidence            3456655432  3455554433  368999999999999999999998  569999999999999999999999999986


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      ......     .....|++.|+|||++.+ .++.++||||||+++|+..+...|+.........+.+..+.
T Consensus       163 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  228 (284)
T 2vgo_A          163 HAPSLR-----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD  228 (284)
T ss_dssp             ECSSSC-----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred             cCcccc-----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc
Confidence            543211     223578999999998765 46889999999999999888888877655544444444443

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.70  E-value=2.6e-18  Score=186.46  Aligned_cols=142  Identities=22%  Similarity=0.333  Sum_probs=101.0

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  +.|..++.......+++..++.++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++.
T Consensus       254 ~iv~e~~~~--gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          254 YIVTEYMSK--GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL  329 (452)
T ss_dssp             EEEECCCTT--CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             EEEehhhcC--CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEECCCCCEEECCCcccee
Confidence            466665332  355555544334568999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ......  .......|++.|+|||++. ..++.++||||||+++|+..+ ...|..+......++.+..|
T Consensus       330 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~  397 (452)
T 1fmk_A          330 IEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG  397 (452)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred             cCCCce--ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            432211  1112335678899999874 457889999999999998877 67777655444344444444

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.70  E-value=4e-18  Score=173.17  Aligned_cols=131  Identities=27%  Similarity=0.447  Sum_probs=91.1

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  ..|...+... ...+++..++.++.|++.||+|||+  .+++||||||+|||++.++.+||+|||+++.
T Consensus        95 ~lv~e~~~~--~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           95 AIVTQWCEG--SSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE  169 (289)
T ss_dssp             EEEEECCCE--EEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred             EEEEEecCC--CcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEEccceeccc
Confidence            455554332  3455555432 3569999999999999999999999  5699999999999999999999999999864


Q ss_pred             cccCCccccccccccCCCCcccccccC----CcCCcccceecchhhhhcccccCCCccchh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~----~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      ...... ........||+.|+|||++.    ..++.++||||||+++|+..+...|+.+..
T Consensus       170 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  229 (289)
T 3og7_A          170 KSRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN  229 (289)
T ss_dssp             ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cccccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence            332111 11123356899999999874    236779999999999999888887776543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.70  E-value=1.1e-17  Score=173.37  Aligned_cols=131  Identities=21%  Similarity=0.293  Sum_probs=96.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+..  .+..+..  ....+++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||+++
T Consensus        99 ~~lv~e~~~~~--~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  172 (331)
T 4aaa_A           99 WYLVFEFVDHT--ILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFAR  172 (331)
T ss_dssp             EEEEEECCSEE--HHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             EEEEEecCCcc--hHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEEcCCCcEEEEeCCCce
Confidence            35666654432  2222222  23469999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      .......   ......||+.|+|||++.+  .++.++|||||||++|+..+...|+......
T Consensus       173 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  231 (331)
T 4aaa_A          173 TLAAPGE---VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI  231 (331)
T ss_dssp             --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             eecCCcc---ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            5432111   1233568999999998755  4688999999999999988887777665443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.70  E-value=1.2e-17  Score=168.24  Aligned_cols=131  Identities=24%  Similarity=0.370  Sum_probs=83.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ..+..++.. ...++++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||++.
T Consensus        86 ~~lv~e~~~~--~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~  160 (278)
T 3cok_A           86 VYLVLEMCHN--GEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLAT  160 (278)
T ss_dssp             EEEEEECCTT--EEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCCC--CcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEEeeccee
Confidence            3456655332  244444443 33579999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      .......   ......||+.|+|||++.+ .++.++||||||+++|+..+...|+.....
T Consensus       161 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  217 (278)
T 3cok_A          161 QLKMPHE---KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV  217 (278)
T ss_dssp             ECC-------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred             eccCCCC---cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence            5432211   1123568999999998755 468899999999999998877777665443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.70  E-value=8.8e-18  Score=176.10  Aligned_cols=129  Identities=17%  Similarity=0.252  Sum_probs=94.6

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+   +.+...... ...++++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus       110 ~lv~e~~~---~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (362)
T 3pg1_A          110 YLVTELMR---TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHE--AGVVHRDLHPGNILLADNNDITICDFNLARE  183 (362)
T ss_dssp             EEEEECCS---EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCTTC---
T ss_pred             EEEEccCC---CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH--CcCEecCCChHHEEEcCCCCEEEEecCcccc
Confidence            56666554   345554443 34579999999999999999999999  5699999999999999999999999999874


Q ss_pred             cccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      .....    ......||+.|+|||++.+  .++.++|||||||++|+..+...|+.+....
T Consensus       184 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  240 (362)
T 3pg1_A          184 DTADA----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY  240 (362)
T ss_dssp             ----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccc----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            33221    1223568999999998754  4788999999999999988887777665433

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.70  E-value=4.8e-18  Score=171.58  Aligned_cols=138  Identities=22%  Similarity=0.320  Sum_probs=103.4

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCc---eEEEeccc
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---PKLGDFGI  503 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~---~kl~DfG~  503 (593)
                      .+++++-+.  ..+...+...  ..+++..+..++.|++.||+|||+  .+++||||||+|||++.++.   +||+|||+
T Consensus        81 ~~v~e~~~~--~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           81 YLVFDLVTG--GELFEDIVAR--EFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             EEEECCCCS--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEecCCC--CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            455554332  2444444332  468999999999999999999999  56999999999999976554   99999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCC
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~  574 (593)
                      +.......    ......||+.|+|||++.+ .++.++||||||+++|+..+...|+.+......++.+..|
T Consensus       155 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  222 (284)
T 3kk8_A          155 AIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  222 (284)
T ss_dssp             CEECCSSC----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             eEEcccCc----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc
Confidence            87544321    1233578999999998755 4788999999999999988888888766555444444433

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.70  E-value=9.8e-18  Score=180.90  Aligned_cols=129  Identities=19%  Similarity=0.262  Sum_probs=91.2

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC-----CCceEEEec
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGDF  501 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~-----~~~~kl~Df  501 (593)
                      .+++++..   +.|..++.... ..+.+..+..++.|++.||+|||+  .+|+||||||+|||++.     ...+||+||
T Consensus        94 ~lv~E~~~---g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF  167 (432)
T 3p23_A           94 YIAIELCA---ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDF  167 (432)
T ss_dssp             EEEEECCS---EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred             EEEEECCC---CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence            45665543   46666665433 345566678999999999999999  56999999999999943     346889999


Q ss_pred             ccceecccCCccccccccccCCCCcccccccCC----cCCcccceecchhhhhcccc-cCCCccc
Q psy9535         502 GIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGAQIKTQHI-TNVDIAD  561 (593)
Q Consensus       502 G~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~----~~~~ksDvwS~G~~i~~~~~-~~~~~~~  561 (593)
                      |+++...............+||+.|+|||++.+    .++.++|||||||++|+.++ ...|+.+
T Consensus       168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~  232 (432)
T 3p23_A          168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK  232 (432)
T ss_dssp             TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred             cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence            998764432211122334679999999998853    35679999999999998777 6666643

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.70  E-value=3.7e-18  Score=190.40  Aligned_cols=115  Identities=17%  Similarity=0.118  Sum_probs=75.0

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  .+|..++...  ++++..   .|+.||+.||+|||+  ++||||||||+||||+.++.+||+|||+++
T Consensus       317 ~yLVMEyv~G--~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~--~GIIHRDIKPeNILL~~dg~vKL~DFGlAr  387 (569)
T 4azs_A          317 GWLVMEKLPG--RLLSDMLAAG--EEIDRE---KILGSLLRSLAALEK--QGFWHDDVRPWNVMVDARQHARLIDFGSIV  387 (569)
T ss_dssp             EEEEEECCCS--EEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHH--TTCEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred             EEEEEecCCC--CcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHH--CCceeccCchHhEEECCCCCEEEeecccCe
Confidence            4677766432  4677766543  567765   488999999999999  569999999999999999999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCCcCCcccceecchhhhhcc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQ  552 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~ksDvwS~G~~i~~~  552 (593)
                      ......   ....+.+||+.|||||++.+++..++|+||+|++++..
T Consensus       388 ~~~~~~---~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l  431 (569)
T 4azs_A          388 TTPQDC---SWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNL  431 (569)
T ss_dssp             SCC------CCSHHHHHHHHHHHHHHC-----------------CCC
T ss_pred             eCCCCC---ccccCceechhhccHHHhCCCCCCcccccccccchhhh
Confidence            643321   12234679999999999988888899999999987753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.70  E-value=6.6e-18  Score=169.18  Aligned_cols=141  Identities=20%  Similarity=0.313  Sum_probs=103.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  ..+..++... ..++++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++.
T Consensus        79 ~lv~e~~~~--~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           79 YIVTEYISN--GCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             EEEEECCTT--CBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             EEEEEccCC--CcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEECCCCCEEEccCcccee
Confidence            456655332  2344444332 2358999999999999999999999  5699999999999999999999999999876


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      .......  ......||+.|+|||++.+ .++.++||||||+++|+..+ ...|............+..+
T Consensus       154 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~  221 (268)
T 3sxs_A          154 VLDDQYV--SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG  221 (268)
T ss_dssp             CCTTCEE--ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred             cchhhhh--cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC
Confidence            4432211  1223456778999998754 47889999999999998776 77776655544444444443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.70  E-value=1.4e-17  Score=167.77  Aligned_cols=122  Identities=19%  Similarity=0.284  Sum_probs=91.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC-----------
Q psy9535         426 PVIILDTGETKQCQLFKLARVN--NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----------  492 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~-----------  492 (593)
                      ..+++++.+.  ++|..++...  ...++++..+..++.|++.||+|||+  ++|+||||||+|||++.           
T Consensus        86 ~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~~~~~~  161 (289)
T 1x8b_A           86 MLIQNEYCNG--GSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEG  161 (289)
T ss_dssp             EEEEEECCTT--CBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC------------
T ss_pred             EEEEEEecCC--CcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCccccccc
Confidence            3566665432  2344443322  12569999999999999999999999  56999999999999984           


Q ss_pred             --------CCceEEEecccceecccCCccccccccccCCCCcccccccCCc--CCcccceecchhhhhcccccCCC
Q psy9535         493 --------NFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGAQIKTQHITNVD  558 (593)
Q Consensus       493 --------~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~ksDvwS~G~~i~~~~~~~~~  558 (593)
                              ...+||+|||++......       ....||+.|+|||++.+.  ++.++||||||+++|+......+
T Consensus       162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~  230 (289)
T 1x8b_A          162 DEDDWASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL  230 (289)
T ss_dssp             --------CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             ccccccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence                    447999999998754322       123589999999988654  45799999999999976554433

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.70  E-value=5.6e-18  Score=173.35  Aligned_cols=109  Identities=27%  Similarity=0.418  Sum_probs=88.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCccccc
Q psy9535         451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPE  530 (593)
Q Consensus       451 ~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE  530 (593)
                      ++++..++.++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++....... ........||+.|+|||
T Consensus       141 ~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE  217 (313)
T 1t46_A          141 ALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPE  217 (313)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEEcCCCCEEEcccccccccccccc-ceeccCCCCcceeeChH
Confidence            69999999999999999999999  5699999999999999999999999999875443221 11123345788999999


Q ss_pred             ccC-CcCCcccceecchhhhhcccc-cCCCccch
Q psy9535         531 AMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADR  562 (593)
Q Consensus       531 ~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~  562 (593)
                      ++. ..++.++||||||+++|+..+ ...|+.+.
T Consensus       218 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          218 SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             HhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            874 457889999999999998776 66666543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.70  E-value=7.7e-18  Score=177.75  Aligned_cols=124  Identities=20%  Similarity=0.357  Sum_probs=96.1

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+   +.+....    ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus       123 ~lv~e~~~---~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          123 YLVMPFMQ---TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             EEEEECCC---EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             EEEEcccc---ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence            45555544   3444443    2359999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ....      .....||+.|+|||++.+  .++.++|||||||++|+..+...|+.+....
T Consensus       194 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  248 (371)
T 4exu_A          194 ADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL  248 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccC------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence            4321      223578999999998754  5788999999999999988888887665433

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.70  E-value=8.7e-18  Score=174.60  Aligned_cols=144  Identities=22%  Similarity=0.312  Sum_probs=98.7

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..|..++... ...+++.+++.++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus       121 ~~lv~e~~~~--~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          121 MMIITEYMEN--GALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEEECCTT--EEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cEEEEeCCCC--CcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChheEEECCCCcEEECCCCcch
Confidence            3566665433  2455554432 3579999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ................||+.|+|||++. ..++.++||||||+++|+..+ ...|+.+......++.+..|
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  266 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG  266 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC
Confidence            5433221111122335678899999874 457889999999999998776 67777655444333444333

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.70  E-value=1.5e-17  Score=166.15  Aligned_cols=131  Identities=18%  Similarity=0.270  Sum_probs=101.8

Q ss_pred             cceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccc
Q psy9535         425 IPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  504 (593)
Q Consensus       425 ~~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~  504 (593)
                      ...+++++.+.  ++|..++......++++..+..++.|++.||+|||+.+.+++||||||+|||++.++.++|+|||++
T Consensus        83 ~~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           83 HPTLITHWMPY--GSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SCEEEEECCTT--CBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CeEeeecccCC--CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence            34566665432  4667766665555799999999999999999999984445999999999999999999999999986


Q ss_pred             eecccCCccccccccccCCCCcccccccCCc-C---CcccceecchhhhhcccccCCCccchhhh
Q psy9535         505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-I---STKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~---~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ....        .....||+.|+|||++.+. .   +.++||||||+++|+..+...|+.+....
T Consensus       161 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  217 (271)
T 3kmu_A          161 FSFQ--------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM  217 (271)
T ss_dssp             CTTS--------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH
T ss_pred             eeec--------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH
Confidence            5321        1224689999999987543 2   33799999999999988887777654443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.69  E-value=9.8e-18  Score=169.12  Aligned_cols=129  Identities=26%  Similarity=0.383  Sum_probs=97.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..+...+...  .++++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~~--~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           84 VYLILEYAPL--GTVYRELQKL--SKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             EEEEECCCTT--EEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             EEEEEecCCC--CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEeccccc
Confidence            3456655432  3444444433  468999999999999999999998  569999999999999999999999999875


Q ss_pred             ecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      .....     ......||+.|+|||++.+. ++.++||||||+++|+..+...|+......
T Consensus       158 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  213 (279)
T 3fdn_A          158 HAPSS-----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ  213 (279)
T ss_dssp             CC-------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             cCCcc-----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH
Confidence            43221     12235789999999987654 678999999999999888777776655443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.69  E-value=6e-18  Score=169.74  Aligned_cols=142  Identities=22%  Similarity=0.345  Sum_probs=104.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ..+..++.. ...++++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus        80 ~~lv~e~~~~--~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  154 (269)
T 4hcu_A           80 ICLVFEFMEH--GCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTR  154 (269)
T ss_dssp             EEEEEECCTT--CBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred             eEEEEEeCCC--CcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEEcCCCCEEeccccccc
Confidence            3566655332  245555433 33569999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ......  ........||+.|+|||++. ..++.++||||||+++|+..+ ...|+.+......++.+..+
T Consensus       155 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~  223 (269)
T 4hcu_A          155 FVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG  223 (269)
T ss_dssp             GBCCHH--HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             cccccc--cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Confidence            543221  11122345678899999875 457889999999999998776 67777665555444444444

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.69  E-value=7.6e-18  Score=180.98  Aligned_cols=131  Identities=27%  Similarity=0.364  Sum_probs=94.1

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCC---CceEEEeccc
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGI  503 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~---~~~kl~DfG~  503 (593)
                      .+++++-+.  ..|+..+.  ...++++..+..++.|++.||+|||+  ++|+||||||+|||++.+   +.+||+|||+
T Consensus       215 ~lv~e~~~~--g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          215 YIVLELMEG--GELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             EEEEECCTT--CBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             EEEEEcCCC--CcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            455554332  23444333  34579999999999999999999998  569999999999999654   4599999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccC----CcCCcccceecchhhhhcccccCCCccchhhhch
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGAQIKTQHITNVDIADRERYYS  567 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~----~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~  567 (593)
                      ++......    .....+||+.|+|||++.    ..++.++|||||||++|+.++...|+.+......
T Consensus       289 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~  352 (419)
T 3i6u_A          289 SKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS  352 (419)
T ss_dssp             TTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC
T ss_pred             ceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH
Confidence            87643221    123457999999999874    3467899999999999998888888876544433

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.69  E-value=1.7e-17  Score=169.93  Aligned_cols=129  Identities=24%  Similarity=0.330  Sum_probs=94.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..+..+...  ...+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus        77 ~~lv~e~~~~--~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  150 (311)
T 4agu_A           77 LHLVFEYCDH--TVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFAR  150 (311)
T ss_dssp             EEEEEECCSE--EHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEeCCC--chHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEEcCCCCEEEeeCCCch
Confidence            3466655433  233333332  3569999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      .......   ......||+.|+|||++.+  .++.++||||||+++|+..+...|+.+..
T Consensus       151 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  207 (311)
T 4agu_A          151 LLTGPSD---YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS  207 (311)
T ss_dssp             ECC---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hccCccc---ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            6432211   1233578999999998743  46889999999999999887777765543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.69  E-value=1.6e-17  Score=172.34  Aligned_cols=110  Identities=26%  Similarity=0.345  Sum_probs=88.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCccccc
Q psy9535         451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPE  530 (593)
Q Consensus       451 ~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE  530 (593)
                      .+++..++.++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++........ .......||+.|+|||
T Consensus       153 ~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE  229 (334)
T 2pvf_A          153 QMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPE  229 (334)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSE-ECCSCCCCCGGGCCHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCccceEEEcCCCCEEEccccccccccccccc-cccCCCCcccceeChH
Confidence            58999999999999999999999  56999999999999999999999999998754432111 1122345788899999


Q ss_pred             ccCC-cCCcccceecchhhhhcccc-cCCCccchh
Q psy9535         531 AMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRE  563 (593)
Q Consensus       531 ~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~  563 (593)
                      ++.+ .++.++||||||+++|+..+ ...|+.+..
T Consensus       230 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          230 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             HHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             HhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            8744 47889999999999998776 666665443

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.69  E-value=7.6e-18  Score=177.33  Aligned_cols=130  Identities=25%  Similarity=0.339  Sum_probs=90.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCc--eEEEeccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV--PKLGDFGI  503 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~--~kl~DfG~  503 (593)
                      ..+++++-+.  +.|...+...  +.+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.  +||+|||+
T Consensus        91 ~~lv~e~~~~--~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~  164 (361)
T 3uc3_A           91 LAIIMEYASG--GELYERICNA--GRFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGY  164 (361)
T ss_dssp             EEEEEECCCS--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred             EEEEEEeCCC--CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEeecCc
Confidence            3466665432  3455554433  369999999999999999999998  56999999999999987765  99999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcc-cceecchhhhhcccccCCCccchhhh
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTK-TDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~k-sDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ++......    ......||+.|+|||++.+ .++.+ +|||||||++|+..+...|+.+.+..
T Consensus       165 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~  224 (361)
T 3uc3_A          165 SKSSVLHS----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP  224 (361)
T ss_dssp             C-------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C
T ss_pred             cccccccC----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH
Confidence            87432211    1223569999999998744 45444 89999999999988888888776554

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.69  E-value=1.1e-17  Score=173.02  Aligned_cols=119  Identities=26%  Similarity=0.364  Sum_probs=92.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP  529 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aP  529 (593)
                      .++++.+++.++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++......    ......+++.|+||
T Consensus       137 ~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aP  210 (327)
T 1fvr_A          137 STLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAI  210 (327)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC----CC----CCTTTCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccceEEEcCCCeEEEcccCcCccccccc----cccCCCCCccccCh
Confidence            579999999999999999999999  569999999999999999999999999987432111    11223578899999


Q ss_pred             cccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         530 EAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       530 E~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      |++.+ .++.++||||||+++|+..+ ...|+.+......++.+..|
T Consensus       211 E~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  257 (327)
T 1fvr_A          211 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  257 (327)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             hhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence            98754 46889999999999999876 77777655444344444433

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.69  E-value=6.9e-18  Score=170.72  Aligned_cols=133  Identities=22%  Similarity=0.307  Sum_probs=102.2

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+  ...|..++......++++..+..++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+++.
T Consensus        85 ~~v~e~~~--~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           85 YIITEFMT--YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             EEEEECCT--TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH--HTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             EEEEEcCC--CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH--CCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            45665433  2466666666566779999999999999999999998  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERY  565 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~  565 (593)
                      ......  .......||+.|+|||++. ..++.++||||||+++|+..+ ...|..+....
T Consensus       161 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~  219 (288)
T 3kfa_A          161 MTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  219 (288)
T ss_dssp             SCSSSS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             ccCCcc--ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            432221  1122345788899999875 457889999999999998776 66666544433

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.69  E-value=5.8e-18  Score=187.63  Aligned_cols=142  Identities=22%  Similarity=0.331  Sum_probs=104.6

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  +.|..++.......+++.+++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       337 ~lv~e~~~~--gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          337 YIVTEYMSK--GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL  412 (535)
T ss_dssp             EEEECCCTT--EEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred             eEeeehhcC--CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence            566665432  356665544333568999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      .....  ........++..|+|||++. ..++.++|||||||+||+..+ ...|+.+......++.+..|
T Consensus       413 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~  480 (535)
T 2h8h_A          413 IEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG  480 (535)
T ss_dssp             CCCHH--HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT
T ss_pred             cCCCc--eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            43211  11112335678899999874 457889999999999999777 66777654443334444444

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.69  E-value=7.7e-18  Score=171.11  Aligned_cols=133  Identities=20%  Similarity=0.312  Sum_probs=99.1

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.  +.|..++...  ..+++..++.++.|++.||+|||+  .+++||||||+|||++.++.+||+|||+++.
T Consensus        93 ~lv~e~~~~--~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           93 MLVMEMAEL--GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEEECCTT--EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCC--CCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            455555432  3555555443  469999999999999999999999  5699999999999999999999999999876


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchhhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERY  565 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~  565 (593)
                      ...............|++.|+|||++.+ .++.++||||||+++|+..+ ...|+.+....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~  227 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS  227 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            5432221111222346788999998754 46889999999999998777 67777654443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.69  E-value=9.5e-18  Score=172.98  Aligned_cols=133  Identities=24%  Similarity=0.309  Sum_probs=97.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..|..++.......+++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||++.
T Consensus       102 ~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A          102 LWLVMEFCGA--GSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             EEEEEECCTT--EEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             EEEEEEcCCC--CcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence            3566665432  345555544444579999999999999999999999  569999999999999999999999999986


Q ss_pred             ecccCCccccccccccCCCCcccccccC------CcCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~------~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ......   .......||+.|+|||++.      ..++.++||||||+++|+..+...|+.+....
T Consensus       178 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  240 (326)
T 2x7f_A          178 QLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM  240 (326)
T ss_dssp             ----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             ecCcCc---cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence            543211   1122356899999999874      24688999999999999988888877655443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.69  E-value=9.4e-18  Score=169.14  Aligned_cols=139  Identities=25%  Similarity=0.351  Sum_probs=97.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ++|..++...+...+++..+..++.|++.||+|||+  ++++||||||+||+++.++.+||+|||+++
T Consensus        90 ~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  165 (278)
T 1byg_A           90 LYIVTEYMAK--GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK  165 (278)
T ss_dssp             CEEEECCCTT--EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             eEEEEecCCC--CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEEeCCCcEEEeeccccc
Confidence            4566665432  244444443333358899999999999999999999  569999999999999999999999999986


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      .....      .....|++.|+|||++.+ .++.++||||||+++|+..+ +..|..+.......+.+..|
T Consensus       166 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~  230 (278)
T 1byg_A          166 EASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG  230 (278)
T ss_dssp             ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred             ccccc------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence            43321      122357889999998744 57889999999999998776 66666554433333333333

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.69  E-value=7.2e-18  Score=179.65  Aligned_cols=128  Identities=21%  Similarity=0.330  Sum_probs=98.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEee----cCCCceEEEe
Q psy9535         426 PVIILDTGETKQCQLFKLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGD  500 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl----~~~~~~kl~D  500 (593)
                      .++++++.+.  ..|..++.... ...+++..++.++.|++.||+|||+  ++|+||||||+|||+    +.++.+||+|
T Consensus        84 ~~lv~e~~~~--g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           84 KVLIMEFCPC--GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             EEEEECCCTT--EEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             eEEEEecCCC--CCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeEEEec
Confidence            3566665332  35555554322 2349999999999999999999999  569999999999999    7788899999


Q ss_pred             cccceecccCCccccccccccCCCCcccccccC---------CcCCcccceecchhhhhcccccCCCccc
Q psy9535         501 FGIVKMSETSNVKTMYTENLTGTRPYMPPEAMH---------CQISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       501 fG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---------~~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      ||+++......    ......||+.|+|||++.         ..++.++|||||||++|+..+...|+..
T Consensus       160 FG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~  225 (396)
T 4eut_A          160 FGAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (396)
T ss_dssp             GGGCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             CCCceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            99997643321    122357999999999874         2357799999999999998888888764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.68  E-value=6.2e-18  Score=171.19  Aligned_cols=140  Identities=21%  Similarity=0.298  Sum_probs=99.9

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.  +.+...+... ...+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~v~e~~~~--~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPL--GSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTT--CBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccC--CCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEEcCCCCEEEcccccccc
Confidence            355554322  3444444332 2458999999999999999999999  5699999999999999999999999999876


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTM  571 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~  571 (593)
                      ...............||+.|+|||++.+ .++.++||||||+++|+..+ ...|+.+......++.+
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  237 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI  237 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH
Confidence            5432222112233457888999998754 46889999999999998877 67776655444333333

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.68  E-value=1e-17  Score=173.99  Aligned_cols=101  Identities=14%  Similarity=0.086  Sum_probs=83.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCcEeecCCC--------------------ceEEEecccceecc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLH-SLSKPIIHRDVKSANVLLDENF--------------------VPKLGDFGIVKMSE  508 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH-~~~~~iiHrdlKp~NILl~~~~--------------------~~kl~DfG~~~~~~  508 (593)
                      ..+++..+..++.|++.||+||| +  ++|+||||||+|||++.++                    .+||+|||+++...
T Consensus       156 ~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~  233 (336)
T 2vuw_A          156 KLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER  233 (336)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC
Confidence            46899999999999999999999 8  5699999999999999887                    89999999998543


Q ss_pred             cCCccccccccccCCCCcccccccCCcCCcccceecchhhhhc-ccccCCCcc
Q psy9535         509 TSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKT-QHITNVDIA  560 (593)
Q Consensus       509 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~ksDvwS~G~~i~~-~~~~~~~~~  560 (593)
                      ..        ..+||+.|||||++.+..+.++||||+|+++.. ......|+.
T Consensus       234 ~~--------~~~gt~~y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          234 DG--------IVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             TT--------EEECCCCTTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             CC--------cEEEeecccChhhhcCCCccceehhhhhCCCCcccccccCCCc
Confidence            21        247999999999997777889999999888443 333444443

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.68  E-value=6.4e-18  Score=174.74  Aligned_cols=133  Identities=18%  Similarity=0.280  Sum_probs=99.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ..|..++.... .++++..++.++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus       101 ~~lv~e~~~~--~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          101 LRLVMEYLPS--GCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEEECCTT--CBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEEEeecCC--CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCCEEEcccccce
Confidence            3456654322  34444443322 359999999999999999999999  569999999999999999999999999988


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      ................||+.|+|||++.+ .++.++||||||+++|+..+...|.....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~  234 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS  234 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence            65433222222334568889999998754 46889999999999998777666654443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.68  E-value=9.2e-18  Score=169.37  Aligned_cols=142  Identities=25%  Similarity=0.352  Sum_probs=104.7

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC----ceEEEec
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLGDF  501 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~----~~kl~Df  501 (593)
                      ..+++++.+.  ..|..++...  .++++..+..++.|++.||+|||+  ++++||||||+||+++.++    .+||+||
T Consensus        83 ~~lv~e~~~~--~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           83 VVLILELVSG--GELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEEECCCS--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEeecCC--CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCCCceEEEec
Confidence            3556655322  3455544332  468999999999999999999998  5699999999999998876    8999999


Q ss_pred             ccceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCC
Q psy9535         502 GIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHE  577 (593)
Q Consensus       502 G~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  577 (593)
                      |++.......    ......||+.|+|||++.+ .++.++||||||+++|+..+...|+.+......++.+..+...
T Consensus       157 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  229 (283)
T 3bhy_A          157 GIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD  229 (283)
T ss_dssp             TTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred             ccceeccCCC----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC
Confidence            9987543221    1223468999999998754 4788999999999999988888887766655555555444433

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.68  E-value=1.4e-17  Score=171.92  Aligned_cols=129  Identities=27%  Similarity=0.384  Sum_probs=99.3

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec-CCCceEEEecccce
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVK  505 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~-~~~~~kl~DfG~~~  505 (593)
                      ++++++.+. ...|..++...  .++++..+..++.|++.||+|||+  .+|+||||||+|||++ .++.+||+|||+++
T Consensus       124 ~lv~e~~~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          124 VLILERPEP-VQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             EEEEECCSS-EEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEcCCC-CccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            445554332 13455554433  468999999999999999999999  5699999999999999 78899999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cC-CcccceecchhhhhcccccCCCccchhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~-~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ......     .....||+.|+|||++.+ .+ +.++||||||+++|+..+...|+...++.
T Consensus       199 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  255 (320)
T 3a99_A          199 LLKDTV-----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI  255 (320)
T ss_dssp             ECCSSC-----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH
T ss_pred             cccccc-----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh
Confidence            644221     223568999999998743 33 67899999999999988888887766544

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.68  E-value=7.6e-18  Score=169.64  Aligned_cols=135  Identities=26%  Similarity=0.376  Sum_probs=97.7

Q ss_pred             ceEeecCCchhhhhHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---CCceecCCCCCcEeecCCCceEEEe
Q psy9535         426 PVIILDTGETKQCQLFKLARV--NNTPPLDSNKRYSIALGVAEALHYLHSLS---KPIIHRDVKSANVLLDENFVPKLGD  500 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~--~~~~~l~~~~~~~i~~~ia~gl~ylH~~~---~~iiHrdlKp~NILl~~~~~~kl~D  500 (593)
                      ..+++++.+.  ..|..++..  ....++++..++.++.|++.||+|||+.+   .+++||||||+|||++.++.+||+|
T Consensus        82 ~~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~d  159 (279)
T 2w5a_A           82 LYIVMEYCEG--GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  159 (279)
T ss_dssp             EEEEEECCTT--EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECC
T ss_pred             EEEEEeCCCC--CCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence            3566665432  233333322  23456999999999999999999999833   2299999999999999999999999


Q ss_pred             cccceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         501 FGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       501 fG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ||+++......   .......||+.|+|||++.+ .++.++||||||+++|+..+...|+......
T Consensus       160 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  222 (279)
T 2w5a_A          160 FGLARILNHDT---SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK  222 (279)
T ss_dssp             CCHHHHC---C---HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             Cchheeecccc---ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH
Confidence            99986543211   11123468999999998754 4788999999999999988877777665443

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.68  E-value=1.3e-17  Score=172.01  Aligned_cols=129  Identities=22%  Similarity=0.313  Sum_probs=98.2

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.  ..|..++..   ..+++..++.++.|++.||+|||+  .+++||||||+|||++.++.+||+|||+++.
T Consensus       111 ~lv~e~~~~--~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          111 QLVMEYVPL--GSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEEECCCTT--CBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEecccC--CcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            456655322  355555543   348999999999999999999999  5699999999999999999999999999876


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccch
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      ...............||+.|+|||++.+ .++.++||||||+++|+..+...|....
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~  240 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP  240 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence            5433221112233467889999998754 4788999999999999988776665543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.68  E-value=2e-17  Score=169.81  Aligned_cols=127  Identities=28%  Similarity=0.428  Sum_probs=92.8

Q ss_pred             eEeecCCchhhhhHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCcEeecCCCc-eEEEeccc
Q psy9535         427 VIILDTGETKQCQLFKLARVNNT-PPLDSNKRYSIALGVAEALHYLHSLS-KPIIHRDVKSANVLLDENFV-PKLGDFGI  503 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~-~~l~~~~~~~i~~~ia~gl~ylH~~~-~~iiHrdlKp~NILl~~~~~-~kl~DfG~  503 (593)
                      .+++++.+.  +.|..++...+. ..+++..++.++.|++.||+|||+.. ++|+||||||+|||++.++. +||+|||+
T Consensus        75 ~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~  152 (307)
T 2eva_A           75 CLVMEYAEG--GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT  152 (307)
T ss_dssp             EEEEECCTT--CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred             EEEEEcCCC--CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence            566665432  355555544332 35788999999999999999999843 46999999999999988876 79999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccc
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      +......      .....||+.|+|||++.+ .++.++||||||+++|+..+...|+.+
T Consensus       153 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  205 (307)
T 2eva_A          153 ACDIQTH------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE  205 (307)
T ss_dssp             ------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred             ccccccc------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence            8643221      122468999999998765 478899999999999988877777653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.68  E-value=4e-18  Score=175.02  Aligned_cols=131  Identities=21%  Similarity=0.270  Sum_probs=94.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCc---eEEEecc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---PKLGDFG  502 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~---~kl~DfG  502 (593)
                      ..+++++-+.  +.|..++...  .++++..+..++.|++.||+|||+  ++|+||||||+|||++.++.   +||+|||
T Consensus        86 ~~lv~e~~~~--~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           86 FYLVFEKMRG--GSILSHIHKR--RHFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             EEEEEECCTT--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             EEEEEEcCCC--CcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            3566665432  3455554433  468999999999999999999999  56999999999999987765   9999999


Q ss_pred             cceecccCCc----cccccccccCCCCcccccccCC------cCCcccceecchhhhhcccccCCCccch
Q psy9535         503 IVKMSETSNV----KTMYTENLTGTRPYMPPEAMHC------QISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       503 ~~~~~~~~~~----~~~~~~~~~Gt~~y~aPE~~~~------~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      +++.......    ........+||+.|+|||++..      .++.++|||||||++|+..+...|+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  229 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR  229 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence            9864322110    0111123469999999998742      3688999999999999988777777553

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.68  E-value=9.9e-18  Score=169.25  Aligned_cols=129  Identities=22%  Similarity=0.262  Sum_probs=95.4

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  +.|..++... ..++++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++.
T Consensus        88 ~~v~e~~~~--~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           88 WIIMELYPY--GELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEEECCTT--CBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEEecCCC--CCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            455554332  3455554433 3468999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccch
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADR  562 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~  562 (593)
                      ......  .......|++.|+|||++.+ .++.++||||||+++|+..+ ...|+...
T Consensus       163 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~  218 (281)
T 3cc6_A          163 IEDEDY--YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL  218 (281)
T ss_dssp             C-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccccc--cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence            432211  11223457888999998753 57889999999999998776 66676543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.68  E-value=3.3e-17  Score=170.31  Aligned_cols=128  Identities=26%  Similarity=0.400  Sum_probs=99.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..|..+....  ..+++.++..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       116 ~~lv~e~~~~--~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          116 VFVVLELCRR--RSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             EEEEECCCTT--CBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCCC--CCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence            3566665432  3444444332  468999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccch
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      .......   ......||+.|+|||++.+ .++.++||||||+++|+..+...|+...
T Consensus       190 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  244 (335)
T 2owb_A          190 KVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS  244 (335)
T ss_dssp             ECCSTTC---CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             ecccCcc---cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence            5432211   1233578999999998754 4688999999999999887777776554

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.68  E-value=1.9e-17  Score=165.51  Aligned_cols=142  Identities=22%  Similarity=0.337  Sum_probs=104.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..|..++... ...+++..+..++.|++.||+|||+  ++++||||||+||+++.++.+||+|||+++
T Consensus        78 ~~lv~e~~~~--~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~  152 (267)
T 3t9t_A           78 ICLVTEFMEH--GCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTR  152 (267)
T ss_dssp             CEEEECCCTT--CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred             eEEEEeCCCC--CcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEECCCCCEEEccccccc
Confidence            4566665432  2455554433 3568999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ......  ........|++.|+|||++. ..++.++||||||+++|+..+ ...|+.+......++.+..|
T Consensus       153 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~  221 (267)
T 3t9t_A          153 FVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG  221 (267)
T ss_dssp             GBCCHH--HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             cccccc--ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Confidence            543211  11122345778899999875 457889999999999998777 67777665444444444444

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.68  E-value=1.1e-17  Score=172.27  Aligned_cols=113  Identities=22%  Similarity=0.357  Sum_probs=89.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP  529 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aP  529 (593)
                      .++++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++........ .......||+.|+||
T Consensus       133 ~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aP  209 (322)
T 1p4o_A          133 APPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSP  209 (322)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCE-EGGGSSEECGGGCCH
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEEEcCCCeEEECcCcccccccccccc-ccccCCCCCCCccCh
Confidence            467999999999999999999999  56999999999999999999999999998754322111 112234578899999


Q ss_pred             cccCC-cCCcccceecchhhhhcccc-cCCCccchhhh
Q psy9535         530 EAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERY  565 (593)
Q Consensus       530 E~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~  565 (593)
                      |++.+ .++.++||||||+++|+..+ ...|..+....
T Consensus       210 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  247 (322)
T 1p4o_A          210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE  247 (322)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred             hhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence            98754 47889999999999998776 56666554433

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.68  E-value=6.8e-18  Score=172.57  Aligned_cols=138  Identities=22%  Similarity=0.311  Sum_probs=103.6

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEee---cCCCceEEEeccc
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI  503 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl---~~~~~~kl~DfG~  503 (593)
                      .+++++.+.  ..|...+...  +++++..+..++.|++.||+|||+  .+++||||||+|||+   +.++.+||+|||+
T Consensus        82 ~lv~e~~~~--~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~  155 (304)
T 2jam_A           82 YLVMQLVSG--GELFDRILER--GVYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGL  155 (304)
T ss_dssp             EEEECCCCS--CBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred             EEEEEcCCC--ccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence            455555322  3444444333  468999999999999999999999  569999999999999   7788999999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCC
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      ++.....     ......||+.|+|||++.+ .++.++||||||+++|+..+...|+.+....-.++.+..|.
T Consensus       156 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  223 (304)
T 2jam_A          156 SKMEQNG-----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY  223 (304)
T ss_dssp             TCCCCCB-----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC
T ss_pred             ceecCCC-----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence            8753321     1123468999999998855 47889999999999999888888876655444444444443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.68  E-value=2.9e-17  Score=166.90  Aligned_cols=131  Identities=25%  Similarity=0.379  Sum_probs=100.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..+..+....  ..+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus        90 ~~lv~e~~~~--~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           90 VFVVLELCRR--RSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             EEEEEECCTT--CBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCCC--CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEcCCCCEEEEeccCce
Confidence            3566665432  3444444332  469999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      .......   ......||+.|+|||++.+. ++.++||||||+++|+..+...|+.+....
T Consensus       164 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  221 (294)
T 2rku_A          164 KVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK  221 (294)
T ss_dssp             ECCSTTC---CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             ecccCcc---ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            5432211   12335689999999987554 688999999999999988877777654433

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.68  E-value=5.8e-18  Score=175.25  Aligned_cols=110  Identities=27%  Similarity=0.413  Sum_probs=88.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP  529 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aP  529 (593)
                      .++++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++....... ........||+.|+||
T Consensus       159 ~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aP  235 (333)
T 2i1m_A          159 STASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAP  235 (333)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCH
T ss_pred             cccCHHHHHHHHHHHHHHHHHHhc--CCcccCCcccceEEECCCCeEEECccccccccccccc-eeecCCCCCCccccCH
Confidence            468999999999999999999999  5699999999999999999999999999875432211 1112334578899999


Q ss_pred             cccC-CcCCcccceecchhhhhcccc-cCCCccch
Q psy9535         530 EAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADR  562 (593)
Q Consensus       530 E~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~  562 (593)
                      |++. ..++.++||||||+++|+..+ ...|+.+.
T Consensus       236 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  270 (333)
T 2i1m_A          236 ESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI  270 (333)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             HHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence            9874 457889999999999998776 55665543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.68  E-value=1.5e-17  Score=173.87  Aligned_cols=105  Identities=22%  Similarity=0.406  Sum_probs=87.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCccccc
Q psy9535         451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPE  530 (593)
Q Consensus       451 ~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE  530 (593)
                      .+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++.....      .....||+.|+|||
T Consensus       122 ~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE  193 (353)
T 3coi_A          122 KFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPE  193 (353)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTCCEEECSTTCTTC--------------CCSBCCSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeECCCCcEEEeecccccCCCCC------ccccccCcCcCCHH
Confidence            59999999999999999999999  56999999999999999999999999998753321      12346899999999


Q ss_pred             ccCC--cCCcccceecchhhhhcccccCCCccchh
Q psy9535         531 AMHC--QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       531 ~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      ++.+  .++.++||||||+++|+..+...|+.+..
T Consensus       194 ~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  228 (353)
T 3coi_A          194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  228 (353)
T ss_dssp             HHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred             HHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            8754  46889999999999999888887776544

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.68  E-value=1.4e-17  Score=169.40  Aligned_cols=141  Identities=24%  Similarity=0.382  Sum_probs=106.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  +.|..++...  .++++..+..++.|++.||+|||+  .+++||||||+||+++.++.+||+|||++.
T Consensus        99 ~~lv~e~~~~--~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           99 FFLVFDLMKK--GELFDYLTEK--VTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             EEEEEECCTT--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeccCC--CcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEcCCCcEEEecccchh
Confidence            3566665432  3455554432  468999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccC-------CcCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-------CQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHH  576 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-------~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  576 (593)
                      ......    ......|++.|+|||++.       ..++.++||||||+++|+..+...|+.+......++.+..+..
T Consensus       173 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  246 (298)
T 1phk_A          173 QLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY  246 (298)
T ss_dssp             ECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             hcCCCc----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence            543221    123356899999999863       2367899999999999998888888776655544444444443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.67  E-value=1.9e-17  Score=171.02  Aligned_cols=122  Identities=21%  Similarity=0.328  Sum_probs=95.0

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC-ceEEEecccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFGIV  504 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~-~~kl~DfG~~  504 (593)
                      ..+++++.+.  ..+..+..     .+++..+..++.|++.||+|||+  ++|+||||||+|||++.++ .+||+|||++
T Consensus       108 ~~lv~e~~~~--~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a  178 (330)
T 3nsz_A          108 PALVFEHVNN--TDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLA  178 (330)
T ss_dssp             EEEEEECCCC--CCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEeccCc--hhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence            3556655432  23443332     38899999999999999999998  5699999999999999776 8999999999


Q ss_pred             eecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCcc
Q psy9535         505 KMSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIA  560 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~  560 (593)
                      +.......    .....||+.|+|||++.+  .++.++|||||||++|+..+...|+.
T Consensus       179 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~  232 (330)
T 3nsz_A          179 EFYHPGQE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF  232 (330)
T ss_dssp             EECCTTCC----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             eEcCCCCc----cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            76433221    233578999999998754  47889999999999999888777774

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.67  E-value=1.4e-17  Score=168.10  Aligned_cols=141  Identities=21%  Similarity=0.322  Sum_probs=103.3

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  ..|..++... ...+++.++..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++.
T Consensus        95 ~lv~e~~~~--~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  169 (283)
T 3gen_A           95 FIITEYMAN--GCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY  169 (283)
T ss_dssp             EEEECCCTT--CBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred             EEEEeccCC--CcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEEcCCCCEEEcccccccc
Confidence            456654322  3455554432 2469999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      .....  ........||+.|+|||++. ..++.++||||||+++|+..+ ...|+.+.......+.+..+
T Consensus       170 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~  237 (283)
T 3gen_A          170 VLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG  237 (283)
T ss_dssp             BCCHH--HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred             ccccc--cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc
Confidence            43221  11122345678899999875 457889999999999998776 77777655544444444433

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.67  E-value=7.9e-18  Score=172.50  Aligned_cols=108  Identities=23%  Similarity=0.327  Sum_probs=87.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCccccc
Q psy9535         451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPE  530 (593)
Q Consensus       451 ~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE  530 (593)
                      .+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++....... ........||+.|+|||
T Consensus       144 ~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE  220 (316)
T 2xir_A          144 FLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPE  220 (316)
T ss_dssp             CEEHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCch
Confidence            38899999999999999999999  5699999999999999999999999999875432211 11223346788999999


Q ss_pred             ccCC-cCCcccceecchhhhhcccc-cCCCccc
Q psy9535         531 AMHC-QISTKTDVFSYGAQIKTQHI-TNVDIAD  561 (593)
Q Consensus       531 ~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~  561 (593)
                      ++.+ .++.++||||||+++|+..+ ...|+.+
T Consensus       221 ~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             hhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            8744 57889999999999998776 6666654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.67  E-value=3.3e-17  Score=168.19  Aligned_cols=131  Identities=23%  Similarity=0.272  Sum_probs=96.7

Q ss_pred             eEeecCCchhhhhHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccc
Q psy9535         427 VIILDTGETKQCQLFKLARV--NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  504 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~--~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~  504 (593)
                      .+++++.+.  +.|..++..  ....++++..++.++.|++.||+|||+  .+++||||||+|||++.++.+||+|||++
T Consensus       106 ~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          106 WLLLPFFKR--GTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEECCTT--CBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             EEEEEeCCC--CcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            455555433  234333322  234679999999999999999999999  56999999999999999999999999987


Q ss_pred             eecccCCccc------cccccccCCCCcccccccCCc----CCcccceecchhhhhcccccCCCccc
Q psy9535         505 KMSETSNVKT------MYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       505 ~~~~~~~~~~------~~~~~~~Gt~~y~aPE~~~~~----~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      +.........      .......||+.|+|||++.+.    ++.++||||||+++|+..+...|+..
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            6432111000      001224579999999987543    57899999999999998877777654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.67  E-value=2.2e-17  Score=169.51  Aligned_cols=127  Identities=29%  Similarity=0.443  Sum_probs=92.9

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.   .+.|..++...  .++++..+..++.|++.||+|||+  .+++||||||+|||+++ +.+||+|||+++.
T Consensus       104 ~lv~e~~---~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~  175 (313)
T 3cek_A          104 YMVMECG---NIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVD-GMLKLIDFGIANQ  175 (313)
T ss_dssp             EEEECCC---SEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred             EEEEecC---CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEEC-CeEEEeecccccc
Confidence            4555532   34566555543  478999999999999999999999  56999999999999965 7999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCC------------cCCcccceecchhhhhcccccCCCccch
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC------------QISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~------------~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      ...... ........||+.|+|||++.+            .++.++||||||+++|+..+...|+.+.
T Consensus       176 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          176 MQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             ---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence            432211 111233568999999998753            4677999999999999988777776543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.67  E-value=3e-17  Score=164.77  Aligned_cols=130  Identities=24%  Similarity=0.364  Sum_probs=98.1

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.  ..|...+.  ....+++..+..++.|++.||+|||+  ++++||||||+||+++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~--~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  154 (276)
T 2yex_A           81 YLFLEYCSG--GELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATV  154 (276)
T ss_dssp             EEEEECCTT--EEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC--CcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence            455554322  23433332  23468999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCCc-C-CcccceecchhhhhcccccCCCccchh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~-~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      ...... ........||+.|+|||++.+. + +.++||||||+++|+..+...|+....
T Consensus       155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  212 (276)
T 2yex_A          155 FRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS  212 (276)
T ss_dssp             CEETTE-ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred             cCCCcc-hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence            432211 1112345789999999988653 3 668999999999999888777775543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.67  E-value=2.3e-17  Score=170.56  Aligned_cols=130  Identities=21%  Similarity=0.287  Sum_probs=97.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..|..++... ...+++..++.++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus       119 ~~lv~e~~~~--~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          119 LKLIMEYLPY--GSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             CEEEECCCTT--CBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eEEEEECCCC--CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            3456655332  3555555443 3469999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCcc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIA  560 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~  560 (593)
                      ................|+..|+|||++.+ .++.++||||||+++|+..+...|..
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~  249 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK  249 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence            65432221111223457788999998754 46889999999999998776555543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.67  E-value=2e-17  Score=165.78  Aligned_cols=130  Identities=25%  Similarity=0.423  Sum_probs=93.6

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCcEeecC--------CCce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDE--------NFVP  496 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~-~iiHrdlKp~NILl~~--------~~~~  496 (593)
                      ..+++++.+.  +.+..++.   ..++++..+..++.|++.||+|||+.+. +++||||||+|||++.        ++.+
T Consensus        81 ~~lv~e~~~~--~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           81 LCLVMEFARG--GPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             CEEEEECCTT--EEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             eEEEEEcCCC--CCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence            3566665432  23444432   3579999999999999999999998432 2899999999999986        6789


Q ss_pred             EEEecccceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         497 KLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       497 kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ||+|||+++......     .....||+.|+|||++.+ .++.++||||||+++|+..+...|+.+....
T Consensus       156 kl~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  220 (271)
T 3dtc_A          156 KITDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL  220 (271)
T ss_dssp             EECCCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred             EEccCCccccccccc-----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999987543221     123468999999998754 4788999999999999988888887765544

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.67  E-value=3.8e-17  Score=167.40  Aligned_cols=109  Identities=27%  Similarity=0.435  Sum_probs=81.3

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcc
Q psy9535         448 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYM  527 (593)
Q Consensus       448 ~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~  527 (593)
                      ....+++..++.++.|++.||+|||+  .+++||||||+|||++.++.+||+|||+++......   .......|++.|+
T Consensus       129 ~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~  203 (310)
T 2wqm_A          129 QKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGTPYYM  203 (310)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC---------------------CCSSC
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC---ccccccCCCeeEe
Confidence            34579999999999999999999999  569999999999999999999999999987543211   1122346899999


Q ss_pred             cccccCC-cCCcccceecchhhhhcccccCCCccc
Q psy9535         528 PPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       528 aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      |||++.+ .++.++||||||+++|+..+...|+.+
T Consensus       204 aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  238 (310)
T 2wqm_A          204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  238 (310)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred             ChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            9998754 478899999999999988877777654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.67  E-value=1.6e-17  Score=168.11  Aligned_cols=118  Identities=23%  Similarity=0.321  Sum_probs=91.6

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCc--------eEE
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV--------PKL  498 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~--------~kl  498 (593)
                      .+++++.+.  +.|..++... ...+++..+..++.|++.||+|||+  ++++||||||+|||++.++.        +||
T Consensus        88 ~lv~e~~~~--~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           88 ILVQEFVKF--GSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             EEEEECCTT--CBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             EEEEECCCC--CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEecCCcccccccceeee
Confidence            566655432  3555555443 2348999999999999999999999  56999999999999988876        999


Q ss_pred             EecccceecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccC
Q psy9535         499 GDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITN  556 (593)
Q Consensus       499 ~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~  556 (593)
                      +|||++.....       .....||+.|+|||++.+  .++.++||||||+++|+..+..
T Consensus       163 ~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~  215 (289)
T 4fvq_A          163 SDPGISITVLP-------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGG  215 (289)
T ss_dssp             CCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTT
T ss_pred             ccCcccccccC-------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCC
Confidence            99999764321       112357899999998754  4788999999999999877633

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.67  E-value=3.9e-17  Score=166.70  Aligned_cols=128  Identities=29%  Similarity=0.402  Sum_probs=99.6

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..+..++.   ..++++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||++.
T Consensus        95 ~~lv~e~~~~--~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  167 (303)
T 3a7i_A           95 LWIIMEYLGG--GSALDLLE---PGPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAG  167 (303)
T ss_dssp             EEEEEECCTT--EEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEeCCC--CcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEECCCCCEEEeecccce
Confidence            3566665432  24444443   3579999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      .......   ......||+.|+|||++.+ .++.++||||||+++|+..+...|..+..
T Consensus       168 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  223 (303)
T 3a7i_A          168 QLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH  223 (303)
T ss_dssp             ECBTTBC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             ecCcccc---ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence            5433211   1234578999999998754 46889999999999999887777765443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.67  E-value=1.9e-17  Score=168.50  Aligned_cols=115  Identities=29%  Similarity=0.406  Sum_probs=89.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCc--cccccccccCCCCc
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNV--KTMYTENLTGTRPY  526 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~Gt~~y  526 (593)
                      ...+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||++........  .........||+.|
T Consensus       115 ~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y  192 (303)
T 2vwi_A          115 SGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW  192 (303)
T ss_dssp             TCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccc
Confidence            4569999999999999999999998  5699999999999999999999999999764332111  11112335689999


Q ss_pred             ccccccCC--cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         527 MPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       527 ~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      +|||++..  .++.++||||||+++|+..+...|+.+....
T Consensus       193 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  233 (303)
T 2vwi_A          193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM  233 (303)
T ss_dssp             CCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred             cCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh
Confidence            99998753  4788999999999999988887777654443

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.67  E-value=3.5e-17  Score=168.07  Aligned_cols=130  Identities=22%  Similarity=0.292  Sum_probs=91.8

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.  ..|..++...  .++++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||++..
T Consensus       110 ~lv~e~~~~--~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (309)
T 2h34_A          110 YVDMRLING--VDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLVDFGIASA  183 (309)
T ss_dssp             EEEEECCCC--EEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred             EEEEEecCC--CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence            455554332  2444444433  469999999999999999999999  5699999999999999999999999999865


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      ......  .......|++.|+|||++.+ .++.++||||||+++|+..+...|+.....
T Consensus       184 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  240 (309)
T 2h34_A          184 TTDEKL--TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL  240 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH
T ss_pred             cccccc--ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH
Confidence            432211  11223468999999998755 468899999999999998887777765443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.67  E-value=2.3e-17  Score=169.20  Aligned_cols=127  Identities=28%  Similarity=0.370  Sum_probs=90.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.......+..    ....++++..+..++.|++.||+|||+. .+++||||||+|||++.++.+||+|||+++
T Consensus        99 ~~lv~e~~~~~~~~l~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  173 (318)
T 2dyl_A           99 VFIAMELMGTCAEKLKK----RMQGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGQIKLCDFGISG  173 (318)
T ss_dssp             EEEEECCCSEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHH-HCCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             EEEEEeccCCcHHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhh-CCEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence            35666665322222221    1235799999999999999999999972 159999999999999999999999999986


Q ss_pred             ecccCCccccccccccCCCCcccccccC------CcCCcccceecchhhhhcccccCCCccc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~------~~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      ......    ......||+.|+|||++.      ..++.++||||||+++|+..+...|+.+
T Consensus       174 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (318)
T 2dyl_A          174 RLVDDK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN  231 (318)
T ss_dssp             -----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             hccCCc----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence            543221    122346899999999873      2367899999999999998888778765

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.67  E-value=2.3e-17  Score=170.24  Aligned_cols=129  Identities=26%  Similarity=0.363  Sum_probs=98.1

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC---ceEEEeccc
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFGI  503 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~---~~kl~DfG~  503 (593)
                      .+++++.+.  ..|...+.  ....+++.....++.|++.||+|||+  ++++||||||+|||++.++   .+||+|||+
T Consensus        90 ~lv~e~~~~--~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           90 YIVLELMEG--GELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             EEEEECCTT--EETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             EEEEecCCC--CcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            455555332  34444443  34579999999999999999999998  5699999999999998765   499999999


Q ss_pred             ceecccCCccccccccccCCCCccccccc----CCcCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~----~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ++......    ......||+.|+|||++    ...++.++||||||+++|+..+...|+......
T Consensus       164 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  225 (322)
T 2ycf_A          164 SKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  225 (322)
T ss_dssp             CEECCCCH----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred             ceeccccc----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence            87643221    11234689999999986    234788999999999999988887777654443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.66  E-value=2.9e-17  Score=170.36  Aligned_cols=123  Identities=24%  Similarity=0.338  Sum_probs=93.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCceecCCCCCcEeecCCCceE
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLH--------SLSKPIIHRDVKSANVLLDENFVPK  497 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH--------~~~~~iiHrdlKp~NILl~~~~~~k  497 (593)
                      ..+++++.+.  +.|..++..   .++++..++.++.|++.||+|||        +  ++++||||||+|||++.++.+|
T Consensus       115 ~~lv~e~~~~--g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          115 LWLVSDYHEH--GSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK--PAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             EEEEECCCTT--CBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB--CEEECSCCSGGGEEECTTSCEE
T ss_pred             eEEEEeecCC--CcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc--CCeeeCCCCHHHEEECCCCCEE
Confidence            3566665433  355555543   35899999999999999999999        6  6699999999999999999999


Q ss_pred             EEecccceecccCCcc-ccccccccCCCCcccccccCCc-------CCcccceecchhhhhccccc
Q psy9535         498 LGDFGIVKMSETSNVK-TMYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGAQIKTQHIT  555 (593)
Q Consensus       498 l~DfG~~~~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~-------~~~ksDvwS~G~~i~~~~~~  555 (593)
                      |+|||+++........ ........||+.|+|||++.+.       ++.++||||||+++|+..+.
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            9999998754332211 1112345799999999988653       23689999999999987665

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.66  E-value=2.2e-17  Score=178.16  Aligned_cols=132  Identities=24%  Similarity=0.347  Sum_probs=88.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCC-----CCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCC-------
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPP-----LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-------  493 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~-----l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~-------  493 (593)
                      ..+++++..   +.|..++.......     .++..++.++.|++.||+|||+  .+|+||||||+|||++.+       
T Consensus        84 ~~lv~E~~~---gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~~  158 (434)
T 2rio_A           84 LYIALELCN---LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQ  158 (434)
T ss_dssp             EEEEECCCS---EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSCC
T ss_pred             EEEEEecCC---CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCccccccc
Confidence            356666543   35666554432111     1333467899999999999999  569999999999999654       


Q ss_pred             ------CceEEEecccceecccCCcc-ccccccccCCCCcccccccCC--------cCCcccceecchhhhhcccc-cCC
Q psy9535         494 ------FVPKLGDFGIVKMSETSNVK-TMYTENLTGTRPYMPPEAMHC--------QISTKTDVFSYGAQIKTQHI-TNV  557 (593)
Q Consensus       494 ------~~~kl~DfG~~~~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~--------~~~~ksDvwS~G~~i~~~~~-~~~  557 (593)
                            +.+||+|||+++........ ........||+.|+|||++.+        .++.++|||||||++|+..+ ...
T Consensus       159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~  238 (434)
T 2rio_A          159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH  238 (434)
T ss_dssp             TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence                  48999999998865432211 111234579999999998743        36889999999999999877 667


Q ss_pred             Cccch
Q psy9535         558 DIADR  562 (593)
Q Consensus       558 ~~~~~  562 (593)
                      |+.+.
T Consensus       239 Pf~~~  243 (434)
T 2rio_A          239 PFGDK  243 (434)
T ss_dssp             TTCST
T ss_pred             CCCCc
Confidence            76543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.66  E-value=5.5e-17  Score=164.67  Aligned_cols=124  Identities=27%  Similarity=0.403  Sum_probs=89.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  +.|..++... ...+++..++.++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus        90 ~~lv~e~~~~--~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  164 (303)
T 1zy4_A           90 LFIQMEYCEN--GTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAK  164 (303)
T ss_dssp             EEEEEECCCS--CBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred             eEEEEecCCC--CCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEEEcCCCCEEEeeCcchh
Confidence            4566665432  3555555432 3467889999999999999999999  569999999999999999999999999986


Q ss_pred             ecccCCc-----------cccccccccCCCCcccccccCC--cCCcccceecchhhhhcccc
Q psy9535         506 MSETSNV-----------KTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHI  554 (593)
Q Consensus       506 ~~~~~~~-----------~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~  554 (593)
                      .......           .........||+.|+|||++.+  .++.++||||||+++|+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            5432100           0011223568999999998754  47889999999999998765

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.66  E-value=1.6e-17  Score=168.38  Aligned_cols=141  Identities=23%  Similarity=0.324  Sum_probs=104.3

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCC---CceEEEeccc
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGI  503 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~---~~~kl~DfG~  503 (593)
                      .+++++.+.  ..+...+...  .++++..+..++.|++.||+|||+  ++++||||||+|||++.+   +.+||+|||+
T Consensus        97 ~lv~e~~~~--~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           97 YIVGELYTG--GELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEECCCCS--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEccCC--CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            455554322  2344443332  368999999999999999999999  569999999999999754   4799999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCCcCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCC
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHE  577 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  577 (593)
                      +........    .....||+.|+|||++.+.++.++||||||+++|+..+...|+.+....-.++.+..|...
T Consensus       171 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  240 (287)
T 2wei_A          171 STCFQQNTK----MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA  240 (287)
T ss_dssp             GGTBCCCSS----CSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             ceeecCCCc----cccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence            875432211    1223588999999998888899999999999999988888887766555445555444433

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.66  E-value=5.5e-17  Score=166.57  Aligned_cols=140  Identities=26%  Similarity=0.321  Sum_probs=97.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.  +.|..++... ...+++..+..++.|++.||+|||+  ++++||||||+|||++ ++.+||+|||+++.
T Consensus       105 ~iv~e~~~~--~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          105 AIITSLCKG--RTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             EEECBCCCS--EEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             EEEeecccC--CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            455554322  4555555432 3469999999999999999999999  5699999999999998 67999999999764


Q ss_pred             cccCCc--cccccccccCCCCcccccccCC----------cCCcccceecchhhhhcccccCCCccchhhhchhhhhc
Q psy9535         507 SETSNV--KTMYTENLTGTRPYMPPEAMHC----------QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTML  572 (593)
Q Consensus       507 ~~~~~~--~~~~~~~~~Gt~~y~aPE~~~~----------~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~  572 (593)
                      ......  .........||+.|+|||++..          .++.++||||||+++|+..+...|+.+......+..+.
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  256 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG  256 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            321111  1111223468999999998753          35779999999999999888777776554443333333

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.65  E-value=8.4e-17  Score=167.43  Aligned_cols=121  Identities=26%  Similarity=0.344  Sum_probs=97.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCccc
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMP  528 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~a  528 (593)
                      ..++++..+..++.|++.||+|||+ .++++||||||+|||++.++.+||+|||++......     ......||+.|+|
T Consensus       145 ~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~a  218 (348)
T 2pml_X          145 TCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMP  218 (348)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecCCChHhEEEcCCCcEEEeccccccccccc-----cccCCCCCcCccC
Confidence            5679999999999999999999997 134999999999999999999999999998754322     1234578999999


Q ss_pred             ccccCCc--CCc-ccceecchhhhhcccccCCCccchhh-hchhhhhcCCC
Q psy9535         529 PEAMHCQ--IST-KTDVFSYGAQIKTQHITNVDIADRER-YYSLQTMLPGH  575 (593)
Q Consensus       529 PE~~~~~--~~~-ksDvwS~G~~i~~~~~~~~~~~~~~~-~~~~~~~~~~~  575 (593)
                      ||++.+.  ++. ++||||||+++|+..+...|+..... ...++.+..+.
T Consensus       219 PE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~  269 (348)
T 2pml_X          219 PEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN  269 (348)
T ss_dssp             GGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCC
T ss_pred             chhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC
Confidence            9988654  445 89999999999998888888876655 33444444443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.65  E-value=4.9e-17  Score=164.90  Aligned_cols=129  Identities=29%  Similarity=0.370  Sum_probs=96.9

Q ss_pred             eEeecCCchhhhhHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC-CCceEEEecccc
Q psy9535         427 VIILDTGETKQCQLFKLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIV  504 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~-~~~~kl~DfG~~  504 (593)
                      .+++++.+.  +.|..++... +..++++..+..++.|++.||+|||+  ++++||||||+|||++. ++.+||+|||++
T Consensus        95 ~lv~e~~~~--~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~  170 (295)
T 2clq_A           95 KIFMEQVPG--GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTS  170 (295)
T ss_dssp             EEEEECCSE--EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred             EEEEEeCCC--CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEECCCCCEEEeecccc
Confidence            455554322  3444444433 23457788999999999999999999  56999999999999987 889999999998


Q ss_pred             eecccCCccccccccccCCCCcccccccCCc---CCcccceecchhhhhcccccCCCccch
Q psy9535         505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~---~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      +......   .......||+.|+|||++.+.   ++.++||||||+++|+..+...|+.+.
T Consensus       171 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  228 (295)
T 2clq_A          171 KRLAGIN---PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL  228 (295)
T ss_dssp             EESCC--------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred             cccCCCC---CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence            7543211   112345789999999987432   678999999999999988877777543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.65  E-value=7e-17  Score=165.56  Aligned_cols=129  Identities=24%  Similarity=0.345  Sum_probs=99.4

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.  +.|..++... ..++++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++..
T Consensus       100 ~lv~e~~~~--~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  174 (314)
T 3com_A          100 WIVMEYCGA--GSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             EEEEECCTT--EEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEeecCCC--CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence            456655332  2444444322 3579999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      ......   ......||+.|+|||++.+ .++.++||||||+++|+..+...|+.+..
T Consensus       175 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  229 (314)
T 3com_A          175 LTDTMA---KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH  229 (314)
T ss_dssp             CBTTBS---CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             hhhhcc---ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            432211   1233568999999998755 47889999999999999887777765543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.65  E-value=2.3e-17  Score=168.03  Aligned_cols=132  Identities=23%  Similarity=0.296  Sum_probs=95.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  +.+..++... ...+++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||++.
T Consensus        91 ~~lv~e~~~~--~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  165 (302)
T 2j7t_A           91 LWIMIEFCPG--GAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSA  165 (302)
T ss_dssp             EEEEEECCTT--EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred             EEEEEEeCCC--CcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence            3556655332  2333333322 3469999999999999999999999  569999999999999999999999999865


Q ss_pred             ecccCCccccccccccCCCCccccccc------CCcCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAM------HCQISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~------~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      .....   ........||+.|+|||++      ...++.++||||||+++|+..+...|.......
T Consensus       166 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  228 (302)
T 2j7t_A          166 KNLKT---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM  228 (302)
T ss_dssp             HHHHH---HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             ccccc---ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence            32111   0111234689999999986      234688999999999999887777776654433

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.65  E-value=7.6e-17  Score=169.93  Aligned_cols=151  Identities=13%  Similarity=0.100  Sum_probs=97.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCC---c----hhHHhh--hcHHHHHHHHHHHhcCCCCc
Q psy9535         109 PYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS---D----NTEAAM--IPILLFENEVQTLSQCKHVN  179 (593)
Q Consensus       109 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~---~----~~~~~~--~~~~~f~~Ev~il~~l~HpN  179 (593)
                      ..++++.+||+|+||.||+|...+|+.||||+++..........   +    ......  +......+|...|.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34567889999999999999988899999998864321100000   0    000000  00011234556666654433


Q ss_pred             eeeEEEEEecccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC
Q psy9535         180 LLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  259 (593)
Q Consensus       180 Iv~l~g~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~  259 (593)
                      +. ....+.....+|||||+.+++|.++..       .  .....++.|++.||.|||+  .+||||||||.|||+++++
T Consensus       175 v~-vp~p~~~~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~--~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          175 FP-VPEPIAQSRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAK--HGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             CS-CCCEEEEETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEEEEE
T ss_pred             CC-CCeeeeccCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEeCCC
Confidence            21 111111234589999999988865321       1  1234678999999999998  5699999999999998776


Q ss_pred             ----------ccEEeeccccee
Q psy9535         260 ----------VPKLGDFGIVKM  271 (593)
Q Consensus       260 ----------~~Kl~DFGla~~  271 (593)
                                .+.|+||+-+..
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEE
T ss_pred             CcccccccccceEEEEeCCccc
Confidence                      378999996543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.65  E-value=4.4e-17  Score=168.45  Aligned_cols=140  Identities=23%  Similarity=0.299  Sum_probs=99.0

Q ss_pred             eEeecCCchhhhhHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC---CCceEE
Q psy9535         427 VIILDTGETKQCQLFKLARVNNT-----PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKL  498 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~---~~~~kl  498 (593)
                      .+++++-+  .+.|..++.....     ..+++..++.++.|++.||+|||+  .+++||||||+|||++.   +..+||
T Consensus       109 ~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          109 FILMELMA--GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             EEEEECCT--TEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             EEEEecCC--CCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecCCCcceEEE
Confidence            56665532  2355555544322     458999999999999999999999  56999999999999984   456999


Q ss_pred             EecccceecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhh
Q psy9535         499 GDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTM  571 (593)
Q Consensus       499 ~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~  571 (593)
                      +|||+++....... ........||+.|+|||++. ..++.++||||||+++|+..+ ...|+.+......++.+
T Consensus       185 ~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  258 (327)
T 2yfx_A          185 GDFGMARDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV  258 (327)
T ss_dssp             CCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             Cccccccccccccc-cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence            99999864322111 11122346789999999874 457889999999999998776 66666554443333333

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.65  E-value=2.9e-17  Score=172.14  Aligned_cols=128  Identities=25%  Similarity=0.395  Sum_probs=97.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..|..++...  +.+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~~lv~e~~~~--~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          106 ISICMEHMDG--GSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSG  180 (360)
T ss_dssp             EEEEECCCTT--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             EEEEEECCCC--CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHh-CCEEcCCccHHHEEECCCCCEEEEECCCCc
Confidence            4566665432  3455554433  3689999999999999999999972 159999999999999999999999999986


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      .....     ......||+.|+|||++.+ .++.++||||||+++|+..+...|+....
T Consensus       181 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          181 QLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             HHHHH-----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             ccccc-----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            43211     1223579999999998755 47889999999999999888777776543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.65  E-value=4.8e-17  Score=184.47  Aligned_cols=131  Identities=26%  Similarity=0.355  Sum_probs=96.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|..++... ..++++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       465 ~~lv~E~~~~--g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          465 VWIIMELCTL--GELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             CEEEEECCTT--CBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             eEEEEEcCCC--CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            3566665432  3555555443 3469999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRE  563 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~  563 (593)
                      .......  .......||+.|||||++.+ .++.++||||||+++|+..+ ...|+.+..
T Consensus       540 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  597 (656)
T 2j0j_A          540 YMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK  597 (656)
T ss_dssp             SCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ecCCCcc--eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            5432211  11223456789999998744 57889999999999998775 556665443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	593
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-63
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-22
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-22
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-52
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-18
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-18
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-51
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-20
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-50
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-17
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-49
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-18
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-49
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-17
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-49
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-19
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-49
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-20
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-16
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-47
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-17
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-47
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-16
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-47
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-16
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-47
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-16
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-47
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-18
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-16
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-46
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-14
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-45
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-19
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-45
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-15
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-45
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-17
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-45
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-18
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-44
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-13
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-14
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-43
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-14
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-15
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-43
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-17
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-42
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-15
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-42
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-16
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-42
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-17
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-42
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-14
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-12
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-13
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-41
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-13
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-39
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-12
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-38
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-10
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-13
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-13
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-13
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-37
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-14
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-37
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-13
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-36
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-12
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-36
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-14
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-08
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-13
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-11
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-35
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-13
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-34
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-12
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-34
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-14
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-34
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-09
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-11
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-12
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-13
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-32
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-12
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-11
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-29
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-10
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-28
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-09
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-27
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-08
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-27
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-08
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-25
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-06
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-08
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-24
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-07
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-19
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-06

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 9e-63
 Identities = 79/281 (28%), Positives = 132/281 (46%), Gaps = 28/281 (9%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           G ++G G FGTVY GK     ++AVK L    N ++      +A       F+NEV  L 
Sbjct: 13  GQRIGSGSFGTVYKGKWHG--DVAVKML----NVTAPTPQQLQA-------FKNEVGVLR 59

Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 233
           + +HVN+L  +G        IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 60  KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGM 117

Query: 234 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 293
            YLH  +K IIHRD+KS N+ L E+   K+GDFG+  +    +    +   L+G+  +M 
Sbjct: 118 DYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMA 174

Query: 294 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 349
           PE +  Q     S ++DV+++G++L EL+TG  P  + N       +V      R  L  
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-----RGYLSP 229

Query: 350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
           +  +      + +  ++  +C   ++D+R     I+  +  
Sbjct: 230 DLSKVRSNCPKAMKRLM-AECLKKKRDERPLFPQILASIEL 269

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.4 bits (237), Expect = 2e-22
 Identities = 35/111 (31%), Positives = 58/111 (52%), Gaps = 8/111 (7%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L+    +  T   +  K   IA   A+ + YLH+  K IIHRD+KS N+ L E+   K+G
Sbjct: 90  LYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIG 146

Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYG 546
           DFG+  +    +    +   L+G+  +M PE +  Q     S ++DV+++G
Sbjct: 147 DFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 9e-55
 Identities = 65/284 (22%), Positives = 117/284 (41%), Gaps = 35/284 (12%)

Query: 110 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 168
           + +   ++G G F TVY G      +E+A   L++     S               F+ E
Sbjct: 10  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-----------FKEE 58

Query: 169 VQTLSQCKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            + L   +H N++R      + +       +V E M +G+L   L R      +      
Sbjct: 59  AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLR 115

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNMKTMYT 282
           S    + + L +LH+ + PIIHRD+K  N+ +       K+GD G+  +   S  K +  
Sbjct: 116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-- 173

Query: 283 ENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
               GT  +M PE    +     DV+++G+ +LE+ T   P  +       Y  V   V 
Sbjct: 174 ---IGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 230

Query: 343 VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD 386
                      +++  +  +  I+ E C    KD+R S++D+++
Sbjct: 231 --------PASFDKVAIPEVKEII-EGCIRQNKDERYSIKDLLN 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.1 bits (236), Expect = 2e-22
 Identities = 26/102 (25%), Positives = 45/102 (44%), Gaps = 6/102 (5%)

Query: 446 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-DENFVPKLGDFGIV 504
           +     +      S    + + L +LH+ + PIIHRD+K  N+ +       K+GD G+ 
Sbjct: 103 LKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162

Query: 505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYG 546
            +   S  K +      GT  +M PE    +     DV+++G
Sbjct: 163 TLKRASFAKAV-----IGTPEFMAPEMYEEKYDESVDVYAFG 199

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 8e-52
 Identities = 63/278 (22%), Positives = 117/278 (42%), Gaps = 30/278 (10%)

Query: 112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
           +   +LG GQFG V+ G      ++AVK+L+  +    +              F  E   
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--------------FLAEANL 61

Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           + Q +H  L+RL  +       I+ EYM NGSL D L +  +   L  NK   +A  +AE
Sbjct: 62  MKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAE 120

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +               +
Sbjct: 121 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG--AKFPIKW 176

Query: 292 MPP-EAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 350
             P    +   + K+DV+S+G++L E++T  +      T       +E+   +       
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM------- 229

Query: 351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL 388
                +   E L  ++   C     + R +   +  +L
Sbjct: 230 --VRPDNCPEELYQLM-RLCWKERPEDRPTFDYLRSVL 264

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.9 bits (207), Expect = 1e-18
 Identities = 26/111 (23%), Positives = 53/111 (47%), Gaps = 5/111 (4%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L    +  +   L  NK   +A  +AE + ++    +  IHRD+++AN+L+ +    K+ 
Sbjct: 94  LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIA 151

Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPP-EAMHCQISTKTDVFSYGAQI 549
           DFG+ ++ E +  +    E       +  P    +   + K+DV+S+G  +
Sbjct: 152 DFGLARLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-51
 Identities = 65/306 (21%), Positives = 112/306 (36%), Gaps = 48/306 (15%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
              +G+G+FG V+ GK + G E+AVK   +    S                 E E+    
Sbjct: 8   QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTV 52

Query: 174 QCKHVNLLRLLGLCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
             +H N+L  +   N          +V +Y  +GSL+D L R      +       +AL 
Sbjct: 53  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALS 108

Query: 229 VAEALHYLHSL------SKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMY 281
            A  L +LH           I HRD+KS N+L+ +N    + D G+       ++   + 
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168

Query: 282 TENLTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY 334
             +  GT+ YM PE +       H +   + D+++ G++  E+         +      Y
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228

Query: 335 LVVEQEVPVREVLDKEAGE----------WNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
             +    P  E + K   E          W       ++  +  +C       R +   I
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288

Query: 385 VDLLSK 390
              LS+
Sbjct: 289 KKTLSQ 294

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.7 bits (206), Expect = 2e-18
 Identities = 28/118 (23%), Positives = 48/118 (40%), Gaps = 14/118 (11%)

Query: 443 LARVNNTPPLDSNKRYSIALGVAEALHYLHSL------SKPIIHRDVKSANVLLDENFVP 496
           L    N   +       +AL  A  L +LH           I HRD+KS N+L+ +N   
Sbjct: 88  LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147

Query: 497 KLGDFGIVK-MSETSNVKTMYTENLTGTRPYMPPEAM-------HCQISTKTDVFSYG 546
            + D G+       ++   +   +  GT+ YM PE +       H +   + D+++ G
Sbjct: 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 5e-51
 Identities = 70/276 (25%), Positives = 119/276 (43%), Gaps = 35/276 (12%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           G  LG+G+FG VY  + K +   +A+K L      +       E           EV+  
Sbjct: 11  GRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQ------LRREVEIQ 60

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H N+LRL G  ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELAN 117

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T+      GT  Y
Sbjct: 118 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL-----CGTLDY 170

Query: 292 MPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 350
           +PPE +  +    K D++S GV+  E L G  P + N     Y  +   E    + + + 
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 230

Query: 351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD 386
           A +            +  +       +R  +R++++
Sbjct: 231 ARD------------LISRLLKHNPSQRPMLREVLE 254

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.1 bits (218), Expect = 4e-20
 Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 8/103 (7%)

Query: 446 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 505
           +      D  +  +    +A AL Y HS  K +IHRD+K  N+LL      K+ DFG   
Sbjct: 97  LQKLSKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSV 154

Query: 506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGA 547
            + +S   T+      GT  Y+PPE +  +    K D++S G 
Sbjct: 155 HAPSSRRTTL-----CGTLDYLPPEMIEGRMHDEKVDLWSLGV 192

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 4e-50
 Identities = 59/281 (20%), Positives = 114/281 (40%), Gaps = 36/281 (12%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             ++G GQFG V+ G   N  ++A+KT+   A                   F  E + + 
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--------------FIEEAEVMM 55

Query: 174 QCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           +  H  L++L G+C      C+V+E+M +G L D            +     + L V E 
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY--LRTQRGLFAAETLLGMCLDVCEG 113

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + YL      +IHRD+ + N L+ EN V K+ DFG+ +     + +   +        + 
Sbjct: 114 MAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWA 169

Query: 293 PPE-AMHCQISTKTDVFSYGVILLELLTGMKPI--DDNNTILYYYLVVEQEVPVREVLDK 349
            PE     + S+K+DV+S+GV++ E+ +  K    + +N+ +   +     +    +   
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 229

Query: 350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
              +            +   C     + R +   ++  L++
Sbjct: 230 HVYQ------------IMNHCWKERPEDRPAFSRLLRQLAE 258

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.6 bits (193), Expect = 8e-17
 Identities = 26/101 (25%), Positives = 44/101 (43%), Gaps = 5/101 (4%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
                  +     + L V E + YL      +IHRD+ + N L+ EN V K+ DFG+ + 
Sbjct: 93  TQRGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRF 150

Query: 507 SETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
                 +   +        +  PE     + S+K+DV+S+G
Sbjct: 151 VLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG 189

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 1e-49
 Identities = 69/284 (24%), Positives = 118/284 (41%), Gaps = 42/284 (14%)

Query: 112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
           +    +G+G+FG V  G  + G ++AVK ++N+A   +               F  E   
Sbjct: 10  KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASV 53

Query: 172 LSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
           ++Q +H NL++LLG+         IV EYM  GSL D L R      L  +     +L V
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDV 112

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
            EA+ YL       +HRD+ + NVL+ E+ V K+ DFG+ K + ++              
Sbjct: 113 CEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK------LPV 164

Query: 290 PYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPI--DDNNTILYYYLVVEQEVPVREV 346
            +  PE     + STK+DV+S+G++L E+ +  +          +   +    ++   + 
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 224

Query: 347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
                 E            V + C   +   R S   + + L  
Sbjct: 225 CPPAVYE------------VMKNCWHLDAAMRPSFLQLREQLEH 256

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.6 bits (201), Expect = 7e-18
 Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 9/108 (8%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L    R      L  +     +L V EA+ YL       +HRD+ + NVL+ E+ V K+ 
Sbjct: 88  LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVS 145

Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
           DFG+ K + ++       +       +  PE     + STK+DV+S+G
Sbjct: 146 DFGLTKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFG 187

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 1e-49
 Identities = 64/280 (22%), Positives = 117/280 (41%), Gaps = 34/280 (12%)

Query: 112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
           R   KLG+G FG V+ G       +A+KTL+       +              F  E Q 
Sbjct: 20  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--------------FLQEAQV 65

Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           + + +H  L++L  + +     IV EYM  GSL D   +      L   +   +A  +A 
Sbjct: 66  MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIAS 124

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + Y+       +HRD+++AN+L+ EN V K+ DFG+ ++ E +       +       +
Sbjct: 125 GMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA--RQGAKFPIKW 180

Query: 292 MPPE-AMHCQISTKTDVFSYGVILLELLTGMKPI--DDNNTILYYYLVVEQEVPVREVLD 348
             PE A++ + + K+DV+S+G++L EL T  +       N  +   +     +P      
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 240

Query: 349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL 388
           +   +            +  +C   E ++R +   +   L
Sbjct: 241 ESLHD------------LMCQCWRKEPEERPTFEYLQAFL 268

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.8 bits (196), Expect = 4e-17
 Identities = 27/108 (25%), Positives = 53/108 (49%), Gaps = 5/108 (4%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 499
           L    +      L   +   +A  +A  + Y+       +HRD+++AN+L+ EN V K+ 
Sbjct: 98  LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVA 155

Query: 500 DFGIVKMSETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
           DFG+ ++ E +       +       +  PE A++ + + K+DV+S+G
Sbjct: 156 DFGLARLIEDNEYTA--RQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 201

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 2e-49
 Identities = 67/285 (23%), Positives = 107/285 (37%), Gaps = 36/285 (12%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
                +G G +G     + K +G  +  K L    +Y S      +          +EV 
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKEL----DYGSMTEAEKQM-------LVSEVN 55

Query: 171 TLSQCKHVNLLRLLGLC---NNIMNCIVYEYMCNGSLYDRLAR-VNNTPPLDSNKRYSIA 226
            L + KH N++R         N    IV EY   G L   + +       LD      + 
Sbjct: 56  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115

Query: 227 LGVAEALHYLHSLSK---PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
             +  AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++       T + +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD---TSFAK 172

Query: 284 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
              GT  YM PE M+    + K+D++S G +L EL   M P    +       + E +  
Sbjct: 173 AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 232

Query: 343 -VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD 386
            +      E  E            +  +    +   R S+ +I++
Sbjct: 233 RIPYRYSDELNE------------IITRMLNLKDYHRPSVEEILE 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.8 bits (212), Expect = 2e-19
 Identities = 33/102 (32%), Positives = 48/102 (47%), Gaps = 7/102 (6%)

Query: 450 PPLDSNKRYSIALGVAEALHYLHSLSK---PIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
             LD      +   +  AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++
Sbjct: 104 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163

Query: 507 SETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGA 547
                  T + +   GT  YM PE M+    + K+D++S G 
Sbjct: 164 LNHD---TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 202

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 5e-49
 Identities = 59/235 (25%), Positives = 97/235 (41%), Gaps = 30/235 (12%)

Query: 98  LERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTE 156
           +E   D F       + ++LG G  G V+    K +G+ +A K +      +  N     
Sbjct: 1   MELKDDDF------EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ---- 50

Query: 157 AAMIPILLFENEVQTLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTP 215
                      E+Q L +C    ++   G   ++    I  E+M  GSL   L +     
Sbjct: 51  --------IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--- 99

Query: 216 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 275
            +       +++ V + L YL      I+HRDVK +N+L++     KL DFG+      S
Sbjct: 100 RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158

Query: 276 NMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 329
              +       GTR YM PE       S ++D++S G+ L+E+  G  PI   + 
Sbjct: 159 MANSF-----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.9 bits (225), Expect = 1e-20
 Identities = 29/97 (29%), Positives = 45/97 (46%), Gaps = 7/97 (7%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
            +       +++ V + L YL      I+HRDVK +N+L++     KL DFG+      S
Sbjct: 100 RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158

Query: 511 NVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
              +       GTR YM PE       S ++D++S G
Sbjct: 159 MANSF-----VGTRSYMSPERLQGTHYSVQSDIWSMG 190

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 1e-47
 Identities = 57/284 (20%), Positives = 103/284 (36%), Gaps = 32/284 (11%)

Query: 115 NKLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
            +LG G FGTV  G  +       +AVK L+N AN  +   +              E   
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE-----------LLAEANV 61

Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           + Q  +  ++R++G+C      +V E    G L   L +      +       +   V+ 
Sbjct: 62  MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSM 118

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + YL       +HRD+ + NVLL      K+ DFG+ K             +      +
Sbjct: 119 GMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176

Query: 292 MPPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK 349
             PE   + + S+K+DV+S+GV++ E  + G KP           ++ + E         
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------- 229

Query: 350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMF 393
                       +  ++   C  ++ + R     +   L    +
Sbjct: 230 ---GCPAGCPREMYDLM-NLCWTYDVENRPGFAAVELRLRNYYY 269

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.2 bits (192), Expect = 1e-16
 Identities = 23/103 (22%), Positives = 41/103 (39%), Gaps = 3/103 (2%)

Query: 446 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 505
           +     +       +   V+  + YL       +HRD+ + NVLL      K+ DFG+ K
Sbjct: 98  LQQNRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSK 155

Query: 506 MSETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGA 547
                        +      +  PE   + + S+K+DV+S+G 
Sbjct: 156 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 198

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (422), Expect = 1e-47
 Identities = 67/277 (24%), Positives = 115/277 (41%), Gaps = 38/277 (13%)

Query: 115 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
            ++G G FG VY+ + ++N   +A+K +  +   S+    +             EV+ L 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD----------IIKEVRFLQ 70

Query: 174 QCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + +H N ++  G         +V EY    +            PL   +  ++  G  + 
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQG 127

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLHS    +IHRDVK+ N+LL E  + KLGDFG   +   +N          GT  +M
Sbjct: 128 LAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-------FVGTPYWM 178

Query: 293 PPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 348
            PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + E P      
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-----A 233

Query: 349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
            ++G W+E +    +    + C       R +   ++
Sbjct: 234 LQSGHWSE-YFRNFV----DSCLQKIPQDRPTSEVLL 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 36/100 (36%), Positives = 50/100 (50%), Gaps = 13/100 (13%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL   +  ++  G  + L YLHS    +IHRDVK+ N+LL E  + KLGDFG   +   +
Sbjct: 111 PLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168

Query: 511 NVKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYG 546
           N       +  GT  +M PE +      Q   K DV+S G
Sbjct: 169 N-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 201

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 1e-47
 Identities = 57/283 (20%), Positives = 106/283 (37%), Gaps = 32/283 (11%)

Query: 116 KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
           +LG G FG+V  G  +     +++A+K L+     + +                 E Q +
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE------------MMREAQIM 63

Query: 173 SQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
            Q  +  ++RL+G+C      +V E    G L+  L  V     +  +    +   V+  
Sbjct: 64  HQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMG 121

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + YL    K  +HRD+ + NVLL      K+ DFG+ K     +              + 
Sbjct: 122 MKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 293 PPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE 350
            PE     + S+++DV+SYGV + E L+ G KP            + + +          
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-------- 231

Query: 351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMF 393
             E        L  ++   C +++ + R     +   +    +
Sbjct: 232 --ECPPECPPELYALM-SDCWIYKWEDRPDFLTVEQRMRACYY 271

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.3 bits (187), Expect = 6e-16
 Identities = 25/103 (24%), Positives = 42/103 (40%), Gaps = 3/103 (2%)

Query: 446 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 505
           V     +  +    +   V+  + YL    K  +HRD+ + NVLL      K+ DFG+ K
Sbjct: 100 VGKREEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSK 157

Query: 506 MSETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGA 547
                +              +  PE     + S+++DV+SYG 
Sbjct: 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 200

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  166 bits (420), Expect = 2e-47
 Identities = 70/311 (22%), Positives = 123/311 (39%), Gaps = 41/311 (13%)

Query: 93  FTFCDLERATDGFNRKPYPRR---GNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNA 145
           FTF D   A   F ++           +G G+FG V  G LK      + +A+KTL++  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 146 NYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSL 204
                              F +E   + Q  H N++ L G+        I+ E+M NGSL
Sbjct: 67  TEKQRRD------------FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL 114

Query: 205 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 264
                   N       +   +  G+A  + YL       +HRD+ + N+L++ N V K+ 
Sbjct: 115 DSF--LRQNDGQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVS 170

Query: 265 DFGIVKMSETSNMKTMYTENLT--GTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGM 321
           DFG+ +  E       YT  L       +  PEA  + + ++ +DV+SYG+++ E+++  
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230

Query: 322 KPI--DDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRA 379
           +    D  N  +   +  +  +P          +            +   C   +++ R 
Sbjct: 231 ERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ------------LMLDCWQKDRNHRP 278

Query: 380 SMRDIVDLLSK 390
               IV+ L K
Sbjct: 279 KFGQIVNTLDK 289

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 76.3 bits (187), Expect = 7e-16
 Identities = 28/103 (27%), Positives = 48/103 (46%), Gaps = 5/103 (4%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            N       +   +  G+A  + YL       +HRD+ + N+L++ N V K+ DFG+ + 
Sbjct: 120 QNDGQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177

Query: 507 SETSNVKTMYTENLT--GTRPYMPPEA-MHCQISTKTDVFSYG 546
            E       YT  L       +  PEA  + + ++ +DV+SYG
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYG 220

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 4e-47
 Identities = 62/278 (22%), Positives = 117/278 (42%), Gaps = 34/278 (12%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
             +LG GQFG V YGK +   ++A+K ++  +                   F  E + + 
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--------------FIEEAKVMM 54

Query: 174 QCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
              H  L++L G+C       I+ EYM NG L + L          + +   +   V EA
Sbjct: 55  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEA 112

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           + YL   SK  +HRD+ + N L+++  V K+ DFG+ +        +  +        + 
Sbjct: 113 MEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPVRWS 168

Query: 293 PPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE 350
           PPE  M+ + S+K+D++++GV++ E+ + G  P +          + +     R      
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP----- 223

Query: 351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL 388
                    E +  I+   C   + D+R + + ++  +
Sbjct: 224 -----HLASEKVYTIM-YSCWHEKADERPTFKILLSNI 255

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.9 bits (186), Expect = 6e-16
 Identities = 25/101 (24%), Positives = 49/101 (48%), Gaps = 5/101 (4%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
                  + +   +   V EA+ YL S  K  +HRD+ + N L+++  V K+ DFG+ + 
Sbjct: 92  EMRHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149

Query: 507 SETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
                  +  +        + PPE  M+ + S+K+D++++G
Sbjct: 150 VLDDEYTS--SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 188

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 7e-47
 Identities = 62/281 (22%), Positives = 115/281 (40%), Gaps = 37/281 (13%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
               +LG+G FG VY  + K   +  A K ++  +     +             +  E+ 
Sbjct: 15  EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-------------YMVEID 61

Query: 171 TLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            L+ C H N+++LL       N  I+ E+   G++   +  +    PL  ++   +    
Sbjct: 62  ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQT 119

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
            +AL+YLH     IIHRD+K+ N+L   +   KL DFG+   +  +  +     +  GT 
Sbjct: 120 LDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD---SFIGTP 174

Query: 290 PYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 343
            +M PE + C+         K DV+S G+ L+E+     P  + N +     + + E P 
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT 234

Query: 344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
                + +  + +      +    +KC     D R +   +
Sbjct: 235 LAQPSRWSSNFKD-----FL----KKCLEKNVDARWTTSQL 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 11/103 (10%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
           PL  ++   +     +AL+YLH     IIHRD+K+ N+L   +   KL DFG+   +  +
Sbjct: 106 PLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163

Query: 511 NVKTMYTENLTGTRPYMPPEAMHCQ------ISTKTDVFSYGA 547
             +     +  GT  +M PE + C+         K DV+S G 
Sbjct: 164 IQRRD---SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGI 203

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 8e-46
 Identities = 66/276 (23%), Positives = 117/276 (42%), Gaps = 34/276 (12%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
            R  K+G+G  GTVY    +  G E+A++ +      +       E       L  NE+ 
Sbjct: 23  TRFEKIGQGASGTVYTAMDVATGQEVAIRQM------NLQQQPKKE-------LIINEIL 69

Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            + + K+ N++  L          +V EY+  GSL D +        +D  +  ++    
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCREC 125

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
            +AL +LHS    +IHRD+KS N+LL  +   KL DFG          +      + GT 
Sbjct: 126 LQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTP 180

Query: 290 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 348
            +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+     P     +
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-----E 235

Query: 349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
            +  E         +     +C   + +KR S +++
Sbjct: 236 LQNPEKLSAIFRDFL----NRCLDMDVEKRGSAKEL 267

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.2 bits (187), Expect = 7e-16
 Identities = 31/106 (29%), Positives = 47/106 (44%), Gaps = 6/106 (5%)

Query: 443 LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG 502
           L  V     +D  +  ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG
Sbjct: 104 LTDVVTETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFG 161

Query: 503 IVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGA 547
                            + GT  +M PE +  +    K D++S G 
Sbjct: 162 FCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 8e-46
 Identities = 73/289 (25%), Positives = 120/289 (41%), Gaps = 31/289 (10%)

Query: 106 NRKPYPRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIP 161
             K   R   KLG+G FG V  G+        + +AVK L+ +        D+       
Sbjct: 6   GEKDL-RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD------- 57

Query: 162 ILLFENEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 221
              F  EV  +    H NL+RL G+       +V E    GSL DRL +      L +  
Sbjct: 58  ---FIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS 114

Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 281
           RY  A+ VAE + YL   SK  IHRD+ + N+LL    + K+GDFG+++    ++   + 
Sbjct: 115 RY--AVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170

Query: 282 TENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ 339
            E+      +  PE       S  +D + +GV L E+ T G +P    N     + + ++
Sbjct: 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230

Query: 340 EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLL 388
              +            E   + +  ++  +C   + + R +   + D L
Sbjct: 231 GERL---------PRPEDCPQDIYNVM-VQCWAHKPEDRPTFVALRDFL 269

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.9 bits (173), Expect = 3e-14
 Identities = 26/101 (25%), Positives = 45/101 (44%), Gaps = 3/101 (2%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            +            A+ VAE + YL S  K  IHRD+ + N+LL    + K+GDFG+++ 
Sbjct: 103 KHQGHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160

Query: 507 SETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
              ++   +  E+      +  PE       S  +D + +G
Sbjct: 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (407), Expect = 2e-45
 Identities = 67/305 (21%), Positives = 119/305 (39%), Gaps = 52/305 (17%)

Query: 114 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
              +GEG FG V+  +            +AVK L+  A+                  F+ 
Sbjct: 18  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD------------FQR 65

Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVN-------------- 212
           E   +++  + N+++LLG+C      C+++EYM  G L + L  ++              
Sbjct: 66  EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 213 -------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 265
                    PPL   ++  IA  VA  + YL    +  +HRD+ + N L+ EN V K+ D
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIAD 183

Query: 266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPID 325
           FG+ +   +++       +    R   P    + + +T++DV++YGV+L E+ +      
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243

Query: 326 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
                        +EV +  V D       E     L  ++   C       R S   I 
Sbjct: 244 YGMA--------HEEV-IYYVRDGNILACPENCPLELYNLM-RLCWSKLPADRPSFCSIH 293

Query: 386 DLLSK 390
            +L +
Sbjct: 294 RILQR 298

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 85.7 bits (211), Expect = 5e-19
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 2/102 (1%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
                PPL   ++  IA  VA  + YL    +  +HRD+ + N L+ EN V K+ DFG+ 
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIADFGLS 187

Query: 505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYG 546
           +   +++       +    R   P    + + +T++DV++YG
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 229

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  159 bits (403), Expect = 4e-45
 Identities = 70/280 (25%), Positives = 119/280 (42%), Gaps = 32/280 (11%)

Query: 114 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
            +KLG GQ+G VY G  K   + +AVKTL+ +                    F  E   +
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------------FLKEAAVM 67

Query: 173 SQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            + KH NL++LLG+C       I+ E+M  G+L D L    N   + +     +A  ++ 
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISS 126

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++                   +
Sbjct: 127 AMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG--AKFPIKW 182

Query: 292 MPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 350
             PE++ + + S K+DV+++GV+L E+ T          +   Y ++E++          
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------- 234

Query: 351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
             E  E   E +  ++   C  +    R S  +I      
Sbjct: 235 -MERPEGCPEKVYELM-RACWQWNPSDRPSFAEIHQAFET 272

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 74.4 bits (182), Expect = 3e-15
 Identities = 33/143 (23%), Positives = 59/143 (41%), Gaps = 3/143 (2%)

Query: 405 KVSSRTQENNNINWELHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGV 464
            V    +  N +      T  P   + T       L    R  N   + +     +A  +
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124

Query: 465 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTR 524
           + A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +
Sbjct: 125 SSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIK 181

Query: 525 PYMPPEAMHCQISTKTDVFSYGA 547
              P    + + S K+DV+++G 
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGV 204

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 6e-45
 Identities = 68/297 (22%), Positives = 123/297 (41%), Gaps = 33/297 (11%)

Query: 112 RRGNKLGEGQFGTVYYGKLKNG-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 166
            R   +G G+FG VY G LK       + +A+KTL+                      F 
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD------------FL 57

Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            E   + Q  H N++RL G+ +      I+ EYM NG+L                +   +
Sbjct: 58  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF--LREKDGEFSVLQLVGM 115

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
             G+A  + YL +     +HRD+ + N+L++ N V K+ DFG+ ++ E     T  T   
Sbjct: 116 LRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173

Query: 286 TGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 344
                +  PEA+   + ++ +DV+S+G+++ E++T  +      +             ++
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------NHEVMK 224

Query: 345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCNSLANL 401
            + D             +  ++  +C   E+ +R    DIV +L K +   +SL  L
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLM-MQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 280

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.5 bits (195), Expect = 5e-17
 Identities = 26/114 (22%), Positives = 50/114 (43%), Gaps = 3/114 (2%)

Query: 434 ETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 493
           E  +                  +   +  G+A  + YL +     +HRD+ + N+L++ N
Sbjct: 89  EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSN 146

Query: 494 FVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYG 546
            V K+ DFG+ ++ E     T  T        +  PEA+   + ++ +DV+S+G
Sbjct: 147 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFG 200

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 6e-45
 Identities = 62/277 (22%), Positives = 104/277 (37%), Gaps = 31/277 (11%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
                LGEG +G V     +     +AVK ++          D  E         + E+ 
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-----MKRAVDCPEN-------IKKEIC 55

Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
                 H N+++  G      +  +  EY   G L+DR+        +           +
Sbjct: 56  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQL 112

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
              + YLH     I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT 
Sbjct: 113 MAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTL 169

Query: 290 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL 347
           PY+ PE +  +   +   DV+S G++L  +L G  P D  +     Y   +++       
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229

Query: 348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
            K            L+     K  V     R ++ DI
Sbjct: 230 KKIDSAPLA-----LL----HKILVENPSARITIPDI 257

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.4 bits (203), Expect = 5e-18
 Identities = 29/104 (27%), Positives = 48/104 (46%), Gaps = 5/104 (4%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
           R+     +           +   + YLH     I HRD+K  N+LLDE    K+ DFG+ 
Sbjct: 93  RIEPDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLA 150

Query: 505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYG 546
            +   +N + +  + + GT PY+ PE +  +   +   DV+S G
Sbjct: 151 TVFRYNNRERLLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCG 193

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 3e-44
 Identities = 65/286 (22%), Positives = 113/286 (39%), Gaps = 37/286 (12%)

Query: 114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
           G  +GEGQFG V+ G   +     + +A+KT +N  + S                F  E 
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 59

Query: 170 QTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            T+ Q  H ++++L+G+       I+ E    G L            LD       A  +
Sbjct: 60  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQL 117

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           + AL YL   SK  +HRD+ + NVL+  N   KLGDFG+ +  E S              
Sbjct: 118 STALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK--ASKGKLPI 173

Query: 290 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP--IDDNNTILYYYLVVEQEVPVREV 346
            +M PE+++ +  ++ +DV+ +GV + E+L           N  +   +   + +P+   
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 233

Query: 347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM 392
                              +  KC  ++  +R    ++   LS  +
Sbjct: 234 CPPTLYS------------LMTKCWAYDPSRRPRFTELKAQLSTIL 267

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.0 bits (168), Expect = 1e-13
 Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 5/101 (4%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
                LD       A  ++ AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ + 
Sbjct: 100 VRKYSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157

Query: 507 SETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
            E S               +M PE+++ +  ++ +DV+ +G
Sbjct: 158 MEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 196

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 1e-43
 Identities = 65/278 (23%), Positives = 108/278 (38%), Gaps = 31/278 (11%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           + G  LGEG F TV   + L    E A+K LE       +                 E  
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY----------VTRERD 60

Query: 171 TLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            +S+  H   ++L     +         Y  NG L   + ++      D          +
Sbjct: 61  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEI 117

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
             AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+    + +        GT 
Sbjct: 118 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTA 174

Query: 290 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 348
            Y+ PE +  +     +D+++ G I+ +L+ G+ P    N  L +  +++ E    E   
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFF 234

Query: 349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD 386
            +A +        L+    EK  V +  KR    ++  
Sbjct: 235 PKARD--------LV----EKLLVLDATKRLGCEEMEG 260

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 28/103 (27%), Positives = 46/103 (44%), Gaps = 4/103 (3%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
            +      D          +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  
Sbjct: 98  YIRKIGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTA 155

Query: 505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
           K+    + +        GT  Y+ PE +  +     +D+++ G
Sbjct: 156 KVLSPESKQARANS-FVGTAQYVSPELLTEKSACKSSDLWALG 197

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 2e-43
 Identities = 74/287 (25%), Positives = 116/287 (40%), Gaps = 38/287 (13%)

Query: 114 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
              +G G FG VY+G L +     +  AVK+L    +    +             F  E 
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ------------FLTEG 79

Query: 170 QTLSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
             +    H N+L LLG+C  +     +V  YM +G L +     N T            L
Sbjct: 80  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF--IRNETHNPTVKDLIGFGL 137

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLT 286
            VA+ + +L S  K  +HRD+ + N +LDE F  K+ DFG+ + M +             
Sbjct: 138 QVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195

Query: 287 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPI--DDNNTILYYYLVVEQEVPV 343
               +M  E     + +TK+DV+S+GV+L EL+T   P   D N   +  YL+  + +  
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255

Query: 344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
            E       E            V  KC   + + R S  ++V  +S 
Sbjct: 256 PEYCPDPLYE------------VMLKCWHPKAEMRPSFSELVSRISA 290

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.6 bits (172), Expect = 6e-14
 Identities = 29/102 (28%), Positives = 46/102 (45%), Gaps = 4/102 (3%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK- 505
           N T            L VA+ + +L S  K  +HRD+ + N +LDE F  K+ DFG+ + 
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARD 179

Query: 506 MSETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
           M +                 +M  E     + +TK+DV+S+G
Sbjct: 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 221

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  153 bits (388), Expect = 4e-43
 Identities = 63/283 (22%), Positives = 101/283 (35%), Gaps = 31/283 (10%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
                LG G    V          E AVK ++     S S  +  E           EV 
Sbjct: 6   EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE----ATLKEVD 61

Query: 171 TLSQCK-HVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
            L +   H N+++L           +V++ M  G L+D L        L   +   I   
Sbjct: 62  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRA 118

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           + E +  LH     I+HRD+K  N+LLD++   KL DFG     +             GT
Sbjct: 119 LLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV----CGT 172

Query: 289 RPYMPPEAMHCQ-------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 341
             Y+ PE + C           + D++S GVI+  LL G  P      +L   +++    
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232

Query: 342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
                   +  +     V+ L+     +  V +  KR +  + 
Sbjct: 233 QFGSPEWDDYSD----TVKDLV----SRFLVVQPQKRYTAEEA 267

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 73.6 bits (180), Expect = 4e-15
 Identities = 28/109 (25%), Positives = 43/109 (39%), Gaps = 13/109 (11%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
            +     L   +   I   + E +  LH     I+HRD+K  N+LLD++   KL DFG  
Sbjct: 100 YLTEKVTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFS 157

Query: 505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYG 546
              +             GT  Y+ PE + C           + D++S G
Sbjct: 158 CQLDPGEKLREV----CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 202

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 6e-43
 Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 51/298 (17%)

Query: 114 GNKLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
            + +GEG FG V   ++K     M+ A+K ++  A+                  F  E++
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD------------FAGELE 62

Query: 171 TLSQC-KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLAR-------------VNNTP 215
            L +   H N++ LLG C +     +  EY  +G+L D L +              +   
Sbjct: 63  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122

Query: 216 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 275
            L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E  
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 276 NMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKP--IDDNNTILY 332
             KTM          +M  E++ +   +T +DV+SYGV+L E+++             LY
Sbjct: 181 VKKTMG----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236

Query: 333 YYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
             L     +      D E  +            +  +C   +  +R S   I+  L++
Sbjct: 237 EKLPQGYRLEKPLNCDDEVYD------------LMRQCWREKPYERPSFAQILVSLNR 282

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.8 bits (196), Expect = 5e-17
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 7/97 (7%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
            L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E  
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 511 NVKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYG 546
             KTM          +M  E++ +   +T +DV+SYG
Sbjct: 181 VKKTMG----RLPVRWMAIESLNYSVYTTNSDVWSYG 213

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-42
 Identities = 67/302 (22%), Positives = 121/302 (40%), Gaps = 46/302 (15%)

Query: 114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
           G  LG G FG V              M +AVK L+ +A+ +   +              +
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA------------LMS 75

Query: 168 EVQTLSQCK-HVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLAR--------------- 210
           E++ LS    H+N++ LLG C       ++ EY C G L + L R               
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 211 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
            ++   LD     S +  VA+ + +L S  K  IHRD+ + N+LL    + K+ DFG+ +
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 330
             +  +   +        +   P    +C  + ++DV+SYG+ L EL +          +
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253

Query: 331 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
              +  +     ++E     + E     +  ++    + C   +  KR + + IV L+ K
Sbjct: 254 DSKFYKM-----IKEGFRMLSPEHAPAEMYDIM----KTCWDADPLKRPTFKQIVQLIEK 304

Query: 391 SM 392
            +
Sbjct: 305 QI 306

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.7 bits (180), Expect = 5e-15
 Identities = 26/101 (25%), Positives = 48/101 (47%), Gaps = 2/101 (1%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
           ++   LD     S +  VA+ + +L S  K  IHRD+ + N+LL    + K+ DFG+ + 
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARD 194

Query: 507 SETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGA 547
            +  +   +        +   P    +C  + ++DV+SYG 
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-42
 Identities = 60/287 (20%), Positives = 117/287 (40%), Gaps = 37/287 (12%)

Query: 112 RRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 166
           ++   LG G FGTVY G          + +A+K L    +  ++                
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------IL 59

Query: 167 NEVQTLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
           +E   ++   + ++ RLLG+C      ++ + M  G L D      +   + S    +  
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDY--VREHKDNIGSQYLLNWC 117

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 286
           + +A+ ++YL    + ++HRD+ + NVL+      K+ DFG+ K+   +  K  + E   
Sbjct: 118 VQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEGGK 174

Query: 287 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPI--DDNNTILYYYLVVEQEVPV 343
               +M  E  +H   + ++DV+SYGV + EL+T           + +   L   + +P 
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 234

Query: 344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
             +   +               +  KC + + D R   R+++   SK
Sbjct: 235 PPICTIDVYM------------IMVKCWMIDADSRPKFRELIIEFSK 269

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.8 bits (188), Expect = 5e-16
 Identities = 25/102 (24%), Positives = 49/102 (48%), Gaps = 4/102 (3%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
            +   + S    +  + +A+ ++YL    + ++HRD+ + NVL+      K+ DFG+ K+
Sbjct: 103 EHKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160

Query: 507 SETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGA 547
                 K  + E       +M  E  +H   + ++DV+SYG 
Sbjct: 161 LGAEE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 201

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 5e-42
 Identities = 67/305 (21%), Positives = 119/305 (39%), Gaps = 55/305 (18%)

Query: 114 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
           G  LG G FG V              +++AVK L+  A+ S   +              +
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA------------LMS 89

Query: 168 EVQTLSQC-KHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRL----------------- 208
           E++ ++Q   H N++ LLG C       +++EY C G L + L                 
Sbjct: 90  ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 149

Query: 209 ---ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 265
                  +   L        A  VA+ + +L    K  +HRD+ + NVL+    V K+ D
Sbjct: 150 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICD 207

Query: 266 FGIVKMSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLT-GMKP 323
           FG+ +   + +   +   N      +M PE       + K+DV+SYG++L E+ + G+ P
Sbjct: 208 FGLARDIMSDSNYVVRG-NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266

Query: 324 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRD 383
                    +Y +++    +         +      E +  I+ + C  F+  KR S  +
Sbjct: 267 YPGIPVDANFYKLIQNGFKM---------DQPFYATEEIYIIM-QSCWAFDSRKRPSFPN 316

Query: 384 IVDLL 388
           +   L
Sbjct: 317 LTSFL 321

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.2 bits (197), Expect = 5e-17
 Identities = 29/118 (24%), Positives = 49/118 (41%), Gaps = 4/118 (3%)

Query: 430 LDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 489
               E +     +L    +   L        A  VA+ + +L    K  +HRD+ + NVL
Sbjct: 139 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVL 196

Query: 490 LDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
           +    V K+ DFG+ +   + +   +   N      +M PE       + K+DV+SYG
Sbjct: 197 VTHGKVVKICDFGLARDIMSDSNYVVRG-NARLPVKWMAPESLFEGIYTIKSDVWSYG 253

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  152 bits (384), Expect = 7e-42
 Identities = 56/276 (20%), Positives = 106/276 (38%), Gaps = 34/276 (12%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
             +LG G FG V+       G   A K +       + +  + E           E+QT+
Sbjct: 31  HEELGTGAFGVVHRVTERATGNNFAAKFV------MTPHESDKET-------VRKEIQTM 77

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S  +H  L+ L     +     ++YE+M  G L++++A  +N   +  ++       V +
Sbjct: 78  SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCK 135

Query: 232 ALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
            L ++H      +H D+K  N++     +   KL DFG+    +      + T    GT 
Sbjct: 136 GLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTA 189

Query: 290 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 348
            +  PE    + +   TD++S GV+   LL+G+ P    N       V   +  + +   
Sbjct: 190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249

Query: 349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
               E      +  I     K  + + + R ++   
Sbjct: 250 SGISE----DGKDFI----RKLLLADPNTRMTIHQA 277

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 70.9 bits (173), Expect = 8e-14
 Identities = 21/100 (21%), Positives = 40/100 (40%), Gaps = 9/100 (9%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGIVKMSE 508
            +  ++       V + L ++H      +H D+K  N++     +   KL DFG+    +
Sbjct: 120 KMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177

Query: 509 TSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGA 547
                    +  TGT  +  PE    + +   TD++S G 
Sbjct: 178 P----KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 213

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-41
 Identities = 53/275 (19%), Positives = 104/275 (37%), Gaps = 33/275 (12%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              LG G+FG V+      +      K ++                     L + E+  L
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV--------------LVKKEISIL 55

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           +  +H N+L L     ++    +++E++    +++R+    +   L+  +  S    V E
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCE 113

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
           AL +LHS    I H D++  N++     +   K+ +FG  +  +  +   +     T   
Sbjct: 114 ALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPE 168

Query: 290 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 349
            Y P    H  +ST TD++S G ++  LL+G+ P            ++  E    E   K
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228

Query: 350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
           E            +    ++  V E+  R +  + 
Sbjct: 229 EISI----EAMDFV----DRLLVKERKSRMTASEA 255

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 27/109 (24%), Positives = 47/109 (43%), Gaps = 8/109 (7%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPK 497
           +F+     +   L+  +  S    V EAL +LHS    I H D++  N++     +   K
Sbjct: 88  IFERIN-TSAFELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIK 144

Query: 498 LGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYG 546
           + +FG  +  +  +   +     T    Y P    H  +ST TD++S G
Sbjct: 145 IIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQHDVVSTATDMWSLG 190

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  150 bits (380), Expect = 4e-41
 Identities = 51/278 (18%), Positives = 100/278 (35%), Gaps = 34/278 (12%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
               +LG G FG V+       G     K +      ++    +           +NE+ 
Sbjct: 32  DILEELGSGAFGVVHRCVEKATGRVFVAKFI------NTPYPLDKYT-------VKNEIS 78

Query: 171 TLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            ++Q  H  L+ L     +     ++ E++  G L+DR+A       +   +  +     
Sbjct: 79  IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQA 136

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIVKMSETSNMKTMYTENLTG 287
            E L ++H     I+H D+K  N++ +       K+ DFG+        +  + T     
Sbjct: 137 CEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT----A 190

Query: 288 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV 346
           T  +  PE +  + +   TD+++ GV+   LL+G+ P    + +     V   +    E 
Sbjct: 191 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED 250

Query: 347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
                        +  I    +     E  KR ++ D 
Sbjct: 251 AFSSVSP----EAKDFI----KNLLQKEPRKRLTVHDA 280

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 67.8 bits (165), Expect = 8e-13
 Identities = 19/104 (18%), Positives = 40/104 (38%), Gaps = 9/104 (8%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIV 504
                +   +  +      E L ++H     I+H D+K  N++ +       K+ DFG+ 
Sbjct: 119 AEDYKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176

Query: 505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGA 547
                  +  +     T T  +  PE +  + +   TD+++ G 
Sbjct: 177 TKLNPDEIVKVT----TATAEFAAPEIVDREPVGFYTDMWAIGV 216

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  147 bits (373), Expect = 5e-41
 Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 31/287 (10%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
             G  LG G    V+  + L+   ++AVK L  +     S            L F  E Q
Sbjct: 10  ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSF----------YLRFRREAQ 59

Query: 171 TLSQCKHVNLLRLLGLC-----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
             +   H  ++ +            +  IV EY+   +L D +       P+   +   +
Sbjct: 60  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV 116

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
                +AL++ H     IIHRDVK AN+++      K+ DFGI +    S      T  +
Sbjct: 117 IADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174

Query: 286 TGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 344
            GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ +   Y  V ++    
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234

Query: 345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKR-ASMRDIVDLLSK 390
               +         ++ ++     K      + R  +  ++   L +
Sbjct: 235 SARHEGLSAD----LDAVV----LKALAKNPENRYQTAAEMRADLVR 273

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 68.2 bits (166), Expect = 3e-13
 Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 3/104 (2%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
            V+   P+   +   +     +AL++ H     IIHRDVK AN+++      K+ DFGI 
Sbjct: 101 IVHTEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIA 158

Query: 505 KMSETSNVKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGA 547
           +    S      T  + GT  Y+ PE A    +  ++DV+S G 
Sbjct: 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 202

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 6e-39
 Identities = 66/294 (22%), Positives = 123/294 (41%), Gaps = 40/294 (13%)

Query: 114 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
             +LG+G FG VY G  K          +A+KT+    N ++S  +  E        F N
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIE--------FLN 72

Query: 168 EVQTLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRL-------ARVNNTPPLDS 219
           E   + +    +++RLLG+ +      ++ E M  G L   L       A      P   
Sbjct: 73  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132

Query: 220 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 279
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ +         
Sbjct: 133 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYY 189

Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
                      +M PE++     +T +DV+S+GV+L E+ T  +      +         
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------- 240

Query: 339 QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM 392
            E  +R V++    +  +   + L  ++   C  +    R S  +I+  + + M
Sbjct: 241 NEQVLRFVMEGGLLDKPDNCPDMLFELM-RMCWQYNPKMRPSFLEIISSIKEEM 293

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.0 bits (160), Expect = 2e-12
 Identities = 26/111 (23%), Positives = 53/111 (47%), Gaps = 4/111 (3%)

Query: 437 QCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP 496
           +     +A      P   +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  
Sbjct: 115 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTV 172

Query: 497 KLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
           K+GDFG+ +    ++              +M PE++     +T +DV+S+G
Sbjct: 173 KIGDFGMTRDIYETDYYRKGG-KGLLPVRWMSPESLKDGVFTTYSDVWSFG 222

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (354), Expect = 4e-38
 Identities = 60/277 (21%), Positives = 104/277 (37%), Gaps = 35/277 (12%)

Query: 114 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
            + LG G F  V   +  +    +A+K +   A      S             ENE+  L
Sbjct: 14  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS------------MENEIAVL 61

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
            + KH N++ L  +  +  +  ++ + +  G L+DR+                +   V +
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLD 118

Query: 232 ALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 288
           A+ YLH     I+HRD+K  N+L    DE+    + DFG+ KM +  ++ +       GT
Sbjct: 119 AVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC----GT 172

Query: 289 RPYMPP-EAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL 347
             Y+ P        S   D +S GVI   LL G  P  D N    +  +++ E       
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232

Query: 348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
             +  +      +  I          + +KR +    
Sbjct: 233 WDDISDS----AKDFI----RHLMEKDPEKRFTCEQA 261

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 58.1 bits (140), Expect = 7e-10
 Identities = 29/107 (27%), Positives = 44/107 (41%), Gaps = 10/107 (9%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDF 501
           R+             +   V +A+ YLH     I+HRD+K  N+L    DE+    + DF
Sbjct: 97  RIVEKGFYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDF 154

Query: 502 GIVKMSETSNVKTMYTENLTGTRPYMPP-EAMHCQISTKTDVFSYGA 547
           G+ KM +  +V +       GT  Y+ P        S   D +S G 
Sbjct: 155 GLSKMEDPGSVLSTAC----GTPGYVAPEVLAQKPYSKAVDCWSIGV 197

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (354), Expect = 5e-38
 Identities = 65/242 (26%), Positives = 103/242 (42%), Gaps = 22/242 (9%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           +    LG G FG V+  + + NG   A+K L+          ++            +E  
Sbjct: 7   QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH----------TNDERL 56

Query: 171 TLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
            LS   H  ++R+ G   +     +      G     L R +   P    K Y  A  V 
Sbjct: 57  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--AAEVC 114

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
            AL YLHS  K II+RD+K  N+LLD+N   K+ DFG  K              L GT  
Sbjct: 115 LALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY------TLCGTPD 166

Query: 291 YMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 349
           Y+ PE +  +  +   D +S+G+++ E+L G  P  D+NT+  Y  ++  E+      ++
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 226

Query: 350 EA 351
           + 
Sbjct: 227 DV 228

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 35/88 (39%), Positives = 46/88 (52%), Gaps = 9/88 (10%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
            A  V  AL YLHS  K II+RD+K  N+LLD+N   K+ DFG  K          YT  
Sbjct: 109 YAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYT-- 160

Query: 520 LTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
           L GT  Y+ PE +  +  +   D +S+G
Sbjct: 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFG 188

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 1e-37
 Identities = 68/276 (24%), Positives = 112/276 (40%), Gaps = 34/276 (12%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              LG+G FG V+  + K      A+K L+ +      + +              E + L
Sbjct: 7   HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----------TMVEKRVL 56

Query: 173 S-QCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
           S   +H  L  +        N   V EY+  G L   +         D ++    A  + 
Sbjct: 57  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEII 113

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
             L +LHS  K I++RD+K  N+LLD++   K+ DFG+ K +   + KT       GT  
Sbjct: 114 LGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT---FCGTPD 168

Query: 291 YMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 349
           Y+ PE +  Q  +   D +S+GV+L E+L G  P    +    ++ +          L+K
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEK 228

Query: 350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIV 385
           EA +            +  K  V E +KR  +R  +
Sbjct: 229 EAKD------------LLVKLFVREPEKRLGVRGDI 252

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.5 bits (164), Expect = 7e-13
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 6/104 (5%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
            + +    D ++    A  +   L +LHS  K I++RD+K  N+LLD++   K+ DFG+ 
Sbjct: 93  HIQSCHKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMC 150

Query: 505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGA 547
           K +   + KT       GT  Y+ PE +  Q  +   D +S+G 
Sbjct: 151 KENMLGDAKTNT---FCGTPDYIAPEILLGQKYNHSVDWWSFGV 191

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-37
 Identities = 60/280 (21%), Positives = 102/280 (36%), Gaps = 41/280 (14%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           + G  LG G FG+VY G  + + + +A+K +E +         N             EV 
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT-------RVPMEVV 59

Query: 171 TLSQCK--HVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 227
            L +       ++RLL       +  ++ E             +     L      S   
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF--ITERGALQEELARSFFW 117

Query: 228 GVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYTENLT 286
            V EA+ + H+    ++HRD+K  N+L+D N    KL DFG   + + +           
Sbjct: 118 QVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-----D 170

Query: 287 GTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 344
           GTR Y PPE +           V+S G++L +++ G  P + +  I+   +   Q V   
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS-- 228

Query: 345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
                       +  + LI      C       R +  +I
Sbjct: 229 ------------SECQHLI----RWCLALRPSDRPTFEEI 252

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.8 bits (165), Expect = 4e-13
 Identities = 29/106 (27%), Positives = 43/106 (40%), Gaps = 10/106 (9%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGI 503
            +     L      S    V EA+ + H+    ++HRD+K  N+L+D N    KL DFG 
Sbjct: 100 FITERGALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGS 157

Query: 504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGA 547
             + + +           GTR Y PPE +           V+S G 
Sbjct: 158 GALLKDTVYTDF-----DGTRVYSPPEWIRYHRYHGRSAAVWSLGI 198

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-37
 Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 49/301 (16%)

Query: 114 GNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 165
           G  LGEG FG V   +             ++AVK L+++A     +              
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD------------L 65

Query: 166 ENEVQTLSQC-KHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRL-------------AR 210
            +E++ +    KH N++ LLG C  +    ++ EY   G+L + L               
Sbjct: 66  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125

Query: 211 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 270
            N    L S    S A  VA  + YL S  K  IHRD+ + NVL+ E+ V K+ DFG+ +
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

Query: 271 MSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNT 329
                +     T N      +M PEA+  +  + ++DV+S+GV+L E+ T          
Sbjct: 184 DIHHIDYYKK-TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242

Query: 330 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLS 389
           +         E   + + +    +        L  ++   C      +R + + +V+ L 
Sbjct: 243 V---------EELFKLLKEGHRMDKPSNCTNELYMMM-RDCWHAVPSQRPTFKQLVEDLD 292

Query: 390 K 390
           +
Sbjct: 293 R 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.2 bits (176), Expect = 1e-14
 Identities = 44/174 (25%), Positives = 71/174 (40%), Gaps = 6/174 (3%)

Query: 376 DKRASMRDIVDLLS--KSMFVCNSLANLYVGKVSSRTQENNNINWELHYTGIPVIILDTG 433
              A+ +D+ DL+S  + M +     N+     +        +  E    G     L   
Sbjct: 54  KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR 113

Query: 434 ETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 493
                +       N    L S    S A  VA  + YL S  K  IHRD+ + NVL+ E+
Sbjct: 114 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTED 171

Query: 494 FVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
            V K+ DFG+ +     +     T N      +M PEA+  +  + ++DV+S+G
Sbjct: 172 NVMKIADFGLARDIHHIDYYKK-TTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 224

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 8e-37
 Identities = 68/290 (23%), Positives = 112/290 (38%), Gaps = 36/290 (12%)

Query: 115 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           + LGEGQF TVY  + KN    +A+K ++      + +  N             E++ L 
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRT--------ALREIKLLQ 55

Query: 174 QCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           +  H N++ LL    +  N  +V+++M            +N+  L  +   +  L   + 
Sbjct: 56  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQG 112

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 292
           L YLH     I+HRD+K  N+LLDEN V KL DFG+ K   + N    +      TR Y 
Sbjct: 113 LEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ---VVTRWYR 167

Query: 293 PPE--AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-VPVREVLDK 349
            PE            D+++ G IL ELL  +  +  ++ +     + E    P  E    
Sbjct: 168 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227

Query: 350 EAGEWNETHVETLIGIVF---------------EKCCVFEKDKRASMRDI 384
                +    ++  GI                 +   +F    R +    
Sbjct: 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.2 bits (163), Expect = 8e-13
 Identities = 33/102 (32%), Positives = 47/102 (46%), Gaps = 7/102 (6%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 506
           +N+  L  +   +  L   + L YLH     I+HRD+K  N+LLDEN V KL DFG+ K 
Sbjct: 92  DNSLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKS 149

Query: 507 SETSNVKTMYTENLTGTRPYMPPE--AMHCQISTKTDVFSYG 546
             + N    +      TR Y  PE            D+++ G
Sbjct: 150 FGSPNRAYTHQ---VVTRWYRAPELLFGARMYGVGVDMWAVG 188

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  137 bits (345), Expect = 3e-36
 Identities = 47/227 (20%), Positives = 83/227 (36%), Gaps = 21/227 (9%)

Query: 114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 172
              +G G FG VY  +    G   A+K L              +      L     +  +
Sbjct: 9   HRIIGRGGFGEVYGCRKADTGKMYAMKCL-------DKKRIKMKQGETLALNERIMLSLV 61

Query: 173 SQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           S      ++ +    +       + + M  G L+  L++       D       A  +  
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD---MRFYAAEIIL 118

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            L ++H+  + +++RD+K AN+LLDE+   ++ D G+                  GT  Y
Sbjct: 119 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHGY 171

Query: 292 MPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV 336
           M PE +       +  D FS G +L +LL G  P   + T   + + 
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 66.7 bits (162), Expect = 2e-12
 Identities = 24/90 (26%), Positives = 40/90 (44%), Gaps = 9/90 (10%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
            A  +   L ++H+  + +++RD+K AN+LLDE+   ++ D G+                
Sbjct: 112 YAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHA 164

Query: 520 LTGTRPYMPPEAMH--CQISTKTDVFSYGA 547
             GT  YM PE +       +  D FS G 
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGC 194

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 5e-36
 Identities = 53/293 (18%), Positives = 111/293 (37%), Gaps = 29/293 (9%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
              + +GEG +G V       N + +A+K +    + +                   E++
Sbjct: 11  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR------------TLREIK 58

Query: 171 TLSQCKHVNLLRLLGLC-----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
            L + +H N++ +  +        + +  +  ++    LY  L        L ++     
Sbjct: 59  ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYF 114

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
              +   L Y+HS    ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +    
Sbjct: 115 LYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172

Query: 286 TGTRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 343
             TR Y  PE M      +   D++S G IL E+L+        + +     ++      
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232

Query: 344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCN 396
            +  +      N      L+ +  +    + +    +    +DLL K M   N
Sbjct: 233 SQ--EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK-MLTFN 282

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.3 bits (179), Expect = 1e-14
 Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 4/98 (4%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
            L ++        +   L Y+HS    ++HRD+K +N+LL+     K+ DFG+ ++++  
Sbjct: 105 HLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162

Query: 511 NVKTMYTENLTGTRPYMPPEAMHCQI--STKTDVFSYG 546
           +  T +      TR Y  PE M      +   D++S G
Sbjct: 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 200

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 1e-35
 Identities = 63/280 (22%), Positives = 110/280 (39%), Gaps = 31/280 (11%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
             G +LG GQF  V   + K  G++ A K ++     SS    + E         E EV 
Sbjct: 13  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-------IEREVS 65

Query: 171 TLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            L + +H N++ L  +  N  +  ++ E +  G L+D    +     L   +       +
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF---LAEKESLTEEEATEFLKQI 122

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENL 285
              ++YLHS    I H D+K  N++L +  VP    K+ DFG+    +  N         
Sbjct: 123 LNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 177

Query: 286 TGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 344
            GT  ++ PE ++ + +  + D++S GVI   LL+G  P   +        V        
Sbjct: 178 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236

Query: 345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
           +              +  I     +  V +  KR +++D 
Sbjct: 237 DEYFSNTSA----LAKDFI----RRLLVKDPKKRMTIQDS 268

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (129), Expect = 2e-08
 Identities = 25/105 (23%), Positives = 45/105 (42%), Gaps = 11/105 (10%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFG 502
                L   +       +   ++YLHS    I H D+K  N++L +  VP    K+ DFG
Sbjct: 105 AEKESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162

Query: 503 IVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
           +    +  N          GT  ++ PE ++ + +  + D++S G
Sbjct: 163 LAHKIDFGNEFKNIF----GTPEFVAPEIVNYEPLGLEADMWSIG 203

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-35
 Identities = 62/286 (21%), Positives = 103/286 (36%), Gaps = 40/286 (13%)

Query: 110 YPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 168
           Y      LG G  G V      +   + A+K L++                        E
Sbjct: 13  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------------------ARRE 54

Query: 169 VQTLSQ-CKHVNLLRLLGLCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKR 222
           V+   +  +  +++R++ +  N+        IV E +  G L+ R+            + 
Sbjct: 55  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREA 113

Query: 223 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKT 279
             I   + EA+ YLHS    I HRDVK  N+L      N + KL DFG  K + + N  T
Sbjct: 114 SEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 171

Query: 280 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
                   T  Y+ PE +  +      D++S GVI+  LL G  P   N+ +     +  
Sbjct: 172 TPCY----TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227

Query: 339 QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDI 384
           +    +              V+ LI          E  +R ++ + 
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVKMLI----RNLLKTEPTQRMTITEF 269

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 33/111 (29%), Positives = 46/111 (41%), Gaps = 10/111 (9%)

Query: 440 LFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVP 496
           LF   +          +   I   + EA+ YLHS    I HRDVK  N+L      N + 
Sbjct: 96  LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAIL 153

Query: 497 KLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
           KL DFG  K + + N  T        T  Y+ PE +  +      D++S G
Sbjct: 154 KLTDFGFAKETTSHNSLTTPCY----TPYYVAPEVLGPEKYDKSCDMWSLG 200

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  132 bits (332), Expect = 3e-35
 Identities = 52/292 (17%), Positives = 99/292 (33%), Gaps = 37/292 (12%)

Query: 112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 171
               K+GEG +G VY  +   G   A+K +          S               E+  
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPST-----------TIREISI 53

Query: 172 LSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 231
           L + KH N+++L  + +     ++     +  L   L        L+S    S  L +  
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLN 111

Query: 232 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
            + Y H   + ++HRD+K  N+L++     K+ DFG+ +       K  +      T  Y
Sbjct: 112 GIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE---IVTLWY 166

Query: 292 MPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE----------Q 339
             P+ +    + ST  D++S G I  E++ G       +       +             
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 340 EVPVREVLDKEAGEWNETHVETLIGIV-------FEKCCVFEKDKRASMRDI 384
            V      D     +     E+ +  +         K    + ++R + +  
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 62.2 bits (150), Expect = 3e-11
 Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 7/98 (7%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
            L+S    S  L +   + Y H   + ++HRD+K  N+L++     K+ DFG+ +     
Sbjct: 96  GLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153

Query: 511 NVKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYG 546
             K  +      T  Y  P+ +    + ST  D++S G
Sbjct: 154 VRKYTHE---IVTLWYRAPDVLMGSKKYSTTIDIWSVG 188

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 5e-35
 Identities = 61/302 (20%), Positives = 105/302 (34%), Gaps = 47/302 (15%)

Query: 114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
           G  LG G FG V                +AVK L+  A +S   +              +
Sbjct: 18  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA------------LMS 65

Query: 168 EVQTLSQCKH-VNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTP--------- 215
           E++ L    H +N++ LLG C        ++ E+   G+L   L    N           
Sbjct: 66  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125

Query: 216 ----PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 271
                L        +  VA+ + +L S  +  IHRD+ + N+LL E  V K+ DFG+ + 
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARD 183

Query: 272 SETSNMKTMYTENLTGTRPYMP-PEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 330
                       +      +M          + ++DV+S+GV+L E+ +          I
Sbjct: 184 IYKDPDYVRKG-DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242

Query: 331 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK 390
              +    +E       D    E  +             C   E  +R +  ++V+ L  
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHLGN 293

Query: 391 SM 392
            +
Sbjct: 294 LL 295

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.4 bits (166), Expect = 3e-13
 Identities = 23/100 (23%), Positives = 42/100 (42%), Gaps = 4/100 (4%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 510
            L        +  VA+ + +L S  +  IHRD+ + N+LL E  V K+ DFG+ +     
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 511 NVKTMYTENLTGTRPYMP-PEAMHCQISTKTDVFSYGAQI 549
                   +      +M          + ++DV+S+G  +
Sbjct: 188 PDYVRKG-DARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 226

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  130 bits (328), Expect = 1e-34
 Identities = 51/293 (17%), Positives = 88/293 (30%), Gaps = 35/293 (11%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           R G K+G G FG +Y G  +  G E+A+K       +                    E +
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ---------------LHIESK 54

Query: 171 TLSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 228
                +    +  +  C      N +V E +              +          +A  
Sbjct: 55  IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQ 111

Query: 229 VAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKM----SETSNMKTMY 281
           +   + Y+HS +   IHRDVK  N L     +  +  + DFG+ K         ++    
Sbjct: 112 MISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169

Query: 282 TENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 340
            +NLTGT  Y      +  + S + D+ S G +L+    G  P                 
Sbjct: 170 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229

Query: 341 VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMF 393
                   +   +   +   T +      C     D +     +  L      
Sbjct: 230 EKKMSTPIEVLCKGYPSEFATYL----NFCRSLRFDDKPDYSYLRQLFRNLFH 278

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 64.1 bits (155), Expect = 8e-12
 Identities = 26/108 (24%), Positives = 42/108 (38%), Gaps = 10/108 (9%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGI 503
             +          +A  +   + Y+HS +   IHRDVK  N L     +  +  + DFG+
Sbjct: 95  FCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152

Query: 504 VKMSETSNVKTMY----TENLTGTRPYMPPEA-MHCQISTKTDVFSYG 546
            K    +           +NLTGT  Y      +  + S + D+ S G
Sbjct: 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG 200

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 3e-34
 Identities = 52/297 (17%), Positives = 98/297 (32%), Gaps = 40/297 (13%)

Query: 112 RRGNKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 169
               ++GEG +G V+  +     G  +A+K +              E   +  +     +
Sbjct: 10  ECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--------RVQTGEEGMPLSTIREVAVL 61

Query: 170 QTLSQCKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
           + L   +H N++RL  +C            +V+E++               P + +    
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT--TYLDKVPEPGVPTETIK 119

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
            +   +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ ++       T    
Sbjct: 120 DMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-- 175

Query: 284 NLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
               T  Y  PE +     +T  D++S G I  E+         ++ +     +++    
Sbjct: 176 --VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233

Query: 343 VREVLDKEAGEWNETHVETLIGIVFE---------------KCCVFEKDKRASMRDI 384
             E               +      E               KC  F   KR S    
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.7 bits (172), Expect = 6e-14
 Identities = 27/114 (23%), Positives = 45/114 (39%), Gaps = 7/114 (6%)

Query: 434 ETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 493
           E     L         P + +     +   +   L +LHS    ++HRD+K  N+L+  +
Sbjct: 95  EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSS 152

Query: 494 FVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYG 546
              KL DFG+ ++       T        T  Y  PE +     +T  D++S G
Sbjct: 153 GQIKLADFGLARIYSFQMALTSV----VVTLWYRAPEVLLQSSYATPVDLWSVG 202

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 4e-34
 Identities = 59/301 (19%), Positives = 102/301 (33%), Gaps = 51/301 (16%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
                +G G FG VY  KL  +G  +A+K +  +  +                    E+Q
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----------------KNRELQ 65

Query: 171 TLSQCKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            + +  H N++RL           + +   +V +Y+                 L      
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 282
                +  +L Y+H  S  I HRD+K  N+LLD +  V KL DFG  K          Y 
Sbjct: 126 LYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183

Query: 283 ENLTGTRPYMPPE--AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q 339
            +    R Y  PE        ++  DV+S G +L ELL G      ++ +     +++  
Sbjct: 184 CS----RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

Query: 340 EVPVREVLDKEAGEWNETHVETLIGIVF----------------EKCCVFEKDKRASMRD 383
             P RE + +    + E     +    +                 +   +    R +  +
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

Query: 384 I 384
            
Sbjct: 300 A 300

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.1 bits (137), Expect = 2e-09
 Identities = 30/99 (30%), Positives = 40/99 (40%), Gaps = 9/99 (9%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSET 509
            L           +  +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K    
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175

Query: 510 SNVKTMYTENLTGTRPYMPPE--AMHCQISTKTDVFSYG 546
                 Y  +    R Y  PE        ++  DV+S G
Sbjct: 176 GEPNVSYICS----RYYRAPELIFGATDYTSSIDVWSAG 210

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 6e-34
 Identities = 61/287 (21%), Positives = 107/287 (37%), Gaps = 35/287 (12%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
                LG+G FG V   + K  G   A+K L      +     +             E +
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH----------TVTESR 57

Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            L   +H  L  L      +   C V EY   G L+  L+R          +       +
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEI 114

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
             AL YLHS  + +++RD+K  N++LD++   K+ DFG+ K   +            GT 
Sbjct: 115 VSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTP 169

Query: 290 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 348
            Y+ PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L 
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS 229

Query: 349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASM--RDIVDLLSKSMF 393
            EA        ++L+          +  +R      D  +++    F
Sbjct: 230 PEA--------KSLL----AGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.0 bits (155), Expect = 1e-11
 Identities = 24/103 (23%), Positives = 43/103 (41%), Gaps = 6/103 (5%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
            ++        +       +  AL YLHS  + +++RD+K  N++LD++   K+ DFG+ 
Sbjct: 95  HLSRERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLC 152

Query: 505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
           K   +            GT  Y+ PE +         D +  G
Sbjct: 153 KEGISDGATMKT---FCGTPEYLAPEVLEDNDYGRAVDWWGLG 192

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 2e-33
 Identities = 59/298 (19%), Positives = 110/298 (36%), Gaps = 31/298 (10%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
            +  K+G+G FG V+  +  K G ++A+K +                          E++
Sbjct: 13  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-----------ALREIK 61

Query: 171 TLSQCKHVNLLRLLGLC---------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 221
            L   KH N++ L+ +C               +V+++  +          N       ++
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSE 118

Query: 222 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTM 280
              +   +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +  
Sbjct: 119 IKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 176

Query: 281 YTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 338
              N   T  Y PPE +  +       D++  G I+ E+ T    +  N       L+ +
Sbjct: 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236

Query: 339 QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCN 396
               +   +      +       L+     K     K         +DL+ K + V +
Sbjct: 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRD-PYALDLIDK-LLVLD 292

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.1 bits (160), Expect = 2e-12
 Identities = 29/103 (28%), Positives = 47/103 (45%), Gaps = 5/103 (4%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK- 505
           N       ++   +   +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ + 
Sbjct: 109 NVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARA 166

Query: 506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYG 546
            S   N +     N   T  Y PPE +  +       D++  G
Sbjct: 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 209

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  127 bits (319), Expect = 2e-33
 Identities = 51/297 (17%), Positives = 99/297 (33%), Gaps = 43/297 (14%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           + G ++GEG FG ++ G  L N  ++A+K     ++               +       +
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ------------LRDEYRTYK 55

Query: 171 TLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
            L+ C  +  +   G    + N +V + +                          A  + 
Sbjct: 56  LLAGCTGIPNVYYFG-QEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQML 111

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVP-----KLGDFGIVKM----SETSNMKTMY 281
             +  +H   K +++RD+K  N L+            + DFG+VK         ++    
Sbjct: 112 ARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169

Query: 282 TENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTG---MKPIDDNNTILYYYLVV 337
            +NL+GT  YM       +  S + D+ + G + +  L G    + +        Y  + 
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229

Query: 338 E--QEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM 392
           E  Q  P+RE+      E+ +                   D       +  L SK +
Sbjct: 230 EKKQSTPLRELCAGFPEEFYK---------YMHYARNLAFDATPDYDYLQGLFSKVL 277

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 69.8 bits (170), Expect = 1e-13
 Identities = 22/110 (20%), Positives = 40/110 (36%), Gaps = 12/110 (10%)

Query: 447 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-----KLGDF 501
                         A  +   +  +H   K +++RD+K  N L+            + DF
Sbjct: 93  LCGRKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150

Query: 502 GIVKM----SETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYG 546
           G+VK         ++     +NL+GT  YM       +  S + D+ + G
Sbjct: 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALG 200

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-32
 Identities = 54/293 (18%), Positives = 106/293 (36%), Gaps = 37/293 (12%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           ++  K+GEG +G VY  + K  G  +A+K +  +       S               E+ 
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPST-----------AIREIS 53

Query: 171 TLSQCKHVNLLRLLGLCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 230
            L +  H N+++LL + +      +     +  L   +   +    +      S    + 
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFM-DASALTGIPLPLIKSYLFQLL 112

Query: 231 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 290
           + L + HS    ++HRD+K  N+L++     KL DFG+ +          +      T  
Sbjct: 113 QGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE---VVTLW 167

Query: 291 YMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL- 347
           Y  PE +      ST  D++S G I  E++T       ++ I   + +        EV+ 
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227

Query: 348 ---------DKEAGEWNETHVETLIGIVFE-------KCCVFEKDKRASMRDI 384
                         +W       ++  + E       +   ++ +KR S +  
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.9 bits (157), Expect = 5e-12
 Identities = 27/116 (23%), Positives = 44/116 (37%), Gaps = 7/116 (6%)

Query: 434 ETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 493
           E     L K    +    +      S    + + L + HS    ++HRD+K  N+L++  
Sbjct: 81  EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTE 138

Query: 494 FVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGA 547
              KL DFG+ +             +   T  Y  PE +      ST  D++S G 
Sbjct: 139 GAIKLADFGLARAFGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 191

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  120 bits (302), Expect = 1e-30
 Identities = 54/243 (22%), Positives = 92/243 (37%), Gaps = 24/243 (9%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
            R   LG G FG V   K  ++G   A+K L+          ++            NE +
Sbjct: 44  DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH----------TLNEKR 93

Query: 171 TLSQCKHVNLLRLLGLCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            L       L++L     +  N  +V EY+  G ++  L R+              A  +
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQI 150

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
                YLHS    +I+RD+K  N+L+D+    ++ DFG  K  +             GT 
Sbjct: 151 VLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC------GTP 202

Query: 290 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 348
             + PE +  +  +   D ++ GV++ E+  G  P   +  I  Y  +V  +V       
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS 262

Query: 349 KEA 351
            + 
Sbjct: 263 SDL 265

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 63.3 bits (153), Expect = 2e-11
 Identities = 25/129 (19%), Positives = 45/129 (34%), Gaps = 9/129 (6%)

Query: 420 LHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPII 479
           L ++      L             + +              A  +     YLHS    +I
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS--LDLI 163

Query: 480 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-IST 538
           +RD+K  N+L+D+    ++ DFG       +      T  L GT   + PE +  +  + 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGF------AKRVKGRTWTLCGTPEALAPEIILSKGYNK 217

Query: 539 KTDVFSYGA 547
             D ++ G 
Sbjct: 218 AVDWWALGV 226

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 6e-29
 Identities = 57/295 (19%), Positives = 108/295 (36%), Gaps = 41/295 (13%)

Query: 112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
            +  K+GEG +GTV+  K +     +A+K +  + +     S               E+ 
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS-----------ALREIC 53

Query: 171 TLSQCKHVNLLRLLGLC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 229
            L + KH N++RL  +  ++    +V+E+          +   +  P       S    +
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP---EIVKSFLFQL 110

Query: 230 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 289
            + L + HS  + ++HRD+K  N+L++ N   KL +FG+ +                 T 
Sbjct: 111 LKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE---VVTL 165

Query: 290 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV--------EQ 339
            Y PP+ +      ST  D++S G I  EL    +P+   N +      +        E+
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225

Query: 340 EVPVREVLDKEAGEWNETHVETLIGIV----------FEKCCVFEKDKRASMRDI 384
           + P    L             +L+ +V           +        +R S  + 
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.8 bits (141), Expect = 4e-10
 Identities = 24/92 (26%), Positives = 41/92 (44%), Gaps = 7/92 (7%)

Query: 457 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMY 516
             S    + + L + HS  + ++HRD+K  N+L++ N   KL +FG+ +           
Sbjct: 103 VKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160

Query: 517 TENLTGTRPYMPPEAMHCQ--ISTKTDVFSYG 546
                 T  Y PP+ +      ST  D++S G
Sbjct: 161 E---VVTLWYRPPDVLFGAKLYSTSIDMWSAG 189

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 8e-28
 Identities = 61/293 (20%), Positives = 102/293 (34%), Gaps = 35/293 (11%)

Query: 112 RRGNKLGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 167
                LG G +G V+  +       G   A+K L+       + +               
Sbjct: 27  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE---------HTRT 77

Query: 168 EVQTLSQCKHVNLLRLLGLC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 225
           E Q L   +    L  L           ++ +Y+  G L+  L   +       ++    
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIY 134

Query: 226 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 285
              +  AL +LH     II+RD+K  N+LLD N    L DFG+ K       +T    + 
Sbjct: 135 VGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKE--FVADETERAYDF 190

Query: 286 TGTRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
            GT  YM P+ +           D +S GV++ ELLTG  P   +        +  + + 
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250

Query: 343 VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASM--RDIVDLLSKSMF 393
                 +E         + LI    ++  + +  KR     RD  ++     F
Sbjct: 251 SEPPYPQEMSA----LAKDLI----QRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.8 bits (131), Expect = 9e-09
 Identities = 32/140 (22%), Positives = 51/140 (36%), Gaps = 9/140 (6%)

Query: 411 QENNNINWELHYTGIPVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHY 470
           Q    +     +     + L        +LF    ++       ++       +  AL +
Sbjct: 87  QSPFLVTLHYAFQTETKLHLILDYINGGELFTH--LSQRERFTEHEVQIYVGEIVLALEH 144

Query: 471 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPE 530
           LH     II+RD+K  N+LLD N    L DFG+ K       +T    +  GT  YM P+
Sbjct: 145 LHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKE--FVADETERAYDFCGTIEYMAPD 200

Query: 531 AMHCQ---ISTKTDVFSYGA 547
            +           D +S G 
Sbjct: 201 IVRGGDSGHDKAVDWWSLGV 220

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 3e-27
 Identities = 59/321 (18%), Positives = 123/321 (38%), Gaps = 55/321 (17%)

Query: 93  FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSN 151
           F   ++ +      R  Y R    +G G +G V      + G ++A+K L          
Sbjct: 4   FYRQEVTKTAWEV-RAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 61

Query: 152 SDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSL 204
                           E++ L   +H N++ LL +        +     +V  +M  G+ 
Sbjct: 62  KR-----------AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTD 108

Query: 205 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 264
             +L +      L  ++   +   + + L Y+H+    IIHRD+K  N+ ++E+   K+ 
Sbjct: 109 LGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKIL 163

Query: 265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMK 322
           DFG+ + ++ S M          TR Y  PE +    + +   D++S G I+ E++TG  
Sbjct: 164 DFGLARQAD-SEMTGY-----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217

Query: 323 P-IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGI---------------- 365
                ++      ++     P  E + +   +  + +++ L  +                
Sbjct: 218 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA 277

Query: 366 --VFEKCCVFEKDKRASMRDI 384
             + EK  V + ++R +  + 
Sbjct: 278 VNLLEKMLVLDAEQRVTAGEA 298

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.7 bits (128), Expect = 2e-08
 Identities = 24/104 (23%), Positives = 49/104 (47%), Gaps = 10/104 (9%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
           ++     L  ++   +   + + L Y+H+    IIHRD+K  N+ ++E+   K+ DFG+ 
Sbjct: 111 KLMKHEKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLA 168

Query: 505 KMSETSNVKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYG 546
           + +++             TR Y  PE +    + +   D++S G
Sbjct: 169 RQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVG 206

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (273), Expect = 6e-27
 Identities = 55/292 (18%), Positives = 109/292 (37%), Gaps = 41/292 (14%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           +   KLG G++  V+    + N  ++ VK L+                       + E++
Sbjct: 38  QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK----------------IKREIK 81

Query: 171 TLSQCK-HVNLLRLLGLCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 226
            L   +   N++ L  +  + ++    +V+E++ N               L         
Sbjct: 82  ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYM 135

Query: 227 LGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENL 285
             + +AL Y H  S  I+HRDVK  NV++D E+   +L D+G+ +         +     
Sbjct: 136 YEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR---- 189

Query: 286 TGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI---DDNNTILYYYLVVEQE 340
             +R +  PE +  +       D++S G +L  ++   +P     DN   L     V   
Sbjct: 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249

Query: 341 VPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASM--RDIVDLLSK 390
             + + +DK   E +    + L     ++   F   +   +   + +D L K
Sbjct: 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 54.5 bits (130), Expect = 1e-08
 Identities = 24/98 (24%), Positives = 41/98 (41%), Gaps = 9/98 (9%)

Query: 451 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSET 509
            L           + +AL Y HS    I+HRDVK  NV++D E+   +L D+G+ +    
Sbjct: 125 TLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182

Query: 510 SNVKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSY 545
                +       +R +  PE +  +       D++S 
Sbjct: 183 GQEYNVR----VASRYFKGPELLVDYQMYDYSLDMWSL 216

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 1e-25
 Identities = 64/294 (21%), Positives = 114/294 (38%), Gaps = 35/294 (11%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           +  + +G G +G+V      K G+ +AVK L                ++I       E++
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-----------SRPFQSIIHAKRTYRELR 69

Query: 171 TLSQCKHVNLLRLLGLC------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 224
            L   KH N++ LL +           +  +  ++    L +    +     L  +    
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQF 125

Query: 225 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 284
           +   +   L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++      +    
Sbjct: 126 LIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA--- 180

Query: 285 LTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
              TR Y  PE M      +   D++S G I+ ELLTG       + I    L++     
Sbjct: 181 ---TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237

Query: 343 VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFVCN 396
               L K+    +E+    +  +       F      +    VDLL K M V +
Sbjct: 238 PGAELLKKI--SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK-MLVLD 288

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.2 bits (111), Expect = 3e-06
 Identities = 26/104 (25%), Positives = 46/104 (44%), Gaps = 10/104 (9%)

Query: 445 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 504
            +     L  +    +   +   L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ 
Sbjct: 111 NIVKCQKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLA 168

Query: 505 KMSETSNVKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYG 546
           + ++      +       TR Y  PE M      +   D++S G
Sbjct: 169 RHTDDEMTGYVA------TRWYRAPEIMLNWMHYNQTVDIWSVG 206

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 1e-24
 Identities = 52/261 (19%), Positives = 90/261 (34%), Gaps = 32/261 (12%)

Query: 112 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 170
           +    +G G  G V           +A+K L       +                  E+ 
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-----------AKRAYRELV 68

Query: 171 TLSQCKHVNLLRLLGLC-------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 223
            +    H N++ LL +              +V E M           +      D  +  
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMS 122

Query: 224 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 283
            +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y  
Sbjct: 123 YLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV- 179

Query: 284 NLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 342
               TR Y  PE  +        D++S G I+ E++         + I  +  V+EQ   
Sbjct: 180 ---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236

Query: 343 VREVLDKEAGEWNETHVETLI 363
                 K+       +VE   
Sbjct: 237 PCPEFMKKLQPTVRNYVENRP 257

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.6 bits (125), Expect = 5e-08
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 7/95 (7%)

Query: 453 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNV 512
           D  +   +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS +
Sbjct: 117 DHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174

Query: 513 KTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYG 546
            T Y      TR Y  PE  +        D++S G
Sbjct: 175 MTPY----VVTRYYRAPEVILGMGYKENVDIWSVG 205

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  101 bits (251), Expect = 6e-24
 Identities = 49/249 (19%), Positives = 90/249 (36%), Gaps = 36/249 (14%)

Query: 103 DGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIP 161
           + +    Y     KLG G F TV+  K + N   +A+K +  +  Y+ +           
Sbjct: 8   EPYKDARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA----------- 55

Query: 162 ILLFENEVQTLSQCKHVNLLRLLGLC----------------NNIMNCIVYEYMCNGSLY 205
               E+E++ L +    +  +   +                 N +   +V+E +    L 
Sbjct: 56  ---AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA 112

Query: 206 DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 265
                 +   PL   K+  I+  +   L Y+H     IIH D+K  NVL++    P+   
Sbjct: 113 LIKKYEHRGIPLIYVKQ--ISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLI 169

Query: 266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 324
              +     +     +  N   TR Y  PE +         D++S   ++ EL+TG    
Sbjct: 170 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229

Query: 325 DDNNTILYY 333
           + +    Y 
Sbjct: 230 EPDEGHSYT 238

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 49.6 bits (117), Expect = 5e-07
 Identities = 25/117 (21%), Positives = 40/117 (34%), Gaps = 2/117 (1%)

Query: 434 ETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 493
           E     L  L +      +       I+  +   L Y+H     IIH D+K  NVL++  
Sbjct: 104 EVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIV 162

Query: 494 FVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQI 549
             P+      +     +     +  N   TR Y  PE +         D++S    I
Sbjct: 163 DSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLI 219

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.9 bits (204), Expect = 6e-19
 Identities = 29/179 (16%), Positives = 56/179 (31%), Gaps = 13/179 (7%)

Query: 114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 173
           G  +GEG+   V+    +   E  VK  +      +S     E      L F       +
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVG---HTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 174 QCKHVNLLRLLGLCNNIMNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALGVAEA 232
           + +   L +L GL       +   Y     ++   L        +       +   + E 
Sbjct: 62  RNEFRALQKLQGL------AVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEE 115

Query: 233 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 291
           +   +   + I+H D+   NVL+ E     + DF           + +   ++     Y
Sbjct: 116 VAKFY--HRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITY 171

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 45.2 bits (106), Expect = 4e-06
 Identities = 11/67 (16%), Positives = 24/67 (35%), Gaps = 3/67 (4%)

Query: 460 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTEN 519
           +   + E +   +   + I+H D+   NVL+ E     + DF           + +   +
Sbjct: 108 VLDMILEEVAKFYH--RGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERD 164

Query: 520 LTGTRPY 526
           +     Y
Sbjct: 165 VRNIITY 171

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	593
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.89
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.89
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.88
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.88
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.88
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.88
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.88
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.87
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.87
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.87
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.87
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.87
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.87
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.87
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.87
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.87
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.87
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.87
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.87
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.86
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.86
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.86
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.86
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.86
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.86
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.86
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.85
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.85
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.85
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.85
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.84
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.84
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.84
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.84
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.84
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.84
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.84
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.84
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.83
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.83
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.83
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.82
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.82
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.82
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.82
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.81
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.81
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.81
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.81
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.8
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.8
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.79
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.79
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.77
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.77
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.77
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.77
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.75
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.73
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.73
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.73
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.66
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.08
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.81
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.33
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.14
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	94.99
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	93.2
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	85.45

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-54  Score=434.36  Aligned_cols=256  Identities=30%  Similarity=0.505  Sum_probs=195.8

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEeccc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  191 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~  191 (593)
                      .++++||+|+||+||+|+++  ..||||+++....    ....       ...|.+|+.+|++++|||||+++|++.+..
T Consensus        11 ~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~----~~~~-------~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~   77 (276)
T d1uwha_          11 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP----TPQQ-------LQAFKNEVGVLRKTRHVNILLFMGYSTAPQ   77 (276)
T ss_dssp             CCCSEEEECSSCEEEEEESS--SEEEEEECCCSSC----CTTH-------HHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             EEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccC----CHHH-------HHHHHHHHHHHHhCCCCCEeeeeEEEeccE
Confidence            45789999999999999865  3699999864321    1111       236899999999999999999999998888


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|||||++|+|.++|...+  ..+++..++.|+.|||+||+|||+  ++||||||||+||||+.++.+||+|||+|+.
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~  153 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATV  153 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred             EEEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEccccceee
Confidence            899999999999999997543  469999999999999999999998  5699999999999999999999999999987


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC----CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~----~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ...... ........||+.|||||++..    .++.++|||||||+||||+||+.||.+.................+.. 
T Consensus       154 ~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~-  231 (276)
T d1uwha_         154 KSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL-  231 (276)
T ss_dssp             -------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG-
T ss_pred             ccccCC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc-
Confidence            543322 122345689999999998742    47889999999999999999999998755443333333222111111 


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ......     +...+..++.+||+.||++||||.||++.|+..
T Consensus       232 ~~~~~~-----~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         232 SKVRSN-----CPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             GGSCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcccc-----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            111111     122355567899999999999999999998763

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-54  Score=442.53  Aligned_cols=278  Identities=24%  Similarity=0.386  Sum_probs=203.0

Q ss_pred             ceeecHHHHHHHhcCCCCCC---CCCCCCcccccCceEEEEEEEc-CCC---EEEEEEeecCCCCCCCCCchhHHhhhcH
Q psy9535          90 LIAFTFCDLERATDGFNRKP---YPRRGNKLGEGQFGTVYYGKLK-NGM---EIAVKTLENNANYSSSNSDNTEAAMIPI  162 (593)
Q Consensus        90 ~~~~~~~~l~~at~~f~~~~---~~~~~~~LG~G~fG~Vy~g~~~-~g~---~vAVK~l~~~~~~~~~~~~~~~~~~~~~  162 (593)
                      +..||++|+.+||.+|+.+.   ..+.+++||+|+||+||+|+++ +|+   .||||++....     . ..      ..
T Consensus         4 ~d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-----~-~~------~~   71 (299)
T d1jpaa_           4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-----T-EK------QR   71 (299)
T ss_dssp             CCGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-----C-HH------HH
T ss_pred             cCCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-----C-HH------HH
Confidence            34578889999999997532   1245678999999999999875 332   58999875321     1 11      12


Q ss_pred             HHHHHHHHHHhcCCCCceeeEEEEEec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q psy9535         163 LLFENEVQTLSQCKHVNLLRLLGLCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK  241 (593)
Q Consensus       163 ~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  241 (593)
                      ..|.+|+++|++++|||||+++|+|.+ ...++|||||++|+|.+++....  ..+++..+..++.|||+||.|||+  +
T Consensus        72 ~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~--~  147 (299)
T d1jpaa_          72 RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLAD--M  147 (299)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHH--T
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhh--C
Confidence            358999999999999999999999976 56789999999999999887533  468999999999999999999998  5


Q ss_pred             CeEecccCCCCeeecCCCccEEeecccceecccCCCcce--eeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHH
Q psy9535         242 PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM--YTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELL  318 (593)
Q Consensus       242 ~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~--~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ell  318 (593)
                      +|+||||||+||||+.++++||+|||+|+..........  ......||+.|||||++. +.++.++|||||||+||||+
T Consensus       148 ~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~  227 (299)
T d1jpaa_         148 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM  227 (299)
T ss_dssp             TCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHH
Confidence            699999999999999999999999999987654322111  122346899999999774 56889999999999999999


Q ss_pred             h-CCCCCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcccc
Q psy9535         319 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFV  394 (593)
Q Consensus       319 t-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~~  394 (593)
                      | |+.||.+.........+..+..+ +     ...     .+...+..++.+||+.||++||||.||++.|++....
T Consensus       228 t~g~~Pf~~~~~~~~~~~i~~~~~~-~-----~~~-----~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         228 SYGERPYWDMTNQDVINAIEQDYRL-P-----PPM-----DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             TTSCCTTTTCCHHHHHHHHHTTCCC-C-----CCT-----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             hCCCCCCCCCCHHHHHHHHHcCCCC-C-----CCc-----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            8 89999876654433333322111 0     001     1123355567899999999999999999999875443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=429.36  Aligned_cols=248  Identities=25%  Similarity=0.370  Sum_probs=196.7

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      ..++||+|+||.||+|++++++.||||+++...    ..          ...|.+|+.+|++++|||||+++|+|.+...
T Consensus        17 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~----~~----------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   82 (272)
T d1qpca_          17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS----MS----------PDAFLAEANLMKQLQHQRLVRLYAVVTQEPI   82 (272)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECTTS----SC----------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             EeEEEecCCCcEEEEEEECCCCEEEEEEEccCc----CC----------HHHHHHHHHHHHhCCCCCEeEEEeeeccCCe
Confidence            357899999999999999888899999996431    11          1258999999999999999999999988888


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++.... ..++++..++.|+.|||+||.|||+  ++|+||||||+||||++++.+||+|||+|+..
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccceEEc
Confidence            99999999999999876432 2358999999999999999999998  56999999999999999999999999999976


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCC-CCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI-DDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~-~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ....  ........||+.|||||++. +.++.++|||||||++|||+||..|+ ...........+.....+.       
T Consensus       160 ~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-------  230 (272)
T d1qpca_         160 EDNE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-------  230 (272)
T ss_dssp             SSSC--EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------
T ss_pred             cCCc--cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-------
Confidence            5433  22234467999999999774 56889999999999999999965555 4433333323222221110       


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ....    +...+..++.+||+.||++||||.||++.|+.
T Consensus       231 ~p~~----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         231 RPDN----CPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             Cccc----ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            0111    12234556789999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=421.66  Aligned_cols=249  Identities=26%  Similarity=0.417  Sum_probs=194.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         110 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       110 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      |.+..++||+|+||+||+|+.. +++.||||++.....    . .. +     ...|.+|+++|++++|||||++++++.
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~----~-~~-~-----~~~~~~E~~il~~l~HpnIv~~~~~~~   78 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL----T-KS-E-----RQRFKEEAEMLKGLQHPNIVRFYDSWE   78 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS----C-HH-H-----HHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC----C-HH-H-----HHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence            3344568999999999999975 688999999875321    1 11 1     235899999999999999999999885


Q ss_pred             c-----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec-CCCccE
Q psy9535         189 N-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPK  262 (593)
Q Consensus       189 ~-----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~-~~~~~K  262 (593)
                      +     ...++||||+++|+|.+++.+.   ..+++..+..++.||++||+|||+.+.+|+||||||+||||+ +++.+|
T Consensus        79 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~K  155 (270)
T d1t4ha_          79 STVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVK  155 (270)
T ss_dssp             EESSSCEEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred             eccccCCEEEEEEeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEE
Confidence            4     2357999999999999999764   358999999999999999999998555599999999999996 578999


Q ss_pred             EeecccceecccCCCcceeeccccCCCCcCCcccccCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCc
Q psy9535         263 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  342 (593)
Q Consensus       263 l~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~  342 (593)
                      |+|||+|+......     ....+||+.|||||++.+.++.++|||||||++|||++|+.||.+................
T Consensus       156 l~DFGla~~~~~~~-----~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~  230 (270)
T d1t4ha_         156 IGDLGLATLKRASF-----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK  230 (270)
T ss_dssp             ECCTTGGGGCCTTS-----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred             EeecCcceeccCCc-----cCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC
Confidence            99999998644322     2346899999999999888999999999999999999999999865443333322222211


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ... ++.   ...     ..+..++.+||+.||++|||+.|+++
T Consensus       231 ~~~-~~~---~~~-----~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 PAS-FDK---VAI-----PEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CGG-GGG---CCC-----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Ccc-cCc---cCC-----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            111 111   111     12455778999999999999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=424.63  Aligned_cols=250  Identities=23%  Similarity=0.334  Sum_probs=195.5

Q ss_pred             CcccccCceEEEEEEEcC---CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEeccc
Q psy9535         115 NKLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  191 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~~---g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~  191 (593)
                      ++||+|+||+||+|.++.   ++.||||+++....    ....       ...|.+|+.+|++++|||||+++|+|.++.
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~----~~~~-------~~~~~~E~~il~~l~HpnIv~~~g~~~~~~   81 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN----DPAL-------KDELLAEANVMQQLDNPYIVRMIGICEAES   81 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC---------CHH-------HHHHHHHHHHHHTCCCTTBCCEEEEEESSS
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC----CHHH-------HHHHHHHHHHHHhCCCCCCceEEEEeccCC
Confidence            469999999999998753   46799999964311    1111       125899999999999999999999998877


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .+||||||++|+|.+++...   .++++..++.++.|||.||+|||+  ++||||||||+||||+.++.+||+|||+++.
T Consensus        82 ~~lvmE~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill~~~~~~kl~DFGla~~  156 (277)
T d1xbba_          82 WMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKA  156 (277)
T ss_dssp             EEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEEcCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcccccCcccccchhhhhh
Confidence            89999999999999999763   469999999999999999999998  5699999999999999999999999999987


Q ss_pred             cccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ...............||+.|||||++ ...++.++|||||||++|||+| |+.||.+.........+..+..+  ..   
T Consensus       157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~--~~---  231 (277)
T d1xbba_         157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--GC---  231 (277)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--CC---
T ss_pred             ccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC--CC---
Confidence            65443322233446799999999976 4568889999999999999998 89999876554433333322211  00   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                       ...     +...+..++.+||+.||++||||.+|++.|+..
T Consensus       232 -p~~-----~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         232 -PAG-----CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             -CTT-----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -Ccc-----cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence             011     122345577899999999999999999988763

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=426.09  Aligned_cols=249  Identities=22%  Similarity=0.364  Sum_probs=198.5

Q ss_pred             cccccCceEEEEEEEc---CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecccc
Q psy9535         116 KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIMN  192 (593)
Q Consensus       116 ~LG~G~fG~Vy~g~~~---~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~~  192 (593)
                      +||+|+||+||+|.++   ++..||||+++...     ....       ...|.+|+++|++++|||||+++|+|..+..
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-----~~~~-------~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~   83 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-----EKAD-------TEEMMREAQIMHQLDNPYIVRLIGVCQAEAL   83 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSC-----CHHH-------HHHHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhc-----CHHH-------HHHHHHHHHHHHhCCCCCEeeEeeeeccCeE
Confidence            5999999999999864   35579999996431     1111       2358999999999999999999999988888


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      +||||||++|+|.+++...+  ..+++..+..++.|+|+||.|||+  ++|+||||||+||||+.++.+||+|||+|+..
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccchhhhcc
Confidence            99999999999999986532  468999999999999999999998  56999999999999999999999999999976


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ..............||+.|||||++. +.++.++|||||||++|||+| |+.||.+.........+..+..+  +     
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~--~-----  232 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM--E-----  232 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC--C-----
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--C-----
Confidence            55433233334567999999999774 568999999999999999998 99999876554433333322211  0     


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ....    +...+..++.+||+.||++||||.+|++.|+..
T Consensus       233 ~p~~----~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         233 CPPE----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             CCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCc----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            0111    122345567899999999999999999998763

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=420.18  Aligned_cols=247  Identities=25%  Similarity=0.409  Sum_probs=186.3

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      .++||+|+||.||+|++.+++.||||+++....    .    +      ..|.+|++++++++|||||+++|+|.. ...
T Consensus        10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~----~----~------~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~   75 (263)
T d1sm2a_          10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----S----E------EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   75 (263)
T ss_dssp             EEEEECCSSCCEEEEEETTTEEEEEEECCSSSS----C----H------HHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             EEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC----c----H------HHHHHHHHHHHhcCCCCcccccceeccCCce
Confidence            578999999999999998888999999864311    1    1      258999999999999999999999975 567


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+++|+|.+++....  ..+++..++.++.|+|+||.|||+  ++|+||||||+|||+|+++.+||+|||+++..
T Consensus        76 ~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  151 (263)
T d1sm2a_          76 CLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  151 (263)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred             EEEEEecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchheec
Confidence            89999999999999987533  468999999999999999999998  56999999999999999999999999999876


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhC-CCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTG-MKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......  ......||+.|||||++. ..++.++|||||||++|||+|| .+||...........+.....+.    .+ 
T Consensus       152 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~----~p-  224 (263)
T d1sm2a_         152 LDDQYT--SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY----KP-  224 (263)
T ss_dssp             ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC----CC-
T ss_pred             cCCCce--eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC----Cc-
Confidence            543321  123457999999999875 4689999999999999999995 55555544433333333221111    01 


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                        ...    ...+..++.+||+.||++||||+||++.|++.
T Consensus       225 --~~~----~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         225 --RLA----STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             --TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --ccc----CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence              111    12345567899999999999999999999863

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-52  Score=418.02  Aligned_cols=242  Identities=29%  Similarity=0.451  Sum_probs=196.9

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +++.||+|+||+||+|+.+ +|+.||||++.+......          .....+.+|+++|++++|||||++++++.+ .
T Consensus        10 i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~----------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1          10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA----------GVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             EEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccCh----------HHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            4678999999999999985 689999999864311110          112358899999999999999999999877 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++|||||++|+|.+++.+.   ..+++..+..++.|+++||+|||+  ++|+||||||+|||++.++.+||+|||+|+
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~~kl~DFG~a~  154 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSV  154 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred             EEEEEEeecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeeeeccccceecCCCCEeecccceee
Confidence            568999999999999999864   358999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......     .....||+.|||||++.+ .++.++|||||||+||||++|+.||...+....+..+.......++.   
T Consensus       155 ~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~---  226 (263)
T d2j4za1         155 HAPSSR-----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF---  226 (263)
T ss_dssp             CCCCCC-----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTT---
T ss_pred             ecCCCc-----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCcc---
Confidence            654332     234689999999998865 47899999999999999999999998876655555544443332221   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                               +...+..++.+||+.||++|||+.|+++
T Consensus       227 ---------~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         227 ---------VTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---------SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                     1123455678999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5e-52  Score=423.31  Aligned_cols=249  Identities=28%  Similarity=0.443  Sum_probs=196.7

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||+||+|+++ +|+.||||+++...    .   .       ...|.+|+++|++++|||||+++|+|.+ +.
T Consensus        22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~---~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_          22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----M---E-------VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----S---C-------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             eeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----c---h-------HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            578999999999999986 58899999986431    1   0       1258999999999999999999999976 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|||||++|+|.++|.... ...+++..+..|+.|+|+||+|||+  ++|+||||||+||||++++.+||+|||+|+.
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             eEEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEccccceee
Confidence            689999999999999997643 3578999999999999999999998  5699999999999999999999999999987


Q ss_pred             cccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......  .......||+.|||||++ ...++.|+|||||||++|||++|..|+...................      .
T Consensus       165 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~------~  236 (287)
T d1opja_         165 MTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------E  236 (287)
T ss_dssp             CCSSSS--EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC------C
T ss_pred             cCCCCc--eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC------C
Confidence            654332  223345689999999976 5678999999999999999999777765443333222222222111      0


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ...    .+...+..++.+||+.||++||||.||++.|+..
T Consensus       237 ~~~----~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         237 RPE----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            011    1122345567899999999999999999998763

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=417.44  Aligned_cols=245  Identities=27%  Similarity=0.443  Sum_probs=196.2

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         111 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       111 ~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      ++..++||+|+||+||+|+.. +|+.||||++.....   ..          ...|.+|+.+|++++|||||++++++.+
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~   88 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PK----------KELIINEILVMRENKNPNIVNYLDSYLV   88 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SC----------HHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hH----------HHHHHHHHHHHHhCCCCCEeeEeEEEEE
Confidence            455688999999999999874 699999999975321   11          1248899999999999999999998876


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...++|||||++|+|.+++.+    ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~ivmEy~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~DFG~  162 (293)
T d1yhwa1          89 GDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGF  162 (293)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEEEecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeeccchh
Confidence             566899999999999998765    358999999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      |+.......   .....+||+.|||||++.+ .++.++|||||||++|||+||+.||.+.+.............+...  
T Consensus       163 a~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~--  237 (293)
T d1yhwa1         163 CAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ--  237 (293)
T ss_dssp             CEECCSTTC---CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS--
T ss_pred             heeeccccc---cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC--
Confidence            987644321   1234689999999998754 5789999999999999999999999876655444443333221111  


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                             .+..+...+..++.+||+.||++|||+.|+++
T Consensus       238 -------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 -------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -------CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   01112234556778999999999999999853

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-52  Score=419.08  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=190.3

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.++||+|+||+||+|+.+ +|+.||||++.......     .       ...|.+|+.+|++++|||||++++++.+ .
T Consensus         9 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-----~-------~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~   76 (271)
T d1nvra_           9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----C-------PENIKKEICINKMLNHENVVKFYGHRREGN   76 (271)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------------------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-----H-------HHHHHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence            4679999999999999985 68999999996532110     0       1148899999999999999999999876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..+||||||++|+|.++|...   ..+++..+..++.|+++||+|||+  ++|+||||||+|||+++++.+||+|||+|+
T Consensus        77 ~~~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl~~~~~~KL~DFG~a~  151 (271)
T d1nvra_          77 IQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLAT  151 (271)
T ss_dssp             EEEEEEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eeEEEEeccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEECCCCCEEEccchhhe
Confidence            568999999999999998642   469999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CC-CCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ....... .......+||+.|||||++.+ .+ +.++|||||||++|||+||+.||......................  
T Consensus       152 ~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~--  228 (271)
T d1nvra_         152 VFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--  228 (271)
T ss_dssp             ECEETTE-ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTT--
T ss_pred             eeccCCc-cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc--
Confidence            7654332 122345689999999998754 44 567999999999999999999997644322222222221111100  


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                             ...+...+..++.+||+.||++|||+.|+++
T Consensus       229 -------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         229 -------WKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                   0111223445678999999999999999853

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-51  Score=414.87  Aligned_cols=255  Identities=26%  Similarity=0.384  Sum_probs=187.7

Q ss_pred             CCCcccccCceEEEEEEEcCC-----CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNG-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g-----~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      ++++||+|+||.||+|.++.+     ..||||++....     . ...      ...|.+|+.+|++++|||||+++|+|
T Consensus        11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-----~-~~~------~~~~~~E~~il~~l~H~nIv~~~g~~   78 (283)
T d1mqba_          11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-----T-EKQ------RVDFLGEAGIMGQFSHHNIIRLEGVI   78 (283)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-----C-HHH------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-----C-hHH------HHHHHHHHHHHHhcCCCCEeeeeEEE
Confidence            367899999999999987642     369999986421     1 111      22589999999999999999999999


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      .+ ...++|||||.+|++.+.+....  ..+++..+..++.|+|.||+|||+  ++|+||||||+||||+.++.+||+||
T Consensus        79 ~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl~~~~~~Kl~DF  154 (283)
T d1mqba_          79 SKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDF  154 (283)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             ecCCceEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEECCCCeEEEccc
Confidence            76 56689999999999999887543  469999999999999999999998  56999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCC-CchHHHHHHHHhhcCccc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDD-NNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~-~~~~~~~~~~~~~~~~~~  344 (593)
                      |+++................||+.|||||++. ..++.++|||||||++|||+||..|+.. .........+..+..+ +
T Consensus       155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-~  233 (283)
T d1mqba_         155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-P  233 (283)
T ss_dssp             CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-C
T ss_pred             chhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC-C
Confidence            99987654332222233457899999999774 5688999999999999999997666544 3333222222222111 0


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcccc
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSMFV  394 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~~~  394 (593)
                            ...    .+...+..++.+||+.||++||||.||++.|++....
T Consensus       234 ------~~~----~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         234 ------TPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             ------CCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ------Cch----hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                  001    1122355677899999999999999999999875443

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-52  Score=421.64  Aligned_cols=248  Identities=24%  Similarity=0.397  Sum_probs=196.2

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe
Q psy9535         110 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN  188 (593)
Q Consensus       110 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~  188 (593)
                      ++++.+.||+|+||+||+|+.+ +|+.||||+++....      ..       ...|.+|+++|++++|||||++++++.
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~-------~~~~~~E~~il~~l~HpnIv~l~~~~~   79 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE------EE-------LEDYMVEIDILASCDHPNIVKLLDAFY   79 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS------GG-------GGGTHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH------HH-------HHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            3455678999999999999975 689999999974311      11       124789999999999999999999887


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      + ...++|||||++|+|.+++.+..  .++++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        80 ~~~~~~lvmEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll~~~~~~Kl~DFG  155 (288)
T d2jfla1          80 YENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFG  155 (288)
T ss_dssp             ETTEEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCeEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeECCCCCEEEEech
Confidence            6 56689999999999999987543  469999999999999999999998  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCccccc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  341 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~  341 (593)
                      +|+......   .......||+.|||||++.      ..++.++|||||||++|||+||+.||.+.+.......+.....
T Consensus       156 ~a~~~~~~~---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~  232 (288)
T d2jfla1         156 VSAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP  232 (288)
T ss_dssp             TCEECHHHH---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC
T ss_pred             hhhccCCCc---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence            997653321   1123468999999999763      2378899999999999999999999987665544444443332


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +...  .       +..+...+..++.+||+.||++|||+.|+++
T Consensus       233 ~~~~--~-------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         233 PTLA--Q-------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CCCS--S-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCC--c-------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2111  0       1112233556778999999999999999854

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-51  Score=408.27  Aligned_cols=247  Identities=24%  Similarity=0.422  Sum_probs=199.6

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      ..++||+|+||+||+|++++++.||||+++....    .    +      ..|.+|+.++++++|||||+++|+|.+ ..
T Consensus         8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~----~----~------~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~   73 (258)
T d1k2pa_           8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----S----E------DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   73 (258)
T ss_dssp             CCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS----C----H------HHHHHHHHHHHTCCCTTBCCEEEEECCSSS
T ss_pred             EeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC----C----H------HHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Confidence            4689999999999999998888999999975311    1    1      148999999999999999999999976 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.+++....  ..+++..+.+++.|+|+||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        74 ~~iv~Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~  149 (258)
T d1k2pa_          74 IFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY  149 (258)
T ss_dssp             EEEEEECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred             eEEEEEccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhhee
Confidence            689999999999999986543  468999999999999999999998  6699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .......  ......||+.|+|||.+. ..++.|+|||||||++|||+| |+.||...........+.....+.    .+
T Consensus       150 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~----~p  223 (258)
T d1k2pa_         150 VLDDEYT--SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----RP  223 (258)
T ss_dssp             CSSSSCC--CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC----CC
T ss_pred             ccCCCce--eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC----Cc
Confidence            5543321  223467999999999764 568899999999999999998 899998766544444333321110    01


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                         .    .....+..++.+||+.||++|||+.||++.|.+
T Consensus       224 ---~----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         224 ---H----LASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ---T----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ---c----cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence               1    112345567789999999999999999998854

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=416.68  Aligned_cols=248  Identities=25%  Similarity=0.369  Sum_probs=184.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec---
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN---  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~---  189 (593)
                      .+.||+|+||+||+|+.+ +|+.||||.+.....    ...  .     ...|.+|+++|++++|||||++++++.+   
T Consensus         9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----~~~--~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   77 (269)
T d2java1           9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM----TEA--E-----KQMLVSEVNLLRELKHPNIVRYYDRIIDRTN   77 (269)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS----CHH--H-----HHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC----CHH--H-----HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence            578999999999999875 689999999965311    111  1     2358899999999999999999998854   


Q ss_pred             ccceEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---CCeEecccCCCCeeecCCCccEEee
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLS---KPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~---~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                      ...++|||||++|+|.+++.+.. ....+++..+..++.|++.||.|||+.+   .+||||||||+||||+.++.+||+|
T Consensus        78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            34589999999999999986532 2356999999999999999999999743   3499999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      ||+|+......   .......||+.|||||++.+ .++.++|||||||++|||+||+.||...+.......+.....+  
T Consensus       158 FG~a~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~--  232 (269)
T d2java1         158 FGLARILNHDT---SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR--  232 (269)
T ss_dssp             HHHHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--
T ss_pred             ccceeecccCC---CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC--
Confidence            99998764332   12335689999999998754 5889999999999999999999999876655444443333221  


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..    ...+     ...+..++.+||+.||++|||+.|+++
T Consensus       233 ~~----~~~~-----s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 RI----PYRY-----SDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CC----CTTS-----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC----Cccc-----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11    1111     123455678999999999999999864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-51  Score=421.21  Aligned_cols=253  Identities=26%  Similarity=0.457  Sum_probs=194.4

Q ss_pred             CCCcccccCceEEEEEEEcC-C-----CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLKN-G-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  185 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~-g-----~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g  185 (593)
                      ++++||+|+||+||+|++.. +     ..||||.+.......            ....|.+|+.+|+++ +|||||+++|
T Consensus        41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS------------EREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------------------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHH------------HHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            36789999999999998753 2     369999986432110            012588999999998 8999999999


Q ss_pred             EEec-ccceEEEEeccCCCHHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q psy9535         186 LCNN-IMNCIVYEYMCNGSLYDRLARVNN--------------------TPPLDSNKRYSIALGVAEALHYLHSLSKPII  244 (593)
Q Consensus       186 ~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~Ii  244 (593)
                      +|.+ ...++|||||++|+|.++|+....                    ...+++..++.|+.|||+||+|||+  ++||
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~--~~Ii  186 (325)
T d1rjba_         109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCV  186 (325)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEE
T ss_pred             EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCee
Confidence            9976 566899999999999999976432                    2358999999999999999999998  5699


Q ss_pred             ecccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCC
Q psy9535         245 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMK  322 (593)
Q Consensus       245 HrDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~  322 (593)
                      ||||||+|||++.++.+||+|||+|+....... ........||+.|||||++ .+.++.++|||||||+||||+| |+.
T Consensus       187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~  265 (325)
T d1rjba_         187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN  265 (325)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             eccCchhccccccCCeEEEeeccccccccCCCc-eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCC
Confidence            999999999999999999999999987654432 2223346789999999976 5678999999999999999998 899


Q ss_pred             CCCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         323 PIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       323 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      ||.+................+.      ....    +...+..++.+||+.||++||||.||++.|..
T Consensus       266 Pf~~~~~~~~~~~~~~~~~~~~------~p~~----~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         266 PYPGIPVDANFYKLIQNGFKMD------QPFY----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             SSTTCCCSHHHHHHHHTTCCCC------CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHhcCCCCC------CCCc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            9987543332333333221111      1111    12335567789999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-51  Score=415.02  Aligned_cols=250  Identities=26%  Similarity=0.354  Sum_probs=192.0

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEeccc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNIM  191 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~~  191 (593)
                      ++++.||+|+||+||+|++++++.||||+++...    ..    .      ..|.+|+.+|++++|||||+++|+|.+..
T Consensus        20 ~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~----~~----~------~~~~~E~~~l~~l~h~nIv~~~g~~~~~~   85 (285)
T d1fmka3          20 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT----MS----P------EAFLQEAQVMKKLRHEKLVQLYAVVSEEP   85 (285)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS----SC----H------HHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             EEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc----CC----H------HHHHHHHHHHHhcccCCEeEEEEEEecCC
Confidence            3467899999999999999888899999986431    11    1      25899999999999999999999998888


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|..++..... ..++|..++.|+.|||.||.|||+  ++|+||||||+|||||.++.+||+|||+|+.
T Consensus        86 ~~lv~Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll~~~~~~kl~DfGla~~  162 (285)
T d1fmka3          86 IYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL  162 (285)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             eEEEEEecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhh--hheecccccceEEEECCCCcEEEcccchhhh
Confidence            8999999999999988875432 459999999999999999999998  5699999999999999999999999999987


Q ss_pred             cccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCC-CchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDD-NNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~-~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......  .......||+.|+|||++ .+.++.++|||||||++|||+||..|+.. .........+...... .  .  
T Consensus       163 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-~--~--  235 (285)
T d1fmka3         163 IEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-P--C--  235 (285)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-C--C--
T ss_pred             ccCCCc--eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-C--C--
Confidence            643322  122345799999999976 56789999999999999999997666544 3333333332222110 0  0  


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                        ..    .+...+..++.+||+.||++||+|.+|+++|+..
T Consensus       236 --~~----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         236 --PP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             --CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             --Cc----ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence              11    1122355667899999999999999999999873

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-51  Score=414.13  Aligned_cols=247  Identities=25%  Similarity=0.390  Sum_probs=195.5

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++++.||+|+||+||+|+.+ +|+.||||++.+......          .....|.+|+++|++++|||||++++++.+ 
T Consensus        11 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~----------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~   80 (288)
T d1uu3a_          11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE----------NKVPYVTRERDVMSRLDHPFFVKLYFTFQDD   80 (288)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCH----------HHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence            34689999999999999985 689999999964311110          112358899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++|||||++|+|.+++...   ..+++..+..++.|++.||+|||+  ++||||||||+|||+++++.+||+|||+|
T Consensus        81 ~~~~ivmEy~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll~~~~~vkl~DFG~a  155 (288)
T d1uu3a_          81 EKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTA  155 (288)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCccccccCCCceEEecccccc
Confidence            4568999999999999998764   358999999999999999999999  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      +....... .......+||+.|||||++.+ .++.++|||||||++|||+||+.||...+.......+......+++.  
T Consensus       156 ~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~--  232 (288)
T d1uu3a_         156 KVLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--  232 (288)
T ss_dssp             EECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTT--
T ss_pred             eecccCCc-ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCcc--
Confidence            87654322 112334689999999998754 58889999999999999999999998876655555554443332221  


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                +...+..++.+||+.||++|||+.|+++
T Consensus       233 ----------~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         233 ----------FFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ----------CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ----------CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                      1123456778999999999999998753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-50  Score=415.37  Aligned_cols=241  Identities=27%  Similarity=0.433  Sum_probs=192.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||+||+|+.. +|+.||||++......     .. +    ....|.+|+.+|++++|||||+++|++.+ ..
T Consensus        20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~-~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   89 (309)
T d1u5ra_          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-----SN-E----KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT   89 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSC-----HH-H----HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhcc-----CH-H----HHHHHHHHHHHHHHCCCCCEeeEEEEEEECCE
Confidence            468999999999999875 6889999999753211     11 1    12358899999999999999999999876 56


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|||||.+|+|..++...   .++++..+..++.||+.||.|||+  ++||||||||+||||+.++.+||+|||+|+.
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EEEEEEecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEECCCCCEEEeecccccc
Confidence            78999999999997666542   469999999999999999999999  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~----~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      ....       ....||+.|||||++.    +.++.++|||||||++|||++|+.||.+...............+..  .
T Consensus       165 ~~~~-------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~  235 (309)
T d1u5ra_         165 MAPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--Q  235 (309)
T ss_dssp             SSSB-------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--S
T ss_pred             cCCC-------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--C
Confidence            4332       2357999999999873    3478899999999999999999999987665554444443332211  1


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         ...+     ...+..++.+||+.||++|||+.|+++
T Consensus       236 ---~~~~-----s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         236 ---SGHW-----SEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ---CTTS-----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCC-----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence               1112     223556778999999999999999865

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-50  Score=414.72  Aligned_cols=246  Identities=24%  Similarity=0.356  Sum_probs=182.9

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.+.||+|+||+||+|+.+ +|+.||||++........      .      ..|.+|+.+|++++|||||++++++.+ 
T Consensus        12 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~------~------~~~~~Ei~il~~l~HpnIv~l~~~~~~~   79 (307)
T d1a06a_          12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK------E------GSMENEIAVLHKIKHPNIVALDDIYESG   79 (307)
T ss_dssp             EEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------------------CHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             EEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH------H------HHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            34678999999999999975 689999999975422110      1      147899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec---CCCccEEeec
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDF  266 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~---~~~~~Kl~DF  266 (593)
                      ...+||||||++|+|.++|...   ..+++..+..++.|++.||+|||+  ++|+||||||+|||+.   +++.+||+||
T Consensus        80 ~~~~lvmE~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~DF  154 (307)
T d1a06a_          80 GHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDF  154 (307)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred             CEEEEEEeccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEecc
Confidence            4568999999999999999753   469999999999999999999998  5699999999999994   5789999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      |+|+.......    ....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+.........+.........
T Consensus       155 G~a~~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  230 (307)
T d1a06a_         155 GLSKMEDPGSV----LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS  230 (307)
T ss_dssp             ----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT
T ss_pred             ceeEEccCCCe----eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC
Confidence            99986543321    234679999999998754 5899999999999999999999999887665555555444332221


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...   .     .+...+..++.+||+.||++|||+.|+++
T Consensus       231 ~~~---~-----~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         231 PYW---D-----DISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTT---T-----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccc---c-----CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            110   1     12223556778999999999999999865

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=406.70  Aligned_cols=252  Identities=25%  Similarity=0.346  Sum_probs=199.3

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         111 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       111 ~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      +++++.||+|+||+||+|+.+ +|+.||||++++..........       ....|.+|+.+|++++|||||++++++.+
T Consensus        12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~-------~~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (293)
T d1jksa_          12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-------SREDIEREVSILKEIQHPNVITLHEVYEN   84 (293)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSB-------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhH-------HHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            455789999999999999985 7999999999765332221111       12358999999999999999999999877


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC----ccEEe
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLG  264 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~----~~Kl~  264 (593)
                       ...+||||||++|+|.++|...   ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++    .+||+
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~--~~ivHrDiKp~Nill~~~~~~~~~vkl~  159 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKII  159 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhh--cceeecccccceEEEecCCCcccceEec
Confidence             4568999999999999999764   358999999999999999999998  5699999999999998776    48999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  343 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~  343 (593)
                      |||+|+.......    .....||+.|||||++.+ .++.++|||||||++|||++|+.||.+.+....+..+.......
T Consensus       160 DfG~a~~~~~~~~----~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~  235 (293)
T d1jksa_         160 DFGLAHKIDFGNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF  235 (293)
T ss_dssp             CCTTCEECTTSCB----CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred             chhhhhhcCCCcc----ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            9999987654332    234679999999998765 58899999999999999999999998866555544444333222


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .....   .     .+...+..++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~---~-----~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         236 EDEYF---S-----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CHHHH---T-----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             Cchhc---C-----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11110   1     11233456778999999999999999864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-50  Score=403.51  Aligned_cols=254  Identities=27%  Similarity=0.387  Sum_probs=190.6

Q ss_pred             CCcccccCceEEEEEEEc--CC--CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         114 GNKLGEGQFGTVYYGKLK--NG--MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~--~g--~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      .+.||+|+||.||+|++.  ++  ..||||++++.....   ..       ....|.+|+.+|++++|||||+++|+|.+
T Consensus        13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~---~~-------~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~   82 (273)
T d1u46a_          13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ---PE-------AMDDFIREVNAMHSLDHRNLIRLYGVVLT   82 (273)
T ss_dssp             EEECC----CCCEEEEEECTTSCEEEEEEEC-----------CH-------HHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC---HH-------HHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            468999999999999864  23  368999986532111   11       12358999999999999999999999988


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++||||+++|+|.+++....  .++++..++.++.|+|.||.|||+  ++|+||||||+||||+.++.+||+|||++
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll~~~~~vkl~DfGl~  158 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLM  158 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             cchheeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhccccccceeeccchhh
Confidence            87899999999999999887643  359999999999999999999998  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      +................||+.|+|||++. ..++.++|||||||++|||+| |+.||.+.+.......+........   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~---  235 (273)
T d1u46a_         159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP---  235 (273)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC---
T ss_pred             hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC---
Confidence            97655443333344567889999999775 457889999999999999998 8999987665554444433322111   


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                        .....     ...+..++.+||+.||++||||.||++.|.+.
T Consensus       236 --~~~~~-----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         236 --RPEDC-----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             --CCTTC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --Ccccc-----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence              01111     12355677899999999999999999998763

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=411.78  Aligned_cols=251  Identities=25%  Similarity=0.393  Sum_probs=192.4

Q ss_pred             CCCcccccCceEEEEEEEc-CCC----EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~----~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      ..++||+|+||+||+|++. +|+    .||||+++....  .   .       ....|.+|+.+|++++|||||+++|+|
T Consensus        13 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~---~-------~~~~~~~E~~~l~~l~HpnIv~l~g~~   80 (317)
T d1xkka_          13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--P---K-------ANKEILDEAYVMASVDNPHVCRLLGIC   80 (317)
T ss_dssp             EEEEEEECSSEEEEEEEECC----CCEEEEEEEECC---------C-------THHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             EeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC--H---H-------HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3579999999999999875 444    588998854211  1   0       122589999999999999999999999


Q ss_pred             ecccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         188 NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       188 ~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      .+...+++|||+++|+|.+.+....  ..+++..+++++.|||.||.|||+  ++||||||||+||||+.++.+||+|||
T Consensus        81 ~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll~~~~~~kl~DFG  156 (317)
T d1xkka_          81 LTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFG  156 (317)
T ss_dssp             ESSSEEEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCCS
T ss_pred             ecCCeeEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhcceeCCCCCeEeeccc
Confidence            9888899999999999999887643  468999999999999999999999  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      +|+....... ...+....||+.|||||++ .+.++.++|||||||++|||+| |..||...........+..+..+.  
T Consensus       157 la~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~--  233 (317)
T d1xkka_         157 LAKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP--  233 (317)
T ss_dssp             HHHHTTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC--
T ss_pred             cceecccccc-cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence            9987654332 2223345799999999976 5668999999999999999998 799998754433333332222110  


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                           ...    .+...+..++.+||+.||++||||.||++.|.+.
T Consensus       234 -----~p~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         234 -----QPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             -----CCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCc----ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence                 001    1122345567899999999999999999988763

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=419.50  Aligned_cols=193  Identities=28%  Similarity=0.409  Sum_probs=163.7

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||+||+|+.. +|+.||||+++...     ....       ...+.+|+.+|++++|||||+++++|.+ ..
T Consensus        11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-----~~~~-------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   78 (322)
T d1s9ja_          11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-----KPAI-------RNQIIRELQVLHECNSPYIVGFYGAFYSDGE   78 (322)
T ss_dssp             EEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-----CTTH-------HHHHHHHGGGGGGCCCTTBCCEEEEEECSSE
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-----CHHH-------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            578999999999999975 68999999997531     1111       1258899999999999999999999976 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|||||++|+|.+++.+.   ..+++..+..++.|+++||.|||+. ++|+||||||+|||++.++.+||+|||+|+.
T Consensus        79 ~~iVmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  154 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  154 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEEEEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence            68999999999999999864   3589999999999999999999972 2599999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCC
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDN  327 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~  327 (593)
                      .....     ..+.+||+.|||||++. ..++.++||||+||++|||++|+.||...
T Consensus       155 ~~~~~-----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         155 LIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             HHHHT-----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             cCCCc-----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            54322     23468999999999875 46899999999999999999999999764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=403.02  Aligned_cols=251  Identities=27%  Similarity=0.400  Sum_probs=188.0

Q ss_pred             CCCCcccccCceEEEEEEEcC----CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~~----g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      ++++.||+|+||.||+|++..    +..||||.++...      .+..      ...|.+|+.+|++++|||||+++|+|
T Consensus        10 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~------~~~~------~~~~~~E~~~l~~l~HpnIv~l~~~~   77 (273)
T d1mp8a_          10 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT------SDSV------REKFLQEALTMRQFDHPHIVKLIGVI   77 (273)
T ss_dssp             EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT------SHHH------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             EEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc------CHHH------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            346789999999999998752    3568999875321      1111      23589999999999999999999999


Q ss_pred             ecccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         188 NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       188 ~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                      .+...++||||+++|+|.+++....  .++++..+..++.||++||.|||+  ++||||||||+|||++.++.+||+|||
T Consensus        78 ~~~~~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          78 TENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             CSSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             ecCeEEEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheeecCCCcEEEccch
Confidence            8888899999999999999887543  468999999999999999999999  569999999999999999999999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  345 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  345 (593)
                      +|+.......  ..+....||+.|+|||++. ..++.++|||||||++|||+| |.+||...........+..+..+  .
T Consensus       154 ~a~~~~~~~~--~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~--~  229 (273)
T d1mp8a_         154 LSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--P  229 (273)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--C
T ss_pred             hheeccCCcc--eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--C
Confidence            9987544321  1233467899999999874 568889999999999999998 89999876554444443333211  0


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                          ....     +...+..++.+||+.||++|||+.||++.|++.
T Consensus       230 ----~~~~-----~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         230 ----MPPN-----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             ----CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCC-----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                0111     122355677899999999999999999988763

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.2e-50  Score=409.23  Aligned_cols=252  Identities=27%  Similarity=0.450  Sum_probs=195.7

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      .+.||+|+||+||+|+++      +++.||||+++...     . ...      ...|.+|+++|++++||||++++++|
T Consensus        18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-----~-~~~------~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_          18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-----S-ADM------QADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-----C-HHH------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-----C-hHH------HHHHHHHHHHHHhcCCCCcccceeee
Confidence            678999999999999874      35789999986421     1 111      23589999999999999999999999


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNN---------------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIH  245 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiH  245 (593)
                      .. ...++||||+++|+|.++|.....                     ...+++..++.|+.|+|.||+|||+  ++|||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~ivH  163 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVH  163 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--CCeEe
Confidence            76 567899999999999999975321                     2358999999999999999999998  56999


Q ss_pred             cccCCCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCC-CC
Q psy9535         246 RDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGM-KP  323 (593)
Q Consensus       246 rDLKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~-~P  323 (593)
                      |||||+|||||.++.+||+|||+|+....... ........||+.|||||.+ ...++.++|||||||++|||++|. +|
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            99999999999999999999999986544322 1223446799999999976 456899999999999999999995 57


Q ss_pred             CCCCchHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         324 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      |...........+..+..+  +.    ....     ...+..++.+||+.+|++||||.||++.|++.
T Consensus       243 ~~~~~~~e~~~~v~~~~~~--~~----p~~~-----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         243 YYGMAHEEVIYYVRDGNIL--AC----PENC-----PLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTTSCHHHHHHHHHTTCCC--CC----CTTC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCHHHHHHHHHcCCCC--CC----Cccc-----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            7766554444443333211  11    0111     12345567899999999999999999999874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.2e-49  Score=396.88  Aligned_cols=256  Identities=24%  Similarity=0.356  Sum_probs=192.7

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      ++.+.||+|+||.||+|+.. +|+.||||+++....   .. .  +    ....|.+|+++|++++|||||++++++...
T Consensus        10 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~-~--~----~~~~~~~E~~~l~~~~hpniv~~~~~~~~~   79 (277)
T d1o6ya_          10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA---RD-P--S----FYLRFRREAQNAAALNHPAIVAVYDTGEAE   79 (277)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT---TC-H--H----HHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc---cC-H--H----HHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence            44678999999999999874 799999999975321   11 1  1    123589999999999999999999988642


Q ss_pred             -----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEee
Q psy9535         191 -----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  265 (593)
Q Consensus       191 -----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~D  265 (593)
                           ..+|||||+++|+|.+++...   .++++..+..++.|++.||+|||+  ++|+||||||+|||++.++..+|+|
T Consensus        80 ~~~~~~~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll~~~~~~~l~d  154 (277)
T d1o6ya_          80 TPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMD  154 (277)
T ss_dssp             CSSSEEEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTSCEEECC
T ss_pred             cCCCceEEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHh--CCccCccccCcccccCccccceeeh
Confidence                 257999999999999988764   358999999999999999999998  5699999999999999999999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccc
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  344 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~  344 (593)
                      ||+++...............+||+.|||||++.+ .++.++|||||||++|||+||+.||...+................
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~  234 (277)
T d1o6ya_         155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP  234 (277)
T ss_dssp             CTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG
T ss_pred             hhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC
Confidence            9998765443322223445689999999998754 588999999999999999999999988765554444443332222


Q ss_pred             cccccccCCCCHHHHHHHHHHHHHHhhccccCCCC-ChHHHHHHHhh
Q psy9535         345 EVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRA-SMRDIVDLLSK  390 (593)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-sm~eV~~~L~~  390 (593)
                      ....+   .     +...+..++.+||+.||++|| |+.++.+.|.+
T Consensus       235 ~~~~~---~-----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         235 SARHE---G-----LSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             GGTSS---S-----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             chhcc---C-----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            11111   1     112345567799999999999 89999888876

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-48  Score=403.58  Aligned_cols=241  Identities=27%  Similarity=0.410  Sum_probs=195.2

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.+.||+|+||+||+|+.+ +|+.||||++++.....          ......|.+|+.+|++++|||||++++++.+ .
T Consensus         8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~----------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   77 (316)
T d1fota_           8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR----------LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   77 (316)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             EEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC----------HHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence            3678999999999999975 69999999996431111          1112358899999999999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++|||||+||+|.+++...   ..+++..+..++.|++.||+|||+  ++||||||||+||||+.++.+||+|||+|+
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NILl~~~g~vkL~DFG~a~  152 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAK  152 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             eeeeEeeecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhcc--CcEEccccCchheeEcCCCCEEEecCccce
Confidence            668999999999999988763   357888889999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .....      ....+||+.|||||++.+ .++.++|||||||++|||+||+.||.+.+.......+.......+..+  
T Consensus       153 ~~~~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~--  224 (316)
T d1fota_         153 YVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF--  224 (316)
T ss_dssp             ECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTS--
T ss_pred             Eeccc------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCC--
Confidence            76432      234689999999998865 478999999999999999999999988776655555554443332221  


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~~  386 (593)
                                ...+..++.+||+.||.+||     |+.|+++
T Consensus       225 ----------s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         225 ----------NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ----------CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----------CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                      12244567899999999996     7877753

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=404.94  Aligned_cols=254  Identities=24%  Similarity=0.378  Sum_probs=188.7

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc---
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI---  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~---  190 (593)
                      .++||+|+||.||+|++ +|+.||||+++...        . ..     ..++.|+..+++++|||||+++|+|...   
T Consensus         8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~--------~-~~-----~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~   72 (303)
T d1vjya_           8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--------E-RS-----WFREAEIYQTVMLRHENILGFIAADNKDNGT   72 (303)
T ss_dssp             EEEEECCSSSEEEEEEE-TTEEEEEEEECGGG--------H-HH-----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             EEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--------h-hH-----HHHHHHHHHHhhCCCCcCcceEEEEEeCCCc
Confidence            56899999999999997 48899999985321        0 11     1245566677789999999999998653   


Q ss_pred             --cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeEecccCCCCeeecCCCccE
Q psy9535         191 --MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------SKPIIHRDVKSANVLLDENFVPK  262 (593)
Q Consensus       191 --~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~IiHrDLKp~NILl~~~~~~K  262 (593)
                        ..++|||||++|+|.++|++    ..++|..++.++.|+|.||.|||+.      .++||||||||+||||+.++.+|
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K  148 (303)
T d1vjya_          73 WTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             ceEEEEEEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence              35899999999999999986    3589999999999999999999974      25799999999999999999999


Q ss_pred             EeecccceecccCCCcc-eeeccccCCCCcCCcccccCC-------CCCcchhhHHHHHHHHHHhCCCCCCCCc------
Q psy9535         263 LGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGVILLELLTGMKPIDDNN------  328 (593)
Q Consensus       263 l~DFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~-------~~~ksDVwSfGvvl~ElltG~~P~~~~~------  328 (593)
                      |+|||+++......... .......||+.|||||++...       ++.|+|||||||+||||+||..|+....      
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            99999998765433211 123456899999999987543       4668999999999999999988874311      


Q ss_pred             --------hHHHHHHHHhhcCcccccccccc-CCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         329 --------TILYYYLVVEQEVPVREVLDKEA-GEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       329 --------~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                              ........... ..    .++.. ..+........+..++.+||+.||++||||.||++.|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~-~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKVVCE-QK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTT-SC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcccccchHHHHHHHHhc-cc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                    11111111111 01    11111 1122223444566677899999999999999999999763

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=398.76  Aligned_cols=241  Identities=30%  Similarity=0.453  Sum_probs=186.3

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec--cc
Q psy9535         114 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN--IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~--~~  191 (593)
                      .++||+|+||.||+|+++ |+.||||+++...     .          ...|.+|+++|++++|||||+++|+|.+  ..
T Consensus        12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-----~----------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~   75 (262)
T d1byga_          12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----T----------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   75 (262)
T ss_dssp             EEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----------------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             eEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-----H----------HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc
Confidence            578999999999999985 7899999996421     1          1248899999999999999999999854  44


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+++|+|.++|.... ...+++..+++|+.|||.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~  152 (262)
T d1byga_          76 LYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  152 (262)
T ss_dssp             CEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             EEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeeccccccee
Confidence            689999999999999997643 2358999999999999999999998  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .....      ....||+.|+|||++ .+.++.++|||||||++|||+| |+.||...........+..+..+       
T Consensus       153 ~~~~~------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~-------  219 (262)
T d1byga_         153 ASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------  219 (262)
T ss_dssp             ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC-------
T ss_pred             cCCCC------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence            54321      234689999999976 5678999999999999999998 68888765443333332221111       


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhh
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSK  390 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~  390 (593)
                      .....    +...+..++.+||+.||++||||.||++.|++
T Consensus       220 ~~~~~----~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         220 DAPDG----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCcc----CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            11111    11234567789999999999999999999976

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.3e-48  Score=408.60  Aligned_cols=245  Identities=21%  Similarity=0.316  Sum_probs=195.3

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.+.||+|+||.||+|+.+ +|+.||||++....      ..  .     ...|.+|+.+|++++|||||++++++.+ .
T Consensus        30 i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~------~~--~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   96 (350)
T d1koaa2          30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH------ES--D-----KETVRKEIQTMSVLRHPTLVNLHDAFEDDN   96 (350)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS------HH--H-----HHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc------hh--h-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            3678999999999999975 68999999986421      11  1     1258899999999999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec--CCCccEEeeccc
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGDFGI  268 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~--~~~~~Kl~DFGl  268 (593)
                      ..+||||||++|+|.+++...  ...+++..+..|+.||+.||.|||+  ++||||||||+|||++  .++.+||+|||+
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~DFG~  172 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGL  172 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEEEcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEeecch
Confidence            668999999999999998643  2469999999999999999999999  5699999999999996  468899999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccc
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  347 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  347 (593)
                      |+.......    .....||+.|||||++.+ .++.++|||||||++|||+||+.||.+.+....+..+...........
T Consensus       173 a~~~~~~~~----~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  248 (350)
T d1koaa2         173 TAHLDPKQS----VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA  248 (350)
T ss_dssp             CEECCTTSC----EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG
T ss_pred             heecccccc----cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence            987654332    234689999999998754 578899999999999999999999987665555554444332222111


Q ss_pred             ccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         348 DKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       348 ~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .        ..+...+..++.+||+.||++|||+.|+++
T Consensus       249 ~--------~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         249 F--------SGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             G--------GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             c--------cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0        111223456778999999999999999865

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=404.68  Aligned_cols=237  Identities=24%  Similarity=0.358  Sum_probs=192.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .+.||+|+||+||+|+.+ +|+.||||++++......          .....+.+|+.+|++++|||||++++++.+ ..
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~----------~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   79 (337)
T d1o6la_          10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR   79 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCH----------HHHHHHHHHHHHHHhCCCCCEEEEEeeeccccc
Confidence            578999999999999974 799999999975321111          112357899999999999999999999877 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++|||||++|+|.+++.+.+   .+++..+..++.|++.||+|||+  ++||||||||+|||++.++.+||+|||+|+.
T Consensus        80 ~~iv~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~  154 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             cccceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEecCCCCEEEeecccccc
Confidence            689999999999999998743   58899999999999999999999  5699999999999999999999999999986


Q ss_pred             cccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  350 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (593)
                      ......   .....+||+.|||||++. ..++.++||||+||++|||++|+.||...+..............++..+   
T Consensus       155 ~~~~~~---~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~---  228 (337)
T d1o6la_         155 GISDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL---  228 (337)
T ss_dssp             SCCTTC---CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS---
T ss_pred             cccCCc---ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccC---
Confidence            543321   133468999999999875 4589999999999999999999999988776555555544443333221   


Q ss_pred             cCCCCHHHHHHHHHHHHHHhhccccCCCCC
Q psy9535         351 AGEWNETHVETLIGIVFEKCCVFEKDKRAS  380 (593)
Q Consensus       351 ~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs  380 (593)
                               ...+..++.+||+.||.+||+
T Consensus       229 ---------s~~~~dli~~~L~~dP~~R~~  249 (337)
T d1o6la_         229 ---------SPEAKSLLAGLLKKDPKQRLG  249 (337)
T ss_dssp             ---------CHHHHHHHHHHTCSSTTTSTT
T ss_pred             ---------CHHHHHHHHhhccCCchhhcc
Confidence                     122455778999999999996

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-48  Score=408.24  Aligned_cols=246  Identities=21%  Similarity=0.309  Sum_probs=196.5

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.+.||+|+||+||+|+.. +|+.||||+++...      ..  .     ...+.+|+.+|++++|||||++++++.+ 
T Consensus        32 ~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~--~-----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   98 (352)
T d1koba_          32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY------PL--D-----KYTVKNEISIMNQLHHPKLINLHDAFEDK   98 (352)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------HH--H-----HHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc------hh--H-----HHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            34678999999999999975 79999999986431      11  1     1257899999999999999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec--CCCccEEeecc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGDFG  267 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~--~~~~~Kl~DFG  267 (593)
                      ...+||||||++|+|.+++...  ..++++..+..|+.||+.||.|||+  ++||||||||+||||+  .++.+||+|||
T Consensus        99 ~~~~ivmE~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~DFG  174 (352)
T d1koba_          99 YEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFG  174 (352)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             CEEEEEEEcCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEeecc
Confidence            5568999999999999987643  3469999999999999999999998  5699999999999998  67899999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      +|+.......    .....||+.|||||++.+ .++.++||||+||++|||+||+.||.+.........+.......+..
T Consensus       175 la~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  250 (352)
T d1koba_         175 LATKLNPDEI----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED  250 (352)
T ss_dssp             TCEECCTTSC----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS
T ss_pred             cceecCCCCc----eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence            9987654332    234579999999998754 58899999999999999999999998876655555544433322211


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..   .     .+...+..++.+||+.||++|||+.|+++
T Consensus       251 ~~---~-----~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         251 AF---S-----SVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TT---T-----TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cc---c-----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10   1     11223455778999999999999999865

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=401.52  Aligned_cols=250  Identities=27%  Similarity=0.421  Sum_probs=190.5

Q ss_pred             CcccccCceEEEEEEEcCC----CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         115 NKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~~g----~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++||+|+||+||+|++.++    ..||||+++...     ...  .     ...|.+|+++|++++|||||+++|+|.+ 
T Consensus        33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-----~~~--~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~  100 (311)
T d1r0pa_          33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-----DIG--E-----VSQFLTEGIIMKDFSHPNVLSLLGICLRS  100 (311)
T ss_dssp             EEEEEETTEEEEEEEECC----CEEEEEEEECCCC-----CHH--H-----HHHHHHHHHHHHTCCCTTBCCCCEEEEET
T ss_pred             eEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-----CHH--H-----HHHHHHHHHHHHhCCCCCEeEEeEEEEec
Confidence            5899999999999997532    358999985321     111  1     2369999999999999999999999865 


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...++|||||++|+|.+++...  ...+++..++.++.|+|.||.|||+  ++|+||||||+||||++++.+||+|||+
T Consensus       101 ~~~~~lv~E~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~  176 (311)
T d1r0pa_         101 EGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGL  176 (311)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGG
T ss_pred             CCceEEEEEEeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccc
Confidence             3568999999999999998753  3457889999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcc-eeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHH-HHHhhcCcccc
Q psy9535         269 VKMSETSNMKT-MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY-LVVEQEVPVRE  345 (593)
Q Consensus       269 a~~~~~~~~~~-~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~-~~~~~~~~~~~  345 (593)
                      ++......... .......||+.|+|||.+ .+.++.++|||||||++|||+||..||.......... .+..+..+.  
T Consensus       177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~--  254 (311)
T d1r0pa_         177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL--  254 (311)
T ss_dssp             GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC--
T ss_pred             hhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence            98765432211 122345799999999976 5678999999999999999999888886543322211 122221110  


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         346 VLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       346 ~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                        .+   ...+    ..+..++.+||+.||++||+|.||++.|++.
T Consensus       255 --~p---~~~~----~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         255 --QP---EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             --CC---TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --Cc---ccCc----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              11   1111    2345567899999999999999999999874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.1e-48  Score=390.00  Aligned_cols=254  Identities=24%  Similarity=0.336  Sum_probs=199.3

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~  189 (593)
                      .+.+.||+|+||+||+|+.. +|+.||||++..........    +........+.+|+.+|++++ |||||++++++.+
T Consensus         6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA----EEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCH----HHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhH----HHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            44689999999999999874 78999999997653222111    111111235889999999997 9999999999876


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccc
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  268 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGl  268 (593)
                       ...+||||||++|+|.++|...   .++++..+..++.||++||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEEcCCCCeEEccchh
Confidence             5568999999999999999764   368999999999999999999998  5699999999999999999999999999


Q ss_pred             ceecccCCCcceeeccccCCCCcCCccccc-------CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC
Q psy9535         269 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  341 (593)
Q Consensus       269 a~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-------~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~  341 (593)
                      ++.......    .....||+.|+|||.+.       ..++.++||||+||++|||+||+.||.+.+.......+..+..
T Consensus       157 a~~~~~~~~----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~  232 (277)
T d1phka_         157 SCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY  232 (277)
T ss_dssp             CEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             eeEccCCCc----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence            987654322    23468999999999763       2367899999999999999999999998776555555444432


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .....   ..     ..+...+..++.+||+.||++|||+.||++
T Consensus       233 ~~~~~---~~-----~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         233 QFGSP---EW-----DDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             CCCTT---TG-----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCCc---cc-----ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            21110   11     112233556778999999999999999854

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=400.18  Aligned_cols=250  Identities=27%  Similarity=0.417  Sum_probs=191.3

Q ss_pred             CCCcccccCceEEEEEEEc-CCC--EEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEEEe
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGLCN  188 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~--~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~~~  188 (593)
                      .+++||+|+||+||+|+++ +|.  .||||++.......     .       ...|.+|+.+|+++ +|||||+++|+|.
T Consensus        14 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~-----~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~~   81 (309)
T d1fvra_          14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----D-------HRDFAGELEVLCKLGHHPNIINLLGACE   81 (309)
T ss_dssp             EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------------------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred             EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH-----H-------HHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence            3678999999999999875 444  47888875432110     0       11589999999999 7999999999997


Q ss_pred             c-ccceEEEEeccCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCee
Q psy9535         189 N-IMNCIVYEYMCNGSLYDRLARV-------------NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  254 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~GsL~~~L~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NIL  254 (593)
                      + ...++||||+++|+|.++|+..             .....+++..+..++.|||+||.|||+  ++|+||||||+|||
T Consensus        82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NIL  159 (309)
T d1fvra_          82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNIL  159 (309)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEE
T ss_pred             cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceEE
Confidence            6 5568999999999999999753             223579999999999999999999999  56999999999999


Q ss_pred             ecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCC-CCCCCCchHHH
Q psy9535         255 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGM-KPIDDNNTILY  332 (593)
Q Consensus       255 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~-~P~~~~~~~~~  332 (593)
                      ++.++.+||+|||+++.......    .....||+.|+|||.+ .+.++.++|||||||++|||++|. .||...+....
T Consensus       160 ~~~~~~~kl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~  235 (309)
T d1fvra_         160 VGENYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL  235 (309)
T ss_dssp             ECGGGCEEECCTTCEESSCEECC----C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             EcCCCceEEcccccccccccccc----ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999986543221    2235799999999976 456889999999999999999976 46766554443


Q ss_pred             HHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         333 YYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ...+..+..+       ...    ..+...+..++.+||+.||++||||.||++.|++.
T Consensus       236 ~~~i~~~~~~-------~~~----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         236 YEKLPQGYRL-------EKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             HHHGGGTCCC-------CCC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhcCCC-------CCC----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            3332222111       000    11223455677899999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-48  Score=397.18  Aligned_cols=254  Identities=24%  Similarity=0.357  Sum_probs=184.1

Q ss_pred             CCCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  185 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g  185 (593)
                      ++++||+|+||.||+|++.      +++.||||+++...     . .. +     ...|.+|+.++.++ +|+|||++++
T Consensus        17 ~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-----~-~~-~-----~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1          17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----T-HS-E-----HRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             EEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC---------C-HH-H-----HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             EeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-----C-cH-H-----HHHHHHHHHHHHhhcCCCeEEEeee
Confidence            4678999999999999864      24689999986421     1 11 1     12477888888776 6899999999


Q ss_pred             EEec--ccceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCC
Q psy9535         186 LCNN--IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKS  250 (593)
Q Consensus       186 ~~~~--~~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp  250 (593)
                      ++..  ...++|||||++|+|.++|.....             ...+++..+..++.|||+||.|||+  ++||||||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrDlKp  162 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAA  162 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCG
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCcCCc
Confidence            9865  346899999999999999975421             2358999999999999999999998  5699999999


Q ss_pred             CCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhC-CCCCCCCc
Q psy9535         251 ANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTG-MKPIDDNN  328 (593)
Q Consensus       251 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG-~~P~~~~~  328 (593)
                      +||||++++.+||+|||+|+....... ........||+.|||||++ ...++.++|||||||++|||+|| ..||....
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceeECCCCcEEEccCcchhhcccccc-ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999986544332 1223456899999999976 45688999999999999999997 55776643


Q ss_pred             hHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         329 TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ............... .     .....+    ..+..++.+||+.||++||||.||++.|++.
T Consensus       242 ~~~~~~~~~~~~~~~-~-----~~~~~~----~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         242 IDEEFCRRLKEGTRM-R-----APDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             CSHHHHHHHHHTCCC-C-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCC-C-----CCccCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            322222222222111 1     111111    2244566799999999999999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-48  Score=396.13  Aligned_cols=253  Identities=25%  Similarity=0.415  Sum_probs=197.0

Q ss_pred             CCCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGL  186 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~  186 (593)
                      ++++||+|+||.||+|++.      +++.||||+++...     . .. +     ...|.+|++++++++|||||+++|+
T Consensus        24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-----~-~~-~-----~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-----S-MR-E-----RIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-----C-HH-H-----HHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-----C-hH-H-----HHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            3578999999999999863      25789999986321     1 11 1     2258999999999999999999999


Q ss_pred             Eec-ccceEEEEeccCCCHHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCC
Q psy9535         187 CNN-IMNCIVYEYMCNGSLYDRLARVN-------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  258 (593)
Q Consensus       187 ~~~-~~~~lV~Ey~~~GsL~~~L~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~  258 (593)
                      |.. ...++|||||++|+|.+++....       ....+++..+..++.|+|+||.|||+  ++|+||||||+|||+|++
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAED  169 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTT
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceeecCC
Confidence            975 56789999999999999986431       22457899999999999999999998  569999999999999999


Q ss_pred             CccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCC-CCCCCCchHHHHHHH
Q psy9535         259 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGM-KPIDDNNTILYYYLV  336 (593)
Q Consensus       259 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~-~P~~~~~~~~~~~~~  336 (593)
                      +++||+|||+|+....... ........||+.|+|||.+ .+.++.++|||||||++|||+||. .||...+.......+
T Consensus       170 ~~~Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i  248 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  248 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             ceEEEeecccceeccCCcc-eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999987654332 2223445799999999976 456788999999999999999985 677665544444433


Q ss_pred             HhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         337 VEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ..+..+  ..    ...     +...+..++.+||+.+|++||||.+|++.|++.
T Consensus       249 ~~~~~~--~~----p~~-----~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         249 MEGGLL--DK----PDN-----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HTTCCC--CC----CTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HhCCCC--CC----ccc-----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            322211  10    011     123355667899999999999999999999874

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-47  Score=401.64  Aligned_cols=241  Identities=25%  Similarity=0.352  Sum_probs=194.5

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.++||+|+||.||+|+.+ +|+.||||++.+.....          ......+.+|+.+|++++|||||++++++.+ .
T Consensus        45 i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~----------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  114 (350)
T d1rdqe_          45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK----------LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             EEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC----------HHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence            3578999999999999975 79999999986431110          1112358899999999999999999998876 4


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++||||+.+|+|.+++.+.+   .+++..+..++.||+.||.|||+  ++||||||||+||||+.++.+||+|||+|+
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl~~~g~ikL~DFG~a~  189 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ccccccccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHcccCCCCCEEeeeceeee
Confidence            5589999999999999997643   58999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      .....      .....||+.|||||++.+ .++.++|||||||++|||+||+.||.+.+.......+.......+..   
T Consensus       190 ~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~---  260 (350)
T d1rdqe_         190 RVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH---  260 (350)
T ss_dssp             ECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT---
T ss_pred             ecccc------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCcc---
Confidence            76432      224679999999998754 57899999999999999999999998876655555554443332211   


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhhccccCCCC-----ChHHHHH
Q psy9535         350 EAGEWNETHVETLIGIVFEKCCVFEKDKRA-----SMRDIVD  386 (593)
Q Consensus       350 ~~~~~~~~~~~~~i~~~~~~C~~~dp~~RP-----sm~eV~~  386 (593)
                               +...+..++.+||+.||.+|+     |+.|+++
T Consensus       261 ---------~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         261 ---------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---------CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---------CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                     112345567899999999994     7888753

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=394.03  Aligned_cols=253  Identities=29%  Similarity=0.474  Sum_probs=195.2

Q ss_pred             CCcccccCceEEEEEEEc------CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeEEEE
Q psy9535         114 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGL  186 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~------~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l~g~  186 (593)
                      +++||+|+||.||+|++.      +++.||||+++...     ...  .     ...|.+|+.+++++ +|||||+++|+
T Consensus        28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-----~~~--~-----~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-----HLT--E-----REALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-----CHH--H-----HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-----CHH--H-----HHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            578999999999999862      45689999996431     111  1     22588999999999 69999999999


Q ss_pred             Eec-ccceEEEEeccCCCHHHHHhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCC
Q psy9535         187 CNN-IMNCIVYEYMCNGSLYDRLARVN---------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKS  250 (593)
Q Consensus       187 ~~~-~~~~lV~Ey~~~GsL~~~L~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp  250 (593)
                      |.+ ...++|||||++|+|.++|++..               ....+++..+..++.|||+||+|||+  ++||||||||
T Consensus        96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~--~~ivHrDLKp  173 (311)
T d1t46a_          96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAA  173 (311)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSG
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccccc
Confidence            977 45689999999999999997643               12358999999999999999999998  5699999999


Q ss_pred             CCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCc
Q psy9535         251 ANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNN  328 (593)
Q Consensus       251 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~~  328 (593)
                      +|||++.++.+||+|||+++....... ........||+.|+|||++. +.++.++|||||||++|||+| |.+||....
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999987654332 22344578999999999764 568999999999999999999 555565543


Q ss_pred             hHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         329 TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ...............      .....    +...+..++.+||+.||++||||.||+++|++.
T Consensus       253 ~~~~~~~~i~~~~~~------~~~~~----~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         253 VDSKFYKMIKEGFRM------LSPEH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             SSHHHHHHHHHTCCC------CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCC------CCccc----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            322222222222111      01111    122345567799999999999999999999874

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=392.46  Aligned_cols=256  Identities=24%  Similarity=0.270  Sum_probs=187.5

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-ccc
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IMN  192 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~~  192 (593)
                      ++||+|+||+||+|+.+ +|+.||||+++.........  .      ....+.+|+.+|++++|||||++++++.+ ...
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~--~------~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~   75 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKD--G------INRTALREIKLLQELSHPNIIGLLDAFGHKSNI   75 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC--------------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhH--H------HHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce
Confidence            57999999999999975 69999999986542211110  0      01248899999999999999999999976 566


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccceec
Q psy9535         193 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  272 (593)
Q Consensus       193 ~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~~  272 (593)
                      ++||||+.+|++...+..   ...+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+|+..
T Consensus        76 ~ivmE~~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~  150 (299)
T d1ua2a_          76 SLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSF  150 (299)
T ss_dssp             EEEEECCSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eehhhhhcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCcccccc
Confidence            899999998877655432   3468889999999999999999998  56999999999999999999999999999865


Q ss_pred             ccCCCcceeeccccCCCCcCCccccc-C-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCc-ccccccc
Q psy9535         273 ETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP-VREVLDK  349 (593)
Q Consensus       273 ~~~~~~~~~~~~~~GT~~Y~APE~~~-~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~  349 (593)
                      .....   .....+||+.|||||++. . .++.++|||||||++|||+||..||...........+...... ..+....
T Consensus       151 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~  227 (299)
T d1ua2a_         151 GSPNR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  227 (299)
T ss_dssp             TSCCC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             CCCcc---cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence            44321   123457999999999764 3 4688999999999999999999999876655444333322111 1100000


Q ss_pred             -----------ccCCCCHH----HHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 -----------EAGEWNET----HVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 -----------~~~~~~~~----~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                 .....+..    .....+..++.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                       00000000    11233556778999999999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=391.19  Aligned_cols=254  Identities=28%  Similarity=0.412  Sum_probs=192.8

Q ss_pred             CCCcccccCceEEEEEEEcC--------CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC-CCCceeeE
Q psy9535         113 RGNKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  183 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~--------g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l-~HpNIv~l  183 (593)
                      +++.||+|+||.||+|+...        +..||||+++...     ...       ....|.+|+..+.++ +|||||++
T Consensus        17 l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-----~~~-------~~~~~~~e~~~l~~~~~HpnIv~~   84 (299)
T d1fgka_          17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-----TEK-------DLSDLISEMEMMKMIGKHKNIINL   84 (299)
T ss_dssp             EEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-----CHH-------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             EeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-----ChH-------HHHHHHHHHHHHHHhcCCCeEEec
Confidence            46789999999999998632        2479999986431     111       123588899999888 89999999


Q ss_pred             EEEEec-ccceEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccC
Q psy9535         184 LGLCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  249 (593)
Q Consensus       184 ~g~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLK  249 (593)
                      +|+|.+ ...++|||||++|+|.++|.....             ...+++..++.++.|+|.||+|||+  ++|||||||
T Consensus        85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~--~~ivHrDiK  162 (299)
T d1fgka_          85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLA  162 (299)
T ss_dssp             EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCS
T ss_pred             ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh--CCEEeeeec
Confidence            999976 456899999999999999975431             2358999999999999999999999  569999999


Q ss_pred             CCCeeecCCCccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCC
Q psy9535         250 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDN  327 (593)
Q Consensus       250 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~Ellt-G~~P~~~~  327 (593)
                      |+|||++.++.+||+|||+++........ .......||+.|+|||.+ .+.++.++|||||||++|||++ |..||.+.
T Consensus       163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~  241 (299)
T d1fgka_         163 ARNVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  241 (299)
T ss_dssp             GGGEEECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceeecCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence            99999999999999999999876544322 223456799999999976 5678999999999999999998 78888776


Q ss_pred             chHHHHHHHHhhcCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhcc
Q psy9535         328 NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKSM  392 (593)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~~  392 (593)
                      .....+..+..+..+ .      ....    +...+..++.+||+.||++|||+.||++.|++..
T Consensus       242 ~~~~~~~~i~~~~~~-~------~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         242 PVEELFKLLKEGHRM-D------KPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             CHHHHHHHHHTTCCC-C------CCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHcCCCC-C------CCcc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            554433333222111 0      0111    1123556778999999999999999999998753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.2e-47  Score=401.47  Aligned_cols=243  Identities=21%  Similarity=0.247  Sum_probs=183.1

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-c
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-I  190 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~  190 (593)
                      +.++||+|+||.||+|+.. +|+.||||++.+........    +.   ......+|+.+++.++|||||++++++.+ .
T Consensus         8 i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~----~~---~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~   80 (364)
T d1omwa3           8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG----ET---LALNERIMLSLVSTGDCPFIVCMSYAFHTPD   80 (364)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTC----HH---HHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             eeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhH----HH---HHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence            4678999999999999975 69999999986431100000    00   01123445788889999999999999876 5


Q ss_pred             cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         191 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       191 ~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      ..++|||||++|+|.++|.+.   ..+++..+..++.||+.||.|||+  ++||||||||+|||++.++.+||+|||+|+
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHH--CCccceeeccceeEEcCCCcEEEeeeceee
Confidence            668999999999999999764   357899999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCCcceeeccccCCCCcCCccccc-C-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         271 MSETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       271 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      ......     .....||+.|||||++. + .++.++|||||||+||||+||+.||............. ......... 
T Consensus       156 ~~~~~~-----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~-  228 (364)
T d1omwa3         156 DFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTMAVEL-  228 (364)
T ss_dssp             ECSSSC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-HSSSCCCCC-
T ss_pred             ecCCCc-----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcccCCCCC-
Confidence            765432     23458999999999874 3 47899999999999999999999997643211111111 110000000 


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCCh
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASM  381 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm  381 (593)
                        ...     +...+..++.+||+.||++|||+
T Consensus       229 --~~~-----~s~~~~~li~~~L~~dP~~R~t~  254 (364)
T d1omwa3         229 --PDS-----FSPELRSLLEGLLQRDVNRRLGC  254 (364)
T ss_dssp             --CSS-----SCHHHHHHHHHHTCSSTTTSTTT
T ss_pred             --CCC-----CCHHHHHHHHHHcccCHHHhCCC
Confidence              011     12234567789999999999994

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=398.50  Aligned_cols=244  Identities=24%  Similarity=0.330  Sum_probs=185.5

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhc-CCCCceeeEEEEEec--
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGLCNN--  189 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~-l~HpNIv~l~g~~~~--  189 (593)
                      ++.||+|+||+||+|+. .+|+.||||+++..           .       .+.+|+.++.+ ++|||||++++++.+  
T Consensus        17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----------~-------~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1          17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------P-------KARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----------H-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             eEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----------H-------HHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            45699999999999987 47899999998632           1       36789998765 589999999998754  


Q ss_pred             ---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC---CCccEE
Q psy9535         190 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKL  263 (593)
Q Consensus       190 ---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~---~~~~Kl  263 (593)
                         ...++|||||+||+|.++|...+ ...+++..+..|+.|++.||.|||+  .+|+||||||+|||++.   ++.+||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~~Kl  155 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKL  155 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHH--cCCccccccccccccccccccccccc
Confidence               34589999999999999998643 2469999999999999999999998  56999999999999985   567999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCc
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  342 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~  342 (593)
                      +|||+|+.......    .....||+.|||||++.+ .++.++|||||||+||||+||+.||.+............. ..
T Consensus       156 ~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~-i~  230 (335)
T d2ozaa1         156 TDFGFAKETTSHNS----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-IR  230 (335)
T ss_dssp             CCCTTCEECCCCCC----CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------C-CC
T ss_pred             cccceeeeccCCCc----cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH-Hh
Confidence            99999987654332    234689999999998754 5889999999999999999999999754321111111000 00


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ...   ..........+...+..++.+||+.||++|||+.|+++
T Consensus       231 ~~~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         231 MGQ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SCS---SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCC---CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            000   00000111223344666788999999999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=395.56  Aligned_cols=242  Identities=26%  Similarity=0.366  Sum_probs=192.0

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHh-cCCCCceeeEEEEEec-
Q psy9535         113 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS-QCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~-~l~HpNIv~l~g~~~~-  189 (593)
                      +++.||+|+||+||+|+.+ +|+.||||++++......          .....+.+|+.++. .++|||||++++++.+ 
T Consensus         6 i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~----------~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~   75 (320)
T d1xjda_           6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD----------DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   75 (320)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             EeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccCh----------HHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence            4679999999999999875 689999999964311111          01224667777765 6899999999999876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++|||||++|+|.+++...   ..+++..+..++.||+.||+|||+  ++|+||||||+|||+++++.+||+|||++
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~--~~iiHrDikp~NiL~~~~~~~kl~DFG~a  150 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMC  150 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceeEEEeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCcccceeecCCCceeccccchh
Confidence            5568999999999999999864   358899999999999999999999  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  348 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  348 (593)
                      +.......   ......||+.|+|||++.+ .++.++|||||||++|||+||+.||.+.+....+..+.......+..  
T Consensus       151 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~--  225 (320)
T d1xjda_         151 KENMLGDA---KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW--  225 (320)
T ss_dssp             BCCCCTTC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--
T ss_pred             hhcccccc---cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc--
Confidence            86543322   2234689999999997754 68899999999999999999999998876655555544443322221  


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhhccccCCCCChH-HH
Q psy9535         349 KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMR-DI  384 (593)
Q Consensus       349 ~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~-eV  384 (593)
                                +...+..++.+||+.||++||++. |+
T Consensus       226 ----------~s~~~~dli~~~L~~dP~~R~s~~~~l  252 (320)
T d1xjda_         226 ----------LEKEAKDLLVKLFVREPEKRLGVRGDI  252 (320)
T ss_dssp             ----------SCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred             ----------CCHHHHHHHHHhcccCCCCCcCHHHHH
Confidence                      122345677899999999999985 55

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=394.70  Aligned_cols=245  Identities=21%  Similarity=0.317  Sum_probs=195.7

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.+.||+|+||+||+|+.+ +|+.||||.++...       .+ .      ..+.+|+++|++++|||||++++++.+ 
T Consensus         8 ~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-------~~-~------~~~~~Ei~il~~l~HpnIv~~~~~~~~~   73 (321)
T d1tkia_           8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-------TD-Q------VLVKKEISILNIARHRNILHLHESFESM   73 (321)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-------HH-H------HHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-------cc-H------HHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            45689999999999999875 68899999996431       11 1      247899999999999999999998876 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC--CCccEEeecc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--NFVPKLGDFG  267 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~--~~~~Kl~DFG  267 (593)
                      ...+||||||++|+|.+++...+  .++++.++..|+.||+.||+|||+  ++|+||||||+|||++.  ...+||+|||
T Consensus        74 ~~~~lvmE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~DFG  149 (321)
T d1tkia_          74 EELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             CEEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcccc
Confidence            56689999999999999997532  468999999999999999999998  56999999999999985  4589999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCccccc
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  346 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~  346 (593)
                      +++.......    .....||+.|+|||.+.+ .++.++||||+||++|||++|+.||...+....+..+......+...
T Consensus       150 ~~~~~~~~~~----~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  225 (321)
T d1tkia_         150 QARQLKPGDN----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE  225 (321)
T ss_dssp             TCEECCTTCE----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH
T ss_pred             hhhccccCCc----ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh
Confidence            9987644321    233579999999997754 57889999999999999999999998877655555555443332211


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         347 LDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       347 ~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ..   ..     +...+..++.+||+.||++|||+.|+++
T Consensus       226 ~~---~~-----~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         226 AF---KE-----ISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HH---TT-----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hc---cC-----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10   11     1223456778999999999999999976

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-47  Score=382.44  Aligned_cols=240  Identities=25%  Similarity=0.369  Sum_probs=185.1

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC--CCceeeEEEEEe
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--HVNLLRLLGLCN  188 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~--HpNIv~l~g~~~  188 (593)
                      +++++||+|+||+||+|+.. +|+.||||++.............       ...+.+|+.+|++++  |||||++++++.
T Consensus         7 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~-------~~~~~~E~~il~~l~~~h~nIv~~~~~~~   79 (273)
T d1xwsa_           7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-------GTRVPMEVVLLKKVSSGFSGVIRLLDWFE   79 (273)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTT-------CCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhH-------HHHHHHHHHHHHHhccCCCCccEEEEEEe
Confidence            45789999999999999975 78999999997542211100000       113568999999987  899999999987


Q ss_pred             c-ccceEEEEeccC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC-CCccEEee
Q psy9535         189 N-IMNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGD  265 (593)
Q Consensus       189 ~-~~~~lV~Ey~~~-GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~-~~~~Kl~D  265 (593)
                      + ...++||||+.+ +++.+++...   ..+++..+..++.|+++||+|||+  ++|+||||||+|||++. ++.+||+|
T Consensus        80 ~~~~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~~~vkl~D  154 (273)
T d1xwsa_          80 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLID  154 (273)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             eCCeEEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEecCCCeEEECc
Confidence            6 556899999976 6778887653   358999999999999999999998  56999999999999985 47999999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCccccc-CCC-CCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  343 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~-~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~  343 (593)
                      ||+|+......     .....||+.|||||++. ..+ +.++|||||||++|||+||+.||...+..      .......
T Consensus       155 FG~a~~~~~~~-----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i------~~~~~~~  223 (273)
T d1xwsa_         155 FGSGALLKDTV-----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVFF  223 (273)
T ss_dssp             CTTCEECCSSC-----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------HHCCCCC
T ss_pred             cccceeccccc-----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH------hhcccCC
Confidence            99998754332     23468999999999874 344 56789999999999999999999764321      1222221


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         344 REVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +..       .     ...+..++.+||+.||++|||+.|+++
T Consensus       224 ~~~-------~-----s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         224 RQR-------V-----SSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             SSC-------C-----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC-------C-----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            111       1     123455678999999999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=382.44  Aligned_cols=255  Identities=21%  Similarity=0.288  Sum_probs=188.4

Q ss_pred             CCcccccCceEEEEEEE-cCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         114 GNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      .++||+|+||+||+|+. .+|+.||||+++..... ..          ....|.+|+++|++++|||||++++++.+ ..
T Consensus         7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~----------~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~   75 (298)
T d1gz8a_           7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EG----------VPSTAIREISLLKELNHPNIVKLLDVIHTENK   75 (298)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEC------------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hH----------HHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence            57899999999999997 47999999999643211 00          01258899999999999999999999876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .++||||+.++ +.+++.... ...+++..+..++.|++.||+|||+  ++||||||||+|||++.++.+||+|||+|+.
T Consensus        76 ~~iv~e~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~  151 (298)
T d1gz8a_          76 LYLVFEFLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARA  151 (298)
T ss_dssp             EEEEEECCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred             eeEEEeecCCc-hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhc--CCEEccccCchheeecccCcceeccCCccee
Confidence            68999998754 555554432 3569999999999999999999998  5699999999999999999999999999987


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcccccccc
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  349 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (593)
                      ......   ......||+.|+|||++..  ..+.++|||||||++|||++|+.||...+................+...+
T Consensus       152 ~~~~~~---~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (298)
T d1gz8a_         152 FGVPVR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  228 (298)
T ss_dssp             HCCCSB---CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccCCcc---cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence            644321   1234579999999997543  35789999999999999999999998766544444433221111111000


Q ss_pred             c----------cCCCC---H----HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         350 E----------AGEWN---E----THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       350 ~----------~~~~~---~----~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .          .....   .    ..+...+..++.+|++.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            0          00000   0    011233456778999999999999999864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.1e-46  Score=377.58  Aligned_cols=255  Identities=20%  Similarity=0.232  Sum_probs=187.1

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-cc
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-IM  191 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-~~  191 (593)
                      +-++||+|+||+||+|+.++|+.||||+++.......           ....|.+|+.+|++++|||||++++++.+ ..
T Consensus         6 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-----------IPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC-----------CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             eccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChH-----------HHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            4578999999999999999999999999965321110           01258899999999999999999998876 45


Q ss_pred             ceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         192 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .+++|||+.++.+..+...   ...+++..+..++.|++.||+|||+  .+||||||||+|||++.++.+||+|||++..
T Consensus        75 ~~i~~e~~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~  149 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARA  149 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             eeEEEEeehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeEcCCCCEEeccccccee
Confidence            6788888877666555433   2469999999999999999999998  5699999999999999999999999999987


Q ss_pred             cccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCcc--c---
Q psy9535         272 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV--R---  344 (593)
Q Consensus       272 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~--~---  344 (593)
                      ......   ......||+.|+|||.+.+  .++.++|||||||++|||++|+.||.+.+...............  .   
T Consensus       150 ~~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  226 (286)
T d1ob3a_         150 FGIPVR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP  226 (286)
T ss_dssp             HCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cccCcc---ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhcc
Confidence            544321   1233569999999997743  46899999999999999999999998765544333322211100  0   


Q ss_pred             ---ccc--c-------cccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         345 ---EVL--D-------KEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       345 ---~~~--~-------~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                         ...  .       +.........+...+..++.+|++.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               000  0       00000001112234556778999999999999999863

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-45  Score=376.85  Aligned_cols=256  Identities=22%  Similarity=0.308  Sum_probs=185.8

Q ss_pred             CCCCcccccCceEEEEEEEc-C-CCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcC---CCCceeeEEEE
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-N-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLLGL  186 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~-g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l---~HpNIv~l~g~  186 (593)
                      ++.++||+|+||+||+|+.. + ++.||||+++.........           ..+.+|+.+|+.+   +|||||+++++
T Consensus        10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~-----------~~~~~E~~~l~~l~~~~HpnIv~~~~~   78 (305)
T d1blxa_          10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP-----------LSTIREVAVLRHLETFEHPNVVRLFDV   78 (305)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB-----------CTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred             EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH-----------HHHHHHHHHHHHHhhcCCCCcceeeee
Confidence            34578999999999999874 4 5679999997542211111           0255677776655   89999999998


Q ss_pred             Eec------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCc
Q psy9535         187 CNN------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  260 (593)
Q Consensus       187 ~~~------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~  260 (593)
                      +..      ...+++|||+.+|++......  ....+++.....++.|++.||+|||+  ++|+||||||+|||++.++.
T Consensus        79 ~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi~~~~~  154 (305)
T d1blxa_          79 CTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQ  154 (305)
T ss_dssp             EEEEECSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCC
T ss_pred             ecccccccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEEcCCCC
Confidence            842      245799999988876544433  23568999999999999999999998  56999999999999999999


Q ss_pred             cEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh
Q psy9535         261 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  339 (593)
Q Consensus       261 ~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~  339 (593)
                      +||+|||+++......    ......||+.|||||++ ...++.++||||+||++|||+||+.||...+.......+...
T Consensus       155 ~kl~dfg~~~~~~~~~----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  230 (305)
T d1blxa_         155 IKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV  230 (305)
T ss_dssp             EEECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             eeecchhhhhhhcccc----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence            9999999988654332    12346899999999976 456899999999999999999999999886654444433221


Q ss_pred             cC-ccccccc-----------cccC---CCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         340 EV-PVREVLD-----------KEAG---EWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       340 ~~-~~~~~~~-----------~~~~---~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .. +......           ....   ......+...+..++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11 1000000           0000   0000112234556778999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-45  Score=382.23  Aligned_cols=250  Identities=23%  Similarity=0.301  Sum_probs=184.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc--
Q psy9535         114 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI--  190 (593)
Q Consensus       114 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~--  190 (593)
                      .++||+|+||+||+|+.. +|+.||||++.....                 .+.+|+++|++++|||||++++++...  
T Consensus        25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----------------~~~~Ei~il~~l~h~niv~~~~~~~~~~~   87 (350)
T d1q5ka_          25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----------------FKNRELQIMRKLDHCNIVRLRYFFYSSGE   87 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----------------SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             eeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----------------HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence            468999999999999985 699999999975321                 134799999999999999999987431  


Q ss_pred             -----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC-ccEEe
Q psy9535         191 -----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLG  264 (593)
Q Consensus       191 -----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~-~~Kl~  264 (593)
                           ..+||||||++|.+............+++..+..++.|++.||+|||+  ++|+||||||+||||+.++ .+||+
T Consensus        88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~--~~IiHrDiKp~NILl~~~~~~~kl~  165 (350)
T d1q5ka_          88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLC  165 (350)
T ss_dssp             CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTTCCEEEC
T ss_pred             cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh--cCCcccCCCcceEEEecCCCceeEe
Confidence                 247999999876544443332334579999999999999999999998  6699999999999999775 89999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCccccc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-C
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-V  341 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~-~  341 (593)
                      |||+++.......    .....||+.|+|||.+.  ..++.++||||+||++|||++|+.||...........+.... .
T Consensus       166 DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~  241 (350)
T d1q5ka_         166 DFGSAKQLVRGEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT  241 (350)
T ss_dssp             CCTTCEECCTTSC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             cccchhhccCCcc----cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999987654332    22457999999999653  357899999999999999999999998765443333322110 0


Q ss_pred             cccccc--------c---cc--c---CCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVL--------D---KE--A---GEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~--------~---~~--~---~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +..+..        +   +.  .   ...........+..++.+|+..||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000        0   00  0   00000112223455678999999999999999864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-45  Score=378.70  Aligned_cols=258  Identities=20%  Similarity=0.306  Sum_probs=188.5

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec
Q psy9535         111 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN  189 (593)
Q Consensus       111 ~~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~  189 (593)
                      +++.++||+|+||+||+|+.. +|+.||||++....     . ..      ....+.+|+++|++++|||||++++++..
T Consensus        10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-----~-~~------~~~~~~~Ei~il~~l~hp~iv~~~~~~~~   77 (345)
T d1pmea_          10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-----H-QT------YCQRTLREIKILLRFRHENIIGINDIIRA   77 (345)
T ss_dssp             EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-----C-HH------HHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-----C-hH------HHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence            345689999999999999864 79999999996421     1 11      12258899999999999999999999865


Q ss_pred             c-----cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         190 I-----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       190 ~-----~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                      .     ..++++||+.+|+|.+++..    ..+++..+..++.|++.||+|||+  ++||||||||+||||+.++.+||+
T Consensus        78 ~~~~~~~~~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~--~~iiHRDIKp~NILl~~~~~~kl~  151 (345)
T d1pmea_          78 PTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKIC  151 (345)
T ss_dssp             SSTTTCCCEEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEEC
T ss_pred             ccccccceEEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCcceEEECCCCCEEEc
Confidence            3     23677888999999999975    258999999999999999999998  569999999999999999999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCccccc-C-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-cC
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EV  341 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-~~  341 (593)
                      |||+|+...............+||+.|+|||++. . .++.++||||+||++|||++|+.||............... ..
T Consensus       152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~  231 (345)
T d1pmea_         152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS  231 (345)
T ss_dssp             CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccC
Confidence            9999987654432222234567999999999763 3 4678999999999999999999999875543322222111 11


Q ss_pred             cccccc--------------ccccCCCCHH----HHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVREVL--------------DKEAGEWNET----HVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~~~--------------~~~~~~~~~~----~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +.....              .+.....+..    .+...+..++.+|++.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            100000              0000000000    11123445678999999999999999964

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-44  Score=368.21  Aligned_cols=259  Identities=21%  Similarity=0.291  Sum_probs=186.1

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.++||+|+||+||+|+.. +|+.||||++....... .          ....+.+|+.+|++++||||+++++++.. 
T Consensus        13 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~----------~~~~~~~E~~il~~l~h~nii~~~~~~~~~   81 (318)
T d3blha1          13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-G----------FPITALREIKILQLLKHENVVNLIEICRTK   81 (318)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-S----------SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-H----------HHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence            34578999999999999974 79999999986532111 0          01247899999999999999999998744 


Q ss_pred             --------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCcc
Q psy9535         190 --------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  261 (593)
Q Consensus       190 --------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~  261 (593)
                              ...++||||+.++.+......   ...++......++.|++.||.|||+  ++|+||||||+|||++.++.+
T Consensus        82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~~~~  156 (318)
T d3blha1          82 ASPYNRCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVL  156 (318)
T ss_dssp             ---------CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCE
T ss_pred             cccccccCceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheeecCCCcE
Confidence                    235799999988766544332   3468889999999999999999998  569999999999999999999


Q ss_pred             EEeecccceecccCCCc-ceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Q psy9535         262 KLGDFGIVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  338 (593)
Q Consensus       262 Kl~DFGla~~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~  338 (593)
                      ||+|||+++........ .......+||+.|+|||++.+  .++.++|||||||++|||++|+.||.+............
T Consensus       157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~  236 (318)
T d3blha1         157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ  236 (318)
T ss_dssp             EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence            99999999865432211 111233579999999997643  478999999999999999999999987655444333322


Q ss_pred             hcCcccc-cccc------------ccC-CCC-HHH-----HHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         339 QEVPVRE-VLDK------------EAG-EWN-ETH-----VETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       339 ~~~~~~~-~~~~------------~~~-~~~-~~~-----~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      ....... ....            ... ... ...     ....+..++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            2111111 0000            000 000 111     1223345678999999999999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-44  Score=374.94  Aligned_cols=251  Identities=22%  Similarity=0.336  Sum_probs=181.9

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEecc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNNI  190 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~~  190 (593)
                      ++.++||+|+||+||+|+.. +|+.||||+++...    .. ..      ....+.+|+++|++++|||||+++++|...
T Consensus        21 ~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~-~~------~~~~~~~Ei~il~~l~hpniv~l~~~~~~~   89 (346)
T d1cm8a_          21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF----QS-EL------FAKRAYRELRLLKHMRHENVIGLLDVFTPD   89 (346)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEECSSTT----SS-HH------HHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh----cC-hH------HHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence            34578999999999999975 69999999996421    11 11      123578999999999999999999998653


Q ss_pred             -------cceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         191 -------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       191 -------~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                             ..++||||+ +++|.+.++.    ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+|+
T Consensus        90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~~~~~~~kl  162 (346)
T d1cm8a_          90 ETLDDFTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKI  162 (346)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEE
T ss_pred             ccccccceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhccccccccc
Confidence                   348999998 5677776654    359999999999999999999998  56999999999999999999999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  341 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~  341 (593)
                      +|||+|+.....      .+...||+.|+|||++.+  .++.++||||+||++|||++|+.||...+.............
T Consensus       163 ~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~  236 (346)
T d1cm8a_         163 LDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG  236 (346)
T ss_dssp             CCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ccccceeccCCc------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence            999999875432      134679999999997743  468899999999999999999999987654433332221111


Q ss_pred             cc-ccccc---------------c-ccCCC--CHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PV-REVLD---------------K-EAGEW--NETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~-~~~~~---------------~-~~~~~--~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .. .+...               . ....+  ....+...+..++.+|+..||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            10 00000               0 00000  00111223445778999999999999999975

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-43  Score=362.53  Aligned_cols=251  Identities=22%  Similarity=0.310  Sum_probs=184.4

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEe-c
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCN-N  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~-~  189 (593)
                      ++.+.||+|+||+||+|++. +|+.||||++......   .            .+.+|++++++++|+|+|..++.|. +
T Consensus        10 ~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~------------~~~~E~~i~~~l~~~~~i~~~~~~~~~   74 (299)
T d1ckia_          10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---P------------QLHIESKIYKMMQGGVGIPTIRWCGAE   74 (299)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---C------------CHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred             EEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---H------------HHHHHHHHHHHccCCCcccEEEEEEec
Confidence            45678999999999999874 6899999998653211   0            3678999999999888777666553 3


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec---CCCccEEee
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGD  265 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~---~~~~~Kl~D  265 (593)
                       ...++||||+ +|+|.+.+....  ..+++..+..++.|++.||+|||+  ++||||||||+|||++   .+..+||+|
T Consensus        75 ~~~~~ivme~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl~D  149 (299)
T d1ckia_          75 GDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIID  149 (299)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred             CCEEEEEEEEc-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeeeec
Confidence             4557899987 667777665433  468999999999999999999999  5699999999999875   456899999


Q ss_pred             cccceecccCCCcc----eeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHH---HH
Q psy9535         266 FGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL---VV  337 (593)
Q Consensus       266 FGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~---~~  337 (593)
                      ||+|+.........    .......||+.|||||++.+ .++.++|||||||++|||+||+.||...........   ..
T Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~  229 (299)
T d1ckia_         150 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  229 (299)
T ss_dssp             CSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred             cCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh
Confidence            99999765432211    12345689999999997754 588999999999999999999999976432211111   11


Q ss_pred             hh--cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         338 EQ--EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       338 ~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      ..  ..+....    ....     ...+..++.+||+.+|++||++.++.+.|+..
T Consensus       230 ~~~~~~~~~~~----~~~~-----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         230 EKKMSTPIEVL----CKGY-----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHHHSCHHHH----TTTS-----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             cccCCCChhHh----ccCC-----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            11  1111111    0111     12345567899999999999999999888763

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-43  Score=356.47  Aligned_cols=256  Identities=21%  Similarity=0.244  Sum_probs=189.0

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.++||+|+||+||+|+.. +|+.||||+++....    ....       ...+.+|+.+|++++|||||++++++.+ 
T Consensus         5 ~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~----~~~~-------~~~~~~E~~il~~l~h~niv~~~~~~~~~   73 (292)
T d1unla_           5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD----DEGV-------PSSALREICLLKELKHKNIVRLHDVLHSD   73 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS----STTH-------HHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC----ChHH-------HHHHHHHHHHHHhcCcCCEEeeccccccc
Confidence            44578999999999999975 789999999965321    1111       2358899999999999999999999877 


Q ss_pred             ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecccc
Q psy9535         190 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  269 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFGla  269 (593)
                      ...++|+||+.+++|..++...   ..+++..+..++.|+++||+|||+  ++|+||||||+|||++.++.+||+|||+|
T Consensus        74 ~~~~iv~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli~~~~~~kl~DFG~a  148 (292)
T d1unla_          74 KKLTLVFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLA  148 (292)
T ss_dssp             SEEEEEEECCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cceeEEeeeccccccccccccc---cccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCcccccccCCceeeeecchh
Confidence            4567899999999988877643   458899999999999999999998  56999999999999999999999999999


Q ss_pred             eecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhhcC-cccc
Q psy9535         270 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQEV-PVRE  345 (593)
Q Consensus       270 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~-~~~~~~~~~~-~~~~  345 (593)
                      +.......   ......+++.|+|||++..  .++.++|||||||++|||++|+.||....... .......... +...
T Consensus       149 ~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (292)
T d1unla_         149 RAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE  225 (292)
T ss_dssp             EECCSCCS---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             hcccCCCc---cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChh
Confidence            87654322   1223467889999997643  36889999999999999999999976543322 2222111111 1000


Q ss_pred             c-------ccc---------ccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         346 V-------LDK---------EAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       346 ~-------~~~---------~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .       .+.         .........+...+..++.+|++.||.+|||+.||++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0       000         0000001112234455678999999999999999854

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.2e-42  Score=354.78  Aligned_cols=251  Identities=21%  Similarity=0.298  Sum_probs=190.0

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCC-CceeeEEEEEec
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH-VNLLRLLGLCNN  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~H-pNIv~l~g~~~~  189 (593)
                      +++++||+|+||+||+|+.. +|+.||||.+......   .            .+.+|+++++.++| +|++.+++++..
T Consensus         8 ~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~------------~~~~e~~~~~~l~~~~~i~~~~~~~~~   72 (293)
T d1csna_           8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---P------------QLRDEYRTYKLLAGCTGIPNVYYFGQE   72 (293)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---C------------CHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---H------------HHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence            45688999999999999975 6899999988643211   0            26788999999976 899999998866


Q ss_pred             -ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecC-----CCccEE
Q psy9535         190 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKL  263 (593)
Q Consensus       190 -~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~-----~~~~Kl  263 (593)
                       ...++||||+ +|+|.+++....  ..+++..+..++.|++.||+|||+  ++||||||||+|||++.     ++.+||
T Consensus        73 ~~~~~~vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~vkl  147 (293)
T d1csna_          73 GLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYV  147 (293)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             CCccEEEEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCceEE
Confidence             4568899997 799999887643  468999999999999999999998  56999999999999974     578999


Q ss_pred             eecccceecccCCCcc----eeeccccCCCCcCCcccccC-CCCCcchhhHHHHHHHHHHhCCCCCCCCc---hHHHHHH
Q psy9535         264 GDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN---TILYYYL  335 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~~~~-~~~~ksDVwSfGvvl~ElltG~~P~~~~~---~~~~~~~  335 (593)
                      +|||+|+.........    .......||+.|||||++.+ .++.++|||||||++|||+||+.||....   .......
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~  227 (293)
T d1csna_         148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  227 (293)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence            9999998765432111    12335689999999998755 58899999999999999999999997532   2222222


Q ss_pred             HHhh--cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHHHHhhc
Q psy9535         336 VVEQ--EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVDLLSKS  391 (593)
Q Consensus       336 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~~L~~~  391 (593)
                      +...  ..+..+..    ...+     ..+..++..|+..+|++||+++.+.+.|++.
T Consensus       228 i~~~~~~~~~~~l~----~~~p-----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         228 IGEKKQSTPLRELC----AGFP-----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHHHHHHSCHHHHT----TTSC-----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HHhccCCCChHHhc----CCCC-----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            2111  11111111    1111     2244566799999999999999998888764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-44  Score=368.55  Aligned_cols=245  Identities=24%  Similarity=0.308  Sum_probs=183.7

Q ss_pred             CCCcccccCceEEEEEEEc----CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCC-CceeeEEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH-VNLLRLLGLC  187 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~----~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~H-pNIv~l~g~~  187 (593)
                      +.++||+|+||+||+|+..    +|+.||||.+++........  .       ...+.+|+++|++++| |||+++++++
T Consensus        28 ~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~--~-------~~~~~~E~~il~~l~h~pnIv~~~~~~   98 (322)
T d1vzoa_          28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK--T-------TEHTRTERQVLEHIRQSPFLVTLHYAF   98 (322)
T ss_dssp             EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES--S-------GGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             EEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchH--H-------HHHHHHHHHHHHhccCCCeEEEeeeee
Confidence            3678999999999999852    48899999986432111100  0       1136789999999977 8999999988


Q ss_pred             ec-ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeec
Q psy9535         188 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  266 (593)
Q Consensus       188 ~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DF  266 (593)
                      .+ ...++||||+.+|+|.+++....   .++......++.|++.||+|||+  .+|+||||||+||||+.++.+||+||
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~vkL~DF  173 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDF  173 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred             ccCCceeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceeecCCCCEEEeec
Confidence            65 56689999999999999998653   46788888999999999999998  56999999999999999999999999


Q ss_pred             ccceecccCCCcceeeccccCCCCcCCcccccC---CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----h
Q psy9535         267 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE----Q  339 (593)
Q Consensus       267 Gla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~----~  339 (593)
                      |+++........  ......||+.|+|||.+..   .++.++|||||||+||||+||+.||..............    .
T Consensus       174 G~a~~~~~~~~~--~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~  251 (322)
T d1vzoa_         174 GLSKEFVADETE--RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  251 (322)
T ss_dssp             SEEEECCGGGGG--GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             cchhhhcccccc--cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence            999875443221  2234679999999997743   367799999999999999999999976432111111111    1


Q ss_pred             cCccccccccccCCCCHHHHHHHHHHHHHHhhccccCCCCC-----hHHHH
Q psy9535         340 EVPVREVLDKEAGEWNETHVETLIGIVFEKCCVFEKDKRAS-----MRDIV  385 (593)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~C~~~dp~~RPs-----m~eV~  385 (593)
                      ..+.+            ......+..++.+||+.||++|||     ++|++
T Consensus       252 ~~~~~------------~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil  290 (322)
T d1vzoa_         252 EPPYP------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK  290 (322)
T ss_dssp             CCCCC------------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred             CCCCc------------ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence            11111            012233455678999999999995     56664

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.2e-43  Score=361.70  Aligned_cols=247  Identities=19%  Similarity=0.294  Sum_probs=184.1

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~  189 (593)
                      ++.++||+|+||+||+|+.. +|+.||||+++...                ...+.+|+++|++++ ||||+++++++..
T Consensus        38 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----------------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~  101 (328)
T d3bqca1          38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----------------KKKIKREIKILENLRGGPNIITLADIVKD  101 (328)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----------------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----------------HHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence            34678999999999999974 68999999986321                114789999999995 9999999998864


Q ss_pred             ---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCC-ccEEee
Q psy9535         190 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGD  265 (593)
Q Consensus       190 ---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~-~~Kl~D  265 (593)
                         ...++|||||.+|+|.+..      ..+++..+..++.||+.||.|||+  ++|+||||||+|||++.++ .+||+|
T Consensus       102 ~~~~~~~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~~~~~vkl~D  173 (328)
T d3bqca1         102 PVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLID  173 (328)
T ss_dssp             TTTCSEEEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             cCCCceeEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcCCCCeeeecc
Confidence               3468999999999997653      248999999999999999999998  5699999999999998654 699999


Q ss_pred             cccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhh---
Q psy9535         266 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQ---  339 (593)
Q Consensus       266 FGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~-~~~~~~~~---  339 (593)
                      ||+|+.......    .....||+.|+|||.+.+  .++.++||||+||++|||++|+.||....... ........   
T Consensus       174 FG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~  249 (328)
T d3bqca1         174 WGLAEFYHPGQE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  249 (328)
T ss_dssp             GGGCEECCTTCC----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred             cccceeccCCCc----ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCC
Confidence            999987654332    234579999999997643  47899999999999999999999997643221 11111000   


Q ss_pred             ----------cC----ccccccccc--------cCCCCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         340 ----------EV----PVREVLDKE--------AGEWNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       340 ----------~~----~~~~~~~~~--------~~~~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                                ..    .........        ........+...+..++.+|++.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      00    000000000        011111222334556778999999999999999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-43  Score=367.62  Aligned_cols=252  Identities=25%  Similarity=0.345  Sum_probs=186.1

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.++||+|+||+||+|+.. +|+.||||+++....    . .. .     ...+.+|+++|++++|||||++++++.. 
T Consensus        21 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~-~~-~-----~~~~~~Ei~il~~l~h~~iv~~~~~~~~~   89 (348)
T d2gfsa1          21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ----S-II-H-----AKRTYRELRLLKHMKHENVIGLLDVFTPA   89 (348)
T ss_dssp             EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS----S-HH-H-----HHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc----C-hH-H-----HHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence            44678999999999999874 799999999864311    1 10 1     2257899999999999999999998853 


Q ss_pred             -----ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEe
Q psy9535         190 -----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  264 (593)
Q Consensus       190 -----~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~  264 (593)
                           ...++||||+.+|+|.+++..    ..+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+|++
T Consensus        90 ~~~~~~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~kl~  163 (348)
T d2gfsa1          90 RSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKIL  163 (348)
T ss_dssp             SSTTTCCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cccccCceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCcccccccccccccc
Confidence                 234788899999999998854    359999999999999999999998  569999999999999999999999


Q ss_pred             ecccceecccCCCcceeeccccCCCCcCCcccccC--CCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCc
Q psy9535         265 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  342 (593)
Q Consensus       265 DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~  342 (593)
                      |||++......      .....||+.|+|||.+.+  .++.++|||||||++|||++|+.||...+.......+......
T Consensus       164 dfg~a~~~~~~------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~  237 (348)
T d2gfsa1         164 DFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  237 (348)
T ss_dssp             CC----CCTGG------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ccchhcccCcc------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99998754332      224579999999997543  3578999999999999999999999876654443333322111


Q ss_pred             cc-ccccc--------------ccCCCCH----HHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         343 VR-EVLDK--------------EAGEWNE----THVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       343 ~~-~~~~~--------------~~~~~~~----~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      .. +....              .......    ..+...+..++.+|++.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            10 00000              0000000    011233456778999999999999999864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-42  Score=359.42  Aligned_cols=252  Identities=23%  Similarity=0.269  Sum_probs=178.4

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEEec-
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLCNN-  189 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~~~-  189 (593)
                      ++.++||+|+||+||+|+.. +|+.||||++.....    . .  .    ....+.+|+.+|++++|||||++++++.. 
T Consensus        20 ~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~----~-~--~----~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~   88 (355)
T d2b1pa1          20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ----N-Q--T----HAKRAYRELVLMKCVNHKNIISLLNVFTPQ   88 (355)
T ss_dssp             EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS----S-H--H----HHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc----C-H--H----HHHHHHHHHHHHHhcCCCCeeEEEEEEecc
Confidence            44679999999999999975 699999999975321    1 1  1    12357899999999999999999999853 


Q ss_pred             ------ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEE
Q psy9535         190 ------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  263 (593)
Q Consensus       190 ------~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl  263 (593)
                            ...|+|||||.+| +.+.+.     ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+|+
T Consensus        89 ~~~~~~~~~~iv~Ey~~~~-l~~~~~-----~~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~~~~~~~kl  160 (355)
T d2b1pa1          89 KTLEEFQDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_dssp             CSTTTCCEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEE
T ss_pred             cccccCceeEEEEeccchH-HHHhhh-----cCCCHHHHHHHHHHHHHHHHHhhh--cccccccCCccccccccccceee
Confidence                  3458999999655 445443     348899999999999999999999  56999999999999999999999


Q ss_pred             eecccceecccCCCcceeeccccCCCCcCCccccc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-C
Q psy9535         264 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-V  341 (593)
Q Consensus       264 ~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~ksDVwSfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~-~  341 (593)
                      +|||+++......    ......||+.|+|||++. ..+++++||||+||++|||++|+.||...+............ .
T Consensus       161 ~df~~~~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~  236 (355)
T d2b1pa1         161 LDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  236 (355)
T ss_dssp             CCCCC-------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             echhhhhcccccc----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence            9999988654432    223457999999999875 457889999999999999999999998765443333322111 0


Q ss_pred             cccc--------------------------ccccccCC---CCHHHHHHHHHHHHHHhhccccCCCCChHHHHH
Q psy9535         342 PVRE--------------------------VLDKEAGE---WNETHVETLIGIVFEKCCVFEKDKRASMRDIVD  386 (593)
Q Consensus       342 ~~~~--------------------------~~~~~~~~---~~~~~~~~~i~~~~~~C~~~dp~~RPsm~eV~~  386 (593)
                      +..+                          ........   .........+..++.+|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000                          00000000   011223445566788999999999999999863

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-37  Score=324.20  Aligned_cols=194  Identities=25%  Similarity=0.294  Sum_probs=152.0

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-----------CCc
Q psy9535         112 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-----------HVN  179 (593)
Q Consensus       112 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-----------HpN  179 (593)
                      ++.++||+|+||+||+|+.. +|+.||||+++...       ..       ...+.+|+.++++++           |+|
T Consensus        16 ~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-------~~-------~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~   81 (362)
T d1q8ya_          16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-------VY-------TEAAEDEIKLLQRVNDADNTKEDSMGANH   81 (362)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-------HH-------HHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-------cc-------hHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence            45789999999999999974 79999999996421       00       124678888887775           578


Q ss_pred             eeeEEEEEec---ccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeec
Q psy9535         180 LLRLLGLCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  256 (593)
Q Consensus       180 Iv~l~g~~~~---~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~  256 (593)
                      ||++++++..   ...+++|+++..+..............+++..+..++.|++.||+|||+ ..+|+||||||+||||+
T Consensus        82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~  160 (362)
T d1q8ya_          82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLME  160 (362)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEE
T ss_pred             eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeee
Confidence            9999998754   2346777777666554444444445678999999999999999999997 24599999999999998


Q ss_pred             CCC------ccEEeecccceecccCCCcceeeccccCCCCcCCcccc-cCCCCCcchhhHHHHHHHHHHhCCCCCCC
Q psy9535         257 ENF------VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDD  326 (593)
Q Consensus       257 ~~~------~~Kl~DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~~ksDVwSfGvvl~ElltG~~P~~~  326 (593)
                      .++      .+|++|||.++......      ....||+.|+|||++ ...++.++||||+||+++||++|+.||..
T Consensus       161 ~~~~~~~~~~~kl~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~  231 (362)
T d1q8ya_         161 IVDSPENLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  231 (362)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             ccCcccccceeeEeeccccccccccc------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence            655      38999999988654322      245799999999976 45688999999999999999999999964

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.3e-25  Score=213.27  Aligned_cols=174  Identities=17%  Similarity=0.140  Sum_probs=121.6

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEeecCCCCCCCCCc-----hhHHhhhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy9535         113 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSD-----NTEAAMIPILLFENEVQTLSQCKHVNLLRLLGLC  187 (593)
Q Consensus       113 ~~~~LG~G~fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~-----~~~~~~~~~~~f~~Ev~il~~l~HpNIv~l~g~~  187 (593)
                      ++++||+|+||.||+|+..+|+.||||.++...........     ...........+.+|...+.++.|+|++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            47899999999999999888999999987643221100000     0000111123456789999999999999988754


Q ss_pred             ecccceEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecccCCCCeeecCCCccEEeecc
Q psy9535         188 NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  267 (593)
Q Consensus       188 ~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~IiHrDLKp~NILl~~~~~~Kl~DFG  267 (593)
                         ..++||||++++.+.+          ++......++.|+++||.|||+  ++|+||||||+|||++++ .++|+|||
T Consensus        84 ---~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          84 ---GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             ---TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred             ---CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhheeeeCC-CEEEEECC
Confidence               3479999998866532          3334456789999999999998  569999999999999965 58999999


Q ss_pred             cceecccCCCcceeeccccCCCCcCC------cccccCCCCCcchhhHHHHH
Q psy9535         268 IVKMSETSNMKTMYTENLTGTRPYMP------PEAMHCQISTKTDVFSYGVI  313 (593)
Q Consensus       268 la~~~~~~~~~~~~~~~~~GT~~Y~A------PE~~~~~~~~ksDVwSfGvv  313 (593)
                      +|+........           .|..      .+.+...++.++|+||..--
T Consensus       148 ~a~~~~~~~~~-----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         148 QSVEVGEEGWR-----------EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             TCEETTSTTHH-----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             CcccCCCCCcH-----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            98765432211           1111      12234567889999997543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=3.8e-24  Score=213.54  Aligned_cols=141  Identities=24%  Similarity=0.343  Sum_probs=113.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ++|..++...  +++++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~ivmEy~~~--g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~~kl~DFG~a~  154 (263)
T d2j4za1          81 VYLILEYAPL--GTVYRELQKL--SKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSV  154 (263)
T ss_dssp             EEEEEECCTT--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred             EEEEEeecCC--CcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeeeeccccceecCCCCEeecccceee
Confidence            4567766443  3566655543  469999999999999999999999  669999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHE  577 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  577 (593)
                      ......     .....||+.|||||++.+. ++.++|||||||++|+.++...|+.+......++.+..+..+
T Consensus       155 ~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~  222 (263)
T d2j4za1         155 HAPSSR-----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT  222 (263)
T ss_dssp             CCCCCC-----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred             ecCCCc-----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence            543321     2335799999999998665 788999999999999999999998877666666666666544

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=7.7e-24  Score=212.09  Aligned_cols=128  Identities=21%  Similarity=0.395  Sum_probs=103.6

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec-CCCceEEEecccce
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVK  505 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~-~~~~~kl~DfG~~~  505 (593)
                      .+++++-+.  ++|..++...  .++++..+..++.|++.||+|||+.+.+|+||||||+||||+ .++.+||+|||+++
T Consensus        88 ~ivmE~~~~--g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          88 VLVTELMTS--GTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEEEECCCS--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEeCCCC--CcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            466665433  3455555443  469999999999999999999998555599999999999996 57899999999997


Q ss_pred             ecccCCccccccccccCCCCcccccccCCcCCcccceecchhhhhcccccCCCccchh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      .....     .....+||+.|||||++.++++.++|||||||++|+..+...|+.+..
T Consensus       164 ~~~~~-----~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~  216 (270)
T d1t4ha_         164 LKRAS-----FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQ  216 (270)
T ss_dssp             GCCTT-----SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred             eccCC-----ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence            54322     123468999999999998889999999999999999888888886544

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=5.3e-24  Score=215.27  Aligned_cols=146  Identities=24%  Similarity=0.344  Sum_probs=113.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ++|+.+....  +++++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~ivmEy~~g--g~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll~~~~~vkl~DFG~a~  156 (288)
T d1uu3a_          83 LYFGLSYAKN--GELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAK  156 (288)
T ss_dssp             EEEEECCCTT--EEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEccCC--CCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCccccccCCCceEEecccccce
Confidence            3566766443  3566655543  469999999999999999999999  569999999999999999999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG  578 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  578 (593)
                      ....... .......+||+.|||||++.+ .++.++|||||||++|+.+++..|+.+..+...++..+.+..++
T Consensus       157 ~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~  229 (288)
T d1uu3a_         157 VLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF  229 (288)
T ss_dssp             ECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred             ecccCCc-ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC
Confidence            6543221 122334679999999998855 57889999999999999999999998877777777777776554

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=4.8e-24  Score=214.25  Aligned_cols=132  Identities=27%  Similarity=0.454  Sum_probs=100.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ++|+.++... ..++++.+++.++.|||.||+|||+  ++|+||||||+||||+.++.+||+|||+++
T Consensus        78 ~~lv~Ey~~~--g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          78 LAIVTQWCEG--SSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLAT  152 (276)
T ss_dssp             CEEEEECCCE--EEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred             EEEEEecCCC--CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEcccccee
Confidence            3566665443  4566666543 3469999999999999999999998  669999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC----cCCcccceecchhhhhcccccCCCccchh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~----~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      ....... ........||+.|||||++.+    .++.++|||||||++|+..+...|+.+..
T Consensus       153 ~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~  213 (276)
T d1uwha_         153 VKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN  213 (276)
T ss_dssp             C-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eccccCC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence            6543221 112234679999999998743    36889999999999999888888876543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=5e-24  Score=213.34  Aligned_cols=143  Identities=25%  Similarity=0.358  Sum_probs=98.6

Q ss_pred             eEeecCCchhhhhHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---CCceecCCCCCcEeecCCCceEEEec
Q psy9535         427 VIILDTGETKQCQLFKLARV--NNTPPLDSNKRYSIALGVAEALHYLHSLS---KPIIHRDVKSANVLLDENFVPKLGDF  501 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~--~~~~~l~~~~~~~i~~~ia~gl~ylH~~~---~~iiHrdlKp~NILl~~~~~~kl~Df  501 (593)
                      .+++++.+.  ++|..++..  ....++++..++.++.|++.||+|||+.+   .+|+||||||+||||+.++.+||+||
T Consensus        81 ~ivmEy~~~--g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF  158 (269)
T d2java1          81 YIVMEYCEG--GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  158 (269)
T ss_dssp             EEEEECCTT--EEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred             EEEEecCCC--CcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence            467776543  244444322  22457999999999999999999999732   34999999999999999999999999


Q ss_pred             ccceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCC
Q psy9535         502 GIVKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       502 G~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~  574 (593)
                      |+++......   ......+||+.|||||++.+ .++.++|||||||++|+..+...|+.+....--++.+..|
T Consensus       159 G~a~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~  229 (269)
T d2java1         159 GLARILNHDT---SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG  229 (269)
T ss_dssp             HHHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred             cceeecccCC---CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence            9998643321   12234679999999999855 5789999999999999988888888765554334444444

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=2.5e-23  Score=214.85  Aligned_cols=143  Identities=19%  Similarity=0.307  Sum_probs=114.0

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.  +.|+.++...  +.+++..+..++.|++.||+|||+  ++|+||||||+|||++.+|.+||+|||+++.
T Consensus        81 ~iv~ey~~g--g~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~  154 (337)
T d1o6la_          81 CFVMEYANG--GELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEECCTT--CBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             ccceeccCC--Cchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEecCCCCEEEeecccccc
Confidence            456665443  3566665543  468999999999999999999999  6699999999999999999999999999985


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG  578 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  578 (593)
                      .....   ......+||+.|||||++.+ .++.++||||+||++|+.+++..|+.+.+...-++....+..++
T Consensus       155 ~~~~~---~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~  224 (337)
T d1o6la_         155 GISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF  224 (337)
T ss_dssp             SCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             cccCC---cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC
Confidence            43221   12334689999999999865 48899999999999999998888888877766666666665543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.88  E-value=1.7e-23  Score=213.61  Aligned_cols=134  Identities=28%  Similarity=0.396  Sum_probs=103.6

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.+.  +.....  ...++++.++..++.||+.||+|||+  ++|+||||||+||||+.++.+||+|||+++
T Consensus        90 ~~iv~E~~~~g~--l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~  163 (309)
T d1u5ra_          90 AWLVMEYCLGSA--SDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSAS  163 (309)
T ss_dssp             EEEEEECCSEEH--HHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred             EEEEEEecCCCc--hHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEECCCCCEEEeeccccc
Confidence            356666654332  222222  23579999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC----cCCcccceecchhhhhcccccCCCccchhhhchhhhhc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTML  572 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~----~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~  572 (593)
                      ....       ....+||+.|||||++.+    .++.++|||||||++|+..+...|+.+....-.+....
T Consensus       164 ~~~~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~  227 (309)
T d1u5ra_         164 IMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA  227 (309)
T ss_dssp             SSSS-------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             ccCC-------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            5332       123579999999998742    47889999999999999888888887665544443333

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=3.6e-23  Score=209.58  Aligned_cols=131  Identities=23%  Similarity=0.316  Sum_probs=104.7

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|+.+...   .++++.++..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        92 ~~ivmEy~~g--g~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~DFG~a~  164 (293)
T d1yhwa1          92 LWVVMEYLAG--GSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (293)
T ss_dssp             EEEEEECCTT--CBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEecCC--CcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeeccchhhe
Confidence            4567765433  345555443   369999999999999999999999  569999999999999999999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYY  566 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~  566 (593)
                      ......   ......+||+.|||||++.+. ++.++|||||||++|+.+++..|+.+.....
T Consensus       165 ~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~  223 (293)
T d1yhwa1         165 QITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR  223 (293)
T ss_dssp             ECCSTT---CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             eecccc---ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH
Confidence            653322   123346799999999988654 7889999999999999888888887655443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=8.9e-24  Score=211.82  Aligned_cols=143  Identities=23%  Similarity=0.363  Sum_probs=106.0

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++-+.  +.|..........++++.+++.|+.|||.||+|||+  ++|+||||||+||||+.++.+||+|||+++.
T Consensus        83 ~iv~Ey~~~--g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~  158 (272)
T d1qpca_          83 YIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (272)
T ss_dssp             EEEEECCTT--CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEeCCC--CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccceEE
Confidence            466666543  345444433333469999999999999999999998  6699999999999999999999999999987


Q ss_pred             cccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccccCC-CccchhhhchhhhhcCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNV-DIADRERYYSLQTMLPGH  575 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~  575 (593)
                      ......  .......||+.|||||++. +.++.++|||||||++|+..+... +........-++.+..|.
T Consensus       159 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~  227 (272)
T d1qpca_         159 IEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY  227 (272)
T ss_dssp             CSSSCE--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             ccCCcc--ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence            543221  2233457899999999875 457899999999999998776443 333333334445555543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.87  E-value=1.8e-23  Score=213.22  Aligned_cols=150  Identities=23%  Similarity=0.286  Sum_probs=106.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec---CCCceEEEecc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFG  502 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~---~~~~~kl~DfG  502 (593)
                      ..+++++-+.  ++|+.++..  .+++++..+..++.|++.||+|||+  ++|+||||||+|||+.   .++.+||+|||
T Consensus        82 ~~lvmE~~~g--g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG  155 (307)
T d1a06a_          82 LYLIMQLVSG--GELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFG  155 (307)
T ss_dssp             EEEEECCCCS--CBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred             EEEEEeccCC--CcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEeccc
Confidence            3567766442  466666653  4579999999999999999999998  6699999999999994   57899999999


Q ss_pred             cceecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeE
Q psy9535         503 IVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV  581 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (593)
                      +++......    .....+||+.|||||++.+. ++.++|||||||++|+..+...|+.+....--++..+.+..++...
T Consensus       156 ~a~~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  231 (307)
T d1a06a_         156 LSKMEDPGS----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP  231 (307)
T ss_dssp             ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTT
T ss_pred             eeEEccCCC----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCc
Confidence            997543221    12346799999999998654 7899999999999999999999998776666666677766655443


Q ss_pred             EEee
Q psy9535         582 SISN  585 (593)
Q Consensus       582 ~~~~  585 (593)
                      .+++
T Consensus       232 ~~~~  235 (307)
T d1a06a_         232 YWDD  235 (307)
T ss_dssp             TTTT
T ss_pred             cccC
Confidence            3333

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=2.7e-23  Score=210.01  Aligned_cols=142  Identities=23%  Similarity=0.295  Sum_probs=108.6

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|..++... ..++++.++..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        84 ~~lvmEy~~~--g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~  158 (288)
T d2jfla1          84 LWILIEFCAG--GAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSA  158 (288)
T ss_dssp             EEEEEECCTT--EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEecCCC--CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeECCCCCEEEEechhhh
Confidence            3567766543  3455544332 3579999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccC------CcCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~------~~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      .....   .......+||+.|||||++.      ..++.++|||||||++|+..+...|+.+....-.+.....+.
T Consensus       159 ~~~~~---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~  231 (288)
T d2jfla1         159 KNTRT---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE  231 (288)
T ss_dssp             ECHHH---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC
T ss_pred             ccCCC---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence            54321   11233468999999999873      236789999999999999888888887766555555444443

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.87  E-value=4.6e-23  Score=211.03  Aligned_cols=141  Identities=31%  Similarity=0.383  Sum_probs=112.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.+......  ...+++.....++.|++.||+|||+  ++|+||||||+||||+.++.+||+|||+++
T Consensus        79 ~~ivmE~~~g--g~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NILl~~~g~vkL~DFG~a~  152 (316)
T d1fota_          79 IFMIMDYIEG--GELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAK  152 (316)
T ss_dssp             EEEEECCCCS--CBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             eeeEeeecCC--ccccccccc--cccccccHHHHHHHHHHHhhhhhcc--CcEEccccCchheeEcCCCCEEEecCccce
Confidence            3566665433  244444443  3468889999999999999999998  669999999999999999999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG  578 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  578 (593)
                      .....      ....+||+.|||||++.+. ++.++|||||||++|+.+++..|+.+......++..+.|...+
T Consensus       153 ~~~~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~  220 (316)
T d1fota_         153 YVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF  220 (316)
T ss_dssp             ECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC
T ss_pred             Eeccc------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC
Confidence            65322      2346899999999998664 7889999999999999999999998877766666666665443

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=1.5e-23  Score=210.08  Aligned_cols=132  Identities=23%  Similarity=0.361  Sum_probs=102.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  ++|+.++.  ..+++++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~ivmEy~~g--g~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl~~~~~~KL~DFG~a~  151 (271)
T d1nvra_          78 QYLFLEYCSG--GELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLAT  151 (271)
T ss_dssp             EEEEEECCTT--EEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEeccCC--CcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEECCCCCEEEccchhhe
Confidence            3567766433  35555543  34579999999999999999999999  569999999999999999999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cC-CcccceecchhhhhcccccCCCccchhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~-~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      ........ ......+||+.|||||++.+ .+ +.++|||||||++|+.++...|+....+
T Consensus       152 ~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~  211 (271)
T d1nvra_         152 VFRYNNRE-RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  211 (271)
T ss_dssp             ECEETTEE-CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred             eeccCCcc-ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence            65432221 12344689999999998854 44 5679999999999998887777755443

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=2.5e-23  Score=213.61  Aligned_cols=128  Identities=25%  Similarity=0.395  Sum_probs=101.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  +.|+.++...  +.+++..+..++.|++.||+|||+. .+|+||||||+||||+.++.+||+|||+|+
T Consensus        79 ~~iVmEy~~g--g~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~  153 (322)
T d1s9ja_          79 ISICMEHMDG--GSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSG  153 (322)
T ss_dssp             EEEEEECCTT--EEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             EEEEEEcCCC--CcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCcc
Confidence            3566665433  3566655543  4699999999999999999999962 259999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      .....     ...+.+||+.|||||++.+ .++.++||||+||++|+..+...|+...+
T Consensus       154 ~~~~~-----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         154 QLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             HHHHH-----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             ccCCC-----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            54321     1234689999999998754 58999999999999999888888886544

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=3.3e-23  Score=213.01  Aligned_cols=120  Identities=23%  Similarity=0.290  Sum_probs=94.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP  529 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aP  529 (593)
                      .++++..++.++.|+|.||+|||+  ++|+||||||+|||++.++.+||+|||+++........ .......||+.||||
T Consensus       159 ~~l~~~~~~~i~~qi~~gl~yLH~--~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aP  235 (325)
T d1rjba_         159 NVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAP  235 (325)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHHHH--TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCchhccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCCh
Confidence            469999999999999999999999  66999999999999999999999999999865432221 122345689999999


Q ss_pred             cccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhc
Q psy9535         530 EAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTML  572 (593)
Q Consensus       530 E~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~  572 (593)
                      |++. +.++.++|||||||++|+.++ ...|+.+......+..++
T Consensus       236 E~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~  280 (325)
T d1rjba_         236 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI  280 (325)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred             HHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9874 458899999999999998775 577776654443444443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=2.5e-23  Score=209.14  Aligned_cols=143  Identities=19%  Similarity=0.284  Sum_probs=106.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.  +.|..++..  ..++++..++.++.|||.||+|||+  ++|+||||||+||||+.++.+||+|||+++.
T Consensus        83 ~lvmE~~~~--g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill~~~~~~kl~DFGla~~  156 (277)
T d1xbba_          83 MLVMEMAEL--GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKA  156 (277)
T ss_dssp             EEEEECCTT--EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEcCCC--CcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcccccCcccccchhhhhh
Confidence            567766543  355555554  3469999999999999999999998  6699999999999999999999999999986


Q ss_pred             cccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      ...............||+.|||||++. ..++.++|||||||++|+..+ ...|..+....--+..+..|.
T Consensus       157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~  227 (277)
T d1xbba_         157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE  227 (277)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             ccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC
Confidence            543322222223457899999999874 457889999999999998765 577776654443334444443

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=3.3e-23  Score=209.08  Aligned_cols=145  Identities=19%  Similarity=0.273  Sum_probs=109.2

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  +.|..++.. ...++++.++..++.|+|.||+|||+  ++|+||||||+||||+.++.+||+|||+++
T Consensus        83 ~~lvmE~~~~--g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~  157 (285)
T d1u59a_          83 LMLVMEMAGG--GPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSK  157 (285)
T ss_dssp             EEEEEECCTT--EEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCC--CcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccchhhh
Confidence            3567766543  355555433 33579999999999999999999999  669999999999999999999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      ................||+.|||||++. +.++.++|||||||++|+.++ +..|+.+....--++.+..|.
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~  229 (285)
T d1u59a_         158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK  229 (285)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC
T ss_pred             cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            7544332222334457899999999875 457889999999999998765 577776654443344444443

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=2.7e-23  Score=209.44  Aligned_cols=127  Identities=24%  Similarity=0.362  Sum_probs=89.2

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++...  +.+..... ....++++.+++.++.|+|.||+|||+  ++|+||||||+||||+.++.+||+|||+++.
T Consensus        85 ~~v~e~~~~--~~l~~~~~-~~~~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          85 MIITEYMEN--GALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEEECCTT--EEHHHHHH-HTTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEEeccc--Ccchhhhh-cccccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEECCCCeEEEcccchhhc
Confidence            455554333  23333333 234579999999999999999999999  6699999999999999999999999999986


Q ss_pred             cccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccccCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVD  558 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~~~~~  558 (593)
                      ...............||+.|||||++. +.++.++|||||||++|+..+...|
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~  212 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER  212 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCC
Confidence            543222222223456899999999874 4588899999999999986654443

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.87  E-value=3.5e-23  Score=209.12  Aligned_cols=130  Identities=22%  Similarity=0.315  Sum_probs=101.7

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  +.+..++.......+++..++.++.|+|.||+|||+  ++|+||||||+||||+.++.+||+|||+++
T Consensus        88 ~~iv~E~~~~--g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~  163 (287)
T d1opja_          88 FYIITEFMTY--GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSR  163 (287)
T ss_dssp             CEEEEECCTT--CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred             eEEEeecccC--cchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEcccccee
Confidence            3566665443  355566655566789999999999999999999999  669999999999999999999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccccCCCccc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      .......  .......|++.|||||++. ..++.++|||||||++|+..+...|...
T Consensus       164 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~  218 (287)
T d1opja_         164 LMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP  218 (287)
T ss_dssp             TCCSSSS--EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ecCCCCc--eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence            6543221  1123346899999999874 4688999999999999987765555443

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.86  E-value=7.9e-23  Score=207.68  Aligned_cols=144  Identities=22%  Similarity=0.300  Sum_probs=98.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.  +.|..+... ..+.+++.+++.++.|||+||+|||+  ++|+||||||+||||+.++.+||+|||+++
T Consensus       102 ~~iv~Ey~~~--g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~  176 (299)
T d1jpaa_         102 VMIITEFMEN--GSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSR  176 (299)
T ss_dssp             CEEEEECCTT--EEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EEEEEEecCC--Ccceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhh--CCCccCccccceEEECCCCcEEECCcccce
Confidence            3566666543  345554443 34579999999999999999999999  669999999999999999999999999998


Q ss_pred             ecccCCcccc--ccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         506 MSETSNVKTM--YTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       506 ~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      ..........  ......||+.|||||++. +.++.++|||||||++|+..+ ...|+.+....--++.+..|
T Consensus       177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~  249 (299)
T d1jpaa_         177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD  249 (299)
T ss_dssp             -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            6543221111  112245789999999874 458889999999999998776 67787766555444444444

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=7.3e-23  Score=204.03  Aligned_cols=142  Identities=22%  Similarity=0.349  Sum_probs=96.1

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  +.|..++.. ....+++..++.++.|+|.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~lv~E~~~~--g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          75 ICLVFEFMEH--GCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             CEEEEECCTT--CBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             eEEEEEecCC--CcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchhe
Confidence            4567766543  455555443 33568999999999999999999999  669999999999999999999999999997


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhccccc-CCCccchhhhchhhhhcCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHIT-NVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~-~~~~~~~~~~~~~~~~~~~  574 (593)
                      ........  ......||+.|||||++.+ .++.++|||||||++|+..+. .++..+.....-++.+..|
T Consensus       150 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~  218 (263)
T d1sm2a_         150 FVLDDQYT--SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG  218 (263)
T ss_dssp             -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT
T ss_pred             eccCCCce--eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc
Confidence            65432211  1233578999999998864 588999999999999987653 4444433333333434333

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.86  E-value=5.4e-23  Score=213.62  Aligned_cols=152  Identities=20%  Similarity=0.246  Sum_probs=119.1

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec--CCCceEEEecccc
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGDFGIV  504 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~--~~~~~kl~DfG~~  504 (593)
                      .+++++-+.  ++|+..... ...+|++.++..|+.||+.||+|||+  ++|+||||||+||||+  .++.+||+|||++
T Consensus       102 ~ivmE~~~g--g~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~DFGla  176 (352)
T d1koba_         102 VLILEFLSG--GELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLA  176 (352)
T ss_dssp             EEEEECCCC--CBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred             EEEEEcCCC--ChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEeecccc
Confidence            566665432  355554433 34579999999999999999999998  6699999999999997  5789999999999


Q ss_pred             eecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeEEE
Q psy9535         505 KMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVSI  583 (593)
Q Consensus       505 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (593)
                      +......    ......||+.|||||++.+. ++.++|||||||++|+.++...|+.+....-.++.+..+..++....+
T Consensus       177 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  252 (352)
T d1koba_         177 TKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF  252 (352)
T ss_dssp             EECCTTS----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTT
T ss_pred             eecCCCC----ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence            8654322    12335799999999988654 788999999999999999999999888777777777777766655444


Q ss_pred             eecc
Q psy9535         584 SNHS  587 (593)
Q Consensus       584 ~~~~  587 (593)
                      +++|
T Consensus       253 ~~~s  256 (352)
T d1koba_         253 SSVS  256 (352)
T ss_dssp             TTSC
T ss_pred             cCCC
Confidence            4444

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=1.3e-22  Score=209.48  Aligned_cols=133  Identities=25%  Similarity=0.337  Sum_probs=107.0

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC---CCceEEEecc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFG  502 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~---~~~~kl~DfG  502 (593)
                      ..+++++-+.  ++|+.++...+..+|++.++..|+.|++.||+|||+  ++|+||||||+|||++.   .+.+||+|||
T Consensus        84 ~~ivmEy~~g--g~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          84 LLIVMECLDG--GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEEECCCS--EEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEECCCC--CcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH--cCCccccccccccccccccccccccccccc
Confidence            3566665332  477777766555679999999999999999999999  56999999999999975   5679999999


Q ss_pred             cceecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhc
Q psy9535         503 IVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYY  566 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~  566 (593)
                      +++......    .....+||+.|||||++.+. ++.++|||||||++|+.+++..|+.+.....
T Consensus       160 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~  220 (335)
T d2ozaa1         160 FAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA  220 (335)
T ss_dssp             TCEECCCCC----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred             eeeeccCCC----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH
Confidence            998654322    12345799999999998664 7899999999999999889888887765443

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.86  E-value=5.2e-23  Score=206.55  Aligned_cols=142  Identities=23%  Similarity=0.388  Sum_probs=102.0

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ..|.......  +++++.++..++.|++.||+|||+  ++|+||||||+|||++.++..+++|||+++
T Consensus        86 ~~lvmE~~~g--~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDG--VTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCE--EEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCC--CEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHh--CCccCccccCcccccCccccceeehhhhhh
Confidence            4577776543  3455554433  479999999999999999999998  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLP  573 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~  573 (593)
                      ...............+||+.|||||++.+ .++.++|||||||++|+.++...|+.+.....-+...+.
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~  228 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR  228 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh
Confidence            54333222223345679999999999865 478899999999999999999999876655443433333

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.86  E-value=6.5e-23  Score=212.85  Aligned_cols=128  Identities=22%  Similarity=0.291  Sum_probs=104.7

Q ss_pred             hHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccc
Q psy9535         439 QLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTE  518 (593)
Q Consensus       439 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~  518 (593)
                      .++..+...  +.+++..+..++.||+.||.|||+  ++||||||||+|||++.++.+||+|||+++.....      ..
T Consensus       127 ~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~------~~  196 (350)
T d1rdqe_         127 EMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW  196 (350)
T ss_dssp             BHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC------BC
T ss_pred             chhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc------cc
Confidence            444444433  369999999999999999999998  56999999999999999999999999999864321      23


Q ss_pred             cccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCC
Q psy9535         519 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHH  576 (593)
Q Consensus       519 ~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  576 (593)
                      ...||+.|||||++.+. ++.++|||||||++|+..+...|+.+.....-++....+..
T Consensus       197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~  255 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV  255 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC
Confidence            46799999999988654 78899999999999999999999887766655555555543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.86  E-value=6.8e-23  Score=212.65  Aligned_cols=153  Identities=19%  Similarity=0.222  Sum_probs=116.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec--CCCceEEEeccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGDFGI  503 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~--~~~~~kl~DfG~  503 (593)
                      ..+++++-+.  +.|+.++.. ..+++++..+..|+.||+.||+|||+  ++|+||||||+|||++  .++.+||+|||+
T Consensus        98 ~~ivmE~~~g--g~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~DFG~  172 (350)
T d1koaa2          98 MVMIYEFMSG--GELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGL  172 (350)
T ss_dssp             EEEEECCCCS--CBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEEcCCC--CCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEeecch
Confidence            3567765433  456665543 23579999999999999999999999  5699999999999995  467899999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeEE
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVS  582 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (593)
                      ++......    ......||+.|||||++.+ .++.++|||||||++|+..++..|+.+......++....+........
T Consensus       173 a~~~~~~~----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  248 (350)
T d1koaa2         173 TAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA  248 (350)
T ss_dssp             CEECCTTS----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG
T ss_pred             heeccccc----ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence            98654322    1234579999999998855 478899999999999999999999887766666666666655554444


Q ss_pred             Eeecc
Q psy9535         583 ISNHS  587 (593)
Q Consensus       583 ~~~~~  587 (593)
                      ++++|
T Consensus       249 ~~~~s  253 (350)
T d1koaa2         249 FSGIS  253 (350)
T ss_dssp             GGGCC
T ss_pred             ccCCC
Confidence            44443

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=8.1e-23  Score=207.38  Aligned_cols=109  Identities=23%  Similarity=0.322  Sum_probs=83.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP  529 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aP  529 (593)
                      ..+++.+++.++.|||+||+|||+  ++|+||||||+||||+.++.+||+|||+++....... ........||+.||||
T Consensus       129 ~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~AP  205 (299)
T d1ywna1         129 DFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAP  205 (299)
T ss_dssp             -CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECGGGCEEECC------CCSCTT-SCCTTSCCCGGGGCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCcCCccceeECCCCcEEEccCcchhhcccccc-ccccCceeeCccccch
Confidence            468999999999999999999999  6699999999999999999999999999986443221 1223346799999999


Q ss_pred             cccCC-cCCcccceecchhhhhccccc-CCCccc
Q psy9535         530 EAMHC-QISTKTDVFSYGAQIKTQHIT-NVDIAD  561 (593)
Q Consensus       530 E~~~~-~~~~ksDvwS~G~~i~~~~~~-~~~~~~  561 (593)
                      |++.+ .++.++|||||||++|+..+. ..|..+
T Consensus       206 E~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         206 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             hHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            98754 478899999999999986543 334433

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.85  E-value=2.3e-22  Score=209.79  Aligned_cols=126  Identities=22%  Similarity=0.273  Sum_probs=102.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  +.|+.++...  ..+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        82 ~~ivmE~~~g--g~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          82 LSFILDLMNG--GDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEEEECCCCS--CBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEEEecCC--CcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHH--CCccceeeccceeEEcCCCcEEEeeeceee
Confidence            3566666443  4566665543  468999999999999999999999  669999999999999999999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccC-C-cCCcccceecchhhhhcccccCCCccch
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      ......     ....+||+.|||||++. + .++.++|||||||++|+.++...|+.+.
T Consensus       156 ~~~~~~-----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  209 (364)
T d1omwa3         156 DFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  209 (364)
T ss_dssp             ECSSSC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             ecCCCc-----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence            644321     23457999999999875 3 3788999999999999988888888654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=2.1e-22  Score=204.58  Aligned_cols=134  Identities=20%  Similarity=0.301  Sum_probs=104.6

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+..   .+.+........+++.....++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~~~~e~~~~~---~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          91 TLVFEHVDQD---LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             EEEEECCSCB---HHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             EEEEEeccCC---chhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence            4555544332   2223333455679999999999999999999999  6699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQ  569 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~  569 (593)
                      ....    .......||+.|||||++.+ .++.++||||+||++|+..+...|+.+..+...++
T Consensus       166 ~~~~----~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  225 (305)
T d1blxa_         166 YSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG  225 (305)
T ss_dssp             CCGG----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             hccc----ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            4322    12345679999999998754 58999999999999999998888887765544333

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=1.1e-22  Score=206.25  Aligned_cols=131  Identities=28%  Similarity=0.349  Sum_probs=101.3

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+..   .+.... .....+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~ivmE~~~~~---~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~a~  148 (299)
T d1ua2a_          75 ISLVFDFMETD---LEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAK  148 (299)
T ss_dssp             CEEEEECCSEE---HHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eeehhhhhcch---HHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCcccc
Confidence            35677665443   222222 234579999999999999999999999  669999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      .......   .....+||+.|||||++..  .++.++|||||||++|+..+...|+....+.
T Consensus       149 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~  207 (299)
T d1ua2a_         149 SFGSPNR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL  207 (299)
T ss_dssp             TTTSCCC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ccCCCcc---cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH
Confidence            5433211   1234579999999998743  3688999999999999988887777665544

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=3.5e-22  Score=202.16  Aligned_cols=150  Identities=21%  Similarity=0.290  Sum_probs=116.6

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC----ceEEEecc
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLGDFG  502 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~----~~kl~DfG  502 (593)
                      .+++++-+.  +.|+.++...  +++++..+..++.|++.||+|||+  ++|+||||||+|||++.++    .+|++|||
T Consensus        89 ~iv~E~~~g--g~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~--~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAG--GELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCS--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCC--ccccchhccc--cccchhHHHHHHHHHHHHHHhhhh--cceeecccccceEEEecCCCcccceEecchh
Confidence            466665433  3566665543  469999999999999999999999  5699999999999998776    49999999


Q ss_pred             cceecccCCccccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeE
Q psy9535         503 IVKMSETSNVKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHV  581 (593)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (593)
                      +++......    ......||+.|||||++.+. ++.++|||||||++|+..+...|+.+..+.-.++.+..+..++...
T Consensus       163 ~a~~~~~~~----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1jksa_         163 LAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE  238 (293)
T ss_dssp             TCEECTTSC----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             hhhhcCCCc----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence            988654322    12345789999999998654 7899999999999999999999988777666667777776665544


Q ss_pred             EEeec
Q psy9535         582 SISNH  586 (593)
Q Consensus       582 ~~~~~  586 (593)
                      .+++.
T Consensus       239 ~~~~~  243 (293)
T d1jksa_         239 YFSNT  243 (293)
T ss_dssp             HHTTS
T ss_pred             hcCCC
Confidence            44443

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.84  E-value=3.7e-22  Score=200.42  Aligned_cols=152  Identities=24%  Similarity=0.377  Sum_probs=120.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  ++|+.++...  +++++.++..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        85 ~~ivmE~~~~--g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          85 FFLVFDLMKK--GELFDYLTEK--VTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             EEEEEECCTT--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEcCCC--chHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEEcCCCCeEEccchhee
Confidence            3577776543  3666666543  479999999999999999999998  569999999999999999999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-------cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-------QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEG  578 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-------~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  578 (593)
                      ......    .....+||+.|+|||++.+       .++.++||||+||++|+.++..+|+.+..+...++..+.|....
T Consensus       159 ~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~  234 (277)
T d1phka_         159 QLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF  234 (277)
T ss_dssp             ECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             EccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            654322    1234679999999998732       25779999999999999999999999888877788788777655


Q ss_pred             CeEEEeecc
Q psy9535         579 DHVSISNHS  587 (593)
Q Consensus       579 ~~~~~~~~~  587 (593)
                      ....++|+|
T Consensus       235 ~~~~~~~~s  243 (277)
T d1phka_         235 GSPEWDDYS  243 (277)
T ss_dssp             CTTTGGGSC
T ss_pred             CCcccccCC
Confidence            444444444

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=3.8e-22  Score=199.92  Aligned_cols=130  Identities=27%  Similarity=0.369  Sum_probs=100.7

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC-CCceEEEecccce
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVK  505 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~-~~~~kl~DfG~~~  505 (593)
                      .+++++.+.. ..++.++...  ..+++..+..++.|++.||+|||+  ++|+||||||+|||++. ++.+||+|||+++
T Consensus        85 ~lv~e~~~~~-~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          85 VLILERPEPV-QDLFDFITER--GALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEECCSSE-EEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEeccCc-chHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEecCCCeEEECccccce
Confidence            4555554322 3444444332  469999999999999999999999  66999999999999985 5799999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cC-CcccceecchhhhhcccccCCCccchhhhc
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGAQIKTQHITNVDIADRERYY  566 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~-~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~  566 (593)
                      ......     ....+||+.|||||++.+ .+ +.++|||||||++|+.++...|+.+.++..
T Consensus       160 ~~~~~~-----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~  217 (273)
T d1xwsa_         160 LLKDTV-----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII  217 (273)
T ss_dssp             ECCSSC-----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH
T ss_pred             eccccc-----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh
Confidence            644321     234679999999998754 34 567899999999999999999988766543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=4.3e-22  Score=199.58  Aligned_cols=145  Identities=20%  Similarity=0.275  Sum_probs=107.5

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.+  .+....... .+++++..++.++.|+|.||+|||+  ++|+||||||+||||+.++.+||+|||+++.
T Consensus        86 ~lv~e~~~~~--~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          86 KMVTELAPLG--SLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEEECCTTC--BHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             heeeeeecCc--chhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhccccccceeeccchhhhh
Confidence            4566655433  333333322 3469999999999999999999999  6699999999999999999999999999986


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPGHH  576 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~  576 (593)
                      ...............|+..|+|||++.+ .++.++||||||+++|+..+ ...|+.+....-.++.+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~  232 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE  232 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC
Confidence            5443332223334567889999998754 46889999999999998775 6788877766666666665543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=3.6e-22  Score=204.37  Aligned_cols=121  Identities=21%  Similarity=0.310  Sum_probs=92.2

Q ss_pred             hhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcccccc
Q psy9535         438 CQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT  517 (593)
Q Consensus       438 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~  517 (593)
                      +.++..... ....+++..++.++.|||.||+|||+  ++|+||||||+||||+.++.+||+|||+++....... ....
T Consensus        95 ~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~  170 (317)
T d1xkka_          95 GCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-EYHA  170 (317)
T ss_dssp             CBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-----
T ss_pred             Ccccccccc-cccCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhcceeCCCCCeEeeccccceecccccc-cccc
Confidence            344444433 34579999999999999999999999  6699999999999999999999999999886543221 1223


Q ss_pred             ccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccch
Q psy9535         518 ENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADR  562 (593)
Q Consensus       518 ~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~  562 (593)
                      ....||+.|||||++. +.++.++|||||||++|+..+ ..+|..+.
T Consensus       171 ~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~  217 (317)
T d1xkka_         171 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI  217 (317)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred             cccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence            3456899999999874 457899999999999998765 45555543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=9.5e-22  Score=201.53  Aligned_cols=139  Identities=22%  Similarity=0.324  Sum_probs=108.8

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.  +.|+.++...  ..+++.++..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        79 yivmEy~~~--g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~--~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~  152 (320)
T d1xjda_          79 FFVMEYLNG--GDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKE  152 (320)
T ss_dssp             EEEEECCTT--CBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             eEEEeecCC--CcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCcccceeecCCCceeccccchhhh
Confidence            567776543  4566666543  468999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~  574 (593)
                      .....   ......+||+.|||||++.+ .++.++|||||||++|+.+++..|+.+.....-++....+
T Consensus       153 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~  218 (320)
T d1xjda_         153 NMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD  218 (320)
T ss_dssp             CCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             ccccc---ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            43221   12334579999999998865 5788999999999999999888888765544333333333

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=6.4e-22  Score=201.26  Aligned_cols=128  Identities=23%  Similarity=0.302  Sum_probs=97.5

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCceecCCCCCcEeecCCCceEEE
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------SKPIIHRDVKSANVLLDENFVPKLG  499 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~------~~~iiHrdlKp~NILl~~~~~~kl~  499 (593)
                      .++++++.+.  +.|..++...   ++++.+++.++.|+|.||+|||+.      .++|+||||||+||||+.++.+||+
T Consensus        76 ~~lv~Ey~~~--g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~  150 (303)
T d1vjya_          76 LWLVSDYHEH--GSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             EEEEEECCTT--CBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEecccC--CCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence            3567776554  4666666543   599999999999999999999974      3579999999999999999999999


Q ss_pred             ecccceecccCCcc-ccccccccCCCCcccccccCCc-------CCcccceecchhhhhcccccCCC
Q psy9535         500 DFGIVKMSETSNVK-TMYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGAQIKTQHITNVD  558 (593)
Q Consensus       500 DfG~~~~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~-------~~~ksDvwS~G~~i~~~~~~~~~  558 (593)
                      |||+++........ ........||+.|||||++...       ++.++|||||||+||+..+...|
T Consensus       151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~  217 (303)
T d1vjya_         151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI  217 (303)
T ss_dssp             CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCB
T ss_pred             ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCC
Confidence            99998865432211 1223456799999999987542       46789999999999986654433

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=3.2e-22  Score=201.68  Aligned_cols=143  Identities=22%  Similarity=0.330  Sum_probs=99.8

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.+  .+..+........+++.+++.++.|||.||+|||+  .+|+||||||+||||+.++.+||+|||+++.
T Consensus        87 ~lv~Ey~~~g--~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll~~~~~~kl~DfGla~~  162 (285)
T d1fmka3          87 YIVTEYMSKG--SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL  162 (285)
T ss_dssp             EEEECCCTTC--BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             EEEEEecCCC--chhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh--hheecccccceEEEECCCCcEEEcccchhhh
Confidence            4666665543  33333333333469999999999999999999999  5699999999999999999999999999976


Q ss_pred             cccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccccC-CCccchhhhchhhhhcCCC
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITN-VDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~  575 (593)
                      ......  .......||+.|+|||++. +.++.++||||||+++|+..+.. ++..+......++.+..|.
T Consensus       163 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~  231 (285)
T d1fmka3         163 IEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY  231 (285)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             ccCCCc--eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence            432221  1223356899999999874 46889999999999999877643 4444444444455555443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=7.1e-22  Score=197.78  Aligned_cols=143  Identities=24%  Similarity=0.329  Sum_probs=97.4

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.  +.++.+... ...++++..++.++.|+++||+|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus        82 ~~iv~E~~~~--g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          82 VWIIMELCTL--GELRSFLQV-RKYSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             CEEEEECCTT--EEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEEEeccC--CcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheeecCCCcEEEccchhhe
Confidence            3566666543  344444333 34579999999999999999999999  669999999999999999999999999998


Q ss_pred             ecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      .......  .......||+.|||||++. ..++.++|||||||++|+..+ ...|..+.....-++.+..|.
T Consensus       157 ~~~~~~~--~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~  226 (273)
T d1mp8a_         157 YMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE  226 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             eccCCcc--eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence            6443221  1223456899999999885 457889999999999998765 566776655544444444443

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.83  E-value=2.9e-22  Score=203.56  Aligned_cols=125  Identities=26%  Similarity=0.404  Sum_probs=97.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCccc
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMP  528 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~a  528 (593)
                      ...+++..++.|+.|+|.||+|||+  ++++||||||+|||++.++.+||+|||+++....... ........||+.|||
T Consensus       134 ~~~l~~~~~~~i~~qi~~gl~ylH~--~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~a  210 (301)
T d1lufa_         134 PPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMP  210 (301)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCC
T ss_pred             CCCCCHHHHHHHHHHHHHHhhhccc--CCeEeeEEcccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCC
Confidence            3469999999999999999999998  6699999999999999999999999999875432221 112234578999999


Q ss_pred             ccccCC-cCCcccceecchhhhhcccccC-CCccchhhhchhhhhcCCCC
Q psy9535         529 PEAMHC-QISTKTDVFSYGAQIKTQHITN-VDIADRERYYSLQTMLPGHH  576 (593)
Q Consensus       529 PE~~~~-~~~~ksDvwS~G~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~  576 (593)
                      ||.+.+ .++.++|||||||++|+..+.. .|..+..+..-++.+..|..
T Consensus       211 PE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~  260 (301)
T d1lufa_         211 PESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI  260 (301)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred             HHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCC
Confidence            998754 5889999999999999876653 56666666555666666653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=4.7e-22  Score=201.69  Aligned_cols=130  Identities=20%  Similarity=0.250  Sum_probs=101.9

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++...   .++..........+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        77 ~iv~e~~~~---~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~  151 (298)
T d1gz8a_          77 YLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARA  151 (298)
T ss_dssp             EEEEECCSE---EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred             eEEEeecCC---chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc--CCEEccccCchheeecccCcceeccCCccee
Confidence            566665433   33444444455679999999999999999999999  5699999999999999999999999999876


Q ss_pred             cccCCccccccccccCCCCcccccccCC-c-CCcccceecchhhhhcccccCCCccchhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC-Q-ISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      ......   ......||+.|+|||++.. . .+.++|||||||++|+..++..|+.+..+
T Consensus       152 ~~~~~~---~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~  208 (298)
T d1gz8a_         152 FGVPVR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE  208 (298)
T ss_dssp             HCCCSB---CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccCCcc---cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH
Confidence            433221   1234579999999997643 3 47899999999999998888888765443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=5e-21  Score=198.52  Aligned_cols=135  Identities=24%  Similarity=0.261  Sum_probs=102.8

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC-ceEEEecccce
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFGIVK  505 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~-~~kl~DfG~~~  505 (593)
                      ++++++...+........ .....++++.++..++.|++.||+|||+  ++|+||||||+|||++.++ .+||+|||+++
T Consensus        95 ~lv~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~--~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHh--cCCcccCCCcceEEEecCCCceeEecccchh
Confidence            467777654433333222 2234579999999999999999999998  6699999999999999775 89999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhhchh
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERYYSL  568 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~  568 (593)
                      ......    ......||+.|+|||.+.+  .++.++||||+||++|+..+...|+........+
T Consensus       172 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l  232 (350)
T d1q5ka_         172 QLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL  232 (350)
T ss_dssp             ECCTTS----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred             hccCCc----ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH
Confidence            654322    1233579999999997643  4788999999999999988888877665544333

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=4.5e-21  Score=190.45  Aligned_cols=143  Identities=20%  Similarity=0.312  Sum_probs=106.0

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++.+.+  .+..+.... ...+++..+..++.|+|.||+|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        74 ~~iv~Ey~~~g--~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          74 IFIITEYMANG--CLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             EEEEEECCTTE--EHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             eEEEEEccCCC--cHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhhe
Confidence            35666665433  344443332 3468999999999999999999998  669999999999999999999999999997


Q ss_pred             ecccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCCC
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPGH  575 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~  575 (593)
                      ........  ......||+.|||||++. ..++.++|||||||++|+..+ +..|+.+.......+.+..|.
T Consensus       149 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~  218 (258)
T d1k2pa_         149 YVLDDEYT--SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL  218 (258)
T ss_dssp             BCSSSSCC--CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             eccCCCce--eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC
Confidence            54432221  122356899999999875 457889999999999998665 567766655444444444443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=1.8e-21  Score=199.60  Aligned_cols=153  Identities=20%  Similarity=0.250  Sum_probs=118.0

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC--CCceEEEeccc
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--NFVPKLGDFGI  503 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~--~~~~kl~DfG~  503 (593)
                      ..+++++-+.  .+|+.++... ..++++.+...|+.||+.||+|||+  ++|+||||||+|||++.  ...+||+|||+
T Consensus        76 ~~lvmE~~~g--g~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~DFG~  150 (321)
T d1tkia_          76 LVMIFEFISG--LDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             EEEEECCCCC--CBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             EEEEEecCCC--CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcccch
Confidence            3566665432  3677666543 3479999999999999999999998  66999999999999985  45899999999


Q ss_pred             ceecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhchhhhhcCCCCCCCeEE
Q psy9535         504 VKMSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTMLPGHHEGDHVS  582 (593)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (593)
                      ++......    ......||+.|+|||.+.+ .++.++||||+||++|+.+++..|+.+....-.+...+.+...++...
T Consensus       151 ~~~~~~~~----~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  226 (321)
T d1tkia_         151 ARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA  226 (321)
T ss_dssp             CEECCTTC----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             hhccccCC----cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh
Confidence            88654322    1233568999999998755 478899999999999999999999888776666666666766666555


Q ss_pred             Eeecc
Q psy9535         583 ISNHS  587 (593)
Q Consensus       583 ~~~~~  587 (593)
                      |+++|
T Consensus       227 ~~~~s  231 (321)
T d1tkia_         227 FKEIS  231 (321)
T ss_dssp             HTTSC
T ss_pred             ccCCC
Confidence            55544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=4.5e-21  Score=198.42  Aligned_cols=123  Identities=24%  Similarity=0.411  Sum_probs=99.5

Q ss_pred             hhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccc
Q psy9535         437 QCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMY  516 (593)
Q Consensus       437 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~  516 (593)
                      ...|+.++..   ..+++.....++.|++.||+|||+  ++|+||||||+||||+.++.+||+|||+++...........
T Consensus        94 ~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~--~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~  168 (345)
T d1pmea_          94 GADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF  168 (345)
T ss_dssp             CEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCT
T ss_pred             CCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcccee
Confidence            3566666654   259999999999999999999999  56999999999999999999999999998765433322223


Q ss_pred             cccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhh
Q psy9535         517 TENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRER  564 (593)
Q Consensus       517 ~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~  564 (593)
                      ....+||+.|+|||++..  .++.++||||+||++|+..+...|+.+.++
T Consensus       169 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~  218 (345)
T d1pmea_         169 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY  218 (345)
T ss_dssp             TCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             eccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence            345679999999998743  357899999999999998888888766543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=7e-21  Score=193.09  Aligned_cols=122  Identities=28%  Similarity=0.336  Sum_probs=97.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP  529 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aP  529 (593)
                      ..+++.+++.++.|+|.||+|||+  ++|+||||||+|||++.++.+||+|||+++........ .......||+.|+||
T Consensus       130 ~~l~~~~~~~~~~qi~~al~ylH~--~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aP  206 (299)
T d1fgka_         130 EQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAP  206 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHhhh--CCEEeeeecccceeecCCCCeEeccchhhccccccccc-cccccCCCChhhhhh
Confidence            468999999999999999999999  56999999999999999999999999998865433221 122345689999999


Q ss_pred             cccC-CcCCcccceecchhhhhcccc-cCCCccchhhhchhhhhcCC
Q psy9535         530 EAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIADRERYYSLQTMLPG  574 (593)
Q Consensus       530 E~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~~~~~~~~~~~~~~  574 (593)
                      |.+. +.++.++|||||||++|+.+. +..|..+....--++.+..|
T Consensus       207 E~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~  253 (299)
T d1fgka_         207 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG  253 (299)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             hHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC
Confidence            9874 468999999999999998765 56676655554444555444

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.81  E-value=9.4e-21  Score=191.57  Aligned_cols=128  Identities=21%  Similarity=0.231  Sum_probs=98.6

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecC-----CCceEEEec
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGDF  501 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~-----~~~~kl~Df  501 (593)
                      ++++++-   ...+...... ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.     .+.+||+||
T Consensus        77 ~~vme~~---~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          77 VLVIDLL---GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             EEEEECC---CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             EEEEEec---CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCceEEccc
Confidence            4555543   2344444443 33579999999999999999999999  56999999999999964     578999999


Q ss_pred             ccceecccCCcc----ccccccccCCCCcccccccCCc-CCcccceecchhhhhcccccCCCcc
Q psy9535         502 GIVKMSETSNVK----TMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIA  560 (593)
Q Consensus       502 G~~~~~~~~~~~----~~~~~~~~Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~  560 (593)
                      |+++........    .......+||+.|||||++.+. ++.++||||||+++|+.++...|..
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~  214 (293)
T d1csna_         151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ  214 (293)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence            999865432111    1123346799999999988654 7889999999999999888777775

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=4.4e-21  Score=190.95  Aligned_cols=125  Identities=27%  Similarity=0.412  Sum_probs=92.4

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+.+  .|..++...+..++++..++.++.|||.||+|||+  ++|+||||||+|||++.++.+|++|||+++.
T Consensus        77 ~lv~ey~~~g--~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~  152 (262)
T d1byga_          77 YIVTEYMAKG--SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  152 (262)
T ss_dssp             EEEECCCTTE--EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             EEEEeccCCC--CHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeeccccccee
Confidence            5677665443  44444433333468999999999999999999998  6699999999999999999999999999885


Q ss_pred             cccCCccccccccccCCCCcccccccC-CcCCcccceecchhhhhcccc-cCCCccc
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHI-TNVDIAD  561 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~-~~~~~~~  561 (593)
                      ....      .....||+.|||||++. +.++.++||||||+++|+..+ ..+|...
T Consensus       153 ~~~~------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~  203 (262)
T d1byga_         153 ASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  203 (262)
T ss_dssp             ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred             cCCC------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence            4321      22346899999999874 568899999999999998765 4555443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=3.8e-21  Score=196.49  Aligned_cols=138  Identities=23%  Similarity=0.285  Sum_probs=102.9

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+..   ++... ......+++.....++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~iv~e~~~~~---~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          93 YLVFDFCEHD---LAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             EEEEECCCEE---HHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEeccCCC---ccchh-hhcccccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheeecCCCcEEeeecceeee
Confidence            4566654433   22222 2234568999999999999999999999  5699999999999999999999999999875


Q ss_pred             cccCCc-cccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhhchhhh
Q psy9535         507 SETSNV-KTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQT  570 (593)
Q Consensus       507 ~~~~~~-~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~  570 (593)
                      ...... ........+||+.|+|||++.+  .++.++||||+||++|+..+...|+.+......++.
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~  233 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL  233 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH
Confidence            443221 1112234579999999998754  468899999999999998888888876555444433

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.80  E-value=1.3e-20  Score=190.87  Aligned_cols=111  Identities=24%  Similarity=0.305  Sum_probs=90.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeec---CCCceEEEecccceecccCCcc----cccccccc
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNVK----TMYTENLT  521 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~---~~~~~kl~DfG~~~~~~~~~~~----~~~~~~~~  521 (593)
                      ...+++..+..++.|++.||+|||+  ++|+||||||+|||++   .+..+||+|||+++........    ........
T Consensus        97 ~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~  174 (299)
T d1ckia_          97 SRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT  174 (299)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCC
T ss_pred             cCCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcC
Confidence            4579999999999999999999999  5699999999999975   3557999999999865432211    11223467


Q ss_pred             CCCCcccccccCCc-CCcccceecchhhhhcccccCCCccc
Q psy9535         522 GTRPYMPPEAMHCQ-ISTKTDVFSYGAQIKTQHITNVDIAD  561 (593)
Q Consensus       522 Gt~~y~aPE~~~~~-~~~ksDvwS~G~~i~~~~~~~~~~~~  561 (593)
                      ||+.|||||++.+. ++.++|||||||++|+..+...|..+
T Consensus       175 gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~  215 (299)
T d1ckia_         175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG  215 (299)
T ss_dssp             CCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccc
Confidence            99999999987654 78999999999999998777777654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.80  E-value=4.9e-21  Score=192.73  Aligned_cols=112  Identities=21%  Similarity=0.269  Sum_probs=90.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCccc
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMP  528 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~a  528 (593)
                      .+.+++.....++.|++.||+|||+  .+|+||||||+|||++.++.+|++|||.+........   ......|++.|+|
T Consensus        94 ~~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~~y~~  168 (286)
T d1ob3a_          94 EGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---KYTHEIVTLWYRA  168 (286)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------------CCCTTCC
T ss_pred             cCCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeEcCCCCEEecccccceecccCcc---ccceecccchhhh
Confidence            4679999999999999999999998  5699999999999999999999999999875433211   2233468999999


Q ss_pred             ccccCC--cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         529 PEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       529 PE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ||.+.+  .++.++|||||||++|+...+..|+.+..+.
T Consensus       169 pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~  207 (286)
T d1ob3a_         169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA  207 (286)
T ss_dssp             HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             HHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH
Confidence            998754  3588999999999999999888888765443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=3e-20  Score=192.13  Aligned_cols=125  Identities=22%  Similarity=0.366  Sum_probs=99.7

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      ++++++...   .+......   .++++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+|++|||+++.
T Consensus        99 ~lv~e~~~~---~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          99 YLVMPFMGT---DLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             EEEEECCSE---EHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecccc---cHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhcccccccccccccceec
Confidence            466666532   33333332   469999999999999999999999  5699999999999999999999999999986


Q ss_pred             cccCCccccccccccCCCCcccccccCC--cCCcccceecchhhhhcccccCCCccchhhh
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRERY  565 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~  565 (593)
                      ....      .....||+.|+|||++.+  .++.++||||+||++|+..+...|+.+.+..
T Consensus       171 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~  225 (346)
T d1cm8a_         171 ADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL  225 (346)
T ss_dssp             CCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cCCc------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH
Confidence            4321      233579999999998743  3578999999999999988888887665443

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=1.6e-20  Score=191.45  Aligned_cols=132  Identities=23%  Similarity=0.361  Sum_probs=99.8

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      ..+++++-+.+  .+..+... ....+++..++.++.|+|.||.|||+  ++|+||||||+||||++++.+||+|||+++
T Consensus       104 ~~lv~E~~~~g--~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~~~  178 (311)
T d1r0pa_         104 PLVVLPYMKHG--DLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLAR  178 (311)
T ss_dssp             EEEEEECCTTC--BHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGGGC
T ss_pred             eEEEEEEeecC--chhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccchh
Confidence            45677665443  44444432 34568889999999999999999998  669999999999999999999999999998


Q ss_pred             ecccCCcc-ccccccccCCCCcccccccC-CcCCcccceecchhhhhcccccCCCccch
Q psy9535         506 MSETSNVK-TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       506 ~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      ........ ........||+.|+|||.+. +.++.++||||||+++|+..+...|....
T Consensus       179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~  237 (311)
T d1r0pa_         179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  237 (311)
T ss_dssp             CTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred             hccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence            65432221 11223356899999999874 46889999999999999877655555443

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=2.9e-20  Score=189.35  Aligned_cols=121  Identities=26%  Similarity=0.362  Sum_probs=93.7

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcc
Q psy9535         448 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYM  527 (593)
Q Consensus       448 ~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~  527 (593)
                      ....|++.+++.++.|||.||.|||+  ++|+||||||+|||++.++.+||+|||+++......    ......||+.|+
T Consensus       120 ~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~  193 (309)
T d1fvra_         120 TASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWM  193 (309)
T ss_dssp             BSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC----CC----CCTTTC
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceEEEcCCCceEEccccccccccccc----cccceecCCccc
Confidence            34679999999999999999999999  669999999999999999999999999987543221    122346899999


Q ss_pred             cccccC-CcCCcccceecchhhhhcccccC-CCccchhhhchhhhhcCC
Q psy9535         528 PPEAMH-CQISTKTDVFSYGAQIKTQHITN-VDIADRERYYSLQTMLPG  574 (593)
Q Consensus       528 aPE~~~-~~~~~ksDvwS~G~~i~~~~~~~-~~~~~~~~~~~~~~~~~~  574 (593)
                      |||.+. +.++.++|||||||++|+..+.. +|..+.....-++.+..|
T Consensus       194 aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~  242 (309)
T d1fvra_         194 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  242 (309)
T ss_dssp             CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             chHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence            999874 45788999999999999876644 456555444444444444

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=4.1e-20  Score=188.21  Aligned_cols=124  Identities=22%  Similarity=0.342  Sum_probs=97.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCcccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMPP  529 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~aP  529 (593)
                      ..+++..+..++.|+|.||.|||+  ++|+||||||+|||++.++.+||+|||+++....... ........||+.||||
T Consensus       128 ~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aP  204 (308)
T d1p4oa_         128 APPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSP  204 (308)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceeecCCceEEEeecccceeccCCcc-eeeccceecccccCCH
Confidence            468999999999999999999998  6699999999999999999999999999986543222 1223345689999999


Q ss_pred             cccCC-cCCcccceecchhhhhccccc-CCCccchhhhchhhhhcCCCC
Q psy9535         530 EAMHC-QISTKTDVFSYGAQIKTQHIT-NVDIADRERYYSLQTMLPGHH  576 (593)
Q Consensus       530 E~~~~-~~~~ksDvwS~G~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~  576 (593)
                      |.+.+ .++.++||||||+++|+..+. ..|..+......++.+..|..
T Consensus       205 e~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~  253 (308)
T d1p4oa_         205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  253 (308)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             HHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence            98754 478899999999999986654 366666655555665555543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=6e-20  Score=188.11  Aligned_cols=138  Identities=25%  Similarity=0.237  Sum_probs=103.9

Q ss_pred             eEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEeccccee
Q psy9535         427 VIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  506 (593)
Q Consensus       427 v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~  506 (593)
                      .+++++.+  .++|+..+...  +.+++.....++.|++.||+|||+  ++|+||||||+||||+.++.+||+|||+++.
T Consensus       105 ~~v~e~~~--~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         105 HLILDYIN--GGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEECCCC--SCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeccc--ccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            34444432  24555555544  357788999999999999999999  5699999999999999999999999999876


Q ss_pred             cccCCccccccccccCCCCcccccccCC---cCCcccceecchhhhhcccccCCCccchhhhchhhhhc
Q psy9535         507 SETSNVKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQTML  572 (593)
Q Consensus       507 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~~~~  572 (593)
                      .....  ........|++.|+|||.+.+   .++.++|||||||++|+..+...|+.+....-.++.+.
T Consensus       179 ~~~~~--~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~  245 (322)
T d1vzoa_         179 FVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS  245 (322)
T ss_dssp             CCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred             hcccc--cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            53322  122334579999999998754   25779999999999999888888887766554444433

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=5.9e-20  Score=187.19  Aligned_cols=108  Identities=27%  Similarity=0.414  Sum_probs=88.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCccc
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMP  528 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~a  528 (593)
                      ..++++..+..++.|||.||+|||+  ++++||||||+|||++.++.+|++|||+++....... ........||+.|+|
T Consensus       139 ~~~l~~~~~~~~~~qi~~gl~~LH~--~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~a  215 (311)
T d1t46a_         139 ELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMA  215 (311)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccccccccccccCcccccccchheeccCCCc-ceEeeecccChHHcC
Confidence            3469999999999999999999999  5699999999999999999999999999986543222 122334578999999


Q ss_pred             ccccC-CcCCcccceecchhhhhcccccCCCc
Q psy9535         529 PEAMH-CQISTKTDVFSYGAQIKTQHITNVDI  559 (593)
Q Consensus       529 PE~~~-~~~~~ksDvwS~G~~i~~~~~~~~~~  559 (593)
                      ||++. +.++.++|||||||++|+.++...|.
T Consensus       216 PE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         216 PESIFNCVYTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             HHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence            99875 45788999999999999876544443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.75  E-value=2.2e-19  Score=184.03  Aligned_cols=108  Identities=22%  Similarity=0.305  Sum_probs=89.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC-ceEEEecccceecccCCccccccccccCCCCccc
Q psy9535         450 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMP  528 (593)
Q Consensus       450 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~a  528 (593)
                      ..+++..+..++.||+.||+|||+  ++|+||||||+|||++.++ .+||+|||+++......    ......||+.|+|
T Consensus       124 ~~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~----~~~~~~~t~~y~a  197 (328)
T d3bqca1         124 QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKG  197 (328)
T ss_dssp             TSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC----CCCSCCSCGGGCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcCCCCeeeecccccceeccCCC----cccccccCccccC
Confidence            369999999999999999999999  5699999999999998654 69999999998654322    1234578999999


Q ss_pred             ccccCC--cCCcccceecchhhhhcccccCCCccchh
Q psy9535         529 PEAMHC--QISTKTDVFSYGAQIKTQHITNVDIADRE  563 (593)
Q Consensus       529 PE~~~~--~~~~ksDvwS~G~~i~~~~~~~~~~~~~~  563 (593)
                      ||.+.+  .++.++||||+||++|+...+..|+....
T Consensus       198 PE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~  234 (328)
T d3bqca1         198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  234 (328)
T ss_dssp             HHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence            998644  36889999999999999888888876544

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.73  E-value=4.1e-19  Score=183.38  Aligned_cols=121  Identities=23%  Similarity=0.376  Sum_probs=94.4

Q ss_pred             hhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCcccccc
Q psy9535         438 CQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYT  517 (593)
Q Consensus       438 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~  517 (593)
                      +.|..++..   ..+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+|++|||++.....      ..
T Consensus       107 g~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~------~~  175 (348)
T d2gfsa1         107 ADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD------EM  175 (348)
T ss_dssp             EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCC----CCTG------GG
T ss_pred             Cchhhhccc---ccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCccccccccccccccccchhcccCc------cc
Confidence            456666532   469999999999999999999999  5699999999999999999999999999864322      12


Q ss_pred             ccccCCCCcccccccCC-c-CCcccceecchhhhhcccccCCCccchhhhchhh
Q psy9535         518 ENLTGTRPYMPPEAMHC-Q-ISTKTDVFSYGAQIKTQHITNVDIADRERYYSLQ  569 (593)
Q Consensus       518 ~~~~Gt~~y~aPE~~~~-~-~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~~~  569 (593)
                      ....||+.|+|||++.+ . ++.++|||||||++|+..+...|+.+......++
T Consensus       176 ~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~  229 (348)
T d2gfsa1         176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK  229 (348)
T ss_dssp             SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence            34578999999997644 3 5789999999999999888888877665543333

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.73  E-value=1.1e-18  Score=175.35  Aligned_cols=106  Identities=25%  Similarity=0.335  Sum_probs=88.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCccc
Q psy9535         449 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMP  528 (593)
Q Consensus       449 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~a  528 (593)
                      .+.+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||.++.......   ......+++.|+|
T Consensus        95 ~~~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~---~~~~~~~~~~~~~  169 (292)
T d1unla_          95 NGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR---CYSAEVVTLWYRP  169 (292)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS---CCCSCCSCGGGCC
T ss_pred             ccccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCcccccccCCceeeeecchhhcccCCCc---cceeeccccchhh
Confidence            3578999999999999999999999  5699999999999999999999999999986543221   1223457888999


Q ss_pred             ccccCCc--CCcccceecchhhhhcccccCCCc
Q psy9535         529 PEAMHCQ--ISTKTDVFSYGAQIKTQHITNVDI  559 (593)
Q Consensus       529 PE~~~~~--~~~ksDvwS~G~~i~~~~~~~~~~  559 (593)
                      ||++...  ++.++|||||||++|+..+...|+
T Consensus       170 pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  202 (292)
T d1unla_         170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_dssp             HHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred             hhHhccCCCCCchhhccccchHHHHHhhCCCCC
Confidence            9987543  578999999999999988777764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.73  E-value=1.2e-18  Score=180.76  Aligned_cols=129  Identities=22%  Similarity=0.329  Sum_probs=94.9

Q ss_pred             ceEeecCCchhhhhHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccce
Q psy9535         426 PVIILDTGETKQCQLFKLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  505 (593)
Q Consensus       426 ~v~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~  505 (593)
                      .++++++-..   .++....    ..+++.....++.|++.||+|||+  .+|+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~---~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDA---NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSE---EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccch---HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhh--cccccccCCccccccccccceeeechhhhh
Confidence            4566665433   3333332    358999999999999999999999  569999999999999999999999999987


Q ss_pred             ecccCCccccccccccCCCCcccccccCC-cCCcccceecchhhhhcccccCCCccchhhhch
Q psy9535         506 MSETSNVKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGAQIKTQHITNVDIADRERYYS  567 (593)
Q Consensus       506 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~ksDvwS~G~~i~~~~~~~~~~~~~~~~~~  567 (593)
                      ......    .....+||+.|+|||++.+ .++.++||||+||++++.++...|+.+.++...
T Consensus       168 ~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~  226 (355)
T d2b1pa1         168 TAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ  226 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             cccccc----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH
Confidence            543321    2234578999999998855 478899999999999999988888876654443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.66  E-value=1.8e-17  Score=171.57  Aligned_cols=112  Identities=21%  Similarity=0.218  Sum_probs=88.4

Q ss_pred             HhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCC------ceEEEecccceecccCCcccccc
Q psy9535         444 ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF------VPKLGDFGIVKMSETSNVKTMYT  517 (593)
Q Consensus       444 ~~~~~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~------~~kl~DfG~~~~~~~~~~~~~~~  517 (593)
                      ........+++..+..++.|++.||+|||+ ..+|+||||||+||||+.++      .++++|||.++.....      .
T Consensus       114 ~~~~~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~------~  186 (362)
T d1q8ya_         114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH------Y  186 (362)
T ss_dssp             HHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC------C
T ss_pred             cccccccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeeeccCcccccceeeEeecccccccccc------c
Confidence            334455678999999999999999999996 24599999999999997654      3899999998754321      2


Q ss_pred             ccccCCCCcccccccC-CcCCcccceecchhhhhcccccCCCccch
Q psy9535         518 ENLTGTRPYMPPEAMH-CQISTKTDVFSYGAQIKTQHITNVDIADR  562 (593)
Q Consensus       518 ~~~~Gt~~y~aPE~~~-~~~~~ksDvwS~G~~i~~~~~~~~~~~~~  562 (593)
                      ...+||+.|+|||++. ..++.++||||+||++++..+.-.|+...
T Consensus       187 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence            3357999999999864 45788999999999999887777776543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.08  E-value=4.2e-12  Score=118.78  Aligned_cols=85  Identities=16%  Similarity=0.096  Sum_probs=61.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcEeecCCCceEEEecccceecccCCccccccccccCCCCccc---
Q psy9535         452 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNVKTMYTENLTGTRPYMP---  528 (593)
Q Consensus       452 l~~~~~~~i~~~ia~gl~ylH~~~~~iiHrdlKp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~Gt~~y~a---  528 (593)
                      ++......++.|++.||+|||+  ++|+||||||+|||+++++ ++|+|||.++........           .|..   
T Consensus       100 l~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~-----------~~l~rd~  165 (191)
T d1zara2         100 VRVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWR-----------EILERDV  165 (191)
T ss_dssp             CCCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTHH-----------HHHHHHH
T ss_pred             hhhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhheeeeCCC-EEEEECCCcccCCCCCcH-----------HHHHHHH
Confidence            4455667899999999999999  5699999999999999764 889999998754322111           1111   


Q ss_pred             ---ccccCCcCCcccceecchhhhh
Q psy9535         529 ---PEAMHCQISTKTDVFSYGAQIK  550 (593)
Q Consensus       529 ---PE~~~~~~~~ksDvwS~G~~i~  550 (593)
                         .+.+...++.++|+||..-.++
T Consensus       166 ~~~~~~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         166 RNIITYFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             HHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCcccHHHHHHHHh
Confidence               1223345788999999875443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.81  E-value=5.6e-05  Score=72.11  Aligned_cols=128  Identities=13%  Similarity=0.094  Sum_probs=77.9

Q ss_pred             ceEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC-CCceeeEEEEEec-ccceEEEEec
Q psy9535         122 FGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGLCNN-IMNCIVYEYM  199 (593)
Q Consensus       122 fG~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~-HpNIv~l~g~~~~-~~~~lV~Ey~  199 (593)
                      -+.||+... +++.+.+|+.........             ..+.+|...+..+. +--+.+++.++.+ +..++||+++
T Consensus        27 ~~~v~rv~~-~~~~~vlk~~~~~~~~~~-------------~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l   92 (263)
T d1j7la_          27 PAKVYKLVG-ENENLYLKMTDSRYKGTT-------------YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             SSEEEEEEC-SSCEEEEEEECGGGTTST-------------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             CCcEEEEEe-CCCeEEEEEcCCCcccch-------------hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence            468998764 456678888754321111             02567888776653 4335667777654 4568999999


Q ss_pred             cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q psy9535         200 CNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL----------------------------------------  239 (593)
Q Consensus       200 ~~GsL~~~L~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------  239 (593)
                      ++.++.+.....     .   ....++.++++.+.-||+.                                        
T Consensus        93 ~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T d1j7la_          93 DGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             SSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred             cccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence            988875433110     0   0111233333333333321                                        


Q ss_pred             -------------C---C-CeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         240 -------------S---K-PIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       240 -------------~---~-~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                                   .   . .++|+|+.|.|||++++...-|.||+.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                         0   1 279999999999999877777999997654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.33  E-value=0.00032  Score=66.22  Aligned_cols=140  Identities=19%  Similarity=0.196  Sum_probs=78.4

Q ss_pred             cccccCc-eEEEEEEEcCCCEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCC--CCceeeEEEEEec-cc
Q psy9535         116 KLGEGQF-GTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--HVNLLRLLGLCNN-IM  191 (593)
Q Consensus       116 ~LG~G~f-G~Vy~g~~~~g~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~--HpNIv~l~g~~~~-~~  191 (593)
                      .+..|.. +.||+....+|..+.+|.-....    ..            .+..|...++.+.  .-.+.++++++.+ +.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~------------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~   80 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LN------------ELQDEAARLSWLATTGVPCAAVLDVVTEAGR   80 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TS------------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC----Hh------------HHHHHHHHHHHHHhcCCCCCceeeecccccc
Confidence            3445543 57999887777778888754321    00            2456777666553  3345667777665 45


Q ss_pred             ceEEEEeccCCCHHH--------------HHhhcCC----CCCC--CHHHHHHHH--------------------HHHHH
Q psy9535         192 NCIVYEYMCNGSLYD--------------RLARVNN----TPPL--DSNKRYSIA--------------------LGVAE  231 (593)
Q Consensus       192 ~~lV~Ey~~~GsL~~--------------~L~~~~~----~~~l--~~~~~~~i~--------------------~~ia~  231 (593)
                      .++||+|++|-++.+              .|.+...    ..++  .+.....-.                    .....
T Consensus        81 ~~~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (255)
T d1nd4a_          81 DWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  160 (255)
T ss_dssp             EEEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             eEEEEEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence            689999998765521              1111100    0011  111111000                    01122


Q ss_pred             HHHHHhcC----CC-CeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         232 ALHYLHSL----SK-PIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       232 gL~yLH~~----~~-~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .+..+...    .. .++|+|+.|.|||++.+..+-|.||+.+..
T Consensus       161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            23333321    11 289999999999999877778999997643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.14  E-value=0.0013  Score=66.77  Aligned_cols=82  Identities=16%  Similarity=0.063  Sum_probs=46.8

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEeecCCCCC-CCCCchhHHhhhcHHHHHHHHHHHhcCC---CCceeeEEEEEec
Q psy9535         115 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYS-SSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLLRLLGLCNN  189 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~l~~~~~~~-~~~~~~~~~~~~~~~~f~~Ev~il~~l~---HpNIv~l~g~~~~  189 (593)
                      +.||.|....||+.... +|+.|.||.-....... .....       ...+...|...|+.+.   ...+.+++.+. .
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~-------~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-~  103 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPL-------TIDRARIESSALIRQGEHVPHLVPRVFYSD-T  103 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCC-------CTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-T
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCC-------CHHHHHHHHHHHHHhhhhCCCCcceEEEEc-C
Confidence            46899999999998765 46789999753321111 00000       0112345666665442   23566666654 4


Q ss_pred             ccceEEEEeccCCCH
Q psy9535         190 IMNCIVYEYMCNGSL  204 (593)
Q Consensus       190 ~~~~lV~Ey~~~GsL  204 (593)
                      ...++||||+.+..+
T Consensus       104 ~~~~lvmE~L~~~~~  118 (392)
T d2pula1         104 EMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTEEEECCCTTSEE
T ss_pred             CCCEEEEeccCCccc
Confidence            456899999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=94.99  E-value=0.023  Score=55.41  Aligned_cols=28  Identities=21%  Similarity=0.376  Sum_probs=22.7

Q ss_pred             CeEecccCCCCeeecCCCccEEeeccccee
Q psy9535         242 PIIHRDVKSANVLLDENFVPKLGDFGIVKM  271 (593)
Q Consensus       242 ~IiHrDLKp~NILl~~~~~~Kl~DFGla~~  271 (593)
                      .+||+|+.|.|||++++  ..+.||+-+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            49999999999999754  35889997653

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=93.20  E-value=0.063  Score=53.66  Aligned_cols=72  Identities=15%  Similarity=0.237  Sum_probs=43.8

Q ss_pred             CcccccCceEEEEEEEcCC--------CEEEEEEeecCCCCCCCCCchhHHhhhcHHHHHHHHHHHhcCCCCce-eeEEE
Q psy9535         115 NKLGEGQFGTVYYGKLKNG--------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL-LRLLG  185 (593)
Q Consensus       115 ~~LG~G~fG~Vy~g~~~~g--------~~vAVK~l~~~~~~~~~~~~~~~~~~~~~~~f~~Ev~il~~l~HpNI-v~l~g  185 (593)
                      +.|+-|---.+|+....++        ..|.++..- .    ...    .      ....+|..+++.+.-.++ .++++
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~----~~~----~------idr~~E~~i~~~ls~~gl~Pkll~  112 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N----PET----E------SHLVAESVIFTLLSERHLGPKLYG  112 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S----CCC----H------HHHHHHHHHHHHHHHTTSSSCEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C----cch----h------hHHHHHHHHHHHHHhCCCCCeEEE
Confidence            4677788889999886543        345555432 1    111    0      023467777777643344 47778


Q ss_pred             EEecccceEEEEeccCCCH
Q psy9535         186 LCNNIMNCIVYEYMCNGSL  204 (593)
Q Consensus       186 ~~~~~~~~lV~Ey~~~GsL  204 (593)
                      ++.+   .+|+||++|-+|
T Consensus       113 ~~~~---g~I~efi~g~~l  128 (395)
T d1nw1a_         113 IFSG---GRLEEYIPSRPL  128 (395)
T ss_dssp             EETT---EEEECCCCEEEC
T ss_pred             EcCC---ceEEEEeccccC
Confidence            7754   689999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=85.45  E-value=0.25  Score=47.07  Aligned_cols=30  Identities=27%  Similarity=0.278  Sum_probs=26.4

Q ss_pred             CCeEecccCCCCeeecCCCccEEeecccce
Q psy9535         241 KPIIHRDVKSANVLLDENFVPKLGDFGIVK  270 (593)
Q Consensus       241 ~~IiHrDLKp~NILl~~~~~~Kl~DFGla~  270 (593)
                      .++||+|+.+.|||++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            459999999999999988777899999764